PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ohlendorf, S; Sprenger, A; Speck, O; Haller, S; Kimmig, H				Ohlendorf, Sabine; Sprenger, Andreas; Speck, Oliver; Haller, Sven; Kimmig, Hubert			Optic Flow Stimuli in and Near the Visual Field Centre: A Group fMRI Study of Motion Sensitive Regions	PLOS ONE			English	Article								Motion stimuli in one visual hemifield activate human primary visual areas of the contralateral side, but suppress activity of the corresponding ipsilateral regions. While hemifield motion is rare in everyday life, motion in both hemifields occurs regularly whenever we move. Consequently, during motion primary visual regions should simultaneously receive excitatory and inhibitory inputs. A comparison of primary and higher visual cortex activations induced by bilateral and unilateral motion stimuli is missing up to now. Many motion studies focused on the MT+ complex in the parieto-occipito-temporal cortex. In single human subjects MT+ has been subdivided in area MT, which was activated by motion stimuli in the contralateral visual field, and area MST, which responded to motion in both the contra and ipsilateral field. In this study we investigated the cortical activation when excitatory and inhibitory inputs interfere with each other in primary visual regions and we present for the first time group results of the MT+ subregions, allowing for comparisons with the group results of other motion processing studies. Using functional magnetic resonance imaging (fMRI), we investigated whole brain activations in a large group of healthy humans by applying optic flow stimuli in and near the visual field centre and performed a second level analysis. Primary visual areas were activated exclusively by motion in the contralateral field but to our surprise not by central flow fields. Inhibitory inputs to primary visual regions appear to cancel simultaneously occurring excitatory inputs during central flow field stimulation. Within MT+ we identified two subregions. Putative area MST (pMST) was activated by ipsi- and contralateral stimulation and located in the anterior part of MT+. The second subregion was located in the more posterior part of MT+ (putative area MT, pMT).	Univ Freiburg Klinikum, Neurol Klin, Freiburg, Germany; [Sprenger, Andreas; Kimmig, Hubert] Universitatsklin Schleswig Holstein, Klin Neurol, Lubeck, Germany; [Ohlendorf, Sabine; Speck, Oliver] Universitatsklin, Abt Rontgendiagnost, Freiburg, Germany; [Speck, Oliver] Univ Magdeburg, Inst Expt Phys, Abt Biomedizin Magnetresonanz, Magdeburg, Germany; [Haller, Sven] Universitatssp, Abt Neuroradiol, Basel, Switzerland; [Ohlendorf, Sabine] Univ Freiburg, Fak Biol, Freiburg, Germany; [Kimmig, Hubert] Univ Freiburg, Acad Teaching Hosp, Schwarzwald Baar Klin, Villingen Schwenningen, Germany	University of Freiburg; University of Kiel; Schleswig Holstein University Hospital; Otto von Guericke University; University of Freiburg; University of Freiburg	Ohlendorf, S (corresponding author), Univ Freiburg Klinikum, Neurol Klin, Freiburg, Germany.	hubert.kimmig@neuro.uni-luebeck.de	Speck, Oliver/F-1406-2013; Sprenger, Andreas/C-7612-2009; Haller, Sven/AAY-2564-2020	Speck, Oliver/0000-0002-6019-5597; Sprenger, Andreas/0000-0001-9255-7911; Haller, Sven/0000-0001-7433-0203; Issa, Naoum Pierre/0000-0001-9247-1341	DFG [SFB654-A4]	DFG(German Research Foundation (DFG))	This study was performed as part of the binational PhD project of author SO (Universities of Freiburg, Germany and Basel, Switzerland) within the Eltem program of Neurex, the 13 Neuroscience network in the upper Rhine Valley. Author HK is currently supported by a grant from DFG (SFB654-A4).	Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; Brandt T, 2003, ANN NY ACAD SCI, V1004, P283, DOI 10.1196/annals.1303.025; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Huk AC, 2002, J NEUROSCI, V22, P7195; Kimmig H, 1999, EXP BRAIN RES, V126, P443, DOI 10.1007/s002210050751; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MARUYAMA M, 2007, HUM BRAIN MAPP; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nelles G, 2002, STROKE, V33, P1286, DOI 10.1161/01.STR.0000013685.76973.67; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Raiguel S, 1997, NEUROREPORT, V8, P2803, DOI 10.1097/00001756-199708180-00030; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; ZEKI S, 1991, J NEUROSCI, V11, P641	42	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4043	10.1371/journal.pone.0004043	http://dx.doi.org/10.1371/journal.pone.0004043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112507	Green Submitted, Green Published, gold			2022-12-27	WOS:000265466000010
J	Leimu, R; Fischer, M				Leimu, Roosa; Fischer, Markus			A Meta-Analysis of Local Adaptation in Plants	PLOS ONE			English	Article							POPULATION GENETIC CONSEQUENCES; PERENNIAL CARLINA-VULGARIS; HABITAT FRAGMENTATION; SIZE; DIFFERENTIATION; EVOLUTION; SELECTION; LIMITS	Local adaptation is of fundamental importance in evolutionary, population, conservation, and global-change biology. The generality of local adaptation in plants and whether and how it is influenced by specific species, population and habitat characteristics have, however, not been quantitatively reviewed. Therefore, we examined published data on the outcomes of reciprocal transplant experiments using two approaches. We conducted a meta-analysis to compare the performance of local and foreign plants at all transplant sites. In addition, we analysed frequencies of pairs of plant origin to examine whether local plants perform better than foreign plants at both compared transplant sites. In both approaches, we also examined the effects of population size, and of the habitat and species characteristics that are predicted to affect local adaptation. We show that, overall, local plants performed significantly better than foreign plants at their site of origin: this was found to be the case in 71.0% of the studied sites. However, local plants performed better than foreign plants at both sites of a pair-wise comparison (strict definition of local adaption) only in 45.3% of the 1032 compared population pairs. Furthermore, we found local adaptation much more common for large plant populations (>1000 flowering individuals) than for small populations (<1000 flowering individuals) for which local adaptation was very rare. The degree of local adaptation was independent of plant life history, spatial or temporal habitat heterogeneity, and geographic scale. Our results suggest that local adaptation is less common in plant populations than generally assumed. Moreover, our findings reinforce the fundamental importance of population size for evolutionary theory. The clear role of population size for the ability to evolve local adaptation raises considerable doubt on the ability of small plant populations to cope with changing environments.	[Leimu, Roosa; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Leimu, Roosa; Fischer, Markus] Univ Bern, Inst Plant Sci, CH-3012 Bern, Switzerland; [Leimu, Roosa] Univ Turku, Sect Ecol, SF-20500 Turku, Finland	University of Potsdam; University of Bern; University of Turku	Leimu, R (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	roosa.leimu@plants.ox.ac.uk	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	Marie Curie [Intra European fellowship]	Marie Curie(European Commission)	The study was funded by a Marie Curie Intra European fellowship to RL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; ANTONOVICS J, 1987, OECOLOGIA, V71, P601, DOI 10.1007/BF00379305; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Bowman G, 2008, J ECOL, V96, P1056, DOI 10.1111/j.1365-2745.2008.01417.x; Callaghan TV., 1996, ECOL B, V45, P133; Clausen J, 1941, AM NAT, V75, P231, DOI 10.1086/280955; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Hedges LV, 2014, STAT METHODS META AN; HILL WG, 1982, P NATL ACAD SCI-BIOL, V79, P142, DOI 10.1073/pnas.79.1.142; Jakobsson A, 2005, EVOL ECOL, V19, P449, DOI 10.1007/s10682-005-8830-0; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Knight TM, 2004, EVOL ECOL RES, V6, P103; Lande R., 1987, P87, DOI 10.1017/CBO9780511623400.007; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Light RJ, 1984, SUMMING SCI REVIEWIN; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; Pertoldi C, 2007, BIODIVERS CONSERV, V16, P4147, DOI 10.1007/s10531-007-9212-4; Provine W. B., 1986, SEWALL WRIGHT EVOLUT; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; SCHMID B, 1985, J ECOL, V73, P819, DOI 10.2307/2260149; Sokal R.R., 2012, BIOMETRY; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stearns S.C., 1992, pi; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; THOMPSON JN, 2005, LOCAL ADAPTATION, V1; Turesson G, 1925, HEREDITAS, V6, P147; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; WASER NM, 1985, AM J BOT, V72, P1726, DOI 10.2307/2443730; WEBER KE, 1990, GENETICS, V125, P585; Willi Y, 2007, J EVOLUTION BIOL, V20, P534, DOI 10.1111/j.1420-9101.2006.01263.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	44	673	684	5	333	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4010	10.1371/journal.pone.0004010	http://dx.doi.org/10.1371/journal.pone.0004010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104660	Green Published, Green Submitted, gold			2022-12-27	WOS:000265462400011
J	Milne, GJ; Kelso, JK; Kelly, HA; Huband, ST; McVernon, J				Milne, George J.; Kelso, Joel K.; Kelly, Heath A.; Huband, Simon T.; McVernon, Jodie			A Small Community Model for the Transmission of Infectious Diseases: Comparison of School Closure as an Intervention in Individual-Based Models of an Influenza Pandemic	PLOS ONE			English	Article							STRATEGIES; SPREAD	Background: In the absence of other evidence, modelling has been used extensively to help policy makers plan for a potential future influenza pandemic. Method: We have constructed an individual based model of a small community in the developed world with detail down to exact household structure obtained from census collection datasets and precise simulation of household demographics, movement within the community and individual contact patterns. We modelled the spread of pandemic influenza in this community and the effect on daily and final attack rates of four social distancing measures: school closure, increased case isolation, workplace non-attendance and community contact reduction. We compared the modelled results of final attack rates in the absence of any interventions and the effect of school closure as a single intervention with other published individual based models of pandemic influenza in the developed world. Results: We showed that published individual based models estimate similar final attack rates over a range of values for R-0 in a pandemic where no interventions have been implemented; that multiple social distancing measures applied early and continuously can be very effective in interrupting transmission of the pandemic virus for R-0 values up to 2.5; and that different conclusions reached on the simulated benefit of school closure in published models appear to result from differences in assumptions about the timing and duration of school closure and flow-on effects on other social contacts resulting from school closure. Conclusion: Models of the spread and control of pandemic influenza have the potential to assist policy makers with decisions about which control strategies to adopt. However, attention needs to be given by policy makers to the assumptions underpinning both the models and the control strategies examined.	[Milne, George J.; Kelso, Joel K.; Kelly, Heath A.; Huband, Simon T.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia; [Kelly, Heath A.] Victorian Infect Dis Reference Lab, Carlton, Vic, Australia; [Kelly, Heath A.; McVernon, Jodie] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia	University of Western Australia; Victorian Infectious Diseases Reference Laboratory; University of Melbourne	Milne, GJ (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	joel@csse.uwa.edu.au	Milne, George/C-6839-2013; Kelso, Joel/C-2433-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600; McVernon, Jodie/0000-0001-9774-1961	National Health and Medical Research Council, Australia [404189]; Commonwealth Department of Health and Ageing, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Department of Health and Ageing, Australia(Australian GovernmentDepartment of Health & Ageing)	Funding from the National Health and Medical Research Council, Australia (grant number 404189), and from the Commonwealth Department of Health and Ageing, Australia, is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ANDERSON R M, 1991; *AUSTR BUR STAT, 2001, 2001 CENS DAT LOC; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass K, 2007, EPIDEMIOLOGY, V18, P623, DOI 10.1097/EDE.0b013e31812713b4; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Papoulis A., 2002, PROBABILITY RANDOM V; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	31	107	110	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4005	10.1371/journal.pone.0004005	http://dx.doi.org/10.1371/journal.pone.0004005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104659	Green Published, gold			2022-12-27	WOS:000265462400006
J	Vukojevic, V; Ming, Y; D'Addario, C; Rigler, R; Johansson, B; Terenius, L				Vukojevic, Vladana; Ming, Yu; D'Addario, Claudio; Rigler, Rudolf; Johansson, Bjorn; Terenius, Lars			Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells	PLOS ONE			English	Article							LIPID-PROTEIN INTERACTIONS; PLASMA-MEMBRANE; ETHANOL; ALCOHOL; NALTREXONE; CHOLESTEROL; ANESTHETICS; SYSTEM; RAFTS; OLIGOMERIZATION	Background: Alcoholism is a widespread chronic disorder of complex aetiology with a significant negative impact on the individual and the society. Mechanisms of ethanol action are not sufficiently well understood at the molecular level and the pharmacotherapy of alcoholism is still in its infancy. Our study focuses at the cellular and molecular level on ethanol-induced effects that are mediated through the mu-opioid receptor ( MOP) and on the effects of naltrexone, a well-known antagonist at MOP that is used clinically to prevent relapse in alcoholism. Methodology/Principal Findings: Advanced fluorescence imaging by Confocal Laser Scanning Microscopy (CLSM) and Fluorescence Correlation Spectroscopy (FCS) are used to study ethanol effects on MOP and plasma membrane lipid dynamics in live PC12 cells. We observed that relevant concentrations of ethanol (10-40 mM) alter MOP mobility and surface density, and affect the dynamics of plasma membrane lipids. Compared to the action of specific ligands at MOP, ethanol-induced effects show complex kinetics and point to a biphasic underlying mechanism. Pretreatment with naloxone or naltrexone considerably mitigates the effects of ethanol. Conclusions/Significance: We suggest that ethanol acts by affecting the sorting of MOP at the plasma membrane of PC12 cells. Naltrexone exerts opposite effects on MOP sorting at the plasma membrane, thereby countering the effects of ethanol. Our experimental findings give new insight on MOP-mediated ethanol action at the cellular and molecular level. We suggest a new hypothesis to explain the well established ethanol-induced increase in the activity of the endogenous opioid system.	[Vukojevic, Vladana; Ming, Yu; D'Addario, Claudio; Johansson, Bjorn; Terenius, Lars] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Rigler, Rudolf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Rigler, Rudolf] Swiss Fed Inst Technol, Lab Biomed Opt, Lausanne, Switzerland	Karolinska Institutet; Karolinska Institutet; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vukojevic, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, CMM L8 01, Stockholm, Sweden.	vladana.vukojevic@ki.se	DAddario, Claudio/A-5970-2010; Vukojevic, Vladana B/AAY-3144-2021	Vukojevic, Vladana/0000-0003-0873-5653; d'addario, claudio/0000-0002-1275-098X	Swedish Research Council; AFA Insurance; Cancerdegradome; The Brain foundation; The Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance; Cancerdegradome; The Brain foundation; The Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Financial support from the Swedish Research Council, AFA Insurance, Cancerdegradome, The Brain foundation and The Knut and Alice Wallenberg Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bacia Kirsten, 2007, V398, P73, DOI 10.1007/978-1-59745-513-8_7; CHIOU JS, 1990, SCIENCE, V248, P583, DOI 10.1126/science.2159183; Coonfield DL, 2002, ALCOHOL, V26, P43, DOI 10.1016/S0741-8329(01)00180-X; D'Addario C, 2008, FASEB J, V22, P662, DOI 10.1096/fj.07-8346com; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Forman Stuart A., 1998, P5; FRASER DM, 1990, BIOCHEMISTRY-US, V29, P2664, DOI 10.1021/bi00463a007; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Grahame NJ, 1998, ALCOHOL CLIN EXP RES, V22, P1093, DOI 10.1111/j.1530-0277.1998.tb03706.x; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Griepernau B, 2007, BBA-BIOMEMBRANES, V1768, P2899, DOI 10.1016/j.bbamem.2007.08.002; Grisel JE, 1999, BRAIN RES, V835, P62, DOI 10.1016/S0006-8993(99)01384-0; Guizzetti M, 2007, HUM EXP TOXICOL, V26, P355, DOI 10.1177/0960327107078412; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Herz A, 1998, CAN J PHYSIOL PHARM, V76, P252, DOI 10.1139/cjpp-76-3-252; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Koenig HN, 2002, NEUROSCI LETT, V325, P75, DOI 10.1016/S0304-3940(02)00242-2; Lerner RA, 1997, P NATL ACAD SCI USA, V94, P13375, DOI 10.1073/pnas.94.25.13375; Levac BAR, 2002, CURR OPIN PHARMACOL, V2, P76, DOI 10.1016/S1471-4892(02)00124-8; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Saland LC, 2005, NEUROSCI LETT, V381, P163, DOI 10.1016/j.neulet.2005.02.016; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; SWIFT RM, 1995, J CLIN PSYCHIAT, V56, P24; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Terama E, 2008, J PHYS CHEM B, V112, P4131, DOI 10.1021/jp0750811; TOCANNE JF, 1994, CHEM PHYS LIPIDS, V73, P139, DOI 10.1016/0009-3084(94)90179-1; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Vukojevic V, 2008, FASEB J, V22, P3537, DOI 10.1096/fj.08-108894; Wallner M, 2006, PHARMACOL THERAPEUT, V112, P513, DOI 10.1016/j.pharmthera.2006.05.004	49	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4008	10.1371/journal.pone.0004008	http://dx.doi.org/10.1371/journal.pone.0004008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104662	gold, Green Published, Green Submitted			2022-12-27	WOS:000265462400009
J	Egeland, T; Salas, A				Egeland, Thore; Salas, Antonio			Estimating Haplotype Frequency and Coverage of Databases	PLOS ONE			English	Article							INTERNATIONAL-SOCIETY; FORENSIC-GENETICS; DNA COMMISSION; MTDNA; NUMBER; POPULATION; DIVERSITY; SAMPLE; ORIGIN; INDIVIDUALS	A variety of forensic, population, and disease studies are based on haploid DNA (e. g. mitochondrial DNA or Y-chromosome data). For any set of genetic markers databases of conventional size will normally contain only a fraction of all haplotypes. For several applications, reliable estimates of haplotype frequencies, the total number of haplotypes and coverage of the database (the probability that the next random haplotype is contained in the database) will be useful. We propose different approaches to the problem based on classical methods as well as new applications of Principal Component Analysis (PCA). We also discuss previous proposals based on saturation curves. Several conclusions can be inferred from simulated and real data. First, classical estimates of the fraction of unseen haplotypes can be seriously biased. Second, there is no obvious way to decide on required sample size based on traditional approaches. Methods based on testing of hypotheses or length of confidence intervals may appear artificial since no single test or parameter stands out as particularly relevant. Rather the coverage may be more relevant since it indicates the percentage of different haplotypes that are contained in a database; if the coverage is low, there is a considerable chance that the next haplotype to be observed does not appear in the database and this indicates that the database needs to be expanded. Finally, freeware and example data sets accompany the methods discussed in this paper: http://folk.uio.no/thoree/nhap/.	Univ Oslo, Inst Forens Med, Oslo, Norway; [Egeland, Thore] Oslo Univ Coll, Oslo, Norway; [Salas, Antonio] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain	University of Oslo; Oslo Metropolitan University (OsloMet); Universidade de Santiago de Compostela	Egeland, T (corresponding author), Univ Oslo, Inst Forens Med, Oslo, Norway.	thore.egeland@medisin.uio.no	Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X	Fundacion de Investigacion Medica Mutua Madrilena	Fundacion de Investigacion Medica Mutua Madrilena	Two grants from the Fundacion de Investigacion Medica Mutua Madrilena awarded to AS partially supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2005, STAT PRACT; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Carracedo A, 2000, FORENSIC SCI INT, V110, P79, DOI 10.1016/S0379-0738(00)00161-4; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2005, SPECIES RICHNESS EST; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Curran JM, 2002, SCI JUSTICE, V42, P29, DOI 10.1016/S1355-0306(02)71794-2; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.1093/biomet/63.3.435; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; ESTY WW, 1983, ANN STAT, V11, P905, DOI 10.1214/aos/1176346256; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gill P, 2001, FORENSIC SCI INT, V124, P5, DOI 10.1016/S0379-0738(01)00498-4; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAAS P, 1998, JASA, V63, P837; Haas PJ, 1998, J AM STAT ASSOC, V93, P1475, DOI 10.2307/2670061; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Huang SP, 2001, GENETICS, V159, P1365; Krawczak M, 2001, FORENSIC SCI INT, V118, P114, DOI 10.1016/S0379-0738(00)00479-5; Mao CX, 2004, J AM STAT ASSOC, V99, P1108, DOI 10.1198/016214504000001709; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; NORDBORG M, 2001, COALESCENT THEORY; Pereira L, 2004, INT J LEGAL MED, V118, P132, DOI 10.1007/s00414-003-0424-1; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Pfeiffer H, 2001, INT J LEGAL MED, V114, P169, DOI 10.1007/s004140000165; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Richards M, 1996, AM J HUM GENET, V59, P185; ROBBINS H, 1956, EMPIRICAL BAYES APPR, P92; Roewer L, 2001, FORENSIC SCI INT, V118, P106, DOI 10.1016/S0379-0738(00)00478-3; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; STARR N, 1979, ANN STAT, V7, P644, DOI 10.1214/aos/1176344684; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264	38	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3988	10.1371/journal.pone.0003988	http://dx.doi.org/10.1371/journal.pone.0003988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098988	gold, Green Published, Green Submitted			2022-12-27	WOS:000265462300001
J	Beaufays, J; Adam, B; Menten-Dedoyart, C; Fievez, L; Grosjean, A; Decrem, Y; Prevot, PP; Santini, S; Brasseur, R; Brossard, M; Vanhaeverbeek, M; Bureau, F; Heinen, E; Lins, L; Vanhamme, L; Godfroid, E				Beaufays, Jerome; Adam, Benoit; Menten-Dedoyart, Catherine; Fievez, Laurence; Grosjean, Amelie; Decrem, Yves; Prevot, Pierre-Paul; Santini, Sebastien; Brasseur, Robert; Brossard, Michel; Vanhaeverbeek, Michel; Bureau, Fabrice; Heinen, Ernst; Lins, Laurence; Vanhamme, Luc; Godfroid, Edmond			Ir-LBP, an Ixodes ricinus Tick Salivary LTB4-Binding Lipocalin, Interferes with Host Neutrophil Function	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; ENDOTHELIAL-CELLS; CHEMOTACTIC FACTOR; BINDING PROTEINS; MECHANISM; RELEASE; BLT1; HYPERADHESIVENESS; ACTIVATION; EVOLUTION	Background: During their blood meal, ticks secrete a wide variety of proteins that can interfere with their host's defense mechanisms. Among these proteins, lipocalins play a major role in the modulation of the inflammatory response. Methodology/Principal Findings: We previously identified 14 new lipocalin genes in the tick Ixodes ricinus. One of them codes for a protein that specifically binds leukotriene B4 with a very high affinity (Kd: +/- 1 nM), similar to that of the neutrophil transmembrane receptor BLT1. By in silico approaches, we modeled the 3D structure of the protein and the binding of LTB4 into the ligand pocket. This protein, called Ir-LBP, inhibits neutrophil chemotaxis in vitro and delays LTB4-induced apoptosis. Ir-LBP also inhibits the host inflammatory response in vivo by decreasing the number and activation of neutrophils located at the tick bite site. Thus, Ir-LBP participates in the tick's ability to interfere with proper neutrophil function in inflammation. Conclusions/Significance: These elements suggest that Ir-LBP is a "scavenger" of LTB4, which, in combination with other factors, such as histamine-binding proteins or proteins inhibiting the classical or alternative complement pathways, permits the tick to properly manage its blood meal. Moreover, with regard to its properties, Ir-LBP could possibly be used as a therapeutic tool for illnesses associated with an increased LTB4 production.	[Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium; [Adam, Benoit; Santini, Sebastien; Brasseur, Robert; Lins, Laurence] Gembloux Agr Univ, Ctr Biophys Mol Numer, Gembloux, Belgium; [Menten-Dedoyart, Catherine; Heinen, Ernst] Univ Liege, Fac Med, Dept Morphol & Immunol, Inst Human Histol, B-4000 Liege, Belgium; [Fievez, Laurence; Bureau, Fabrice] Univ Liege, GIGA Res, Lab Cellular & Mol Physiol, B-4000 Liege, Belgium; [Grosjean, Amelie; Vanhaeverbeek, Michel] ISPPC Hop Andre Vesale, Lab Med Expt, Montignies le Tilleul, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, CH-2000 Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, IBMM, Lab Mol Parasitol, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; University of Liege; University of Liege; University of Neuchatel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Beaufays, J (corresponding author), Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be	LINS, LAURENCE/Y-1661-2019	LINS, LAURENCE/0000-0001-7772-6748; Santini, Sebastien/0000-0001-7087-1950	Belgian National Fund for Scientific Research [Senior Research Associate]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Adam B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-1; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOMALASKI JS, 1987, PROSTAGLANDINS, V33, P855, DOI 10.1016/0090-6980(87)90114-6; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Edwards SW, 2003, CHEM IMMUNOL, V83, P204; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GOETZL EJ, 1980, BIOCHEM BIOPH RES CO, V94, P881, DOI 10.1016/0006-291X(80)91317-0; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; GOLDMAN DW, 1984, J EXP MED, V159, P1027, DOI 10.1084/jem.159.4.1027; GOLDSTEIN I, 1973, P NATL ACAD SCI USA, V70, P2916, DOI 10.1073/pnas.70.10.2916; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hebert MJ, 1996, J IMMUNOL, V157, P3105; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jozefowski S, 2005, IMMUNOLOGY, V116, P418, DOI 10.1111/j.1365-2567.2005.02241.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee E, 1999, AM J RESP CRIT CARE, V160, P2079, DOI 10.1164/ajrccm.160.6.9903136; LIN AH, 1984, PROSTAGLANDINS, V28, P837, DOI 10.1016/0090-6980(84)90038-8; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Murray J, 2003, BRIT J PHARMACOL, V139, P388, DOI 10.1038/sj.bjp.0705265; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; NG CF, 1991, J IMMUNOL, V147, P3096; Nohgawa M, 1997, J LEUKOCYTE BIOL, V62, P203, DOI 10.1002/jlb.62.2.203; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PALMBLAD J, 1984, J IMMUNOL, V132, P3041; PALMBLAD J, 1994, J IMMUNOL, V152, P262; PALMBLAD JEW, 1992, CLIN EXP IMMUNOL, V90, P300; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; RIBEIRO JMC, 1990, EXP PARASITOL, V70, P382, DOI 10.1016/0014-4894(90)90121-R; ROLAPLESZCZYNSKI M, 1985, J IMMUNOL, V135, P3958; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; SCHRODER JM, 1989, J EXP MED, V170, P847, DOI 10.1084/jem.170.3.847; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHAW JO, 1981, J IMMUNOL, V127, P1250; SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154; SNYDERMAN R, 1969, J IMMUNOL, V103, P413; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WARLOW RS, 1987, MOL IMMUNOL, V24, P27, DOI 10.1016/0161-5890(87)90108-8; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	52	57	59	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3987	10.1371/journal.pone.0003987	http://dx.doi.org/10.1371/journal.pone.0003987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096526	Green Published, gold			2022-12-27	WOS:000265458800009
J	Rafii, A; Mirshahi, P; Poupot, M; Faussat, AM; Simon, A; Ducros, E; Mery, E; Couderc, B; Lis, R; Capdet, J; Bergalet, J; Querleu, D; Dagonnet, F; Fournie, JJ; Marie, JP; Pujade-Lauraine, E; Favre, G; Soria, J; Mirshahi, M				Rafii, Arash; Mirshahi, Pejman; Poupot, Mary; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Mery, Eliane; Couderc, Bettina; Lis, Raphael; Capdet, Jerome; Bergalet, Julie; Querleu, Denis; Dagonnet, Francoise; Fournie, Jean-Jacques; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Favre, Gilles; Soria, Jeanine; Mirshahi, Massoud			Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours	PLOS ONE			English	Article							PERITONEAL MESOTHELIAL CELLS; MULTIDRUG-RESISTANCE; STEM-CELLS; INTERCELLULAR TRANSFER; MOLECULAR PREDICTOR; ADHESION MOLECULE; IN-VITRO; CANCER; GROWTH; EXPRESSION	Background: The microenvironment plays a major role in the onset and progression of metastasis. Epithelial ovarian cancer (EOC) tends to metastasize to the peritoneal cavity where interactions within the microenvironment might lead to chemoresistance. Mesothelial cells are important actors of the peritoneal homeostasis; we determined their role in the acquisition of chemoresistance of ovarian tumours. Methodology/Principal Findings: We isolated an original type of stromal cells, referred to as "Hospicells'' from ascitis of patients with ovarian carcinosis using limiting dilution. We studied their ability to confer chemoresistance through heterocellular interactions. These stromal cells displayed a new phenotype with positive immunostaining for CD9, CD10, CD29, CD146, CD166 and Multi drug resistance protein. They preferentially interacted with epithelial ovarian cancer cells. This interaction induced chemoresistance to platin and taxans with the implication of multi-drug resistance proteins. This contact enabled EOC cells to capture patches of the Hospicells membrane through oncologic trogocytosis, therefore acquiring their functional P-gp proteins and thus developing chemoresistance. Presence of Hospicells on ovarian cancer tissue micro-array from patients with neo-adjuvant chemotherapy was also significantly associated to chemoresistance. Conclusions/Significance: This is the first report of trogocytosis occurring between a cancer cell and an original type of stromal cell. This interaction induced autonomous acquisition of chemoresistance. The presence of stromal cells within patient's tumour might be predictive of chemoresistance. The specific interaction between cancer cells and stromal cells might be targeted during chemotherapy.	[Mirshahi, Pejman; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Dagonnet, Francoise; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Soria, Jeanine; Mirshahi, Massoud] Univ Paris 06, INSERM, UMR 872, Paris, France; [Mirshahi, Pejman; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Dagonnet, Francoise; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Soria, Jeanine; Mirshahi, Massoud] Univ Paris 05, Ctr Rech Cordeliers, Equipe 18, Paris, France; [Rafii, Arash; Mery, Eliane; Querleu, Denis] Inst Claudius Regaud, IFR 31, LFR 44, Toulouse, France; [Couderc, Bettina; Lis, Raphael; Capdet, Jerome; Bergalet, Julie; Favre, Gilles] Inst Claudius Regaud, Fac Sci Pharm, Dept Innovat Therapeut Oncol Mol, INSERM U563, Toulouse, France; [Poupot, Mary; Fournie, Jean-Jacques] CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM U563, BP3028, Toulouse, France; [Rafii, Arash] Qatar Fdn, WCMC Qatar, Dept Genet Med & Obstet & Gynecol, Doha, Qatar	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Institut Claudius Regaud; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Rafii, A (corresponding author), Univ Paris 06, INSERM, UMR 872, Paris, France.	hospicells@gmail.com	Fournie, Jean-Jacques/J-7805-2013; FAVRE, Gilles/K-9189-2014; Couderc, Bettina/P-1576-2014; Rafii, Arash/E-4106-2013; Poupot, Mary/F-8570-2013; Mery-Lamarche, Eliane/P-2795-2014	Fournie, Jean-Jacques/0000-0001-6542-6908; FAVRE, Gilles/0000-0002-2344-1883; Couderc, Bettina/0000-0002-4530-5508; Mery-Lamarche, Eliane/0000-0002-0354-4519; Poupot, Mary/0000-0002-2688-1091; jerome, capdet/0000-0001-8340-4921				Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BENDAYAN M, 1987, J HISTOCHEM CYTOCHEM, V35, P983, DOI 10.1177/35.9.3302022; BETJES MGH, 1993, J INFECT DIS, V168, P1202, DOI 10.1093/infdis/168.5.1202; Bhoola S, 2006, OBSTET GYNECOL, V107, P1399, DOI 10.1097/01.AOG.0000220516.34053.48; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Di Nicolantonio F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-78; Eisenkop SM, 2006, GYNECOL ONCOL, V103, P329, DOI 10.1016/j.ygyno.2006.07.004; ESPINOSA E, 2001, J IMMUNOL, V166, P3645; Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Houle CD, 2002, GYNECOL ONCOL, V86, P69, DOI 10.1006/gyno.2002.6729; Jayne DG, 2000, BRIT J CANCER, V82, P1233; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; JONES LMH, 1995, CLIN EXP METASTAS, V13, P373; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khin EE, 2003, INT J GYNECOL PATHOL, V22, P175, DOI 10.1097/00004347-200304000-00010; KISHIKAWA T, 1995, INVAS METAST, V15, P11; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; MUIJSKEN MA, 1991, J CLIN PATHOL, V44, P600, DOI 10.1136/jcp.44.7.600; Naniwa J, 2007, INT J GYNECOL CANCER, V17, P76, DOI 10.1111/j.1525-1438.2006.00752.x; Pfisterer J, 2006, SEMIN ONCOL, V33, pS12, DOI 10.1053/j.seminoncol.2006.03.012; Poupot M, 2005, J IMMUNOL, V174, P1717, DOI 10.4049/jimmunol.174.3.1717; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Rodriguez-Rodriguez L, 2003, MED ONCOL, V20, P255, DOI 10.1385/MO:20:3:255; Sako A, 2006, J SURG RES, V130, P94, DOI 10.1016/j.jss.2005.08.007; Sako A, 2003, J SURG RES, V115, P113, DOI 10.1016/S0022-4804(03)00307-X; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301; Shih IM, 1996, CLIN CANCER RES, V2, P569; SHOSTAK A, 1988, KIDNEY INT, V34, P786, DOI 10.1038/ki.1988.250; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith JA, 2005, GYNECOL ONCOL, V98, P141, DOI 10.1016/j.ygyno.2005.02.006; Trimble E L, 2001, Expert Opin Pharmacother, V2, P1299, DOI 10.1517/14656566.2.8.1299; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Wang E, 2005, CLIN CANCER RES, V11, P113; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; WILSON AP, 1989, BRIT J CANCER, V59, P876, DOI 10.1038/bjc.1989.186; Yakirevich E, 2006, GYNECOL ONCOL, V100, P152, DOI 10.1016/j.ygyno.2005.08.050; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang XY, 1999, J SOC GYNECOL INVEST, V6, P333, DOI 10.1016/S1071-5576(99)00040-4; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	54	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3894	10.1371/journal.pone.0003894	http://dx.doi.org/10.1371/journal.pone.0003894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079610	gold, Green Published			2022-12-27	WOS:000265458400001
J	Kaito, C; Omae, Y; Matsumoto, Y; Nagata, M; Yamaguchi, H; Aoto, T; Ito, T; Hiramatsu, K; Sekimizu, K				Kaito, Chikara; Omae, Yosuke; Matsumoto, Yasuhiko; Nagata, Makiko; Yamaguchi, Hiroki; Aoto, Taiji; Ito, Teruyo; Hiramatsu, Keiichi; Sekimizu, Kazuhisa			A Novel Gene, fudoh, in the SCCmec Region Suppresses the Colony Spreading Ability and Virulence of Staphylococcus aureus	PLOS ONE			English	Article								Staphylococcus aureus colonies can spread on soft agar plates. We compared colony spreading of clinically isolated methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). All MSSA strains showed colony spreading, but most MRSA strains (73%) carrying SCCmec type-II showed little colony spreading. Deletion of the entire SCCmec type-II region from these MRSA strains restored colony spreading. Introduction of a novel gene, fudoh, carried by SCCmec type-II into Newman strain suppressed colony spreading. MRSA strains with high spreading ability (27%) had no fudoh or a point-mutated fudoh that did not suppress colony spreading. The fudoh-transformed Newman strain had decreased exotoxin production and attenuated virulence in mice. Most community-acquired MRSA strains carried SCCmec type-IV, which does not include fudoh, and showed high colony spreading ability. These findings suggest that fudoh in the SCCmec type-II region suppresses colony spreading and exotoxin production, and is involved in S. aureus pathogenesis.	[Kaito, Chikara; Omae, Yosuke; Matsumoto, Yasuhiko; Nagata, Makiko; Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Yamaguchi, Hiroki] Nippon Med Sch, Dept Internal Med, Div Hematol, Tokyo, Japan; [Aoto, Taiji] Nippon Med Sch, Dept Cent Lab, Tokyo, Japan; [Ito, Teruyo; Hiramatsu, Keiichi] Juntendo Univ, Fac Med, Dept Infect Control Sci, Tokyo, Japan	University of Tokyo; Nippon Medical School; Nippon Medical School; Juntendo University	Kaito, C (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017; Matsumoto, Yasuhiko/H-5767-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Matsumoto, Yasuhiko/0000-0002-0796-2304	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Genome Pharmaceuticals Institute;  [19041022];  [20790057];  [20390021]	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Pharmaceuticals Institute; ; ; 	This work was supported by Grants-in-Aid for Scientific Research (19041022, 20790057, 20390021). This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Genome Pharmaceuticals Institute.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; MIZOBUCHI S, 1994, MICROBIOL IMMUNOL, V38, P599, DOI 10.1111/j.1348-0421.1994.tb01829.x; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Rozgonyi F, 2007, CLIN MICROBIOL INFEC, V13, P843, DOI 10.1111/j.1469-0691.2007.01780.x; Sambrook J., 1989, MOL CLONING LAB MANU, p3 v; SUZUKI E, 1993, ANTIMICROB AGENTS CH, V37, P1219, DOI 10.1128/AAC.37.6.1219; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	29	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3921	10.1371/journal.pone.0003921	http://dx.doi.org/10.1371/journal.pone.0003921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079549	Green Submitted, Green Published, gold			2022-12-27	WOS:000265455900007
J	Schneider, H; Valk, E; Leung, R; Rudd, CE				Schneider, Helga; Valk, Elke; Leung, Rufina; Rudd, Christopher E.			CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death	PLOS ONE			English	Article								The balance of T-cell proliferation, anergy and apoptosis is central to immune function. In this regard, co-receptor CTLA-4 is needed for the induction of anergy and tolerance. One central question concerns the mechanism by which CTLA-4 can induce T-cell non-responsiveness without a concurrent induction of antigen induced cell death (AICD). In this study, we show that CTLA-4 activation of the phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. CTLA-4 ligation induced PI 3K activation as evidenced by the phosphorylation of PKB/AKT that in turn inactivated GSK-3. The level of activation was similar to that observed with CD28. CTLA-4 induced PI 3K and AKT activation also led to phosphorylation of the pro-apoptotic factor BAD as well as the up-regulation of BcL-XL. In keeping with this, CD3/CTLA-4 co-ligation prevented apoptosis under the same conditions where T-cell non-responsiveness was induced. This effect was PI 3K and PKB/AKT dependent since inhibition of these enzymes under conditions of anti-CD3/CTLA-4 co-ligation resulted in cell death. Our findings therefore define a mechanism by which CTLA-4 can induce anergy (and possibly peripheral tolerance) by preventing the induction of cell death.	[Schneider, Helga; Valk, Elke; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Schneider, Helga; Valk, Elke; Leung, Rufina; Rudd, Christopher E.] Imperial Coll London, Hammersmith Hosp, Fac Med, Div Investigative Sci, Mol Immunol Sect, London, England; [Rudd, Christopher E.] Cambridge Inst Med Res, Cambridge, England	University of Cambridge; Imperial College London; University of Cambridge	Schneider, H (corresponding author), Univ Cambridge, Dept Pathol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; 	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust, BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing financial interests.	Abbas AK, 2004, AUTOIMMUN REV, V3, P471, DOI 10.1016/j.autrev.2004.07.004; Abbas AK, 2003, AUTOIMMUN REV, V2, P115, DOI 10.1016/S1568-9972(03)00028-4; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Bauer B, 2002, MOL IMMUNOL, V38, P1087, DOI 10.1016/S0161-5890(02)00011-1; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dias SD, 2001, BLOOD, V97, P1134, DOI 10.1182/blood.V97.4.1134; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Janssen O, 2000, INT ARCH ALLERGY IMM, V121, P183, DOI 10.1159/000024316; Kato T, 2000, J IMMUNOL, V164, P3554, DOI 10.4049/jimmunol.164.7.3554; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lin SS, 2006, J BIOL CHEM, V281, P23003, DOI 10.1074/jbc.M602648200; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schneider H, 2002, J IMMUNOL, V169, P3475, DOI 10.4049/jimmunol.169.7.3475; Schneider H, 1999, J IMMUNOL, V163, P1868; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zheng XG, 1998, TRANSPL P, V30, P2146, DOI 10.1016/S0041-1345(98)00568-5	36	56	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3842	10.1371/journal.pone.0003842	http://dx.doi.org/10.1371/journal.pone.0003842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052636	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452200002
J	Meyer, RD; Sacks, DB; Rahimi, N				Meyer, Rosana D.; Sacks, David B.; Rahimi, Nader			IQGAP1-Dependent Signaling Pathway Regulates Endothelial Cell Proliferation and Angiogenesis	PLOS ONE			English	Article								Background: Vascular endothelial growth factor receptor-2 (VEGFR-2) signaling is an obligate requirement for normal development and pathological angiogenesis such as cancer and age-related macular degeneration. Although autophosphorylation of tyrosine 1173 (Y1173) of VEGFR-2 is considered a focal point for its angiogenic signal relay, however, the mechanism of phosphorylation of Y1173, signaling proteins that are recruited to this residue and their role in angiogenesis is not fully understood. Methodology/Principal Findings: In this study we demonstrate that c-Src kinase directly through its Src homology 2 (SH2) domain and indirectly via c-Cbl binds to phospho-Y1057 of VEGFR-2. Activation of c-Src kinase by a positive feedback mechanism phosphorylates VEGFR-2 at multi-docking site, Y1173. c-Src also catalyzes tyrosine phosphorylation of IQGAP1 and acts as an adaptor to bridge IQGAP1 to VEGFR-2. In turn, IQGAP1 activates b-Raf and mediates proliferation of endothelial cells. Silencing expression of IQGAP1 and b-Raf revealed that their activity is essential for VEGF to stimulate angiogenesis in an in vivo angiogenesis model of chicken chorioallantoic membrane (CAM). Conclusions/Significance: Angiogenesis contributes to the pathology of numerous human diseases ranging from cancer to age-related macular degeneration. Determining molecular mechanism of tyrosine phosphorylation of VEGFR-2 and identification of molecules that are relaying its angiogenic signaling may identify novel targets for therapeutic intervention against angiogenesis-associated diseases. Our study shows that recruitment and activation of c-Src by VEGFR-2 plays a pivotal role in relaying angiogenic signaling of VEGFR-2; it phosphorylates VEGFR-2 at Y1173, facilitates association and activation of IQGAP1 and other signaling proteins to VEGFR-2. IQGAP1-dependent signaling, in part, is critically required for endothelial cell proliferation, a key step in angiogenesis. Thus, Y1057 of VEGFR-2 serves to regulate VEGFR-2 function in a combinatorial manner by supporting both diversity of recruitment of angiogenic signaling proteins to VEGFR-2, and its ability to promote angiogenesis.	[Meyer, Rosana D.; Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Sacks, David B.] Harvard Univ, Sch Med, Boston, MA USA; [Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Boston University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Meyer, RD (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.	nrahimi@bu.edu		Rahimi, Nader/0000-0002-6745-1725; Sacks, David/0000-0003-3100-0735	National Institutes of Health; Massachusetts Lions Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Foundation	This study was supported in part by grants from the National Institutes of Health (NR and DBS) and Massachusetts Lions Foundation grant to the Department of Ophthalmology.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V251, P77, DOI 10.1006/bbrc.1998.9442; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Meyer RD, 2004, ONCOGENE, V23, P5523, DOI 10.1038/sj.onc.1207712; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Meyer RD, 2002, J BIOL CHEM, V277, P27081, DOI 10.1074/jbc.M110544200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ratcliffe KE, 2002, ONCOGENE, V21, P6307, DOI 10.1038/sj.onc.1205781; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Warner AJ, 2000, BIOCHEM J, V347, P501, DOI 10.1042/0264-6021:3470501; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	33	72	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3848	10.1371/journal.pone.0003848	http://dx.doi.org/10.1371/journal.pone.0003848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050761	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452100007
J	Petkova, VI; Ehrsson, HH				Petkova, Valeria I.; Ehrsson, H. Henrik			If I Were You: Perceptual Illusion of Body Swapping	PLOS ONE			English	Article							RUBBER HAND ILLUSION; MULTISENSORY INTEGRATION; PHYSIOLOGICAL CONDITION; PARIETAL CORTEX; REPRESENTATION; FEEL; SPACE; SENSE; INTEROCEPTION; MECHANISMS	The concept of an individual swapping his or her body with that of another person has captured the imagination of writers and artists for decades. Although this topic has not been the subject of investigation in science, it exemplifies the fundamental question of why we have an ongoing experience of being located inside our bodies. Here we report a perceptual illusion of body-swapping that addresses directly this issue. Manipulation of the visual perspective, in combination with the receipt of correlated multisensory information from the body was sufficient to trigger the illusion that another person's body or an artificial body was one's own. This effect was so strong that people could experience being in another person's body when facing their own body and shaking hands with it. Our results are of fundamental importance because they identify the perceptual processes that produce the feeling of ownership of one's body.	[Petkova, Valeria I.; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Petkova, VI (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	Valeria.Petkova@ki.se			Swedish Medical Research Council; Swedish Foundation for Strategic Research; Human Frontier Science Programme; European Research Council; KI-NIH [PhD fellowship]; European Union	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Human Frontier Science Programme(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); KI-NIH; European Union(European Commission)	This work was supported by grants from the Swedish Medical Research Council, the Swedish Foundation for Strategic Research, the Human Frontier Science Programme, and the European Research Council. V.I.P was supported by a PhD fellowship from the KI-NIH graduate programme. The study was conducted as part of Stockholm Brain Institute, a consortium for Cognitive and Computational Neuroscience in Stockholm, and PRESENCCIA (Presence: Research Encompassing Sensory Enhancement,Neuroscience, Cerebral-Computer Interfaces, and Applications) project, a European Union-funded project under the Information Society Technologies program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler EL, 2007, PERCEPTION, V36, P632, DOI 10.1068/p5730; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Cole J, 2000, TRENDS COGN SCI, V4, P167, DOI 10.1016/S1364-6613(00)01459-5; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley M., 1953, PARIETAL LOBES; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gibson J.J., 1986, ECOLOGICAL APPROACH; GRAZIANO M, 2002, COMMON MECH PERCEPTI; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; JAMES W, 1890, PRINICPLES PSYCHOL; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lenggenhager B, 2006, REV NEUROSCIENCE, V17, P643; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Levelt WJM, 1965, BINOCULAR RIVALRY; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Meador KJ, 2000, NEUROLOGY, V55, P816, DOI 10.1212/WNL.55.6.816; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; METZINGER T, 2003, BEING ONE SELF MODEL; MINSKY M, 1980, OMNI, V45; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; SLATER M, 2008, FRONTIERS HUMAN NEUR; Slater M, 2007, IEEE COMPUT GRAPH, V27, P90, DOI 10.1109/MCG.2007.93; Stratton GM, 1899, MIND, V8, P492, DOI DOI 10.1093/MINDNIII.4.492; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; WELCH RB, 1986, HDB PERCEPTION HUMAN; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005	52	536	544	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3832	10.1371/journal.pone.0003832	http://dx.doi.org/10.1371/journal.pone.0003832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YN	19050755	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452100002
J	Seitsonen, SP; Onkamo, P; Peng, G; Xiong, MM; Tommila, PV; Ranta, PH; Holopainen, JM; Moilanen, JA; Palosaari, T; Kaarniranta, K; Meri, S; Immonen, IR; Jarvela, IE				Seitsonen, Sanna P.; Onkamo, Paivi; Peng, Gang; Xiong, Momiao; Tommila, Petri V.; Ranta, Paivi H.; Holopainen, Juha M.; Moilanen, Jukka A.; Palosaari, Tapani; Kaarniranta, Kai; Meri, Seppo; Immonen, Ilkka R.; Jarvela, Irma E.			Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration	PLOS ONE			English	Article							HTRA1 PROMOTER POLYMORPHISM; CIGARETTE-SMOKING; GEOGRAPHIC ATROPHY; VARIANT INCREASES; 3RD COMPONENT; IN-VITRO; RISK; GENE; SUSCEPTIBILITY; ASSOCIATION	Background: Variants in the complement cascade genes and the LOC387715/HTRA1, have been widely reported to associate with age-related macular degeneration (AMD), the most common cause of visual impairment in industrialized countries. Methods/Principal Findings: We investigated the association between the LOC387715 A69S and complement component C3 R102G risk alleles in the Finnish case-control material and found a significant association with both variants (OR 2.98, p = 3.75x10(-9); non-AMD controls and OR 2.79, p = 2.78x10(-19), blood donor controls and OR 1.83, p = 0.008; non-AMD controls and OR 1.39, p = 0.039; blood donor controls), respectively. Previously, we have shown a strong association between complement factor H (CFH) Y402H and AMD in the Finnish population. A carrier of at least one risk allele in each of the three susceptibility loci (LOC387715, C3, CFH) had an 18-fold risk of AMD when compared to a non-carrier homozygote in all three loci. A tentative gene-gene interaction between the two major AMD-associated loci, LOC387715 and CFH, was found in this study using a multiplicative (logistic regression) model, a synergy index (departure-from-additivity model) and the mutual information method (MI), suggesting that a common causative pathway may exist for these genes. Smoking (ever vs. never) exerted an extra risk for AMD, but somewhat surprisingly, only in connection with other factors such as sex and the C3 genotype. Population attributable risks (PAR) for the CFH, LOC387715 and C3 variants were 58.2%, 51.4% and 5.8%, respectively, the summary PAR for the three variants being 65.4%. Conclusions/Significance: Evidence for gene-gene interaction between two major AMD associated loci CFH and LOC387715 was obtained using three methods, logistic regression, a synergy index and the mutual information (MI) index.	[Seitsonen, Sanna P.; Tommila, Petri V.; Ranta, Paivi H.; Holopainen, Juha M.; Moilanen, Jukka A.; Meri, Seppo; Immonen, Ilkka R.] Univ Helsinki, Dept Ophthalmol, Helsinki, Finland; [Seitsonen, Sanna P.; Jarvela, Irma E.] Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Peng, Gang; Xiong, Momiao] Fudan Univ, Sch Life Sci, Fudan, Peoples R China; [Xiong, Momiao] Univ Texas, Sch Publ Hlth, Human Genet Ctr, Houston, TX USA; [Palosaari, Tapani] Univ Oulu, Dept Ophthalmol, Helsinki, Finland; [Kaarniranta, Kai] Univ Kuopio, Dept Ophthalmol, FIN-70211 Kuopio, Finland; Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Jarvela, Irma E.] Univ Helsinki, Cent Hosp, Lab Mol Genet, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Fudan University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Oulu; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Seitsonen, SP (corresponding author), Univ Helsinki, Dept Ophthalmol, Helsinki, Finland.	sanna.seitsonen@hus.fi	Jarvela, Irma E/L-5836-2013; Peng, Gang/AAN-5355-2020	Jarvela, Irma E/0000-0002-1770-6187; Peng, Gang/0000-0003-0307-9351; Kaarniranta, Kai/0000-0003-2600-8679; Meri, Seppo/0000-0001-9142-501X	Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland; Helsinki University Central Hospital Research Funds, Helsinki, Finland [TYH5117, TYH6233]; National Institutes of Health [EY11515]; NATIONAL EYE INSTITUTE [R01EY011515] Funding Source: NIH RePORTER	Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland(Academy of Finland); Helsinki University Central Hospital Research Funds, Helsinki, Finland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by grants from the Paivikki and Sakari Sohlberg Foundation, Hel-sinki, Finland; The Mary and Georg Ehrnrooth Foundation, Helsinki, Finland; The Eye and Tissue Bank Foundation, Helsinki, Finland; The Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland; Helsinki University Central Hospital Research Funds (TYH5117, TYH6233), Helsinki, Finland; and National Institutes of Health (EY11515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors do not have any financial interests to disclose.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cameron DJ, 2007, CELL CYCLE, V6, P1122, DOI 10.4161/cc.6.9.4157; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cover T. M., 1991, ELEMENTS INFORM THEO; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Francis PJ, 2008, MOL VIS, V14, P1395; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; GICLAS PC, 1979, J IMMUNOL, V122, P146; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; KEW RR, 1987, CLIN IMMUNOL IMMUNOP, V44, P248, DOI 10.1016/0090-1229(87)90069-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Liew G, 2007, OPHTHALMOLOGY, V114, P1793, DOI 10.1016/j.ophtha.2007.04.036; Lu F, 2007, VISION RES, V47, P3120, DOI 10.1016/j.visres.2007.08.010; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mori K, 2007, J HUM GENET, V52, P636, DOI 10.1007/s10038-007-0162-1; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; ROBBINS RA, 1991, AM J PHYSIOL, V260, pL254, DOI 10.1152/ajplung.1991.260.4.L254; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Scott WK, 2007, OPHTHALMOLOGY, V114, P1151, DOI 10.1016/j.ophtha.2006.08.054; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seitsonen S, 2006, MOL VIS, V12, P796; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Souied EH, 2005, MOL VIS, V11, P1135; Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; TUO J, 2008, OPHTHALMOLO IN PRESS; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weger M, 2007, MOL VIS, V13, P1274; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida T, 2007, MOL VIS, V13, P545; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	62	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3833	10.1371/journal.pone.0003833	http://dx.doi.org/10.1371/journal.pone.0003833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048105	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452000006
J	Carling, C; Kristoffersen, DT; Herrin, J; Treweek, S; Oxman, AD; Schunemann, H; Akl, EA; Montori, V				Carling, Cheryl; Kristoffersen, Doris Tove; Herrin, Jeph; Treweek, Shaun; Oxman, Andrew D.; Schunemann, Holger; Akl, Elie A.; Montori, Victor			How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial	PLOS ONE			English	Article							PRESENTING RISK INFORMATION; EXPECTED UTILITY; DECISION-MAKING; HEALTH; COMMUNICATION; METAANALYSIS; PREFERENCES; BENEFITS; FORMATS	Background: Different presentations of treatment effects can affect decisions. However, previous studies have not evaluated which presentations best help people make decisions that are consistent with their own values. We undertook a pilot study to compare different methods for doing this. Methods and Findings: We conducted an Internet-based randomized trial comparing summary statistics for communicating the effects of statins on the risk of coronary heart disease (CHD). Participants rated the relative importance of treatment consequences using visual analogue scales (VAS) and category rating scales (CRS) with five response options. We randomized participants to either VAS or CRS first and to one of six summary statistics: relative risk reduction (RRR) and five absolute measures of effect: absolute risk reduction, number needed to treat, event rates, tablets needed to take, and natural frequencies (whole numbers). We used logistic regression to determine the association between participants' elicited values and treatment choices. 770 participants age 18 or over and literate in English completed the study. In all, 13% in the VAS-first group failed to complete their VAS rating, while 9% of the CRS-first group failed to complete their scoring (p = 0.03). Different ways of weighting the elicited values had little impact on the analyses comparing the different presentations. Most (51%) preferred the RRR compared to the other five summary statistics (1% to 25%, p = 0.074). However, decisions in the group presented the RRR deviated substantially from those made in the other five groups. The odds of participants in the RRR group deciding to take statins were 3.1 to 5.8 times that of those in the other groups across a wide range of values (p = 0.0007). Participants with a scientific background, who were more numerate or had more years of education were more likely to decide not to take statins. Conclusions: Internet-based trials comparing different presentations of treatment effects are feasible, but recruiting participants is a major challenge. Despite a slightly higher response rate for CRS, VAS is preferable to avoid approximation of a continuous variable. Although most participants preferred the RRR, participants shown the RRR were more likely to decide to take statins regardless of their values compared with participants who were shown any of the five other summary statistics.	[Carling, Cheryl; Kristoffersen, Doris Tove; Treweek, Shaun; Oxman, Andrew D.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Herrin, Jeph] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Schunemann, Holger] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, Clin Res & INFORMAt Translat Unit, Rome, Italy; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY USA; [Montori, Victor] Mayo Clin Coll Med, Div Endocrinol & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN USA	Norwegian Knowledge Centre for Health Services; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Mayo Clinic	Carling, C (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway.	cheryl.carling@kunnskapssenteret.no	Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016; Kristoffersen, Doris Tove/GWQ-3158-2022; Oxman, Andrew/Y-3004-2019; Treweek, Shaun/AAE-8006-2019	Akl, Elie A/0000-0002-3444-8618; Oxman, Andrew/0000-0002-5608-5061; Treweek, Shaun/0000-0002-7239-7241; Schunemann, Holger/0000-0003-3211-8479; Montori, Victor/0000-0003-0595-2898	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1986, MED THINKING PSYCHOL; Cohen J, 1988, STAT POWER ANAL BEHA, Veds, P109, DOI 10.1016/B978-0-12-179060-8.50009-8; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Edwards A, 1999, MED DECIS MAKING, V19, P428, DOI 10.1177/0272989X9901900411; Edwards A, 2006, PATIENT EDUC COUNS, V63, P336, DOI 10.1016/j.pec.2005.12.016; Entwistle VA, 1998, INT J TECHNOL ASSESS, V14, P212, DOI 10.1017/S0266462300012204; FRISCH D, 1994, PSYCHOL BULL, V116, P46, DOI 10.1037/0033-2909.116.1.46; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; Ghosh AK, 2005, J LAB CLIN MED, V145, P171, DOI 10.1016/j.lab.2005.02.006; GHOSH AK, 2002, J INVEST MED, V50, P182; GUYATT GH, 1987, J CHRON DIS, V40, P1129, DOI 10.1016/0021-9681(87)90080-4; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; HELLINGER FJ, 1989, MED CARE, V27, P273, DOI 10.1097/00005650-198903000-00005; HOLLNAGEL H, 1996, PRACTICUS, V116, P237; Holmes-Rovner M, 1999, MED CARE, V37, P270, DOI 10.1097/00005650-199903000-00007; Hosmer D., 2002, APPL LOGISTIC REGRES; Kahneman D., 1982, JUDGEMENT UNCERTAINT; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Llach XB, 1999, MED CARE, V37, P671, DOI 10.1097/00005650-199907000-00007; Llewellyn-Thomas H, 1982, Med Decis Making, V2, P449, DOI 10.1177/0272989X8200200407; LLOYD AJ, 2001, QUAL HLTH CARE S1, V10, P14; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; McGettigan P, 1999, J GEN INTERN MED, V14, P633, DOI 10.1046/j.1525-1497.1999.09038.x; Misselbrook D, 2001, BRIT J GEN PRACT, V51, P276; Morimoto Takeshi, 2002, J Epidemiol, V12, P160; Moxey A, 2003, J GEN INTERN MED, V18, P948, DOI 10.1046/j.1525-1497.2003.20928.x; O'Connor A M, 1985, Med Decis Making, V5, P453; O'Connor A. M., 2005, IPDAS COLLABORATION; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; Ratliff A, 1999, Eff Clin Pract, V2, P185; Rothman AJ, 1999, PERS SOC PSYCHOL B, V25, P1355, DOI 10.1177/0146167299259003; Ryan M, 2001, Health Technol Assess, V5, P1; SCHOEMAKER PJH, 1982, J ECON LIT, V20, P529; Schonlau M., 2002, CONDUCTING RES SURVE; Schunemann HJ, 2003, J CLIN EPIDEMIOL, V56, P1170, DOI 10.1016/S0895-4356(03)00115-X; Skolbekken JA, 1998, BMJ-BRIT MED J, V316, P1956, DOI 10.1136/bmj.316.7149.1956; Slovic P, 2000, PERCEPTION RISK; Stiggelbout A, 2000, DECISION MAKING HLTH, P289; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wills CE, 2003, PATIENT EDUC COUNS, V50, P285, DOI 10.1016/S0738-3991(03)00051-X; Wiseman DB, 1996, ORGAN BEHAV HUM DEC, V66, P241, DOI 10.1006/obhd.1996.0053	48	21	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3693	10.1371/journal.pone.0003693	http://dx.doi.org/10.1371/journal.pone.0003693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YA	19030110	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265450800001
J	Ma, JG; Xin, XL; Meng, LH; Tong, LJ; Lin, LP; Geng, MY; Ding, J				Ma, Jingui; Xin, Xianliang; Meng, Linghua; Tong, Linjiang; Lin, Liping; Geng, Meiyu; Ding, Jian			The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; CATALYTIC DOMAIN; ACQUIRED-RESISTANCE; MUTATION; GEFITINIB; SUNITINIB; IMATINIB; THERAPY; DESIGN	Despite the emerging success of multi-targeted protein tyrosine kinase (PTK) inhibitors in cancer therapy, significant side effects and resistance concerns seems to be avoided unlikely. The aim of the present study was to identify novel multi-targeting PTK inhibitors. The kinase enzymatic activities were measured by enzyme-linked immunosorbent assay (ELISA). The antiproliferative activities in human microvascular endothelial cells (HMECs) were evaluated by sulforhodamine (SRB) assay. The phosphorylation of kinases and their downstream molecules was probed by western blot analysis. The binding mode between MdOS and PTKs was profiled by surface plasmon resonance (SPR) approach and molecular simulation. Tube formation assay, rat aortic ring method and chicken chorioallantoic membrane assay were combined to illustrate the in vitro and in vivo anti-angiogenic effects. Results indicated that MdOS, a novel marine-derived oligosaccharide sulfate, exhibited a broad-spectrum PTK inhibitory action. At an enzymatic level, MdOS inhibited HER2, EGFR, VEGFR, PDGFR, c-Kit, FGFR1 and c-Src, with little impact on FGFR2. In cellular settings, MdOS inhibited phosphorylation of PTKs, exemplified by HER2, EGFR and VEGFR2, and downstream molecules of Erk1/2 and AKT. Further studies demonstrated that MdOS acted as an ATP-competitive inhibitor via directly binding to the residues of entrance rather than those of the ATP-binding pocket. Furthermore, MdOS inhibited proliferation and tube formation of HMECs, arrested microvessel outgrowth of rat aortic rings and hindered the neovascularization of chick allantoic membrane. Taken together, results presented here indicated that MdOS exhibited anti-angiogenic activity in a PTK-dependent manner and make it a promising agent for further evaluation in PTK-associated cancer therapy.	[Ma, Jingui; Xin, Xianliang; Meng, Linghua; Tong, Linjiang; Lin, Liping; Geng, Meiyu; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Div Antitumor Pharmacol,State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Ma, JG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Div Antitumor Pharmacol,State Key Lab Drug Res, Shanghai 200031, Peoples R China.	mygeng@mail.shcnc.ac.cn; suozhang@mail.shcnc.ac.cn	meng, linghua/Y-8110-2019; lin, liping/HGE-0871-2022		Science Foundation of China; Natural Science Foundation of China [30725046, 30721005]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-YW-R-25]; Science and Technology Commission of Shanghai [07dz05906]; National Basic Research Program [2003CB716400]	Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program(National Basic Research Program of China)	National Basic Research Program Grant (2003CB716400) of China, Natural Science Foundation of China for Distinguished Young Scholars (30725046) and Natural Science Foundation of China for Innovation Research Group (30721005). Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-25), Science and Technology Commission of Shanghai Municipality Grant 07dz05906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Baselga J, 2004, NAT MED, V10, P786, DOI 10.1038/nm0804-786; Baselga J, 2001, ANN ONCOL, V12, P35, DOI 10.1023/A:1011163824080; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Ciardiello F, 2003, CLIN CANCER RES, V9, P1546; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Cole CL, 2008, EXPERT OPIN BIOL TH, V8, P351, DOI 10.1517/14712598.8.3.351 ; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Guo XN, 2004, BBA-GEN SUBJECTS, V1673, P186, DOI 10.1016/j.bbagen.2004.04.015; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Klein S, 2007, ADV CANCER RES, V97, P295, DOI 10.1016/S0065-230X(06)97013-4; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LAZARO I, 1991, ANAL BIOCHEM, V192, P257, DOI 10.1016/0003-2697(91)90533-Y; LI F, 2002, CHEM RES CHINESE U, V9, P1704; Lin LG, 2008, J MED CHEM, V51, P4419, DOI 10.1021/jm701501x; Madhusudan S, 2004, CLIN BIOCHEM, V37, P618, DOI 10.1016/j.clinbiochem.2004.05.006; Maione P, 2006, ONCOLOGIST, V11, P274, DOI 10.1634/theoncologist.11-3-274; Miao BC, 2005, MOL PHARMACOL, V68, P1716, DOI 10.1124/mol.105.015412; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rock EP, 2007, ONCOLOGIST, V12, P107, DOI 10.1634/theoncologist.12-1-107; Sawyers CL, 2001, SCIENCE, V294, P1834; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sosman JA, 2007, CLIN CANCER RES, V13, p764S, DOI 10.1158/1078-0432.CCR-06-1975; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang XH, 2007, BBA-GEN SUBJECTS, V1770, P1490, DOI 10.1016/j.bbagen.2007.06.017; Zhang YX, 2005, ANTI-CANCER DRUG, V16, P515, DOI 10.1097/00001813-200506000-00007; Zhong L, 2005, BBA-GEN SUBJECTS, V1722, P254, DOI 10.1016/j.bbagen.2004.12.015	39	31	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3774	10.1371/journal.pone.0003774	http://dx.doi.org/10.1371/journal.pone.0003774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020661	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448600007
J	Vogt, A; D'Angelo, C; Oswald, F; Denzel, A; Mazel, CH; Matz, MV; Ivanchenko, S; Nienhaus, GU; Wiedenmann, J				Vogt, Alexander; D'Angelo, Cecilia; Oswald, Franz; Denzel, Andrea; Mazel, Charles H.; Matz, Mikhail V.; Ivanchenko, Sergey; Nienhaus, G. Ulrich; Wiedenmann, Joerg			A Green Fluorescent Protein with Photoswitchable Emission from the Deep Sea	PLOS ONE			English	Article							GFP-LIKE PROTEINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC RED; ANTHOZOA; CORAL; MICROSCOPY; ORANGE; MARKER; COLOR	A colorful variety of fluorescent proteins (FPs) from marine invertebrates are utilized as genetically encoded markers for live cell imaging. The increased demand for advanced imaging techniques drives a continuous search for FPs with new and improved properties. Many useful FPs have been isolated from species adapted to sun-flooded habitats such as tropical coral reefs. It has yet remained unknown if species expressing green fluorescent protein (GFP)-like proteins also exist in the darkness of the deep sea. Using a submarine-based and -operated fluorescence detection system in the Gulf of Mexico, we discovered ceriantharians emitting bright green fluorescence in depths between 500 and 600 m and identified a GFP, named cerFP505, with bright fluorescence emission peaking at 505 nm. Spectroscopic studies showed that similar to 15% of the protein bulk feature reversible ON/OFF photo switching that can be induced by alternating irradiation with blue und near-UV light. Despite being derived from an animal adapted to essentially complete darkness and low temperatures, cerFP505 maturation in living mammalian cells at 37 degrees C, its brightness and photostability are comparable to those of EGFP and cmFP512 from shallow water species. Therefore, our findings disclose the deep sea as a potential source of GFP-like molecular marker proteins.	[Vogt, Alexander; D'Angelo, Cecilia; Denzel, Andrea; Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany; [Mazel, Charles H.] NightSea, Andover, MA USA; [Matz, Mikhail V.] Univ Texas, Austin, TX USA; [Ivanchenko, Sergey; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanography Ctr, Southampton SO9 5NH, Hants, England	Ulm University; Ulm University; University of Texas System; University of Texas Austin; Ulm University; University of Illinois System; University of Illinois Urbana-Champaign; NERC National Oceanography Centre; University of Southampton	Vogt, A (corresponding author), Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany.	J.Wiedenmann@soton.ac.uk	Oswald, Franz/AAO-9584-2020; Matz, Mikhail V/K-4392-2017; Nienhaus, Gerd Ulrich/G-8698-2012	Matz, Mikhail V/0000-0001-5453-9819; Nienhaus, Gerd Ulrich/0000-0002-5027-3192	Deutsche Forschungsgemeinschaft [Wi1990/2-1, SFB 497/B9, SFB518/A18, SFB 497/D2]; NOAA Ocean Exploration Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NOAA Ocean Exploration Program(National Oceanic Atmospheric Admin (NOAA) - USA)	The work was supported by the Deutsche Forschungsgemeinschaft (Wi1990/2-1 to JW, SFB 497/B9 and SFB518/A18 to FO, SFB 497/D2 to GUN) and NOAA Ocean Exploration Program ("Operation Deep Scope" to MVM and CHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARLGREN OSKAR, 1952, PUBL INST MARINE SCI UNIV TEXAS [PORT ARANSAS], V2, P141; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; den Hartog J. C., 1977, Zoologische Meded Leiden, V51, P211; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Flors C, 2007, J AM CHEM SOC, V129, P13970, DOI 10.1021/ja074704l; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2006, PHOTOCH PHOTOBIO SCI, V5, P567, DOI 10.1039/b516339k; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Ip DTM, 2007, MAR BIOTECHNOL, V9, P469, DOI 10.1007/s10126-007-9005-5; Ip DTM, 2004, ACTA CRYSTALLOGR D, V60, P340, DOI 10.1107/S0907444903027100; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kawaguti S., 1969, Micronesica, V5, P313; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Leutenegger A, 2007, J EXP MAR BIOL ECOL, V353, P221, DOI 10.1016/j.jembe.2007.09.013; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2002, CELL STRUCT FUNCT, V27, P343, DOI 10.1247/csf.27.343; Mocz G, 2007, MAR BIOTECHNOL, V9, P305, DOI 10.1007/s10126-006-7145-7; Molodtsova T.N., 2003, Zoologische Verhandelingen (Leiden), V345, P249; Molodtsova TN, 2004, HYDROBIOLOGIA, V530, P261, DOI 10.1007/s10750-004-2671-7; Nienhaus K, 2006, BIOPHYS J, V91, P4210, DOI 10.1529/biophysj.106.087411; Nienhaus K, 2006, BIOCHEMISTRY-US, V45, P12942, DOI 10.1021/bi060885c; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHNITZLER CE, 2008, MAR BIOTECHNOL; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; SHEPARD AN, 1986, FISH B-NOAA, V84, P625; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Wiedenmann J, 2000, P NATL ACAD SCI USA, V97, P14091, DOI 10.1073/pnas.97.26.14091; Wiedenmann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854680; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2000, OPHELIA, V52, P57, DOI 10.1080/00785236.1999.10409419; Wiedenmann J, 2004, MAR BIOTECHNOL, V6, P270, DOI 10.1007/s10126-004-3006-4; Wiedenmann J., 1997, (sulcata) Pennant, (Cnidaria, Anthozoa, Actinaria) in Gentechnologie und Molekularbiologie, Offenlegungsschrift DE, Patent No. [197 18 640 A1, 19718640]; Wiedenmann J, 1999, VERHANDLUNGEN GESELL, V29, P497; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	81	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3766	10.1371/journal.pone.0003766	http://dx.doi.org/10.1371/journal.pone.0003766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018285	gold, Green Published, Green Submitted			2022-12-27	WOS:000265448500013
J	Molla-Herman, A; Boularan, C; Ghossoub, R; Scott, MGH; Burtey, A; Zarka, M; Saunier, S; Concordet, JP; Marullo, S; Benmerah, A				Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Saunier, Sophie; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre			Targeting of beta-Arrestin2 to the Centrosome and Primary Cilium: Role in Cell Proliferation Control	PLOS ONE			English	Article								Background: The primary cilium is a sensory organelle generated from the centrosome in quiescent cells and found at the surface of most cell types, from where it controls important physiological processes. Specific sets of membrane proteins involved in sensing the extracellular milieu are concentrated within cilia, including G protein coupled receptors (GPCRs). Most GPCRs are regulated by beta-arrestins, beta arr1 and beta arr2, which control both their signalling and endocytosis, suggesting that beta arrs may also function at primary cilium. Methodology/Principal Findings: In cycling cells, beta arr2 was observed at the centrosome, at the proximal region of the centrioles, in a microtubule independent manner. However, beta arr2 did not appear to be involved in classical centrosome-associated functions. In quiescent cells, both in vitro and in vivo, beta arr2 was found at the basal body and axoneme of primary cilia. Interestingly, beta arr2 was found to interact and colocalize with 14-3-3 proteins and Kif3A, two proteins known to be involved in ciliogenesis and intraciliary transport. In addition, as suggested for other centrosome or cilia-associated proteins, beta arrs appear to control cell cycle progression. Indeed, cells lacking beta arr2 were unable to properly respond to serum starvation and formed less primary cilia in these conditions. Conclusions/Significance: Our results show that beta arr2 is localized to the centrosome in cycling cells and to the primary cilium in quiescent cells, a feature shared with other proteins known to be involved in ciliogenesis or primary cilium function. Within cilia, beta arr2 may participate in the signaling of cilia-associated GPCRs and, therefore, in the sensory functions of this cell "antenna".	[Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre] INSERM, U567, Paris, France; [Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U574, Paris, France; [Saunier, Sophie] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Molla-Herman, A (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	alexandre.benmerah@inserm.fr	concordet, jean-paul/C-3417-2015; benmerah, alexandre/H-3742-2017; Scott, Mark/R-3521-2019; Saunier, Sophie/G-6044-2015; Ghossoub, Rania/AAO-9580-2020; Marullo, Stefano/C-6142-2008	benmerah, alexandre/0000-0003-0188-8016; Saunier, Sophie/0000-0002-1069-0047; Marullo, Stefano/0000-0001-9604-9973; Scott, Mark G.H./0000-0002-1557-1856; Burtey, Anne/0000-0003-4548-8807; Ghossoub, Rania/0000-0003-1886-343X; Concordet, Jean-Paul/0000-0001-8924-4316	Association pour la recherche contre le cancer [36-91, 3925]; Ligue nationale contre le cancer; Agence nationale de la recherche [BLAN07-3-187842]	Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Agence nationale de la recherche(French National Research Agency (ANR))	This work was supported by grants from the "Association pour la recherche contre le cancer" (ARC, 36-91, AB; 3925 JPC) and from the " Ligue nationale contre le cancer" and "Agence nationale de la recherche" ("ANR" BLAN07-3-187842, SM). Anne Burtey was supported by a doctoral fellowship from ARC.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Benmerah A, 2003, TRAFFIC, V4, P503, DOI 10.1034/j.1600-0854.2003.00102.x; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; GERDES J, 1984, J IMMUNOL, V133, P1710; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Menco BPM, 2005, J NEUROCYTOL, V34, P11, DOI 10.1007/s11068-005-5045-9; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Piu F, 2006, ONCOGENE, V25, P218, DOI 10.1038/sj.onc.1209024; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; REID DM, 1987, EXP EYE RES, V45, P731, DOI 10.1016/S0014-4835(87)80121-5; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; VANVEEN T, 1986, EXP BIOL, V45, P15; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; WHEATLEY DN, 1969, J ANAT, V105, P351; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215	65	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3728	10.1371/journal.pone.0003728	http://dx.doi.org/10.1371/journal.pone.0003728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008961	Green Submitted, Green Published, gold			2022-12-27	WOS:000265166400006
J	Wang, Y; Leung, FCC				Wang, Yong; Leung, Frederick C. C.			GC Content Increased at CpG Flanking Positions of Fish Genes Compared with Sea Squirt Orthologs as a Mechanism for Reducing Impact of DNA Methylation	PLOS ONE			English	Article								Background: Fractional DNA methylation in sea squirts evolved to global DNA methylation in fish. The impact of global DNA methylation is reflected by more CpG depletions and/or more A/T to G/C changes at CpG flanking positions due to context-dependent mutations of methylated CpG sites. Methods and Findings: In this report, we demonstrate that the sea squirt genes have undergone more CpG to TpG/CpA substitutions than the fish orthologs using homologous fragments from orthologous genes among Ciona intestinalis, Ciona savignyi, fugufish and zebrafish. To avoid premature transcription, the TGA sites derived from CGA were largely converted to TGG in sea squirt genes. By contrast, a significant increment of GC content at CpG flanking positions was shown in fish genes. The positively selected A/T to G/C substitutions, in combination with the CpG to TpG/CpA substitutions, are the sources of the extremely low CpG observed/expected ratios in vertebrates. The nonsynonymous substitutions caused by the GC content increase have resulted in frequent amino acid replacements in the directions that were not noticed previously. Conclusion: The increased GC content at CpG flanking positions can reduce CpG loss in fish genes and attenuate the impact of DNA methylation on CpG-containing codons, probably accounting for evolution towards vertebrates.	[Wang, Yong; Leung, Frederick C. C.] Univ Hong Kong, Dept Zool, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wang, Y (corresponding author), Univ Hong Kong, Dept Zool, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk	Leung, Frederick/D-3098-2009	wang, yong/0000-0003-3595-3867				Aniello F, 2003, GENE, V302, P1, DOI 10.1016/S0378-1119(02)01138-1; Aniello F, 1996, GENE, V178, P57, DOI 10.1016/0378-1119(96)00334-4; Antri S. E., 1993, Journal of Molecular Biology, V230, P373; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; Bernardi G, 2000, GENE, V259, P31, DOI 10.1016/S0378-1119(00)00441-8; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BULLOCK E, 1972, J MOL EVOL, V1, P315, DOI 10.1007/BF01653960; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Elango N, 2008, MOL BIOL EVOL, V25, P1602, DOI 10.1093/molbev/msn110; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fryxell KJ, 2005, MOL BIOL EVOL, V22, P650, DOI 10.1093/molbev/msi043; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIAIMO RD, 2001, GENE, V272, P199; Han L, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/565631; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jabbari K, 1997, GENE, V205, P109, DOI 10.1016/S0378-1119(97)00475-7; JOST JP, DNA METHYLATON MOL B; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; NEI M, 1987, MOL EVOLUTIONARY GEN, P73; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; Ream RA, 2003, MOL BIOL EVOL, V20, P105, DOI 10.1093/molbev/msg008; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Wang Y, 2004, BIOINFORMATICS, V20, P3336, DOI 10.1093/bioinformatics/bth393; Wang Y, 2004, J MOL EVOL, V58, P692, DOI 10.1007/s00239-004-2591-1; WANG Y, 2008, GENOMICS PR IN PRESS; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Wu PY, 2003, J BIOL CHEM, V278, P5285, DOI 10.1074/jbc.M210884200; Xia XH, 2003, J MOL EVOL, V56, P362, DOI 10.1007/s00239-002-2406-1	39	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3612	10.1371/journal.pone.0003612	http://dx.doi.org/10.1371/journal.pone.0003612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005573	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166200001
J	Nygren, JM; Bryder, D				Nygren, Jens M.; Bryder, David			A Novel Assay to Trace Proliferation History In Vivo Reveals that Enhanced Divisional Kinetics Accompany Loss of Hematopoietic Stem Cell Self-Renewal	PLOS ONE			English	Article								Background: The maintenance of lifelong blood cell production ultimately rests on rare hematopoietic stem cells (HSCs) that reside in the bone marrow microenvironment. HSCs are traditionally viewed as mitotically quiescent relative to their committed progeny. However, traditional techniques for assessing proliferation activity in vivo, such as measurement of BrdU uptake, are incompatible with preservation of cellular viability. Previous studies of HSC proliferation kinetics in vivo have therefore precluded direct functional evaluation of multi-potency and self-renewal, the hallmark properties of HSCs. Methodology/Principal Findings: We developed a non-invasive labeling technique that allowed us to identify and isolate candidate HSCs and early hematopoietic progenitor cells based on their differential in vivo proliferation kinetics. Such cells were functionally evaluated for their abilities to multi-lineage reconstitute myeloablated hosts. Conclusions: Although at least a few HSC divisions per se did not influence HSC function, enhanced kinetics of divisional activity in steady state preceded the phenotypic changes that accompanied loss of HSC self-renewal. Therefore, mitotic quiescence of HSCs, relative to their committed progeny, is key to maintain the unique functional and molecular properties of HSCs.	[Nygren, Jens M.; Bryder, David] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Nygren, JM (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	jens.nygren@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237; Nygren, Jens M/0000-0002-3576-2393	Swedish Childhood Cancer Foundation; Mary Beves Stiftelse; The Crafoord Foundation; The Swedish Society for Medical Research; The Swedish Strategic Research Foundation	Swedish Childhood Cancer Foundation(European Commission); Mary Beves Stiftelse; The Crafoord Foundation; The Swedish Society for Medical Research; The Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research)	This study was supported by grants from the Swedish Childhood Cancer Foundation, Mary Beves Stiftelse, The Crafoord Foundation, The Swedish Society for Medical Research, The Swedish Cancer Society, The Swedish Medical Research Council, and The Swedish Strategic Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; CHRISTIAN JA, 1993, BLOOD, V82, P3469; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gardner RV, 2001, EUR J HAEMATOL, V67, P14, DOI 10.1034/j.1600-0609.2001.067001014.x; HEILMANN E, 1993, BRIT J HAEMATOL, V85, P729, DOI 10.1111/j.1365-2141.1993.tb03216.x; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nygren JM, 2006, J IMMUNOL, V177, P201, DOI 10.4049/jimmunol.177.1.201; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Seitz G, 2005, ANN NY ACAD SCI, V1044, P84, DOI 10.1196/annals.1349.011; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yan F, 2003, EXP HEMATOL, V31, P56, DOI 10.1016/S0301-472X(02)01012-3; Yanai N, 2000, BLOOD, V96, P139, DOI 10.1182/blood.V96.1.139.013k15_139_144	28	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3710	10.1371/journal.pone.0003710	http://dx.doi.org/10.1371/journal.pone.0003710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002266	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166000010
J	Evnouchidou, I; Momburg, F; Papakyriakou, A; Chroni, A; Leondiadis, L; Chang, SC; Goldberg, AL; Stratikos, E				Evnouchidou, Irini; Momburg, Frank; Papakyriakou, Athanasios; Chroni, Angeliki; Leondiadis, Leondios; Chang, Shih-Chung; Goldberg, Alfred L.; Stratikos, Efstratios			The Internal Sequence of the Peptide-Substrate Determines Its N-Terminus Trimming by ERAP1	PLOS ONE			English	Article								Background: Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims N-terminally extended antigenic peptide precursors down to mature antigenic peptides for presentation by major histocompatibility complex (MHC) class I molecules. ERAP1 has unique properties for an aminopeptidase being able to trim peptides in vitro based on their length and the nature of their C-termini. Methodology/Principal Findings: In an effort to better understand the molecular mechanism that ERAP1 uses to trim peptides, we systematically analyzed the enzyme's substrate preferences using collections of peptide substrates. We discovered strong internal sequence preferences of peptide N-terminus trimming by ERAP1. Preferences were only found for positively charged or hydrophobic residues resulting to trimming rate changes by up to 100 fold for single residue substitutions and more than 40,000 fold for multiple residue substitutions for peptides with identical N-termini. Molecular modelling of ERAP1 revealed a large internal cavity that carries a strong negative electrostatic potential and is large enough to accommodate peptides adjacent to the enzyme's active site. This model can readily account for the strong preference for positively charged side chains. Conclusions/Significance: To our knowledge no other aminopeptidase has been described to have such strong preferences for internal residues so distal to the N-terminus. Overall, our findings indicate that the internal sequence of the peptide can affect its trimming by ERAP1 as much as the peptide's length and C-terminus. We therefore propose that ERAP1 recognizes the full length of its peptide-substrate and not just the N- and C-termini. It is possible that ERAP1 trimming preferences influence the rate of generation and the composition of antigenic peptides in vivo.	[Evnouchidou, Irini; Leondiadis, Leondios; Stratikos, Efstratios] IRRP, Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece; [Momburg, Frank] German Canc Res Ctr, Dept Mol Immunol, Heidelberg, Germany; [Papakyriakou, Athanasios] Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece; [Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biol, Aghia Paraskevi, Greece; [Chang, Shih-Chung] Natl Taiwan Univ, Dept Biochem Sci & Technol, Inst Microbiol & Biochem, Taipei, Taiwan; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	National Centre of Scientific Research "Demokritos"; Helmholtz Association; German Cancer Research Center (DKFZ); National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; National Taiwan University; Harvard University; Harvard Medical School	Evnouchidou, I (corresponding author), IRRP, Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece.	stratos@rrp.demokritos.gr	Evnouchidou, Irini/Z-3072-2019; Papakyriakou, Athanasios/K-7033-2012; Hsiao, Wei-Hung/B-9931-2013; Stratikos, Efstratios/N-2969-2014	Papakyriakou, Athanasios/0000-0003-3931-6232; Stratikos, Efstratios/0000-0002-3566-2309; Chroni, Angeliki/0000-0003-3107-1189; CHANG, SHIH-CHUNG/0000-0002-5015-8178	The Medical Foundation, Boston; Marie-Curie; NCSR; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	The Medical Foundation, Boston; Marie-Curie(European Commission); NCSR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by funding by The Medical Foundation, Boston (Charles A. King Grant to E.S.), by a Marie-Curie International Reintegration Grant (E.S.) a NCSR "Demokritos" "Demoerevna 2007" research grant (E.S) and by the National Institutes of Health (A.L.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano W.L., PYMOL MOL GRAPHICS S; Falk K, 2002, NAT IMMUNOL, V3, P1121, DOI 10.1038/ni1202-1121; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; Papakyriakou A, 2007, BIOCHEMISTRY-US, V46, P8753, DOI 10.1021/bi700253q; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	41	71	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3658	10.1371/journal.pone.0003658	http://dx.doi.org/10.1371/journal.pone.0003658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987748	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134500005
J	Aleman, A; Swart, M				Aleman, Andre; Swart, Marte			Sex Differences in Neural Activation to Facial Expressions Denoting Contempt and Disgust	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; GENDER-DIFFERENCES; AMYGDALA ACTIVATION; VISUAL-STIMULI; PERCEPTION; RESPONSES; COMPETITION; PICTURES; FEARFUL; SYSTEMS	The facial expression of contempt has been regarded to communicate feelings of moral superiority. Contempt is an emotion that is closely related to disgust, but in contrast to disgust, contempt is inherently interpersonal and hierarchical. The aim of this study was twofold. First, to investigate the hypothesis of preferential amygdala responses to contempt expressions versus disgust. Second, to investigate whether, at a neural level, men would respond stronger to biological signals of interpersonal superiority (e. g., contempt) than women. We performed an experiment using functional magnetic resonance imaging (fMRI), in which participants watched facial expressions of contempt and disgust in addition to neutral expressions. The faces were presented as distractors in an oddball task in which participants had to react to one target face. Facial expressions of contempt and disgust activated a network of brain regions, including prefrontal areas (superior, middle and medial prefrontal gyrus), anterior cingulate, insula, amygdala, parietal cortex, fusiform gyrus, occipital cortex, putamen and thalamus. Contemptuous faces did not elicit stronger amygdala activation than did disgusted expressions. To limit the number of statistical comparisons, we confined our analyses of sex differences to the frontal and temporal lobes. Men displayed stronger brain activation than women to facial expressions of contempt in the medial frontal gyrus, inferior frontal gyrus, and superior temporal gyrus. Conversely, women showed stronger neural responses than men to facial expressions of disgust. In addition, the effect of stimulus sex differed for men versus women. Specifically, women showed stronger responses to male contemptuous faces (as compared to female expressions), in the insula and middle frontal gyrus. Contempt has been conceptualized as signaling perceived moral violations of social hierarchy, whereas disgust would signal violations of physical purity. Thus, our results suggest a neural basis for sex differences in moral sensitivity regarding hierarchy on the one hand and physical purity on the other.	[Aleman, Andre; Swart, Marte] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Aleman, Andre] Univ Utrecht, Dept Expt Psychol, NL-3508 TC Utrecht, Netherlands	University of Groningen; Utrecht University	Aleman, A (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands.	a.aleman@med.umcg.nl	Aleman, Andre/E-1341-2012		Netherlands Organisation for Scientific Research [026.027.028]; European Science Foundation [EURYI Award]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Science Foundation(European Science Foundation (ESF)European Commission)	This research was supported by a grant from the Netherlands Organisation for Scientific Research (N.W.O. 026.027.028) and a EURYI Award from the European Science Foundation. The funding agencies had no role in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Caseras X, 2007, BIOL PSYCHIAT, V62, P464, DOI 10.1016/j.biopsych.2006.10.030; Ekman P., 2003, EMOTIONS REVEALED, V2; Fischer H, 2007, EMOTION, V7, P767, DOI 10.1037/1528-3542.7.4.767; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goldsmith J, 2002, HDB AFFECTIVE SCI, P852; Gottman J. M., 2001, J FAMILY COMMUNICATI, V1, P37, DOI DOI 10.1207/S15327698JFC0101_06; Hofer A, 2007, PSYCHOL MED, V37, P109, DOI 10.1017/S0033291706008919; Houston JM, 2005, PSYCHOL REP, V97, P205, DOI 10.2466/pr0.97.1.205-212; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Matsumoto D, 2004, J PERS SOC PSYCHOL, V87, P529, DOI 10.1037/0022-3514.87.4.529; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Miller William Ian, 1997, ANATOMY DISGUST; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; PREHN K, 2008, SOC COGN AF IN PRESS; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Scheuerecker J, 2007, NEUROPSYCHOBIOLOGY, V56, P32, DOI 10.1159/000110726; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; SCHWEDER RJ, 1997, BIG 3 MORALITY AUTON; Shirao N, 2005, EUR ARCH PSY CLIN N, V255, P327, DOI 10.1007/s00406-005-0566-x; SIDANIUS J, 1994, J PERS SOC PSYCHOL, V67, P998, DOI 10.1037/0022-3514.67.6.998; Talairach I., 1988, COPLANAR STEREOTACTI; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Wang LH, 2005, EMOTION, V5, P12, DOI 10.1037/1528-3542.5.1.12; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whiting JB, 2008, J MARITAL FAM THER, V34, P44, DOI 10.1111/j.1752-0606.2008.00052.x; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499	44	60	61	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3622	10.1371/journal.pone.0003622	http://dx.doi.org/10.1371/journal.pone.0003622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LK	18985147	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134400004
J	van der Linden, M; Murre, JMJ; van Turennout, M				van der Linden, Marieke; Murre, Jaap M. J.; van Turennout, Miranda			Birds of a Feather Flock Together: Experience-Driven Formation of Visual Object Categories in Human Ventral Temporal Cortex	PLOS ONE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; FALSE DISCOVERY RATE; PREFRONTAL CORTEX; NEURAL MECHANISMS; HUMAN-BODY; SELECTIVITY; REPRESENTATION; MEMORY; PERCEPTION	The present functional magnetic resonance imaging study provides direct evidence on visual object-category formation in the human brain. Although brain imaging has demonstrated object-category specific representations in the occipitotemporal cortex, the crucial question of how the brain acquires this knowledge has remained unresolved. We designed a stimulus set consisting of six highly similar bird types that can hardly be distinguished without training. All bird types were morphed with one another to create different exemplars of each category. After visual training, fMRI showed that responses in the right fusiform gyrus were larger for bird types for which a discrete category-boundary was established as compared with not-trained bird types. Importantly, compared with not-trained bird types, right fusiform responses were smaller for visually similar birds to which subjects were exposed during training but for which no category-boundary was learned. These data provide evidence for experience-induced shaping of occipitotemporal responses that are involved in category learning in the human brain.	[van Turennout, Miranda] FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Murre, Jaap M. J.] Univ Amsterdam, Dept Psychol, NL-1012 WX Amsterdam, Netherlands; [van Turennout, Miranda] Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands	University of Amsterdam; Radboud University Nijmegen	van der Linden, M (corresponding author), FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands.	mail@mariekevanderlinden.com	Murre, Jaap MJ/A-3813-2010; van der Linden, Marieke/J-2851-2012	Murre, Jaap/0000-0003-4447-9482	Netherlands Organisation for Scientific Research [NWO 400-03-338]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Netherlands Organisation for Scientific Research (NWO 400-03-338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilaie-Dotan S, 2007, CEREB CORTEX, V17, P325, DOI 10.1093/cercor/bhj150; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PEISSIG JJ, 2007, EFFECTS LONG TERM OB, P1323; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Scott LS, 2006, J COGNITIVE NEUROSCI, V18, P1453, DOI 10.1162/jocn.2006.18.9.1453; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Szabo M, 2006, BIOL CYBERN, V94, P351, DOI 10.1007/s00422-006-0054-z; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006; Zago L, 2005, CEREB CORTEX, V15, P1655, DOI 10.1093/cercor/bhi060	46	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3995	10.1371/journal.pone.0003995	http://dx.doi.org/10.1371/journal.pone.0003995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107187	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000006
J	Vieira, KS; Arzabe, C; Hernandez, MIM; Vieira, WLS				Vieira, Kleber S.; Arzabe, Cristina; Hernandez, Malva I. M.; Vieira, Washington L. S.			An Examination of Morphometric Variations in a Neotropical Toad Population (Proceratophrys cristiceps, Amphibia, Anura, Cycloramphidae)	PLOS ONE			English	Article							INTRASPECIFIC VARIATION; COLUBRIDAE; SNAKE; SHAPE	The species Proceratophrys cristiceps belongs to the genus Proceratophrys within the family Cycloramphidae. These amphibians are found exclusively in South America in the morphoclimatic domain of the semi-arid depression zones in northeastern Brazil known as the Caatinga. We examined intrapopulational variation using univariate and multivariate statistics with traditional and geometric morphometrics, which supported the existence of two morphotypes of this species. Our results indicated significant degrees of variation in skeletal characteristics between some natural populations of this species. Careful analyses of variability levels are fundamental to avoid taxonomic errors, principally in populations that demonstrate characteristics intimately associated with their area of occurrence, as is the case of Proceratophrys cristiceps.	Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Arzabe, Cristina] UEP Parnaiba, Embrapa Meio Norte, Parnaiba, Piaui, Brazil; [Hernandez, Malva I. M.] Univ Fed Santa Catarina, Dept Ecol Zool, Florianopolis, SC, Brazil; [Vieira, Washington L. S.] Univ Fed Paraiba, Dept Sistematica Ecol, Programa Pos Grad Ciencias Biol, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Santa Catarina (UFSC); Universidade Federal da Paraiba	Vieira, KS (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, Campus 1, BR-58059900 Joao Pessoa, Paraiba, Brazil.	ksvieira04@yahoo.com.br	Vieira, Kleber/C-1354-2013; ARZABE, CRISTINA/I-7585-2013; Vieira, Kleber/AAF-8220-2019; Vieira, Washington Luiz/U-1122-2019; Hernandez, Malva I. M./E-3485-2013	Vieira, Kleber/0000-0001-7664-6236; Vieira, Washington Luiz/0000-0002-0673-262X; Hernandez, Malva I. M./0000-0002-6820-5980	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Pos-graduacao em Ciencias Biologicas (Zoologia) of the Universidade Federal da Paraiba	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Pos-graduacao em Ciencias Biologicas (Zoologia) of the Universidade Federal da Paraiba	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa de Pos-graduacao em Ciencias Biologicas (Zoologia) of the Universidade Federal da Paraiba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Arango HG., 2001, BIOESTATISTICA TEORI; Barahona F, 1998, J ZOOL, V245, P393, DOI 10.1017/S0952836998008036; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BOOKSTEIN FL, 1990, SPECIAL PUBLICATION, V2, P215; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1993, CONTRIBUTIONS MORPHO, P15; Braun P.C., 1973, Iheringia Zoologia, VNo. 43, P91; Chapman R, 1990, SPECIAL PUBLICATION, V2, P251; CRUZ CAG, 2005, ARQUIVOS MUSEU NACL, V63, P289; Vieira WLD, 2007, ZOOTAXA, P17; Dias Andre Goncalves, 1993, Revista Brasileira de Zoologia, V10, P439; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Giaretta AA, 2000, J HERPETOL, V34, P173, DOI 10.2307/1565412; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; *HACC AM SOC ICHTH, GUID US LIV AMPH REP; HAMMER O, 2007, PAST VERSION 1 73C P; HAMMER O, 2002, MORPHOMETRICS BRIEF, P49; Heyer W.R., 1994, MEASURING MONITORING; IZECKSOHN E, 1981, Revista Brasileira de Biologia, V41, P19; IZECKSOHN E, 1980, Revista Brasileira de Biologia, V40, P605; Izecksohn Eugenio, 2005, Rev. Bras. Zool., V22, P225, DOI 10.1590/S0101-81752005000100028; KARIYA T, 1981, ANN STAT, V9, P211, DOI 10.1214/aos/1176345350; Krystufek B, 2002, J ZOOL, V258, P365, DOI 10.1017/S0952836902001516; LOPEZ JRF, 1991, REV CUBA MED TROP, V43, P26; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; LYNCH JD, 1971, U KANSAS MISCELLANEO, V53; Manier MK, 2004, BIOL J LINN SOC, V83, P65, DOI 10.1111/j.1095-8312.2004.00373.x; Marcus Leslie F., 2000, Hystrix, V11, P27; Martin GM, 2005, J MAMMAL, V86, P793, DOI 10.1644/1545-1542(2005)086[0793:IVILHM]2.0.CO;2; MAYR E, 1971, POPULATIONS SPECIES; Miller R.L., 1962, STAT ANAL GEOLOGICAL; Miranda-Ribeiro A. de, 1920, REV MUS PAUL SAO PAU, V12, P291; MIRANDARIBEIRO A, 1937, ESPECIES NOVAS GENER; Monteiro L. R., 1999, PRINCIPIOS MORFOMERI; Monteiro LR, 2002, EVOLUTION, V56, P563, DOI 10.1111/j.0014-3820.2002.tb01367.x; Moore MK, 2003, J HERPETOL, V37, P714, DOI 10.1670/246-01N; MULLER F, 1883, KATALOG TYPUSEXEMPLA, V57; Napoli Marcelo Felgueiras, 1999, Alytes (Paris), V16, P165; Pretorius E, 2005, AUST J ENTOMOL, V44, P113, DOI 10.1111/j.1440-6055.2005.00464.x; Rohlf F. James, 1992, P95; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 2006, TPSDIG VERSION 2 05; Sanchiz B., 1998, SALIENTIA HDB PALA 4; Savage JM, 1996, BIOL J LINN SOC, V57, P129, DOI 10.1111/j.1095-8312.1996.tb01833.x; STRAUGHAN I. R., 1966, PROC ROY SOC QUEENSLAND, V78, P11; VIEIRA S, 1989, ESTATISTICA EXPT; WEYGOLDT P, 1985, Senckenbergiana Biologica, V66, P1; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; WILEY EO, 1981, PHYLOGENETICS  THEOR; Zar JH, 1999, BIOSTATISTICAL ANAL; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	53	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3934	10.1371/journal.pone.0003934	http://dx.doi.org/10.1371/journal.pone.0003934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088855	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458500001
J	Chen, CTL; Gottlieb, DI; Cohen, BA				Chen, Christina T. L.; Gottlieb, David I.; Cohen, Barak A.			Ultraconserved Elements in the Olig2 Promoter	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; OLIGODENDROCYTE DEVELOPMENT; TRANSCRIPTION FACTOR; NEURONAL PROPERTIES; SPINAL-CORD; DIFFERENTIATION; IDENTIFICATION; SEQUENCES; PATTERNS	Background: Oligodendrocytes are specialized cells of the nervous system that produce the myelin sheaths surrounding the axons of neurons. Myelinating the axons increases the speed of nerve conduction and demyelination contributes to the pathology of neurodegenerative diseases such as multiple sclerosis. Oligodendrocyte differentiation is specified early in development by the expression of the basic-helix-loop-helix transcription factor Olig2 in the ventral region of the neural tube. Understanding how Olig2 expression is controlled is therefore essential for elucidating the mechanisms governing oligodendrocyte differentiation. A method is needed to identify potential regulatory sequences in the long stretches of adjacent non-coding DNA that flank Olig2. Methodology/Principal Findings: We identified ten potential regulatory regions upstream of Olig2 based on a combination of bioinformatics metrics that included evolutionary conservation across multiple vertebrate genomes, the presence of potential transcription factor binding sites and the existence of ultraconserved elements. One of our computational predictions includes a region previously identified as the Olig2 basal promoter, suggesting that our criterion represented characteristics of known regulatory regions. In this study, we tested one candidate regulatory region for its ability to modulate the Olig2 basal promoter and found that it represses expression in undifferentiated embryonic stem cells. Conclusions/Significance: The regulatory region we identified modifies the expression regulated by the Olig2 basal promoter in a manner consistent with our current understanding of Olig2 expression during oligodendrocyte differentiation. Our results support a model in which constitutive activation of Olig2 by its basal promoter is repressed in undifferentiated cells by upstream repressive elements until that repression is relieved during differentiation. We conclude that the potential regulatory elements presented in this study provide a good starting point for unraveling the cis-regulatory logic that governs Olig2 expression. Future studies of the functionality of the potential regulatory elements we present will help reveal the interactions that govern Olig2 expression during development.	[Cohen, Barak A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Gottlieb, David I.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chen, CTL (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	cohen@genetics.wustl.edu			National Science Foundation [MCB-0543156]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (MCB-0543156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bauer DC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-220; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Bronchain OJ, 2007, DEV GENES EVOL, V217, P485, DOI 10.1007/s00427-007-0158-z; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chen CTL, 2007, AM J HUM GENET, V80, P692, DOI 10.1086/513149; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Du ZW, 2004, STEM CELLS DEV, V13, P372, DOI 10.1089/scd.2004.13.372; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Girault JA, 2003, BIOL CELL, V95, P447, DOI 10.1016/S0248-4900(03)00073-X; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KUHLMANN T, 2008, BRAIN; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MEISSNER A, 2008, NATURE; Murakami K, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-16; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Park HC, 2007, DEV DYNAM, V236, P3402, DOI 10.1002/dvdy.21365; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sun T, 2006, DEV BIOL, V292, P152, DOI 10.1016/j.ydbio.2005.12.047; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Xian HQ, 2003, STEM CELLS, V21, P41, DOI 10.1634/stemcells.21-1-41; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; ZHANG X, 2008, STEM CELLS	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3946	10.1371/journal.pone.0003946	http://dx.doi.org/10.1371/journal.pone.0003946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079603	Green Published, gold			2022-12-27	WOS:000265458400005
J	Yamanaka, S; Zahanich, I; Wersto, RP; Boheler, KR				Yamanaka, Satoshi; Zahanich, Ihor; Wersto, Robert P.; Boheler, Kenneth R.			Enhanced Proliferation of Monolayer Cultures of Embryonic Stem (ES) Cell-Derived Cardiomyocytes Following Acute Loss of Retinoblastoma	PLOS ONE			English	Article							CARDIAC PRECURSOR CELLS; SMOOTH MUSCLE ACTIN; DNA-SYNTHESIS; CYCLE PROGRESSION; SARCOMERIC ACTIN; FAMILY-MEMBERS; TROPONIN-I; RAT-HEART; B-MYB; EXPRESSION	Background: Cardiomyocyte (CM) cell cycle analysis has been impeded because of a reliance on primary neonatal cultures of poorly proliferating cells or chronic transgenic animal models with innate compensatory mechanisms. Methodology/Principal Findings: We describe an in vitro model consisting of monolayer cultures of highly proliferative embryonic stem (ES) cell-derived CM. Following induction with ascorbate and selection with puromycin, early CM cultures are >98% pure, and at least 85% of the cells actively proliferate. During the proliferative stage, cells express high levels of E2F3a, B-Myb and phosphorylated forms of retinoblastoma (Rb), but with continued cultivation, cells stop dividing and mature functionally. This developmental transition is characterized by a switch from slow skeletal to cardiac TnI, an increase in binucleation, cardiac calsequestrin and hypophosphorylated Rb, a decrease in E2F3, B-Myb and atrial natriuretic factor, and the establishment of a more negative resting membrane potential. Although previous publications suggested that Rb was not necessary for cell cycle control in heart, we find following acute knockdown of Rb that this factor actively regulates progression through the G1 checkpoint and that its loss promotes proliferation at the expense of CM maturation. Conclusions/Significance: We have established a unique model system for studying cardiac cell cycle progression, and show in contrast to previous reports that Rb actively regulates both cell cycle progression through the G1 checkpoint and maturation of heart cells. We conclude that this in vitro model will facilitate the analysis of cell cycle control mechanisms of CMs.	[Yamanaka, Satoshi; Zahanich, Ihor; Boheler, Kenneth R.] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, NIH, Resource Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yamanaka, S (corresponding author), NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov			Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZICAG000618, Z01AG000618, Z01AG000849, ZIAAG000849] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging (KRB, RPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Anversa P, 2002, J MOL CELL CARDIOL, V34, P91, DOI 10.1006/jmcc.2001.1506; BABAI F, 1990, DIFFERENTIATION, V44, P132, DOI 10.1111/j.1432-0436.1990.tb00546.x; Baker JE, 1999, CIRCULATION, V99, P1249, DOI 10.1161/01.CIR.99.9.1249; Barth AS, 2008, MOL THER, V16, P957, DOI 10.1038/mt.2008.30; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; Fijnvandraat AC, 2003, J MOL CELL CARDIOL, V35, P1461, DOI 10.1016/j.yjmcc.2003.09.011; Fijnvandraat AC, 2003, CARDIOVASC RES, V58, P399, DOI 10.1016/S0008-6363(03)00282-7; Flink IL, 1998, J MOL CELL CARDIOL, V30, P563, DOI 10.1006/jmcc.1997.0620; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Klug MG, 1995, AM J PHYSIOL-HEART C, V269, pH1913, DOI 10.1152/ajpheart.1995.269.6.H1913; Koban MU, 1998, CARDIOVASC RES, V37, P405, DOI 10.1016/S0008-6363(97)00276-9; Koban MU, 2001, MECH DEVELOP, V109, P267, DOI 10.1016/S0925-4773(01)00548-2; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; KOH GY, 1995, J INTERV CARDIOL, V8, P387, DOI 10.1111/j.1540-8183.1995.tb00564.x; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Liu Y, 1996, J CELL BIOL, V133, P325, DOI 10.1083/jcb.133.2.325; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; MILLERHANCE WC, 1993, J BIOL CHEM, V268, P25244; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muhlfeld C, 2006, ANAT REC PART A, V288A, P297, DOI 10.1002/ar.a.20315; Muhlfeld C, 2005, COMP BIOCHEM PHYS A, V141, P310, DOI 10.1016/j.cbpb.2005.06.001; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Papadimou E, 2005, EMBO J, V24, P1750, DOI 10.1038/sj.emboj.7600652; Park KW, 1998, GENE, V217, P25, DOI 10.1016/S0378-1119(98)00372-2; Perino MG, 2008, J MOL CELL CARDIOL, V45, P475, DOI 10.1016/j.yjmcc.2008.05.002; Puceat M, 2005, CELL CYCLE, V4, P1030, DOI 10.4161/cc.4.8.1905; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Rubart M, 2006, ANN NY ACAD SCI, V1080, P34, DOI 10.1196/annals.1380.004; SABRY MA, 1989, J MUSCLE RES CELL M, V10, P85, DOI 10.1007/BF01739858; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; Shackney SE, 1999, CYTOMETRY, V35, P97, DOI 10.1002/(SICI)1097-0320(19990201)35:2<97::AID-CYTO1>3.3.CO;2-X; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yutzey KE, 2007, CIRCULATION, V115, P792, DOI 10.1161/CIRCULATIONAHA.106.682534; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449	70	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3896	10.1371/journal.pone.0003896	http://dx.doi.org/10.1371/journal.pone.0003896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066628	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455700006
J	Lewkowich, IP; Lajoie, S; Clark, JR; Herman, NS; Sproles, AA; Wills-Karp, M				Lewkowich, Ian P.; Lajoie, Stephane; Clark, Jennifer R.; Herman, Nancy S.; Sproles, Alyssa A.; Wills-Karp, Marsha			Allergen Uptake, Activation, and IL-23 Production by Pulmonary Myeloid DCs Drives Airway Hyperresponsiveness in Asthma-Susceptible Mice	PLOS ONE			English	Article								Maladaptive, Th2-polarized inflammatory responses are integral to the pathogenesis of allergic asthma. As regulators of T cell activation, dendritic cells (DCs) are important mediators of allergic asthma, yet the precise signals which render endogenous DCs "pro-asthmatic'', and the extent to which these signals are regulated by the pulmonary environment and host genetics, remains unclear. Comparative phenotypic and functional analysis of pulmonary DC populations in mice susceptible (A/J), or resistant (C3H) to experimental asthma, revealed that susceptibility to airway hyperresponsiveness is associated with preferential myeloid DC (mDC) allergen uptake, and production of Th17-skewing cytokines (IL-6, IL-23), whereas resistance is associated with increased allergen uptake by plasmacytoid DCs. Surprisingly, adoptive transfer of syngeneic HDM-pulsed bone marrow derived mDCs (BMDCs) to the lungs of C3H mice markedly enhanced lung IL-17A production, and rendered them susceptible to allergen-driven airway hyperresponsiveness. Characterization of these BMDCs revealed levels of antigen uptake, and Th17 promoting cytokine production similar to that observed in pulmonary mDCs from susceptible A/J mice. Collectively these data demonstrate that the lung environment present in asthma-resistant mice promotes robust pDC allergen uptake, activation, and limits Th17-skewing cytokine production responsible for driving pathologic T cell responses central to the development of allergen-induced airway hyperresponsiveness.	[Lewkowich, Ian P.; Lajoie, Stephane; Clark, Jennifer R.; Herman, Nancy S.; Sproles, Alyssa A.; Wills-Karp, Marsha] Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Immunobiol, Cincinnati, OH 45267 USA; [Wills-Karp, Marsha] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lewkowich, IP (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Immunobiol, Cincinnati, OH 45267 USA.	wildc7@cchmc.org		Lajoie, Stephane/0000-0002-0514-1801	NHLBI [HL67736, HL076383]; NIH [AR47363]; American Lung Association [Senior Research Training Fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736, P01HL076383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NHLBI grants HL67736 and HL076383 to MWK, and NIH grant AR47363 to support the flow cytometry core at Cincinnati Children's Hospital Medical Center. IPL is the recipient of a Senior Research Training Fellowship from the American Lung Association. The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1997, CELL IMMUNOL, V181, P86, DOI 10.1006/cimm.1997.1180; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Betti M, 2006, ANN ONCOL, V17, P235; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cates EC, 2003, J ALLERGY CLIN IMMUN, V111, P1076, DOI 10.1067/mai.2003.1460; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Deurloo DT, 2003, CLIN EXP ALLERGY, V33, P1297, DOI 10.1046/j.1365-2222.2003.01757.x; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Faith A, 2005, J ALLERGY CLIN IMMUN, V116, P1136, DOI 10.1016/j.jaci.2005.08.002; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Finkelman FD, 2005, J IMMUNOL, V174, P4630, DOI 10.4049/jimmunol.174.8.4630; FUKUSHIMA A, 2006, BR J OPHTHALMOL; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Graffi SJ, 2002, CLIN IMMUNOL, V103, P176, DOI 10.1006/clim.2002.5190; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hewitt CRA, 1997, CLIN EXP ALLERGY, V27, P201, DOI 10.1111/j.1365-2222.1997.tb00694.x; Holt Patrick G, 2005, Proc Am Thorac Soc, V2, P116, DOI 10.1513/pats.200502-017AW; HOLT PG, 1988, J EXP MED, V167, P262, DOI 10.1084/jem.167.2.262; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Ito T, 2004, J IMMUNOL, V172, P4253, DOI 10.4049/jimmunol.172.7.4253; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KATAMURA K, 1995, J IMMUNOL, V155, P4604; Keane-Myers A, 1998, J IMMUNOL, V161, P919; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lambrecht BN, 2000, CLIN EXP ALLERGY, V30, P214; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Piconi S, 2007, J IMMUNOL, V178, P1931, DOI 10.4049/jimmunol.178.3.1931; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Ritz SA, 2002, AM J RESP CELL MOL, V27, P428, DOI 10.1165/rcmb.4824; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; Tokita D, 2008, TRANSPLANTATION, V85, P369, DOI 10.1097/TP.0b013e3181612ded; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wang YL, 2006, LIVER TRANSPLANT, V12, P1850, DOI 10.1002/lt.20919; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	76	79	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3879	10.1371/journal.pone.0003879	http://dx.doi.org/10.1371/journal.pone.0003879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060952	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455100004
J	Montag, C; Schubert, F; Heinz, A; Gallinat, J				Montag, Christiane; Schubert, Florian; Heinz, Andreas; Gallinat, Juergen			Prefrontal Cortex Glutamate Correlates with Mental Perspective-Taking	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MRS; INDIVIDUAL-DIFFERENCES; SCHIZOPHRENIA; EMPATHY; HIPPOCAMPAL; AUTISM; MIND; STIMULATION; REGIONS	Background: Dysfunctions in theory of mind and empathic abilities have been suggested as core symptoms in major psychiatric disorders including schizophrenia and autism. Since self monitoring, perspective taking and empathy have been linked to prefrontal (PFC) and anterior cingulate cortex (ACC) function, neurotransmitter variations in these areas may account for normal and pathological variations of these functions. Converging evidence indicates an essential role of glutamatergic neurotransmission in psychiatric diseases with pronounced deficits in empathy. However, the role of the glutamate system for different dimensions of empathy has not been investigated so far. Methodology/Principal Findings: Absolute concentrations of cerebral glutamate in the ACC, left dorsolateral PFC and left hippocampus were determined by 3-tesla proton magnetic resonance spectroscopy (1H-MRS) in 17 healthy individuals. Three dimensions of empathy were estimated by a self-rating questionnaire, the Interpersonal Reactivity Index (IRI). Linear regression analysis showed that dorsolateral PFC glutamate concentration was predicted by IRI factor "perspective taking'' (T = 22.710, p = 0.018; adjusted alpha-level of 0.017, Bonferroni) but not by "empathic concern'' or "personal distress''. No significant relationship between IRI subscores and the glutamate levels in the ACC or left hippocampus was detected. Conclusions/Significance: This is the first study to investigate the role of the glutamate system for dimensions of theory of mind and empathy. Results are in line with recent concepts that executive top-down control of behavior is mediated by prefrontal glutamatergic projections. This is a preliminary finding that needs a replication in an independent sample.	[Heinz, Andreas; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Schubert, Florian] Phys Tech Bundesanstalt Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB)	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de	Heinz, Andreas/ABB-7736-2020	Heinz, Andreas/0000-0001-5405-9065; Montag, Christiane/0000-0002-3307-276X	German Federal Ministry of Education and Research [01G00208]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Support from the German Federal Ministry of Education and Research (BMBF, Project Berlin Neuroimaging Center, No. 01G00208), is gratefully acknowledged. The German Federal Ministry of Education and Research had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deakin JFW, 2008, ARCH GEN PSYCHIAT, V65, P154, DOI 10.1001/archgenpsychiatry.2007.37; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Elster C, 2005, MAGN RESON MED, V53, P1288, DOI 10.1002/mrm.20500; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Harich S, 2007, PSYCHOPHARMACOLOGY, V192, P511, DOI 10.1007/s00213-007-0742-y; Janssen I, 2003, ACTA PSYCHIAT SCAND, V108, P110, DOI 10.1034/j.1600-0447.2003.00092.x; Langdon R, 2004, PSYCHIAT RES, V125, P9, DOI 10.1016/j.psychres.2003.10.005; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luborzewski A, 2007, J PSYCHIATR RES, V41, P606, DOI 10.1016/j.jpsychires.2006.02.003; McDougle CJ, 2005, J CLIN PSYCHIAT, V66, P9; Melendez RI, 2004, NEUROPSYCHOPHARMACOL, V29, P1980, DOI 10.1038/sj.npp.1300507; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Ohrmann P, 2007, J PSYCHIATR RES, V41, P625, DOI 10.1016/j.jpsychires.2006.07.002; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Sanacora G, 2003, ANN NY ACAD SCI, V1003, P292, DOI 10.1196/annals.1300.018; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; Tibbo P, 2004, AM J PSYCHIAT, V161, P1116, DOI 10.1176/appi.ajp.161.6.1116; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041	36	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3890	10.1371/journal.pone.0003890	http://dx.doi.org/10.1371/journal.pone.0003890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZO	19060949	Green Submitted, Green Published, gold			2022-12-27	WOS:000265455100009
J	Terzibasi, E; Valenzano, DR; Benedetti, M; Roncaglia, P; Cattaneo, A; Domenici, L; Cellerino, A				Terzibasi, Eva; Valenzano, Dario Riccardo; Benedetti, Mauro; Roncaglia, Paola; Cattaneo, Antonino; Domenici, Luciano; Cellerino, Alessandro			Large Differences in Aging Phenotype between Strains of the Short-Lived Annual Fish Nothobranchius furzeri	PLOS ONE			English	Article							LIFE-SPAN; EXTRINSIC MORTALITY; SENESCENCE; EVOLUTION; AGE; MODEL; CYPRINODONTIFORMES; GENETICS	Background: A laboratory inbred strain of the annual fish Nothobranchius furzeri shows exceptionally short life expectancy and accelerated expression of age markers. In this study, we analyze new wild-derived lines of this short-lived species. Methodology/Principal Findings: We characterized captive survival and age-related traits in F1 and F2 offspring of wild-caught N. furzeri. Wild-derived N. furzeri lines showed expression of lipofuscin and neurodegeneration at age 21 weeks. Median lifespan in the laboratory varied from to 20 to 23 weeks and maximum lifespan from 25 to 32 weeks. These data demonstrate that rapid age-dependent decline and short lifespan are natural characteristics of this species. The N. furzeri distribution range overlaps with gradients in altitude and aridity. Fish from more arid habitats are expected to experience a shorter survival window in the wild. We tested whether captive lines stemming from semi-arid and sub-humid habitats differ in longevity and expression of age-related traits. We detected a clear difference in age-dependent cognitive decline and a slight difference in lifespan (16% for median, 15% for maximum lifespan) between these lines. Finally, we observed shorter lifespan and accelerated expression of age-related markers in the inbred laboratory strain compared to these wild-derived lines. Conclusions/Significance: Owing to large differences in aging phenotypes in different lines, N. furzeri could represent a model system for studying the genetic control of life-history traits in natural populations.	[Domenici, Luciano] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Terzibasi, Eva; Cellerino, Alessandro] Leibniz Inst, Fritz Lipmann Inst Age Res, Jena, Germany; [Valenzano, Dario Riccardo; Cellerino, Alessandro] Scuola Normale Superiore, Pisa, Italy; [Valenzano, Dario Riccardo] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Benedetti, Mauro; Roncaglia, Paola; Cattaneo, Antonino] Int Sch Advanced Stud, Trieste, Italy; [Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Domenici, Luciano] Univ LAquila, Sch Med, Laquila, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Stanford University; International School for Advanced Studies (SISSA); University of L'Aquila	Terzibasi, E (corresponding author), CNR, Ist Neurosci, I-56100 Pisa, Italy.	acellerino@fli-leibniz.de	Cattaneo, Antonino/AAA-7252-2019; Cellerino, Alessandro/AAJ-7453-2020; Tozzini, Eva Terzibasi/J-9466-2016; Cattaneo, Antonino/K-4471-2016; Cellerino, Alessandro/M-9380-2013; terzibasi tozzini, eva/AEA-0204-2022; Cellerino, Alessandro/AAB-4398-2020	Cellerino, Alessandro/0000-0003-3834-0097; Tozzini, Eva Terzibasi/0000-0003-3317-1538; Cattaneo, Antonino/0000-0002-6975-8923; Cellerino, Alessandro/0000-0003-3834-0097; terzibasi tozzini, eva/0000-0003-3317-1538; Cellerino, Alessandro/0000-0003-3834-0097; Valenzano, Dario Riccardo/0000-0002-8761-8289; Domenici, Luciano/0000-0003-2923-9421; Roncaglia, Paola/0000-0002-2825-0621	LayLineGenomics S.p.A.; Scuola Normale Superiore; Leibniz Gemeinschaft	LayLineGenomics S.p.A.; Scuola Normale Superiore; Leibniz Gemeinschaft	This work was supported by LayLineGenomics S.p.A., Scuola Normale Superiore, and the Leibniz Gemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABRAMS PA, 1991, EVOL ECOL, V5, P343, DOI 10.1007/BF02214152; Austad SN, 2004, J GERONTOL A-BIOL, V59, P99; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Blanco MA, 2005, MECH AGEING DEV, V126, P794, DOI 10.1016/j.mad.2005.02.006; BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Foersch W, 1975, J AM GROWTH DEV AGIN, V8, P315; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hendry AP, 2004, P ROY SOC B-BIOL SCI, V271, P259, DOI 10.1098/rspb.2003.2600; Hoback WW, 2000, J COMP PHYSIOL B, V170, P307, DOI 10.1007/s003600000104; Horiuchi J, 2005, AGEING RES REV, V4, P83, DOI 10.1016/j.arr.2004.10.001; JUBB R A, 1971, Journal of the American Killifish Association, V8, P12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; LEVELS PJ, 1986, COMP BIOCHEM PHYS A, V84, P767, DOI 10.1016/0300-9629(86)90403-2; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Medawar P B., 1952, UNSOLVED PROBLEM BIO; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Promislow DEL, 1998, GENETICA, V102-3, P299, DOI 10.1023/A:1017047212008; REICHARD M, 2008, J FISH BIOL IN PRESS; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SGRO CM, 2000, AM NATUR, V156; SITNIKOVA T, 1995, MOL BIOL EVOL, V12, P319; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Strauss RE, 1999, GROWTH DEVELOP AGING, V63, P151; Swindell WR, 2006, GENETICS, V172, P317, DOI 10.1534/genetics.105.045740; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERZIBASI E, 2006, EXP GERONTOL; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; WOOD T, 2000, BKA KILLI NEWS, V419, P105; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014	43	119	120	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3866	10.1371/journal.pone.0003866	http://dx.doi.org/10.1371/journal.pone.0003866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052641	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452200012
J	Engineer, N; O'Donoghue, K; Wimalasundera, RC; Fisk, NM				Engineer, Neelam; O'Donoghue, Keelin; Wimalasundera, Ruwan C.; Fisk, Nicholas M.			The Effect of Polyhydramnios on Cervical Length in Twins: A Controlled Intervention Study in Complicated Monochorionic Pregnancies	PLOS ONE			English	Article								Objective: To test the hypothesis that cervical shortening in polyhydramnios reflects the degree of excess amniotic fluid, and increases with normalisation of amniotic fluid volume. Study Design: Prospective cohort study of 40 women with monochorionic twins undergoing interventional procedures between 16-26 weeks. Cervical length was assessed via transvaginal sonography pre-procedure, 1 and 24 hours post-procedure, and results compared between amnioreduction and control procedures. Amniotic fluid index (AFI) was measured pre- and post-procedure. Results: Pre-procedural cervical length correlated with AFI (linear fit = 5.07 -0.04x, R(2) = 0.17, P = 0.03) in patients with polyhydramnios (n = 28). Drainage of 2000ml fluid (range 700-3500ml), reduced AFI from 42cm to 21cm (P<0.001). Their pre-procedural cervical length did not change at one (mean Delta:-0.1cm, 95%Cl, -0.4 to 0.2) or 24 hours (0.2cm, -0.1 to 0.6) after amnioreduction. There was no change in cervical length at control procedures. Conclusion: Cervical shortening in twins with polyhydramnios does not appear to be an acute process; cervical length can be measured before or after therapeutic procedures.	[Engineer, Neelam; O'Donoghue, Keelin; Wimalasundera, Ruwan C.; Fisk, Nicholas M.] Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England; [O'Donoghue, Keelin; Fisk, Nicholas M.] Imperial Coll London, Fac Med, Div Surg, Oncol, Reprod & Anaesthesia, Inst Reprod & Dev Biol, London, England; [Fisk, Nicholas M.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia	Imperial College London; Imperial College London; University of Queensland	Engineer, N (corresponding author), Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England.	nejengineer@aol.com	Moore, Thomas/F-2033-2010; Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975; O'Donoghue, Keelin/0000-0002-4616-2887	Richard and Jack Wiseman Trust; Institute of Obstetrics & Gynecology Trust; NIHR Biomedical Research Centre	Richard and Jack Wiseman Trust; Institute of Obstetrics & Gynecology Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	We acknowledge program funding from the Richard and Jack Wiseman Trust for our work in twins with additional support from the Institute of Obstetrics & Gynecology Trust. NMF was an obstetric advisory board member for Ferring UK and a consultant to Ferring International between 1996 2007. NMF and RCW are grateful for support from the NIHR Biomedical Research Centre funding scheme.	Berghella V, 2006, AM J OBSTET GYNECOL, V195, P809, DOI 10.1016/j.ajog.2006.06.007; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Chau AC, 1996, AM J OBSTET GYNECOL, V174, P1003, DOI 10.1016/S0002-9378(96)70340-X; Denbow ML, 1997, OBSTET GYNECOL, V90, P529, DOI 10.1016/S0029-7844(97)00356-6; Fait G, 2005, J CLIN ULTRASOUND, V33, P329, DOI 10.1002/jcu.20159; FISK NM, 1990, OBSTET GYNECOL, V76, P210; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Hershkovitz R, 2006, ULTRASOUND OBST GYN, V28, P775, DOI 10.1002/uog.3818; HILL LM, 1987, OBSTET GYNECOL, V69, P21; Humphrey RG, 2001, OBSTET GYNECOL, V98, P555, DOI 10.1016/S0029-7844(01)01491-0; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 2001, J SOC GYNECOL INVEST, V8, P39, DOI 10.1016/S1071-5576(00)00093-9; Imseis HM, 1997, AM J OBSTET GYNECOL, V177, P1149, DOI 10.1016/S0002-9378(97)70032-2; Kagan KO, 2006, BJOG-INT J OBSTET GY, V113, P52, DOI 10.1111/j.1471-0528.2006.01124.x; Meath AI, 2005, AM J OBSTET GYNECOL, V192, P1410, DOI 10.1016/j.ajog.2005.01.033; MOISE KJ, 1993, SEMIN PERINATOL, V17, P197; MOORE TR, 1990, AM J OBSTET GYNECOL, V163, P762, DOI 10.1016/0002-9378(90)91064-J; Pasquini L, 2006, ULTRASOUND OBST GYN, V28, P681, DOI 10.1002/uog.3811; Quintero R A, 1999, J Perinatol, V19, P550, DOI 10.1038/sj.jp.7200292; Ramin KD, 1999, AM J OBSTET GYNECOL, V180, P1442, DOI 10.1016/S0002-9378(99)70033-5; Robyr R, 2005, ULTRASOUND OBST GYN, V25, P37, DOI 10.1002/uog.1798; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597; Souka AP, 1999, OBSTET GYNECOL, V94, P450, DOI 10.1016/S0029-7844(99)00277-X; To MS, 2006, AM J OBSTET GYNECOL, V194, P1360, DOI 10.1016/j.ajog.2005.11.001	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3834	10.1371/journal.pone.0003834	http://dx.doi.org/10.1371/journal.pone.0003834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048106	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452000007
J	Perron, GG; Quessy, S; Bell, G				Perron, Gabriel G.; Quessy, Sylvain; Bell, Graham			A Reservoir of Drug-Resistant Pathogenic Bacteria in Asymptomatic Hosts	PLOS ONE			English	Article							SEROTYPE TYPHIMURIUM DT104; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; UNITED-STATES; ANTIBACTERIAL RESISTANCE; MULTIDRUG-RESISTANCE; ADAPTIVE RADIATION; DNA POLYMORPHISM; SALMONELLA	The population genetics of pathogenic bacteria has been intensively studied in order to understand the spread of disease and the evolution of virulence and drug resistance. However, much less attention has been paid to bacterial carriage populations, which inhabit hosts without producing disease. Since new virulent strains that cause disease can be recruited from the carriage population of bacteria, our understanding of infectious disease is seriously incomplete without knowledge on the population structure of pathogenic bacteria living in an asymptomatic host. We report the first extensive survey of the abundance and diversity of a human pathogen in asymptomatic animal hosts. We have found that asymptomatic swine from livestock productions frequently carry populations of Salmonella enterica with a broad range of drug-resistant strains and genetic diversity greatly exceeding that previously described. This study shows how agricultural practice and human intervention may lead and influence the evolution of a hidden reservoir of pathogens, with important implications for human health.	[Perron, Gabriel G.; Bell, Graham] McGill Univ, Dept Biol, Montreal, PQ H3A 2T5, Canada; [Quessy, Sylvain] Univ Montreal, Fac Med Vet, Dept Pathol Microbiol, Montreal, PQ H3C 3J7, Canada	McGill University; Universite de Montreal	Perron, GG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	gabriel.guimond-perron@zoo.ox.ac.uk			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by NSERC to G. Bell. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaska JM, 2008, VET MICROBIOL, V128, P90, DOI 10.1016/j.vetmic.2007.08.033; Amar CFL, 2008, MICROB DRUG RESIST, V14, P79, DOI 10.1089/mdr.2008.0812; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; Bahnson PB, 2005, J FOOD PROTECT, V68, P246, DOI 10.4315/0362-028X-68.2.246; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Bell G, 2008, SELECTION: THE MECHANISM OF EVOLUTION, 2ND EDITION, P1; Beloeil PA, 2004, PREV VET MED, V63, P103, DOI 10.1016/j.prevetmed.2004.01.010; Botteldoorn N, 2003, J APPL MICROBIOL, V95, P891, DOI 10.1046/j.1365-2672.2003.02042.x; Brown EW, 2003, P NATL ACAD SCI USA, V100, P15676, DOI 10.1073/pnas.2634406100; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Chopra I, 2003, DRUG RESIST UPDATE, V6, P137, DOI 10.1016/S1368-7646(03)00041-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Day T, 2003, TRENDS ECOL EVOL, V18, P113, DOI 10.1016/S0169-5347(02)00049-6; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Frank SA, 2008, J EVOLUTION BIOL, V21, P396, DOI 10.1111/j.1420-9101.2007.01480.x; Fu YX, 1997, GENETICS, V147, P915; Gebreyes WA, 2004, J ANTIMICROB CHEMOTH, V53, P997, DOI 10.1093/jac/dkh247; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Hauser AR, 2007, ANTIBIOTICS BASICS C; Hopkins KL, 2007, J ANTIMICROB CHEMOTH, V59, P1071, DOI 10.1093/jac/dkm081; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Khachatryan AR, 2008, APPL ENVIRON MICROB, V74, P391, DOI 10.1128/AEM.01534-07; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Lawson AJ, 2004, CLIN MICROBIOL INFEC, V10, P143, DOI 10.1111/j.1469-0691.2004.00754.x; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; McVean G, 2002, GENETICS, V160, P1231; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Murphy TM, 2001, EPIDEMIOL INFECT, V126, P3, DOI 10.1017/S0950268801005143; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perron GG, 2008, FEMS MICROBIOL LETT, V281, P17, DOI 10.1111/j.1574-6968.2007.01045.x; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Poppe C, 2005, APPL ENVIRON MICROB, V71, P1184, DOI 10.1128/AEM.71.3.1184-1192.2005; Poppe C, 2002, MICROB DRUG RESIST, V8, P107, DOI 10.1089/107662902760190653; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Randall LP, 2004, J ANTIMICROB CHEMOTH, V53, P208, DOI 10.1093/jac/dkh070; Ribot EM, 2002, EMERG INFECT DIS, V8, P387, DOI 10.3201/eid0804.010202; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TAJIMA F, 1989, GENETICS, V123, P585; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Witte W, 2000, INT J ANTIMICROB AG, V16, pS19, DOI 10.1016/S0924-8579(00)00301-0; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500	58	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3749	10.1371/journal.pone.0003749	http://dx.doi.org/10.1371/journal.pone.0003749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015729	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448400006
J	Frobisch, J				Frobisch, Jorg			Global Taxonomic Diversity of Anomodonts (Tetrapoda, Therapsida) and the Terrestrial Rock Record Across the Permian-Triassic Boundary	PLOS ONE			English	Article							MASS EXTINCTION; KAROO BASIN; FOSSIL RECORD; BIODIVERSITY; ORIGINATION; VERTEBRATES; AGE; STANDARDIZATION; DICYNODONT; COMPONENTS	The end-Permian biotic crisis (similar to 252.5 Ma) represents the most severe extinction event in Earth's history. This paper investigates diversity patterns in Anomodontia, an extinct group of therapsid synapsids ('mammal-like reptiles'), through time and in particular across this event. As herbivores and the dominant terrestrial tetrapods of their time, anomodonts play a central role in assessing the impact of the end-Permian extinction on terrestrial ecosystems. Taxonomic diversity analysis reveals that anomodonts experienced three distinct phases of diversification interrupted by the same number of extinctions, i.e. an end-Guadalupian, an end-Permian, and a mid-Triassic extinction. A positive correlation between the number of taxa and the number of formations per time interval shows that anomodont diversity is biased by the Permian-Triassic terrestrial rock record. Normalized diversity curves indicate that anomodont richness continuously declines from the Middle Permian to the Late Triassic, but also reveals all three extinction events. Taxonomic rates ( origination and extinction) indicate that the end-Guadalupian and end-Permian extinctions were driven by increased rates of extinction as well as low origination rates. However, this pattern is not evident at the final decline of anomodont diversity during the Middle Triassic. Therefore, it remains unclear whether the Middle Triassic extinction represents a gradual or abrupt event that is unique to anomodonts or more common among terrestrial tetrapods. The end-Permian extinction represents the most distinct event in terms of decline in anomodont richness and turnover rates.	[Frobisch, Jorg] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Frobisch, J (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	jorg.frobisch@utoronto.ca			Full Doctoral Scholarship of the Government of Canada Awards Program; Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)	Full Doctoral Scholarship of the Government of Canada Awards Program; Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	Full Doctoral Scholarship of the Government of Canada Awards Program and a Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 1998, BIODIVERSITY DYNAMICS, P232; Alroy J, 2003, PALEOBIOLOGY, V29, P26, DOI 10.1666/0094-8373(2003)029<0026:GDWYRM>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bakker R.T., 1977, PATTERNS EVOLUTION I, P439; BARRY JC, 1995, PALAEOGEOGR PALAEOCL, V115, P209, DOI 10.1016/0031-0182(94)00112-L; Battail B, 1993, NEW MEXICO MUSEUM NA, V3, P31; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Benton M. J., 2003, WHEN LIFE NEARLY DIE; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Benton MJ, 1998, ADEQUACY OF THE FOSSIL RECORD, P269; BENTON MJ, 1985, SP PAP PALAEONTOL, P185; BENTON MJ, 1989, PHILOS T ROY SOC B, V325, P369, DOI 10.1098/rstb.1989.0094; BENTON MJ, 1985, NATURE, V316, P811, DOI 10.1038/316811a0; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Erwin D. H., 2006, EXTINCTION LIFE EART; Fitzgerald PC, 2006, PALEOBIOLOGY, V32, P367, DOI 10.1666/05029.1; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; FROBISCH J, 2008, THESIS U TORONTO TOR; Frobisch J, 2007, ZOOL J LINN SOC-LOND, V150, P117, DOI 10.1111/j.1096-3642.2007.00285.x; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; GOLUBEV VK, 2005, NEW MEXICO MUSEUM NA, V30, P95; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grine Frederick E., 2006, P432; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; Harper Charles W. Jr, 1996, Historical Biology, V11, P267; IVAKHNENKO MF, 1994, PALEONTOL J, V28, P96; Jaanusson V., 1976, P301; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; Keyser AW., 1993, GEOL SURV S AFR MEM, V82, P1; KING AW, 1991, LANDSCAPE ECOL, V5, P239, DOI 10.1007/BF00141438; KING G M, 1990, Palaeontologia Africana, V27, P31; King G. M., 1990, S HAUGHTON MEMORIAL, V3, P17; King Gillian M., 1993, Annals of the South African Museum, V102, P303; King GM, 1997, PALAEONTOLOGY, V40, P149; KING GM, 1993, ZOOL J LINN SOC-LOND, V107, P131, DOI 10.1111/j.1096-3642.1993.tb00218.x; King GM., 1988, ANOMODONTIA; KURKIN AA, 2000, PALEONTOL J, V34, P203; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; [刘俊 Liu Shun], 2004, [古脊椎动物学报, Vertebrata Palasiatica], V42, P77; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; Lucas S. G., 2007, NEW MEXICO MUSEUM NA, V41, P229; Lucas S.G., 1999, ZENTRALBLATT GEOLO 1, P497; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Lucas SG, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P143; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V30, P197; LUCAS SG, 1995, ALBERTIANA, V16, P33; Lucas Spencer G., 2002, Canadian Society of Petroleum Geologists Memoir, V19, P479; Lucas Spencer G., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P869; Lucas Spencer G., 2006, V265, P1, DOI 10.1144/GSL.SP.2006.265.01.01; MacLeod KG, 2000, GEOLOGY, V28, P227, DOI 10.1130/0091-7613(2000)28<227:TOMREA>2.0.CO;2; Maisch MW, 2002, PALAEONTOLOGY, V45, P343, DOI 10.1111/1475-4983.00240; Marshall CR, 1998, ADEQUACY OF THE FOSSIL RECORD, P23; MAXWELL WD, 1992, PALAEONTOLOGY, V35, P571; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Modesto S, 1999, P ROY SOC B-BIOL SCI, V266, P331, DOI 10.1098/rspb.1999.0642; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Norell Mark A., 1992, P89; OGG JG, 2008, CONCISE GEOLOGIC TIM, P95; Olson E.C., 1989, Historical Biology, V2, P17; OLSON EC, 1982, GEOLOGICAL SOC AM SP, V190, P501; Padian K., 1985, P41; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; PITRAT CW, 1973, PALAEOGEOGR PALAEOCL, V14, P249, DOI 10.1016/0031-0182(73)90011-4; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Renaut A.J., 2000, THESIS U WITWATERSRA; Retallack GJ, 2006, GEOL SOC AM BULL, V118, P1398, DOI 10.1130/B26011.1; Riggs NR, 2003, GEOL SOC AM BULL, V115, P1315, DOI 10.1130/B25254.1; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; Steiner M. B., 2006, GEOLOGICAL SOC LONDO, V265, P15, DOI DOI 10.1144/GSL.SP.2006.265.01.02; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; VANVALEN LM, 1984, NATURE, V307, P50, DOI 10.1038/307050a0; Vermeij GJ, 2003, PALEOBIOLOGY, V29, P3, DOI 10.1666/0094-8373(2003)029<0003:DGDMA>2.0.CO;2; Wagner PJ, 2007, P ROY SOC B-BIOL SCI, V274, P439, DOI 10.1098/rspb.2006.3742; Ward PD, 2005, SCIENCE, V307, P709, DOI 10.1126/science.1107068	87	100	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3733	10.1371/journal.pone.0003733	http://dx.doi.org/10.1371/journal.pone.0003733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011684	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300001
J	Manirarora, JN; Kosiewicz, MM; Parnell, SA; Alard, P				Manirarora, Jean N.; Kosiewicz, Michele M.; Parnell, Sarah A.; Alard, Pascale			APC Activation Restores Functional CD4(+)CD25(+) Regulatory T Cells in NOD Mice that Can Prevent Diabetes Development	PLOS ONE			English	Article							COMPLETE FREUND ADJUVANT; DENDRITIC CELLS; CUTTING EDGE; TGF-BETA; TOLERANCE; DEFECTS; CD25(+); MOUSE; FOXP3; ONSET	Background: Defects in APC and regulatory cells are associated with diabetes development in NOD mice. We have shown previously that NOD APC are not effective at stimulating CD4(+)CD25(+) regulatory cell function in vitro. We hypothesize that failure of NOD APC to properly activate CD4(+)CD25(+) regulatory cells in vivo could compromise their ability to control pathogenic cells, and activation of NOD APC could restore this defect, thereby preventing disease. Methodology/Principal Findings: To test these hypotheses, we used the well-documented ability of complete Freund's adjuvant (CFA), an APC activator, to prevent disease in NOD mice. Phenotype and function of CD4(+)CD25(+) regulatory cells from untreated and CFA-treated NOD mice were determined by FACS, and in vitro and in vivo assays. APC from these mice were also evaluated for their ability to activate regulatory cells in vitro. We have found that sick NOD CD4(+)CD25(+) cells expressed Foxp3 at the same percentages, but decreased levels per cell, compared to young NOD or non-NOD controls. Treatment with CFA increased Foxp3 expression in NOD cells, and also increased the percentages of CD4(+)CD25(+)Foxp3+ cells infiltrating the pancreas compared to untreated NOD mice. Moreover, CD4(+)CD25(+) cells from pancreatic LN of CFA-treated, but not untreated, NOD mice transferred protection from diabetes. Finally, APC isolated from CFA-treated mice increased Foxp3 and granzyme B expression as well as regulatory function by NOD CD4(+)CD25(+) cells in vitro compared to APC from untreated NOD mice. Conclusions/Significance: These data suggest that regulatory T cell function and ability to control pathogenic cells can be enhanced in NOD mice by activating NOD APC.	[Manirarora, Jean N.; Kosiewicz, Michele M.; Parnell, Sarah A.; Alard, Pascale] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Manirarora, Jean N.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA	University of Louisville; St Jude Children's Research Hospital	Manirarora, JN (corresponding author), Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	p0alar01@gwise.louisville.edu			American Diabetes Association [Junior Faculty Award]; University of Louisville School of Medicine; Ruth L. Kirschstein NRSA	American Diabetes Association(American Diabetes Association); University of Louisville School of Medicine; Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Junior Faculty Award (Pascale Alard) from the American Diabetes Association, and in part by a grant from the University of Louisville School of Medicine. Jean N. Manirarora was supported by a Ruth L. Kirschstein NRSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Dahlen E, 2000, J IMMUNOL, V164, P2444, DOI 10.4049/jimmunol.164.5.2444; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lee IF, 2004, J IMMUNOL, V172, P937, DOI 10.4049/jimmunol.172.2.937; Lee M, 2000, J KOREAN MED SCI, V15, P217, DOI 10.3346/jkms.2000.15.2.217; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; MANIRARORA JN, 2008, FASEB J, V22; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; QIN HY, 1993, J IMMUNOL, V150, P2072; Rosignoli F, 2006, ANN NY ACAD SCI, V1070, P525, DOI 10.1196/annals.1317.073; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SERREZE DV, 1988, J IMMUNOL, V140, P3801; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Takahashi K, 1998, J IMMUNOL, V161, P2629; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	43	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3739	10.1371/journal.pone.0003739	http://dx.doi.org/10.1371/journal.pone.0003739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011680	gold, Green Submitted, Green Published			2022-12-27	WOS:000265448300007
J	Cortese, K; Sahores, M; Madsen, CD; Tacchetti, C; Blasi, F				Cortese, Katia; Sahores, Macarena; Madsen, Chris D.; Tacchetti, Carlo; Blasi, Francesco			Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of uPAR	PLOS ONE			English	Article							RECEPTOR-RELATED-PROTEIN; PLASMINOGEN-ACTIVATOR RECEPTOR; MEDIATED ENDOCYTOSIS; UROKINASE; MACROPINOCYTOSIS; INTERNALIZATION; BINDING; PATHWAYS; LOCALIZATION; DYNAMICS	Background: The urokinase receptor (uPAR/CD87) is highly expressed in malignant tumours. uPAR, as a GPI anchored protein, is preferentially located at the cell surface, where it interacts with its ligands urokinase (uPA) and the extracellular matrix protein vitronectin, thus promoting plasmin generation, cell-matrix interactions and intracellular signalling events. Interaction with a complex formed by uPA and its inhibitor PAI-1 induces cell surface down regulation and recycling of the receptor via the clathrin-coated pathway, a process dependent on the association to LRP-1. Methodology/Principal Findings: In this study, we have found that along with the ligand-induced down-regulation, uPAR also internalizes and recycles constitutively through a second pathway that is independent of LRP-1 and clathrin but shares some properties with macropinocytosis. The ligand-independent route is amiloride-sensitive, does not require uPAR partitioning into lipid rafts, is independent of the activity of small GTPases RhoA, Rac1 and Cdc42, and does not require PI3K activity. Constitutively endocytosed uPAR is found in EEA1 positive early/recycling endosomes but does not reach lysosomes in the absence of ligands. Electron microscopy analysis reveals the presence of uPAR in ruffling domains at the cell surface, in macropinosome-like vesicles and in endosomal compartments. Conclusions/Significance: These results indicate that, in addition to the ligand-induced endocytosis of uPAR, efficient surface expression and membrane trafficking might also be driven by an uncommon macropinocytic mechanism coupled with rapid recycling to the cell surface.	[Cortese, Katia; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, Sez Anat Umana, FIRC Inst Mol Oncol,Ctr Ric MicroSCoBio IFOM, Genoa, Italy; [Sahores, Macarena; Madsen, Chris D.; Blasi, Francesco] FIRC Inst Mol Oncol, IFOM, Univ Vita Salute San Raffaele, Mol Genet Unit, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University	Cortese, K (corresponding author), Univ Genoa, Dipartimento Med Sperimentale, Sez Anat Umana, FIRC Inst Mol Oncol,Ctr Ric MicroSCoBio IFOM, Genoa, Italy.	Carlo.Tacchetti@unige.it; Francesco.Blasi@hsr.it	Cortese, Katia/AAC-2990-2021	Cortese, Katia/0000-0001-9218-8933; Blasi, Francesco/0000-0001-9406-1784; TACCHETTI, CARLO/0000-0003-4602-000X; Madsen, Chris D/0000-0001-6838-2103	AIRC Italian Association for Cancer Research; ISS Istituto Superiore di Sanita	AIRC Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ISS Istituto Superiore di Sanita	AIRC (Italian Association for Cancer Research) to FB, ISS (Istituto Superiore di Sanita) Special Project on Oncology, to FB	Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fretz M, 2006, J CONTROL RELEASE, V116, P247, DOI 10.1016/j.jconrel.2006.07.009; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; GECKLE M, 1999, J PHYSL, V520, P709; GECKLE M, 2001, J PHYSL, V560, P267; HASEGAWA T, 1993, J CELL BIOL, V120, P1439, DOI 10.1083/jcb.120.6.1439; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Masilamani M, 2008, TRAFFIC, V9, P1019, DOI 10.1111/j.1600-0854.2008.00738.x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sahores M, 2008, BBA-BIOMEMBRANES, V1778, P250, DOI 10.1016/j.bbamem.2007.09.030; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	43	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3730	10.1371/journal.pone.0003730	http://dx.doi.org/10.1371/journal.pone.0003730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008962	Green Published, Green Submitted, gold			2022-12-27	WOS:000265166400008
J	Fanello, CI; Karema, C; Avellino, P; Bancone, G; Uwimana, A; Lee, SJ; d'Alessandro, U; Modiano, D				Fanello, Caterina I.; Karema, Corine; Avellino, Pamela; Bancone, Germana; Uwimana, Aline; Lee, Sue J.; d'Alessandro, Umberto; Modiano, David			High Risk of Severe Anaemia after Chlorproguanil-Dapsone plus Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency	PLOS ONE			English	Article								Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited human enzyme defect. This deficiency provides some protection from clinical malaria, but it can also cause haemolysis after administration of drugs with oxidant properties. Methods: The safety of chlorproguanil-dapsone+artesunate (CD+A) and amodiaquine+sulphadoxine-pyrimethamine (AQ+SP) for the treatment of uncomplicated P. falciparum malaria was evaluated according to G6PD deficiency in a secondary analysis of an open-label, randomized clinical trial [1]. 702 children, treated with CD+A or AQ+SP and followed for 28 days after treatment were genotyped for G6PD A-deficiency. Findings: In the first 4 days following CD+A treatment, mean haematocrit declined on average 1.94% (95% CI 1.54 to 2.33) and 1.05% per day (95% CI 0.95 to 1.15) respectively in patients with G6PD deficiency and normal patients; a mean reduction of 1.3% per day was observed among patients who received AQ+SP regardless of G6PD status (95% CI 1.25 to 1.45). Patients with G6PD deficiency recipients of CD+A had significantly lower haematocrit than the other groups until day 7 (p = 0.04). In total, 10 patients had severe post-treatment haemolysis requiring blood transfusion. Patients with G6PD deficiency showed a higher risk of severe anaemia following treatment with CD+A (RR = 10.2; 95% CI 1.8 to 59.3) or AQ+SP ( RR = 5.6; 95% CI 1.0 to 32.7). Conclusions: CD+A showed a poor safety profile in individuals with G6PD deficiency most likely as a result of dapsone induced haemolysis. Screening for G6PD deficiency before drug administration of potentially pro-oxidants drugs, like dapsone-containing combinations, although seldom available, is necessary.	[Lee, Sue J.] Univ Oxford, Nuffield Dept Med, Ctr Vaccinol & Trop Med, Oxford, England; [Karema, Corine; Uwimana, Aline] Natl Malaria Control Program, Kigali, Rwanda; [Avellino, Pamela; Bancone, Germana; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, Rome, Italy; [Fanello, Caterina I.; Lee, Sue J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Res Unit, Bangkok 10700, Thailand; [d'Alessandro, Umberto] Prince Leopold Inst Trop Med, Antwerp, Belgium	University of Oxford; Sapienza University Rome; Mahidol University; Institute of Tropical Medicine (ITM)	Fanello, CI (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Vaccinol & Trop Med, Oxford, England.	Caterina.Fanello@ndm.ox.ac.uk	Fanello, Caterina/AAT-9679-2021; D'Alessandro, Umberto/D-3457-2015	Fanello, Caterina/0000-0003-1932-9562; D'Alessandro, Umberto/0000-0001-6341-5009; Bancone, Germana/0000-0003-4550-0431	Sir Halley Stewart Trust; University of Rome La Sapienza; EU, Sixth Framework Programme, BIOMALPAR Network of Excellence [LSHP-CT-2004-503578]; Belgian Development Cooperation (DGIS); Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium	Sir Halley Stewart Trust; University of Rome La Sapienza; EU, Sixth Framework Programme, BIOMALPAR Network of Excellence; Belgian Development Cooperation (DGIS); Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium	CIF was funded by the Sir Halley Stewart Trust. The laboratory analyses were financed by the University of Rome La Sapienza and by the EU, Sixth Framework Programme, BIOMALPAR Network of Excellence, Contract Number LSHP-CT-2004-503578. The clinical study was financed by the Belgian Development Cooperation (DGIS) in collaboration with the Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; BATTISTUZZI G, 1977, AM J HUM GENET, V29, P31; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Brabin BJ, 2004, DRUG SAFETY, V27, P633, DOI 10.2165/00002018-200427090-00002; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; Fanello CI, 2008, T ROY SOC TROP MED H, V102, P412, DOI 10.1016/j.trstmh.2008.01.013; Munyanganizi R, 2006, J MED SCREEN, V13, P129, DOI 10.1258/096914106778440626; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WHITE NJ, 1992, ADV PARASIT, P84; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, 2008, QSMMCIEA117 WHO; *WHO, 2004, WHOHTMMAL20051106; Wolf Ronni, 2002, Dermatol Online J, V8, P2; Wootton DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001779	19	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4031	10.1371/journal.pone.0004031	http://dx.doi.org/10.1371/journal.pone.0004031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112496	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000004
J	Li, TS; Dai, Y; Kuang, JQ; Jiang, JM; Han, Y; Qiu, ZF; Xie, J; Zuo, LY; Li, YL				Li, Taisheng; Dai, Yi; Kuang, Jiqiu; Jiang, Jingmei; Han, Yang; Qiu, Zhifeng; Xie, Jing; Zuo, Lingyan; Li, Yanling			Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort	PLOS ONE			English	Article							DRUG-RESISTANCE; THERAPY; HEPATOTOXICITY	Background: The purpose of this study was to evaluate the efficacy and safety of three nevirapine-based antiretroviral treatments for adult antiretroviral-naive Chinese patients with HIV-1 infection. Methodology: This was a prospective, multicenter study. 198 antiretroviral-naive HIV-1 positive subjects with CD4 lymphocyte counts between 100/ul and 350/ul and plasma HIV-1 RNA levels more than 500 copies/ml were randomized to start three NVP-based antiretroviral treatments: group A, NVP+AZT+ddI; group B, NVP+3TC+d4T; group C, NVP+AZT+3TC. Viral responses, immunologic responses, adverse events and drug resistence were monitored at baseline and the end of week 4, 12, 24, 36, 52. Viralogical response and immunological response were also comparaed in different strata of baseline CD4 T lymphocyte counts and plasma HIV-1 RNA concentrations. At baseline, the plasma HIV-1 RNA was 4.44 +/- 0.68, 4.52 +/- 0.71 and 4.41 +/- 0.63 Ig copies/ml in group A, B and C respectively (p = 0.628). At the end of the study, the plasma viral load reached 2.54 +/- 1.11, 1.89 +/- 0.46 and 1.92 +/- 0.58 Ig copies/ml in group A, B and C respectively (p<0.001). At week 52, suppression of plasma HIV-1 RNA to less than 50 copies/ml was achieved in more patients in group B and C than in group A (68.2%, 69% vs. 39.7%; p<0.001). In planned subgroup analyses, the decrease of viral response rate was seen in group A when CD4 cell count.200/ul (subgroup H). But in subgroup L, viral response rate of three groups has no significant statistic difference. There were no statistically significant differences among three groups in immunological response wthin any of the CD4 or pVL strata. 3 out of 193 patients with available genotype at baseline showed primary drug resistant. Of 26 patients with virologic failure, 17 patients showed secondary drug resistant, 16 subjects in group A and 1 subject in group B. Logistic regression analysis indicated that presence of hepatotoxicity was associated with HCV-Ab positive (OR = 2.096, 95% CI: 1.106-3.973, P = 0.023) and higher CD4 baseline (CD4 count.250/ul)( OR = 2.096, 95% CI: 1.07-4.107, P = 0.031). Conclusion: Our findings strongly support the use of 3TC+d4T and 3TC+AZT as the nucleoside analogue combination in NVP-based antiretroviral therapy. The regimen of AZT+ddI+NVP produced poor virological response especially in the stratum of CD4 count more than 200/ul. More patients showed secondary drug resistant in this arm too. Patients with HCV-Ab+ and CD4 count.250/ul appear to have significantly high risk of hepatoxicity.	[Li, Taisheng; Dai, Yi; Kuang, Jiqiu; Han, Yang; Qiu, Zhifeng; Xie, Jing; Zuo, Lingyan; Li, Yanling] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100037, Peoples R China; [Jiang, Jingmei] Peking Union Med Coll, Sch Basic Med, Dept Epidemiol & Med Stat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, TS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100037, Peoples R China.	litsh@263.net	han, yang/GRS-2388-2022; li, yan/GTI-4638-2022		National Key Technologies R&D Programm for the 10th Five-year Plan [2004BA719A10]; Clinial Key Research Project of Affiliated Medical Institution of Ministry of Health, and National Sciences foundation of China [30571641]	National Key Technologies R&D Programm for the 10th Five-year Plan; Clinial Key Research Project of Affiliated Medical Institution of Ministry of Health, and National Sciences foundation of China	This study was Supported by the National Key Technologies R&D Programm for the 10th Five-year Plan (2004BA719A10). Clinial Key Research Project of Affiliated Medical Institution of Ministry of Health, and National Sciences foundation of China (30571641). The sponsors only provided the funds.	[Anonymous], 2004, DIVISION AIDS TABLE; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; *CHIN GOV OFF WEB, 2006, HIV VICT CHIN ASS; Conway B, 2001, AIDS, V15, P1269, DOI 10.1097/00002030-200107060-00008; Dube MP, 2005, AIDS, V19, P1807, DOI 10.1097/01.aids.0000183629.20041.bb; French Martyn, 2002, HIV Clin Trials, V3, P177; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; HOGG RS, 2001, JAMA-J AM MED ASSOC, V286, P2560; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Ma LY, 2007, JAIDS-J ACQ IMM DEF, V44, P14, DOI 10.1097/01.qai.0000243049.27580.cc; MONTANER JSG, 1998, JAMA-J AM MED ASSOC, V297, P930; Nunez M, 2006, J HEPATOL, V44, pS132, DOI 10.1016/j.jhep.2005.11.027; PHILLIPS AN, 2001, JAMA-J AM MED ASSOC, V286, P2568; Pujari SN, 2005, JAIDS-J ACQ IMM DEF, V39, P199; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; STERN J, 2002, 14 INT AIDS C JUL 7; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; *UK GROUP TRANSM H, 2005, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.38665.534595.55; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Weitzel T, 1999, AIDS, V13, P2309, DOI 10.1097/00002030-199911120-00018; *XINH, 2004, WHAT IS 4 FREE ON CA	23	34	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3918	10.1371/journal.pone.0003918	http://dx.doi.org/10.1371/journal.pone.0003918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081791	Green Published, Green Submitted, gold			2022-12-27	WOS:000265456300002
J	Nakano, T; Homae, F; Watanabe, H; Taga, G				Nakano, Tamami; Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro			Anticipatory Cortical Activation Precedes Auditory Events in Sleeping Infants	PLOS ONE			English	Article							HUMAN PREFRONTAL CORTEX; FALSE DISCOVERY RATE; VISUAL-STIMULATION; AWAKE INFANTS; HUMAN BRAIN; HEMODYNAMIC-RESPONSES; PRENATAL DEVELOPMENT; MISMATCH NEGATIVITY; OPTICAL TOPOGRAPHY; FRONTAL-CORTEX	Background: Behavioral studies have shown that infants can form associations between environmental events and produce anticipatory actions for the predictable event, but the neural mechanisms for the learning and anticipation of events in infants are not known. Recent neuroimaging studies revealed that the association cortices of infants show activation related to auditory-stimulus discrimination and novelty detection during sleep. In the present study, we expected that when an auditory cue (beeps) predicted an auditory event (a female voice), specific regions of the infant cortex would show anticipatory activation before the event onset even while sleeping. Methodology/Principal Findings: We examined the cortical activation of 3-month-old infants during delays between the cue and the event by using multi-channel near-infrared spectroscopy. To investigate spatiotemporal changes in cortical activation over the experimental session, we divided the session into two phases (early and late phase) and analyzed each phase separately. In the early phase, the frontal regions showed activation in response to the cue that was followed by the event compared with another cue that was not followed by any event. In the late phase, the temporoparietal region, in addition to the frontal region, showed prominent activation in response to the cue followed by the event. In contrast, when the cue was followed by an event and no-event in equal proportions, cortical activation in response to the cue was not observed in any phase. Conclusions: Sleeping 3-month-old infants showed anticipatory cortical activation in the temporoparietal and frontal regions only in response to the cue predicting the event, suggesting that infants can implicitly form associations between temporally separated events and generate the anticipatory activation before the predictable event. Furthermore, the different time evolution of activation in the temporoparietal and frontal regions suggests that these regions may be involved in different aspects of learning and predicting future events.	[Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan; [Nakano, Tamami] Japan Soc Promot Sci, Tokyo, Japan; [Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro] CREST, Japan Sci & Technol Agcy, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Nakano, T (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan.	tamami@p.u-tokyo.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Core Research for Evolution Science and Technology (CREST); Japan Science and Technology Agency	Core Research for Evolution Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruce D J, 1970, Nature, V225, P873, DOI 10.1038/225873a0; CANFIELD RL, 1991, DEV PSYCHOL, V27, P198, DOI 10.1037/0012-1649.27.2.198; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Coenen AML, 2002, INT J PSYCHOPHYSIOL, V46, P163, DOI 10.1016/S0167-8760(02)00110-1; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Csibra G, 2001, INFANCY, V2, P159, DOI 10.1207/S15327078IN0202_3; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.1111/j.1467-8624.1985.tb00160.x; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; GILMORE RO, 1995, J EXP CHILD PSYCHOL, V59, P70418; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; HENNEVIN E, 1992, PSYCHOBIOLOGY, V20, P166; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; KAPLAN PS, 1992, DEV PSYCHOBIOL, V25, P299, DOI 10.1002/dev.420250407; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight DC, 2003, P NATL ACAD SCI USA, V100, P15280, DOI 10.1073/pnas.2535780100; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kotilahti K, 2005, NEUROREPORT, V16, P1373, DOI 10.1097/01.wnr.0000175247.35837.15; MAHO C, 1992, BRAIN RES, V581, P115, DOI 10.1016/0006-8993(92)90350-I; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Martynova O, 2003, NEUROSCI LETT, V340, P75, DOI 10.1016/S0304-3940(02)01401-5; Maurer D., 1988, WORLD NEWBORN; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; Minagawa-Kawai Y, 2007, J NEUROSCI, V27, P315, DOI 10.1523/JNEUROSCI.1984-06.2007; MRZLJAK L, 1992, J COMP NEUROL, V316, P485, DOI 10.1002/cne.903160408; MRZLJAK L, 1988, J COMP NEUROL, V271, P355, DOI 10.1002/cne.902710306; NAKANO T, CEREB CORTEX, DOI DOI 10.1092/CERCOR/BHN096; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Peirano P, 2003, J PEDIATR-US, V143, pS70, DOI 10.1067/S0022-3476(03)00404-9; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; REEVE L, 1993, J EXP ANAL BEHAV, V60, P515, DOI 10.1901/jeab.1993.60-515; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050; Taga G, 2007, NEUROIMAGE, V36, P1246, DOI 10.1016/j.neuroimage.2007.04.037; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Watanabe H, 2008, NEUROIMAGE, V43, P346, DOI 10.1016/j.neuroimage.2008.07.014; WENTWORTH N, 1992, DEV PSYCHOL, V28, P842, DOI 10.1037/0012-1649.28.5.842; Wilcox T, 2008, DEVELOPMENTAL SCI, V11, P361, DOI 10.1111/j.1467-7687.2008.00681.x	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3912	10.1371/journal.pone.0003912	http://dx.doi.org/10.1371/journal.pone.0003912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZS	19066629	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455700009
J	Whittaker, E; Gordon, A; Kampmann, B				Whittaker, Elizabeth; Gordon, Andrea; Kampmann, Beate			Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFN gamma?	PLOS ONE			English	Article								Background: The blood based interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis do not discriminate between active TB disease and latent TB infection (LTBI). The search for distinguishing biomarkers therefore continues, as the accurate diagnosis of tuberculosis is particularly challenging in children. IFN-gamma-inducible protein 10 (IP-10/CXCL10) has recently been evaluated as a marker for active TB in adults with promising results. Aim: To investigate this new biomarker for active TB and LTBI in paediatrics. Method: We measured IP-10 levels using ELISA in supernatants of whole blood samples stimulated with TB-specific-antigens and negative control antigen. Results: IP-10 is produced in high levels following mycobacterial antigen stimulation in active TB (n = 17) and LTBI (n = 16) compared to controls (n = 16) and to IFN-gamma. The baseline levels of IP-10 are increased in active TB and in LTBI, but there is no significant difference of stimulated levels of IP-10 between active TB and LTBI. Conclusions: IP-10 is a biomarker for tuberculosis in children. However like IFN gamma, IP-10 also does not distinguish between active TB and LTBI.	[Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Gordon, Andrea; Kampmann, Beate] Imperial Coll London, Wellcome Ctr Clin Trop Med, London, England	Imperial College London; Imperial College London	Whittaker, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.	e.whittaker@imperial.ac.uk		Whittaker, Elizabeth/0000-0002-7944-8793	Peel Foundation; European Society for Paediatric Infectious Diseases (ESPID); Wellcome Trust [GR 077273]; Biomedical Research Centre at Imperial College; National Institute for Health Research [ACF-2006-21-031] Funding Source: researchfish	Peel Foundation; European Society for Paediatric Infectious Diseases (ESPID); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre at Imperial College; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was facilitated by consumable grants from the Peel Foundation and the European Society for Paediatric Infectious Diseases (ESPID). BK is funded by the Wellcome Trust (GR 077273). LW and BK are supported by the Biomedical Research Centre at Imperial College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Kawamura A, 2003, CIRC J, V67, P851, DOI 10.1253/circj.67.851; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Lit LCW, 2006, ANN RHEUM DIS, V65, P209, DOI 10.1136/ard.2005.038315; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Romagnani P, 2002, AM J PATHOL, V161, P195, DOI 10.1016/S0002-9440(10)64171-5; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Tan JQ, 2000, J IMMUNOL, V165, P1548, DOI 10.4049/jimmunol.165.3.1548	25	106	107	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3901	10.1371/journal.pone.0003901	http://dx.doi.org/10.1371/journal.pone.0003901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065267	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455200013
J	Kinameri, E; Inoue, T; Aruga, J; Imayoshi, I; Kageyama, R; Shimogori, T; Moore, AW				Kinameri, Emi; Inoue, Takashi; Aruga, Jun; Imayoshi, Itaru; Kageyama, Ryoichiro; Shimogori, Tomomi; Moore, Adrian W.			Prdm Proto-Oncogene Transcription Factor Family Expression and Interaction with the Notch-Hes Pathway in Mouse Neurogenesis	PLOS ONE			English	Article								Background: Establishment and maintenance of a functional central nervous system (CNS) requires a highly orchestrated process of neural progenitor cell proliferation, cell cycle exit, and differentiation. An evolutionary conserved program consisting of Notch signalling mediated by basic Helix-Loop-Helix (bHLH) transcription factor activity is necessary for both the maintenance of neural progenitor cell character and the progression of neurogenesis; however, additional players in mammalian CNS neural specification remain largely unknown. In Drosophila we recently characterized Hamlet, a transcription factor that mediates Notch signalling and neural cell fate. Methodology/Principal Findings: Hamlet is a member of the Prdm (PRDI-BF1 and RIZ homology domain containing) protooncogene transcription factor family, and in this study we report that multiple genes in the Prdm family (Prdm6, 8, 12, 13 and 16) are expressed in the developing mouse CNS in a spatially and temporally restricted manner. In developing spinal cord Prdm8, 12 and 13 are expressed in precise neuronal progenitor zones suggesting that they may specify discrete neuronal subtypes. In developing telencephalon Prdm12 and 16 are expressed in the ventricular zone in a lateral to medial graded manner, and Prdm8 is expressed in a complementary domain in postmitotic neurons. In postnatal brain Prdm8 additionally shows restricted expression in cortical layers 2/3 and 4, the hippocampus, and the amygdala. To further elucidate roles of Prdm8 and 16 in the developing telencephalon we analyzed the relationship between these factors and the bHLH Hes (Hairy and enhancer of split homolog) effectors of Notch signalling. In Hes null telencephalon neural differentiation is enhanced, Prdm8 expression is upregulated, and Prdm16 expression is downregulated; conversely in utero electroporation of Hes1 into the developing telencephalon upregulates Prdm16 expression. Conclusions/Significance: Our data demonstrate that Prdm genes are regulated by the Notch-Hes pathway and represent strong candidates to control neural class specification and the sequential progression of mammalian CNS neurogenesis.	[Kinameri, Emi; Moore, Adrian W.] RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Wako, Saitama, Japan; [Inoue, Takashi; Aruga, Jun] RIKEN Brain Sci Inst, Lab Behavioral & Dev Disorders, Wako, Saitama, Japan; [Imayoshi, Itaru; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto, Japan; [Shimogori, Tomomi] RIKEN Brain Sci Inst, Shimogori Res Unit, Wako, Saitama, Japan	RIKEN; RIKEN; Kyoto University; RIKEN	Kinameri, E (corresponding author), RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Wako, Saitama, Japan.	tshimogori@brain.riken.jp; adrianm@brain.riken.jp	Shimogori, Tomomi/L-2893-2013; Aruga, Jun/H-5837-2011; Moore, Adrian Walton/AAN-5656-2021; Moore, Adrian W/A-3339-2013	Shimogori, Tomomi/0000-0002-6931-5401; Aruga, Jun/0000-0001-7936-1375; Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X	RIKEN Brain Science Institute	RIKEN Brain Science Institute	Funding provided by the RIKEN Brain Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; CATTANEO F, 2008, J CELL BIOCH; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; GARRIGA G, 1993, GENE DEV, V7, P2097, DOI 10.1101/gad.7.11.2097; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Hazourli S, 2006, GENE CHROMOSOME CANC, V45, P1072, DOI 10.1002/gcc.20370; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Hwang BJ, 2007, DEVELOPMENT, V134, P669, DOI 10.1242/dev.02769; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; MODLICH U, 2008, LEUKEMIA; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Ng T, 2006, DEV GENES EVOL, V216, P243, DOI 10.1007/s00427-005-0044-5; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Reid AG, 2004, LEUKEMIA, V18, P178, DOI 10.1038/sj.leu.2403162; Rimann I, 2007, DEV BIOL, V308, P187, DOI 10.1016/j.ydbio.2007.05.023; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Santiago AC, 2004, J COMP NEUROL, V471, P314, DOI 10.1002/cne.20028; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SHIMOGORI T, 2008, DEV GROWTH DIFFER; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	59	87	89	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3859	10.1371/journal.pone.0003859	http://dx.doi.org/10.1371/journal.pone.0003859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050759	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452100010
J	Pi, M; Chen, L; Huang, MZ; Zhu, WY; Ringhofer, B; Luo, JM; Christenson, L; Li, BY; Zhang, JH; Jackson, PD; Faber, P; Brunden, KR; Harrington, JJ; Quarles, LD				Pi, Min; Chen, Ling; Huang, Min-Zhao; Zhu, Wenyu; Ringhofer, Brian; Luo, Junming; Christenson, Lane; Li, Benyi; Zhang, Jianghong; Jackson, P. David; Faber, Pieter; Brunden, Kurt R.; Harrington, John J.; Quarles, L. Darryl			GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome	PLOS ONE			English	Article								Background: GPRC6A is a widely expressed orphan G-protein coupled receptor that senses extracellular amino acids, osteocalcin and divalent cations in vitro. The physiological functions of GPRC6A are unknown. Methods/Principal Findings: In this study, we created and characterized the phenotype of GPRC6A(-/-) mice. We observed complex metabolic abnormalities in GPRC6A(-/-) mice involving multiple organ systems that express GPRC6A, including bone, kidney, testes, and liver. GPRC6A(-/-) mice exhibited hepatic steatosis, hyperglycemia, glucose intolerance, and insulin resistance. In addition, we observed high expression of GPRC6A in Leydig cells in the testis. Ablation of GPRC6A resulted in feminization of male GPRC6A(-/-) mice in association with decreased lean body mass, increased fat mass, increased circulating levels of estradiol, and reduced levels of testosterone. GPRC6A was also highly expressed in kidney proximal and distal tubules, and GPRC6A(-/-) mice exhibited increments in urine Ca/Cr and PO4/Cr ratios as well as low molecular weight proteinuria. Finally, GPRC6A(-/-) mice exhibited a decrease in bone mineral density (BMD) in association with impaired mineralization of bone. Conclusions/Significance: GPRC6A(-/-) mice have a metabolic syndrome characterized by defective osteoblast-mediated bone mineralization, abnormal renal handling of calcium and phosphorus, fatty liver, glucose intolerance and disordered steroidogenesis. These findings suggest the overall function of GPRC6A may be to coordinate the anabolic responses of multiple tissues through the sensing of extracellular amino acids, osteocalcin and divalent cations.	[Pi, Min; Chen, Ling; Huang, Min-Zhao; Zhu, Wenyu; Ringhofer, Brian; Luo, Junming; Quarles, L. Darryl] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Christenson, Lane; Li, Benyi] Univ Kansas, Med Ctr, Dept Mol & Integrative Physiol, Kansas City, KS USA; [Zhang, Jianghong] Vanderbilt Univ, Ctr Bone Biol, Nashville, TN USA; [Jackson, P. David; Faber, Pieter; Brunden, Kurt R.; Harrington, John J.] Athersys Inc, Cleveland, OH USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University	Pi, M (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA.	dquarles@kumc.edu	Christenson, Lane K/G-6435-2013; Brunden, Kurt/D-1994-2009	Quarles, L. Darryl/0000-0002-5082-7896; Pi, Min/0000-0002-0319-8003	NIH [R01-AR37308]; COBRE [P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH R01-AR37308 (L. D. Q.) and COBRE grant P20 RR017686 (M. P.).	Auchus RJ, 2004, SEMIN REPROD MED, V22, P281, DOI 10.1055/s-2004-861545; Bodine PVN, 1999, BONE, V25, P535, DOI 10.1016/S8756-3282(99)00213-6; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Cohen A, 2002, CURR OPIN PHARMACOL, V2, P734, DOI 10.1016/S1471-4892(02)00210-2; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FOLKERS K, 1986, P NATL ACAD SCI USA, V83, P1070, DOI 10.1073/pnas.83.4.1070; GASPAR ML, 1991, P NATL ACAD SCI USA, V88, P8606, DOI 10.1073/pnas.88.19.8606; Giannini S, 2005, CRIT REV CL LAB SCI, V42, P229, DOI 10.1080/10408360590913533; HE WW, 1991, NUCLEIC ACIDS RES, V19, P2373, DOI 10.1093/nar/19.9.2373; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hu JX, 2002, J BIOL CHEM, V277, P46622, DOI 10.1074/jbc.M207100200; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2004, J BONE MINER RES, V19, P862, DOI 10.1359/JBMR.040114; Pi M, 2000, J BIOL CHEM, V275, P3256, DOI 10.1074/jbc.275.5.3256; QUARLES LD, 1988, J CLIN INVEST, V81, P1056, DOI 10.1172/JCI113417; Reim NS, 2008, J BONE MINER RES, V23, P694, DOI 10.1359/JBMR.080202; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tong MH, 2004, ENDOCRINOLOGY, V145, P2487, DOI 10.1210/en.2003-1237; Tu QS, 2003, J CLIN INVEST, V111, P1029, DOI 10.1172/JCI200317054; Ulloa-Aguirre A, 1990, Gac Med Mex, V126, P297; ULLOAAGUIRRE A, 1990, GAC MED MEX, V126, P304; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; WELLENDORPH P, 2007, GENE; Xiao ZS, 2003, J CELL BIOCHEM, V88, P493, DOI 10.1002/jcb.10375; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; ZAIDI M, 1995, J CLIN INVEST, V96, P1582, DOI 10.1172/JCI118197; ZERWEKH JE, 1992, OSTEOPOROSIS INT, V2, P128, DOI 10.1007/BF01623819	40	182	197	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3858	10.1371/journal.pone.0003858	http://dx.doi.org/10.1371/journal.pone.0003858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050760	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452100009
J	McGowan, J; Hogg, W; Campbell, C; Rowan, M				McGowan, Jessie; Hogg, William; Campbell, Craig; Rowan, Margo			Just-in-Time Information Improved Decision-Making in Primary Care: A Randomized Controlled Trial	PLOS ONE			English	Article							CLINICAL INFORMATICIST; BEHAVIOR	Background: The "Just-in-time Information'' (JIT) librarian consultation service was designed to provide rapid information to answer primary care clinical questions during patient hours. This study evaluated whether information provided by librarians to answer clinical questions positively impacted time, decision-making, cost savings and satisfaction. Methods and Finding: A randomized controlled trial (RCT) was conducted between October 2005 and April 2006. A total of 1,889 questions were sent to the service by 88 participants. The object of the randomization was a clinical question. Each participant had clinical questions randomly allocated to both intervention (librarian information) and control (no librarian information) groups. Participants were trained to send clinical questions via a hand-held device. The impact of the information provided by the service (or not provided by the service), additional resources and time required for both groups was assessed using a survey sent 24 hours after a question was submitted. The average time for JIT librarians to respond to all questions was 13.68 minutes/question (95% CI, 13.38 to 13.98). The average time for participants to respond their control questions was 20.29 minutes/question (95% CI, 18.72 to 21.86). Using an impact assessment scale rating cognitive impact, participants rated 62.9% of information provided to intervention group questions as having a highly positive cognitive impact. They rated 14.8% of their own answers to control question as having a highly positive cognitive impact, 44.9% has having a negative cognitive impact, and 24.8% with no cognitive impact at all. In an exit survey measuring satisfaction, 86% (62/72 responses) of participants scored the service as having a positive impact on care and 72% (52/72) indicated that they would use the service frequently if it were continued. Conclusions: In this study, providing timely information to clinical questions had a highly positive impact on decision-making and a high approval rating from participants. Using a librarian to respond to clinical questions may allow primary care professionals to have more time in their day, thus potentially increasing patient access to care. Such services may reduce costs through decreasing the need for referrals, further tests, and other courses of action.	[McGowan, Jessie; Hogg, William; Rowan, Margo] Univ Ottawa, Fac Family Med, Ottawa, ON, Canada; [McGowan, Jessie; Hogg, William] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [McGowan, Jessie] Univ Wales Coll Cardiff, Dept Informat Studies, Cardiff CF1 3NS, S Glam, Wales; [Hogg, William] Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Campbell, Craig] Royal Coll Physicians & Surgeons Canada, Ottawa, ON, Canada; [McGowan, Jessie; Campbell, Craig] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [McGowan, Jessie] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Rowan, Margo] Rowan Hlth Policy Consulting, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Cardiff University; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	McGowan, J (corresponding author), Univ Ottawa, Fac Family Med, Ottawa, ON, Canada.	jmcgowan@uottawa.ca			Ontario Ministry of Health and Long Term Care Primary Health Care Transition Fund	Ontario Ministry of Health and Long Term Care Primary Health Care Transition Fund	Funding for this research was provided by the Ontario Ministry of Health and Long Term Care Primary Health Care Transition Fund. The views expressed in this report are the views of the authors and do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper BS, 2005, ANN FAM MED, V3, P507, DOI 10.1370/afm.370; Brassey J, 2001, BRIT MED J, V322, P529, DOI 10.1136/bmj.322.7285.529; Brettle A, 2006, HEALTH INFO LIBR J, V23, P239, DOI 10.1111/j.1471-1842.2006.00670.x; Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Del Mar CB, 2001, MED J AUSTRALIA, V175, P134, DOI 10.5694/j.1326-5377.2001.tb143060.x; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Ely JW, 2005, J AM MED INFORM ASSN, V12, P217, DOI 10.1197/jamia.M1608; Gray J.A., 2006, CMAJ, V175, P131; Gray JAM, 2006, CAN MED ASSOC J, V175, P129; GREEN ME, 2008, FINANCIAL W IN PRESS; Greenhalgh T, 2002, BRIT MED J, V324, P524, DOI 10.1136/bmj.324.7336.524; MARSHALL JG, 1992, B MED LIBR ASSOC, V80, P169; Pluye Pierre, 2005, AMIA Annu Symp Proc, P609; POCOCK SJ, 1985, BMJ-BRIT MED J, V290, P39, DOI 10.1136/bmj.290.6461.39; Richardson WS, 1995, ACP J CLUB, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12; Sackett DL, 2007, EVIDENCE BASED MED P; Schwartz Alan, 2006, BMC Med Inform Decis Mak, V6, P16, DOI 10.1186/1472-6947-6-16; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Swinglehurst DA, 2001, QUAL HEALTH CARE, V10, P245, DOI 10.1136/qhc.0100245..; Urquhart C, 1995, Health Libr Rev, V12, P201, DOI 10.1046/j.1365-2532.1995.1230201.x; Urquhart C, 2007, J MED LIBR ASSOC, V95, P14; *WHO, 2003, GLOB REV PRIM HLTH C	22	53	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3785	10.1371/journal.pone.0003785	http://dx.doi.org/10.1371/journal.pone.0003785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XG	19023446	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448800006
J	Maeda, YT; Inose, J; Matsuo, MY; Iwaya, S; Sano, M				Maeda, Yusuke T.; Inose, Junya; Matsuo, Miki Y.; Iwaya, Suguru; Sano, Masaki			Ordered Patterns of Cell Shape and Orientational Correlation during Spontaneous Cell Migration	PLOS ONE			English	Article								Background: In the absence of stimuli, most motile eukaryotic cells move by spontaneously coordinating cell deformation with cell movement in the absence of stimuli. Yet little is known about how cells change their own shape and how cells coordinate the deformation and movement. Here, we investigated the mechanism of spontaneous cell migration by using computational analyses. Methodology: We observed spontaneously migrating Dictyostelium cells in both a vegetative state ( round cell shape and slow motion) and starved one ( elongated cell shape and fast motion). We then extracted regular patterns of morphological dynamics and the pattern-dependent systematic coordination with filamentous actin (F-actin) and cell movement by statistical dynamic analyses. Conclusions/Significance: We found that Dictyostelium cells in both vegetative and starved states commonly organize their own shape into three ordered patterns, elongation, rotation, and oscillation, in the absence of external stimuli. Further, cells inactivated for PI3-kinase (PI3K) and/or PTEN did not show ordered patterns due to the lack of spatial control in pseudopodial formation in both the vegetative and starved states. We also found that spontaneous polarization was achieved in starved cells by asymmetric localization of PTEN and F-actin. This breaking of the symmetry of protein localization maintained the leading edge and considerably enhanced the persistence of directed migration, and overall random exploration was ensured by switching among the different ordered patterns. Our findings suggest that Dictyostelium cells spontaneously create the ordered patterns of cell shape mediated by PI3K/PTEN/F-actin and control the direction of cell movement by coordination with these patterns even in the absence of external stimuli.	[Maeda, Yusuke T.; Inose, Junya; Matsuo, Miki Y.; Iwaya, Suguru; Sano, Masaki] Univ Tokyo, Grad Sch Sci, Dept, Phys, Tokyo, Japan	University of Tokyo	Maeda, YT (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	ymaeda@rockefeller.edu	Sano, Masaki/E-4434-2012	Sano, Masaki/0000-0002-6262-9635	Japanese Society for Promotion of Science [fellowship]	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the fellowship DC1 (YTM) and the postdoctoral fellowship (YTM and MYM) from Japanese Society for Promotion of Science.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; KILLICH T, 1993, J CELL SCI, V106, P1005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee E, 2003, EUKARYOT CELL, V2, P474, DOI 10.1128/EC.2.3.474-485.2003; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PARTIN AW, 1989, P NATL ACAD SCI USA, V86, P1254, DOI 10.1073/pnas.86.4.1254; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Somesh BP, 2006, EUKARYOT CELL, V5, P1648, DOI 10.1128/EC.00221-06; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876	32	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3734	10.1371/journal.pone.0003734	http://dx.doi.org/10.1371/journal.pone.0003734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011688	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300002
J	van Loo, KMJ; Dejaegere, T; van Zweeden, M; van Schijndel, JE; Wijmenga, C; Trip, MD; Martens, GJM				van Loo, Karen M. J.; Dejaegere, Tim; van Zweeden, Martine; van Schijndel, Jessica E.; Wijmenga, Cisca; Trip, Mieke D.; Martens, Gerard J. M.			Male-Specific Association between a gamma-Secretase Polymorphism and Premature Coronary Atherosclerosis	PLOS ONE			English	Article								Background: Atherosclerosis is a common multifactorial disease resulting from an interaction between susceptibility genes and environmental factors. The causative genes that contribute to atherosclerosis are elusive. Based on recent findings with a Wistar rat model, we speculated that the gamma-secretase pathway may be associated with atherosclerosis. Methodology/Principal Findings: We have tested for association of premature coronary atherosclerosis with a non-synonymous single-nucleotide polymorphism (SNP) in the gamma-secretase component APH1B (Phe217Leu; rs1047552), a SNP previously linked to Alzheimer's disease. Analysis of a Dutch Caucasian cohort (780 cases; 1414 controls) showed a higher prevalence of the risk allele in the patients (odds ratio (OR) = 1.35), albeit not statistically different from the control population. Intriguingly, after gender stratification, the difference was significant in males (OR = 1.63; p = 0.033), but not in females (OR = 0.50; p = 0.20). Since Phe217Leu-mutated APH1B showed reduced gamma-secretase activity in mouse embryonic fibroblasts, the genetic variation is likely functional. Conclusion/Significance: We conclude that, in a male-specific manner, disturbed gamma-secretase signalling may play a role in the susceptibility for premature coronary atherosclerosis.	[van Loo, Karen M. J.; van Zweeden, Martine; van Schijndel, Jessica E.; Martens, Gerard J. M.] Radboud Univ Nijmegen, Dept Mol Anim Physiol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Dejaegere, Tim] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Dejaegere, Tim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands; [Wijmenga, Cisca] Univ Groningen, Med Ctr, Dept Genet, NL-9700 AB Groningen, Netherlands; [Trip, Mieke D.] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands	Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	van Loo, KMJ (corresponding author), Radboud Univ Nijmegen, Dept Mol Anim Physiol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	Wijmenga, Cisca/AAE-7719-2019; Martens, Gerard JM/D-1925-2010; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; 	Dutch Top Institute Pharma [T5-209]	Dutch Top Institute Pharma	This work was performed within the framework of project T5-209 of the Dutch Top Institute Pharma.	Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; Ellenbroek BA, 2000, PSYCHOPHARMACOLOGY, V148, P124, DOI 10.1007/s002130050033; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Horejsi B, 2000, PHYSIOL RES, V49, pS63; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morita H, 1997, J Cardiol, V29, P309; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Poli M, 2008, NEUROBIOL AGING, V29, P1494, DOI 10.1016/j.neurobiolaging.2007.03.019; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; Rebeck GW, 2001, MOL BRAIN RES, V87, P238, DOI 10.1016/S0169-328X(01)00006-7; Riksen NR, 2003, J CARDIOVASC PHARM, V41, P625, DOI 10.1097/00005344-200304000-00016; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Salazar LA, 2000, CLIN CHIM ACTA, V300, P139, DOI 10.1016/S0009-8981(00)00308-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Schulz Susanne, 2002, Hum Mutat, V20, P404, DOI 10.1002/humu.9070; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Smits BW, 2002, J CARDIOVASC PHARM, V40, P678, DOI 10.1097/00005344-200211000-00005; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	38	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3662	10.1371/journal.pone.0003662	http://dx.doi.org/10.1371/journal.pone.0003662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987747	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134500008
J	Wyatt, KB; Campos, PF; Gilbert, MTP; Kolokotronis, SO; Hynes, WH; DeSalle, R; Daszak, P; MacPhee, RDE; Greenwood, AD				Wyatt, Kelly B.; Campos, Paula F.; Gilbert, M. Thomas P.; Kolokotronis, Sergios-Orestis; Hynes, Wayne H.; DeSalle, Rob; Daszak, Peter; MacPhee, Ross D. E.; Greenwood, Alex D.			Historical Mammal Extinction on Christmas Island (Indian Ocean) Correlates with Introduced Infectious Disease	PLOS ONE			English	Article								It is now widely accepted that novel infectious disease can be a leading cause of serious population decline and even outright extinction in some invertebrate and vertebrate groups (e. g., amphibians). In the case of mammals, however, there are still no well-corroborated instances of such diseases having caused or significantly contributed to the complete collapse of species. A case in point is the extinction of the endemic Christmas Island rat (Rattus macleari): although it has been argued that its disappearance ca. AD 1900 may have been partly or wholly caused by a pathogenic trypanosome carried by fleas hosted on recently-introduced black rats (Rattus rattus), no decisive evidence for this scenario has ever been adduced. Using ancient DNA methods on samples from museum specimens of these rodents collected during the extinction window (AD 1888-1908), we were able to resolve unambiguously sequence evidence of murid trypanosomes in both endemic and invasive rats. Importantly, endemic rats collected prior to the introduction of black rats were devoid of trypanosome signal. Hybridization between endemic and black rats was also previously hypothesized, but we found no evidence of this in examined specimens, and conclude that hybridization cannot account for the disappearance of the endemic species. This is the first molecular evidence for a pathogen emerging in a naive mammal species immediately prior to its final collapse.	[Wyatt, Kelly B.; Hynes, Wayne H.; Greenwood, Alex D.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Campos, Paula F.; Gilbert, M. Thomas P.] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark; [Kolokotronis, Sergios-Orestis; DeSalle, Rob] American Museum Nat Hist, Sackler Inst Comparative Genom, Div Invertebrate Zool, New York, NY USA; [Daszak, Peter] Wildlife Trust, Consortium Conservat Med, New York, NY USA; [MacPhee, Ross D. E.; Greenwood, Alex D.] American Museum Nat Hist, New York, NY USA	Old Dominion University; University of Copenhagen; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Wyatt, KB (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	macphee@amnh.org; agreenwo@odu.edu	Gilbert, Marcus TP/A-8936-2013; daszak, peter/U-4588-2017; Kolokotronis, Sergios-Orestis/A-1910-2009; Campos, Paula/ABF-9898-2021; Greenwood, Alex/GWU-8292-2022; Campos, Paula F/B-1634-2010; Kolokotronis, Sergios-Orestis/GWM-5773-2022	Gilbert, Marcus TP/0000-0002-5805-7195; daszak, peter/0000-0002-2046-5695; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Campos, Paula F/0000-0003-1285-4671; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Hynes, Wayne/0000-0003-3998-7781	National Science Foundation [OPP 0117400]; V. Kann Rasmussen Foundation; Marie Curie	National Science Foundation(National Science Foundation (NSF)); V. Kann Rasmussen Foundation; Marie Curie(European Commission)	K.B.W., W.H., R.D., R.D.E.M. and A.D.G. were supported by the National Science Foundation (OPP 0117400), P.D. by the V. Kann Rasmussen Foundation and P.F.C. and M.T.P.G. by the Marie Curie Actions Genetime Grant. The agencies had no role in design, conduct, collection, analysis, or interpretation of the data or in preparation or approval of the manuscript.	Andrews C. W., 1900, MONOGRAPH CHRISTMAS; [Anonymous], 1999, WALKERS MAMMALS WORL; Calvignac S, 2008, MOL BIOL EVOL, V25, P1093, DOI 10.1093/molbev/msn054; Cooper A, 2000, SCIENCE, V289, P1139; Durham Herbert E., 1908, Parasitology Cambridge, V1; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lyons SK, 2004, ECOL LETT, V7, P859, DOI 10.1111/j.1461-0248.2004.00643.x; MacPhee R.D.E., 1999, P333; MacPhee Ross D.E., 1997, P169; Musser Guy G., 1993, P501; Norris C.A, 1996, AUST MAMMAL, V19, P35, DOI [10.1071/AM96019, DOI 10.1071/AM96019]; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Sarataphan N, 2007, J MED MICROBIOL, V56, P1118, DOI 10.1099/jmm.0.47222-0; Schulz M., 2004, NATL RECOVERY PLAN C; SHAW GL, 1973, EXP PARASITOL, V33, P46, DOI 10.1016/0014-4894(73)90008-8; Spennemann D.H.R., 1997, Atoll Research Bulletin, V446, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; THOMAS O, 1887, P ZOOL SOC LOND, P511; WILLERSLEV E, 2003, P R SOC, V272, P3; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	29	169	183	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3602	10.1371/journal.pone.0003602	http://dx.doi.org/10.1371/journal.pone.0003602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985148	Green Published, gold			2022-12-27	WOS:000265134400002
J	Thompson, O; Kleino, I; Crimaldi, L; Gimona, M; Saksela, K; Winder, SJ				Thompson, Oliver; Kleino, Iivari; Crimaldi, Luca; Gimona, Mario; Saksela, Kalle; Winder, Steve J.			Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts	PLOS ONE			English	Article								Background: Dystroglycan is a ubiquitously expressed cell adhesion receptor best understood in its role as part of the dystrophin glycoprotein complex of mature skeletal muscle. Less is known of the role of dystroglycan in more fundamental aspects of cell adhesion in other cell types, nor of its role in myoblast cell adhesion. Principal Findings: We have examined the role of dystroglycan in the early stages of myoblast adhesion and spreading and found that dystroglycan initially associates with other adhesion proteins in large puncta morphologically similar to podosomes. Using a human SH3 domain phage display library we identified Tks5, a key regulator of podosomes, as interacting with beta-dystroglycan. We verified the interaction by immunoprecipitation, GST-pulldown and immunfluorescence localisation. Both proteins localise to puncta during early phases of spreading, but importantly following stimulation with phorbol ester, also localise to structures indistinguishable from podosomes. Dystroglycan overexpression inhibited podosome formation by sequestering Tks5 and Src. Mutation of dystroglycan tyrosine 890, previously identified as a Src substrate, restored podosome formation. Conclusions: We propose therefore, that Src-dependent phosphorylation of beta-dystroglycan results in the formation of a Src/dystroglycan complex that drives the SH3-mediated association between dystroglycan and Tks5 which together regulate podosome formation in myoblasts.	[Thompson, Oliver; Winder, Steve J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Kleino, Iivari; Saksela, Kalle] Univ Helsinki, Hosp, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Crimaldi, Luca; Gimona, Mario] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Chieti, Italy	University of Sheffield; University of Helsinki; Consorzio Mario Negri Sud	Thompson, O (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	s.winder@sheffield.ac.uk		Saksela, Kalle/0000-0003-0827-122X; Thompson, Oliver/0000-0002-4134-8674; Kleino, Iivari/0000-0001-6219-8575	Wellcome Trust [GR077544AIA]; White Rose PhD Studentship; MRC [G00000114]; Academy of Finland; Sigrid Juselius Foundation; Helsinki University Hospital EVO; European Union [002573]	Wellcome Trust(Wellcome TrustEuropean Commission); White Rose PhD Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital EVO; European Union(European Commission)	The light microscopy imaging centre at the University of Sheffield was funded by a grant from the Wellcome Trust (GR077544AIA), Oliver Thompson was supported by a White Rose PhD Studentship, the work was also supported by MRC grant G00000114 to Steve Winder, grants from the Academy of Finland, the Sigrid Juselius Foundation, and Helsinki University Hospital EVO funds to Kalle Saksela and a Marie Curie Excellence grant 002573 from the European Union to Mario Gimona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Anderson C, 2007, DEV DYNAM, V236, P2627, DOI 10.1002/dvdy.21259; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; BARZAIDEL R, 2007, NAT CELL BIOL, V99, P858; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; BELKIN AM, 1995, EXP CELL RES, V221, P132, DOI 10.1006/excr.1995.1360; Belkin AM, 1996, CELL ADHES COMMUN, V4, P281, DOI 10.3109/15419069609010772; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Gad A, 2008, CELL MOTIL CYTOSKEL, V65, P614, DOI 10.1002/cm.20287; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; James M, 2000, J CELL SCI, V113, P1717; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Pereboev AV, 2001, BBA-GEN SUBJECTS, V1527, P54, DOI 10.1016/S0304-4165(01)00147-7; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Russett B.M., 2000, HDB WAR STUDIES, VII, P93; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; THOMPSON O, 2007, GAFSA FOCUS BIOCH GE, P364; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; ZHANG D, 1995, J CELL SCI, V108, P2285; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	60	53	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3638	10.1371/journal.pone.0003638	http://dx.doi.org/10.1371/journal.pone.0003638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982058	Green Published, gold, Green Accepted			2022-12-27	WOS:000265134300008
J	Chang, Q; Tang, WX; Ahmad, S; Zhou, BF; Lin, X				Chang, Qing; Tang, Wenxue; Ahmad, Shoeb; Zhou, Binfei; Lin, Xi			Gap Junction Mediated Intercellular Metabolite Transfer in the Cochlea Is Compromised in Connexin30 Null Mice	PLOS ONE			English	Article								Connexin26 (Cx26) and connexin30 (Cx30) are two major protein subunits that co-assemble to form gap junctions (GJs) in the cochlea. Mutations in either one of them are the major cause of non-syndromic prelingual deafness in humans. Because the mechanisms of cochlear pathogenesis caused by Cx mutations are unclear, we investigated effects of Cx30 null mutation on GJ-mediated ionic and metabolic coupling in the cochlea of mice. A novel flattened cochlear preparation was used to directly assess intercellular coupling in the sensory epithelium of the cochlea. Double-electrode patch clamp recordings revealed that the absence of Cx30 did not significantly change GJ conductance among the cochlear supporting cells. The preserved electrical coupling is consistent with immunolabeling data showing extensive Cx26 GJs in the cochlea of the mutant mice. In contrast, dye diffusion assays showed that the rate and extent of intercellular transfer of multiple fluorescent dyes (including a non-metabolizable D-glucose analogue, 2-NBDG) among cochlear supporting cells were severely reduced in Cx30 null mice. Since the sensory epithelium in the cochlea is an avascular organ, GJ-facilitated intercellular transfer of nutrient and signaling molecules may play essential roles in cellular homeostasis. To test this possibility, NBDG was used as a tracer to study the contribution of GJs in transporting glucose into the cochlear sensory epithelium when delivered systemically. NBDG uptake in cochlear supporting cells was significantly reduced in Cx30 null mice. The decrease was also observed with GJ blockers or glucose competition, supporting the specificity of our tests. These data indicate that GJs facilitate efficient uptake of glucose in the supporting cells. This study provides the first direct experimental evidence showing that the transfer of metabolically-important molecules in cochlear supporting cells is dependent on the normal function of GJs, thereby suggesting a novel pathogenesis process in the cochlea for Cx-mutation-linked deafness.	[Chang, Qing; Tang, Wenxue; Ahmad, Shoeb; Zhou, Binfei; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA; [Lin, Xi] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Chang, Q (corresponding author), Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA.	xlin2@emory.edu	lin, xi/GZL-4959-2022	Tang, Wenxue/0000-0001-8087-0900	National Institute on Deafness and other Communication Disorders NIDCD [RO1-DC006483, R21-DC008353, R21 DC008672, R03-DC008693]; Woodruff Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008693, R21DC008353, R21DC008672, R01DC006483] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Woodruff Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants to X.Lin from National Institute on Deafness and other Communication Disorders (NIDCD, RO1-DC006483 and R21-DC008353) and Woodruff Foundation. W.Tang received grant supports from NIDCD (R21 DC008672) and the Deafness Research Foundation. S.Ahmad is a recipient of NIDCD RO3 (R03-DC008693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Ahmad S, 2007, P NATL ACAD SCI USA, V104, P1337, DOI 10.1073/pnas.0606855104; Axelsson A, 1968, ACTA OTOLARYNGOL S, V243, P3; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; Jagger DJ, 2006, J NEUROSCI, V26, P1260, DOI 10.1523/JNEUROSCI.4278-05.2006; Kameritsch P, 2005, J CELL PHYSIOL, V203, P233, DOI 10.1002/jcp.20218; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Matsunami T, 2006, CELL COMMUN ADHES, V13, P93, DOI 10.1080/15419060600631805; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Qu Y, 2002, P NATL ACAD SCI USA, V99, P697, DOI 10.1073/pnas.022324499; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SANTOS-SACCHI J, 1983, HEARING RES, V9, P317, DOI 10.1016/0378-5955(83)90034-5; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P127, DOI 10.1177/37.2.2536055; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; STERKERS O, 1982, AM J PHYSIOL, V243, pF173, DOI 10.1152/ajprenal.1982.243.2.F173; Sun JJ, 2005, AM J PHYSIOL-CELL PH, V288, pC613, DOI 10.1152/ajpcell.00341.2004; SUZUKI T, 2008, HISTOCHEM CELL BIOL; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	38	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4088	10.1371/journal.pone.0004088	http://dx.doi.org/10.1371/journal.pone.0004088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116647	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600009
J	Eichorst, JP; Lu, SY; Xu, J; Wang, YX				Eichorst, John Paul; Lu, Shaoying; Xu, Jing; Wang, Yingxiao			Differential RhoA Dynamics in Migratory and Stationary Cells Measured by FRET and Automated Image Analysis	PLOS ONE			English	Article								Genetically-encoded biosensors based on fluorescence resonance energy transfer (FRET) have been widely applied to study the spatiotemporal regulation of molecular activity in live cells with high resolution. The efficient and accurate quantification of the large amount of imaging data from these single-cell FRET measurements demands robust and automated data analysis. However, the nonlinear movement of live cells presents tremendous challenge for this task. Based on image registration of the single-cell movement, we have developed automated image analysis methods to track and quantify the FRET signals within user-defined subcellular regions. In addition, the subcellular pixels were classified according to their associated FRET signals and the dynamics of the clusters analyzed. The results revealed that the EGF-induced reduction of RhoA activity in migratory HeLa cells is significantly less than that in stationary cells. Furthermore, the RhoA activity is polarized in the migratory cells, with the gradient of polarity oriented toward the opposite direction of cell migration. In contrast, there is a lack of consistent preference in RhoA polarity among stationary cells. Therefore, our image analysis methods can provide powerful tools for high-throughput and systematic investigation of the spatiotemporal molecular activities in regulating functions of live cells with their shapes and positions continuously changing in time.	[Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Lu, Shaoying; Xu, Jing; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Beckman Inst Advanced Sci & Technol, Dept Mol & Integrat Physiol, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Eichorst, JP (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	yingxiao@uiuc.edu			Bioengineering Department of the University of Illinois, Urbana-Champaign; Wallace H. Coulter Foundation; Beckman Laser Institute Inc; NSF [08-00870]; NIH [NS-063405]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	Bioengineering Department of the University of Illinois, Urbana-Champaign; Wallace H. Coulter Foundation; Beckman Laser Institute Inc; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Bioengineering Department of the University of Illinois, Urbana-Champaign, the Wallace H. Coulter Foundation, Beckman Laser Institute Inc., NSF grant 08-00870, and NIH grant NS-063405. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Chamberlain CE, 2000, METHOD ENZYMOL, V325, P389; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; El-Sibai M, 2008, EXP CELL RES, V314, P1540, DOI 10.1016/j.yexcr.2008.01.016; GEORGE PL, 1991, AUTOMATIC MESH GENER, P333; GOSHTASBY A, 1986, PATTERN RECOGN, V19, P459, DOI 10.1016/0031-3203(86)90044-0; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jagalur M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S5; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Matula P, 2006, IEEE T IMAGE PROCESS, V15, P2388, DOI 10.1109/TIP.2006.875209; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieger B, 2004, MICROSC RES TECHNIQ, V64, P142, DOI 10.1002/jemt.20069; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Shen FM, 2006, CYTOM PART A, V69A, P563, DOI 10.1002/cyto.a.20283; Shi LZ, 2008, BIOMED MICRODEVICES, V10, P573, DOI 10.1007/s10544-008-9169-4; Shi LZ, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357735; SPATH H, 1985, CLUSTER DISSECTION A; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vielkind S, 2005, J IMMUNOL, V175, P350, DOI 10.4049/jimmunol.175.1.350; WANG Y, 2008, ANN REV BIO IN PRESS, V10; Wang YT, 2008, J COMMUN NETW-S KOR, V10, P38, DOI 10.1109/JCN.2008.6388326; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4082	10.1371/journal.pone.0004082	http://dx.doi.org/10.1371/journal.pone.0004082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114999	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466300019
J	Eldin, NS; Ismail, S; Mansour, H; Rekacewicz, C; El-Houssinie, M; El-Kafrawy, S; El Aidi, S; Abdel-Hamid, M; Esmat, G; Pol, S; Fontanet, A; Mohamed, MK				Eldin, Noha Sharaf; Ismail, Soheir; Mansour, Hala; Rekacewicz, Claire; El-Houssinie, Moustafa; El-Kafrawy, Sherif; El Aidi, Saeed; Abdel-Hamid, Mohamed; Esmat, Gamal; Pol, Stanislas; Fontanet, Arnaud; Mohamed, Mostafa K.			Symptomatic Acute Hepatitis C in Egypt: Diagnosis, Spontaneous Viral Clearance, and Delayed Treatment with 12 Weeks of Pegylated Interferon Alfa-2a	PLOS ONE			English	Article							INFECTION; THERAPY; VIRUS; MONOTHERAPY; SPREAD	Background and Objectives: The aim of this study was to estimate the proportion of spontaneous viral clearance (SVC) after symptomatic acute hepatitis C and to evaluate the efficacy of 12 weeks of pegylated interferon alfa-2a in patients who did not clear the virus spontaneously. Methods: Patients with symptomatic acute hepatitis C were recruited from two "fever hospitals'' in Cairo, Egypt. Patients still viremic three months after the onset of symptoms were considered for treatment with 12 weeks of pegylated interferon alfa-2a (180 mu g/week). Results: Between May 2002 and February 2006, 2243 adult patients with acute hepatitis were enrolled in the study. The SVC rate among 117 patients with acute hepatitis C was 33.8% (95%CI [25.9%-43.2%]) at three months and 41.5% (95%CI [33.0%-51.2%]) at six months. The sustained virological response (SVR) rate among the 17 patients who started treatment 4-6 months after onset of symptoms was 15/17=88.2% (95%CI [63.6%-98.5%]). Conclusion: Spontaneous viral clearance was high (41.5% six months after the onset of symptoms) in this population with symptomatic acute hepatitis C. Allowing time for spontaneous clearance should be considered before treatment is initiated for symptomatic acute hepatitis C.	[El-Houssinie, Moustafa; Mohamed, Mostafa K.] Ain Shams Univ, Dept Community Med, Cairo, Egypt; [Ismail, Soheir; Mansour, Hala] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt; [Rekacewicz, Claire; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [El-Kafrawy, Sherif] Menoufia Univ, Natl Liver Inst, Menoufia, Egypt; [El Aidi, Saeed] Imbaba Fever Hosp, Cairo, Egypt; [Abdel-Hamid, Mohamed] Menia Univ, Fac Med, Al Minya, Egypt; [Esmat, Gamal] Cairo Univ, Fac Med, Dept Trop Med & Hepatol, Cairo, Egypt; [Pol, Stanislas] AP HP, Hop Cochin, Unite Hepatol, Paris, France	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Cairo University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Eldin, NS (corresponding author), Ain Shams Univ, Dept Community Med, Cairo, Egypt.	fontanet@pasteur.fr	Sharafeldin, Noha/K-5040-2014; mohamed, mostafa/AFE-7371-2022	mohamed, mostafa/0000-0002-1421-2667; , arnaud/0000-0002-5239-6110; Esmat, Gamal/0000-0001-8614-1629	Agence Nationale de Recherche contre le SIDA et les hepatites virales [1213]	Agence Nationale de Recherche contre le SIDA et les hepatites virales(French National Research Agency (ANR))	This study was funded by the Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS 1213). We would like to thank the Roche laboratories for supplying Pegylated Interferon (PEG-IFNalpha-2a) PEGASYS 180 mg free of charge to study participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 1997, J Hum Virol, V1, P58; Arafa N, 2005, J HEPATOL, V43, P418, DOI 10.1016/j.jhep.2005.03.021; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Calleri G, 2007, J VIRAL HEPATITIS, V14, P116, DOI 10.1111/j.1365-2893.2006.00802.x; De Rosa F, 2006, HEPATOLOGY, V44, P511, DOI 10.1002/hep.21273; De Rosa FG, 2007, CLIN INFECT DIS, V45, P583, DOI 10.1086/520660; El Gaafary MM, 2005, J MED VIROL, V76, P520, DOI 10.1002/jmv.20392; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kamal SM, 2006, HEPATOLOGY, V43, P923, DOI 10.1002/hep.21197; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nomura H, 2004, HEPATOLOGY, V39, P1213, DOI 10.1002/hep.20196; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Santantonio T, 2006, CLIN INFECT DIS, V43, P1154, DOI 10.1086/507640; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Wedemeyer H, 2004, HEPATOLOGY, V39, P1201, DOI 10.1002/hep.20221; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Zekry A, 2005, J HEPATOL, V42, P293, DOI 10.1016/j.jhep.2004.12.012	21	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4085	10.1371/journal.pone.0004085	http://dx.doi.org/10.1371/journal.pone.0004085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115010	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466300021
J	Garofalo, M; Quintavalle, C; Zanca, C; De Rienzo, A; Romano, G; Acunzo, M; Puca, L; Incoronato, M; Croce, CM; Condorelli, G				Garofalo, Michela; Quintavalle, Cristina; Zanca, Ciro; De Rienzo, Assunta; Romano, Giulia; Acunzo, Mario; Puca, Loredana; Incoronato, Mariarosaria; Croce, Carlo M.; Condorelli, Gerolama			RETRACTED: Akt Regulates Drug-Induced Cell Death through Bcl-w Downregulation (Publication with Expression of Concern. See vol. 14, 2019) (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							CANCER; EXPRESSION; APOPTOSIS; SURVIVAL; TRANSCRIPTION; PATHWAY; PHOSPHORYLATION; ACTIVATION; MECHANISMS; PI3K/AKT	Akt is a serine threonine kinase with a major role in transducing survival signals and regulating proteins involved in apoptosis. To find new interactors of Akt involved in cell survival, we performed a two-hybrid screening in yeast using human full-length Akt c-DNA as bait and a murine c-DNA library as prey. Among the 80 clones obtained, two were identified as Bcl-w. Bcl-w is a member of the Bcl-2 family that is essential for the regulation of cellular survival, and that is up-regulated in different human tumors, such as gastric and colorectal carcinomas. Direct interaction of Bcl-w with Akt was confirmed by immunoprecipitation assays. Subsequently, we addressed the function of this interaction: by interfering with the activity or amount of Akt, we have demonstrated that Akt modulates the amount of Bcl-w protein. We have found that inhibition of Akt activity may promote apoptosis through the downregulation of Bcl-w protein and the consequential reduction in interaction of Bcl-w with proapoptotic members of the Bcl-2 family. Our data provide evidence that Bcl-w is a new member of the Akt pathway and that Akt may induce anti-apoptotic signals at least in part through the regulation of the amount and activity of Bcl-w.	[Garofalo, Michela; Quintavalle, Cristina; Zanca, Ciro; Acunzo, Mario; Puca, Loredana; Condorelli, Gerolama] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Garofalo, Michela; Croce, Carlo M.] Ohio State Univ, Comprehensive Canc Ctr, Human Canc Genet Program, Dept Mol Virol, Immunol & Med Genet, Columbus, OH 43210 USA; [Quintavalle, Cristina; Acunzo, Mario; Condorelli, Gerolama] CNR, IEOS, Naples, Italy; [Romano, Giulia; Incoronato, Mariarosaria] Fdn SDN, Naples, Italy; [De Rienzo, Assunta] Biogem scarl, IRGS, Ariano Irpino, Avellino, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Fac Sci Biotecnol, Naples, Italy	University of Naples Federico II; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II	Garofalo, M (corresponding author), Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy.	gecondor@unina.it	Incoronato, Mariarosaria/AAA-7541-2021; Incoronato, Mariarosaria/K-8727-2016; Young, Richard A/F-6495-2012; Puca, Loredana/O-4182-2019; Condorelli, Gerolama/AAC-3472-2022	Incoronato, Mariarosaria/0000-0001-7019-0581; Incoronato, Mariarosaria/0000-0001-7019-0581; Young, Richard A/0000-0001-8855-8647; Puca, Loredana/0000-0002-0895-1519; Condorelli, Gerolama/0000-0003-0177-8829	Associazione Italiana Ricerca sul Cancro, AIRC; MIUR-FIRB [RBIN04J4J7]; EU [503569]; Clinica Mediterranea- Federico II FiXO Training program; Fondazione SDN [fellowship]	Associazione Italiana Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); EU(European Commission); Clinica Mediterranea- Federico II FiXO Training program; Fondazione SDN	This work was partially supported by funds from: Associazione Italiana Ricerca sul Cancro, AIRC (G.C.), MIUR-FIRB (RBIN04J4J7), EU grant EMIL (European Molecular Imaging Laboratories Network) contract No 503569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.Q. is a recipient of Clinica Mediterranea- Federico II FiXO Training program. G.R. is recipient of Fondazione SDN fellowship. We wish to thank Dr. Vittorio de Franciscis and Michael Latronico for paper revision, and Maria Fiammetta Romano and Simona Romano for their help with FACS analysis.	Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; BELLACOSA A, 1993, ONCOGENE, V8, P745; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Garofalo M, 2007, INT J CANCER, V120, P1215, DOI 10.1002/ijc.22495; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gibson L, 1996, ONCOGENE, V13, P665; HAN Z, 2008, DIG DIS SCI; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Houghton Janet A., 1999, Current Opinion in Oncology, V11, P475, DOI 10.1097/00001622-199911000-00008; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaufmann T, 2004, TRENDS CELL BIOL, V14, P8, DOI 10.1016/j.tcb.2003.11.005; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lee HW, 2003, CANCER RES, V63, P1093; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Russell LD, 2001, BIOL REPROD, V65, P318, DOI 10.1095/biolreprod65.1.318; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; STRASSER A, 2000, ANN REV BIOCH, V69; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682; Yao MZ, 2007, J NEUROSCI, V27, P1422, DOI 10.1523/JNEUROSCI.2382-06.2007; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	41	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4070	10.1371/journal.pone.0004070	http://dx.doi.org/10.1371/journal.pone.0004070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114998	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466300010
J	Mine, S; Fortunel, NO; Pageon, H; Asselineau, D				Mine, Solene; Fortunel, Nicolas O.; Pageon, Herve; Asselineau, Daniel			Aging Alters Functionally Human Dermal Papillary Fibroblasts but Not Reticular Fibroblasts: A New View of Skin Morphogenesis and Aging	PLOS ONE			English	Article							AGE-RELATED-CHANGES; IN-VITRO; GROWTH-FACTOR; REPLICATIVE SENESCENCE; HUMAN KERATINOCYTES; MATRIX METALLOPROTEINASES; EPIDERMAL-KERATINOCYTES; SERIAL CULTIVATION; BASEMENT-MEMBRANE; GENE-EXPRESSION	Understanding the contribution of the dermis in skin aging is a key question, since this tissue is particularly important for skin integrity, and because its properties can affect the epidermis. Characteristics of matched pairs of dermal papillary and reticular fibroblasts (Fp and Fr) were investigated throughout aging, comparing morphology, secretion of cytokines, MMPs/TIMPs, growth potential, and interaction with epidermal keratinocytes. We observed that Fp populations were characterized by a higher proportion of small cells with low granularity and a higher growth potential than Fr populations. However, these differences became less marked with increasing age of donors. Aging was also associated with changes in the secretion activity of both Fp and Fr. Using a reconstructed skin model, we evidenced that Fp and Fr cells do not possess equivalent capacities to sustain keratinopoiesis. Comparing Fp and Fr from young donors, we noticed that dermal equivalents containing Fp were more potent to promote epidermal morphogenesis than those containing Fr. These data emphasize the complexity of dermal fibroblast biology and document the specific functional properties of Fp and Fr. Our results suggest a new model of skin aging in which marked alterations of Fp may affect the histological characteristics of skin.	[Mine, Solene; Fortunel, Nicolas O.; Pageon, Herve; Asselineau, Daniel] LOreal, Sci Vivant, Clichy, France	L'Oreal Group	Mine, S (corresponding author), LOreal, Sci Vivant, Clichy, France.	dasselineau@rd.loreal.com		FORTUNEL, Nicolas/0000-0001-8702-247X				Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; ANGELLO JC, 1987, J CELL PHYSIOL, V132, P125, DOI 10.1002/jcp.1041320117; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; AZZARONE B, 1982, J CELL SCI, V57, P177; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELL E, 1978, SCIENCE, V202, P1158, DOI 10.1126/science.725592; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Boehnke K, 2007, EUR J CELL BIOL, V86, P731, DOI 10.1016/j.ejcb.2006.12.005; Brash DE, 1997, TRENDS GENET, V13, P410, DOI 10.1016/S0168-9525(97)01246-8; Buckley CD, 2004, ANN RHEUM DIS, V63, P92, DOI 10.1136/ard.2004.028332; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; Carrino DA, 2003, J BIOL CHEM, V278, P17566, DOI 10.1074/jbc.M300124200; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Chuttani Anjali, 1995, P309; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770; DEMARCHEZ M, 1992, TRANSPLANTATION, V54, P317, DOI 10.1097/00007890-199208000-00023; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; FELDMAN SR, 1993, AM J MED SCI, V305, P203, DOI 10.1097/00000441-199304000-00002; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fortunel NO, 2003, J CELL SCI, V116, P4043, DOI 10.1242/jcs.00702; GARMYN M, 1992, J INVEST DERMATOL, V99, P743, DOI 10.1111/1523-1747.ep12614470; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARPER RA, 1979, SCIENCE, V204, P526, DOI 10.1126/science.432659; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; IRWIN CR, 1994, J CELL SCI, V107, P1333; IZUMI T, 1995, J BIOCHEM-TOKYO, V117, P1004, DOI 10.1093/oxfordjournals.jbchem.a124798; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; LAVKER RM, 1987, J INVEST DERMATOL, V88, pS44, DOI 10.1111/1523-1747.ep12468934; Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; MONTAGNA W, 1979, J INVEST DERMATOL, V73, P47, DOI 10.1111/1523-1747.ep12532761; Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1; Odorisio T, 2002, EUR J DERMATOL, V12, pVII; POSTLETHWAITE AE, 1999, INFLAMMATION BASIC P, P227; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; REENSTRA WR, 1993, EXP CELL RES, V209, P118, DOI 10.1006/excr.1993.1291; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rittie L, 2005, METH MOLEC MED, V117, P83; SCHAFER IA, 1989, EXP CELL RES, V183, P112, DOI 10.1016/0014-4827(89)90422-9; SCHAFER IA, 1985, MECH AGEING DEV, V31, P275, DOI 10.1016/0047-6374(85)90095-8; SCHNEIDER EL, 1979, J INVEST DERMATOL, V73, P15, DOI 10.1111/1523-1747.ep12532753; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; SCHONHERR E, 1993, BIOCHEM J, V290, P893, DOI 10.1042/bj2900893; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SMITH JR, 1978, P NATL ACAD SCI USA, V75, P1353, DOI 10.1073/pnas.75.3.1353; Smith RS, 1997, AM J PATHOL, V151, P317; Sorrell JM, 2004, J CELL PHYSIOL, V200, P134, DOI 10.1002/jcp.10474; TAJIMA S, 1981, J INVEST DERMATOL, V77, P410, DOI 10.1111/1523-1747.ep12494614; Tajima S, 1996, ARCH DERMATOL RES, V288, P753, DOI 10.1007/BF02505292; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Yaar M, 2002, ARCH DERMATOL, V138, P1429, DOI 10.1001/archderm.138.11.1429	74	132	140	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4066	10.1371/journal.pone.0004066	http://dx.doi.org/10.1371/journal.pone.0004066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115004	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466300008
J	Saaf, AM; Tengvall-Linder, M; Chang, HY; Adler, AS; Wahlgren, CF; Scheynius, A; Nordenskjold, M; Bradley, M				Saaf, Annika M.; Tengvall-Linder, Maria; Chang, Howard Y.; Adler, Adam S.; Wahlgren, Carl-Fredrik; Scheynius, Annika; Nordenskjold, Magnus; Bradley, Maria			Global Expression Profiling in Atopic Eczema Reveals Reciprocal Expression of Inflammatory and Lipid Genes	PLOS ONE			English	Article							PITYROSPORUM-ORBICULARE; MALASSEZIA-SYMPODIALIS; BARRIER FUNCTION; STRATUM-CORNEUM; SKIN-LESIONS; FATTY-ACIDS; DERMATITIS; ASSOCIATION; LINKAGE; PROTEIN	Background: Atopic eczema (AE) is a common chronic inflammatory skin disorder. In order to dissect the genetic background several linkage and genetic association studies have been performed. Yet very little is known about specific genes involved in this complex skin disease, and the underlying molecular mechanisms are not fully understood. Methodology/Findings: We used human DNA microarrays to identify a molecular picture of the programmed responses of the human genome to AE. The transcriptional program was analyzed in skin biopsy samples from lesional and patch-tested skin from AE patients sensitized to Malassezia sympodialis (M. sympodialis), and corresponding biopsies from healthy individuals. The most notable feature of the global gene-expression pattern observed in AE skin was a reciprocal expression of induced inflammatory genes and repressed lipid metabolism genes. The overall transcriptional response in M. sympodialis patch-tested AE skin was similar to the gene-expression signature identified in lesional AE skin. In the constellation of genes differentially expressed in AE skin compared to healthy control skin, we have identified several potential susceptibility genes that may play a critical role in the pathological condition of AE. Many of these genes, including genes with a role in immune responses, lipid homeostasis, and epidermal differentiation, are localized on chromosomal regions previously linked to AE. Conclusions/Significance: Through genome-wide expression profiling, we were able to discover a distinct reciprocal expression pattern of induced inflammatory genes and repressed lipid metabolism genes in skin from AE patients. We found a significant enrichment of differentially expressed genes in AE with cytobands associated to the disease, and furthermore new chromosomal regions were found that could potentially guide future region-specific linkage mapping in AE. The full data set is available at http://microarray-pubs.stanford.edu/eczema.	[Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Tengvall-Linder, Maria; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden; [Chang, Howard Y.; Adler, Adam S.] Stanford Univ, Sch Med, Programs Epithelial Biol & Canc Biol, Stanford, CA 94305 USA; [Wahlgren, Carl-Fredrik; Bradley, Maria] Karolinska Inst, Dept Med Solna, Dermatol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stanford University; Karolinska Institutet	Saaf, AM (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	annika.saaf@ki.se		Nordenskjold, Magnus/0000-0002-4974-425X; Adler, Adam/0000-0001-9301-0037	Swedish Research Council Vetenskapsradet; U.S. National Eczema Association for Science and Education; Edward Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Stockholm County Council; Karolinska Institutet	Swedish Research Council Vetenskapsradet(Swedish Research Council); U.S. National Eczema Association for Science and Education; Edward Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council Vetenskapsradet (A.S), the U.S. National Eczema Association for Science and Education, the Edward Welander-Finsen Foundation, the Swedish Asthma and Allergy Association and through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beyer K, 2000, J INVEST DERMATOL, V115, P906, DOI 10.1046/j.1523-1747.2000.00096.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; Calder PC, 2006, CLIN EXP ALLERGY, V36, P138, DOI 10.1111/j.1365-2222.2006.02433.x; Calder PC, 2000, PEDIAT ALLERG IMM-UK, V11, P29, DOI 10.1034/j.1399-3038.2000.00508.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Choi MJ, 2005, AM J CLIN DERMATOL, V6, P215, DOI 10.2165/00128071-200506040-00002; Christensen U, 2006, EUR J HUM GENET, V14, P227, DOI 10.1038/sj.ejhg.5201541; Colgan J, 2007, CURR OPIN ALLERGY CL, V7, P51, DOI 10.1097/ACI.0b013e32801297e6; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Enomoto H, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-5; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; Haagerup A, 2004, ALLERGY, V59, P88, DOI 10.1111/j.1398-9995.2004.00294.x; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Jarvikallio A, 1997, BRIT J DERMATOL, V136, P871, DOI 10.1046/j.1365-2133.1997.01831.x; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kere J, 2005, PHILOS T R SOC B, V360, P1551, DOI 10.1098/rstb.2005.1684; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Laitinen K, 2006, CLIN EXP ALLERGY, V36, P166, DOI 10.1111/j.1365-2222.2006.02417.x; LARSEN FS, 1993, J AM ACAD DERMATOL, V28, P719, DOI 10.1016/0190-9622(93)70099-F; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lin YT, 2007, CLIN REV ALLERG IMMU, V33, P167, DOI 10.1007/s12016-007-0044-5; Linder MT, 2000, CLIN EXP ALLERGY, V30, P122, DOI 10.1046/j.1365-2222.2000.00702.x; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Mizuno M, 2006, CURR MED CHEM, V13, P1707, DOI 10.2174/092986706777441959; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ogawa K, 2005, J DERMATOL SCI, V40, P35, DOI 10.1016/j.jdermsci.2005.06.001; Oiso N, 2000, BRIT J DERMATOL, V142, P1003, DOI 10.1046/j.1365-2133.2000.03485.x; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Pivarcsi A, 2004, J IMMUNOL, V173, P5810, DOI 10.4049/jimmunol.173.9.5810; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scheynius A, 2002, INT ARCH ALLERGY IMM, V127, P161, DOI 10.1159/000053860; Schmid-Grendelmeier P, 2006, CHEM IMMUNOL ALLERGY, V91, P98; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Sugiura H, 2005, BRIT J DERMATOL, V152, P146, DOI 10.1111/J.1365-2133.2005.06352.X; Takahashi N, 2005, HUM MOL GENET, V14, P3149, DOI 10.1093/hmg/ddi347; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vasilopoulos Y, 2004, J INVEST DERMATOL, V123, P62, DOI 10.1111/j.0022-202X.2004.22708.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Yen CH, 2008, ANN ALLERG ASTHMA IM, V100, P66, DOI 10.1016/S1081-1206(10)60407-3; ZARGARI A, 1994, ALLERGY, V49, P50, DOI 10.1111/j.1398-9995.1994.tb00773.x	70	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4017	10.1371/journal.pone.0004017	http://dx.doi.org/10.1371/journal.pone.0004017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107207	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000012
J	Suryan, RM; Anderson, DJ; Shaffer, SA; Roby, DD; Tremblay, Y; Costa, DP; Sievert, PR; Sato, F; Ozaki, K; Balogh, GR; Nakamura, N				Suryan, Robert M.; Anderson, David J.; Shaffer, Scott A.; Roby, Daniel D.; Tremblay, Yann; Costa, Daniel P.; Sievert, Paul R.; Sato, Fumio; Ozaki, Kiyoaki; Balogh, Gregory R.; Nakamura, Noboru			Wind, Waves, and Wing Loading: Morphological Specialization May Limit Range Expansion of Endangered Albatrosses	PLOS ONE			English	Article							FORAGING DESTINATIONS; WANDERING ALBATROSSES; PHOEBASTRIA-ALBATRUS; NORTH PACIFIC; TRACKING; PROCELLARIIFORMES; HABITAT; FLIGHT	Among the varied adaptations for avian flight, the morphological traits allowing large-bodied albatrosses to capitalize on wind and wave energy for efficient long-distance flight are unparalleled. Consequently, the biogeographic distribution of most albatrosses is limited to the windiest oceanic regions on earth; however, exceptions exist. Species breeding in the North and Central Pacific Ocean (Phoebastria spp.) inhabit regions of lower wind speed and wave height than southern hemisphere genera, and have large intrageneric variation in body size and aerodynamic performance. Here, we test the hypothesis that regional wind and wave regimes explain observed differences in Phoebastria albatross morphology and we compare their aerodynamic performance to representatives from the other three genera of this globally distributed avian family. In the North and Central Pacific, two species (short-tailed P. albatrus and waved P. irrorata) are markedly larger, yet have the smallest breeding ranges near highly productive coastal upwelling systems. Short-tailed albatrosses, however, have 60% higher wing loading (weight per area of lift) compared to waved albatrosses. Indeed, calculated aerodynamic performance of waved albatrosses, the only tropical albatross species, is more similar to those of their smaller congeners (black-footed P. nigripes and Laysan P. immutabilis), which have relatively low wing loading and much larger foraging ranges that include central oceanic gyres of relatively low productivity. Globally, the aerodynamic performance of short-tailed and waved albatrosses are most anomalous for their body sizes, yet consistent with wind regimes within their breeding season foraging ranges. Our results are the first to integrate global wind and wave patterns with albatross aerodynamics, thereby identifying morphological specialization that may explain limited breeding ranges of two endangered albatross species. These results are further relevant to understanding past and potentially predicting future distributional limits of albatrosses globally, particularly with respect to climate change effects on basin-scale and regional wind fields.	Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Shaffer, Scott A.; Tremblay, Yann; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolut Biol, Long Marine Lab, Santa Cruz, CA 95064 USA; [Roby, Daniel D.] Oregon State Univ, Dept Fisheries & Wildlife, USGS, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Sievert, Paul R.] Univ Massachusetts, Dept Nat Resources Conservat, USGS, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Sato, Fumio; Ozaki, Kiyoaki; Nakamura, Noboru] Yamashina Inst Ornithol, Abiko, Chiba, Japan; [Balogh, Gregory R.] US Fish & Wildlife Serv, Ecol Serv, Anchorage, AK USA	Oregon State University; Wake Forest University; University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of the Interior; US Fish & Wildlife Service	Suryan, RM (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA.	rob.suryan@oregonstate.edu	Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Shaffer, Scott A/0000-0002-7751-5059; Suryan, Robert/0000-0003-0755-8317; Tremblay, Yann/0000-0002-4653-9269; Costa, Daniel/0000-0002-0233-5782	U.S. Fish and Wildlife Service; Ministry of Environment, Japan; North Pacific Research Board; U.S. National Science Foundation [DEB 98-06606, DEB 0235818]; National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-1-0880, N00014-03-1-0651]; Alfred P. Sloan Foundation; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; NOAA [Fisheries Oceanography Fellowship]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Ministry of Environment, Japan(Ministry of the Environment, Japan); North Pacific Research Board; U.S. National Science Foundation(National Science Foundation (NSF)); National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Financial support was provided by the U.S. Fish and Wildlife Service, Ministry of Environment, Japan, the North Pacific Research Board, U.S. National Science Foundation (awards DEB 98-06606 and DEB 0235818), and through the Tagging of Pacific Predators (TOPP) program, which is funded by the National Ocean Partnership Program (N00014-02-1-1012), the Office of Naval Research (N00014-00-1-0880 & N00014-03-1-0651) and the Alfred P. Sloan, David and Lucille Packard, and Gordon and Betty Moore foundations. R. Suryan was supported, in part, by the Cooperative Institute for Marine Resource Studies, Oregon State University, through a NOAA Fisheries Oceanography Fellowship. The funders had no role in study design, data collection and analysis, or decision to publish.	Anderson DJ, 2003, BIOL CONSERV, V110, P367, DOI 10.1016/S0006-3207(02)00238-0; ANDERSON DJ, 2008, ENDANGERED SPECIES R, DOI DOI 10.3354/ESR0089; Baker J.D., 2006, ENDANGER SPECIES RES, V2, P21, DOI DOI 10.3354/ESR002021; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; COSTA DP, 1987, IBIS, V129, P149, DOI 10.1111/j.1474-919X.1987.tb03196.x; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; HASEGAWA H, 1982, American Birds, V36, P806; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Murray MD, 2003, EMU, V103, P59, DOI 10.1071/MU01011; Nunn GB, 1996, AUK, V113, P784; Olson SL, 2003, P NATL ACAD SCI USA, V100, P12825, DOI 10.1073/pnas.1934576100; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PENNYCUICK CJ, 2002, AVIAN SCI, V1, P1; PENNYCUICK CJ, 1998, BIRD FLIGHT PERFORMA; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Rayleigh L., 1883, NATURE, V27, P534, DOI DOI 10.1038/027388A0; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Spear LB, 1997, IBIS, V139, P234, DOI 10.1111/j.1474-919X.1997.tb04621.x; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; TICKELL, 2000, ALBATROSSES; Walkden SL, 1925, NATURE, V116, P132, DOI 10.1038/116132b0; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034	29	54	55	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4016	10.1371/journal.pone.0004016	http://dx.doi.org/10.1371/journal.pone.0004016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107200	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000011
J	Lehmann, MB; Funston, PJ; Owen, CR; Slotow, R				Lehmann, Monika B.; Funston, Paul J.; Owen, Cailey R.; Slotow, Rob			Home Range Utilisation and Territorial Behaviour of Lions (Panthera leo) on Karongwe Game Reserve, South Africa	PLOS ONE			English	Article								Interventionist conservation management of territorial large carnivores has increased in recent years, especially in South Africa. Understanding of spatial ecology is an important component of predator conservation and management. Spatial patterns are influenced by many, often interacting, factors making elucidation of key drivers difficult. We had the opportunity to study a simplified system, a single pride of lions (Panthera leo) after reintroduction onto the 85 km(2) Karongwe Game Reserve, from 1999-2005, using radio-telemetry. In 2002 one male was removed from the paired coalition which had been present for the first three years. A second pride and male were in a fenced reserve adjacent of them to the east. This made it possible to separate social and resource factors in both a coalition and single male scenario, and the driving factors these seem to have on spatial ecology. Male ranging behaviour was not affected by coalition size, being driven more by resource rather than social factors. The females responded to the lions on the adjacent reserve by avoiding the area closest to them, therefore females may be more driven by social factors. Home range size and the resource response to water are important factors to consider when reintroducing lions to a small reserve, and it is hoped that these findings lead to other similar studies which will contribute to sound decisions regarding the management of lions on small reserves.	[Funston, Paul J.] Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa; [Lehmann, Monika B.; Owen, Cailey R.] Ecol Inst Res, Schagen, South Africa; [Owen, Cailey R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	Tshwane University of Technology; University of Kwazulu Natal	Lehmann, MB (corresponding author), Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa.	FunstonPJ@TUT.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	Tshwane University of Technology [scholarship]; NRF [FA2004050400038]	Tshwane University of Technology; NRF	The author was funded by a Tshwane University of Technology scholarship as well as an NRF grant-holder linked bursary (grant: FA2004050400038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPS CD, 1999, USDA FOREST SERVICE, P1; BERTRAM B, 1973, E AFR WILDL J, V2, P215; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRADBURY JW, 1976, BEHAV ECOL SOCIOBIOL, V1, P337, DOI 10.1007/BF00299399; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Druce D., 2004, Koedoe, V47, P103; Funston P.J, 1999, THESIS U PRETORIA PR; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; FUNSTON PJ, 1997, 597 SCI SERV; Garai Marion E., 2004, Pachyderm, V37, P28; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; GRINNEL J, 1996, BEHAV ECOL, V1, P55; Grinnell J, 2001, ANIM BEHAV, V62, P93, DOI 10.1006/anbe.2001.1735; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; Hayward Matt W., 2007, Open Conservation Biology Journal, V1, P1, DOI 10.2174/1874839200701010001; HOOGE PN, 1999, ANIMAL MOVEMENT ANAL; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HUNTER L, 1999, SOCIOECOLOGY REINTRO; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Low A. B., 1998, VEGETATION S AFRICA; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mills M. G. L., 1996, P223; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C, 2000, AM ANTHROPOL, V102, P829, DOI 10.1525/aa.2000.102.4.829; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PACKER C, 1997, DIVIDED WE FALL COOP, P32; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; RUTHERFORD MC, 2003, BIOMES SO AFRICA OBJ; Schaller G. B., 1972, SERENGETI LION STUDY; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Slotow R., 2008, REINTRODUCTION TOP O; Spong G, 2002, BEHAV ECOL SOCIOBIOL, V52, P303, DOI 10.1007/s00265-002-0515-x; STANDER P E, 1991, Madoqua, V18, P1; Starfield A.M., 1981, P121; VANORSDOL KG, 1985, J ZOOL, V206, P97; WHYTE J, 1985, THESIS U NATAL	41	21	21	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3998	10.1371/journal.pone.0003998	http://dx.doi.org/10.1371/journal.pone.0003998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098987	Green Published, gold, Green Submitted			2022-12-27	WOS:000265462300009
J	Derikx, JPM; van Waardenburg, DA; Thuijls, G; Willigers, HM; Koenraads, M; van Bijnen, AA; Heineman, E; Poeze, M; Ambergen, T; van Ooij, A; van Rhijn, LW; Buurman, WA				Derikx, Joep P. M.; van Waardenburg, Dick A.; Thuijls, Geertje; Willigers, Henriette M.; Koenraads, Marianne; van Bijnen, Annemarie A.; Heineman, Erik; Poeze, Martijn; Ambergen, Ton; van Ooij, Andre; van Rhijn, Lodewijk W.; Buurman, Wim A.			New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MULTIPLE ORGAN DYSFUNCTION; INTESTINAL PERMEABILITY; CARDIOPULMONARY BYPASS; CONTROLLED HYPOTENSION; SYSTEMIC INFLAMMATION; COMPLICATIONS; HYPOPERFUSION; ENDOTOXEMIA; EXPRESSION	Background: Gut barrier loss has been implicated as a critical event in the occurrence of postoperative complications. We aimed to study the development of gut barrier loss in patients undergoing major non-abdominal surgery. Methodology/Principal Findings: Twenty consecutive children undergoing spinal fusion surgery were included. This kind of surgery is characterized by long operation time, significant blood loss, prolonged systemic hypotension, without directly leading to compromise of the intestines by intestinal manipulation or use of extracorporeal circulation. Blood was collected preoperatively, every two hours during surgery and 2, 4, 15 and 24 hours postoperatively. Gut mucosal barrier was assessed by plasma markers for enterocyte damage (I-FABP, I-BABP) and urinary presence of tight junction protein claudin-3. Intestinal mucosal perfusion was measured by gastric tonometry (PrCO2, Pr-aCO2-gap). Plasma concentration of I-FABP, I-BABP and urinary expression of claudin-3 increased rapidly and significantly after the onset of surgery in most children. Postoperatively, all markers decreased promptly towards baseline values together with normalisation of MAP. Plasma levels of I-FABP, I-BABP were significantly negatively correlated with MAP at K hour before blood sampling (-0.726 (p<0.001), -0.483 (P<0.001), respectively). Furthermore, circulating I-FABP correlated with gastric mucosal PrCO2, Pr-aCO2-gap measured at the same time points (0.553 (p = 0.040), 0.585 (p = 0.028), respectively). Conclusions/Significance: This study shows the development of gut barrier loss in children undergoing major non-abdominal surgery, which is related to preceding hypotension and mesenterial hypoperfusion. These data shed new light on the potential role of peroperative circulatory perturbation and intestinal barrier loss.	[Derikx, Joep P. M.; Thuijls, Geertje; Koenraads, Marianne; van Bijnen, Annemarie A.; Heineman, Erik; Poeze, Martijn; Buurman, Wim A.] Maastricht Univ, Nutr & Toxicol Res Inst NUTRIM, Maastricht, Netherlands; [van Waardenburg, Dick A.] Univ Hosp Maastricht, Dept Paediat, Maastricht, Netherlands; [Willigers, Henriette M.] Univ Hosp Maastricht, Dept Anaesthesiol, Maastricht, Netherlands; [Ambergen, Ton] Univ Maastricht, Dept Methodol & Stat, Maastricht, Netherlands; [van Ooij, Andre; van Rhijn, Lodewijk W.] Univ Hosp Maastricht, Dept Orthopaed Surg, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Derikx, JPM (corresponding author), Maastricht Univ, Dept Surg, Univ Hosp Maastricht, Maastricht, Netherlands.	w.buurman@ah.unimaas.nl	Heineman, Erik/ABG-9592-2021	derikx, joep/0000-0003-0694-7679	AGIKO [920-03-438]; Netherlands Organisation for Health Research and Development; University Hospital Maastricht [Profileringsfonds grant]	AGIKO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); University Hospital Maastricht	This research was supported by AGIKO-stipendium 920-03-438 (to JPM Derikx) from the Netherlands Organisation for Health Research and Development. This work was partially funded by a Profileringsfonds grant from the University Hospital Maastricht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akata T, 2007, ANESTHESIOLOGY, V106, P365, DOI 10.1097/00000542-200702000-00026; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; Braun JP, 2007, J INT MED RES, V35, P72, DOI 10.1177/147323000703500107; Buttenschoen K, 2001, AM J SURG, V181, P36, DOI 10.1016/S0002-9610(00)00534-1; Degoute CS, 2007, DRUGS, V67, P1053, DOI 10.2165/00003495-200767070-00007; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; DERIKX JP, 2008, ANN ONCOL; Deyo RA, 2007, NEW ENGL J MED, V356, P2239, DOI 10.1056/NEJMp078052; Dutton RP, 2004, EUR SPINE J, V13, pS66, DOI 10.1007/s00586-004-0756-7; Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005; HAAN JD, 2008, POST SHOCK INTERVENT; Hannan EL, 2003, JAMA-J AM MED ASSOC, V290, P773, DOI 10.1001/jama.290.6.773; Hanssen SJ, 2008, ANN SURG, V248, P117, DOI 10.1097/SLA.0b013e3181784cc5; Holland J, 2005, AM J SURG, V190, P393, DOI 10.1016/j.amjsurg.2005.03.038; Holmes JH, 2001, J SURG RES, V100, P192, DOI 10.1006/jsre.2001.6237; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Kanwar S, 2000, ANN SURG, V231, P88, DOI 10.1097/00000658-200001000-00013; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Luyer MD, 2005, J EXP MED, V202, P1023, DOI 10.1084/jem.20042397; Malagon I, 2005, BRIT J ANAESTH, V94, P181, DOI 10.1093/bja/aei014; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Morariu AM, 2005, CHEST, V128, P2677, DOI 10.1378/chest.128.4.2677; OHRI SK, 1994, GASTROENTEROLOGY, V106, P318, DOI 10.1016/0016-5085(94)90588-6; QUEZADO ZMN, 1994, J EXP MED, V179, P569, DOI 10.1084/jem.179.2.569; Riddington DW, 1996, JAMA-J AM MED ASSOC, V275, P1007, DOI 10.1001/jama.275.13.1007; Rizoli SB, 2002, LANCET INFECT DIS, V2, P137, DOI 10.1016/S1473-3099(02)00220-7; Rossi M, 2004, ANN THORAC SURG, V77, P612, DOI 10.1016/S0003-4975(03)01520-0; Rotstein O D, 2000, Surg Infect (Larchmt), V1, P217, DOI 10.1089/109629600750018141; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Soong CV, 1997, CRIT CARE MED, V25, P1472, DOI 10.1097/00003246-199709000-00013; Suttner SW, 1999, ANESTH ANALG, V89, P1371, DOI 10.1097/00000539-199912000-00008; van de Poll MCG, 2007, WORLD J SURG, V31, P2033, DOI 10.1007/s00268-007-9182-4; WATANABE K, 1995, ARCH HISTOL CYTOL, V58, P303, DOI 10.1679/aohc.58.303; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	37	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3954	10.1371/journal.pone.0003954	http://dx.doi.org/10.1371/journal.pone.0003954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088854	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458500004
J	Rao, KN; Burley, SK; Swaminathan, S				Rao, Krishnamurthy N.; Burley, Stephen K.; Swaminathan, Subramanyam			UPF201 Archaeal Specific Family Members Reveal Structural Similarity to RNA-Binding Proteins but Low Likelihood for RNA-Binding Function	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LARGE RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; THERMOTOGA-MARITIMA; RECOGNITION; DOMAIN; THERMOSTABILITY; EVOLUTION; SERVER; RESOLUTION	We have determined X-ray crystal structures of four members of an archaeal specific family of proteins of unknown function (UPF0201; Pfam classification: DUF54) to advance our understanding of the genetic repertoire of archaea. Despite low pairwise amino acid sequence identities (10-40%) and the absence of conserved sequence motifs, the three-dimensional structures of these proteins are remarkably similar to one another. Their common polypeptide chain fold, encompassing a five-stranded antiparallel beta-sheet and five alpha-helices, proved to be quite unexpectedly similar to that of the RRM-type RNA-binding domain of the ribosomal L5 protein, which is responsible for binding the 5S- rRNA. Structure-based sequence alignments enabled construction of a phylogenetic tree relating UPF0201 family members to L5 ribosomal proteins and other structurally similar RNA binding proteins, thereby expanding our understanding of the evolutionary purview of the RRM superfamily. Analyses of the surfaces of these newly determined UPF0201 structures suggest that they probably do not function as RNA binding proteins, and that this domain specific family of proteins has acquired a novel function in archaebacteria, which awaits experimental elucidation.	[Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, New York, NY USA; [Burley, Stephen K.] Eli Lilly & Co, San Diego, CA USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Eli Lilly	Rao, KN (corresponding author), Brookhaven Natl Lab, Dept Biol, New York, NY USA.	swami@bnl.gov		Burley, Stephen K./0000-0002-2487-9713	National Institute of General Medical Sciences [GM074945]; DOE [DEAC02- 98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by a U54 award from the National Institute of General Medical Sciences to the NYSGXRC (GM074945; PI: Stephen K. Burley) under DOE Prime Contract No. DEAC02- 98CH10886 with Brookhaven National Laboratory. Financial support for X12C beamline comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health.	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013; BAJAJ M, 1984, ANNU REV BIOPHYS BIO, V13, P453; Balaji S, 2007, J BIOSCIENCES, V32, P83, DOI 10.1007/s12038-007-0008-1; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Canaves JM, 2004, J MOL BIOL, V344, P977, DOI 10.1016/j.jmb.2004.09.076; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Charlebois RL, 2000, GENOME, V43, P116, DOI 10.1139/gen-43-1-116; Chivers PT, 2005, J MOL BIOL, V348, P597, DOI 10.1016/j.jmb.2005.03.017; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Egorova K, 2005, CURR OPIN MICROBIOL, V8, P649, DOI 10.1016/j.mib.2005.10.015; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Galperin MY, 2007, ENVIRON MICROBIOL, V9, P279, DOI 10.1111/j.1462-2920.2006.01223.x; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; GODZIK A, 1995, PROTEIN SCI, V4, P2107, DOI 10.1002/pro.5560041016; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Huber H, 2003, RES MICROBIOL, V154, P165, DOI 10.1016/S0923-2508(03)00035-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nakashima T, 2001, RNA, V7, P692, DOI 10.1017/S1355838201002345; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Olsen GJ, 1997, CELL, V89, P991, DOI 10.1016/S0092-8674(00)80284-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Perederina A, 2002, RNA, V8, P1548, DOI 10.1017/S1355838202029953; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; RAO KN, 2007, PROTEINS; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Robinson-Rechavi M, 2005, STRUCTURE, V13, P857, DOI 10.1016/j.str.2005.03.011; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1978, J MOL EVOL, V11, P245, DOI 10.1007/BF01734485; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	75	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3903	10.1371/journal.pone.0003903	http://dx.doi.org/10.1371/journal.pone.0003903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079550	Green Published, gold			2022-12-27	WOS:000265455900001
J	Resa-Infante, P; Jorba, N; Zamarreno, N; Fernandez, Y; Juarez, S; Ortin, J				Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan			The Host-Dependent Interaction of alpha-Importins with Influenza PB2 Polymerase Subunit Is Required for Virus RNA Replication	PLOS ONE			English	Article								The influenza virus polymerase is formed by the PB1, PB2 and PA subunits and is required for virus transcription and replication in the nucleus of infected cells. As PB2 is a relevant host-range determinant we expressed a TAP-tagged PB2 in human cells and isolated intracellular complexes. Alpha-importin was identified as a PB2-associated factor by proteomic analyses. To study the relevance of this interaction for virus replication we mutated the PB2 NLS and analysed the phenotype of mutant subunits, polymerase complexes and RNPs. While mutant PB2 proteins showed reduced nuclear accumulation, they formed polymerase complexes normally when co expressed with PB1 and PA. However, mutant RNPs generated with a viral CAT replicon showed up to hundred-fold reduced CAT accumulation. Rescue of nuclear localisation of mutant PB2 by insertion of an additional SV40 TAg-derived NLS did not revert the mutant phenotype of RNPs. Furthermore, determination of recombinant RNP accumulation in vivo indicated that PB2 NLS mutations drastically reduced virus RNA replication. These results indicate that, above and beyond its role in nuclear accumulation, PB2 interaction with alpha-importins is required for virus RNA replication. To ascertain whether PB2-alpha-importin binding could contribute to the adaptation of H5N1 avian viruses to man, their association in vivo was determined. Human alpha importin isoforms associated efficiently to PB2 protein of an H3N2 human virus but bound to diminished and variable extents to PB2 from H5N1 avian or human strains, suggesting that the function of alpha importin during RNA replication is important for the adaptation of avian viruses to the human host.	[Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan] CIBER Enfermedades Resp, Palma de Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Resa-Infante, P (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3 Campus Cantoblanco, Madrid, Spain.	jortin@cnb.csic.es	Resa-Infante, Patricia/D-3843-2018; Ortin, Juan/L-3622-2013	Resa-Infante, Patricia/0000-0002-1727-592X; Zamarreno, Noelia/0000-0002-7968-9458; Moron, Yolanda Fernandez/0000-0002-2256-163X; Ortin, Juan/0000-0002-6200-4678	Ministerio de Educacion y Ciencia [fellows, BFU2004-491, BFU2007-60046]; Consejo Superior de Investigaciones Cientificas [fellows]; European Union; VIRGIL [FP6-503359]; FLUPOL [SP5B-CT-2007-044263]; Comunidad de Madrid (VIRHOST) [S-SAL-0815-2006]	Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas; European Union(European Commission); VIRGIL; FLUPOL; Comunidad de Madrid (VIRHOST)(Comunidad de Madrid)	N.J. and P.R-I were fellows from Ministerio de Educacion y Ciencia and Consejo Superior de Investigaciones Cientificas, respectively. This work was funded by Ministerio de Educacion y Ciencia (BFU2004-491 and BFU2007-60046), European Union. (VIRGIL)( FP6-503359) and (FLUPOL) (SP5B-CT-2007-044263) and Comunidad de Madrid (VIRHOST) (S-SAL-0815-2006).	ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BARCENA J, 1994, J VIROL, V68, P6900; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Elton D, 2005, CURRENT TOPICS INFLU, P1; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gastaminza P, 2003, J VIROL, V77, P5098, DOI 10.1128/JVI.77.9.5098-5108.2003; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MENA I, 1994, J GEN VIROL, V75, P2109, DOI 10.1099/0022-1317-75-8-2109; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; NATH ST, 1990, MOL CELL BIOL, V10, P4139, DOI 10.1128/MCB.10.8.4139; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; OCHOA M, 1995, VIRUS RES, V37, P305, DOI 10.1016/0168-1702(95)00039-S; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Palese P, 2006, FIELDS VIROLOGY, P1647; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Zhang J, 2004, J MASS SPECTROM, V39, P808, DOI 10.1002/jms.657	42	85	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3904	10.1371/journal.pone.0003904	http://dx.doi.org/10.1371/journal.pone.0003904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066626	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455700008
J	Poynard, T; Ingiliz, P; Elkrief, L; Munteanu, M; Lebray, P; Morra, R; Messous, D; Bismut, FI; Roulot, D; Benhamou, Y; Thabut, D; Ratziu, V				Poynard, Thierry; Ingiliz, Patrick; Elkrief, Laure; Munteanu, Mona; Lebray, Pascal; Morra, Rachel; Messous, Djamila; Bismut, Francoise Imbert; Roulot, Dominique; Benhamou, Yves; Thabut, Dominique; Ratziu, Vlad			Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; DIAGNOSTIC EVALUATION; HEPATITIS-C; FIBROTEST; STIFFNESS; VARIABILITY; BIOMARKERS	Background: Assessing liver fibrosis is traditionally performed by biopsy, an imperfect gold standard. Non-invasive techniques, liver stiffness measurements (LSM) and biomarkers [FibroTest (R) (FT)], are widely used in countries where they are available. The aim was to identify factors associated with LSM accuracy using FT as a non-invasive endpoint and vice versa. Methods: The proof of concept was taken using the manufacturers recommendations for excluding patients at high risk of false negative/positive. The hypothesis was that the concordance between LSM and FT, would be improved by excluding high-risk patients. Thereafter, the impact of potential variability factors was assessed by the same methods. Liver biopsy and independent endpoints were used to validate the results. Results: Applying manufacturers' recommendations in 2,004 patients increased the strength of concordance between LSM and FT (P<0.00001). Among the 1,338 patients satisfying recommendations, the methodology identified a significant LSM operator effect (P = 0.001) and the following variability factors (all P<0.01), related to LSM: male gender, older age, and NAFLD as a cause of liver disease. Biopsy confirmed in 391 patients these results. Conclusion: This study has validated the concept of using the strength of concordance between non-invasive estimates of liver fibrosis for the identification of factors associated with variability and precautions of use.	[Poynard, Thierry; Ingiliz, Patrick; Elkrief, Laure; Lebray, Pascal; Morra, Rachel; Messous, Djamila; Bismut, Francoise Imbert; Benhamou, Yves; Thabut, Dominique; Ratziu, Vlad] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France; [Munteanu, Mona] Biopredictive, Paris, France; [Roulot, Dominique] APHP Hop Avicennes, Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Poynard, T (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France.	tpoynard@teaser.fr	Poynard, Thierry/C-1355-2010; Elkrief, Laure/AAC-9142-2022; Roulot, Dominique/U-1732-2018	Poynard, Thierry/0000-0002-3726-7230; Elkrief, Laure/0000-0003-2843-1710; Roulot, Dominique/0000-0003-0926-3563; Poynard, Thierry/0000-0002-2050-640X; Munteanu, Mona/0000-0003-4517-2757	Association de Recherche sur les Maladies Virales et Hepatiques	Association de Recherche sur les Maladies Virales et Hepatiques	The study has funding support from the Association de Recherche sur les Maladies Virales et Hepatiques providing part of secretary assistance and biochemical kits. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2007, J HEPATOL, V46, P528, DOI 10.1016/j.jhep.2006.12.002; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Corpechot C, 2006, HEPATOLOGY, V44, P513, DOI 10.1002/hep.21306; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; *HAS FRANC, HAS REC MAN CHRON HE; HINTZE JL, 2007, NCSS 2007 USER GUIDE, P200; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kettaneh A, 2007, J HEPATOL, V46, P628, DOI 10.1016/j.jhep.2006.11.010; Kim KM, 2007, J GASTROENTEROL, V42, P382, DOI 10.1007/s00535-007-2016-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin L, 2007, J BIOPHARM STAT, V17, P629, DOI 10.1080/10543400701376498; Lucidarme D, 2007, HEPATOLOGY, V46, p318A; MUNTEANU M, 2006, GASTROENTEROLOGY, V130, P195; Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961; Pouillot R, 2002, PREV VET MED, V53, P67, DOI 10.1016/S0167-5877(01)00272-0; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Ratziu V, 2005, J HEPATOL, V42, P12, DOI 10.1016/j.jhep.2004.11.027; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; ZHOU X, 2002, STAT METHODS DIAGNOS, P235; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	36	69	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3857	10.1371/journal.pone.0003857	http://dx.doi.org/10.1371/journal.pone.0003857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052646	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452200009
J	Brown, JN; Kohler, JJ; Coberley, CR; Sleasman, JW; Goodenow, MM				Brown, Joseph N.; Kohler, James J.; Coberley, Carter R.; Sleasman, John W.; Goodenow, Maureen M.			HIV-1 Activates Macrophages Independent of Toll-Like Receptors	PLOS ONE			English	Article								Background: Macrophages provide an interface between innate and adaptive immunity and are important long-lived reservoirs for Human Immunodeficiency Virus Type-1 (HIV-1). Multiple genetic networks involved in regulating signal transduction cascades and immune responses in macrophages are coordinately modulated by HIV-1 infection. Methodology/Principal Findings: To evaluate complex interrelated processes and to assemble an integrated view of activated signaling networks, a systems biology strategy was applied to genomic and proteomic responses by primary human macrophages over the course of HIV-1 infection. Macrophage responses, including cell cycle, calcium, apoptosis, mitogen-activated protein kinases (MAPK), and cytokines/chemokines, to HIV-1 were temporally regulated, in the absence of cell proliferation. In contrast, Toll-like receptor (TLR) pathways remained unaltered by HIV-1, although TLRs 3, 4, 7, and 8 were expressed and responded to ligand stimulation in macrophages. HIV-1 failed to activate phosphorylation of IRAK-1 or IRF-3, modulate intracellular protein levels of Mx1, an interferon-stimulated gene, or stimulate secretion of TNF, IL-1 beta, or IL-6. Activation of pathways other than TLR was inadequate to stimulate, via cross-talk mechanisms through molecular hubs, the production of proinflammatory cytokines typical of a TLR response. HIV-1 sensitized macrophage responses to TLR ligands, and the magnitude of viral priming was related to virus replication. Conclusions/Significance: HIV-1 induced a primed, proinflammatory state, M1(HIV), which increased the responsiveness of macrophages to TLR ligands. HIV-1 might passively evade pattern recognition, actively inhibit or suppress recognition and signaling, or require dynamic interactions between macrophages and other cells, such as lymphocytes or endothelial cells. HIV-1 evasion of TLR recognition and simultaneous priming of macrophages may represent a strategy for viral survival, contribute to immune pathogenesis, and provide important targets for therapeutic approaches.	[Brown, Joseph N.; Kohler, James J.; Coberley, Carter R.; Goodenow, Maureen M.] Univ Florida, Coll Med, Lab Med, & Pediat, Dept Pathol, Immunol, Div Rheumatol, Immunol & Inf, Gainesville, FL 32611 USA; [Sleasman, John W.] Univ S Florida, Coll Med, All Childrens Hosp, Dept Pediat, Div Allergy, Immunol & Rheumatol, St Petersburg, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Brown, JN (corresponding author), Pacific NW Natl Lab, Richland, WA USA.	goodenow@pathology.ufl.edu			Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research;  [HD032259];  [AI047723];  [AI065265];  [AR07603];  [CA09126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047723, R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007603] Funding Source: NIH RePORTER	Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research was supported in part by PHS R01 awards HD032259, AI047723, and AI065265; T32 awards AR07603 and CA09126; the Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Arthos J, 2000, J VIROL, V74, P6418, DOI 10.1128/JVI.74.14.6418-6424.2000; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Baur Andreas, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P309, DOI 10.2174/1568008043339749; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Coberley CR, 2004, J VIROL, V78, P11477, DOI 10.1128/JVI.78.21.11477-11486.2004; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DeFilippis VR, 2007, ADV EXP MED BIOL, V598, P309; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; Douek Daniel, 2007, Top HIV Med, V15, P114; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; Freedman BD, 2006, CRIT REV IMMUNOL, V26, P97, DOI 10.1615/CritRevImmunol.v26.i2.10; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghaffari G, 2001, CLIN DIAGN LAB IMMUN, V8, P880, DOI 10.1128/CDLI.8.5.880-883.2001; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Goodenow MM, 2003, J LEUKOCYTE BIOL, V74, P657, DOI 10.1189/jlb.0403186; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Guntermann C, 1999, BIOCHEM BIOPH RES CO, V256, P429, DOI 10.1006/bbrc.1999.0333; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hamilton T.A., 2002, MACROPHAGE, V2, P73; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Ho W Z, 1994, Immunol Ser, V60, P569; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Janket ML, 2004, BIOCHEM BIOPH RES CO, V314, P1126, DOI 10.1016/j.bbrc.2004.01.008; Khati M, 2001, ARCH IMMUNOL THER EX, V49, P367; Kim WK, 2005, NEUROTOX RES, V8, P107, DOI 10.1007/BF03033823; Kitaya K, 2007, INT J MOL MED, V20, P689; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Kootstra NA, 1998, AIDS RES HUM RETROV, V14, P339, DOI 10.1089/aid.1998.14.339; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Lee SK, 2007, BIOCHEM BIOPH RES CO, V352, P756, DOI 10.1016/j.bbrc.2006.11.098; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; LLEONART R, 1990, BIO-TECHNOL, V8, P1263, DOI 10.1038/nbt1290-1263; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Muthumani K, 2004, AIDS, V18, P739, DOI 10.1097/00002030-200403260-00004; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Ortutay C, 2007, IMMUNOGENETICS, V59, P333, DOI 10.1007/s00251-007-0191-0; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; Popik W, 1998, VIROLOGY, V252, P210, DOI 10.1006/viro.1998.9466; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SCHUITEMAKER H, 1994, J LEUKOCYTE BIOL, V56, P218, DOI 10.1002/jlb.56.3.218; SCHUITEMAKER H, 1994, EMBO J, V13, P5929, DOI 10.1002/j.1460-2075.1994.tb06938.x; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Verani A, 2002, J IMMUNOL, V168, P6388, DOI 10.4049/jimmunol.168.12.6388; Verani A, 1997, J EXP MED, V185, P805, DOI 10.1084/jem.185.5.805; Wang XP, 2001, J LEUKOCYTE BIOL, V69, P405; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Zybarth G, 1999, J IMMUNOL, V162, P400	78	78	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3664	10.1371/journal.pone.0003664	http://dx.doi.org/10.1371/journal.pone.0003664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048100	Green Submitted, gold, Green Published			2022-12-27	WOS:000265452000001
J	Pears, CJ; Thornber, K; Auger, JM; Hughes, CE; Grygielska, B; Protty, MB; Pearce, AC; Watson, SP				Pears, Catherine J.; Thornber, Kelly; Auger, Jocelyn M.; Hughes, Craig E.; Grygielska, Beata; Protty, Majd B.; Pearce, Andrew C.; Watson, Steve P.			Differential Roles of the PKC Novel Isoforms, PKC delta and PKC epsilon, in Mouse and Human Platelets	PLOS ONE			English	Article								Background: Increasing evidence suggests that individual isoforms of protein kinase C (PKC) play distinct roles in regulating platelet activation. Methodology/Principal Findings: In this study, we focus on the role of two novel PKC isoforms, PKC delta and PKC epsilon, in both mouse and human platelets. PKC delta is robustly expressed in human platelets and undergoes transient tyrosine phosphorylation upon stimulation by thrombin or the collagen receptor, GPVI, which becomes sustained in the presence of the pan-PKC inhibitor, Ro 31-8220. In mouse platelets, however, PKC delta undergoes sustained tyrosine phosphorylation upon activation. In contrast the related isoform, PKC epsilon, is expressed at high levels in mouse but not human platelets. There is a marked inhibition in aggregation and dense granule secretion to low concentrations of GPVI agonists in mouse platelets lacking PKC epsilon in contrast to a minor inhibition in response to G protein-coupled receptor agonists. This reduction is mediated by inhibition of tyrosine phosphorylation of the FcR gamma-chain and downstream proteins, an effect also observed in wild-type mouse platelets in the presence of a PKC inhibitor. Conclusions: These results demonstrate a reciprocal relationship in levels of the novel PKC isoforms delta and epsilon in human and mouse platelets and a selective role for PKC epsilon in signalling through GPVI.	[Pears, Catherine J.; Thornber, Kelly] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Auger, Jocelyn M.; Hughes, Craig E.; Grygielska, Beata; Protty, Majd B.; Pearce, Andrew C.; Watson, Steve P.] Univ Birmingham, Sch Med, Div Med Sci, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Pears, CJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	catherine.pears@bioch.ox.ac.uk	Protty, Majd B/B-5054-2014; Watson, Stephen P/Q-6292-2016	Protty, Majd B/0000-0001-8992-9120; Watson, Stephen P/0000-0002-7846-7423; , Kelly/0000-0003-0484-8458; Hughes, Craig/0000-0002-9790-5820; Pears, Catherine/0000-0003-1290-8326	British Heart Foundation [Studentship]; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the British Heart Foundation and The Wellcome Trust. KT was funded by a British Heart Foundation Studentship. SPW holds a BHF Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CS, 1995, J BIOL CHEM, V270, P23317, DOI 10.1074/jbc.270.40.23317; Atkinson BT, 2001, EUR J BIOCHEM, V268, P5242, DOI 10.1046/j.0014-2956.2001.02448.x; Auger JM, 2003, J THROMB HAEMOST, V1, P2419, DOI 10.1046/j.1538-7836.2003.00464.x; Best D, 2003, BLOOD, V102, P2811, DOI 10.1182/blood-2003-01-0231; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Calaminus SDJ, 2007, J THROMB HAEMOST, V5, P535, DOI 10.1111/j.1538-7836.2007.02377.x; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; GERMANO P, 1994, J BIOL CHEM, V269, P23102; Gries A, 1996, ARTERIOSCL THROM VAS, V16, P648, DOI 10.1161/01.ATV.16.5.648; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Jarvis GE, 2002, BRIT J PHARMACOL, V137, P107, DOI 10.1038/sj.bjp.0704834; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Marshall SJ, 2002, BIOCHEM J, V361, P297, DOI 10.1042/0264-6021:3610297; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moussazadeh M, 1998, FEBS LETT, V438, P225, DOI 10.1016/S0014-5793(98)01302-7; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Polanowska-Grabowska R, 1999, ARTERIOSCL THROM VAS, V19, P3044, DOI 10.1161/01.ATV.19.12.3044; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Swann PG, 1999, J BIOL CHEM, V274, P23068, DOI 10.1074/jbc.274.33.23068; Thornber K, 2006, FEBS J, V273, P5032, DOI 10.1111/j.1742-4658.2006.05500.x; vanWilligen G, 1996, BIOCHEM J, V314, P769, DOI 10.1042/bj3140769; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; WATSON SP, 1989, BIOCHEM J, V258, P479, DOI 10.1042/bj2580479; Wentworth JKI, 2006, BIOCHEM J, V393, P555, DOI 10.1042/BJ20050796	35	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3793	10.1371/journal.pone.0003793	http://dx.doi.org/10.1371/journal.pone.0003793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030108	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265450800003
J	Schneider, A; Spitkovsky, D; Riess, P; Molcanyi, M; Kamisetti, N; Maegele, M; Hescheler, J; Schaefer, U				Schneider, Annette; Spitkovsky, Dimitry; Riess, Peter; Molcanyi, Marek; Kamisetti, Naidu; Maegele, Marc; Hescheler, Juergen; Schaefer, Ute			"The Good into the Pot, the Bad into the Crop!" - A New Technology to Free Stem Cells from Feeder Cells	PLOS ONE			English	Article							SERUM-FREE; CONDITIONED MEDIUM; STROMAL CELLS; FREE CULTURE; GROWTH; DIFFERENTIATION; SUPPORT; REPLACEMENT; PROPAGATION; EXPRESSION	A variety of embryonic and adult stem cell lines require an intial co-culturing with feeder cells for non-differentiated growth, self renewal and maintenance of pluripotency. However for many downstream ES cell applications the feeder cells have to be considered contaminations that might interfere not just with the analysis of experimental data but also with clinical application and tissue engineering approaches. Here we introduce a novel technique that allows for the selection of pure feeder-freed stem cells, following stem cell proliferation on feeder cell layers. Complete and reproducible separation of feeder and embryonic stem cells was accomplished by adaptation of an automated cell selection system that resulted in the aspiration of distinct cell colonies or fraction of colonies according to predefined physical parameters. Analyzing neuronal differentiation we demonstrated feeder-freed stem cells to exhibit differentiation potentials comparable to embryonic stem cells differentiated under standard conditions. However, embryoid body growth as well as differentiation of stem cells into cardiomyocytes was significantly enhanced in feeder-freed cells, indicating a feeder cell dependent modulation of lineage differentiation during early embryoid body development. These findings underline the necessity to separate stem and feeder cells before the initiation of in vitro differentiation. The complete separation of stem and feeder cells by this new technology results in pure stem cell populations for translational approaches. Furthermore, a more detailed analysis of the effect of feeder cells on stem cell differentiation is now possible, that might facilitate the identification and development of new optimized human or genetically modified feeder cell lines.	[Schneider, Annette] Univ Witten Herdecke, Inst Res Operat Med IFOM, Fac Med, Witten, Germany; [Spitkovsky, Dimitry; Kamisetti, Naidu; Hescheler, Juergen] Univ Cologne, Fac Med, Inst Neurophysiol, Ctr Physiol, D-5000 Cologne, Germany; [Riess, Peter; Maegele, Marc] Univ Witten Herdecke, Hosp Merheim, Fac Med, Dept Trauma & Orthoped Surg, Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Fac Med, Dept Neurophysiol 2, Clin Neurosurg, D-5000 Cologne, Germany; [Schaefer, Ute] Med Univ Graz, Dept Expt Neurotraumatol, Graz, Austria	Witten Herdecke University; University of Cologne; University of Cologne; Witten Herdecke University; University of Cologne; Medical University of Graz	Schneider, A (corresponding author), Univ Witten Herdecke, Inst Res Operat Med IFOM, Fac Med, Witten, Germany.	ute.schaefer@meduni-graz.at	Spitkovsky, Dimitry/ABA-1605-2020					Amit M, 2006, METHOD ENZYMOL, V420, P37, DOI 10.1016/S0076-6879(06)20003-X; Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Bentz K, 2006, CELL PHYSIOL BIOCHEM, V18, P275, DOI 10.1159/000097674; Bigdeli N, 2008, J BIOTECHNOL, V133, P146, DOI 10.1016/j.jbiotec.2007.08.045; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Djordjevic B, 2006, ACTA ONCOL, V45, P412, DOI 10.1080/02841860500520743; Dravid G, 2006, METH MOL B, V331, P91; EHMANN UK, 1992, EXP CELL RES, V199, P314, DOI 10.1016/0014-4827(92)90440-J; Fujimoto N, 2007, BIOMATERIALS, V28, P4795, DOI 10.1016/j.biomaterials.2007.07.033; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; He J, 2007, J BIOMED SCI, V14, P617, DOI 10.1007/s11373-007-9185-z; Hiroyama T, 2008, CELL BIOL INT, V32, P1, DOI 10.1016/j.cellbi.2007.08.001; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Lee JB, 2004, REPRODUCTION, V128, P727, DOI 10.1530/rep.1.00415; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li FF, 2007, CELLS TISSUES ORGANS, V186, P221, DOI 10.1159/000107637; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Lorincz Matthew T., 2006, V330, P55; Mangel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001591; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Michelini M, 2006, CELL PROLIFERAT, V39, P217, DOI 10.1111/j.1365-2184.2006.00381.x; Moore H, 2006, NAT BIOTECHNOL, V24, P160, DOI 10.1038/nbt0206-160; Nichols Jennifer, 2006, V329, P91; Peterkin T, 2003, EMBO J, V22, P4260, DOI 10.1093/emboj/cdg400; Richards M, 2006, METH MOL B, V331, P23; SAXENA S, 2008, MOL REPROD DEV; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Steinschneider R, 1996, DEV BRAIN RES, V95, P15, DOI 10.1016/0165-3806(96)00052-1; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Xie CQ, 2005, CELL BIOL INT, V29, P623, DOI 10.1016/j.cellbi.2005.03.015; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yoo SJ, 2005, EXP MOL MED, V37, P399, DOI 10.1038/emm.2005.50	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3788	10.1371/journal.pone.0003788	http://dx.doi.org/10.1371/journal.pone.0003788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023443	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448800009
J	Fernando, C; Karishma, KK; Szathmary, E				Fernando, Chrisantha; Karishma, K. K.; Szathmary, Eoers			Copying and Evolution of Neuronal Topology	PLOS ONE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; THALAMOCORTICAL CIRCUITRY; MEMORY CONSOLIDATION; CEREBELLAR CORTEX; AUDITORY-CORTEX; NEURAL-NETWORKS; DENTATE GYRUS; D1 RECEPTORS	We propose a mechanism for copying of neuronal networks that is of considerable interest for neuroscience for it suggests a neuronal basis for causal inference, function copying, and natural selection within the human brain. To date, no model of neuronal topology copying exists. We present three increasingly sophisticated mechanisms to demonstrate how topographic map formation coupled with Spike-Time Dependent Plasticity (STDP) can copy neuronal topology motifs. Fidelity is improved by error correction and activity-reverberation limitation. The high-fidelity topology-copying operator is used to evolve neuronal topologies. Possible roles for neuronal natural selection are discussed.	[Fernando, Chrisantha; Karishma, K. K.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Fernando, Chrisantha; Szathmary, Eoers] Inst Advanced Study, Budapest, Hungary; [Szathmary, Eoers] Parmenides Fdn, Munich, Germany; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary	MRC National Institute for Medical Research; Eotvos Lorand University	Fernando, C (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	ctf20@sussex.ac.uk	Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Szathmary, Eors/0000-0001-5227-2997	MRC National Institute for Medical Research, Mill Hill, London; Marie Curie; Hungarian National Office for Research and Technology [NAP 2005/KCKHA005]; Regional Knowledge Centre of Eotvos University [RET2.4/2005]; MRC [MC_U117573805] Funding Source: UKRI; Medical Research Council [MC_U117573805] Funding Source: researchfish	MRC National Institute for Medical Research, Mill Hill, London; Marie Curie(European Commission); Hungarian National Office for Research and Technology(National Office for Research and Technology); Regional Knowledge Centre of Eotvos University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Thanks to a Career Development Fellowship at the MRC National Institute for Medical Research, Mill Hill, London, and to a Marie Curie Inter-European Grant to work at Collegium Budapest, Hungary. Partial support of this work has generously been provided by the Hungarian National Office for Research and Technology (NAP 2005/KCKHA005) and by the Regional Knowledge Centre of Eotvos University (National Office for Research and Technology grant No. RET2.4/2005).	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adams P, 2002, PHILOS T ROY SOC B, V357, P1767, DOI 10.1098/rstb.2002.1164; Adams P, 1998, J THEOR BIOL, V195, P419, DOI 10.1006/jtbi.1997.0620; Aunger R., 2002, ELECT MEME NEW THEOR; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; BEYER HG, 2001, THEORY EVOLUTION; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Calvin W. H., 1996, CEREBRAL CODE; CALVIN WH, 1987, NATURE, V330, P33, DOI 10.1038/330033a0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Changeux J.-P., 1985, NEURONAL MAN BIOL MI; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chronicle EP, 2004, J EXP PSYCHOL LEARN, V30, P14, DOI 10.1037/0278-7393.30.1.14; Churchland PatriciaS., 2002, BRAIN WISE STUDIES N; CRICK F, 1990, TRENDS NEUROSCI, V13, P13, DOI 10.1016/0166-2236(90)90055-F; CRICK F, 1995, BEHAV BRAIN RES, V69, P147, DOI 10.1016/0166-4328(95)00006-F; CRICK F, 1989, TRENDS NEUROSCI, V12, P240, DOI 10.1016/0166-2236(89)90019-2; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAWKINS R, 1971, NATURE, V229, P118, DOI 10.1038/229118a0; Dayan P, 2001, COMPUTATIONAL NEUROS; Dayan P., 1995, NEURAL COMPUT, V7, P1022, DOI [10.1162/neco.1995.7.5.889, DOI 10.1162/NECO.1995.7.5.889]; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DEHAENE S, 1987, P NATL ACAD SCI USA, V84, P2727, DOI 10.1073/pnas.84.9.2727; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; DENK W, PLOS BIOL, V2, pE329; Dennett Daniel, 1969, CONTENT CONSCIOUSNES; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Eckardt LH, 2002, NATURE, V420, P286, DOI 10.1038/420286a; EDELMAN GM, 1994, GENETICS, V138, P975; Edelman GM, 1987, NEURAL DARWINISM THE; Elliott T, 2002, TRENDS COGN SCI, V6, P147, DOI 10.1016/S1364-6613(02)01886-7; FERNANDO C, 2009, NEURONAL RE IN PRESS; FISCHER TM, 1993, J NEUROSCI, V13, P1302; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Frankland PW, 2006, P NATL ACAD SCI USA, V103, P509, DOI 10.1073/pnas.0510133103; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Ganti T., 2003, PRINCIPLES LIFE; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gisiger T, 2000, CURR OPIN NEUROBIOL, V10, P250, DOI 10.1016/S0959-4388(00)00075-1; Glymour C, 2003, TRENDS COGN SCI, V7, P43, DOI 10.1016/S1364-6613(02)00009-8; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kandel E., 2000, PRINCIPLES NEURAL SC; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Krichmar JL, 2005, ARTIF LIFE, V11, P63, DOI 10.1162/1064546053278946; Lagnado D.A., 2007, CAUSAL LEARNING PSYC, P154, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0011; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; LEE R, 2001, HIPPOCAMPUS, V11, P707; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Marr D, 1983, VISION COMPUTATIONAL; Maynard Smith J., 1986, PROBLEMS BIOL; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; Michod R. E., 1988, EVOLUTION, V43, P694, DOI DOI 10.1111/J.1558-5646.1989.TB04268.X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell M., 1996, INTRO GENETIC ALGORI; MULLER HJ, 1966, AM NAT, V100, P493, DOI 10.1086/282445; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; SCHELER G, 2003, PRESYNAPTIC MODULATI; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Sirota Anton, 2005, Thalamus & Related Systems, V3, P245, DOI 10.1017/S1472928807000258; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Steels L, 2006, TRENDS COGN SCI, V10, P347, DOI 10.1016/j.tics.2006.06.002; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; STERIADE M, 2007, GATING NEURONAL NETW; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Szathmary E, 1995, MAJOR TRANSITIONS EV; Takayanagi M, 2006, NEUROSCIENCE, V142, P769, DOI 10.1016/j.neuroscience.2006.06.048; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Thivierge JP, 2007, TRENDS NEUROSCI, V30, P251, DOI 10.1016/j.tins.2007.04.004; Toussaint M, 2003, EVOLUTION GENETIC RE; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913	127	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3775	10.1371/journal.pone.0003775	http://dx.doi.org/10.1371/journal.pone.0003775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020662	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265448600008
J	Woodland, HR; Fry, AM				Woodland, Hugh R.; Fry, Andrew M.			Pix Proteins and the Evolution of Centrioles	PLOS ONE			English	Article								We have made a wide phylogenetic survey of Pix proteins, which are constituents of vertebrate centrioles in most eukaryotes. We have also surveyed the presence and structure of flagella or cilia and centrioles in these organisms, as far as is possible from published information. We find that Pix proteins are present in a vast range of eukaryotes, but not all. Where centrioles are absent so are Pix proteins. If one considers the maintenance of Pix proteins over evolutionary time scales, our analysis would suggest that their key function is to make cilia and flagella, and the same is true of centrioles. Moreover, this survey raises the possibility that Pix proteins are only maintained to make cilia and flagella that undulate, and even then only when they are constructed by transporting ciliary constituents up the cilium using the intraflagellar transport (IFT) system. We also find that Pix proteins have become generally divergent within Ecdysozoa and between this group and other taxa. This correlates with a simplification of centrioles within Ecdysozoa and a loss or divergence of cilia/flagella. Thus Pix proteins act as a weathervane to indicate changes in centriole function, whose core activity is to make cilia and flagella.	[Woodland, Hugh R.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Warwick; University of Leicester	Woodland, HR (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	h.r.woodland@warwick.ac.uk			Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F010702/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010702/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Wellcome Trust (HRW) and The Biotechnology and Biological Sciences Research Council (BBSRC)(AMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 1999, INT J DEV BIOL, V43, P283; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dutcher SK, 2001, CURR BIOL, V11, pR419, DOI 10.1016/S0960-9822(01)00250-0; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Feldman JL, 2004, CURR BIOL, V14, pR659, DOI 10.1016/j.cub.2004.08.019; GARBARY DJ, 1993, PLANT SYST EVOL, V188, P237; Gonzalez C, 1998, J CELL SCI, V111, P2697; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2000, CURR OPIN CELL BIOL, V12, P119, DOI 10.1016/S0955-0674(99)00065-4; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Nielsen MG, 2001, CURR BIOL, V11, P529, DOI 10.1016/S0960-9822(01)00150-6; PITNICK S, 1995, NATURE, V375, P109, DOI 10.1038/375109a0; Popodi EM, 2008, CELL MOTIL CYTOSKEL, V65, P216, DOI 10.1002/cm.20256; Renzaglia KS, 1999, INT J PLANT SCI, V160, P14, DOI 10.1086/314103; Renzaglia KS, 2000, MICROSC RES TECHNIQ, V49, P496, DOI 10.1002/(SICI)1097-0029(20000601)49:5<496::AID-JEMT12>3.0.CO;2-H; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Valentine JW, 2000, EVOL DEV, V2, P152, DOI 10.1046/j.1525-142x.2000.00043.x; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	44	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3778	10.1371/journal.pone.0003778	http://dx.doi.org/10.1371/journal.pone.0003778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020665	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448600011
J	Dubin-Thaler, BJ; Hofman, JM; Cai, YF; Xenias, H; Spielman, I; Shneidman, AV; David, LA; Dobereiner, HG; Wiggins, CH; Sheetz, MP				Dubin-Thaler, Benjamin J.; Hofman, Jake M.; Cai, Yunfei; Xenias, Harry; Spielman, Ingrid; Shneidman, Anna V.; David, Lawrence A.; Doebereiner, Hans-Guenther; Wiggins, Chris H.; Sheetz, Michael P.			Quantification of Cell Edge Velocities and Traction Forces Reveals Distinct Motility Modules during Cell Spreading	PLOS ONE			English	Article								Actin-based cell motility and force generation are central to immune response, tissue development, and cancer metastasis, and understanding actin cytoskeleton regulation is a major goal of cell biologists. Cell spreading is a commonly used model system for motility experiments-spreading fibroblasts exhibit stereotypic, spatially-isotropic edge dynamics during a reproducible sequence of functional phases: 1) During early spreading, cells form initial contacts with the surface. 2) The middle spreading phase exhibits rapidly increasing attachment area. 3) Late spreading is characterized by periodic contractions and stable adhesions formation. While differences in cytoskeletal regulation between phases are known, a global analysis of the spatial and temporal coordination of motility and force generation is missing. Implementing improved algorithms for analyzing edge dynamics over the entire cell periphery, we observed that a single domain of homogeneous cytoskeletal dynamics dominated each of the three phases of spreading. These domains exhibited a unique combination of biophysical and biochemical parameters-a motility module. Biophysical characterization of the motility modules revealed that the early phase was dominated by periodic, rapid membrane blebbing; the middle phase exhibited continuous protrusion with very low traction force generation; and the late phase was characterized by global periodic contractions and high force generation. Biochemically, each motility module exhibited a different distribution of the actin-related protein VASP, while inhibition of actin polymerization revealed different dependencies on barbed-end polymerization. In addition, our whole-cell analysis revealed that many cells exhibited heterogeneous combinations of motility modules in neighboring regions of the cell edge. Together, these observations support a model of motility in which regions of the cell edge exhibit one of a limited number of motility modules that, together, determine the overall motility function. Our data and algorithms are publicly available to encourage further exploration.	[Dubin-Thaler, Benjamin J.; Cai, Yunfei; Xenias, Harry; Spielman, Ingrid; Shneidman, Anna V.; Doebereiner, Hans-Guenther; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Dubin-Thaler, Benjamin J.] Cell Motion Lab Inc, New York, NY USA; [Hofman, Jake M.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Hofman, Jake M.; Wiggins, Chris H.] Columbia Univ, Dept Applied Phys & Applied Math, New York, NY 10027 USA; [David, Lawrence A.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Doebereiner, Hans-Guenther] Univ Bremen, Inst Biophys, D-2800 Bremen, Germany	Columbia University; Columbia University; Columbia University; Columbia University; University of Bremen	Dubin-Thaler, BJ (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ben@cellmotion.org	David, Lawrence/B-1044-2010; David, Lawrence Anthony/HCJ-0062-2022; Döbereiner, Hans-Günther/F-7302-2012	David, Lawrence/0000-0002-3570-4767; David, Lawrence Anthony/0000-0002-3570-4767; Döbereiner, Hans-Günther/0000-0003-1691-634X	National Institutes of Health [PN2 EY016586]; Training Program in Molecular Biophysics [GM008281]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Molecular Biophysics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded from the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586) and the Training Program in Molecular Biophysics, GM008281 (BJD).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Adamsky K, 2001, ONCOGENE, V20, P609, DOI 10.1038/sj.onc.1204119; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; BARDSLEY WG, 1983, J CELL SCI, V61, P365; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Baum B, 2004, CURR BIOL, V14, pR716, DOI 10.1016/j.cub.2004.08.047; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Betz T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098103; BLIOKH ZL, 1977, BIOFIZIKA+, V22, P281; BOSS J, 1955, EXP CELL RES, V8, P181, DOI 10.1016/0014-4827(55)90055-0; CAI Y, 2006, BIOPHYS J; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CHURCH GM, 2005, MOL SYST BIOL; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; Dobereiner HG, 2005, J APPL PHYSIOL, V98, P1542, DOI 10.1152/japplphysiol.01181.2004; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Dustin ML, 2001, TRENDS IMMUNOL, V22, P192, DOI 10.1016/S1471-4906(01)01872-5; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FUJINAMI N, 1975, J CELL SCI, V19, P169; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; HASTIE T, 2001, ELEMENTS STAT LEARNI, V16, P533; Heo WD, 2003, CELL, V113, P315; KAGEYAMA T, 1977, DEV GROWTH DIFFER, V19, P103; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keller HU, 1996, CELL MOTIL CYTOSKEL, V33, P241, DOI 10.1002/(SICI)1097-0169(1996)33:4<241::AID-CM1>3.0.CO;2-C; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Silva HS, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041903; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; VASILIEV JM, 1982, PHILOS T ROY SOC B, V299, P159, DOI 10.1098/rstb.1982.0122; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; WEISS Y, 2000, OPHTHALMOLOGY VISUAL, V795, pS795; WINKLBAUER R, 1992, DEV BIOL, V150, P335, DOI 10.1016/0012-1606(92)90246-D; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; ZHANG X, 2008, NAT CELL BIOL	68	95	97	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3735	10.1371/journal.pone.0003735	http://dx.doi.org/10.1371/journal.pone.0003735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011687	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300003
J	Tricco, AC; Brehaut, J; Chen, MH; Moher, D				Tricco, Andrea C.; Brehaut, Jamie; Chen, Maggie H.; Moher, David			Following 411 Cochrane Protocols to Completion: A Retrospective Cohort Study	PLOS ONE			English	Article							PUBLICATION BIAS; SYSTEMATIC REVIEWS	Background: Cochrane reviews are regarded as being scientifically rigorous and are increasingly used by a variety of stakeholders. However, factors predicting the publication of Cochrane reviews have never been reported. This is important because if a higher proportion of Cochrane protocols with certain characteristics (e. g., funding) are being published, this may lead to inaccurate decisions. We examined the frequency of published and unpublished Cochrane reviews and protocol factors that predict the publication of Cochrane reviews. Methodology/Principal Findings: Retrospective cohort study of Cochrane protocols published in 2000 (Issues 2 to 4) and 2001 (Issue 1). The publication status of these reviews was followed up to Issue 1, 2008 in The Cochrane Library. Survival analysis of the time from protocol publication to the first review publication and protocol factors predicting the time to publication was conducted. There were 411 new Cochrane protocols in the cohort. After excluding 39; 71/372 (19.1%) were unpublished and 301/372 (80.9%) were published as full Cochrane reviews at the time of study analysis (January 2008). The median time to publication was 2.4 years (range: 0.15 to 8.96). Multivariate analyses revealed that shorter time to publication was associated with the review subsequently being updated (hazard ratio, HR: 1.80 [95% confidence interval, CI: 1.39 to 2.33 years]) and longer time to publication was associated with the review having two published protocols, indicating changes to the review plan (HR: 0.33 [95% CI: 0.12 to 0.90 years]). Conclusions/Significance: Only about 80% Cochrane protocols were published as full reviews after over 8 years of follow-up. The median time to publication was 2.4 years and some reviews took much longer. Strategies to decrease time to publication should be considered, such as streamlining the review process, increased support for authors when protocol amendments occur, and better infrastructure for updating Cochrane reviews.	[Tricco, Andrea C.; Moher, David] Childrens Hosp Eastern Ontario, Inst Res, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; [Tricco, Andrea C.] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [Brehaut, Jamie; Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [Brehaut, Jamie] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Chen, Maggie H.] Univ Toronto, Dept Biostat, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto	Tricco, AC (corresponding author), Childrens Hosp Eastern Ontario, Inst Res, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada.	dmoher@uottawa.ca	Tricco, Andrea/B-9920-2011	Tricco, Andrea/0000-0002-4114-8971; Moher, David/0000-0003-2434-4206	Canadian Institutes of Health Research [Canada Graduate Scholarship]; University of Ottawa [Excellence Scholarship]; Ontario Ministry of Health Career Scientist Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Ottawa; Ontario Ministry of Health Career Scientist Award	Andrea C. Tricco is funded by a Canadian Institutes of Health Research Canada Graduate Scholarship and University of Ottawa Excellence Scholarship. Dr. Brehaut is funded by an Ontario Ministry of Health Career Scientist Award. Dr. Moher is funded by a University of Ottawa Research Chair.	[Anonymous], 2008, COCHRANE HDB SYSTEMA; BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; HOPEWELL S, 2001, COCHRANE DATABASE ME; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Lavis John N, 2006, Healthc Policy, V1, P21; Moher D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000023.pub3; Moher D, 2007, J CLIN EPIDEMIOL, V60, P1095, DOI 10.1016/j.jclinepi.2007.03.008; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P531, DOI 10.1016/j.jclinepi.2008.02.004; SCHWARZER G, 2001, 9 INT COCHR C LYON F; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; SIMES RJ, 1987, STAT MED, V6, P11, DOI 10.1002/sim.4780060104; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Tierney JF, 2000, INT J TECHNOL ASSESS, V16, P657, DOI 10.1017/S0266462300101217	19	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3684	10.1371/journal.pone.0003684	http://dx.doi.org/10.1371/journal.pone.0003684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997866	Green Submitted, gold, Green Published			2022-12-27	WOS:000265165500007
J	Kimman, TG; Banus, S; Reijmerink, N; Reimerink, J; Stelma, FF; Koppelman, GH; Thijs, C; Postma, DS; Kerkhof, M				Kimman, Tjeerd G.; Banus, Sander; Reijmerink, Naomi; Reimerink, Johan; Stelma, Foekje F.; Koppelman, Gerard H.; Thijs, Carel; Postma, Dirkje S.; Kerkhof, Marjan			Association of Interacting Genes in the Toll-Like Receptor Signaling Pathway and the Antibody Response to Pertussis Vaccination	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; BORDETELLA-PERTUSSIS; TLR4 POLYMORPHISMS; CELL RESPONSES; INFECTION; OX40; ACTIVATION; DISEASE; MICE; CD14	Background: Activation of the Toll-like receptor (TLR) signaling pathway through TLR4 may be important in the induction of protective immunity against Bordetella pertussis with TLR4-mediated activation of dendritic and B cells, induction of cytokine expression, and reversal of tolerance as crucial steps. We examined whether single nucleotide polymorphisms (SNPs) in genes of the TLR4 pathway and their interaction are associated with the response to whole-cell vaccine (WCV) pertussis vaccination in 490 one-year-old children. Methodology/Principal Findings: We analyzed associations of 75 haplotype-tagging SNPs in genes in the TLR4 signaling pathway with pertussis toxin (PT)-IgG titers. We found significant associations between the PT-IgG titer and SNPs in CD14, TLR4, TOLLIP, TIRAP, IRAK3, IRAK4, TICAM1, and TNFRSF4 in one or more of the analyses. The strongest evidence for association was found for two SNPs (rs5744034 and rs5743894) in TOLLIP that were almost completely in linkage disequilibrium, provided statistically significant associations in all tests with the lowest p-values, and displayed a dominant mode of inheritance. However, none of these single gene associations would withstand correction for multiple testing. In addition, Multifactor Dimensionality Reduction Analysis, an approach that does not need correction for multiple testing, showed significant and strong two and three locus interactions between SNPs in TOLLIP (rs4963060), TLR4 (rs6478317) and IRAK1 (rs1059703). Conclusions/Significance: We have identified significant interactions between genes in the TLR pathway in the induction of vaccine-induced immunity. These interactions underline that these genes are functionally related and together form a true biological relationship in a protein-protein interaction network. Practically all our findings may be explained by genetic variation in directly or indirectly interacting proteins at the extra-and intracytoplasmic sites of the cell membrane of antigen-presenting cells, B cells, or both. Fine tuning of interacting proteins in the TLR pathway appears important for the induction of an optimal vaccine response.	[Kimman, Tjeerd G.; Banus, Sander; Reimerink, Johan] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Kimman, Tjeerd G.] Cent Vet Inst, Lelystad, Netherlands; [Reijmerink, Naomi; Postma, Dirkje S.] Univ Groningen, Med Ctr, Dept Pulmonol, Groningen, Netherlands; [Stelma, Foekje F.] Acad Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Med Ctr, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Thijs, Carel] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht Nutrim, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, Maastricht, Netherlands; [Kerkhof, Marjan] Univ Groningen, Med Ctr, Dept Epidemiol, NL-9700 AB Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Maastricht University; University of Groningen	Kimman, TG (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	tg.kimman@rivm.nl	Thijs, Carel/H-8340-2019; Koppelman, Gerard/AAG-9187-2020	Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252				Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Banus HA, 2006, INFECT IMMUN, V74, P2596, DOI 10.1128/IAI.74.5.2596-2605.2006; Banus S, 2007, CLIN VACCINE IMMUNOL, V14, P1377, DOI 10.1128/CVI.00175-07; Banus S, 2007, IMMUNOGENETICS, V59, P555, DOI 10.1007/s00251-007-0227-5; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bruss JB, 2002, INFECT IMMUN, V70, P4600, DOI 10.1128/IAI.70.8.4600-4608.2002; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dudbridge Frank, 2006, Human Genomics, V2, P310; Elston RC, 2006, STAT MED, V25, P3049, DOI 10.1002/sim.2650; Girard Dorota Z, 2002, Paediatr Drugs, V4, P299, DOI 10.2165/00128072-200204050-00003; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hori T, 2006, INT J HEMATOL, V83, P17, DOI 10.1532/IJH97.05151; Humphreys IR, 2003, J EXP MED, V198, P1237, DOI 10.1084/jem.20030351; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Kimman T.G., 2001, GENETICS INFECT DIS; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Moore JH, 2008, EUR J HUM GENET, V16, P143, DOI 10.1038/sj.ejhg.5201936; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Munks MW, 2004, IMMUNOLOGY, V112, P559, DOI 10.1111/j.1365-2567.2004.01917.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sabatti Chiara, 2007, Methods Mol Biol, V376, P195; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shin HJ, 2007, MOL CELLS, V24, P119; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; van Buuren S., 1999, PGVGZ99054 TNO; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	50	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3665	10.1371/journal.pone.0003665	http://dx.doi.org/10.1371/journal.pone.0003665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987746	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134500010
J	Rajagovindan, R; Ding, MZ				Rajagovindan, Rajasimhan; Ding, Mingzhou			Decomposing Neural Synchrony: Toward an Explanation for Near-Zero Phase-Lag in Cortical Oscillatory Networks	PLOS ONE			English	Article							GRANGER CAUSALITY; VISUOMOTOR INTEGRATION; NEURONAL OSCILLATIONS; BETA-OSCILLATIONS; FREQUENCIES; MECHANISM; COHERENCE; DYNAMICS; BINDING; CORTEX	Background: Synchronized oscillation in cortical networks has been suggested as a mechanism for diverse functions ranging from perceptual binding to memory formation to sensorimotor integration. Concomitant with synchronization is the occurrence of near-zero phase-lag often observed between network components. Recent theories have considered the importance of this phenomenon in establishing an effective communication framework among neuronal ensembles. Methodology/Principal Findings: Two factors, among possibly others, can be hypothesized to contribute to the near-zero phase-lag relationship: (1) positively correlated common input with no significant relative time delay and (2) bidirectional interaction. Thus far, no empirical test of these hypotheses has been possible for lack of means to tease apart the specific causes underlying the observed synchrony. In this work simulation examples were first used to illustrate the ideas. A quantitative method that decomposes the statistical interdependence between two cortical areas into a feed-forward, a feed-back and a common-input component was then introduced and applied to test the hypotheses on multichannel local field potential recordings from two behaving monkeys. Conclusion/Significance: The near-zero phase-lag phenomenon is important in the study of large-scale oscillatory networks. A rigorous mathematical theorem is used for the first time to empirically examine the factors that contribute to this phenomenon. Given the critical role that oscillatory activity is likely to play in the regulation of biological processes at all levels, the significance of the proposed method may extend beyond systems neuroscience, the level at which the present analysis is conceived and performed.	[Rajagovindan, Rajasimhan; Ding, Mingzhou] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Rajagovindan, R (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	mingzhou.ding@bme.ufl.edu			NIH [MH079388, MH070498]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070498, R01MH079388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grants MH079388 and MH070498.	Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cassidy M, 2003, J NEUROSCI METH, V127, P95, DOI 10.1016/S0165-0270(03)00129-8; Chawla D, 2001, NEURAL NETWORKS, V14, P727, DOI 10.1016/S0893-6080(01)00043-0; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Liang HL, 2002, NEUROREPORT, V13, P2011, DOI 10.1097/00001756-200211150-00004; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; MACKLIN JT, 1982, MON NOT R ASTRON SOC, V199, P1119, DOI 10.1093/mnras/199.4.1119; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Slotnick SD, 2002, P NATL ACAD SCI USA, V99, P6440, DOI 10.1073/pnas.092514899; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X; Wang X, 2008, NEUROIMAGE, V41, P767, DOI 10.1016/j.neuroimage.2008.03.025; Wang X, 2007, INT J NEURAL SYST, V17, P71, DOI 10.1142/S0129065707000944; Witham CL, 2007, EUR J NEUROSCI, V26, P2677, DOI 10.1111/j.1460-9568.2007.05890.x; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wu JH, 2008, J NEUROSCI METH, V167, P367, DOI 10.1016/j.jneumeth.2007.08.022; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	42	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3649	10.1371/journal.pone.0003649	http://dx.doi.org/10.1371/journal.pone.0003649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987745	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134500001
J	Judge, KA; Bonanno, VL				Judge, Kevin A.; Bonanno, Vanessa L.			Male Weaponry in a Fighting Cricket	PLOS ONE			English	Article							MALE-MALE COMPETITION; SEXUAL-DIMORPHISM; FIELD CRICKET; MATING SUCCESS; BODY-SIZE; ASSESSMENT STRATEGIES; GRYLLUS-BIMACULATUS; ACHETA-DOMESTICUS; SHORE CRABS; EVOLUTION	Sexually selected male weaponry is widespread in nature. Despite being model systems for the study of male aggression in Western science and for cricket fights in Chinese culture, field crickets (Orthoptera, Gryllidae, Gryllinae) are not known to possess sexually dimorphic weaponry. In a wild population of the fall field cricket, Gryllus pennsylvanicus, we report sexual dimorphism in head size as well as the size of mouthparts, both of which are used when aggressive contests between males escalate to physical combat. Male G. pennsylvanicus have larger heads, maxillae and mandibles than females when controlling for pronotum length. We conducted two experiments to test the hypothesis that relatively larger weaponry conveys an advantage to males in aggressive contests. Pairs of males were selected for differences in head size and consequently were different in the size of maxillae and mandibles. In the first experiment, males were closely matched for body size (pronotum length), and in the second, they were matched for body mass. Males with proportionately larger weaponry won more fights and increasing differences in weaponry size between males increased the fighting success of the male with the larger weaponry. This was particularly true when contests escalated to grappling, the most intense level of aggression. However, neither contest duration nor intensity was related to weaponry size as predicted by models of contest settlement. These results are the first evidence that the size of the head capsule and mouthparts are under positive selection via male-male competition in field crickets, and validate 800-year-old Chinese traditional knowledge.	[Judge, Kevin A.; Bonanno, Vanessa L.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Bonanno, Vanessa L.] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	University of Toronto; University Toronto Mississauga; Laurentian University	Judge, KA (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	kevin.judge@utoronto.ca	Judge, Kevin A/A-5404-2013		Natural Sciences and Engineering Research Council (NSERC) [Postgraduate Scholarship, Discovery Grant]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship to KAJ, and an NSERC Discovery Grant to Darryl Gwynne.	ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; ALEXANDER RICHARD D., 1957, ANN ENT SOC AMER, V50, P584; Andersson Malte, 1994; Arlington L. C., 1929, China Journal Shanghai, V10, P135; Arnqvist Goran, 2005, pUnpaginated; Bonduriansky R, 2006, J MORPHOL, V267, P602, DOI 10.1002/jmor.10426; Bonduriansky R, 2003, EVOLUTION, V57, P2046, DOI 10.1111/j.0014-3820.2003.tb00384.x; Bonduriansky R, 2003, CAN J ZOOL, V81, P479, DOI 10.1139/Z03-031; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; BROWN L, 1986, AM NAT, V127, P565, DOI 10.1086/284504; CADE WH, 1981, SCIENCE, V212, P563, DOI 10.1126/science.212.4494.563; CHIA ST, TSU CHIH CHING; CLUTTONBROCK TH, 1982, BEHAVIOUR, V79, P108, DOI 10.1163/156853982X00201; CRESPI BJ, 1986, ECOL ENTOMOL, V11, P119, DOI 10.1111/j.1365-2311.1986.tb00286.x; Darwin C., 1871, P423; DAVISON GWH, 1985, J ZOOL, V206, P353; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; Eberhard W.G., 1979, P231; Eberhard WG, 2002, CAN ENTOMOL, V134, P667, DOI 10.4039/Ent134667-5; EBERHARD WG, 1980, SCI AM, V242, P166, DOI 10.1038/scientificamerican0380-166; ECKHOLM E, 2000, NY TIMES        1004; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Field L.H., 1983, P120; Field Laurence H., 2001, P179, DOI 10.1079/9780851994086.0179; Forslund P, 2000, ANIM BEHAV, V59, P753, DOI 10.1006/anbe.1999.1359; GANGWERE S. K., 1965, EOS REV ESPAN ENTOMOL, V41, P67; Gwynne DT, 1998, ETHOL ECOL EVOL, V10, P393, DOI 10.1080/08927014.1998.9522852; Hack MA, 1997, ANIM BEHAV, V53, P733, DOI 10.1006/anbe.1996.0310; HAMMERSTEIN P, 1982, J THEOR BIOL, V96, P647, DOI 10.1016/0022-5193(82)90235-1; Hofmann H, 1996, BIOL ZBL, V115, P206; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; HOLM S, 1979, SCAND J STAT, V6, P65; HSU YC, 1928, PEKING SOC NATURAL H, V3, P5; Huang Y, 2000, MOL PHYLOGENET EVOL, V17, P48, DOI 10.1006/mpev.2000.0815; Husain Mainul, 2006, Plant Biology (Rockville), V2006, P301; Jang Y, 2008, BEHAV ECOL SOCIOBIOL, V62, P1397, DOI 10.1007/s00265-008-0568-6; Jin XB, 1998, J INSECT CONSERV, V2, P211, DOI 10.1023/A:1009616418149; JIN XB, 1994, CHINESE CRICKET CULT; Karino K, 2005, J INSECT BEHAV, V18, P805, DOI 10.1007/s10905-005-8741-5; Kelly CD, 2005, BEHAV ECOL, V16, P145, DOI 10.1093/beheco/arh141; Kelly CD, 2006, ANIM BEHAV, V72, P727, DOI 10.1016/j.anbehav.2006.02.007; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Lappin AK, 2005, AM NAT, V166, P426, DOI 10.1086/432564; LATOURETTE KS, 1936, BIOGRAPHICAL MEMOIRS, V18, P41; Laufer B, 1927, FIELD MUSEUM NATURAL, V22, P1; LINCOLN GA, 1972, J EXP ZOOL, V182, P233, DOI 10.1002/jez.1401820208; LOHER W, 1989, CRICKET BEHAV NEUROB, P1; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Maskell F. G., 1927, Transactions and Proceedings of the New Zealand Institute, V57, P637; MestertonGibbons M, 1996, J THEOR BIOL, V181, P65, DOI 10.1006/jtbi.1996.0115; MOORE AJ, 1993, BEHAV ECOL, V4, P40, DOI 10.1093/beheco/4.1.40; OTTE D, 1983, P ACAD NAT SCI PHILA, V135, P241; OTTE D, 1984, P ACAD NAT SCI PHILA, V136, P98; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; Payne RJH, 1998, ANIM BEHAV, V56, P651, DOI 10.1006/anbe.1998.0835; PLAVCAN JM, 1992, AM J PHYS ANTHROPOL, V87, P461, DOI 10.1002/ajpa.1330870407; RADESATER T, 1993, ETHOLOGY, V95, P89, DOI 10.1111/j.1439-0310.1993.tb00460.x; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Roff DA, 2003, J EVOLUTION BIOL, V16, P744, DOI 10.1046/j.1420-9101.2003.00570.x; SCHILLER B, 2007, TORONTO STAR    1027; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Sneddon LU, 1997, BEHAV ECOL SOCIOBIOL, V41, P237, DOI 10.1007/s002650050384; Sneddon LU, 2000, J ZOOL, V250, P397, DOI 10.1017/S0952836900003125; Styrsky JD, 1999, J INSECT BEHAV, V12, P475, DOI 10.1023/A:1020962606724; Suga Y., 2006, INT J ASIAN STUD, V3, P77, DOI DOI 10.1017/S1479591405000239; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Walker SE, 2008, CAN J ZOOL, V86, P253, DOI 10.1139/Z08-001; Walker T.J., 1989, P1; Walker T. J., 2004, FIELD GUIDE GRASSHOP; Wilkinson Gerald S., 1997, P310, DOI 10.1017/CBO9780511721946.019; Zar J. H., 1996, BIOSTATISTICAL ANAL; ZEH DW, 1987, EVOLUTION, V41, P1072, DOI 10.1111/j.1558-5646.1987.tb05877.x	82	72	76	9	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3980	10.1371/journal.pone.0003980	http://dx.doi.org/10.1371/journal.pone.0003980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107188	gold, Green Submitted, Green Published			2022-12-27	WOS:000265463000005
J	Rubinoff, D; Le Roux, JJ				Rubinoff, Daniel; Le Roux, Johannes J.			Evidence of Repeated and Independent Saltational Evolution in a Peculiar Genus of Sphinx Moths (Proserpinus: Sphingidae)	PLOS ONE			English	Article								Background: Saltational evolution in which a particular lineage undergoes relatively rapid, significant, and unparalleled change as compared with its closest relatives is rarely invoked as an alternative model to the dominant paradigm of gradualistic evolution. Identifying saltational events is an important first-step in assessing the importance of this discontinuous model in generating evolutionary novelty. We offer evidence for three independent instances of saltational evolution in a charismatic moth genus with only eight species. Methodology/Principal Findings: Maximum parsimony, maximum likelihood and Bayesian search criteria offered congruent, well supported phylogenies based on 1,965 base pairs of DNA sequence using the mitochondrial gene cytochrome oxidase subunit I, and the nuclear genes elongation factor-1 alpha and wingless. Using a comparative methods approach, we examined three taxa exhibiting novelty in the form of Batesian mimicry, host plant shift, and dramatic physiological differences in light of the phylogenetic data. All three traits appear to have evolved relatively rapidly and independently in three different species of Proserpinus. Each saltational species exhibits a markedly different and discrete example of discontinuous trait evolution while remaining canalized for other typical traits shared by the rest of the genus. All three saltational taxa show insignificantly different levels of overall genetic change as compared with their congeners, implying that their divergence is targeted to particular traits and not genome-wide. Conclusions/Significance: Such rapid evolution of novel traits in individual species suggests that the pace of evolution can be quick, dramatic, and isolated-even on the species level. These results may be applicable to other groups in which specific taxa have generated pronounced evolutionary novelty. Genetic mechanisms and methods for assessing such relatively rapid changes are postulated.	[Le Roux, Johannes J.] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Rubinoff, D (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu		Le Roux, Johannes/0000-0001-7911-9810	U.S. Fish and Wildlife Service, Recovery Branch of the Sacramento Field Office	U.S. Fish and Wildlife Service, Recovery Branch of the Sacramento Field Office(US Fish & Wildlife Service)	This research was funded in part by a grant from the U.S. Fish and Wildlife Service, Recovery Branch of the Sacramento Field Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 1999, P NATL ACAD SCI USA, V96, P10224, DOI 10.1073/pnas.96.18.10224; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Boggs CL, 1997, ECOLOGY, V78, P181, DOI 10.1890/0012-9658(1997)078[0181:RAFRAI]2.0.CO;2; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWN JM, 1995, OECOLOGIA, V104, P52, DOI 10.1007/BF00365562; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Cognato AI, 2001, SYST BIOL, V50, P758, DOI 10.1080/106351501753462803; Dobzhansky T., 1937; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Gratton C, 1999, ECOLOGY, V80, P773, DOI 10.1890/0012-9658(1999)080[0773:DEFSEE]2.0.CO;2; Hodges R. W., 1971, MOTHS AM N MEXICO IN; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; KAWAHARA AY, 2007, THESIS U MARYLAND CO; Langham GM, 2004, EVOLUTION, V58, P2783; Linn C, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.15; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; Mayr E, 1942, SYSTEMATICS ORIGIN S; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nutt P, 2006, PLANT SYST EVOL, V259, P217, DOI 10.1007/s00606-006-0420-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RITLAND DB, 1991, NATURE, V350, P497, DOI 10.1038/350497a0; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; RUBINOFF D, 2002, J LEP SOC, V55, P78; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Shedlock AM, 2000, SYST BIOL, V49, P808, DOI 10.1080/106351500750049851; SORENSON MD, 1999, TREEROT VERSION 2; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; Theissen G, 2006, THEOR BIOSCI, V124, P349, DOI 10.1016/j.thbio.2005.11.002; TUTTLE JP, 2007, HAWK MOTHS N AM; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wright S, 1931, GENETICS, V16, P0097; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494	45	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4035	10.1371/journal.pone.0004035	http://dx.doi.org/10.1371/journal.pone.0004035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107205	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000026
J	Kawakita, A; Sato, K; Makino, H; Ikegami, H; Takayama, S; Toyama, Y; Umezawa, A				Kawakita, Atsuo; Sato, Kazuki; Makino, Hatsune; Ikegami, Hiroyasu; Takayama, Shinichiro; Toyama, Yoshiaki; Umezawa, Akihiro			Nicotine Acts on Growth Plate Chondrocytes to Delay Skeletal Growth through the alpha 7 Neuronal Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article								Background: Cigarette smoking adversely affects endochondral ossification during the course of skeletal growth. Among a plethora of cigarette chemicals, nicotine is one of the primary candidate compounds responsible for the cause of smoking-induced delayed skeletal growth. However, the possible mechanism of delayed skeletal growth caused by nicotine remains unclarified. In the last decade, localization of neuronal nicotinic acetylcholine receptor (nAChR), a specific receptor of nicotine, has been widely detected in non-excitable cells. Therefore, we hypothesized that nicotine affect growth plate chondrocytes directly and specifically through nAChR to delay skeletal growth. Methodology/Principal Findings: We investigated the effect of nicotine on human growth plate chondrocytes, a major component of endochondral ossification. The chondrocytes were derived from extra human fingers. Nicotine inhibited matrix synthesis and hypertrophic differentiation in human growth plate chondrocytes in suspension culture in a concentration-dependent manner. Both human and murine growth plate chondrocytes expressed alpha7 nAChR, which constitutes functional homopentameric receptors. Methyllycaconitine (MLA), a specific antagonist of alpha7 nAChR, reversed the inhibition of matrix synthesis and functional calcium signal by nicotine in human growth plate chondrocytes in vitro. To study the effect of nicotine on growth plate in vivo, ovulation-controlled pregnant alpha7 nAChR +/- mice were given drinking water with or without nicotine during pregnancy, and skeletal growth of their fetuses was observed. Maternal nicotine exposure resulted in delayed skeletal growth of alpha7 nAChR +/+ fetuses but not in alpha7 nAChR -/- fetuses, implying that skeletal growth retardation by nicotine is specifically mediated via fetal alpha7 nAChR. Conclusions/Significance: These results suggest that nicotine, from cigarette smoking, acts directly on growth plate chondrocytes to decrease matrix synthesis, suppress hypertrophic differentiation via alpha7 nAChR, leading to delayed skeletal growth.	[Makino, Hatsune; Umezawa, Akihiro] NICHD, Dept Reprod Biol, Tokyo, Japan; [Kawakita, Atsuo; Sato, Kazuki; Ikegami, Hiroyasu; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 108, Japan; [Takayama, Shinichiro] Natl Ctr Child Hlth & Dev, Dept Orthopaed Surg, Tokyo, Japan	National Center for Child Health & Development - Japan; Keio University; National Center for Child Health & Development - Japan	Kawakita, A (corresponding author), NICHD, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp	Toyama, Yoshiaki/K-5743-2013; Sato, Kazuki/AAL-2166-2021		Smoking Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare (MHLW); Japan Health Science Foundation; program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency	Smoking Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency	This study was supported by a grant from the Smoking Research Foundation; by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by the Ministry of Health, Labour and Welfare (MHLW) Sciences Research Grants; by a Research Grant on Health Science focusing on Drug Innovation from the Japan Health Science Foundation; by the program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a Research Grant for Cardiovascular Disease from the MHLW; and by a Grant for Child Health and Development from the MHLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNERIC SP, 1999, NEURONAL NICOTINIC R, pR12; Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; DAVIES DP, 1976, LANCET, V1, P385; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; El-Zawawy HB, 2006, J ORTHOP RES, V24, P2150, DOI 10.1002/jor.20263; Gullahorn L, 2005, OSTEOARTHR CARTILAGE, V13, P942, DOI 10.1016/j.joca.2005.03.001; HADDON W, 1961, OBSTET GYNECOL, V18, P262; HARDY JB, 1972, LANCET, V2, P1332; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Karatza AA, 2003, CLIN PEDIATR, V42, P533, DOI 10.1177/000992280304200608; Kurtoglu S, 2007, EXP BIOL MED, V232, P398; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MAU G, 1976, LANCET, V1, P972; MOCHIZUKI M, 1985, ACTA PHYSIOL HUNG, V65, P295; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; Nordstrom ML, 1996, SCAND J SOC MED, V24, P55, DOI 10.1177/140349489602400109; OLSEN J, 1991, AM J PUBLIC HEALTH, V81, P69, DOI 10.2105/AJPH.81.1.69; OLSEN J, 1992, INT J EPIDEMIOL, V21, P279, DOI 10.1093/ije/21.2.279; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Sano M, 2000, EXP CELL RES, V259, P127, DOI 10.1006/excr.2000.4977; Sano M, 2001, EXP CELL RES, V266, P114, DOI 10.1006/excr.2001.5203; SEXTON M, 1984, JAMA-J AM MED ASSOC, V251, P911, DOI 10.1001/jama.251.7.911; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; TACCHETTI C, 1987, J CELL BIOL, V105, P999, DOI 10.1083/jcb.105.2.999; TRYGG K, 1995, PAEDIATR PERINAT EP, V9, P307, DOI 10.1111/j.1365-3016.1995.tb00147.x; WINGERD J, 1974, PEDIATRICS, V53, P737; YERUSHALMY J, 1971, AM J EPIDEMIOL, V93, P443, DOI 10.1093/oxfordjournals.aje.a121278	28	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3945	10.1371/journal.pone.0003945	http://dx.doi.org/10.1371/journal.pone.0003945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079602	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458400004
J	Eswarappa, SM; Janice, J; Nagarajan, AG; Balasundaram, SV; Karnam, G; Dixit, NM; Chakravortty, D				Eswarappa, Sandeepa M.; Janice, Jessin; Nagarajan, Arvindhan G.; Balasundaram, Sudhagar V.; Karnam, Guruswamy; Dixit, Narendra M.; Chakravortty, Dipshikha			Differentially Evolved Genes of Salmonella Pathogenicity Islands: Insights into the Mechanism of Host Specificity in Salmonella	PLOS ONE			English	Article								Background: The species Salmonella enterica (S. enterica) includes many serovars that cause disease in avian and mammalian hosts. These serovars differ greatly in their host range and their degree of host adaptation. The host specificity of S. enterica serovars appears to be a complex phenomenon governed by multiple factors acting at different stages of the infection process, which makes identification of the cause/s of host specificity solely by experimental methods difficult. Methodology/Principal Findings: In this study, we have employed a molecular evolution and phylogenetics based approach to identify genes that might play important roles in conferring host specificity to different serovars of S. enterica. These genes are 'differentially evolved' in different S. enterica serovars. This list of 'differentially evolved' genes includes genes that encode translocon proteins (SipD, SseC and SseD) of both Salmonella pathogenicity islands 1 and 2 encoded type three secretion systems, sptP, which encodes an effector protein that inhibits the mitogen-activated protein kinase pathway of the host cell, and genes which encode effector proteins (SseF and SifA) that are important in placing the Salmonella-containing vacuole in a juxtanuclear position. Conclusions/Significance: Analysis of known functions of these 'differentially evolved genes' indicates that the products of these genes directly interact with the host cell and manipulate its functions and thereby confer host specificity, at least in part, to different serovars of S. enterica that are considered in this study.	[Eswarappa, Sandeepa M.; Janice, Jessin; Nagarajan, Arvindhan G.; Balasundaram, Sudhagar V.; Karnam, Guruswamy; Chakravortty, Dipshikha] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Ctr Infect Dis Res, Dept Chem Engn, Biosafety Lab, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009; Eswarappa, Sandeep/AFG-1997-2022	Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354; Chakravortty, Dipshikha/0000-0002-7838-5145; Eswarappa, Sandeep/0000-0002-7903-5198; Janice, Jessin/0000-0001-9991-6315	Department of Biotechnology [DBTO/197]; Department of Atomic Energy [DAEO/119]; Government of India; Indian Institute of Science [191/MCB]; ICMR; DBT	Department of Biotechnology; Department of Atomic Energy(Department of Atomic Energy (DAE)); Government of India; Indian Institute of Science; ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology (DBTO/197) and Department of Atomic Energy (DAEO/119), Government of India, the director of Indian Institute of Science [Provision (2A) Tenth Plan (191/MCB)], ICMR center for Medical Microbiology and DBT program support on Basic Biology of Microbial Pathogens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Elewaut D, 1999, J IMMUNOL, V163, P1457; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Klein JR, 2001, INFECT IMMUN, V69, P737, DOI 10.1128/IAI.69.2.737-743.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; MCCORMICK BA, 1995, INFECT IMMUN, V63, P2302, DOI 10.1128/IAI.63.6.2302-2309.1995; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PASCOPELLA L, 1995, INFECT IMMUN, V63, P4329, DOI 10.1128/IAI.63.11.4329-4335.1995; Paulin SM, 2002, INFECT IMMUN, V70, P6788, DOI 10.1128/IAI.70.12.6788-6797.2002; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tracz DM, 2006, J CLIN MICROBIOL, V44, P2007, DOI 10.1128/JCM.02630-05; Uzzau S, 2001, INFECT IMMUN, V69, P3092, DOI 10.1128/IAI.69.5.3092-3099.2001; Weinstein DL, 1998, INFECT IMMUN, V66, P2310, DOI 10.1128/IAI.66.5.2310-2318.1998; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003	59	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3829	10.1371/journal.pone.0003829	http://dx.doi.org/10.1371/journal.pone.0003829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050757	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452100001
J	Clements, A; Gaboriaud, F; Duval, JFL; Farn, JL; Jenney, AW; Lithgow, T; Wijburg, OLC; Hartland, EL; Strugnell, RA				Clements, Abigail; Gaboriaud, Fabien; Duval, Jerome F. L.; Farn, Jacinta L.; Jenney, Adam W.; Lithgow, Trevor; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.			The Major Surface-Associated Saccharides of Klebsiella pneumoniae Contribute to Host Cell Association	PLOS ONE			English	Article								Analysing the pathogenic mechanisms of a bacterium requires an understanding of the composition of the bacterial cell surface. The bacterial surface provides the first barrier against innate immune mechanisms as well as mediating attachment to cells/surfaces to resist clearance. We utilised a series of Klebsiella pneumoniae mutants in which the two major polysaccharide layers, capsule and lipopolysaccharide (LPS), were absent or truncated, to investigate the ability of these layers to protect against innate immune mechanisms and to associate with eukaryotic cells. The capsule alone was found to be essential for resistance to complement mediated killing while both capsule and LPS were involved in cell-association, albeit through different mechanisms. The capsule impeded cell-association while the LPS saccharides increased cell-association in a non-specific manner. The electrohydrodynamic characteristics of the strains suggested the differing interaction of each bacterial strain with eukaryotic cells could be partly explained by the charge density displayed by the outermost polysaccharide layer. This highlights the importance of considering not only specific adhesin: ligand interactions commonly studied in adherence assays but also the initial non-specific interactions governed largely by the electrostatic interaction forces.	[Clements, Abigail; Farn, Jacinta L.; Jenney, Adam W.; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.] Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia; [Clements, Abigail; Farn, Jacinta L.; Jenney, Adam W.; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Co operative Res Ctr Vaccine Technol, Parkville, Vic 3052, Australia; [Gaboriaud, Fabien] Univ Nancy, CNRS, Lab Phys Chem & Microbiol Environm, F-54013 Nancy, France; [Duval, Jerome F. L.] Univ Nancy, CNRS, Lab Environm & Mineral Processing, F-54013 Nancy, France; [Lithgow, Trevor] Univ Melbourne, Bio21 Inst, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Melbourne	Clements, A (corresponding author), Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia.	abigailc@unimelb.edu.au	Lithgow, Trevor J/H-5925-2017; Jerome, Duval/H-6421-2011; Hartland, Elizabeth/O-2569-2014	Lithgow, Trevor J/0000-0002-0102-7884; Jerome, Duval/0000-0002-5458-3761; Strugnell, Richard/0000-0003-0614-5641; Clements, Abigail/0000-0003-2285-777X; Hartland, Elizabeth/0000-0003-4254-2863	NHMRC; Co-operative Research Centre for Vaccine Technology	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Co-operative Research Centre for Vaccine Technology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	NHMRC Australian Bacterial Pathogenesis Program Grant 2003 2008, Co-operative Research Centre for Vaccine Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1983, PATHOLOGY, V15, P247, DOI 10.3109/00313028309083501; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; AMAKO K, 1988, J BACTERIOL, V170, P4960, DOI 10.1128/jb.170.10.4960-4962.1988; BELANGER M, 1990, INFECT IMMUN, V58, P3523; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Corsaro MM, 2005, CARBOHYD RES, V340, P2212, DOI 10.1016/j.carres.2005.07.006; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Dague E, 2006, BIOPHYS J, V90, P2612, DOI 10.1529/biophysj.105.068205; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Domenico P, 1999, INFECT IMMUN, V67, P664, DOI 10.1128/IAI.67.2.664-669.1999; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Fresno S, 2007, J BACTERIOL, V189, P1128, DOI 10.1128/JB.01489-06; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Hanberger H, 1999, JAMA-J AM MED ASSOC, V281, P67, DOI 10.1001/jama.281.1.67; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; JOHANSON WG, 1969, NEW ENGL J MED, V281, P1137, DOI 10.1056/NEJM196911202812101; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Kostina E, 2005, INFECT IMMUN, V73, P8282, DOI 10.1128/IAI.73.12.8282-8290.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Maneval WE, 1941, STAIN TECHNOL, V16, P13, DOI 10.3109/10520294109106189; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; ROSENTHAL S, 1975, ANN INTERN MED, V83, P355, DOI 10.7326/0003-4819-83-3-355; Rotureau E, 2007, LANGMUIR, V23, P8460, DOI 10.1021/la700427p; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; TOMAS JM, 1986, INFECT IMMUN, V54, P85; Trautmann M, 2004, VACCINE, V22, P818, DOI 10.1016/j.vaccine.2003.11.026; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f; Waters V, 2004, CLIN INFECT DIS, V38, P1682, DOI 10.1086/386331; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x	56	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3817	10.1371/journal.pone.0003817	http://dx.doi.org/10.1371/journal.pone.0003817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043570	gold, Green Published			2022-12-27	WOS:000265451400009
J	Sakai, Y; Fukai, T				Sakai, Yutaka; Fukai, Tomoki			When Does Reward Maximization Lead to Matching Law?	PLOS ONE			English	Article							CONCURRENT VARIABLE-INTERVAL; BEHAVIOR; OPTIMIZATION; SCHEDULES; CHOICE; REINFORCEMENT; MELIORATION; ALGORITHMS; MODELS; SIGNAL	What kind of strategies subjects follow in various behavioral circumstances has been a central issue in decision making. In particular, which behavioral strategy, maximizing or matching, is more fundamental to animal's decision behavior has been a matter of debate. Here, we prove that any algorithm to achieve the stationary condition for maximizing the average reward should lead to matching when it ignores the dependence of the expected outcome on subject's past choices. We may term this strategy of partial reward maximization "matching strategy". Then, this strategy is applied to the case where the subject's decision system updates the information for making a decision. Such information includes subject's past actions or sensory stimuli, and the internal storage of this information is often called "state variables". We demonstrate that the matching strategy provides an easy way to maximize reward when combined with the exploration of the state variables that correctly represent the crucial information for reward maximization. Our results reveal for the first time how a strategy to achieve matching behavior is beneficial to reward maximization, achieving a novel insight into the relationship between maximizing and matching.	[Sakai, Yutaka] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Fukai, Tomoki] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan	RIKEN	Sakai, Y (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	tfukai@brain.riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638	Grant in Aid for Priority Researches [17022036, 17021038]	Grant in Aid for Priority Researches	This work was partially supported by the Grant in Aid for Priority Researches, no. 17022036 and no. 17021038. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSOP B, 1991, J EXP ANAL BEHAV, V56, P67, DOI 10.1901/jeab.1991.56-67; [Anonymous], 1996, NEURO DYNAMIC PROGRA; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; DAVISON M, 1989, J EXP ANAL BEHAV, V51, P215, DOI 10.1901/jeab.1989.51-215; Davison M, 1999, J EXP ANAL BEHAV, V71, P439, DOI 10.1901/jeab.1999.71-439; Davison M. C., 1987, MATCHING LAW RES REV; Dayan P, 2001, COMPUTATIONAL NEUROS; DECARLO LT, 1985, J EXP ANAL BEHAV, V43, P75, DOI 10.1901/jeab.1985.43-75; HERMSTEIN RJ, 1997, MATCHING LAW PAPERS; Herrnstein R.J., 1980, LIMITS ACTION ALLOCA; HERRNSTEIN RJ, 1979, J EXP ANAL BEHAV, V31, P209, DOI 10.1901/jeab.1979.31-209; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HEYMAN GM, 1979, J EXP ANAL BEHAV, V31, P41, DOI 10.1901/jeab.1979.31-41; Houk J, 1994, MODELS INFORM PROCES; Konda VR, 2003, SIAM J CONTROL OPTIM, V42, P1143, DOI 10.1137/S0363012901385691; Loewenstein Y, 2006, P NATL ACAD SCI USA, V103, P15224, DOI 10.1073/pnas.0505220103; Marbach P, 2001, IEEE T AUTOMAT CONTR, V46, P191, DOI 10.1109/9.905687; MAZUR JE, 1981, SCIENCE, V214, P823, DOI 10.1126/science.7292017; Mazur JE, 2005, LEARNING BEHAV; Sakai Y, 2008, NEURAL COMPUT, V20, P227, DOI 10.1162/neco.2008.20.1.227; Sakai Y, 2006, NEURAL NETWORKS, V19, P1091, DOI 10.1016/j.neunet.2006.05.034; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shanks DR, 2002, J BEHAV DECIS MAKING, V15, P233, DOI 10.1002/bdm.413; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; VAUGHAN W, 1981, J EXP ANAL BEHAV, V36, P141, DOI 10.1901/jeab.1981.36-141	30	23	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3795	10.1371/journal.pone.0003795	http://dx.doi.org/10.1371/journal.pone.0003795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YA	19030101	gold, Green Submitted, Green Published			2022-12-27	WOS:000265450800005
J	Hung, J; Colicos, MA				Hung, Johanna; Colicos, Michael A.			Astrocytic Ca2+ Waves Guide CNS Growth Cones to Remote Regions of Neuronal Activity	PLOS ONE			English	Article								Activity plays a critical role in network formation during developmental, experience-dependent, and injury related remodeling. Here we report a mechanism by which axon trajectory can be altered in response to remote neuronal activity. Using photoconductive stimulation to trigger high frequency action potentials in rat hippocampal neurons in vitro, we find that activity functions as an attractive cue for growth cones in the local environment. The underlying guidance mechanism involves astrocyte Ca2+ waves, as the connexin-43 antagonist carbenoxolone abolishes the attraction when activity is initiated at a distance greater than 120 mm. The asymmetric growth cone filopodia extension that precedes turning can be blocked with CNQX (10 mu M), but not with the ATP and adenosine receptor antagonists suramin (100 mu M) and alloxazine (4 mu M), suggesting non-NMDA glutamate receptors on the growth cone mediate the interaction with astrocytes. These results define a potential long-range signalling pathway for activity-dependent axon guidance in which growth cones turn towards directional, temporally coordinated astrocyte Ca2+ waves that are triggered by neuronal activity. To assess the viability of the guidance effect in an injury paradigm, we performed the assay in the presence of conditioned media from lipopolysaccharide (LPS) activated purified microglial cultures, as well as directly activating the glia present in our co-cultures. Growth cone attraction was not inhibited under these conditions, suggesting this mechanism could be used to guide regeneration following axonal injury.	[Hung, Johanna; Colicos, Michael A.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada	University of Calgary	Hung, J (corresponding author), Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada.	mcolicos@ucalgary.ca			CIHR; AIF; AHFMR; HSFC	CIHR(Canadian Institutes of Health Research (CIHR)); AIF; AHFMR(Alberta Heritage Foundation for Medical Research); HSFC(Heart & Stroke Foundation of Canada)	This work was supported by CIHR and AIF grants to M.C. M.C. is an AHFMR Scholar and an HSFC Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; FONTANA A, 1987, IMMUNOL REV, V100, P185, DOI 10.1111/j.1600-065X.1987.tb00532.x; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Fu WM, 1997, NEUROREPORT, V8, P2005, DOI 10.1097/00001756-199705260-00041; Goda Y, 2006, NAT PROTOC, V1, P461, DOI 10.1038/nprot.2006.67; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Hassinger TD, 1996, P NATL ACAD SCI USA, V93, P13268, DOI 10.1073/pnas.93.23.13268; Innocenti B, 2000, J NEUROSCI, V20, P1800; KATER SB, 1994, PROG BRAIN RES, V102, P4999; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McFarlane S, 2000, BIOCHEM CELL BIOL, V78, P563, DOI 10.1139/bcb-78-5-563; McKenna WL, 2008, J NEUROCHEM, V104, P1081, DOI 10.1111/j.1471-4159.2007.05040.x; Miller RF, 2004, GLIA, V47, P275, DOI 10.1002/glia.20073; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Mundigl O, 1998, J NEUROSCI, V18, P93; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PATEL NB, 1984, J NEUROSCI, V4, P2939; Ponimaskin E, 2007, MOL NEUROBIOL, V35, P278, DOI 10.1007/s12035-007-0023-0; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Starovoytov A, 2005, J NEUROPHYSIOL, V93, P1090, DOI 10.1152/jn.00836.2004; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	55	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3692	10.1371/journal.pone.0003692	http://dx.doi.org/10.1371/journal.pone.0003692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002247	gold, Green Submitted, Green Published			2022-12-27	WOS:000265166000003
J	Dupaigne, P; Lavelle, C; Justome, A; Lafosse, S; Mirambeau, G; Lipinski, M; Pietrement, O; Le Cam, E				Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Mirambeau, Gilles; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric			Rad51 Polymerization Reveals a New Chromatin Remodeling Mechanism	PLOS ONE			English	Article								Rad51 protein is a well known protagonist of homologous recombination in eukaryotic cells. Rad51 polymerization on single-stranded DNA and its role in presynaptic filament formation have been extensively documented. Rad51 polymerizes also on double-stranded DNA but the significance of this filament formation remains unclear. We explored the behavior of Saccharomyces cerevisiae Rad51 on dsDNA and the influence of nucleosomes on Rad51 polymerization mechanism to investigate its putative role in chromatin accessibility to recombination machinery. We combined biochemical approaches, transmission electron microscopy (TEM) and atomic force microscopy (AFM) for analysis of the effects of the Rad51 filament on chromatinized templates. Quantitative analyses clearly demonstrated the occurrence of chromatin remodeling during nucleoprotein filament formation. During Rad51 polymerization, recombinase proteins moved all the nucleosomal arrays in front of the progressing filament. This polymerization process had a powerful remodeling effect, as Rad51 destabilized the nucleosomes along considerable stretches of DNA. Similar behavior was observed with RecA. Thus, recombinase polymerization is a powerful mechanism of chromatin remodeling. These remarkable features open up new possibilities for understanding DNA recombination and reveal new types of ATP-dependent chromatin dynamics.	[Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Mirambeau, Gilles; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric] CNRS, Inst Canc Gustave Roussy, Lab Microscopie Mol & Cellulaire, UMR Interact Mol & Canc 8126, Villejuif, France; [Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric] Univ Paris Sud, Villejuif, France; [Mirambeau, Gilles] Univ Paris 06, UFR Sci Vie, Div Biochim, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Dupaigne, P (corresponding author), CNRS, Inst Canc Gustave Roussy, Lab Microscopie Mol & Cellulaire, UMR Interact Mol & Canc 8126, Villejuif, France.	olivier.pietrement@igr.fr; elecam@igr.fr	Dupaigne, Pauline/C-6873-2019; Lavelle, Christophe/F-2377-2013; PIETREMENT, Olivier/T-2555-2017	Le cam, Eric/0000-0002-6832-6117; PIETREMENT, Olivier/0000-0002-0018-7202; Mirambeau, Gilles/0000-0001-8308-4948; Dupaigne, Pauline/0000-0001-7033-4055	CNRS; ANR; Ligue contre le Cancer; ARC; INCa; Region Ile de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); Region Ile de France(Region Ile-de-France)	This work was supported by grants from CNRS, ANR, Ligue contre le Cancer, ARC, INCa and Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; Kwon Y, 2007, DNA REPAIR, V6, P1496, DOI 10.1016/j.dnarep.2007.04.012; Lavelle C, 2007, BIOCHIMIE, V89, P516, DOI 10.1016/j.biochi.2006.09.019; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Pastre D, 2006, LANGMUIR, V22, P6651, DOI 10.1021/la053387y; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sauvageau S, 2005, MOL CELL BIOL, V25, P4377, DOI 10.1128/MCB.25.11.4377-4387.2005; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Sivolob A, 2003, J MOL BIOL, V326, P49, DOI 10.1016/S0022-2836(02)01372-4; Sivolob A, 1999, J MOL BIOL, V285, P1081, DOI 10.1006/jmbi.1998.2380; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	44	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3643	10.1371/journal.pone.0003643	http://dx.doi.org/10.1371/journal.pone.0003643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982066	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134300012
J	Gray, DJ; Williams, GM; Li, YS; McManus, DP				Gray, Darren J.; Williams, Gail M.; Li, Yuesheng; McManus, Donald P.			Transmission Dynamics of Schistosoma japonicum in the Lakes and Marshlands of China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; YANGTZE-RIVER VALLEY; SAMAR PROVINCE; POYANG LAKE; BASE-LINE; ANHUI PROVINCE; WATER-BUFFALOS; WESTERN SAMAR; INFECTION; INTERVENTION	Background: Schistosoma japonicum is a major public health concern in China, with over one million people infected and another 40 million living in areas at risk of infection. Unlike the disease caused by S. mansoni and S. haematobium, schistosomiasis japonica is a zoonosis, involving a number of different mammalian species as reservoir hosts. As a result of a number of published reports from China, it has long been considered that bovines, particularly water buffaloes, play a major role in human S. japonicum transmission there, and a drug-based intervention study (1998-2003) around the Poyang Lake in Jiangxi Province provided proof of concept that water buffaloes are, indeed, major reservoirs of human infection in this setting. Methods and Findings: In this study we incorporated recently obtained epidemiological information to model the steady-state S. japonicum transmission as well as the impact of the removal of S. japonicum transmission attributable to water buffaloes on human infection rates across six different endemic scenarios within three villages in the Dongting (Hunan) and Poyang (Jiangxi) lakes of southern China. Similar results were obtained for all scenarios. Steady-state S. japonicum infection rates remained constant and human prevalence and incidence were predicted to fall considerably over time. The model showed that the contribution of S. japonicum water buffalo transmission to human infection ranged from 39.1% to 99.1% and predicted that the removal of water buffalo transmission would reduce parasite reproductive rates below 1. This indicates that without the contribution of water buffaloes, S. japonicum transmission is interrupted and unsustainable. These scenarios are generalizable to other endemic villages in the lake and marshland areas of China where a similar cycle of snail infection and infection/reinfection of humans and bovines occurs. Conclusions: Along with previous epidemiological data, our findings strongly support water buffaloes as an important component of the transmission cycle that affects humans in the lake and marshlands region of China, a feature which appears to differ from the situation prevalent in the Philippines where their contribution is less pronounced. Our conclusions underscore the rationale for removal, replacement or treatment of water buffaloes, and for the development and deployment of a transmission blocking buffalo vaccine against S. japonicum for this setting to achieve the goal of transmission control. The Chinese Government has recently commenced a new integrated national strategy to improve on existing approaches to control schistosomiasis in the lake and marshlands region by reducing bovines and humans as a source of S. japonicum infection to Oncomelania snails.	[Li, Yuesheng; McManus, Donald P.] Queensland Inst Med Res, Mol Parasitol Lab, Herston, Qld 4006, Australia; [Gray, Darren J.; Williams, Gail M.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Li, Yuesheng] WHO, Collaborating Ctr Res & Control Schistosomiasis, Hunan Inst Parasit Dis, Yueyang, Peoples R China	QIMR Berghofer Medical Research Institute; University of Queensland; World Health Organization	Gray, DJ (corresponding author), Queensland Inst Med Res, Mol Parasitol Lab, Bramston Terrace, Herston, Qld 4006, Australia.	donM@qimr.edu.au	Gray, Darren/A-8455-2011; McManus, Don/AAC-5394-2020; McManus, Donald P./G-2678-2013; Williams, Gail/S-8833-2019; LI, Yue/GRS-8071-2022	McManus, Don/0000-0001-6443-1449; Williams, Gail/0000-0002-4822-5263; Gray, Darren/0000-0003-3525-1339	Wellcome Trust (UK); National Health and Medical Research Council of Australia	Wellcome Trust (UK)(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Wellcome Trust (UK) and National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Barbour AD, 1996, AM J TROP MED HYG, V55, P135, DOI 10.4269/ajtmh.1996.55.135; Carabin H, 2005, INT J PARASITOL, V35, P1517, DOI 10.1016/j.ijpara.2005.06.010; *COMM NEA, 1998, CHIN J PARASITOL PAR, V16, P84; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Davis GM, 2002, AM J TROP MED HYG, V66, P359, DOI 10.4269/ajtmh.2002.66.359; DeBont J, 1997, PARASITOL TODAY, V13, P255, DOI 10.1016/S0169-4758(97)01057-0; Fedorko James M., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P343; Fernandez TJ, 2007, VECTOR-BORNE ZOONOT, V7, P147, DOI 10.1089/vbz.2006.0565; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; Guo JG, 2001, AM J TROP MED HYG, V65, P272, DOI 10.4269/ajtmh.2001.65.272; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Ho Yi-HsuN, 1963, Chinese Medical Journal, V82, P403; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Johansen MV, 2000, ACTA TROP, V76, P85, DOI 10.1016/S0001-706X(00)00103-0; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; LU YL, 1980, SELECTION SCHISTOSOM, P453; LUO XF, 1988, CHIN J VET SCI TECHN, V8, P42; *MATHS ENG ED INC, 2004, MATHC VERS 14; McGarvey ST, 2006, B WORLD HEALTH ORGAN, V84, P446, DOI 10.2471/BLT.05.026427; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Minggang Chen, 1999, Parasitology International, V48, P11, DOI 10.1016/S1383-5769(99)00004-5; MITCHELL GF, 1990, PARASITOLOGY, V101, P27, DOI 10.1017/S0031182000079713; Riley S, 2008, PLOS MED, V5, P70, DOI 10.1371/journal.pmed.0050018; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; WANG LD, 2006, EPIDEMIC STATUS SCHI; Wang LK, 2007, INT SER DEV HEAT TRA, P11; Wang TP, 2006, INT J PARASITOL, V36, P1317, DOI 10.1016/j.ijpara.2006.06.011; Wang TP, 2006, J PARASITOL, V92, P1088, DOI 10.1645/GE-806R.1; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; *WHO, 1993, CONTR SCH; Williams GM, 2002, ACTA TROP, V82, P253, DOI 10.1016/S0001-706X(02)00017-7; Willingham A. L., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P128; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	40	77	85	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4058	10.1371/journal.pone.0004058	http://dx.doi.org/10.1371/journal.pone.0004058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115007	Green Published, gold			2022-12-27	WOS:000265466300004
J	Stabell, C; Fisker, AB; Rodrigues, A; Ravn, H; Sartono, E; Whittle, H; Yazdanbakhsh, M; Aaby, P				Stabell, Christine; Fisker, Ane Baerent; Rodrigues, Amabelia; Ravn, Henrik; Sartono, Erliyani; Whittle, Hilton; Yazdanbakhsh, Maria; Aaby, Peter			Sex-Differential Effect on Infant Mortality of Oral Polio Vaccine Administered with BCG at Birth in Guinea-Bissau. A Natural Experiment	PLOS ONE			English	Article							IMMUNIZATION	Background: The policy to provide oral polio vaccine (OPV) at birth was introduced in low-income countries to increase coverage. The effect of OPV at birth on overall child mortality was never studied. During a trial of vitamin A supplementation (VAS) at birth in Guinea-Bissau, OPV was not available during several periods. We took advantage of this "natural experiment" to test the effect on mortality of receiving OPV at birth. Methodology: Between 2002 and 2004, the VAS trial randomised normal-birth-weight infants to 50,000 IU VAS or placebo administered with BCG. Provision of OPV at birth was not part of the trial, but we noted whether the infants received OPV or not. OPV was missing during several periods in 2004. We used Cox proportional hazards models to compute mortality rate ratios (MRR) of children who had received or not received OPV at birth. Principal Findings: A total of 962 (22.1%) of the 4345 enrolled children did not receive OPV at birth; 179 children died within the first year of life. Missing OPV at birth was associated with a tendency for decreased mortality (adjusted MRR=0.69 (95% CI = 0.46-1.03)), the effect being similar among recipients of VAS and placebo. There was a highly significant interaction between OPV at birth and sex (p = 0.006). Not receiving OPV at birth was associated with a weak tendency for increased mortality in girls (1.14 (0.70-1.89)) but significantly decreased mortality in boys (0.35 (0.18-0.71)). Conclusions: In our study OPV at birth had a sex-differential effect on mortality. Poliovirus is almost eradicated and OPV at birth contributes little to herd immunity. A randomised study of the effect of OPV at birth on overall mortality in both sexes is warranted.	[Ravn, Henrik] Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen, Denmark; [Fisker, Ane Baerent; Rodrigues, Amabelia; Aaby, Peter] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Immunoparasitol, NL-2300 RA Leiden, Netherlands; [Whittle, Hilton] MRC Labs, Fajara, Gambia	Statens Serum Institut; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MRC Laboratory Molecular Biology	Stabell, C (corresponding author), Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen, Denmark.	cb@ssi.dk	Yazdanbakhsh, Maria/AAI-3996-2020; Fisker, Ane B/E-9283-2019	Yazdanbakhsh, Maria/0000-0002-7666-1441; Fisker, Ane B/0000-0002-8521-0992; Aaby, Peter/0000-0001-8331-1389	EU [ICA4-CT-2002-10053]; Danish Medical Research Council; University of Copenhagen; March of Dimes; Ville Heise Foundation; DANIDA; Danish National Research Foundation; Novo Nordisk Foundation [research professorship]	EU(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen; March of Dimes(March of Dimes); Ville Heise Foundation; DANIDA; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The vitamin A trial was funded by the EU (ICA4-CT-2002-10053), The Danish Medical Research Council, University of Copenhagen, March of Dimes, and the Ville Heise Foundation. The Bandim Health Project received support from DANIDA and the Danish National Research Foundation. PA holds a research professorship grant from the Novo Nordisk Foundation. The sponsors had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Aaby P, 2005, VACCINE, V23, P1746, DOI 10.1016/j.vaccine.2004.02.054; Aaby P, 2004, VACCINE, V22, P3014, DOI 10.1016/j.vaccine.2004.02.009; Aaby P, 2004, INT J EPIDEMIOL, V33, P374, DOI 10.1093/ije/dyh005; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2002, VACCINE, V21, P15, DOI 10.1016/S0264-410X(02)00441-3; ANKER M, 1999, WHOCDSIRS994; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Cox D. R., 1984, ANAL SURVIVAL DATA; DASILVA ZJ, AIDS IN PRESS; *EXP PROGR IMM, 1985, WKLY EPIDEMIOL REC, V60, P13; Hull HF, 2001, AM J EPIDEMIOL, V153, P215, DOI 10.1093/aje/153.3.215; Khare Shashi, 1993, Indian Journal of Pediatrics, V60, P275, DOI 10.1007/BF02822191; Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584.5.2.277; WECKX LY, 1992, B WORLD HEALTH ORGAN, V70, P85; *WHO, IMM POL GLOB PROGR V	16	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4056	10.1371/journal.pone.0004056	http://dx.doi.org/10.1371/journal.pone.0004056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112511	Green Submitted, gold, Green Published			2022-12-27	WOS:000265466000016
J	Gilge, JL; Fisher, M; Chai, YC				Gilge, Jasen Lee; Fisher, Michael; Chai, Yuh-Cherng			The Effect of Oxidant and the Non-Oxidant Alteration of Cellular Thiol Concentration on the Formation of Protein Mixed-Disulfides in HEK 293 Cells	PLOS ONE			English	Article							S-GLUTATHIONYLATION; REDOX REGULATION; OXIDATION; CHROMATOGRAPHY; STRESS	Cellular molecules possess various mechanisms in responding to oxidant stress. In terms of protein responses, protein S-glutathionylation is a unique post-translational modification of protein reactive cysteines forming disulfides with glutathione molecules. This modification has been proposed to play roles in antioxidant, regulatory and signaling in cells under oxidant stress. Recently, the increased level of protein S-glutathionylation has been linked with the development of diseases. In this report, specific S-glutathionylated proteins were demonstrated in human embryonic kidney 293 cells treated with two different oxidative reagents: diamide and hydrogen peroxide. Diamide is a chemical oxidizing agent whereas hydrogen peroxide is a physiological oxidant. Under the experimental conditions, these two oxidants decreased glutathione concentration without toxicity. S-glutathionylated proteins were detected by immunoblotting and glutathione concentrations were determined by high performance liquid chromatography. We further show the effect of alteration of the cellular thiol pool on the amount of protein S-glutathionylation in oxidant-treated cells. Cellular thiol concentrations were altered either by a specific way using buthionine sulfoximine, a specific inhibitor of glutathione biosynthesis or by a non-specific way, incubating cells in cystine-methionine deficient media. Cells only treated with either buthionine sulfoximine or cystine-methionine deficient media did not induce protein S-glutathionylation, even though both conditions decreased 65% of cellular glutathione. Moreover, the amount of protein S-glutathionylation under both conditions in the presence of oxidants was not altered when compared to the amount observed in regular media with oxidants present. Protein S-glutathionylation is a dynamic reaction which depends on the rate of adding and removing glutathione. Phenylarsine oxide, which specifically forms a covalent adduct with vicinal thiols, was used to determine the possible role of vicinal thiols in the amount of glutathionylation. Our data shows phenylarsine oxide did not change glutathione concentrations, but it did enhance the amount of glutathionylation in oxidant-treated cells.	[Gilge, Jasen Lee; Fisher, Michael; Chai, Yuh-Cherng] John Carroll Univ, Dept Chem, University Hts, OH USA	John Carroll University	Gilge, JL (corresponding author), John Carroll Univ, Dept Chem, University Hts, OH USA.	ychai@jcu.edu			Cottrell College [CC 6143]; Research Corporation	Cottrell College; Research Corporation(Research Corporation for Science Advancement)	This work was financially supported by a Cottrell College Science Grant (CC 6143) from the Research Corporation to Y-C Chai. Jasen Gilge was supported by the same grant to Y-C Chai for an undergraduate student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ME, 1998, CHEM BIOL INTERACT; Anselmo Anthony N, 2004, Biochem J, V381, pe1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P264, DOI 10.1006/abbi.1994.1166; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Di Simplicio P, 2005, ANTIOXID REDOX SIGN, V7, P951; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; ISHII T, 2007, SUBCELL BIOCH, V44; KALEF E, 1993, ANAL BIOCHEM, V212, P325, DOI 10.1006/abio.1993.1337; KOSOWER NS, 1995, METHODS ENZYMOL, V251; Leonberg AK, 2007, MOL CELL BIOCHEM, V304, P207, DOI 10.1007/s11010-007-9501-y; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SIES H, 1991, OXIDATIVE STRESS, V2; Thomas JA, 2001, EXP GERONTOL, V36, P1519, DOI 10.1016/S0531-5565(01)00137-1; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; WANG J, 2001, J BIOL CHEM, V276; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	28	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4015	10.1371/journal.pone.0004015	http://dx.doi.org/10.1371/journal.pone.0004015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107210	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000010
J	Quintana, FJ; Mimran, A; Carmi, P; Mor, F; Cohen, IR				Quintana, Francisco J.; Mimran, Avishai; Carmi, Pnina; Mor, Felix; Cohen, Irun R.			HSP60 as a Target of Anti-Ergotypic Regulatory T Cells	PLOS ONE			English	Article							JUVENILE CHRONIC ARTHRITIS; HEAT-SHOCK PROTEINS; ADJUVANT ARTHRITIS; DNA VACCINATION; AUTOIMMUNE-DISEASE; GROWTH-FACTOR; HEAT-SHOCK-PROTEIN-60; INHIBITION; RESPONSES; RATS	The 60 kDa heat shock protein (HSP60) has been reported to influence T-cell responses in two ways: as a ligand of toll-like receptor 2 signalling and as an antigen. Here we describe a new mechanism of T-cell immuno-regulation focused on HSP60: HSP60 is up-regulated and presented by activated T cells ( HSP60 is an ergotope) to regulatory (anti-ergotypic) T cells. Presentation of HSP60 by activated T cells was found to be MHC-restricted and dependent on accessory molecules - CD28, CD80 and CD86. Anti-ergotypic T cells responded to T-cell HSP60 by proliferation and secreted IFN gamma and TGF beta 1. In vitro, the anti-ergotypic T cells inhibited IFN gamma production by their activated T-cell targets. In vivo, adoptive transfer of an anti-ergotypic HSP60-specific T-cell line led to decreased secretion of IFN gamma by arthritogenic T cells and ameliorated adjuvant arthritis ( AA). Thus, the presentation of HSP60 by activated T cells turns them into targets for anti-ergotypic regulatory T cells specific for HSP60. However, the direct interaction between the anti-ergotypic T regulators (anti-HSP60) and the activated T cells also down-regulated the regulators. Thus, by functioning as an ergotope, HSP60 can control both the effector T cells and the regulatory HSP60-specific T cells that control them.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Quintana, Francisco J.; Mimran, Avishai; Carmi, Pnina; Mor, Felix; Cohen, Irun R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA USA	Weizmann Institute of Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Quintana, FJ (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	fquintana@rics.bwh.harvard.edu	Mor, Felix/K-1093-2012; Quintana, Francisco Javier/AAB-6915-2020		Center for the Study of Emerging Diseases; EU	Center for the Study of Emerging Diseases; EU(European Commission)	This work was partially supported by grants from the Center for the Study of Emerging Diseases and by the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERTON SM, 1994, J IMMUNOL, V152, P3656; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Chen GJ, 2007, ARTHRITIS RHEUM-US, V56, P453, DOI 10.1002/art.22316; Cohen I. R., 2000, TENDING ADAMS GARDEN; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; Cohen IR, 2003, PROG INFLAM RES, P1; Cohen IR, 2001, VACCINE, V20, P706, DOI 10.1016/S0264-410X(01)00419-4; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; Correale J, 1997, J NEUROIMMUNOL, V80, P47, DOI 10.1016/S0926-9851(97)00020-7; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1995, J CLIN INVEST, V95, P934, DOI 10.1172/JCI117801; Delaleu N, 2008, ARTHRITIS RHEUM-US, V58, P2318, DOI 10.1002/art.23656; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Elias D, 1997, DIABETES, V46, P758, DOI 10.2337/diabetes.46.5.758; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; Elias D, 1996, DIABETES, V45, P1168, DOI 10.2337/diabetes.45.9.1168; FERRIS DK, 1988, P NATL ACAD SCI USA, V85, P3850, DOI 10.1073/pnas.85.11.3850; Hakamada-Taguchi R, 1998, EUR J IMMUNOL, V28, P865, DOI 10.1002/(SICI)1521-4141(199803)28:03<865::AID-IMMU865>3.0.CO;2-T; HOLOSHITZ J, 1984, J CLIN INVEST, V73, P211, DOI 10.1172/JCI111193; Hong J, 2006, P NATL ACAD SCI USA, V103, P5024, DOI 10.1073/pnas.0508784103; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; LOHSE AW, 1989, SCIENCE, V244, P820, DOI 10.1126/science.2471264; LOPEZGUERRERO JA, 1993, INFECT IMMUN, V61, P4225; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Mimran A, 2005, INT REV IMMUNOL, V24, P159, DOI 10.1080/08830180590934949; Mimran A, 2005, J AUTOIMMUN, V24, P191, DOI 10.1016/j.jaut.2004.12.002; Mimran A, 2004, J CLIN INVEST, V113, P924, DOI 10.1172/JCI200417772; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Mor F, 1996, J IMMUNOL, V157, P4855; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Prakken ABJ, 1997, IMMUNOL LETT, V57, P139, DOI 10.1016/S0165-2478(97)00090-4; Prakken ABJ, 1996, ARTHRITIS RHEUM-US, V39, P1826, DOI 10.1002/art.1780391108; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Quintana FJ, 2004, ARTHRITIS RHEUM-US, V50, P3712, DOI 10.1002/art.20635; Quintana FJ, 2003, J IMMUNOL, V171, P3533, DOI 10.4049/jimmunol.171.7.3533; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Quintana FJ, 2002, J IMMUNOL, V169, P6030, DOI 10.4049/jimmunol.169.10.6030; Quintana FJ, 2002, J IMMUNOL, V169, P3422, DOI 10.4049/jimmunol.169.6.3422; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Ragno S, 1997, ARTHRITIS RHEUM-US, V40, P277, DOI 10.1002/art.1780400212; Ramage JM, 1999, J IMMUNOL, V162, P704; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Reizis B, 1996, INT IMMUNOL, V8, P1825, DOI 10.1093/intimm/8.12.1825; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stinissen P, 1998, J NEUROIMMUNOL, V87, P94, DOI 10.1016/S0165-5728(98)00060-5; Strawbridge AB, 2007, CURR OPIN IMMUNOL, V19, P87, DOI 10.1016/j.coi.2006.11.009; Taams LS, 1999, EUR J IMMUNOL, V29, P1543, DOI 10.1002/(SICI)1521-4141(199905)29:05<1543::AID-IMMU1543>3.0.CO;2-R; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Zang YCQ, 2000, EUR J IMMUNOL, V30, P908, DOI 10.1002/1521-4141(200003)30:3<908::AID-IMMU908>3.0.CO;2-1; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; ZHANG JW, 1993, SCIENCE, V261, P1451, DOI 10.1126/science.7690157	64	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4026	10.1371/journal.pone.0004026	http://dx.doi.org/10.1371/journal.pone.0004026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107191	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000020
J	Swoap, SJ; Weinshenker, D				Swoap, Steven J.; Weinshenker, David			Norepinephrine Controls Both Torpor Initiation and Emergence via Distinct Mechanisms in the Mouse	PLOS ONE			English	Article								Some mammals, including laboratory mice, enter torpor in response to food deprivation, and leptin can attenuate these bouts of torpor. We previously showed that dopamine beta-hydroxylase knockout (Dbh -/-) mice, which lack norepinephrine (NE), do not reduce circulating leptin upon fasting nor do they enter torpor. To test whether the onset of torpor in mice during a fast requires a NE-mediated reduction in circulating leptin, double mutant mice deficient in both leptin (ob/ob) and DBH (DBL MUT) were generated. Upon fasting, control and ob/ob mice entered torpor as assessed by telemetric core T(b) acquisition. While fasting failed to induce torpor in Dbh -/- mice, leptin deficiency bypassed the requirement for NE, as DBL MUT mice readily entered torpor upon fasting. These data indicate that sympathetic activation of white fat and suppression of leptin is required for the onset of torpor in the mouse. Emergence from torpor was severely retarded in DBL MUT mice, revealing a novel, leptin-independent role for NE in torpor recovery. This phenotype was mimicked by administration of a beta 3 adrenergic receptor antagonist to control mice during a torpor bout. Hence, NE signaling via b3 adrenergic receptors presumably in brown fat is the first neurotransmitter-receptor system identified that is required for normal recovery from torpor.	Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Weinshenker, David] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Williams College; Emory University	Swoap, SJ (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	sswoap@williams.edu	Weinshenker, David/V-3998-2019		NIH [R15 HL081101-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL081101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R15 HL081101-01 (to SJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bouthegourd JC, 2004, APPETITE, V42, P91, DOI 10.1016/j.appet.2003.07.003; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; COLEMAN DL, 1982, DIABETOLOGIA, V22, P205, DOI 10.1007/BF00283754; Doring H, 1998, INT J OBESITY, V22, P83, DOI 10.1038/sj.ijo.0800547; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Geiser F, 1998, AM J PHYSIOL-REG I, V275, pR1627, DOI 10.1152/ajpregu.1998.275.5.R1627; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gluck EF, 2006, AM J PHYSIOL-REG I, V291, pR1303, DOI 10.1152/ajpregu.00232.2006; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; HAYWARD JS, 1992, CAN J ZOOL, V70, P171, DOI 10.1139/z92-025; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; HIMMSHAGEN J, 1985, AM J PHYSIOL, V248, pE531, DOI 10.1152/ajpendo.1985.248.5.E531; HOGAN S, 1980, AM J PHYSIOL-ENDOC M, V239, pR301; HORWITZ BA, 1985, AM J PHYSIOL, V249, pR689, DOI 10.1152/ajpregu.1985.249.6.R689; HUDSON JW, 1979, PHYSIOL ZOOL, V52, P205, DOI 10.1086/physzool.52.2.30152564; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909; MORY G, 1984, FEBS LETT, V166, P393, DOI 10.1016/0014-5793(84)80120-9; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; NIZIELSKI SE, 1989, AM J PHYSIOL, V257, pR536, DOI 10.1152/ajpregu.1989.257.3.R536; Rasmussen AT, 1923, J MORPHOL, V38, P147, DOI 10.1002/jmor.1050380106; Rayner DV, 2001, P NUTR SOC, V60, P357, DOI 10.1079/PNS2001101; Sato M, 2007, MOL PHARMACOL, V72, P1359, DOI 10.1124/mol.107.035337; SEYDOUX J, 1982, ENDOCRINOLOGY, V110, P432, DOI 10.1210/endo-110-2-432; SMITH RE, 1963, SCIENCE, V140, P199, DOI 10.1126/science.140.3563.199; Swoap SJ, 2006, J NEUROSCI, V26, P241, DOI 10.1523/JNEUROSCI.3721-05.2006; Thomas SA, 1998, J NEUROCHEM, V70, P2468; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049	35	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4038	10.1371/journal.pone.0004038	http://dx.doi.org/10.1371/journal.pone.0004038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107190	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000027
J	Wu, MM; Sato, TN				Wu, Mingming; Sato, Thomas N.			On the Mechanics of Cardiac Function of Drosophila Embryo	PLOS ONE			English	Article								The heart is a vital organ that provides essential circulation throughout the body. Malfunction of cardiac pumping, thus, leads to serious and most of the times, to fatal diseases. Mechanics of cardiac pumping is a complex process, and many experimental and theoretical approaches have been undertaken to understand this process. We have taken advantage of the simplicity of the embryonic heart of an invertebrate, Drosophila melanogaster, to understand the fundamental mechanics of the beating heart. We applied a live imaging technique to the beating embryonic heart combined with analytical imaging tools to study the dynamic mechanics of the pumping. Furthermore, we have identified one mutant line that exhibits aberrant pumping mechanics. The Drosophila embryonic heart consists of only 104 cardiac cells forming a simple straight tube that can be easily accessed for real-time imaging. Therefore, combined with the wealth of available genetic tools, the embryonic Drosophila heart may serve as a powerful model system for studies of human heart diseases, such as arrhythmia and congenital heart diseases. We, furthermore, believe our mechanistic data provides important information that is useful for our further understanding of the design of biological structure and function and for engineering the pumps for medical uses.	Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Wu, Mingming] Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY 14853 USA; [Sato, Thomas N.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Wu, MM (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	island1005@aol.com	wu, mingming/GXN-1864-2022		Joseph C. Hinsey Chair, National Science Foundation [CBET-0619626]	Joseph C. Hinsey Chair, National Science Foundation(National Science Foundation (NSF))	Joseph C. Hinsey Chair, National Science Foundation (CBET-0619626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Dulcis D, 2003, J COMP NEUROL, V465, P560, DOI 10.1002/cne.10869; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; FISHMAN MC, 1994, CIRC RES, V74, P757, DOI 10.1161/01.RES.74.5.757; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Glass L, 1991, THEORY HEART BIOMECH; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Helenius IT, 2008, J CELL BIOL, V182, P221, DOI 10.1083/jcb.200806186; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Karma A, 2007, PHYS TODAY, V60, P51, DOI 10.1063/1.2718757; Krasnow NA, 1997, COLD SPRING HARB SYM, V62, P235; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; POULSON EF, 1950, BIOL DROSOPHILA, P168; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Rubin GM, 1996, GENOME RES, V6, P71, DOI 10.1101/gr.6.2.71; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Wang JB, 2005, MOL CELL BIOL, V25, P4200, DOI 10.1128/MCB.25.10.4200-4210.2005; Warren KS, 2000, PHILOS T R SOC B, V355, P939, DOI 10.1098/rstb.2000.0629	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4045	10.1371/journal.pone.0004045	http://dx.doi.org/10.1371/journal.pone.0004045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107195	Green Published, gold, Green Submitted			2022-12-27	WOS:000265463000031
J	Byakika-Tusiime, J; Chinn, LW; Oyugi, JH; Obua, C; Bangsberg, DR; Kroetz, DL				Byakika-Tusiime, Jayne; Chinn, Leslie W.; Oyugi, Jessica H.; Obua, Celestino; Bangsberg, David R.; Kroetz, Deanna L.			Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-Infected Ugandan Adults	PLOS ONE			English	Article								Background: Generic antiretroviral therapy is the mainstay of HIV treatment in resource-limited settings, yet there is little evidence confirming the bioequivalence of generic and brand name formulations. We compared the steady-state pharmacokinetics of lamivudine, stavudine and nevirapine in HIV-infected subjects who were receiving a generic formulation (Triomune (R)) or the corresponding brand formulations (Epivir (R), Zerit (R), and Viramune (R)). Methodology/Principal Findings: An open-label, randomized, crossover study was carried out in 18 HIV-infected Ugandan subjects stabilized on Triomune-40. Subjects received lamivudine (150 mg), stavudine (40 mg), and nevirapine (200 mg) in either the generic or brand formulation twice a day for 30 days, before switching to the other formulation. At the end of each treatment period, blood samples were collected over 12 h for pharmacokinetic analysis. The main outcome measures were the mean AUC(0-12h) and C(max). Bioequivalence was defined as a geometric mean ratio between the generic and brand name within the 90% confidence interval of 0.8-1.25. The geometric mean ratios and the 90% confidence intervals were: stavudine C(max), 1.3 (0.99-1.71) and AUC(0-12h), 1.1 (0.87-1.38); lamivudine C(max), 0.8 (0.63-0.98) and AUC(0-12h), 0.8 (0.65-0.99); and nevirapine C(max), 1.1 (0.95-1.23) and AUC(0-12h), 1.1 (0.95-1.31). The generic formulation was not statistically bioequivalent to the brand formulations during steady state, although exposures were comparable. A mixed random effects model identified about 50% intersubject variability in the pharmacokinetic parameters. Conclusions/Significant Findings: These findings provide support for the use of Triomune in resource-limited settings, identification of the sources of intersubject variability in these populations is critical.	Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Chinn, Leslie W.; Kroetz, Deanna L.] Univ Calif San Francisco, Dept Biopharm Sci, San Francisco, CA 94143 USA; [Oyugi, Jessica H.] Makerere Univ, Fac Med, Infect Dis Inst, Kampala, Uganda; [Obua, Celestino] Makerere Univ, Dept Pharmacol & Therapeut, Kampala, Uganda; [Bangsberg, David R.] Harvard Univ, Sch Med, Mass Gen Hosp, Harvard Initiative Glob Hlth, Boston, MA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Makerere University; Makerere University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Byakika-Tusiime, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	deanna.kroetz@ucsf.edu		Obua, Celestino/0000-0001-6949-3059; Chinn, Leslie/0000-0003-3127-6758	AIDS Care and Research in Africa (ACRiA); Doris Duke Charitable Foundation; NIH [GM61390, AA014784, MH54907, AA015287]; Amgen [Fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA015287, R21AA014784] Funding Source: NIH RePORTER	AIDS Care and Research in Africa (ACRiA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by the AIDS Care and Research in Africa (ACRiA) grant, supported by the Doris Duke Charitable Foundation (JB-T) and by NIH grants GM61390 (DLK), AA014784 (DRB), MH54907 (DRB)and AA015287 (DRB). LWC was funded by an Amgen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2006, JAIDS-J ACQ IMM DEF, V42, P441, DOI 10.1097/01.qai.0000225013.53568.69; HAVLIR D, 1995, J INFECT DIS, V171, P537, DOI 10.1093/infdis/171.3.537; Hosseinipour MC, 2007, AIDS, V21, P59, DOI 10.1097/QAD.0b013e3280117ca0; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Mistri HN, 2007, J CHROMATOGR B, V853, P320, DOI 10.1016/j.jchromb.2007.03.047; Narang VS, 2005, J CLIN PHARMACOL, V45, P265, DOI 10.1177/0091270004273343; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Penzak SR, 2007, HIV MED, V8, P86, DOI 10.1111/j.1468-1293.2007.00432.x; Saitoh A, 2007, AIDS, V21, P2191, DOI 10.1097/QAD.0b013e3282ef9695; von Hentig N, 2006, BRIT J CLIN PHARMACO, V62, P552, DOI 10.1111/j.1365-2125.2006.02664.x; *WHO GUID DEV GROU, 2007, IMP ADD 2006 WHO GUI; Wyen C, 2008, J ANTIMICROB CHEMOTH, V61, P914, DOI 10.1093/jac/dkn029; Yuen GJ, 2001, J CLIN PHARMACOL, V41, P277, DOI 10.1177/00912700122010096; Zhang JF, 2003, J EVOL ECON, V13, P529, DOI 10.1007/s00191-003-0178-4	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3981	10.1371/journal.pone.0003981	http://dx.doi.org/10.1371/journal.pone.0003981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096711	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458800004
J	Szendroedi, J; Zwettler, E; Schmid, AI; Chmelik, M; Pacini, G; Kacerovsky, G; Smekal, G; Nowotny, P; Wagner, O; Schnack, C; Schernthaner, G; Klaushofer, K; Roden, M				Szendroedi, Julia; Zwettler, Elisabeth; Schmid, Albrecht Ingo; Chmelik, Marek; Pacini, Giovanni; Kacerovsky, Gertrud; Smekal, Gerhard; Nowotny, Peter; Wagner, Oswald; Schnack, Christoph; Schernthaner, Guntram; Klaushofer, Klaus; Roden, Michael			Reduced Basal ATP Synthetic Flux of Skeletal Muscle in Patients with Previous Acromegaly	PLOS ONE			English	Article							FREE FATTY-ACIDS; BETA-CELL FUNCTION; GROWTH-HORMONE; INSULIN SENSITIVITY; PROTEIN-METABOLISM; DIABETES-MELLITUS; GLUCOSE; PATHOGENESIS; RESISTANCE; DYSFUNCTION	Background: Impaired mitochondrial function and ectopic lipid deposition in skeletal muscle and liver have been linked to decreased insulin sensitivity. As growth hormone (GH) excess can reduce insulin sensitivity, we examined the impact of previous acromegaly (AM) on glucose metabolism, lipid storage and muscular ATP turnover. Participants and Methods: Seven AM (4f/3 m, age: 46+/-4 years, BMI: 28+/-1 kg/m(2)) and healthy volunteers (CON: 3f/4 m, 43+/-4 years, 26+/-2 kg/m(2)) matched for age and body mass underwent oral glucose testing for assessment of insulin sensitivity (OGIS) and beta-cell function (adaptation index, ADAP). Whole body oxidative capacity was measured with indirect calorimetry and spiroergometry. Unidirectional ATP synthetic flux (fATP) was assessed from P-31 magnetic resonance spectroscopy (MRS) of calf muscle. Lipid contents of tibialis anterior (IMCLt) and soleus muscles (IMCLs) and liver (HCL) were measured with H-1 MRS. Results: Despite comparable GH, insulin-like growth factor-1 (IGF-I) and insulin sensitivity, AM had similar to 85% lower ADAP (p<0.01) and similar to 21% reduced VO(2)max (p<0.05). fATP was similarly, similar to 25% lower in AM (p<0.05) and related positively to ADAP (r = 0.744, p<0.01), but negatively to BMI (r = -0.582, p<0.05). AM had similar to 3fold higher HCL (p<0.05) while IMCLt and IMCLs did not differ between the groups. Conclusions: Humans with a history of acromegaly exhibit reduced insulin secretion, muscular ATP synthesis and oxidative capacity but elevated liver fat content. This suggests that alterations in beta-cell function and myocellular ATP production may persist despite normalization of GH secretion after successful treatment of acromegaly.	[Szendroedi, Julia; Kacerovsky, Gertrud; Roden, Michael] Hanusch Hosp, Dept Med 1, Vienna, Austria; [Szendroedi, Julia; Roden, Michael] Leibniz Ctr Diabetes Res, German Diabetes Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Zwettler, Elisabeth; Klaushofer, Klaus] Hanusch Hosp, Dept Med 4, Vienna, Austria; [Zwettler, Elisabeth; Klaushofer, Klaus] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Schmid, Albrecht Ingo; Chmelik, Marek] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria; [Pacini, Giovanni] CNR, Padua, Italy; [Smekal, Gerhard] Univ Vienna, Inst Sports Sci, Dept Sport Physiol, Vienna, Austria; [Nowotny, Peter] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Wagner, Oswald] Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria; [Schnack, Christoph; Schernthaner, Guntram] Rudolfstiftung Hosp, Dept Med 1, Vienna, Austria; [Roden, Michael] Heinrich Heine Univ Dusseldorf, Dept Med Metabol Dis, Dusseldorf, Germany; [Szendroedi, Julia; Schmid, Albrecht Ingo; Chmelik, Marek; Kacerovsky, Gertrud; Roden, Michael] Hanusch Hosp, Karl Landsteiner Inst Endocrinol & Metabolism, Vienna, Austria	WGKK - Hanusch Hospital; Deutsches Diabetes-Zentrum (DDZ); WGKK - Hanusch Hospital; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); University of Vienna; Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital; Heinrich Heine University Dusseldorf; WGKK - Hanusch Hospital	Szendroedi, J (corresponding author), Hanusch Hosp, Dept Med 1, Vienna, Austria.	michael.roden@ddz.uni-duesseldorf.de	Chmelik, Marek/AAR-3911-2020; Roden, Michael/AAD-3843-2019	Schmid, Albrecht Ingo/0000-0002-5196-151X; Chmelik, Marek/0000-0002-9727-9014	European Foundation for the Study of Diabetes; Austrian Science Foundation [P15656]; Austrian National Bank [OENB 11459]; Hochschuljubilaumsstiftung Vienna; Novo Nordisk; Baxter	European Foundation for the Study of Diabetes; Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian National Bank; Hochschuljubilaumsstiftung Vienna; Novo Nordisk(Novo Nordisk); Baxter	This study was supported by grants from the European Foundation for the Study of Diabetes (EFSD, Novo Nordisk Type 2 Diabetes Grant), Austrian Science Foundation (P15656), Austrian National Bank (OENB 11459), Hochschuljubilaumsstiftung Vienna and unrestricted grants by Novo Nordisk and Baxter to M.R.. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahren B, 2004, EUR J ENDOCRINOL, V150, P97, DOI 10.1530/eje.0.1500097; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Battezzati A, 2003, AM J PHYSIOL-ENDOC M, V284, pE823, DOI 10.1152/ajpendo.00020.2002; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Brehm A, 2006, DIABETES, V55, P136, DOI 10.2337/diabetes.55.1.136; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; CHEAH JS, 1975, AM J MED SCI, V269, P183, DOI 10.1097/00000441-197503000-00003; Clemmons David Robert, 2002, Pituitary, V5, P181, DOI 10.1023/A:1023321421760; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Costa C, 1998, FASEB J, V12, P1455, DOI 10.1096/fasebj.12.14.1455; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; De P, 2003, J CLIN ENDOCR METAB, V88, P3567, DOI 10.1210/jc.2002-021822; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; FOSS MC, 1991, J CLIN ENDOCR METAB, V72, P1048, DOI 10.1210/jcem-72-5-1048; HANSEN I, 1986, AM J PHYSIOL, V250, pE269, DOI 10.1152/ajpendo.1986.250.3.E269; Holdaway IM, 2004, J CLIN ENDOCR METAB, V89, P667, DOI 10.1210/jc.2003-031199; Kasayama S, 2000, CLIN ENDOCRINOL, V52, P549, DOI 10.1046/j.1365-2265.2000.00986.x; Kauppinen-Makelin R, 2005, J CLIN ENDOCR METAB, V90, P4081, DOI 10.1210/jc.2004-1381; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kemp GJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE640, DOI 10.1152/ajpendo.00797.2007; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Krebs M, 2001, J CLIN ENDOCR METAB, V86, P2153, DOI 10.1210/jc.86.5.2153; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Lange KHW, 2000, AM J PHYSIOL-ENDOC M, V279, pE989, DOI 10.1152/ajpendo.2000.279.5.E989; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Meyer T, 2004, BRIT J SPORT MED, V38, P622, DOI 10.1136/bjsm.2003.007815; MILNER EA, 1993, JPEN-PARENTER ENTER, V17, P414, DOI 10.1177/0148607193017005414; MOLLER N, 1992, J CLIN ENDOCR METAB, V74, P1012, DOI 10.1210/jc.74.5.1012; Moller N, 2003, HORM RES, V59, P62, DOI 10.1159/000067827; MOLLER N, 1991, HORM RES, V36, P32, DOI 10.1159/000182185; OSULLIVAN AJ, 1995, J CLIN ENDOCR METAB, V80, P486, DOI 10.1210/jc.80.2.486; Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; REES D, 1989, MAGNET RESON MED, V9, P39, DOI 10.1002/mrm.1910090107; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102; Roden M, 1999, DIABETES, V48, P358, DOI 10.2337/diabetes.48.2.358; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; SHORT KR, 2007, J CLIN ENDOCRINOL ME; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; UGURBIL K, 1986, BIOCHEMISTRY-US, V25, P100, DOI 10.1021/bi00349a015; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Wasada T, 1997, ENDOCR J, V44, P617, DOI 10.1507/endocrj.44.617; ZIERLER KL, 1963, MEDICINE, V42, P385, DOI 10.1097/00005792-196311000-00002	54	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3958	10.1371/journal.pone.0003958	http://dx.doi.org/10.1371/journal.pone.0003958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093000	Green Submitted, gold, Green Published			2022-12-27	WOS:000265458600003
J	Stiefel, KM; Gutkin, BS; Sejnowski, TJ				Stiefel, Klaus M.; Gutkin, Boris S.; Sejnowski, Terrence J.			Cholinergic Neuromodulation Changes Phase Response Curve Shape and Type in Cortical Pyramidal Neurons	PLOS ONE			English	Article								Spike generation in cortical neurons depends on the interplay between diverse intrinsic conductances. The phase response curve (PRC) is a measure of the spike time shift caused by perturbations of the membrane potential as a function of the phase of the spike cycle of a neuron. Near the rheobase, purely positive (type I) phase-response curves are associated with an onset of repetitive firing through a saddle-node bifurcation, whereas biphasic (type II) phase-response curves point towards a transition based on a Hopf-Andronov bifurcation. In recordings from layer 2/3 pyramidal neurons in cortical slices, cholinergic action, consistent with down-regulation of slow voltage-dependent potassium currents such as the M-current, switched the PRC from type II to type I. This is the first report showing that cholinergic neuromodulation may cause a qualitative switch in the PRCs type implying a change in the fundamental dynamical mechanism of spike generation.	[Stiefel, Klaus M.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA USA; [Gutkin, Boris S.] CNRS, Coll France, ENS, DEC, Grp Neural Theory, Paris, France; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); University of California System; University of California San Diego	Stiefel, KM (corresponding author), Okinawa Inst Sci & Technol, Theoret & Expt Neurobiol Unit, Okinawa, Japan.	Boris.Gutkin@ens.fr	Gutkin, Boris/A-7420-2014; Gutkin, Boris/ABC-5754-2020; Sejnowski, Terrence/AAV-5558-2021	Gutkin, Boris/0000-0001-6409-979X; 	Deutsche Forschungsgemeinschaft; Gatsby Foundation; CNRS; College de France; MEXT "BIND"; Howard Hughes Medical Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gatsby Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); College de France; MEXT "BIND"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Deutsche Forschungsgemeinschaft (K.M.S.), the Gatsby Foundation, CNRS, College de France and MEXT "BIND" (B.S.G.) and the Howard Hughes Medical Institute (T.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout GB, 1996, NEURAL COMPUT, V8, P979, DOI DOI 10.1162/NECO.1996.8.5.979; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; MCCORMICK DA, 1993, PROG BRAIN RES, V98, P303; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Schobesberger H, 2000, J NEUROPHYSIOL, V83, P1912, DOI 10.1152/jn.2000.83.4.1912; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Stiefel KM, 2005, EUR J NEUROSCI, V21, P2605, DOI 10.1111/j.1460-9568.2005.04094.x; STIEFEL KM, 2008, J COMPUT NEUROSCI; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x	23	89	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3947	10.1371/journal.pone.0003947	http://dx.doi.org/10.1371/journal.pone.0003947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079601	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458400006
J	Mace, C; Seyer, D; Chemani, C; Cosette, P; Di-Martino, P; Guery, B; Filloux, A; Fontaine, M; Molle, V; Junter, GA; Jouenne, T				Mace, Camille; Seyer, Damien; Chemani, Chanez; Cosette, Pascal; Di-Martino, Patrick; Guery, Benoit; Filloux, Alain; Fontaine, Marc; Molle, Virginie; Junter, Guy-Alain; Jouenne, Thierry			Identification of Biofilm-Associated Cluster (bac) in Pseudomonas aeruginosa Involved in Biofilm Formation and Virulence	PLOS ONE			English	Article								Biofilms are prevalent in diseases caused by Pseudomonas aeruginosa, an opportunistic and nosocomial pathogen. By a proteomic approach, we previously identified a hypothetical protein of P. aeruginosa (coded by the gene pA3731) that was accumulated by biofilm cells. We report here that a Delta pA3731 mutant is highly biofilm-defective as compared with the wildtype strain. Using a mouse model of lung infection, we show that the mutation also induces a defect in bacterial growth during the acute phase of infection and an attenuation of the virulence. The pA3731 gene is found to control positively the ability to swarm and to produce extracellular rhamnolipids, and belongs to a cluster of 4 genes (pA3729-pA3732) not previously described in P. aeruginosa. Though the protein PA3731 has a predicted secondary structure similar to that of the Phage Shock Protein, some obvious differences are observed compared to already described psp systems, e. g., this unknown cluster is monocistronic and no homology is found between the other proteins constituting this locus and psp proteins. As E. coli PspA, the amount of the protein PA3731 is enlarged by an osmotic shock, however, not affected by a heat shock. We consequently named this locus bac for biofilm-associated cluster.	[Cosette, Pascal; Junter, Guy-Alain; Jouenne, Thierry] Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Plate Forme Prote IFRMP 23,FRE 3101, Mont St Aignan, France; [Seyer, Damien; Di-Martino, Patrick] Univ Cergy Pontoise, Lab ERRMECe, EA1391, Pontoise, France; [Chemani, Chanez; Guery, Benoit] Univ Lille 2, Lab Detresses Resp Circulat Physiopathol, Mecan, F-59800 Lille, France; [Filloux, Alain] Imperial Coll London, Fac Nat Sci, Ctr Mol Microbiol & Infect, London, England; [Fontaine, Marc] Univ Rouen, EA 4130, F-76821 Mont St Aignan, France; [Molle, Virginie] Inst Biol Chim Proteines, CNRS, UMR 5086, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie; CY Cergy Paris Universite; Universite de Lille - ISITE; Universite de Lille; Imperial College London; Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mace, C (corresponding author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Plate Forme Prote IFRMP 23,FRE 3101, Mont St Aignan, France.	thierry.jouenne@univ-rouen.fr	Guery, Benoit/D-8089-2017; Guery, Benoit/AAP-2046-2021; MOLLE, Virginie/D-4050-2019	Guery, Benoit/0000-0002-6526-0714; MOLLE, Virginie/0000-0002-6573-3411; jouenne, thierry/0000-0003-0994-9944; Cosette, Pascal/0000-0002-7588-0167; Seyer, Damien/0000-0001-7510-0573; DI MARTINO, Patrick/0000-0001-5450-2733	French Cystic Fibrosis Foundation; French Research and Technology Ministry	French Cystic Fibrosis Foundation; French Research and Technology Ministry	The authors thank the French Cystic Fibrosis Foundation (VLM) for its financial support. CM is supported by the French Research and Technology Ministry.	Bailey J, 2002, NAT BIOTECHNOL, V20, P839, DOI 10.1038/nbt715; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Chandrasekaran EV, 1980, METHODS CARBOHYDRATE, P89; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; Darwin AJ, 2001, MOL MICROBIOL, V39, P429, DOI 10.1046/j.1365-2958.2001.02235.x; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Di Martino P, 2002, MICROBES INFECT, V4, P613, DOI 10.1016/S1286-4579(02)01579-4; Dworkin J, 2000, J BACTERIOL, V182, P311, DOI 10.1128/JB.182.2.311-319.2000; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Green RC, 2004, J BACTERIOL, V186, P4910, DOI 10.1128/JB.186.15.4910-4920.2004; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; KOCH A, 1991, J BACTERIOL, V17, P4212; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Robriquet L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-41; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sharma M, 2002, CURR SCI INDIA, V83, P707; Thompson LS, 2003, FEMS MICROBIOL LETT, V220, P187, DOI 10.1016/S0378-1097(03)00097-1; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	35	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3897	10.1371/journal.pone.0003897	http://dx.doi.org/10.1371/journal.pone.0003897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065261	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455200010
J	Zeng, YA; Rahnama, M; Wang, S; Lee, W; Verheyen, EM				Zeng, Yi Arial; Rahnama, Maryam; Wang, Simon; Lee, Wendy; Verheyen, Esther M.			Inhibition of Drosophila Wg Signaling Involves Competition between Mad and Armadillo/beta-Catenin for dTcf Binding	PLOS ONE			English	Article								Precisely regulated signal transduction pathways are crucial for the regulation of developmental events and prevention of tumorigenesis. Both the Transforming Growth Factor beta (TGF beta)/Bone morphogenetic protein (BMP) and Wnt/Wingless (Wg) pathways play essential roles in organismal patterning and growth, and their deregulation can lead to cancers. We describe a mechanism of interaction between Drosophila Wg and BMP signaling in which Wg target gene expression is antagonized by BMP signaling. In vivo, high levels of both an activated BMP receptor and the BMP effector Mad can inhibit the expression of Wg target genes. Conversely, loss of mad can induce Wg target gene expression. In addition, we find that ectopic expression in vivo of the Wg transcription factor dTcf is able to suppress the inhibitory effect caused by ectopic Mad. In vitro binding studies revealed competition for dTcf binding between Mad and the Wnt effector beta-catenin/Armadillo (Arm). Our in vivo genetic analyses and target gene studies support a mechanism consistent with the in vitro binding and competition studies, namely that BMP pathway components can repress Wg target gene expression by influencing the binding of Arm and dTcf.	[Zeng, Yi Arial; Rahnama, Maryam; Wang, Simon; Lee, Wendy; Verheyen, Esther M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Zeng, YA (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	everheye@sfu.ca		Verheyen, Esther/0000-0002-9795-5094; Wang, Simon/0000-0003-0624-5482; Lee, Wendy/0000-0002-8807-0550	MacMillan-Bloedel Graduate Scholarship; CIHR [Doctoral Research Award]	MacMillan-Bloedel Graduate Scholarship; CIHR(Canadian Institutes of Health Research (CIHR))	Y.A.Z. was supported by a MacMillan-Bloedel Graduate Scholarship. M. R. is supported by a CIHR Doctoral Research Award. This work was supported by an operating grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Campbell G, 1998, DEVELOPMENT, V125, P4483; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COUSO JP, 1994, DEVELOPMENT, V120, P621; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Glise B, 2002, DEV BIOL, V248, P93, DOI 10.1006/dbio.2002.0720; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Ito K, 1997, DEVELOPMENT, V124, P761; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Lim SK, 2006, P NATL ACAD SCI USA, V103, P18580, DOI 10.1073/pnas.0604773103; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morimura S, 1996, DEV BIOL, V177, P136, DOI 10.1006/dbio.1996.0151; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Newfeld SJ, 2002, GENETICS, V161, P685; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parker DS, 2002, DEVELOPMENT, V129, P2565; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TAKAESU NT, 2005, DEVELOPMENT; Theil T, 2002, DEVELOPMENT, V129, P3045; Theisen H, 1996, DEVELOPMENT, V122, P3939; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Willert K, 1999, DEVELOPMENT, V126, P4165; Yang X, 2000, DEVELOPMENT, V127, P3695; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 1996, DEVELOPMENT, V122, P849; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zhang J, 1998, DEVELOPMENT, V125, P3075	52	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3893	10.1371/journal.pone.0003893	http://dx.doi.org/10.1371/journal.pone.0003893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065265	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455200008
J	Young, ME; Norman, GR; Humphreys, KR				Young, Meredith E.; Norman, Geoffrey R.; Humphreys, Karin R.			The Role of Medical Language in Changing Public Perceptions of Illness	PLOS ONE			English	Article							FEMALE SEXUAL DYSFUNCTION; DISEASE; DEFINITIONS; NONDISEASE; JUDGMENTS; IMPACT	This study was designed to investigate the impact of medical terminology on perceptions of disease. Specifically, we look at the changing public perceptions of newly medicalized disorders with accompanying newly medicalized terms (e. g. impotence has become erectile dysfunction disorder). Does using "medicalese'' to label a recently medicalized disorder lead to a change in the perception of that condition? Undergraduate students (n = 52) rated either the medical or lay label for recently medicalized disorders (such as erectile dysfunction disorder vs. impotence) and established medical conditions (such as a myocardial infarction vs. heart attack) for their perceived seriousness, disease representativeness and prevalence. Students considered the medical label of the recently medicalized disease to be more serious (mean = 4.95 (SE = .27) vs. mean = 3.77 (SE = .24) on a ten point scale), more representative of a disease (mean = 2.47 (SE = .09) vs. mean = 1.83 (SE = .09) on a four point scale), and have lower prevalence (mean = 68 (SE = 12.6) vs. mean = 122 (SE = 18.1) out of 1,000) than the same disease described using common language. A similar pattern was not seen in the established medical conditions, even when controlled for severity. This study demonstrates that the use of medical language in communication can induce bias in perception; a simple switch in terminology results in a disease being perceived as more serious, more likely to be a disease, and more likely to be a rare condition. These findings regarding the conceptualization of disease have implications for many areas, including medical communication with the public, advertising, and public policy.	[Humphreys, Karin R.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Norman, Geoffrey R.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Young, ME (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	youngme2@mcmaster.ca			Natural Science and Engineering Research Council (NSERC) of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was conducted with the assistance from the Natural Science and Engineering Research Council (NSERC) of Canada to the second and third authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACESAVILA FS, 2004, BEST PRACT RES CLIN, V18, P155; Applbaum K, 2006, PLOS MED, V3, P445, DOI 10.1371/journal.pmed.0030189; CAMPBELL EJM, 1979, BMJ-BRIT MED J, V2, P757, DOI 10.1136/bmj.2.6193.757; Chan DJ, 2005, INT J STD AIDS, V16, P91, DOI 10.1258/0956462053057657; Cooper Y, 2008, INT J NUMBER THEORY, V4, P1, DOI 10.1142/S1793042108001171; COTTERILL JA, 2002, DERMATOL PSYCHOSOM, V3, P60; CRIXER G, 2005, GENERATION RX PRESCR; DITTO PH, 1987, RARITY EVALUAT UNPUB; Eva KW, 2001, ACAD MED, V76, pS11, DOI 10.1097/00001888-200110001-00005; Flower R, 2004, TRENDS PHARMACOL SCI, V25, P182, DOI 10.1016/j.tips.2004.02.006; Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062; Jason LA, 2002, AM J COMMUN PSYCHOL, V30, P133, DOI 10.1023/A:1014328319297; JEMMOTT JB, 1988, HEALTH PSYCHOL, V7, P55, DOI 10.1037/0278-6133.7.1.55; Jones MP, 2003, AM J GASTROENTEROL, V98, P2813; Lexchin J, 2006, PLOS MED, V3, P429, DOI 10.1371/journal.pmed.0030132; Melton LJ, 2003, BONE, V32, P327, DOI 10.1016/S8756-3282(03)00022-X; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2003, BRIT MED J, V326, P45, DOI 10.1136/bmj.326.7379.45; Norman GR, 2003, ACAD MED, V78, pS82, DOI 10.1097/00001888-200310001-00026; Payer L., 1992, DIS MONGERS DOCTORS; Scully JL, 2004, EMBO REP, V5, P650, DOI 10.1038/sj.embor.7400195; Smith R, 2002, BRIT MED J, V324, P883, DOI 10.1136/bmj.324.7342.883; Tiefer L, 2006, PLOS MED, V3, P436, DOI 10.1371/journal.pmed.0030178; Wessely S, 2002, BRIT MED J, V324, P912, DOI 10.1136/bmj.324.7342.912; Young M, 2007, MED EDUC, V41, P1146, DOI 10.1111/j.1365-2923.2007.02913.x; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	26	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3875	10.1371/journal.pone.0003875	http://dx.doi.org/10.1371/journal.pone.0003875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZO	19060953	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455100003
J	Sevillano, D; Aguilar, L; Alou, L; Gimenez, MJ; Gonzalez, N; Torrico, M; Cafini, F; Coronel, P; Prieto, J				Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Coronel, Pilar; Prieto, Jose			beta-Lactam Effects on Mixed Cultures of Common Respiratory Isolates as an Approach to Treatment Effects on Nasopharyngeal Bacterial Population Dynamics	PLOS ONE			English	Article								Background: Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae are bacteria present in the nasopharynx as part of normal flora. The ecological equilibrium in the nasopharynx can be disrupted by the presence of antibiotics. Methodology/Principal Findings: A computerized two-compartment pharmacodynamic model was used to explore beta-lactam effects on the evolution over time of a bacterial load containing common pharyngeal isolates by simulating free serum concentrations obtained with amoxicillin (AMX) 875 mg tid, amoxicillin/clavulanic acid (AMC) 875/125 mg tid and cefditoren (CDN) 400 mg bid regimens over 24 h. Strains and MICs (mu g/ml) of AMX, AMC and CDN were: S. pyogenes (0.03, 0.03 and 0.015), S. pneumoniae (2, 2 and 0.25), a beta-lactamase positive H. influenzae (BL(+); >16, 2 and 0.06) and a beta-lactamase positive AMC-resistant H. influenzae (BLPACR, >16, 8 and 0.06). Mixture of identical 1:1:1:1 volumes of each bacterial suspension were prepared yielding an inocula of approximate to 4 x 10(6) cfu/ml. Antibiotic concentrations were measured both in bacterial and in bacteria-free antibiotic simulations. beta-lactamase production decreased AMX concentrations and fT(>MIC) against S. pneumoniae (from 43.2% to 17.7%) or S. pyogenes (from 99.9% to 24.9%), and eradication was precluded. The presence of clavulanic acid countered this effect of co-pathogenicity, and S. pyogenes (but not BL(+) and S. pneumoniae) was eradicated. Resistance of CDN to TEM b-lactamase avoided this co-pathogenicity effect, and CDN eradicated S. pyogenes and H. influenzae strains (fT(>MIC) >58%), and reduced in 94% S. pneumoniae counts (fT(>MIC) approximate to 25%). Conclusions/Significance: Co-pathogenicity seems to be gradual since clavulanic acid countered this effect for strains very susceptible to AMX as S. pyogenes but not for strains with AMX MIC values in the limit of susceptibility as S. pneumoniae. There is a potential therapeutic advantage for beta-lactamase resistant cephalosporins with high activity against streptococci.	[Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Prieto, Jose] Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Sci Dept, Madrid, Spain	Complutense University of Madrid	Sevillano, D (corresponding author), Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Prieto, José/G-5644-2010; Cafini, Fabio/AAA-7938-2020; Hidalgo, Natalia González/X-6840-2018; Sevillano, David/G-5661-2010; Alou, Luis/B-8170-2011; Gimenez, Maria Jose/GXF-2237-2022	Cafini, Fabio/0000-0002-5442-1674; Hidalgo, Natalia González/0000-0002-6874-954X; Alou, Luis/0000-0002-0859-008X; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano Fernandez, David/0000-0003-0212-2194	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported in part by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews J.M., 1999, CLIN ANTIMICROBIAL A, P35; [Anonymous], PRINCIPLES PRACTICE; Ball P, 2002, J ANTIMICROB CHEMOTH, V49, P31, DOI 10.1093/jac/49.1.31; Baquero F, 2005, INT MICROBIOL, V8, P81; Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520; Brook I, 2005, ARCH OTOLARYNGOL, V131, P509, DOI 10.1001/archotol.131.6.509; Brook I, 2001, INT J ANTIMICROB AG, V17, P439, DOI 10.1016/S0924-8579(01)00321-1; Brook I, 2005, ANTIMICROB AGENTS CH, V49, P4787, DOI 10.1128/AAC.49.11.4787-4788.2005; Brook I, 2006, J MED MICROBIOL, V55, P989, DOI 10.1099/jmm.0.46325-0; Brook I, 2006, J MED MICROBIOL, V55, P1741, DOI 10.1099/jmm.0.46796-0; Cafini F, 2008, MICROB DRUG RESIST, V14, P13, DOI 10.1089/mdr.2008.0783; Casey JR, 2007, DIAGN MICR INFEC DIS, V57, p39S, DOI 10.1016/j.diagmicrobio.2006.12.020; Dabernat H, 2002, ANTIMICROB AGENTS CH, V46, P2208, DOI 10.1128/AAC.46.7.2208-2218.2002; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Garcia-Cobos S, 2007, ANTIMICROB AGENTS CH, V51, P2564, DOI 10.1128/AAC.00354-07; Gillespie SH, 2002, MICROB DRUG RESIST, V8, P79, DOI 10.1089/107662902760190617; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Martin JM, 2004, PEDIATRICS, V114, P1212, DOI 10.1542/peds.2004-0133; Martin M, 1997, J ANTIMICROB CHEMOTH, V39, P290, DOI 10.1093/jac/39.2.290; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; MURTHY TF, 2005, MANDELL DOUGLAS BENN, P2661; Musher DM, 2005, MANDELL DOUGLAS BENN, P2362; National Committee for Clinical Laboratory Standards, 2003, METH DIL ANT SUSC TE; Nuermberger EL, 2004, CLIN INFECT DIS, V38, pS363, DOI 10.1086/382696; Perez-Trallero E, 2005, ANTIMICROB AGENTS CH, V49, P1965, DOI 10.1128/AAC.49.5.1965-1972.2005; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P917, DOI 10.1097/00006454-200009000-00035; Prieto J, 1998, ANTIMICROB AGENTS CH, V42, P1574, DOI 10.1128/AAC.42.7.1574; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2002, J CLIN MICROBIOL, V40, P3577, DOI 10.1128/JCM.40.10.3577-3585.2002; SCRIVER SR, 1994, ANTIMICROB AGENTS CH, V38, P1678, DOI 10.1128/AAC.38.7.1678; Sevillano D, 2006, J ANTIMICROB CHEMOTH, V58, P794, DOI 10.1093/jac/dkl307; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Shulman ST, 2004, PEDIATRICS, V113, P1816, DOI 10.1542/peds.113.6.1816; SmithVaughan HC, 1996, EPIDEMIOL INFECT, V116, P177, DOI 10.1017/S0950268800052419; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; Torrico M, 2007, ANTIMICROB AGENTS CH, V51, P3699, DOI 10.1128/AAC.01530-06; AUGMENTIN PACKAGE IN; CEFDITOREN PACKAGE I	40	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3846	10.1371/journal.pone.0003846	http://dx.doi.org/10.1371/journal.pone.0003846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052648	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452200003
J	Thibonnier, M; Thiberge, JM; De Reuse, H				Thibonnier, Marie; Thiberge, Jean-Michel; De Reuse, Hilde			Trans-Translation in Helicobacter pylori: Essentiality of Ribosome Rescue and Requirement of Protein Tagging for Stress Resistance and Competence	PLOS ONE			English	Article								Background: The ubiquitous bacterial trans-translation is one of the most studied quality control mechanisms. Trans-translation requires two specific factors, a small RNA SsrA (tmRNA) and a protein co-factor SmpB, to promote the release of ribosomes stalled on defective mRNAs and to add a specific tag sequence to aberrant polypeptides to direct them to degradation pathways. Helicobacter pylori is a pathogen persistently colonizing a hostile niche, the stomach of humans. Principal Findings: We investigated the role of trans-translation in this bacterium well fitted to resist stressful conditions and found that both smpB and ssrA were essential genes. Five mutant versions of ssrA were generated in H. pylori in order to investigate the function of trans-translation in this organism. Mutation of the resume codon that allows the switch of template of the ribosome required for its release was essential in vivo, however a mutant in which this codon was followed by stop codons interrupting the tag sequence was viable. Therefore one round of translation is sufficient to promote the rescue of stalled ribosomes. A mutant expressing a truncated SsrA tag was viable in H. pylori, but affected in competence and tolerance to both oxidative and antibiotic stresses. This demonstrates that control of protein degradation through trans-translation is by itself central in the management of stress conditions and of competence and supports a regulatory role of trans-translation-dependent protein tagging. In addition, the expression of smpB and ssrA was found to be induced upon acid exposure of H. pylori. Conclusions: We conclude to a central role of trans-translation in H. pylori both for ribosome rescue possibly due to more severe stalling and for protein degradation to recover from stress conditions frequently encountered in the gastric environment. Finally, the essential trans-translation machinery of H. pylori is an excellent specific target for the development of novel antibiotics.	[Thibonnier, Marie; Thiberge, Jean-Michel; De Reuse, Hilde] Inst Pasteur, Unite Postulante Pathogenese Helicobacter, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thibonnier, M (corresponding author), Inst Pasteur, Unite Postulante Pathogenese Helicobacter, Paris, France.	hdereuse@pasteur.fr		DE REUSE, Hilde/0000-0002-0100-4826	FRM	FRM(Fondation pour la Recherche Medicale)	MT was supported by a FRM grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Braud S, 2006, ARCH MICROBIOL, V184, P343, DOI 10.1007/s00203-005-0051-y; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Bury-Mone S, 2001, MOL MICROBIOL, V42, P1021, DOI 10.1046/j.1365-2958.2001.02689.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; de la Cruz J, 2001, RNA, V7, P1708; Dong QJ, 2007, ANTON LEEUW INT J G, V92, P301, DOI 10.1007/s10482-007-9152-8; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; EBELING S, 1991, J BACTERIOL, V173, P6373, DOI 10.1128/jb.173.20.6373-6382.1991; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Falnes Pal O, 2005, RNA Biol, V2, P14, DOI 10.4161/rna.2.1.1602; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Julio SM, 2000, J BACTERIOL, V182, P1558, DOI 10.1128/JB.182.6.1558-1563.2000; Kaakoush NO, 2007, FEMS IMMUNOL MED MIC, V50, P177, DOI 10.1111/j.1574-695X.2007.00259.x; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Lessner FH, 2007, J BACTERIOL, V189, P272, DOI 10.1128/JB.01387-06; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sambrook J., 2001, MOL CLONING LAB MANU; Skouloubris S, 2001, MOL MICROBIOL, V40, P596, DOI 10.1046/j.1365-2958.2001.02400.x; STINGL K, 2008, MOL CELL PR IN PRESS; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Vioque A, 2003, FEMS MICROBIOL LETT, V218, P9, DOI 10.1016/S0378-1097(02)01110-2; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x	57	54	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3810	10.1371/journal.pone.0003810	http://dx.doi.org/10.1371/journal.pone.0003810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043582	Green Submitted, Green Published, gold			2022-12-27	WOS:000265451400002
J	Hacker, KE; Lee, CM; Rathmell, WK				Hacker, Kathryn E.; Lee, Caroline Martz; Rathmell, W. Kimryn			VHL Type 2B Mutations Retain VBC Complex Form and Function	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; TUMOR-SUPPRESSOR PROTEIN; RENAL-CELL CARCINOMA; UBIQUITIN LIGASE; GERMLINE MUTATIONS; GENE ALTERATIONS; ELONGIN-C; BINDING; PVHL; IDENTIFICATION	Background: von Hippel-Lindau disease is characterized by a spectrum of hypervascular tumors, including renal cell carcinoma, hemangioblastoma, and pheochromocytoma, which occur with VHL genotype-specific differences in penetrance. VHL loss causes a failure to regulate the hypoxia inducible factors (HIF-1 alpha and HIF-2 alpha), resulting in accumulation of both factors to high levels. Although HIF dysregulation is critical to VHL disease-associated renal tumorigenesis, increasing evidence points toward gradations of HIF dysregulation contributing to the degree of predisposition to renal cell carcinoma and other manifestations of the disease. Methodology/Principal Findings: This investigation examined the ability of disease-specific VHL missense mutations to support the assembly of the VBC complex and to promote the ubiquitylation of HIF. Our interaction analysis supported previous observations that VHL Type 2B mutations disrupt the interaction between pVHL and Elongin C but maintain partial regulation of HIF. We additionally demonstrated that Type 2B mutant pVHL forms a remnant VBC complex containing the active members ROC1 and Cullin-2 which retains the ability to ubiquitylate HIF-1 alpha. Conclusions: Our results suggest that subtypes of VHL mutations support an intermediate level of HIF regulation via a remnant VBC complex. These findings provide a mechanism for the graded HIF dysregulation and genetic predisposition for cancer development in VHL disease.	[Hacker, Kathryn E.; Lee, Caroline Martz; Rathmell, W. Kimryn] Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Hacker, KE (corresponding author), Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Med, Durham, NC USA.	Rathmell@med.unc.edu			VHL Family Alliance;  [F30 ES015248];  [R01 CA121781];  [K08 CA098410]; NATIONAL CANCER INSTITUTE [R01CA121781, K08CA098410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES015248] Funding Source: NIH RePORTER	VHL Family Alliance; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has been supported by F30 ES015248 (CML), R01 CA121781 (WKR, KEH), K08 CA098410 (WKR), and the VHL Family Alliance (WKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Megumi Y, 2005, GENES CELLS, V10, P679, DOI 10.1111/j.1365-2443.2005.00869.x; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Rathmell WK, 2005, J THROMB HAEMOST, V3, P2627, DOI 10.1111/j.1538-7836.2005.01441.x; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	30	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3801	10.1371/journal.pone.0003801	http://dx.doi.org/10.1371/journal.pone.0003801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030229	gold, Green Published, Green Submitted			2022-12-27	WOS:000265451100001
J	de Bruyn, PJN; Bastos, ADS; Eadie, C; Tosh, CA; Bester, MN				de Bruyn, P. J. Nico; Bastos, Armanda D. S.; Eadie, Candice; Tosh, Cheryl A.; Bester, Marthan N.			Mass Mortality of Adult Male Subantarctic Fur Seals: Are Alien Mice the Culprits?	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS-VIRUS; HOUSE MICE; IDENTIFICATION; ARCTOCEPHALUS; LEPTOSPIRA; PATTERNS; SUSCEPTIBILITY; ELEPHANTS; DISEASE; BIOLOGY	Background: Mass mortalities of marine mammals due to infectious agents are increasingly reported. However, in contrast to previous die-offs, which were indiscriminate with respect to sex and age, here we report a land-based mass mortality of Subantarctic fur seals with apparent exclusivity to adult males. An infectious agent with a male-predilection is the most plausible explanation for this die-off. Although pathogens with gender-biased transmission and pathologies are unusual, rodents are known sources of male-biased infectious agents and the invasive Mus musculus house mouse, occurs in seal rookeries. Methodology/Principal Findings: Molecular screening for male-biased pathogens in this potential rodent reservoir host revealed the absence of Cardiovirus and Leptospirosis genomes in heart and kidney samples, respectively, but identified a novel Streptococcus species with 30% prevalence in mouse kidneys. Conclusions/Significance: Inter-species transmission through environmental contamination with this novel bacterium, whose congenerics display male-bias and have links to infirmity in seals and terrestrial mammals (including humans), highlights the need to further evaluate disease risks posed by alien invasive mice to native species, on this and other islands.	[de Bruyn, P. J. Nico; Bastos, Armanda D. S.; Eadie, Candice; Tosh, Cheryl A.; Bester, Marthan N.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Pretoria	de Bruyn, PJN (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	pjndebruyn@zoology.up.ac.za	Tosh, Cheryl/D-5623-2016; De Bruyn, P.J.N./E-4176-2010; Bastos, Armanda/B-6357-2009; Bester, Marthán N/E-5387-2010	Tosh, Cheryl/0000-0003-0243-5422; De Bruyn, P.J.N./0000-0002-9114-9569; Bastos, Armanda/0000-0002-9223-4204; 	Department of Science and Technology, through the National Research Foundation (South Africa)	Department of Science and Technology, through the National Research Foundation (South Africa)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	The Department of Science and Technology, through the National Research Foundation (South Africa), provided financial support.	Avenant NL, 2003, POLAR BIOL, V26, P129, DOI 10.1007/s00300-002-0464-x; Bastos ADS, 1998, ONDERSTEPOORT J VET, V65, P37; Baumann CD, 2001, J WILDLIFE DIS, V37, P661, DOI 10.7589/0090-3558-37.4.661; BESTER MN, 1990, J ZOOL, V222, P177, DOI 10.1111/j.1469-7998.1990.tb05670.x; BESTER MN, 1994, S AFR J ZOOL, V29, P168; BESTER MN, 1977, THESIS U PRETORIA; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; CONDY PR, 1978, S AFR J WILDL RES, V8, P159; Fenwick SG, 2004, J WILDLIFE DIS, V40, P566, DOI 10.7589/0090-3558-40.3.566; FRIEDMAN SB, 1972, INFECT IMMUN, V5, P637, DOI 10.1128/IAI.5.5.637-644.1972; GROBLER DG, 1995, ONDERSTEPOORT J VET, V62, P97; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harwood J, 1998, NATURE, V393, P17, DOI 10.1038/29877; HEIDEJORGENSEN MP, 1992, J APPL ECOL, V29, P99, DOI 10.2307/2404353; Hofmeyr GJG, 2006, S AFR J WILDL RES, V36, P55; Hofmeyr GJG, 2007, S AFR J WILDL RES, V37, P1, DOI 10.3957/0379-4369-37.1.1; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Hunter P, 1998, VACCINE, V16, P55, DOI 10.1016/S0264-410X(97)00158-8; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kerley G.J.H., 1987, NOAA Technical Report NMFS, V51, P61; KERLEY GIH, 1983, S AFR J WILDL RES, V13, P71; Kirkman SP, 2002, AFR ZOOL, V37, P13; Knox G. A., 2007, BIOL SO OCEAN; KYU B, 1992, CIRCULATION, V86, P522, DOI 10.1161/01.CIR.86.2.522; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; MATTHEWSON DC, 1994, S AFR J ZOOL, V29, P99; Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964; MILLER E H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P170; MILLER EH, 1975, BEHAVIOUR, V53, P268, DOI 10.1163/156853975X00227; Nikkari S, 2002, EMERG INFECT DIS, V8, P188, DOI 10.3201/eid0802.010150; OSHEA TJ, 1999, BIOL MARINE MAMMALS; Shin GY, 2005, HEART, V91, DOI 10.1136/hrt.2004.056762; Smith VR, 2002, POLAR BIOL, V25, P703, DOI 10.1007/s00300-002-0405-8; Smith VR, 2002, CLIMATIC CHANGE, V52, P345, DOI 10.1023/A:1013718617277; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMSON GR, 2001, INFECT DIS WILD MAMM, P124; van Vuuren BJ, 2007, POLAR BIOL, V30, P327, DOI 10.1007/s00300-006-0188-4; Vanderhallen H, 1998, J CLIN MICROBIOL, V36, P3463, DOI 10.1128/JCM.36.12.3463-3467.1998; Wickens P, 1997, MAR MAMMAL SCI, V13, P241, DOI 10.1111/j.1748-7692.1997.tb00631.x; WILLOUGHBY DS, 1964, J BACTERIOL, V87, P1457, DOI 10.1128/JB.87.6.1457-1461.1964	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3757	10.1371/journal.pone.0003757	http://dx.doi.org/10.1371/journal.pone.0003757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018284	gold, Green Published			2022-12-27	WOS:000265448500004
J	Krintel, C; Osmark, P; Larsen, MR; Resjo, S; Logan, DT; Holm, C				Krintel, Christian; Osmark, Peter; Larsen, Martin R.; Resjo, Svante; Logan, Derek T.; Holm, Cecilia			Ser649 and Ser650 Are the Major Determinants of Protein Kinase A-Mediated Activation of Human Hormone-Sensitive Lipase against Lipid Substrates	PLOS ONE			English	Article								Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of fatty acids from stored triacylglycerols. Its activity is regulated by reversible protein phosphorylation. In rat HSL Ser563, Ser659 and Ser660 have been shown to be phosphorylated by protein kinase A (PKA) in vitro as well as in vivo. Methodology/Principal Findings: In this study we employed site-directed mutagenesis, in vitro phosphorylation and mass spectrometry to show that in vitro phosphorylation of human HSL by PKA occurs primarily on Ser649 and Ser650 (Ser659 and Ser660 in rat HSL). The wild type enzyme and four mutants were expressed in C-terminally His-tagged form in Sf9 insect cells and purified to homogeneity. HSL variants in which Ser552 and/or Ser554 were mutated to Ala or Glu retained both lipolytic and non-lipolytic activity and were phosphorylated by PKA and activated to a similar extent as the wild type enzyme. (32)P-labeling studies revealed that the bulk of the phosphorylation was on the Ser649/Ser650 site, with only a minor phosphorylation of Ser552 and Ser554. MS/MS analysis demonstrated that the peptide containing Ser649 and Ser650 was primarily phosphorylated on Ser650. The mutant lacking all four serines had severely reduced lipolytic activity, but a lesser reduction in non-lipolytic activity, had S(0.5) values for p-nitrophenol butyrate and triolein comparable to those of wild type HSL and was not phosphorylated by PKA. PKA phosphorylation of the wild type enzyme resulted in an increase in both the maximum turnover and S(0,5) using the TO substrate. Conclusions: Our results demonstrate that PKA activates human HSL against lipid substrates in vitro primarily through phosphorylation of Ser649 and Ser650. In addition the results suggest that Ser649 and Ser650 are located in the vicinity of a lipid binding region and that PKA phosphorylation controls the accessibility of this region.			Krintel, C (corresponding author), Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden.	cecilia.holm@med.lu.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019; Larsen, Martin Rossel/F-1411-2015	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; krintel, christian/0000-0001-5925-5639; Larsen, Martin Rossel/0000-0001-6203-0123				Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BELFRAGE P, 1984, ADV CYCLIC NUCL PROT, V17, P351; Ben Ali Y, 2004, BIOCHEMISTRY-US, V43, P9298, DOI 10.1021/bi049479o; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chahinian H, 2005, BBA-MOL CELL BIOL L, V1738, P29, DOI 10.1016/j.bbalip.2005.11.003; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; COOK KG, 1983, BIOCHIM BIOPHYS ACTA, V752, P46, DOI 10.1016/0005-2760(83)90231-X; FELLER G, 1991, DNA CELL BIOL, V10, P381, DOI 10.1089/dna.1991.10.381; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; HOLM C, 1994, PROTEIN ENG, V7, P537, DOI 10.1093/protein/7.4.537; Holm C, 1997, METHOD ENZYMOL, V284, P272; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; NILSSON NO, 1980, FEBS LETT, V111, P125, DOI 10.1016/0014-5793(80)80776-9; Osterlund T, 1999, J BIOL CHEM, V274, P15382, DOI 10.1074/jbc.274.22.15382; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Talanian JL, 2006, AM J PHYSIOL-REG I, V291, pR1094, DOI 10.1152/ajpregu.00130.2006; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; TORNQVIST H, 1978, J LIPID RES, V19, P654; TORNQVIST H, 1972, J LIPID RES, V13, P424; Wang J, 2005, BIOCHEMISTRY-US, V44, P1953, DOI 10.1021/bi049206t; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Watt MJ, 2003, J PHYSIOL-LONDON, V547, P301, DOI 10.1113/jphysiol.2002.034595	33	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3756	10.1371/journal.pone.0003756	http://dx.doi.org/10.1371/journal.pone.0003756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018281	Green Submitted, gold, Green Published			2022-12-27	WOS:000265448500003
J	Sundelacruz, S; Levin, M; Kaplan, DL				Sundelacruz, Sarah; Levin, Michael; Kaplan, David L.			Membrane Potential Controls Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article								Background: Control of stem cell behavior is a crucial aspect of developmental biology and regenerative medicine. While the functional role of electrophysiology in stem cell biology is poorly understood, it has become clear that endogenous ion flows represent a powerful set of signals by means of which cell proliferation, differentiation, and migration can be controlled in regeneration and embryonic morphogenesis. Methodology/Principal Findings: We examined the membrane potential (Vmem) changes exhibited by human mesenchymal stem cells (hMSCs) undergoing adipogenic ( AD) and osteogenic ( OS) differentiation, and uncovered a characteristic hyperpolarization of differentiated cells versus undifferentiated cells. Reversal of the progressive polarization via pharmacological modulation of transmembrane potential revealed that depolarization of hMSCs prevents differentiation. In contrast, treatment with hyperpolarizing reagents upregulated osteogenic markers. Conclusions/Significance: Taken together, these data suggest that the endogenous hyperpolarization is a functional determinant of hMSC differentiation and is a tractable control point for modulating stem cell function.	[Sundelacruz, Sarah; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Levin, Michael] Tufts Univ, Tufts Ctr Regenerat & Dev Biol, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Sundelacruz, S (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	NIH [P41 EB002520]; NHTSA [DTNH22-06-G-00001]; DARPA [W911NF-07-1-0572]; NSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHTSA; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge support from NIH through the Tissue Engineering Resource Center (P41 EB002520) (D.K.), from NHTSA (DTNH22-06-G-00001) (M.L.), from DARPA (W911NF-07-1-0572) (M.L. and D.K.), and from NSF through the Graduate Research Fellowship Program (S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Altizer AM, 2002, J EXP ZOOL, V293, P467, DOI 10.1002/jez.10141; Altizer AM, 2001, DEV DYNAM, V221, P391, DOI 10.1002/dvdy.1158; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Arcangeli A, 1997, EUR J NEUROSCI, V9, P2596, DOI 10.1111/j.1460-9568.1997.tb01689.x; AUWERX J, 1992, CRIT REV CL LAB SCI, V29, P243, DOI 10.3109/10408369209114602; Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; BECKER RO, 1972, B NEW YORK ACAD MED, V48, P627; Biagiotti T, 2006, STEM CELLS, V24, P443, DOI 10.1634/stemcells.2004-0264; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1979, J EXP ZOOL, V209, P377, DOI 10.1002/jez.1402090304; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; BORGENS RB, 1987, J EXP ZOOL, V244, P203, DOI 10.1002/jez.1402440204; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; CONE C D JR, 1970, Oncology (Basel), V24, P438; CONE CD, 1971, J THEOR BIOL, V30, P151, DOI 10.1016/0022-5193(71)90042-7; CONE CD, 1971, ONCOLOGY-BASEL, V25, P168; Erdogan A, 2005, J VASC RES, V42, P368, DOI 10.1159/000087159; ERSKINE L, 1995, DEV BIOL, V171, P330, DOI 10.1006/dbio.1995.1285; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hoenicke EM, 2001, J HEART LUNG TRANSPL, V20, P1106, DOI 10.1016/S1053-2498(01)00307-2; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jenkins LS, 1996, DEV BIOL, V178, P251, DOI 10.1006/dbio.1996.0216; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Korsgaard MPG, 2001, PFLUG ARCH EUR J PHY, V443, P18, DOI 10.1007/s004240100625; Lawson K, 2000, KIDNEY INT, V57, P838, DOI 10.1046/j.1523-1755.2000.00923.x; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G; MCCAIG CD, 1996, NERVE GROWTH GUIDANC, P151; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; NielsenKudsk JE, 1996, DAN MED BULL, V43, P429; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nuccitelli R, 2003, RADIAT PROT DOSIM, V106, P375, DOI 10.1093/oxfordjournals.rpd.a006375; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SMITH SD, 1974, ANN NY ACAD SCI, V238, P500, DOI 10.1111/j.1749-6632.1974.tb26816.x; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; STEWART R, 1995, DEV BIOL, V171, P340, DOI 10.1006/dbio.1995.1286; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; van Kempen MJA, 2003, CELL PHYSIOL BIOCHEM, V13, P263, DOI 10.1159/000074541; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Xiong YM, 1995, SKIN PHARMACOL, V8, P309, DOI 10.1159/000211362; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	63	177	184	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3737	10.1371/journal.pone.0003737	http://dx.doi.org/10.1371/journal.pone.0003737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011685	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448300005
J	Mehraj, V; Hatcher, J; Akhtar, S; Rafique, G; Beg, MA				Mehraj, Vikram; Hatcher, Juanita; Akhtar, Saeed; Rafique, Ghazala; Beg, Mohammad Asim			Prevalence and Factors Associated with Intestinal Parasitic Infection among Children in an Urban Slum of Karachi	PLOS ONE			English	Article							HELMINTH INFECTIONS; HOOKWORM INFECTION; COMMUNITY; DIARRHEA; GROWTH; RISK	Background: Intestinal parasitic infections are endemic worldwide and have been described as constituting the greatest single worldwide cause of illness and disease. Poverty, illiteracy, poor hygiene, lack of access to potable water and hot and humid tropical climate are the factors associated with intestinal parasitic infections. The study aimed to estimate prevalence and identify factors associated with intestinal parasitic infections among 1 to 5 years old children residing in an urban slum of Karachi Pakistan. Methods and Principal Findings: A cross sectional survey was conducted from February to June 2006 in Ghosia Colony Gulshan Town Karachi, Pakistan. A simple random sample of 350 children aged 1-5 years was collected. The study used structured pre-tested questionnaire, anthropometric tools and stool tests to obtain epidemiological and disease data. Data were analyzed using appropriate descriptive, univariate and multivariable logistic regression methods. The mean age of participants was 2.8 years and 53% were male. The proportions of wasted, stunted and underweight children were 10.4%, 58.9% and 32.7% respectively. The prevalence of Intestinal parasitic infections was estimated to be 52.8% (95% CI: 46.1; 59.4). Giardia lamblia was the most common parasite followed by Ascaris lumbricoides, Blastocystis hominis and Hymenolepis nana. About 43% children were infected with single parasite and 10% with multiple parasites. Age {Adjusted Odds Ratio (aOR) = 1.5; 95% CI: 1.1; 1.9}, living in rented households (aOR = 2.0; 95% CI: 1.0; 3.9) and history of excessive crying (aOR = 1.9; 95% CI: 1.0; 3.4) were significantly associated with intestinal parasitic infections. Conclusions: Intestinal parasites are highly prevalent in this setting and poverty was implicated as an important risk factor for infection. Effective poverty reduction programmes and promotion of deworming could reduce intestinal parasite carriage. There is a need for mass scale campaigns to create awareness about health and hygiene.	[Mehraj, Vikram; Beg, Mohammad Asim] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Mehraj, Vikram; Hatcher, Juanita; Akhtar, Saeed; Rafique, Ghazala] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Mehraj, Vikram] Univ Aix Marseille 2, Fac Med, Ctr Natl Rech Sci, Unite Mixte Rech 6236, Marseille, France; [Akhtar, Saeed] Kuwait Univ, Fac Med, Dept Community Med & Behavioral Sci, Safat 13060, Kuwait	Aga Khan University; Aga Khan University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Kuwait University	Mehraj, V (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	masim.beg@aku.edu	Akhtar, Saeed/AAG-2334-2021	Akhtar, Saeed/0000-0002-1261-788X	International Maternal and Child Health Research Training Program, NIH [5 D43 TW05497-03]; Aga Khan University; University of Alabama at Birmingham; FOGARTY INTERNATIONAL CENTER [D43TW005497] Funding Source: NIH RePORTER	International Maternal and Child Health Research Training Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aga Khan University; University of Alabama at Birmingham; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We acknowledge International Maternal and Child Health Research Training Program (FIC, NIH # 5 D43 TW05497-03) of Aga Khan University (AKU) and University of Alabama at Birmingham (UAB) for providing financial support in the development of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Akbar K, 2003, J Ayub Med Coll Abbottabad, V15, P28; AKPEDE GO, 1995, J ROY SOC HEALTH, V115, P164, DOI 10.1177/146642409511500309; Akpede GO, 1995, J ROY SOC HEALTH, V115, P173; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; [Anonymous], WORLD URB PROSP 2005; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; *CDC, 2001, EP INF; CDC DPDx, 2006, LAB ID PAR PUBL HLTH; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Curtale F, 1998, HEALTH POLICY PLANN, V13, P423, DOI 10.1093/heapol/13.4.423; Ensink JHJ, 2005, T ROY SOC TROP MED H, V99, P809, DOI 10.1016/j.trstmh.2005.01.005; Glickman LT, 1999, INT J EPIDEMIOL, V28, P169, DOI 10.1093/ije/28.1.169; Harpham T, 2002, J TROP PEDIATRICS, V48, P128, DOI 10.1093/tropej/48.3.128; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Iacono G, 2005, DIGEST LIVER DIS, V37, P432, DOI 10.1016/j.dld.2005.01.009; Kaur Ravinder, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P725; Kucik CJ, 2004, AM FAM PHYSICIAN, V69, P1161; Lunn PG, 1999, J NUTR, V129, P872, DOI 10.1093/jn/129.4.872; MARTI H, 1993, J CLIN MICROBIOL, V31, P3044, DOI 10.1128/JCM.31.11.3044-3045.1993; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Muniz PT, 2002, ANN TROP MED PARASIT, V96, P503, DOI 10.1179/000349802125001311; Naish S, 2004, ACTA TROP, V91, P177, DOI 10.1016/j.actatropica.2004.04.004; Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010; Pegelow K., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P173; Pillai D.R., 2003, CURR TREATMENT OPTIO, V5, P207; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Siddiqui M I, 2002, J Pak Med Assoc, V52, P315; *SPSS, 2005, STAT PACK SOC SCI; SRINIVASAN V, 1987, T ROY SOC TROP MED H, V81, P973, DOI 10.1016/0035-9203(87)90369-5; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Tahir Z., 2002, BIOMEDICA, V18, P74; WAQAR SN, 2003, INFECT DIS J PAK, V12, P73; WENDER EH, 1976, AM J PSYCHIAT, V133, P20; WHO, 2006, GEOGR DISTR US FACTS; WHO, 2006, SOFTWARE ASSESSING G; 1998, DISTRICT CENSUS REPO; 2005, KARACHI CITY INFORM	39	139	145	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3680	10.1371/journal.pone.0003680	http://dx.doi.org/10.1371/journal.pone.0003680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WR	18997865	Green Published, gold			2022-12-27	WOS:000265165500003
J	Camas, FM; Poyatos, JF				Camas, Francisco M.; Poyatos, Juan F.			What Determines the Assembly of Transcriptional Network Motifs in Escherichia coli?	PLOS ONE			English	Article							REGULATORY NETWORK; HIERARCHICAL STRUCTURE; EVOLUTION; GROWTH; ORGANIZATION; INTEGRATION; PROTEIN	Transcriptional networks are constituted by a collection of building blocks known as network motifs. Why do motifs appear? An adaptive model of motif emergence was recently questioned in favor of neutralist scenarios. Here, we provide a new picture of motif assembly in Escherichia coli which partially clarifies these contrasting explanations. This is based on characterizing the linkage between motifs and sensing or response specificity of their constituent transcriptional factors (TFs). We find that sensing specificity influences the distribution of autoregulation, while the tendency of a TF to establish feed-forward loops (FFLs) depends on response specificity, i.e., regulon size. Analysis of the latter pattern reveals that coregulation between large regulon-size TFs is common under a network neutral model, leading to the assembly of a great number of FFLs and bifans. In addition, neutral exclusive regulation also leads to a collection of single input modules - the fourth basic motif. On the whole, and even under the conservative neutralist scenario considered, a substantial group of regulatory structures revealed adaptive. These structures visibly function as fully-fledged working units.	[Camas, Francisco M.; Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Camas, FM (corresponding author), CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain.	jpoyatos@cnb.csic.es			Ministerio de Educacion y Ciencia (MEC) [Formacion de Profesorado Universitario fellowship, FIS2006-10368]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government)	This work was supported in part by a Ministerio de Educacion y Ciencia (MEC) Formacion de Profesorado Universitario fellowship (F.M.C.), and MEC Grant FIS2006-10368 (to J.F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Artzy-Randrup Y, 2004, SCIENCE, V305; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Banzhaf Wolfgang, 2004, Journal of Biological Physics and Chemistry, V4, P85, DOI 10.4024/2040405.jbpc.04.02; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; Cordero OX, 2006, MOL BIOL EVOL, V23, P1931, DOI 10.1093/molbev/msl060; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; ISHIZUKA H, 1994, EMBO J, V13, P3077, DOI 10.1002/j.1460-2075.1994.tb06606.x; Janga SC, 2007, NUCLEIC ACIDS RES, V35, P6963, DOI 10.1093/nar/gkm743; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazurie A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r35; Milo R, 2004, SCIENCE, V305; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Ward JJ, 2007, PLOS COMPUT BIOL, V3, P1993, DOI 10.1371/journal.pcbi.0030198; Warren PB, 2004, J MOL BIOL, V342, P1379, DOI 10.1016/j.jmb.2004.07.074; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3657	10.1371/journal.pone.0003657	http://dx.doi.org/10.1371/journal.pone.0003657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987754	Green Submitted, gold, Green Published			2022-12-27	WOS:000265134500004
J	Sun, YM; Cooper, M; Finch, S; Lin, HH; Chen, ZF; Williams, BP; Buckley, NJ				Sun, Yuh-Man; Cooper, Megan; Finch, Sophie; Lin, Hsuan-Hwai; Chen, Zhou-Feng; Williams, Brenda P.; Buckley, Noel J.			Rest-Mediated Regulation of Extracellular Matrix Is Crucial for Neural Development	PLOS ONE			English	Article							TARGET GENES; RE-1 SILENCER; STEM-CELLS; IN-VIVO; FATE; TRANSCRIPTION; REPRESSION; IDENTIFICATION; PRECURSORS; EXPRESSION	Neural development from blastocysts is strictly controlled by intricate transcriptional programmes that initiate the down-regulation of pluripotent genes, Oct4, Nanog and Rex1 in blastocysts followed by up-regulation of lineage-specific genes as neural development proceeds. Here, we demonstrate that the expression pattern of the transcription factor Rest mirrors those of pluripotent genes during neural development from embryonic stem (ES) cells and an early abrogation of Rest in ES cells using a combination of gene targeting and RNAi approaches causes defects in this process. Specifically, Rest ablation does not alter ES cell pluripotency, but impedes the production of Nestin(+) neural stem cells, neural progenitor cells and neurons, and results in defective adhesion, decrease in cell proliferation, increase in cell death and neuronal phenotypic defects typified by a reduction in migration and neurite elaboration. We also show that these Rest-null phenotypes are due to the dysregulation of its direct or indirect target genes, Lama1, Lamb1, Lamc1 and Lama2 and that these aberrant phenotypes can be rescued by laminins.	[Sun, Yuh-Man; Cooper, Megan; Finch, Sophie; Lin, Hsuan-Hwai; Williams, Brenda P.; Buckley, Noel J.] Kings Coll London, James Black Ctr, CCBB, Inst Psychiat, London WC2R 2LS, England; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, Psychiat & Dev Biol, St Louis, MO 63130 USA	University of London; King's College London; Washington University (WUSTL)	Sun, YM (corresponding author), Kings Coll London, James Black Ctr, CCBB, Inst Psychiat, London WC2R 2LS, England.	yuh-man.sun@iop.kcl.ac.uk	Buckley, Noel J/B-9675-2012; Sun, Yuh-Man/N-1579-2014	Buckley, Noel J/0000-0003-1152-0653; Sun, Yuh-Man/0000-0002-8863-4280; Williams, Brenda Patricia/0000-0003-4690-5932	Neuroscience, IOP, King's College London, UK; Wellcome Trust	Neuroscience, IOP, King's College London, UK; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a start up fund (Y-M. Sun) from Neuroscience, IOP, King's College London, UK and Wellcome Trust grants (N. J. Buckley).	Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017; Aumailley M, 2000, J CELL SCI, V113, P259; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Colognato H, 2005, TRENDS NEUROSCI, V28, P480, DOI 10.1016/j.tins.2005.07.004; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; EKBLOM P, 1996, LAMININS; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; LAWSON KA, 1992, CIBA F SYMP, V165, P3; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Olguin P, 2006, J NEUROSCI, V26, P2820, DOI 10.1523/JNEUROSCI.5037-05.2006; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Thiel G, 1999, NATURWISSENSCHAFTEN, V86, P1, DOI 10.1007/s001140050561; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	43	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3656	10.1371/journal.pone.0003656	http://dx.doi.org/10.1371/journal.pone.0003656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987749	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134500003
J	Martinato, F; Cesaroni, M; Amati, B; Guccione, E				Martinato, Francesca; Cesaroni, Matteo; Amati, Bruno; Guccione, Ernesto			Analysis of Myc-Induced Histone Modifications on Target Chromatin	PLOS ONE			English	Article								The c-myc proto-oncogene is induced by mitogens and is a central regulator of cell growth and differentiation. The c-myc product, Myc, is a transcription factor that binds a multitude of genomic sites, estimated to be over 10-15% of all promoter regions. Target promoters generally pre-exist in an active or poised chromatin state that is further modified by Myc, contributing to fine transcriptional regulation (activation or repression) of the afferent gene. Among other mechanisms, Myc recruits histone acetyl-transferases to target chromatin and locally promotes hyper-acetylation of multiple lysines on histones H3 and H4, although the identity and combination of the modified lysines is unknown. Whether Myc dynamically regulates other histone modifications (or marks) at its binding sites also remains to be addressed. Here, we used quantitative chromatin immunoprecipitation (qChIP) to profile a total of 24 lysine-acetylation and -methylation marks modulated by Myc at target promoters in a human B-cell line with a regulatable c-myc transgene. Myc binding promoted acetylation of multiple lysines, primarily of H3K9, H3K14, H3K18, H4K5 and H4K12, but significantly also of H4K8, H4K91 and H2AK5. Dimethylation of H3K79 was also selectively induced at target promoters. A majority of target promoters showed co-induction of multiple marks - in various combinations - correlating with recruitment of the two HATs tested (Tip60 and HBO1), incorporation of the histone variant H2A.Z and transcriptional activation. Based on this and previous findings, we surmise that Myc recruits the Tip60/p400 complex to achieve a coordinated histone acetylation/exchange reaction at activated promoters. Our data are also consistent with the additive and redundant role of multiple acetylation events in transcriptional activation.	[Martinato, Francesca; Cesaroni, Matteo; Amati, Bruno; Guccione, Ernesto] IFOM IEO, Dept Expt Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Martinato, F (corresponding author), IFOM IEO, Dept Expt Oncol, Milan, Italy.	bruno.amati@ifom-ieo-campus.it; eguccione@imcb.a-star.edu.sg	Amati, Bruno/AAM-3418-2020; guccione, ernesto/G-9874-2011	Amati, Bruno/0000-0002-2958-1799	Italian Association for Cancer Research (AIRC) [fellowship]; Ricerca Finalizzata" program of the Italian Health Ministry	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata" program of the Italian Health Ministry	This work was supported by grants from the Italian Association for Cancer Research (AIRC) and the "Ricerca Finalizzata" program of the Italian Health Ministry to BA, and by a fellowship from the Italian Association for Cancer Research (FIRC) to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; GUCCIONE E, 2007, NATURE; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; KUSCH T, 2004, ACETYLATION TIP60 IS; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; LOIDL P, 1994, CHROMOSOMA, V103, P441; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SQUATRITO M, 2006, TRENDS CELL IN PTRDD; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	78	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3650	10.1371/journal.pone.0003650	http://dx.doi.org/10.1371/journal.pone.0003650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985155	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134400012
J	Mandl, RCW; Schnack, HG; Zwiers, MP; van der Schaaf, A; Kahn, RS; Pol, HEH				Mandl, Rene C. W.; Schnack, Hugo G.; Zwiers, Marcel P.; van der Schaaf, Arjen; Kahn, Rene S.; Pol, Hilleke E. Hulshoff			Functional Diffusion Tensor Imaging: Measuring Task-Related Fractional Anisotropy Changes in the Human Brain along White Matter Tracts	PLOS ONE			English	Article								Background: Functional neural networks in the human brain can be studied from correlations between activated gray matter regions measured with fMRI. However, while providing important information on gray matter activation, no information is gathered on the co-activity along white matter tracts in neural networks. Methodology/Principal Findings: We report on a functional diffusion tensor imaging (fDTI) method that measures task-related changes in fractional anisotropy (FA) along white matter tracts. We hypothesize that these fractional anisotropy changes relate to morphological changes of glial cells induced by axonal activity although the exact physiological underpinnings of the measured FA changes remain to be elucidated. As expected, these changes are very small as compared to the physiological noise and a reliable detection of the signal change would require a large number of measurements. However, a substantial increase in signal-to-noise ratio was achieved by pooling the signal over the complete fiber tract. Adopting such a tract-based statistics enabled us to measure the signal within a practically feasible time period. Activation in the sensory thalamocortical tract and optic radiation in eight healthy human subjects was found during tactile and visual stimulation, respectively. Conclusions/Significance: The results of our experiments indicate that these FA changes may serve as a functional contrast mechanism for white matter. This noninvasive fDTI method may provide a new approach to study functional neural networks in the human brain.	[Mandl, Rene C. W.; Schnack, Hugo G.; van der Schaaf, Arjen; Kahn, Rene S.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Zwiers, Marcel P.] Radboud Univ Nijmegen, Ctr Cognitive Neuroimaging, Donders Inst Brain, Cognit & Behaviour, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Mandl, RCW (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	r.mandl@umcutrecht.nl	Mandl, René C.W./AAU-7037-2020; Zwiers, Marcel P/D-2968-2009; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Van+Der+Schaaf, Arjen/AEX-0530-2022	Zwiers, Marcel P/0000-0001-5483-2935; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Van+Der+Schaaf, Arjen/0000-0003-4067-7975	Dutch Organization for Medical Research NWO ZON-MW VIDI Program [917.46.370]	Dutch Organization for Medical Research NWO ZON-MW VIDI Program	This work was supported by a grant from the Dutch Organization for Medical Research NWO ZON-MW VIDI Program (H.E.H., 917.46.370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AW, 1996, MAGN RESON MED, V35, P162, DOI 10.1002/mrm.1910350206; Armitage P., 2002, STAT METHODS MED RES; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beshay JE, 2005, GLIA, V51, P121, DOI 10.1002/glia.20192; Blankenburg F, 2003, SCIENCE, V299, P1864, DOI 10.1126/science.1080806; Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; CATANI M, 2005, RISES FALLS DISCONNE; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; COLES JAD, 2005, NEUROGLIA; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; Gulani V, 1999, MAGNET RESON MED, V41, P241, DOI 10.1002/(SICI)1522-2594(199902)41:2<241::AID-MRM5>3.0.CO;2-E; HARDY TL, 1979, APPL NEUROPHYSIOL, V42, P335; Harshbarger TB, 2006, NMR BIOMED, V19, P1020, DOI 10.1002/nbm.1067; Iguchi Y, 2005, CLIN NEUROPHYSIOL, V116, P1077, DOI 10.1016/j.clinph.2004.12.005; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Kandel E., 2000, PRINCIPLES NEURAL SC; Kennan Richard P., 1995, P110; Le Bihan D., 2006, P NATL ACAD SCI US, V103, P8263; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lu H, 2003, MAGNET RESON MED, V50, P263, DOI 10.1002/mrm.10519; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Mesulam M, 2005, ANN NEUROL, V57, P5, DOI 10.1002/ana.20368; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; Pol HEH, 2004, NEUROIMAGE, V21, P27, DOI 10.1016/j.neuroimage.2003.09.026; Prichard JW, 1995, NMR BIOMED, V8, P359, DOI 10.1002/nbm.1940080709; RANSOM BR, 1985, J NEUROSCI, V5, P532; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Skare S, 2000, MAGN RESON IMAGING, V18, P659, DOI 10.1016/S0730-725X(00)00153-3; Sommer IEC, 2004, BRIT J PSYCHIAT, V184, P128, DOI 10.1192/bjp.184.2.128; Stroman PW, 2008, MAGN RESON MED, V59, P700, DOI 10.1002/mrm.21534; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Sykova E, 2003, NEUROIMAGE, V18, P214, DOI 10.1016/S1053-8119(02)00014-9; Sykova E, 2000, NEUROCHEM INT, V36, P397, DOI 10.1016/S0197-0186(99)00131-X; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810	46	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3631	10.1371/journal.pone.0003631	http://dx.doi.org/10.1371/journal.pone.0003631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982065	Green Submitted, gold, Green Published			2022-12-27	WOS:000265134300002
J	Wong, ML; Dong, CH; Esposito, K; Thakur, S; Liu, WQ; Elashoff, RM; Licinio, J				Wong, Ma-Li; Dong, Chuanhui; Esposito, Karin; Thakur, Sarika; Liu, Weiqing; Elashoff, Robert M.; Licinio, Julio			Elevated Stress-Hemoconcentration in Major Depression Is Normalized by Antidepressant Treatment: Secondary Analysis from a Randomized, Double-Blind Clinical Trial and Relevance to Cardiovascular Disease Risk	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ACUTE PSYCHOLOGICAL STRESS; BLOOD-VISCOSITY; MENTAL STRESS; AFFECTIVE-DISORDERS; TREATMENT RESPONSE; ARTERY-DISEASE; MORTALITY; ASSOCIATION	Background: Major depressive disorder (MDD) is an independent risk factor for cardiovascular disease (CVD); the presence of MDD symptoms in patients with CVD is associated with a higher incidence of cardiac complications following acute myocardial infarction (MI). Stress-hemoconcentration, a result of psychological stress that might be a risk factor for the pathogenesis of CVD, has been studied in stress-challenge paradigms but has not been systematically studied in MDD. Methods: Secondary analysis of stress hemoconcentration was performed on data from controls and subjects with mild to moderate MDD participating in an ongoing pharmacogenetic study of antidepressant treatment response to desipramine or fluoxetine. Hematologic and hemorheologic measures of stress-hemoconcentration included blood cell counts, hematocrit, hemoglobin, total serum protein, and albumin, and whole blood viscosity. Findings: Subjects with mild to moderate MDD had significantly increased hemorheologic measures of stress-hemoconcentration and blood viscosity when compared to controls; these measures were correlated with depression severity. Measures of stress-hemoconcentration improved significantly after 8 weeks of antidepressant treatment. Improvements in white blood cell count, red blood cell measures and plasma volume were correlated with decreased severity of depression. Conclusions: Our secondary data analyses support that stress-hemoconcentration, possibly caused by decrements in plasma volume during psychological stress, is present in Mexican-American subjects with mild to moderate MDD at non-challenged baseline conditions. We also found that after antidepressant treatment hemorheologic measures of stress-hemoconcentration are improved and are correlated with improvement of depressive symptoms. These findings suggest that antidepressant treatment may have a positive impact in CVD by ameliorating increased blood viscosity. Physicians should be aware of the potential impact of measures of hemoconcentration and consider the implications for cardiovascular risk in depressed patients.	[Wong, Ma-Li; Dong, Chuanhui; Esposito, Karin; Licinio, Julio] Univ Miami, Dept Psychiat & Behav Sci, Leonard M Miller Sch Med, Miami, FL 33152 USA; [Thakur, Sarika] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, David Geffen Sch Med, Los Angeles, CA USA; [Liu, Weiqing; Elashoff, Robert M.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA	University of Miami; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wong, ML (corresponding author), Univ Miami, Dept Psychiat & Behav Sci, Leonard M Miller Sch Med, Miami, FL 33152 USA.	mali@miami.edu	Wong, Ma-Li/ABD-5525-2020; Licinio, Julio/L-4244-2013; Esposito, Karin/AAG-6878-2019; Wong, Ma-Li/D-7903-2011	Licinio, Julio/0000-0001-6905-5884; Wong, Ma-Li/0000-0003-1512-3073	NIH [GM61394, RR017365, MH062777, RR000865, RR16996, HG002500, DK063240]; University of Miami, Department of Psychiatry & Behavioral Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR017365, K24RR016996, M01RR000865] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG002500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH062777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami, Department of Psychiatry & Behavioral Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH grants GM61394, RR017365, MH062777, RR000865, RR16996, HG002500, and DK063240, and Institutional Funds from the University of Miami, Department of Psychiatry & Behavioral Sciences	AHRENS B, 1995, J AFFECT DISORDERS, V33, P67, DOI 10.1016/0165-0327(94)00074-J; ALLEN MT, 1995, BIOL PSYCHOL, V41, P1, DOI 10.1016/0301-0511(95)05123-R; AVERY D, 1976, ARCH GEN PSYCHIAT, V33, P1029; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bremmer MA, 2006, AM J GERIAT PSYCHIAT, V14, P523, DOI 10.1097/01.JGP.0000216172.31735.d5; BURGE PS, 1975, LANCET, V1, P1266; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; CASSEM NH, 1977, MED CLIN N AM, V61, P711, DOI 10.1016/S0025-7125(16)31291-3; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; DESIMONE G, 1990, CIRCULATION, V81, P107, DOI 10.1161/01.CIR.81.1.107; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dintenfass L, 1977, Bibl Anat, P498; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Gold PW, 2005, P NATL ACAD SCI USA, V102, P8303, DOI 10.1073/pnas.0503069102; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Holmes SD, 2006, PROG CARDIOVASC DIS, V49, P106, DOI 10.1016/j.pcad.2006.08.013; Huang Tiao-Lai, 2002, Chang Gung Med J, V25, P509; Isbister J P, 1987, Baillieres Clin Haematol, V1, P665, DOI 10.1016/S0950-3536(87)80020-3; JAN KM, 1975, CIRCULATION, V51, P1079, DOI 10.1161/01.CIR.51.6.1079; LADWIG KH, 1991, EUR HEART J, V12, P959; Licinio J, 2004, MOL PSYCHIATR, V9, P1075, DOI 10.1038/sj.mp.4001587; LOWE GDO, 1986, CLIN SCI, V71, P137, DOI 10.1042/cs0710137; Maes M, 1996, J AFFECT DISORDERS, V40, P23, DOI 10.1016/0165-0327(96)00038-9; Maes M, 1998, PSYCHIAT RES, V80, P201, DOI 10.1016/S0165-1781(98)00059-6; MULDOON MF, 1995, ARCH INTERN MED, V155, P615, DOI 10.1001/archinte.155.6.615; MULDOON MF, 1992, ARCH INTERN MED, V152, P775, DOI 10.1001/archinte.152.4.775; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; PATTERSON SM, 1995, HEALTH PSYCHOL, V14, P319, DOI 10.1037/0278-6133.14.4.319; PATTERSON SM, 1995, PSYCHOSOM MED, V57, P592, DOI 10.1097/00006842-199511000-00012; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; SORLIE PD, 1981, AM HEART J, V101, P456, DOI 10.1016/0002-8703(81)90136-8; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; VanHunsel F, 1996, PSYCHIAT RES, V65, P159, DOI 10.1016/S0165-1781(96)03010-7; Wong ML, 2006, P NATL ACAD SCI USA, V103, P15124, DOI 10.1073/pnas.0602795103	38	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2350	10.1371/journal.pone.0002350	http://dx.doi.org/10.1371/journal.pone.0002350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18985146	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200001
J	Hausmann, S; Marq, JB; Tapparel, C; Kolakofsky, D; Garcin, D				Hausmann, Stephane; Marq, Jean-Baptiste; Tapparel, Caroline; Kolakofsky, Daniel; Garcin, Dominique			RIG-I and dsRNA-Induced IFN beta Activation	PLOS ONE			English	Article							INNATE IMMUNITY; ANTIVIRAL RESPONSES; INTERFERON-BETA; RNA HELICASE; RECOGNITION; VIRUSES; ACID; INDUCTION; PROMOTER; DOMAIN	Except for viruses that initiate RNA synthesis with a protein primer (e. g., picornaviruses), most RNA viruses initiate RNA synthesis with an NTP, and at least some of their viral (ppp)RNAs remain unblocked during the infection. Consistent with this, most viruses require RIG-I to mount an innate immune response, whereas picornaviruses require mda-5. We have examined a SeV infection whose ability to induce interferon depends on the generation of capped dsRNA (without free 5' triphosphate ends), and found that this infection as well requires RIG-I and not mda-5. We also provide evidence that RIG-I interacts with poly-I/C in vivo, and that heteropolymeric dsRNA and poly-I/C interact directly with RIG-I in vitro, but in different ways; i.e., poly-I/C has the unique ability to stimulate the helicase ATPase of RIG-I variants which lack the C-terminal regulatory domain.	[Hausmann, Stephane; Marq, Jean-Baptiste; Tapparel, Caroline; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Tapparel, Caroline] Univ Geneva Hosp, Fac Med, Div Infect Dis, Lab Virol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Hausmann, S (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	daniel.kolakofsky@medecine.unige.ch		Tapparel Vu, Caroline/0000-0002-0411-6567	Swiss National Science Fund; Canton of Geneva	Swiss National Science Fund(Swiss National Science Foundation (SNSF)); Canton of Geneva	The work was funded by the Swiss National Science Fund, plus the Canton of Geneva. Neither had any role in the study or the decision to submit the manuscript, or its preparation.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; CHILDS K, 2006, VIROLOGY; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KING P, 1994, J BIOL CHEM, V269, P30609; KOLAKOFSKY D, 1976, CELL, V8, P547, DOI 10.1016/0092-8674(76)90223-3; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Poast J, 2002, J INTERF CYTOK RES, V22, P1035, DOI 10.1089/107999002760624260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strahle L, 2003, J VIROL, V77, P7903, DOI 10.1128/JVI.77.14.7903-7913.2003; STRAHLE L, 2007, J VIROL; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; TAKAHASI K, 2008, MOL CELL; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	30	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e3965	10.1371/journal.pone.0003965	http://dx.doi.org/10.1371/journal.pone.0003965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115016	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466300001
J	Xiao, QZ; Ye, S; Oberhollenzer, F; Mayr, A; Jahangiri, M; Willeit, J; Kiechl, S; Xu, QB				Xiao, Qingzhong; Ye, Shu; Oberhollenzer, Friedrich; Mayr, Agnes; Jahangiri, Marjan; Willeit, Johann; Kiechl, Stefan; Xu, Qingbo			SDF1 Gene Variation Is Associated with Circulating SDF1 alpha Level and Endothelial Progenitor Cell Number-The Bruneck Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHEMOKINE RECEPTOR CXCR4; PERIPHERAL-BLOOD; HEMATOPOIETIC PROGENITOR; MOLECULAR-CLONING; RISK-FACTORS; TOPCARE-AMI; MOBILIZATION; STEM; RECRUITMENT	Background: Stromal cell-derived factor-1 (SDF1) and its receptor CXC chemokine receptor 4 (CXCR4) play a critical role in progenitor cell homing, mobilization and differentiation. It would be interesting to assess the predictive value of SDF-1alpha level for EPC number, and to ascertain whether there is a relationship between SDF1 gene variation, plasma SDF-1alpha level, and the number and function of circulating EPCs. We also tested whether EPC number and function was related to CXCR4 gene variation. Methodology and Principal Findings: We genotyped a cohort of individuals who participated in the Bruneck Study for single nucleotide polymorphisms (SNPs) in the SDF1 and CXCR4 genes, and measured blood SDF1 alpha level as well as EPC number and function. SDF1 alpha levels were correlated with age, gender, alcohol consumption, circulating reticulocyte numbers, and concentrations of matrix metalloproteinase-9, C-reactive protein, cystatin C, fibrinogen and homocytein. In blood samples taken in 2005, EPC number was inversely associated with SDF1a level (p<0.001). EPC number in 2005 was also inversely associated with SDF1 alpha level in 2000 (p = 0.009), suggesting a predictive value of plasma SDF1 alpha level for EPC number. There was an association between the SDF1 gene rs2297630 SNP A/A genotype, increased SDF1 alpha level (p=0.002) and lower EPC number (p=0.006). Conclusions: Our data indicate that a SDF1 gene variation (rs2297630) has an influence on SDF1 alpha level and circulating EPC number, and that plasma SDF1 alpha level is a predictor of EPC number.	[Xu, Qingbo] Kings Coll London, Div Cardiovasc, BHF Ctr, London WC2R 2LS, England; [Ye, Shu] Queen Marys Univ London, Barts & London Sch Med & Dentist, London, England; [Oberhollenzer, Friedrich; Mayr, Agnes] Bruneck Hosp, Dept Internal & Lab Med, Brunico, Italy; [Jahangiri, Marjan] St George Hosp, Dept Cardiothorac Surg, London, England; [Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria	University of London; King's College London; University of London; Queen Mary University London; St Georges University London; Medical University of Innsbruck	Xiao, QZ (corresponding author), Kings Coll London, Div Cardiovasc, BHF Ctr, London WC2R 2LS, England.	qingbo.xu@kcl.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009	Ye, Shu/0000-0002-4126-4278; 	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	QX thanks support from the British Heart Foundation and Oak Foundation, and SY thanks support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arya SK, 1999, J HUMAN VIROL, V2, P133; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; de Oliveira CEC, 2007, J CLIN LAB ANAL, V21, P49, DOI 10.1002/jcla.20142; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimberg J, 2007, INT J MOL MED, V19, P11; Dommange F, 2006, FASEB J, V20, P1913, DOI 10.1096/fj.05-5667fje; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Foresta C, 2005, INT J IMPOT RES, V17, P288, DOI 10.1038/sj.ijir.3901311; Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16; Ghilardi G, 2008, CYTOKINE, V41, P24, DOI 10.1016/j.cyto.2007.10.007; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kimura R, 2005, HUM MOL GENET, V14, P1579, DOI 10.1093/hmg/ddi166; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lima G, 2007, HUM IMMUNOL, V68, P980, DOI 10.1016/j.humimm.2007.10.007; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Whittaker A, 2008, EUR HEART J, V29, P332, DOI 10.1093/eurheartj/ehm602; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiao QZ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000975; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zafiropoulos A, 2004, J MED GENET, V41, DOI 10.1136/JMG.2003.013649; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	51	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4061	10.1371/journal.pone.0004061	http://dx.doi.org/10.1371/journal.pone.0004061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115008	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000265466300005
J	Zhang, B; Ma, JX				Zhang, Bin; Ma, Jian-xing			SERPINA3K Prevents Oxidative Stress Induced Necrotic Cell Death by Inhibiting Calcium Overload	PLOS ONE			English	Article								Background: SERPINA3K, an extracellular serine proteinase inhibitor (serpin), has been shown to have decreased levels in the retinas of diabetic rats, which may contribute to diabetic retinopathy. The function of SERPINA3K in the retina has not been investigated. Methodology/Principal Findings: The present study identified a novel function of SERPINA3K, i.e. it protects retinal cells against oxidative stress-induced cell death including retinal neuronal cells and Muller cells. Flow-cytometry showed that the protective effect of SERPINA3K on Muller cells is via reducing oxidation-induced necrosis. Measurements of intracellular calcium concentration showed that SERPINA3K prevented the intracellular calcium overload induced by H(2)O(2). A similar protective effect was observed using a calcium chelator (BAPTA/AM). Further, SERPINA3K inhibited the phosphorylation of phospholipase C (PLC)-gamma1 induced by H(2)O(2). Likewise, a specific PLC inhibitor showed similar protective effects on Muller cells exposed to H(2)O(2). Furthermore, the protective effect of SERPINA3K was attenuated by a specific PLC activator (m-3M3FBS). Finally, in a binding assay, SERPINA3K displayed saturable and specific binding on Muller cells. Conclusion/Significance: These results for the first time demonstrate that SERPINA3K is an endogenous serpin which protects cells from oxidative stress-induced cells death, and its protective effect is via blocking the calcium overload through the PLC pathway. The decreased retinal levels of SERPINA3K may represent a new pathogenic mechanism for the retinal Muller cell dysfunction and neuron loss in diabetes.	[Zhang, Bin; Ma, Jian-xing] Univ Oklahoma, Dept Cell Biol, Dept Med, Hlth Sci Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhang, B (corresponding author), Univ Oklahoma, Dept Cell Biol, Dept Med, Hlth Sci Ctr, Oklahoma City, OK USA.	jian-xing-ma@ouhsc.edu			NIH [EY012231, EY015650, EY004939, P20RR024215]; National Center for Research Resources; OCAST; Foundation fighting Blindness and Research for Prevention of Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY015650, R01EY004939, R33EY015650, R01EY012231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OCAST; Foundation fighting Blindness and Research for Prevention of Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants EY012231, EY015650, EY004939, and P20RR024215 from the National Center for Research Resources, and grants from OCAST, Foundation fighting Blindness and Research for Prevention of Blindness. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Abraham MC, 2007, DEV CELL, V13, P464, DOI 10.1016/j.devcel.2007.09.008; Altomare E, 1997, EUR J CLIN INVEST, V27, P141, DOI 10.1046/j.1365-2362.1997.780629.x; ANDERSON RE, 1994, ADV EXP MED BIOL, V366, P73; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; CHAO J, 1990, J BIOL CHEM, V265, P16394; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; Clement MV, 1998, FEBS LETT, V440, P13, DOI 10.1016/S0014-5793(98)01410-0; CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Gao G, 2003, DIABETOLOGIA, V46, P689, DOI 10.1007/s00125-003-1085-9; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gosbell AD, 2006, INVEST OPHTH VIS SCI, V47, P2613, DOI 10.1167/iovs.05-0962; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hatcher HC, 1997, INVEST OPHTH VIS SCI, V38, P658; Hong JH, 2006, J BIOL CHEM, V281, P13057, DOI 10.1074/jbc.M601726200; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; MA JX, 1995, J BIOL CHEM, V270, P451, DOI 10.1074/jbc.270.1.451; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; MURRAY SR, 1990, J CARDIOVASC PHARM, V15, pS7, DOI 10.1097/00005344-199000156-00003; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; Ohira A, 2003, INVEST OPHTH VIS SCI, V44, P1230, DOI 10.1167/iovs.02-0191; Poitry S, 2000, J NEUROSCI, V20, P1809; Puro Donald G, 2002, Trans Am Ophthalmol Soc, V100, P339; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rothstein EC, 2002, AM J PHYSIOL-HEART C, V283, pH598, DOI 10.1152/ajpheart.00198.2002; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Syntichaki P, 2002, EMBO REP, V3, P604, DOI 10.1093/embo-reports/kvf138; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Willbold E, 1997, J BRAIN RES, V38, P383; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	40	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4077	10.1371/journal.pone.0004077	http://dx.doi.org/10.1371/journal.pone.0004077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115003	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466300016
J	Gingras, Y; Lariviere, V; Macaluso, B; Robitaille, JP				Gingras, Yves; Lariviere, Vincent; Macaluso, Benoit; Robitaille, Jean-Pierre			The Effects of Aging on Researchers' Publication and Citation Patterns	PLOS ONE			English	Article							RESEARCH PERFORMANCE; AGE; SCIENCE; PRODUCTIVITY; INDICATORS; SCIENTISTS; IMPACT; OUTPUT	The average age at which U. S. researchers receive their first grant from NIH has increased from 34.3 in 1970, to 41.7 in 2004. These data raise the crucial question of the effects of aging on the scientific productivity and impact of researchers. Drawing on a sizeable sample of 6,388 university professors in Quebec who have published at least one paper between 2000 and 2007, our results identify two turning points in the professors' careers. A first turning point is visible at age 40 years, where researchers start to rely on older literature and where their productivity increases at a slower pace-after having increased sharply since the beginning of their career. A second turning point can be seen around age 50, when researchers are the most productive whereas their average scientific impact is at its lowest. Our results also show that older professors publish fewer first-authored papers and move closer to the end of the list of co-authors. Although average scientific impact per paper decreases linearly until about age 50, the average number of papers in highly cited journals and among highly cited papers rises continuously until retirement. Our results show clearly that productivity and impact are not a simple and declining function of age and that we must take into account the collaborative aspects of scientific research. Science is a collective endeavor and, as our data shows, researchers of all ages play a significant role in its dynamic.	[Gingras, Yves; Lariviere, Vincent; Macaluso, Benoit; Robitaille, Jean-Pierre] Univ Quebec, OST, CIRST, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Gingras, Y (corresponding author), Univ Quebec, OST, CIRST, Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.	gingras.yves@uqam.ca	Lariviere, Vincent/AAF-3179-2019; GIngras, Yves/AAQ-7556-2020		Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation; Fonds de la recherche en sante du Quebec; Fonds quebecois de la recherche sur la societe et la culture; Fonds quebecois de la recherche sur la nature et les technologies	Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds quebecois de la recherche sur la societe et la culture(FQRNT); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This research was made possible by research contracts with Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation, Fonds de la recherche en sante du Quebec, Fonds quebecois de la recherche sur la societe et la culture and the Fonds quebecois de la recherche sur la nature et les technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS C W, 1946, Isis, V36, P166, DOI 10.1086/347941; ALLISON PD, 1974, AM SOCIOL REV, V39, P596, DOI 10.2307/2094424; ARCHAMBAULT E, 2009, SCIENTOMETR IN PRESS, V79; Archambault E, 2006, SCIENTOMETRICS, V68, P329, DOI 10.1007/s11192-006-0115-z; *ASS U COLL CAN, 2007, TRENDS HIGH ED, V2; Barnett GA, 2008, J AM SOC INF SCI TEC, V59, P526, DOI 10.1002/asi.20706; Biagioli Mario, 2003, SCI AUTHORSHIP CREDI; Birnholtz JP, 2006, J AM SOC INF SCI TEC, V57, P1758, DOI 10.1002/asi.20380; BOURDIEU P, 1975, SOC SCI INFORM, V14, P19, DOI 10.1177/053901847501400602; COLE S, 1979, AM J SOCIOL, V84, P958, DOI 10.1086/226868; *CREPUQ, 2006, SYST U QUEB DONN IND; DENNIS W, 1956, SCIENCE, V123, P724, DOI 10.1126/science.123.3200.724; Dietrich A, 2007, J CREATIVE BEHAV, V41, P54, DOI 10.1002/j.2162-6057.2007.tb01281.x; Feist G., 2006, PSYCHOL SCI ORIGINS; GARFIELD E, 1990, J AM SOC INF SCI TEC, V57, P997; GIERYN TF, 1981, SCIENTOMETRICS, V3, P325, DOI 10.1007/BF02021125; HOLDEN C, 2008, SCIENCE, V31, P391; Horner K L, 1986, Psychol Aging, V1, P319, DOI 10.1037/0882-7974.1.4.319; Kaiser J, 2008, SCIENCE, V322, P848, DOI 10.1126/science.322.5903.848; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Kyvik S, 2008, SCIENTOMETRICS, V76, P439, DOI 10.1007/s11192-007-1767-z; Lariviere V, 2008, J AM SOC INF SCI TEC, V59, P288, DOI 10.1002/asi.20744; Lehman H., 1953, AGE ACHIEVEMENT; Liang LM, 2001, SCIENTOMETRICS, V52, P471, DOI 10.1023/A:1014252017971; Merton R. K., 1957, SOCIAL THEORY SOCIAL; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; Moed HF, 1996, SCIENTOMETRICS, V35, P177, DOI 10.1007/BF02018476; OVER R, 1988, SCIENTOMETRICS, V13, P215, DOI 10.1007/BF02019959; Pontille D., 2004, SIGNATURE SCI SOCIOL; PRICE DJD, 1970, COMMUNICATION SCI EN, P155; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Shinn Terry, 1988, ACTES RECHERCHE SCI, V74, P2, DOI DOI 10.3406/ARSS.1988.2430; Sigogneau A, 2000, SCIENTOMETRICS, V47, P589, DOI 10.1023/A:1005628218890; Simonton D.K., 1994, GREATNESS WHO MAKES; SIMONTON DK, 1984, DEV REV, V4, P77, DOI 10.1016/0273-2297(84)90020-0; SIMONTON DK, 1997, PSYCHO REV, V104, P251; STERN N, 1978, SOC STUD SCI, V8, P127, DOI 10.1177/030631277800800105; Wray KB, 2004, SCIENTOMETRICS, V61, P117, DOI 10.1023/B:SCIE.0000037367.99073.bb; Wray KB, 2003, SOC STUD SCI, V33, P137, DOI 10.1177/0306312703033001961; Zuckerman H., 1977, SCI ELITE NOBEL LAUR; Zuckerman H., 1973, SOCIOL SCI, P493	43	119	128	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4048	10.1371/journal.pone.0004048	http://dx.doi.org/10.1371/journal.pone.0004048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112502	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466000012
J	Klyubin, AS; Polani, D; Nehaniv, CL				Klyubin, Alexander S.; Polani, Daniel; Nehaniv, Chrystopher L.			Keep Your Options Open: An Information-Based Driving Principle for Sensorimotor Systems	PLOS ONE			English	Article							THEORETIC APPROACH; INTEGRATION; COMPLEXITY; ENERGY; BACK	The central resource processed by the sensorimotor system of an organism is information. We propose an information-based quantity that allows one to characterize the efficiency of the perception-action loop of an abstract organism model. It measures the potential of the organism to imprint information on the environment via its actuators in a way that can be recaptured by its sensors, essentially quantifying the options available and visible to the organism. Various scenarios suggest that such a quantity could identify the preferred direction of evolution or adaptation of the sensorimotor loop of organisms.	[Klyubin, Alexander S.; Polani, Daniel; Nehaniv, Chrystopher L.] Univ Hertfordshire, Sch Comp Sci, Adapt Syst Res Grp, Hatfield AL10 9AB, Herts, England; [Polani, Daniel; Nehaniv, Chrystopher L.] Univ Hertfordshire, Sch Comp Sci, Algorithms Res Grp, Hatfield AL10 9AB, Herts, England	University of Hertfordshire; University of Hertfordshire	Klyubin, AS (corresponding author), Univ Hertfordshire, Sch Comp Sci, Adapt Syst Res Grp, Hatfield AL10 9AB, Herts, England.	D.Polani@herts.ac.uk	Polani, Daniel/AAJ-9529-2020	Nehaniv, Chrystopher L./0000-0002-7807-1875	University of Hertfordshire [PhD studentship]	University of Hertfordshire	Alexander Klyubin was funded by a PhD studentship of the University of Hertfordshire. Daniel Polani and Chrystopher Nehaniv are staff members of the University of Hertfordshire. The funders played no role in the study design and execution.	Anthony T., 2008, P ARTIFICIAL LIFE, P25; Ashby W. R., 1956, INTRO CYBERNETICS; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Ay N, 2008, EUR PHYS J B, V63, P329, DOI 10.1140/epjb/e2008-00175-0; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1959, SENS COMMUN, P217; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bergstrom CT, 2004, 2004 IEEE INFORMATION THEORY WORKSHOP, PROCEEDINGS, P50; BERTSCHINGER N, 2006, P WORKSH ART AUT AL, P7; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; BLAHUT RE, 1972, IEEE T INFORM THEORY, V18, P460, DOI 10.1109/TIT.1972.1054855; BLANK D, 2005, CYBERNETICS SYSTEMS, V36; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARIANI P, 1992, PRACTICE AUTONOMOUS, P484; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Csikszentmihalyi M, 1978, BOREDOM ANXIETY EXPE; Der R, 1999, CONCUR SYST ENGN SER, V55, P43; Der R, 2000, P WORKSH SOAVE 2000, V643, P39; Emmeche C, 2001, SEMIOTICA, V134, P653; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; GIBSON James J., 1979, ECOLOGICAL APPROACH; Harvey I, 2004, Artificial Life IX, P309; Kaplan F, 2004, LECT NOTES ARTIF INT, V3139, P259; Kauffman Stuart A., 1993; Klyubin AS, 2007, NEURAL COMPUT, V19, P2387, DOI 10.1162/neco.2007.19.9.2387; Klyubin AS, 2004, ARTIFICIAL LIFE IX, P563; Klyubin AS, 2005, LECT NOTES ARTIF INT, V3630, P744, DOI 10.1007/11553090_75; Klyubin AS, 2004, 2004 NASA/DOD CONFERENCE ON EVOLVABLE HARDWARE, PROCEEDINGS, P177; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LAUGHLIN SB, 2000, INFORMATION THEORY B, P41; Lungarella M, 2005, NEUROINFORMATICS, V3, P243, DOI 10.1385/NI:3:3:243; Lungarella M, 2003, CONNECT SCI, V15, P151, DOI 10.1080/09540090310001655110; LUNGARELLA M, 2006, PLOS COMPUTATIONAL B, V2; MORISSET J, 1995, CELL SIGNAL, V7, P195, DOI 10.1016/0898-6568(94)00081-L; Nadal JP, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P153; Nehaniv C. L., 1999, Proceedings of the 1999 IEEE International Symposium on Intelligent Control Intelligent Systems and Semiotics (Cat. No.99CH37014), P435, DOI 10.1109/ISIC.1999.796694; NEHANIV CL, 2002, ARTIF LIFE, V8, P345; Pfeifer R, 2001, LECT NOTES COMPUT SC, V2000, P294; PHILIPONA D, 2004, ADV NEURAL INFORM PR, V16; Polani D., 2006, P ARTIFICIAL LIFE, VX, P337; Polani D, 2001, LECT NOTES ARTIF INT, V2159, P704; Porr B, 2003, NEURAL COMPUT, V15, P865, DOI 10.1162/08997660360581930; Press W.H., 1996, NUMERICAL RECIPES C; Prokopenko M, 2006, LECT NOTES COMPUT SC, V4095, P558; RIEKE F, 1999, SPIKES BRADFORD BOOK; ROCHA LM, 2006, P ARTIFICIAL LIFE, V10; SCHMIDHUBER J, 2002, ADV EVOLUTIONARY COM, P579; Shalizi CR, 2001, J STAT PHYS, V104, P817, DOI 10.1023/A:1010388907793; SHANNON CE, 1958, IBM J RES DEV, V2, P289, DOI 10.1147/rd.24.0289; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SINGH S, 2005, P 18 ANN C NEUR INF; SPORNS O, 2006, P ARTIFICIAL LIFE, V10, P323; Steels L, 2004, LECT NOTES ARTIF INT, V3139, P231; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; TAYLOR SF, 2007, ARXIVORG07124382QBIO; Tishby Naftali, 1999, P ANN ALL C COMM CON; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Touchette H, 2004, PHYSICA A, V331, P140, DOI 10.1016/j.physa.2003.09.007; Touchette H, 2000, PHYS REV LETT, V84, P1156, DOI 10.1103/PhysRevLett.84.1156; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464	71	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4018	10.1371/journal.pone.0004018	http://dx.doi.org/10.1371/journal.pone.0004018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107219	gold, Green Published, Green Submitted			2022-12-27	WOS:000265463000013
J	Tsakiris, M				Tsakiris, Manos			Looking for Myself: Current Multisensory Input Alters Self-Face Recognition	PLOS ONE			English	Article							OWN FACE; RIGHT-HEMISPHERE; BODY-OWNERSHIP; PERCEPTION; HAND; AGENCY; EXPERIENCE; ILLUSION; NETWORK; OTHERS	How do I know the person I see in the mirror is really me? Is it because I know the person simply looks like me, or is it because the mirror reflection moves when I move, and I see it being touched when I feel touch myself? Studies of face-recognition suggest that visual recognition of stored visual features inform self-face recognition. In contrast, body-recognition studies conclude that multisensory integration is the main cue to selfhood. The present study investigates for the first time the specific contribution of current multisensory input for self-face recognition. Participants were stroked on their face while they were looking at a morphed face being touched in synchrony or asynchrony. Before and after the visuo-tactile stimulation participants performed a self-recognition task. The results show that multisensory signals have a significant effect on self-face recognition. Synchronous tactile stimulation while watching another person's face being similarly touched produced a bias in recognizing one's own face, in the direction of the other person included in the representation of one's own face. Multisensory integration can update cognitive representations of one's body, such as the sense of ownership. The present study extends this converging evidence by showing that the correlation of synchronous multisensory signals also updates the representation of one's face. The face is a key feature of our identity, but at the same time is a source of rich multisensory experiences used to maintain or update self-representations.	Univ London, Dept Psychol, Egham, Surrey, England; [Tsakiris, Manos] UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; Royal Holloway University London; University of London; University College London	Tsakiris, M (corresponding author), Univ London, Dept Psychol, Egham, Surrey, England.	manos.tsakiris@rhul.ac.uk	TSAKIRIS, MANOS/C-1529-2008	TSAKIRIS, MANOS/0000-0001-7753-7576	ESRC [RES-061-25-0233]	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ESRC First Grant RES-061-25-0233 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnier Amanda J, 2008, Cogn Neuropsychiatry, V13, P406, DOI 10.1080/13546800802355666; BERTENTHAL B, 1987, DEV PSYCHOL, V14, P44; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; Bredart Serge, 2004, Cogn Neuropsychiatry, V9, P183, DOI 10.1080/13546800344000075; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Farrer C, 2003, CONSCIOUS COGN, V12, P609, DOI 10.1016/S1053-8100(03)00047-3; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; LONGO M, WHAT IS EMBODIMENT P, V107, P978; LONGO M, ACTA PSYCHO IN PRESS; METLZOFF AN, 2008, DEVELOPMENTAL SCI, V10, P126; METLZOFF AN, 2006, ACTA PSYCHOL, V124, P26; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2004, CONSCIOUS COGN, V13, P197, DOI 10.1016/j.concog.2003.10.001; Postal K. S., 2005, LOST SELF PATHOLOGIE, P131; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Slaughter V, 2004, CURR DIR PSYCHOL SCI, V13, P219, DOI 10.1111/j.0963-7214.2004.00312.x; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2	44	204	209	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4040	10.1371/journal.pone.0004040	http://dx.doi.org/10.1371/journal.pone.0004040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107208	Green Published, gold, Green Submitted			2022-12-27	WOS:000265463000028
J	Wang, FY; Xiao, JF; Pan, LL; Yang, M; Zhang, G; Jin, SG; Yu, J				Wang, Fengyu; Xiao, Jingfa; Pan, Linlin; Yang, Ming; Zhang, Guoqiang; Jin, Shouguang; Yu, Jun			A Systematic Survey of Mini-Proteins in Bacteria and Archaea	PLOS ONE			English	Article								Background: Mini-proteins, defined as polypeptides containing no more than 100 amino acids, are ubiquitous in prokaryotes and eukaryotes. They play significant roles in various biological processes, and their regulatory functions gradually attract the attentions of scientists. However, the functions of the majority of mini-proteins are still largely unknown due to the constraints of experimental methods and bioinformatic analysis. Methodology/Principal Findings: In this article, we extracted a total of 180,879 mini-proteins from the annotations of 532 sequenced genomes, including 491 strains of Bacteria and 41 strains of Archaea. The average proportion of mini-proteins among all genomic proteins is approximately 10.99%, but different strains exhibit remarkable fluctuations. These mini-proteins display two notable characteristics. First, the majority are species-specific proteins with an average proportion of 58.79% among six representative phyla. Second, an even larger proportion (70.03% among all strains) is hypothetical proteins. However, a fraction of highly conserved hypothetical proteins potentially play crucial roles in organisms. Among mini-proteins with known functions, it seems that regulatory and metabolic proteins are more abundant than essential structural proteins. Furthermore, domains in mini-proteins seem to have greater distributions in Bacteria than Eukarya. Analysis of the evolutionary progression of these domains reveals that they have diverged to new patterns from a single ancestor. Conclusions/Significance: Mini-proteins are ubiquitous in bacterial and archaeal species and play significant roles in various functions. The number of mini-proteins in each genome displays remarkable fluctuation, likely resulting from the differential selective pressures that reflect the respective life-styles of the organisms. The answers to many questions surrounding mini-proteins remain elusive and need to be resolved experimentally.	[Wang, Fengyu; Xiao, Jingfa; Yang, Ming; Zhang, Guoqiang; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wang, Fengyu; Xiao, Jingfa; Yang, Ming; Zhang, Guoqiang; Yu, Jun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Pan, Linlin] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; State University System of Florida; University of Florida	Wang, FY (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	xiaojingfa@big.ac.cn; junyu56@gmail.com	郑, 征/C-8514-2011; Jin, Shouguang/N-5548-2016		Chinese Academy of Science [100 Talents]	Chinese Academy of Science(Chinese Academy of Sciences)	The work was supported by "100 Talents" grant from the Chinese Academy of Science awarded to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175; [Anonymous], NCBI GEN; [Anonymous], INTERPROSCAN SEQUENC; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ebedes J, 2004, BIOINFORMATICS, V20, P1193, DOI 10.1093/bioinformatics/bth055; *FAB POLT GR MAPA, 2001, BIOCH MOL BIOL ED, V29, P16; Gellman SH, 2002, NAT STRUCT BIOL, V9, P408, DOI 10.1038/nsb0602-408; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; Imperiali B, 1999, J PEPT RES, V54, P177, DOI 10.1034/j.1399-3011.1999.00121.x; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; KRIEGER DT, 1983, SCIENCE, V222, P975, DOI 10.1126/science.6139875; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Martin L, 2000, CURR PROTEIN PEPT SC, V1, P403, DOI 10.2174/1389203003381306; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wu WH, 2005, J BACTERIOL, V187, P6058, DOI 10.1128/JB.187.17.6058-6068.2005	24	34	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4027	10.1371/journal.pone.0004027	http://dx.doi.org/10.1371/journal.pone.0004027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107199	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000021
J	Rits, MAN; van Dort, KA; Kootstra, NA				Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.			Polymorphisms in the Regulatory Region of the Cyclophilin A Gene Influence the Susceptibility for HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLD-WORLD MONKEY; CLINICAL-COURSE; LIFE-CYCLE; RESTRICTION; VARIANTS; TRANSDUCTION; PROGRESSION; RESISTANCE; MUTATIONS	Background: Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression. Here we studied whether these polymorphisms are associated with susceptibility to HIV-1 infection and disease progression in the Amsterdam Cohort on HIV-1 infection and AIDS (ACS) in a group of men having sex with men (MSM) and drug users (DU). Methodology/Principal Findings: We screened participants of the ACS for the C1604G and A1650G polymorphisms in the regulatory regions of CypA. The prevalence of the 1650G allele was significantly higher in high risk seronegative MSM than in HIV-1 infected MSM. However, C1604G or A1650G were not associated with the clinical course of infection in MSM of the ACS. Interestingly, participants of the ACS-DU who carried the 1604G allele showed a significantly accelerated progression when viral RNA load above 10(4.5) copies per ml plasma was used as an endpoint in survival analysis. Conclusion/Significance: The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the CypA gene may be associated with protection from HIV-1 infection, while the 1604G allele may have a weak association with the clinical course of infection in DU.	[Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rits, MAN (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Netherlands Organization for scientific Research [96.36.024]; Dutch AIDS fund [2004062]; Landsteiner Foundation for Blood Transfusion Research [0435]	Netherlands Organization for scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch AIDS fund; Landsteiner Foundation for Blood Transfusion Research	Netherlands Organization for scientific Research (NWO grant number 96.36.024); the Dutch AIDS fund (grant 2004062) and the Landsteiner Foundation for Blood Transfusion Research (grant 0435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; An P, 2007, PLOS PATHOG, V3, P849, DOI 10.1371/journal.ppat.0030088; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bleiber G, 2005, J VIROL, V79, P12674, DOI 10.1128/JVI.79.20.12674-12680.2005; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V21, p1S; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Geskus RB, 2000, STAT MED, V19, P1753, DOI 10.1002/1097-0258(20000715)19:13&lt;1753::AID-SIM487&gt;3.0.CO;2-F; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Palacin M, 2008, INT J IMMUNOGENET, V35, P159, DOI 10.1111/j.1744-313X.2008.00755.x; Rits MAN, 2007, MOL THER, V15, P930, DOI 10.1038/mt.sj.6300091; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; TERSMETTE M, 1989, VIROLOGY, V171, P149, DOI 10.1016/0042-6822(89)90521-7; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3975	10.1371/journal.pone.0003975	http://dx.doi.org/10.1371/journal.pone.0003975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092998	Green Submitted, gold, Green Published			2022-12-27	WOS:000265458600010
J	Humbert, M; Rasmussen, RA; Ong, H; Kaiser, FMP; Hu, SL; Ruprecht, RM				Humbert, Michael; Rasmussen, Robert A.; Ong, Helena; Kaiser, Fabian M. P.; Hu, Shiu-Lok; Ruprecht, Ruth M.			Inducing Cross-Clade Neutralizing Antibodies against HIV-1 by Immunofocusing	PLOS ONE			English	Article								Background: Although vaccines are important in preventing viral infections by inducing neutralizing antibodies (nAbs), HIV-1 has proven to be a difficult target and escapes humoral immunity through various mechanisms. We sought to test whether HIV-1 Env mimics may serve as immunogens. Methodology/Principal Findings: Using random peptide phage display libraries, we identified the epitopes recognized by polyclonal antibodies of a rhesus monkey that had developed high-titer, broadly reactive nAbs after infection with a simian-human immunodeficiency virus (SHIV) encoding env of a recently transmitted HIV-1 clade C (HIV-C). Phage peptide inserts were analyzed for conformational and linear homology using computational analysis; some peptides mimicked various domains of the original HIV-C Env, such as conformational V3 loop epitopes and the conserved linear region of the gp120 C-terminus. Next, we devised a novel prime/boost strategy to test the immunogenicity of such phage-displayed peptides and primed mice only once with HIV-C gp160 DNA followed by boosting with mixtures of recombinant phages. Conclusions/Significance: This strategy, which was designed to focus the immune system on a few Env epitopes (immunofocusing), not only induced HIV-C gp160 binding antibodies andcross-clade nAbs, but also linked a conserved HIV Env region for the first time to the induction of nAbs: the C-terminus of gp120. The identification of conserved antigen mimics may lead to novel immunogens capable of inducing broadly reactive nAbs.	[Rasmussen, Robert A.; Ong, Helena; Kaiser, Fabian M. P.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Humbert, Michael; Rasmussen, Robert A.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Hu, Shiu-Lok] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Humbert, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu			NIH [PO1 AI048240, R37 AI034266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R37AI034266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant PO1 AI048240 to RMR, RAR, and SLH and R37 AI034266 to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bublil EM, 2006, FASEB J, V20, P1762, DOI 10.1096/fj.05-5509rev; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Conley AJ, 1996, J VIROL, V70, P6751, DOI 10.1128/JVI.70.10.6751-6758.1996; Davis D, 1997, VACCINE, V15, P1661, DOI 10.1016/S0264-410X(97)00084-4; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Enshell-Seijffers D, 2001, FASEB J, V15, P2112, DOI 10.1096/fj.00-0898com; Felici F, 1996, METHOD ENZYMOL, V267, P116; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Ferrantelli F, 2004, J INFECT DIS, V189, P71, DOI 10.1086/380102; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Galfre G, 1996, METHOD ENZYMOL, V267, P109; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 1997, INT IMMUNOL, V9, P1281, DOI 10.1093/intimm/9.9.1281; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-451; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; KELLER PM, 1993, VIROLOGY, V193, P709, DOI 10.1006/viro.1993.1179; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Konigs C, 2000, EUR J IMMUNOL, V30, P1162, DOI 10.1002/(SICI)1521-4141(200004)30:4<1162::AID-IMMU1162>3.0.CO;2-L; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; MEOLA A, 1995, J IMMUNOL, V154, P3162; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POSNER MR, 1991, J IMMUNOL, V146, P4325; Prezzi C, 1996, J IMMUNOL, V156, P4504; Rasmussen RA, 2006, VACCINE, V24, P2324, DOI 10.1016/j.vaccine.2005.11.063; Riemer AB, 2006, EUR J IMMUNOL, V36, P1267, DOI 10.1002/eji.200535279; Roccasecca R, 2001, MOL IMMUNOL, V38, P485, DOI 10.1016/S0161-5890(01)00084-0; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Rowland-Jones S, 2008, EUR J IMMUNOL, V38, P13, DOI 10.1002/eji.200790061; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scala G, 1999, J IMMUNOL, V162, P6155; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; SIDDAPPA NB, J VIROL IN PRESS; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; *UNAIDS, 2007, AIDS EP UPD; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu WD, 2001, J HUMAN VIROL, V4, P55; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zuercher AW, 2000, EUR J IMMUNOL, V30, P128, DOI 10.1002/1521-4141(200001)30:1<128::AID-IMMU128>3.3.CO;2-O; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001	71	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3937	10.1371/journal.pone.0003937	http://dx.doi.org/10.1371/journal.pone.0003937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081789	Green Submitted, Green Published, gold			2022-12-27	WOS:000265458200004
J	Tachikawa, M				Tachikawa, Masashi			Fluctuation Induces Evolutionary Branching in a Mathematical Model of Ecosystems	PLOS ONE			English	Article								Ecological systems are always subjected to various environmental fluctuations. They evolve under these fluctuations and the resulting systems are robust against them. The diversity in ecological systems is also acquired through the evolution. How do the fluctuations affect the evolutionary processes? Do the fluctuations have direct impact on the species diversity in ecological systems? In the present paper, we investigate the relation between the environmental fluctuation and the evolution of species diversity with a mathematical model of evolutionary ecology. In the model, individual organisms compete for a single restricted resource and the temporal fluctuation in the resource supply is introduced as the environmental fluctuation. The evolutionary process is represented by the mutational change of genotypes which determines their resource utilization strategies. We found that when the environmental state is switched form static to fluctuating conditions, the initial closely related population distributed around the genotype adapted for the static environment is destabilized and divided into two groups in the genotype space; i.e., the evolutionary branching is induced by the environmental fluctuation. The consequent multiple species structures is evolutionary stable at the presence of the fluctuation. We perform the evolutionary invasion analysis for the phenomena and illustrate the mechanisms of the branchings. The results indicate a novel process of increasing the species diversity via evolutionary branching, and the analysis reveals the mechanisims of the branching preocess as the response to the environmental fluctuation. The robustness of the evolutionary process is also discussed.	Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Complex Syst Biol Project, Tokyo, Japan	Japan Science & Technology Agency (JST)	Tachikawa, M (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Complex Syst Biol Project, Tokyo, Japan.	mtach@complex.c.u-tokyo.ac.jp						ARMSTRONG R, 1980, AM NAT, V15, P151; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CUSHING JM, 1984, SIAM J APPL MATH, V44, P392, DOI 10.1137/0144026; Dieckmann U, 2007, BIOL MED PHYS BIOMED, P145, DOI 10.1007/978-3-540-34428-5_8; Eigen M, 1979, THE HYPERCYCLE, P60; Gause G. F., 1934, STRUGGLE EXISTENCE; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Geritz SAH, 2007, THEOR POPUL BIOL, V71, P424, DOI 10.1016/j.tpb.2007.03.006; Holling C.S., 1965, MEM ENTOMOL SOC CAN, V45, P3; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; KANEKO K, 1992, PHYSICA D, V56, P406, DOI 10.1016/0167-2789(92)90179-Q; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Smith H.L., 1996, J AM CHEM SOC, V117, P11616, DOI [10.1021/ja9654387, DOI 10.1021/JA9654387]; TILMAN D, 1987, RESOURCE COMPETITION; White A, 2006, EVOL ECOL RES, V8, P387; Yanagida T, 2007, BIOSYSTEMS, V88, P228, DOI 10.1016/j.biosystems.2006.08.012	25	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3925	10.1371/journal.pone.0003925	http://dx.doi.org/10.1371/journal.pone.0003925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081842	gold, Green Published, Green Submitted			2022-12-27	WOS:000265456300004
J	Le Clech, M				Le Clech, Mikael			Role of CAP350 in Centriolar Tubule Stability and Centriole Assembly	PLOS ONE			English	Article								Background: Centrioles are microtubule-based cylindrical structures composed of nine triplet tubules and are required for the formation of the centrosome, flagella and cilia. Despite theirs importance, centriole biogenesis is poorly understood. Centrosome duplication is initiated at the G1/S transition by the sequential recruitment of a set of conserved proteins under the control of the kinase Plk4. Subsequently, the procentriole is assembled by the polymerization of centriolar tubules via an unknown mechanism involving several tubulin paralogs. Methodology/Principal Findings: Here, we developed a cellular assay to study centrosome duplication and procentriole stability based on its sensitivity to the microtubule-depolymerizing drug nocodazole. By using RNA interference experiments, we show that the stability of growing procentrioles is regulated by the microtubule-stabilizing protein CAP350, independently of hSAS-6 and CPAP which initiate procentriole growth. Furthermore, our analysis reveals the critical role of centriolar tubule stability for an efficient procentriole growth. Conclusions/Significance: CAP350 belongs to a new class of proteins which associate and stabilize centriolar tubules to control centriole duplication.			Le Clech, M (corresponding author), CNRS, Inst Genet Humaine, UPR 1142, Montpellier, France.	mikael.leclech@igh.cnrs.fr			Max Planck society [postdoctoral fellowship]	Max Planck society(Max Planck Society)	This work was supported by the Max Planck society. M Le CLech was a recipient of a postdoctoral fellowship from the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Hoppeler-Lebel A, 2007, J CELL SCI, V120, P3299, DOI 10.1242/jcs.013102; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KURIYAMA R, 1982, J CELL SCI, V53, P155; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lohret TA, 1998, MOL BIOL CELL, V9, P1195, DOI 10.1091/mbc.9.5.1195; Marshall WF, 2003, CURR BIOL, V13, pR55, DOI 10.1016/S0960-9822(02)01427-6; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Regnard C, 1999, J CELL SCI, V112, P4281; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Uetake Y, 2007, CURR BIOL, V17, P2081, DOI 10.1016/j.cub.2007.10.065; WENDELL KL, 1993, J CELL SCI, V104, P261; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3855	10.1371/journal.pone.0003855	http://dx.doi.org/10.1371/journal.pone.0003855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052644	Green Published, gold			2022-12-27	WOS:000265452200007
J	Luo, HW; Shi, J; Arndt, W; Tang, JJ; Friedman, R				Luo, Haiwei; Shi, Jian; Arndt, William; Tang, Jijun; Friedman, Robert			Gene Order Phylogeny of the Genus Prochlorococcus	PLOS ONE			English	Article							RECONSTRUCTION; ECOTYPES; TREE	Background: Using gene order as a phylogenetic character has the potential to resolve previously unresolved species relationships. This character was used to resolve the evolutionary history within the genus Prochlorococcus, a group of marine cyanobacteria. Methodology/Principal Findings: Orthologous gene sets and their genomic positions were identified from 12 species of Prochlorococcus and 1 outgroup species of Synechococcus. From this data, inversion and breakpoint distance-based phylogenetic trees were computed by GRAPPA and FastME. Statistical support of the resulting topology was obtained by application of a 50% jackknife resampling technique. The result was consistent and congruent with nucleotide sequence-based and gene-content based trees. Also, a previously unresolved clade was resolved, that of MIT9211 and SS120. Conclusions/Significance: This is the first study to use gene order data to resolve a bacterial phylogeny at the genus level. It suggests that the technique is useful in resolving the Tree of Life.	[Luo, Haiwei; Friedman, Robert] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Shi, Jian; Arndt, William; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Luo, HW (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	bobf@biol.sc.edu	Luo, Haiwei/AAE-1958-2021; Tang, Jijun/ABH-6528-2020	Luo, Haiwei/0000-0001-8452-6066; Friedman, Robert/0000-0002-1061-4909	National Institutes of Health [GM078991, GM43940]; University of South Carolina; NSF [CNS 0708391]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940, R01GM078991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants GM078991 and GM43940 from the National Institutes of Health; University of South Carolina startup funds; and NSF grant CNS 0708391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; FELSENSTEIN J, 1989, PHYLIP PHYLOGENY INF, V5, P164; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moret B M, 2001, Bioinformatics, V17 Suppl 1, pS165; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Palmer Jeffrey D., 1992, P99; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang LS, 2006, J MOL EVOL, V63, P473, DOI 10.1007/s00239-005-0216-y	26	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3837	10.1371/journal.pone.0003837	http://dx.doi.org/10.1371/journal.pone.0003837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050756	Green Published, gold, Green Submitted			2022-12-27	WOS:000265452100003
J	Touboul, C; Badiou, W; Saada, J; Pelage, JP; Payen, D; Vicaut, E; Jacob, D; Rafii, A				Touboul, Cyril; Badiou, Wassim; Saada, Julien; Pelage, Jean-Pierre; Payen, Didier; Vicaut, Eric; Jacob, Denis; Rafii, Arash			Efficacy of Selective Arterial Embolisation for the Treatment of Life-Threatening Post-Partum Haemorrhage in a Large Population	PLOS ONE			English	Article								Background: The objective of this study was to assess efficacy and determine the optimal indication of selective arterial embolisation (SAE) in patients with life-threatening post-partum haemorrhage (PPH). Methodology/Principal Findings: One hundred and two patients with PPH underwent SAE and were included from January 1998 to January 2002 in our university care center. Embolisation was considered effective when no other surgical procedure was required. Univariate and multivariate statistical analysis were performed. SAE was effective for 73 patients (71.5%), while 29 required surgical procedures. SAE was effective in 88.6% of women with uterine atony that was associated with positive outcome (OR 4.13, 1.35-12.60), whereas caesarean deliveries (OR 0.16, 0.04-0.5) and haemodynamic shock (OR 0.21, 0.07-0.60) were associated with high failure rates, 47.6% and 39.1%, respectively. Conclusions/Significance: Success rate for SAE observed in a large population is lower than previously reported. It is most likely to succeed for uterine atony but not recommended in case of haemodynamic shock or after caesarean section.	[Touboul, Cyril; Badiou, Wassim; Saada, Julien; Jacob, Denis] Hop Lariboisiere, AP HP, Dept Obstet & Gynaecol, F-75475 Paris, France; [Pelage, Jean-Pierre] Hop Lariboisiere, AP HP, Dept Vasc Imaging, Paris, France; [Payen, Didier] Hop Lariboisiere, AP HP, Dept Anaesthesiol & Critical Care, Paris, France; [Vicaut, Eric] Hop Lariboisiere, AP HP, Dept Nuclear Med, Paris, France; [Rafii, Arash] Weill Cornell Med Coll, Dept Genet Med & Obstet & Gynecol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Touboul, C (corresponding author), Hop Lariboisiere, AP HP, Dept Obstet & Gynaecol, F-75475 Paris, France.	jat2021@qatar-med.cornell.edu	Pelage, Jean-Pierre/L-2488-2015; Rafii, Arash/E-4106-2013					ABDRABBO SA, 1994, AM J OBSTET GYNECOL, V171, P694, DOI 10.1016/0002-9378(94)90084-1; Bouvier-Colle M H, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P768; Bouvier-Colle M H, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, pS5; BURCHELL R C, 1968, Journal of Obstetrics and Gynaecology of the British Commonwealth, V75, P642; CHATTOPADHYAY SK, 1990, INT J GYNECOL OBSTET, V32, P345, DOI 10.1016/0020-7292(90)90112-X; CLARK SL, 1985, OBSTET GYNECOL, V66, P353; Corr P, 2001, BEST PRACT RES CL OB, V15, P557, DOI 10.1053/beog.2001.0200; den Hertog CEC, 2001, EUR J OBSTET GYN R B, V94, P8, DOI 10.1016/S0301-2115(00)00311-0; Descargues G, 2004, HUM REPROD, V19, P339, DOI 10.1093/humrep/deh082; EVANS S, 1985, SURG GYNECOL OBSTET, V160, P250; GILBERT L, 1987, BRIT J OBSTET GYNAEC, V94, P67, DOI 10.1111/j.1471-0528.1987.tb02255.x; Nizard J, 2003, HUM REPROD, V18, P844, DOI 10.1093/humrep/deg161; OLEARY JA, 1995, J REPROD MED, V40, P189; Ornan D, 2003, OBSTET GYNECOL, V102, P904, DOI 10.1016/S0029-7844(03)00769-5; Pelage JP, 1999, ACTA OBSTET GYN SCAN, V78, P698, DOI 10.1034/j.1600-0412.1999.780807.x; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; POESCHMANN RP, 1991, BRIT J OBSTET GYNAEC, V98, P528, DOI 10.1111/j.1471-0528.1991.tb10364.x; Prendiville WJ, 1996, EUR J OBSTET GYN R B, V69, P19, DOI 10.1016/0301-2115(95)02529-4; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; Tamizian O, 2002, BEST PRACT RES CL OB, V16, P81, DOI 10.1053/beog.2002.0257; Vedantham S, 1997, AM J OBSTET GYNECOL, V176, P938, DOI 10.1016/S0002-9378(97)70624-0	22	56	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3819	10.1371/journal.pone.0003819	http://dx.doi.org/10.1371/journal.pone.0003819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043573	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451400010
J	Mazzaccara, C; Labruna, G; Cito, G; Scarfo, M; De Felice, M; Pastore, L; Sacchetti, L				Mazzaccara, Cristina; Labruna, Giuseppe; Cito, Gennaro; Scarfo, Marzia; De Felice, Mario; Pastore, Lucio; Sacchetti, Lucia			Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse Strains	PLOS ONE			English	Article								Background: Although the mouse is the animal model most widely used to study the pathogenesis and treatment of human diseases, reference values for biochemical parameters are scanty or lacking for the most frequently used strains. We therefore evaluated these parameters in the C57BL/6J, 129SV/EV and C3H/HeJ mice. Methodology/Principal Findings: We measured by dry chemistry 26 analytes relative to electrolyte balance, lipoprotein metabolism, and muscle/heart, liver, kidney and pancreas functions, and by automated blood counter 5 hematological parameters in 30 animals (15 male and 15 female) of each mouse strain at three age ranges: 1-2 months, 3-8 months and 9 12 months. Whole blood was collected from the retro-orbital sinus. We used quality control procedures to investigate analytical imprecision and inaccuracy. Reference values were calculated by non parametric methods (median and 2.5(th) and 97.5(th) percentiles). The Mann-Whitney and Kruskal-Wallis tests were used for between-group comparisons. Median levels of GLU, LDH, Chol and BUN were higher, and LPS, AST, ALP and CHE were lower in males than in females (p range: 0.05-0.001). Inter-strain differences were observed for: (1) GLU, t-Bil, K(+), Ca(++), PO(4)(-) (p<0.05) and for TAG, Chol, AST, Fe(++) (p<0.001) in 4-8 month-old animals; (2) for CK, Crea, Mg(++), Na(++), K(+), Cl(-) (p<0.05) and BUN (p<0.001) in 2-and in 10-12 month-old mice; and (3) for WBC, RBC, HGB, HCT and PLT (p<0.05) during the 1 year life span. Conclusion/Significance: Our results indicate that metabolic variations in C57BL/6J, 129SV/EV and C3H/HeJ mice after therapeutic intervention should be evaluated against gender-and age-dependent reference intervals.	[Mazzaccara, Cristina; Labruna, Giuseppe; Pastore, Lucio; Sacchetti, Lucia] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Cito, Gennaro; Scarfo, Marzia; De Felice, Mario] Biogem SCaRL, Naples, Italy	University of Naples Federico II	Mazzaccara, C (corresponding author), Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy.	sacchetti@dbbm.unina.it	Pastore, Lucio/F-4668-2010; Pastore, Lucio/AAF-3487-2019; Labruna, Giuseppe/K-6670-2016; Mazzaccara, Cristina/AAC-5361-2022	Pastore, Lucio/0000-0001-6894-9317; Labruna, Giuseppe/0000-0002-4436-846X; Mazzaccara, Cristina/0000-0001-7774-2799	Centro di Eccellenza MIUR; Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali; CEINGE-Regione Campania; Ministero Salute	Centro di Eccellenza MIUR; Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali; CEINGE-Regione Campania; Ministero Salute(Ministry of Health, Italy)	This work was supported by grants from Centro di Eccellenza MIUR ex. D.M. 11/2000, Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali. Grants from CEINGE-Regione Campania (Convenzione del G.R. 29/12/2007), from MUR art. 5.2 and from Ministero Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CRAIGEN WJ, 2001, METABOLIC MOL BASES, P379; HARRISON SD, 1978, CANCER RES, V38, P2636; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; *MOUS PHEN, MOUS PHEN DAT; *NAT RES COUNC, 1985, GUID CAR US LAB AN; Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700; Zhou XH, 2004, COMPARATIVE MED, V54, P176	9	71	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3772	10.1371/journal.pone.0003772	http://dx.doi.org/10.1371/journal.pone.0003772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020657	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448600005
J	Xiaos, GP; Lundblad, EW; Izadjoo, M; Altman, S				Xiaos, Gaoping; Lundblad, Eirik W.; Izadjoo, Mina; Altman, Sidney			Inhibition of Expression in Escherichia coli of a Virulence Regulator MgIB of Francisella tularensis Using External Guide Sequence Technology	PLOS ONE			English	Article								External guide sequences (EGSs) have successfully been used to inhibit expression of target genes at the post-transcriptional level in both prokaryotes and eukaryotes. We previously reported that EGS accessible and cleavable sites in the target RNAs can rapidly be identified by screening random EGS (rEGS) libraries. Here the method of screening rEGS libraries and a partial RNase T1 digestion assay were used to identify sites accessible to EGSs in the mRNA of a global virulence regulator MglB from Francisella tularensis, a Gram-negative pathogenic bacterium. Specific EGSs were subsequently designed and their activities in terms of the cleavage of mglB mRNA by RNase P were tested in vitro and in vivo. EGS73, EGS148, and EGS155 in both stem and M1 EGS constructs induced mglB mRNA cleavage in vitro. Expression of stem EGS73 and EGS155 in Escherichia coli resulted in significant reduction of the mglB mRNA level coded for the F. tularensis mglB gene inserted in those cells.	[Xiaos, Gaoping; Lundblad, Eirik W.; Altman, Sidney] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Lundblad, Eirik W.] Univ Hosp N Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrob Resistance, Tromso, Norway; [Izadjoo, Mina] Armed Forces Inst Pathol, Washington, DC USA	Yale University; UiT The Arctic University of Tromso; University Hospital of North Norway; United States Department of Defense	Xiaos, GP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	sidney.altman@yale.edu			Defense Threat Reduction Agency [W81XWH-06-2-0066]; Fulbright Foundation; Research Council of Norway; Northern Norway Regional Health Authority Medical Research Program	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Fulbright Foundation; Research Council of Norway(Research Council of Norway); Northern Norway Regional Health Authority Medical Research Program	This work was supported by Defense Threat Reduction Agency Grant W81XWH-06-2-0066, the Fulbright Foundation (E.W.L.), Research Council of Norway grants (to E.W.L.), and Northern Norway Regional Health Authority Medical Research Program grants (to E.W.L.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN S, 1993, P NATL ACAD SCI USA, V90, P10898, DOI 10.1073/pnas.90.23.10898; BAER MF, 1990, METHOD ENZYMOL, V181, P569; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bistue AJCS, 2007, ANTIMICROB AGENTS CH, V51, P1918, DOI 10.1128/AAC.01500-06; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Guerrier-Takada C, 2000, METHOD ENZYMOL, V313, P442; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; Hansen A, 2001, MOL MICROBIOL, V41, P131, DOI 10.1046/j.1365-2958.2001.02467.x; Kim K, 2007, BBA-GENE STRUCT EXPR, V1769, P603, DOI 10.1016/j.bbaexp.2007.09.001; Ko JH, 2008, RNA, V14, P1656, DOI 10.1261/rna.1120508; Ko JH, 2007, P NATL ACAD SCI USA, V104, P7815, DOI 10.1073/pnas.0701715104; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lundblad EW, 2008, P NATL ACAD SCI USA, V105, P2354, DOI 10.1073/pnas.0711977105; McKinney J, 2001, P NATL ACAD SCI USA, V98, P6605, DOI 10.1073/pnas.121180398; McKinney JS, 2004, NUCLEIC ACIDS RES, V32, P848, DOI 10.1093/nar/gkh219; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3719	10.1371/journal.pone.0003719	http://dx.doi.org/10.1371/journal.pone.0003719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005569	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166200007
J	Seko, Y; Azuma, N; Takahashi, Y; Makino, H; Morito, T; Muneta, T; Matsumoto, K; Saito, H; Sekiya, I; Umezawa, A				Seko, Yuko; Azuma, Noriyuki; Takahashi, Yoriko; Makino, Hatsune; Morito, Toshiyuki; Muneta, Takeshi; Matsumoto, Kenji; Saito, Hirohisa; Sekiya, Ichiro; Umezawa, Akihiro			Human Sclera Maintains Common Characteristics with Cartilage throughout Evolution	PLOS ONE			English	Article								Background: The sclera maintains and protects the eye ball, which receives visual inputs. Although the sclera does not contribute significantly to visual perception, scleral diseases such as refractory scleritis, scleral perforation and pathological myopia are considered incurable or difficult to cure. The aim of this study is to identify characteristics of the human sclera as one of the connective tissues derived from the neural crest and mesoderm. Methodology/Principal Findings: We have demonstrated microarray data of cultured human infant scleral cells. Hierarchical clustering was performed to group scleral cells and other mesenchymal cells into subcategories. Hierarchical clustering analysis showed similarity between scleral cells and auricular cartilage-derived cells. Cultured micromasses of scleral cells exposed to TGF-beta s and BMP2 produced an abundant matrix. The expression of cartilage-associated genes, such as Indian hedge hog, type X collagen, and MMP13, was up-regulated within 3 weeks in vitro. These results suggest that human 'sclera'-derived cells can be considered chondrocytes when cultured ex vivo. Conclusions/Significance: Our present study shows a chondrogenic potential of human sclera. Interestingly, the sclera of certain vertebrates, such as birds and fish, is composed of hyaline cartilage. Although the human sclera is not a cartilaginous tissue, the human sclera maintains chondrogenic potential throughout evolution. In addition, our findings directly explain an enigma that the sclera and the joint cartilage are common targets of inflammatory cells in rheumatic arthritis. The present global gene expression database will contribute to the clarification of the pathogenesis of developmental diseases such as high myopia.	[Seko, Yuko; Takahashi, Yoriko; Makino, Hatsune; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan; [Seko, Yuko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Morito, Toshiyuki; Muneta, Takeshi] Tokyo Med & Dent Univ, Sect Orthopaed Surg, Tokyo, Japan; [Matsumoto, Kenji; Saito, Hirohisa] Natl Inst Child & Hlth Dev, Dept Allergy & Immunol, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Sect Cartilage Regen, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU)	Seko, Y (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Saito, Hirohisa/0000-0002-6630-8337; Muneta, Takeshi/0000-0003-1018-2939	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation; Cardiovascular Disease from the Ministry of Health, Labor and Welfare; Ministry of Health, Labor and Welfare.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation(Terumo Life Science Foundation); Cardiovascular Disease from the Ministry of Health, Labor and Welfare; Ministry of Health, Labor and Welfare.(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists; a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Health and Labor Sciences Research Grants; by a Research grant on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation; by the Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a grant from the Terumo Life Science Foundation; by a Research Grant for Cardiovascular Disease from the Ministry of Health, Labor and Welfare; and by a Grant for Child Health and Development from the Ministry of Health, Labor and Welfare.	Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; ARCHER CW, 1990, J CELL SCI, V97, P361; BARR CC, 1981, OPHTHALMOLOGY, V88, P1269; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; Connon CJ, 2004, EXP EYE RES, V78, P909, DOI 10.1016/j.exer.2004.01.005; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; ISAAK BL, 1986, OPHTHALMOLOGY, V93, P681; JAYSON MIV, 1971, ANN RHEUM DIS, V30, P343, DOI 10.1136/ard.30.4.343; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SEGAWA Y, J ORTHOPAED IN PRESS; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; SEKO Y, 1995, OPHTHALMIC RES, V27, P144, DOI 10.1159/000267651; SEKO Y, 1995, INVEST OPHTH VIS SCI, V36, P1183; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Tsuruga Y, 2008, TRANSPL P, V40, P617, DOI 10.1016/j.transproceed.2008.02.007; Van Camp G, 2006, AM J HUM GENET, V79, P449, DOI 10.1086/506478; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Young T, 2003, MOL VIS, V9, P508; Zhou J, 2006, INVEST OPHTH VIS SCI, V47, P1794, DOI 10.1167/iovs.05-0759	34	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3709	10.1371/journal.pone.0003709	http://dx.doi.org/10.1371/journal.pone.0003709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002264	Green Submitted, Green Published, gold			2022-12-27	WOS:000265166000009
J	Renteria, ME; Gandhi, NS; Vinuesa, P; Helmerhorst, E; Mancera, RL				Renteria, Miguel E.; Gandhi, Neha S.; Vinuesa, Pablo; Helmerhorst, Erik; Mancera, Ricardo L.			A Comparative Structural Bioinformatics Analysis of the Insulin Receptor Family Ectodomain Based on Phylogenetic Information	PLOS ONE			English	Article							GROWTH-FACTOR-I; ALANINE-SCANNING MUTAGENESIS; LIGAND-BINDING-SITE; DIABETES-ASSOCIATED MUTATIONS; HAMSTER OVARY CELLS; TYPE-1 IGF RECEPTOR; 1ST 3 DOMAINS; ALPHA-SUBUNIT; B-CHAIN; CRYSTAL-STRUCTURE	The insulin receptor (IR), the insulin-like growth factor 1 receptor (IGF1R) and the insulin receptor-related receptor (IRR) are covalently-linked homodimers made up of several structural domains. The molecular mechanism of ligand binding to the ectodomain of these receptors and the resulting activation of their tyrosine kinase domain is still not well understood. We have carried out an amino acid residue conservation analysis in order to reconstruct the phylogeny of the IR Family. We have confirmed the location of ligand binding site 1 of the IGF1R and IR. Importantly, we have also predicted the likely location of the insulin binding site 2 on the surface of the fibronectin type III domains of the IR. An evolutionary conserved surface on the second leucine-rich domain that may interact with the ligand could not be detected. We suggest a possible mechanical trigger of the activation of the IR that involves a slight 'twist' rotation of the last two fibronectin type III domains in order to face the likely location of insulin. Finally, a strong selective pressure was found amongst the IRR orthologous sequences, suggesting that this orphan receptor has a yet unknown physiological role which may be conserved from amphibians to mammals.	[Renteria, Miguel E.; Gandhi, Neha S.; Helmerhorst, Erik; Mancera, Ricardo L.] Curtin Univ Technol, Sch Biomed Sci, Perth, WA, Australia; [Renteria, Miguel E.; Gandhi, Neha S.; Helmerhorst, Erik; Mancera, Ricardo L.] West Australian Biomed Res Inst, Perth, WA, Australia; [Mancera, Ricardo L.] Curtin Univ Technol, Sch Pharm, Perth, WA, Australia; [Vinuesa, Pablo] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Mexico City 04510, DF, Mexico	Curtin University; Curtin University; Universidad Nacional Autonoma de Mexico	Renteria, ME (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	R.Mancera@curtin.edu.au	Gandhi, Neha S/E-7688-2010; Vinuesa, Pablo/AAJ-1851-2020; Rentería, Miguel E./M-6671-2017; Gandhi, Neha S./AAX-9592-2021	Gandhi, Neha S/0000-0003-3119-6731; Vinuesa, Pablo/0000-0001-6119-2956; Rentería, Miguel E./0000-0003-4626-7248; Gandhi, Neha S./0000-0003-3119-6731; Mancera, Ricardo L/0000-0002-9191-5622	Western Australian Biomedical Research Institute; School of Biomedical Sciences and School of Pharmacy, Curtin University of Technology	Western Australian Biomedical Research Institute; School of Biomedical Sciences and School of Pharmacy, Curtin University of Technology	Western Australian Biomedical Research Institute and School of Biomedical Sciences and School of Pharmacy, Curtin University of Technology	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Branden C., 1999, INTRO PROTEIN STRUCT; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Dissen GA, 2006, ENDOCRINOLOGY, V147, P155, DOI 10.1210/en.2005-0386; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; Florke RR, 2001, BIOCHEM J, V360, P189, DOI 10.1042/0264-6021:3600189; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Garza-Garcia A, 2007, HUM MUTAT, V28, P660, DOI 10.1002/humu.20491; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Govindarajan S, 1997, PROTEINS, V29, P461, DOI 10.1002/(SICI)1097-0134(199712)29:4<461::AID-PROT6>3.0.CO;2-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; HEDO JA, 1981, P NATL ACAD SCI-BIOL, V78, P4791, DOI 10.1073/pnas.78.8.4791; Heldin Carl-Henrik, 1996, Cytokine and Growth Factor Reviews, V7, P3, DOI 10.1016/1359-6101(96)00002-0; HERNANDEZSANCHE.C, 2008, MOL BIOL EVOL; HERZBERG VL, 1985, BIOCHEM BIOPH RES CO, V129, P789, DOI 10.1016/0006-291X(85)91961-8; Hoyne PA, 2000, FEBS LETT, V469, P57, DOI 10.1016/S0014-5793(00)01237-0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUANG K, 2007, J BIOL CHEM; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; JENSEN M, 2008, BIOCH J; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kelly-Spratt KS, 1999, CELL GROWTH DIFFER, V10, P805; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LAWRENCE MC, 2007, CURR OPIN STRUCT BIO; Leevers SJ, 2001, CURR BIOL, V11, pR209, DOI 10.1016/S0960-9822(01)00107-5; Leibush BN, 1998, COMP BIOCHEM PHYS B, V121, P57, DOI 10.1016/S0305-0491(98)10109-8; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Marino-Buslje C, 1998, FEBS LETT, V441, P331, DOI 10.1016/S0014-5793(98)01509-9; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Mynarcik DC, 1997, J BIOL CHEM, V272, P2077; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; NAKAE J, 1995, J BIOL CHEM, V270, P22017, DOI 10.1074/jbc.270.37.22017; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parisi G, 2001, MOL BIOL EVOL, V18, P750, DOI 10.1093/oxfordjournals.molbev.a003857; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pashmforoush M, 1996, MOL ENDOCRINOL, V10, P857, DOI 10.1210/me.10.7.857; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Pollak Michael, 2007, V174, P49; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROOVERS E, 1995, GENE, V162, P181, DOI 10.1016/0378-1119(95)00323-X; Rouard M, 1999, J BIOL CHEM, V274, P18487, DOI 10.1074/jbc.274.26.18487; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SHIER P, 1989, J BIOL CHEM, V264, P14605; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; Sparrow LG, 2007, PROTEINS, V66, P261, DOI 10.1002/prot.21261; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SURINYA KH, 2002, J BIOL CHEM; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Ward CW, 1999, GROWTH FACTORS, V16, P315, DOI 10.3109/08977199909069149; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; ZHANG B, 1992, J BIOL CHEM, V267, P18320	111	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3667	10.1371/journal.pone.0003667	http://dx.doi.org/10.1371/journal.pone.0003667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989367	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134600003
J	Al Mahmud, A; Amore, G; Bernardi, G				Al Mahmud, Abdullah; Amore, Gabriele; Bernardi, Giorgio			Compositional Genome Contexts Affect Gene Expression Control in Sea Urchin Embryo	PLOS ONE			English	Article							INTEGRATION; VIRUS	Gene expression is widely perceived as exclusively controlled by the information contained in cis-regulatory regions. These are built in a modular way, each module being a cluster of binding sites for the transcription factors that control the level, the location and the time at which gene transcription takes place. On the other hand, results from our laboratory have shown that gene expression is affected by the compositional properties (GC levels) of the isochores in which genes are embedded, i.e. the genome context. To clarify how compositional genomic properties affect the way cis-regulatory information is utilized, we have changed the genome context of a GFP-reporter gene containing the complete cis-regulatory region of the gene spdeadringer (spdri), expressed during sea urchin embryogenesis. We have observed that GC levels higher or lower than those found in the natural genome context can alter the reporter expression pattern. We explain this as the result of an interference with the functionality of specific modules in the gene's cis-regulatory region. From these observations we derive the notion that the compositional properties of the genome context can affect cis-regulatory control of gene expression. Therefore although the way a gene works depends on the information contained in its cis-regulatory region, availability of such information depends on the compositional properties of the genomic context.	[Al Mahmud, Abdullah; Amore, Gabriele; Bernardi, Giorgio] Stn Zool A Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Al Mahmud, A (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	gabriele.amore@szn.it	Bernardi, Giorgio/G-1639-2011		MIRG [036543]	MIRG	This work was funded in part with a MIRG 036543 Grant, FP6th. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024; Arhondakis S, 2008, BIOCHEM BIOPH RES CO, V367, P542, DOI 10.1016/j.bbrc.2007.12.155; Bernardi G., 2004, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; Davidson EH, 2006, REG GEN GEN REG; DESARIO A, 1995, NUCLEIC ACIDS RES, V23, P4013, DOI 10.1093/nar/23.19.4013; MAHMUD A, 2008, DEV BIOL; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; RYNDITCH A, 1991, GENE, V106, P165, DOI 10.1016/0378-1119(91)90196-I; Rynditch AV, 1998, GENE, V222, P1, DOI 10.1016/S0378-1119(98)00451-X; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; ZERIAL M, 1986, NUCLEIC ACIDS RES, V14, P8373, DOI 10.1093/nar/14.21.8373; ZOUBAK B, 1994, GENE, V143, P155	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4025	10.1371/journal.pone.0004025	http://dx.doi.org/10.1371/journal.pone.0004025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112499	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466000002
J	Zarse, K; Ristow, M				Zarse, Kim; Ristow, Michael			Antidepressants of the Serotonin-Antagonist Type Increase Body Fat and Decrease Lifespan of Adult Caenorhabditis elegans	PLOS ONE			English	Article							DIETARY RESTRICTION; STRESS RESISTANCE; OXIDATIVE STRESS; BACTERIAL DEPRIVATION; EXTENDS; RESVERATROL; LONGEVITY; SURVIVAL; GENES; ACID	It was recently suggested that specific antidepressants of the serotonin-antagonist type, namely mianserin and methiothepin, may exert anti-aging properties and specifically extend lifespan of the nematode C. elegans by causing a state of perceived calorie restriction (Petrascheck M, Ye X, Buck LB: An antidepressant that extends lifespan in adult Caenorhabditis elegans; Nature, Nov 22, 2007; 450( 7169): 553-6, PMID 18033297). Using the same model organism, we instead observe a reduction of life expectancy when employing the commonly used, standardized agar-based solid-phase assay while applying the same or lower concentrations of the same antidepressants. Consistent with a well-known sideeffect of these compounds in humans, antidepressants not only reduced lifespan but also increased body fat accumulation in C. elegans reflecting the mammalian phenotype. Taken together and in conflict with previously published findings, we find that antidepressants of the serotonin-antagonist type not only promote obesity, but also decrease nematode lifespan.	[Ristow, Michael] Univ Jena, Inst Nutr, Jena, Germany; [Ristow, Michael] German Inst Human Nutr, Potsdam, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Zarse, K (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	mristow@mristow.org	Sanguansri, Luz/B-6630-2011; Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Sanguansri, Luz/0000-0003-1908-7604; Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123				Adachi H, 2000, J GERONTOL A-BIOL, V55, pB280, DOI 10.1093/gerona/55.6.B280; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bakaev V., 2002, BIOGERONTOLOGY S1, V3, P23; Bakaev V. V., 2002, BIOGERONTOLOGY S1, V3, P12; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benedetti MG, 2008, EXP GERONTOL, V43, P882, DOI 10.1016/j.exger.2008.08.049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; Broue F, 2007, AGING CELL, V6, P87, DOI 10.1111/j.1474-9726.2006.00268.x; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Castelein Natascha, 2008, Biotechnology Journal, V3, P803, DOI 10.1002/biot.200800003; CROLL N A, 1977, Experimental Aging Research, V3, P175, DOI 10.1080/03610737708257101; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; HARRIS B, 1980, LANCET, V1, P590; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim J, 2008, MECH AGEING DEV, V129, P322, DOI 10.1016/j.mad.2008.02.011; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kornfeld K, 2006, ARCH NEUROL-CHICAGO, V63, P491, DOI 10.1001/archneur.63.4.491; Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; PINDER RM, 1980, INT PHARMACOPSYCHIAT, V15, P218, DOI 10.1159/000468441; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shook DR, 1999, GENETICS, V153, P1233; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WIEGANT FA, 2008, BIOGERONTOL IN PRESS; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zou SG, 2007, MECH AGEING DEV, V128, P222, DOI 10.1016/j.mad.2006.11.026	51	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4062	10.1371/journal.pone.0004062	http://dx.doi.org/10.1371/journal.pone.0004062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112515	Green Submitted, Green Published, gold			2022-12-27	WOS:000265466000019
J	Staiger, H; Machicao, F; Schafer, SA; Kirchhoff, K; Kantartzis, K; Guthoff, M; Silbernagel, G; Stefan, N; Haring, HU; Fritsche, A				Staiger, Harald; Machicao, Fausto; Schaefer, Silke A.; Kirchhoff, Kerstin; Kantartzis, Konstantinos; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas			Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine beta-Cell Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-SECRETION; COMMON VARIANTS; SUSCEPTIBILITY LOCI; FASTING GLUCOSE; MELATONIN; RELEASE; HHEX; GENE; RECEPTOR	Background: Very recently, a novel type 2 diabetes risk gene, i.e., MTNR1B, was identified and reported to affect fasting glycemia. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of common genetic variation within the MTNR1B locus with obesity and prediabetes traits, namely impaired insulin secretion and insulin resistance. Methodology/Principal Findings: We genotyped 1,578 non-diabetic subjects, metabolically characterized by oral glucose tolerance test, for five tagging single nucleotide polymorphisms (SNPs) covering 100% of common genetic variation (minor allele frequency >0.05) within the MTNR1B locus (rs10830962, rs4753426, rs12804291, rs10830963, rs3781638). In a subgroup (N = 513), insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp, and in a further subgroup (N = 301), glucose-stimulated insulin secretion was determined by intravenous glucose tolerance test. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons, none of the tagging SNPs was reliably associated with measures of adiposity. SNPs rs10830962, rs4753426, and rs10830963 were significantly associated with higher fasting plasma glucose concentrations (p<0.0001) and reduced OGTT- and IVGTT-induced insulin release (p <= 0.0007 and p <= 0.01, respectively). By contrast, SNP rs3781638 displayed significant association with lower fasting plasma glucose levels and increased OGTT-induced insulin release (p<0.0001 and p <= 0.0002, respectively). Moreover, SNP rs3781638 revealed significant association with elevated fasting-and OGTT-derived insulin sensitivity (p <= 0.0021). None of the MTNR1B tagging SNPs altered proinsulin-to-insulin conversion. Conclusions/Significance: In conclusion, common genetic variation within MTNR1B determines glucose-stimulated insulin secretion and plasma glucose concentrations. Their impact on beta-cell function might represent the prevailing pathomechanism how MTNR1B variants increase the type 2 diabetes risk.	[Staiger, Harald; Machicao, Fausto; Schaefer, Silke A.; Kirchhoff, Kerstin; Kantartzis, Konstantinos; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen Hosp, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Dept Internal Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Dept Internal Med, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Kantartzis, Konstantinos/AAC-3999-2019; Staiger, Harald/N-5871-2014; Guthoff, Martina/D-3960-2018	Guthoff, Martina/0000-0002-4294-980X; Staiger, Harald/0000-0002-9507-5333; Silbernagel, Guenther/0000-0001-9323-329X; Stefan, Norbert/0000-0002-2186-9595; Kantartzis, Konstantinos/0000-0002-0584-1138	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2). The funding organisation is a non-profit organisation and was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; de Sousa AGP, 2008, OBES REV, V9, P340, DOI 10.1111/j.1467-789X.2008.00478.x; Duesing K, 2008, DIABETOLOGIA, V51, P821, DOI 10.1007/s00125-008-0973-4; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; *INT HAPMAP PROJ, NATURE, V426, P789; Kashyap Sangeeta R, 2007, Diab Vasc Dis Res, V4, P13, DOI 10.3132/dvdr.2007.001; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Prokopenko I, 2008, DIABETOLOGIA, V51, pS11; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; van Vliet-Ostaptchouk JV, 2008, EUR J HUM GENET, V16, P652, DOI 10.1038/sj.ejhg.5202008; Watanabe RM, 2008, DIABETES, V57, pA42; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	38	93	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3962	10.1371/journal.pone.0003962	http://dx.doi.org/10.1371/journal.pone.0003962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088850	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458500008
J	Kempa, S; Krasensky, J; Dal Santo, S; Kopka, J; Jonak, C				Kempa, Stefan; Krasensky, Julia; Dal Santo, Silvia; Kopka, Joachim; Jonak, Claudia			A Central Role of Abscisic Acid in Stress-Regulated Carbohydrate Metabolism	PLOS ONE			English	Article								Background: Abiotic stresses adversely affect plant growth and development. The hormone abscisic acid (ABA) plays a central role in the response and adaptation to environmental constraints. However, apart from the well established role of ABA in regulating gene expression programmes, little is known about its function in plant stress metabolism. Principal Findings: Using an integrative multiparallel approach of metabolome and transcriptome analyses, we studied the dynamic response of the model glyophyte Arabidopsis thaliana to ABA and high salt conditions. Our work shows that salt stress induces complex re-adjustment of carbohydrate metabolism and that ABA triggers the initial steps of carbon mobilisation. Significance: These findings open new perspectives on how high salinity and ABA impact on central carbohydrate metabolism and highlight the power of iterative combinatorial approaches of non-targeted and hypothesis-driven experiments in stress biology.	[Kempa, Stefan; Krasensky, Julia; Dal Santo, Silvia; Jonak, Claudia] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria; [Kopka, Joachim] Max Plank Inst Mol Plant Physiol, Golm, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Max Planck Society	Kempa, S (corresponding author), Max Plank Inst Mol Plant Physiol, Golm, Germany.	claudia.jonak@gmi.oeaw.ac.at	Jonak, Claudia/G-1362-2016; kempa, stefan/C-5213-2008	kempa, stefan/0000-0002-0696-9299; Krasensky-Wrzaczek, Julia/0000-0002-5989-9984; Dal Santo, Silvia/0000-0001-5012-1140; Kopka, Joachim/0000-0001-9675-4883; Jonak, Claudia/0000-0001-9605-6751	Austrian Science Fund; Vienna Science and Technology Fund; GEN-AU	Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; GEN-AU	This work was supported by the Austrian Science Fund (FWF), the Vienna Science and Technology Fund (WWTF) and GEN-AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRANCOPRICE C, 2008, PLANT J; Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Geigenberger P, 1997, PLANTA, V201, P502, DOI 10.1007/s004250050095; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; HANDA S, 1986, PLANT PHYSIOL, V80, P938, DOI 10.1104/pp.80.4.938; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Khelil A, 2007, PLANT PHYSIOL BIOCH, V45, P551, DOI 10.1016/j.plaphy.2007.05.003; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; OPARKA KJ, 1988, PLANTA, V174, P123, DOI 10.1007/BF00394884; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Ruggiero B, 2004, PLANT PHYSIOL, V136, P3134, DOI 10.1104/pp.104.046169; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Scholz M, 2004, BIOINFORMATICS, V20, P2447, DOI 10.1093/bioinformatics/bth270; SCHOLZ M, 2005, NONLINEAR PCA MISSIN; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tetlow IJ, 2004, J EXP BOT, V55, P2131, DOI 10.1093/jxb/erh248; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Todaka D, 2000, J EXP BOT, V51, P739, DOI 10.1093/jexbot/51.345.739; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Weise SE, 2005, PLANT PHYSIOL, V137, P756, DOI 10.1104/pp.104.055996; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; ZENNER R, 1991, PLANT CELL ENVIRON, V14, P939; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	63	141	146	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3935	10.1371/journal.pone.0003935	http://dx.doi.org/10.1371/journal.pone.0003935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081841	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000265456300010
J	Sernandez, IV; de Yebenes, VG; Dorsett, Y; Ramiro, AR				Sernandez, Isora V.; de Yebenes, Virginia G.; Dorsett, Yair; Ramiro, Almudena R.			Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations both In Vitro and In Vivo	PLOS ONE			English	Article								The humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induced Cytidine Deaminase (AID) initiates both SHM and CSR by deaminating cytosine residues on the DNA of immunoglobulin genes. While crucial for immunity, AID-catalysed deamination is also the triggering event for the generation of lymphomagenic chromosome translocations. To address whether restricting the levels of AID expression in vivo contributes to the regulation of its function, we analysed mice harbouring a single copy of the AID gene (AID(+/-)). AID(+/-) mice express roughly 50% of normal AID levels, and display a mild hyperplasia, reminiscent of AID deficient mice and humans. Moreover, we found that AID(+/-) cells have an impaired competence for CSR and SHM, which indicates that AID gene dose is limiting for its physiologic function. We next evaluated the impact of AID reduction in AID(+/-) mice on the generation of chromosome translocations. Our results show that the frequency of AID-promoted c-myc/IgH translocations is reduced in AID(+/-) mice, both in vivo and in vitro. Therefore, AID is haploinsufficient for antibody diversification and chromosome translocations. These findings suggest that limiting the physiologic levels of AID expression can be a regulatory mechanism that ensures an optimal balance between immune proficiency and genome integrity.	[Sernandez, Isora V.; de Yebenes, Virginia G.; Ramiro, Almudena R.] Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid, Spain; [Dorsett, Yair] Rockefeller Univ, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Rockefeller University	Sernandez, IV (corresponding author), Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid, Spain.	aramiro@cnio.es	de Yébenes, Virginia/F-3156-2016; Ramiro, Almudena R/H-6037-2015	de Yébenes, Virginia/0000-0002-3785-5868; Ramiro, Almudena R/0000-0002-7539-3844	Comunidad Autonoma de Madrid; CNIO investigator; Ramon y Cajal programe from the Ministerio de Educacion y Ciencia [SAF2007-63130]; European Research Council [BCLYM-207844]	Comunidad Autonoma de Madrid(Comunidad de Madrid); CNIO investigator; Ramon y Cajal programe from the Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	IVS is funded by Comunidad Autonoma de Madrid, VGY is a CNIO investigator and ARR is supported by the Ramon y Cajal programe from the Ministerio de Educacion y Ciencia. This work has been funded by grants from Ministerio de Educacion y Ciencia (SAF2007-63130), Comunidad Autonoma de Madrid (DIFHEMAT-CM) and European Research Council (BCLYM-207844). They have not had any role in the design, implementation, analysis, etc of the analysis.	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kasahara Y, 2003, J ALLERGY CLIN IMMUN, V112, P755, DOI 10.1016/S0091-6749(03)01860-8; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	46	39	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3927	10.1371/journal.pone.0003927	http://dx.doi.org/10.1371/journal.pone.0003927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079594	gold, Green Submitted, Green Published			2022-12-27	WOS:000265456300006
J	Field, CB; Johnston, K; Gati, JS; Menon, RS; Everling, S				Field, Courtney B.; Johnston, Kevin; Gati, Joseph S.; Menon, Ravi S.; Everling, Stefan			Connectivity of the Primate Superior Colliculus Mapped by Concurrent Microstimulation and Event-Related fMRI	PLOS ONE			English	Article								Background: Neuroanatomical studies investigating the connectivity of brain areas have heretofore employed procedures in which chemical or viral tracers are injected into an area of interest, and connected areas are subsequently identified using histological techniques. Such experiments require the sacrifice of the animals and do not allow for subsequent electrophysiological studies in the same subjects, rendering a direct investigation of the functional properties of anatomically identified areas impossible. Methodology/Principal Findings: Here, we used a combination of microstimulation and fMRI in an anesthetized monkey preparation to study the connectivity of the superior colliculus (SC). Microstimulation of the SC resulted in changes in the blood oxygenation level-dependent (BOLD) signals in the SC and in several cortical and subcortical areas consistent with the known connectivity of the SC in primates. Conclusions/Significance: These findings demonstrates that the concurrent use of microstimulation and fMRI can be used to identify brain networks for further electrophysiological or fMRI investigation.	[Field, Courtney B.; Everling, Stefan] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Johnston, Kevin; Gati, Joseph S.; Menon, Ravi S.; Everling, Stefan] Robarts Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Field, CB (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	severlin@uwo.ca	Menon, Ravi S/K-5500-2013; Everling, Stefan/K-5208-2013; Menon, Ravi/ABA-8654-2020; Gati, Joseph S/K-5476-2013; Johnston, Kevin/U-4453-2018; Everling, Stefan/AAR-8687-2020	Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; Everling, Stefan/0000-0001-9714-9757; Johnston, Kevin/0000-0001-9481-6251	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; Barry RL, 2005, MAGN RESON MED, V54, P411, DOI 10.1002/mrm.20591; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; CRAPSE TB, 2006, NEUR CONTR MOV M KEY; Dueck MH, 2005, ACTA ANAESTH SCAND, V49, P784, DOI 10.1111/j.1399-6576.2005.00703.x; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Funahashi M, 2001, NEUROSCI LETT, V311, P177, DOI 10.1016/S0304-3940(01)02169-3; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kashiwagi M, 2004, ANESTH ANALG, V99, P49, DOI 10.1213/01.ANE.0000117226.45704.65; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; LEICHNETZ GR, 1981, NEUROSCIENCE, V6, P1023, DOI 10.1016/0306-4522(81)90068-3; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Lock TM, 2003, EXP BRAIN RES, V151, P455, DOI 10.1007/s00221-003-1500-y; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1281, DOI 10.1177/24.12.826585; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; OHSHIMA K, 1981, INVEST UROL, V19, P79; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Paxinos G., 2000, RHESUS MONKEY BRAIN; Payne BR, 1999, J NEUROSCI METH, V86, P195, DOI 10.1016/S0165-0270(98)00166-6; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Robinson D L, 1989, Rev Oculomot Res, V3, P337; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Schall JD, 1997, CEREBR CORT, V12, P527; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Steinhausen M, 1997, J PHYSIOL-LONDON, V505, P493, DOI 10.1111/j.1469-7793.1997.493bb.x; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Vanduffel W, 1997, P NATL ACAD SCI USA, V94, P7617, DOI 10.1073/pnas.94.14.7617; Wang X, 2004, ANESTHESIOLOGY, V100, P1198, DOI 10.1097/00000542-200405000-00023; Wang Y, 2004, NEUROREPORT, V15, P1559, DOI 10.1097/01.wnr.0000133300.62031.9b; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5	66	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3928	10.1371/journal.pone.0003928	http://dx.doi.org/10.1371/journal.pone.0003928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079541	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455900009
J	Hromada, M; Antczak, M; Valone, TJ; Tryjanowski, P				Hromada, Martin; Antczak, Marcin; Valone, Thomas J.; Tryjanowski, Piotr			Settling Decisions and Heterospecific Social Information Use in Shrikes	PLOS ONE			English	Article							PUBLIC INFORMATION; CONSPECIFIC ATTRACTION; HABITAT SELECTION; LANIUS-EXCUBITOR; FITNESS CONSEQUENCES; MIGRANT; BIRDS; SIZE; FOOD; AGGREGATION	Animals often settle near competitors, a behavior known as social attraction, which belies standard habitat selection theory. Two hypotheses account for these observations: individuals obtain Allee benefits mediated by the physical presence of a competitor, or they use successfully settled individual as a source of information indicating the location of high quality habitat. We evaluated these hypotheses experimentally in two species of shrikes. These passerine birds with a raptor-like mode of life impale prey to create larders that serve as an indicator of male/habitat quality. Thus, two forms of indirect information are available in our system: a successfully settled shrike and its larder. Typically these two cues are associated with each other, however, our experimental treatment created an unnatural situation by disassociating them. We manipulated the presence of larders of great grey shrikes and examined the settling decisions of red-backed shrikes within and outside the great grey shrike territories. Male red-backed shrikes did not settle sooner on plots with great grey shrikes compared to plots that only contained artificial larders indicating that red-backed shrikes do not use the physical presence of a great grey shrike when making settling decisions which is inconsistent with the Allee effect hypothesis. In contrast, for all plots without great grey shrikes, red-backed shrikes settled, paired and laid clutches sooner on plots with larders compared to plots without larders. We conclude that red-backed shrikes use larders of great grey shrikes as a cue to rapidly assess habitat quality.	[Antczak, Marcin] Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Hromada, Martin; Antczak, Marcin; Tryjanowski, Piotr] Adam Mickiewicz Univ, Dept Behav Ecol, PL-61712 Poznan, Poland; [Valone, Thomas J.] St Louis Univ, Dept Biol, St Louis, MO USA	University of South Bohemia Ceske Budejovice; Adam Mickiewicz University; Saint Louis University	Hromada, M (corresponding author), Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	hromada.martin@gmail.com	Antczak, Marcin/F-1204-2011; Hromada, Martin/I-7409-2019	Hromada, Martin/0000-0002-5626-1205; Valone, Thomas/0000-0002-7657-3126; Tryjanowski, Piotr/0000-0002-8358-0797	University of South Bohemia Ceske Budejovice [MSMT600766580MH]; Foundation Kasa im. Mianowskiego; SGA 2003; GACR [206/05/H012]; NSF; Scientific Grant of Ministry of Science of Poland [N N 303 317 433];  [VEGA 1/0139/08]	University of South Bohemia Ceske Budejovice; Foundation Kasa im. Mianowskiego; SGA 2003; GACR(Grant Agency of the Czech Republic); NSF(National Science Foundation (NSF)); Scientific Grant of Ministry of Science of Poland; 	The work was supported by University of South Bohemia Ceske Budejovice, MSMT600766580MH to MH and MA, Foundation Kasa im. Mianowskiego and VEGA 1/0139/08 to MH, SGA 2003 and GACR no.206/05/H012 to MA, NSF grant to TJV and by Scientific Grant of Ministry of Science of Poland No.N N 303 317 433.	Allee W. C, 1951, SOCIAL LIFE ANIMALS; Antczak M, 2004, ACTA ORNITHOL, V39, P9, DOI 10.3161/068.039.0105; Cade Tom J., 1995, Proceedings of the Western Foundation of Vertebrate Zoology, V6, P1; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Cramp S, 1993, BIRDS W PALEARTIC, VVII; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Forsman JT, 2002, P ROY SOC B-BIOL SCI, V269, P1619, DOI 10.1098/rspb.2002.2065; Forsman JT, 1998, OECOLOGIA, V115, P278, DOI 10.1007/s004420050517; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GETTY T, 1981, AM NAT, V118, P426, DOI 10.1086/283834; Greene CM, 2001, ECOLOGY, V82, P2091; Harris T., 2000, SHRIKES BUSH SHRIKES; HERNANDEZ A, 1995, CONDOR, V97, P1002, DOI 10.2307/1369539; Hodge MA, 1997, ETHOLOGY, V103, P815; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hromada M, 1996, BIOLOGIA, V51, P227; Hromada M, 2002, ANN ZOOL FENN, V39, P125; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Kuzniak S., 2003, RED BACKED SHRIKE; Lefranc N., 1997, SHRIKES GUIDE SHRIKE; Marcin A, 2005, ARDEA, V93, P101; Monkkonen M, 1996, OIKOS, V77, P127, DOI 10.2307/3545592; Monkkonen M, 1997, CAN J ZOOL, V75, P2077, DOI 10.1139/z97-842; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Muller KL, 1997, AM NAT, V150, P650, DOI 10.1086/286087; OLIVEIRA RF, 1998, P ROY SOC LOND B BIO, V268, P1183; Parejo D, 2005, BEHAV ECOL, V16, P96, DOI 10.1093/beheco/arh136; Ryttman Hans, 1996, Ornis Svecica, V6, P122; Simek J, 2001, ORNIS FENNICA, V78, P61; SLOANE SA, 1991, NAT HIST, P32; SMITH AT, 1990, CONSERV BIOL, V4, P320, DOI 10.1111/j.1523-1739.1990.tb00294.x; STAMPS JA, 1991, BEHAV ECOL SOCIOBIOL, V28, P29; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stamps Judy A., 2001, P230; TEMPLETON JJ, 1995, BEHAV ECOL, V6, P65, DOI 10.1093/beheco/6.1.65; Thomson RL, 2003, OECOLOGIA, V134, P431, DOI 10.1007/s00442-002-1140-0; Tryjanowski P, 2004, J ORNITHOL, V145, P264, DOI 10.1007/s10336-004-0035-8; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; Tryjanowski Piotr, 1999, Acta Ornithologica (Warsaw), V34, P59; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Votypka J, 2003, ANN ZOOL FENN, V40, P431; YOSEF R, 1989, AUK, V106, P418; Yosef Reuven, 1995, Proceedings of the Western Foundation of Vertebrate Zoology, V6, P251	50	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3930	10.1371/journal.pone.0003930	http://dx.doi.org/10.1371/journal.pone.0003930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079540	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455900010
J	Kagaayi, J; Gray, RH; Brahmbhatt, H; Kigozi, G; Nalugoda, F; Wabwire-Mangen, F; Serwadda, D; Sewankambo, N; Ddungu, V; Ssebagala, D; Sekasanvu, J; Kigozi, G; Makumbi, F; Kiwanuka, N; Lutalo, T; Reynolds, SJ; Wawer, MJ				Kagaayi, Joseph; Gray, Ronald H.; Brahmbhatt, Heena; Kigozi, Godfrey; Nalugoda, Fred; Wabwire-Mangen, Fred; Serwadda, David; Sewankambo, Nelson; Ddungu, Veronica; Ssebagala, Darix; Sekasanvu, Joseph; Kigozi, Grace; Makumbi, Fredrick; Kiwanuka, Noah; Lutalo, Tom; Reynolds, Steven J.; Wawer, Maria J.			Survival of Infants Born to HIV-Positive Mothers, by Feeding Modality, in Rakai, Uganda	PLOS ONE			English	Article								Background: Data comparing survival of formula-fed to breast-fed infants in programmatic settings are limited. We compared mortality and HIV-free of breast and formula-fed infants born to HIV-positive mothers in a program in rural, Rakai District Uganda. Methodology/Principal Findings: One hundred eighty two infants born to HIV-positive mothers were followed at one, six and twelve months postpartum. Mothers were given infant-feeding counseling and allowed to make informed choices as to whether to formula-feed or breast-feed. Eligible mothers and infants received antiretroviral therapy (ART) if indicated. Mothers and their newborns received prophylaxis for prevention of mother-to-child HIV transmission (pMTCT) if they were not receiving ART. Infant HIV infection was detected by PCR (Roche Amplicor 1.5) during the follow-up visits. Kaplan Meier time-to-event methods were used to compare mortality and HIV-free survival. The adjusted hazard ratio (Adjusted HR) of infant HIV-free survival was estimated by Cox regression. Seventy-five infants (41%) were formula-fed while 107 (59%) were breast-fed. Exclusive breast-feeding was practiced by only 25% of breast-feeding women at one month postpartum. The cumulative 12-month probability of infant mortality was 18% (95% CI = 11%-29%) among the formula-fed compared to 3% (95% CI = 1%-9%) among the breast-fed infants (unadjusted hazard ratio (HR) = 6.1(95% CI = 1.7-21.4, P-value<0.01). There were no statistically significant differentials in HIV-free survival by feeding choice (86% in the formula-fed compared to 96% in breast-fed group (Adjusted RH = 2.8[ 95% CI = 0.67-11.7, P-value = 0.16] Conclusions/Significance: Formula-feeding was associated with a higher risk of infant mortality than breastfeeding in this rural population. Our findings suggest that formula-feeding should be discouraged in similar African settings.	[Kigozi, Godfrey; Nalugoda, Fred; Ddungu, Veronica] Rakai Hlth Sci Program, Dept Clin Res Studies, Entebbe, Uganda; [Gray, Ronald H.; Brahmbhatt, Heena; Wawer, Maria J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat, Family & Reproduct Hlth, Baltimore, MD 21218 USA; [Wabwire-Mangen, Fred; Makumbi, Fredrick; Kiwanuka, Noah] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Dept Dis Control, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Sch Med, Dept Med, Clin Epidemiol Unit, Kampala, Uganda; [Ssebagala, Darix; Sekasanvu, Joseph; Lutalo, Tom] Rakai Hlth Sci Program, Dept Biostat & Data Management, Entebbe, Uganda; [Kigozi, Grace] Rakai Hlth Sci Program, Dept Quality Control & Quality Assurance, Entebbe, Uganda; [Reynolds, Steven J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21218 USA; [Reynolds, Steven J.] NIAID, NIH, Div Intramural Res, Lab Immunoregulat, Bethesda, MD USA	Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University; Makerere University; Rakai Health Sciences Program; Rakai Health Sciences Program; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kagaayi, J (corresponding author), Rakai Hlth Sci Program, Dept Clin Res Studies, Entebbe, Uganda.	jkagayi@rhsp.org		Sewankambo, Nelson/0000-0001-9362-053X; Kagaayi, Joseph/0000-0003-4101-3038; Reynolds, Steven/0000-0002-5403-2759	National Institute of Child Health and Human Development(NICHD); Presidential Emergency Plan for AIDS Relief(PEPFAR)	National Institute of Child Health and Human Development(NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Presidential Emergency Plan for AIDS Relief(PEPFAR)	National Institute of Child Health and Human Development(NICHD). Presidential Emergency Plan for AIDS Relief(PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bobat R, 1997, AIDS, V11, P1627, DOI 10.1097/00002030-199713000-00012; Coovadia HM, 2007, AIDS, V21, P1837, DOI 10.1097/QAD.0b013e32826fb731; Coutsoudis A, 2003, ACTA PAEDIATR, V92, P890, DOI 10.1080/08035250310004261; Coutsoudis A, 2008, B WORLD HEALTH ORGAN, V86, P210, DOI 10.2471/BLT.07.041673; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2007, HIV INF FEED NEW EV; *WHO, 2006, WHO HIV INF FEED TEC	18	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3877	10.1371/journal.pone.0003877	http://dx.doi.org/10.1371/journal.pone.0003877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065270	Green Submitted, gold, Green Published			2022-12-27	WOS:000265455200003
J	Fischer-Rosinsky, A; Fisher, E; Kovacs, P; Bluher, M; Mohlig, M; Pfeiffer, AFH; Boeing, H; Spranger, J				Fischer-Rosinsky, Antje; Fisher, Eva; Kovacs, Peter; Blueher, Matthias; Moehlig, Matthias; Pfeiffer, Andreas F. H.; Boeing, Heiner; Spranger, Joachim			Lack of Association between the Tagging SNP A+930 -> G of SOCS3 and Type 2 Diabetes Mellitus: Meta-Analysis of Four Independent Study Populations	PLOS ONE			English	Article								Background: The suppressor of cytokine signalling 3 (SOCS3) provides a link between cytokine action and their negative consequences on insulin signalling. Thus SOCS3 is a potential candidate gene for type 2 diabetes (T2DM). Methodology/Principal Findings: Based on HapMap we identified the polymorphism A+930 -> G (rs4969168) as a haplotype tagging SNP (htSNP) sufficiently covering the genetic variation of the whole gene. We therefore examined the association between rs4969168 within SOCS3 and T2DM in three independent study populations; one prospective case-cohort study and two cross-sectional study populations. Due to the low frequency of individuals being homozygous for the polymorphism a dominant model of inheritance was assumed. The case-cohort study with 2,957 individuals (764 of them with incident T2DM) showed no effect of the polymorphism on diabetes risk (hazard ratio (95%Cl): 0.86 (0.66-1.13); p = 0.3). Within the MeSyBePo-study population 325 subjects had T2DM from a total of 1,897 individuals, while the second cross-sectional cohort included 851 cases of T2DM within a total of 1653 subjects. According to the results in the prospective study, no association with T2DM was found (odds ratio (95%Cl): 0.78 (0.54-1.12) for MesyBepo and 1.13 (0.90-1.42) for the Leipzig study population). There was also no association with metabolic subtraits such as insulin sensitivity (p = 0.7), insulin secretion (p = 0.8) or the hyperbolic relation of both, the disposition index (p = 0.7). In addition, no evidence for interaction with BMI or sex was found. We subsequently performed a meta-analysis, additionally including the publicly available data from the T2DM-subcohort of the WTCCC (n = 4,855). The overall odds ratio within that meta-analysis was 0.96 (0.88-1.06). Conclusions/Significance: There is no strong effect of the common genetic variation within the SOCS3 gene on the development of T2DM.	[Fischer-Rosinsky, Antje; Moehlig, Matthias; Pfeiffer, Andreas F. H.; Spranger, Joachim] Charite, Dept Endocrinol, D-13353 Berlin, Germany; [Fischer-Rosinsky, Antje; Moehlig, Matthias; Pfeiffer, Andreas F. H.; Spranger, Joachim] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [Fisher, Eva; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Blueher, Matthias] Univ Leipzig, Dept Internal Med III, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Leipzig University; Leipzig University	Fischer-Rosinsky, A (corresponding author), Charite, Dept Endocrinol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	joachim.spranger@charite.de	Pfeiffer, Andreas F.H./AAJ-2311-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Kovacs, Peter/0000-0002-0290-5423; Venkatasubramanian, Siddharth/0000-0002-5860-0768	BMBF [01GSO487]; Heisenberg-Professorship [SP716/2-1]; KFO [192/0, BL 833/1-1 to MB]; Deutsche Forschungsgemeinschaft (DFG) [GK1208]; Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig [Project N06]	BMBF(Federal Ministry of Education & Research (BMBF)); Heisenberg-Professorship(German Research Foundation (DFG)); KFO; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig	JS was supported by a research group of the BMBF (Molecular Nutrition), a Heisenberg-Professorship (SP716/2-1), a clinical research group (KFO 192/0) and a graduate school (GK1208) of the Deutsche Forschungsgemeinschaft (DFG). This project has been additionally funded by the BMBF (01GSO487) within the framework of NGFN2 (Neuronetz Adipositas). The Leipzig study was also supported by grants from DFG, the Clinical Research Group Atherobesity KFO 152 (projects BL 833/1-1 to MB) and from the Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig (Project N06 to PK). The funding institutions had no role within the design, analysis or interpretation of the data and the study was not approved by those institutions.	Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; FISCHER A, 2007, DIABETES CARE; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; SCHULZE MB, 2007, DIABETOLOGIA; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295	9	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3852	10.1371/journal.pone.0003852	http://dx.doi.org/10.1371/journal.pone.0003852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052638	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452200005
J	Srivastava, S; Zhang, LX; Jin, R; Chan, C				Srivastava, Shireesh; Zhang, Linxia; Jin, Rong; Chan, Christina			A Novel Method Incorporating Gene Ontology Information for Unsupervised Clustering and Feature Selection	PLOS ONE			English	Article							EXPRESSION PROFILES; CLASSIFICATION; APOPTOSIS; TISSUES; ACID	Background: Among the primary goals of microarray analysis is the identification of genes that could distinguish between different phenotypes (feature selection). Previous studies indicate that incorporating prior information of the genes' function could help identify physiologically relevant features. However, current methods that incorporate prior functional information do not provide a relative estimate of the effect of different genes on the biological processes of interest. Results: Here, we present a method that integrates gene ontology (GO) information and expression data using Bayesian regression mixture models to perform unsupervised clustering of the samples and identify physiologically relevant discriminating features. As a model application, the method was applied to identify the genes that play a role in the cytotoxic responses of human hepatoblastoma cell line (HepG2) to saturated fatty acid (SFA) and tumor necrosis factor (TNF)-alpha, as compared to the non-toxic response to the unsaturated FFAs (UFA) and TNF-alpha. Incorporation of prior knowledge led to a better discrimination of the toxic phenotypes from the others. The model identified roles of lysosomal ATPases and adenylate cyclase (AC9) in the toxicity of palmitate. To validate the role of AC in palmitate-treated cells, we measured the intracellular levels of cyclic AMP (cAMP). The cAMP levels were found to be significantly reduced by palmitate treatment and not by the other FFAs, in accordance with the model selection of AC9. Conclusions: A framework is presented that incorporates prior ontology information, which helped to (a) perform unsupervised clustering of the phenotypes, and (b) identify the genes relevant to each cluster of phenotypes. We demonstrate the proposed framework by applying it to identify physiologically-relevant feature genes that conferred differential toxicity to saturated vs. unsaturated FFAs. The framework can be applied to other problems to efficiently integrate ontology information and expression data in order to identify feature genes.	[Srivastava, Shireesh; Zhang, Linxia; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Jin, Rong; Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Srivastava, S (corresponding author), NIAAA, Lab Metab Control, Rockville, MD 20852 USA.	krischan@egr.msu.edu			National Science Foundation [BES 0425821, IIS-0643494]; National Institute of Health [1R01GM079688-01, 1R21CA126136-01]; Environmental Protection Agency [RD83184701]; MSU Foundation; Center for Systems Biology; NATIONAL CANCER INSTITUTE [R21CA126136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Environmental Protection Agency(United States Environmental Protection Agency); MSU Foundation; Center for Systems Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Science Foundation (BES 0425821 and IIS-0643494), the National Institute of Health (1R01GM079688-01 and 1R21CA126136-01), the Environmental Protection Agency (RD83184701), and the MSU Foundation and the Center for Systems Biology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach F.R., 2008, ADV NEURAL INFORM PR, P49; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chan C, 2003, BIOTECHNOL PROGR, V19, P580, DOI 10.1021/bp025660h; Chen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S20; Cho JH, 2004, FEBS LETT, V571, P93, DOI 10.1016/j.febslet.2004.05.087; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Distelhorst CW, 2003, BIOCHEM SOC T, V31, P958; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0; Hirota N, 2006, LIFE SCI, V79, P1312, DOI 10.1016/j.lfs.2006.03.048; Hwang D, 2003, ORAL ONCOL, V39, P259, DOI 10.1016/S1368-8375(02)00108-2; Le Phillip P, 2004, In Silico Biol, V4, P335; LI T, 2007, P 24 ANN INT C MACH; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Pan W, 2005, STAT APPL GENET MOL, V4; Robbins MJ, 2002, MOL BRAIN RES, V106, P136, DOI 10.1016/S0169-328X(02)00420-5; Roth V, 2004, IEEE T NEURAL NETWOR, V15, P16, DOI 10.1109/TNN.2003.809398; Saukkonen T, 2006, DIABETES, V55, P2365, DOI 10.2337/db05-1646; Soldatenkov VA, 1998, CELL DEATH DIFFER, V5, P307, DOI 10.1038/sj.cdd.4400345; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan YX, 2004, COMPUT BIOL CHEM, V28, P235, DOI 10.1016/j.compbiolchem.2004.05.002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Wang ZY, 2006, BIOINFORMATICS, V22, P755, DOI 10.1093/bioinformatics/btk036; Ye J., 2008, ADV NEURAL INFORM PR	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3860	10.1371/journal.pone.0003860	http://dx.doi.org/10.1371/journal.pone.0003860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052637	gold, Green Published			2022-12-27	WOS:000265452200010
J	McNamara, A; Buccino, G; Menz, MM; Glascher, J; Wolbers, T; Baumgartner, A; Binkofski, F				McNamara, Adam; Buccino, Giovanni; Menz, Mareike M.; Glaescher, Jan; Wolbers, Thomas; Baumgaertner, Annette; Binkofski, Ferdinand			Neural Dynamics of Learning Sound - Action Associations	PLOS ONE			English	Article							TEMPORAL CORTEX; BROCAS AREA; ACTION REPRESENTATION; OBJECT MANIPULATION; ACTION RECOGNITION; SPEECH; FMRI; LANGUAGE; MOTOR; HAND	A motor component is pre-requisite to any communicative act as one must inherently move to communicate. To learn to make a communicative act, the brain must be able to dynamically associate arbitrary percepts to the neural substrate underlying the pre-requisite motor activity. We aimed to investigate whether brain regions involved in complex gestures (ventral pre-motor cortex, Brodmann Area 44) were involved in mediating association between novel abstract auditory stimuli and novel gestural movements. In a functional resonance imaging (fMRI) study we asked participants to learn associations between previously unrelated novel sounds and meaningless gestures inside the scanner. We use functional connectivity analysis to eliminate the often present confound of 'strategic covert naming' when dealing with BA44 and to rule out effects of non-specific reductions in signal. Brodmann Area 44, a region incorporating Broca's region showed strong, bilateral, negative correlation of BOLD (blood oxygen level dependent) response with learning of sound-action associations during data acquisition. Left-inferior-parietal-lobule (l-IPL) and bilateral loci in and around visual area V5, right-orbital-frontal-gyrus, right-hippocampus, left-para-hippocampus, right-head-of-caudate, right-insula and left-lingual-gyrus also showed decreases in BOLD response with learning. Concurrent with these decreases in BOLD response, an increasing connectivity between areas of the imaged network as well as the right-middle-frontal-gyrus with rising learning performance was revealed by a psychophysiological interaction (PPI) analysis. The increasing connectivity therefore occurs within an increasingly energy efficient network as learning proceeds. Strongest learning related connectivity between regions was found when analysing BA44 and l-IPL seeds. The results clearly show that BA44 and l-IPL is dynamically involved in linking gesture and sound and therefore provides evidence that one of the mechanisms required for the evolution of human communication is found within these motor regions.	[McNamara, Adam; Menz, Mareike M.; Binkofski, Ferdinand] UKSH, Dept Neurol, Lubeck, Germany; [McNamara, Adam] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Buccino, Giovanni] Univ Degli Studi Parma, Dept Neurosci, Parma, Italy; [Menz, Mareike M.; Glaescher, Jan; Wolbers, Thomas; Baumgaertner, Annette] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Surrey; University of Parma; University of Hamburg; University Medical Center Hamburg-Eppendorf	McNamara, A (corresponding author), UKSH, Dept Neurol, Lubeck, Germany.	a.mcnamara@surrey.ac.uk	Binkofski, Ferdinand/S-6997-2017; Gläscher, Jan/H-2930-2019; Buccino, Giovanni/AAC-4503-2022	Binkofski, Ferdinand/0000-0002-6750-943X; Gläscher, Jan/0000-0002-1020-7115; Buccino, Giovanni/0000-0001-5432-1756; Wolbers, Thomas/0000-0003-2943-8949	Volkswagenstiftung [I/79006]; BMBF [01GW0571, 01GO0207]; DFG	Volkswagenstiftung(Volkswagen); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	AM and FB were funded by the Volkswagenstiftung (I/79006). MM and FB were supported by BMBF (01GW0571). NeuroImage Nord is supported by the BMBF (01GO0207) and the DFG.	Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2005, J COGNITIVE NEUROSCI, V17, P928, DOI 10.1162/0898929054021157; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Binkofski Ferdinand, 2004, Cortex, V40, P159, DOI 10.1016/S0010-9452(08)70933-X; BLAKE RW, 1992, EFFICIENCY EC ANIMAL; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corina DP, 2006, CORTEX, V42, P529, DOI 10.1016/S0010-9452(08)70393-9; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gandour J, 2003, BRAIN LANG, V84, P318, DOI 10.1016/S0093-934X(02)00505-9; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Gron G, 2001, LEARN MEMORY, V8, P336, DOI 10.1101/lm.42901; Hurford JR, 2004, VIENNA S THEOR BIOL, P297; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lindenberg R, 2007, BRAIN LANG, V102, P22, DOI 10.1016/j.bandl.2006.11.012; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MATELLI M, 1991, J COMP NEUROL, V311, P445, DOI 10.1002/cne.903110402; McNamara A, 2007, NEUROIMAGE, V35, P1211, DOI 10.1016/j.neuroimage.2007.01.009; Menz MM, 2006, NEUROIMAGE, V32, P1185, DOI 10.1016/j.neuroimage.2006.06.003; MEYER M, 2006, INVOLVEMENT LEFT RIG; Muller RA, 2004, BRAIN LANG, V89, P329, DOI 10.1016/S0093-934X(03)00346-8; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Puce A, 1998, J NEUROSCI, V18, P2188; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005	63	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3845	10.1371/journal.pone.0003845	http://dx.doi.org/10.1371/journal.pone.0003845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YN	19050764	gold, Green Published			2022-12-27	WOS:000265452100006
J	Kulick, S; Moccia, C; Didelot, X; Falush, D; Kraft, C; Suerbaum, S				Kulick, Stefan; Moccia, Claudia; Didelot, Xavier; Falush, Daniel; Kraft, Christian; Suerbaum, Sebastian			Mosaic DNA Imports with Interspersions of Recipient Sequence after Natural Transformation of Helicobacter pylori	PLOS ONE			English	Article								Helicobacter pylori colonizes the gastric mucosa of half of the human population, causing gastritis, ulcers, and cancer. H. pylori is naturally competent for transformation by exogenous DNA, and recombination during mixed infections of one stomach with multiple H. pylori strains generates extensive allelic diversity. We developed an in vitro transformation protocol to study genomic imports after natural transformation of H. pylori. The mean length of imported fragments was dependent on the combination of donor and recipient strain and varied between 1294 bp and 3853 bp. In about 10% of recombinant clones, the imported fragments of donor DNA were interrupted by short interspersed sequences of the recipient (ISR) with a mean length of 82 bp. 18 candidate genes were inactivated in order to identify genes involved in the control of import length and generation of ISR. Inactivation of the antimutator glycosylase MutY increased the length of imports, but did not have a significant effect on ISR frequency. Overexpression of mutY strongly increased the frequency of ISR, indicating that MutY, while not indispensable for ISR formation, is part of at least one ISR-generating pathway. The formation of ISR in H. pylori increases allelic diversity, and contributes to the uniquely low linkage disequilibrium characteristic of this pathogen.	[Kulick, Stefan; Moccia, Claudia; Kraft, Christian; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany; [Didelot, Xavier] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Falush, Daniel] Univ Coll Cork, Environm Res Inst, Cork, Ireland	Hannover Medical School; University of Warwick; University College Cork	Kulick, S (corresponding author), Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany.	suerbaum.sebastian@mh-hannover.de	Didelot, Xavier/H-1608-2013; Didelot, Xavier/P-4282-2019	Didelot, Xavier/0000-0003-1885-500X; Didelot, Xavier/0000-0003-1885-500X	European Union, project INCA [LSHC-CT-2005-018704]; German Research Foundation (DFG); German Academic Exchange Service (DAAD); Wilhelm Hirte Foundation	European Union, project INCA; German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Wilhelm Hirte Foundation	This work was supported by funding under the Sixth Research Framework Programme of the European Union, project INCA (LSHC-CT-2005-018704). S.K. received a Ph.D. stipend from Research Training Group GRK745 funded by the German Research Foundation (DFG). C.M. received a Ph.D. stipend from the German Academic Exchange Service (DAAD) and the Wilhelm Hirte Foundation.	ABASTADO JP, 1984, P NATL ACAD SCI-BIOL, V81, P5792, DOI 10.1073/pnas.81.18.5792; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; CAMI B, 1984, P NATL ACAD SCI-BIOL, V81, P503, DOI 10.1073/pnas.81.2.503; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Eutsey R, 2007, DNA REPAIR, V6, P19, DOI 10.1016/j.dnarep.2006.08.006; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; FORNILI SL, 1977, J MOL BIOL, V113, P181, DOI 10.1016/0022-2836(77)90048-1; Furuta T, 2007, J GASTROEN HEPATOL, V22, P1810, DOI 10.1111/j.1440-1746.2007.04919.x; GE ZM, 1995, MOL MICROBIOL, V15, P97, DOI 10.1111/j.1365-2958.1995.tb02224.x; Go MF, 1996, J BACTERIOL, V178, P3934, DOI 10.1128/jb.178.13.3934-3938.1996; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GUILD WR, 1968, COLD SPRING HARB SYM, V33, P643, DOI 10.1101/SQB.1968.033.01.072; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Huang S, 2006, J BACTERIOL, V188, P6224, DOI 10.1128/JB.00477-06; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kulick S, 2008, ARCH MICROBIOL, V189, P263, DOI 10.1007/s00203-007-0315-9; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; Mathieu A, 2006, J BACTERIOL, V188, P7464, DOI 10.1128/JB.00851-06; MCKANE M, 1995, GENETICS, V139, P35; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Sambrook J., 2004, MOL CLONING LAB MANU; Samrakandi MM, 2000, J BACTERIOL, V182, P3353, DOI 10.1128/JB.182.12.3353-3360.2000; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	40	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3797	10.1371/journal.pone.0003797	http://dx.doi.org/10.1371/journal.pone.0003797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030104	gold, Green Submitted, Green Published			2022-12-27	WOS:000265450800007
J	Labalette, C; Nouet, Y; Levillayer, F; Armengol, C; Renard, CA; Soubigou, G; Xia, T; Buendia, MA; Wei, Y				Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Armengol, Carolina; Renard, Claire-Angelique; Soubigou, Guillaume; Xia, Tian; Buendia, Marie-Annick; Wei, Yu			The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways	PLOS ONE			English	Article								Background: Four and a half LIM-only protein 2 (FHL2) has been implicated in multiple signaling pathways that regulate cell growth and tissue homeostasis. We reported previously that FHL2 regulates cyclin D1 expression and that immortalized FHL2-null mouse embryo fibroblasts (MEFs) display reduced levels of cyclin D1 and low proliferative activity. Methodology/Principal Findings: Here we address the contribution of FHL2 in cell transformation by investigating the effects of oncogenic Ras in FHL2-null context. We show that H-RasV12 provokes cell cycle arrest accompanied by accumulation of p53 and p16(INK4a) in immortalized FHL2(-/-) MEFs. These features contrast sharply with Ras transforming activity in wild type cell lines. We further show that establishment of FHL2-null cell lines differs from conventional immortalization scheme by retaining functional p19(ARF)/p53 checkpoint that is required for cell cycle arrest imposed by Ras. However, after serial passages of Ras-expressing FHL2(-/-) cells, dramatic increase in the levels of D-type cyclins and Rb phosphorylation correlates with the onset of cell proliferation and transformation without disrupting the p19(ARF)/p53 pathway. Interestingly, primary FHL2-null cells overexpressing cyclin D1 undergo a classical immortalization process leading to loss of the p19(ARF)/p53 checkpoint and susceptibility to Ras transformation. Conclusions/Significance: Our findings uncover a novel aspect of cellular responses to mitogenic stimulation and illustrate a critical role of FHL2 in the signalling network that implicates Ras, cyclin D1 and p53.			Labalette, C (corresponding author), Inst Pasteur, Unite Oncogenese & Virol Mol, Paris, France.	yu.wei@pasteur.fr	XIA, Tian/A-5392-2015; Wei, Yu/A-7289-2016; Armengol, Carol/D-5253-2014	XIA, Tian/0000-0002-9665-5858; Armengol, Carol/0000-0002-3723-7760; ARMENGOL, CAROLINA/0000-0002-4690-4027				Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Chen DH, 2003, CANCER RES, V63, P6626; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Gabriel B, 2004, ANTICANCER RES, V24, P921; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Heemers HV, 2007, CANCER RES, V67, P10592, DOI 10.1158/0008-5472.CAN-07-1917; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kong YF, 2001, CIRCULATION, V103, P2731; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ongusaha PP, 2003, ONCOGENE, V22, P3749, DOI 10.1038/sj.onc.1206439; PARK J, 2008, FASEB J; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wu Q, 2002, J BIOL CHEM, V277, P36329, DOI 10.1074/jbc.M204962200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853	49	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3761	10.1371/journal.pone.0003761	http://dx.doi.org/10.1371/journal.pone.0003761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018287	Green Submitted, gold, Green Published			2022-12-27	WOS:000265448500008
J	Gee, EPS; Ingber, DE; Stultz, CM				Gee, Elaine P. S.; Ingber, Donald E.; Stultz, Collin M.			Fibronectin Unfolding Revisited: Modeling Cell Traction-Mediated Unfolding of the Tenth Type-III Repeat	PLOS ONE			English	Article								Fibronectin polymerization is essential for the development and repair of the extracellular matrix. Consequently, deciphering the mechanism of fibronectin fibril formation is of immense interest. Fibronectin fibrillogenesis is driven by cell-traction forces that mechanically unfold particular modules within fibronectin. Previously, mechanical unfolding of fibronectin has been modeled by applying tensile forces at the N- and C-termini of fibronectin domains; however, physiological loading is likely focused on the solvent-exposed RGD loop in the 10(th) type-III repeat of fibronectin (10FNIII), which mediates binding to cell-surface integrin receptors. In this work we used steered molecular dynamics to study the mechanical unfolding of 10FNIII under tensile force applied at this RGD site. We demonstrate that mechanically unfolding 10FNIII by pulling at the RGD site requires less work than unfolding by pulling at the N- and C-termini. Moreover, pulling at the N- and C-termini leads to 10FNIII unfolding along several pathways while pulling on the RGD site leads to a single exclusive unfolding pathway that includes a partially unfolded intermediate with exposed hydrophobic N- terminal beta-strands - residues that may facilitate fibronectin self-association. Additional mechanical unfolding triggers an essential arginine residue, which is required for high affinity binding to integrins, to move to a position far from the integrin binding site. This cell traction-induced conformational change may promote cell detachment after important partially unfolded kinetic intermediates are formed. These data suggest a novel mechanism that explains how cell-mediated forces promote fibronectin fibrillogenesis and how cell surface integrins detach from newly forming fibrils. This process enables cells to bind and unfold additional fibronectin modules - a method that propagates matrix assembly.	[Gee, Elaine P. S.; Ingber, Donald E.; Stultz, Collin M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA USA; [Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA USA; [Stultz, Collin M.] MIT, Department of Elect Engn & Comp Sci, Harvard MIT Div Hlth Sci & Technol, Rese Lab Elect, Cambridge, MA USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Gee, EPS (corresponding author), Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA.	cmstultz@csail.mit.edu	Ingber, Donald E/AAC-5894-2019		NIH [T32 GM008313, CA45548]; Keck Foundation; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (NIH/NIGMS Molecular Biophysics Training Grant T32 GM008313 and NIH CA45548) as well as the Keck Foundation (NAKFI Nano 06). No funding agency was directly involved in the collection, analysis, interpretation of the data, or in preparation, review or approval of the manuscript.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; AOTA S, 1994, J BIOL CHEM, V269, P24756; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Kauf ACW, 2001, BIOCHEMISTRY-US, V40, P9159, DOI 10.1021/bi010503x; Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Li PC, 2004, J CHEM PHYS, V121, P4826, DOI 10.1063/1.1778152; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Ng SP, 2007, J MOL BIOL, V371, P851, DOI 10.1016/j.jmb.2007.06.015; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALGANICOFF L, 1985, AM J PHYSIOL, V249, pC279, DOI 10.1152/ajpcell.1985.249.3.C279; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sottile J, 1998, J CELL SCI, V111, P2933; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Toofanny RD, 2006, J MOL GRAPH MODEL, V24, P396, DOI 10.1016/j.jmgm.2005.09.005; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Zanotti G, 2003, FEBS LETT, V534, P7, DOI 10.1016/S0014-5793(02)03853-X; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	56	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2373	10.1371/journal.pone.0002373	http://dx.doi.org/10.1371/journal.pone.0002373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	19020673	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800014
J	Bauler, TJ; Hendriks, WJAJ; King, PD				Bauler, Timothy J.; Hendriks, Wiljan J. A. J.; King, Philip D.			The FERM and PDZ Domain-Containing Protein Tyrosine Phosphatases, PTPN4 and PTPN3, Are Both Dispensable for T Cell Receptor Signal Transduction	PLOS ONE			English	Article								PTPN3 and PTPN4 are two closely-related non-receptor protein tyrosine phosphatases (PTP) that, in addition to a PTP domain, contain FERM (Band 4.1, Ezrin, Radixin, and Moesin) and PDZ (PSD-95, Dlg, ZO-1) domains. Both PTP have been implicated as negative-regulators of early signal transduction through the T cell antigen receptor (TCR), acting to dephosphorylate the TCR zeta chain, a component of the TCR complex. Previously, we reported upon the production and characterization of PTPN3-deficient mice which show normal TCR signal transduction and T cell function. To address if the lack of a T cell phenotype in PTPN3-deficient mice can be explained by functional redundancy of PTPN3 with PTPN4, we generated PTPN4-deficient and PTPN4/PTPN3 double-deficient mice. As in PTPN3 mutants, T cell development and homeostasis and TCR-induced cytokine synthesis and proliferation were found to be normal in PTPN4-deficient and PTPN4/PTPN3 double-deficient mice. PTPN13 is another FERM and PDZ domain-containing non-receptor PTP that is distantly-related to PTPN3 and PTPN4 and which has been shown to function as a negative-regulator of T helper-1 (Th1) and Th2 differentiation. Therefore, to determine if PTPN13 might compensate for the loss of PTPN3 and PTPN4 in T cells, we generated mice that lack functional forms of all three PTP. T cells from triple-mutant mice developed normally and showed normal cytokine secretion and proliferative responses to TCR stimulation. Furthermore, T cell differentiation along the Th1, Th2 and Th17 lineages was largely unaffected in triple-mutants. We conclude that PTPN3 and PTPN4 are dispensable for TCR signal transduction.	[King, Philip D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Cell Biol, Nijmegen, Netherlands	University of Michigan System; University of Michigan; Radboud University Nijmegen	Bauler, TJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	kingp@umich.edu	Hendriks, Wiljan/Q-4325-2019; King, Phil/C-7104-2013; Hendriks, Wiljan J.A.J./A-5214-2013	Hendriks, Wiljan/0000-0001-9481-8281; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Bauler, Timothy/0000-0002-5170-0125	American Heart Association [0555597Z]; NIH National Research Service Award [5-T32-GM07544]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association grant 0555597Z and by NIH National Research Service Award #5-T32-GM07544 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Bauler TJ, 2007, J IMMUNOL, V178, P3680, DOI 10.4049/jimmunol.178.6.3680; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; Han SL, 2000, EUR J IMMUNOL, V30, P1318, DOI 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; KENNETH M, 2007, JANEWAYS IMMUNOBIOLO; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Lorber B, 2005, EUR J NEUROSCI, V21, P2375, DOI 10.1111/j.1460-9568.2005.04065.x; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Park KW, 2000, GENE, V257, P45, DOI 10.1016/S0378-1119(00)00351-6; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Patrignani C, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-36; Pilecka I, 2007, J BIOL CHEM, V282, P35405, DOI 10.1074/jbc.M705814200; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Sozio MS, 2004, J BIOL CHEM, V279, P7760, DOI 10.1074/jbc.M309994200; Spanos WC, 2008, J VIROL, V82, P2493, DOI 10.1128/JVI.02188-07; Topffer S, 2007, J GEN VIROL, V88, P2956, DOI 10.1099/vir.0.83123-0; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; Young JA, 2008, MOL IMMUNOL, V45, P3756, DOI 10.1016/j.molimm.2008.05.023; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	38	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4014	10.1371/journal.pone.0004014	http://dx.doi.org/10.1371/journal.pone.0004014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107198	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000009
J	Wang, AL; Mouraux, A; Liang, M; Iannetti, GD				Wang, An Li; Mouraux, Andre; Liang, Meng; Iannetti, Gian Domenico			The Enhancement of the N1 Wave Elicited by Sensory Stimuli Presented at Very Short Inter-Stimulus Intervals Is a General Feature across Sensory Systems	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; MISMATCH NEGATIVITY; SCALP TOPOGRAPHY; TRACE FORMATION; RESPONSES; COMPONENTS; HUMANS; CORTEX; MEMORY; HABITUATION	Background: A paradoxical enhancement of the magnitude of the N1 wave of the auditory event-related potential (ERP) has been described when auditory stimuli are presented at very short (<400 ms) inter-stimulus intervals (ISI). Here, we examined whether this enhancement is specific for the auditory system, or whether it also affects ERPs elicited by stimuli belonging to other sensory modalities. Methodology and Principal Findings: We recorded ERPs elicited by auditory and somatosensory stimuli in 13 healthy subjects. For each sensory modality, 4800 stimuli were presented. Auditory stimuli consisted in brief tones presented binaurally, and somatosensory stimuli consisted in constant-current electrical pulses applied to the right median nerve. Stimuli were delivered continuously, and the ISI was varied randomly between 100 and 1000 ms. We found that the ISI had a similar effect on both auditory and somatosensory ERPs. In both sensory modalities, ISI had an opposite effect on the magnitude of the N1 and P2 waves: the magnitude of the auditory and the somatosensory N1 was significantly increased at ISI <= 200 ms, while the magnitude of the auditory and the somatosensory P2 was significantly decreased at ISI <= 200 ms. Conclusion and Significance: The observation that both the auditory and the somatosensory N1 are enhanced at short ISIs indicates that this phenomenon reflects a physiological property that is common across sensory systems, rather than, as previously suggested, unique for the auditory system. Two of the hypotheses most frequently put forward to explain this observation, namely (i) the decreased contribution of inhibitory postsynaptic potentials to the recorded scalp ERPs and (ii) the decreased contribution of 'latent inhibition', are discussed. Because neither of these two hypotheses can satisfactorily account for the concomitant reduction of the auditory and the somatosensory P2, we propose a third, novel hypothesis, consisting in the modulation of a single neural component contributing to both the N1 and the P2 waves.	[Wang, An Li; Liang, Meng; Iannetti, Gian Domenico] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Mouraux, Andre] Univ Oxford, Ctr Funct Magnetic Resonance Imaging Brain, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Wang, AL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	andre.mouraux@clneuro.ox.ac.uk	Wang, An-Li/O-9099-2016; Mouraux, Andre/F-3724-2012	Lauwereyns, Jan/0000-0003-0551-2550; Iannetti, Giandomenico/0000-0002-4364-2068; Mouraux, Andre/0000-0003-1056-5980	Marie-Curie [post-doctoral Research Fellow]; Belgian National Fund for Scientific Research (FNRS); Volkswagen-Stiftung; The Royal Society [University Research Fellow]	Marie-Curie(European Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Volkswagen-Stiftung(Volkswagen); The Royal Society(Royal Society of London)	AM is a Marie-Curie post-doctoral Research Fellow, and a charge de recherches of the Belgian National Fund for Scientific Research (FNRS). ML is funded by the Volkswagen-Stiftung. GDI is a University Research Fellow of The Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka K, 2007, CLIN NEUROPHYSIOL, V118, P403, DOI 10.1016/j.clinph.2006.09.030; ANGEL RW, 1985, ELECTROEN CLIN NEURO, V60, P335, DOI 10.1016/0013-4694(85)90007-0; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Czigler I, 2006, NEUROSCI LETT, V401, P178, DOI 10.1016/j.neulet.2006.03.018; DAVIS H, 1966, ELECTROEN CLIN NEURO, V21, P105, DOI 10.1016/0013-4694(66)90118-0; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DESMEDT JE, 1983, ELECTROEN CLIN NEURO, V56, P272, DOI 10.1016/0013-4694(83)90252-3; FUJII M, 1994, ELECTROEN CLIN NEURO, V92, P518, DOI 10.1016/0168-5597(94)90136-8; GARCIALARREA L, 1995, PSYCHOPHYSIOLOGY, V32, P526, DOI 10.1111/j.1469-8986.1995.tb01229.x; GOFF GD, 1977, ELECTROEN CLIN NEURO, V42, P57, DOI 10.1016/0013-4694(77)90151-1; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; HARI R, 1982, ELECTROEN CLIN NEURO, V54, P561, DOI 10.1016/0013-4694(82)90041-4; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; LARREA LG, 1992, ELECTROEN CLIN NEURO, V84, P71, DOI 10.1016/0168-5597(92)90069-N; LEHTONEN JB, 1973, ELECTROEN CLIN NEURO, V35, P75, DOI 10.1016/0013-4694(73)90133-8; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; LOVELESS NE, 1993, BIOL PSYCHOL, V35, P1, DOI 10.1016/0301-0511(93)90088-P; Luck S.J., 2005, INTRO EVENT RELATED; McEvoy L, 1997, PSYCHOPHYSIOLOGY, V34, P308, DOI 10.1111/j.1469-8986.1997.tb02401.x; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2008, PAIN, V136, P219, DOI 10.1016/j.pain.2008.02.010; MOURAUX A, 2007, PAIN, V131, P43; MOURAUX A, NOCICEPTIVE IN PRESS; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NACIMIENTO AC, 1964, PFLUG ARCH EUR J PHY, V281, P152, DOI 10.1007/BF00363624; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P186, DOI 10.1016/0013-4694(78)90003-2; ROSSINI PM, 1987, ELECTROEN CLIN NEURO, V68, P88, DOI 10.1016/0168-5597(87)90036-0; Sable JJ, 2004, PSYCHOPHYSIOLOGY, V41, P636, DOI 10.1111/j.1469-8986.2004.00192.x; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; Todd J, 2000, PSYCHIAT RES, V96, P99, DOI 10.1016/S0165-1781(00)00205-5; TOMBERG C, 1989, ELECTROEN CLIN NEURO, V74, P347, DOI 10.1016/0168-5597(89)90002-6; Truini A, 2004, EXP BRAIN RES, V155, P120, DOI 10.1007/s00221-003-1785-x; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	38	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3929	10.1371/journal.pone.0003929	http://dx.doi.org/10.1371/journal.pone.0003929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZW	19081790	Green Submitted, Green Published, gold			2022-12-27	WOS:000265456300007
J	Zhou, JF; Li, WH; Kamei, H; Duan, CM				Zhou, Jianfeng; Li, Wenhong; Kamei, Hiroyasu; Duan, Cunming			Duplication of the IGFBP-2 Gene in Teleost Fish: Protein Structure and Functionality Conservation and Gene Expression Divergence	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; CELL-PROLIFERATION; GROWTH; MUTATION; ROLES; MICE	Background: Insulin-like growth factor binding protein-2 (IGFBP-2) is a secreted protein that binds and regulates IGF actions in controlling growth, development, reproduction, and aging. Elevated expression of IGFBP-2 is often associated with progression of many types of cancers. Methodology/Principal Findings: We report the identification and characterization of two IGFBP-2 genes in zebrafish and four other teleost fish. Comparative genomics and structural analyses suggest that they are co-orthologs of the human IGFBP-2 gene. Biochemical assays show that both zebrafish igfbp-2a and -2b encode secreted proteins that bind IGFs. These two genes exhibit distinct spatiotemporal expression patterns. During embryogenesis, IGFBP-2a mRNA is initially detected in the lens, then in the brain boundary vasculature, and subsequently becomes highly expressed in the liver. In the adult stage, liver has the highest levels of IGFBP-2a mRNA, followed by the brain. Low levels of IGFBP-2a mRNA were detected in muscle and in the gonad in male adults only. IGFBP-2b mRNA is detected initially in all tissues at low levels, but later becomes abundant in the liver. In adult males, IGFBP-2b mRNA is only detected in the liver. In adult females, it is also found in the gut, kidney, ovary, and muscle. To gain insights into how the IGFBP-2 genes may have evolved through partitioning of ancestral functions, functional and mechanistic studies were carried out. Expression of zebrafish IGFBP-2a and -2b caused significant decreases in the growth and developmental rates and their effects are comparable to that of human IGFBP-2. IGFBP-2 mutants with altered IGF binding-, RGD-, and heparin- binding sites were generated and their actions examined. While mutating the RGD and heparin binding sites had little effect, altering the IGF binding site abolished its biological activity. Conclusions/Significance: These results suggest that IGFBP-2 is a conserved regulatory protein and it inhibits growth and development primarily by binding to and inhibiting IGF actions in vivo. The duplicated IGFBP-2 genes may provide additional flexibility in the regulation of IGF activities.	[Zhou, Jianfeng; Li, Wenhong; Kamei, Hiroyasu; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zhou, Jianfeng; Duan, Cunming] Ocean Univ China, Sch Med & Pharm, Lab Mol Med, Qingdao, Peoples R China; [Li, Wenhong] Guangxi Univ, Dept Aquacult, Nanning, Peoples R China	University of Michigan System; University of Michigan; Ocean University of China; Guangxi University	Zhou, JF (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X	NSF [IOB 0110864]; Changjiang Scholars Program [fellowship]; Chinese Academy of Sciences [scholarship]; Guangxi Government [fellowship]	NSF(National Science Foundation (NSF)); Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangxi Government	This study was supported by NSF Research Grant IOB 0110864 and by a fellowship from the Changjiang Scholars Program to CD. JZ was supported in part by a scholarship from the Chinese Academy of Sciences and WL was supported in part by a fellowship from the Guangxi Government during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANDER SV, 1994, J BIOL CHEM, V269, P10891; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes BE, 1998, J BIOL CHEM, V273, P4647, DOI 10.1074/jbc.273.8.4647; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Hoeflich A, 2002, FEBS LETT, V523, P63, DOI 10.1016/S0014-5793(02)02935-6; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Pozios KC, 2001, AM J PHYSIOL-REG I, V280, pR1230, DOI 10.1152/ajpregu.2001.280.4.R1230; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Wood AW, 2005, MOL ENDOCRINOL, V19, P1024, DOI 10.1210/me.2004-0392; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472	31	69	74	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3926	10.1371/journal.pone.0003926	http://dx.doi.org/10.1371/journal.pone.0003926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081843	gold, Green Published, Green Submitted			2022-12-27	WOS:000265456300005
J	Gonzalez-Barroso, MM; Giurgea, I; Bouillaud, F; Anedda, A; Bellanne-Chantelot, C; Hubert, L; de Keyzer, Y; de Lonlay, P; Ricquier, D				Gonzalez-Barroso, M. Mar; Giurgea, Irina; Bouillaud, Frederic; Anedda, Andrea; Bellanne-Chantelot, Christine; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale; Ricquier, Daniel			Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion	PLOS ONE			English	Article							MITOCHONDRIAL PROTON LEAK; BETA-CELL DYSFUNCTION; UNCOUPLING PROTEIN-2; FAMILIAL HYPERINSULINISM; COMMON POLYMORPHISM; GLUCOSE-HOMEOSTASIS; HYPOGLYCEMIA; OBESITY; EXPRESSION; GENE	Although the most common mechanism underlying congenital hyperinsulinism is dysfunction of the pancreatic ATP-sensitive potassium channel, the pathogenesis and genetic origins of this disease remains largely unexplained in more than half of all patients. UCP2 knockout mice exhibit an hyperinsulinemic hypoglycemia, suggesting an involment of UCP2 in insulin secretion. However, a possible pathogenic role for UCP2 protein in the development of human congenital hyperinsulinism or of any human disease has not yet been investigated. We studied ten children exhibiting congenital hyperinsulinism, without detectable mutations in the known congenital hyperinsulinism-causing genes. Parental-inherited heterozygous UCP2 variants encoding amino-acid changes were found in two unrelated children with congenital hyperinsulinism. Functional assays in yeast and in insulin-secreting cells revealed an impaired activity of UCP2 mutants. Therefore, we report the finding of UCP2 coding variants in human congenital hyperinsulinism, which reveals a role for this gene in the regulation of insulin secretion and glucose metabolism in humans. Our results show for the first time a direct association between UCP2 amino acid alteration and human disease and highlight a role for mitochondria in hormone secretion.	[Bouillaud, Frederic; Ricquier, Daniel] Univ Paris Descartes Site Necker Enfants Malad, CNRS, UPR 9078, BIOTRAM, Paris, France; [Giurgea, Irina; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale] AP HP, Hop Necker Enfants Malades, Dept Pediat, Paris, France; [Giurgea, Irina; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale] Univ Paris Descartes Site Necker enfants Malades, INSERM U781, Paris, France; [Gonzalez-Barroso, M. Mar; Anedda, Andrea] CSIC, Ctr Investigac Biol, Madrid, Spain; [Bellanne-Chantelot, Christine] AP HP, Grp Hosp Pitie Salpetriere, Dept Genet, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gonzalez-Barroso, MM (corresponding author), Univ Paris Descartes Site Necker Enfants Malad, CNRS, UPR 9078, BIOTRAM, Paris, France.	ricquier@necker.fr	Giurgea, Irina/AGX-6879-2022; Bouillaud, Frédéric R/L-3238-2017	Giurgea, Irina/0000-0002-5035-2958; Bouillaud, Frédéric R/0000-0002-7518-9237; GONZALEZ BARROSO, MARIA DEL MAR/0000-0002-0278-8298	Centre National de la Recherche Scientifique; European Union	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission)	Academic support was obtained from the Centre National de la Recherche Scientifique and from the European Union (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOURTIT C, 2007, NOVART FDN SYMP, V28, P70; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; BRUNELLE F, 1989, PEDIATR RADIOL, V19, P100, DOI 10.1007/BF02387895; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Clayton PT, 2001, J CLIN INVEST, V108, P457; De Leon DD, 2007, NAT CLIN PRACT ENDOC, V3, P57, DOI 10.1038/ncpendmet0368; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Glaser B, 2000, ARCH DIS CHILD-FETAL, V82, pF79, DOI 10.1136/fn.82.2.F79; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hojlund K, 2004, DIABETES, V53, P1592, DOI 10.2337/diabetes.53.6.1592; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331; LOCKE RM, 1982, EUR J BIOCHEM, V129, P381, DOI 10.1111/j.1432-1033.1982.tb07061.x; Magge SN, 2004, J CLIN ENDOCR METAB, V89, P4450, DOI 10.1210/jc.2004-0441; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Saleh MC, 2006, J ENDOCRINOL, V190, P659, DOI 10.1677/joe.1.06715; Sempoux C, 1998, J CLIN ENDOCR METAB, V83, P1455, DOI 10.1210/jc.83.5.1455; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Sheets AR, 2008, AM J PHYSIOL-GASTR L, V294, pG1017, DOI 10.1152/ajpgi.00016.2008; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Thomas PM, 1996, P ASSOC AM PHYSICIAN, V108, P14; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	51	78	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3850	10.1371/journal.pone.0003850	http://dx.doi.org/10.1371/journal.pone.0003850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065272	Green Published, gold			2022-12-27	WOS:000265455200002
J	Phimpraphi, W; Paul, R; Witoonpanich, B; Turbpaiboon, C; Peerapittayamongkol, C; Louicharoen, C; Casademont, I; Tungpradabkul, S; Krudsood, S; Kaewkunwal, J; Sura, T; Looareesuwan, S; Singhasivanon, P; Sakuntabhai, A				Phimpraphi, Waraphon; Paul, Richard; Witoonpanich, Bhee; Turbpaiboon, Chairat; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Casademont, Isabelle; Tungpradabkul, Sumalee; Krudsood, Srivicha; Kaewkunwal, Jaranit; Sura, Thanyachai; Looareesuwan, Sornchai; Singhasivanon, Pratap; Sakuntabhai, Anavaj			Heritability of P. falciparum and P. vivax Malaria in a Karen Population in Thailand	PLOS ONE			English	Article								The majority of studies concerning malaria host genetics have focused on individual genes that confer protection against rather than susceptibility to malaria. Establishing the relative impact of genetic versus non-genetic factors on malaria infection and disease is essential to focus effort on key determinant factors. This relative contribution has rarely been evaluated for Plasmodium falciparum and almost never for Plasmodium vivax. We conducted a longitudinal cohort study in a Karen population of 3,484 individuals in a region of mesoendemic malaria, Thailand from 1998 to 2005. The number of P. falciparum and P. vivax clinical cases and the parasite density per person were determined. Statistical analyses were performed to account for the influence of environmental factors and the genetic heritability of the phenotypes was calculated using the pedigree-based variance components model. The genetic contribution to the number of clinical episodes resulting from P. falciparum and P. vivax were 10% and 19% respectively. There was also moderate genetic contribution to the maximum and overall parasite trophozoite density phenotypes for both P. falciparum (16%&16%) and P. vivax (15%&13%). These values, for P. falciparum, were similar to those previously observed in a region of much higher transmission intensity in Senegal, West Africa. Although environmental factors play an important role in acquiring an infection, genetics plays a determinant role in the outcome of an infection with either malaria parasite species prior to the development of immunity.	[Phimpraphi, Waraphon; Paul, Richard; Witoonpanich, Bhee; Turbpaiboon, Chairat; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Casademont, Isabelle; Sakuntabhai, Anavaj] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France; [Phimpraphi, Waraphon; Krudsood, Srivicha; Kaewkunwal, Jaranit; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hygiene, Bangkok 10700, Thailand; [Witoonpanich, Bhee; Turbpaiboon, Chairat; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10700, Thailand; [Sura, Thanyachai; Sakuntabhai, Anavaj] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand; [Looareesuwan, Sornchai] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Phimpraphi, W (corresponding author), Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France.	anavaj@pasteur.fr	Peerapittayamongkol, Chayanon/K-7965-2019; Peerapittayamongkol, Chayanon/B-4920-2010	Singhasivanon, Pratap/0000-0002-9759-1702	BIOTEC [BT-B06-MG-14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; Institut Pasteur; Inserm [post-doctoral fellowship]; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [post-doctoral fellowship]; Royal Golden Jubilee Program; French Embassy in Thailand; Medical Scholar Program, Mahidol University	BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Royal Golden Jubilee Program; French Embassy in Thailand; Medical Scholar Program, Mahidol University	This work was funded in part by grants from BIOTEC (BT-B06-MG-14-4507), the Thailand Research Fund (BRG/16/2544), Mahidol University grant (OR-9123) and the Institut Pasteur to AS. Microsatellite genotyping was performed at Centre National de Genotypage, Evry, France. CP was supported by post-doctoral fellowships from Inserm and from the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. CT, WP and CL were supported by the Royal Golden Jubilee Program, the Thailand Research Fund and the French Embassy in Thailand. BW was supported by the Medical Scholar Program, Mahidol University and the French Embassy in Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ABEL L, 1992, AM J HUM GENET, V50, P1308; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Boyd M. F., 1937, American Journal of Tropical Medicine, V17, P855; BOYD MARK F., 1938, AMER JOUR TROP MED, V18, P505; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Gilmour A. R., ASREML USER GUIDE RE; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Haldane J.B.S., 1949, HEREDITAS, V35, P267; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; NAGEL RL, 1989, BLOOD, V74, P1213; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stirnadel HA, 1999, GENET EPIDEMIOL, V17, P16, DOI 10.1002/(SICI)1098-2272(1999)17:1<16::AID-GEPI2>3.0.CO;2-7; Stirnadel HA, 2000, EPIDEMIOL INFECT, V124, P153, DOI 10.1017/S0950268899003325; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; WARD RH, 1975, AM J HUM GENET, V27, P1; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3887	10.1371/journal.pone.0003887	http://dx.doi.org/10.1371/journal.pone.0003887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060954	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455100007
J	Seelow, D; Schwarz, JM; Schuelke, M				Seelow, Dominik; Schwarz, Jana Marie; Schuelke, Markus			GeneDistiller-Distilling Candidate Genes from Linkage Intervals	PLOS ONE			English	Article								Background: Linkage studies often yield intervals containing several hundred positional candidate genes. Different manual or automatic approaches exist for the determination of the gene most likely to cause the disease. While the manual search is very flexible and takes advantage of the researchers' background knowledge and intuition, it may be very cumbersome to collect and study the relevant data. Automatic solutions on the other hand usually focus on certain models, remain "black boxes'' and do not offer the same degree of flexibility. Methodology: We have developed a web-based application that combines the advantages of both approaches. Information from various data sources such as gene-phenotype associations, gene expression patterns and protein-protein interactions was integrated into a central database. Researchers can select which information for the genes within a candidate interval or for single genes shall be displayed. Genes can also interactively be filtered, sorted and prioritised according to criteria derived from the background knowledge and preconception of the disease under scrutiny. Conclusions: GeneDistiller provides knowledge-driven, fully interactive and intuitive access to multiple data sources. It displays maximum relevant information, while saving the user from drowning in the flood of data. A typical query takes less than two seconds, thus allowing an interactive and explorative approach to the hunt for the candidate gene. Access: GeneDistiller can be freely accessed at http://www.genedistiller.org	[Seelow, Dominik; Schwarz, Jana Marie; Schuelke, Markus] Charite, Dept Neuropaediat, Berlin, Germany; [Schuelke, Markus] Charite, Sch Med, NeuroCure Clin Res Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seelow, D (corresponding author), Charite, Dept Neuropaediat, Berlin, Germany.	markus.schuelke@charite.de	Schwarz, Jana Marie/AAZ-7833-2021; Seelow, Dominik/HGB-3124-2022	Schwarz, Jana Marie/0000-0002-7048-208X; Seelow, Dominik/0000-0002-9746-4412; Schuelke, Markus/0000-0003-2824-3891	NeuroCure Clinical Research Centre of the Charite Berlin; Deutsche Forschungsgemeinschaft [SFB665]	NeuroCure Clinical Research Centre of the Charite Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been supported by funds of the NeuroCure Clinical Research Centre of the Charite Berlin, and by the Deutsche Forschungsgemeinschaft (SFB665 TP A6 to M.S.)	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Safran M, 2003, NUCLEIC ACIDS RES, V31, P142, DOI 10.1093/nar/gkg050; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thornblad TA, 2007, TWIN RES HUM GENET, V10, P861, DOI 10.1375/twin.10.6.861; van Driel MA, 2005, NUCLEIC ACIDS RES, V33, pW758, DOI 10.1093/nar/gki435; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000	33	88	90	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3874	10.1371/journal.pone.0003874	http://dx.doi.org/10.1371/journal.pone.0003874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057649	gold, Green Submitted, Green Published			2022-12-27	WOS:000265452300010
J	Santi, I; Pezzicoli, A; Bosello, M; Berti, F; Mariani, M; Telford, JL; Grandi, G; Soriani, M				Santi, Isabella; Pezzicoli, Alfredo; Bosello, Mattia; Berti, Francesco; Mariani, Massimo; Telford, John L.; Grandi, Guido; Soriani, Marco			Functional Characterization of a Newly Identified Group B Streptococcus Pullulanase Eliciting Antibodies Able to Prevent Alpha-Glucans Degradation	PLOS ONE			English	Article								Streptococcal pullulanases have been recently proposed as key components of the metabolic machinery involved in bacterial adaptation to host niches. By sequence analysis of the Group B Streptococcus (GBS) genome we found a novel putative surface exposed protein with pullulanase activity. We named such a protein SAP. The sap gene is highly conserved among GBS strains and homologous genes, such as PulA and SpuA, have been described in other pathogenic streptococci. The SAP protein contains two N-terminal carbohydrate-binding motifs, followed by a catalytic domain and a C-terminal LPXTG cell wall-anchoring domain. In vitro analysis revealed that the recombinant form of SAP is able to degrade alpha-glucan polysaccharides, such as pullulan, glycogen and starch. Moreover, NMR analysis showed that SAP acts as a type I pullulanase. Studies performed on whole bacteria indicated that the presence of alpha-glucan polysaccharides in culture medium up-regulated the expression of SAP on bacterial surface as confirmed by FACS analysis and confocal imaging. Deletion of the sap gene resulted in a reduced capacity of bacteria to grow in medium containing pullulan or glycogen, but not glucose or maltose, confirming the pivotal role of SAP in GBS metabolism of alpha-glucans. As reported for other streptococcal pullulanases, we found specific anti-SAP antibodies in human sera from healthy volunteers. Investigation of the functional role of anti-SAP antibodies revealed that incubation of GBS in the presence of sera from animals immunized with SAP reduced the capacity of the bacterium to degrade pullulan. Of interest, anti-SAP sera, although to a lower extent, also inhibited Group A Streptococcus pullulanase activity. These data open new perspectives on the possibility to use SAP as a potential vaccine component inducing functional cross-reacting antibodies interfering with streptococcal infections.	[Santi, Isabella; Pezzicoli, Alfredo; Bosello, Mattia; Berti, Francesco; Mariani, Massimo; Telford, John L.; Grandi, Guido; Soriani, Marco] Novartis Vaccines & Diagnost Srl, Siena, Italy	Novartis	Santi, I (corresponding author), Novartis Vaccines & Diagnost Srl, Siena, Italy.	Marco.Soriani@novartis.com	Telford, John Laird/ABG-8144-2020	SORIANI, Marco/0000-0002-9752-5844; Grandi, Guido/0000-0001-9724-2185	Novartis Vaccines & Diagnostic	Novartis Vaccines & Diagnostic	This work was supported by internal funding from Novartis Vaccines & Diagnostic.	ADAM MN, 1994, PATHOL BIOL, V42, P544; ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; ARNOSTI C, 1994, APPL ENVIRON MICROB, V60, P840, DOI 10.1128/AEM.60.3.840-846.1994; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Bertoldo C, 1999, APPL ENVIRON MICROB, V65, P2084; Bertoldo C, 2004, APPL ENVIRON MICROB, V70, P3407, DOI 10.1128/AEM.70.6.3407-3416.2004; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Glinel K, 2000, CARBOHYD RES, V328, P343, DOI 10.1016/S0008-6215(00)00120-8; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; GREGOIRE AT, 1971, FERTIL STERIL, V22, P64; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hytonen J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-18; Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MILLER G, 1959, ANAL CHEM, V31; PAAVONEN J, 1983, SCAND J INFECT DIS, P31; Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000	37	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3787	10.1371/journal.pone.0003787	http://dx.doi.org/10.1371/journal.pone.0003787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023424	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448800008
J	Robertson, AJ; Coluccio, A; Knowlton, P; Dickey-Sims, C; Coffman, JA				Robertson, Anthony J.; Coluccio, Alison; Knowlton, Peter; Dickey-Sims, Carrie; Coffman, James A.			Runx Expression Is Mitogenic and Mutually Linked to Wnt Activity in Blastula-Stage Sea Urchin Embryos	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; EPITHELIAL-CELLS; GROWTH; GENE; DIFFERENTIATION; CATENIN; PHOSPHORYLATION; UBIQUITINATION	Background: The Runt homology domain (Runx) defines a metazoan family of sequence-specific transcriptional regulatory proteins that are critical for animal development and causally associated with a variety of mammalian cancers. The sea urchin Runx gene SpRunt-1 is expressed throughout the blastula stage embryo, and is required globally during embryogenesis for cell survival and differentiation. Methodology/Principal Findings: Depletion of SpRunt-1 by morpholino antisense-mediated knockdown causes a blastula stage deficit in cell proliferation, as shown by bromodeoxyuridine (BrdU) incorporation and direct cell counts. Reverse transcription coupled polymerase chain reaction (RT-PCR) studies show that the cell proliferation deficit is presaged by a deficit in the expression of several zygotic wnt genes, including wnt8, a key regulator of endomesoderm development. In addition, SpRunt-1-depleted blastulae underexpress cyclinD, an effector of mitogenic Wnt signaling. Blastula stage cell proliferation is also impeded by knockdown of either wnt8 or cyclinD. Chromatin immunoprecipitation (ChIP) indicates that Runx target sites within 59 sequences flanking cyclinD, wnt6 and wnt8 are directly bound by SpRunt-1 protein at late blastula stage. Furthermore, experiments using a green fluorescent protein (GFP) reporter transgene show that the blastulastage operation of a cis-regulatory module previously shown to be required for wnt8 expression (Minokawa et al., Dev. Biol. 288: 545-558, 2005) is dependent on its direct sequence-specific interaction with SpRunt-1. Finally, inhibitor studies and immunoblot analysis show that SpRunt-1 protein levels are negatively regulated by glycogen synthase kinase (GSK)-3. Conclusions/Significance: These results suggest that Runx expression and Wnt signaling are mutually linked in a feedback circuit that controls cell proliferation during development.	[Robertson, Anthony J.; Coluccio, Alison; Knowlton, Peter; Coffman, James A.] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Dickey-Sims, Carrie] Stowers Inst Med Res, Kansas City, MO USA	Mount Desert Island Biological Laboratory; Stowers Institute for Medical Research	Robertson, AJ (corresponding author), Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA.	jcoffman@mdibl.org			NIH [GM070840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the NIH (GM070840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Coffman JA, 1996, DEV BIOL, V174, P43, DOI 10.1006/dbio.1996.0050; Coffman JA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-6; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Davidson EH, 2006, REG GEN GEN REG; Dickey-Sims C, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-18; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Fukamachi H, 2004, ONCOGENE, V23, P4330, DOI 10.1038/sj.onc.1207121; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kagoshima H, 2005, DEV BIOL, V287, P262, DOI 10.1016/j.ydbio.2005.08.034; Kagoshima H, 2007, J CELL BIOCHEM, V100, P1119, DOI 10.1002/jcb.21174; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; KNOWLTON P, 2007, MDIBL B, V46, P65; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li J, 2004, J CLIN PATHOL, V57, P294, DOI 10.1136/jcp.2003.013011; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Mikesch JH, 2007, LEUKEMIA, V21, P1638, DOI 10.1038/sj.leu.2404732; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Moore JC, 2002, MOL CELL BIOL, V22, P4863, DOI 10.1128/MCB.22.13.4863-4875.2002; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nimmo R, 2008, DEV BIOL, V313, P492, DOI 10.1016/j.ydbio.2007.11.002; Peterson LF, 2005, MOL CELL BIOL, V25, P10205, DOI 10.1128/MCB.25.23.10205-10219.2005; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Robertson AJ, 2002, MECH DEVELOP, V117, P327, DOI 10.1016/S0925-4773(02)00201-0; Robertson AJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-4; Selvamurugan N, 2004, J BIOL CHEM, V279, P27764, DOI 10.1074/jbc.M312870200; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; SMITH J, 2007, DEV BIOL; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Sun LX, 2004, ONCOGENE, V23, P4722, DOI 10.1038/sj.onc.1207589; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Vilimek D, 2006, BIOCHEM CELL BIOL, V84, P20, DOI 10.1139/O05-154; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westendorf JJ, 1999, J CELL BIOCHEM, P51; Wheeler JC, 2000, SEMIN CELL DEV BIOL, V11, P369, DOI 10.1006/scdb.2000.0184; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wotton S, 2002, CANCER RES, V62, P7181; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	59	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3770	10.1371/journal.pone.0003770	http://dx.doi.org/10.1371/journal.pone.0003770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020668	gold, Green Published, Green Submitted			2022-12-27	WOS:000265448600003
J	Caiado, F; Real, C; Carvalho, T; Dias, S				Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio			Notch Pathway Modulation on Bone Marrow-Derived Vascular Precursor Cells Regulates Their Angiogenic and Wound Healing Potential	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MOBILIZATION; STEM; ARTERIAL; REPAIR; DIFFERENTIATION; TRANSPLANTATION; RECRUITMENT; HYPOXIA	Bone marrow (BM) derived vascular precursor cells (BM-PC, endothelial progenitors) are involved in normal and malignant angiogenesis, in ischemia and in wound healing. However, the mechanisms by which BM-PC stimulate the pre-existing endothelial cells at sites of vascular remodelling/recovery, and their contribution towards the formation of new blood vessels are still undisclosed. In the present report, we exploited the possibility that members of the Notch signalling pathway, expressed by BM-PC during endothelial differentiation, might regulate their pro-angiogenic or pro-wound healing properties. We demonstrate that Notch pathway modulates the adhesion of BM-PC to extracellular matrix (ECM) in vitro via regulation of integrin alpha3beta1; and that Notch pathway inhibition on BM-PC impairs their capacity to stimulate endothelial cell tube formation on matrigel and to promote endothelial monolayer recovery following wounding in vitro. Moreover, we show that activation of Notch pathway on BM-PC improved wound healing in vivo through angiogenesis induction. Conversely, inoculation of BM-PC pre-treated with a gamma secretase inhibitor (GSI) into wounded mice failed to induce angiogenesis at the wound site and did not promote wound healing, presumably due to a lower frequency of BM-PC at the wound area. Our data suggests that Notch pathway regulates BM-PC adhesion to ECM at sites of vascular repair and that it also regulates the capacity of BM-PC to stimulate angiogenesis and to promote wound healing. Drug targeting of the Notch pathway on BM-PC may thus represent a novel strategy to modulate neo-angiogenesis and vessel repair.	[Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio] Portuguese Inst Oncol, CIPM, Angiogenesis Lab, Lisbon, Portugal; [Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Dias, Sergio] Inst Med Mol, Lisbon, Portugal	Universidade de Coimbra; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Caiado, F (corresponding author), Portuguese Inst Oncol, CIPM, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Carvalho, Tânia/X-2873-2019; Dias, Sergio/L-1250-2014; Carvalho, Tânia/GNM-6203-2022; Real, Carla/D-5444-2009	Carvalho, Tânia/0000-0002-5283-5013; Dias, Sergio/0000-0002-7603-4616; Real, Carla/0000-0001-8067-2023; Caiado, Francisco/0000-0003-4096-4448	Fundacao para a Ciencia e Tecnologia fellowships [SFRH/BD/31381/2006, SFRH/BPD/17479/2004, SFRH/BPD/41378/2007]; Crioestaminal; Gulbenkian Foundation	Fundacao para a Ciencia e Tecnologia fellowships; Crioestaminal; Gulbenkian Foundation	Francisco Caiado, Carla Real and Tania Carvalho are supported by Fundacao para a Ciencia e Tecnologia fellowships (SFRH/BD/31381/2006, SFRH/BPD/17479/2004 and SFRH/BPD/41378/2007). This work was supported by Crioestaminal and by the Gulbenkian Foundation.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Karsan A, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe2; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; ROGERS LC, 2008, INT WOUND J, P520; Silvestre JS, 2008, DIABETES METAB, V34, pS33, DOI 10.1016/S1262-3636(08)70101-0; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wilson Joyce A, 2004, Adv Skin Wound Care, V17, P426, DOI 10.1097/00129334-200410000-00013; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50	39	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3752	10.1371/journal.pone.0003752	http://dx.doi.org/10.1371/journal.pone.0003752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015735	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448400009
J	Schmid, K; Yang, ZH				Schmid, Karl; Yang, Ziheng			The Trouble with Sliding Windows and the Selective Pressure in BRCA1	PLOS ONE			English	Article								Sliding-window analysis has widely been used to uncover synonymous (silent, d(S)) and nonsynonymous (replacement, d(N)) rate variation along the protein sequence and to detect regions of a protein under selective constraint (indicated by d(N)<d(S)) or positive selection (indicated by d(N)>d(S)). The approach compares two or more protein-coding genes and plots estimates <(d)over cap>(S) and (d) over cap (N) from each sliding window along the sequence. Here we demonstrate that the approach produces artifactual trends of synonymous and nonsynonymous rate variation, with greater variation in (d) over cap (S) than in (d) over cap (N). Such trends are generated even if the true dS and dN are constant along the whole protein and different codons are evolving independently. Many published tests of negative and positive selection using sliding windows that we have examined appear to be invalid because they fail to correct for multiple testing. Instead, likelihood ratio tests provide a more rigorous framework for detecting signals of natural selection affecting protein evolution. We demonstrate that a previous finding that a particular region of the BRCA1 gene experienced a synonymous rate reduction driven by purifying selection is likely an artifact of the sliding window analysis. We evaluate various sliding-window analyses in molecular evolution, population genetics, and comparative genomics, and argue that the approach is not generally valid if it is not known a priori that a trend exists and if no correction for multiple testing is applied.	[Schmid, Karl] Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Yang, Ziheng] UCL, Dept Biol, London WC1E 6BT, England	Swedish University of Agricultural Sciences; University of London; University College London	Schmid, K (corresponding author), Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala, Sweden.	z.yang@ucl.ac.uk						Andolfatto P, 1999, GENETICS, V153, P1297; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Ardell DH, 2004, BIOINFORMATICS, V20, P1986, DOI 10.1093/bioinformatics/bth187; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Fares MA, 2002, J MOL EVOL, V55, P509, DOI 10.1007/s00239-002-2346-9; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Kawabe A, 2000, GENETICS, V156, P1339; Ladoukakis ED, 2001, MOL BIOL EVOL, V18, P2127, DOI 10.1093/oxfordjournals.molbev.a003755; Llopart A, 1999, GENETICS, V152, P269; Makova KD, 2001, GENETICS, V158, P1253; Malik HS, 2001, GENETICS, V157, P1293; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; McClellan DA, 2000, J MOL EVOL, V50, P131, DOI 10.1007/s002399910015; Nielsen R, 1998, GENETICS, V148, P929; Peek AS, 2001, J MOL EVOL, V52, P193, DOI 10.1007/s002390010148; Polley SD, 2001, GENETICS, V158, P1505; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Simon AL, 2002, P NATL ACAD SCI USA, V99, P2912, DOI 10.1073/pnas.042692299; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176	39	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3746	10.1371/journal.pone.0003746	http://dx.doi.org/10.1371/journal.pone.0003746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015730	Green Published, gold			2022-12-27	WOS:000265448400003
J	Noel, F; Mehta, S; Zhu, YW; Rouzier, PD; Marcelin, A; Shi, JR; Nolte, C; Severe, L; Deschamps, MM; Fitzgerald, DW; Johnson, WD; Wright, PF; Pape, JW				Noel, Francine; Mehta, Sapna; Zhu, Yuwei; Rouzier, Patricia De Matteis; Marcelin, Abdias; Shi, Jian R.; Nolte, Claudine; Severe, Linda; Deschamps, Marie Marcelle; Fitzgerald, Daniel W.; Johnson, Warren D.; Wright, Peter F.; Pape, Jean W.			Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; BREAST-FED CHILDREN; ANTIRETROVIRAL THERAPY; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; MORTALITY; COTRIMOXAZOLE; PROPHYLAXIS; MOTHERS	Background: Since 1999 GHESKIO, a large voluntary counseling and HIV testing center in Port-au-Prince, Haiti, has had an ongoing collaboration with the Haitian Ministry of Health to reduce the rate of mother to child HIV transmission. There are limited data on the ability to administer complex regimens for reducing mother to child transmission and on risk factors for continued transmission and infant mortality within programmatic settings in developing countries. Methods and Findings: We analyzed data from 551 infants born to HIV-infected mothers seen at GHESKIO, between 1999 and 2005. HIV-infected mothers and their infants were given "short-course" monotherapy with antiretrovirals for prophylaxis; and, since 2003, highly active antiretroviral therapy (HAART) when clinical or laboratory indications were met. Infected women seen in the pre-treatment era had 27% transmission rates, falling to 10% in this cohort of 551 infants, and to only 1.9% in infants of women on HAART. Mortality rate after HAART introduction (0.12 per year of follow-up [0.08-0.16]) was significantly lower than the period before the availability of such therapy (0.23 [0.16-0.30], P<0.0001). The effects of maternal health, infant feeding, completeness of prophylaxis, and birth weight on mortality and transmission were determined using univariate and multivariate analysis. Infant HIV-1 infection and low birth weight were associated with infant mortality in less than 15 month olds in multivariate analysis. Conclusions: Our findings demonstrate success in prevention of mother-to-child HIV transmission and mortality in a highly resource constrained setting. Elements contributing to programmatic success include provision of HAART in the context of a comprehensive program with pre and postnatal care for both mother and infant.	[Noel, Francine; Rouzier, Patricia De Matteis; Marcelin, Abdias; Nolte, Claudine; Severe, Linda; Deschamps, Marie Marcelle; Pape, Jean W.] Ctr GHESKIO, Port Au Prince, Haiti; [Mehta, Sapna; Shi, Jian R.; Wright, Peter F.] Vanderbilt Univ, Sch Med, Nashville, TN USA; [Zhu, Yuwei] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Fitzgerald, Daniel W.; Johnson, Warren D.; Pape, Jean W.] Cornell Univ, Weill Med Coll, Div Infect Dis & Int Hlth, Dept Med, New York, NY USA; [Wright, Peter F.] Dartmouth Coll, Dartmouth Med Sch, Div Infect Dis & Int Med, Lebanon, NH USA	Vanderbilt University; Vanderbilt University; Cornell University; Dartmouth College	Noel, F (corresponding author), Ctr GHESKIO, Port Au Prince, Haiti.	peter.f.wright@dartmouth.edu	Marcelin, Anne-Genevieve/D-8272-2014	Marcelin, Anne-Genevieve/0000-0003-4808-8999	NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program [1 U01 AI069923-01]; Global fund; United Nations Population Fund (UNFPA); The Elizabeth Glaser Foundation; BioMeriux foundation; Norwegian Church; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program; Global fund; United Nations Population Fund (UNFPA); The Elizabeth Glaser Foundation; BioMeriux foundation; Norwegian Church; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by a PEPFAR supplement to cooperative agreement 1 U01 AI069923-01 from NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program, by the Global fund and United Nations Population Fund (UNFPA), The Elizabeth Glaser Foundation, BioMeriux foundation and the Norwegian Church. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; CAYEMITTES M, 2005, ENQUETE MORTALITE MO; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; CONNOR EM, 1995, PEDIATR INFECT DIS J, V14, P536, DOI 10.1097/00006454-199506000-00012; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; DESCHAMPS MM, REV PANAMER IN PRESS, P1; EKOUEVI DKT, 2008, ANRS DITRAME PLUS CO; George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Jean SS, 1999, PEDIATR INFECT DIS J, V18, P58, DOI 10.1097/00006454-199901000-00014; Kourtis AP, 2007, AM J OBSTET GYNECOL, V197, pS113, DOI 10.1016/j.ajog.2007.03.003; Lipsitz SR, 1998, J ROY STAT SOC B, V60, P127, DOI 10.1111/1467-9868.00113; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Mofenson LM, 2003, J INFECT DIS, V187, P721, DOI 10.1086/367905; Mofenson Lynne M, 2002, MMWR Recomm Rep, V51, P1; Morris K, 1998, LANCET, V351, P651, DOI 10.1016/S0140-6736(05)78436-1; MURPHY JMH, 2004, 15 INT AIDS CBANGK T; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Noel F, 2006, JAIDS-J ACQ IMM DEF, V43, P313, DOI 10.1097/01.qai.0000242463.73817.c6; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2003, LANCET, V362, P667, DOI 10.1016/S0140-6736(03)14172-4; Taha TE, 1999, PEDIATR INFECT DIS J, V18, P689, DOI 10.1097/00006454-199908000-00007; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UNAID WHO, 2000, US COTR PROPH AD CHI; *UNAIDS WHO, 2007, AIDS EP UPD; Wei RL, 2004, PEDIATR INFECT DIS J, V23, P530, DOI 10.1097/01.inf.0000129691.42964.eb; *WHO, 2004, GENEVA; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; *WHO UNICEF UNU, 2001, IR DEF AN; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; 1998, MMWR MORB MORTAL WKL, V47, P151; 1985, MMWR MORB MORTAL WKL, V55, P592	44	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3723	10.1371/journal.pone.0003723	http://dx.doi.org/10.1371/journal.pone.0003723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009021	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166400002
J	Zhang, Y; Turner, JG				Zhang, Yi; Turner, John G.			Wound-Induced Endogenous Jasmonates Stunt Plant Growth by Inhibiting Mitosis	PLOS ONE			English	Article								When plants are repeatedly injured their growth is stunted and the size of organs such as leaves is greatly reduced. The basis of this effect is not well-understood however, even though it reduces yield of crops injured by herbivory, and produces dramatic effects exemplified in ornamental bonsai plants. We have investigated the genetic and physiological basis of this "bonsai effect" by repeatedly wounding leaves of the model plant Arabidopsis. This treatment stunted growth by 50% and increased the endogenous content of jasmonate (JA), a growth inhibitor, by seven-fold. Significantly, repeated wounding did not stunt the growth of the leaves of mutants unable to synthesise JA, or unable to respond to JA including coi1, jai3, myc2, but not jar1. The stunted growth did not result from reduced cell size, but resulted instead from reduced cell number, and was associated with reduced expression of CycB1;2. Wounding caused systemic disappearance of constitutively expressed JAZ1::GUS. Wounding also activates plant immunity. We show that a gene, 12-oxo-phytodienoate reductase, which catalyses a step in JA biosynthesis, and which we confirm is not required for defence, is however required for wound-induced stunting. Our data suggest that intermediates in the JA biosynthetic pathway activate defence, but a primary function of wound-induced JA is to stunt growth through the suppression of mitosis.	[Zhang, Yi; Turner, John G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Zhang, Y (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	j.g.turner@uea.ac.uk			China Scholarship Council; University of East Anglia; BBSRC	China Scholarship Council(China Scholarship Council); University of East Anglia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	YZ was in receipt of a scholarship from the China Scholarship Council and University of East Anglia, and the research was funded by the BBSRC.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chouinard A, 2005, ECOSCIENCE, V12, P506, DOI 10.2980/i1195-6860-12-4-506.1; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; DATHE W, 1981, PLANTA, V153, P530, DOI 10.1007/BF00385537; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Flescher E, 2007, CANCER LETT, V245, P1, DOI 10.1016/j.canlet.2006.03.001; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; JEFFERSON RA, 1987, EMBO J, V6, P3901; KORNER C, 1989, AUST J PLANT PHYSIOL, V16, P443, DOI 10.1071/PP9890443; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mussig C, 2000, J PLANT PHYSIOL, V157, P143, DOI 10.1016/S0176-1617(00)80184-4; NGUYEN T, 2006, MECH JASMONATE INDUC; Parchmann S, 1997, PLANT PHYSIOL, V115, P1057, DOI 10.1104/pp.115.3.1057; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Poveda K, 2003, OECOLOGIA, V135, P601, DOI 10.1007/s00442-003-1228-1; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stelmach BA, 1998, PHYTOCHEMISTRY, V47, P539, DOI 10.1016/S0031-9422(97)00547-5; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Swiatek A, 2004, FEBS LETT, V572, P118, DOI 10.1016/j.febslet.2004.07.018; Swiatek A, 2002, PLANT PHYSIOL, V128, P201, DOI 10.1104/pp.010592; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; UEDA J, 1982, PHYSIOL PLANTARUM, V54, P249, DOI 10.1111/j.1399-3054.1982.tb00255.x; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; YAMANE H, 1980, AGR BIOL CHEM TOKYO, V44, P2857, DOI 10.1080/00021369.1980.10864412; YAN Y, 2007, PLANT CELL	53	218	221	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3699	10.1371/journal.pone.0003699	http://dx.doi.org/10.1371/journal.pone.0003699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002244	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165600005
J	Tucker, NP; Hicks, MG; Clarke, TA; Crack, JC; Chandra, G; Le Brun, NE; Dixon, R; Hutchings, MI				Tucker, Nicholas P.; Hicks, Matthew G.; Clarke, Thomas A.; Crack, Jason C.; Chandra, Govind; Le Brun, Nick E.; Dixon, Ray; Hutchings, Matthew I.			The Transcriptional Repressor Protein NsrR Senses Nitric Oxide Directly via a [2Fe-2S] Cluster	PLOS ONE			English	Article								The regulatory protein NsrR, a member of the Rrf2 family of transcription repressors, is specifically dedicated to sensing nitric oxide ( NO) in a variety of pathogenic and non-pathogenic bacteria. It has been proposed that NO directly modulates NsrR activity by interacting with a predicted [Fe-S] cluster in the NsrR protein, but no experimental evidence has been published to support this hypothesis. Here we report the purification of NsrR from the obligate aerobe Streptomyces coelicolor. We demonstrate using UV-visible, near UV CD and EPR spectroscopy that the protein contains an NO-sensitive [2Fe-2S] cluster when purified from E. coli. Upon exposure of NsrR to NO, the cluster is nitrosylated, which results in the loss of DNA binding activity as detected by bandshift assays. Removal of the [2Fe-2S] cluster to generate apo-NsrR also resulted in loss of DNA binding activity. This is the first demonstration that NsrR contains an NO-sensitive [2Fe-2S] cluster that is required for DNA binding activity.	[Tucker, Nicholas P.; Chandra, Govind; Dixon, Ray] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England; [Hicks, Matthew G.; Clarke, Thomas A.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Crack, Jason C.; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich, Norfolk, England; [Hutchings, Matthew I.] Univ E Anglia, Sch Med, Hlth Policy & Practice, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of East Anglia; University of East Anglia	Tucker, NP (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich, Norfolk, England.	nick.tucker@bbsrc.ac.uk; m.hutchings@uea.ac.uk	Hutchings, Matt/D-1923-2009; Hicks, Matthew/I-3689-2012; clarke, tom/D-1837-2009	Hutchings, Matt/0000-0001-6628-5940; clarke, tom/0000-0002-6234-1914; Le Brun, Nick/0000-0001-9780-4061; Crack, Jason C./0000-0002-4979-1910; Chandra, Govind/0000-0002-7882-6676; Dixon, Ray/0000-0002-6348-639X; Tucker, Nicholas/0000-0002-6331-3704	Research Councils UK Fellowships; Biotechnology and Biological Sciences Research Council [F009429/1, A51065X/1]; Biotechnology and Biological Sciences Research Council [BB/D009588/1, BBS/E/J/00000016, BB/F009429/1] Funding Source: researchfish; BBSRC [BB/F009429/1, BB/D009588/1] Funding Source: UKRI	Research Councils UK Fellowships; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Research Councils UK Fellowships to MIH and TAC. We are grateful to the Biotechnology and Biological Sciences Research Council for financial support [grant numbers F009429/1 to MIH and A51065X/1 to RAD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; CAMMACK R, 1980, NATURE, V286, P442, DOI 10.1038/286442a0; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Couture MMJ, 2001, BIOCHEMISTRY-US, V40, P84, DOI 10.1021/bi001780r; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; De Mot R, 2007, ARCH MICROBIOL, V188, P257, DOI 10.1007/s00203-007-0243-8; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kimura S, 2005, BIOCHEM J, V388, P869, DOI 10.1042/BJ20042077; Lane N, 2007, NATURE, V449, P778, DOI 10.1038/449778a; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Overton TW, 2006, J BIOL CHEM, V281, P33115, DOI 10.1074/jbc.M607056200; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; Tucker NP, 2008, J BIOL CHEM, V283, P908, DOI 10.1074/jbc.M705850200; Tucker NP, 2004, J BACTERIOL, V186, P6656, DOI 10.1128/JB.186.19.6656-6660.2004; Vanin AF, 1998, NITRIC OXIDE-BIOL CH, V2, P224, DOI 10.1006/niox.1998.0180; WIESNER W, 1988, J BIOL CHEM, V263, P13725	35	107	109	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3623	10.1371/journal.pone.0003623	http://dx.doi.org/10.1371/journal.pone.0003623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989365	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000265134600001
J	Griguer, CE; Oliva, CR; Gobin, E; Marcorelles, P; Benos, DJ; Lancaster, JR; Gillespie, GY				Griguer, Corinne E.; Oliva, Claudia R.; Gobin, Eric; Marcorelles, Pascale; Benos, Dale J.; Lancaster, Jack R., Jr.; Gillespie, G. Yancey			CD133 Is a Marker of Bioenergetic Stress in Human Glioma	PLOS ONE			English	Article								Mitochondria dysfunction and hypoxic microenvironment are hallmarks of cancer cell biology. Recently, many studies have focused on isolation of brain cancer stem cells using CD133 expression. In this study, we investigated whether CD133 expression is regulated by bioenergetic stresses affecting mitochondrial functions in human glioma cells. First, we determined that hypoxia induced a reversible up-regulation of CD133 expression. Second, mitochondrial dysfunction through pharmacological inhibition of the Electron Transport Chain (ETC) produced an up-regulation of CD133 expression that was inversely correlated with changes in mitochondrial membrane potential. Third, generation of stable glioma cells depleted of mitochondrial DNA showed significant and stable increases in CD133 expression. These glioma cells, termed rho(0) or rho(0), are characterized by an exaggerated, uncoupled glycolytic phenotype and by constitutive and stable up-regulation of CD133 through many cell passages. Moreover, these rho(0) cells display the ability to form "tumor spheroids'' in serumless medium and are positive for CD133 and the neural progenitor cell marker, nestin. Under differentiating conditions, rho(0) cells expressed multi-lineage properties. Reversibility of CD133 expression was demonstrated by transfering parental mitochondria to rho(0) cells resulting in stable trans-mitochondrial "cybrid'' clones. This study provides a novel mechanistic insight about the regulation of CD133 by environmental conditions (hypoxia) and mitochondrial dysfunction (genetic and chemical). Considering these new findings, the concept that CD133 is a marker of brain tumor stem cells may need to be revised.	[Griguer, Corinne E.; Oliva, Claudia R.; Gillespie, G. Yancey] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Benos, Dale J.; Lancaster, Jack R., Jr.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL USA; [Lancaster, Jack R., Jr.] Univ Alabama, Dept Anesthesiol, Birmingham, AL USA; [Griguer, Corinne E.; Lancaster, Jack R., Jr.] Univ Alabama, Ctr Free Radical Biol, Birmingham, AL USA; [Griguer, Corinne E.; Benos, Dale J.; Gillespie, G. Yancey] Univ Alabama, Ctr Glial Biol Med, Birmingham, AL USA; [Lancaster, Jack R., Jr.; Gillespie, G. Yancey] Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL USA; [Oliva, Claudia R.] Univ Alabama, Dept Microbiol, Birmingham, AL USA; [Gobin, Eric; Marcorelles, Pascale] CHU Brest, Hop Morvan, Pole Biol Pathol, Serv Anat Pathol, Dept Med, Brest, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; CHU Brest; Universite de Bretagne Occidentale	Griguer, CE (corresponding author), Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA.	cgriguer@uab.edu		Gillespie, George/0000-0001-6436-9542; Oliva, Claudia/0000-0003-0624-5490; , Corinne/0000-0003-3877-5031	American Brain Tumor Association; UAB Brain Tumor SPORE [Career Development Award]; U.S. Public Health Service NIH [P50CA97247, P01 CA 071933, HL074391, HL71189, CA101952]; NATIONAL CANCER INSTITUTE [P01CA071933, R01CA101952, P50CA097247] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074391, R01HL071189] Funding Source: NIH RePORTER	American Brain Tumor Association; UAB Brain Tumor SPORE; U.S. Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Brain Tumor Association (C.E.G.) and a Career Development Award from the UAB Brain Tumor SPORE (C.E.G.), U.S. Public Health Service NIH grant P50CA97247 and P01 CA 071933 (G.Y.G.), NIH research grants HL074391 and HL71189 (J.R.L., Jr.) and NIH research grant CA101952 (D.J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barnhart BC, 2007, CANCER METAST REV, V26, P261, DOI 10.1007/s10555-007-9053-3; Beckner ME, 2005, LAB INVEST, V85, P1457, DOI 10.1038/labinvest.3700355; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P621, DOI 10.4161/cbt.4.6.1818; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Bouzier AK, 1998, J BIOL CHEM, V273, P27162, DOI 10.1074/jbc.273.42.27162; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; BROWN GC, 1992, BIOCHEM J, V284, P1; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GILLIES RJ, 2007, J BIOENERG BIOMEMBR; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2007, J NEURO-ONCOL, V81, P9, DOI 10.1007/s11060-006-9201-6; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; LEWIS LD, 1992, ANTIMICROB AGENTS CH, V36, P2061, DOI 10.1128/AAC.36.9.2061; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Morange M, 2007, ONCOGENE, V26, P7607, DOI 10.1038/sj.onc.1210583; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PEEK R, 1993, J CELL SCI, V106, P929; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sakariassen PO, 2007, NEOPLASIA, V9, P882, DOI 10.1593/neo.07658; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Turcotte ML, 2002, BRIT J CANCER, V86, P619, DOI 10.1038/sj.bjc.6600087; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zheng L, 2007, INT J INF SECUR, V6, P67, DOI 10.1007/s10207-007-0019-9; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	53	193	203	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3655	10.1371/journal.pone.0003655	http://dx.doi.org/10.1371/journal.pone.0003655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985161	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134400015
J	Aon, MA; Roussel, MR; Cortassa, S; O'Rourke, B; Murray, DB; Beckmann, M; Lloyd, D				Aon, Miguel A.; Roussel, Marc R.; Cortassa, Sonia; O'Rourke, Brian; Murray, Douglas B.; Beckmann, Manfred; Lloyd, David			The Scale-Free Dynamics of Eukaryotic Cells	PLOS ONE			English	Article							MITOCHONDRIAL ION CHANNELS; SACCHAROMYCES-CEREVISIAE; RESPIRATORY OSCILLATIONS; BIOLOGICAL RHYTHMS; CONTINUOUS-CULTURE; ORGANIZATION; YEAST; CLOCK; BENZODIAZEPINE; ARCHITECTURE	Temporal organization of biological processes requires massively parallel processing on a synchronized time-base. We analyzed time-series data obtained from the bioenergetic oscillatory outputs of Saccharomyces cerevisiae and isolated cardiomyocytes utilizing Relative Dispersional (RDA) and Power Spectral (PSA) analyses. These analyses revealed broad frequency distributions and evidence for long-term memory in the observed dynamics. Moreover RDA and PSA showed that the bioenergetic dynamics in both systems show fractal scaling over at least 3 orders of magnitude, and that this scaling obeys an inverse power law. Therefore we conclude that in S. cerevisiae and cardiomyocytes the dynamics are scale-free in vivo. Applying RDA and PSA to data generated from an in silico model of mitochondrial function indicated that in yeast and cardiomyocytes the underlying mechanisms regulating the scale-free behavior are similar. We validated this finding in vivo using single cells, and attenuating the activity of the mitochondrial inner membrane anion channel with 4-chlorodiazepam to show that the oscillation of NAD(P)H and reactive oxygen species (ROS) can be abated in these two evolutionarily distant species. Taken together these data strongly support our hypothesis that the generation of ROS, coupled to redox cycling, driven by cytoplasmic and mitochondrial processes, are at the core of the observed rhythmicity and scale-free dynamics. We argue that the operation of scale-free bioenergetic dynamics plays a fundamental role to integrate cellular function, while providing a framework for robust, yet flexible, responses to the environment.	[Aon, Miguel A.; Cortassa, Sonia; O'Rourke, Brian] Johns Hopkins Univ, Inst Mol Cardiobiol, Baltimore, MD 21218 USA; [Roussel, Marc R.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Murray, Douglas B.] Keio Univ, Inst Advanced Biosci, Tokyo 108, Japan; [Beckmann, Manfred] Univ Wales Coll Cardiff, Inst Biol Sci, Cardiff CF1 3NS, S Glam, Wales; [Lloyd, David] Cardiff Univ, Cardiff Sch Biosci, Microbiol Grp, Cardiff, S Glam, Wales	Johns Hopkins University; University of Lethbridge; Keio University; Cardiff University; Cardiff University	Aon, MA (corresponding author), Johns Hopkins Univ, Inst Mol Cardiobiol, Baltimore, MD 21218 USA.	maon1@jhmi.edu; lloydd@Cardiff.ac.uk	Cortassa, Sonia/AAO-1633-2020; Beckmann, Manfred/AAX-9979-2021; Roussel, Marc/A-8957-2011; Lloyd, David/D-2483-2010	Cortassa, Sonia/0000-0001-7224-9858; Roussel, Marc/0000-0002-7795-4756; O'Rourke, Brian/0000-0002-5548-4853; Lloyd, David/0000-0002-5656-0571; Beckmann, Manfred/0000-0002-4320-5001	NIH [R37-HL54598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grant R37-HL54598. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Alon U, 2007, INTRO SYSTEMS BIOL D; Aon M. A., 2007, MOL SYSTEM BIOENERGE, P111; Aon MA, 2000, CELL BIOL INT, V24, P581, DOI 10.1006/cbir.2000.0572; Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; AON MA, 1993, MOL CELL BIOCHEM, V120, P1, DOI 10.1007/BF00925979; Aon MA, 2004, MOL CELL BIOCHEM, V256, P169, DOI 10.1023/B:MCBI.0000009867.54552.09; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Aon MA., 1997, DYNAMIC BIOL ORG FUN, V1st edn; Aon MA, 2007, FEBS LETT, V581, P8, DOI 10.1016/j.febslet.2006.11.068; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2006, BIOPHYS J, V91, P4317, DOI 10.1529/biophysj.106.087817; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Brodin LA, 1998, COMPUT CARDIOL, V25, P253, DOI 10.1109/CIC.1998.731781; Brodsky VY, 2006, BIOL REV, V81, P143, DOI 10.1017/S1464793105006937; Brown DA, 2008, CARDIOVASC RES, V79, P141, DOI 10.1093/cvr/cvn053; Brown J., 2000, SCALING BIOL; CHANCE B, 1973, BIOL BIOCH OSCILLATI; CHANDRASHEKARAN MK, 2005, TIME LIVING WORLD; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; LLOYD AL, 1993, BIOSYSTEMS, V29, P77, DOI 10.1016/0303-2647(93)90085-Q; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lloyd D, 2003, MITOCHONDRION, V3, P139, DOI 10.1016/j.mito.2003.08.002; LLOYD D, 1993, BIOL REV, V68, P563, DOI 10.1111/j.1469-185X.1993.tb01244.x; Lloyd D, 2000, REDOX STATE AND CIRCADIAN RHYTHMS, P85; LLOYD D, 1985, BIOSENSORS, V1, P179, DOI 10.1016/0265-928X(85)80003-1; LLOYD D, 1982, CELL DIVISION CYCLE; Lloyd D, 2007, BIOESSAYS, V29, P465, DOI 10.1002/bies.20575; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Murray DB, 1999, MICROBIOL-SGM, V145, P2739, DOI 10.1099/00221287-145-10-2739; Murray DB, 1998, FEBS LETT, V431, P297, DOI 10.1016/S0014-5793(98)00777-7; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Murray DB, 2001, J BACTERIOL, V183, P7253, DOI 10.1128/JB.183.24.7253-7259.2001; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Roussel MR, 2007, FEBS J, V274, P1011, DOI 10.1111/j.1742-4658.2007.05651.x; Slocinska M, 2004, ACTA BIOCHIM POL, V51, P953; Sohn HY, 2000, YEAST, V16, P1185, DOI 10.1002/1097-0061(20000930)16:13<1185::AID-YEA619>3.0.CO;2-W; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; West B.J., 1995, LURE MODERN SCI FRAC; West BJ, 1999, PHYSICA A, V270, P552, DOI 10.1016/S0378-4371(99)00175-2; WEST BJ, 1999, PHYSL PROMISCUITY PR; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Yates F. Eugene, 1993, P189; YATES FE, 1992, METHOD ENZYMOL, V210, P636; Zhou T, 2005, J THEOR BIOL, V236, P438, DOI 10.1016/j.jtbi.2005.03.023; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	74	56	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3624	10.1371/journal.pone.0003624	http://dx.doi.org/10.1371/journal.pone.0003624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982073	Green Published, Green Accepted, gold			2022-12-27	WOS:000265134300001
J	Sueur, J; Pavoine, S; Hamerlynck, O; Duvail, S				Sueur, Jerome; Pavoine, Sandrine; Hamerlynck, Olivier; Duvail, Stephanie			Rapid Acoustic Survey for Biodiversity Appraisal	PLOS ONE			English	Article							INDICATOR TAXA; COMMUNICATION; EVOLUTION; FOREST; SIGNAL; IDENTIFICATION; INTERFERENCE; CONSERVATION; DIVERSITY	Biodiversity assessment remains one of the most difficult challenges encountered by ecologists and conservation biologists. This task is becoming even more urgent with the current increase of habitat loss. Many methods-from rapid biodiversity assessments (RBA) to all-taxa biodiversity inventories (ATBI)-have been developed for decades to estimate local species richness. However, these methods are costly and invasive. Several animals-birds, mammals, amphibians, fishes and arthropods-produce sounds when moving, communicating or sensing their environment. Here we propose a new concept and method to describe biodiversity. We suggest to forego species or morphospecies identification used by ATBI and RBA respectively but rather to tackle the problem at another evolutionary unit, the community level. We also propose that a part of diversity can be estimated and compared through a rapid acoustic analysis of the sound produced by animal communities. We produced alpha and beta diversity indexes that we first tested with 540 simulated acoustic communities. The alpha index, which measures acoustic entropy, shows a logarithmic correlation with the number of species within the acoustic community. The beta index, which estimates both temporal and spectral dissimilarities, is linearly linked to the number of unshared species between acoustic communities. We then applied both indexes to two closely spaced Tanzanian dry lowland coastal forests. Indexes reveal for this small sample a lower acoustic diversity for the most disturbed forest and acoustic dissimilarities between the two forests suggest that degradation could have significantly decreased and modified community composition. Our results demonstrate for the first time that an indicator of biological diversity can be reliably obtained in a non-invasive way and with a limited sampling effort. This new approach may facilitate the appraisal of animal diversity at large spatial and temporal scales.	Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 5202, Paris, France; [Pavoine, Sandrine] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 2JD, England; [Pavoine, Sandrine] Museum Natl Hist Nat, Dept Ecol Gest Biodivers, CNRS, UPMC USM 305 MNHN, Paris, France; [Hamerlynck, Olivier] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Duvail, Stephanie] IRD, IFRA, UR 200, Nairobi, Kenya	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Oxford; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UK Centre for Ecology & Hydrology (UKCEH); Institut de Recherche pour le Developpement (IRD)	Sueur, J (corresponding author), Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 5202, CP 50, Paris, France.	sueur@mnhn.fr	Duvail, Stéphanie/B-3297-2011; Sueur, Jerome/G-5364-2011	Duvail, Stéphanie/0000-0001-5963-3038; 	Institut Francais de la Biodiversite (IFB, Paris, France); Marie Curie Programme	Institut Francais de la Biodiversite (IFB, Paris, France); Marie Curie Programme(European Commission)	This work was funded by Institut Francais de la Biodiversite (IFB, Paris, France). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SP is supported by the European Commission under the Marie Curie Programme.	Amezquita A, 2006, EVOLUTION, V60, P1874; [Anonymous], 2007, FORESTRY GOVERNANCE; [Anonymous], 1995, GLOBAL BIODIVERSITY; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Bercher JF, 2000, IEEE T SIGNAL PROCES, V48, P1687, DOI 10.1109/78.845926; BONNET FR, 1995, GUIDE SONORE SAUTERE; Bradbury Jack W., 1998, pi; Brandes TS, 2006, J ACOUST SOC AM, V120, P2950, DOI 10.1121/1.2355479; Buddle CM, 2005, CAN ENTOMOL, V137, P120; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; BURGESS ND, 2001, COASTAL FORESTS E AF; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Chen ZX, 2006, J ACOUST SOC AM, V120, P2974, DOI 10.1121/1.2345831; Chesmore ED, 2001, APPL ACOUST, V62, P1359, DOI 10.1016/S0003-682X(01)00009-3; DEROUSSEN F, 2003, GUIDE SONORE AMPHIBI; Deroussen F., 2001, OISEAUX JARDINS FRAN; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; DURAND JM, 2003, 45 RUF ENV MAN PROJ; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; FICKEN RW, 1974, SCIENCE, V183, P762, DOI 10.1126/science.183.4126.762; Hammer Oyvind, 2001, Bioacoustics, V12, P21; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Luddecke H, 2000, STUD NEOTROP FAUNA E, V35, P185, DOI 10.1076/snfe.35.3.185.8855; Magurran A.E., 2004, MEASURING BIOL DIVER; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mitterrneier R, 1993, RAPID ASSESSMENT PRO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Narins Peter M., 2001, P61; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Parsons S, 2000, J EXP BIOL, V203, P2641; PEARSON DL, 1994, PHILOS T ROY SOC B, V345, P75, DOI 10.1098/rstb.1994.0088; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2007, R LANG ENV STAT COMP; Ricketts TH, 1999, BIOSCIENCE, V49, P369, DOI 10.2307/1313630; Riede K., 1997, P442; RIEDE K, 1993, AMBIO, V22, P546; Romer H., 1993, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V340, P179, DOI 10.1098/rstb.1993.0056; Rossman AY., 1998, PROTOCOLS ALL TAXA B, P208; Sanborn AF, 2006, CONT T ENT, P111; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wollerman L, 2002, BEHAV ECOL SOCIOBIOL, V52, P465, DOI 10.1007/s00265-002-0534-7; YOUNG AM, 1981, AM NAT, V117, P826, DOI 10.1086/283770	55	335	352	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4065	10.1371/journal.pone.0004065	http://dx.doi.org/10.1371/journal.pone.0004065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115006	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466300007
J	Banks, WE; d'Errico, F; Peterson, AT; Kageyama, M; Sima, A; Sanchez-Goni, MF				Banks, William E.; d'Errico, Francesco; Peterson, A. Townsend; Kageyama, Masa; Sima, Adriana; Sanchez-Goni, Maria-Fernanda			Neanderthal Extinction by Competitive Exclusion	PLOS ONE			English	Article							CHATELPERRONIAN-TYPE-SITE; UPPER PALEOLITHIC TRANSITION; MODERN HUMAN ORIGINS; EARLY-MODERN HUMANS; SPECIES DISTRIBUTIONS; ECOLOGICAL NICHES; WESTERN-EUROPE; CHRONOLOGY; CLIMATE; AURIGNACIAN	Background: Despite a long history of investigation, considerable debate revolves around whether Neanderthals became extinct because of climate change or competition with anatomically modern humans (AMH). Methodology/Principal Findings: We apply a new methodology integrating archaeological and chronological data with high-resolution paleoclimatic simulations to define eco-cultural niches associated with Neanderthal and AMH adaptive systems during alternating cold and mild phases of Marine Isotope Stage 3. Our results indicate that Neanderthals and AMH exploited similar niches, and may have continued to do so in the absence of contact. Conclusions/Significance: The southerly contraction of Neanderthal range in southwestern Europe during Greenland Interstadial 8 was not due to climate change or a change in adaptation, but rather concurrent AMH geographic expansion appears to have produced competition that led to Neanderthal extinction.	[d'Errico, Francesco] Univ Bordeaux 1, CNRS, Inst Prehist & Geol Quaternaire, UMR 5199 PACEA, F-33405 Talence, France; [d'Errico, Francesco] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Peterson, A. Townsend] Univ Kansas, Nat Hist Mus & Biodivers Res Ctr, Lawrence, KS 66045 USA; [Kageyama, Masa; Sima, Adriana] CEA, Lab Sci Climat Environn, CNRS, UVSQ, UMR 1572, Gif Sur Yvette, France; [Sanchez-Goni, Maria-Fernanda] Univ Bordeaux 1, CNRS, EPOC, UMR5805, EPHE, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Kansas; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux	Banks, WE (corresponding author), Univ Bordeaux 1, CNRS, Inst Prehist & Geol Quaternaire, UMR 5199 PACEA, F-33405 Talence, France.	w.banks@ipgq.u-bordeaux1.fr	Peterson, A. Townsend/I-5697-2013; KAGEYAMA, Masa/F-2389-2010; Goñi, Maria Fernanda Sanchez/R-3699-2019; Banks, William E./H-3494-2019	Peterson, A. Townsend/0000-0003-0243-2379; KAGEYAMA, Masa/0000-0003-0822-5880; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Banks, William E./0000-0003-1835-6315	National Science Foundation International Research Fellowship Program [0653000]; EuroClimate and OMLL programs of the European Science Foundation; ANR-BLANC IDEGLACE project [ANR-05-BLAN-0310-01]; CNRS/ECLIPSE project EOLE	National Science Foundation International Research Fellowship Program(National Science Foundation (NSF)); EuroClimate and OMLL programs of the European Science Foundation; ANR-BLANC IDEGLACE project(French National Research Agency (ANR)); CNRS/ECLIPSE project EOLE(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the National Science Foundation International Research Fellowship Program (grant no. 0653000), and the EuroClimate and OMLL programs of the European Science Foundation. The climate simulations were produced in the framework of the ANR-BLANC IDEGLACE project (ANR-05-BLAN-0310-01) and the CNRS/ECLIPSE project EOLE.	Adjemian JCZ, 2006, J MED ENTOMOL, V43, P93, DOI 10.1603/0022-2585(2006)043[0093:AOGAFR]2.0.CO;2; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; BANKS WE, 2006, PALEOANTHROPOLOGY, V4, P68; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; Bard E, 2004, SCIENCE, V303, P178, DOI 10.1126/science.1091964; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; CARNES BA, 1982, ECOLOGY, V63, P888, DOI 10.2307/1937227; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; CLIMAP, 1981, MAP CHART SER CLIMAP; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davies W., 2007, RETHINKING HUMAN REV, P263; DERRICO F, 2006, HOMME FACE CLIMAT, P265; FINLAYSON C, 2004, NEANDERTHALS MODERN, P266; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson C, 2008, QUATERNARY SCI REV, V27, P2246, DOI 10.1016/j.quascirev.2008.08.033; Giaccio B., 2006, NEANDERTHALS MODERN, P343; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Gravina B, 2005, NATURE, V438, P51, DOI 10.1038/nature04006; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Joris O., 2003, TRABAJOS PREHIST, V60, P15, DOI DOI 10.3989/TP.2003.V60.I2.79; Jost A, 2005, CLIM DYNAM, V24, P577, DOI 10.1007/s00382-005-0009-4; Kissel C, 2005, CR GEOSCI, V337, P908, DOI 10.1016/j.crte.2005.04.009; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2007, P NATL ACAD SCI USA, V104, P3657, DOI 10.1073/pnas.0608053104; Morin E, 2008, P NATL ACAD SCI USA, V105, P48, DOI 10.1073/pnas.0709372104; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pettitt PB, 2003, J ARCHAEOL SCI, V30, P1685, DOI 10.1016/S0305-4403(03)00070-0; Pettitt PB, 2001, ANTIQUITY, V75, P415, DOI 10.1017/S0003598X0006107X; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rouquerol N, 2007, CHEMINS ART AURIGNAC, P37; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000769; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Straus LG, 2005, QUATERN INT, V137, P47, DOI 10.1016/j.quaint.2004.11.019; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Tzedakis PC, 2007, NATURE, V449, P206, DOI 10.1038/nature06117; VALDES VC, 2006, NEANDERTHALS MODERNS, P441; Van Der Plicht J, 1999, ANTIQUITY, V73, P119, DOI 10.1017/S0003598X00087895; VANANDEL TH, 2003, NEANDERTHALS MODERN, P265; Vega Toscano L.G., 1990, PALEOLITHIQUE MOYEN, P169; WENINGER B, CALPAL 2007; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; ZILHAO J, 2008, PALEOANTHROPOLOGY, V6, P1; Zilhao J, 2003, TRABALHOS ARQUEOLOGI, P313, DOI DOI 10.1007/S10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	74	136	139	1	616	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3972	10.1371/journal.pone.0003972	http://dx.doi.org/10.1371/journal.pone.0003972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107186	gold, Green Published, Green Submitted			2022-12-27	WOS:000265463000004
J	Melott, AL				Melott, Adrian L.			Long-Term Cycles in the History of Life: Periodic Biodiversity in the Paleobiology Database	PLOS ONE			English	Article							FOSSIL; DIVERSITY	Time series analysis of fossil biodiversity of marine invertebrates in the Paleobiology Database (PBDB) shows a significant periodicity at approximately 63 My, in agreement with previous analyses based on the Sepkoski database. I discuss how this result did not appear in a previous analysis of the PBDB. The existence of the 63 My periodicity, despite very different treatment of systematic error in both PBDB and Sepkoski databases strongly argues for consideration of its reality in the fossil record. Cross-spectral analysis of the two datasets finds that a 62 My periodicity coincides in phase by 1.6 My, equivalent to better than the errors in either measurement. Consequently, the two data sets not only contain the same strong periodicity, but its peaks and valleys closely correspond in time. Two other spectral peaks appear in the PBDB analysis, but appear to be artifacts associated with detrending and with the increased interval length. Sampling-standardization procedures implemented by the PBDB collaboration suggest that the signal is not an artifact of sampling bias. Further work should focus on finding the cause of the 62 My periodicity.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas	Melott, AL (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	melott@ku.edu			University of Kansas	University of Kansas	The University of Kansas had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2008, P NATL ACAD SCI; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; BRIGHAM FO, 1988, FAST FOURIER TRANSFO; Clouvas A, 2003, HEALTH PHYS, V84, P212, DOI 10.1097/00004032-200302000-00009; Cornette JL, 2007, COMPUT SCI ENG, V9, P61, DOI 10.1109/MCSE.2007.76; Ding GH, 2006, PLOS COMPUT BIOL, V2, P918, DOI 10.1371/journal.pcbi.0020102; Ferrari A, 1997, RADIAT PROT DOSIM, V74, P227, DOI 10.1093/oxfordjournals.rpd.a032201; Lieberman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000759; Lockwood M, 2007, P ROY SOC A-MATH PHY, V463, P2447, DOI 10.1098/rspa.2007.1880; MCNULTY PJ, 1974, INT J RADIAT BIOL, V25, P315, DOI 10.1080/09553007414550381; Medvedev MV, 2007, ASTROPHYS J, V664, P879, DOI 10.1086/518757; Melott AL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003206; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; MULLER RA, 2002, ICE AGES ASTRONOMICA, P47; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; Press W.H., 2007, NUMERICAL RECIPES AR, P640; Rohde RA, 2005, NATURE, V434, P208, DOI 10.1038/nature03339; ROHDE RA, 2006, GEOL SOC AM ABSTR, V38, P170; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; SEPKOSKI JA, 2002, B AMPALEONTOL; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Svensmark H, 2007, ASTRON GEOPHYS, V48, P18; Turner JE, 2005, HEALTH PHYS, V88, P520, DOI 10.1097/00004032-200506000-00002	27	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4044	10.1371/journal.pone.0004044	http://dx.doi.org/10.1371/journal.pone.0004044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107212	Green Published, gold, Green Submitted			2022-12-27	WOS:000265463000030
J	Zhang, XY; Xu, JQ; Peng, H; Ma, Y; Han, LF; Ruan, YH; Su, B; Wang, N; Shao, YM				Zhang, Xiaoyan; Xu, Jianqing; Peng, Hong; Ma, Yan; Han, Lifeng; Ruan, Yuhua; Su, Bing; Wang, Ning; Shao, Yiming			HCV Coinfection Associated with Slower Disease Progression in HIV-Infected Former Plasma Donors Naive to ART	PLOS ONE			English	Article								Background: It remains controversial how HCV coinfection influences the disease progression during HIV-1 infection. This study aims to define the influence of HCV infection on the replication of HIV-1 and the disease progression in HIV-infected former plasma donors (FPDs) naive to ART. Methodology/Principal Findings: 168 HIV-1-infected FPDs were enrolled into a cohort study from Anhui province in central China, and thereafter monitored at month 3, 9, 15, 21 and 33. Fresh whole blood samples were used for CD4+ T-cell counting. Their plasma samples were collected and stored for quantification of HIV-1 viral loads and for determination of HCV and Toxoplasma. Out of 168 HIV-infected FBDs, 11.9% (20 cases), 80.4% (135 cases) and 7.7% (13 cases) were infected with HIV-1 alone, HIV-1/HCV and HIV/HCV/Toxoplasma, respectively. During the 33-month follow-up, only 35% (7 out of 20 cases) HIV-1 mono-infected subjects remained their CD4+ T-cell counts above 200 cells/ml and retained on the cohort study, which was significantly lower than 56% (75 out of 135 cases) for HIV/HCV group and 69% (9 out of 13 cases) for HIV/HCV/Toxoplasma group (p < 0.05). CD4+ T cells in HIV mono infection group were consistently lower than that in HIV/HCV group (p = 0.04, 0.18, 0.03 and 0.04 for baseline, month 9, month 21 and month 33 visit, respectively). In accordance with those observations, HIV viral loads in HIV mono- infection group were consistently higher than that in HIV/HCV group though statistical significances were only reached at baseline (p = 0.04). Conclusions/Significance: These data indicated HCV coinfection with HIV-1 is associated with the slower disease progression at the very late stage when comparing with HIV-1 mono-infection. The coinfection of Toxoplasma with HIV and HCV did not exert additional influence on the disease progression. It will be highly interesting to further explore the underlying mechanism for this observation in the future.	[Zhang, Xiaoyan; Xu, Jianqing; Peng, Hong; Ma, Yan; Han, Lifeng; Ruan, Yuhua; Wang, Ning; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Su, Bing] Anhui Provinc Ctr Dis Control & Prevent, Hefei, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Fudan University; Fudan University	Zhang, XY (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao@bbn.cn	MA, YAN/HHN-2912-2022		Chinese Ministry of Health [WA-2006-01, 2008ZX10001-015, 2008ZX10001-02]; China National Program on Key Basic Research Projects [2005CB522903]; China Ministry of Science and Technology, China	Chinese Ministry of Health; China National Program on Key Basic Research Projects; China Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by grants from Chinese Ministry of Health (WA-2006-01, 2008ZX10001-015, 2008ZX10001-02), and by China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China.	Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Beach MV, 2001, LANCET, V357, P49, DOI 10.1016/S0140-6736(05)71551-8; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bertschy S, 2006, CLIN MICROBIOL INFEC, V12, P666, DOI 10.1111/j.1469-0691.2006.01459.x; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Dorrucci M, 2004, AIDS, V18, P2313, DOI 10.1097/00002030-200411190-00012; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harcourt GC, 2005, AIDS, V19, P1135, DOI 10.1097/01.aids.0000176213.10367.05; Hershow RC, 2005, CLIN INFECT DIS, V40, P859, DOI 10.1086/428121; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Klein MB, 2003, JAIDS-J ACQ IMM DEF, V33, P365, DOI 10.1097/00126334-200307010-00011; Law WP, 2004, AIDS, V18, P1169, DOI 10.1097/00002030-200405210-00010; MCGOVERN H, 2007, J ACQ IMMUN DEF SYND, V45, pS47; MCGOVERN H, 2007, J ACQ IMMUN DEF SYND, V45, pS66; Micheloud D, 2007, PEDIATR INFECT DIS J, V26, P846, DOI 10.1097/INF.0b013e318123e8e6; Miro JM, 2006, CLIN INFECT DIS, V43, P79, DOI 10.1086/504872; Morsica G, 2007, J CLIN VIROL, V39, P82, DOI 10.1016/j.jcv.2007.03.007; Neau D, 2001, AIDS, V15, P1736, DOI 10.1097/00002030-200109070-00021; Rauch A, 2008, ANTIVIR THER, V13, P455; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shivraj SO, 2006, J TROP PEDIATRICS, V52, P206, DOI 10.1093/tropej/fmi103; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Trimoulet P, 2002, J MED VIROL, V67, P143, DOI 10.1002/jmv.2203; Voirin N, 2004, J VIRAL HEPATITIS, V11, P559, DOI 10.1111/j.1365-2893.2004.00544.x; Wang Shu-hua, 2007, Zhonghua Yi Xue Za Zhi, V87, P1535; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; YANG Y, 2008, CHINESE J M IN PRESS; Yoo TW, 2005, J INFECT DIS, V191, P4, DOI 10.1086/426513; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	31	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3992	10.1371/journal.pone.0003992	http://dx.doi.org/10.1371/journal.pone.0003992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098990	gold, Green Published, Green Submitted			2022-12-27	WOS:000265462300005
J	Coutant, F; Frenkiel, MP; Despres, P; Charneau, P				Coutant, Frederic; Frenkiel, Marie-Pascale; Despres, Philippe; Charneau, Pierre			Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine	PLOS ONE			English	Article								Lentiviral vectors are under intense scrutiny as unique candidate viral vector vaccines against tumor and aggressive pathogens because of their ability to initiate potent and durable specific immune responses. Strategies that alleviate safety concerns will facilitate the clinical developments involving lentiviral vectors. In this respect, the development of integration deficient lentiviral vectors circumvents the safety concerns relative to insertional mutagenesis and might pave the way for clinical applications in which gene transfer is targeted to non-dividing cells. We thus evaluated the potential use of nonintegrative lentiviral vectors as vaccination tools since the main targeted cell in vaccination procedures is the nondividing dendritic cell (DC). In this study, we demonstrated that a single administration of nonintegrative vectors encoding a secreted form of the envelope of a virulent strain of West Nile Virus (WNV) induces a robust B cell response. Remarkably, nonintegrative lentiviral vectors fully protected mice from a challenge with a lethal dose of WNV and a single immunization was sufficient to induce early and long-lasting protective immunity. Thus, nonintegrative lentiviral vectors might represent a safe and efficacious vaccination platform for the development of prophylactic vaccines against infectious agents.	[Charneau, Pierre] Inst Pasteur, Lab Virol Mol & Vectorol, Paris, France; [Frenkiel, Marie-Pascale; Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Coutant, F (corresponding author), Inst Pasteur, Lab Virol Mol & Vectorol, Paris, France.	charneau@pasteur.fr	Coutant, Frederic/P-8401-2015; CHARNEAU, Pierre/M-1565-2017; Coutant, Frederic/J-6336-2019	CHARNEAU, Pierre/0000-0003-1184-5773; Coutant, Frederic/0000-0003-2485-5284	Pasteur Institute; Sidaction	Pasteur Institute; Sidaction	This work was supported by the Pasteur Institute. FC was supported by a grant from Sidaction. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Breckpot K, 2007, GENE THER, V14, P847, DOI 10.1038/sj.gt.3302947; Brown BD, 2007, BLOOD, V109, P2797, DOI 10.1182/blood-2006-10-049312; Buffa V, 2006, VIRAL IMMUNOL, V19, P690, DOI 10.1089/vim.2006.19.690; Buffa V, 2006, J GEN VIROL, V87, P1625, DOI 10.1099/vir.0.81706-0; Chapatte L, 2006, CANCER RES, V66, P1155, DOI 10.1158/0008-5472.CAN-05-2597; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; Chen XC, 2006, CELL IMMUNOL, V243, P10, DOI 10.1016/j.cellimm.2006.11.001; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Esslinger C, 2002, HUM GENE THER, V13, P1091, DOI 10.1089/104303402753812494; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Firat H, 2002, J GENE MED, V4, P38, DOI 10.1002/jgm.243; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Iglesias MC, 2007, MOL THER, V15, P1203, DOI 10.1038/sj.mt.6300135; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Metharom P, 2005, CELL MOL IMMUNOL, V2, P281; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; NEGRI DR, 2007, MOL THER; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Rohrlich PS, 2004, HUM IMMUNOL, V65, P514, DOI 10.1016/j.humimm.2004.02.018; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zarei S, 2004, J VIROL, V78, P7843, DOI 10.1128/JVI.78.14.7843-7845.2004; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	32	59	74	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3973	10.1371/journal.pone.0003973	http://dx.doi.org/10.1371/journal.pone.0003973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096527	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458800002
J	Roestenberg, M; Remarque, E; de Jonge, E; Hermsen, R; Blythman, H; Leroy, O; Imoukhuede, E; Jepsen, S; Ofori-Anyinam, O; Faber, B; Kocken, CHM; Arnold, M; Walraven, V; Teelen, K; Roeffen, W; de Mast, Q; Ballou, WR; Cohen, J; Dubois, MC; Ascarateil, S; van der Ven, A; Thomas, A; Sauerwein, R				Roestenberg, Meta; Remarque, Ed; de Jonge, Erik; Hermsen, Rob; Blythman, Hildur; Leroy, Odile; Imoukhuede, Egeruan; Jepsen, Soren; Ofori-Anyinam, Opokua; Faber, Bart; Kocken, Clemens H. M.; Arnold, Miranda; Walraven, Vanessa; Teelen, Karina; Roeffen, Will; de Mast, Quirijn; Ballou, W. Ripley; Cohen, Joe; Dubois, Marie Claude; Ascarateil, Stephane; van der Ven, Andre; Thomas, Alan; Sauerwein, Robert			Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel (TM), Montanide ISA 720 or AS02	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; BLOOD-STAGE VACCINE; PHASE I/IIA SAFETY; CLINICAL-TRIAL; I TRIAL; CANDIDATE; EFFICACY; RTS,S/AS02A; ANTIBODIES; MULTISTAGE	Background: Plasmodium falciparum Apical Membrane Antigen 1 (PfAMA1) is a candidate vaccine antigen expressed by merozoites and sporozoites. It plays a key role in red blood cell and hepatocyte invasion that can be blocked by antibodies. Methodology/Principal Findings: We assessed the safety and immunogenicity of recombinant PfAMA1 in a dose-escalating, phase Ia trial. PfAMA1 FVO strain, produced in Pichia pastoris, was reconstituted at 10 mu g and 50 mu g doses with three different adjuvants, Alhydrogel (TM), Montanide ISA720 and AS02 Adjuvant System. Six randomised groups of healthy male volunteers, 8-10 volunteers each, were scheduled to receive three immunisations at 4-week intervals. Safety and immunogenicity data were collected over one year. Transient pain was the predominant injection site reaction (80-100%). Induration occurred in the Montanide 50 mg group, resulting in a sterile abscess in two volunteers. Systemic adverse events occurred mainly in the AS02 groups lasting for 1-2 days. Erythema was observed in 22% of Montanide and 59% of AS02 group volunteers. After the second dose, six volunteers in the AS02 group and one in the Montanide group who reported grade 3 erythema (>50 mm) were withdrawn as they met the stopping criteria. All adverse events resolved. There were no vaccine-related serious adverse events. Humoral responses were highest in the AS02 groups. Antibodies showed activity in an in vitro growth inhibition assay up to 80%. Upon stimulation with the vaccine, peripheral mononuclear cells from all groups proliferated and secreted IFN gamma and IL-5 cytokines. Conclusions/Significance: All formulations showed distinct reactogenicity profiles. All formulations with PfAMA1 were immunogenic and induced functional antibodies.	[Roestenberg, Meta; de Jonge, Erik; Hermsen, Rob; Teelen, Karina; Roeffen, Will; de Mast, Quirijn; van der Ven, Andre; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Remarque, Ed; Faber, Bart; Kocken, Clemens H. M.; Arnold, Miranda; Walraven, Vanessa; Thomas, Alan] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Blythman, Hildur; Leroy, Odile; Imoukhuede, Egeruan; Jepsen, Soren] European Malaria Vaccine Initiative, Copenhagen, Denmark; [Ofori-Anyinam, Opokua; Ballou, W. Ripley; Cohen, Joe; Dubois, Marie Claude] GlaxoSmithKline Biol, Rixensart, Belgium; [Ascarateil, Stephane] SEPPIC, Paris, France	Radboud University Nijmegen; GlaxoSmithKline	Roestenberg, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	M.Roestenberg@mmb.umcn.nl	de Mast, Quirijn/H-3427-2015; Hermsen, C.C./L-4368-2015; Roestenberg, Meta/AAP-9413-2021; van der Ven, A.J.A.M./H-8102-2014; Sauerwein, Robert/C-8519-2013; Roeffen, W.F.G./L-4607-2015; Remarque, Ed/AAE-8643-2020	Roestenberg, Meta/0000-0002-5052-2830; van der Ven, A.J.A.M./0000-0003-1833-3391; de Mast, Quirijn/0000-0001-6056-157X; Kocken, Clemens/0000-0002-4784-1734; Imoukhuede, Egeruan Babatunde/0000-0001-6679-0904; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative	European Malaria Vaccine Initiative	This work was funded by a grant from the European Malaria Vaccine Initiative. Collaborators from the European Malaria Vaccine Initiative have been involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; AMADOR R, 1992, VACCINE, V10, P179, DOI 10.1016/0264-410X(92)90009-9; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; BALLOU WR, 1987, LANCET, V1, P1277; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; FABER BW, 2008, VACCINE; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Human D, 2001, BMJ-BRIT MED J, V323, P283; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; KSHIRSAGAR N, 2007, VACCINE; Langermans JAM, 2005, VACCINE, V23, P4935, DOI 10.1016/j.vaccine.2005.05.036; Langermans JAM, 2006, HUM VACCINES, V2, P222, DOI 10.4161/hv.2.5.3276; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Lawrence GW, 1997, VACCINE, V15, P176, DOI 10.1016/S0264-410X(96)00150-8; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miles AP, 2005, VACCINE, V23, P2530, DOI 10.1016/j.vaccine.2004.08.049; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Schijns VEJC, 2007, CLIN PHARMACOL THER, V82, P750, DOI 10.1038/sj.clpt.6100394; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Toledo H, 2001, VACCINE, V19, P4328, DOI 10.1016/S0264-410X(01)00111-6; Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001; Vandepapeliere P, 2005, VACCINE, V23, P2591, DOI 10.1016/j.vaccine.2004.11.034; Zepp F, 2006, J PEDIATR-US, V149, P603, DOI 10.1016/j.jpeds.2006.06.016	40	82	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3960	10.1371/journal.pone.0003960	http://dx.doi.org/10.1371/journal.pone.0003960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093004	Green Submitted, Green Published, gold			2022-12-27	WOS:000265458600004
J	Wilson, JW; Ott, CM; Quick, L; Davis, R; Bentrup, KHZ; Crabbe, A; Richter, E; Sarker, S; Barrila, J; Porwollik, S; Cheng, P; McClelland, M; Tsaprailis, G; Radabaugh, T; Hunt, A; Shah, M; Nelman-Gonzalez, M; Hing, S; Parra, M; Dumars, P; Norwood, K; Bober, R; Devich, J; Ruggles, A; CdeBaca, A; Narayan, S; Benjamin, J; Goulart, C; Rupert, M; Catella, L; Schurr, MJ; Buchanan, K; Morici, L; McCracken, J; Porter, MD; Pierson, DL; Smith, SM; Mergeay, M; Leys, N; Stefanyshyn-Piper, HM; Gorie, D; Nickerson, CA				Wilson, James W.; Ott, C. Mark; Quick, Laura; Davis, Richard; Bentrup, Kerstin Hoener zu; Crabbe, Aurelie; Richter, Emily; Sarker, Shameema; Barrila, Jennifer; Porwollik, Steffen; Cheng, Pui; McClelland, Michael; Tsaprailis, George; Radabaugh, Timothy; Hunt, Andrea; Shah, Miti; Nelman-Gonzalez, Mayra; Hing, Steve; Parra, Macarena; Dumars, Paula; Norwood, Kelly; Bober, Ramona; Devich, Jennifer; Ruggles, Ashleigh; CdeBaca, Autumn; Narayan, Satro; Benjamin, Joseph; Goulart, Carla; Rupert, Mark; Catella, Luke; Schurr, Michael J.; Buchanan, Kent; Morici, Lisa; McCracken, James; Porter, Marc D.; Pierson, Duane L.; Smith, Scott M.; Mergeay, Max; Leys, Natalie; Stefanyshyn-Piper, Heidemarie M.; Gorie, Dominic; Nickerson, Cheryl A.			Media Ion Composition Controls Regulatory and Virulence Response of Salmonella in Spaceflight	PLOS ONE			English	Article								The spaceflight environment is relevant to conditions encountered by pathogens during the course of infection and induces novel changes in microbial pathogenesis not observed using conventional methods. It is unclear how microbial cells sense spaceflight-associated changes to their growth environment and orchestrate corresponding changes in molecular and physiological phenotypes relevant to the infection process. Here we report that spaceflight-induced increases in Salmonella virulence are regulated by media ion composition, and that phosphate ion is sufficient to alter related pathogenesis responses in a spaceflight analogue model. Using whole genome microarray and proteomic analyses from two independent Space Shuttle missions, we identified evolutionarily conserved molecular pathways in Salmonella that respond to spaceflight under all media compositions tested. Identification of conserved regulatory paradigms opens new avenues to control microbial responses during the infection process and holds promise to provide an improved understanding of human health and disease on Earth.	[Quick, Laura; Davis, Richard; Crabbe, Aurelie; Richter, Emily; Sarker, Shameema; Barrila, Jennifer; Nickerson, Cheryl A.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Wilson, James W.; Quick, Laura] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Ott, C. Mark; Pierson, Duane L.] NASA, Johnson Space Center, Habitabil & Environm Factors Div, Houston, TX USA; [Bentrup, Kerstin Hoener zu; Morici, Lisa] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Crabbe, Aurelie] Free Univ Brussels, Flanders Inst Biotechnol, B-1050 Brussels, Belgium; [Crabbe, Aurelie; Mergeay, Max; Leys, Natalie] Belgian Nuclear Res Ctr, Mol, Belgium; [Porwollik, Steffen; Cheng, Pui; McClelland, Michael] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Tsaprailis, George; Radabaugh, Timothy; Hunt, Andrea] Univ Arizona, Ctr Toxicol, Tucson, AZ 85721 USA; [Shah, Miti] Arizona State Univ, Ctr Glycosci Technol, Biodesign Inst, Tempe, AZ 85287 USA; [Nelman-Gonzalez, Mayra] Wyle Lab, Houston, TX USA; [Hing, Steve; Parra, Macarena; Dumars, Paula] NASA, Ames Res Ctr, Moffett Field, CA USA; [Norwood, Kelly; Bober, Ramona; Devich, Jennifer; Ruggles, Ashleigh; CdeBaca, Autumn; Narayan, Satro; Benjamin, Joseph; Catella, Luke] Kennedy Space Ctr, Space Life Sci Lab, Cape Canaveral, FL USA; [Goulart, Carla; Rupert, Mark] Univ Colorado, Boulder, CO 80309 USA; [Schurr, Michael J.] Univ Colorado, Sch Med, Aurora, CO USA; [Buchanan, Kent] Oklahoma City Univ, Oklahoma City, OK USA; [McCracken, James] Univ Chicago, Sect Gen Surg, Chicago, IL 60637 USA; [Porter, Marc D.] Univ Utah, Dept Chem, Chem Engn & Bioengn, Salt Lake City, UT 84112 USA; [Smith, Scott M.] Natl Aeronaut & Space Adm, Johnson Space Ctr, Human Adapt & Countermeasures Div, Houston, TX USA; [Stefanyshyn-Piper, Heidemarie M.; Gorie, Dominic] NASA, Johnson Space Ctr, Astronaut Office, Houston, TX USA	Arizona State University; Arizona State University-Tempe; Villanova University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Tulane University; Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Belgian Nuclear Research Centre (SCK-CEN); University of Arizona; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Chicago; Utah System of Higher Education; University of Utah; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Wilson, JW (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	Cheryl.A.Nickerson@asu.edu	Leys, Natalie M.E.J./P-2761-2017; Schurr, Michael/AAX-6596-2020; Mergeay, Max/H-2003-2011; McClelland, Michael/A-8583-2011; Schurr, Michael/I-2481-2013	Schurr, Michael/0000-0003-2585-0477; Ott, Mark/0000-0002-3101-4806; Crabbe, Aurelie/0000-0003-3084-4418; McClelland, Michael/0000-0003-1788-9347; Barrila, Jennifer/0000-0002-6597-3001; Tsaprailis, George/0000-0003-1239-2358	NASA [NCC2-1362]; NIEHS [ES06694]; NIH/NCI [CA023074]; BIO5 Institute of the University of Arizona; King Baudouin Foundation [Henri Benedictus Fellowship]; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; King Baudouin Foundation; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NASA grant NCC2-1362 to CAN; Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the AZCC, and by the BIO5 Institute of the University of Arizona; AC supported by Henri Benedictus Fellowship of the King Baudouin Foundation and the Belgian American Educational Foundation (B.A.E.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Aertsen A, 2004, CRIT REV MICROBIOL, V30, P263, DOI 10.1080/10408410490884757; *ASTM, D4327 ASTM; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; CRABBE A, 2008, ENV MICROBIOL; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Guo P, 2000, AM J PHYSIOL-RENAL, V279, pF698, DOI 10.1152/ajprenal.2000.279.4.F698; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KHANNA R, 1988, DIGEST DIS SCI, V33, P1147, DOI 10.1007/BF01535792; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Mahmood S, 2005, EXP PARASITOL, V110, P91, DOI 10.1016/j.exppara.2005.03.017; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Poelstra K, 1997, LAB INVEST, V76, P319; Poelstra K, 1997, AM J PATHOL, V151, P1163; REED LJ, 1938, AM J HYG, V27; Ruiz N, 2003, J BACTERIOL, V185, P5984, DOI 10.1128/JB.185.20.5984-5992.2003; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Tucker DL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-15; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	33	102	115	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3923	10.1371/journal.pone.0003923	http://dx.doi.org/10.1371/journal.pone.0003923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079590	Green Submitted, gold, Green Published			2022-12-27	WOS:000265456300003
J	Klemm, K; Eipel, C; Cantre, D; Abshagen, K; Menger, MD; Vollmar, B				Klemm, Katja; Eipel, Christian; Cantre, Daniel; Abshagen, Kerstin; Menger, Michael D.; Vollmar, Brigitte			Multiple Doses of Erythropoietin Impair Liver Regeneration by Increasing TNF-alpha, the Bax to Bcl-xL Ratio and Apoptotic Cell Death	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PROTECTS; FAILURE; INFLAMMATION; HEPATECTOMY; DARBEPOETIN; BIOLOGY; SIZE	Background: Liver resection and the use of small-for-size grafts are restricted by the necessity to provide a sufficient amount of functional liver mass. Only few promising strategies to maximize liver regeneration are available. Apart from its erythropoiesis-stimulating effect, erythropoietin (EPO) has meanwhile been recognized as mitogenic, tissue-protective, and anti-apoptotic pleiotropic cytokine. Thus, EPO may support regeneration of hepatic tissue. Methodology: Rats undergoing 68% hepatectomy received daily either high dose (5000 IU/kg bw iv) or low dose (500 IU/kg bw iv) recombinant human EPO or equal amounts of physiologic saline. Parameters of liver regeneration and hepatocellular apoptosis were assessed at 24 h, 48 h and 5 d after resection. In addition, red blood cell count, hematocrit and serum EPO levels as well as plasma concentrations of TNF-alpha and IL-6 were evaluated. Further, hepatic Bcl-x(L) and Bax protein expression were analyzed by Western blot. Principal Findings: Administration of EPO significantly reduced the expression of PCNA at 24 h followed by a significant decrease in restitution of liver mass at day 5 after partial hepatectomy. EPO increased TNF-alpha levels and shifted the Bcl-x(L) to Bax ratio towards the pro-apoptotic Bax resulting in significantly increased hepatocellular apoptosis. Conclusions: Multiple doses of EPO after partial hepatectomy increase hepatocellular apoptosis and impair liver regeneration in rats. Thus, careful consideration should be made in pre- and post-operative recombinant human EPO administration in the setting of liver resection and transplantation.	[Klemm, Katja; Eipel, Christian; Cantre, Daniel; Abshagen, Kerstin; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, Rostock, Germany; [Menger, Michael D.] Univ Saarland, Inst Clin & Exp Surg, Homburg, Germany	University of Rostock; Saarland University	Klemm, K (corresponding author), Univ Rostock, Inst Expt Surg, Rostock, Germany.	christian.eipel@uni-rostock.de			Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany [Vo 450/10-1]	Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany(German Research Foundation (DFG))	This work is supported by a grant of the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany (Vo 450/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardet V, 2006, LIVER TRANSPLANT, V12, P1649, DOI 10.1002/lt.20898; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Buemi M., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P299, DOI 10.2174/187152506778520754; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Cantre D, 2008, BRIT J SURG, V95, P785, DOI 10.1002/bjs.6139; Chen GG, 2002, CLIN EXP METASTAS, V19, P457, DOI 10.1023/A:1016336724463; Diehl AM, 1996, J GASTROEN HEPATOL, V11, P466, DOI 10.1111/j.1440-1746.1996.tb00292.x; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Higgins GM, 1931, ARCH PATHOL, V12, P186; Humar A, 2004, LIVER TRANSPLANT, V10, P374, DOI 10.1002/lt.20096; Jelkmann W, 2004, ANN HEMATOL, V83, P673, DOI 10.1007/s00277-004-0911-6; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kawashima Y, 2001, J HEART LUNG TRANSPL, V20, P568, DOI 10.1016/S1053-2498(01)00243-1; Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P556; Le Minh K, 2007, AM J PATHOL, V170, P1954, DOI 10.2353/ajpath.2007.061056; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258; MACDOUGALL IC, 1991, CLIN PHARMACOKINET, V20, P99, DOI 10.2165/00003088-199120020-00002; MICHALOPOULOS GK, 1997, LIVER REGENERATION S, V276, P60; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Nadalin S, 2004, LIVER TRANSPLANT, V10, P1024, DOI 10.1002/lt.20182; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Nagy LE, 2004, ALCOHOL, V33, P229, DOI 10.1016/j.alcohol.2004.09.002; Ogata T, 2008, SURGERY, V143, P545, DOI 10.1016/j.surg.2007.11.010; Okada T, 2007, TRANSPLANTATION, V84, P504, DOI 10.1097/01.tp.0000277672.02783.33; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Rafiee P, 2005, BASIC RES CARDIOL, V100, P187, DOI 10.1007/s00395-004-0508-1; Schmeding M, 2008, J GASTROEN HEPATOL, V23, P1125, DOI 10.1111/j.1440-1746.2007.05265.x; Seehofer D, 2008, LANGENBECK ARCH SURG, V393, P325, DOI 10.1007/s00423-008-0290-x; Sharples EJ, 2006, CURR OPIN PHARMACOL, V6, P184, DOI 10.1016/j.coph.2006.01.003; SPIVAK JL, 1989, BLOOD, V73, P90; Tsutsumi R, 2004, HEPATO-GASTROENTEROL, V51, P701; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Yilmaz Sezgin, 2004, HPB (Oxford), V6, P169, DOI 10.1080/13651820410026077; Zhande R, 2007, AM J PHYSIOL-HEART C, V292, pH2467, DOI 10.1152/ajpheart.00649.2006; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007	43	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3924	10.1371/journal.pone.0003924	http://dx.doi.org/10.1371/journal.pone.0003924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079544	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455900008
J	Vera, PL; Iczkowski, KA; Wang, XH; Meyer-Siegler, KL				Vera, Pedro L.; Iczkowski, Kenneth A.; Wang, Xihai; Meyer-Siegler, Katherine L.			Cyclophosphamide-Induced Cystitis Increases Bladder CXCR4 Expression and CXCR4-Macrophage Migration Inhibitory Factor Association	PLOS ONE			English	Article							CHEMOKINE RECEPTORS; RAT BLADDER; FACTOR MIF; PAIN HYPERSENSITIVITY; FUNCTIONAL EXPRESSION; URINARY-BLADDER; INFLAMMATION; ACTIVATION; CD74; BARRIER	Background: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine involved in cystitis and a non-cognate ligand of the chemokine receptor CXCR4 in vitro. We studied whether CXCR4-MIF associations occur in rat bladder and the effect of experimental cystitis. Methods and Findings: Twenty male rats received saline or cyclophosphamide (40 mg/kg; i.p.; every 3(rd) day) to induce persistent cystitis. After eight days, urine was collected and bladders excised under anesthesia. Bladder CXCR4 and CXCR4-MIF co-localization were examined with immunhistochemistry. ELISA determined MIF and stromal derived factor-1 (SDF-1; cognate ligand for CXCR4) levels. Bladder CXCR4 expression (real-time RTC-PCR) and protein levels (Western blotting) were examined. Co-immunoprecipitations studied MIF-CXCR4 associations. Urothelial basal and intermediate (but not superficial) cells in saline-treated rats contained CXCR4, co-localized with MIF. Cyclophosphamide treatment caused: 1) significant redistribution of CXCR4 immunostaining to all urothelial layers (especially apical surface of superficial cells) and increased bladder CXCR4 expression; 2) increased urine MIF with decreased bladder MIF; 3) increased bladder SDF-1; 4) increased CXCR4-MIF associations. Conclusions: These data demonstrate CXCR4-MIF associations occur in vivo in rat bladder and increase in experimental cystitis. Thus, CXCR4 represents an alternative pathway for MIF-mediated signal transduction during bladder inflammation. In the bladder, MIF may compete with SDF-1 (cognate ligand) to activate signal transduction mediated by CXCR4.	[Wang, Xihai; Meyer-Siegler, Katherine L.] Bay Pines VA Healthcare Syst, Res & Dev 151, Bay Pines, FL USA; [Vera, Pedro L.; Wang, Xihai] Univ S Florida, Coll Med, Dept Surg, Tampa, FL USA; [Iczkowski, Kenneth A.] Univ Colorado, Prostate Canc Res Lab, Aurora, CO USA; [Meyer-Siegler, Katherine L.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of South Florida	Vera, PL (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev 151, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institute of Diabetes and Digestive and Kidney Diseases [DK075059]; Bay Pines Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bay Pines Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (PLV; KLMS). This work was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases DK075059 (PLV; KLMS; XW), and the Bay Pines Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bhangoo SK, 2007, BRAIN BEHAV IMMUN, V21, P581, DOI 10.1016/j.bbi.2006.12.003; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Eisenhardt A, 2005, EUR UROL, V47, P111, DOI 10.1016/j.eururo.2004.10.001; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; KOSS LG, 1967, LAB INVEST, V16, P44; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Malley SE, 2002, PHYSIOL GENOMICS, V9, P5, DOI 10.1152/physiolgenomics.00117.2001; McClure CP, 2005, AIDS, V19, P1257, DOI 10.1097/01.aids.0000180096.50393.96; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Meyer-Siegler KL, 2004, J INTERF CYTOK RES, V24, P55, DOI 10.1089/107999004772719918; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Murdoch C, 1999, IMMUNOLOGY, V98, P36; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Woo LL, 2007, J UROLOGY, V177, P1568, DOI 10.1016/j.juro.2006.11.047; Yuridullah R, 2006, AUTON NEUROSCI-BASIC, V126, P380, DOI 10.1016/j.autneu.2006.02.030; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	36	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3898	10.1371/journal.pone.0003898	http://dx.doi.org/10.1371/journal.pone.0003898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066630	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455700007
J	Blinder, P; Cove, J; Foox, M; Baranes, D				Blinder, Pablo; Cove, Joshua; Foox, Maytal; Baranes, Danny			Convergence among Non-Sister Dendritic Branches: An Activity-Controlled Mean to Strengthen Network Connectivity	PLOS ONE			English	Article							HIPPOCAMPAL MOSSY FIBER; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; WIRING OPTIMIZATION; NEURONS; MODEL; ELECTROPHYSIOLOGY; RAT; ORGANELLES; MORPHOLOGY	The manner by which axons distribute synaptic connections along dendrites remains a fundamental unresolved issue in neuronal development and physiology. We found in vitro and in vivo indications that dendrites determine the density, location and strength of their synaptic inputs by controlling the distance of their branches from those of their neighbors. Such control occurs through collective branch convergence, a behavior promoted by AMPA and NMDA glutamate receptor activity. At hubs of convergence sites, the incidence of axo-dendritic contacts as well as clustering levels, pre- and postsynaptic protein content and secretion capacity of synaptic connections are higher than found elsewhere. This coupling between synaptic distribution and the pattern of dendritic overlapping results in 'Economical Small World Network', a network configuration that enables single axons to innervate multiple and remote dendrites using short wiring lengths. Thus, activity-mediated regulation of the proximity among dendritic branches serves to pattern and strengthen neuronal connectivity.	[Blinder, Pablo; Cove, Joshua; Foox, Maytal; Baranes, Danny] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Baranes, Danny] Ariel Univ, Ctr Samaria, Ariel, Israel	Ben Gurion University; Ariel University	Blinder, P (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbaranes@bgu.ac.il	Blinder, Pablo/AAX-7980-2020; Blinder, Pablo/GQI-2237-2022	Blinder, Pablo/0000-0002-4042-214X; 	Canada Foundation of Innovation; Kreitman and Horowitz foundations	Canada Foundation of Innovation(Canada Foundation for Innovation); Kreitman and Horowitz foundations	Canada Foundation of Innovation, The Kreitman and Horowitz foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bortolotto ZA, 2005, NEUROTOXICOLOGY, V26, P769, DOI 10.1016/j.neuro.2005.02.004; Chauvet GA, 2002, HIPPOCAMPUS, V12, P698, DOI 10.1002/hipo.10106; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Criado R, 2005, J MATH MODELLING ALG, V4, P307, DOI DOI 10.1007/S10852-005-9006-1; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; Grebenyuk SE, 2004, NEUROSCI LETT, V361, P60, DOI 10.1016/j.neulet.2004.02.040; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hasegawa H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066107; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; MASON A, 1990, J NEUROSCI, V10, P1415; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Migliore M, 1995, J COMPUT NEUROSCI, V2, P335, DOI 10.1007/BF00961444; OLSON CF, 1995, PARALLEL COMPUT, V21, P1313, DOI 10.1016/0167-8191(95)00017-I; OSTLING A, 2000, SCIENCE, V290, P627; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Skoglund TS, 2004, NEUROSCI RES, V50, P189, DOI 10.1016/j.neures.2004.06.017; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; vanPelt J, 1997, J THEOR BIOL, V186, P17, DOI 10.1006/jtbi.1996.0341; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Washington SD, 2000, NEUROCOMPUTING, V32, P261, DOI 10.1016/S0925-2312(00)00173-9; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Zheng JQ, 1996, J NEUROSCI, V16, P1140	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3782	10.1371/journal.pone.0003782	http://dx.doi.org/10.1371/journal.pone.0003782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023423	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448800003
J	Sun, H; Skogerbo, G; Wang, Z; Liu, W; Li, YX				Sun, Hong; Skogerbo, Geir; Wang, Zhen; Liu, Wei; Li, Yixue			Structural Relationships between Highly Conserved Elements and Genes in Vertebrate Genomes	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; NONCODING ELEMENTS; SEGMENTAL DUPLICATIONS; MOUSE; IDENTIFICATION; EXPRESSION; SEQUENCES; DELETION; REGIONS; LOCUS	Large numbers of sequence elements have been identified to be highly conserved among vertebrate genomes. These highly conserved elements (HCEs) are often located in or around genes that are involved in transcription regulation and early development. They have been shown to be involved in cis-regulatory activities through both in vivo and additional computational studies. We have investigated the structural relationships between such elements and genes in six vertebrate genomes human, mouse, rat, chicken, zebrafish and tetraodon and detected several thousand cases of conserved HCE-gene associations, and also cases of HCEs with no common target genes. A few examples underscore the potential significance of our findings about several individual genes. We found that the conserved association between HCE/HCEs and gene/genes are not restricted to elements by their absolute distance on the genome. Notably, long-range associations were identified and the molecular functions of the associated genes do not show any particular overrepresentation of the functional categories previously reported. HCEs in close proximity are found to be linked with different set of gene/genes. The results reflect the highly complex correlation between HCEs and their putative target genes.	[Sun, Hong; Wang, Zhen; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Sun, Hong; Liu, Wei] Wyeth Res, Cambridge, MA USA; [Sun, Hong; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Skogerbo, Geir] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Bioinformat Lab, Beijing 100864, Peoples R China; [Sun, Hong] Zhongxin Biotechnol Shanghai Co Ltd, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Pfizer; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS	Sun, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	wliu@wyeth.com; yxli@sibs.ac.cn			Wyeth-Zhongxin Joint postdoctoral program; National High-Tech R&D Program [2006AA02Z334, 2007AA02Z330]; National Basic Research Program of China [2006CB910700, 2003CB715901]; Key Research Program [KSCX2-YW-R-112]; Shanghai Committee of Science and Technology [07JC14048]	Wyeth-Zhongxin Joint postdoctoral program; National High-Tech R&D Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Key Research Program; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	Hong Sun is supported by Wyeth-Zhongxin Joint postdoctoral program. This work is supported by grants National High-Tech R&D Program (863) (2006AA02Z334, 2007AA02Z330), National Basic Research Program of China (2006CB910700, 2003CB715901), Key Research Program (CAS) KSCX2-YW-R-112 and the Shanghai Committee of Science and Technology (07JC14048).	Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bachman NJ, 1999, MAMM GENOME, V10, P506, DOI 10.1007/s003359901031; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dirksen WP, 2000, J BIOL CHEM, V275, P29170, DOI 10.1074/jbc.M001126200; Dubourg O, 2006, NEUROMOL MED, V8, P75, DOI 10.1385/NMM:8:1:75; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kikuchi M, 2000, ONCOGENE, V19, P4941, DOI 10.1038/sj.onc.1203864; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lin CJ, 2001, J IMMUNOL, V166, P6134, DOI 10.4049/jimmunol.166.10.6134; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Sun H, 2006, HUM MOL GENET, V15, P2911, DOI 10.1093/hmg/ddl232; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	39	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3727	10.1371/journal.pone.0003727	http://dx.doi.org/10.1371/journal.pone.0003727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008958	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166400005
J	Gu, XS; Liu, X; Guise, KG; Fossella, J; Wang, K; Fan, J				Gu, Xiaosi; Liu, Xun; Guise, Kevin G.; Fossella, John; Wang, Kai; Fan, Jin			Alexithymic Trait and Voluntary Control in Healthy Adults	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; OBSESSIVE-COMPULSIVE DISORDER; FACIAL EXPRESSIONS; 5-FACTOR MODEL; ATTENTIONAL NETWORKS; EMOTIONAL AWARENESS; NEURAL PROCESSES; COUNTING STROOP; PAIN; TEMPERAMENT	Background: Alexithymia is a personality trait characterized by deficiency in understanding, processing, or describing emotions. Recent studies have revealed that alexithymia is associated with less activation of the anterior cingulate cortex, a brain region shown to play a role in cognitive and emotional processing. However, few studies have directly investigated the cognitive domain in relation to alexithymia to examine whether alexithymic trait is related to less efficient voluntary control. Methodology/Principal Findings: We examined the relationship between alexithymic trait and voluntary control in a group of healthy volunteers. We used the 20-item Toronto Alexithymia Scale (TAS-20) to measure alexithymic trait. Additionally, we examined state and trait voluntary control using the revised Attention Network Test (ANT-R) and the Adult Temperament Questionnaire (ATQ), respectively. Alexithymic trait was positively correlated with the overall reaction time of the ANT-R, and negatively correlated with the Effortful Control factor of the ATQ. Conclusions/Significance: Our results suggest that alexithymic trait is associated with less efficient voluntary control.	[Gu, Xiaosi; Fan, Jin] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Liu, Xun; Guise, Kevin G.; Fossella, John; Fan, Jin] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Wang, Kai] Anhui Med Univ, Hefei, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Anhui Medical University	Gu, XS (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY USA.	Jin.Fan@mssm.edu	Liu, Xun/C-2400-2009; Fan, Jin/A-6716-2009; Fan, Jin/L-2055-2019; Guise, Kevin G/C-1145-2009; Gu, Xiaosi/A-7724-2010	Liu, Xun/0000-0003-1366-8926; Fan, Jin/0000-0001-9630-8330; Fan, Jin/0000-0001-9630-8330; Gu, Xiaosi/0000-0002-9373-987X	NIH [R21MH083164]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083164] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH Grant Number R21MH083164 to J.F.. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASENDORPF JB, 1983, J PERS SOC PSYCHOL, V45, P1334, DOI 10.1037/0022-3514.45.6.1334; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Casey BJ, 1997, DEV PSYCHOBIOL, V30, P61, DOI 10.1002/(SICI)1098-2302(199701)30:1<61::AID-DEV6>3.3.CO;2-B; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DERRYBERRY D, 1988, J PERS SOC PSYCHOL, V55, P958, DOI 10.1037/0022-3514.55.6.958; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; Frewen PA, 2006, ANN NY ACAD SCI, V1071, P397, DOI 10.1196/annals.1364.029; Gignac GE, 2007, J PERS ASSESS, V89, P247, DOI 10.1080/00223890701629730; Grabe HJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P312, DOI 10.1159/000093954; Grabe HJ, 2004, AM J PSYCHIAT, V161, P1299, DOI 10.1176/appi.ajp.161.7.1299; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gu XS, 2007, BEHAV BRAIN RES, V181, P218, DOI 10.1016/j.bbr.2007.04.008; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; HEIBERG A, 1977, PSYCHOTHER PSYCHOSOM, V28, P221, DOI 10.1159/000287066; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jorgensen MM, 2007, PSYCHOTHER PSYCHOSOM, V76, P369, DOI 10.1159/000107565; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Karlsson H, 2008, BRIT J PSYCHIAT, V192, P32, DOI 10.1192/bjp.bp.106.034728; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Loas G, 2001, J PSYCHOSOM RES, V50, P255, DOI 10.1016/S0022-3999(01)00197-0; Luminet O, 1999, J PERS ASSESS, V73, P345, DOI 10.1207/S15327752JPA7303_4; Martinez-Sanchez Francisco, 2003, Span J Psychol, V6, P51; McRae K, 2008, NEUROIMAGE, V41, P648, DOI 10.1016/j.neuroimage.2008.02.030; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nemiah JC, 1996, PSYCHOSOM MED, V58, P217, DOI 10.1097/00006842-199605000-00004; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; Pandey R, 1997, BRIT J CLIN PSYCHOL, V36, P631, DOI 10.1111/j.2044-8260.1997.tb01269.x; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; Parker PD, 2005, J PERS, V73, P1087, DOI 10.1111/j.1467-6494.2005.00339.x; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picardi A, 2005, PSYCHOTHER PSYCHOSOM, V74, P371, DOI 10.1159/000087785; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Rufer M, 2006, COMPR PSYCHIAT, V47, P394, DOI 10.1016/j.comppsych.2005.12.004; Schafer R, 2007, NEUROCASE, V13, P201, DOI 10.1080/13554790701494964; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Suslow T, 2003, PSYCHOL REP, V93, P1003, DOI 10.2466/PR0.93.7.1003-1012; Suslow T, 2002, PERS INDIV DIFFER, V32, P541, DOI 10.1016/S0191-8869(01)00056-3; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; TAYLOR GJ, 1984, AM J PSYCHIAT, V141, P725; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; Valera EM, 2001, PSYCHOTHER PSYCHOSOM, V70, P239, DOI 10.1159/000056261; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; WEINBERGER DA, 1979, J ABNORM PSYCHOL, V88, P369, DOI 10.1037/0021-843X.88.4.369; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; WISE TN, 1992, COMPR PSYCHIAT, V33, P147, DOI 10.1016/0010-440X(92)90023-J	71	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3702	10.1371/journal.pone.0003702	http://dx.doi.org/10.1371/journal.pone.0003702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WW	19002254	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166000005
J	Rogers, BP; Gore, JC				Rogers, Baxter P.; Gore, John C.			Empirical Comparison of Sources of Variation for FMRI Connectivity Analysis	PLOS ONE			English	Article								Background: In neuroimaging, connectivity refers to the correlations between signals in different brain regions. Although fMRI measures of connectivity have been widely explored, the methods used have varied. This complicates the interpretation of existing literature in cases when different techniques have been used with fMRI data to measure the single concept of "connectivity.'' Additionally the optimum choice of method for future analyses is often unclear. Methodology/Principal Findings: In this study, measures of functional and effective connectivity in the motor system were calculated based on three sources of variation: inter-subject variation in task activation level; within-subject variation in task-related responses; and within-subject residual variation after removal of task effects. Two task conditions were compared. The methods yielded different inter-regional correlation coefficients. However, all three approaches produced similar results, qualitatively and sometimes quantitatively, for condition differences in connectivity. Conclusions/Significance: While these results are specific to the motor regions studied, they do suggest that within-subject and across-subject results may be usefully compared. Also, the presence of task-specific correlations in residual time series supports arguments that residuals may not substitute for resting-state data, but rather may reflect the same underlying variations present during steady-state performance.	[Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Vanderbilt Univ Inst Imaging Sci, Nashville, TN 37235 USA; [Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA; [Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA; [Gore, John C.] Vanderbilt Univ, Dept Phys, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Rogers, BP (corresponding author), Vanderbilt Univ, Vanderbilt Univ Inst Imaging Sci, Nashville, TN 37235 USA.	baxter.rogers@vanderbilt.edu	Rogers, Baxter P/B-7897-2010; anand, amit/A-7222-2009	Rogers, Baxter/0000-0002-5666-2797	NIH [5T32EB001628, 5R03EY014437]; NATIONAL EYE INSTITUTE [R03EY014437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000461, T32EB001628] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was funded by NIH grants 5T32EB001628 and 5R03EY014437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Caclin A, 2006, NEUROIMAGE, V33, P515, DOI 10.1016/j.neuroimage.2006.07.019; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fisher R. A., 1915, BIOMETRIKA, P507, DOI DOI 10.2307/2331838; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Horwitz B, 2005, PHILOS T R SOC B, V360, P1093, DOI 10.1098/rstb.2005.1647; Kruggel F, 2002, MED IMAGE ANAL, V6, P63, DOI 10.1016/S1361-8415(01)00052-4; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; NEWTON AT, 2006, HUM BRAIN MAPP; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Rogers BP, 2004, NEUROIMAGE, V22, P855, DOI 10.1016/j.neuroimage.2004.02.027; ROGERS BP, 2007, MAGN RESON IMAGING; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Serences JT, 2004, NEUROIMAGE, V21, P1690, DOI 10.1016/j.neuroimage.2003.12.021; Stanberry LI, 2006, MAGN RESON IMAGING, V24, P217, DOI 10.1016/j.mri.2005.12.006; Stephan KE, 2001, PSYCHOL MED, V31, P1065, DOI 10.1017/S0033291701004330; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3708	10.1371/journal.pone.0003708	http://dx.doi.org/10.1371/journal.pone.0003708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002252	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166000008
J	Jia, L; Berman, BP; Jariwala, U; Yan, XT; Cogan, JP; Walters, A; Chen, T; Buchanan, G; Frenkel, B; Coetzee, GA				Jia, Li; Berman, Benjamin P.; Jariwala, Unnati; Yan, Xiting; Cogan, Jon P.; Walters, Allison; Chen, Ting; Buchanan, Grant; Frenkel, Baruch; Coetzee, Gerhard A.			Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity	PLOS ONE			English	Article								Background: The androgen receptor (AR) is a steroid-activated transcription factor that binds at specific DNA locations and plays a key role in the etiology of prostate cancer. While numerous studies have identified a clear connection between AR binding and expression of target genes for a limited number of loci, high-throughput elucidation of these sites allows for a deeper understanding of the complexities of this process. Methodology/Principal Findings: We have mapped 189 AR occupied regions (ARORs) and 1,388 histone H3 acetylation (AcH3) loci to a 3% continuous stretch of human genomic DNA using chromatin immunoprecipitation (ChIP) microarray analysis. Of 62 highly reproducible ARORs, 32 (52%) were also marked by AcH3. While the number of ARORs detected in prostate cancer cells exceeded the number of nearby DHT-responsive genes, the AcH3 mark defined a subclass of ARORs much more highly associated with such genes - 12% of the genes flanking AcH3+ARORs were DHT-responsive, compared to only 1% of genes flanking AcH3-ARORs. Most ARORs contained enhancer activities as detected in luciferase reporter assays. Analysis of the AROR sequences, followed by site-directed ChIP, identified binding sites for AR transcriptional coregulators FoxA1, CEBP beta, NFI and GATA2, which had diverse effects on endogenous AR target gene expression levels in siRNA knockout experiments. Conclusions/Significance: We suggest that only some ARORs function under the given physiological conditions, utilizing diverse mechanisms. This diversity points to differential regulation of gene expression by the same transcription factor related to the chromatin structure.	[Jia, Li; Walters, Allison; Buchanan, Grant; Coetzee, Gerhard A.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Jia, Li; Coetzee, Gerhard A.] Univ So Calif, Dept Urol, Los Angeles, CA USA; [Jariwala, Unnati; Cogan, Jon P.; Frenkel, Baruch] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Frenkel, Baruch] Univ So Calif, Dept Orthoped Surg, Los Angeles, CA USA; [Jia, Li; Walters, Allison; Coetzee, Gerhard A.] Univ So Calif, Norris Canc Ctr, Los Angeles, CA USA; [Jariwala, Unnati; Cogan, Jon P.; Frenkel, Baruch] Univ So Calif, Inst Genet Med, Los Angeles, CA USA; [Yan, Xiting; Chen, Ting] Univ So Calif, Dept Biol Sci, Los Angeles, CA USA; [Berman, Benjamin P.] Univ So Calif, Keck Sch Med, Mol & Computat Biol Program, Epigenome Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Jia, L (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	frenkel@usc.edu; coetzee@usc.edu	BERMAN, BENJAMIN/AAT-3720-2021; Berman, Benjamin P/D-5942-2014; li, jia/GVT-7587-2022; Coetzee, Gerhard/AAG-8439-2019; Jia, li/GPW-8015-2022; coetzee, Gerhard/AAT-6203-2020	BERMAN, BENJAMIN/0000-0002-2099-9005; Berman, Benjamin P/0000-0002-2099-9005; Coetzee, Gerhard/0000-0001-8820-8364; Cogan, Jon/0000-0001-9327-8711	Department of Defense [W81XWH-05-1-0025, W81XWH-04-1-0823]; National Institutes of Health [CA109147, LM008991, PAR-02-021, DK071122, CA009142-26, T32CA009659]; NSF [0241102]; American Cancer Society [IRG - 58-007-48]; Prostate Cancer Foundation; Alfred P Sloan; National Health and Medical Research Council of Australia [CJ Martin Biomedical Fellowship]; NIH/NCI [P30CA014089-30]; NIH/NCRR [RR10600-01, CA62528-01, RR14514-01]; NATIONAL CANCER INSTITUTE [P30CA014089, T32CA009142, T32CA009659, C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK071122, R01DK071122] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Prostate Cancer Foundation; Alfred P Sloan(Alfred P. Sloan Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support From: W81XWH-05-1-0025 to BF and W81XWH-04-1-0823 to GAC from the Department of Defense. CA109147 to GAC, LM008991 to TC, PAR-02-021 to TC, DK071122 to BF, and CA009142-26 to BPB from the National Institutes of Health. NSF 0241102 to TC from the National Science Foundation, #IRG - 58-007-48 to LJ from an American Cancer Society Institutional Research Grant. Awards from the Prostate Cancer Foundation to GAC and Alfred P Sloan to TC. GB is a recipient of a National Health and Medical Research Council of Australia CJ Martin Biomedical Fellowship, and UJ is supported by NIH training grant T32CA009659. The experiments were conducted in facilities (i) supported by P30CA014089-30 from the NIH/NCI and (ii) constructed with support from Research Facilities Improvement Program Grant Number C06 (RR10600-01, CA62528-01, RR14514-01) from the NIH/NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cesena TI, 2007, MOL GENET METAB, V90, P126, DOI 10.1016/j.ymgme.2006.10.006; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2007, CANCER J, V13, P70, DOI 10.1097/PPO.0b013e31803c6e3b; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Gonzalez MI, 2002, MOL CELL ENDOCRINOL, V190, P39, DOI 10.1016/S0303-7207(02)00035-7; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hudson ME, 2006, BIOTECHNIQUES, V41, P673, DOI 10.2144/000112322; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; Jenster G, 1999, SEMIN ONCOL, V26, P407; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jia L, 2005, CANCER RES, V65, P8003, DOI 10.1158/0008-5472.CAN-04-3679; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Jia L, 2003, MOL CANCER RES, V1, P385; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MASSIE CE, 2007, NEW ANDROGEN RECEPTO; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; THALMANN GN, 1994, CANCER RES, V54, P2577; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yin H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-158; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009	52	122	123	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3645	10.1371/journal.pone.0003645	http://dx.doi.org/10.1371/journal.pone.0003645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997859	gold, Green Published, Green Submitted			2022-12-27	WOS:000265165500001
J	Kulkarni, H; Marconi, VC; Agan, BK; McArthur, C; Crawford, G; Clark, RA; Dolan, MJ; Ahuja, SK				Kulkarni, Hemant; Marconi, Vincent C.; Agan, Brian K.; McArthur, Carole; Crawford, George; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			Role of CCL3L1-CCR5 Genotypes in the Epidemic Spread of HIV-1 and Evaluation of Vaccine Efficacy	PLOS ONE			English	Article								Background: Polymorphisms in CCR5, the major coreceptor for HIV, and CCL3L1, a potent CCR5 ligand and HIV-suppressive chemokine, are determinants of HIV-AIDS susceptibility. Here, we mathematically modeled the potential impact of these genetic factors on the epidemic spread of HIV, as well as on its prevention. Methods and Results: Ro, the basic reproductive number, is a fundamental concept in explaining the emergence and persistence of epidemics. By modeling sexual transmission among HIV+/HIV- partner pairs, we find that Ro estimates, and concordantly, the temporal and spatial patterns of HIV outgrowth are highly dependent on the infecting partners' CCL3L1-CCR5 genotype. Ro was least and highest when the infected partner possessed protective and detrimental CCL3L1-CCR5 genotypes, respectively. The modeling data indicate that in populations such as Pygmies with a high CCL3L1 gene dose and protective CCR5 genotypes, the spread of HIV might be minimal. Additionally, Pc, the critical vaccination proportion, an estimate of the fraction of the population that must be vaccinated successfully to eradicate an epidemic was <1 only when the infected partner had a protective CCL3L1-CCR5 genotype. Since in practice Pc cannot be >1, to prevent epidemic spread, population groups defined by specific CCL3L1-CCR5 genotypes might require repeated vaccination, or as our models suggest, a vaccine with an efficacy of >70%. Further, failure to account for CCL3L1-CCR5-based genetic risk might confound estimates of vaccine efficacy. For example, in a modeled trial of 500 subjects, misallocation of CCL3L1-CCR5 genotype of only 25 (5%) subjects between placebo and vaccine arms results in a relative error of similar to 12% from the true vaccine efficacy. Conclusions: CCL3L1-CCR5 genotypes may impact on the dynamics of the HIV epidemic and, consequently, the observed heterogeneous global distribution of HIV infection. As Ro is lowest when the infecting partner has beneficial CCL3L1-CCR5 genotypes, we infer that therapeutic vaccines directed towards reducing the infectivity of the host may play a role in halting epidemic spread. Further, CCL3L1-CCR5 genotype may provide critical guidance for optimizing the design and evaluation of HIV-1 vaccine trials and prevention programs.	[Kulkarni, Hemant; Crawford, George; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA; [Marconi, Vincent C.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD USA; [Marconi, Vincent C.; Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Infect Dis Serv, Lackland AFB, TX USA; [Marconi, Vincent C.; Dolan, Matthew J.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [McArthur, Carole] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO USA; [Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr, Dept Med, Microbiol & Immunol & Biochem, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; San Antonio Military Medical Center; University of Missouri System; University of Missouri Kansas City; United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio	Kulkarni, H (corresponding author), S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA.	kulkarnih@uthscsa.edu; ahujas@uthscsa.edu	Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022; Clark, Robert/Q-6764-2019; Kulkarni, Hemant/AEM-5750-2022; Marconi, Vincent/AFK-5812-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Clark, Robert/0000-0002-4892-3619; Agan, Brian/0000-0002-5114-1669; McArthur, Carole/0000-0002-9286-8362	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System; MERIT [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine; HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System(US Department of Veterans Affairs); MERIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine; HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) and other awards (AI043279 and MH069270) from the NIH to S.K.A. S.K.A. is also supported by a VA MERIT award and is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the DoD HIV Natural History Study cohort and staff involved in this work was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting the views of the Departments of the Army, Navy, Air Force, or the Department of Defense.	Abu-Raddad LJ, 2007, JAIDS-J ACQ IMM DEF, V45, P454, DOI 10.1097/QAI.0b013e3180959a94; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; An P, 2000, AIDS, V14, P2117, DOI 10.1097/00002030-200009290-00007; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Andre FE, 2003, VACCINE, V21, P593, DOI 10.1016/S0264-410X(02)00702-8; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Aquaro S, 2001, J VIROL, V75, P4402, DOI 10.1128/JVI.75.9.4402-4406.2001; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blower S., 2003, AIDS Reviews, V5, P113; Blower SM, 2001, P NATL ACAD SCI USA, V98, P3618, DOI 10.1073/pnas.061029998; Buve A, 2002, IUBMB LIFE, V53, P193, DOI 10.1080/15216540212641; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Garber DA, 2004, LANCET INFECT DIS, V4, P397, DOI 10.1016/S1473-3099(04)01056-4; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hendrickson SL, 2008, JAIDS-J ACQ IMM DEF, V48, P263, DOI 10.1097/QAI.0b013e31816fdc5f; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Hutcheson HB, 2008, VACCINE, V26, P2951, DOI 10.1016/j.vaccine.2007.12.054; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; KINOSHITAMOLEKA R, 2007, LOW PREVALENCE HIV O, P1; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kulkarni H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003165; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; LUO M, 2007, CAHR C; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Mokili J, 2005, J NEUROVIROL, V11, P66, DOI 10.1080/13550280590923008; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; Mulanga C, 2004, AIDS, V18, P832, DOI 10.1097/00002030-200403260-00024; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; Ndembi N, 2003, AIDS RES HUM RETROV, V19, P435, DOI 10.1089/088922203765551773; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; *NIH, 2001, AIDS VACC TRIALS CON; Nolan D, 2004, AIDS, V18, P1231, DOI 10.1097/00002030-200406180-00001; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Pepin J, 2005, TROP MED INT HEALTH, V10, P627, DOI 10.1111/j.1365-3156.2005.01441.x; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rutjens E, 2003, FRONT BIOSCI-LANDMRK, V8, pD1134, DOI 10.2741/1125; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; SADAM M, 2008, CCL361 VAR GEN COP N; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Shalekoff S, 2008, JAIDS-J ACQ IMM DEF, V48, P245, DOI 10.1097/QAI.0b013e31816fdc77; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Struyf S, 2001, EUR J IMMUNOL, V31, P2170, DOI 10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D; Sullivan AD, 2001, P NATL ACAD SCI USA, V98, P10214, DOI 10.1073/pnas.181325198; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Valdez H, 1999, JAMA-J AM MED ASSOC, V282, P734, DOI 10.1001/jama.282.8.734; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927; Xin XM, 1999, FEBS LETT, V457, P219, DOI 10.1016/S0014-5793(99)01035-2; Zekeng L, 2001, PHILOS T ROY SOC B, V356, P799, DOI 10.1098/rstb.2001.0858; Zimet GD, 2000, INT J STD AIDS, V11, P143, DOI 10.1258/0956462001915570; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	96	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3671	10.1371/journal.pone.0003671	http://dx.doi.org/10.1371/journal.pone.0003671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989363	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134600007
J	Saba, R; Goodman, CD; Huzarewich, RLCH; Robertson, C; Booth, SA				Saba, Reuben; Goodman, Chelsey D.; Huzarewich, Rhiannon L. C. H.; Robertson, Catherine; Booth, Stephanie A.			A miRNA Signature of Prion Induced Neurodegeneration	PLOS ONE			English	Article								MicroRNAs (miRNAs) are small, non-coding RNA molecules which are emerging as key regulators of numerous cellular processes. Compelling evidence links miRNAs to the control of neuronal development and differentiation, however, little is known about their role in neurodegeneration. We used microarrays and RT-PCR to profile miRNA expression changes in the brains of mice infected with mouse-adapted scrapie. We determined 15 miRNAs were de-regulated during the disease processes; miR-342-3p, miR-320, let-7b, miR-328, miR-128, miR-139-5p and miR-146a were over 2.5 fold up-regulated and miR-338-3p and miR-337-3p over 2.5 fold down-regulated. Only one of these miRNAs, miR-128, has previously been shown to be de-regulated in neurodegenerative disease. De-regulation of a unique subset of miRNAs suggests a conserved, disease-specific pattern of differentially expressed miRNAs is associated with prion-induced neurodegeneration. Computational analysis predicted numerous potential gene targets of these miRNAs, including 119 genes previously determined to be also de-regulated in mouse scrapie. We used a co-ordinated approach to integrate miRNA and mRNA profiling, bioinformatic predictions and biochemical validation to determine miRNA regulated processes and genes potentially involved in disease progression. In particular, a correlation between miRNA expression and putative gene targets involved in intracellular protein-degradation pathways and signaling pathways related to cell death, synapse function and neurogenesis was identified.	[Saba, Reuben; Goodman, Chelsey D.; Huzarewich, Rhiannon L. C. H.; Robertson, Catherine; Booth, Stephanie A.] Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada; [Saba, Reuben; Booth, Stephanie A.] Univ Manitoba, Fac Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3T 2N2, Canada	Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Manitoba	Saba, R (corresponding author), Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada.	Stephanie_Booth@phac-aspc.gc.ca	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	PHAC; Canadian Biotechnology Strategy Fund	PHAC; Canadian Biotechnology Strategy Fund	PHAC. Canadian Biotechnology Strategy Fund: Genomics Initiative for Government Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; DOHURA K, 1995, MICROB PATHOGENESIS, V18, P1, DOI 10.1016/S0882-4010(05)80008-7; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Greenwood AD, 2005, J MOL BIOL, V349, P487, DOI 10.1016/j.jmb.2005.03.076; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HELLWEG R, 1994, LIFE SCI, V55, P2165, DOI 10.1016/0024-3205(94)00397-1; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; JEFFREY M, 1995, NEUROPATH APPL NEURO, V21, P41, DOI 10.1111/j.1365-2990.1995.tb01027.x; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KITAMOTO T, 1992, AM J PATHOL, V141, P271; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Martinez T, 2007, EUR J NEUROSCI, V26, P51, DOI 10.1111/j.1460-9568.2007.05646.x; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Saba Reuben, 2006, BMC Biotechnol, V6, P47, DOI 10.1186/1472-6750-6-47; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	57	198	203	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3652	10.1371/journal.pone.0003652	http://dx.doi.org/10.1371/journal.pone.0003652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987751	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134500002
J	Dyck, M; Winbeck, M; Leiberg, S; Chen, Y; Gur, RC; Mathiak, K				Dyck, Miriam; Winbeck, Maren; Leiberg, Susanne; Chen, Yuhan; Gur, Rurben C.; Mathiak, Klaus			Recognition Profile of Emotions in Natural and Virtual Faces	PLOS ONE			English	Article							DYNAMIC FACIAL EXPRESSIONS; ADULT LIFE-SPAN; BASIC EMOTIONS; REALITY; ENVIRONMENTS; FMRI; SCHIZOPHRENIA; ACTIVATION; BEHAVIOR; THERAPY	Background: Computer-generated virtual faces become increasingly realistic including the simulation of emotional expressions. These faces can be used as well-controlled, realistic and dynamic stimuli in emotion research. However, the validity of virtual facial expressions in comparison to natural emotion displays still needs to be shown for the different emotions and different age groups. Methodology/Principal Findings: Thirty-two healthy volunteers between the age of 20 and 60 rated pictures of natural human faces and faces of virtual characters (avatars) with respect to the expressed emotions: happiness, sadness, anger, fear, disgust, and neutral. Results indicate that virtual emotions were recognized comparable to natural ones. Recognition differences in virtual and natural faces depended on specific emotions: whereas disgust was difficult to convey with the current avatar technology, virtual sadness and fear achieved better recognition results than natural faces. Furthermore, emotion recognition rates decreased for virtual but not natural faces in participants over the age of 40. This specific age effect suggests that media exposure has an influence on emotion recognition. Conclusions/Significance: Virtual and natural facial displays of emotion may be equally effective. Improved technology ( e. g. better modelling of the naso-labial area) may lead to even better results as compared to trained actors. Due to the ease with which virtual human faces can be animated and manipulated, validated artificial emotional expressions will be of major relevance in future research and therapeutic applications.	[Dyck, Miriam; Winbeck, Maren; Chen, Yuhan; Mathiak, Klaus] Rhein Westfal TH Aachen, Dept Psychiat, Aachen, Germany; [Leiberg, Susanne] Univ Zurich, Ctr Social Neurosci & Neuroeconom, CH-8006 Zurich, Switzerland; [Dyck, Miriam; Gur, Rurben C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Mathiak, Klaus] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	RWTH Aachen University; University of Zurich; University of Pennsylvania; University of London; King's College London	Dyck, M (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat, Aachen, Germany.	mdyck@ukaachen.de		Leiberg, Susanne/0000-0001-9427-7614	German Research Foundation [IRTG 1328]; EU STREP FUGA; AstraZeneca foundation	German Research Foundation(German Research Foundation (DFG)); EU STREP FUGA; AstraZeneca foundation(AstraZeneca)	This work was supported by the German Research Foundation (DFG, IRTG 1328) and EU STREP FUGA (FP6). K. Mathiak is supported by an AstraZeneca foundation.	Anderson PL, 2005, DEPRESS ANXIETY, V22, P156, DOI 10.1002/da.20090; Anderson R.E, 2002, CHANGING ADOLESCENT, P175; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5; da Costa RMEM, 2004, COMPUT METH PROG BIO, V73, P173, DOI 10.1016/S0169-2607(03)00066-X; Deutsch JE, 2007, TOP STROKE REHABIL, V14, P45, DOI 10.1310/tsr1406-45; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2002, FACIAL ACTION CODING; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Ku J, 2005, CYBERPSYCHOL BEHAV, V8, P493, DOI 10.1089/cpb.2005.8.493; Ku J, 2003, CYBERPSYCHOL BEHAV, V6, P397, DOI 10.1089/109493103322278781; Kunzmann U, 2005, PSYCHOL AGING, V20, P47, DOI 10.1037/0882-7974.20.1.47; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Loughead J, 2008, BRAIN RES, V1194, P37, DOI 10.1016/j.brainres.2007.10.105; Mathiak K, 2006, HUM BRAIN MAPP, V27, P948, DOI 10.1002/hbm.20234; Merz J, 1975, Psychiatr Neurol Med Psychol (Leipz), V27, P423; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; MORENO C, 1993, DEV NEUROPSYCHOL, V9, P305, DOI 10.1080/87565649309540559; Moser E, 2007, J NEUROSCI METH, V161, P126, DOI 10.1016/j.jneumeth.2006.10.016; Nowak KL, 2003, PRESENCE-TELEOP VIRT, V12, P481, DOI 10.1162/105474603322761289; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; PIAZZA M, 2008, 12 C NAZ SOC IT PSIC; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2007, EPILEPSY BEHAV, V11, P316, DOI 10.1016/j.yebeh.2007.06.006; Smith J, 1997, PSYCHOL AGING, V12, P458, DOI 10.1037/0882-7974.12.3.458; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Spencer-Smith J, 2001, BEHAV RES METH INS C, V33, P115, DOI 10.3758/BF03195356; Sullivan S, 2004, INT J NEUROSCI, V114, P403, DOI 10.1080/00207450490270901; Tapscott D., 1998, GROWING DIGITAL RISE; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wittchen H-U., 1997, STRUCTURED CLIN INTE	42	81	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3628	10.1371/journal.pone.0003628	http://dx.doi.org/10.1371/journal.pone.0003628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LK	18985152	gold, Green Published			2022-12-27	WOS:000265134400006
J	Serrano, MA; De Los Rios, P				Serrano, M. Angeles; De Los Rios, Paolo			Structural Efficiency of Percolated Landscapes in Flow Networks	PLOS ONE			English	Article								The large-scale structure of complex systems is intimately related to their functionality and evolution. In particular, global transport processes in flow networks rely on the presence of directed pathways from input to output nodes and edges, which organize in macroscopic connected components. However, the precise relation between such structures and functional or evolutionary aspects remains to be understood. Here, we investigate which are the constraints that the global structure of directed networks imposes on transport phenomena. We define quantitatively under minimal assumptions the structural efficiency of networks to determine how robust communication between the core and the peripheral components through interface edges could be. Furthermore, we assess that optimal topologies in terms of access to the core should look like "hairy balls'' so to minimize bottleneck effects and the sensitivity to failures. We illustrate our investigation with the analysis of three real networks with very different purposes and shaped by very different dynamics and time scales-the Internet customer provider set of relationships, the nervous system of the worm Caenorhabditis elegans, and the metabolism of the bacterium Escherichia coli. Our findings prove that different global connectivity structures result in different levels of structural efficiency. In particular, biological networks seem to be close to the optimal layout.	[Serrano, M. Angeles] CSIC UIB, IFISC, Palma de Mallorca, Spain; [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, SB, LBS, Inst Theoret Phys, Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Serrano, MA (corresponding author), CSIC UIB, IFISC, Campus Univ Illes Balears, Palma de Mallorca, Spain.	marian.serrano@ifisc.uib-csic.es	Serrano, M. Ángeles/AAS-8246-2020; De Los Rios, Paolo/B-2456-2010; EPFL, LBS/B-3567-2010; Serrano, M. Angeles/A-4198-2013	De Los Rios, Paolo/0000-0002-5394-5062; Serrano, M. Angeles/0000-0001-8779-5931	DELIS [001907]; SER-Bern [02.0234]	DELIS; SER-Bern	This work has been financially supported by DELIS under contract FET Open 001907 and the SER-Bern under contract 02.0234.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Boguna M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016106; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; *CAIDA, REL DAT RES PROJ; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dimitropoulos X, 2007, ACM SIGCOMM COMP COM, V37, P31, DOI 10.1145/1198255.1198259; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066110; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRONCZAK P, 2006, SOC NETWORKS, V73; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Guimera R, 2007, BIOINFORMATICS, V23, P1616, DOI 10.1093/bioinformatics/btm150; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Marsili M, 2004, P NATL ACAD SCI USA, V101, P1439, DOI 10.1073/pnas.0305684101; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Serrano M. A., 2007, J ECON INTERACT COOR, V2, P111, DOI DOI 10.1007/S11403-007-0026-Y; Serrano MA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056121; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Vazquez F, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046120; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; *WORM, WORM DAT	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3654	10.1371/journal.pone.0003654	http://dx.doi.org/10.1371/journal.pone.0003654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985157	Green Submitted, gold, Green Published			2022-12-27	WOS:000265134400014
J	Wakuda, T; Matsuzaki, H; Suzuki, K; Iwata, Y; Shinmura, C; Suda, S; Iwata, K; Yamamoto, S; Sugihara, G; Tsuchiya, KJ; Ueki, T; Nakamura, K; Nakahara, D; Takei, N; Mori, N				Wakuda, Tomoyasu; Matsuzaki, Hideo; Suzuki, Katsuaki; Iwata, Yasuhide; Shinmura, Chie; Suda, Shiro; Iwata, Keiko; Yamamoto, Shigeyuki; Sugihara, Genichi; Tsuchiya, Kenji J.; Ueki, Takatoshi; Nakamura, Kazuhiko; Nakahara, Daiichiro; Takei, Nori; Mori, Norio			Perinatal Asphyxia Reduces Dentate Granule Cells and Exacerbates Methamphetamine-Induced Hyperlocomotion in Adulthood	PLOS ONE			English	Article								Background: Obstetric complications have been regarded as a risk factor for schizophrenia later in life. One of the mechanisms underlying the association is postulated to be a hypoxic process in the brain in the offspring around the time of birth. Hippocampus is one of the brain regions implicated in the late-onset dopaminergic dysfunction associated with hypoxic obstetric complications. Methodology/Principal Findings: We used an animal model of perinatal asphyxia, in which rat pups were exposed to 15 min of intrauterine anoxia during Cesarean section birth. At 6 and 12 weeks after birth, the behavior of the pups was assessed using a methamphetamine-induced locomotion test. In addition, the histopathology of the hippocampus was examined by means of stereology. At 6 weeks, there was no change in the methamphetamine-induced locomotion. However, at 12 weeks of age, we found an elevation in methamphetamine-induced locomotor activity, which was associated with an increase of dopamine release in the nucleus accumbens. At the same age, we also found a reduction of the dentate granule cells of the hippocampus. Conclusions/Significance: These results suggest that the dopaminergic dysregulation after perinatal asphyxia is associated with a reduction in hippocampal dentate granule cells, and this may partly contribute to the pathogenesis of schizophrenia.	[Wakuda, Tomoyasu; Iwata, Yasuhide; Shinmura, Chie; Suda, Shiro; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Ueki, Takatoshi] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Shizuoka, Japan; [Nakahara, Daiichiro] Hamamatsu Univ Sch Med, Dept Psychol, Shizuoka, Japan; [Suzuki, Katsuaki; Iwata, Keiko; Yamamoto, Shigeyuki; Sugihara, Genichi; Tsuchiya, Kenji J.; Takei, Nori] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Shizuoka, Japan; [Matsuzaki, Hideo] Osaka Univ, Grad Sch Med, Res Ctr Child Mental Dev, Suita, Osaka 565, Japan; [Takei, Nori] Inst Psychiat, London, England	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; University of London; King's College London	Wakuda, T (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan.	k-suzuki@hama-med.ac.jp	MATSUZAKI, HIDEO/AAE-5246-2020; Tsuchiya, Kenji J./I-9123-2019; Takei, Nori/GWZ-7464-2022; Takei, Nori/AAC-8578-2019	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tsuchiya, Kenji J./0000-0002-1314-4199; Suzuki, Katsuaki/0000-0003-0446-3355; Wakuda, Tomoyasu/0000-0002-1924-8167	Japan Society for the Promotion of Science [15209036]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding for this study was provided by a Grant-in-Aid for Scientific Research (#15209036; to N.M.) from the Japan Society for the Promotion of Science. This funding played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	BJELKE B, 1991, BRAIN RES, V543, P1, DOI 10.1016/0006-8993(91)91041-X; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; CANNON TD, 2008, BIOL PSYCHIAT, DOI DOI 10.1016/J.BIOP-SYCH.2008.04.012; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; Dalman C, 1999, ARCH GEN PSYCHIAT, V56, P234, DOI 10.1001/archpsyc.56.3.234; DEFRANCE JF, 1980, BRAIN RES, V185, P183, DOI 10.1016/0006-8993(80)90681-2; DellAnna E, 1997, EXP BRAIN RES, V115, P105, DOI 10.1007/PL00005670; El-Khodor BF, 1998, NEUROSCIENCE, V87, P893, DOI 10.1016/S0306-4522(98)00194-8; Geddes JR, 1999, SCHIZOPHRENIA BULL, V25, P413, DOI 10.1093/oxfordjournals.schbul.a033389; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; IMPERATO A, 1990, BRAIN RES, V530, P223, DOI 10.1016/0006-8993(90)91286-P; Juarez I, 2003, BRAIN RES, V992, P281, DOI 10.1016/j.brainres.2003.08.060; Kohlhauser C, 1999, LIFE SCI, V64, P2109, DOI 10.1016/S0024-3205(99)00160-5; LIPSKA BK, 1992, BRAIN RES, V585, P1, DOI 10.1016/0006-8993(92)91184-G; Matsuzaki H, 2007, EUR J NEUROSCI, V25, P3376, DOI 10.1111/j.1460-9568.2007.05564.x; McNeil TF, 2000, AM J PSYCHIAT, V157, P203, DOI 10.1176/appi.ajp.157.2.203; MITTLEMAN G, 1993, BEHAV BRAIN RES, V55, P253, DOI 10.1016/0166-4328(93)90121-6; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Schaub CL, 1997, BEHAV BRAIN RES, V84, P129, DOI 10.1016/S0166-4328(96)00142-8; Schulze K, 2003, BIOL PSYCHIAT, V53, P562, DOI 10.1016/S0006-3223(02)01910-8; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; SHIMIZU N, 1990, BRAIN RES BULL, V25, P99, DOI 10.1016/0361-9230(90)90258-2; Tani K, 2001, BRIT J PHARMACOL, V134, P1411, DOI 10.1038/sj.bjp.0704370; Vaillancourt C, 2000, NEUROPSYCHOPHARMACOL, V23, P654, DOI 10.1016/S0893-133X(00)00164-0; Vaillancourt C, 1998, NEUROREPORT, V9, P2953, DOI 10.1097/00001756-199809140-00007; Vaillancourt C, 1999, EXP NEUROL, V160, P142, DOI 10.1006/exnr.1999.7201; WHISHAW IQ, 1991, BEHAV NEURAL BIOL, V55, P289, DOI 10.1016/0163-1047(91)90633-2; WILKINSON LS, 1993, BEHAV BRAIN RES, V55, P143, DOI 10.1016/0166-4328(93)90110-C; Zornberg GL, 2000, AM J PSYCHIAT, V157, P196, DOI 10.1176/appi.ajp.157.2.196	29	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3648	10.1371/journal.pone.0003648	http://dx.doi.org/10.1371/journal.pone.0003648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985150	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134400011
J	Barnighausen, T; Wallrauch, C; Welte, A; McWalter, TA; Mbizana, N; Viljoen, J; Graham, N; Tanser, F; Puren, A; Newell, ML				Barnighausen, Till; Wallrauch, Claudia; Welte, Alex; McWalter, Thomas A.; Mbizana, Nhlanhla; Viljoen, Johannes; Graham, Natalie; Tanser, Frank; Puren, Adrian; Newell, Marie-Louise			HIV Incidence in Rural South Africa: Comparison of Estimates from Longitudinal Surveillance and Cross-Sectional cBED Assay Testing	PLOS ONE			English	Article								Background: The BED IgG-Capture Enzyme Immunoassay (cBED assay), a test of recent HIV infection, has been used to estimate HIV incidence in cross-sectional HIV surveys. However, there has been concern that the assay overestimates HIV incidence to an unknown extent because it falsely classifies some individuals with non-recent HIV infections as recently infected. We used data from a longitudinal HIV surveillance in rural South Africa to measure the fraction of people with non-recent HIV infection who are falsely classified as recently HIV-infected by the cBED assay (the long-term false-positive ratio (FPR)) and compared cBED assay-based HIV incidence estimates to longitudinally measured HIV incidence. Methodology/Principal Findings: We measured the long-term FPR in individuals with two positive HIV tests (in the HIV surveillance, 2003-2006) more than 306 days apart (sample size n = 1,065). We implemented four different formulae to calculate HIV incidence using cBED assay testing (n = 11,755) and obtained confidence intervals (CIs) by directly calculating the central 95(th) percentile of incidence values. We observed 4,869 individuals over 7,685 person-years for longitudinal HIV incidence estimation. The long-term FPR was 0.0169 (95% CI 0.0100-0.0266). Using this FPR, the cross-sectional cBED-based HIV incidence estimates (per 100 people per year) varied between 3.03 (95% CI 2.44-3.63) and 3.19 ( 95% CI 2.57-3.82), depending on the incidence formula. Using a long-term FPR of 0.0560 based on previous studies, HIV incidence estimates varied between 0.65 (95% CI 0.00-1.32) and 0.71 (95% CI 0.00-1.43). The longitudinally measured HIV incidence was 3.09 per 100 people per year (95% CI 2.69-3.52), after adjustment to the sex-age distribution of the sample used in cBED assay-based estimation. Conclusions/Significance: In a rural community in South Africa with high HIV prevalence, the long-term FPR of the cBED assay is substantially lower than previous estimates. The cBED assay performs well in HIV incidence estimation if the locally measured long-term FPR is used, but significantly underestimates incidence when a FPR estimate based on previous studies in other settings is used.	[Barnighausen, Till; Wallrauch, Claudia; Mbizana, Nhlanhla; Viljoen, Johannes; Graham, Natalie; Tanser, Frank; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Welte, Alex; McWalter, Thomas A.] Univ Witwatersrand, Sch Computat & Appl Math, ZA-2050 Wits, South Africa; [Welte, Alex] Univ Stellenbosch, DST NRF, SACEMA, ZA-7600 Stellenbosch, South Africa; [Puren, Adrian] Natl Inst Communicable Dis, Johannesburg, South Africa; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1E 6BT, England	University of Kwazulu Natal; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; National Institute for Communicable Diseases (NICD); University of London; University College London	Barnighausen, T (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	tbarnighausen@africacentre.ac.za	Tanser, Frank/ABE-8326-2021; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019; Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Newell, Marie-Louise/0000-0002-1074-7699; Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Tanser, Frank/0000-0001-9797-0000; McWalter, Thomas/0000-0002-2163-4112	Wellcome Trust [GR065377/Z/01/B, GR065377/Z/01/H]; Centers for Disease Control and Prevention (CDC) [5U62PS022901]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS022901] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by grants from the Wellcome Trust through grants to the Africa Centre for Health and Population Studies, University of KwaZulu-Natal, South Africa (GR065377/Z/01/B), and the Africa Centre's Demographic Surveillance Information System (GR065377/Z/01/H), which funds the population-based HIV surveillance. In addition, this publication was supported by Cooperative Agreement Number 5U62PS022901 from Centers for Disease Control and Prevention (CDC). Till Barnighausen and Frank Tanser were supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the any of the funding organizations. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript.	ANDERSON RN, 1998, NATL VITAL STAT REP, V47, P20; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; *CDC, 2007, US BED HIV 1 CAPT EI; Celentano DD, 2000, ARCH INTERN MED, V160, P535, DOI 10.1001/archinte.160.4.535; *DHS, 2008, ALL SURV COUNTR; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Gupta SB, 2007, AIDS RES HUM RETROV, V23, P1475, DOI 10.1089/aid.2006.0240; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; HERBST K, 2008, ADULT MORTALIT UNPUB; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Loschen S, 2008, J CLIN MICROBIOL, V46, P341, DOI 10.1128/JCM.01055-07; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; MCWALTER TA, 2008, RELATING RECENT INFE; MCWALTER TA, 2008, ESTIMATION PROPORTIO; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Nesheim S, 2005, AIDS RES HUM RETROV, V21, P537, DOI 10.1089/aid.2005.21.537; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; SHISANA O, 2005, S AFRICAN NATL HIV P; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; UNAIDS Reference Group for Estimates MaP, 2005, STAT US BED ASS EST; WELTE A, 2008, AIDS RES HU IN PRESS; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840; Wolday D, 2007, J INTERN MED, V261, P132, DOI 10.1111/j.1365-2796.2006.01740.x; World Health Organisation, 2007, WHO CAS DEF HIV SURV	39	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3640	10.1371/journal.pone.0003640	http://dx.doi.org/10.1371/journal.pone.0003640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982059	Green Published, gold			2022-12-27	WOS:000265134300010
J	Teichmann, MDH; Wegner, FV; Fink, RHA; Chamberlain, JS; Launikonis, BS; Martinac, B; Friedrich, O				Teichmann, Martin D. H.; Wegner, Frederic V.; Fink, Rainer H. A.; Chamberlain, Jeffrey S.; Launikonis, Bradley S.; Martinac, Boris; Friedrich, Oliver			Inhibitory Control Over Ca2+ Sparks via Mechanosensitive Channels Is Disrupted in Dystrophin Deficient Muscle but Restored by Mini-Dystrophin Expression	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSVERSE TUBULAR SYSTEM; SKELETAL-MUSCLE; MDX MOUSE; CALCIUM INFLUX; GENE-THERAPY; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTORS; ANIMAL-MODELS; IN-SITU	Background: In dystrophic skeletal muscle, osmotic stimuli somehow relieve inhibitory control of dihydropyridine receptors (DHPR) on spontaneous sarcoplasmic reticulum elementary Ca2+ release events (ECRE) in high Ca2+ external environments. Such 'uncontrolled' Ca2+ sparks were suggested to act as dystrophic signals. They may be related to mechanosensitive pathways but the mechanisms are elusive. Also, it is not known whether truncated dystrophins can correct the dystrophic disinhibition. Methodology/Principal Findings: We recorded ECRE activity in single intact fibers from adult wt, mdx and mini-dystrophin expressing mice (MinD) under resting isotonic conditions and following hyper-/hypo-osmolar external shock using confocal microscopy and imaging techniques. Isotonic ECRE frequencies were small in wt and MinD fibers, but were markedly increased in mdx fibers. Osmotic challenge dramatically increased ECRE activity in mdx fibers. Sustained osmotic challenge induced marked exponential ECRE activity adaptation that was three times faster in mdx compared to wt and MinD fibers. Rising external Ca2+ concentrations amplified osmotic ECRE responses. The eliminated ECRE suppression in intact osmotically stressed mdx fibers was completely and reversibly resuscitated by streptomycine (200 mu M), spider peptide GsMTx-4 (5 mu M) and Gd3+ (20 mu M) that block unspecific, specific cationic and Ca2+ selective mechanosensitive channels (MsC), respectively. ECRE morphology was not substantially altered by membrane stress. During hyperosmotic challenge, membrane potentials were polarised and a putative depolarisation through aberrant MsC negligible excluding direct activation of ECRE through tubular depolarisation. Conclusions/Significance: Dystrophin suppresses spontaneous ECRE activity by control of mechanosensitive pathways which are suggested to interact with the inhibitory DHPR loop to the ryanodine receptor. MsC-related disinhibition prevails in dystrophic muscle and can be resuscitated by transgenic mini-dystrophin expression. Our results have important implications for the pathophysiology of DMD where abnormal MsC in dystrophic muscle confer disruption of microdomain Ca2+ homeostasis. MsC blockers should have considerable therapeutic potential if more muscle specific compounds can be found.	[Teichmann, Martin D. H.; Wegner, Frederic V.; Fink, Rainer H. A.; Friedrich, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany; [Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Launikonis, Bradley S.; Martinac, Boris; Friedrich, Oliver] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4067, Australia	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; University of Queensland	Teichmann, MDH (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Bergheimer Str 58, Heidelberg, Germany.	oliver.friedrich@physiologie.uni-heidelberg.de	Launikonis, Bradley/K-6256-2015; Martinac, Boris/A-7178-2018	Launikonis, Bradley/0000-0003-0700-4867; Martinac, Boris/0000-0001-8422-7082; Friedrich, Oliver/0000-0003-2238-2049; von Wegner, Frederic/0000-0002-6779-9959; Chamberlain, Jeffrey/0000-0001-5299-0059	Australian Research Council International Linkage Fellowship [LX0882427]; German National Merit Foundation	Australian Research Council International Linkage Fellowship(Australian Research Council); German National Merit Foundation	This study was partly supported by an Australian Research Council International Linkage Fellowship (LX0882427) to O.F. and a scholarship of the German National Merit Foundation to M.D.H.T. This study is part of a doctorate thesis (Dr.med.) of M.D.H.T.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Carlson CG, 2005, NEUROBIOL DIS, V20, P719, DOI 10.1016/j.nbd.2005.05.003; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2001, BRIT J PHARMACOL, V132, P1047, DOI 10.1038/sj.bjp.0703907; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; DiFranco M, 2005, J MEMBRANE BIOL, V208, P141, DOI 10.1007/s00232-005-0825-9; FINK RHA, 1990, J PHYSIOL-LONDON, V420, P337, DOI 10.1113/jphysiol.1990.sp017916; FRANCO A, 1991, BIOPHYS J, V59, P1164, DOI 10.1016/S0006-3495(91)82332-3; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; Fraser JA, 2006, J MUSCLE RES CELL M, V27, P591, DOI 10.1007/s10974-006-9091-4; Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002; Friedrich O, 2002, J MEMBRANE BIOL, V188, P11, DOI 10.1007/s00232-001-0168-0; FRIEDRICH O, 2004, J PHYSL, P251; Friedrich O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001762; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Haarmann CS, 2005, BIOCHEM J, V387, P429, DOI 10.1042/BJ20040786; Han RZ, 2006, CELL CALCIUM, V40, P299, DOI 10.1016/j.ceca.2006.04.016; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HUTTER OF, 1992, J INHERIT METAB DIS, V15, P565, DOI 10.1007/BF01799615; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Imbert N, 1996, NEUROMUSCULAR DISORD, V6, P351, DOI 10.1016/0960-8966(96)00351-3; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Khammari A, 1998, CAN J PHYSIOL PHARM, V76, P1161, DOI 10.1139/cjpp-76-12-1161; KIRSCH WG, 2001, J PHYSL, P379; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; LAMB GD, 1993, J PHYSIOL-LONDON, V464, P629, DOI 10.1113/jphysiol.1993.sp019655; Lansman JB, 2006, CLIN EXP PHARMACOL P, V33, P649, DOI 10.1111/j.1440-1681.2006.04393.x; Launikonis BS, 2000, J PHYSIOL-LONDON, V526, P299, DOI 10.1111/j.1469-7793.2000.00299.x; Launikonis BS, 2002, J PHYSIOL-LONDON, V538, P607, DOI 10.1113/jphysiol.2001.012920; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Maier F, 1999, MUSCLE NERVE, V22, P578, DOI 10.1002/(SICI)1097-4598(199905)22:5<578::AID-MUS5>3.3.CO;2-K; Mallouk N, 2002, BIOPHYS J, V82, P3012, DOI 10.1016/S0006-3495(02)75642-7; Marchand E, 2004, EXP CELL RES, V297, P363, DOI 10.1016/j.yexcr.2004.02.032; Marini J F, 1991, Neuromuscul Disord, V1, P397, DOI 10.1016/0960-8966(91)90003-B; Martin CA, 2003, J MUSCLE RES CELL M, V24, P407, DOI 10.1023/A:1027356410698; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Plant DR, 2003, AM J PHYSIOL-CELL PH, V285, pC522, DOI 10.1152/ajpcell.00369.2002; Sieber MA, 2008, J MAGN RESON IMAGING, V27, P955, DOI 10.1002/jmri.21368; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Von Wegner F, 2006, BIOPHYS J, V90, P2151, DOI 10.1529/biophysj.105.069930; Von Wegner F, 2007, IEEE T MED IMAGING, V26, P925, DOI 10.1109/TMI.2007.895471; Wang SQ, 2004, CIRC RES, V94, P1011, DOI 10.1161/01.RES.0000125883.68447.A1; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Whitehead NP, 2006, NEUROMUSCULAR DISORD, V16, P845, DOI 10.1016/j.nmd.2006.07.024; Woods CE, 2005, J PHYSIOL-LONDON, V568, P867, DOI 10.1113/jphysiol.2005.089318; WOODS CE, 2004, J PHYSL, P59; Yeung EW, 2003, J PHYSIOL-LONDON, V552, P449, DOI 10.1113/jphysiol.2003.047373; YEUNG EW, 2005, J PHYSL, P367; Zhou JS, 2006, AM J PHYSIOL-CELL PH, V290, pC539, DOI 10.1152/ajpcell.00592.2004; Zhou JS, 2005, J GEN PHYSIOL, V126, P301, DOI 10.1085/jgp.200509353	87	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3644	10.1371/journal.pone.0003644	http://dx.doi.org/10.1371/journal.pone.0003644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982068	gold, Green Submitted, Green Published			2022-12-27	WOS:000265134300013
J	Raurell, I; Codina, M; Casagolda, D; del Valle, B; Baulida, J; de Herreros, AG; Dunach, M				Raurell, Imma; Codina, Montserrat; Casagolda, David; del Valle, Beatriz; Baulida, Josep; Garcia de Herreros, Antonio; Dunach, Mireia			Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on beta-Catenin.Tcf-4 Transcriptional Activity	PLOS ONE			English	Article								Presenilin1 (PS1) is a component of the gamma-secretase complex mutated in cases of Familial Alzheimer's disease (FAD). PS1 is synthesized as a 50 kDa peptide subsequently processed to two 29 and 20 kDa subunits that remain associated. Processing of PS1 is inhibited by several mutations detected in FAD patients. PS1 acts as negative modulator of beta-catenin.Tcf-4 transcriptional activity. In this article we show that in murine embryonic fibroblasts (MEFs) the mechanisms of action of the processed and non-processed forms of PS1 on beta-catenin.Tcf-4 transcription are different. Whereas non-processed PS1 inhibits beta-catenin.Tcf-4 activity through a mechanism independent of gamma-secretase and associated with the interaction of this protein with plakoglobin and Tcf-4, the effect of processed PS1 is prevented by gamma-secretase inhibitors, and requires its interaction with E-or N-cadherin and the generation of cytosolic terminal fragments of these two cadherins, which in turn destabilize the beta-catenin transcriptional cofactor CBP. Accordingly, the two forms of PS1 interact differently with E-cadherin or beta-catenin and plakoglobin: whereas processed PS1 binds E-cadherin with high affinity and beta-catenin or plakoglobin weakly, the non-processed form behaves inversely. Moreover, contrarily to processed PS1, that decreases the levels of c-fos RNA, non-processed PS1 inhibits the expression c-myc, a known target of beta-catenin.Tcf-4, and does not block the activity of other transcriptional factors requiring CBP. These results indicate that prevention of PS1 processing in FAD affects the mechanism of repression of the transcriptional activity dependent on beta-catenin.	[Raurell, Imma; Codina, Montserrat; Casagolda, David; del Valle, Beatriz; Dunach, Mireia] Univ Autonoma Barcelona, Unitat Biofis CEB, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Codina, Montserrat; Baulida, Josep; Garcia de Herreros, Antonio] IMIM Hosp Mar, Programa Recerca Canc, Barcelona, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Raurell, I (corresponding author), Univ Autonoma Barcelona, Unitat Biofis CEB, Dept Bioquim & Biol Mol, Bellaterra, Spain.	agarcia@imim.es; mireia.dunach@uab.es	Dunach, Mireia/E-3604-2015; de Herreros, A Garcia/H-3104-2014	Dunach, Mireia/0000-0001-9844-5603; de Herreros, A Garcia/0000-0001-5270-0808; Codina, Montserrat/0000-0001-5591-8095	Spanish Ministerio de Educacion y Ciencia [BFU2006-03203, SAF2006-00339, predoctoral fellowships]; Instituto Carlos III [RD06/0020/0040, predoctoral fellowships, postdoctoral fellowship]; Generalitat de Catalunya [2005SGR00970]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants BFU2006-03203 and SAF2006-00339 awarded by the Spanish Ministerio de Educacion y Ciencia to M.D. and A.G.H, repectively. Partial support from Instituto Carlos III (RD06/0020/0040) and the Generalitat de Catalunya (2005SGR00970) is also appreciated. I.R. and D.C. were recipients of predoctoral fellowships from the Instituto Carlos III and from the Ministerio de Educacion y Ciencia, respectively. M.C. was recipient of a postdoctoral fellowship from the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chan HM, 2001, J CELL SCI, V114, P2363; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Cox RT, 2000, GENETICS, V155, P1725; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goodman RH, 2000, GENE DEV, V14, P1553; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herrick C. J., 1899, ARCH NEUROLOGY PSYCH, V2, P1; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Lalonde R, 2005, BEHAV BRAIN RES, V162, P182, DOI 10.1016/j.bbr.2005.02.037; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Noll E, 2000, DEV BIOL, V227, P450, DOI 10.1006/dbio.2000.9925; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Polakis P, 2000, GENE DEV, V14, P1837; Prager K, 2007, J BIOL CHEM, V282, P14083, DOI 10.1074/jbc.M608437200; Raurell I, 2006, J BIOL CHEM, V281, P1401, DOI 10.1074/jbc.M508153200; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Soria Miguel F., 2001, Monografias del Museo Argentino de Ciencias Naturales, V1, P1; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Uemura K, 2007, NEUROSCIENCE, V145, P5, DOI 10.1016/j.neuroscience.2006.12.022; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	62	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4080	10.1371/journal.pone.0004080	http://dx.doi.org/10.1371/journal.pone.0004080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114997	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466300018
J	Ahn, SM; Byun, K; Kim, D; Lee, K; Yoo, JS; Kim, SU; Jho, EH; Simpson, RJ; Lee, B				Ahn, Sung-Min; Byun, Kyunghee; Kim, Deokhoon; Lee, Kiyoung; Yoo, Jong Shin; Kim, Seung U.; Jho, Eek-hoon; Simpson, Richard J.; Lee, Bonghee			Olig2-Induced Neural Stem Cell Differentiation Involves Downregulation of Wnt Signaling and Induction of Dickkopf-1 Expression	PLOS ONE			English	Article								Understanding stem cell-differentiation at the molecular level is important for clinical applications of stem cells and for finding new therapeutic approaches in the context of cancer stem cells. To investigate genome-wide changes involved in differentiation, we have used immortalized neural stem cell (NSC) line (HB1.F3) and Olig2-induced NSC differentiation model (F3.Olig2). Using microarray analysis, we revealed that Olig2-induced NSC differentiation involves downregulation of Wnt pathway, which was further confirmed by TOPflash/FOPflash reporter assay, RT-PCR analysis, immunoblots, and immunocytochemistry. Furthermore, we found that Olig2-induced differentiation induces the expression of Dickkopf-1(Dkk1), a potent antagonist of Wnt signaling. Dkk1 treatment blocked Wnt signaling in HB1.F3 in a dosage-dependent manner, and induced differentiation into astrocytes, oligodendrocytes, and neurons. Our results support cancer stem cell hypothesis which implies that signaling pathway for self-renewal and proliferation of stem cells is maintained till the late stage of differentiation. In our proposed model, Dkk1 may play an important role in downregulating self-renewal and proliferation pathway of stem cells at the late stage of differentiation, and its failure may lead to carcinogenesis.	[Ahn, Sung-Min; Byun, Kyunghee; Kim, Deokhoon; Lee, Kiyoung; Lee, Bonghee] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea; [Yoo, Jong Shin] Korea Basic Sci Inst, Mass Spectrometry Anal Grp, Daejeon, South Korea; [Kim, Seung U.] Gachon Univ Med & Sci, Gachon Inst Regen Med, Inchon, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Jho, Eek-hoon] Univ Seoul, Dept Life Sci, Seoul, South Korea; [Simpson, Richard J.] Walter & Eliza Hall Inst Med Res, Ludwig Inst Canc Res, Joint Proteom Lab, Melbourne, Vic, Australia	Gachon University; Korea Basic Science Institute (KBSI); Gachon University; University of British Columbia; University of Seoul; Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute	Ahn, SM (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea.	sukim2005@gmail.com; Richard.simpson@ludwig.edu.au; bhlee@gachon.ac.kr	Simpson, Richard/A-6947-2012	Simpson, Richard/0000-0002-9834-0796; Ahn, Sung-Min/0000-0002-5031-1929; Jho, Eek-hoon/0000-0003-2414-6234	Korea Science and Engineering Foundation [2006-04090]; 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council [280912]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Korea Science and Engineering Foundation grant (#2006-04090, B.L.), 21ST frontier science program SC-2110 of Korea stem cell research center ( B.L.), and a National Health & Medical Research Council Program Grant (#280912, R.J.S).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Copray S, 2006, STEM CELLS, V24, P1001, DOI 10.1634/stemcells.2005-0239; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lee J, 2008, GYNECOL ONCOL, V109, P270, DOI 10.1016/j.ygyno.2008.01.034; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Sell S, 2006, TUMOR BIOL, V27, P59, DOI 10.1159/000092323; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	55	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3917	10.1371/journal.pone.0003917	http://dx.doi.org/10.1371/journal.pone.0003917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093005	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458600002
J	Wallach, MG; Ashash, U; Michael, A; Smith, NC				Wallach, Michael G.; Ashash, Udi; Michael, Amnon; Smith, Nicholas C.			Field Application of a Subunit Vaccine against an Enteric Protozoan Disease	PLOS ONE			English	Article								Background: Coccidiosis is a major global veterinary health problem in intensively reared chickens. It is caused by apicomplexan parasites of the genus Eimeria. Principal Findings: A subunit vaccine composed of purified antigens from the gametocytes of Eimeria maxima was used to stimulate the production and transfer of maternal antibodies between breeding hens and their hatchlings. The vaccine was injected into hens twice before they began laying eggs. Immunization had no adverse affects on egg laying or health of the hens and resulted in high antibody levels throughout the life of the hens. Progeny of immunized hens excreted significantly less oocysts of various species of Eimeria in their faeces than chicks from unvaccinated hens. Furthermore, the offspring of vaccinated hens developed stronger natural immunity to Eimeria, so that they were resistant to challenge infection even at 8 weeks of age, well after all maternal antibodies had left their circulation. Field trials were conducted in South Africa, Brazil and Thailand, involving at least 1 million progeny of vaccinated hens and at least 1 million positive control birds (raised on feed containing anticoccidial drugs or immunized with a live vaccine) in each country. Additionally, trials were carried out in Israel involving 60 million progeny of vaccinated hens and 112 million positive control birds. There were no significant differences in growth rate, feed conversion ratios or mortality in the offspring of vaccinated hens compared with the positive control chickens in any of these countries regardless of different management practices, different breeds of chickens or climate. Conclusions: These results demonstrate that a vaccine composed of antigens purified from the gametocytes of Eimeria can be used safely and effectively to prevent the deleterious effects of coccidiosis. It is the first subunit vaccine against any protozoan parasite to be successfully applied on a commercial scale.	[Wallach, Michael G.; Smith, Nicholas C.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Broadway, Australia; [Ashash, Udi; Michael, Amnon] ABIC Biol Lab Teva Ltd, Bet Shemesh, Israel	University of Technology Sydney; Teva Pharmaceutical Industries	Wallach, MG (corresponding author), Univ Technol Sydney, Inst Biotechnol Infect Dis, Broadway, Australia.	michael.wallach@uts.edu.au		Smith, Nicholas/0000-0002-7467-1451	ABIC Ltd, Israel; Australian Research Council [LP0454145]	ABIC Ltd, Israel; Australian Research Council(Australian Research Council)	This work received support from ABIC Ltd, Israel, and the Australian Research Council Linkage Grant Scheme (Project No. LP0454145). The trials described in this manuscript were performed by independent research groups or poultry farmers who collected and analysed the data by themselves. The decision to publish, interpretation of the data and preparation of the manuscript was carried out by Professor Michael Wallach and Associate Professor Nick Smith who had no role in funding the project.	Belli SI, 2006, TRENDS PARASITOL, V22, P416, DOI 10.1016/j.pt.2006.07.004; Belli SI, 2003, EUKARYOT CELL, V2, P456, DOI 10.1128/EC.2.3.456-464.2003; Ferguson DJP, 2003, INT J PARASITOL, V33, P1329, DOI 10.1016/S0020-7519(03)00185-1; Hafeez MA, 2006, PARASITOL RES, V98, P539, DOI 10.1007/s00436-005-0113-8; MCDONALD V, 1986, PARASITOLOGY, V93, P1, DOI 10.1017/S0031182000049775; ROSE ME, 1987, VET IMMUNOL IMMUNOP, V17, P333, DOI 10.1016/0165-2427(87)90152-8; ROSE ME, 1972, PARASITOLOGY, V65, P273, DOI 10.1017/S0031182000045054; ROSE ME, 1971, PARASITOLOGY, V63, P299, DOI 10.1017/S0031182000079610; RYLEY JF, 1976, PARASITOLOGY, V73, P311, DOI 10.1017/S0031182000046990; SHIRLEY MW, 1995, VET REC, V137, P453, DOI 10.1136/vr.137.18.453; SMITH NC, 1994, PARASITOLOGY, V109, P551, DOI 10.1017/S0031182000076423; SMITH NC, 1994, INFECT IMMUN, V62, P1348, DOI 10.1128/IAI.62.4.1348-1357.1994; WALLACH M, 1992, INFECT IMMUN, V60, P2036, DOI 10.1128/IAI.60.5.2036-2039.1992; Wallach M, 1997, INT J PARASITOL, V27, P1159, DOI 10.1016/S0020-7519(97)00113-6; WALLACH M, 1995, VACCINE, V13, P347, DOI 10.1016/0264-410X(95)98255-9; Williams RB, 1999, INT J PARASITOL, V29, P1209, DOI 10.1016/S0020-7519(99)00086-7	16	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3948	10.1371/journal.pone.0003948	http://dx.doi.org/10.1371/journal.pone.0003948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079606	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265458400007
J	Hnia, K; Notarnicola, C; de Santa Barbara, P; Hugon, G; Rivier, F; Laoudj-Chenibvesse, D; Mornet, D				Hnia, Karim; Notarnicola, Cecile; de Santa Barbara, Pascal; Hugon, Gerald; Rivier, Francois; Laoudj-Chenibvesse, Dalila; Mornet, Dominique			Biochemical Properties of Gastrokine-1 Purified from Chicken Gizzard Smooth Muscle	PLOS ONE			English	Article								The potential role and function of gastrokine-1 (GNK1) in smooth muscle cells is investigated in this work by first establishing a preparative protocol to obtain this native protein from freshly dissected chicken gizzard. Some unexpected biochemical properties of gastrokine-1 were deduced by producing specific polyclonal antibody against the purified protein. We focused on the F-actin interaction with gastrokine-1 and the potential role and function in smooth muscle contractile properties. Background: GNK1 is thought to provide mucosal protection in the superficial gastric epithelium. However, the actual role of gastrokine-1 with regards to its known decreased expression in gastric cancer is still unknown. Recently, trefoil factors (TFF) were reported to have important roles in gastric epithelial regeneration and cell turnover, and could be involved in GNK1 interactions. The aim of this study was to evaluate the role and function of GNK1 in smooth muscle cells. Methodology/Principal Findings: From fresh chicken gizzard smooth muscle, an original purification procedure was used to purify a heat soluble 20 kDa protein that was sequenced and found to correspond to the gastrokine-1 protein sequence containing one BRICHOS domain and at least two or possibly three transmembrane regions. The purified protein was used to produce polyclonal antibody and highlighted the smooth muscle cell distribution and F-actin association of GNK1 through a few different methods. Conclusion/Significance: Altogether our data illustrate a broader distribution of gastrokine-1 in smooth muscle than only in the gastrointestinal epithelium, and the specific interaction with F-actin highlights and suggests a new role and function of GNK1 within smooth muscle cells. A potential role via TFF interaction in cell-cell adhesion and assembly of actin stress fibres is discussed.	[Hnia, Karim; Notarnicola, Cecile; de Santa Barbara, Pascal; Hugon, Gerald; Rivier, Francois; Laoudj-Chenibvesse, Dalila; Mornet, Dominique] Univ Montpellier 1, CHU Arnaud de Villeneuve, INSERM, ERI Muscle & Pathol 25,EA 4202, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Hnia, K (corresponding author), Univ Montpellier 1, CHU Arnaud de Villeneuve, INSERM, ERI Muscle & Pathol 25,EA 4202, Montpellier, France.	mornet@montp.inserm.fr	Notarnicola, Cecile/N-9032-2018; de Santa Barbara, Pascal/AAO-5969-2021; de Santa Barbara, Pascal/N-6426-2015; Laoudj-Chenivesse, dalila/N-7097-2018	Notarnicola, Cecile/0000-0001-8363-1614; de Santa Barbara, Pascal/0000-0001-9040-2481; de Santa Barbara, Pascal/0000-0001-9040-2481; HNIA, karim/0000-0001-5298-3000; Laoudj-Chenivesse, dalila/0000-0003-4356-9187	INSERM; University Montpellier1	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Montpellier1	The funders (INSERM and University Montpellier1)have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; DALLALIBERA L, 1990, BIOCHEM BIOPH RES CO, V167, P1249; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; HALLIDAY DC, 2008, GENE EXPR PATTERNS; IKEBE M, 1978, J BIOCHEM, V83, P1643, DOI 10.1093/oxfordjournals.jbchem.a132077; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; MORNET D, 1988, BIOCHEM BIOPH RES CO, V154, P564, DOI 10.1016/0006-291X(88)90177-5; MORNET D, 1981, NATURE, V292, P301, DOI 10.1038/292301a0; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Nardone G, 2007, DIGEST LIVER DIS, V39, P122, DOI 10.1016/j.dld.2006.09.017; Oien KA, 2004, J PATHOL, V203, P789, DOI 10.1002/path.1583; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shiozaki K, 2001, INT J ONCOL, V19, P701; SOBIESZEK A, 1975, EUR J BIOCHEM, V55, P49, DOI 10.1111/j.1432-1033.1975.tb02137.x; SOBUE K, 1983, P NATL ACAD SCI-BIOL, V80, P6868, DOI 10.1073/pnas.80.22.6868; Sutoh K, 1985, Tanpakushitsu Kakusan Koso, V30, P1290; SUTOH K, 1986, BIOCHEMISTRY-US, V25, P435, DOI 10.1021/bi00350a024; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; SUTOH K, 1984, BIOCHEMISTRY-US, V23, P1942, DOI 10.1021/bi00304a009; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Yoshihara T, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-75; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x	29	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3854	10.1371/journal.pone.0003854	http://dx.doi.org/10.1371/journal.pone.0003854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057650	gold, Green Submitted, Green Published			2022-12-27	WOS:000265452300003
J	Kobayashi, T; Morone, N; Kashiyama, T; Oyamada, H; Kurebayashi, N; Murayama, T				Kobayashi, Takuya; Morone, Nobuhiro; Kashiyama, Taku; Oyamada, Hideto; Kurebayashi, Nagomi; Murayama, Takashi			Engineering a Novel Multifunctional Green Fluorescent Protein Tag for a Wide Variety of Protein Research	PLOS ONE			English	Article								Background: Genetically encoded tag is a powerful tool for protein research. Various kinds of tags have been developed: fluorescent proteins for live-cell imaging, affinity tags for protein isolation, and epitope tags for immunological detections. One of the major problems concerning the protein tagging is that many constructs with different tags have to be made for different applications, which is time- and resource-consuming. Methodology/Principal Findings: Here we report a novel multifunctional green fluorescent protein (mfGFP) tag which was engineered by inserting multiple peptide tags, i.e., octa-histidine (86His), streptavidin-binding peptide (SBP), and c-Myc tag, in tandem into a loop of GFP. When fused to various proteins, mfGFP monitored their localization in living cells. Streptavidin agarose column chromatography with the SBP tag successfully isolated the protein complexes in a native form with a high purity. Tandem affinity purification (TAP) with 8xHis and SBP tags in mfGFP further purified the protein complexes. mfGFP was clearly detected by c-Myc-specific antibody both in immunofluorescence and immuno-electron microscopy (EM). These findings indicate that mfGFP works well as a multifunctional tag in mammalian cells. The tag insertion was also successful in other fluorescent protein, mCherry. Conclusions and Significance: The multifunctional fluorescent protein tag is a useful tool for a wide variety of protein research, and may have the advantage over other multiple tag systems in its higher expandability and compatibility with existing and future tag technologies.	[Kobayashi, Takuya; Kashiyama, Taku; Kurebayashi, Nagomi; Murayama, Takashi] Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; [Oyamada, Hideto] Showa Univ, Sch Med, Dept Pharmacol, Tokyo, Japan	Juntendo University; National Center for Neurology & Psychiatry - Japan; Showa University	Kobayashi, T (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan.	takashim@juntendo.ac.jp		Morone, Nobuhiro/0000-0002-7672-158X	Japan Science and Technology Agency (SENTAN); Japan Society for Promotion of Science [Grants-in-Aid]; Health Labor Sciences Research [NANO-001]	Japan Science and Technology Agency (SENTAN)(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research	This work was supported in part by grants from the Japan Science and Technology Agency (SENTAN), Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science, and a Health Labor Sciences Research Grant (NANO-001).	Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fritze CE, 2000, METHOD ENZYMOL, V327, P3, DOI 10.1016/S0076-6879(00)27263-7; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Los GV, 2007, METH MOL B, V356, P195; Miyawaki A, 2005, ADV BIOCHEM ENG BIOT, V95, P1, DOI 10.1007/b102208; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Paramban RI, 2004, BIOTECHNOL BIOENG, V86, P687, DOI 10.1002/bit.20077; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Wu CF, 2000, APPL MICROBIOL BIOT, V54, P78, DOI 10.1007/s002539900286; Zhong JQ, 2004, BIOMOL ENG, V21, P67, DOI 10.1016/j.bioeng.2003.10.004	25	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3822	10.1371/journal.pone.0003822	http://dx.doi.org/10.1371/journal.pone.0003822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048102	Green Submitted, gold, Green Published			2022-12-27	WOS:000265452000003
J	Tamai, SI; Sanada, K; Fukada, Y				Tamai, So-ichi; Sanada, Kamon; Fukada, Yoshitaka			Time-of-Day-Dependent Enhancement of Adult Neurogenesis in the Hippocampus	PLOS ONE			English	Article								Background: Adult neurogenesis occurs in specific regions of the mammalian brain such as the dentate gyrus of the hippocampus. In the neurogenic region, neural progenitor cells continuously divide and give birth to new neurons. Although biological properties of neurons and glia in the hippocampus have been demonstrated to fluctuate depending on specific times of the day, it is unclear if neural progenitors and neurogenesis in the adult brain are temporally controlled within the day. Methodology/Principal Findings: Here we demonstrate that in the dentate gyrus of the adult mouse hippocampus, the number of M-phase cells shows a day/night variation throughout the day, with a significant increase during the nighttime. The M-phase cell number is constant throughout the day in the subventricular zone of the forebrain, another site of adult neurogenesis, indicating the daily rhythm of progenitor mitosis is region-specific. Importantly, the nighttime enhancement of hippocampal progenitor mitosis is accompanied by a nighttime increase of newborn neurons. Conclusions/Significance: These results indicate that neurogenesis in the adult hippocampus occurs in a time-of-day-dependent fashion, which may dictate daily modifications of dentate gyrus physiology.	[Tamai, So-ichi; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Sanada, Kamon] Osaka Univ, Grad Sch Med, Dept Dev Neurosci, Suita, Osaka 565, Japan; [Sanada, Kamon] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST)	Tamai, SI (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	kamon_sanada@neuro.med.osaka-u.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	SANADA, YOSHIKADO/G-5014-2014; 吉孝, 深田/G-5090-2014	Sanada, Kamon/0000-0002-0280-8957	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [Grants-in-Aid]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research and for Young Scientist from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Global COE Program "Integrative Life Science Based on the Study of Biosignaling Mechanisms", MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368	30	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3835	10.1371/journal.pone.0003835	http://dx.doi.org/10.1371/journal.pone.0003835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048107	Green Published, gold, Green Submitted			2022-12-27	WOS:000265452000008
J	Bem, T; Meyrand, P; Branchereau, P; Hallam, J				Bem, Tiaza; Meyrand, Pierre; Branchereau, Pascal; Hallam, John			Multi-Stability and Pattern-Selection in Oscillatory Networks with Fast Inhibition and Electrical Synapses	PLOS ONE			English	Article								A model or hybrid network consisting of oscillatory cells interconnected by inhibitory and electrical synapses may express different stable activity patterns without any change of network topology or parameters, and switching between the patterns can be induced by specific transient signals. However, little is known of properties of such signals. In the present study, we employ numerical simulations of neural networks of different size composed of relaxation oscillators, to investigate switching between in-phase (IP) and anti-phase (AP) activity patterns. We show that the time windows of susceptibility to switching between the patterns are similar in 2-, 4- and 6-cell fully-connected networks. Moreover, in a network (N = 4, 6) expressing a given AP pattern, a stimulus with a given profile consisting of depolarizing and hyperpolarizing signals sent to different subpopulations of cells can evoke switching to another AP pattern. Interestingly, the resulting pattern encodes the profile of the switching stimulus. These results can be extended to different network architectures. Indeed, relaxation oscillators are not only models of cellular pacemakers, bursting or spiking, but are also analogous to firing-rate models of neural activity. We show that rules of switching similar to those found for relaxation oscillators apply to oscillating circuits of excitatory cells interconnected by electrical synapses and cross-inhibition. Our results suggest that incoming information, arriving in a proper time window, may be stored in an oscillatory network in the form of a specific spatio-temporal activity pattern which is expressed until new pertinent information arrives.	[Bem, Tiaza] Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Meyrand, Pierre; Branchereau, Pascal] Univ Bordeaux 1, CNRS, UMR 5228, Ctr Neurosci Integratives Cognitives, F-33405 Talence, France; [Hallam, John] Univ So Denmark, Maersk Mc Kinney Moller Inst, Odense, Denmark	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Southern Denmark	Bem, T (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland.	tiaza.bem@ibib.waw.pl	Branchereau, Pascal/B-9206-2011; Bem, Tiaza/N-1841-2016	Branchereau, Pascal/0000-0003-3972-8229; 	MNiSW; Danish Agency for Science, Technology and Innovation [274-06-0292]; Conseil Regional d'Aquitaine	MNiSW(Ministry of Science and Higher Education, Poland); Danish Agency for Science, Technology and Innovation; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This study was supported by MNiSW (status grant 18/st, TB), Danish Agency for Science, Technology and Innovation" (TB and JH grant number 274-06-0292), Conseil Regional d'Aquitaine (PM and PB).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Bem T, 2005, EUR J NEUROSCI, V22, P2661, DOI 10.1111/j.1460-9568.2005.04405.x; Bem T, 2004, J NEUROPHYSIOL, V91, P693, DOI 10.1152/jn.00783.2003; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hultborn H, 2004, PROG BRAIN RES, V143, P77, DOI 10.1016/S0079-6123(03)43008-2; Jirsa VK, 1998, NEURAL COMPUT, V10, P2019, DOI 10.1162/089976698300016954; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Merriam EB, 2005, J NEUROSCI, V25, P6175, DOI 10.1523/JNEUROSCI.0512-05.2005; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; MEYRAND P, 1991, NATURE, V351, P60, DOI 10.1038/351060a0; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; ROWAT PF, 1993, J NEUROPHYSIOL, V70, P1030, DOI 10.1152/jn.1993.70.3.1030; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Tabak J, 2006, J COMPUT NEUROSCI, V21, P307, DOI 10.1007/s10827-006-8862-7; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Zhang K, 1996, J NEUROSCI, V16, P2112	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3830	10.1371/journal.pone.0003830	http://dx.doi.org/10.1371/journal.pone.0003830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043586	Green Published, gold			2022-12-27	WOS:000265451500009
J	Bartolazzi, A; D'Alessandria, C; Parisella, MG; Signore, A; Del Prete, F; Lavra, L; Braesch-Andersen, S; Massari, R; Trotta, C; Soluri, A; Sciacchitano, S; Scopinaro, F				Bartolazzi, Armando; D'Alessandria, Calogero; Parisella, Maria Gemma; Signore, Alberto; Del Prete, Fabrizio; Lavra, Luca; Braesch-Andersen, Sten; Massari, Roberto; Trotta, Carlo; Soluri, Alessandro; Sciacchitano, Salvatore; Scopinaro, Francesco			Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3	PLOS ONE			English	Article							ANTIAPOPTOTIC MOLECULE; CARCINOMA; NODULES; INHIBITION; EXPRESSION; CYTOLOGY; MARKERS; TUMORS; P53	Background: The prevalence of thyroid nodules increases with age, average 4-7% for the U. S. A. adult population, but it is much higher (19-67%) when sub-clinical nodules are considered. About 90% of these lesions are benign and a reliable approach to their preoperative characterization is necessary. Unfortunately conventional thyroid scintigraphy does not allow the distinction among benign and malignant thyroid proliferations but it provides only functional information (cold or hot nodules). The expression of the anti-apoptotic molecule galectin-3 is restricted to cancer cells and this feature has potential diagnostic and therapeutic implications. We show here the possibility to obtain thyroid cancer imaging in vivo by targeting galectin-3. Methods: The galectin-3 based thyroid immuno-scintigraphy uses as radiotracer a specific 99m Tc-radiolabeled mAb. A position-sensitive high-resolution mini-gamma camera was used as imaging capture device. Human galectin-3 positive thyroid cancer xenografts (ARO) and galectin-3 knockout tumors were used as targets in different experiments in vivo. 38 mice with tumor mass of about 1 gm were injected in the tail vein with 100 mu Ci of Tc-99m-labeled mAb to galectin-3 (30 mu g protein/in 100 mu l saline solution). Tumor images were acquired at 1 hr, 3 hrs, 6 hrs, 9 hrs and 24 hrs post injection by using the mini-gamma camera. Findings: Results from different consecutive experiments show an optimal visualization of thyroid cancer xenografts between 6 and 9 hours from injection of the radiotracer. Galectin-3 negative tumors were not detected at all. At 6 hrs post-injection galectin-3 expressing tumors were correctly visualized, while the whole-body activity had essentially cleared. Conclusions: These results demonstrate the possibility to distinguish preoperatively benign from malignant thyroid nodules by using a specific galectin-3 radio-immunotargeting. In vivo imaging of thyroid cancer may allow a better selection of patients referred to surgery. The possibility to apply this method for imaging and treatment of other galectin-3 expressing tumors is also discussed.	[Bartolazzi, Armando; Del Prete, Fabrizio] Karolinska Hosp, Cellular & Mol Tumor Pathol Lab, Canc Ctr Karolinska, S-10401 Stockholm, Sweden; [Bartolazzi, Armando; Del Prete, Fabrizio] St Andrea Univ Hosp, Pathol Res Lab, Rome, Italy; [D'Alessandria, Calogero; Parisella, Maria Gemma; Signore, Alberto; Scopinaro, Francesco] Univ Roma La Sapienza, St Andrea Univ Hosp, Lab Nuclear Med, Rome, Italy; [Lavra, Luca; Sciacchitano, Salvatore] Assoc Fatebenefratelli Ricerca AfaR, S Pietro Fatebenefratelli Hosp, Rome, Italy; [Lavra, Luca; Sciacchitano, Salvatore] Univ Roma La Sapienza, Fac Med 2, Dept Expt Med & Pathol, Rome, Italy; [Braesch-Andersen, Sten] Mabtech Res Lab, Nacka, Sweden; [Massari, Roberto; Trotta, Carlo; Soluri, Alessandro] Natl Council Res, ISIB, Rome, Italy	Karolinska Institutet; Karolinska University Hospital; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Bartolazzi, A (corresponding author), Karolinska Hosp, Cellular & Mol Tumor Pathol Lab, Canc Ctr Karolinska, S-10401 Stockholm, Sweden.	Armando.Bartolazzi@ki.se; Francesco.Scopinaro@uniroma1.it	Sciacchitano, Salvatore/AAM-5895-2020; Massari, Roberto/H-7579-2015; Signore, Alberto/E-5812-2010; Bartolazzi, Armando/K-9708-2016	Sciacchitano, Salvatore/0000-0003-1492-5365; Massari, Roberto/0000-0001-9266-8910; Signore, Alberto/0000-0001-8923-648X; SOLURI, ALESSANDRO/0000-0002-1600-8790; Bartolazzi, Armando/0000-0001-7820-5127; Scopinaro, Francesco/0000-0003-1924-3005	AIRC (Italian Association for Cancer Research)	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	Supported by AIRC (Italian Association for Cancer Research). No other sponsors played a role in this paper.	Akahani S, 1997, CANCER RES, V57, P5272; Bartolazzi A, 2000, LANCET, V355, P1661, DOI 10.1016/S0140-6736(00)02233-9; Bartolazzi A, 2001, LANCET, V357, P1644, DOI 10.1016/S0140-6736(00)04817-0; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Becker D, 1996, J NUCL MED, V37, P1264; Carpi A, 2006, BRIT J CANCER, V95, P204, DOI 10.1038/sj.bjc.6603232; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Dalessandria C, 2007, Q J NUCL MED MOL IM, V51, P334; DIVIGI CR, 1996, ONCOLOGY HUNTINGTON, V10, P939; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kim HRC, 1999, CANCER RES, V59, P4148; Kumar SR, 2008, J NUCL MED, V49, P796, DOI 10.2967/jnumed.107.048751; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MATHER SJ, 1990, J NUCL MED, V31, P692; Moiseeva EV, 2005, BREAST CANCER RES TR, V91, P227, DOI 10.1007/s10549-005-0289-8; Moretti F, 1997, ONCOGENE, V14, P729, DOI 10.1038/sj.onc.1200887; Papotti M, 2005, MODERN PATHOL, V18, P541, DOI 10.1038/modpathol.3800321; Prieto VG, 2006, CLIN CANCER RES, V12, P6709, DOI 10.1158/1078-0432.CCR-06-0758; Rosai J., 1992, ATLAS TUMOR PATHOL, P1; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Saggiorato E, 2001, J CLIN ENDOCR METAB, V86, P5152, DOI 10.1210/jc.86.11.5152; SCHWEPPE RE, 2008, J CLIN ENDOCRIN 0819; Scopinaro F, 2007, Q J NUCL MED MOL IM, V51, P204; SHI Y, 1993, J CLIN INVEST, V91, P179; Shi YH, 2007, INT J CANCER, V121, P1175, DOI 10.1002/ijc.22848; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Takenaka Y, 2003, CANCER LETT, V195, P111, DOI 10.1016/S0304-3835(03)00056-9; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; The American Thyroid Association, 2003, THYROID, V13, P80; Trotta C, 2007, NUCL INSTRUM METH A, V577, P604, DOI 10.1016/j.nima.2007.03.037; Yoshii T, 2001, INT J ONCOL, V18, P787	31	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3768	10.1371/journal.pone.0003768	http://dx.doi.org/10.1371/journal.pone.0003768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020658	gold, Green Published, Green Submitted			2022-12-27	WOS:000265448600001
J	Skerritt, MR; Campbell, DL				Skerritt, Matthew R.; Campbell, Donald L.			Non-Native R1 Substitution in the S4 Domain Uniquely Alters Kv4.3 Channel Gating	PLOS ONE			English	Article							CLOSED-STATE INACTIVATION; POTASSIUM CHANNEL; VOLTAGE SENSOR; ELECTRIC-FIELD; AMINO-ACID; CHARGE; RESIDUES; PATHWAY; TIME	The S4 transmembrane domain in Shaker (Kv1) voltage-sensitive potassium channels has four basic residues (R1-R4) that are responsible for carrying the majority of gating charge. In Kv4 channels, however, R1 is replaced by a neutral valine at position 287. Among other differences, Kv4 channels display prominent closed state inactivation, a mechanism which is minimal in Shaker. To determine if the absence of R1 is responsible for important variation in gating characteristics between the two channel types, we introduced the V287R mutant into Kv4.3 and analyzed its effects on several voltage sensitive gating transitions. We found that the mutant increased the voltage sensitivity of steady-state activation and altered the kinetics of activation and deactivation processes. Although the kinetics of macroscopic inactivation were minimally affected, the characteristics of closed-state inactivation and recovery from open and closed inactivated states were significantly altered. The absence of R1 can only partially account for differences in the effective voltage sensitivity of gating between Shaker and Kv4.3. These results suggest that the S4 domain serves an important functional role in Kv4 channel activation and deactivation processes, and also those of closed-state inactivation and recovery.	[Skerritt, Matthew R.; Campbell, Donald L.] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Skerritt, MR (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	dc25@buffalo.edu			American Heart Association [Predoctoral Fellowship]; Department of Physiology and Biophysics	American Heart Association(American Heart Association); Department of Physiology and Biophysics	American Heart Association Predoctoral Fellowship (MRS) and Department of Physiology and Biophysics (DLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Aldrich RW, 2001, NATURE, V411, P643, DOI 10.1038/35079705; Amadi CC, 2007, CHANNELS, V1, P305, DOI 10.4161/chan.5017; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chanda B, 2008, NEURON, V57, P345, DOI 10.1016/j.neuron.2008.01.015; Claydon TW, 2008, CHANNELS, V2, P139, DOI 10.4161/chan.2.2.6231; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; HILLE B, 2001, ION CHANNELS EXCITAB, P603; JACKSON MB, 2006, MOL CELLULAR BIOPHYS, P1; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Patel SP, 2002, J PHYSIOL-LONDON, V539, P649, DOI 10.1113/jphysiol.2001.015156; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SKERITT MR, 2008, BIOCH BIOPH IN PRESS; Skerritt MR, 2007, AM J PHYSIOL-CELL PH, V293, pC906, DOI 10.1152/ajpcell.00167.2007; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang SM, 2005, BIOPHYS J, V89, P3026, DOI 10.1529/biophysj.105.059378; Wang SM, 2004, J PHYSIOL-LONDON, V557, P705, DOI 10.1113/jphysiol.2003.058578; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3773	10.1371/journal.pone.0003773	http://dx.doi.org/10.1371/journal.pone.0003773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020667	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448600006
J	Kirk, U				Kirk, Ulrich			The Neural Basis of Object-Context Relationships on Aesthetic Judgment	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; EMOTIONAL RESPONSES; BRAIN MECHANISMS; TARGET DETECTION; PARIETAL CORTEX; VISUAL TARGET; PERCEPTION; REWARD	The relationship between contextual information and object perception has received considerable attention in neuroimaging studies. In the work reported here, we used functional magnetic resonance imaging ( \fMRI) to investigate the relationship between aesthetic judgment and images of objects in their normal contextual setting versus images of objects in abnormal contextual settings and the underlying brain activity. When object-context relationships are violated changes in visual perception and aesthetic judgment emerges that exposes the contribution of vision to interpretations shaped by previous experience. We found that effects of context on aesthetic judgment modulates different memory subsystems, while aesthetic judgment regardless of context recruit medial and lateral aspects of the orbitofrontal cortex, consistent with previous findings. Visual cortical areas traditionally associated with the processing of visual features are recruited in normal contexts, irrespective of aesthetic ratings, while prefrontal areas are significantly more engaged when objects are viewed in unaccustomed settings.			Kirk, U (corresponding author), Baylor Coll Med, Human Neuroimaging Lab, Houston, TX 77030 USA.	ulrich.kirk@uclmail.net		kirk, ulrich/0000-0002-2121-2016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; [Anonymous], 1974, STUDIES NEW EXPT AES; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BOYCE SJ, 1992, J EXP PSYCHOL LEARN, V18, P531, DOI 10.1037/0278-7393.18.3.531; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; German TP, 2004, J COGNITIVE NEUROSCI, V16, P1805, DOI 10.1162/0898929042947892; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Mellet E, 2000, NEUROIMAGE, V12, P588, DOI 10.1006/nimg.2000.0648; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; Mummery CJ, 2000, ANN NEUROL, V47, P36; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180	61	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3754	10.1371/journal.pone.0003754	http://dx.doi.org/10.1371/journal.pone.0003754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XD	19018279	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448500002
J	Remaud, S; Audibert, A; Gho, M				Remaud, Sylvie; Audibert, Agnes; Gho, Michel			S-Phase Favours Notch Cell Responsiveness in the Drosophila Bristle Lineage	PLOS ONE			English	Article								We have studied cell sensitivity to Notch pathway signalling throughout the cell cycle. As model system, we used the Drosophila bristle lineage where at each division N plays a crucial role in fate determination. Using in vivo imaging, we followed this lineage and activated the N-pathway at different moments of the secondary precursor cell cycle. We show that cells are more susceptible to respond to N-signalling during the S-phase. Thus, the period of heightened sensitivity coincided with the period of the S-phase. More importantly, modifications of S-phase temporality induced corresponding changes in the period of the cell's reactivity to N-activation. Moreover, S-phase abolition was correlated with a decrease in the expression of tramtrack, a downstream N-target gene. Finally, N cell responsiveness was modified after changes in chromatin packaging. We suggest that high-order chromatin structures associated with the S-phase create favourable conditions that increase the efficiency of the transcriptional machinery with respect to N-target genes.	[Remaud, Sylvie; Audibert, Agnes; Gho, Michel] Univ Paris 06, UMR 7622, Paris, France; [Remaud, Sylvie; Audibert, Agnes; Gho, Michel] CNRS, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Remaud, S (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	Michel.Gho@snv.jussieu.fr	Audibert, Agnès/ABG-2084-2021		ARC [3291]; ANR [05-BLAN-0133]; CNRS; UPMC; FRM	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; FRM(Fondation pour la Recherche Medicale)	ARC (grant 3291), ANR (grant 05-BLAN-0133), CNRS, UPMC, FRM to SR.	Ambros V, 1999, DEVELOPMENT, V126, P1947; Armstrong JA, 2005, GENETICS, V170, P1761, DOI 10.1534/genetics.105.041327; Audibert A, 2005, DEVELOPMENT, V132, P2287, DOI 10.1242/dev.01797; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; EISSENBERG JC, 1992, GENETICS, V131, P345; Elfring LK, 1998, GENETICS, V148, P251; Falbo KB, 2006, J CELL BIOCHEM, V97, P684, DOI 10.1002/jcb.20752; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; HOLTZER H, 1975, Q REV BIOPHYS, V8, P523, DOI 10.1017/S0033583500001980; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Negre N, 2003, MECH DEVELOP, V120, P253, DOI 10.1016/S0925-4773(02)00419-7; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Schweisguth F, 1999, P NATL ACAD SCI USA, V96, P11382, DOI 10.1073/pnas.96.20.11382; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; TAMKUN JW, 1995, CURR OPIN GENET DEV, V5, P473, DOI 10.1016/0959-437X(95)90051-H; USUI K, 1992, DEVELOPMENT, V116, P601; Vanderwaal RP, 2001, J CELL PHYSIOL, V187, P236, DOI 10.1002/jcp.1073; Wang SW, 1997, DEVELOPMENT, V124, P4435; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XU T, 1992, DEVELOPMENT, V115, P913; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3646	10.1371/journal.pone.0003646	http://dx.doi.org/10.1371/journal.pone.0003646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985153	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134400009
J	Seoane, M; Iglesias, P; Gonzalez, T; Dominguez, F; Fraga, M; Aliste, C; Forteza, J; Costoya, JA				Seoane, Marcos; Iglesias, Pablo; Gonzalez, Teresa; Dominguez, Fernando; Fraga, Maximo; Aliste, Carlos; Forteza, Jeronimo; Costoya, Jose A.			Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression	PLOS ONE			English	Article								Senescence is one of the main barriers against tumor progression. Oncogenic signals in primary cells result in oncogene-induced senescence (OIS), crucial for protection against cancer development. It has been described in premalignant lesions that OIS requires DNA damage response (DDR) activation, safeguard of the integrity of the genome. Here we demonstrate how the cellular mechanisms involved in oncogenic transformation in a model of glioma uncouple OIS and DDR. We use this tumor type as a paradigm of oncogenic transformation. In human gliomas most of the genetic alterations that have been previously identified result in abnormal activation of cell growth signaling pathways and deregulation of cell cycle, features recapitulated in our model by oncogenic Ras expression and retinoblastoma (Rb) inactivation respectively. In this scenario, the absence of pRb confers a proliferative advantage and activates DDR to a greater extent in a DNA lesion-independent fashion than cells that express only HRas(V12). Moreover, Rb loss inactivates the stress kinase DDR-associated p38MAPK by specific Wip1-dependent dephosphorylation. Thus, Rb loss acts as a switch mediating the transition between premalignant lesions and cancer through DDR modulation. These findings may have important implications for the understanding the biology of gliomas and anticipate a new target, Wip1 phosphatase, for novel therapeutic strategies.	[Seoane, Marcos; Iglesias, Pablo; Costoya, Jose A.] Univ Santiago De Compostela, Mol Oncol Lab, Dept Fisioloxia, Fac Med, Santiago De Compostela, Spain; [Gonzalez, Teresa; Dominguez, Fernando] Univ Santiago Compostela, Serv Galego Saude, Fdn Galega Med Xenom, Santiago De Compostela, Spain; [Fraga, Maximo; Aliste, Carlos; Forteza, Jeronimo] Univ Santiago Compostela, Dept Anat Patol Ciencias Forenses, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Seoane, M (corresponding author), Univ Santiago De Compostela, Mol Oncol Lab, Dept Fisioloxia, Fac Med, Santiago De Compostela, Spain.	josea.costoya@usc.es	Souto, Marcos Seoane/I-3380-2018; Costoya, Jose A./B-2718-2009; Fraga, Máximo/AAC-9417-2020	Costoya, Jose A./0000-0003-3691-6419; Iglesias Vazquez, Pablo/0000-0003-2506-5313; dominguez, fernando/0000-0002-5003-4335; Fraga Rodriguez, Maximo/0000-0001-6185-9562	Spanish Ministry of Education and Science [SAF2005-00306]; Xunta de Galicia [PGIDIT05PXIB20801PR, 2007/064]; Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Programme (Spanish Ministry of Education and Science)	Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Programme (Spanish Ministry of Education and Science)(Spanish Government)	This study was supported by Spanish Ministry of Education and Science (SAF2005-00306) and Xunta de Galicia grants (PGIDIT05PXIB20801PR); Grupos emerxentes 2007/064) (J.A.C.), and by Fundacion de Investigacion Medica Mutua Madrilena (J.A.C., P.I.). J.A.C. is an Investigator of Ramon y Cajal Programme (Spanish Ministry of Education and Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding H, 2001, CANCER RES, V61, P3826; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; HE J, 1995, CANCER RES, V55, P4833; HE J, 1994, CANCER RES, V54, P5804; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Ichimura K, 1996, ONCOGENE, V13, P1065; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; JEN J, 1994, CANCER RES, V54, P6353; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marino S, 2000, GENE DEV, V14, P994; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Powers JT, 2004, MOL CANCER RES, V2, P203; QUELLE DE, 1995, CELL, V83, P993; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rathore A, 1999, Pathol Oncol Res, V5, P21, DOI 10.1053/paor.1999.0021; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rich JN, 2001, CANCER RES, V61, P3556; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Uhrbom L, 2002, CANCER RES, V62, P5551; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	57	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3632	10.1371/journal.pone.0003632	http://dx.doi.org/10.1371/journal.pone.0003632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985151	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134400007
J	Cherian, S; Forbes, DA; Cook, AG; Sanfilippo, FM; Kemna, EH; Swinkels, DW; Burgner, DP				Cherian, Sarah; Forbes, David A.; Cook, Angus G.; Sanfilippo, Frank M.; Kemna, Erwin H.; Swinkels, Dorine W.; Burgner, David P.			An Insight into the Relationships between Hepcidin, Anemia, Infections and Inflammatory Cytokines in Pediatric Refugees: A Cross-Sectional Study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; HELICOBACTER-PYLORI INFECTION; HIGH-PREVALENCE; SERUM HEPCIDIN; CHILDREN; FERRITIN; HYPOFERREMIA; ADOLESCENTS; FERROPORTIN; HEMOJUVELIN	Background: Hepcidin, a key regulator of iron homeostasis, is increased in response to inflammation and some infections, but the in vivo role of hepcidin, particularly in children with iron deficiency anemia (IDA) is unclear. We investigated the relationships between hepcidin, cytokines and iron status in a pediatric population with a high prevalence of both anemia and co-morbid infections. Methodology/Principal Findings: African refugee children,16 years were consecutively recruited at the initial post-resettlement health check with 181 children meeting inclusion criteria. Data on hematological parameters, cytokine levels and co-morbid infections (Helicobacter pylori, helminth and malaria) were obtained and urinary hepcidin assays performed. The primary outcome measure was urinary hepcidin levels in children with and without iron deficiency ( ID) and/or ID anaemia (IDA). The secondary outcome measures included were the relationship between co-morbid infections and (i) ID and IDA, (ii) urinary hepcidin levels and (iii) cytokine levels. IDA was present in 25/181 (13.8%). Children with IDA had significantly lower hepcidin levels (IDA median hepcidin 0.14 nmol/mmol Cr (interquartile range 0.05-0.061) versus non-IDA 2.96 nmol/mmol Cr, (IQR 0.95-6.72), p<0.001). Hemoglobin, log-ferritin, iron, mean cell volume (MCV) and transferrin saturation were positively associated with log-hepcidin levels (log-ferritin beta coefficient (beta): 1.30, 95% CI 1.02 to 1.57) and transferrin was inversely associated (beta: -0.12, 95% CI -0.15 to -0.08). Cytokine levels (including IL-6) and co-morbid infections were not associated with IDA or hepcidin levels. Conclusions/Significance: This is the largest pediatric study of the in vivo associations between hepcidin, iron status and cytokines. Gastro-intestinal infections (H. pylori and helminths) did not elevate urinary hepcidin or IL-6 levels in refugee children, nor were they associated with IDA. Longitudinal and mechanistic studies of IDA will further elucidate the role of hepcidin in paediatric iron regulation.	[Forbes, David A.; Burgner, David P.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Cherian, Sarah; Forbes, David A.; Burgner, David P.] Princess Margaret Hosp Children, Pediat Infect Dis & Refugee Hlth, Perth, WA, Australia; [Cherian, Sarah; Cook, Angus G.; Sanfilippo, Frank M.] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia; [Kemna, Erwin H.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands	University of Western Australia; University of Western Australia; University of Western Australia; Radboud University Nijmegen	Cherian, S (corresponding author), Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia.	dburgner@meddent.uwa.edu.au	Cherian, Sarah/ABA-6207-2021; Sanfilippo, Frank M/H-9334-2013; Swinkels, Dorine W./H-8098-2014; Cherian, /411001/H-1332-2016	Sanfilippo, Frank M/0000-0003-3639-0787; Swinkels, Dorine W./0000-0002-1040-9446; Burgner, David/0000-0002-8304-4302; Cook, Angus/0000-0002-1758-6496	University of Western Australia; Royal Australasian College of Physicians; Princess Margaret Foundation	University of Western Australia; Royal Australasian College of Physicians(General Electric); Princess Margaret Foundation	SC received a 2007 University of Western Australia Research Grant, a 2007 Royal Australasian College of Physicians Grant and a 2007 Princess Margaret Foundation Seeding Grant for laboratory assays and consumables.Faecal antigen kits were supplied by Dako, Denmark and Oxoid, Australia to the investigating team without charge or with any other provision of research funding. Neither company had any input or influence into the study design, data collection and analysis, interpretation, decision to publish or preparation of this manuscript.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Baggett HC, 2006, PEDIATRICS, V117, pE396, DOI 10.1542/peds.2005-1129; Cardamone M, 2008, J PAEDIATR CHILD H, V44, P647, DOI 10.1111/j.1440-1754.2008.01374.x; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Cherian S, 2008, J PEDIATR GASTR NUTR, V47, P130, DOI 10.1097/MPG.0b013e31815bc5b3; Cherian S, 2008, MED J AUSTRALIA, V189, P438, DOI 10.5694/j.1326-5377.2008.tb02116.x; Choe YH, 2003, J GASTROEN HEPATOL, V18, P980, DOI 10.1046/j.1440-1746.2003.03098.x; Dale JC, 2002, AM J CLIN PATHOL, V117, P802, DOI 10.1309/2YT4-CMP3-KYW7-9RK1; DEMAST Q, 2008, J INFECT DI IN PRESS; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; DiGirolamo AM, 2007, PEDIATR INFECT DIS J, V26, P927, DOI 10.1097/INF.0b013e31812e52cd; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Fleming RE, 2008, J MOL MED, V86, P491, DOI 10.1007/s00109-008-0349-8; Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005; *GEN DIAGN LTD, 2003, HPG SCREEN ELISA KIT; *GOV W AUSTR, 2006, MIGR HLTH SCREEN PRO, P1; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Hopkins RM, 1997, MED J AUSTRALIA, V166, P241, DOI 10.5694/j.1326-5377.1997.tb140103.x; Howard CT, 2007, AM J TROP MED HYG, V77, P623, DOI 10.4269/ajtmh.2007.77.623; Karr MA, 2001, MED J AUSTRALIA, V174, P165, DOI 10.5694/j.1326-5377.2001.tb143208.x; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kawabata H, 2007, HAEMATOLOGICA, V92, P857, DOI 10.3324/haematol.10794; Kearney SL, 2007, PEDIATR BLOOD CANCER, V48, P57, DOI 10.1002/pbc.20616; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Martin JA, 2006, MED J AUSTRALIA, V185, P607, DOI 10.5694/j.1326-5377.2006.tb00726.x; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McGillivray G, 2007, ARCH DIS CHILD, V92, P1088, DOI 10.1136/adc.2006.112813; Nahon S, 2003, HELICOBACTER, V8, P573, DOI 10.1111/j.1523-5378.2003.00184.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nguyen ND, 2004, J PAEDIATR CHILD H, V40, P424, DOI 10.1111/j.1440-1754.2004.00423.x; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Oti-Boateng P, 1998, J PAEDIATR CHILD H, V34, P250, DOI 10.1046/j.1440-1754.1998.00205.x; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pellicano R, 2004, PANMINERVA MED, V46, P165; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; SCHWARTZ E, 2007, NELSONS TXB PEDIAT; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Suoglu OD, 2007, PEDIATR INT, V49, P858, DOI 10.1111/j.1442-200X.2007.02444.x; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Theurl I, 2006, BLOOD, V107, P4142, DOI 10.1182/blood-2005-08-3364; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; *WOM CHILDR PATH H, 2003, HAEM DEP REF RANG BI; World Health Organization, 2001, INT CLASS FUNCT DIS, P1	59	66	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4030	10.1371/journal.pone.0004030	http://dx.doi.org/10.1371/journal.pone.0004030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107209	Green Published, gold			2022-12-27	WOS:000265463000023
J	Sakihama, T; Sato, T; Iwanari, H; Kitamura, T; Sakaguchi, S; Kodama, T; Hamakubo, T				Sakihama, Toshiko; Sato, Takato; Iwanari, Hiroko; Kitamura, Toshio; Sakaguchi, Shimon; Kodama, Tatsuhiko; Hamakubo, Takao			A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display	PLOS ONE			English	Article							BUDDED BACULOVIRUS; COUPLED RECEPTOR; HUMAN CD2; LIGAND; RECONSTITUTION; ACTIVATION; RECOVERY; SYSTEM; CELLS; EXPRESSION	Background: Membrane protein interactions play an important role in cell-to-cell recognition in various biological activities such as in the immune or neural system. Nevertheless, there has remained the major obstacle of expression of the membrane proteins in their active form. Recently, we and other investigators found that functional membrane proteins express on baculovirus particles (budded virus, BV). In this study, we applied this BV display system to detect interaction between membrane proteins important for cell-to-cell interaction in immune system. Methodology/Principal Findings: We infected Sf9 cells with recombinant baculovirus encoding the T cell membrane protein CD2 or its ligand CD58 and recovered the BV. We detected specific interaction between CD2-displaying BV and CD58-displaying BV by an enzyme-linked immunosorbent assay (ELISA). Using this system, we also detected specific interaction between two other membrane receptor-ligand pairs, CD40-CD40 ligand (CD40L), and glucocorticoid-induced TNFR family-related protein (GITR)-GITR ligand (GITRL). Furthermore, we observed specific binding of BV displaying CD58, CD40L, or GITRL to cells naturally expressing their respective receptors by flowcytometric analysis using anti-baculoviral gp64 antibody. Finally we isolated CD2 cDNA from a cDNA expression library by magnetic separation using CD58-displayng BV and anti-gp64 antibody. Conclusions: We found the BV display system worked effectively in the detection of the interaction of membrane proteins. Since various membrane proteins and their oligomeric complexes can be displayed on BV in the native form, this BV display system should prove highly useful in the search for natural ligands or to develop screening systems for therapeutic antibodies and/or compounds.	[Sakihama, Toshiko; Sato, Takato; Iwanari, Hiroko; Hamakubo, Takao] Univ Tokyo, Dept Mol Biol & Med, Tokyo, Japan; [Sakihama, Toshiko; Sato, Takato; Iwanari, Hiroko; Kodama, Tatsuhiko; Hamakubo, Takao] Univ Tokyo, Res Ctr Advanced Sci & Technol, Lab Syst Biol & Med, Tokyo, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University	Sakihama, T (corresponding author), Univ Tokyo, Dept Mol Biol & Med, Tokyo, Japan.	sakihama@med.rcast.u-tokyo.ac.jp	Kitamura, Toshio/AAA-2071-2021; Sakaguchi, Shimon/C-9535-2009		Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); NFAT project of the New Energy and Industrial Technology Development Organization (NEDO);  [S-20221010];  [B-18310142];  [C-18570120];  [16657034]	Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); NFAT project of the New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); ; ; ; 	This study was supported in part by Grant-in-Aid for Scientific Research (S-20221010, B-18310142, and C-18570120), by Grant-in-Aid for Exploratory Research (16657034), by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), by the NFAT project of the New Energy and Industrial Technology Development Organization (NEDO). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abad LW, 2002, ANAL BIOCHEM, V310, P107, DOI 10.1016/S0003-2697(02)00314-7; ARULANANDAM ARN, 1993, P NATL ACAD SCI USA, V90, P11613, DOI 10.1073/pnas.90.24.11613; ARULANANDAM ARN, 1993, J EXP MED, V177, P1439, DOI 10.1084/jem.177.5.1439; Brown MJ, 1999, CURR BIOL, V9, pR26, DOI 10.1016/S0960-9822(99)80038-4; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Hoffman TL, 2000, P NATL ACAD SCI USA, V97, P11215, DOI 10.1073/pnas.190274097; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Liu JN, 2004, J IMMUNOL METHODS, V291, P39, DOI 10.1016/j.jim.2004.04.026; Loisel TP, 1997, NAT BIOTECHNOL, V15, P1300, DOI 10.1038/nbt1197-1300; Makela AR, 2008, COMB CHEM HIGH T SCR, V11, P86, DOI 10.2174/138620708783744525; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Saitoh R, 2006, PROTEIN EXPRES PURIF, V46, P130, DOI 10.1016/j.pep.2005.08.008; Sakihama T, 2008, J BIOTECHNOL, V135, P28, DOI 10.1016/j.jbiotec.2008.02.022; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Van Broekhoven CL, 2001, IMMUNOL CELL BIOL, V79, P274, DOI 10.1046/j.1440-1711.2001.01010.x; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839	22	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4024	10.1371/journal.pone.0004024	http://dx.doi.org/10.1371/journal.pone.0004024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107192	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000019
J	Lorkovic, ZJ; Barta, A				Lorkovic, Zdravko J.; Barta, Andrea			Role of Cajal Bodies and Nucleolus in the Maturation of the U1 snRNP in Arabidopsis	PLOS ONE			English	Article								Background: The biogenesis of spliceosomal snRNPs takes place in both the cytoplasm where Sm core proteins are added and snRNAs are modified at the 5' and 3' termini and in the nucleus where snRNP-specific proteins associate. U1 snRNP consists of U1 snRNA, seven Sm proteins and three snRNP-specific proteins, U1-70K, U1A, and U1C. It has been shown previously that after import to the nucleus U2 and U4/U6 snRNP-specific proteins first appear in Cajal bodies ( CB) and then in splicing speckles. In addition, in cells grown under normal conditions U2, U4, U5, and U6 snRNAs/snRNPs are abundant in CBs. Therefore, it has been proposed that the final assembly of these spliceosomal snRNPs takes place in this nuclear compartment. In contrast, U1 snRNA in both animal and plant cells has rarely been found in this nuclear compartment. Methodology/Principal Findings: Here, we analysed the subnuclear distribution of Arabidopsis U1 snRNP-specific proteins fused to GFP or mRFP in transiently transformed Arabidopsis protoplasts. Irrespective of the tag used, U1-70K was exclusively found in the nucleus, whereas U1A and U1C were equally distributed between the nucleus and the cytoplasm. In the nucleus all three proteins localised to CBs and nucleoli although to different extent. Interestingly, we also found that the appearance of the three proteins in nuclear speckles differ significantly. U1-70K was mostly found in speckles whereas U1A and U1C in similar to 90% of cells showed diffuse nucleoplasmic in combination with CBs and nucleolar localisation. Conclusions/Significance: Our data indicate that CBs and nucleolus are involved in the maturation of U1 snRNP. Differences in nuclear accumulation and distribution between U1-70K and U1A and U1C proteins may indicate that either U1-70K or U1A and U1C associate with, or is/are involved, in other nuclear processes apart from pre-mRNA splicing.	[Barta, Andrea] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Lorkovic, ZJ (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria.	zdravko.lorkovic@meduniwien.ac.at		Barta, Andrea/0000-0002-8851-406X; Lorkovic, Zdravko/0000-0002-3074-7258	Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [SFB-F017/10/11]; EURASNET	Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); EURASNET	This work was supported by grants from the Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF) to Andrea Barta (SFB-F017/10/11) and EURASNET.	Acevedo R, 2002, CHROMOSOMA, V110, P559, DOI 10.1007/s00412-001-0178-9; Ali GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001953; ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; BEVEN AF, 1995, J CELL SCI, V108, P509; Boudonck K, 1998, J CELL SCI, V111, P3687; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Carmo-Fonseca M, 2002, EMBO REP, V3, P726, DOI 10.1093/embo-reports/kvf154; CARMOFONSECA M, 1991, EMBO J, V10, P1863, DOI 10.1002/j.1460-2075.1991.tb07712.x; CARMOFONSECA M, 1991, EMBO J, V10, P195, DOI 10.1002/j.1460-2075.1991.tb07936.x; CARMOFONSECA M, 1992, J CELL BIOL, V117, P11; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gall JG, 2001, FEBS LETT, V498, P164, DOI 10.1016/S0014-5793(01)02461-9; Guan F, 2003, MOL CELL BIOL, V23, P3163, DOI 10.1128/MCB.23.9.3163-3172.2003; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Gunnewiek JMTK, 1997, EXP CELL RES, V235, P265, DOI 10.1006/excr.1997.3663; Hetzer M, 2000, J CELL BIOL, V148, P293, DOI 10.1083/jcb.148.2.293; Hieda M, 2001, J BIOL CHEM, V276, P16824, DOI 10.1074/jbc.M008299200; Hoet RMA, 1998, MOL IMMUNOL, V35, P1045, DOI 10.1016/S0161-5890(98)00093-5; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; JANTSCH MF, 1992, J CELL BIOL, V119, P1037, DOI 10.1083/jcb.119.5.1037; KAMBACH C, 1994, J CELL SCI, V107, P1807; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Lambermon MHL, 2000, EMBO J, V19, P1638, DOI 10.1093/emboj/19.7.1638; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lorkovic ZJ, 2008, EXP CELL RES, V314, P3175, DOI 10.1016/j.yexcr.2008.06.020; Lorkovic ZJ, 2000, RNA, V6, P1610, DOI 10.1017/S1355838200001163; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; LUHRMANN R, 1982, NUCLEIC ACIDS RES, V10, P7103, DOI 10.1093/nar/10.22.7103; Ma JL, 2006, RNA, V12, P122, DOI 10.1261/rna.2159506; MATERA AG, 1993, J CELL BIOL, V121, P715, DOI 10.1083/jcb.121.4.715; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Ogg SC, 2002, J CELL BIOL, V159, P17, DOI 10.1083/jcb.200206111; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; ROMAC JM, 1993, MOL CELL BIOL, V14, P4662; SIMPSON GG, 1995, EMBO J, V14, P4540, DOI 10.1002/j.1460-2075.1995.tb00133.x; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Sleeman JE, 2001, J CELL SCI, V114, P4407; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; WU ZG, 1991, J CELL BIOL, V113, P465, DOI 10.1083/jcb.113.3.465; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Yu YT, 2001, J CELL BIOL, V152, P1279, DOI 10.1083/jcb.152.6.1279; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	58	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3989	10.1371/journal.pone.0003989	http://dx.doi.org/10.1371/journal.pone.0003989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098980	Green Published, gold, Green Submitted			2022-12-27	WOS:000265462300002
J	McIntyre, KM; Gubbins, S; Goldmann, W; Hunter, N; Baylis, M				McIntyre, K. Marie; Gubbins, Simon; Goldmann, Wilfred; Hunter, Nora; Baylis, Matthew			Epidemiological Characteristics of Classical Scrapie Outbreaks in 30 Sheep Flocks in the United Kingdom	PLOS ONE			English	Article							PRP GENOTYPE; NATURAL SCRAPIE; GREAT-BRITAIN; BRITISH SHEEP; TRANSMISSION FACTORS; CLOSED FLOCK; SUSCEPTIBILITY; GENE; ASSOCIATION; FREQUENCIES	Background: Most previous analyses of scrapie outbreaks have focused on flocks run by research institutes, which may not reflect the field situation. Within this study, we attempt to rectify this deficit by describing the epidemiological characteristics of 30 sheep flocks naturally-infected with classical scrapie, and by exploring possible underlying causes of variation in the characteristics between flocks, including flock-level prion protein (PrP) genotype profile. In total, the study involved PrP genotype data for nearly 8600 animals and over 400 scrapie cases. Methodology/Principal Findings: We found that most scrapie cases were restricted to just two PrP genotypes (ARQ/VRQ and VRQ/VRQ), though two flocks had markedly different affected genotypes, despite having similar underlying genotype profiles to other flocks of the same breed; we identified differences amongst flocks in the age of cases of certain PrP genotypes; we found that the age-at-onset of clinical signs depended on peak incidence and flock type; we found evidence that purchasing infected animals is an important means of introducing scrapie to a flock; we found some evidence that flock-level PrP genotype profile and flock size account for variation in outbreak characteristics; identified seasonality in cases associated with lambing time in certain flocks; and we identified one case that was homozygous for phenylalanine at codon 141, a polymorphism associated with a very high risk of atypical scrapie, and 28 cases that were heterozygous at this codon. Conclusions/Significance: This paper presents the largest study to date on commercially-run sheep flocks naturally-infected with classical scrapie, involving 30 study flocks, more than 400 scrapie cases and over 8500 PrP genotypes. We show that some of the observed variation in epidemiological characteristics between farms is related to differences in their PrP genotype profile; although much remains unexplained and may instead be attributed to the stochastic nature of scrapie dynamics.	[Gubbins, Simon] Inst Anim Hlth, Pirbright Lab, Pirbright, Surrey, England; [Goldmann, Wilfred; Hunter, Nora] Univ Edinburgh, RDSVS, Edinburgh EH8 9YL, Midlothian, Scotland; [Goldmann, Wilfred; Hunter, Nora] Univ Edinburgh, Roslin Inst, Neuropathogenesis Div, Edinburgh EH8 9YL, Midlothian, Scotland; [Baylis, Matthew] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool	McIntyre, KM (corresponding author), Inst Anim Hlth, Pirbright Lab, Pirbright, Surrey, England.	simon.gubbins@bbsrc.ac.uk	Baylis, Matthew/S-7694-2019; McIntyre, (Kirsty) Marie/B-6907-2013	Baylis, Matthew/0000-0003-0335-187X; Gubbins, Simon/0000-0003-0538-4173; McIntyre, Kirsty Marie/0000-0003-1360-122X	Biotechnology and Biological Sciences Research Council (BBSRC) [BS309857, IAH1055, IAH1320]; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241340, BBS/E/A/00001651, BBS/E/I/00001055, BBS/E/I/00001320] Funding Source: researchfish; BBSRC [BBS/E/A/00001651, BBS/E/D/05241340, BBS/E/I/00001320] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) [grant numbers BS309857, IAH1055, IAH1320]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Baylis M, 2002, J GEN VIROL, V83, P2907, DOI 10.1099/0022-1317-83-11-2907; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Collett D, 1994, MODELLING SURVIVAL D; Dawson M, 1998, VET REC, V142, P623; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; Elsen JM, 1999, ARCH VIROL, V144, P431, DOI 10.1007/s007050050516; *EUR FOOD SAF AUTH, 2005, EFSA J, V276, P1; FOSTER JD, 1989, VET REC, V125, P415, DOI 10.1136/vr.125.16.415; Goldmann W, 2005, J APPL MICROBIOL, V98, P1294, DOI 10.1111/j.1365-2672.2005.02568.x; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gubbins S, 2006, PREV VET MED, V73, P17, DOI 10.1016/j.prevetmed.2005.08.001; Gubbins S, 2005, PREV VET MED, V67, P143, DOI 10.1016/j.prevetmed.2004.08.007; Hagenaars TJ, 2003, EPIDEMIOL INFECT, V131, P1015, DOI 10.1017/S0950268803001055; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Healy AM, 2004, VET REC, V155, P493, DOI 10.1136/vr.155.16.493; Hoinville LJ, 2000, VET REC, V146, P455, DOI 10.1136/vr.146.16.455; Hopp P, 2001, PREV VET MED, V51, P183, DOI 10.1016/S0167-5877(01)00225-2; Houston EF, 2003, VET REC, V152, P333, DOI 10.1136/vr.152.11.333; Hunter N, 1998, J GEN VIROL, V79, P2079, DOI 10.1099/0022-1317-79-8-2079; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Luhken G, 2004, ARCH VIROL, V149, P1571, DOI 10.1007/s00705-004-0303-1; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; McIntyre K Marie, 2006, BMC Vet Res, V2, P20, DOI 10.1186/1746-6148-2-20; McIntyre K Marie, 2006, BMC Vet Res, V2, P25, DOI 10.1186/1746-6148-2-25; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Parry H.B., 1983, SCRAPIE DIS SHEEP HI; Redman CA, 2002, EPIDEMIOL INFECT, V128, P513, DOI 10.1017/S0950268802007008; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Sivam SK, 2006, VET REC, V158, P501, DOI 10.1136/vr.158.15.501; Sokal R. R., 1981, BIOMETRY; Tongue SC, 2006, VET REC, V158, P43, DOI 10.1136/vr.158.2.43; Touzeau S, 2006, ARCH VIROL, V151, P735, DOI 10.1007/s00705-005-0666-y; Vaccari G, 2007, J VIROL, V81, P7306, DOI 10.1128/JVI.02880-06; Vilas VJDR, 2006, VET REC, V159, P799; Woolhouse MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1205, DOI 10.1098/rspb.1998.0421; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	44	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3994	10.1371/journal.pone.0003994	http://dx.doi.org/10.1371/journal.pone.0003994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098982	Green Published, gold, Green Submitted			2022-12-27	WOS:000265462300006
J	Habuchi, S; Tsutsui, H; Kochaniak, AB; Miyawaki, A; van Oijen, AM				Habuchi, Satoshi; Tsutsui, Hidekazu; Kochaniak, Anna B.; Miyawaki, Atsushi; van Oijen, Antoine M.			mKikGR, a Monomeric Photoswitchable Fluorescent Protein	PLOS ONE			English	Article							PHOTOINDUCED PEPTIDE CLEAVAGE; TO-RED CONVERSION; PHOTOCONVERSION; MICROSCOPY; RESOLUTION; PROBES; GFP	The recent demonstration and utilization of fluorescent proteins whose fluorescence can be switched on and off has greatly expanded the toolkit of molecular and cell biology. These photoswitchable proteins have facilitated the characterization of specifically tagged molecular species in the cell and have enabled fluorescence imaging of intracellular structures with a resolution far below the classical diffraction limit of light. Applications are limited, however, by the fast photobleaching, slow photoswitching, and oligomerization typical for photoswitchable proteins currently available. Here, we report the molecular cloning and spectroscopic characterization of mKikGR, a monomeric version of the previously reported KikGR that displays high photostability and switching rates. Furthermore, we present single-molecule imaging experiments that demonstrate that individual mKikGR proteins can be localized with a precision of better than 10 nanometers, suggesting their suitability for super-resolution imaging.	[Kochaniak, Anna B.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tsutsui, Hidekazu; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan; [Habuchi, Satoshi] Tokyo Inst Technol, Graduate School of Science and Engineering, Tokyo, Japan; [Kochaniak, Anna B.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; RIKEN; Tokyo Institute of Technology; Harvard University	Habuchi, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	matsushi@brain.riken.go.jp; antoine_van_oijen@hms.harvard.edu	Miyawaki, Atsushi/K-3569-2014; van Oijen, Antoine/I-3167-2014; Habuchi, Satoshi/N-6037-2018	Miyawaki, Atsushi/0000-0002-2329-3235; van Oijen, Antoine/0000-0002-1794-5161; Habuchi, Satoshi/0000-0002-6663-2807; Loveland, Anna B./0000-0001-9172-7747	Armenise-Harvard Foundation; Searle Scholars Program	Armenise-Harvard Foundation; Searle Scholars Program	A.M.v.O. acknowledges financial support from the Armenise-Harvard Foundation and the Searle Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Cotlet M, 2001, CHEM PHYS LETT, V336, P415, DOI 10.1016/S0009-2614(01)00165-8; Dittrich PS, 2005, BIOPHYS J, V89, P3446, DOI 10.1529/biophysj.105.061713; Flors C, 2007, J AM CHEM SOC, V129, P13970, DOI 10.1021/ja074704l; Geisler C, 2007, APPL PHYS A-MATER, V88, P223, DOI 10.1007/s00339-007-4144-0; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Habuchi S, 2005, J AM CHEM SOC, V127, P8977, DOI 10.1021/ja047023o; Habuchi S, 2006, PHOTOCH PHOTOBIO SCI, V5, P567, DOI 10.1039/b516339k; Hayashi I, 2007, J MOL BIOL, V372, P918, DOI 10.1016/j.jmb.2007.06.037; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	34	132	142	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3944	10.1371/journal.pone.0003944	http://dx.doi.org/10.1371/journal.pone.0003944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079591	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458200008
J	Ren, CC; Gao, XW; Niu, G; Yan, ZM; Chen, XY; Zhao, H				Ren, Chuancheng; Gao, Xuwen; Niu, Gang; Yan, Zhimin; Chen, Xiaoyuan; Zhao, Heng			Delayed Postconditioning Protects against Focal Ischemic Brain Injury in Rats	PLOS ONE			English	Article								Background: We and others have reported that rapid ischemic postconditioning, interrupting early reperfusion after stroke, reduces infarction in rats. However, its extremely short therapeutic time windows, from a few seconds to minutes after reperfusion, may hinder its clinical translation. Thus, in this study we explored if delayed postconditioning, which is conducted a few hours after reperfusion, offers protection against stroke. Methods and Results: Focal ischemia was generated by 30 min occlusion of bilateral common carotid artery (CCA) combined with permanent occlusion of middle cerebral artery (MCA); delayed postconditioning was performed by repetitive, brief occlusion and release of the bilateral CCAs, or of the ipsilateral CCA alone. As a result, delayed postconditioning performed at 3h and 6h after stroke robustly reduced infarct size, with the strongest protection achieved by delayed postconditioning with 6 cycles of 15 min occlusion/15 min release of the ipsilateral CCA executed from 6h. We found that this delayed postconditioning provided long-term protection for up to two months by reducing infarction and improving outcomes of the behavioral tests; it also attenuated reduction in 2-[(18)F]-fluoro-2-deoxy-D-glucose (FDG)-uptake therefore improving metabolism, and reduced edema and blood brain barrier leakage. Reperfusion in ischemic stroke patients is usually achieved by tissue plasminogen activator (tPA) application, however, t-PA's side effect may worsen ischemic injury. Thus, we tested whether delayed postconditioning counteracts the exacerbating effect of t-PA. The results showed that delayed postconditioning mitigated the worsening effect of t-PA on infarction. Conclusion: Delayed postconditioning reduced ischemic injury after focal ischemia, which opens a new research avenue for stroke therapy and its underlying protective mechanisms.	[Gao, Xuwen; Yan, Zhimin; Zhao, Heng] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Niu, Gang; Chen, Xiaoyuan] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Ren, Chuancheng] Fudan Univ, Shanghai Med Sch, Shanghai No 5 Hosp, Dept Neurol, Shanghai, Peoples R China	Stanford University; Stanford University; Fudan University	Ren, CC (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	AHA [SDG 0730113N]; NIH [1R21NS057750-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057750] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by AHA grant SDG 0730113N (HZ) and NIH grant 1R21NS057750-01A2 (HZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2001, CIRCULATION, V103, P2897, DOI 10.1161/01.CIR.103.24.2897; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Belayev L, 1996, NEUROREPORT, V8, P55, DOI 10.1097/00001756-199612200-00012; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Deriu G P, 1994, Ann Vasc Surg, V8, P337, DOI 10.1007/BF02132994; GAO X, 2008, J NEUROSCI RES; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; GELB AW, 1989, ANESTHESIOLOGY, V70, P678, DOI 10.1097/00000542-198904000-00023; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Grego F, 2005, ANN VASC SURG, V19, P882, DOI 10.1007/s10016-005-7719-2; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; Nemethova M, 2008, CELL BIOL INT, V32, P128, DOI 10.1016/j.cellbi.2007.08.023; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Rehni AK, 2007, PHARMACOL REP, V59, P192; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Sakakibara Y, 1998, ANN SURG, V227, P134, DOI 10.1097/00000658-199801000-00019; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; TODD MM, 1992, ANESTHESIOLOGY, V76, P161; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x; WARNER DS, 1986, ANESTHESIOLOGY, V64, P19, DOI 10.1097/00000542-198601000-00004; Yang DY, 2007, NEUROL RES, V29, P274, DOI 10.1179/016164107X159171; Yoshimura S, 2006, AM J NEURORADIOL, V27, P1710; Zhang HF, 2008, NEUROREPORT, V19, P821, DOI 10.1097/WNR.0b013e3282ffda72; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2004, J CEREBR BLOOD F MET, V24, P681, DOI 10.1097/01.WCB.0000127161.89708.A5; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao JL, 2007, MICROVASC RES, V73, P137, DOI 10.1016/j.mvr.2006.09.002; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	41	94	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3851	10.1371/journal.pone.0003851	http://dx.doi.org/10.1371/journal.pone.0003851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066627	Green Submitted, Green Published, gold			2022-12-27	WOS:000265455700001
J	Wang-Sattler, R; Yu, Y; Mittelstrass, K; Lattka, E; Altmaier, E; Gieger, C; Ladwig, KH; Dahmen, N; Weinberger, KM; Hao, P; Liu, L; Li, Y; Wichmann, HE; Adamski, J; Suhre, K; Illig, T				Wang-Sattler, Rui; Yu, Yao; Mittelstrass, Kirstin; Lattka, Eva; Altmaier, Elisabeth; Gieger, Christian; Ladwig, Karl H.; Dahmen, Norbert; Weinberger, Klaus M.; Hao, Pei; Liu, Lei; Li, Yixue; Wichmann, H. -Erich; Adamski, Jerzy; Suhre, Karsten; Illig, Thomas			Metabolic Profiling Reveals Distinct Variations Linked to Nicotine Consumption in Humans - First Results from the KORA Study	PLOS ONE			English	Article							H-1-NMR METABONOMICS; MEMBRANE REPAIR; LUNG; SMOKING; DISEASE; BIOSYNTHESIS; PLASMALOGENS; DEFICIENCY; EXPRESSION; CONTINUUM	Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e. g. plasmalogens). Consistently significant results were further found for the ratios of plasmalogens to diacyl-phosphatidylcolines, which are reduced in smokers and regulated by the enzyme alkylglycerone phosphate synthase (alkyl-DHAP) in both ether lipid and glycerophospholipid pathways. Notably, our metabolite profiles are consistent with the strong down-regulation of the gene for alkyl-DHAP (AGPS) in smokers that has been found in a study analyzing gene expression in human lung tissues. Our data suggest that smoking is associated with plasmalogen-deficiency disorders, caused by reduced or lack of activity of the peroxisomal enzyme alkyl-DHAP. Our findings provide new insight into the pathophysiology of smoking addiction. Activation of the enzyme alkyl-DHAP by small molecules may provide novel routes for therapy.	[Mittelstrass, Kirstin; Lattka, Eva; Gieger, Christian; Ladwig, Karl H.; Wichmann, H. -Erich; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Yu, Yao; Hao, Pei; Liu, Lei; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab of Syst Biol, Bioinformat Ctr, Beijing 100864, Peoples R China; [Altmaier, Elisabeth; Suhre, Karsten] German Res Ctr Environm Hlth, Helmholtz Zent Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Gieger, Christian; Wichmann, H. -Erich] Univ Munich, Inst Med Informat, Biomet & Epidemiol, D-80539 Munich, Germany; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Weinberger, Klaus M.] Biocrates Life Sci AG, Innsbruck, Austria; [Hao, Pei; Liu, Lei; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zent Munchen, Genome Anal Ctr, Inst Experiment Genet, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Experiment Genet, D-8000 Munich, Germany; [Suhre, Karsten] Univ Munich, Fac Biol, D-80539 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Johannes Gutenberg University of Mainz; Chinese Academy of Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich	Wang-Sattler, R (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany.	rui.wang-sattler@helmholtz-muenchen.de	Wang-Sattler, Rui/B-5354-2014; Wichmann, Heinz Erich/AAA-5695-2022; Reischl, Eva/B-9311-2013; Suhre, Karsten/AAF-1778-2020; Ladwig, Karl-Heinz/B-5351-2014; Yu, Yao/B-5868-2015	Wang-Sattler, Rui/0000-0002-8794-8229; Reischl, Eva/0000-0003-4055-8060; Suhre, Karsten/0000-0001-9638-3912; Ladwig, Karl-Heinz/0000-0003-0710-1720; Yu, Yao/0000-0002-2727-1746; Adamski, Jerzy/0000-0001-9259-0199; Weinberger, Klaus/0000-0002-8947-5306; Gieger, Christian/0000-0001-6986-9554; Hao, Pei/0000-0002-1498-7059	Helmholtz Zentrum Munchen; German National Genome Research Network (NGFN); DFG program "SPP 1226" [DA 370/6-1]; 863 Hi-Tech Program of China [2007AA02Z304]	Helmholtz Zentrum Munchen(Helmholtz Association); German National Genome Research Network (NGFN); DFG program "SPP 1226"(German Research Foundation (DFG)); 863 Hi-Tech Program of China(National High Technology Research and Development Program of China)	This work was supported by the Helmholtz Zentrum Munchen, the German National Genome Research Network (NGFN), the DFG program "SPP 1226" (Nicotine: Molecular and Physiological Effects in Central Nervous System, grant DA 370/6-1) and the 863 Hi-Tech Program of China (863) (grant 2007AA02Z304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Korpela M, 2007, EXPERT REV MOL DIAGN, V7, P761, DOI 10.1586/14737159.7.6.761; ALTMAIER E, 2008, ENDOCRINOLOGY; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chambers JM., 1992, STAT MODELS S; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; GIEGER C, 2008, PLOS GENET IN PRESS; Gochman E, 2007, AM J MED SCI, V333, P346, DOI 10.1097/MAJ.0b013e318065b57c; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hecht SS, 2004, JNCI-J NATL CANCER I, V96, P107, DOI 10.1093/jnci/djh016; HOLLANDER M, 1973, NONPARAMETRIC STAT I; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Huth C, 2007, J STUD ALCOHOL DRUGS, V68, P6, DOI 10.15288/jsad.2007.68.6; JALEEL A, 2007, WORLD APPL SCI J, V2, P348; Joseph AM, 2005, CANCER EPIDEM BIOMAR, V14, P2963, DOI 10.1158/1055-9965.EPI-04-0768; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Leone A, 2005, CURR PHARM DESIGN, V11, P2199, DOI 10.2174/1381612054367391; Li Ming D, 2006, Curr Psychiatry Rep, V8, P158, DOI 10.1007/s11920-006-0016-0; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Mackay J, 2006, TOBACCO ATLAS; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; MOCHIZUKI M, 1984, AM J OBSTET GYNECOL, V149, P413, DOI 10.1016/0002-9378(84)90156-X; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Ofman R, 2001, BIOCHEM BIOPH RES CO, V281, P754, DOI 10.1006/bbrc.2001.4407; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rehan VK, 2007, AM J PHYSIOL-LUNG C, V292, pL323, DOI 10.1152/ajplung.00071.2006; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Robertson DG, 2007, J PROTEOME RES, V6, P526, DOI 10.1021/pr060535c; Rudiger M, 1998, AM J PHYSIOL-LUNG C, V274, pL143, DOI 10.1152/ajplung.1998.274.1.L143; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; UNTERWURZACHER I, 2008, CLIN CHEM LAB MED; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; WANDERS RJA, 1986, EUR J PEDIATR, V145, P172, DOI 10.1007/BF00446057; WANG T, 2008, ENV TOXICOL; Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weckwerth W, 2002, CURR OPIN BIOTECH, V13, P156, DOI 10.1016/S0958-1669(02)00299-9; Weinberger Klaus M, 2008, Ther Umsch, V65, P487, DOI 10.1024/0040-5930.65.9.487; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; XAVIER F, 1996, REV PAUL MED, V114, P1298; Yildiz D, 1998, TOXICOLOGY, V130, P155, DOI 10.1016/S0300-483X(98)00105-X	53	92	93	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3863	10.1371/journal.pone.0003863	http://dx.doi.org/10.1371/journal.pone.0003863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057651	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452300005
J	Palacios, C; Zettler, E; Amils, R; Amaral-Zettler, L				Palacios, Carmen; Zettler, Erik; Amils, Ricardo; Amaral-Zettler, Linda			Contrasting Microbial Community Assembly Hypotheses: A Reconciling Tale from the Rio Tinto	PLOS ONE			English	Article							EXTREME ACIDIC ENVIRONMENT; DIVERSITY; ECOLOGY; RIVER; SEQUENCES; CHANCE; UNITS	Background: The Rio Tinto (RT) is distinguished from other acid mine drainage systems by its natural and ancient origins. Microbial life from all three domains flourishes in this ecosystem, but bacteria dominate metabolic processes that perpetuate environmental extremes. While the patchy geochemistry of the RT likely influences the dynamics of bacterial populations, demonstrating which environmental variables shape microbial diversity and unveiling the mechanisms underlying observed patterns, remain major challenges in microbial ecology whose answers rely upon detailed assessments of community structures coupled with fine-scale measurements of physico-chemical parameters. Methodology/Principal Findings: By using high-throughput environmental tag sequencing we achieved saturation of richness estimators for the first time in the RT. We found that environmental factors dictate the distribution of the most abundant taxa in this system, but stochastic niche differentiation processes, such as mutation and dispersal, also contribute to observed diversity patterns. Conclusions/Significance: We predict that studies providing clues to the evolutionary and ecological processes underlying microbial distributions will reconcile the ongoing debate between the Baas Becking vs. Hubbell community assembly hypotheses.	[Palacios, Carmen; Amaral-Zettler, Linda] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA; [Palacios, Carmen; Amaral-Zettler, Linda] NASA Astrobiol Inst, Marine Biol Lab, Woods Hole, MA USA; [Zettler, Erik; Amils, Ricardo] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Zettler, Erik] Sea Educ Assoc, Woods Hole, MA USA; [Amils, Ricardo] INTA CSIC, Ctr Astrobiol, Torrejon de Ardoz, Spain	Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; National Aeronautics & Space Administration (NASA); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Palacios, C (corresponding author), Univ Perpignan Via Domitia, CNRS EPHE UPVD, UMR 5244, Ctr Biol & Ecol Trop & Mediterraneenne,Equipe Par, Perpignan, France.	amaral@mbl.edu	Amils, Ricardo/X-2706-2019	Zettler, Erik/0000-0002-9266-1142	NASA Astrobiology Institute [NC-1054 LAZ]; Ministry of Science and Education [CGL2006/02534/BOS RA]; Spanish Centro de Astrobiologia	NASA Astrobiology Institute; Ministry of Science and Education; Spanish Centro de Astrobiologia	This work was supported by grants from NASA Astrobiology Institute (NC-1054 LAZ) and from the Ministry of Science and Education (CGL2006/02534/BOS RA) and support to CP by the Spanish Centro de Astrobiologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Aguilera A, 2006, APPL ENVIRON MICROB, V72, P5325, DOI 10.1128/AEM.00513-06; Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Amils R, 2007, PLANET SPACE SCI, V55, P370, DOI 10.1016/j.pss.2006.02.006; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; COLE JR, 2005, NUCLEIC ACIDS RES, V33, P1362, DOI DOI 10.1093/NAR/GKI254; Colwell RK, 2013, ESTIMATES STAT ESTIM; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dobyns JR, 1997, ENVIRON ENTOMOL, V26, P150, DOI 10.1093/ee/26.2.150; DYSZYNSKI G, RDPQUERY JAVA PROGRA; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Green BD, 2006, CURR OPIN BIOTECH, V17, P236, DOI 10.1016/j.copbio.2006.05.004; Hallberg KB, 2006, APPL ENVIRON MICROB, V72, P2022, DOI 10.1128/AEM.72.3.2022-2030.2006; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hubbell Stephen P., 2001, V32, pi; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; Karavaiko GI, 2003, INT J SYST EVOL MICR, V53, P113, DOI 10.1099/ijs.0.02319-0; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Klepac-Ceraj V., 2006, ONLINE J BIOINFORM, V7, P15; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Kysela DT, 2005, ENVIRON MICROBIOL, V7, P356, DOI 10.1111/j.1462-2920.2004.00712.x; LEGENDRE P, 1998, NUMERICAL ECOLOGY, P445; Lopez-Archilla AI, 2001, MICROB ECOL, V41, P20; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; PALACIOS C, 2006, P OC BIOD INF INT C; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SLAYMAN CL, 1985, BIOSCIENCE, V35, P16, DOI 10.2307/1310077; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	52	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3853	10.1371/journal.pone.0003853	http://dx.doi.org/10.1371/journal.pone.0003853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052647	Green Published, gold			2022-12-27	WOS:000265452200006
J	Martinovic, J; Gruber, T; Muller, MM				Martinovic, Jasna; Gruber, Thomas; Mueller, Matthias M.			Coding of Visual Object Features and Feature Conjunctions in the Human Brain	PLOS ONE			English	Article							GAMMA BAND RESPONSES; REPETITION PRIMING TASK; TIME-COURSE; NEUROPHYSIOLOGICAL EVIDENCE; BIOELECTRIC EVENTS; EVOKED-POTENTIALS; RECOGNITION; COLOR; EEG; REPRESENTATIONS	Object recognition is achieved through neural mechanisms reliant on the activity of distributed coordinated neural assemblies. In the initial steps of this process, an object's features are thought to be coded very rapidly in distinct neural assemblies. These features play different functional roles in the recognition process - while colour facilitates recognition, additional contours and edges delay it. Here, we selectively varied the amount and role of object features in an entry-level categorization paradigm and related them to the electrical activity of the human brain. We found that early synchronizations (approx. 100 ms) increased quantitatively when more image features had to be coded, without reflecting their qualitative contribution to the recognition process. Later activity (approx. 200-400 ms) was modulated by the representational role of object features. These findings demonstrate that although early synchronizations may be sufficient for relatively crude discrimination of objects in visual scenes, they cannot support entry-level categorization. This was subserved by later processes of object model selection, which utilized the representational value of object features such as colour or edges to select the appropriate model and achieve identification.	[Martinovic, Jasna] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, D-4500 Osnabruck, Germany; [Mueller, Matthias M.] Univ Leipzig, Inst Psychol I, Leipzig, Germany	University of Liverpool; University Osnabruck; Leipzig University	Martinovic, J (corresponding author), Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England.	m.mueller@rz.uni-leipzig.de	Martinovic, Jasna/C-7633-2009; martinovic, jasna/AAH-9926-2019	Martinovic, Jasna/0000-0001-9141-2577; martinovic, jasna/0000-0001-9141-2577; Lauwereyns, Jan/0000-0003-0551-2550	Deutsche Forschungsgemeinschaft; DAAD; ESRC; ESRC [ES/G006180/1] Funding Source: UKRI; Economic and Social Research Council [ES/G006180/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Deutsche Forschungsgemeinschaft supported this research. J.M. was supported by the DAAD and the ESRC.	Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; BERTRAND O, 1994, NATO ADV SCI INST SE, V271, P231; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Conrad N, 2007, NEUROSCI LETT, V429, P126, DOI 10.1016/j.neulet.2007.09.065; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doniger GM, 2000, J COGNITIVE NEUROSCI, V12, P615, DOI 10.1162/089892900562372; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; ENGBERT R, 2006, FUNDAMENTALS VISION, P177; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fize D, 2005, BRAIN COGNITION, V59, P145, DOI 10.1016/j.bandc.2005.06.002; Frund I, 2007, VISION RES, V47, P2086, DOI 10.1016/j.visres.2007.03.022; Frund I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001675; Funnell E, 2006, Q J EXP PSYCHOL, V59, P268, DOI 10.1080/02724980443000674; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Herrmann CS, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-13; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Karakas S, 1998, INT J PSYCHOPHYSIOL, V31, P13, DOI 10.1016/S0167-8760(98)00030-0; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Martinovic J, 2008, BRAIN RES, V1198, P93, DOI 10.1016/j.brainres.2007.12.050; Martinovic J, 2007, J COGNITIVE NEUROSCI, V19, P921, DOI 10.1162/jocn.2007.19.6.921; Muller MM, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904322926827; Naor-Raz G, 2003, PERCEPTION, V32, P667, DOI 10.1068/p5050; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Regan D., 1989, HUMAN BRAIN ELECTROP; Reis A, 2006, BRAIN COGNITION, V60, P49, DOI 10.1016/j.bandc.2005.09.012; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Rousselet GA, 2007, J COGNITIVE NEUROSCI, V19, P1241, DOI 10.1162/jocn.2007.19.8.1241; Schendan HE, 2007, J COGNITIVE NEUROSCI, V19, P734, DOI 10.1162/jocn.2007.19.5.734; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schendan HE, 2002, NEUROPSYCHOLOGIA, V40, P931, DOI 10.1016/S0028-3932(01)00176-2; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka J, 2001, TRENDS COGN SCI, V5, P211, DOI 10.1016/S1364-6613(00)01626-0; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; van Schie HT, 2003, BRAIN LANG, V86, P300, DOI 10.1016/S0093-934X(02)00546-1; VANRIJN AC, 1991, MED BIOL ENG COMPUT, V29, P433, DOI 10.1007/BF02441666; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	55	55	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3781	10.1371/journal.pone.0003781	http://dx.doi.org/10.1371/journal.pone.0003781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XG	19023428	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448800002
J	Yang, CY; Cao, GC; Li, Y; Zhang, XJ; Ren, HY; Wang, X; Feng, JH; Zhao, LP; Xu, P				Yang, Chunyu; Cao, Guangchun; Li, Yang; Zhang, Xiaojun; Ren, Hongyan; Wang, Xia; Feng, Jinhui; Zhao, Liping; Xu, Ping			A Constructed Alkaline Consortium and Its Dynamics in Treating Alkaline Black Liquor with Very High Pollution Load	PLOS ONE			English	Article							MILL WASTE-WATER; PULP-MILL; MICROBIAL DIVERSITY; POPULATION-DYNAMICS; COMMUNITY DYNAMICS; WHEAT-STRAW; LIGNIN; REACTOR; DECOLORIZATION; EFFLUENTS	Background: Paper pulp wastewater resulting from alkaline extraction of wheat straw, known as black liquor, is very difficult to be treated and causes serious environmental problems due to its high pH value and chemical oxygen demand (COD) pollution load. Lignin, semicellulose and cellulose are the main contributors to the high COD values in black liquor. Very few microorganisms can survive in such harsh environments of the alkaline wheat straw black liquor. A naturally developed microbial community was found accidentally in a black liquor storing pool in a paper pulp mill of China. The community was effective in pH decreasing, color and COD removing from the high alkaline and high COD black liquor. Findings: Thirty-eight strains of bacteria were isolated from the black liquor storing pool, and were grouped as eleven operational taxonomy units (OTUs) using random amplified polymorphic DNA-PCR profiles (RAPD). Eleven representative strains of each OTU, which were identified as genera of Halomonas and Bacillus, were used to construct a consortium to treat black liquor with a high pH value of 11.0 and very high COD pollution load of 142,600 mg l(-1). After treatment by the constructed consortium, about 35.4% of color and 39,000 mg l(-1) (27.3%) CODcr were removed and the pH decreased to 7.8. 16S rRNA gene polymerase chain reaction denaturant gradient gel electrophoresis (PCR-DGGE) and gas chromatography/mass spectrometry (GC/MS) analysis suggested a two-stage treatment mechanism to elucidate the interspecies collaboration: Halomonas isolates were important in the first stage to produce organic acids that contributed to the pH decline, while Bacillus isolates were involved in the degradation of lignin derivatives in the second stage under lower pH conditions. Conclusions/Significance: Tolerance to the high alkaline environment and good controllability of the simple consortium suggested that the constructed consortium has good potential for black liquor treatment. Facilitating the treatment process by the constructed consortium would provide a promising opportunity to reduce the pollution, as well as to save forest resources and add value to a waste product.	[Yang, Chunyu; Cao, Guangchun; Li, Yang; Wang, Xia; Feng, Jinhui; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Xiaojun; Ren, Hongyan; Zhao, Liping; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Minist Ed, Key Lab Microbial Metabolism, Shanghai, Peoples R China	Shandong University; Shanghai Jiao Tong University	Yang, CY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	pingxu@sdu.edu.cn	Zhang, Xiaojun/AAH-2256-2019; Zhang, Xiaojun/E-9521-2016; Liu, Wenjun/L-5256-2016	Zhang, Xiaojun/0000-0002-4559-0177; Zhang, Xiaojun/0000-0002-4559-0177; Liu, Wenjun/0000-0001-9380-2990	Ministry of Science and Technology of China; National Basic Research Program of China [2007CB707803]; Chinese National Programs for High Technology Research and Development [2006AA020101, 2006AA02Z244]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China)	The work was partially supported by the grants from the Ministry of Science and Technology of China, National Basic Research Program of China (2007CB707803) and Chinese National Programs for High Technology Research and Development (2006AA020101 and 2006AA02Z244).	BAJPAI P, 1993, PROCESS BIOCHEM, V28, P377, DOI 10.1016/0032-9592(93)80024-B; Buzzini AP, 2006, PROCESS BIOCHEM, V41, P168, DOI 10.1016/j.procbio.2005.06.009; Buzzini AP, 2005, CHEMOSPHERE, V59, P55, DOI 10.1016/j.chemosphere.2004.09.102; Camarero S, 2001, J ANAL APPL PYROL, V58, P413, DOI 10.1016/S0165-2370(00)00115-7; Carrero-Colon M, 2006, FEMS MICROBIOL ECOL, V57, P1, DOI 10.1111/j.1574-6941.2006.00095.x; CPPA, 1974, TECHN SECT STAND MET; Dafinov A, 2005, DESALINATION, V173, P83, DOI 10.1016/j.desal.2004.07.044; Fenning TM, 2002, TRENDS BIOTECHNOL, V20, P291, DOI 10.1016/S0167-7799(02)01983-2; Font X, 2003, J CHEM TECHNOL BIOT, V78, P548, DOI 10.1002/jctb.834; Ganjidoust H, 1997, WATER SCI TECHNOL, V35, P291, DOI 10.2166/wst.1997.0541; Garg SK, 1999, CRIT REV BIOTECHNOL, V19, P85, DOI 10.1080/0738-859991229206; Greenberg A.E., 1992, STANDARD METHODS EXA, V18; Grover R, 2001, J CHEM TECHNOL BIOT, V76, P251, DOI 10.1002/jctb.371; Gupta VK, 2001, J CHEM TECHNOL BIOT, V76, P547, DOI 10.1002/jctb.417.abs; Harris AT, 2008, J CLEAN PROD, V16, P1971, DOI 10.1016/j.jclepro.2008.02.005; Huang GL, 2007, BIORESOURCE TECHNOL, V98, P2829, DOI 10.1016/j.biortech.2006.09.029; Jain Neeraj, 1997, Indian Journal of Experimental Biology, V35, P139; KAAL EEJ, 1995, BIORESOURCE TECHNOL, V53, P133, DOI 10.1016/0960-8524(95)00066-N; Ko CH, 2007, BIORESOURCE TECHNOL, V98, P2727, DOI 10.1016/j.biortech.2006.09.034; Konopka A, 2007, ENVIRON MICROBIOL, V9, P1584, DOI 10.1111/j.1462-2920.2007.01326.x; Kumar Lokesh, 2001, Indian Journal of Experimental Biology, V39, P584; Lara MA, 2003, INT BIODETER BIODEGR, V52, P167, DOI 10.1016/S0964-8305(03)00055-6; Lim JM, 2004, INT J SYST EVOL MICR, V54, P2037, DOI 10.1099/ijs.0.63194-0; Liu BB, 2006, FEMS MICROBIOL ECOL, V55, P274, DOI 10.1111/j.1574-6941.2005.00033.x; Liu GL, 2004, DESALINATION, V160, P131, DOI 10.1016/S0011-9164(04)90003-3; Lozada M, 2006, ENVIRON MICROBIOL, V8, P625, DOI 10.1111/j.1462-2920.2005.00939.x; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; REN X, 1998, J CLEAN PROD, V6, P349, DOI DOI 10.1016/S0959-6526(98)00023-7; Roncero MB, 2003, BIORESOURCE TECHNOL, V87, P305, DOI 10.1016/S0960-8524(02)00224-9; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Stougaard P, 2002, ENVIRON MICROBIOL, V4, P487, DOI 10.1046/j.1462-2920.2002.00327.x; SUTHERLAND JB, 1983, CAN J MICROBIOL, V29, P1253, DOI 10.1139/m83-195; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiago I, 2004, APPL ENVIRON MICROB, V70, P7378, DOI 10.1128/AEM.70.12.7378-7387.2004; Tresse O, 2005, J APPL MICROBIOL, V98, P440, DOI 10.1111/j.1365-2672.2004.02475.x; Wu J, 2005, BIORESOURCE TECHNOL, V96, P1357, DOI 10.1016/j.biortech.2004.11.019; Xiong Z, 2007, J BIOSCI BIOENG, V104, P446, DOI 10.1263/jbb.104.446; Zhang QL, 2001, ADV ENVIRON RES, V5, P251, DOI 10.1016/S1093-0191(00)00059-9	41	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3777	10.1371/journal.pone.0003777	http://dx.doi.org/10.1371/journal.pone.0003777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020664	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448600010
J	Iliopoulos, D; Malizos, KN; Oikonomou, P; Tsezou, A				Iliopoulos, Dimitrios; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia			Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks	PLOS ONE			English	Article								Background: Osteoarthritis is a multifactorial disease characterized by destruction of the articular cartilage due to genetic, mechanical and environmental components affecting more than 100 million individuals all over the world. Despite the high prevalence of the disease, the absence of large-scale molecular studies limits our ability to understand the molecular pathobiology of osteoathritis and identify targets for drug development. Methodology/Principal Findings: In this study we integrated genetic, bioinformatic and proteomic approaches in order to identify new genes and their collaborative networks involved in osteoarthritis pathogenesis. MicroRNA profiling of patient-derived osteoarthritic cartilage in comparison to normal cartilage, revealed a 16 microRNA osteoarthritis gene signature. Using reverse-phase protein arrays in the same tissues we detected 76 differentially expressed proteins between osteoarthritic and normal chondrocytes. Proteins such as SOX11, FGF23, KLF6, WWOX and GDF15 not implicated previously in the genesis of osteoarthritis were identified. Integration of microRNA and proteomic data with microRNA gene-target prediction algorithms, generated a potential "interactome'' network consisting of 11 microRNAs and 58 proteins linked by 414 potential functional associations. Comparison of the molecular and clinical data, revealed specific microRNAs (miR-22, miR-103) and proteins (PPARA, BMP7, IL1B) to be highly correlated with Body Mass Index (BMI). Experimental validation revealed that miR-22 regulated PPARA and BMP7 expression and its inhibition blocked inflammatory and catabolic changes in osteoarthritic chondrocytes. Conclusions/Significance: Our findings indicate that obesity and inflammation are related to osteoarthritis, a metabolic disease affected by microRNA deregulation. Gene network approaches provide new insights for elucidating the complexity of diseases such as osteoarthritis. The integration of microRNA, proteomic and clinical data provides a detailed picture of how a network state is correlated with disease and furthermore leads to the development of new treatments. This strategy will help to improve the understanding of the pathogenesis of multifactorial diseases such as osteoarthritis and provide possible novel therapeutic targets.	[Iliopoulos, Dimitrios; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia] Inst Biomed Res & Technol, Larisa, Greece; [Malizos, Konstantinos N.] Univ Thessaly, Sch Med, Dept Orthopaed, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Univ Hosp, Sch Med, Lab Cytogenet & Mol Genet, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Sch Med, Dept Biol, Larisa, Greece	University of Thessaly; General University Hospital of Larissa; University of Patras; University of Thessaly; University of Thessaly	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	atsezou@med.uth.gr	Iliopoulos, Dimitrios/AAE-9106-2019		Hellenic Association of Orthopaedic Surgery and Traumatology	Hellenic Association of Orthopaedic Surgery and Traumatology	Funding support was provided from Hellenic Association of Orthopaedic Surgery and Traumatology. Funding organizations did not have any role in study design, data collection, interpretation of the results, decision to publish, or preparation of the manuscript.	AQEILAN RI, 2008, J BIOL CHEM, V16; Aspden RM, 2001, LANCET, V357, P1118, DOI 10.1016/S0140-6736(00)04264-1; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gulmann C, 2005, CLIN CANCER RES, V11, P5847, DOI 10.1158/1078-0432.CCR-05-0637; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; HUBER J, 2008, J CLIN ENDOCRINOL ME, V20; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lementowski Peter W, 2008, Am J Orthop (Belle Mead NJ), V37, P148; LOHMANDER LS, 2008, ANN RHEUM DIS, V8; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MARCH LM, 2008, AM J ORTHOPSYCHIAT, V37, P148; Marks R, 2007, OBESITY, V15, P1867, DOI 10.1038/oby.2007.221; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Ostalowska A, 2006, OSTEOARTHR CARTILAGE, V14, P139, DOI 10.1016/j.joca.2005.08.009; SELBACH M, 2008, NATURE          0730; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Spector T. D., 2004, Osteoarthritis and Cartilage, V12, P39, DOI 10.1016/j.joca.2003.09.005; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tongbai R, 2008, AM J PATHOL, V172, P495, DOI 10.2353/ajpath.2008.061079; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Vincourt JB, 2006, MOL CELL PROTEOMICS, V5, P1984, DOI 10.1074/mcp.T600007-MCP200; Watters JW, 2007, ARTHRITIS RHEUM, V56, P2999, DOI 10.1002/art.22836; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yeh LCC, 2004, BIOCHEM BIOPH RES CO, V323, P223, DOI 10.1016/j.bbrc.2004.08.080	40	397	428	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3740	10.1371/journal.pone.0003740	http://dx.doi.org/10.1371/journal.pone.0003740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011694	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300008
J	Lopes, PC; Sucena, E; Santos, ME; Magalhaes, S				Lopes, Patricia C.; Sucena, Elio; Santos, M. Emilia; Magalhaes, Sara			Rapid Experimental Evolution of Pesticide Resistance in C. elegans Entails No Costs and Affects the Mating System	PLOS ONE			English	Article								Pesticide resistance is a major concern in natural populations and a model trait to study adaptation. Despite the importance of this trait, the dynamics of its evolution and of its ecological consequences remain largely unstudied. To fill this gap, we performed experimental evolution with replicated populations of Caenorhabditis elegans exposed to the pesticide Levamisole during 20 generations. Exposure to Levamisole resulted in decreased survival, fecundity and male frequency, which declined from 30% to zero. This was not due to differential susceptibility of males. Rather, the drug affected mobility, resulting in fewer encounters, probably leading to reduced outcrossing rates. Adaptation, i.e., increased survival and fecundity, occurred within 10 and 20 generations, respectively. Male frequency also increased by generation 20. Adaptation costs were undetected in the ancestral environment and in presence of Ivermectin, another widely-used pesticide with an opposite physiological effect. Our results demonstrate that pesticide resistance can evolve at an extremely rapid pace. Furthermore, we unravel the effects of behaviour on life-history traits and test the environmental dependence of adaptation costs. This study establishes experimental evolution as a powerful tool to tackle pesticide resistance, and paves the way to further investigations manipulating environmental and/or genetic factors underlying adaptation to pesticides.	[Lopes, Patricia C.] Univ Porto, Programa Grad Areas Biol Basica & Aplicada GABBA, Fac Med, P-4100 Oporto, Portugal; [Lopes, Patricia C.; Sucena, Elio; Santos, M. Emilia; Magalhaes, Sara] Inst Gulbenkian Ciencias, Ctr Biol Desenvolvimento, Oeiras, Portugal; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal	Universidade do Porto; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Lopes, PC (corresponding author), Univ Porto, Programa Grad Areas Biol Basica & Aplicada GABBA, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	smagalhaes@igc.gulbenkian.pt	S., Magalhaes/B-9673-2012; Sucena, Élio/M-1753-2015; Sucena, Élio/ABF-6684-2020; Lopes, Patricia C./AFK-9377-2022	S., Magalhaes/0000-0002-8609-7768; Sucena, Élio/0000-0001-8810-870X; Sucena, Élio/0000-0001-8810-870X; Santos, M. Emilia/0000-0003-3158-7935; Soares Castro Lopes, Patricia/0000-0001-5170-3230	Marie Curie [36589]; Fundacao para a Ciencia e Tecnologia (Portugal) [POCTI/BSE/48402/2002]	Marie Curie(European Commission); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	Marie Curie Reintegration grant (36589 - EVOL HET and ENV) and POCTI/BSE/48402/2002 grant from Fundacao para a Ciencia e Tecnologia (Portugal)	Anderson JB, 2003, GENETICS, V163, P1287; Arnaud L, 2005, FUNCT ECOL, V19, P1032, DOI 10.1111/j.1365-2435.2005.01055.x; Arnaud L, 2002, EVOLUTION, V56, P2435, DOI 10.1111/j.0014-3820.2002.tb00169.x; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; Bull JJ, 2001, ANNU REV ECOL SYST, V32, P183, DOI 10.1146/annurev.ecolsys.32.081501.114020; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; DELAGUERIE P, 1991, EVOL ECOL, V5, P361, DOI 10.1007/BF02214153; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Ffrench-Constant RH, 2007, TRENDS GENET, V23, P1, DOI 10.1016/j.tig.2006.11.006; Fleming JT, 1997, J NEUROSCI, V17, P5843; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Jasmin JN, 2007, ECOL LETT, V10, P272, DOI 10.1111/j.1461-0248.2007.01021.x; Kim J, 2001, GENETICS, V157, P1599; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; LEJAMBRE LF, 1995, INT J PARASITOL, V25, P691, DOI 10.1016/0020-7519(94)00200-8; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Sokal RR, 1995, BIOMETRY; Stewart AD, 2002, GENETICS, V160, P975; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Tietjen WJ, 2006, J ARACHNOL, V34, P285, DOI 10.1636/S04-50.1; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547	44	50	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3741	10.1371/journal.pone.0003741	http://dx.doi.org/10.1371/journal.pone.0003741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011681	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300009
J	Fredriksson, K; Tjader, I; Keller, P; Petrovic, N; Ahlman, B; Scheele, C; Wernerman, J; Timmons, JA; Rooyackers, O				Fredriksson, Katarina; Tjader, Inga; Keller, Pernille; Petrovic, Natasa; Ahlman, Bo; Scheele, Camilla; Wernerman, Jan; Timmons, James A.; Rooyackers, Olav			Dysregulation of Mitochondrial Dynamics and the Muscle Transcriptome in ICU Patients Suffering from Sepsis Induced Multiple Organ Failure	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BLOOD-GLUCOSE CONTROL; GENE-EXPRESSION; PROTEIN-SYNTHESIS; INFLAMMATORY RESPONSE; RECEPTOR EXPRESSION; ATROPHY INVOLVE; INSULIN; TRANSLATION; DYSFUNCTION	Background: Septic patients treated in the intensive care unit (ICU) often develop multiple organ failure including persistent skeletal muscle dysfunction which results in the patient's protracted recovery process. We have demonstrated that muscle mitochondrial enzyme activities are impaired in septic ICU patients impairing cellular energy balance, which will interfere with muscle function and metabolism. Here we use detailed phenotyping and genomics to elucidate mechanisms leading to these impairments and the molecular consequences. Methodology/Principal Findings: Utilising biopsy material from seventeen patients and ten age-matched controls we demonstrate that neither mitochondrial in vivo protein synthesis nor expression of mitochondrial genes are compromised. Indeed, there was partial activation of the mitochondrial biogenesis pathway involving NRF2a/GABP and its target genes TFAM, TFB1M and TFB2M yet clearly this failed to maintain mitochondrial function. We therefore utilised transcript profiling and pathway analysis of ICU patient skeletal muscle to generate insight into the molecular defects driving loss of muscle function and metabolic homeostasis. Gene ontology analysis of Affymetrix analysis demonstrated substantial loss of muscle specific genes, a global oxidative stress response related to most probably cytokine signalling, altered insulin related signalling and a substantial overlap between patients and muscle wasting/inflammatory animal models. MicroRNA 21 processing appeared defective suggesting that post-transcriptional protein synthesis regulation is altered by disruption of tissue microRNA expression. Finally, we were able to demonstrate that the phenotype of skeletal muscle in ICU patients is not merely one of inactivity, it appears to be an actively remodelling tissue, influenced by several mediators, all of which may be open to manipulation with the aim to improve clinical outcome. Conclusions/Significance: This first combined protein and transcriptome based analysis of human skeletal muscle obtained from septic patients demonstrated that losses of mitochondria and muscle mass are accompanied by sustained protein synthesis (anabolic process) while dysregulation of transcription programmes appears to fail to compensate for increased damage and proteolysis. Our analysis identified both validated and novel clinically tractable targets to manipulate these failing processes and pursuit of these could lead to new potential treatments.	[Fredriksson, Katarina; Tjader, Inga; Scheele, Camilla; Wernerman, Jan; Rooyackers, Olav] Karolinska Univ Hosp, Dept Anesthesiol & Intens Care, Karolinska Inst, Stockholm, Sweden; [Keller, Pernille; Timmons, James A.] Heriot Watt Univ, Edinburgh EH14 4AS, Midlothian, Scotland; [Ahlman, Bo] Karolinska Inst, CLINTEC, Dept Surg, Stockholm, Sweden; [Petrovic, Natasa; Timmons, James A.] Stockholm Univ, Wenner Gren Inst, Arrhenius Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Heriot Watt University; Karolinska Institutet; Stockholm University	Fredriksson, K (corresponding author), Karolinska Univ Hosp, Dept Anesthesiol & Intens Care, Karolinska Inst, Stockholm, Sweden.	olav.rooyackers@ki.se	Scheele, Camilla/S-6401-2017; Timmons, James A/M-6350-2019; Scheele, Camilla/AAA-3599-2020; Timmons, James A/J-4698-2014	Scheele, Camilla/0000-0002-6055-9709; Timmons, James A/0000-0002-2255-1220; Scheele, Camilla/0000-0002-6055-9709; Timmons, James A/0000-0002-2255-1220	Swedisch Research Council [04210, 14244]; Karolinska Research Foundation; Karolinska University Hospital; Heriot-Watt University	Swedisch Research Council; Karolinska Research Foundation; Karolinska University Hospital(Karolinska Institutet); Heriot-Watt University	These studies were supported by grants from the Swedisch Research Council (grants 04210 and 14244), Karolinska Research Foundation, Karolinska University Hospital Research Funds and Heriot-Watt University Funds. None of the sponsors or funders were involved in design or conduct of the study or the manuscript.	Almon RR, 2007, PHYSIOL GENOMICS, V30, P282, DOI 10.1152/physiolgenomics.00242.2006; Banwell BL, 2003, NEUROLOGY, V61, P1779, DOI 10.1212/01.WNL.0000098886.90030.67; Boczkowski J, 1999, FASEB J, V13, P1637, DOI 10.1096/fasebj.13.12.1637; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; BONE RC, 1992, JAMA-J AM MED ASSOC, V267, P1518, DOI 10.1001/jama.267.11.1518; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; CORBUCCI GG, 1985, CIRC SHOCK, V15, P15; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Cree MG, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-9; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; De Jonghe B, 1998, INTENS CARE MED, V24, P1242, DOI 10.1007/s001340050757; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fink Mitchell P, 2004, Curr Opin Crit Care, V10, P279, DOI 10.1097/01.ccx.0000130150.33814.71; Flaring UB, 2003, INTENS CARE MED, V29, P2193, DOI 10.1007/s00134-003-2031-5; Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; GASPARETTO A, 1983, LANCET, V2, P1486; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; HELLIWELL TR, 1990, J NEUROL SCI S, V98, P329; HENNIG G, 1975, FEBS LETT, V59, P142, DOI 10.1016/0014-5793(75)80361-9; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu ZY, 2007, DIABETES, V56, P2449, DOI 10.2337/db06-1731; Januszkiewicz A, 2005, CLIN SCI, V108, P179, DOI 10.1042/CS20040271; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; MCNURLAN MA, 1994, AM J PHYSIOL, V267, pE102, DOI 10.1152/ajpendo.1994.267.1.E102; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robinson CE, 1999, ENDOCRINOLOGY, V140, P1586, DOI 10.1210/en.140.4.1586; Rooyackers OE, 1997, CLIN SCI, V92, P189, DOI 10.1042/cs0920189; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; STEPHENS FB, 2005, FASEB J; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Sugiura T, 2006, J PHYSIOL SCI, V56, P393, DOI 10.2170/physiolsci.RP006906; Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thorell A, 2004, J CLIN ENDOCR METAB, V89, P5382, DOI 10.1210/jc.2004-1118; Timmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Wiik A, 2005, ACTA PHYSIOL SCAND, V184, P105, DOI 10.1111/j.1365-201X.2005.01433.x	69	115	119	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3686	10.1371/journal.pone.0003686	http://dx.doi.org/10.1371/journal.pone.0003686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997871	Green Published, Green Submitted, gold			2022-12-27	WOS:000265165500009
J	Catano, G; Kulkarni, H; He, W; Marconi, VC; Agan, BK; Landrum, M; Anderson, S; Delmar, J; Telles, V; Song, L; Castiblanco, J; Clark, RA; Dolan, MJ; Ahuja, SK				Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Delmar, Judith; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles	PLOS ONE			English	Article								A recent genome-wide association study (GWAS) suggested that polymorphisms in or around the genes HCP5, HLA-C and ZNRD1 confer restriction against HIV-1 viral replication or disease progression. Here, we also find that these alleles are associated with different aspects of HIV disease, albeit mainly in European Americans. Additionally, we offer that because the GWAS cohort was a subset of HIV-positive individuals, selected based in part on having a low viral load, the observed associations for viral load are magnified compared with those we detect in a large well-characterized prospective natural history cohort of HIV-1-infected persons. We also find that because of linkage disequilibrium (LD) patterns, the dominant viral load- and disease-influencing associations for the ZNRD1 or HLA-C and HCP5 alleles are apparent mainly when these alleles are present in HLA-A10- or HLA-B*57-containing haplotypes, respectively. ZNRD1 alleles lacking HLA-A10 did not confer disease protection whereas ZNRD1-A10 haplotypes did. When examined in isolation, the HCP5-G allele associates with a slow disease course and lower viral loads. However, in multivariate models, after partitioning out the protective effects of B*57, the HCP5-G allele associates with disease-acceleration and enhanced viral replication; these associations for HCP5-G are otherwise obscured because of the very strong LD between this allele and a subset of protective B*57 alleles. Furthermore, HCP5 and HLA-C alleles stratify B*57-containing genotypes into those that associate with either striking disease retardation or progressive disease, providing one explanation for the long-standing conundrum of why some HLA-B*57-carrying individuals are long-term non-progressors, whereas others exhibit progressive disease. Collectively, these data generally underscore the strong dependence of genotype-phenotype relationships upon cohort design, phenotype selection, LD patterns and populations studied. They specifically demonstrate that the influence of ZNRD1 alleles on disease progression rates are attributable to HLA-A10, help clarify the relationship between the HCP5, HLA-C and HLA-B*57 alleles, and reaffirm a critical role of HLA-B*57 alleles in HIV disease. Furthermore, as the protective B*57-containing genotypes convey striking salutary effects independent of their strong impact on viral control, it is conceivable that T cell-based therapeutic vaccine strategies aimed at reducing viral loads may be inadequate for limiting AIDS progression, raising the potential need for complementary strategies that target viral load- independent determinants of pathogenesis.	[Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Ahuja, Sunil K.] Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; [Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Delmar, Judith; Dolan, Matthew J.] Uniformed Serv Univ Hlth Sci, IDCRP, Bethesda, MD USA; [Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Delmar, Judith; Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol, San Antonio, TX USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Catano, G (corresponding author), Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA.	mdolan@hjf.org; ahujas@uthscsa.edu	Clark, Robert/Q-6764-2019; CASTIBLANCO, JOHN/B-6599-2009; Catano, Gabriel/AAQ-5387-2020; Kulkarni, Hemant/AEM-5750-2022; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/AFK-5812-2022	Clark, Robert/0000-0002-4892-3619; CASTIBLANCO, JOHN/0000-0002-7965-9822; Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; CASTIBLANCO, JOHN/0000-0003-2556-3697; Agan, Brian/0000-0002-5114-1669	Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System; MERIT award [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF); HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326, R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System; MERIT award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF); HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System, and by a MERIT award (R37046326) and other awards (AI043279 and MH069270) from the NIH (to S.K.A.). S.K.A. is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the WHMC cohort was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2007, JAIDS-J ACQ IMM DEF, V45, P454, DOI 10.1097/QAI.0b013e3180959a94; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blower S., 2003, AIDS Reviews, V5, P113; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DEBAKKER PIW, 2008, KEYST S MOL CELL BIO; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Dorak MT, 2006, GENES IMMUN, V7, P450, DOI 10.1038/sj.gene.6364315; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gilbert PB, 2003, BIOMETRICS, V59, P531, DOI 10.1111/1541-0420.00063; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Goulder P, 1996, AIDS, V10, P1441, DOI 10.1097/00002030-199610000-00025; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Henry WK, 2006, JAMA-J AM MED ASSOC, V296, P1523, DOI 10.1001/jama.296.12.1523; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Klenerman P, 1996, AIDS, V10, P348, DOI 10.1097/00002030-199603000-00023; Kurane I, 2003, J CLIN VIROL, V27, P38, DOI 10.1016/S1386-6532(02)00109-9; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; *NIH, 2001, AIDS VACC TRIALS CON; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Smith Miranda Z, 2005, Sex Health, V2, P53, DOI 10.1071/SH04057; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; vanBaalen CA, 1996, J GEN VIROL, V77, P1659, DOI 10.1099/0022-1317-77-8-1659; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075	60	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3636	10.1371/journal.pone.0003636	http://dx.doi.org/10.1371/journal.pone.0003636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982067	Green Submitted, gold, Green Published			2022-12-27	WOS:000265134300006
J	Cummings, WJ; Bednarski, DW; Maizels, N				Cummings, W. Jason; Bednarski, David W.; Maizels, Nancy			Genetic Variation Stimulated by Epigenetic Modification	PLOS ONE			English	Article								Homologous recombination is essential for maintaining genomic integrity. A common repair mechanism, it uses a homologous or homeologous donor as a template for repair of a damaged target gene. Such repair must be regulated, both to identify appropriate donors for repair, and to avoid excess or inappropriate recombination. We show that modifications of donor chromatin structure can promote homology-directed repair. These experiments demonstrate that either the activator VP16 or the histone chaperone, HIRA, accelerated gene conversion approximately 10-fold when tethered within the donor array for Ig gene conversion in the chicken B cell line DT40. VP16 greatly increased levels of acetylated histones H3 and H4, while tethered HIRA did not affect histone acetylation, but caused an increase in local nucleosome density and levels of histone H3.3. Thus, epigenetic modification can stimulate genetic variation. The evidence that distinct activating modifications can promote similar functional outcomes suggests that a variety of chromatin changes may regulate homologous recombination, and that disregulation of epigenetic marks may have deleterious genetic consequences.	[Cummings, W. Jason; Bednarski, David W.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cummings, WJ (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			NIH [R01 GM41712, RL1 GM084434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041712, RL1GM084434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH R01 GM41712 and RL1 GM084434. The funders played no role in the study design, implementation or decision to write or publish this manuscript.	Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; CUMMINGS WJ, 2007, PLOS BIOL IN PRESS; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lin W, 2008, GENES CELLS, V13, P255, DOI 10.1111/j.1365-2443.2008.01166.x; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Murre C, 2007, CURR OPIN GENET DEV, V17, P415, DOI 10.1016/j.gde.2007.08.006; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Preston CR, 2006, CURR BIOL, V16, P2009, DOI 10.1016/j.cub.2006.08.058; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Sen R, 2006, CURR OPIN IMMUNOL, V18, P237, DOI 10.1016/j.coi.2006.03.008; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Tycko B, 2003, ANN NY ACAD SCI, V983, P43, DOI 10.1111/j.1749-6632.2003.tb05961.x; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiktor-Brown DM, 2006, P NATL ACAD SCI USA, V103, P11862, DOI 10.1073/pnas.0604943103; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	53	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4075	10.1371/journal.pone.0004075	http://dx.doi.org/10.1371/journal.pone.0004075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115012	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466300014
J	Liu, YJ; Papasian, CJ; Liu, JF; Hamilton, J; Deng, HW				Liu, Yong-Jun; Papasian, Christopher J.; Liu, Jian-Feng; Hamilton, James; Deng, Hong-Wen			Is Replication the Gold Standard for Validating Genome-Wide Association Findings?	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM PATTERNS; GENETIC ASSOCIATION; POPULATION STRATIFICATION; ADULT OBESITY; FTO GENE; DISEASE; EPIDEMIOLOGY; TRAITS; FALSE; POWER	With the advent of genome-wide association (GWA) studies, researchers are hoping that reliable genetic association of common human complex diseases/traits can be detected. Currently, there is an increasing enthusiasm about GWA and a number of GWA studies have been published. In the field a common practice is that replication should be used as the gold standard to validate an association finding. In this article, based on empirical and theoretical data, we emphasize that replication of GWA findings can be quite difficult, and should not always be expected, even when true variants are identified. The probability of replication becomes smaller with the increasing number of independent GWA studies if the power of individual replication studies is less than 100% (which is usually the case), and even a finding that is replicated may not necessarily be true. We argue that the field may have unreasonably high expectations on success of replication. We also wish to raise the question whether it is sufficient or necessary to treat replication as the ultimate and gold standard for defining true variants. We finally discuss the usefulness of integrating evidence from multiple levels/sources such as genetic epidemiological studies (at the DNA level), gene expression studies (at the RNA level), proteomics (at the protein level), and follow-up molecular and cellular studies for eventual validation and illumination of the functional relevance of the genes uncovered.	[Liu, Yong-Jun; Papasian, Christopher J.; Liu, Jian-Feng; Hamilton, James; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn Minist Ed, Xian, Peoples R China; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University; Hunan Normal University	Liu, YJ (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu		Deng, Hong-Wen/0000-0002-0387-8818; Liu, Jian-Feng/0000-0002-5766-7864	NIH [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Natural Science Foundation of China [30570875]; Xi'an Jiaotong University; Huo YingDong Education Foundation, Hunan Province; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); Huo YingDong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were partially supported by grants from NIH (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The study also benefited from National Natural Science Foundation of China (30570875), Xi'an Jiaotong University, Huo YingDong Education Foundation, Hunan Province, and the Ministry of Education of China.	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; DE LV, 2005, GENOME RES, V15, P454; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Liu NJ, 2004, GENET EPIDEMIOL, V27, P385, DOI 10.1002/gepi.20026; Lundmark PE, 2008, EUR J HUM GENET, V16, P1142, DOI 10.1038/ejhg.2008.77; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	49	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4037	10.1371/journal.pone.0004037	http://dx.doi.org/10.1371/journal.pone.0004037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112512	Green Submitted, gold, Green Published			2022-12-27	WOS:000265466000007
J	Walsh, MC; Kim, GK; Maurizio, PL; Molnar, EE; Choi, Y				Walsh, Matthew C.; Kim, Gregory K.; Maurizio, Paul L.; Molnar, Elizabeth E.; Choi, Yongwon			TRAF6 Autoubiquitination-Independent Activation of the NF kappa B and MAPK Pathways in Response to IL-1 and RANKL	PLOS ONE			English	Article								The adapter protein TRAF6 is critical for mediating signal transduction from members of the IL-1R/TLR and TNFR superfamilies. The TRAF6 RING finger domain functions as an ubiquitin E3 ligase capable of generating non-degradative K63-linked ubiquitin chains. It is believed that these chains serve as docking sites for formation of signaling complexes, and that K63-linked autoubiquitination of TRAF6 is essential for formation and activation of a complex involving the kinase TAK1 and its adapters, TAB1 and TAB2. In order to assess independently the E3 ligase and ubiquitin substrate functions of TRAF6, we generated, respectively, RING domain and complete lysine-deficient TRAF6 mutants. We found that while the TRAF6 RING domain is required for activation of TAK1, it is dispensable for interaction between TRAF6 and the TAK1-TAB1-TAB2 complex. Likewise, lysine-deficient TRAF6 was found to interact with the TAK1-TAB1-TAB2 complex, but surprisingly was also found to be fully competent to activate TAK1, as well as NF kappa B and AP-1 reporters. Furthermore, lysine-deficient TRAF6 rescued IL-1-mediated NF kappa B and MAPK activation, as well as IL-6 elaboration in retrovirally-rescued TRAF6-deficient fibroblasts. Lysine-deficient TRAF6 also rescued RANKL-mediated NF kappa B and MAPK activation, and osteoclastogenesis in retrovirally-rescued TRAF6-deficient bone marrow macrophages. While incapable of being ubiquitinated itself, we demonstrate that lysine-deficient TRAF6 remains competent to induce ubiquitination of IKK gamma/NEMO. Further, this NEMO modification contributes to TRAF6-mediated activation of NF kappa B. Collectively, our results suggest that while TRAF6 autoubiquitination may serve as a marker of activation, it is unlikely to underpin RING finger-dependent TRAF6 function.	[Walsh, Matthew C.; Kim, Gregory K.; Maurizio, Paul L.; Molnar, Elizabeth E.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Walsh, MC (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Maurizio, Paul L/B-7747-2013	Maurizio, Paul L/0000-0002-5859-6260	 [5R01AI044264-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044264] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5R01AI044264-10 (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; BALKHI MY, 2008, MOL CELL BIOL; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2002, J CELL SCI, V115, P679; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lowe EL, 2006, J ENDOTOXIN RES, V12, P337, DOI 10.1179/096805106X118915; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rudolph D, 2000, GENE DEV, V14, P854; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	42	132	139	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4064	10.1371/journal.pone.0004064	http://dx.doi.org/10.1371/journal.pone.0004064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112497	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466000020
J	Green, RE; Hunt, WG; Parish, CN; Newton, I				Green, Rhys E.; Hunt, W. Grainger; Parish, Christopher N.; Newton, Ian			Effectiveness of Action to Reduce Exposure of Free-Ranging California Condors in Arizona and Utah to Lead from Spent Ammunition	PLOS ONE			English	Article								California condors (Gymnogyps californianus) released into the wild in Arizona ranged widely in Arizona and Utah. Previous studies have shown that the blood lead concentrations of many of the birds rise because of ingestion of spent lead ammunition. Condors were routinely recaptured and treated to reduce their lead levels as necessary but, even so, several died from lead poisoning. We used tracking data from VHF and satellite tags, together with the results of routine testing of blood lead concentrations, to estimate daily changes in blood lead level in relation to the location of each bird. The mean daily increment in blood lead concentration depended upon both the location of the bird and the time of year. Birds that spent time during the deer hunting season in two areas in which deer were shot with lead ammunition (Kaibab Plateau (Arizona) and Zion (Utah)) were especially likely to have high blood lead levels. The influence upon blood lead level of presence in a particular area declined with time elapsed since the bird was last there. We estimated the daily blood lead level for each bird and its influence upon daily mortality rate from lead poisoning. Condors with high blood lead over a protracted period were much more likely to die than birds with low blood lead or short-term elevation. We simulated the effect of ending the existing lead exposure reduction measures at Kaibab Plateau, which encourage the voluntary use of non-lead ammunition and removal of gut piles of deer and elk killed using lead ammunition. The estimated mortality rate due to lead in the absence of this program was sufficiently high that the condor population would be expected to decline rapidly. The extension of the existing lead reduction program to cover Zion (Utah), as well as the Kaibab plateau, would be expected to reduce mortality caused by lead substantially and allow the condor population to increase.	Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Green, Rhys E.] Roy Soc Protect Birds, The Lodge, Sandy, Beds, England; [Hunt, W. Grainger; Parish, Christopher N.] Peregrine Fund, Boise, ID USA; [Newton, Ian] Ctr Ecol & Hydrol, Monks Wood Expt Stat, Huntingdon, England	University of Cambridge; Royal Society for Protection of Birds; UK Centre for Ecology & Hydrology (UKCEH)	Green, RE (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.	reg29@hermes.cam.ac.uk			U.S. Fish and Wildlife Service; Arizona Game and Fish Department; Bureau of Land Management; The Charles Engelhard Foundation; Liz Claiborne and Art Ortenberg Foundation; Nina Mason Pulliam Charitable Trust; Grand Canyon Conservation Fund; National Fish and Wildlife Foundation; Jane Smith Turner Foundation; Natural Environment Research Council [CEH010021] Funding Source: researchfish	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Arizona Game and Fish Department; Bureau of Land Management; The Charles Engelhard Foundation; Liz Claiborne and Art Ortenberg Foundation; Nina Mason Pulliam Charitable Trust; Grand Canyon Conservation Fund; National Fish and Wildlife Foundation; Jane Smith Turner Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data were collected as part of The Peregrine Fund's California Condor restoration project, which is supported by the U.S. Fish and Wildlife Service, Arizona Game and Fish Department, Bureau of Land Management, The Charles Engelhard Foundation, Liz Claiborne and Art Ortenberg Foundation, Nina Mason Pulliam Charitable Trust, Grand Canyon Conservation Fund, National Fish and Wildlife Foundation, Jane Smith Turner Foundation, and other important donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Franson J. Christian, 1996, P265; Fry D.M., 2003, ASSESSMENT LEAD CONT; Grand JB, 1998, J WILDLIFE MANAGE, V62, P1103, DOI 10.2307/3802564; Hunt W. Grainger, 2007, P79; Kalbfleisch JG., 1985, PROBABILITY STAT INF; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Parish Chris N., 2007, P97; Sullivan Kathy, 2007, P109; Tavecchia G, 2001, J APPL ECOL, V38, P1197, DOI 10.1046/j.0021-8901.2001.00684.x	10	30	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4022	10.1371/journal.pone.0004022	http://dx.doi.org/10.1371/journal.pone.0004022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107211	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000017
J	Susanto, J; Lin, YH; Chen, YN; Shen, CR; Yan, YT; Tsai, ST; Chen, CH; Shen, CN				Susanto, Jimmy; Lin, Yu-Hsing; Chen, Yun-Nan; Shen, Chia-Rui; Yan, Yu-Ting; Tsai, Sheng-Ta; Chen, Chung-Hsuan; Shen, Chia-Ning			Porphyrin Homeostasis Maintained by ABCG2 Regulates Self-Renewal of Embryonic Stem Cells	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PROTOPORPHYRIN-IX; DNA-DAMAGE; 5-AMINOLEVULINIC ACID; HEME-SYNTHESIS; P53 PROTEIN; PHOSPHORYLATION; EXPRESSION; RESISTANCE; ACCUMULATION	Background: Under appropriate culture conditions, undifferentiated embryonic stem (ES) cells can undergo multiple self-renewal cycles without loss of pluripotency suggesting they must be equipped with specific defense mechanisms to ensure sufficient genetic stability during self-renewal expansion. The ATP binding cassette transporter ABCG2 is expressed in a wide variety of somatic and embryonic stem cells. However, whether it plays an important role in stem cell maintenance remains to be defined. Methodology/Principal Findings: Here we provide evidence to show that an increase in the level of ABCG2 was observed accompanied by ES colony expansion and then were followed by decreases in the level of protoporphyrin IX (PPIX) indicating that ABCG2 plays a role in maintaining porphyrin homoeostasis. RNA-interference mediated inhibition of ABCG2 as well as functional blockage of ABCG2 transporter with fumitremorgin C (FTC), a specific and potent inhibitor of ABCG2, not only elevated the cellular level of PPIX, but also arrest the cell cycle and reduced expression of the pluripotent gene Nanog. Overexpression of ABCG2 in ES cells was able to counteract the increase of endogenous PPIX induced by treatment with 5-Aminolevulinic acid suggesting ABCG2 played a direct role in removal of PPIX from ES cells. We also found that excess PPIX in ES cells led to elevated levels of reactive oxygen species which in turn triggered DNA damage signals as indicated by increased levels of gamma H2AX and phosphorylated p53. The increased level of p53 reduced Nanog expression because RNA-interference mediated inhibition of p53 was able to prevent the downregulation of Nanog induced by FTC treatment. Conclusions/Significance: The present work demonstrated that ABCG2 protects ES cells from PPIX accumulation during colony expansion, and that p53 and gamma H2AX acts as a downstream checkpoint of ABCG2-dependent defense machinery in order to maintain the self-renewal of ES cells.	[Tsai, Sheng-Ta; Chen, Chung-Hsuan; Shen, Chia-Ning] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Yu-Hsing; Shen, Chia-Ning] Natl Defense Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Yun-Nan; Shen, Chia-Ning] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Shen, Chia-Rui] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Yan, Yu-Ting] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University; Chang Gung University; Academia Sinica - Taiwan	Susanto, J (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	cnshen@gate.sinica.edu.tw	Shen, Chia-Rui/B-1617-2012; SHEN, CHIA-NING/C-6878-2011; Yan, Yu-Ting/Q-3065-2018; Chen, Chung-Hsuan/F-7940-2012	Shen, Chia-Rui/0000-0002-8386-3965; SHEN, CHIA-NING/0000-0002-0747-217X; Yan, Yu-Ting/0000-0002-9559-706X; 	Academia Sinica [5202402020-0, 96-3114-P-001-006-Y02, 95-2311-B-001-057-MY3]; Genomics Research Center; National Science Council [96-3114-P-001-006-Y02, 95-2311-B-001-057-MY3]	Academia Sinica(Academia Sinica - Taiwan); Genomics Research Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by Summit Project Grants of Academia Sinica #5202402020-0; Genomics Research Center, Academia Sinica and National Science Council grants 96-3114-P-001-006-Y02 and 95-2311-B-001-057-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; GLAVINAS H, 2005, CURRENT DRUG DELIVER, V1, P27; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Jonker JW, 2007, AM J PHYSIOL-CELL PH, V292, pC2204, DOI 10.1152/ajpcell.00359.2006; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Krishnamurthy P, 2005, BIOMETALS, V18, P349, DOI 10.1007/s10534-005-3709-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Lu SJ, 2002, STEM CELLS, V20, P428, DOI 10.1634/stemcells.20-5-428; MARTIN CM, 2008, CIRC RES; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Moan J, 1998, INT J CANCER, V75, P134, DOI 10.1002/(SICI)1097-0215(19980105)75:1<134::AID-IJC20>3.0.CO;2-F; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Mutoh K, 2006, MOL CANCER THER, V5, P877, DOI 10.1158/1535-7163.MCT-05-0240; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Onuki J, 2004, ARCH BIOCHEM BIOPHYS, V432, P178, DOI 10.1016/j.abb.2004.09.030; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Ponka P, 1997, BLOOD, V89, P1; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Rabindran SK, 2000, CANCER RES, V60, P47; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wolun-Cholewa M, 2007, PHOTOMED LASER SURG, V25, P526, DOI 10.1089/pho.2007.2113; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Zawacka-Pankau J, 2007, J BIOL CHEM, V282, P2466, DOI 10.1074/jbc.M608906200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	43	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4023	10.1371/journal.pone.0004023	http://dx.doi.org/10.1371/journal.pone.0004023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107196	gold, Green Submitted, Green Published			2022-12-27	WOS:000265463000018
J	Gigandet, X; Hagmann, P; Kurant, M; Cammoun, L; Meuli, R; Thiran, JP				Gigandet, Xavier; Hagmann, Patric; Kurant, Maciej; Cammoun, Leila; Meuli, Reto; Thiran, Jean-Philippe			Estimating the Confidence Level of White Matter Connections Obtained with MRI Tractography	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; DIFFUSION-TENSOR; FIBER TRACKING; ARCHITECTURE; BRAIN; SIMULATIONS; NETWORKS; IMAGES	Background: Since the emergence of diffusion tensor imaging, a lot of work has been done to better understand the properties of diffusion MRI tractography. However, the validation of the reconstructed fiber connections remains problematic in many respects. For example, it is difficult to assess whether a connection is the result of the diffusion coherence contrast itself or the simple result of other uncontrolled parameters like for example: noise, brain geometry and algorithmic characteristics. Methodology/Principal Findings: In this work, we propose a method to estimate the respective contributions of diffusion coherence versus other effects to a tractography result by comparing data sets with and without diffusion coherence contrast. We use this methodology to assign a confidence level to every gray matter to gray matter connection and add this new information directly in the connectivity matrix. Conclusions/Significance: Our results demonstrate that whereas we can have a strong confidence in mid- and long-range connections obtained by a tractography experiment, it is difficult to distinguish between short connections traced due to diffusion coherence contrast from those produced by chance due to the other uncontrolled factors of the tractography methodology.	[Gigandet, Xavier; Hagmann, Patric; Cammoun, Leila; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Lausanne, Univ Hosp Ctr, Dept Radiol, CH-1015 Lausanne, Switzerland; [Kurant, Maciej] Ecole Polytech Fed Lausanne, Lab Comp Communications & Applicat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gigandet, X (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland.	xavier.gigandet@epfl.ch		Thiran, Jean-Philippe/0000-0003-2938-9657	Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundations Leenaards and Louis-Jeantet	Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundations Leenaards and Louis-Jeantet	This work was supported by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities and the EPFL, the foundations Leenaards and Louis-Jeantet, as well as Mr. Yves Paternot and Prof. Pierre Schnyder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Callaghan P., 1991, PRINCIPLES NUCL MAGN; CAMMOUN L, 2007, P INT SOC MAG RESON, V15, P235; Campbell JSW, 2005, NEUROIMAGE, V27, P725, DOI 10.1016/j.neuroimage.2005.05.014; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P., 2005, DIFFUSION MRI BRAIN; HAGMANN P, 2004, P INT SOC MAG RESON, V12; Hagmann P., 2008, ISMRM 2008 16 SCI M; Hagmann P, 2006, P INT SOC MAG RESON, V14; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hagmann P, 2006, HUM BRAIN MAPP, V27, P828, DOI 10.1002/hbm.20224; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; Koch M, 2001, NEUROIMAGE, V13, pS176; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Tournier JD, 2002, MAGN RESON MED, V47, P701, DOI 10.1002/mrm.10116; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; TUCH DS, 2000, P INT SOC MAG RESON, V8; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; WEDEEEN VJ, 2000, P INT SOC MAG RESON, V8; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	40	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4006	10.1371/journal.pone.0004006	http://dx.doi.org/10.1371/journal.pone.0004006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104666	gold, Green Published			2022-12-27	WOS:000265462400007
J	Jin, RZ; Lv, ZB; Chen, Q; Quan, YP; Zhang, HH; Li, S; Chen, GG; Zheng, QL; Jin, LR; Wu, XF; Chen, JG; Zhang, YZ				Jin, Rongzhong; Lv, Zhengbing; Chen, Qin; Quan, Yanping; Zhang, Haihua; Li, Si; Chen, Guogang; Zheng, Qingliang; Jin, Lairong; Wu, Xiangfu; Chen, Jianguo; Zhang, Yaozhou			Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AVIAN INFLUENZA; MF59-ADJUVANTED INFLUENZA; A H5N1; HEMAGGLUTININ; ANTIGENICITY; EXPRESSION; MORTALITY; STRAINS; PROTECT	Avian influenza virus (H5N1) has caused serious infections in human beings. This virus has the potential to emerge as a pandemic threat in humans. Effective vaccines against H5N1 virus are needed. A recombinant Bombyx mori baculovirus, Bmg64HA, was constructed for the expression of HA protein of H5N1 influenza virus displaying on the viral envelope surface. The HA protein accounted for approximately 3% of the total viral proteins in silkworm pupae infected with the recombinant virus. Using a series of separation and purification methods, pure Bmgp64HA virus was isolated from these silkworm pupae bioreactors. Aluminum hydroxide adjuvant was used for an H5N1 influenza vaccine. Immunization with this vaccine at doses of 2 mg/kg and 0.67 mg/kg was carried out to induce the production of neutralizing antibodies, which protected monkeys against influenza virus infection. At these doses, the vaccine induced 1: 40 antibody titers in 50% and 67% of the monkeys, respectively. The results of safety evaluation indicated that the vaccine did not cause any toxicity at the dosage as large as 3.2 mg/kg in cynomolgus monkeys and 1.6 mg/kg in mice. The results of dose safety evaluation of vaccine indicated that the safe dose of the vaccine were higher than 0.375 mg/kg in rats and 3.2 mg/kg in cynomolgus monkeys. Our work showed the vaccine may be a candidate for a highly effective, cheap, and safe influenza vaccine for use in humans.	[Zhang, Yaozhou] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Rongzhong; Lv, Zhengbing; Chen, Qin; Quan, Yanping; Zhang, Haihua; Li, Si; Chen, Guogang; Zheng, Qingliang; Jin, Lairong; Wu, Xiangfu; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Peoples R China; [Chen, Jianguo] Peking Univ, Coll Life Sci, Beijing, Peoples R China	Zhejiang University; Zhejiang Sci-Tech University; Peking University	Jin, RZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chenjg@pku.edu.cn; yaozhou@zstu.edu			National High Technology Research and Development Program [2007AA021703, 2007AA100504]; National Basic Research Program of China [2005CB121006]; National Natural Science Foundation of China [30740015]; Zhejiang Natural Science Foundation [Y205449]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National High Technology Research and Development Program (No. 2007AA021703, No. 2007AA100504), the National Basic Research Program of China (973 Program, No. 2005CB121006), the National Natural Science Foundation of China (No. 30740015), and the Zhejiang Natural Science Foundation (No.Y205449).	Bender C, 1999, VIROLOGY, V254, P115, DOI 10.1006/viro.1998.9529; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; JX H, 1994, THESIS SHANGHAI I BI; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lu LQ, 2007, BIOCHEM BIOPH RES CO, V358, P404, DOI 10.1016/j.bbrc.2007.04.148; Matsouka Y, 2003, AVIAN DIS, V47, P926, DOI 10.1637/0005-2086-47.s3.926; MILLER LK, 1983, SCIENCE, V219, P715, DOI 10.1126/science.219.4585.715; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Possee R.D., 1992, BACULOVIRUS EXPRESSI, Vfirst; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Stephenson I, 2006, LANCET, V368, P965, DOI 10.1016/S0140-6736(06)69340-9; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Subbarao K, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030040; Tami C, 2004, VACCINE, V23, P840, DOI 10.1016/j.vaccine.2004.03.070; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Wood JM, 2001, INT CONGR SER, V1219, P751, DOI 10.1016/S0531-5131(01)00385-5; Yan JY, 2007, DIAGN MICR INFEC DIS, V58, P399, DOI 10.1016/j.diagmicrobio.2007.03.004; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131; Yongfeng Jin, 2002, J Biochem Mol Biol Biophys, V6, P293; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Zhang W, 2006, CHAOS SOLITON FRACT, V29, P223, DOI 10.1016/j.chaos.2005.08.020; 1988, ANN REV MICROBIOL, V42, P177; 2002, WKLY EPIDEMIOL REC, V77, P381	43	32	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3933	10.1371/journal.pone.0003933	http://dx.doi.org/10.1371/journal.pone.0003933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079592	Green Published, gold, Green Submitted			2022-12-27	WOS:000265456300009
J	Kent, J; Meredith, AL				Kent, Jack; Meredith, Andrea L.			BK Channels Regulate Spontaneous Action Potential Rhythmicity in the Suprachiasmatic Nucleus	PLOS ONE			English	Article								Background: Circadian (similar to 24 hr) rhythms are generated by the central pacemaker localized to the suprachiasmatic nucleus (SCN) of the hypothalamus. Although the basis for intrinsic rhythmicity is generally understood to rely on transcription factors encoded by "clock genes'', less is known about the daily regulation of SCN neuronal activity patterns that communicate a circadian time signal to downstream behaviors and physiological systems. Action potentials in the SCN are necessary for the circadian timing of behavior, and individual SCN neurons modulate their spontaneous firing rate (SFR) over the daily cycle, suggesting that the circadian patterning of neuronal activity is necessary for normal behavioral rhythm expression. The BK K(+) channel plays an important role in suppressing spontaneous firing at night in SCN neurons. Deletion of the Kcnma1 gene, encoding the BK channel, causes degradation of circadian behavioral and physiological rhythms. Methodology/Principal Findings: To test the hypothesis that loss of robust behavioral rhythmicity in Kcnma1(-/-) mice is due to the disruption of SFR rhythms in the SCN, we used multi-electrode arrays to record extracellular action potentials from acute wild-type (WT) and Kcnma1(-/-) slices. Patterns of activity in the SCN were tracked simultaneously for up to 3 days, and the phase, period, and synchronization of SFR rhythms were examined. Loss of BK channels increased arrhythmicity but also altered the amplitude and period of rhythmic activity. Unexpectedly, Kcnma1(-/-) SCNs showed increased variability in the timing of the daily SFR peak. Conclusions/Significance: These results suggest that BK channels regulate multiple aspects of the circadian patterning of neuronal activity in the SCN. In addition, these data illustrate the characteristics of a disrupted SCN rhythm downstream of clock gene-mediated timekeeping and its relationship to behavioral rhythms.	[Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kent, J (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	ameredith@som.umaryland.edu		Meredith, Andrea/0000-0003-1061-2302	University of Maryland School of Medicine [Seed funds]	University of Maryland School of Medicine	This work was funded by University of Maryland School of Medicine Seed funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brown TM, 2006, J NEUROSCI METH, V156, P173, DOI 10.1016/j.jneumeth.2006.02.024; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hodge JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002274; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Mistlberger RE, 2000, AM J PHYSIOL-REG I, V279, pR813, DOI 10.1152/ajpregu.2000.279.3.R813; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Yamazaki S, 1998, J NEUROSCI, V18, P10709	33	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3884	10.1371/journal.pone.0003884	http://dx.doi.org/10.1371/journal.pone.0003884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060951	gold, Green Published			2022-12-27	WOS:000265455100006
J	Chikayama, E; Suto, M; Nishihara, T; Shinozaki, K; Hirayama, T; Kikuchi, J				Chikayama, Eisuke; Suto, Michitaka; Nishihara, Takashi; Shinozaki, Kazuo; Hirayama, Takashi; Kikuchi, Jun			Systematic NMR Analysis of Stable Isotope Labeled Metabolite Mixtures in Plant and Animal Systems: Coarse Grained Views of Metabolic Pathways	PLOS ONE			English	Article								Background: Metabolic phenotyping has become an important 'bird's-eye-view' technology which can be applied to higher organisms, such as model plant and animal systems in the post-genomics and proteomics era. Although genotyping technology has expanded greatly over the past decade, metabolic phenotyping has languished due to the difficulty of 'top-down' chemical analyses. Here, we describe a systematic NMR methodology for stable isotope-labeling and analysis of metabolite mixtures in plant and animal systems. Methodology/Principal Findings: The analysis method includes a stable isotope labeling technique for use in living organisms; a systematic method for simultaneously identifying a large number of metabolites by using a newly developed HSQC-based metabolite chemical shift database combined with heteronuclear multidimensional NMR spectroscopy; Principal Components Analysis; and a visualization method using a coarse-grained overview of the metabolic system. The database contains more than 1000 (1)H and (13)C chemical shifts corresponding to 142 metabolites measured under identical physicochemical conditions. Using the stable isotope labeling technique in Arabidopsis T87 cultured cells and Bombyx mori, we systematically detected >450 HSQC peaks in each (13)C-HSQC spectrum derived from model plant, Arabidopsis T87 cultured cells and the invertebrate animal model Bombyx mori. Furthermore, for the first time, efficient (13)C labeling has allowed reliable signal assignment using analytical separation techniques such as 3D HCCH-COSY spectra in higher organism extracts. Conclusions/Significance: Overall physiological changes could be detected and categorized in relation to a critical developmental phase change in B. mori by coarse-grained representations in which the organization of metabolic pathways related to a specific developmental phase was visualized on the basis of constituent changes of 56 identified metabolites. Based on the observed intensities of (13)C atoms of given metabolites on development-dependent changes in the 56 identified (13)C-HSQC signals, we have determined the changes in metabolic networks that are associated with energy and nitrogen metabolism.	[Chikayama, Eisuke; Shinozaki, Kazuo; Hirayama, Takashi; Kikuchi, Jun] RIKEN, Plant Sci Ctr, Kanagawa, Japan; [Suto, Michitaka; Nishihara, Takashi; Hirayama, Takashi; Kikuchi, Jun] Yokohama City Univ, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Nagoya, Aichi, Japan	RIKEN; Yokohama City University; Nagoya University	Chikayama, E (corresponding author), RIKEN, Plant Sci Ctr, Kanagawa, Japan.	kikuchi@psc.riken.jp	Shinozaki, Kazuo/AAB-4945-2019; HIRAYAMA, Takashi/B-2496-2011; Kikuchi, Jun/M-5512-2015; Shinozaki, Kazuo/G-4202-2013; Kikuchi, Jun/O-4725-2019	Shinozaki, Kazuo/0000-0002-6317-9867; HIRAYAMA, Takashi/0000-0002-3868-2380; Kikuchi, Jun/0000-0002-6809-394X; Shinozaki, Kazuo/0000-0002-6317-9867; Kikuchi, Jun/0000-0002-6809-394X	RIKEN; Japan Science and Technology Agency; Bio-oriented Technology Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan [17710191]	RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Bio-oriented Technology Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	J.K. and T.H. were supported in part by grants from RIKEN (the President's Special Research Grant), the Japan Science and Technology Agency (CREST to J.K.), Bio-oriented Technology Advancement Institution (BRAIN to J.K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 17710191 to J.K.).	AKIYAMA K, 2008, SILICO BIOL, V8; [Anonymous], 1969, GEN SYSTEM THEORY FD; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Bhavsar AP, 2006, NAT BIOTECHNOL, V24, P1098, DOI 10.1038/nbt0906-1098; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; de Graaf RA, 2004, P NATL ACAD SCI USA, V101, P12700, DOI 10.1073/pnas.0405065101; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Garrahan JP, 2003, P NATL ACAD SCI USA, V100, P9710, DOI 10.1073/pnas.1233719100; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Graca G, 2007, ANAL CHEM, V79, P8367, DOI 10.1021/ac071278d; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hirayama C, 2002, BBA-GEN SUBJECTS, V1571, P131, DOI 10.1016/S0304-4165(02)00207-6; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Huang JTJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000756; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; JUE T, 1989, P NATL ACAD SCI USA, V86, P4489, DOI 10.1073/pnas.86.12.4489; KALDERON B, 1989, P NATL ACAD SCI USA, V86, P4690, DOI 10.1073/pnas.86.12.4690; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lane AN, 2008, METHOD CELL BIOL, V84, P541, DOI 10.1016/S0091-679X(07)84018-0; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rabani E, 2003, NATURE, V426, P271, DOI 10.1038/nature02087; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ratcliffe RG, 2006, PLANT J, V45, P490, DOI 10.1111/j.1365-313X.2005.02649.x; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Russell R, 2002, P NATL ACAD SCI USA, V99, P4266, DOI 10.1073/pnas.072589599; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Sakellariou D, 2007, NATURE, V447, P694, DOI 10.1038/nature05897; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shanaiah N, 2007, P NATL ACAD SCI USA, V104, P11540, DOI 10.1073/pnas.0704449104; Sobolev AP, 2005, MAGN RESON CHEM, V43, P625, DOI 10.1002/mrc.1618; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Steinbeck C, 2004, PHYTOCHEMISTRY, V65, P2711, DOI 10.1016/j.phytochem.2004.08.027; Tadmor AD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000038; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WISHART DS, 2008, J CHROMATOGR B; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853	84	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3805	10.1371/journal.pone.0003805	http://dx.doi.org/10.1371/journal.pone.0003805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030231	Green Submitted, gold, Green Published			2022-12-27	WOS:000265451100005
J	Meneghini, R; Packer, AL; Nassi-Calo, L				Meneghini, Rogerio; Packer, Abel L.; Nassi-Calo, Lilian			Articles by Latin American Authors in Prestigious Journals Have Fewer Citations	PLOS ONE			English	Article							IMPACT FACTOR; INDICATORS; SCIENCE	Background: The journal Impact factor (IF) is generally accepted to be a good measurement of the relevance/quality of articles that a journal publishes. In spite of an, apparently, homogenous peer-review process for a given journal, we hypothesize that the country affiliation of authors from developing Latin American (LA) countries affects the IF of a journal detrimentally. Methodology/Principal Findings: Seven prestigious international journals, one multidisciplinary journal and six serving specific branches of science, were examined in terms of their IF in the Web of Science. Two subsets of each journal were then selected to evaluate the influence of author's affiliation on the IF. They comprised contributions (i) with authorship from four Latin American (LA) countries (Argentina, Brazil, Chile and Mexico) and (ii) with authorship from five developed countries (England, France, Germany, Japan and USA). Both subsets were further subdivided into two groups: articles with authorship from one country only and collaborative articles with authorship from other countries. Articles from the five developed countries had IF close to the overall IF of the journals and the influence of collaboration on this value was minor. In the case of LA articles the effect of collaboration (virtually all with developed countries) was significant. The IFs for non-collaborative articles averaged 66% of the overall IF of the journals whereas the articles in collaboration raised the IFs to values close to the overall IF. Conclusion/Significance: The study shows a significantly lower IF in the group of the subsets of non-collaborative LA articles and thus that country affiliation of authors from non-developed LA countries does affect the IF of a journal detrimentally. There are no data to indicate whether the lower IFs of LA articles were due to their inherent inferior quality/relevance or psycho-social trend towards under-citation of articles from these countries. However, further study is required since there are foreseeable consequences of this trend as it may stimulate strategies by editors to turn down articles that tend to be under-cited.	[Meneghini, Rogerio; Packer, Abel L.; Nassi-Calo, Lilian] Latin Amer & Caribbean Ctr Hlth Sci Informat, BIREME PAHO WHO, Sao Paulo, Brazil; [Meneghini, Rogerio; Packer, Abel L.] Univ Fed Sao Paulo, DIS Dept Informat Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Meneghini, R (corresponding author), Latin Amer & Caribbean Ctr Hlth Sci Informat, BIREME PAHO WHO, Sao Paulo, Brazil.	rogerio.meneghini@bireme.org	Packer, Abel Laerte L/J-9350-2012; Meneghini, Rogério/I-2961-2015; NASSI-CALO, LILIAN/K-8743-2015	Packer, Abel Laerte L/0000-0001-9610-5728; NASSI-CALO, LILIAN/0000-0002-0470-8458	FAPESP [05/57665-8]; CNPq [2006-0919]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FAPESP (Sao Paulo State Foundation for Research Support) grant number 05/57665-8 and CNPq (National Council for Scientific and Technological Development) 2006-0919.	[Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; CALZA L, 1995, NATURE, V374, P492, DOI 10.1038/374492a0; GLANZEL W, 2006, HDB QUANTITATIVE SCI; Karpas A, 2002, TRENDS IMMUNOL, V23, P321, DOI 10.1016/S1471-4906(02)02247-0; Meneghini R, 2007, EMBO REP, V8, P112, DOI 10.1038/sj.embor.7400906; Moed HF, 1999, SCIENTOMETRICS, V46, P575, DOI 10.1007/BF02459613; Moed HF., 2005, CITATION ANAL RES EV; Norris M, 2003, J DOC, V59, P709, DOI 10.1108/00220410310698734; Ostriker JP, 2003, ASSESSING RES DOCTOR; Pinto AC, 1999, QUIM NOVA, V22, P448, DOI 10.1590/S0100-40421999000300026; Postma E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000999; SCHUBERT A, 1989, SCIENTOMETRICS, V16, P3, DOI 10.1007/BF02093234; Seglen PO, 1997, BRIT MED J, V314, P498; TAUBES G, 1993, SCIENCE, V260, P884, DOI 10.1126/science.8493516; Vieira CL, 1999, SCIENCE, V285, P1346, DOI 10.1126/science.285.5432.1346; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039	16	71	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3804	10.1371/journal.pone.0003804	http://dx.doi.org/10.1371/journal.pone.0003804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YD	19030227	gold, Green Published, Green Submitted			2022-12-27	WOS:000265451100004
J	Lietha, D; Eck, MJ				Lietha, Daniel; Eck, Michael J.			Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation	PLOS ONE			English	Article								Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase required for cell migration, proliferation and survival. FAK overexpression has been documented in diverse human cancers and is associated with a poor clinical outcome. Recently, a novel bis-anilino pyrimidine inhibitor, TAE226, was reported to efficiently inhibit FAK signaling, arrest tumor growth and invasion and prolong the life of mice with glioma or ovarian tumor implants. Here we describe the crystal structures of the FAK kinase bound to TAE226 and three related bis-anilino pyrimidine compounds. TAE226 induces a conformation of the N-terminal portion of the kinase activation loop that is only observed in FAK, but is distinct from the conformation in both the active and inactive states of the kinase. This conformation appears to require a glycine immediately N-terminal to the "DFG motif", which adopts a helical conformation stabilized by interactions with TAE226. The presence of a glycine residue in this position contributes to the specificity of TAE226 and related compounds for FAK. Our work highlights the fact that kinases can access conformational space that is not necessarily utilized for their native catalytic regulation, and that such conformations can explain and be exploited for inhibitor specificity.	[Lietha, Daniel; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lietha, Daniel; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Lietha, D (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Lietha, Daniel/AAD-1952-2022; Lietha, Daniel/L-8041-2014	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486	NIH [HL048675, CA080942]; Leukemia and Lymphoma Society; NCI [5T32CA09361]; NATIONAL CANCER INSTITUTE [T32CA009361, R01CA080942] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The research was supported in part by NIH grants HL048675 and CA080942 (MJE). MJE is the recipient of a Scholar Award from the Leukemia and Lymphoma Society. DL was supported by an institutional training grant from the NCI (5T32CA09361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Beattie JF, 2003, BIOORG MED CHEM LETT, V13, P2955, DOI 10.1016/S0960-894X(03)00202-6; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLUBOVSKAYA VM, 2007, MOL CARCINOG; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Han NM, 1997, ANN SURG ONCOL, V4, P264, DOI 10.1007/BF02306620; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jones G, 2001, CANCER RES, V61, P5688; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6	38	73	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3800	10.1371/journal.pone.0003800	http://dx.doi.org/10.1371/journal.pone.0003800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030106	Green Published, Green Submitted, gold			2022-12-27	WOS:000265450800010
J	Malavige, GN; Jones, L; Kamaladasa, SD; Wijewickrama, A; Seneviratne, SL; Black, AP; Ogg, GS				Malavige, Gathsaurie Neelika; Jones, Louise; Kamaladasa, S. D.; Wijewickrama, A.; Seneviratne, S. L.; Black, Antony P.; Ogg, Graham S.			Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri Lanka	PLOS ONE			English	Article								Background: In Sri Lanka, varicella zoster virus (VZV) is typically acquired during adulthood with significant associated disease morbidity and mortality. T cells are believed to be important in the control of VZV replication and in the prevention of reactivation. The relationship between viral load, disease severity and cellular immune responses in primary VZV infection has not been well studied. Methodology: We used IFN gamma ELISpot assays and MHC class II tetramers based on VZV gE and IE63 epitopes, together with quantitative real time PCR assays to compare the frequency and phenotype of specific T cells with virological and clinical outcomes in 34 adult Sri Lankan individuals with primary VZV infection. Principal Findings: Viral loads were found to be significantly higher in patients with moderate to severe infection compared to those with mild infection (p < 0.001) and were significantly higher in those over 25 years of age (P < 0.01). A significant inverse correlation was seen between the viral loads and the ex vivo IFN gamma ELISpot responses of patients (P < 0.001, r = -0.85). VZV-specific CD4+ T cells expressed markers of intermediate differentiation and activation. Conclusions: Overall, these data show that increased clinical severity in Sri Lankan adults with primary VZV infection associates with higher viral load and reduced viral specific T cell responses.	[Malavige, Gathsaurie Neelika; Jones, Louise; Black, Antony P.; Ogg, Graham S.] John Radcliffe Hosp, Oxford Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Kamaladasa, S. D.] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med, Nugegoda, Sri Lanka; [Wijewickrama, A.] Infect Dis Hosp, Colombo, Sri Lanka; [Seneviratne, S. L.] Imperial Coll AHSC, St Marys Hosp, Dept Clin Immunol, London, England; [Malavige, Gathsaurie Neelika] Univ Sri Jayewardenepura, Fac Med Sci, Dept Microbiol, Nugegoda, Sri Lanka; [Ogg, Graham S.] Churchill Hosp, Dept Dermatol, Oxford, England	University of Oxford; University Sri Jayewardenepura; Imperial College London; University Sri Jayewardenepura; University of Oxford	Malavige, GN (corresponding author), John Radcliffe Hosp, Oxford Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	graham.ogg@ndm.ox.ac.uk	; Malavige, Gathsaurie/J-5483-2015	Ogg, Graham/0000-0002-3097-045X; Malavige, Gathsaurie/0000-0001-9201-0449	NIHR Biomedical Research Centre Programme; MRC; Commonwealth Commission; Medical Research Council [MC_U137881017, G116/150] Funding Source: researchfish; MRC [G116/150, MC_U137881017] Funding Source: UKRI	NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commonwealth Commission; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by NIHR Biomedical Research Centre Programme, MRC and Commonwealth Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth A, 2001, J VIROL, V75, P6183, DOI 10.1128/JVI.75.13.6183-6192.2001; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Asanuma H, 2000, J INFECT DIS, V181, P859, DOI 10.1086/315347; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; de Jong MD, 2000, J CLIN MICROBIOL, V38, P2568, DOI 10.1128/JCM.38.7.2568-2573.2000; de Melker H, 2006, VACCINE, V24, P3946, DOI 10.1016/j.vaccine.2006.02.017; Eisfeld AJ, 2007, J VIROL, V81, P9034, DOI 10.1128/JVI.00711-07; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; GERSHON AA, 1979, INFECT IMMUN, V25, P170, DOI 10.1128/IAI.25.1.170-174.1979; GERSHON AA, 1979, INFECT IMMUN, V25, P164, DOI 10.1128/IAI.25.1.164-169.1979; Ito Y, 2001, MICROBIOL IMMUNOL, V45, P267, DOI 10.1111/j.1348-0421.2001.tb02617.x; Jones L, 2007, EUR J IMMUNOL, V37, P3393, DOI 10.1002/eji.200737648; Jones L, 2006, J VIROL, V80, P9772, DOI 10.1128/JVI.00564-06; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Khoshnood B, 2006, PEDIATR INFECT DIS J, V25, P41, DOI 10.1097/01.inf.0000195636.43584.bb; Kimura H, 2000, J CLIN MICROBIOL, V38, P2447; Konig A, 2003, MICROBES INFECT, V5, P879, DOI 10.1016/S1286-4579(03)00177-1; Ku CC, 2005, J VIROL, V79, P2651, DOI 10.1128/JVI.79.5.2651-2658.2005; Ku CC, 2004, J EXP MED, V200, P917, DOI 10.1084/jem.20040634; Ku CC, 2002, J VIROL, V76, P11425, DOI 10.1128/JVI.76.22.11425-11433.2002; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; LEIBOVITZ E, 1993, PEDIATRICS, V92, P838; Liyanage N P M, 2007, Indian J Med Sci, V61, P128; Lokeshwar M R, 2000, Indian Pediatr, V37, P714; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Mainka C, 1998, J MED VIROL, V56, P91, DOI 10.1002/(SICI)1096-9071(199809)56:1<91::AID-JMV15>3.0.CO;2-Z; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Malavige GN, 2007, J INFECT DIS, V195, P660, DOI 10.1086/511274; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; MILONE G, 1992, ANN HEMATOL, V64, P155, DOI 10.1007/BF01697404; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; Mohsen AH, 2001, THORAX, V56, P796, DOI 10.1136/thorax.56.10.796; PATEL PA, 1979, J PEDIATR-US, V94, P223, DOI 10.1016/S0022-3476(79)80828-8; Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999; Quinlivan ML, 2007, J CLIN MICROBIOL, V45, P3909, DOI 10.1128/JCM.00874-07; Rentenaar RJ, 2000, J CLIN INVEST, V105, P541, DOI 10.1172/JCI8229; SCREATON G, 2006, NOVART FDN SYMP, V277, P251; SCREATON G, 2006, NOVART FDN SYMP, V277, P177; Screaton Gavin, 2006, Novartis Found Symp, V277, P164, DOI 10.1002/0470058005.ch12; Simpson DM, 2002, AIDS, V16, P407, DOI 10.1097/00002030-200202150-00012; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Ulsenheimer A, 2006, J VIRAL HEPATITIS, V13, P708, DOI 10.1111/j.1365-2893.2006.00747.x; VADOUDSEYEDI R, 1993, DERMATOLOGY, V187, P47, DOI 10.1159/000247197; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; VENKITARAMAN AR, 1984, INT J EPIDEMIOL, V13, P502, DOI 10.1093/ije/13.4.502; Vyse AJ, 2004, EPIDEMIOL INFECT, V132, P1129, DOI 10.1017/S0950268804003140; Welgama U., 2003, Ceylon Medical Journal, V48, P119	50	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3789	10.1371/journal.pone.0003789	http://dx.doi.org/10.1371/journal.pone.0003789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023425	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448800010
J	Stover, J; Fidzani, B; Molomo, BC; Moeti, T; Musuka, G				Stover, John; Fidzani, Boga; Molomo, Batho Chris; Moeti, Themba; Musuka, Godfrey			Estimated HIV Trends and Program Effects in Botswana	PLOS ONE			English	Article							MORTALITY	Background: This study uses surveillance, survey and program data to estimate past trends and current levels of HIV in Botswana and the effects of treatment and prevention programs. Methods/Principal Findings: Data from sentinel surveillance at antenatal clinics and a national population survey were used to estimate the trend of adult HIV prevalence from 1980 to 2007. Using the prevalence trend we estimated the number of new adult infections, the transmission from mothers to children, the need for treatment and the effects of antiretroviral therapy (ART) and adult and child deaths. Prevalence has declined slowly in urban areas since 2000 and has remained stable in rural areas. National prevalence is estimated at 26% (25-27%) in 2007. About 330,000 (318,000-335,000) people are infected with HIV including 20,000 children. The number of new adult infections has been stable for several years at about 20,000 annually (12,000-26,000). The number of new child infections has declined from 4600 in 1999 to about 890 (810-980) today due to nearly complete coverage of an effective program to prevent mother-to-child transmission (PMTCT). The annual number of adult deaths has declined from a peak of over 15,500 in 2003 to under 7400 (5000-11,000) today due to coverage of ART that reaches over 80% in need. The need for ART will increase by 60% by 2016. Conclusions: Botswana's PMTCT and treatment programs have achieved significant results in preventing new child infections and deaths among adults and children. The number of new adult infections continues at a high level. More effective prevention efforts are urgently needed.	[Stover, John] Futures Inst, Glastonbury, CT USA; [Fidzani, Boga; Molomo, Batho Chris] Natl AIDS Coordinating Agcy, Gaborone, Botswana; [Fidzani, Boga; Moeti, Themba; Musuka, Godfrey] African Comprehensive HIV AIDS Partnership, Gaborone, Botswana		Stover, J (corresponding author), Futures Inst, Glastonbury, CT USA.	JStover@FuturesInstitute.org			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the Bill and Melinda Gates Foundation through the African Comprehensive HIV/AIDS Partnership. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	*ABT ASS S AFR INC, 2000, IMP ASS HIV AIDS CUR; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; *MIN HLTH, 2005, BOTSW 2 GEN HIV AIDS; *NACA CSO OTH DEV, 2005, BOSTSW AIDS IMP SURV, V2; *NAT AIDS COORD AG, 2008, OCT DEC 2007 NAT AID; *NAT AIDS COORD AG, 2007, 2008 PROGR REP NAT R; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; STOVER J, 2008, AIM COMPUTER PROGRAM; TLALE J, 2008, INT AIDS C MEX CIT A; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E	13	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3729	10.1371/journal.pone.0003729	http://dx.doi.org/10.1371/journal.pone.0003729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008957	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166400007
J	Pinto, FR; Melo-Cristino, J; Ramirez, M				Pinto, Francisco R.; Melo-Cristino, Jose; Ramirez, Mario			A Confidence Interval for the Wallace Coefficient of Concordance and Its Application to Microbial Typing Methods	PLOS ONE			English	Article								Very diverse research fields frequently deal with the analysis of multiple clustering results, which should imply an objective detection of overlaps and divergences between the formed groupings. The congruence between these multiple results can be quantified by clustering comparison measures such as the Wallace coefficient (W). Since the measured congruence is dependent on the particular sample taken from the population, there is variability in the estimated values relatively to those of the true population. In the present work we propose the use of a confidence interval (CI) to account for this variability when W is used. The CI analytical formula is derived assuming a Gaussian sampling distribution and recurring to the algebraic relationship between W and the Simpson's index of diversity. This relationship also allows the estimation of the expected Wallace value under the assumption of independence of classifications. We evaluated the CI performance using simulated and published microbial typing data sets. The simulations showed that the CI has the desired 95% coverage when the W is greater than 0.5. This behaviour is robust to changes in cluster number, cluster size distributions and sample size. The analysis of the published data sets demonstrated the usefulness of the new CI by objectively validating some of the previous interpretations, while showing that other conclusions lacked statistical support.	[Pinto, Francisco R.; Melo-Cristino, Jose; Ramirez, Mario] Fac Med, Inst Mol Med, Inst Microbiol, Lisbon, Portugal; [Pinto, Francisco R.] Univ Lisbon, Fac Ciencias, Dept Quim Bioquim, Ctr Quim Bioquim, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Pinto, FR (corresponding author), Fac Med, Inst Mol Med, Inst Microbiol, Lisbon, Portugal.	frpinto@fc.ul.pt	Ramirez, Mario/B-4993-2008; Pinto, Francisco/A-7443-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Pinto, Francisco/0000-0002-4217-0054; Melo-Cristino, Jose A G/0000-0001-8643-1722	Fundacao para a Ciencia e Tecnologia, Portugal; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-ESA/71499/2006]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FRP is a research member of the Lisbon Epidemiology Consortium (CEL) funded by Fundacao para a Ciencia e Tecnologia, Portugal. Partial support for this work was provided by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-ESA/71499/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camiz S, 2007, COMMUNITY ECOL, V8, P25, DOI 10.1556/ComEc.8.2007.1.4; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Erlandsson M, 2008, SCAND J INFECT DIS, V40, P487, DOI 10.1080/00365540701864641; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Friaes A, 2007, J CLIN MICROBIOL, V45, P2044, DOI 10.1128/JCM.00496-07; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Pinto FR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-44; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Vainio A, 2008, EUR J CLIN MICROBIOL, V27, P545, DOI 10.1007/s10096-008-0470-1; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118	14	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3696	10.1371/journal.pone.0003696	http://dx.doi.org/10.1371/journal.pone.0003696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002246	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165600003
J	Yerushalmi, U; Teicher, M				Yerushalmi, Uri; Teicher, Mina			Evolving Synaptic Plasticity with an Evolutionary Cellular Development Model	PLOS ONE			English	Article								Since synaptic plasticity is regarded as a potential mechanism for memory formation and learning, there is growing interest in the study of its underlying mechanisms. Recently several evolutionary models of cellular development have been presented, but none have been shown to be able to evolve a range of biological synaptic plasticity regimes. In this paper we present a biologically plausible evolutionary cellular development model and test its ability to evolve different biological synaptic plasticity regimes. The core of the model is a genomic and proteomic regulation network which controls cells and their neurites in a 2D environment. The model has previously been shown to successfully evolve behaving organisms, enable gene related phenomena, and produce biological neural mechanisms such as temporal representations. Several experiments are described in which the model evolves different synaptic plasticity regimes using a direct fitness function. Other experiments examine the ability of the model to evolve simple plasticity regimes in a task-based fitness function environment. These results suggest that such evolutionary cellular development models have the potential to be used as a research tool for investigating the evolutionary aspects of synaptic plasticity and at the same time can serve as the basis for novel artificial computational systems.	[Yerushalmi, Uri; Teicher, Mina] Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University	Yerushalmi, U (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel.	uri.yerushalmi@gmail.com			DIP	DIP	This work was supported by a DIP grant for compositionality.	[Anonymous], 1989, GENETIC ALGORITHM SE; Astor JC, 2000, ARTIF LIFE, V6, P189, DOI 10.1162/106454600568834; BENTLEY PJ, 1999, WAYS GROW DESIGNS CO, P35; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Cangelosi A, 1997, NEURAL PROCESS LETT, V6, P91, DOI 10.1023/A:1009615807222; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DELLAERT F, 1994, COEVOLVING BODY BRAI; DELLAERT F, 1996, DEV MODEL EVOLUTION; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; FEDERICI D, 2005, EVOLVING DEV SPIKING; Floreano D, 2001, THEOR BIOSCI, V120, P225, DOI 10.1078/1431-7613-00042; GERARD B, 1990, P 17 ACM SIGPLAN SIG, P81; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; HARP SA, 1989, 3RD P INT C GEN ALG, P360; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1994, PHYS TODAY, V47, P40, DOI 10.1063/1.881412; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; JAKOBI N, 1995, HARNESSING MORPHOGEN; Kitano H., 1995, ARTIF LIFE, V2, P79; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; MONTANA D, 1989, P INT JOINT C ART IN; REIL T, 1999, DYNAMICS GENE EXPRES, P457; Ruppin E, 2002, NAT REV NEUROSCI, V3, P132, DOI 10.1038/nrn729; RUST AG, 1998, DEV ORG ARTIFICIAL N; RUST AG, 2000, ARTIFICIAL LIFE, V7; SIMS K, 1994, COMPUT GRAPH, V28, P15; SIMS K, 1994, ARTIF LIFE, V1, P535; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; THOMAS B, 1993, EVOL COMPUT, V1, P1; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; YERUSHALMI U, 2006, REGULATION NETWORK B; Yerushalmi U, 2007, B MATH BIOL, V69, P2261, DOI 10.1007/s11538-007-9219-8; Yerushalmi U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001863; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3697	10.1371/journal.pone.0003697	http://dx.doi.org/10.1371/journal.pone.0003697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002249	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165600004
J	Andersson, A; Isaksson, M; Wefer, J; Norling, A; Flores-Morales, A; Rorsman, F; Kampe, O; Harris, RA; Lobell, A				Andersson, Asa; Isaksson, Magnus; Wefer, Judit; Norling, Anna; Flores-Morales, Amilcar; Rorsman, Fredrik; Kampe, Olle; Harris, Robert A.; Lobell, Anna			Impaired Autoimmune T Helper 17 Cell Responses Following DNA Vaccination against Rat Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article								Background: We have previously shown that vaccination with DNA encoding the encephalitogenic peptide myelin oligodendrocyte glycoprotein (MOG)(91-108) (pMOG) suppresses MOG(91-108)-induced rat Experimental Autoimmune Encephalomyelitis (EAE), a model for human Multiple Sclerosis (MS). The suppressive effect of pMOG is dependent on inclusion of CpG DNA in the plasmid backbone and is associated with early induction of Interferon (IFN)-beta. Principal Findings: In this study we examined the mechanisms underlying pMOG-induced protection. We found that in the DNA vaccinated cohort proinflammatory Interleukin (IL)-17 and IL-21 responses were dramatically reduced compared to in the control group, but that the expression of Foxp3 and Tumor Growth Factor (TGF)-beta 1, which are associated with regulatory T cells, was not enhanced. Moreover, genes associated with Type I IFNs were upregulated. To delineate the role of IFN-beta in the protective mechanism we employed short interfering RNA (siRNA) to IFN-beta in the DNA vaccine. SiRNA to IFN-beta completely abrogated the protective effects of the vaccine, demonstrating that a local early elaboration of IFN-beta is important for EAE protection. IL-17 responses comparable to those in control rats developed in rats injected with the IFN-beta-silencing DNA vaccine. Conclusions: We herein demonstrate that DNA vaccination protects from proinflammatory Th17 cell responses during induction of EAE. The mechanism involves IFN-beta as IL-17 responses are rescued by silencing of IFN-beta during DNA vaccination.	[Andersson, Asa; Wefer, Judit; Harris, Robert A.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Asa] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Isaksson, Magnus; Norling, Anna; Rorsman, Fredrik; Kampe, Olle; Lobell, Anna] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Flores-Morales, Amilcar] Karolinska Inst, Dept Mol Med, Stockholm, Sweden	Karolinska Institutet; University of California System; University of California Los Angeles; Uppsala University; Karolinska Institutet	Andersson, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	Anna.Lobell@medsci.uu.se	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Andersson, Anders/0000-0002-3627-6899; Kampe, Olle/0000-0001-6091-9914	Montel Williams MS foundation; Petrus and Augusta Hedlunds foundation; Swedish Foundation for Strategic Research; Center for Autoimmunity and inflammation at Uppsala University; Ake Wiberg foundation; Tore Nilson foundation; Karolinska Institutet; Socialstyrelsen; Swedish Association for Neurologically disabled; Swedish Research Council	Montel Williams MS foundation; Petrus and Augusta Hedlunds foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Center for Autoimmunity and inflammation at Uppsala University; Ake Wiberg foundation; Tore Nilson foundation; Karolinska Institutet(Karolinska Institutet); Socialstyrelsen; Swedish Association for Neurologically disabled; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Montel Williams MS foundation (A. Lobell), Petrus and Augusta Hedlunds foundation (A. Lobell), the "Network for Inflammation research" funded by the Swedish Foundation for Strategic Research (A. Lobell), Center for Autoimmunity and inflammation at Uppsala University (A. Lobell and O. Kampe), Ake Wiberg foundation (A. Lobell), Tore Nilson foundation (A. Lobell), Karolinska Institutet funds (A. Lobell), Socialstyrelsen funds (A. Lobell), the Swedish Association for Neurologically disabled (A. Lobell) and the Swedish Research Council (O. Kampe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial, personal, or professional interests that have influenced the paper.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BETTELLI E, 2007, CURR OPIN IMMUNOL; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Koike F, 2003, J NEUROIMMUNOL, V139, P109, DOI 10.1016/S0165-5728(03)00155-3; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lobell A, 1999, J IMMUNOL, V163, P4754; Lobell A, 1998, J EXP MED, V187, P1543, DOI 10.1084/jem.187.9.1543; Lobell A, 2003, J IMMUNOL, V170, P1806, DOI 10.4049/jimmunol.170.4.1806; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller A, 1996, J NEUROIMMUNOL, V64, P151, DOI 10.1016/0165-5728(95)00164-6; Muhallab S, 2002, SCAND J IMMUNOL, V55, P264, DOI 10.1046/j.0300-9475.2002.01038.x; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Silver PB, 2007, J IMMUNOL, V179, P5146, DOI 10.4049/jimmunol.179.8.5146; Stahlberg N, 2004, ENDOCRINOLOGY, V145, P1972, DOI 10.1210/en.2003-0874; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallin H, 1999, J IMMUNOL, V163, P6306; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wefer J, 2004, J NEUROIMMUNOL, V149, P66, DOI 10.1016/j.jneuroim.2003.12.012; Weissert R, 2000, P NATL ACAD SCI USA, V97, P1689, DOI 10.1073/pnas.030390097	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3682	10.1371/journal.pone.0003682	http://dx.doi.org/10.1371/journal.pone.0003682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997868	Green Submitted, Green Published, gold			2022-12-27	WOS:000265165500005
J	Dehlin, M; Bokarewa, M; Rottapel, R; Foster, SJ; Magnusson, M; Dahlberg, LE; Tarkowski, A				Dehlin, Mats; Bokarewa, Maria; Rottapel, Robert; Foster, Simon J.; Magnusson, Mattias; Dahlberg, Leif E.; Tarkowski, Andrej			Intra-Articular Fms-Like Tyrosine Kinase 3 Ligand Expression Is a Driving Force in Induction and Progression of Arthritis	PLOS ONE			English	Article							FLT3 LIGAND; DIFFERENTIATION; SUBSETS	Background: One of the hallmarks of rheumatoid arthritis ( RA) is hyperplasia and inflammation of the synovial tissue being characterized by in situ occurrence of highly differentiated leukocytes. Fms-like tyrosine kinase 3 (Flt3) has a crucial role in hematopoiesis, regulation of cell proliferation, differentiation and apoptosis. Typically, Flt3 is expressed on early myeloid and lymphoid progenitors and is activated by its soluble ligand (Flt3-L). The highly differentiated cellular pattern in the synovium of the RA patients made us hypothesize that Flt3-L, with its ability to induce proliferation and differentiation, could be of importance in induction and/or progression of arthritis. Methodology/Principal Findings: To investigate occurrence of Flt3-L in RA we have measured its levels in matched serum and synovial fluid samples from 130 patients and 107 controls. To analyse the pro-inflammatory role of Flt3-L, we continuously overexpressed this protein locally in healthy mouse joints using homologous B-cell line transfected with Flt3-L gene. Additionally, recombinant Flt3-L was instillated intra-articularly in combination with peptidoglycans, a Toll Like Receptor 2-ligand with stong arthritogenic properties. Our results show significantly higher levels of Flt3-L in the synovial fluid as compared to serum levels in RA subjects (p=0.0001). In addition, RA synovial fluid levels of Flt-3-L were significantly higher than these obtained from synovial fluids originating fromnon-inflammatory joint diseases (p=0.022). Intra-articular administration of B-cell line transfected with Flt3-L gene resulted in highly erosive arthritis while inoculation of the same B-cell line without hyperexpression of Flt3-L did not induce erosivity and only in a minority of cases caused synovial proliferation! Flt3-ligand potentiated peptidoglycan induced arthritis as compared to mice injected with peptidoglycan alone (p < 0.05). Conclusions/Significance: Our findings indicate that Flt3-L is strongly expressed at the site of inflammation in human RA. It exerts both pro-inflammatory and tissue destructive properties once in the joint cavity. Owing to these properties, treatment attempts to neutralize this molecule should be considered in RA.	[Dehlin, Mats; Bokarewa, Maria; Magnusson, Mattias; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Dahlberg, Leif E.] UMAS, Univ Hosp, Dept Orthopaed, Malmo, Sweden	University of Gothenburg; University of Toronto; University of Sheffield; Lund University; Skane University Hospital	Dehlin, M (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	mats.dehlin@vgregion.se	Bokarewa, Maria I/A-8114-2019; magnusson, mattias/G-2079-2011	Bokarewa, Maria I/0000-0001-9424-5145; magnusson, mattias/0000-0002-6565-4027; Rottapel, Robert/0000-0002-6024-5558	Goteborg Medical Society; Swedish Association Against Rheumatism; King Gustav V's Foundation; Swedish Medical Research Council; Nanna Svartz Foundation; University of Goteborg; A.-G. Crafoord Foundation; Borje Dahlin Foundation; European Union; Inflammation Network; Rune And Ulla Amlovs Foundation; A. M. E. Wolff Foundation	Goteborg Medical Society; Swedish Association Against Rheumatism; King Gustav V's Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Nanna Svartz Foundation; University of Goteborg; A.-G. Crafoord Foundation; Borje Dahlin Foundation; European Union(European Commission); Inflammation Network; Rune And Ulla Amlovs Foundation; A. M. E. Wolff Foundation	This work was supported by the Goteborg Medical Society, Swedish Association Against Rheumatism, King Gustav V's Foundation, Swedish Medical Research Council, Nanna Svartz Foundation, University of Goteborg, A.-G. Crafoord Foundation, Borje Dahlin Foundation, European Union grants, Inflammation Network, Rune And Ulla Amlovs Foundation, and A. M. E. Wolff Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Liu ZQ, 2001, ARTHRITIS RES, V3, P375, DOI 10.1186/ar330; Maraskovsky E, 2000, BLOOD, V96, P878, DOI 10.1182/blood.V96.3.878.015k15_878_884; Namikawa R, 1996, BLOOD, V87, P1881; Papayannopoulou T, 1997, BLOOD, V90, P620, DOI 10.1182/blood.V90.2.620.620_620_629; Rappold I, 1997, BLOOD, V90, P111; Rosnet O, 1996, LEUKEMIA, V10, P238; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169	12	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3633	10.1371/journal.pone.0003633	http://dx.doi.org/10.1371/journal.pone.0003633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982072	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265134300003
J	Fan, XX; Martin-Brown, S; Florens, L; Li, R				Fan, Xiaoxue; Martin-Brown, Skylar; Florens, Laurence; Li, Rong			Intrinsic Capability of Budding Yeast Cofilin to Promote Turnover of Tropomyosin-Bound Actin Filaments	PLOS ONE			English	Article							BINDING-PROTEIN; TROPONIN COMPLEX; ARP2/3 COMPLEX; F-ACTIN; CABLES; POLYMERIZATION; STABILIZES; MECHANISM; ISOFORMS; FORMIN	The ability of actin filaments to function in cell morphogenesis and motility is closely coupled to their dynamic properties. Yeast cells contain two prominent actin structures, cables and patches, both of which are rapidly assembled and disassembled. Although genetic studies have shown that rapid actin turnover in patches and cables depends on cofilin, how cofilin might control cable disassembly remains unclear, because tropomyosin, a component of actin cables, is thought to protect actin filaments against the depolymerizing activity of ADF/cofilin. We have identified cofilin as a yeast tropomyosin (Tpm1) binding protein through Tpm1 affinity column and mass spectrometry. Using a variety of assays, we show that yeast cofilin can efficiently depolymerize and sever yeast actin filaments decorated with either Tpm1 or mouse tropomyosins TM1 and TM4. Our results suggest that yeast cofilin has the intrinsic ability to promote actin cable turnover, and that the severing activity may rely on its ability to bind Tpm1.	[Fan, Xiaoxue; Martin-Brown, Skylar; Florens, Laurence; Li, Rong] Stowers Inst Med Res, Kansas City, MO USA	Stowers Institute for Medical Research	Fan, XX (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	rli@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650	National Institutes of Health [GM057063, GM066311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066311, R01GM057063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health GM057063 and GM066311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami R, 2002, BIOCHEMISTRY-US, V41, P5907, DOI 10.1021/bi0116745; ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Asakura T, 1998, ONCOGENE, V16, P121, DOI 10.1038/sj.onc.1201487; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1989, BIOCHEMISTRY-US, V28, P8501, DOI 10.1021/bi00447a035; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FATTOUM A, 1983, BIOCHEMISTRY-US, V22, P1187, DOI 10.1021/bi00274a031; Florens Laurence, 2006, V328, P159; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HITCHCOCK SE, 1976, CELL, V7, P531, DOI 10.1016/0092-8674(76)90203-8; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; Maciver SK, 2002, GENOME BIOL, V3; McGough Amy, 2001, Results and Problems in Cell Differentiation, V32, P135; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Wawro B, 2007, BIOCHEMISTRY-US, V46, P8146, DOI 10.1021/bi700686p; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; WEGNER A, 1982, J MOL BIOL, V161, P217, DOI 10.1016/0022-2836(82)90149-8; WEIGT C, 1990, FEBS LETT, V260, P266, DOI 10.1016/0014-5793(90)80119-4; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	40	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3641	10.1371/journal.pone.0003641	http://dx.doi.org/10.1371/journal.pone.0003641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982060	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134300011
J	Mendiola, M; Barriuso, J; Redondo, A; Marino-Enriquez, A; Madero, R; Espinosa, E; Vara, JAF; Sanchez-Navarro, I; Hernandez-Cortes, G; Zamora, P; Perez-Fernandez, E; Miguel-Martin, M; Suarez, A; Palacios, J; Gonzalez-Baron, M; Hardisson, D				Mendiola, Marta; Barriuso, Jorge; Redondo, Andres; Marino-Enriquez, Adrian; Madero, Rosario; Espinosa, Enrique; Fresno Vara, Juan Angel; Sanchez-Navarro, Iker; Hernandez-Cortes, Gines; Zamora, Pilar; Perez-Fernandez, Elia; Miguel-Martin, Maria; Suarez, Asuncion; Palacios, Jose; Gonzalez-Baron, Manuel; Hardisson, David			Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN EXPRESSION; PHASE-II; CANCER; MODEL; BEVACIZUMAB; RESISTANCE; RECEPTORS; SIGNATURE; PATTERNS	Background: Ovarian carcinoma is the most important cause of gynecological cancer-related mortality in Western societies. Despite the improved median overall survival in patients receiving chemotherapy regimens such as paclitaxel and carboplatin combination, relapse still occurs in most advanced diseased patients. Increased angiogenesis is associated with rapid recurrence and decreased survival in ovarian cancer. This study was planned to identify an angiogenesis-related gene expression profile with prognostic value in advanced ovarian carcinoma patients. Methodology/Principal Findings: RNAs were collected from formalin-fixed paraffin-embedded samples of 61 patients with III/IV FIGO stage ovarian cancer who underwent surgical cytoreduction and received a carboplatin plus paclitaxel regimen. Expression levels of 82 angiogenesis related genes were measured by quantitative real-time polymerase chain reaction using TaqMan low-density arrays. A 34-gene-profile which was able to predict the overall survival of ovarian carcinoma patients was identified. After a leave-one-out cross validation, the profile distinguished two groups of patients with different outcomes. Median overall survival and progression-free survival for the high risk group was 28.3 and 15.0 months, respectively, and was not reached by patients in the low risk group at the end of follow-up. Moreover, the profile maintained an independent prognostic value in the multivariate analysis. The hazard ratio for death was 2.3 (95% CI, 1.5 to 3.2; p<0.001). Conclusions/Significance: It is possible to generate a prognostic model for advanced ovarian carcinoma based on angiogenesis-related genes using formalin-fixed paraffin-embedded samples. The present results are consistent with the increasing weight of angiogenesis genes in the prognosis of ovarian carcinoma.	[Mendiola, Marta; Marino-Enriquez, Adrian; Miguel-Martin, Maria; Suarez, Asuncion; Hardisson, David] Univ Autonoma Madrid, Dept Pathol, Hosp Univ La Paz, Dept Pathol, Madrid, Spain; [Barriuso, Jorge; Redondo, Andres; Espinosa, Enrique; Zamora, Pilar; Gonzalez-Baron, Manuel] Univ Autonoma Madrid, Hosp Univ La Paz, Translat Oncol Unit, Madrid, Spain; [Madero, Rosario; Perez-Fernandez, Elia] Univ Autonoma Madrid, Hosp Univ La Paz, Unit Biostat, Madrid, Spain; [Mendiola, Marta; Barriuso, Jorge; Madero, Rosario; Fresno Vara, Juan Angel; Sanchez-Navarro, Iker; Perez-Fernandez, Elia; Miguel-Martin, Maria] FIBHULP, Madrid, Spain; [Hernandez-Cortes, Gines; Palacios, Jose] Hosp Univ Virgen Rocio, Dept Pathol, Seville, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Virgen del Rocio University Hospital	Mendiola, M (corresponding author), Univ Autonoma Madrid, Dept Pathol, Hosp Univ La Paz, Dept Pathol, Madrid, Spain.	dhardisson.hulp@salud.madrid.org	Vara, Juan Ángel Fresno/Y-9928-2019; Hardisson, David/A-6259-2011; Fresno Vara, Juan Angel/F-6702-2010; Zamora, Pilar/AAM-9336-2021; Hardisson, David/E-2832-2010; Hardisson, David/AAN-3833-2020	Vara, Juan Ángel Fresno/0000-0003-1527-1252; Fresno Vara, Juan Angel/0000-0003-1527-1252; Hardisson, David/0000-0002-2183-3699; Barriuso, Jorge/0000-0002-5641-9105; Perez-Fernandez, Elia/0000-0003-2726-8683; Marino-Enriquez, Adrian/0000-0002-7680-9901; Redondo Sanchez, Andres/0000-0002-7257-5642; Espinosa Arranz, Enrique/0000-0001-6562-7902	Fondo de Investigacion Sanitaria; Instituto de Salud Carlos III; Ministerio de Sanidad y Consumo, Spain [FIS07/0651, CM05/00143, CP05/00248]; Fundacion de Investigacion Medica Mutua Madrilena	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Sanidad y Consumo, Spain; Fundacion de Investigacion Medica Mutua Madrilena	Financial support was given by Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain (FIS07/0651 to MM, JB, AR, GHC, and DH), CM05/00143 to JB, and CP05/00248 to JAFV); and Fundacion de Investigacion Medica Mutua Madrilena (MM, JB, AR, AME, EE, JAFV, GHC, and DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuJawdeh GM, 1996, LAB INVEST, V74, P1105; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Borgstrom P, 1996, CANCER RES, V56, P4032; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Deeds J, 2000, HUM PATHOL, V31, P1346, DOI 10.1053/hupa.2000.19441; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duncan TJ, 2008, CLIN CANCER RES, V14, P3030, DOI 10.1158/1078-0432.CCR-07-1888; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Goodheart MJ, 2005, CLIN CANCER RES, V11, P3733, DOI 10.1158/1078-0432.CCR-04-0056; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; HENRIKSEN R, 1993, CANCER RES, V53, P4550; Husain A, 1998, CANCER RES, V58, P1120; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong JY, 2008, INT J CANCER, V122, P274, DOI 10.1002/ijc.23068; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lassus H, 2004, BRIT J CANCER, V91, P2048, DOI 10.1038/sj.bjc.6602252; McGuire WP, 1997, SEMIN ONCOL, V24, pS13; Olivier RI, 2006, EUR J CANCER, V42, P2930, DOI 10.1016/j.ejca.2006.04.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; QAZI F, 1995, CA-CANCER J CLIN, V45, P88, DOI 10.3322/canjclin.45.2.88; Schindl M, 2003, CLIN CANCER RES, V9, P779; Simon R, 2006, PHARMACOGENOMICS J, V6, P166, DOI 10.1038/sj.tpj.6500349; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERSNEL MA, 1994, CANCER GENET CYTOGEN, V73, P60, DOI 10.1016/0165-4608(94)90183-X; Wu QH, 2006, GYNECOL ONCOL, V102, P15, DOI 10.1016/j.ygyno.2005.11.034; You B, 2008, CLIN BIOCHEM, V41, P785, DOI 10.1016/j.clinbiochem.2008.04.001; Yuan SSF, 1999, CANCER RES, V59, P3547	38	18	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4051	10.1371/journal.pone.0004051	http://dx.doi.org/10.1371/journal.pone.0004051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112514	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466000013
J	Gross, E; Busse, B; Riemenschneider, M; Neubauer, S; Seck, K; Klein, HG; Kiechle, M; Lordick, F; Meindl, A				Gross, Eva; Busse, Birgit; Riemenschneider, Matthias; Neubauer, Steffi; Seck, Katharina; Klein, Hanns-Georg; Kiechle, Marion; Lordick, Florian; Meindl, Alfons			Strong Association of a Common Dihydropyrimidine Dehydrogenase Gene Polymorphism with Fluoropyrimidine-Related Toxicity in Cancer Patients	PLOS ONE			English	Article							DPD DEFICIENCY; IVS14+1G-GREATER-THAN-A MUTATION; 5-FLUOROURACIL TOXICITY; BREAST-CANCER; PHARMACOGENETICS; IDENTIFICATION; CHEMOTHERAPY; CAPECITABINE; PHARMACOKINETICS; FLUOROURACIL	Background: Cancer patients carrying mutations in the dihydropyrimidine dehydrogenase gene (DPYD) have a high risk to experience severe drug-adverse effects following chemotherapy with fluoropyrimidine drugs such as 5-fluorouracil (5-FU) or capecitabine. The pretreatment detection of this impairment of pyrimidine catabolism could prevent serious, potentially lethal side effects. As known deleterious mutations explain only a limited proportion of the drug-adverse events, we systematically searched for additional DPYD variations associated with enhanced drug toxicity. Methodology/Principal Findings: We performed a whole gene approach covering the entire coding region and compared DPYD genotype frequencies between cancer patients with good (n = 89) and with poor ( n = 39) tolerance of a fluoropyrimidine-based chemotherapy regimen. Applying logistic regression analysis and sliding window approaches we identified the strongest association with fluoropyrimidine-related grade III and IV toxicity for the non-synonymous polymorphism c.496A>G (p.Met166Val). We then confirmed our initial results using an independent sample of 53 individuals suffering from drug-adverse-effects. The combined odds ratio calculated for 92 toxicity cases was 4.42 [95% CI 2.12-9.23]; p (trend)<0.001; p (corrected) = 0.001; the attributable risk was 56.9%. Comparing tumor-type matched sets of samples, correlation of c.496A>G with toxicity was particularly present in patients with gastroesophageal and breast cancer, but did not reach significance in patients with colorectal malignancies. Conclusion: Our results show compelling evidence that, at least in distinct tumor types, a common DPYD polymorphism strongly contributes to the occurrence of fluoropyrimidine-related drug adverse effects. Carriers of this variant could benefit from individual dose adjustment of the fluoropyrimidine drug or alternate therapies.	[Gross, Eva; Neubauer, Steffi; Seck, Katharina; Kiechle, Marion; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-8000 Munich, Germany; [Busse, Birgit; Klein, Hanns-Georg] Ctr Human Genet & Lab Med, Martinsried, Germany; [Riemenschneider, Matthias] Tech Univ Munich, Klinikum Rechts Isar, Dept Psych & Psychotherapy, Munich, Germany; [Lordick, Florian] Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gross, E (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-8000 Munich, Germany.	eva.gross@lrz.tum.de			Kommission fur klinische Forschung (KKF); Technischen Universitat Munchen [18-02]; Deutsche Krebshilfe e.V. [107352]; German National Genome Research Network (NGFN) [01GS0465]	Kommission fur klinische Forschung (KKF); Technischen Universitat Munchen; Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); German National Genome Research Network (NGFN)	This work was supported by the Kommission fur klinische Forschung (KKF) der Technischen Universitat Munchen (No. 18-02), by the Deutsche Krebshilfe e.V. (DKH No. 107352) and by the German National Genome Research Network (NGFN) (No. 01GS0465). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani J, 2006, CANCER-AM CANCER SOC, V107, P221, DOI 10.1002/cncr.21986; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENFREDJ R, 2008, PATHOL BIOL PAR 0710; Bosch Tessa M., 2008, V448, P63, DOI 10.1007/978-1-59745-205-2_5; Ciccolini J, 2006, THER DRUG MONIT, V28, P678, DOI 10.1097/01.ftd.0000245771.82720.c7; Cinieri S, 2007, ANN ONCOL, V18, P63, DOI 10.1093/annonc/mdm227; Collie-Duguid ESR, 2000, PHARMACOGENETICS, V10, P217, DOI 10.1097/00008571-200004000-00002; Di Paolo A, 2001, ANN ONCOL, V12, P1301, DOI 10.1023/A:1012294617392; Diasio R B, 2001, Oncology (Williston Park), V15, P21; Diasio RB, 2000, PHARMACOLOGY, V61, P199, DOI 10.1159/000028401; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Goldberg RM, 2006, ONCOLOGIST, V11, P981, DOI 10.1634/theoncologist.11-9-981; Gross E, 2003, INT J ONCOL, V22, P325; Gross E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9201; HEGGIE GD, 1987, CANCER RES, V47, P2203; Hormozian F, 2007, CANCER LETT, V246, P82, DOI 10.1016/j.canlet.2006.02.004; Johnson MR, 2002, CLIN CANCER RES, V8, P768; Largillier R, 2006, CLIN CANCER RES, V12, P5496, DOI 10.1158/1078-0432.CCR-06-0320; Lazar A, 2008, DEUT MED WOCHENSCHR, V133, P1501, DOI 10.1055/s-2008-1081098; Maekawa K, 2007, J HUM GENET, V52, P804, DOI 10.1007/s10038-007-0186-6; Magne N, 2007, BRIT J CLIN PHARMACO, V64, P237, DOI 10.1111/j.1365-2125.2007.02869.x; Mattison LK, 2004, CLIN CANCER RES, V10, P2652, DOI 10.1158/1078-0432.CCR-03-0374; Mattison LK, 2002, PHARMACOGENETICS, V12, P133, DOI 10.1097/00008571-200203000-00007; Mercier C, 2008, J CLIN ONCOL, V26; Morel A, 2006, MOL CANCER THER, V5, P2895, DOI 10.1158/1535-7163.MCT-06-0327; Ogura K, 2005, CLIN CANCER RES, V11, P5104, DOI 10.1158/1078-0432.CCR-05-0217; Reerink O, 2004, ANTICANCER RES, V24, P1969; Ridge SA, 1998, BRIT J CLIN PHARMACO, V46, P151, DOI 10.1046/j.1365-2125.1998.00751.x; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Saif AW, 2006, CLIN COLORECTAL CANC, V5, P359, DOI 10.3816/CCC.2006.n.007; Salgueiro N, 2004, GENET MED, V6, P102, DOI 10.1097/01.GIM.0000118061.66602.A5; Scheithauer W, 2003, ANN ONCOL, V14, P1735, DOI 10.1093/annonc/mdg500; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Seck K, 2005, CLIN CANCER RES, V11, P5886, DOI 10.1158/1078-0432.CCR-04-1784; Sun Weijing, 2005, Curr Oncol Rep, V7, P181, DOI 10.1007/s11912-005-0071-4; van Kuilenburg ABP, 2004, EUR J CANCER, V40, P939, DOI 10.1016/j.ejca.2003.12.004; van Kuilenburg ABP, 2002, BIOCHEM J, V364, P157, DOI 10.1042/bj3640157; van Kuilenburg ABP, 2002, PHARMACOGENETICS, V12, P555, DOI 10.1097/00008571-200210000-00007; Van Kuilenburg ABP, 2000, ADV EXP MED BIOL, V486, P251; van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705; van Kuilenburg ABP, 2007, EUR J CANCER, V43, P459, DOI 10.1016/j.ejca.2006.09.017; Vreken P, 1997, HUM GENET, V101, P333, DOI 10.1007/s004390050637; YOKOTA H, 1994, J BIOL CHEM, V269, P23192; Zhang H, 2007, MED ONCOL, V24, P251, DOI 10.1007/BF02698048; Zhou ZW, 2007, CHEMOTHERAPY, V53, P127, DOI 10.1159/000099984	45	84	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4003	10.1371/journal.pone.0004003	http://dx.doi.org/10.1371/journal.pone.0004003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104657	gold, Green Published, Green Submitted			2022-12-27	WOS:000265462400004
J	Lo, LJ; Zhang, ZH; Hong, N; Peng, JR; Hong, YH				Lo, Lijan; Zhang, Zhenhai; Hong, Ni; Peng, Jinrong; Hong, Yunhan			3640 Unique EST Clusters from the Medaka Testis and Their Potential Use for Identifying Conserved Testicular Gene Expression in Fish and Mammals	PLOS ONE			English	Article								Background: The fish medaka is the first vertebrate capable of full spermatogenesis in vitro from self-renewing spermatogonial stem cells to motile test-tube sperm. Precise staging and molecular dissection of this process has been hampered by the lack of suitable molecular markers. Methodology and Principal Findings: We have generated a normalized medaka testis cDNA library and obtained 7040 high quality sequences representing 3641 unique gene clusters. Among these, 1197 unique clusters are homologous to known genes, and 2444 appear to be novel genes. Ontology analysis shows that the 1197 gene products are implicated in diverse molecular and cellular processes. These genes include markers for all major types of testicular somatic and germ cells. Furthermore, markers were identified for major spermatogenic stages ranging from spermatogonial stem cell self-renewal to meiosis entry, progression and completion. Intriguingly, the medaka testis expresses at least 13 homologs of the 33 mouse X-chromosomal genes that are enriched in the testis. More importantly, we show that key components of several signaling pathways known to be important for testicular function in mammals are well represented in the medaka testicular EST collection. Conclusions/Significance: Medaka exhibits a considerable similarity in testicular gene expression to mammals. The medaka testicular EST collection we obtained has wide range coverage and will not only consolidate our knowledge on the comparative analysis of known genes' functions in the testis but also provide a rich resource to dissect molecular events and mechanism of spermatogenesis in vivo and in vitro in medaka as an excellent vertebrate model.	[Lo, Lijan; Hong, Ni; Peng, Jinrong; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Zhang, Zhenhai; Peng, Jinrong] Inst Mol & Cell Biol, Proteos, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lo, LJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	pengjr@imcb.a-star.edu.sg; dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Hong, Ni/Y-6114-2018; Zhang, Zhenhai/GRX-5887-2022; Test Account, SLB-WOS/E-5790-2010	Hong, Ni/0000-0002-9404-3110; Zhang, Zhenhai/0000-0002-4310-0525; Peng, Jinrong/0000-0002-0793-4848	National University of Singapore [R-154-000-153-720]; Biomedical Research Council of Singapore [R-154-000-204-305]; Ministry of Education of Singapore [R154-000-285-112]; Agency for Science, Technology and Research (A*STAR), Singapore	National University of Singapore(National University of Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education of Singapore(Ministry of Education, Singapore); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the National University of Singapore (R-154-000-153-720), Biomedical Research Council of Singapore (R-154-000-204-305) and Ministry of Education of Singapore (R154-000-285-112), and by Agency for Science, Technology and Research (A*STAR) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2004, BIOL REPROD, V70, P1751, DOI 10.1095/biolreprod.103.026575; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chini V, 2008, GENE, V410, P207, DOI 10.1016/j.gene.2007.12.012; Coimbra RS, 2002, GENOME RES, V12, P1007, DOI 10.1101/gr.227502; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Guo R, 2004, MOL REPROD DEV, V67, P264, DOI 10.1002/mrd.20026; Hayashi T, 2001, J ANDROL, V22, P999; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; JOHNSTON DS, 2008, P NATL ACAD SCI US; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; Li CY, 2007, DEV BIOL, V309, P70, DOI 10.1016/j.ydbio.2007.06.019; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Maratou K, 2004, MOL REPROD DEV, V67, P26, DOI 10.1002/mrd.20010; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pang ALY, 2003, J ANDROL, V24, P899; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; Piquet-Pellorce C, 2000, ENDOCRINOLOGY, V141, P1136, DOI 10.1210/en.141.3.1136; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Sakai N, 2002, DEVELOPMENT, V129, P3359; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Strothmann K, 2004, CELL TISSUE RES, V315, P249, DOI 10.1007/s00441-003-0834-x; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Wu SM, 2004, GENOMICS, V84, P971, DOI 10.1016/j.ygeno.2004.08.018; Xiao P, 2008, BIOL PHARM BULL, V31, P201, DOI 10.1248/bpb.31.201; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6	39	16	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e3915	10.1371/journal.pone.0003915	http://dx.doi.org/10.1371/journal.pone.0003915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104663	Green Published, Green Submitted, gold			2022-12-27	WOS:000265462400001
J	Lopez, F; Textoris, J; Bergon, A; Didier, G; Remy, E; Granjeaud, S; Imbert, J; Nguyen, C; Puthier, D				Lopez, Fabrice; Textoris, Julien; Bergon, Aurelie; Didier, Gilles; Remy, Elisabeth; Granjeaud, Samuel; Imbert, Jean; Nguyen, Catherine; Puthier, Denis			TranscriptomeBrowser: A Powerful and Flexible Toolbox to Explore Productively the Transcriptional Landscape of the Gene Expression Omnibus Database	PLOS ONE			English	Article								Background: As public microarray repositories are constantly growing, we are facing the challenge of designing strategies to provide productive access to the available data. Methodology: We used a modified version of the Markov clustering algorithm to systematically extract clusters of coregulated genes from hundreds of microarray datasets stored in the Gene Expression Omnibus database (n = 1,484). This approach led to the definition of 18,250 transcriptional signatures (TS) that were tested for functional enrichment using the DAVID knowledgebase. Over-representation of functional terms was found in a large proportion of these TS (84%). We developed a JAVA application, TBrowser that comes with an open plug-in architecture and whose interface implements a highly sophisticated search engine supporting several Boolean operators (http://tagc.univ-mrs.fr/tbrowser/). User can search and analyze TS containing a list of identifiers (gene symbols or AffyIDs) or associated with a set of functional terms. Conclusions/Significance: As proof of principle, TBrowser was used to define breast cancer cell specific genes and to detect chromosomal abnormalities in tumors. Finally, taking advantage of our large collection of transcriptional signatures, we constructed a comprehensive map that summarizes gene-gene co-regulations observed through all the experiments performed on HGU133A Affymetrix platform. We provide evidences that this map can extend our knowledge of cellular signaling pathways.	[Lopez, Fabrice; Textoris, Julien; Bergon, Aurelie; Granjeaud, Samuel; Imbert, Jean; Nguyen, Catherine; Puthier, Denis] TAGC, U928, INSERM, Marseille, France; [Lopez, Fabrice; Textoris, Julien; Bergon, Aurelie; Didier, Gilles; Remy, Elisabeth; Granjeaud, Samuel; Imbert, Jean; Nguyen, Catherine] Univ Mediterranee, Marseille, France; [Didier, Gilles; Remy, Elisabeth] Inst Math Luminy, Marseille, France; [Puthier, Denis] Univ Provence Mediterranee, ESIL, Marseille, France; [Textoris, Julien] Hop Marseille, Hop Nord Assistance Publ, Serv Anesth Reanimat, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Lopez, F (corresponding author), TAGC, U928, INSERM, Parc Sci Luminy, Marseille, France.	puthier@tagc.univ-mrs.fr	Lopez, Fabrice/M-5021-2016; Imbert, Jean/AAG-1165-2020; Nguyen, Catherine/M-4119-2016; Bergon, Aurélie/M-4977-2016; puthier, denis/AFV-1973-2022; Textoris, Julien/H-3317-2019; Imbert, Jean/G-3248-2013; Granjeaud, Samuel/AAE-6488-2022; Puthier, Denis/N-5018-2016	Lopez, Fabrice/0000-0002-2401-0292; Imbert, Jean/0000-0002-0478-9593; Nguyen, Catherine/0000-0001-9376-6360; Bergon, Aurélie/0000-0003-1518-4562; puthier, denis/0000-0002-7240-5280; Textoris, Julien/0000-0002-3821-9337; Imbert, Jean/0000-0002-0478-9593; Granjeaud, Samuel/0000-0001-9245-1535; Didier, Gilles/0000-0003-0596-9112	Institut National de la Sante et de la Recherche Medicale (Inserm); Canceropcle PACA; Marseille-Nice Genopole; EU STREP; IntegraTCell project (ANR, National Research Agency)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canceropcle PACA; Marseille-Nice Genopole; EU STREP(European Commission); IntegraTCell project (ANR, National Research Agency)(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the Canceropcle PACA and Marseille-Nice Genopole. Fabrice Lopez was supported by a fellowship from the EU STREP grant Diamonds and through funding from the IntegraTCell project (ANR, National Research Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Boles KS, 1999, TISSUE ANTIGENS, V54, P27, DOI 10.1034/j.1399-0039.1999.540103.x; *CHAMELEON, HIER CLUST ALG US DY; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lattimore BS, 2005, COMPUT BIOL CHEM, V29, P354, DOI 10.1016/j.compbiolchem.2005.07.002; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Rabot M, 2007, INT IMMUNOL, V19, P401, DOI 10.1093/intimm/dxm005; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDONGEN S, 2000, CLUSTER ALGORITHM GR, P1386; Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637; PUBMED SNAPSHOT	28	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4001	10.1371/journal.pone.0004001	http://dx.doi.org/10.1371/journal.pone.0004001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104654	Green Published, gold			2022-12-27	WOS:000265462400002
J	Sabath, N; Landan, G; Graur, D				Sabath, Niv; Landan, Giddy; Graur, Dan			A Method for the Simultaneous Estimation of Selection Intensities in Overlapping Genes	PLOS ONE			English	Article							H5N1 INFLUENZA-VIRUS; NUCLEOTIDE SUBSTITUTION; READING FRAMES; SEQUENCE-ANALYSIS; EVOLUTION; LIKELIHOOD; RATES; MODELS; COMPRESSION; ANNOTATION	Inferring the intensity of positive selection in protein-coding genes is important since it is used to shed light on the process of adaptation. Recently, it has been reported that overlapping genes, which are ubiquitous in all domains of life, seem to exhibit inordinate degrees of positive selection. Here, we present a new method for the simultaneous estimation of selection intensities in overlapping genes. We show that the appearance of positive selection is caused by assuming that selection operates independently on each gene in an overlapping pair, thereby ignoring the unique evolutionary constraints on overlapping coding regions. Our method uses an exact evolutionary model, thereby voiding the need for approximation or intensive computation. We test the method by simulating the evolution of overlapping genes of different types as well as under diverse evolutionary scenarios. Our results indicate that the independent estimation approach leads to the false appearance of positive selection even though the gene is in reality subject to negative selection. Finally, we use our method to estimate selection in two influenza A genes for which positive selection was previously inferred. We find no evidence for positive selection in both cases.	[Sabath, Niv; Landan, Giddy; Graur, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	University of Houston System; University of Houston	Sabath, N (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	nsabath@uh.edu	Landan, Giddy/C-1086-2019	Landan, Giddy/0000-0002-2502-8750	National Science Foundation [DBI-0543342]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by grant DBI-0543342 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; Campitelli L, 2006, J GEN VIROL, V87, P955, DOI 10.1099/vir.0.81397-0; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; de Groot S, 2007, BIOINFORMATICS, V23, P1080, DOI 10.1093/bioinformatics/btm078; de Groot S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-304; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112; Holmes EC, 2006, SCIENCE, V313, DOI 10.1126/science.1131729; Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; JONES CE, 1995, EUR J BIOCHEM, V233, P800, DOI 10.1111/j.1432-1033.1995.800_3.x; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; LI WH, 1985, MOL BIOL EVOL, V2, P150; Lillo F, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-22; Makalowska I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-193; McCauley S, 2007, BIOINFORMATICS, V23, P2978, DOI 10.1093/bioinformatics/btm472; McCauley S, 2006, BIOINFORMATICS, V22, P1308, DOI 10.1093/bioinformatics/btl092; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OKAMOTO H, 1986, J GEN VIROL, V67, P2305, DOI 10.1099/0022-1317-67-11-2305; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pavesi A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/vir.0.81375-0; Pavesi A, 2007, GENE, V402, P28, DOI 10.1016/j.gene.2007.07.013; Pedersen AMK, 2001, MOL BIOL EVOL, V18, P763, DOI 10.1093/oxfordjournals.molbev.a003859; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Sakharkar KR, 2005, INT J SYST EVOL MICR, V55, P1205, DOI 10.1099/ijs.0.63446-0; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Zaaijer HL, 2007, J GEN VIROL, V88, P2137, DOI 10.1099/vir.0.82906-0; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	45	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3996	10.1371/journal.pone.0003996	http://dx.doi.org/10.1371/journal.pone.0003996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098983	gold, Green Submitted, Green Published			2022-12-27	WOS:000265462300007
J	Foerstner, KU; Doerks, T; Muller, J; Raes, J; Bork, P				Foerstner, Konrad U.; Doerks, Tobias; Muller, Jean; Raes, Jeroen; Bork, Peer			A Nitrile Hydratase in the Eukaryote Monosiga brevicollis	PLOS ONE			English	Article								Bacterial nitrile hydratase (NHases) are important industrial catalysts and waste water remediation tools. In a global computational screening of conventional and metagenomic sequence data for NHases, we detected the two usually separated NHase subunits fused in one protein of the choanoflagellate Monosiga brevicollis, a recently sequenced unicellular model organism from the closest sister group of Metazoa. This is the first time that an NHase is found in eukaryotes and the first time it is observed as a fusion protein. The presence of an intron, subunit fusion and expressed sequence tags covering parts of the gene exclude contamination and suggest a functional gene. Phylogenetic analyses and genomic context imply a probable ancient horizontal gene transfer (HGT) from proteobacteria. The newly discovered NHase might open biotechnological routes due to its unconventional structure, its new type of host and its apparent integration into eukaryotic protein networks.	[Foerstner, Konrad U.; Doerks, Tobias; Muller, Jean; Raes, Jeroen; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Foerstner, KU (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	bork@embl.de	Förstner, Konrad U./B-1531-2010; raes, jeroen/D-7835-2018; Muller, Jean/L-7412-2018; Bork, Peer/F-1813-2013	Förstner, Konrad U./0000-0002-1481-2996; raes, jeroen/0000-0002-1337-041X; Muller, Jean/0000-0002-7682-559X; Bork, Peer/0000-0002-2627-833X	EU FP7 programme [HEALTH-F4-2007-201052]	EU FP7 programme(European Commission)	This work was supported by the EU FP7 programme (HEALTH-F4-2007-201052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; BLAKEY AJ, 1995, FEMS MICROBIOL LETT, V129, P57; Brandao PFB, 2003, ANTON LEEUW INT J G, V84, P89, DOI 10.1023/A:1025409818275; BUCK KR, 1988, MAR BIOL, V98, P263, DOI 10.1007/BF00391204; Colquhoun JA, 1998, EXTREMOPHILES, V2, P269, DOI 10.1007/s007920050069; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DIGERONIMO MJ, 1976, APPL ENVIRON MICROB, V31, P900, DOI 10.1128/AEM.31.6.900-906.1976; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo I, 2001, J INORG BIOCHEM, V83, P247, DOI 10.1016/S0162-0134(00)00171-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrop TC, 2004, ACCOUNTS CHEM RES, V37, P253, DOI 10.1021/ar0301532; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Langdahl BR, 1996, MICROBIOL-UK, V142, P145, DOI 10.1099/13500872-142-1-145; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAYH N, 1994, J BIOTECHNOL, V33, P175, DOI 10.1016/0168-1656(94)90109-0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; NAGASAWA T, 1995, PURE APPL CHEM, V67, P1241, DOI 10.1351/pac199567071241; Nakasako M, 1999, BIOCHEMISTRY-US, V38, P9887, DOI 10.1021/bi982753s; NARAYANASAMY K, 1990, INDIAN J EXP BIOL, V28, P968; Pereira RA, 1998, EXTREMOPHILES, V2, P347, DOI 10.1007/s007920050078; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shaw NM, 2003, ADV SYNTH CATAL, V345, P425, DOI 10.1002/adsc.200390049; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TOSHIFUMI Y, 1997, J FERMENTATION BIOEN, V83, P474; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340	38	18	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3976	10.1371/journal.pone.0003976	http://dx.doi.org/10.1371/journal.pone.0003976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096720	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265458800003
J	Moioli, EK; Clark, PA; Chen, M; Dennis, JE; Erickson, HP; Gerson, SL; Mao, JJ				Moioli, Eduardo K.; Clark, Paul A.; Chen, Mo; Dennis, James E.; Erickson, Helaman P.; Gerson, Stanton L.; Mao, Jeremy J.			Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EX-VIVO EXPANSION; STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; ANGIOGENESIS; REGENERATION	Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration. In this study, we tested this hypothesis by using bone as a model whose regeneration is impaired unless it is vascularized. Hematopoietic stem/progenitor cells (HSCs) and mesenchymal stem/progenitor cells (MSCs) were isolated from each of three healthy human bone marrow samples and reconstituted in a porous scaffold. MSCs were seeded in micropores of 3D calcium phosphate (CP) scaffolds, followed by infusion of gel-suspended CD34(+) hematopoietic cells. Co-transplantation of CD34(+) HSCs and CD34(-) MSCs in microporous CP scaffolds subcutaneously in the dorsum of immunocompromized mice yielded vascularized tissue. The average vascular number of co-transplanted CD34(+) and MSC scaffolds was substantially greater than MSC transplantation alone. Human osteocalcin was expressed in the micropores of CP scaffolds and was significantly increased upon co-transplantation of MSCs and CD34(+) cells. Human nuclear staining revealed the engraftment of transplanted human cells in vascular endothelium upon co-transplantation of MSCs and CD34(+) cells. Based on additional in vitro results of endothelial differentiation of CD34(+) cells by vascular endothelial growth factor (VEGF), we adsorbed VEGF with co-transplanted CD34(+) and MSCs in the microporous CP scaffolds in vivo, and discovered that vascular number and diameter further increased, likely owing to the promotion of endothelial differentiation of CD34(+) cells by VEGF. Together, co-transplantation of hematopoietic and mesenchymal stem/progenitor cells may improve the regeneration of vascular dependent tissues such as bone, adipose, muscle and dermal grafts, and may have implications in the regeneration of internal organs.	[Moioli, Eduardo K.; Chen, Mo; Erickson, Helaman P.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Coll Dent Med, TERML, New York, NY 10027 USA; [Clark, Paul A.] Univ Wisconsin, Madison Hosp, Dept Neurol Surg CSC, Madison, WI 53706 USA; [Dennis, James E.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Gerson, Stanton L.] Case Western Reserve Univ, Case Comprehensive Canc Ctr, Cleveland, OH 44106 USA	Columbia University; University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Case Western Reserve University	Moioli, EK (corresponding author), Columbia Univ, Med Ctr, Coll Dent Med, TERML, New York, NY 10027 USA.	jmao@columbia.edu	Chen, Mo/E-8234-2010		NIH [DE015391, EB02332, P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015391, RC2DE020767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIH grants DE015391 and EB02332 to J.J.M and P30CA043703 to SLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556; Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee; Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Bachier CR, 1999, EXP HEMATOL, V27, P615, DOI 10.1016/S0301-472X(98)00085-X; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; Clark PA, 2008, FASEB J, V22, P1684, DOI 10.1096/fj.07-094789; Collins JM, 2005, J BIOMECH, V38, P485, DOI 10.1016/j.jbiomech.2004.04.018; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Eghbali-Fatourechi GZ, 2007, BONE, V40, P1370, DOI 10.1016/j.bone.2006.12.064; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Graziano A, 2008, CELL PROLIFERAT, V41, P1, DOI 10.1111/j.1365-2184.2007.00497.x; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Jyotsna M, 2006, CARDIOVASC REVASCULA, V7, P217, DOI 10.1016/j.carrev.2006.06.004; Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Koike Y, 2003, SPINE, V28, P1928, DOI 10.1097/01.BRS.0000083324.65405.AE; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Lundell BI, 1999, J HEMATOTHER, V8, P115, DOI 10.1089/106161299320398; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Moioli EK, 2008, BONE, V42, P332, DOI 10.1016/j.bone.2007.10.004; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Olmsted-Davis EA, 2003, P NATL ACAD SCI USA, V100, P15877, DOI 10.1073/pnas.2632959100; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rivas R, 2002, J BONE JOINT SURG AM, V84A, P85, DOI 10.2106/00004623-200201000-00013; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078; Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N; Vij K, 2006, BONE, V38, P722, DOI 10.1016/j.bone.2005.10.028; Woo SY, 2002, SCAND J IMMUNOL, V55, P88, DOI 10.1046/j.1365-3083.2002.01031.x; WRIGHT KT, 2008, SPINAL CORD; Yue WM, 2008, STEM CELLS DEV, V17, P785, DOI 10.1089/scd.2007.0243	64	75	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3922	10.1371/journal.pone.0003922	http://dx.doi.org/10.1371/journal.pone.0003922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081793	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458200002
J	Horita, H; Frankel, AE; Thorburn, A				Horita, Henrick; Frankel, Arthur E.; Thorburn, Andrew			Acute Myeloid Leukemia-Targeted Toxin Activates Both Apoptotic and Necroptotic Death Mechanisms	PLOS ONE			English	Article							NONAPOPTOTIC CELL-DEATH; DIPHTHERIA-TOXIN; FUSION PROTEIN; RECEPTOR; RESISTANCE; INTERLEUKIN-3; INDUCTION	Background: Acute myelogenous leukemia (AML) is the second most common leukemia with approximately 13,410 new cases and 8,990 deaths annually in the United States. A novel fusion toxin treatment, diphtheria toxin GM-CSF (DT-GMCSF) has been shown to selectively eliminate leukemic repopulating cells that are critical for the formation of AML. We previously showed that DT-GMCSF treatment of U937 cells, an AML cell line, causes activation of caspases and the induction of apoptosis. Methods and Findings: In this study we further investigate the mechanisms of cell death induced by DT-GMCSF and show that, in addition to the activation of caspase-dependent apoptosis, DT-GMCSF also kills AML cells by simultaneously activating caspase-independent necroptosis. These mechanisms depend on the ability of the targeted toxin to inhibit protein synthesis, and are not affected by the receptor that is targeted or the mechanism through which protein synthesis is blocked. Conclusions: We conclude that fusion toxin proteins may be effective for treating AML cells whether or not they are defective in apoptosis.	[Thorburn, Andrew] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA; [Frankel, Arthur E.] Scott & White Canc Res Inst, Temple, TX USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Horita, H (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA.	Andrew.Thorburn@ucdenver.edu			NIH [CA11421]; Leukemia Society [LLS-R-6028-08]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Society	NIH grant CA11421. Leukemia Society Grant LLS-R-6028-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abi-Habib RJ, 2004, BLOOD, V104, P2143, DOI 10.1182/blood-2004-01-0339; BUDEL LM, 1989, BLOOD, V74, P565; Cros E, 2004, LEUKEMIA LYMPHOMA, V45, P1123, DOI 10.1080/1042819032000159861; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Frankel AE, 2002, CLIN CANCER RES, V8, P1004; Frankel A, 2008, LEUKEMIA LYMPHOMA, V49, P543, DOI 10.1080/10428190701799035; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hara T, 1996, STEM CELLS, V14, P605, DOI 10.1002/stem.140605; Hogge DE, 1998, BLOOD, V92, P589; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Horita H, 2008, LEUKEMIA, V22, P652, DOI 10.1038/sj.leu.2404956; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kern W, 2006, CANCER-AM CANCER SOC, V107, P116, DOI 10.1002/cncr.21543; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Terpstra W, 1997, BLOOD, V90, P3735, DOI 10.1182/blood.V90.9.3735; Thorburn A, 2004, APOPTOSIS, V9, P19, DOI 10.1023/B:APPT.0000012118.95548.88; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Thorburn J, 2003, CLIN CANCER RES, V9, P861; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Westcott MM, 2004, MOL CANCER THER, V3, P1681	23	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3909	10.1371/journal.pone.0003909	http://dx.doi.org/10.1371/journal.pone.0003909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079542	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455900003
J	Mann, J; Sargeant, BL; Watson-Capps, JJ; Gibson, QA; Heithaus, MR; Connor, RC; Patterson, E				Mann, Janet; Sargeant, Brooke L.; Watson-Capps, Jana J.; Gibson, Quincy A.; Heithaus, Michael R.; Connor, Richard C.; Patterson, Eric			Why Do Dolphins Carry Sponges?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TOOL-USE; TURSIOPS SP.; INDIVIDUAL VARIATION; SEX-DIFFERENCES; NICHE WIDTH; WILD; SPECIALIZATION; COMPETITION; ECOLOGY	Tool use is rare in wild animals, but of widespread interest because of its relationship to animal cognition, social learning and culture. Despite such attention, quantifying the costs and benefits of tool use has been difficult, largely because if tool use occurs, all population members typically exhibit the behavior. In Shark Bay, Australia, only a subset of the bottlenose dolphin population uses marine sponges as tools, providing an opportunity to assess both proximate and ultimate costs and benefits and document patterns of transmission. We compared sponge-carrying (sponger) females to non-sponge-carrying (non-sponger) females and show that spongers were more solitary, spent more time in deep water channel habitats, dived for longer durations, and devoted more time to foraging than non-spongers; and, even with these potential proximate costs, calving success of sponger females was not significantly different from non-spongers. We also show a clear female-bias in the ontogeny of sponging. With a solitary lifestyle, specialization, and high foraging demands, spongers used tools more than any non-human animal. We suggest that the ecological, social, and developmental mechanisms involved likely (1) help explain the high intrapopulation variation in female behaviour, (2) indicate tradeoffs (e. g., time allocation) between ecological and social factors and, (3) constrain the spread of this innovation to primarily vertical transmission.	[Mann, Janet; Sargeant, Brooke L.; Watson-Capps, Jana J.; Gibson, Quincy A.; Patterson, Eric] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC USA; [Sargeant, Brooke L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Watson-Capps, Jana J.] Metropolitan State Coll, Dept Biol, Denver, CO USA; [Heithaus, Michael R.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, Miami, FL 33199 USA; [Connor, Richard C.] Univ Massachusetts, Dept Biol, Dartmouth, MA USA	Georgetown University; Georgetown University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Massachusetts System; University Massachusetts Dartmouth	Mann, J (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	mannj2@georgetown.edu	Mann, Janet/L-2311-2019; Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003	NSF [0316800, OCE0526065]; The Eppley Foundation for Research; The Brach Foundation; The National Geographic Society; Georgetown University; West Australian Department of Environment and Conservation	NSF(National Science Foundation (NSF)); The Eppley Foundation for Research; The Brach Foundation; The National Geographic Society(National Geographic Society); Georgetown University; West Australian Department of Environment and Conservation	Support for this research was from grants to JM from NSF#0316800, The Eppley Foundation for Research, The Brach Foundation, The National Geographic Society, and Georgetown University. The orthophoto in Fig. 2 was supported by NSF grant OCE0526065 to MRH and the West Australian Department of Environment and Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp G, 1997, ETHOL ECOL EVOL, V9, P105, DOI 10.1080/08927014.1997.9522890; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHEVALIERSKOLNIKOFF S, 1993, ANIM BEHAV, V46, P209, DOI 10.1006/anbe.1993.1183; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; Gibson QA, 2008, ANIM BEHAV, V76, P375, DOI 10.1016/j.anbehav.2008.01.021; Gibson QA, 2008, ANIM BEHAV, V76, P389, DOI 10.1016/j.anbehav.2008.01.022; Goodall J., 1986, CHIMPANZEES GOMBE PA; Harley HE, 2003, NATURE, V424, P667, DOI 10.1038/nature01846; Herman LM, 2002, COGNITIVE ANIMAL, P275; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; LALAND KN, 2006, TREE, V22, P7; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Mann J, 2005, ANIM BEHAV, V69, P899, DOI 10.1016/j.anbehav.2004.04.024; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; Maynard Smith J., 1982, pi; McCullagh P, 1989, GEN LINEAR MODELS; Mercado E, 1998, ANIM LEARN BEHAV, V26, P210, DOI 10.3758/BF03199213; Partridge L., 1985, P207; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; ROITBLAT HL, 1988, SYSTEMS LEARNING MEM, P13; ROITBLAT HL, 1991, SIMULATION ADAPTIVE, P444; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, J HUM EVOL, V44, P11, DOI 10.1016/S0047-2484(02)00164-1	41	96	99	18	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3868	10.1371/journal.pone.0003868	http://dx.doi.org/10.1371/journal.pone.0003868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZS	19066625	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455700002
J	Melle, C; Ernst, G; Schimmel, B; Bleul, A; von Eggeling, F				Melle, Christian; Ernst, Guenther; Schimmel, Bettina; Bleul, Annett; von Eggeling, Ferdinand			Colon-Derived Liver Metastasis, Colorectal Carcinoma, and Hepatocellular Carcinoma Can Be Discriminated by the Ca2+-Binding Proteins S100A6 and S100A11	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOLECULAR-DETECTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; IDENTIFICATION; CANCER; DISCOVERY; MARKERS; BIOMARKERS; FAMILY	Background: It is unknown, on the proteomic level, whether the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known. Methodology/Principal Findings: In this study, tissue from colon-derived liver metastases (n = 17) were classified, laser-microdissected, and analysed by ProteinChip arrays (SELDI). The resulting spectra were compared with data for primary colorectal (CRC) and hepatocellular carcinomas (HCC) from our former studies. Of 49 signals differentially expressed in primary HCC, primary CRC, and liver metastases, two were identified by immunodepletion as S100A6 and S100A11. Both proteins were precisely localized immunohistochemically in cells. S100A6 and S100A11 can discriminate significantly between the two primary tumor entities, CRC and HCC, whereas S100A6 allows the discrimination of metastases and HCC. Conclusions: Both identified proteins can be used to discriminate different tumor entities. Specific markers or proteomic patterns for the metastases of different primary cancers will allow us to determine the biological characteristics of metastasis in general. It is unknown how the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known.	[Melle, Christian; Ernst, Guenther; Schimmel, Bettina; Bleul, Annett; von Eggeling, Ferdinand] Univ Jena, Fac Med, Core Unit Chip Applicat, Inst Human Genet & Anthropol, Jena, Germany	Friedrich Schiller University of Jena	Melle, C (corresponding author), Univ Jena, Fac Med, Core Unit Chip Applicat, Inst Human Genet & Anthropol, Jena, Germany.	fegg@mti.uni-jena.de	von Eggeling, Ferdinand/AAC-8349-2022; von Eggeling, Ferdinand/B-4033-2014	von Eggeling, Ferdinand/0000-0002-8062-6999; von Eggeling, Ferdinand/0000-0002-8062-6999; Melle, Christian/0000-0002-1870-9419	German Federal Ministry of Education and Research (BMBF); Interdisciplinary Center for Clinical Research (ICCR), Jena	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (ICCR), Jena	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF) and the Interdisciplinary Center for Clinical Research (ICCR), Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Conzelmann M, 2005, INT J COLORECTAL DIS, V20, P137, DOI 10.1007/s00384-004-0640-2; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drake RR, 2006, MOL CELL PROTEOMICS, V5, P1957, DOI 10.1074/mcp.M600176-MCP200; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; Guedj N, 2006, LAB INVEST, V86, P951, DOI 10.1038/labinvest.3700450; Helmberger TK, 2002, EUR RADIOL, V12, P62, DOI 10.1007/s003300101122; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Khan ZAJ, 2000, CLIN CANCER RES, V6, P3499; Komatsu K, 2002, ONCOLOGY-BASEL, V63, P192, DOI 10.1159/000063812; Komatsu K, 2000, BRIT J CANCER, V83, P769, DOI 10.1054/bjoc.2000.1356; Kreunin Paweena, 2007, Cancer Genomics & Proteomics, V4, P329; Li YT, 2006, PROTEOMICS, V6, P3426, DOI 10.1002/pmic.200500472; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; MC DS, 1999, CLIN EXP METASTAS, V17, P341; Melle C, 2006, INT J ONCOL, V28, P195; Melle C, 2004, CANCER RES, V64, P4099, DOI 10.1158/0008-5472.CAN-03-3807; Melle C, 2003, MOL CELL PROTEOMICS, V2, P443, DOI 10.1074/mcp.M300033-MCP200; Melle C, 2005, GASTROENTEROLOGY, V129, P66, DOI 10.1053/j.gastro.2005.05.014; Melle C, 2007, J PROTEOME RES, V6, P306, DOI 10.1021/pr060439b; Nakamura S, 1997, WORLD J SURG, V21, P741, DOI 10.1007/s002689900300; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Raslich MA, 2007, BIOCHEM MEDICA, V17, P151; Ridley A, 2000, NATURE, V406, P466, DOI 10.1038/35020170; Sanchez-Cespedes M, 1999, CLIN CANCER RES, V5, P2450; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Tang N, 2004, MASS SPECTROM REV, V23, P34, DOI 10.1002/mas.10066; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Ueda J, 2007, PATHOBIOLOGY, V74, P32, DOI 10.1159/000101049; von Eggeling F, 2007, PROTEOMICS, V7, P2729, DOI 10.1002/pmic.200700079; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; Weiss L, 2000, CANCER METAST REV, V19, P381, DOI 10.1023/A:1010623111204; Yao R, 2007, HISTOL HISTOPATHOL, V22, P1025, DOI 10.14670/HH-22.1025; Zhen Cai, 2004, Genomics Proteomics & Bioinformatics, V2, P152	37	36	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3767	10.1371/journal.pone.0003767	http://dx.doi.org/10.1371/journal.pone.0003767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048101	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452000002
J	Paulson, TG; Galipeau, PC; Xu, LJ; Kissel, HD; Li, XH; Blount, PL; Sanchez, CA; Odze, RD; Reid, BJ				Paulson, Thomas G.; Galipeau, Patricia C.; Xu, Lianjun; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Sanchez, Carissa A.; Odze, Robert D.; Reid, Brian J.			p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus	PLOS ONE			English	Article								Background: Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions. Methods and Findings: We have determined the p16 mutation spectrum for a cohort of 304 patients with Barrett's esophagus, a premalignant condition that predisposes to the development of esophageal adenocarcinoma. Forty seven mutations were detected by sequencing of p16 exon 2 in 44 BE patients (14.5%) with a mutation spectrum consistent with that caused by oxidative damage and chronic inflammation. The percentage of patients with p16 mutations increased with increasing histologic grade. In addition, samples from 3 out of 19 patients (15.8%) who underwent esophagectomy were found to have mutations. Conclusions: The results of this study suggest the environment of the esophagus in BE patients can both generate and select for clones with p16 mutations.	[Paulson, Thomas G.; Galipeau, Patricia C.; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Paulson, Thomas G.; Galipeau, Patricia C.; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Xu, Lianjun] Oregon Hlth & Sci Univ, Dept Gen Surg, Portland, OR USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Odze, Robert D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	Paulson, TG (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	tpaulson@fhcrc.org	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X; Galipeau, Patricia/0000-0001-7961-7430	NIH [K07CA089147, R01CA78828, R01CA61202, PO1CA91955]; Ryan Hill Foundation; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE [P01CA091955, K07CA089147, R01CA078828, R01CA061202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Hill Foundation; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH K07CA089147, R01CA78828, R01CA61202, PO1CA91955, the Ryan Hill Foundation (TGP) and The Fred Hutchinson Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MT, 1996, ONCOGENE, V13, P1867; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; BLOUNT PL, 1993, P NATL ACAD SCI USA, V90, P3221, DOI 10.1073/pnas.90.8.3221; BLOUNT PL, 1994, CANCER RES, V54, P2292; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Dvorak K, 2006, DIS ESOPHAGUS, V19, P366, DOI 10.1111/j.1442-2050.2006.00596.x; Esteve A, 1996, INT J CANCER, V66, P301; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Foulkes WD, 1997, MOL MED, V3, P5, DOI 10.1007/BF03401664; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Galipeau PC, 1999, J NATL CANCER I, V91, P2087, DOI 10.1093/jnci/91.24.2087; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Gamieldien W, 1998, INT J CANCER, V78, P544, DOI 10.1002/(SICI)1097-0215(19981123)78:5<544::AID-IJC3>3.3.CO;2-K; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Giroux MA, 2002, EUR J GASTROEN HEPAT, V14, P15, DOI 10.1097/00042737-200201000-00004; Gonzalez MV, 1997, J CLIN PATHOL, V50, P212, DOI 10.1136/jcp.50.3.212; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Hardie JJ, 2005, CANCER LETT, V217, P221, DOI 10.1016/j.canlet.2004.06.025; Hiroyasu M, 2002, AM J PATHOL, V160, P419, DOI 10.1016/S0002-9440(10)64860-2; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Lin J, 2004, SEMIN ONCOL, V31, P476, DOI 10.1053/j.seminoncol.2004.04.019; Liu L, 2003, ALIMENT PHARM THER, V18, P693, DOI 10.1046/j.1365-2036.2003.01734.x; Murphy JA, 2004, HUM MUTAT, V24, P296, DOI 10.1002/humu.20083; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Paulson TG, 1999, GENOME RES, V9, P482; PHILLIPS RW, 1991, GASTROENTEROL CLIN N, V20, P791; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Prevo LJ, 1999, CANCER RES, V59, P4784; REID BJ, 1988, GASTROENTEROLOGY, V94, P81, DOI 10.1016/0016-5085(88)90613-0; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Reid BJ, 2000, AM J GASTROENTEROL, V95, P3089, DOI 10.1111/j.1572-0241.2000.03182.x; Reid Brian J, 2003, Gastrointest Endosc Clin N Am, V13, P369, DOI 10.1016/S1052-5157(03)00006-0; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Roncalli M, 1998, LAB INVEST, V78, P1049; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645; Tanaka T, 1999, ONCOGENE, V18, P3793, DOI 10.1038/sj.onc.1202707; Turker MS, 1999, CANCER RES, V59, P1837; Turner DR, 2003, MUTAT RES-FUND MOL M, V522, P21, DOI 10.1016/S0027-5107(02)00194-X; Vieth M, 2004, VIRCHOWS ARCH, V445, P135, DOI 10.1007/s00428-004-1042-0; Wetscher G J, 1997, Dis Esophagus, V10, P29; Wetscher GJ, 1997, DIS ESOPHAGUS, V10, P33; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wong DJ, 2001, CANCER RES, V61, P8284; Yarbrough WG, 1999, J NATL CANCER I, V91, P1569, DOI 10.1093/jnci/91.18.1569; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZHOU XL, 1994, ONCOGENE, V9, P3737	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3809	10.1371/journal.pone.0003809	http://dx.doi.org/10.1371/journal.pone.0003809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043591	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451500002
J	Manich, M; Knapp, O; Gibert, M; Maier, E; Jolivet-Reynaud, C; Geny, B; Benz, R; Popoff, MR				Manich, Maria; Knapp, Oliver; Gibert, Maryse; Maier, Elke; Jolivet-Reynaud, Colette; Geny, Blandine; Benz, Roland; Popoff, Michel R.			Clostridium perfringens Delta Toxin Is Sequence Related to Beta Toxin, NetB, and Staphylococcus Pore-Forming Toxins, but Shows Functional Differences	PLOS ONE			English	Article								Clostridium perfringens produces numerous toxins, which are responsible for severe diseases in man and animals. Delta toxin is one of the three hemolysins released by a number of C. perfringens type C and possibly type B strains. Delta toxin was characterized to be cytotoxic for cells expressing the ganglioside G(M2) in their membrane. Here we report the genetic characterization of Delta toxin and its pore forming activity in lipid bilayers. Delta toxin consists of 318 amino acids, its 28 N-terminal amino acids corresponding to a signal peptide. The secreted Delta toxin (290 amino acids; 32619 Da) is a basic protein (pI 9.1) which shows a significant homology with C. perfringens Beta toxin (43% identity), with C. perfringens NetB (40% identity) and, to a lesser extent, with Staphylococcus aureus alpha toxin and leukotoxins. Recombinant Delta toxin showed a preference for binding to G(M2), in contrast to Beta toxin, which did not bind to gangliosides. It is hemolytic for sheep red blood cells and cytotoxic for HeLa cells. In artificial diphytanoyl phosphatidylcholine membranes, Delta and Beta toxin formed channels. Conductance of the channels formed by Delta toxin, with a value of about 100 pS to more than 1 nS in 1 M KCl and a membrane potential of 20 mV, was higher than those formed by Beta toxin and their distribution was broader. The results of zero-current membrane potential measurements and single channel experiments suggest that Delta toxin forms slightly anion-selective channels, whereas the Beta toxin channels showed a preference for cations under the same conditions. C. perfringens Delta toxin shows a significant sequence homolgy with C. perfringens Beta and NetB toxins, as well as with S. aureus alpha hemolysin and leukotoxins, but exhibits different channel properties in lipid bilayers. In contrast to Beta toxin, Delta toxin recognizes G(M2) as receptor and forms anion-selective channels.	[Manich, Maria; Knapp, Oliver; Gibert, Maryse; Geny, Blandine; Popoff, Michel R.] Inst Pasteur, Paris, France; [Knapp, Oliver; Maier, Elke; Benz, Roland] Univ Wurzburg, Theodor Boveri Inst Biozentrum, Lehrstuhl Biotechnol, D-97070 Wurzburg, Germany; [Jolivet-Reynaud, Colette] BioMerieux, Dept Nouveaux Marqueurs, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; bioMerieux	Manich, M (corresponding author), Inst Pasteur, Paris, France.	mpopoff@pasteur.fr		Benz, Roland/0000-0002-9510-9265	IP; Deutsche Forschungsgemeinschaft [SFB 487]; Funds of the Chemical Industry	IP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Funds of the Chemical Industry	This work was financially supported by IP funding, the Deutsche Forschungsgemeinschaft (project A5 of the SFB 487), and the Funds of the Chemical Industry (to RB).	ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; BALLARD J, 1993, MOL MICROBIOL, V10, P627, DOI 10.1111/j.1365-2958.1993.tb00934.x; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Freer JH., 2006, COMPREHENSIVE SOURCE, P590, DOI 10.1016/B978-012088445-2/50037-8; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gibert M, 1997, GENE, V203, P65, DOI 10.1016/S0378-1119(97)00493-9; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; HUNTER SEC, 1993, INFECT IMMUN, V61, P3958, DOI 10.1128/IAI.61.9.3958-3965.1993; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1993, ANTI-CANCER DRUG, V4, P65, DOI 10.1097/00001813-199302000-00009; JOLIVETREYNAUD C, 1988, ARCH BIOCHEM BIOPHYS, V262, P59, DOI 10.1016/0003-9861(88)90168-3; JOLIVETREYNAUD C, 1983, J BIOL CHEM, V258, P1871; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; JOLIVETREYNAUD C, 1986, ZBL BAKTERIOL S, V15, P145; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Michelet N., 2006, COMPREHENSIVE SOURCE, P779; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Nagahama M, 1999, BBA-MOL BASIS DIS, V1454, P97, DOI 10.1016/S0925-4439(99)00026-5; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Popoff Michel R., 2005, P323; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; SAKURAI J, 1978, INFECT IMMUN, V21, P678, DOI 10.1128/IAI.21.2.678-680.1978; SAKURAI J, 1987, TOXICON, V25, P1301, DOI 10.1016/0041-0101(87)90008-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID A, 1994, J BIOL CHEM, V269, P16706; SELLMAN BR, 1997, MOL MICROBIOL, V23, P531; Shatursky O, 2000, INFECT IMMUN, V68, P5546, DOI 10.1128/IAI.68.10.5546-5551.2000; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; SHERRER R, 1971, J BACTERIOL, V107, P718; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Songer J. Glenn, 2005, P527; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; [No title captured]	55	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3764	10.1371/journal.pone.0003764	http://dx.doi.org/10.1371/journal.pone.0003764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018299	gold, Green Published, Green Submitted			2022-12-27	WOS:000265448500011
J	Lenselink, CH; Melchers, WJG; Quint, WGV; Hoebers, AMJ; Hendriks, JCM; Massuger, LFAG; Bekkers, RLM				Lenselink, Charlotte H.; Melchers, Willem J. G.; Quint, Wim G. V.; Hoebers, Annelies M. J.; Hendriks, Jan C. M.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.			Sexual Behaviour and HPV Infections in 18 to 29 Year Old Women in the Pre-Vaccine Era in the Netherlands	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ONCOGENIC HUMAN-PAPILLOMAVIRUS; LINE PROBE ASSAY; RISK-FACTORS; YOUNG-WOMEN; CLINICAL-EVALUATION; CONDOM USE; PREVALENCE; HISTORY; BRITAIN		[Lenselink, Charlotte H.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Melchers, Willem J. G.; Hoebers, Annelies M. J.] Univ Nijmegen, Ctr Infect Dis, Dept Med Microbiol, Nijmegen, Netherlands; [Quint, Wim G. V.] DDL Diagnost Lab, Voorburg, Netherlands; [Hendriks, Jan C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; DDL Diagnostic Laboratory; Radboud University Nijmegen	Lenselink, CH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands.	c.lenselink@obgyn.umcn.nl	Hendriks, J.C.M./L-4363-2015; Melchers, Willem/C-8819-2015; Bekkers, Ruud/AAU-5319-2020; Bekkers, Ruud/M-3866-2014; Massuger, Leon F.A.G./H-8072-2014	Melchers, Willem/0000-0002-5446-2230; Bekkers, Ruud/0000-0002-4577-8495; 	GlaxoSmithKline [2702-HPV-109932]	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline (GSK 2702-HPV-109932 to R.L.B, L.F.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; BRABIN L, 2008, BMJ; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; COUPE VM, 2008, BR J CANC; Dempsey AF, 2008, VACCINE, V26, P1111, DOI 10.1016/j.vaccine.2007.11.088; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fenton KA, 2003, CLIN MED, V3, P199; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jonsson M, 1997, INT J STD AIDS, V8, P501, DOI 10.1258/0956462971920659; KARLSSON R, 1995, SEX TRANSM DIS, V22, P119, DOI 10.1097/00007435-199503000-00008; Kjaer SK, 1997, CANCER EPIDEM BIOMAR, V6, P799; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Melchers WJG, 1999, AM J PATHOL, V155, P1473, DOI 10.1016/S0002-9440(10)65462-4; Stewart DE, 2007, J OBSTET GYNAECOL CA, V29, P817, DOI 10.1016/S1701-2163(16)32636-6; Tabora N, 2005, AM J TROP MED HYG, V73, P50, DOI 10.4269/ajtmh.2005.73.1.0730050; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; van Ham MAPC, 2005, J CLIN MICROBIOL, V43, P2662, DOI 10.1128/JCM.43.6.2662-2667.2005; van Hamont D, 2006, J CLIN MICROBIOL, V44, P3122, DOI 10.1128/JCM.00517-06; Wiley DJ, 2006, CANCER EPIDEM BIOMAR, V15, P915, DOI 10.1158/1055-9965.EPI-05-0963; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	24	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3743	10.1371/journal.pone.0003743	http://dx.doi.org/10.1371/journal.pone.0003743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011683	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448300011
J	Kumashiro, M; Yokoyama, O; Ishibashi, H				Kumashiro, Mari; Yokoyama, Osamu; Ishibashi, Hidetoshi			Imitation of Body Movements Facilitated by Joint Attention through Eye Contact and Pointing in Japanese Monkey	PLOS ONE			English	Article							MIRROR NEURONS; GAZE; CHIMPANZEES	Eye contact and pointing are typical gestures in order to direct another individual's attention toward a target. We previously investigated on Japanese monkeys whether joint attention ability encouraged by eye contact and pointing was associated with the imitation of human's actions. The monkeys with the joint attention skills showed the imitation of human's actions. In the current study, we investigated on a monkey whether joint attention ability also facilitated the imitation of human body-movements. Results showed that the monkey being taught eye contact and pointing showed the imitation of human body-movements. These results suggest that the monkeys have basic potential for following another individual's motion, and that what imitation expresses depends on where the monkeys are paying attention. Thus, eye contact and pointing are suitable for directing the monkey's attention toward the human.	[Kumashiro, Mari; Yokoyama, Osamu; Ishibashi, Hidetoshi] Tokyo Med & Dent Univ, Dept Maxillofacial Biol, Sect Cognit Neurobiol, Tokyo, Japan; [Kumashiro, Mari; Yokoyama, Osamu; Ishibashi, Hidetoshi] Natl Inst Neurosci, Dept Anim Models Human Dis, Tokyo, Japan; [Kumashiro, Mari] Nihon Univ, Grad Sch Med Sci, Dept Advanced Med Res Ctr, Div Applied Syst Neurosci, Tokyo 102, Japan; [Kumashiro, Mari] Nihon Univ, Advanced Res Inst Sci & Humanities, Tokyo 102, Japan	Tokyo Medical & Dental University (TMDU); National Center for Neurology & Psychiatry - Japan; Nihon University; Nihon University	Kumashiro, M (corresponding author), Tokyo Med & Dent Univ, Dept Maxillofacial Biol, Sect Cognit Neurobiol, Tokyo, Japan.	mari@ncnp.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [grant-in-aid]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Dr. Atsushi Iriki and by a grant-in-aid and by Support of Young Researchers with a Term from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Dr. Hidetoshi Ishibashi.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; BUTTERWORTH G, 1980, INT J BEHAV DEV, V3, P253, DOI 10.1177/016502548000300303; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; CARPENTER M, 1995, SOC DEV, V4, P217, DOI 10.1111/j.1467-9507.1995.tb00063.x; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Ferrari PF, 2000, P NATL ACAD SCI USA, V97, P13997, DOI 10.1073/pnas.250241197; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; JACOBSON SW, 1979, CHILD DEV, V50, P425, DOI 10.2307/1129418; Kumashiro M, 2003, INT J PSYCHOPHYSIOL, V50, P81, DOI 10.1016/S0167-8760(03)00126-0; Kumashiro M, 2002, CAH PSYCHOL COGN, V21, P3; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; Moore C., 1995, JOINT ATTENTION ITS; Myowa-Yamakoshi M, 2004, DEVELOPMENTAL SCI, V7, P437, DOI 10.1111/j.1467-7687.2004.00364.x; Oztop E, 2006, NEURAL NETWORKS, V19, P254, DOI 10.1016/j.neunet.2006.02.002; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; VYGOTSKY LS, 1978, MIND SOCI DEV HIGH P	23	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3704	10.1371/journal.pone.0003704	http://dx.doi.org/10.1371/journal.pone.0003704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WS	19002250	Green Submitted, Green Published, gold			2022-12-27	WOS:000265165600009
J	Mudge, J; Miller, NA; Khrebtukova, I; Lindquist, IE; May, GD; Huntley, JJ; Luo, S; Zhang, L; van Velkinburgh, JC; Farmer, AD; Lewis, S; Beavis, WD; Schilkey, FD; Virk, SM; Black, CF; Myers, MK; Mader, LC; Langley, RJ; Utsey, JP; Kim, RW; Roberts, RC; Khalsa, SK; Garcia, M; Ambriz-Griffith, V; Harlan, R; Czika, W; Martin, S; Wolfinger, RD; Perrone-Bizzozero, NI; Schroth, GP; Kingsmore, SF				Mudge, Joann; Miller, Neil A.; Khrebtukova, Irina; Lindquist, Ingrid E.; May, Gregory D.; Huntley, Jim J.; Luo, Shujun; Zhang, Lu; van Velkinburgh, Jennifer C.; Farmer, Andrew D.; Lewis, Sharon; Beavis, William D.; Schilkey, Faye D.; Virk, Selene M.; Black, C. Forrest; Myers, M. Kathy; Mader, Lar C.; Langley, Ray J.; Utsey, John P.; Kim, Ryan W.; Roberts, Rosalinda C.; Khalsa, Sat Kirpal; Garcia, Meredith; Ambriz-Griffith, Victoria; Harlan, Richard; Czika, Wendy; Martin, Stanton; Wolfinger, Russell D.; Perrone-Bizzozero, Nora I.; Schroth, Gary P.; Kingsmore, Stephen F.			Genomic Convergence Analysis of Schizophrenia: mRNA Sequencing Reveals Altered Synaptic Vesicular Transport in Post-Mortem Cerebellum	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; AGE-AT-ONSET; MICROARRAY ANALYSIS; BIPOLAR DISORDER; CANDIDATE GENES; TRANSCRIPTOME; IDENTIFICATION; ASSOCIATION; DISCOVERY; DISEASE	Schizophrenia (SCZ) is a common, disabling mental illness with high heritability but complex, poorly understood genetic etiology. As the first phase of a genomic convergence analysis of SCZ, we generated 16.7 billion nucleotides of short read, shotgun sequences of cDNA from post-mortem cerebellar cortices of 14 patients and six, matched controls. A rigorous analysis pipeline was developed for analysis of digital gene expression studies. Sequences aligned to approximately 33,200 transcripts in each sample, with average coverage of 450 reads per gene. Following adjustments for confounding clinical, sample and experimental sources of variation, 215 genes differed significantly in expression between cases and controls. Golgi apparatus, vesicular transport, membrane association, Zinc binding and regulation of transcription were over-represented among differentially expressed genes. Twenty three genes with altered expression and involvement in presynaptic vesicular transport, Golgi function and GABAergic neurotransmission define a unifying molecular hypothesis for dysfunction in cerebellar cortex in SCZ.	[Mudge, Joann; Miller, Neil A.; Lindquist, Ingrid E.; May, Gregory D.; Huntley, Jim J.; van Velkinburgh, Jennifer C.; Farmer, Andrew D.; Lewis, Sharon; Beavis, William D.; Schilkey, Faye D.; Virk, Selene M.; Black, C. Forrest; Myers, M. Kathy; Mader, Lar C.; Langley, Ray J.; Utsey, John P.; Kim, Ryan W.; Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Khrebtukova, Irina; Luo, Shujun; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Perrone-Bizzozero, Nora I.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Khalsa, Sat Kirpal; Garcia, Meredith; Ambriz-Griffith, Victoria; Harlan, Richard] No New Mexico Coll, Espanola, NM USA; [Roberts, Rosalinda C.] Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL USA; [Czika, Wendy; Martin, Stanton; Wolfinger, Russell D.] SAS Inst, Cary, NC USA	National Center for Genome Resources (NCGR); Illumina; University of New Mexico; University of Alabama System; University of Alabama Birmingham; SAS Institute Inc	Mudge, J (corresponding author), Natl Ctr Genome Resources, Santa Fe, NM USA.	sfk@ncgr.org	; van Velkinburgh, Jennifer/D-7205-2015	Mudge, Joann/0000-0002-2972-1640; van Velkinburgh, Jennifer/0000-0002-4592-2397; kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527	National Science Foundation; State of New Mexico; National Institutes of Mental Health; National Center for Research Resources	National Science Foundation(National Science Foundation (NSF)); State of New Mexico; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Science Foundation, State of New Mexico, National Institutes of Mental Health, National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusaad I, 1999, J COMP NEUROL, V408, P560, DOI 10.1002/(SICI)1096-9861(19990614)408:4<560::AID-CNE9>3.0.CO;2-P; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen NC, 2008, SCHIZOPHRENIA BULL, V34, P708, DOI 10.1093/schbul/sbn034; Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bottmer C, 2005, PSYCHIAT RES-NEUROIM, V140, P239, DOI 10.1016/j.pscychresns.2005.02.011; BULLOCK WM, 2008, AM J PSYCHI IN PRESS; Butz JA, 2004, BIOTECHNOL PROGR, V20, P1836, DOI 10.1021/bp0343054; Butz JA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-3; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Cheng C, 2007, BIOINFORMATION, V1, P436, DOI 10.6026/97320630001436; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Chiu KP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-109; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Edwards CR, 2008, PSYCHIAT RES-NEUROIM, V162, P185, DOI 10.1016/j.pscychresns.2007.06.001; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Faraone SV, 2000, BIOL PSYCHIAT, V48, P120, DOI 10.1016/S0006-3223(99)00263-2; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Kirov G, 2005, J CLIN INVEST, V115, P1440, DOI 10.1172/JCI24759; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lichtermann D, 2000, EUR ARCH PSY CLIN N, V250, P304, DOI 10.1007/s004060070005; Lipska Barbara K, 2006, Dialogues Clin Neurosci, V8, P353; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Malaspina D, 2004, BIOL PSYCHIAT, V56, P931, DOI 10.1016/j.biopsych.2004.09.013; MARIONI J, 2008, RNA SEQ ASSESSMENT T; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Mikkilineni V, 2004, BIOTECHNOL BIOENG, V86, P117, DOI 10.1002/bit.20048; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Noureddine MA, 2005, MOVEMENT DISORD, V20, P1299, DOI 10.1002/mds.20573; Ohtsu K, 2007, PLANT J, V52, P391, DOI 10.1111/j.1365-313X.2007.03244.x; Okugawa G, 2007, NEUROPSYCHOBIOLOGY, V56, P216, DOI 10.1159/000122268; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Olsen L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-39; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Paz RD, 2006, AM J PSYCHIAT, V163, P1829, DOI 10.1176/appi.ajp.163.10.1829; PONTIUS JU, 2003, UNIGENE UNIFIED VIEW; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Potkin SG, 2002, AM J PSYCHIAT, V159, P227, DOI 10.1176/appi.ajp.159.2.227; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Puri BK, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-S1-S6; Riley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sillanpaa MJ, 2004, ANN HUM GENET, V68, P646, DOI 10.1046/j.1529-8817.2004.00122.x; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Thompson G, 2003, AM BOOK REV, V25, P27; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Tsuang MT, 2000, AM J PSYCHIAT, V157, P1041, DOI 10.1176/appi.ajp.157.7.1041; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Vawter MP, 2002, SCHIZOPHR RES, V58, P11, DOI 10.1016/S0920-9964(01)00377-2; Wang ET, 2008, NATURE; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	82	90	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3625	10.1371/journal.pone.0003625	http://dx.doi.org/10.1371/journal.pone.0003625			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985160	Green Published, gold			2022-12-27	WOS:000265134400005
J	Frobius, AC; Matus, DQ; Seaver, EC				Frobius, Andreas C.; Matus, David Q.; Seaver, Elaine C.			Genomic Organization and Expression Demonstrate Spatial and Temporal Hox Gene Colinearity in the Lophotrochozoan Capitella sp I	PLOS ONE			English	Article								Hox genes define regional identities along the anterior-posterior axis in many animals. In a number of species, Hox genes are clustered in the genome, and the relative order of genes corresponds with position of expression in the body. Previous Hox gene studies in lophotrochozoans have reported expression for only a subset of the Hox gene complement and/or lack detailed genomic organization information, limiting interpretations of spatial and temporal colinearity in this diverse animal clade. We studied expression and genomic organization of the single Hox gene complement in the segmented polychaete annelid Capitella sp. I. Total genome searches identified 11 Hox genes in Capitella, representing 11 distinct paralog groups thought to represent the ancestral lophotrochozoan complement. At least 8 of the 11 Capitella Hox genes are genomically linked in a single cluster, have the same transcriptional orientation, and lack interspersed non-Hox genes. Studying their expression by situ hybridization, we find that the 11 Capitella Hox genes generally exhibit spatial and temporal colinearity. With the exception of CapI-Post1, Capitella Hox genes are all expressed in broad ectodermal domains during larval development, consistent with providing positional information along the anterior-posterior axis. The anterior genes CapI-lab, CapI-pb, and CapI-Hox3 initiate expression prior to the appearance of segments, while more posterior genes appear at or soon after segments appear. Many of the Capitella Hox genes have either an anterior or posterior expression boundary coinciding with the thoracic-abdomen transition, a major body tagma boundary. Following metamorphosis, several expression patterns change, including appearance of distinct posterior boundaries and restriction to the central nervous system. Capitella Hox genes have maintained a clustered organization, are expressed in the canonical anterior-posterior order found in other metazoans, and exhibit spatial and temporal colinearity, reflecting Hox gene characteristics that likely existed in the protostome-deuterostome ancestor.	[Frobius, Andreas C.; Matus, David Q.; Seaver, Elaine C.] Univ Hawaii, Pacific Biosci Res Ctr, Kewalo Marine Lab, Honolulu, HI 96822 USA	University of Hawaii System	Frobius, AC (corresponding author), Univ Giessen, Inst Allgemeine & Spezielle Zool, Abt Entwicklungsbiol, Heinrich Buff Ring 29, D-6300 Giessen, Germany.	seaver@hawaii.edu	Matus, David/E-9972-2010	Matus, David/0000-0002-1570-5025	Robert Black Fellow of the Damon Runyon Cancer Research Foundation [DRG-1949-07]; National Science Foundation [IBN00-94925]	Robert Black Fellow of the Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David Q. Matus is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-1949-07). This work was supported by the National Science Foundation to E. C. S. (IBN00-94925).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; AISEMBERG GO, 1993, J NEUROBIOL, V24, P1423, DOI 10.1002/neu.480241012; AISEMBERG GO, 1994, DEV BIOL, V161, P455, DOI 10.1006/dbio.1994.1044; Aronowicz J, 2006, INTEGR COMP BIOL, V46, P890, DOI 10.1093/icb/icl045; AVEROF M, 1993, CURR BIOL, V3, P73, DOI 10.1016/0960-9822(93)90158-K; BALAVOINE G, 1995, P NATL ACAD SCI USA, V92, P7227, DOI 10.1073/pnas.92.16.7227; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Bayascas Jose Ramon, 1996, International Journal of Developmental Biology, V40, p173S; Bayascas JR, 1998, DEV GENES EVOL, V208, P467, DOI 10.1007/s004270050204; Bayascas JR, 1997, DEVELOPMENT, V124, P141; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BHUP R, 1982, CAN J ZOOL, V60, P2284, DOI 10.1139/z82-295; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; BREIER G, 1988, EMBO J, V7, P1329, DOI 10.1002/j.1460-2075.1988.tb02948.x; Brown SJ, 2002, GENETICS, V160, P1067; Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Cook CE, 2004, EVOL DEV, V6, P154, DOI 10.1111/j.1525-142X.2004.04020.x; Damen WGM, 1998, DEV GENES EVOL, V208, P586, DOI 10.1007/s004270050218; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DUBOULE D, 1986, EMBO J, V5, P1973, DOI 10.1002/j.1460-2075.1986.tb04452.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; EISIG H, 1899, MITTHEILUNGEN ZOOLOG, V13, P1; Ferrier DEK, 1996, P NATL ACAD SCI USA, V93, P13024, DOI 10.1073/pnas.93.23.13024; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GRAHAM A, 1988, GENE DEV, V2, P1424, DOI 10.1101/gad.2.11.1424; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Irvine SQ, 2000, DEV BIOL, V217, P333, DOI 10.1006/dbio.1999.9541; Irvine SQ, 2001, AM ZOOL, V41, P640, DOI 10.1668/0003-1569(2001)041[0640:CAOHGE]2.0.CO;2; Kaufman T C, 1990, Adv Genet, V27, P309; Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030; Kourakis MJ, 1997, DEV BIOL, V190, P284, DOI 10.1006/dbio.1997.8689; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kulakova M, 2007, DEV GENES EVOL, V217, P39, DOI 10.1007/s00427-006-0119-y; Lee PN, 2003, NATURE, V424, P1061, DOI 10.1038/nature01872; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; Matus DQ, 2007, INTEGR COMP BIOL, V47, P854, DOI 10.1093/icb/icm077; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Pierce RJ, 2005, MOL BIOL EVOL, V22, P2491, DOI 10.1093/molbev/msi239; Prince VE, 1998, AM ZOOL, V38, P634; PULTZ MA, 1988, GENE DEV, V2, P901, DOI 10.1101/gad.2.7.901; Reish D.J., 1974, Thalassia Jugosl, V10, P181; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Schweigkofler M, 1998, ZOOMORPHOLOGY, V118, P117, DOI 10.1007/s004350050062; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Seaver EC, 2005, EVOL DEV, V7, P312, DOI 10.1111/j.1525-142X.2005.05037.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Shippy TD, 2008, DEV GENES EVOL, V218, P127, DOI 10.1007/s00427-008-0213-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; Thamm K, 2008, DEV BIOL, V320, P304, DOI 10.1016/j.ydbio.2008.04.015; Werbrock AH, 2001, DEV BIOL, V235, P476, DOI 10.1006/dbio.2001.0272; WONG VY, 1995, J NEUROSCI, V15, P5551; WYSOCKADILLER JW, 1989, NATURE, V341, P760, DOI 10.1038/341760a0	70	76	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4004	10.1371/journal.pone.0004004	http://dx.doi.org/10.1371/journal.pone.0004004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104667	gold, Green Submitted, Green Published			2022-12-27	WOS:000265462400005
J	Gallagher, A				Gallagher, Andrew			Size Variation in Small-Bodied Humans from Palau, Micronesia	PLOS ONE			English	Article							OLD-WORLD MONKEYS; DIAPHYSEAL STRUCTURE; SEXUAL-DIMORPHISM; LATE PLEISTOCENE; FLORES; PROPORTIONS; ARCHAEOLOGY; HOMININ; BONES; APES	Background: Recent discoveries on Palau are claimed to represent the remains of small-bodied humans that may display evidence insular size reduction. This claim has yet to be statistically validated Methodology/Principal Findings: Published postcranial specimens (n = 16) from Palau were assessed relative to recent small-bodied comparative samples. Resampling statistical approaches were employed to test specific hypotheses relating to body size in the Palau sample. Results confirm that the Palau postcranial sample is indisputably small-bodied. Conclusions/Significance: A single, homogenous body size morph is represented in early prehistoric postcrania from Palau. Small body size in early Palauans is an ancestral characteristic and was likely not a consequence of in-situ size reduction. Specimens from Palau have little bearing upon hypothesised insular size reduction in the ancestral lineage of Homo floresiensis.	Univ Witwatersrand, Sch Anat Sci, Johannesburg, South Africa	University of Witwatersrand	Gallagher, A (corresponding author), Univ Witwatersrand, Sch Anat Sci, Johannesburg, South Africa.	Andrew.Gallagher@wits.ac.za			Natural Environment Research Council (UK); University of the Witwatersrand	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of the Witwatersrand	The Natural Environment Research Council (UK), University of the Witwatersrand	BEAN RB, 1923, Q REV BIOL, V1, P360; Berger LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001780; BLANK S, 2008, RESAMPLING STATS EXC; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; BROWN P, 2004, FARMING, P6; Dalton R, 2008, NATURE, V452, P806, DOI 10.1038/452806a; Dalton R, 2008, NATURE, V452, P133, DOI 10.1038/452133a; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Eveleth PB, 1990, WORLDWIDE VARIATION; Fitzpatrick SM, 2003, J ARCHAEOL SCI, V30, P1175, DOI 10.1016/S0305-4403(03)00014-1; Good P, 2000, PERMUTATION TESTS PR; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; JADWISZCZAK P, 2003, RUNDOM PROJECTS 2; Liston J, 2005, RADIOCARBON, V47, P295, DOI 10.1017/S0033822200019780; Lockwood CA, 1996, J HUM EVOL, V31, P537, DOI 10.1006/jhev.1996.0078; Manly BFJ, 1997, RANDOMIZATION BOOTST; MARTIN R, 1957, LEHRBUCH ANTHR, V3; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; Nelson GC, 2006, ANTHROPOL SCI, V114, P1, DOI 10.1537/ase.040710; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; Schrein CM, 2006, J HUM EVOL, V50, P460, DOI 10.1016/j.jhevol.2005.11.007; Shea BT, 1996, AM J PHYS ANTHROPOL, V100, P311; Sokal R.R., 2012, BIOMETRY	28	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3939	10.1371/journal.pone.0003939	http://dx.doi.org/10.1371/journal.pone.0003939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437AS	19088844	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458500002
J	Marinelli, LJ; Piuri, M; Swigonova, Z; Balachandran, A; Oldfield, LM; van Kessel, JC; Hatfull, GF				Marinelli, Laura J.; Piuri, Mariana; Swigonova, Zuzana; Balachandran, Amrita; Oldfield, Lauren M.; van Kessel, Julia C.; Hatfull, Graham F.			BRED: A Simple and Powerful Tool for Constructing Mutant and Recombinant Bacteriophage Genomes	PLOS ONE			English	Article							CHROMOSOMAL GENES; PHAGE GENOMICS; DNA; MUTAGENESIS; EVOLUTION	Advances in DNA sequencing technology have facilitated the determination of hundreds of complete genome sequences both for bacteria and their bacteriophages. Some of these bacteria have well-developed and facile genetic systems for constructing mutants to determine gene function, and recombineering is a particularly effective tool. However, generally applicable methods for constructing defined mutants of bacteriophages are poorly developed, in part because of the inability to use selectable markers such as drug resistance genes during viral lytic growth. Here we describe a method for simple and effective directed mutagenesis of bacteriophage genomes using Bacteriophage Recombineering of Electroporated DNA (BRED), in which a highly efficient recombineering system is utilized directly on electroporated phage DNA; no selection is required and mutants can be readily detected by PCR. We describe the use of BRED to construct unmarked gene deletions, in-frame internal deletions, base substitutions, precise gene replacements, and the addition of gene tags.	[Marinelli, Laura J.; Piuri, Mariana; Swigonova, Zuzana; Balachandran, Amrita; Oldfield, Lauren M.; van Kessel, Julia C.; Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marinelli, LJ (corresponding author), Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		van Kessel, Julia/0000-0002-1612-2403; Piuri, Mariana/0000-0001-9058-8247	NIH [AI067649]; Science Education Partnership Award (SEPA), NIH [RR-020463]; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR020463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067649] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Education Partnership Award (SEPA), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US NIH grant AI067649. Students in the Gene Team program at the University of Pittsburgh contributed to this work and were supported by a Science Education Partnership Award (SEPA) RR-020463 from the NIH National Institute for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Calendar R., 2006, BACTERIOPHAGES; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Ghosh P, 2006, PLOS BIOL, V4, P964, DOI 10.1371/journal.pbio.0040186; Hatfull GF, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P203; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; Jacobs WR, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P1; Link AJ, 2007, NAT REV MICROBIOL, V5, P680, DOI 10.1038/nrmicro1715; Manna D, 2005, J BACTERIOL, V187, P3586, DOI 10.1128/JB.187.10.3586-3588.2005; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Norrby E, 2008, ARCH VIROL, V153, P1109, DOI 10.1007/s00705-008-0088-8; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Ranallo RT, 2006, FEMS IMMUNOL MED MIC, V47, P462, DOI 10.1111/j.1574-695X.2006.00118.x; Rees CED, 2006, ADV APPL MICROBIOL, V59, P159, DOI 10.1016/S0065-2164(06)59006-9; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	38	113	122	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3957	10.1371/journal.pone.0003957	http://dx.doi.org/10.1371/journal.pone.0003957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088849	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265458500005
J	Zhang, WY; Chen, GY; Niewiadomska, AM; Xu, RZ; Yu, XF				Zhang, Wenyan; Chen, Gongying; Niewiadomska, Anna Maria; Xu, Rongzhen; Yu, Xiao-Fang			Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins	PLOS ONE			English	Article							VIRUS TYPE-1 VIF; E3 UBIQUITIN LIGASE; CYTIDINE DEAMINASE; URACIL-DNA; SOCS-BOX; ANTIRETROVIRAL FACTOR; ENZYME APOBEC3G; EDITING ENZYMES; IMMUNODEFICIENCY; INHIBITION	Background: APOBEC3G (A3G) and related cytidine deaminases of the APOBEC3 family of proteins are potent inhibitors of many retroviruses, including HIV-1. Formation of infectious HIV-1 requires the suppression of multiple cytidine deaminases by Vif. HIV-1 Vif suppresses various APOBEC3 proteins through the common mechanism of recruiting the Cullin5-ElonginB-ElonginC E3 ubiquitin ligase to induce target protein polyubiquitination and proteasome-mediated degradation. The domains in Vif and various APOBEC3 proteins required for APOBEC3 recognition and degradation have not been fully characterized. Methods and Findings: In the present study, we have demonstrated that the regions of APOBEC3F (A3F) that are required for its HIV-1-mediated binding and degradation are distinct from those reported for A3G. We found that the C-terminal cytidine deaminase domain (C-CDD) of A3F alone is sufficient for its interaction with HIV-1 Vif and its Vif-mediated degradation. We also observed that the domains of HIV-1 Vif that are uniquely required for its functional interaction with full-length A3F are also required for the degradation of the C-CDD of A3F; in contrast, those Vif domains that are uniquely required for functional interaction with A3G are not required for the degradation of the C-CDD of A3F. Interestingly, the HIV-1 Vif domains required for the degradation of A3F are also required for the degradation of A3C and A3DE. On the other hand, the Vif domains uniquely required for the degradation of A3G are dispensable for the degradation of cytidine deaminases A3C and A3DE. Conclusions: Our data suggest that distinct regions of A3F and A3G are targeted by HIV-1 Vif molecules. However, HIV-1 Vif suppresses A3F, A3C, and A3DE through similar recognition determinants, which are conserved among Vif molecules from diverse HIV-1 strains. Mapping these determinants may be useful for the design of novel anti-HIV inhibitors.	[Zhang, Wenyan; Chen, Gongying; Niewiadomska, Anna Maria; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Xu, Rongzhen; Yu, Xiao-Fang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Zhejiang, Peoples R China; [Zhang, Wenyan] Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Chen, Gongying] Hosp Hangzhou 6, Zhejiang, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Zhejiang University; Jilin University	Zhang, WY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	xfyu@jhsph.edu			 [AI062644];  [AI071769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062644, R21AI071769, R01AI062644] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI062644 and AI071769	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Berk LS, 2008, FASEB J, V22; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Navarro F, 2004, CURR OPIN IMMUNOL, V16, P477, DOI 10.1016/j.coi.2004.05.006; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Rosler C, 2004, SCIENCE, V305, p1403A, DOI 10.1126/science.1100464; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Turelli P, 2004, SCIENCE, V305, p1403B; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Zhang WY, 2008, CELL MICROBIOL, V10, P1662, DOI 10.1111/j.1462-5822.2008.01157.x; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	91	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3963	10.1371/journal.pone.0003963	http://dx.doi.org/10.1371/journal.pone.0003963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088851	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458500009
J	Fadista, J; Nygaard, M; Holm, LE; Thomsen, B; Bendixen, C				Fadista, Joao; Nygaard, Marianne; Holm, Lars-Erik; Thomsen, Bo; Bendixen, Christian			A Snapshot of CNVs in the Pig Genome	PLOS ONE			English	Article								Recent studies of mammalian genomes have uncovered the extent of copy number variation (CNV) that contributes to phenotypic diversity, including health and disease status. Here we report a first account of CNVs in the pig genome covering part of the chromosomes 4, 7, 14, and 17 already sequenced and assembled. A custom tiling oligonucleotide array was used with a median probe spacing of 409 bp for screening 12 unrelated Duroc boars that are founders of a large family material. After a strict CNV calling pipeline, 37 copy number variable regions (CNVRs) across all four chromosomes were identified, with five CNVRs overlapping segmental duplications, three overlapping pig unigenes and one overlapping a RefSeq pig mRNA. This CNV snapshot analysis is the first of its kind in the porcine genome and constitutes the basis for a better understanding of porcine phenotypes and genotypes with the prospect of identifying important economic traits.	[Fadista, Joao; Nygaard, Marianne; Holm, Lars-Erik; Thomsen, Bo; Bendixen, Christian] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Grp Mol Genet & Syst Biol, Tjele, Denmark	Aarhus University	Fadista, J (corresponding author), Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Grp Mol Genet & Syst Biol, Tjele, Denmark.	Christian.Bendixen@agrsci.dk	Holm, Lars-Erik/A-4678-2013; Fadista, Joao/AAM-4870-2020	Holm, Lars-Erik/0000-0002-5312-3579; Fadista, Joao/0000-0003-2539-634X; Thomsen, Bo/0000-0001-9622-0929; Nygaard, Marianne/0000-0003-0703-2665; fadista, joao/0000-0001-7558-7043	Marie Curie [Host Fellowships for Early Stage Research Training]; European Commission	Marie Curie(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors of this paper did not receive any commercial funding for this project. This work was conducted as part of the SABRETRAIN Project, funded by the Marie Curie Host Fellowships for Early Stage Research Training, as part of the 6th Framework Programme of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorodkin J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r45; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; LIU G, 2007, INT S AN GEN AN HLTH; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Luethy Roland, 2004, Biosilico, V2, P12; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Madsen LB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-72; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rennie C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-317; RETTENBERGER G, 1995, GENOMICS, V26, P372, DOI 10.1016/0888-7543(95)80222-8; SAMBROOK J, 1989, MOL CLONING LAB MANU, V2, P11; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith M.L., 2006, BIOCONDUCTOR; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tumbleson ME, 1996, ADV SWINE BIOMEDICAL; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	63	97	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3916	10.1371/journal.pone.0003916	http://dx.doi.org/10.1371/journal.pone.0003916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079605	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458400002
J	Rigourd, V; Chauvet, C; Chelbi, ST; Rebourcet, R; Mondon, F; Letourneur, F; Mignot, TM; Barbaux, S; Vaiman, D				Rigourd, Virginie; Chauvet, Caroline; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel			STOX1 Overexpression in Choriocarcinoma Cells Mimics Transcriptional Alterations Observed in Preeclamptic Placentas	PLOS ONE			English	Article								Background: Mutations in STOX1 were proposed to be causal for predisposing to preeclampsia, a hypertensive disorder originating from placental defects, affecting up to 10% of human pregnancies. However, after the first study published in 2005 three other groups have dismissed the polymorphism described in the first paper as a causal mutation. Methodology and Principal Findings: In the present study, we have produced a choriocarcinoma cell line overexpressing STOX1. This overexpression results in transcriptional modification of 12.5% of the genes, some of them being direct targets as shown by chromatin immunoprecipitation. STOX1 overexpression correlates strongly and specifically with transcriptomic alterations in preeclamptic placentas (r=0.30, p=9.10(-7)). Numerous known key modulators of preeclampsia (such as Endoglin, Syncytin, human chorionic gonadotrophin -hCG-, and Glial Cell Missing Homolog -GCM1-) were modified in these transformed choriocarcinoma cells. Conclusions: Our results contribute to reconcile contradictory data concerning the involvement of STOX1 in preeclampsia. In addition, they strongly suggest that anomalies in STOX1 expression are associated with the onset of preeclampsia, thus indicating that this gene should be the target of future studies. Our cellular model could constitute an invaluable resource for studying specific aspects of this human disease.	[Rigourd, Virginie; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Equipe 21, Paris, France; [Rigourd, Virginie; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel] Inserm, U567, Paris, France; [Letourneur, Franck] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Plate forme Genom, Paris, France; [Chauvet, Caroline] Univ Paris 05, Ctr Univ St Peres 45, Inserm, UMR S747, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rigourd, V (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Equipe 21, Paris, France.	vaiman@cochin.inserm.fr	chelbi, sonia/C-1165-2016; Vaiman, Daniel/O-6030-2015; chelbi, sonia/Q-5150-2019; Barbaux, Sandrine C/B-2878-2019	chelbi, sonia/0000-0003-3465-6537; Vaiman, Daniel/0000-0002-1915-0717; chelbi, sonia/0000-0003-3465-6537; Barbaux, Sandrine C/0000-0002-8204-1855; rigourd, virginie/0000-0002-2638-4343	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funding by INSERM. INSERM has no role in managing the research.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Berends AL, 2007, BJOG-INT J OBSTET GY, V114, P1163, DOI 10.1111/j.1471-0528.2007.01414.x; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djian P, 2000, J CELL BIOL, V151, P381, DOI 10.1083/jcb.151.2.381; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; FERRE F, 1993, J CARDIOVASC PHARM, V22, pS214, DOI 10.1097/00005344-199322008-00058; Graves JAM, 1998, REPROD FERT DEVELOP, V10, P23, DOI 10.1071/R98014; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Iglesias-Platas I, 2007, NAT GENET, V39, P279, DOI 10.1038/ng0307-279; Kivinen K, 2007, EUR J HUM GENET, V15, P494, DOI 10.1038/sj.ejhg.5201788; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kudo Y, 2004, PLACENTA, V25, P479, DOI 10.1016/j.placenta.2003.12.001; Ledee-Bataille N, 2005, FERTIL STERIL, V83, P598, DOI 10.1016/j.fertnstert.2004.11.021; MALASSINE A, 1990, PLACENTA, V11, P191, DOI 10.1016/S0143-4004(05)80180-8; MONDON F, 1993, J CLIN ENDOCR METAB, V76, P237, DOI 10.1210/jc.76.1.237; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Perkins J, 2002, MOL MED, V8, P847, DOI 10.1007/BF03402090; Rinkenberger J, 2000, NAT GENET, V25, P248, DOI 10.1038/76985; Sibai BM, 2005, HYPERTENSION, V46, P1252, DOI 10.1161/01.HYP.0000188904.47575.7e; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Vaiman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-111; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683	27	50	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3905	10.1371/journal.pone.0003905	http://dx.doi.org/10.1371/journal.pone.0003905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079545	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455900002
J	Malone, JH; Fontenot, BE				Malone, John H.; Fontenot, Brian E.			Patterns of Reproductive Isolation in Toads	PLOS ONE			English	Article							FROG RANA-RUGOSA; HALDANES RULE; POSTZYGOTIC ISOLATION; HYBRID INVIABILITY; CHARACTER DISPLACEMENT; HETEROGAMETIC SEX; GENE-EXPRESSION; MOLECULAR SYSTEMATICS; CENTRARCHID FISHES; DARWINS COROLLARY	Understanding the general features of speciation is an important goal in evolutionary biology, and despite significant progress, several unresolved questions remain. We analyzed an extensive comparative dataset consisting of more than 1900 crosses between 92 species of toads to infer patterns of reproductive isolation. This unique dataset provides an opportunity to examine the strength of reproductive isolation, the development and sex ratios of hybrid offspring, patterns of fertility and infertility, and polyploidization in hybrids all in the context of genetic divergence between parental species. We found that the strength of intrinsic postzygotic isolation increases with genetic divergence, but relatively high levels of divergence are necessary before reproductive isolation is complete in toads. Fertilization rates were not correlated to genetic divergence, but hatching success, the number of larvae produced, and the percentage of tadpoles reaching metamorphosis were all inversely related with genetic divergence. Hybrids between species with lower levels of divergence developed to metamorphosis, while hybrids with higher levels of divergence stopped developing in gastrula and larval stages. Sex ratios of hybrid offspring were biased towards males in 70% of crosses and biased towards females in 30% of crosses. Hybrid females from crosses between closely related species were completely fertile, while approximately half (53%) of hybrid males were sterile, with sterility predicted by genetic divergence. The degree of abnormal ploidy in hybrids was positively related to genetic divergence between parental species, but surprisingly, polyploidization had no effect on patterns of asymmetrical inviability. We discuss explanations for these patterns, including the role of Haldane's rule in toads and anurans in general, and suggest mechanisms generating patterns of reproductive isolation in anurans.	[Malone, John H.; Fontenot, Brian E.] Univ Texas, Dept Biol, Arlington, TX USA	University of Texas System; University of Texas Arlington	Malone, JH (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	malonej@niddk.nih.gov						Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold Michael L., 2006, P399; Blair AP, 1941, GENETICS, V26, P398; BLAIR AP, 1942, BIOL S, V6, P235; Blair W. F., 1956, Texas Journal of Science, V8, P87; BLAIR W. F, 1972, EVOLUTION GENUS BUFO; BLAIR W. FRANK, 1959, TEXAS JOUR SCI, V11, P427; BLAIR W. FRANK, 1963, TEXAS JOUR SCI, V15, P15; BLAIR W. FRANK, 1961, TEXAS JOUR SCI, V13, P163; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; BLAIR WF, 1963, EVOLUTION, V17, P1, DOI 10.2307/2406331; BLAIR WF, 1966, TEX J SCI, V18, P333; BLAIR WF, 1955, EVOLUTION, V9, P469, DOI 10.2307/2405481; Bogart J.P., 1972, EVOLUTION GENUS BUFO, P171; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; BRIGGS RW, 1959, J EXP ZOOL, V111, P255; Christianson SJ, 2005, EVOLUTION, V59, P849, DOI 10.1554/04-291; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Cunningham M, 2004, MOL PHYLOGENET EVOL, V32, P671, DOI 10.1016/j.ympev.2004.03.003; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; ENGEL W, 1981, CYTOGENET CELL GENET, V30, P130, DOI 10.1159/000131600; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitzpatrick BM, 2006, EVOLUTION, V60, P601; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; FOUQUETTE MJ, 1975, SYST ZOOL, V24, P16, DOI 10.2307/2412694; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Herrmann Matthias, 2006, Front Zool, V3, P14, DOI 10.1186/1742-9994-3-14; HILLIS DM, 1990, J EVOLUTION BIOL, V3, P49, DOI 10.1046/j.1420-9101.1990.3010049.x; Johnson Norman A., 2000, P197; Johnson Norman A., 2006, P374; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOBEL HR, 1985, S AFR J SCI, V81, P205; KOBEL HR, 1996, BIOL XENOPUS, P391; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Leary CJ, 2001, ANIM BEHAV, V61, P431, DOI 10.1006/anbe.2000.1597; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2008, SCIENCE, V319, P59, DOI 10.1126/science.1148231; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; Mendelson TC, 2004, EVOLUTION, V58, P1424; Mendelson TC, 2003, EVOLUTION, V57, P317; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; MOORE JA, 1955, ADV GENET, V7, P139, DOI 10.1016/S0065-2660(08)60095-4; Moyle LC, 2004, EVOLUTION, V58, P1195, DOI 10.1111/j.0014-3820.2004.tb01700.x; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P35; Ogata M, 2003, GENETICS, V164, P613; Ohtani H, 2000, J EXP ZOOL, V286, P313, DOI 10.1002/(SICI)1097-010X(20000215)286:3<313::AID-JEZ10>3.3.CO;2-2; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Pauly GB, 2004, EVOLUTION, V58, P2517; Petrini S, 1998, J EXP ZOOL, V280, P245, DOI 10.1002/(SICI)1097-010X(19980215)280:3<245::AID-JEZ6>3.0.CO;2-N; Pfennig KS, 2002, EVOLUTION, V56, P1840; PONSE KITTY, 1941, REV SUISSE ZOOL, V48, P541; Pramuk JB, 2006, ZOOL J LINN SOC-LOND, V146, P407, DOI 10.1111/j.1096-3642.2006.00212.x; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; RAMBAUT A, 2006, SE AL SEQUENCE ALIGN; Russell ST, 2003, ANN ZOOL FENN, V40, P321; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Sawamura K, 1996, GENETICS, V143, P609; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMID M, 2001, GENES MECH VERTEBRAT, P143; Scopece G, 2007, EVOLUTION, V61, P2623, DOI 10.1111/j.1558-5646.2007.00231.x; Slotman M, 2005, EVOLUTION, V59, P1016, DOI 10.1111/j.0014-3820.2005.tb01040.x; Sokal RR, 1995, BIOMETRY; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; SWOFFORD D, 2001, PAUP 4 0 BETA PHYLOG; THORNTON WA, 1955, AM MID NAT, V71, P232; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; VOLPE EP, 1955, AM NAT, V89, P303, DOI 10.1086/281895; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1992, EVOLUTION, V46, P1584, DOI 10.1111/j.1558-5646.1992.tb01152.x; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; ZOUROS E, 1973, EVOLUTION, V27, P601, DOI 10.1111/j.1558-5646.1973.tb00709.x	89	78	79	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3900	10.1371/journal.pone.0003900	http://dx.doi.org/10.1371/journal.pone.0003900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065271	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455200012
J	Doheny, JG; Mottus, R; Grigliatti, TA				Doheny, J. Greg; Mottus, Randy; Grigliatti, Thomas A.			Telomeric Position Effect-A Third Silencing Mechanism in Eukaryotes	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; HETEROCHROMATIN PROTEIN-1 HP1; ORIGIN RECOGNITION COMPLEX; DROSOPHILA-MELANOGASTER; EFFECT VARIEGATION; CHROMATIN-STRUCTURE; POLYCOMB-GROUP; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; POLYTENE CHROMOSOMES	Eukaryotic chromosomes terminate in telomeres, complex nucleoprotein structures that are required for chromosome integrity that are implicated in cellular senescence and cancer. The chromatin at the telomere is unique with characteristics of both heterochromatin and euchromatin. The end of the chromosome is capped by a structure that protects the end and is required for maintaining proper chromosome length. Immediately proximal to the cap are the telomere associated satellite-like (TAS) sequences. Genes inserted into the TAS sequences are silenced indicating the chromatin environment is incompatible with transcription. This silencing phenomenon is called telomeric position effect (TPE). Two other silencing mechanisms have been identified in eukaryotes, suppressors position effect variegation [Su(var) s, greater than 30 members] and Polycomb group proteins (PcG, approximately 15 members). We tested a large number of each group for their ability to suppress TPE [Su(TPE)]. Our results showed that only three Su(var) s and only one PcG member are involved in TPE, suggesting silencing in the TAS sequences occurs via a novel silencing mechanism. Since, prior to this study, only five genes have been identified that are Su(TPE) s, we conducted a candidate screen for Su(TPE) in Drosophila by testing point mutations in, and deficiencies for, proteins involved in chromatin metabolism. Screening with point mutations identified seven new Su(TPE) s and the deficiencies identified 19 regions of the Drosophila genome that harbor suppressor mutations. Chromatin immunoprecipitation experiments on a subset of the new Su(TPE) s confirm they act directly on the gene inserted into the telomere. Since the Su(TPE) s do not overlap significantly with either PcGs or Su(var) s, and the candidates were selected because they are involved generally in chromatin metabolism and act at a wide variety of sites within the genome, we propose that the Su(TPE) represent a third, widely used, silencing mechanism in the eukaryotic genome.	[Doheny, J. Greg; Mottus, Randy; Grigliatti, Thomas A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Grigliatti, TA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	grigliat@zoology.ubc.ca			Natural Sciences and Engineering Research Council of Canada 3005	Natural Sciences and Engineering Research Council of Canada 3005	Natural Sciences and Engineering Research Council of Canada 3005 to TAG. This is a public granting agency. Therefore, there are no commercial or competing interests.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Baur Joseph A, 2004, Methods Mol Biol, V287, P121; Berloco M, 2001, P NATL ACAD SCI USA, V98, P12126, DOI 10.1073/pnas.211428798; Biessmann H, 2005, BIOCHEM CELL BIOL, V83, P477, DOI 10.1139/O05-053; BIESSMANN H, 2005, 2 DISTINCT DOMAINS D; Boivin A, 2003, GENETICS, V164, P195; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; BRUNK BP, 1991, NUCLEIC ACIDS RES, V19, P3149, DOI 10.1093/nar/19.11.3149; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Cernilogar FM, 2005, BIOCHEM CELL BIOL, V83, P322, DOI 10.1139/o05-040; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Crabbe L, 2005, CURR MOL MED, V5, P135, DOI 10.2174/1566524053586527; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Daubresse G, 1999, DEVELOPMENT, V126, P1175; DECAMILLIS M, 1992, GENE DEV, V6, P223, DOI 10.1101/gad.6.2.223; Dejardin J, 2005, PROG MOLEC, V38, P31; DeRubertis F, 1996, NATURE, V384, P589; Donaldson KM, 2002, GENETICS, V160, P995; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Eissenberg JC, 2003, PROG NUCLEIC ACID RE, V74, P275, DOI 10.1016/S0079-6603(03)01016-X; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; GRIGLIATTI T, 1991, METHOD CELL BIOL, V35, P587; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; HENDERSON DS, 1987, MUTAT RES, V177, P83, DOI 10.1016/0027-5107(87)90024-8; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; Henikoff S, 1992, CURR OPIN GENET DEV, V2, P907, DOI 10.1016/S0959-437X(05)80114-5; Hodgson JW, 1997, MECH DEVELOP, V66, P69, DOI 10.1016/S0925-4773(97)00091-9; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LOCKE J, 1988, GENETICS, V120, P181; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mason JM, 2004, GENETICS, V168, P1353, DOI 10.1534/genetics.104.030676; Mason JM, 2000, GENETICA, V109, P61, DOI 10.1023/A:1026548503320; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mis J, 2006, MOL GENET GENOMICS, V275, P513, DOI 10.1007/s00438-006-0116-x; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; MOORE GD, 1979, NATURE, V282, P312, DOI 10.1038/282312a0; Mottus R, 2000, GENETICS, V154, P657; MOTTUS R, 1979, EFFECT N BUTYRATE N; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ner SS, 2002, GENETICS, V162, P1763; NORRIS D, 1988, SCIENCE, V242, P759, DOI 10.1126/science.2847314; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; REUTER G, 1987, MOL GEN GENET, V210, P429, DOI 10.1007/BF00327193; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; SAMAL B, 1981, CELL, V23, P401, DOI 10.1016/0092-8674(81)90135-5; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; Schotta G, 2000, MOL GEN GENET, V262, P916, DOI 10.1007/PL00008659; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; SINCLAIR DA, 1992, GENETICS, V130, P333; SINCLAIR DAR, 1989, MOL GEN GENET, V216, P328, DOI 10.1007/BF00334372; Sinclair DAR, 1998, GENETICS, V148, P211; SINCLAIR DAR, 1983, MOL GEN GENET, V191, P326, DOI 10.1007/BF00334834; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Spofford J., 1976, GENET BIOL DROSOPHIL, VVolume 1, P955; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wallrath LL, 2000, GENETICA, V109, P25, DOI 10.1023/A:1026556705137; WALTER MF, 1995, CHROMOSOMA, V104, P229, DOI 10.1007/BF00352254; WU CT, 1995, GENETICS, V140, P139; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhimulev IF, 2003, J CELL SCI, V116, P169, DOI 10.1242/jcs.00196	104	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3864	10.1371/journal.pone.0003864	http://dx.doi.org/10.1371/journal.pone.0003864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057646	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452300006
J	Cremer, S; Ugelvig, LV; Drijfhout, FP; Schlick-Steiner, BC; Steiner, FM; Seifert, B; Hughes, DP; Schulz, A; Petersen, KS; Konrad, H; Stauffer, C; Kiran, K; Espadaler, X; d'Ettorre, P; Aktac, N; Eilenberg, J; Jones, GR; Nash, DR; Pedersen, JS; Boomsma, JJ				Cremer, Sylvia; Ugelvig, Line V.; Drijfhout, Falko P.; Schlick-Steiner, Birgit C.; Steiner, Florian M.; Seifert, Bernhard; Hughes, David P.; Schulz, Andreas; Petersen, Klaus S.; Konrad, Heino; Stauffer, Christian; Kiran, Kadri; Espadaler, Xavier; d'Ettorre, Patrizia; Aktac, Nihat; Eilenberg, Jorgen; Jones, Graeme R.; Nash, David R.; Pedersen, Jes S.; Boomsma, Jacobus J.			The Evolution of Invasiveness in Garden Ants	PLOS ONE			English	Article							LASIUS-NEGLECTUS HYMENOPTERA; INTRODUCED POPULATIONS; LINEPITHEMA-HUMILE; ARGENTINE ANT; WOLBACHIA INFECTION; SOCIAL INSECTS; FIRE ANTS; FORMICIDAE; EUROPE; SUPERCOLONIES	It is unclear why some species become successful invaders whilst others fail, and whether invasive success depends on pre-adaptations already present in the native range or on characters evolving de-novo after introduction. Ants are among the worst invasive pests, with Lasius neglectus and its rapid spread through Europe and Asia as the most recent example of a pest ant that may become a global problem. Here, we present the first integrated study on behavior, morphology, population genetics, chemical recognition and parasite load of L. neglectus and its non-invasive sister species L. turcicus. We find that L. neglectus expresses the same supercolonial syndrome as other invasive ants, a social system that is characterized by mating without dispersal and large networks of cooperating nests rather than smaller mutually hostile colonies. We conclude that the invasive success of L. neglectus relies on a combination of parasite-release following introduction and pre-adaptations in mating system, body-size, queen number and recognition efficiency that evolved long before introduction. Our results challenge the notion that supercolonial organization is an inevitable consequence of low genetic variation for chemical recognition cues in small invasive founder populations. We infer that low variation and limited volatility in cuticular hydrocarbon profiles already existed in the native range in combination with low dispersal and a highly viscous population structure. Human transport to relatively disturbed urban areas thus became the decisive factor to induce parasite release, a well established general promoter of invasiveness in non-social animals and plants, but understudied in invasive social insects.	[Cremer, Sylvia; Ugelvig, Line V.; Hughes, David P.; Petersen, Klaus S.; d'Ettorre, Patrizia; Nash, David R.; Pedersen, Jes S.; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Cremer, Sylvia; Ugelvig, Line V.; d'Ettorre, Patrizia] Univ Regensburg, Regensburg, Germany; [Drijfhout, Falko P.; Jones, Graeme R.] Univ Keele, Sch Phys & Geograph Sci, Chem Ecol Grp, Keele, Staffs, England; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Innsbruck, Inst Ecol, Innsbruck, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Nat Resources & Appl Life Sci Vienna, Dept Intergrat Biol & Biodiversit Res, Vienna, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.; Konrad, Heino; Stauffer, Christian] Univ Nat Resources & Appl Life Sci Vienna, Dept Forest & Soil Sci Boku, Vienna, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] James Cook Univ N Queensland, Sch marine & Trop Biol, Townsville, Qld, Australia; [Seifert, Bernhard] Nat Hist Museum Gorlitz, Gorlitz, Germany; [Hughes, David P.] Univ Oulu, Dept Biol, Oulu, Finland; [Konrad, Heino] Fed Res & Training Ctr Forest Nat Hazards & Landsc, Dept Genet, Vienna, Austria; [Kiran, Kadri; Aktac, Nihat] Trakya Univ, Dept Biol, Edirne, Turkey; [Espadaler, Xavier] Autonomous Univ Barcelona, Dept Anim Biol Plant Biol & Ecol, Bellaterra, Spain; [Eilenberg, Jorgen] Univ Copenhagen, Dept Ecol, Frederiksberg, Denmark	University of Copenhagen; University of Regensburg; Keele University; University of Innsbruck; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; James Cook University; University of Oulu; Trakya University; Autonomous University of Barcelona; University of Copenhagen	Cremer, S (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	sylvia.cremer@biologie.uni-regensburg.de	Kiran, Kadri/X-7064-2019; Eilenberg, Jorgen/F-7444-2014; Boomsma, Jacobus J/M-2785-2014; Espadaler, Xavier/F-1898-2011; Ugelvig, Line V./K-5120-2012; Nash, David R./B-2916-2009; Pedersen, Jes Søe/J-6337-2014; Cremer, Sylvia/B-2199-2013	Kiran, Kadri/0000-0001-7983-0194; Eilenberg, Jorgen/0000-0002-9273-5252; Boomsma, Jacobus J/0000-0002-3598-1609; Espadaler, Xavier/0000-0002-7681-5957; Ugelvig, Line V./0000-0003-1832-8883; Nash, David R./0000-0002-0462-6794; Pedersen, Jes Søe/0000-0002-4439-2638; Cremer, Sylvia/0000-0002-2193-3868; Konrad, Heino/0000-0003-1820-9550; Drijfhout, Falko/0000-0002-3210-8038; Steiner, Florian M./0000-0003-2414-4650; Schlick-Steiner, Birgit/0000-0003-4026-5778	INSECTS; Marie Curie EIF; Alexander-von-Humboldt Foundation; Danish Natural Science Research Council; Danish National Research Foundation; Austrian Science Fund	INSECTS; Marie Curie EIF(European Commission); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Austrian Science Fund(Austrian Science Fund (FWF))	Funding was obtained from the European Community: FP5 EU research-training network INSECTS (JJB SC PD FPD DPH) and FP6 Individual Marie Curie EIF grant (SC), the Alexander-von-Humboldt Foundation (Feodor-Lynen postdoctoral stipend to SC), the Danish Natural Science Research Council (JSP), the Danish National Research Foundation (JJB DRN JSP), and the Austrian Science Fund (BCS FMS CS HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bouwma AM, 2006, INSECT MOL BIOL, V15, P89, DOI 10.1111/j.1365-2583.2006.00614.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Elias M, 2005, BEHAV ECOL SOCIOBIOL, V57, P339, DOI 10.1007/s00265-004-0864-8; ELMES GW, 1973, J ANIM ECOL, V42, P761, DOI 10.2307/3136; Espadaler X, 2007, INSECT SOC, V54, P293, DOI 10.1007/s00040-007-0944-7; Espadaler X, 2001, INSECT SOC, V48, P159, DOI 10.1007/PL00001760; ESPADALER X, 2005, LASIUS NEGLECTUS POL; Fenollar F, 2003, ANTIMICROB AGENTS CH, V47, P1665, DOI 10.1128/AAC.47.5.1665-1671.2003; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Groden E, 2005, J ECON ENTOMOL, V98, P1774, DOI 10.1603/0022-0493-98.6.1774; Heller NE, 2004, INSECT SOC, V51, P378, DOI 10.1007/s00040-004-0770-0; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holzer B, 2006, J EVOLUTION BIOL, V19, P2031, DOI 10.1111/j.1420-9101.2006.01133.x; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kummerli R, 2007, MOL ECOL, V16, P4493, DOI 10.1111/j.1365-294X.2007.03514.x; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lowe S., 2000, ENCY BIOL INVASIONS; McGlynn TP, 1999, AM NAT, V154, P690, DOI 10.1086/303270; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; PASSERA L, 1994, WESTV STUD, P23; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Queller DC, 2000, NATURE, V405, P519, DOI 10.1038/35014705; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reuter M, 2005, HEREDITY, V94, P364, DOI 10.1038/sj.hdy.6800601; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Schultz Roland, 2005, Myrmecologische Nachrichten, V7, P47; Seifert B, 2000, DEUT ENTOMOL Z, V47, P173; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Starks PT, 2003, TRENDS ECOL EVOL, V18, P159, DOI 10.1016/S0169-5347(03)00038-7; Steiner FM, 2007, CURR BIOL, V17, P1903, DOI 10.1016/j.cub.2007.09.061; Steiner FM, 2004, INSECT SOC, V51, P24, DOI 10.1007/s00040-003-0699-8; Tartally A., 2000, TISCIA (Szeged), V32, P43; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, MOL ECOL, V12, P3057, DOI 10.1046/j.1365-294X.2003.01979.x; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van der Hammen T, 2002, HEREDITY, V89, P83, DOI 10.1038/sj.hdy.6800098; VANLOON AJ, 1990, INSECT SOC, V37, P348, DOI 10.1007/BF02225997; Williamson M., 1996, BIOL INVASIONS	47	74	80	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3838	10.1371/journal.pone.0003838	http://dx.doi.org/10.1371/journal.pone.0003838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050762	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265452100004
J	Tran, H; Chen, HY; Walz, A; Posthumus, JC; Gong, QZ				Tran, Ha; Chen, Huaiyang; Walz, Andreas; Posthumus, Jamie C.; Gong, Qizhi			Influence of Olfactory Epithelium on Mitral/Tufted Cell Dendritic Outgrowth	PLOS ONE			English	Article								Stereotypical connections between olfactory sensory neuron axons and mitral cell dendrites in the olfactory bulb establish the first synaptic relay for olfactory perception. While mechanisms of olfactory sensory axon targeting are reported, molecular regulation of mitral cell dendritic growth and refinement are unclear. During embryonic development, mitral cell dendritic distribution overlaps with olfactory sensory axon terminals in the olfactory bulb. In this study, we investigate whether olfactory sensory neurons in the olfactory epithelium influence mitral cell dendritic outgrowth in vitro. We report a soluble trophic activity in the olfactory epithelium conditioned medium which promotes mitral/tufted cell neurite outgrowth. While the trophic activity is present in both embryonic and postnatal olfactory epithelia, only embryonic but not postnatal mitral/tufted cells respond to this activity. We show that BMP2, 5 and 7 promote mitral/tufted cells neurite outgrowth. However, the BMP antagonist, Noggin, fails to neutralize the olfactory epithelium derived neurite growth promoting activity. We provide evidence that olfactory epithelium derived activity is a protein factor with molecular weight between 50-100 kD. We also observed that Follistatin can effectively neutralize the olfactory epithelium derived activity, suggesting that TGF-beta family proteins are involved to promote mitral/tufted dendritic elaboration.	[Tran, Ha; Chen, Huaiyang; Posthumus, Jamie C.; Gong, Qizhi] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Walz, Andreas] Rockefeller Univ, New York, NY USA	University of California System; University of California Davis; Rockefeller University	Tran, H (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	qzgong@ucdavis.edu			National Institutes of Health [DC06015]; National Science Foundation [IBN0324769]; National Center for Research Resources, National Institutes of Health [C06 RR12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institutes of Health DC06015 and National Science Foundation IBN0324769 to QG. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR12088-01 from the National Center for Research Resources, National Institutes of Health.	Bailey MS, 1999, J COMP NEUROL, V415, P423; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Binder DK, 1999, J NEUROSCI, V19, P1424; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; BYRD CA, 1993, J NEUROBIOL, V24, P1229, DOI 10.1002/neu.480240909; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Esquenazi S, 2002, EXP NEUROL, V176, P41, DOI 10.1006/exnr.2002.7906; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; GRAZIADEI PPC, 1992, NEUROSCIENCE, V46, P617, DOI 10.1016/0306-4522(92)90149-V; HINDS JW, 1972, J COMP NEUROL, V146, P233, DOI 10.1002/cne.901460207; HINDS JW, 1973, J COMP NEUROL, V151, P281, DOI 10.1002/cne.901510305; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kobayashi H, 1997, J NEUROSCI, V17, P8339; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Lee W, 2008, J COMP NEUROL, V507, P1076, DOI 10.1002/cne.21569; Lein PJ, 2002, J NEUROSCI, V22, P10377; Leo JMC, 2000, J COMP NEUROL, V417, P325, DOI 10.1002/(SICI)1096-9861(20000214)417:3<325::AID-CNE6>3.0.CO;2-Y; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Lopez-Mascaraque L, 1998, ANN NY ACAD SCI, V855, P83, DOI 10.1111/j.1749-6632.1998.tb10549.x; Lopez-Mascaraque L, 2005, DEV DYNAM, V232, P325, DOI 10.1002/dvdy.20239; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; Matsutani S, 2000, J COMP NEUROL, V418, P402; Matsuura I, 2007, BIOCHEM BIOPH RES CO, V360, P868, DOI 10.1016/j.bbrc.2007.06.157; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Nakajima D, 2001, MOL BRAIN RES, V94, P85; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; Peretto P, 2002, J COMP NEUROL, V451, P267, DOI 10.1002/cne.10343; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Shou JY, 2000, DEVELOPMENT, V127, P5403; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Treloar HB, 1999, J COMP NEUROL, V413, P289; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Walz A, 2006, J NEUROBIOL, V66, P835, DOI 10.1002/neu.20266; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3816	10.1371/journal.pone.0003816	http://dx.doi.org/10.1371/journal.pone.0003816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043569	Green Submitted, gold, Green Published			2022-12-27	WOS:000265451400008
J	Skinner, MK; Anway, MD; Savenkova, MI; Gore, AC; Crews, D				Skinner, Michael K.; Anway, Matthew D.; Savenkova, Marina I.; Gore, Andrea C.; Crews, David			Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior	PLOS ONE			English	Article								Embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination promotes an epigenetic reprogramming of the male germ-line that is associated with transgenerational adult onset disease states. Further analysis of this transgenerational phenotype on the brain demonstrated reproducible changes in the brain transcriptome three generations (F3) removed from the exposure. The transgenerational alterations in the male and female brain transcriptomes were distinct. In the males, the expression of 92 genes in the hippocampus and 276 genes in the amygdala were transgenerationally altered. In the females, the expression of 1,301 genes in the hippocampus and 172 genes in the amygdala were transgenerationally altered. Analysis of specific gene sets demonstrated that several brain signaling pathways were influenced including those involved in axon guidance and long-term potentiation. An investigation of behavior demonstrated that the vinclozolin F3 generation males had a decrease in anxiety-like behavior, while the females had an increase in anxiety-like behavior. These observations demonstrate that an embryonic exposure to an environmental compound appears to promote a reprogramming of brain development that correlates with transgenerational sex-specific alterations in the brain transcriptomes and behavior. Observations are discussed in regards to environmental and transgenerational influences on the etiology of brain disease.	[Skinner, Michael K.; Anway, Matthew D.; Savenkova, Marina I.] Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Gore, Andrea C.] Univ Texas, Div Pharmacol & Toxicol, Austin, TX USA; [Crews, David] Univ Texas, Sect Integrat Biol, Austin, TX USA	Washington State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Skinner, MK (corresponding author), Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA.	Skinner@mail.wsu.edu	Savenkova, Marina/AAN-9927-2021	Gore, Andrea/0000-0001-5549-6793	National Institute of Environmental Health Sciences, NIEHS	National Institute of Environmental Health Sciences, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a grant from the National Institute of Environmental Health Sciences, NIEHS to MKS.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; ANWAY MD, 2006, ENDOCRINOLOGY, V147; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Burwell RD, 2001, J COMP NEUROL, V437, P17, DOI 10.1002/cne.1267; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Chen JJ, 2004, BIOINFORMATICS, V20, P1436, DOI 10.1093/bioinformatics/bth118; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cloutier S, 2006, TOXICOLOGY, V217, P147, DOI 10.1016/j.tox.2005.09.003; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; CREWS D, 2008, FRONTIERS N IN PRESS; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Cupp AS, 2003, J ANDROL, V24, P736; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; FILE SE, 1993, BEHAV BRAIN RES, V58, P199, DOI 10.1016/0166-4328(93)90103-W; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gomez C, 2002, PHARMACOL BIOCHEM BE, V72, P543, DOI 10.1016/S0091-3057(02)00722-0; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heindel JJ, 2005, BIRTH DEFECTS RES A, V73, P131, DOI 10.1002/bdra.20119; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klose R, 2003, SCIENCE, V302, P793, DOI 10.1126/science.1091762; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2005, BRAIN DEV-JPN, V27, P321, DOI 10.1016/j.braindev.2004.08.003; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Newbold RR, 1998, CARCINOGENESIS, V19, P1655, DOI 10.1093/carcin/19.9.1655; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NILSSON E, 2008, REPRODUCTIO IN PRESS, V135; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; PIAZZA PV, 1989, BEHAV BRAIN RES, V31, P267, DOI 10.1016/0166-4328(89)90008-9; PICAZO O, 1995, BRAIN RES, V680, P135, DOI 10.1016/0006-8993(95)00254-N; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P196, DOI 10.1159/000077366; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Walf AA, 2008, NEUROPSYCHOPHARMACOL, V33, P431, DOI 10.1038/sj.npp.1301416; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	53	199	204	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3745	10.1371/journal.pone.0003745	http://dx.doi.org/10.1371/journal.pone.0003745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015723	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448400002
J	Zhu, CH; Kim, J; Shay, JW; Wright, WE				Zhu, Chun-Hong; Kim, Jinyong; Shay, Jerry W.; Wright, Woodring E.			SGNP: An Essential Stress Granule/Nucleolar Protein Potentially Involved in 5.8s rRNA Processing/Transport	PLOS ONE			English	Article								Background: Stress Granules (SG) are sites of accumulation of stalled initiation complexes that are induced following a variety of cellular insults. In a genetic screen for factors involved in protecting human myoblasts from acute oxidative stress, we identified a gene encoding a protein we designate SGNP (Stress Granule and Nucleolar Protein). Methodology/Principal Findings: A gene-trap insertional mutagenesis screen produced one insertion that conferred resistance to sodium arsenite. RT-PCR/39 RACE was used to identify the endogenous gene expressed as a GFP-fusion transcript. SGNP is localized in both the cytoplasm and nucleolus and defines a non-nucleolar compartment containing 5.8S rRNA, a component of the 60S ribosomal subunit. Under oxidative stress, SGNP nucleolar localization decreases and it rapidly co-localizes with stress granules. The decrease in nucleolar SGNP following oxidative stress was accompanied by a large increase in nucleolar 5.8S rRNA. Knockdown of SGNP with shRNA increased global mRNA translation but induced growth arrest and cell death. Conclusions: These results suggest that SGNP is an essential gene that may be involved in ribosomal biogenesis and translational control in response to oxidative stress.	[Zhu, Chun-Hong; Kim, Jinyong; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, CH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Shay, Jerry W/F-7878-2011		American Heart Association [0525069Y]; National Institutes of Health [AG07992]; NATIONAL INSTITUTE ON AGING [R01AG007992] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by American Heart Association postdoctoral fellowship No. 0525069Y (C-H Z), and National Institutes of Health grant AG07992 (WEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YH, 1999, J NEUROSCI, V19, P10338; DANOVA M, 1988, BIOL CELL, V64, P23, DOI 10.1016/0248-4900(88)90089-5; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; HODGES D, 1992, MECH DEVELOP, V37, P127, DOI 10.1016/0925-4773(92)90075-U; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Skuk D, 1998, CELL TRANSPLANT, V7, P427, DOI 10.1016/S0963-6897(98)00029-3; Smythe GM, 2000, MOL THER, V1, P304, DOI 10.1006/mthe.2000.0049; Suzuki N, 2001, GENETICS, V158, P613; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	24	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3716	10.1371/journal.pone.0003716	http://dx.doi.org/10.1371/journal.pone.0003716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005571	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166200004
J	Lee, PS; Patel, SR; Christiani, DC; Bajwa, E; Stossel, TP; Waxman, AB				Lee, Po-Shun; Patel, Sanjay R.; Christiani, David C.; Bajwa, Ednan; Stossel, Thomas P.; Waxman, Aaron B.			Plasma Gelsolin Depletion and Circulating Actin in Sepsis-A Pilot Study	PLOS ONE			English	Article								Background: Depletion of the circulating actin-binding protein, plasma gelsolin (pGSN) has been described in septic patients and animals. We hypothesized that the extent of pGSN reduction correlates with outcomes of septic patients and that circulating actin is a manifestation of sepsis. Methodology/Principal Findings: We assayed pGSN in plasma samples from non-surgical septic patients identified from a pre-existing database which prospectively enrolled patients admitted to adult intensive care units at an academic hospital. We identified 21 non-surgical septic patients for the study. Actinemia was detected in 17 of the 21 patients, suggesting actin released into circulation from injured tissues is a manifestation of sepsis. Furthermore, we documented the depletion of pGSN in human clinical sepsis, and that the survivors had significantly higher pGSN levels than the non-survivors (163 +/- 47 mg/L vs. 89 +/- 48 mg/L, p = 0.01). pGSN levels were more strongly predictive of 28-day mortality than APACHE III scores. For every quartile reduction in pGSN, the odds of death increased 3.4-fold. Conclusion: We conclude that circulating actin and pGSN deficiency are associated with early sepsis. The degree of pGSN deficiency correlates with sepsis mortality. Reversing pGSN deficiency may be an effective treatment for sepsis.	[Lee, Po-Shun] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Lee, Po-Shun; Christiani, David C.; Bajwa, Ednan; Stossel, Thomas P.; Waxman, Aaron B.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Po-Shun; Stossel, Thomas P.] Brigham & Womens Hosp, Translat Med Div, Boston, MA USA; [Patel, Sanjay R.] Case Western Reserve Univ, Univ Hosp Cleveland, Div Pulmonary & Critical Care Med, Cleveland, OH USA; [Christiani, David C.; Bajwa, Ednan; Waxman, Aaron B.] Mass Gen Hosp, Pulmonary & Critical Care Unit, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Harvard University; Massachusetts General Hospital	Lee, PS (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	plee4@partners.org	Waxman, Aaron/I-8659-2019; Waxman, Aaron/L-7450-2019	Waxman, Aaron/0000-0001-7797-0361; Patel, Sanjay/0000-0002-9142-5172; Bajwa, Ednan/0000-0001-9026-1009	NIH [5R01HL074859-04]; AHA [0735620N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH 5R01HL074859-04, AHA Scientist Development Grant 0735620N. The funding institutions played no role in the designed of the study or in the preparation of this manuscript.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1984, J BIOL CHEM, V259, P3262; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SMITH DB, 1988, BLOOD, V72, P214; SMITH DB, 1987, J LAB CLIN MED, V110, P189; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	28	46	57	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3712	10.1371/journal.pone.0003712	http://dx.doi.org/10.1371/journal.pone.0003712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002257	Green Submitted, gold, Green Published			2022-12-27	WOS:000265166000012
J	Wierzba, TF; Abdel-Messih, IA; Gharib, B; Baqar, S; Hendaui, A; Khalil, I; Omar, TA; Khayat, HE; Putnam, SD; Sanders, JW; Ng, LK; Price, LJ; Scott, DA; Frenck, RR				Wierzba, Thomas F.; Abdel-Messih, Ibrahim Adib; Gharib, Bayoumi; Baqar, Shahida; Hendaui, Amina; Khalil, Ibrahim; Omar, Tarek A.; Khayat, Hamed E.; Putnam, Shannon D.; Sanders, John W.; Ng, Lai-King; Price, Lawrence J.; Scott, Daniel A.; Frenck, Robert R.			Campylobacter Infection as a Trigger for Guillain-Barre Syndrome in Egypt	PLOS ONE			English	Article							CLINICAL MANIFESTATIONS; LONGITUDINAL DATA; JEJUNI INFECTION; LIPOPOLYSACCHARIDES; DIARRHEA; MIMICRY; IDENTIFICATION; FEATURES; STRAINS	Background: Most studies of Campylobacter infection triggering Guillain-Barre Syndrome (GBS) are conducted in western nations were Campylobacter infection and immunity is relatively rare. In this study, we explored Campylobacter infections, Campylobacter serotypes, autoantibodies to gangliosides, and GBS in Egypt, a country where Campylobacter exposure is common. Methods: GBS cases (n = 133) were compared to age-and hospital-matched patient controls (n = 374). A nerve conduction study was performed on cases and a clinical history, serum sample, and stool specimen obtained for all subjects. Results: Most (63.3%) cases were demyelinating type; median age four years. Cases were more likely than controls to have diarrhea (29.5% vs. 22.5%, Adjusted Odds Ratio (ORa) = 1.69, P = 0.03), to have higher geometric mean IgM anti-Campylobacter antibody titers (8.18 vs. 7.25 P < 0.001), and to produce antiganglioside antibodies (e.g., anti-Gd1a, 35.3 vs. 11.5, ORa = 4.39, P < 0.0001). Of 26 Penner:Lior Campylobacter serotypes isolated, only one (41:27, C. jejuni, P = 0.02) was associated with GBS. Conclusions: Unlike results from western nations, data suggested that GBS cases were primarily in the young and cases and many controls had a history of infection to a variety of Campylobacter serotypes. Still, the higher rates of diarrhea and greater antibody production against Campylobacter and gangliosides in GBS patients were consistent with findings from western countries.	[Wierzba, Thomas F.; Abdel-Messih, Ibrahim Adib; Putnam, Shannon D.; Frenck, Robert R.] USN, Med Res Unit 3, Cairo, Egypt; [Gharib, Bayoumi; Khalil, Ibrahim] Alexandra Univ Hosp, Neurol Dept, Alexandria, Egypt; [Baqar, Shahida; Omar, Tarek A.] Naval Med Res Ctr, Silver Spring, MD USA; [Hendaui, Amina] Cairo Univ Hosp, Neurol Dept, Cairo, Egypt; [Khayat, Hamed E.] Ain Shams Univ, Childrens Hosp, Neurol Dept, Ain Shams, Egypt; [Sanders, John W.] USN, Med Res Unit 3, Cairo, Egypt; [Ng, Lai-King; Price, Lawrence J.] Natl Microbiol Lab, Bacteriol & Enter Dis Program, Winnipeg, MB, Canada; [Scott, Daniel A.] Naval Med Res Ctr, Bethesda, MD USA	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); United States Department of Defense; United States Navy; Egyptian Knowledge Bank (EKB); Alexandria University; Naval Medical Research Center (NMRC); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC)	Wierzba, TF (corresponding author), USN, Med Res Unit 2, Jakarta, Indonesia.	Director@NAMRU2.org.kh	Putnam, Shan D/F-2345-2013	Putnam, Shan D/0000-0001-8353-4400	Military Infectious Diseases Research Program of the United States Department of Defense [6000.RAD1.DA3.A0308]	Military Infectious Diseases Research Program of the United States Department of Defense	Funding was provided by the Military Infectious Diseases Research Program of the United States Department of Defense (Work Unit:6000.RAD1.DA3.A0308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam TA, 1998, MUSCLE NERVE, V21, P1275, DOI 10.1002/(SICI)1097-4598(199810)21:10<1275::AID-MUS5>3.0.CO;2-8; Allos BM, 1998, INFECT DIS CLIN N AM, V12, P173, DOI 10.1016/S0891-5520(05)70416-5; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; ASPINALL GO, 1994, INFECT IMMUN, V62, P2122, DOI 10.1128/IAI.62.5.2122-2125.1994; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Bushra JS, 2000, J EMERG MED, V18, P427, DOI 10.1016/S0736-4679(00)00158-X; *CYT SOFTW CORP, 1998, STATXACT 4 US MAN; DEJAGER AEJ, 1991, J NEUROL SCI, V104, P143, DOI 10.1016/0022-510X(91)90303-O; FUJIMOTO S, 1992, J INFECT DIS, V165, P183, DOI 10.1093/infdis/165.1.183; Geleijns K, 2005, NEUROLOGY, V64, P44, DOI 10.1212/01.WNL.0000148727.02732.01; Goddard EA, 1997, ARCH DIS CHILD, V76, P526, DOI 10.1136/adc.76.6.526; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; KUROKI S, 1993, ANN NEUROL, V33, P243, DOI 10.1002/ana.410330304; Lastovica AJ, 1997, J INFECT DIS, V176, pS139, DOI 10.1086/513796; LIOR H, 1982, J CLIN MICROBIOL, V15, P761, DOI 10.1128/JCM.15.5.761-768.1982; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Nachamkin I, 1997, J INFECT DIS, V176, pS106, DOI 10.1086/513789; PAZZAGLIA G, 1993, J DIARRHOEAL DIS RES, V11, P6; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; RANTALA H, 1991, ARCH DIS CHILD, V66, P706, DOI 10.1136/adc.66.6.706; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371; Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359; Walz SE, 2001, AM J TROP MED HYG, V65, P652, DOI 10.4269/ajtmh.2001.65.652; Wierzba TF, 2006, AM J TROP MED HYG, V74, P148, DOI 10.4269/ajtmh.2006.74.148; Willison HJ, 1999, EUR J NEUROL, V6, P71, DOI 10.1046/j.1468-1331.1999.610071.x; Yuki N, 2007, J PERIPHER NERV SYST, V12, P238, DOI 10.1111/j.1529-8027.2007.00153.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3674	10.1371/journal.pone.0003674	http://dx.doi.org/10.1371/journal.pone.0003674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002255	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166000001
J	Durand, PM; Naidoo, K; Coetzer, TL				Durand, Pierre M.; Naidoo, Kubendran; Coetzer, Theresa L.			Evolutionary Patterning: A Novel Approach to the Identification of Potential Drug Target Sites in Plasmodium falciparum	PLOS ONE			English	Article							AMINO-ACID SITES; COLI GLYCEROL KINASE; ESCHERICHIA-COLI; PURIFYING SELECTION; POSITIVE SELECTION; TRYPANOSOMA-BRUCEI; MALARIA PARASITES; BINDING SURFACES; SEQUENCE; AQUAGLYCEROPORIN	Malaria continues to be the most lethal protozoan disease of humans. Drug development programs exhibit a high attrition rate and parasite resistance to chemotherapeutic drugs exacerbates the problem. Strategies that limit the development of resistance and minimize host side-effects are therefore of major importance. In this study, a novel approach, termed evolutionary patterning (EP), was used to identify suitable drug target sites that would minimize the emergence of parasite resistance. EP uses the ratio of non-synonymous to synonymous substitutions (omega) to assess the patterns of evolutionary change at individual codons in a gene and to identify codons under the most intense purifying selection (omega <= 0.1). The extreme evolutionary pressure to maintain these residues implies that resistance mutations are highly unlikely to develop, which makes them attractive chemotherapeutic targets. Method validation included a demonstration that none of the residues providing pyrimethamine resistance in the Plasmodium falciparum dihydrofolate reductase enzyme were under extreme purifying selection. To illustrate the EP approach, the putative P. falciparum glycerol kinase (PfGK) was used as an example. The gene was cloned and the recombinant protein was active in vitro, verifying the database annotation. Parasite and human GK gene sequences were analyzed separately as part of protozoan and metazoan clades, respectively, and key differences in the evolutionary patterns of the two molecules were identified. Potential drug target sites containing residues under extreme evolutionary constraints were selected. Structural modeling was used to evaluate the functional importance and drug accessibility of these sites, which narrowed down the number of candidates. The strategy of evolutionary patterning and refinement with structural modeling addresses the problem of targeting sites to minimize the development of drug resistance. This represents a significant advance for drug discovery programs in malaria and other infectious diseases.	[Durand, Pierre M.; Naidoo, Kubendran; Coetzer, Theresa L.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa	University of Witwatersrand	Durand, PM (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	pierre.durand@wits.ac.za		Durand, Pierre M./0000-0002-9614-1371	National Research Foundation [GUN 2069449]; National Health Laboratory Service Research Trust; University of the Witwatersrand Endowment Fund; National Bioinformatics Network Travel Fund	National Research Foundation; National Health Laboratory Service Research Trust; University of the Witwatersrand Endowment Fund; National Bioinformatics Network Travel Fund	National Research Foundation (SA) GUN 2069449, National Health Laboratory Service Research Trust, University of the Witwatersrand Endowment Fund, National Bioinformatics Network Travel Fund	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CREAVIN T, 2004, DRUG DISCOV TODAY, V3, P178; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; Furlong RF, 2008, J MOL EVOL, V66, P384, DOI 10.1007/s00239-008-9092-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Ho CK, 2001, J BIOL CHEM, V276, P46182, DOI 10.1074/jbc.M108706200; Holbrook JD, 2007, DRUG DISCOV TODAY, V12, P826, DOI 10.1016/j.drudis.2007.08.015; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; INA Y, 1995, J MOL EVOL, V40, P190, DOI 10.1007/BF00167113; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 2002, CURR OPIN STRUC BIOL, V12, P21, DOI 10.1016/S0959-440X(02)00284-1; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LJUNGSTROM I, 2004, MR4ATCC; Agosto JAM, 2006, MOL GENET METAB, V88, P334, DOI 10.1016/j.ymgme.2006.01.002; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PETTIGREW DW, 1990, BIOCHEMISTRY-US, V29, P8620, DOI 10.1021/bi00489a018; Philippe H, 2001, TRENDS BIOCHEM SCI, V26, P414, DOI 10.1016/S0968-0004(01)01877-1; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Searls DB, 2003, NAT REV DRUG DISCOV, V2, P613, DOI 10.1038/nrd1152; SELTZER WK, 1986, LIFE SCI, V39, P1417, DOI 10.1016/0024-3205(86)90545-X; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thomas MA, 2003, MOL BIOL EVOL, V20, P964, DOI 10.1093/molbev/msg110; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	70	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3685	10.1371/journal.pone.0003685	http://dx.doi.org/10.1371/journal.pone.0003685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997863	gold, Green Submitted, Green Published			2022-12-27	WOS:000265165500008
J	Kamath, AT; Rochat, AF; Valenti, MP; Agger, EM; Lingnau, K; Andersen, P; Lambert, PH; Siegrist, CA				Kamath, Arun T.; Rochat, Anne-Francoise; Valenti, Mario P.; Agger, Else Marie; Lingnau, Karen; Andersen, Peter; Lambert, Paul-Henri; Siegrist, Claire-Anne			Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31 (R) Adjuvant	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; EARLY-LIFE; IMMUNE-RESPONSES; CPG OLIGODEOXYNUCLEOTIDES; VACCINE ANTIGENS; INNATE IMMUNITY; TUBERCULOSIS; SYSTEM; MYCOBACTERIAL; INFECTIONS	Background: With the exception of some live vaccines, e. g. BCG, subunit vaccines formulated with "classical" adjuvants do not induce similar responses in neonates as in adults. The usual neonatal profile is characterized by lower levels of TH1-associated biomarkers. This has hampered the development of new neonatal vaccines for diseases that require early protection. Tuberculosis is one of the major targets for neonatal immunization. In this study, we assessed the immunogenicity of a novel candidate vaccine comprising a mycobacterial fusion protein, Ag85B-ESAT-6, in a neonatal murine immunization model. Methods/Findings: The Ag85B-ESAT-6 fusion protein was formulated either with a classical alum based adjuvant or with the novel IC31 (R) adjuvant. Following neonatal or adult immunization, 3 parameters were studied in vivo: (1) CD4(+) T cell responses, (2) vaccine targeting/activation of dendritic cells (DC) and (3) protection in a surrogate mycobacterial challenge model. Conversely to Alum, IC31 (R) induced in both age groups strong Th1 and Th17 responses, characterized by multifunctional T cells expressing IL-2 and TNF-alpha with or without IFN-gamma. In the draining lymph nodes, a similarly small number of DC contained the adjuvant and/or the antigen following neonatal or adult immunization. Expression of CD40, CD80, CD86 and IL-12p40 production was focused on the minute adjuvant-bearing DC population. Again, DC targeting/activation was similar in adults and neonates. These DC/T cell responses resulted in an equivalent reduction of bacterial growth following infection with M. bovis BCG, whereas no protection was observed when Alum was used as adjuvant. Conclusion: Neonatal immunization with the IC31 (R)- adjuvanted Ag85B-ESAT-6 subunit vaccine elicited adult-like multifunctional protective anti-mycobacterial T cell responses through the induction of an adult pattern of in vivo DC activation.	[Kamath, Arun T.; Rochat, Anne-Francoise; Valenti, Mario P.; Lambert, Paul-Henri; Siegrist, Claire-Anne] Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland; [Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Lingnau, Karen] Intercell AG, Vienna, Austria	University of Geneva; World Health Organization; Statens Serum Institut; Intercell	Kamath, AT (corresponding author), Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland.	Claire-Anne.Siegrist@unige.ch		Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Swiss Office Federal of Education and Sciences (OFES)	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Office Federal of Education and Sciences (OFES)	This study was funded by the European Commission (contract no. LSHP-CT-2003-503367) and the Swiss Office Federal of Education and Sciences (OFES).	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Barrios C, 1996, EUR J IMMUNOL, V26, P2666, DOI 10.1002/eji.1830261118; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Jong R, 1998, SCIENCE, V280, P1435; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; GILLIS S, 1978, J IMMUNOL, V120, P2027; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Ito S, 2005, J IMMUNOL, V174, P777, DOI 10.4049/jimmunol.174.2.777; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; KNUF M, 2008, J PEDIAT, V152, P660; KNUF M, 2008, J PEDIAT, V152, pE651; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; Kovarik J, 2000, VIROLOGY, V268, P122, DOI 10.1006/viro.1999.0159; Kovarik J, 2001, IMMUNOLOGY, V102, P67, DOI 10.1046/j.1365-2567.2001.01158.x; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mandalakas Anna M, 2005, Semin Pediatr Infect Dis, V16, P93, DOI 10.1053/j.spid.2005.01.001; Martinez X, 2003, VIROLOGY, V305, P428, DOI 10.1006/viro.2002.1775; Miles DJC, 2008, CLIN VACCINE IMMUNOL, V15, P995, DOI 10.1128/CVI.00037-08; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Regner M, 2004, J IMMUNOL, V173, P2669, DOI 10.4049/jimmunol.173.4.2669; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Riedl K, 2008, VACCINE, V26, P3461, DOI 10.1016/j.vaccine.2008.04.029; Roduit C, 2002, INFECT IMMUN, V70, P3521, DOI 10.1128/IAI.70.7.3521-3528.2002; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	47	58	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3683	10.1371/journal.pone.0003683	http://dx.doi.org/10.1371/journal.pone.0003683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997860	Green Submitted, Green Published, gold			2022-12-27	WOS:000265165500006
J	Widmann, T; Sester, U; Gartner, BC; Schubert, J; Pfreundschuh, M; Kohler, H; Sester, M				Widmann, Thomas; Sester, Urban; Gaertner, Barbara C.; Schubert, Joerg; Pfreundschuh, Michael; Koehler, Hans; Sester, Martina			Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article								Cytomegalovirus (CMV) infection is the most frequent viral complication in patients after allogeneic stem cell transplantation. As CMV replication is tightly controlled by the cellular arm of specific immunity, the kinetics of CMV-specific T cells in association with individual reactivation episodes were prospectively analyzed in 40 allogeneic transplant recipients in a routine clinical setting and evaluated as determinant of impaired CMV control. Antigen-specific CD4 and CD8 T cells were quantified directly from whole blood using intracellular cytokine staining after specific stimulation and MHC class I multimers, respectively. Highly dynamic intraindividual changes of CMV-specific CD4 T cells were observed in patients experiencing CMV viremia. Episodes of CMV reactivation were associated with a drop of CMV-specific CD4 T cells that reincreased after viral clearance (p < 0.0001). Furthermore, levels of CMV-specific CD4 T cells at the onset of viremia inversely correlated with peak viral load thereafter (p = 0.02). In contrast, CMV-peptide specific CD8 T cells did not show any association with viremia (p = 0.82). Interestingly, therapeutic dosages of cyclosporine A and corticosteroids led to a dose-dependent reduction of CMV-specific T-cell functions, indicating a causal link between intensified immunosuppressive treatment and CMV reactivation. In conclusion, levels of CMV-specific CD4 T cells inversely correlate with reactivation episodes and may represent a valuable measure to individually guide antiviral therapy after stem cell transplantation.	[Widmann, Thomas; Schubert, Joerg; Pfreundschuh, Michael] Univ Clin Saarland, Dept Internal Med 1, Homburg, Germany; [Sester, Urban; Koehler, Hans; Sester, Martina] Univ Clin Saarland, Dept Internal Med IV, Homburg, Germany; [Gaertner, Barbara C.] Univ Clin Saarland, Dept Virol, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Widmann, T (corresponding author), Univ Clin Saarland, Dept Internal Med 1, Homburg, Germany.	martina.sester@uks.eu	Sester, Martina/AAA-3383-2022	Sester, Martina/0000-0001-5482-0002; Sester, Urban/0000-0003-4007-5595	Deutsche Jose Carreras Leukamie Stiftung; HOMFOR	Deutsche Jose Carreras Leukamie Stiftung; HOMFOR	Financial support was given by the Deutsche Jose Carreras Leukamie Stiftung e.V. and HOMFOR to M.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Avetisyan G, 2007, BONE MARROW TRANSPL, V40, P865, DOI 10.1038/sj.bmt.1705825; Avetisyan G, 2006, BONE MARROW TRANSPL, V38, P687, DOI 10.1038/sj.bmt.1705507; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Boeckh M, 1996, BLOOD, V88, P4063, DOI 10.1182/blood.V88.10.4063.bloodjournal88104063; Breinig T, 2006, METHODS, V38, P77, DOI 10.1016/j.ymeth.2005.09.016; Einsele H, 2004, HUM IMMUNOL, V65, P558, DOI 10.1016/j.humimm.2004.02.003; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Foster AE, 2002, BIOL BLOOD MARROW TR, V8, P501, DOI 10.1053/bbmt.2002.v8.pm12374455; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Ganepola S, 2007, BONE MARROW TRANSPL, V39, P293, DOI 10.1038/sj.bmt.1705585; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hebart H, 2002, BLOOD, V99, P3830, DOI 10.1182/blood.V99.10.3830; Hebart H, 2004, HUM IMMUNOL, V65, P432, DOI 10.1016/j.humimm.2004.02.022; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Lilleri D, 2008, HAEMATOLOGICA, V93, P248, DOI 10.3324/haematol.11912; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Ljungman P, 2007, BEST PRACT RES CL HA, V20, P209, DOI 10.1016/j.beha.2006.09.003; Micklethwaite K, 2007, BIOL BLOOD MARROW TR, V13, P707, DOI 10.1016/j.bbmt.2007.02.004; Nicholson VA, 1997, BONE MARROW TRANSPL, V19, P37, DOI 10.1038/sj.bmt.1700612; Ozdemir E, 2002, BLOOD, V100, P3690, DOI 10.1182/blood-2002-05-1387; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1992, SCIENCE, V257, P238; Sester M, 2003, TRANSPLANTATION, V76, P1229, DOI 10.1097/01.TP.0000083894.61333.56; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sester U, 2005, AM J TRANSPLANT, V5, P1483, DOI 10.1111/j.1600-6143.2005.00871.x; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603	32	68	71	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3634	10.1371/journal.pone.0003634	http://dx.doi.org/10.1371/journal.pone.0003634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982061	Green Published, gold			2022-12-27	WOS:000265134300004
J	Vanengelsdorp, D; Hayes, J; Underwood, RM; Pettis, J				vanEngelsdorp, Dennis; Hayes, Jerry, Jr.; Underwood, Robyn M.; Pettis, Jeffery			A Survey of Honey Bee Colony Losses in the US, Fall 2007 to Spring 2008	PLOS ONE			English	Article								Background: Honey bees are an essential component of modern agriculture. A recently recognized ailment, Colony Collapse Disorder (CCD), devastates colonies, leaving hives with a complete lack of bees, dead or alive. Up to now, estimates of honey bee population decline have not included losses occurring during the wintering period, thus underestimating actual colony mortality. Our survey quantifies the extent of colony losses in the United States over the winter of 2007-2008. Methodology/Principal Findings: Surveys were conducted to quantify and identify management factors (e. g. operation size, hive migration) that contribute to high colony losses in general and CCD symptoms in particular. Over 19% of the country's estimated 2.44 million colonies were surveyed. A total loss of 35.8% of colonies was recorded; an increase of 11.4% compared to last year. Operations that pollinated almonds lost, on average, the same number of colonies as those that did not. The 37.9% of operations that reported having at least some of their colonies die with a complete lack of bees had a total loss of 40.8% of colonies compared to the 17.1% loss reported by beekeepers without this symptom. Large operations were more likely to have this symptom suggesting that a contagious condition may be a causal factor. Sixty percent of all colonies that were reported dead in this survey died without dead bees, and thus possibly suffered from CCD. In PA, losses varied with region, indicating that ambient temperature over winter may be an important factor. Conclusions/Significance: Of utmost importance to understanding the recent losses and CCD is keeping track of losses over time and on a large geographic scale. Given that our surveys are representative of the losses across all beekeeping operations, between 0.75 and 1.00 million honey bee colonies are estimated to have died in the United States over the winter of 2007-2008. This article is an extensive survey of U. S. beekeepers across the continent, serving as a reference for comparison with future losses as well as providing guidance to future hypothesis-driven research on the causes of colony mortality.	Bur Plant Ind Apiculture, Penn Dept Agr, Harrisburg, PA USA; [vanEngelsdorp, Dennis; Underwood, Robyn M.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hayes, Jerry, Jr.] Florida State Dept Agr, Bur Plant & Apiary Inspect, Div Plant Ind, Apiary Inspect Sect, Gainesville, FL USA; [Pettis, Jeffery] USDA, ARS Bee Res Lab, Beltsville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Vanengelsdorp, D (corresponding author), Bur Plant Ind Apiculture, Penn Dept Agr, Harrisburg, PA USA.	dennis.vanengelsdorp@gmail.com	vanEngelsdorp, Dennis/E-7934-2010		Pennsylvania and Florida Departments of Agriculture; United States Department of Agriculture - Ag. Research Station in Beltsville, MD	Pennsylvania and Florida Departments of Agriculture; United States Department of Agriculture - Ag. Research Station in Beltsville, MD	Funding was provided by the Pennsylvania and Florida Departments of Agriculture and United States Department of Agriculture - Ag. Research Station in Beltsville, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey L., 1991, HONEY BEE PATHOLOGY; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Downey DL, 2001, APIDOLOGIE, V32, P567, DOI 10.1051/apido:2001144; GALLAI N, 2008, ECOL EC IN PRESS; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; *NAT AGR STAT SERV, 2008, HON; *NAT RES COUNC, 2006, STAT POLL N AM; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Paoli B., 2002, CONFIDENCE INTERVALS; Pernal S, 2008, CAPA STATEMENT HONEY; Vanengelsdorp D, 2007, AM BEE J, V147, P599	15	391	411	5	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4071	10.1371/journal.pone.0004071	http://dx.doi.org/10.1371/journal.pone.0004071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115015	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466300011
J	D'Agata, EMC; Dupont-Rouzeyrol, M; Magal, P; Olivier, D; Ruan, S				D'Agata, Erika M. C.; Dupont-Rouzeyrol, Myrielle; Magal, Pierre; Olivier, Damien; Ruan, Shigui			The Impact of Different Antibiotic Regimens on the Emergence of Antimicrobial-Resistant Bacteria	PLOS ONE			English	Article								Backgroud: The emergence and ongoing spread of antimicrobial-resistant bacteria is a major public health threat. Infections caused by antimicrobial-resistant bacteria are associated with substantially higher rates of morbidity and mortality compared to infections caused by antimicrobial-susceptible bacteria. The emergence and spread of these bacteria is complex and requires incorporating numerous interrelated factors which clinical studies cannot adequately address. Methods/Principal Findings: A model is created which incorporates several key factors contributing to the emergence and spread of resistant bacteria including the effects of the immune system, acquisition of resistance genes and antimicrobial exposure. The model identifies key strategies which would limit the emergence of antimicrobial-resistant bacterial strains. Specifically, the simulations show that early initiation of antimicrobial therapy and combination therapy with two antibiotics prevents the emergence of resistant bacteria, whereas shorter courses of therapy and sequential administration of antibiotics promote the emergence of resistant strains. Conclusions/Significance: The principal findings suggest that (i) shorter lengths of antibiotic therapy and early interruption of antibiotic therapy provide an advantage for the resistant strains, (ii) combination therapy with two antibiotics prevents the emergence of resistance strains in contrast to sequential antibiotic therapy, and (iii) early initiation of antibiotics is among the most important factors preventing the emergence of resistant strains. These findings provide new insights into strategies aimed at optimizing the administration of antimicrobials for the treatment of infections and the prevention of the emergence of antimicrobial resistance.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA; [Dupont-Rouzeyrol, Myrielle] Univ Havre, Lab Ecotoxicol Milieux Aquatiques, Le Havre, France; [Magal, Pierre] Univ Havre, Lab Math Appl, Le Havre, France; [Olivier, Damien] Univ Havre, Lab Informat Traitement Informat Syst, Le Havre, France; [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universite Le Havre Normandie; Universite Le Havre Normandie; Universite Le Havre Normandie; University of Miami	D'Agata, EMC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA.	ruan@math.miami.edu	Dupont, Myrielle/GZH-2138-2022; Ruan, Shigui/AAF-9165-2020	Ruan, Shigui/0000-0002-6348-8205; magal, pierre/0000-0002-4776-0061	DMS/NIGMS Initiative through the National Institute of Health (NIH) [R01GM083607]; National Science Foundation (NSF) [DMS-0715772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	DMS/NIGMS Initiative through the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the joint DMS/NIGMS Initiative through the National Institute of Health (NIH) grant R01GM083607 (E.M.C.D., S.R.) and the National Science Foundation (NSF) grant DMS-0715772 (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Bahl ML, 2004, FEMS MICROBIOL LETT, V232, P45, DOI 10.1016/S0378-1097(04)00015-1; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Boldin B, 2007, B MATH BIOL, V69, P2227, DOI 10.1007/s11538-007-9205-1; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; *CONS REX, 2007, PLOS ONE, V2, pE1275, DOI DOI 10.1371/JOURNAL.PONE.0001275; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Daxboeck F, 2006, J HOSP INFECT, V62, P214, DOI 10.1016/j.jhin.2005.07.009; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Forum on Emerging Infections Institute of Medicine, 1998, ANT RES ISS OPT; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Haneda T, 2004, PLASMID, V52, P218, DOI 10.1016/j.plasmid.2004.07.002; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Imran M, 2007, DISCRETE CONT DYN-B, V8, P127; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lenski R E, 1998, Int Microbiol, V1, P265; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LIPSITCH M, 2002, INFECT CONTROL ICU E, P1; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; NORDSTROM K, 1984, MOL GEN GENET, V197, P1, DOI 10.1007/BF00327915; Pilyugin SS, 2000, B MATH BIOL, V62, P869, DOI 10.1006/bulm.2000.0181; POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995; Reluga TC, 2005, MATH MED BIOL, V22, P187, DOI 10.1093/imammb/dqi002; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Smets BF, 2005, NAT REV MICROBIOL, V3, P675, DOI 10.1038/nrmicro1253; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorensen TL, 2001, NEW ENGL J MED, V345, P1161, DOI 10.1056/NEJMoa010692; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Temime L, 2008, EPIDEMIOL INFECT, V136, P289, DOI 10.1017/S0950268807009442; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh TR, 2005, CLIN MICROBIOL INFEC, V11, P2, DOI 10.1111/j.1469-0691.2005.01264.x; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102	50	73	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4036	10.1371/journal.pone.0004036	http://dx.doi.org/10.1371/journal.pone.0004036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112501	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000006
J	Grieve, IC; Dickens, NJ; Pravenec, M; Kren, V; Hubner, N; Cook, SA; Aitman, TJ; Petretto, E; Mangion, J				Grieve, Ian C.; Dickens, Nicholas J.; Pravenec, Michal; Kren, Vladimir; Hubner, Norbert; Cook, Stuart A.; Aitman, Timothy J.; Petretto, Enrico; Mangion, Jonathan			Genome-Wide Co-Expression Analysis in Multiple Tissues	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEGREGATING MOUSE-POPULATION; GENE-EXPRESSION; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; BLOOD-PRESSURE; IDENTIFICATION; NETWORK; MICE; DISCOVERY	Expression quantitative trait loci (eQTLs) represent genetic control points of gene expression, and can be categorized as cis- and trans-acting, reflecting local and distant regulation of gene expression respectively. Although there is evidence of co-regulation within clusters of trans-eQTLs, the extent of co-expression patterns and their relationship with the genotypes at eQTLs are not fully understood. We have mapped thousands of cis- and trans-eQTLs in four tissues ( fat, kidney, adrenal and left ventricle) in a large panel of rat recombinant inbred ( RI) strains. Here we investigate the genome-wide correlation structure in expression levels of eQTL transcripts and underlying genotypes to elucidate the nature of co-regulation within cis- and trans-eQTL datasets. Across the four tissues, we consistently found statistically significant correlations of cis-regulated gene expression to be rare (<0.9% of all pairs tested). Most (>80%) of the observed significant correlations of cis-regulated gene expression are explained by correlation of the underlying genotypes. In comparison, co-expression of transregulated gene expression is more common, with significant correlation ranging from 2.9%-14.9% of all pairs of trans-eQTL transcripts. We observed a total of 81 trans-eQTL clusters (hot-spots), defined as consisting of >= 10 eQTLs linked to a common region, with very high levels of correlation between trans-regulated transcripts (77.2-90.2%). Moreover, functional analysis of large trans-eQTL clusters (>= 30 eQTLs) revealed significant functional enrichment among genes comprising 80% of the large clusters. The results of this genome-wide co-expression study show the effects of the eQTL genotypes on the observed patterns of correlation, and suggest that functional relatedness between genes underlying trans-eQTLs is reflected in the degree of co-expression observed in trans-eQTL clusters. Our results demonstrate the power of an integrative, systematic approach to the analysis of a large gene expression dataset to uncover underlying structure, and inform future eQTL studies.	[Grieve, Ian C.; Dickens, Nicholas J.; Cook, Stuart A.; Aitman, Timothy J.; Petretto, Enrico; Mangion, Jonathan] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London, England; [Dickens, Nicholas J.] Inst Canc Res, Sutton, Surrey, England; [Pravenec, Michal; Kren, Vladimir] Charles Univ Prague, First Fac Med & Gen Teaching Hosp, Inst Biol & Med Genet, Prague, Czech Republic; [Pravenec, Michal; Kren, Vladimir] Czech Acad Sci, Inst Physiol, Prague, Czech Republic; [Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Cook, Stuart A.] Univ London Imperial Coll, Natl Heart & Lung Inst, London, England; [Petretto, Enrico] Univ London Imperial Coll, Div Epidemiol, London, England	Imperial College London; University of London; Institute of Cancer Research - UK; Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; Imperial College London	Grieve, IC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London, England.	enrico.petretto@imperial.ac.uk	Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Dickens, Nicholas/G-1445-2013	Pravenec, Michal/0000-0001-9197-5871; Dickens, Nicholas/0000-0003-0492-5855; Cook, Stuart/0000-0001-6628-194X; Aitman, Timothy/0000-0002-7875-4502	Wellcome Trust [069962/Z/02/Z]; Medical Research Council Clinical Sciences Centre; Wellcome Trust Cardiovascular Functional Genomics award; Fondation Leducq; Medical Research Council; Department of Health UK; British Heart Foundation; German Ministry of Science and Education (BMBF/NGFN); Grant Agency of the Czech Republic; Ministry of Education of the Czech Republic; Howard Hughes Medical Institute; EU-funded EURATools Integrated Project; Medical Research Council [MC_U120085815, MC_U120061454] Funding Source: researchfish; MRC [MC_U120061454, MC_U120085815] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council Clinical Sciences Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Cardiovascular Functional Genomics award(Wellcome Trust); Fondation Leducq(Leducq Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health UK; British Heart Foundation(British Heart Foundation); German Ministry of Science and Education (BMBF/NGFN)(Federal Ministry of Education & Research (BMBF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EU-funded EURATools Integrated Project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding to ICG from the Wellcome Trust (069962/Z/02/Z); to TJA from the Medical Research Council Clinical Sciences Centre, the Wellcome Trust Cardiovascular Functional Genomics award; to TJA and SAC from the Fondation Leducq; to EP, NJD, SAC and JM from the Medical Research Council; to SAC from The Department of Health UK and British Heart Foundation; to NH from the German Ministry of Science and Education (BMBF/NGFN); to MP from the Grant Agency of the Czech Republic; to MP and VK from the Ministry of Education of the Czech Republic; MP is an international research scholar of the Howard Hughes Medical Institute; and to NH, MP and TJA from the EU-funded EURATools Integrated Project. Sponsors/funders played no direct role in the design or conduct of this study.	Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; CHURCHILL GA, 1994, GENETICS, V138, P963; DAMERVAL C, 1994, GENETICS, V137, P289; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mueller M, 2006, BIOINFORMATICS, V22, P509, DOI 10.1093/bioinformatics/btk007; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Petretto E, 2006, MAMM GENOME, V17, P480, DOI 10.1007/s00335-005-0181-1; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Pravenec M, 2008, NAT GENET, V40, P952, DOI 10.1038/ng.164; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tu ZD, 2006, BIOINFORMATICS, V22, pE489, DOI 10.1093/bioinformatics/btl234; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; WU C, 2008, PLOS GENETICS, V4; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4033	10.1371/journal.pone.0004033	http://dx.doi.org/10.1371/journal.pone.0004033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112506	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000005
J	Schillaci, MA; Waitzkin, H; Sharmen, T; Romain, SJ				Schillaci, Michael A.; Waitzkin, Howard; Sharmen, Tom; Romain, Sandra J.			The Impact of Changing Medicaid Enrollments on New Mexico's Immunization Program	PLOS ONE			English	Article							MANAGED CARE; WELFARE-REFORM; COVERAGE; CHILDREN; QUALITY; INSURANCE; ACCESS	Background: Immunizations are an important component to pediatric primary care. New Mexico is a relatively poor and rural state which has sometimes struggled to achieve and maintain its childhood immunization rates. We evaluated New Mexico's immunization rates between 1996 and 2006. Specifically, we examined the increase in immunization rates between 2002 and 2004, and how this increase may have been associated with Medicaid enrollment levels, as opposed to changes in government policies concerning immunization practices. Methods and Findings: This study examines trends in childhood immunization coverage rates relative to Medicaid enrollment among those receiving Temporary Assistance for Needy Families (TANF) in New Mexico. Information on health policy changes and immunization coverage was obtained from state governmental sources and the National Immunization Survey. We found statistically significant correlations varying from 0.86 to 0.93 between immunization rates and Medicaid enrollment. Conclusions: New Mexico's improvement and subsequent deterioration in immunization rates corresponded with changing Medicaid coverage, rather than the state's efforts to change immunization practices. Maintaining high Medicaid enrollment levels may be important for achieving high childhood immunization levels.	Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada; [Waitzkin, Howard] Univ New Mexico, Dept Sociol & Family & Community Med, Albuquerque, NM 87131 USA; [Sharmen, Tom] New Mexico Dept Hlth, Office Community Assessment, Publ Hlth Div, N Valley Publ Hlth Office, Albuquerque, NM USA; [Romain, Sandra J.] Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of New Mexico; New Mexico Department of Health; University of Toronto; University Toronto Scarborough	Schillaci, MA (corresponding author), Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada.	schillaci@utsc.utoronto.ca; waitzkin@unm.edu			Agency for Healthcare Research and Quality [R01 HS09703]; New Mexico Department of Health [98/665.42.194]; Hospital of the University of New Mexico; Dedicated Health Research Funds of the University of New Mexico School of Medicine; University of Toronto; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New Mexico Department of Health; Hospital of the University of New Mexico; Dedicated Health Research Funds of the University of New Mexico School of Medicine; University of Toronto(University of Toronto); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Partial funding for our research was provided by the Agency for Healthcare Research and Quality (R01 HS09703), the New Mexico Department of Health (98/665.42.194) the Hospital of the University of New Mexico, the Dedicated Health Research Funds of the University of New Mexico School of Medicine, and the University of Toronto. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini EA, 2001, PEDIATRICS, V107, P1335, DOI 10.1542/peds.107.6.1335; [Anonymous], STAT SURV IMM COV US; Berman S, 2005, PEDIATRICS, V116, P1474, DOI 10.1542/peds.2005-0923; Burns Ilene Timko, 2005, J Fam Pract, V54, pS58; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P177; Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P108; Chavkin W, 2000, AM J PUBLIC HEALTH, V90, P900, DOI 10.2105/AJPH.90.6.900; ELLIS ER, 2006, MEDICAID ENROLLMENT; Fry AM, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e60; Hartley H, 2005, J HEALTH CARE POOR U, V16, P536, DOI 10.1353/hpu.2005.0051; Kirschke DL, 2004, ARCH PEDIAT ADOL MED, V158, P230, DOI 10.1001/archpedi.158.3.230; Kronebusch K, 2001, J HEALTH POLIT POLIC, V26, P1223, DOI 10.1215/03616878-26-6-1223; Raghunathan TE, 2003, J EDUC BEHAV STAT, V28, P1, DOI 10.3102/10769986028001001; Romero D, 2001, Matern Child Health J, V5, P199, DOI 10.1023/A:1011352118970; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; Santoli JM, 2004, PEDIATRICS, V113, P1959; Schillaci MA, 2004, ANN FAM MED, V2, P13, DOI 10.1370/afm.100; Smith RR, 2007, CIRCULATION, V116, P130; Szilagyi P G, 1998, J Public Health Manag Pract, V4, P67; Thompson JW, 2003, JAMA-J AM MED ASSOC, V290, P1486, DOI 10.1001/jama.290.11.1486; *U NM HLTH SCI CTR, NEW MEX IMM COAL; U.S. Department of Health and Human Services Administration for Children and Families Office of Family Assistance, TEMP ASS NEED FAM TA; *US BUR CENS, HLTH NUTR HLTH INS 2; *US BUR CENS, IND FAM POV LEV NUMB; Vivier PM, 2000, ARCH PEDIAT ADOL MED, V154, P1243, DOI 10.1001/archpedi.154.12.1243; Waitzkin H, 2008, HEALTH SERV RES, V43, P1325, DOI 10.1111/j.1475-6773.2008.00842.x; Weissman JS, 2008, J HEALTH CARE POOR U, V19, P307, DOI 10.1353/hpu.2008.0021; Wood D, 1994, J Health Care Poor Underserved, V5, P112	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3953	10.1371/journal.pone.0003953	http://dx.doi.org/10.1371/journal.pone.0003953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107189	Green Published, gold, Green Submitted			2022-12-27	WOS:000265463000002
J	Xue, XY; Sun, J; Zhang, QF; Wang, ZX; Huang, YF; Pan, WQ				Xue, Xiangyang; Sun, Jun; Zhang, Qingfeng; Wang, Zhangxun; Huang, Yufu; Pan, Weiqing			Identification and Characterization of Novel MicroRNAs from Schistosoma japonicum	PLOS ONE			English	Article							RT-PCR; RNA; EXPRESSION; GENE; MANSONI; QUANTIFICATION; BIOGENESIS; PATHWAYS	Background: Schistosomiasis japonica remains a major public health problem in China. Its pathogen, Schistosoma japonicum has a complex life cycle and a unique repertoire of genes expressed at different life cycle stages. Exploring schistosome gene regulation will yield the best prospects for new drug targets and vaccine candidates. MicroRNAs (miRNAs) are a highly conserved class of noncoding RNA that control many biological processes by sequence-specific inhibition of gene expression. Although a large number of miRNAs have been identified from plants to mammals, it remains no experimental proof whether schistosome exist miRNAs. Methodology and Results: We have identified novel miRNAs from Schistosoma japonicum by cloning and sequencing a small (18-26 nt) RNA cDNA library from the adult worms. Five novel miRNAs were identified from 227 cloned RNA sequences and verified by Northern blot. Alignments of the miRNAs with corresponding family members indicated that four of them belong to a metazoan miRNA family: let-7, miR-71, bantam and miR-125. The fifth potentially new (non conserved) miRNA appears to belong to a previously undescribed family in the genus Schistosome. The novel miRNAs were designated as sja-let-7, sja-miR-71, sja-bantam, sja-miR-125 and sja-miR-new1, respectively. Expression of sja-let-7, sja-miR-71 and sja-bantam were analyzed in six stages of the life cycle, i.e. egg, miracidium, sporocyst, cercaria, schistosomulum, and adult worm, by a modified stem-loop reverse transcribed polymerase chain reaction (RT-PCR) method developed in our laboratory. The expression patterns of these miRNAs were highly stage-specific. In particular, sja-miR-71 and sja-bantam expression reach their peaks in the cercaria stage and then drop quickly to the nadirs in the schistosomulum stage, following penetration of cercaria into a mammalian host. Conclusions: Authentic miRNAs were identified for the first time in S. japonicum, including a new schistosome family member. The different expression patterns of the novel miRNAs over the life stages of S. japonicum suggest that they may mediate important roles in Schistosome growth and development.	[Xue, Xiangyang; Sun, Jun; Zhang, Qingfeng; Wang, Zhangxun; Pan, Weiqing] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China; [Huang, Yufu; Pan, Weiqing] Second Milit Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China; [Xue, Xiangyang] Wenzhou Med Coll, Dept Microbiol, Wenzhou, Peoples R China	Tongji University; Naval Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China.	wqpan0912@yahoo.com.cn		Sun, Jun/0000-0003-0720-1879	National Basic Research Program (973 Program) in China [2007CB513100]	National Basic Research Program (973 Program) in China(National Basic Research Program of China)	This work is supported by grants from the National Basic Research Program (973 Program) in China (2007CB513100).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boyle JP, 2003, MOL BIOCHEM PARASIT, V128, P205, DOI 10.1016/S0166-6851(03)00078-1; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Kim VN, 2005, MOL CELLS, V19, P1; Krautz-Peterson G, 2008, EXP PARASITOL, V118, P122, DOI 10.1016/j.exppara.2007.06.013; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; TENNISWOOD MPR, 1982, PARASITOLOGY, V84, P253, DOI 10.1017/S0031182000044814; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	28	90	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4034	10.1371/journal.pone.0004034	http://dx.doi.org/10.1371/journal.pone.0004034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107204	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000025
J	Kidder, BL; Yang, J; Palmer, S				Kidder, Benjamin L.; Yang, Jim; Palmer, Stephen			Stat3 and c-Myc Genome-Wide Promoter Occupancy in Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; COREPRESSOR COMPLEX; BINDING-SITES; MOUSE; PLURIPOTENCY; ACTIVATION; TARGET	Embryonic stem ( ES) cell pluripotency is regulated in part by transcription factor (TF) pathways that maintain self-renewal and inhibit differentiation. Stat3 and c-Myc TFs are essential for maintaining mouse ES cell self-renewal. c-Myc, together with Oct4, Sox2, and Klf4, is a reprogramming factor. While previous studies have investigated core transcriptional circuitry in ES cells, other TF pathways that promote ES cell pluripotency have yet to be investigated. Therefore, to further understand ES cell transcriptional networks, we used genome-wide chromatin immunoprecipitation and microarray analysis (ChIP-chip) to map Stat3 and c-Myc binding targets in ES cells. Our results show that Stat3 and c-Myc occupy a significant number of genes whose expression is highly enriched in ES cells. By comparing Stat3 and c-Myc target genes with gene expression data from undifferentiated ES cells and embryoid bodies (EBs), we found that Stat3 binds active and inactive genes in ES cells, while c-Myc binds predominantly active genes. Moreover, the transcriptional states of Stat3 and c-Myc targets are correlated with co-occupancy of pluripotency-related TFs, polycomb group proteins, and active and repressive histone modifications. We also provide evidence that Stat3 targets are differentially expressed in ES cells following removal of LIF, where culture of ES cells in the absence of LIF resulted in downregulation of Stat3 target genes enriched in ES cells, and upregulation of lineage specific Stat3 target genes. Altogether, we reveal transcriptional targets of two key pluripotency-related genes in ES cells - Stat3 and c-Myc, thus providing further insight into the ES cell transcriptional network.	[Palmer, Stephen] EMD Serono Res Inst Inc, Rockland, MA USA; [Yang, Jim] EMD Serono Res Ctr, Billerica, MA USA	Merck KGaA; EMD Serono Inc.	Kidder, BL (corresponding author), EMD Serono Res Inst Inc, Rockland, MA USA.	benjamin.kidder@emdserono.com			EMD Serono Research Institute, Inc	EMD Serono Research Institute, Inc	Funding was provided by EMD Serono Research Institute, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; JIANG J, 2008, NAT CELL BIOL; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Rasmussen MD, 2003, PLANT PHYSIOL, V133, P510, DOI 10.1104/pp.103.024885; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	48	146	153	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3932	10.1371/journal.pone.0003932	http://dx.doi.org/10.1371/journal.pone.0003932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079543	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455900011
J	Spronk, S; Bosch, JL; Ryjewski, C; Rosenblum, J; Kaandorp, GC; White, JV; Hunink, MGM				Spronk, Sandra; Bosch, Johanna L.; Ryjewski, Constance; Rosenblum, Judith; Kaandorp, Guido C.; White, John V.; Hunink, M. G. Myriam			Cost-Effectiveness of New Cardiac and Vascular Rehabilitation Strategies for Patients with Coronary Artery Disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; AORTOILIAC OCCLUSIVE DISEASE; STENT PLACEMENT; MYOCARDIAL-INFARCTION; DECISION-MAKING; INTERMITTENT CLAUDICATION; LOWER-EXTREMITY; BYPASS GRAFTS; LIMB ISCHEMIA	Objective: Peripheral arterial disease (PAD) often hinders the cardiac rehabilitation program. The aim of this study was evaluating the relative cost-effectiveness of new rehabilitation strategies which include the diagnosis and treatment of PAD in patients with coronary artery disease (CAD) undergoing cardiac rehabilitation. Data Sources: Best-available evidence was retrieved from literature and combined with primary data from 231 patients. Methods: We developed a Markov decision model to compare the following treatment strategies: 1. cardiac rehabilitation only; 2. ankle-brachial index (ABI) if cardiac rehabilitation fails followed by diagnostic work-up and revascularization for PAD if needed; 3. ABI prior to cardiac rehabilitation followed by diagnostic work-up and revascularization for PAD if needed. Quality-adjusted-life years (QALYs), life-time costs (US $), incremental cost-effectiveness ratios (ICER), and gain in net health benefits (NHB) in QALY equivalents were calculated. A threshold willingness-to-pay of $ 75 000 was used. Results: ABI if cardiac rehabilitation fails was the most favorable strategy with an ICER of $ 44 251 per QALY gained and an incremental NHB compared to cardiac rehabilitation only of 0.03 QALYs (95% CI: -0.17, 0.29) at a threshold willingness-to-pay of $ 75 000/QALY. After sensitivity analysis, a combined cardiac and vascular rehabilitation program increased the success rate and would dominate the other two strategies with total lifetime costs of $ 30 246 a quality-adjusted life expectancy of 3.84 years, and an incremental NHB of 0.06 QALYs (95% CI: -0.24, 0.46) compared to current practice. The results were robust for other different input parameters. Conclusion: ABI measurement if cardiac rehabilitation fails followed by a diagnostic work-up and revascularization for PAD if needed are potentially cost-effective compared to cardiac rehabilitation only.	[Spronk, Sandra; Bosch, Johanna L.; Kaandorp, Guido C.; Hunink, M. G. Myriam] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Spronk, Sandra; Bosch, Johanna L.; Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ryjewski, Constance; Rosenblum, Judith; White, John V.] Advocate Lutheran Gen Hosp, Dept Surg, Chicago, IL USA; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; [White, John V.] Univ Illinois, Coll Med, Dept Surg, Chicago, IL 60680 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Spronk, S (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	s.spronk@erasmusmc.nl						Albers M, 2003, J VASC SURG, V37, P1263, DOI 10.1016/S0741-5214(02)75332-9; Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Bergqvist D, 1998, EUR J SURG, V164, P3; Bosch JL, 1999, CIRCULATION, V99, P3155, DOI 10.1161/01.CIR.99.24.3155; Bosch JL, 1998, RADIOLOGY, V208, P641, DOI 10.1148/radiology.208.3.9722840; Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Busschbach JJV, 1999, J HEALTH ECON, V18, P551, DOI 10.1016/S0167-6296(99)00008-9; Chang RW, 2008, J VASC SURG, V48, P362, DOI 10.1016/j.jvs.2008.03.042; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Conrad MF, 2006, J VASC SURG, V44, P762, DOI 10.1016/j.jvs.2006.06.025; Davidovic Lazar, 2004, Vascular, V12, P171; de Vries SO, 2002, RADIOLOGY, V222, P25, DOI 10.1148/radiol.2221001743; DeRubertis BG, 2007, ANN SURG, V246, P415, DOI 10.1097/SLA.0b013e31814699a2; Dugmore LD, 1999, HEART, V81, P359, DOI 10.1136/hrt.81.4.359; Evenson K R, 2000, J Cardiopulm Rehabil, V20, P241, DOI 10.1097/00008483-200007000-00005; FOWKES FGR, 1988, INT J EPIDEMIOL, V17, P248, DOI 10.1093/ije/17.2.248; Gentile AT, 1996, J VASC SURG, V23, P272, DOI 10.1016/S0741-5214(96)70271-9; Glasziou PP, 2001, DECISION MAKING HLTH; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Green RM, 2000, J VASC SURG, V31, P417, DOI 10.1016/S0741-5214(00)90300-8; HESSEL SJ, 1981, RADIOLOGY, V138, P273, DOI 10.1148/radiology.138.2.7455105; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; HUNINK MGM, 1995, JAMA-J AM MED ASSOC, V274, P165, DOI 10.1001/jama.274.2.165; HUNINK MGM, 1994, MED DECIS MAKING, V14, P71, DOI 10.1177/0272989X9401400109; Jansen RMG, 1998, J VASC SURG, V28, P617, DOI 10.1016/S0741-5214(98)70085-0; Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; MELNYK KAM, 1988, NURS RES, V37, P196; Morgan MBF, 2001, J VASC SURG, V33, P679, DOI 10.1067/mva.2001.112326; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; Murphy TP, 2004, RADIOLOGY, V231, P243, DOI 10.1148/radiol.2311030408; NorekvOl TM, 2006, EUR J CARDIOVASC NUR; Poredos P, 2007, ANGIOLOGY, V58, P309, DOI 10.1177/0003319707302494; Prager MR, 2003, SURGERY, V134, P80, DOI 10.1067/msy.2003.179; Reed AB, 2003, J VASC SURG, V37, P1219, DOI 10.1016/S0741-5214(02)75179-3; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Sanderson Bonnie K, 2004, J Cardiopulm Rehabil, V24, P68, DOI 10.1097/00008483-200403000-00002; Schanzer A, 2008, J VASC SURG, V47, P774, DOI 10.1016/j.jvs.2007.11.056; Schweikert B, 2006, HEART, V92, P62, DOI 10.1136/hrt.2004.052787; SCOTT EC, 2008, J VASC SURG; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; SMITH GD, 1990, CIRCULATION, V82, P1925, DOI 10.1161/01.CIR.82.6.1925; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SPRONK S, 2008, THESIS ERASMUS U ROT; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Tetteroo E, 1998, LANCET, V351, P1153, DOI 10.1016/S0140-6736(97)09508-1; TIRRELL BE, 1980, HEART LUNG, V9, P487; TSEVAT J, 1991, MED CARE, V29, P1153, DOI 10.1097/00005650-199111000-00007; WAUGH JR, 1992, RADIOLOGY, V182, P243, DOI 10.1148/radiology.182.1.1727290; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WITTELS EH, 1990, AM J CARDIOL, V65, P432, DOI 10.1016/0002-9149(90)90806-C; Yu CM, 2004, ARCH PHYS MED REHAB, V85, P1915, DOI 10.1016/j.apmr.2004.05.010; STAT BOL; STAT DNCFH	59	4	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3883	10.1371/journal.pone.0003883	http://dx.doi.org/10.1371/journal.pone.0003883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZP	19065259	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455200004
J	Roder, IV; Petersen, Y; Choi, KR; Witzemann, V; Hammer, JA; Rudolf, R				Roeder, Ira Verena; Petersen, Yvonne; Choi, Kyeong Rok; Witzemann, Veit; Hammer, John A., III; Rudolf, Ruediger			Role of Myosin Va in the Plasticity of the Vertebrate Neuromuscular Junction In Vivo	PLOS ONE			English	Article								Background: Myosin Va is a motor protein involved in vesicular transport and its absence leads to movement disorders in humans (Griscelli and Elejalde syndromes) and rodents (e. g. dilute lethal phenotype in mice). We examined the role of myosin Va in the postsynaptic plasticity of the vertebrate neuromuscular junction (NMJ). Methodology/Principal Findings: Dilute lethal mice showed a good correlation between the propensity for seizures, and fragmentation and size reduction of NMJs. In an aneural C2C12 myoblast cell culture, expression of a dominant-negative fragment of myosin Va led to the accumulation of punctate structures containing the NMJ marker protein, rapsyn-GFP, in perinuclear clusters. In mouse hindlimb muscle, endogenous myosin Va co-precipitated with surface-exposed or internalised acetylcholine receptors and was markedly enriched in close proximity to the NMJ upon immunofluorescence. In vivo microscopy of exogenous full length myosin Va as well as a cargo-binding fragment of myosin Va showed localisation to the NMJ in wildtype mouse muscles. Furthermore, local interference with myosin Va function in live wildtype mouse muscles led to fragmentation and size reduction of NMJs, exclusion of rapsyn-GFP from NMJs, reduced persistence of acetylcholine receptors in NMJs and an increased amount of punctate structures bearing internalised NMJ proteins. Conclusions/Significance: In summary, our data show a crucial role of myosin Va for the plasticity of live vertebrate neuromuscular junctions and suggest its involvement in the recycling of internalised acetylcholine receptors back to the postsynaptic membrane.	[Roeder, Ira Verena; Petersen, Yvonne; Choi, Kyeong Rok; Rudolf, Ruediger] Res Ctr Karlsruhe, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Witzemann, Veit] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Hammer, John A., III] NIH, Lab Cell Biol, Bethesda, MD USA	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; National Institutes of Health (NIH) - USA	Roder, IV (corresponding author), Res Ctr Karlsruhe, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	ruediger.rudolf@itg.fzk.de	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053	DFG [RU923/3-1]; AFM [12056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000514, ZIAHL000514] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); AFM(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	RR was supported by grants from the DFG (RU923/3-1) and AFM (# 12056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BERG DK, 1975, J PHYSIOL-LONDON, V252, P771, DOI 10.1113/jphysiol.1975.sp011169; BLOCH RJ, 1987, J CELL BIOL, V104, P645, DOI 10.1083/jcb.104.3.645; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FUMAGALLI G, 1990, NEURON, V4, P563, DOI 10.1016/0896-6273(90)90114-U; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; KENNEDY MJ, 2006, ANN REV NEUROSCI; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1967, NATURE, V215, P1177, DOI 10.1038/2151177a0; LEVITT TA, 1981, NATURE, V291, P239, DOI 10.1038/291239a0; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marchand S, 2002, J NEUROSCI, V22, P8891; Marchand S, 2002, MOL NEUROBIOL, V26, P117, DOI 10.1385/MN:26:1:117; Marchand S, 2000, J NEUROSCI, V20, P521, DOI 10.1523/JNEUROSCI.20-02-00521.2000; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER J, 1990, NATURE, V352, P547; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Rudolf R, 2003, NAT REV MOL CELL BIO, V4, P579, DOI 10.1038/nrm1153; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Sandona D, 2004, BIOCHEM J, V381, P105, DOI 10.1042/BJ20031644; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Santos AF, 2003, J NEUROCYTOL, V32, P849, DOI 10.1023/B:NEUR.0000020628.36013.88; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Slater CR, 1997, BRAIN, V120, P1513, DOI 10.1093/brain/120.9.1513; SMITH MM, 1987, J BIOL CHEM, V262, P4367; STEINBACH JH, 1989, ANNU REV PHYSIOL, V51, P353, DOI 10.1146/annurev.physiol.51.1.353; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Takagishi Y, 2007, DEV NEUROBIOL, V67, P909, DOI 10.1002/dneu.20375; Tothova J, 2006, J CELL SCI, V119, P1604, DOI 10.1242/jcs.02875; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; WEINBERG CB, 1981, J CELL BIOL, V88, P215, DOI 10.1083/jcb.88.1.215; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Xu RF, 1997, J NEUROSCI, V17, P8194; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014	60	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3871	10.1371/journal.pone.0003871	http://dx.doi.org/10.1371/journal.pone.0003871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057648	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452300009
J	Wang, CK; Schirra, HJ; Craik, DJ				Wang, Conan K.; Schirra, Horst Joachim; Craik, David J.			NMRDyn: A Program for NMR Relaxation Studies of Protein Association	PLOS ONE			English	Article								Self-association is an important biological phenomenon that is associated with many cellular processes. NMR relaxation measurements provide data about protein molecular dynamics at the atomic level and are sensitive to changes induced by self-association. Thus, measurements and analysis of NMR relaxation data can provide structurally resolved information on self-association that would not be accessible otherwise. Here, we present a computer program, NMRdyn, which analyses relaxation data to provide parameters defining protein self-association. Unlike existing relaxation analysis software, NMRdyn can explicitly model the monomer-oligomer equilibrium while fitting measured relaxation data. Additionally, the program is packaged with a user-friendly interface, which is important because relaxation data can often be large and complex. NMRdyn is available from http://research1t.imb.uq.edu.au/nmr/NMRdyn.	[Wang, Conan K.; Schirra, Horst Joachim; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Wang, CK (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.craik@imb.uq.edu.au	Wang, Conan K/D-1481-2010; Schirra, Horst Joachim/B-4210-2009; Craik, David/B-1695-2010	Wang, Conan K/0000-0002-7973-7632; Schirra, Horst Joachim/0000-0002-7541-246X; Craik, David/0000-0003-0007-6796	Australian Research Council	Australian Research Council(Australian Research Council)	Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; Bader R, 2001, J MOL BIOL, V305, P307, DOI 10.1006/jmbi.2000.4264; Bernado P, 2003, J AM CHEM SOC, V125, P916, DOI 10.1021/ja027836h; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; CRAIK DJ, 1983, J CHEM INF COMP SCI, V23, P30, DOI 10.1021/ci00037a006; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; McPhee F, 1996, P NATL ACAD SCI USA, V93, P11477, DOI 10.1073/pnas.93.21.11477; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WENNERSTROM H, 1972, MOL PHYS, V24, P69, DOI 10.1080/00268977200101261; WOESSNER DE, 1962, J CHEM PHYS, V37, P647, DOI 10.1063/1.1701390	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3820	10.1371/journal.pone.0003820	http://dx.doi.org/10.1371/journal.pone.0003820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043572	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451400011
J	Weissman, JR; Kelley, RI; Bauman, ML; Cohen, BH; Murray, KF; Mitchell, RL; Kern, RL; Natowicz, MR				Weissman, Jacqueline R.; Kelley, Richard I.; Bauman, Margaret L.; Cohen, Bruce H.; Murray, Katherine F.; Mitchell, Rebecca L.; Kern, Rebecca L.; Natowicz, Marvin R.			Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis	PLOS ONE			English	Article							RESPIRATORY-CHAIN DISORDERS; MTDNA MUTATIONS; GASTROINTESTINAL SYMPTOMS; DEVELOPMENTAL REGRESSION; DIAGNOSTIC-CRITERIA; DNA MUTATIONS; COMPLEX-I; DYSFUNCTION; PREVALENCE; CHILDREN	Background: Previous reports indicate an association between autism spectrum disorders (ASD) and disorders of mitochondrial oxidative phosphorylation. One study suggested that children with both diagnoses are clinically indistinguishable from children with idiopathic autism. There are, however, no detailed analyses of the clinical and laboratory findings in a large cohort of these children. Therefore, we undertook a comprehensive review of patients with ASD and a mitochondrial disorder. Methodology/Principal Findings: We reviewed medical records of 25 patients with a primary diagnosis of ASD by DSM-IV-TR criteria, later determined to have enzyme- or mutation-defined mitochondrial electron transport chain (ETC) dysfunction. Twenty-four of 25 patients had one or more major clinical abnormalities uncommon in idiopathic autism. Twenty-one patients had histories of significant non-neurological medical problems. Nineteen patients exhibited constitutional symptoms, especially excessive fatigability. Fifteen patients had abnormal neurological findings. Unusual developmental phenotypes included marked delay in early gross motor milestones (32%) and unusual patterns of regression (40%). Levels of blood lactate, plasma alanine, and serum ALT and/or AST were increased at least once in 76%, 36%, and 52% of patients, respectively. The most common ETC disorders were deficiencies of complex I (64%) and complex III (20%). Two patients had rare mtDNA mutations of likely pathogenicity. Conclusions/Significance: Although all patients' initial diagnosis was idiopathic autism, careful clinical and biochemical assessment identified clinical findings that differentiated them from children with idiopathic autism. These and prior data suggest a disturbance of mitochondrial energy production as an underlying pathophysiological mechanism in a subset of individuals with autism.	[Weissman, Jacqueline R.; Natowicz, Marvin R.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Kelley, Richard I.; Kern, Rebecca L.] Kennedy Krieger Inst, Division of Metabolism, Baltimore, MD USA; [Kelley, Richard I.; Kern, Rebecca L.] Johns Hopkins Univ, Med Ctr, Dept Pediat, Baltimore, MD 21218 USA; [Bauman, Margaret L.; Murray, Katherine F.] Massachusetts Gen Hosp, LADDERS, Dept Pediat, Boston, MA 02114 USA; [Cohen, Bruce H.; Natowicz, Marvin R.] Cleveland Clin, Pediatrics Inst, Neurol Inst, Cleveland, OH USA; [Mitchell, Rebecca L.; Natowicz, Marvin R.] Cleveland Clin, Genom Med Inst, Cleveland, OH USA; [Natowicz, Marvin R.] Cleveland Clin, Lab Med Inst, Cleveland, OH USA	Case Western Reserve University; Cleveland Clinic Foundation; Kennedy Krieger Institute; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Weissman, JR (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	natowim@ccf.org	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880; Bauman, Margaret/0000-0002-3229-0458	Solving the Mystery of Autism Foundation, Inc; Green Foundation	Solving the Mystery of Autism Foundation, Inc; Green Foundation	This work was supported in part by a grant from the Solving the Mystery of Autism Foundation, Inc. and from the Green Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; APA, 2000, DIAGN STAT MAN MENT; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Cavelier L, 2001, HEREDITAS, V135, P65, DOI 10.1111/j.1601-5223.2001.00065.x; COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dipchand AI, 2001, PEDIATR CARDIOL, V22, P14, DOI 10.1007/s002460010145; Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; Finnila Saara, 2001, Mutation Research, V458, P31, DOI 10.1016/S1383-5726(01)00012-7; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Hallmayer J, 2002, AM J HUM GENET, V71, P941, DOI 10.1086/342990; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Lombard J, 1998, MED HYPOTHESES, V50, P497, DOI 10.1016/S0306-9877(98)90270-5; Mackay N, 2007, METHOD CELL BIOL, V80, P173, DOI 10.1016/S0091-679X(06)80008-7; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; Ming X, 2008, J CHILD NEUROL, V23, P6, DOI 10.1177/0883073807307102; Ming X, 2007, BRAIN DEV-JPN, V29, P565, DOI 10.1016/j.braindev.2007.03.002; Molloy CA, 2003, AUTISM, V7, P165, DOI 10.1177/1362361303007002004; Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002; Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110; Offit PA, 2008, NEW ENGL J MED, V358, P2089, DOI 10.1056/NEJMp0802904; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401; Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rogers SJ, 2004, MENT RETARD DEV D R, V10, P139, DOI 10.1002/mrdd.20027; Rutter M., 2005, HDB AUTISM PERVASIVE, V1, P425; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Sugarman SD, 2007, NEW ENGL J MED, V357, P1275, DOI 10.1056/NEJMp078168; Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89; Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8; Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807; Wong LJC, 2002, CLIN CHEM, V48, P1901; Zankl A, 2003, AM J MED GENET A, V121A, P146, DOI 10.1002/ajmg.a.20185; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N	63	168	173	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3815	10.1371/journal.pone.0003815	http://dx.doi.org/10.1371/journal.pone.0003815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YG	19043581	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451400007
J	Petter, M; Bonow, I; Klinkert, MQ				Petter, Michaela; Bonow, Insa; Klinkert, Mo-Quen			Diverse Expression Patterns of Subgroups of the rif Multigene Family during Plasmodium falciparum Gametocytogenesis	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; TRANSMISSION STAGES; VARIANT PROTEINS; GENE-EXPRESSION; BONE-MARROW; START SITES; MALARIA; SEQUENCE; ADHESION; IDENTIFICATION	Background: The maturation of Plasmodium falciparum gametocytes in the human host takes several days, during which the parasites need to efficiently evade the host immune system. Like asexual stage parasites, immature gametocytes can sequester at various sites in the human body, and only mature sexual stages are found in the circulation. Although the fundamental mechanisms of gametocyte immune evasion are still largely unknown, candidate molecules that may be involved include variant antigens encoded by multigene families in the P. falciparum genome, such as the PfEMP1, STEVOR and RIFIN proteins. While expression of the former two families in sexual stages has been investigated earlier, we report here RIFIN expression during gametocytogenesis. Methodology/Principal Findings: Variants of two previously characterized RIFIN subfamilies (A-and B-type RIFINs) were found to be synthesized in gametocytes. Immunofluorescence experiments showed A-type RIFINs to be accumulated in a crescent-shaped pattern of discrete punctate structures at the infected erythrocyte membrane, while members of the B-type family were associated with the parasite. Transcription analysis demonstrated the existence of diverse transcriptional regulation patterns during sexual differentiation and indicated variant-specific regulation of B-type RIFINs, in contrast to group-specific regulation for A-type RIFINs. Phylogenetic analysis of 5'-upstream regions showed that the rif-gene family falls into five defined clusters, designated rups (rif upstream) A1, A2, AB, B and C. In trophozoites and early gametocytes, rif variants of the rupsA2-type were preferentially expressed. Conclusions/Significance: In this work we demonstrate the expression dynamics of the rif-gene family during sexual differentiation and present indications for subgroup specific regulation patterns. Therefore, our data provide a first foundation and point to new directions for future investigations of the potential role of RIFINs in gametocyte immune evasion.	[Petter, Michaela; Bonow, Insa; Klinkert, Mo-Quen] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Petter, M (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia.	mpetter@unimelb.edu.au	Petter, Michaela/N-9876-2017	Petter, Michaela/0000-0002-1837-2756	Friends of the Bernhard-Nocht Institute; Chica and Heinz Schaller Foundation	Friends of the Bernhard-Nocht Institute; Chica and Heinz Schaller Foundation	This work received funding from Friends of the Bernhard-Nocht Institute and the Chica and Heinz Schaller Foundation.	Abdel-Latif MS, 2003, INFECT IMMUN, V71, P6229, DOI 10.1128/IAI.71.11.6229-6233.2003; Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; ALANO P, 1991, MOL BIOCHEM PARASIT, V46, P81, DOI 10.1016/0166-6851(91)90201-G; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; BLYTHE JE, 2008, INFECT IMMUN; CARTER R, 1989, EXP PARASITOL, V69, P140, DOI 10.1016/0014-4894(89)90182-3; Carter R, 1979, Bull World Health Organ, V57 Suppl 1, P37; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Dzikowski R, 2006, CELL MICROBIOL, V8, P1371, DOI 10.1111/j.1462-5822.2006.00760.x; Eksi S, 2008, MOL BIOCHEM PARASIT, V160, P148, DOI 10.1016/j.molbiopara.2008.04.005; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; HELMBY H, 1993, INFECT IMMUN, V61, P284, DOI 10.1128/IAI.61.1.284-288.1993; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horrocks P, 1996, MOL BIOCHEM PARASIT, V82, P207, DOI 10.1016/0166-6851(96)02737-5; Horrocks P, 1999, MOL BIOCHEM PARASIT, V99, P77, DOI 10.1016/S0166-6851(98)00182-0; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Khattab A, 2006, TRAFFIC, V7, P1654, DOI 10.1111/j.1600-0854.2006.00494.x; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; KYES SA, 2007, EUKARYOT CELL; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lindenthal C, 2002, MOL BIOCHEM PARASIT, V120, P257, DOI 10.1016/S0166-6851(02)00007-5; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Militello KT, 2004, MOL BIOCHEM PARASIT, V134, P75, DOI 10.1016/j.molbiopara.2003.11.004; Olivieri A, 2008, INT J PARASITOL, V38, P299, DOI 10.1016/j.ijpara.2007.08.014; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Porter ME, 2002, MOL BIOCHEM PARASIT, V122, P9, DOI 10.1016/S0166-6851(02)00064-6; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Preiser PR, 2002, SCIENCE, V295, P342, DOI 10.1126/science.1064938; Rogers NJ, 1996, INFECT IMMUN, V64, P1480, DOI 10.1128/IAI.64.4.1480-1483.1996; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Rogers NJ, 1996, INFECT IMMUN, V64, P4261, DOI 10.1128/IAI.64.10.4261-4268.1996; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schreiber N, 2006, MICROBES INFECT, V8, P1269, DOI 10.1016/j.micinf.2005.12.007; Sharp S, 2006, EUKARYOT CELL, V5, P1206, DOI 10.1128/EC.00029-06; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; Sutherland CJ, 2001, MOL BIOCHEM PARASIT, V113, P331, DOI 10.1016/S0166-6851(01)00225-0; Tham WH, 2007, INT J PARASITOL, V37, P605, DOI 10.1016/j.ijpara.2006.11.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMSON J. G., 1935, TRANS ROY SOC TROP MED AND HYG, V29, P31, DOI 10.1016/S0035-9203(35)90015-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UHLEMANN AC, 2000, MACS MORE, V4, P7; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Watanabe J, 2002, GENE, V291, P105, DOI 10.1016/S0378-1119(02)00552-8; *WHO, 2005, WORLD MAL REP; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	68	50	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3779	10.1371/journal.pone.0003779	http://dx.doi.org/10.1371/journal.pone.0003779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020666	Green Published, gold			2022-12-27	WOS:000265448600012
J	Skogsberg, J; Dicker, A; Ryden, M; Astrom, G; Nilsson, R; Bhuiyan, H; Vitols, S; Mairal, A; Langin, D; Alberts, P; Walum, E; Tegner, J; Hamsten, A; Arner, P; Bjorkegren, J				Skogsberg, Josefin; Dicker, Andrea; Ryden, Mikael; Astrom, Gaby; Nilsson, Roland; Bhuiyan, Hasanuzzaman; Vitols, Sigurd; Mairal, Aline; Langin, Dominique; Alberts, Peteris; Walum, Erik; Tegner, Jesper; Hamsten, Anders; Arner, Peter; Bjorkegren, Johan			ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PROTEIN-KINASE-A; ADIPOSE-TISSUE; MICE; APOLIPOPROTEIN; ACTIVATION	Background: Free fatty acids released from adipose tissue affect the synthesis of apolipoprotein B-containing lipoproteins and glucose metabolism in the liver. Whether there also exists a reciprocal metabolic arm affecting energy metabolism in white adipose tissue is unknown. Methods and Findings: We investigated the effects of apoB-containing lipoproteins on catecholamine-induced lipolysis in adipocytes from subcutaneous fat cells of obese but otherwise healthy men, fat pads from mice with plasma lipoproteins containing high or intermediate levels of apoB100 or no apoB100, primary cultured adipocytes, and 3T3-L1 cells. In subcutaneous fat cells, the rate of lipolysis was inversely related to plasma apoB levels. In human primary adipocytes, LDL inhibited lipolysis in a concentration-dependent fashion. In contrast, VLDL had no effect. Lipolysis was increased in fat pads from mice lacking plasma apoB100, reduced in apoB100-only mice, and intermediate in wild-type mice. Mice lacking apoB100 also had higher oxygen consumption and lipid oxidation. In 3T3-L1 cells, apoB100-containing lipoproteins inhibited lipolysis in a dose-dependent fashion, but lipoproteins containing apoB48 had no effect. ApoB100-LDL mediated inhibition of lipolysis was abolished in fat pads of mice deficient in the LDL receptor ( Ldlr(-/-) Apob(100/100)). Conclusions: Our results show that the binding of apoB100-LDL to adipocytes via the LDL receptor inhibits intracellular noradrenaline-induced lipolysis in adipocytes. Thus, apoB100-LDL is a novel signaling molecule from the liver to peripheral fat deposits that may be an important link between atherogenic dyslipidemias and facets of the metabolic syndrome.	[Skogsberg, Josefin; Bjorkegren, Johan] Karolinska Univ Hosp, Karolinska Inst, Computat Med Grp, Stockholm, Sweden; [Dicker, Andrea; Ryden, Mikael; Astrom, Gaby; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Nilsson, Roland; Tegner, Jesper] Linkoping Univ, Dept Phys, Computat Biol Unit, S-58183 Linkoping, Sweden; [Bhuiyan, Hasanuzzaman; Vitols, Sigurd] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Clin Pharmacol, Stockholm, Sweden; [Mairal, Aline; Langin, Dominique] Inserm, U586, Obesity Res Unit, Toulouse, France; [Alberts, Peteris; Walum, Erik] Biovitrum AB, Stockholm, Sweden; [Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Swedish Orphan Biovitrum; Karolinska Institutet; Karolinska University Hospital	Skogsberg, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Computat Med Grp, Stockholm, Sweden.	josefin.skogsberg@ki.se	Nilsson, Roland/AAJ-3519-2021; tegner, jesper N/R-5095-2017; Alberts, Peteris/AAQ-6327-2021	tegner, jesper N/0000-0002-9568-5588; Alberts, Peteris/0000-0001-9585-9288; Langin, Dominique/0000-0002-2669-7825; Nilsson, Roland/0000-0002-6020-7498; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Diabetes Association; Swedish Heart-Lung Foundation; Novo Nordic Foundation; King Gustaf V and Queen Victoria Foundation; European Commission, 6th Framework Program [LSHM-CT-2005-01873]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); King Gustaf V and Queen Victoria Foundation; European Commission, 6th Framework Program(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council (P.Ar. and J.B.), the Swedish Diabetes Association (P.Ar.), the Swedish Heart-Lung Foundation (P.Ar., J.B., and A.H.), the Novo Nordic Foundation (P.Ar.) and the King Gustaf V and Queen Victoria Foundation (P.Ar., J.B.) and the European Commission, 6th Framework Program (contract LSHM-CT-2005-01873). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Arner P, 1997, CURR OPIN LIPIDOL, V8, P89, DOI 10.1097/00041433-199704000-00006; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; CIANFLONE KM, 1990, J CLIN INVEST, V85, P722, DOI 10.1172/JCI114497; Dicker A, 2004, DIABETOLOGIA, V47, P420, DOI 10.1007/s00125-003-1324-0; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Frayn KN, 1998, ADV EXP MED BIOL, V441, P171; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; HELLMER J, 1989, ANAL BIOCHEM, V177, P132, DOI 10.1016/0003-2697(89)90027-4; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; HIRSCH J, 1968, J LIPID RES, V9, P110; Hogberg H, 2006, OBESITY, V14, P673, DOI 10.1038/oby.2006.76; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KOLACZYNSKI JW, 1994, INT J OBESITY, V18, P161; KRAEMER FB, 1994, AM J PHYSIOL, V266, pE26, DOI 10.1152/ajpendo.1994.266.1.E26; KRIEGER M, 1978, J BIOL CHEM, V253, P4093; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Sniderman AD, 2004, CURR OPIN LIPIDOL, V15, P433, DOI 10.1097/01.mol.0000137220.39031.3b; Sniderman AD, 1998, ARTERIOSCL THROM VAS, V18, P147, DOI 10.1161/01.ATV.18.2.147; Sniderman AD, 2000, CURR OPIN LIPIDOL, V11, P291, DOI 10.1097/00041433-200006000-00010; Spalding K.L., 2008, NATURE	31	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3771	10.1371/journal.pone.0003771	http://dx.doi.org/10.1371/journal.pone.0003771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020660	gold, Green Published			2022-12-27	WOS:000265448600004
J	Pereira, PJB; Empadinhas, N; Albuquerque, L; Sa-Moura, B; da Costa, MS; Macedo-Ribeiro, S				Barbosa Pereira, Pedro Jose; Empadinhas, Nuno; Albuquerque, Luciana; Sa-Moura, Bebiana; da Costa, Milton S.; Macedo-Ribeiro, Sandra			Mycobacterium tuberculosis Glucosyl-3-Phosphoglycerate Synthase: Structure of a Key Enzyme in Methylglucose Lipopolysaccharide Biosynthesis	PLOS ONE			English	Article							FATTY-ACID SYNTHETASE; MACROMOLECULAR CRYOCRYSTALLOGRAPHY; METHYLMANNOSE POLYSACCHARIDE; CRYSTAL-STRUCTURE; IDENTIFICATION; PATHWAY; MANNOSYLGLYCERATE; GLUCOSYLGLYCERATE; CRYSTALLIZATION; PROTEINS	Tuberculosis constitutes today a serious threat to human health worldwide, aggravated by the increasing number of identified multi-resistant strains of Mycobacterium tuberculosis, its causative agent, as well as by the lack of development of novel mycobactericidal compounds for the last few decades. The increased resilience of this pathogen is due, to a great extent, to its complex, polysaccharide-rich, and unusually impermeable cell wall. The synthesis of this essential structure is still poorly understood despite the fact that enzymes involved in glycosidic bond synthesis represent more than 1% of all M. tuberculosis ORFs identified to date. One of them is GpgS, a retaining glycosyltransferase (GT) with low sequence homology to any other GTs of known structure, which has been identified in two species of mycobacteria and shown to be essential for the survival of M. tuberculosis. To further understand the biochemical properties of M. tuberculosis GpgS, we determined the three-dimensional structure of the apo enzyme, as well as of its ternary complex with UDP and 3-phosphoglycerate, by X-ray crystallography, to a resolution of 2.5 and 2.7 angstrom, respectively. GpgS, the first enzyme from the newly established GT-81 family to be structurally characterized, displays a dimeric architecture with an overall fold similar to that of other GT-A-type glycosyltransferases. These three-dimensional structures provide a molecular explanation for the enzyme's preference for UDP-containing donor substrates, as well as for its glucose versus mannose discrimination, and uncover the structural determinants for acceptor substrate selectivity. Glycosyltransferases constitute a growing family of enzymes for which structural and mechanistic data urges. The three-dimensional structures of M. tuberculosis GpgS now determined provide such data for a novel enzyme family, clearly establishing the molecular determinants for substrate recognition and catalysis, while providing an experimental scaffold for the structure-based rational design of specific inhibitors, which lay the foundation for the development of novel anti-tuberculosis therapies.	[Barbosa Pereira, Pedro Jose; Sa-Moura, Bebiana; Macedo-Ribeiro, Sandra] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Empadinhas, Nuno; Albuquerque, Luciana] Univ Coimbra, Dept Zool, Ctr Neuroci Biol Celular, P-3000 Coimbra, Portugal; [da Costa, Milton S.] Univ Coimbra, Dept Bioquim, P-3000 Coimbra, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Pereira, PJB (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sribeiro@ibmc.up.pt	Pereira, Pedro/F-8972-2011; Empadinhas, Nuno/G-3118-2011; Macedo-Ribeiro, Sandra/D-9258-2011	Pereira, Pedro/0000-0003-0969-5438; Empadinhas, Nuno/0000-0001-8938-7560; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Albuquerque, Luciana/0000-0002-6957-4673; Sa-Moura, Bebiana/0000-0003-2943-8818; da Costa, Milton/0000-0003-4027-4412	Fundacao para a Ciencia e a Tecnologia (Portugal) [POCI/BIA-MIC/56511/2004, PTDC/SAU-MII/70634/2006]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work had the financial support of grants POCI/BIA-MIC/56511/2004 and PTDC/SAU-MII/70634/2006 from Fundacao para a Ciencia e a Tecnologia (Portugal). The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANIS RJ, 1977, J BIOL CHEM, V252, P5740; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Costa J, 2006, J BACTERIOL, V188, P1022, DOI 10.1128/JB.188.3.1022-1030.2006; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON JA, 1970, J BIOL CHEM, V245, P4213; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAY GR, 1971, J BIOL CHEM, V246, P6835; Hanson BL, 2003, J STRUCT BIOL, V142, P77, DOI 10.1016/S1047-8477(03)00040-6; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAIRSON LL, 2008, ANN REV BIOCH, V77; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE YC, 1964, J BIOL CHEM, V239, P3602; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pflugrath JW, 2004, METHODS, V34, P415, DOI 10.1016/j.ymeth.2004.03.032; POMMIER MT, 1986, J GEN MICROBIOL, V132, P2433; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Sa-Moura B, 2008, ACTA CRYSTALLOGR F, V64, P760, DOI 10.1107/S1744309108021490; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WEISMAN LS, 1984, J BIOL CHEM, V259, P3457; WEISMAN LS, 1984, J BIOL CHEM, V259, P3464; Wimmerova M, 2003, BIOCHIMIE, V85, P691, DOI 10.1016/S0300-9084(03)00120-2; YABUSAKI KK, 1978, P NATL ACAD SCI USA, V75, P691, DOI 10.1073/pnas.75.2.691	48	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3748	10.1371/journal.pone.0003748	http://dx.doi.org/10.1371/journal.pone.0003748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015727	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448400005
J	Tzur, G; Levy, A; Meiri, E; Barad, O; Spector, Y; Bentwich, Z; Mizrahi, L; Katzenellenbogen, M; Ben-Shushan, E; Reubinoff, BE; Galun, E				Tzur, Galit; Levy, Asaf; Meiri, Eti; Barad, Omer; Spector, Yael; Bentwich, Zvi; Mizrahi, Lina; Katzenellenbogen, Mark; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Galun, Eithan			MicroRNA Expression Patterns and Function in Endodermal Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article								Background/Aims: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally. Human embryonic stem cells (hESC), which exhibit the characteristics of pluripotency and self-renewal, may serve as a model to study the role of miRNAs in early human development. We aimed to determine whether endodermally-differentiated hESC demonstrate a unique miRNA expression pattern, and whether overexpression of endoderm-specific miRNA may affect hESC differentiation. Methods: miRNA expression was profiled in undifferentiated and NaButyrate-induced differentiated hESC of two lines, using microarray and quantitative RT-PCR. Then, the effect of lentiviral-based overexpression of liver-specific miR-122 on hESC differentiation was analyzed, using genomewide gene microarrays. Results: The miRNA profiling revealed expression of three novel miRNAs in undifferentiated and differentiated hESC. Upon NaButyrate induction, two of the most upregulated miRNAs common to both cell lines were miR-24 and miR-10a, whose target genes have been shown to inhibit endodermal differentiation. Furthermore, induction of several liver-enriched miRNAs, including miR-122 and miR-192, was observed in parallel to induction of endodermal gene expression. Stable overexpression of miR-122 in hESC was unable to direct spontaneous differentiation towards a clear endodermal fate, but rather, delayed general differentiation of these cells. Conclusions: Our results demonstrate that expression of specific miRNAs correlates with that of specific genes upon differentiation, and highlight the potential role of miRNAs in endodermal differentiation of hESC.	[Tzur, Galit; Mizrahi, Lina; Katzenellenbogen, Mark; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Galun, Eithan] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Levy, Asaf; Meiri, Eti; Barad, Omer; Spector, Yael; Bentwich, Zvi] Rosetta Genom, Rehovot, Israel	Hebrew University of Jerusalem	Tzur, G (corresponding author), Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.	eithang@hadassah.org.il	Levy, Asaf/ABA-2623-2020; Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; Reubinoff, Benjamin/0000-0003-0353-1299	Israeli Science Foundation; Israeli Ministry of Science; National Gene Therapy Knowledge Center [LSHB-CT-2004-512034, LSHB-CT-2005-018961, LSHB-CT-2008- 223317]; Horowitz Foundation; Wolfson Foundation	Israeli Science Foundation(Israel Science Foundation); Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); National Gene Therapy Knowledge Center; Horowitz Foundation; Wolfson Foundation	This work is supported by the Israeli Science Foundation, the Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center and through grants LSHB-CT-2004-512034 (MOLEDA), LSHB-CT-2005-018961 (INTHER) and the FP7 program LSHB-CT-2008- 223317 (LIV-ES). Additional support was provided through grants from Lille and Alfy Nathan, Barbara Fox Miller, the Horowitz and the Wolfson Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang J, 2004, RNA BIOL, V1, P17; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COHEN MA, 2007, NEURAL DIFFERENTIATI; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fuchs O, 2007, FOLIA BIOL-PRAGUE, V53, P97; Fukuda Yoko, 2005, Nucleic Acids Symp Ser (Oxf), P341; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Gropp M, 2007, CLONING STEM CELLS, V9, P339, DOI 10.1089/clo.2006.0077; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kikuchi Y, 2004, DEV DYNAM, V229, P756, DOI 10.1002/dvdy.10483; KOSAKA M, 1991, EXP CELL RES, V192, P46, DOI 10.1016/0014-4827(91)90155-N; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar BM, 2007, J REPROD DEVELOP, V53, P903, DOI 10.1262/jrd.18180; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LAKSHMIPATHY U, 2007, STEM CELLS DEV; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LAURENT LC, 2008, STEM CELLS; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; TAY YM, 2007, STEM CELLS; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; XANTHOPOULOS KG, 1993, EUR J BIOCHEM, V216, P353, DOI 10.1111/j.1432-1033.1993.tb18152.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	84	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3726	10.1371/journal.pone.0003726	http://dx.doi.org/10.1371/journal.pone.0003726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015728	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448400001
J	Gowen, BB; Smee, DF; Wong, MH; Hall, JO; Jung, KH; Bailey, KW; Stevens, JR; Furuta, Y; Morrey, JD				Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Hall, Jeffery O.; Jung, Kie-Hoon; Bailey, Kevin W.; Stevens, John R.; Furuta, Yousuke; Morrey, John D.			Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin	PLOS ONE			English	Article								A growing number of arenaviruses are known to cause viral hemorrhagic fever (HF), a severe and life-threatening syndrome characterized by fever, malaise, and increased vascular permeability. Ribavirin, the only licensed antiviral indicated for the treatment of certain arenaviral HFs, has had mixed success and significant toxicity. Since severe arenaviral infections initially do not present with distinguishing symptoms and are difficult to clinically diagnose at early stages, it is of utmost importance to identify antiviral therapies effective at later stages of infection. We have previously reported that T-705, a substituted pyrazine derivative currently under development as an anti-influenza drug, is highly active in hamsters infected with Pichinde virus when the drug is administered orally early during the course of infection. Here we demonstrate that T-705 offers significant protection against this lethal arenaviral infection in hamsters when treatment is begun after the animals are ill and the day before the animals begin to succumb to disease. Importantly, this coincides with the time when peak viral loads are present in most organs and considerable tissue damage is evident. We also show that T-705 is as effective as, and less toxic than, ribavirin, as infected T-705-treated hamsters on average maintain their weight better and recover more rapidly than animals treated with ribavirin. Further, there was no added benefit to combination therapy with T-705 and ribavirin. Finally, pharmacokinetic data indicate that plasma T-705 levels following oral administration are markedly reduced during the latter stages of disease, and may contribute to the reduced efficacy seen when treatment is withheld until day 7 of infection. Our findings support further pre-clinical development of T-705 for the treatment of severe arenaviral infections.	[Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Jung, Kie-Hoon; Bailey, Kevin W.; Morrey, John D.] Inst Antiviral Res, Logan, UT USA; [Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Hall, Jeffery O.; Jung, Kie-Hoon; Bailey, Kevin W.; Morrey, John D.] Utah State Univ, Dept Anim, Dairy, & Vet Sci, Logan, UT 84322 USA; [Stevens, John R.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Furuta, Yousuke] Toyama Chem Co Ltd, Res Lab, Toyama, Japan	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Inst Antiviral Res, Logan, UT USA.	brian.gowen@usu.edu			Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-15435, N01-AI-30048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048, N01AI015435] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract grants N01-AI-15435 and N01-AI-30048 from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; FOLLEY LS, 1983, J CHROMATOGR, V281, P199, DOI 10.1016/S0021-9673(01)87878-X; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033; Hedstrom L, 1999, CURR MED CHEM, V6, P545; KENYON RH, 1986, J MED VIROL, V20, P207, DOI 10.1002/jmv.1890200303; KENYON RH, 1988, INTERVIROLOGY, V29, P133, DOI 10.1159/000150039; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MCKEE KT, 1987, J MED VIROL, V22, P99, DOI 10.1002/jmv.1890220202; MORREY JD, 2008, ANTIVIRAL R IN PRESS; MURPHY FA, 1977, LAB INVEST, V37, P502; *NIAID, 2002, COUNT BIOT RES AG NA; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; SMEE DF, 1993, ANTIVIR RES, V20, P57, DOI 10.1016/0166-3542(93)90059-R; Takahashi Kazumi, 2003, Antiviral Chemistry & Chemotherapy, V14, P235; 2007, FDANEWS DRUG PIPELIN	27	68	71	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3725	10.1371/journal.pone.0003725	http://dx.doi.org/10.1371/journal.pone.0003725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008960	Green Published, gold			2022-12-27	WOS:000265166400004
J	Peck, G; Smeeth, L; Whittaker, J; Casas, JP; Hingorani, A; Sharma, P				Peck, George; Smeeth, Liam; Whittaker, John; Casas, Juan Pablo; Hingorani, Aroon; Sharma, Pankaj			The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults	PLOS ONE			English	Article								Background: The genetic basis of haemorrhagic stroke has proved difficult to unravel, partly hampered by the small numbers of subjects in any single study. A meta-analysis of all candidate gene association studies of haemorrhagic stroke (including ruptured subarachnoid haemorrhage and amyloid angiopathy-related haemorrhage) was performed, allowing more reliable estimates of risk. Methods: A systematic review and meta-analysis of all genetic studies in haemorrhagic stroke was conducted. Electronic databases were searched until and including March 2007 for any candidate gene in haemorrhagic stroke. Odds ratio (OR) and 95% confidence intervals (CI) were determined for each gene disease association using fixed and random effect models. Results: Our meta-analyses included 6,359 cases and 13,805 controls derived from 55 case-control studies, which included 12 genes (13 polymorphisms). Statistically significant associations with haemorrhagic stroke were identified for those homozygous for the ACE/I allele (OR, 1.48; 95% CI, 1.20-1.83; p = 0.0003) and for the 5G allele in the SERPINE1 4G/5G polymorphism (OR, 1.42; 95% CI, 1.03-1.96; p = 0.03). In addition, both epsilon 2 and epsilon 4 alleles of APOE were significantly associated with lobar haemorrhage (OR, 1.81; 95% CI, 1.26-2.62; p = 0.002 and OR, 1.49; 95% 1.08-2.05; p = 0.01 respectively). Furthermore, a significant protective association against haemorrhagic stroke was found for the factor V Leiden mutation (OR, 0.30; 95% CI, 0.10-0.87; p = 0.03). Conclusion: Our data suggests a genetic contribution to some types of haemorrhagic stroke, with no overall responsible single gene but rather supporting a polygenic aetiology. However, the evidence base is smaller compared to ischaemic stroke. Importantly, for several alleles previously found to be associated with protection from ischaemic stroke, there was a trend towards an increased risk of haemorrhagic stroke.	[Peck, George; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, Dept Clin Neurosci, London, England; [Smeeth, Liam; Whittaker, John; Casas, Juan Pablo] Univ London, Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HU, England; [Hingorani, Aroon] Univ London, Ctr Clin Pharmacol, BHF Lab, London WC1E 7HU, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London	Peck, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICCRU, Dept Clin Neurosci, London, England.	pankaj.sharma@imperial.ac.uk	Whittaker, John C/B-8609-2012; sharma, pankaj/HGE-4423-2022; Smeeth, Liam/X-5862-2018	Whittaker, John C/0000-0002-3529-2379; Hingorani, Aroon/0000-0001-8365-0081; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [082178] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akagawa H, 2005, J NEUROSURG, V102, P68, DOI 10.3171/jns.2005.102.1.0068; Alberts MJ, 2002, NEUROEPIDEMIOLOGY, V21, P18, DOI 10.1159/000048609; Alberts MJ, 1997, ANN NEUROL, V41, P683, DOI 10.1002/ana.410410519; Ariyaratnam R, 2007, PLOS MED, V4, P728, DOI 10.1371/journal.pmed.0040131; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; BROMBERG JEC, 1995, BRIT MED J, V311, P288, DOI 10.1136/bmj.311.7000.288; BROTT T, 1986, STROKE, V17, P1078, DOI 10.1161/01.STR.17.6.1078; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carter AM, 1998, ARTERIOSCL THROM VAS, V18, P1124, DOI 10.1161/01.ATV.18.7.1124; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Catto A, 1996, STROKE, V27, P435, DOI 10.1161/01.STR.27.3.435; CATTO A, 1995, ARTERIOSCL THROM VAS, V15, P783, DOI 10.1161/01.ATV.15.6.783; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P730; Catto AJ, 2000, ACTA NEUROL SCAND, V101, P399, DOI 10.1034/j.1600-0404.2000.90308a.x; Chowdhury A H, 2001, J Epidemiol, V11, P131; Corral J, 2000, Hematol J, V1, P269, DOI 10.1038/sj.thj.6200043; Corral J, 2001, BLOOD, V97, P2979, DOI 10.1182/blood.V97.10.2979; DEEK JJ, 2001, SYSTEMIC REV HLTH CA; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dichgans M, 2005, STROKE, V36, P2027, DOI 10.1161/01.STR.0000177498.21594.9e; Dikmen M, 2006, ACTA NEUROL SCAND, V113, P307, DOI 10.1111/j.1600-0404.2005.00556.x; Dikmen M, 2006, ARQ NEURO-PSIQUIAT, V64, P211; Donahue BS, 2003, CIRCULATION, V107, P1003, DOI 10.1161/01.CIR.0000051864.28048.01; Duzenli S, 2004, J NEUROGENET, V18, P365, DOI 10.1080/01677060490500294; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Saed A, 2006, STROKE, V37, P1975, DOI 10.1161/01.STR.0000231453.98473.67; Endler G, 2003, BRIT J HAEMATOL, V120, P310, DOI 10.1046/j.1365-2141.2003.04047.x; Fang X, 2005, NEUROL RES, V27, P73, DOI 10.1179/016164105X18313; Fontanella M, 2007, J NEUROSURG, V106, P245, DOI 10.3171/jns.2007.106.2.245; Fu Yu, 2002, Zhonghua Yi Xue Za Zhi, V82, P915; Gaist D, 2000, BRIT MED J, V320, P141, DOI 10.1136/bmj.320.7228.141; Garcia C, 1999, J NEUROL, V246, P830, DOI 10.1007/s004150050463; Gemmati D, 2001, AM J HEMATOL, V67, P183, DOI 10.1002/ajh.1104; Hindorff LA, 2002, J CARDIOVASC RISK, V9, P131, DOI 10.1097/00043798-200204000-00009; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Iniesta JA, 2004, STROKE, V35, P2282, DOI 10.1161/01.STR.0000141978.33388.eb; Iniesta JA, 2003, CEREBROVASC DIS, V15, P51, DOI 10.1159/000067126; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Keavney B, 2000, LANCET, V355, P434; Keramatipour M, 2000, J MED GENET, V37, P498, DOI 10.1136/jmg.37.7.498; Khurana VG, 2005, J NEUROSURG, V102, P526, DOI 10.3171/jns.2005.102.3.0526; Kokubo Y, 2000, STROKE, V31, P1299, DOI 10.1161/01.STR.31.6.1299; Krischek B, 2007, CEREBROVASC DIS, V23, P46, DOI 10.1159/000095758; Krischek B, 2006, J NEUROSURG, V105, P717, DOI 10.3171/jns.2006.105.5.717; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Lin JJ, 2000, J FORMOS MED ASSOC, V99, P895; Lindqvist PG, 1998, THROMB HAEMOSTASIS, V79, P69; Longstreth WT, 1998, STROKE, V29, P577, DOI 10.1161/01.STR.29.3.577; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; McCarron MO, 1999, J NEUROPATH EXP NEUR, V58, P711, DOI 10.1097/00005072-199907000-00005; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; Nakata Y, 1998, AM J HYPERTENS, V11, P1019, DOI 10.1016/S0895-7061(98)00046-6; Nicoll JAR, 2001, AMYLOID, V8, P51; Obach V, 2001, STROKE, V32, P2588, DOI 10.1161/hs1101.097378; Pannu H, 2005, J NEUROSURG, V103, P92, DOI 10.3171/jns.2005.103.1.0092; Pera J, 2006, STROKE, V37, P906, DOI 10.1161/01.STR.0000202655.64413.0c; Pera J, 2005, J NEUROSURG, V102, P879, DOI 10.3171/jns.2005.102.5.0879; Peters DG, 2005, CEREBROVASC DIS, V20, P96, DOI 10.1159/000086513; Qureshi AI, 1997, STROKE, V28, P961, DOI 10.1161/01.STR.28.5.961; Reiner AP, 2001, STROKE, V32, P2580, DOI 10.1161/hs1101.098150; Reiner AP, 2000, STROKE, V31, P1628, DOI 10.1161/01.STR.31.7.1628; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Sazci A, 2006, BRAIN RES BULL, V71, P45, DOI 10.1016/j.brainresbull.2006.07.014; SCHIEVINK WI, 1995, J NEUROSURG, V83, P426, DOI 10.3171/jns.1995.83.3.0426; Seifert T, 2006, CEREBROVASC DIS, V21, P266, DOI 10.1159/000091225; Slowik A, 2005, STROKE, V36, P737, DOI 10.1161/01.STR.0000157598.02014.37; Slowik A, 2005, CEREBROVASC DIS, V19, P165, DOI 10.1159/000083251; Slowik A, 2004, NEUROLOGY, V63, P359, DOI 10.1212/01.WNL.0000130200.12993.0C; Slowik A, 2004, STROKE, V35, P1594, DOI 10.1161/01.STR.0000131655.45227.f7; Song MK, 2006, J KOREAN MED SCI, V21, P922, DOI 10.3346/jkms.2006.21.5.922; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Sutherland GR, 2006, J CLIN NEUROSCI, V13, P511, DOI 10.1016/j.jocn.2004.12.012; SUZUKI K, 1987, STROKE, V18, P402, DOI 10.1161/01.STR.18.2.402; Tang J, 2003, SURG NEUROL, V60, P391, DOI 10.1016/S0090-3019(03)00323-9; Vila N, 2000, STROKE, V31, P2103, DOI 10.1161/01.STR.31.9.2103; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wiklund PG, 2005, STROKE, V36, P1661, DOI 10.1161/01.STR.0000174485.10277.24; Woo D, 2005, STROKE, V36, P1874, DOI 10.1161/01.STR.0000177891.15082.b9; Yamada Y, 2006, CIRC J, V70, P1240, DOI 10.1253/circj.70.1240; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; YI HA, 2007, KOREAN J ANAT, V35, P355; Zhang C, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P383; ZHANG C, 2001, CHUNG HUA HSUEH CHUA, V18, P383	88	53	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3691	10.1371/journal.pone.0003691	http://dx.doi.org/10.1371/journal.pone.0003691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008959	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265166400001
J	Langer, M; Malykhin, A; Maeda, K; Chakrabarty, K; Williamson, KS; Feasley, CL; West, CM; Metcalf, JP; Coggeshall, KM				Langer, Marybeth; Malykhin, Alexander; Maeda, Kenichiro; Chakrabarty, Kaushik; Williamson, Kelly S.; Feasley, Christa L.; West, Christopher M.; Metcalf, Jordan P.; Coggeshall, K. Mark			Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article								We hypothesized that the peptidoglycan component of B. anthracis may play a critical role in morbidity and mortality associated with inhalation anthrax. To explore this issue, we purified the peptidoglycan component of the bacterial cell wall and studied the response of human peripheral blood cells. The purified B. anthracis peptidoglycan was free of non-covalently bound protein but contained a complex set of amino acids probably arising from the stem peptide. The peptidoglycan contained a polysaccharide that was removed by mild acid treatment, and the biological activity remained with the peptidoglycan and not the polysaccharide. The biological activity of the peptidoglycan was sensitive to lysozyme but not other hydrolytic enzymes, showing that the activity resides in the peptidoglycan component and not bacterial DNA, RNA or protein. B. anthracis peptidoglycan stimulated monocytes to produce primarily TNF alpha; neutrophils and lymphocytes did not respond. Peptidoglycan stimulated monocyte p38 mitogen-activated protein kinase and p38 activity was required for TNFa production by the cells. We conclude that peptidoglycan in B. anthracis is biologically active, that it stimulates a proinflammatory response in monocytes, and uses the p38 kinase signal transduction pathway to do so. Given the high bacterial burden in pulmonary anthrax, these findings suggest that the inflammatory events associated with peptidoglycan may play an important role in anthrax pathogenesis.	[Langer, Marybeth; Malykhin, Alexander; Maeda, Kenichiro; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Chakrabarty, Kaushik; Metcalf, Jordan P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Pulmonary & Crit Care Div, Oklahoma City, OK USA; [Williamson, Kelly S.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Program, Oklahoma City, OK USA; [Feasley, Christa L.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Langer, M (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Mark-Coggeshall@omrf.ouhsc.edu			NIH [1U19 AI062629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 1U19 AI062629	Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chakrabarty K, 2006, INFECT IMMUN, V74, P4430, DOI 10.1128/IAI.00446-06; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; Cleret A, 2006, J INFECT DIS, V194, P86, DOI 10.1086/504686; Coffey R G, 1992, Immunol Ser, V57, P301; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; DAYNES RA, 1991, J EXP MED, V174, P1323, DOI 10.1084/jem.174.6.1323; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DUBRAVEC DB, 1990, P NATL ACAD SCI USA, V87, P6758, DOI 10.1073/pnas.87.17.6758; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; EZZELL JW, 1988, INFECT IMMUN, V56, P349, DOI 10.1128/IAI.56.2.349-356.1988; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Garrido G, 2004, PHARMACOL RES, V50, P165, DOI 10.1016/j.phrs.2003.12.020; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hattar K, 2006, CRIT CARE MED, V34, P835, DOI 10.1097/01.CCM.0000202204.01230.44; Heninger S, 2006, INFECT IMMUN, V74, P6067, DOI 10.1128/IAI.00719-06; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; IWASAKI H, 1986, J BACTERIOL, V167, P508, DOI 10.1128/jb.167.2.508-516.1986; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; KALECHMAN Y, 1993, CELL IMMUNOL, V148, P114, DOI 10.1006/cimm.1993.1095; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Myhre AE, 2004, INFECT IMMUN, V72, P1311, DOI 10.1128/IAI.72.3.1311-1317.2004; NAGAO S, 1990, INFECT IMMUN, V58, P536, DOI 10.1128/IAI.58.2.536-542.1990; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Rhie GE, 2003, P NATL ACAD SCI USA, V100, P10925, DOI 10.1073/pnas.1834478100; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Standiford TJ, 2000, CURR PHARM DESIGN, V6, P633, DOI 10.2174/1381612003400533; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Vollmer W, 2008, FEMS MICROBIOL REV; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723; Zhang X, 2001, ANN RHEUM DIS, V60, P269, DOI 10.1136/ard.60.3.269	64	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3706	10.1371/journal.pone.0003706	http://dx.doi.org/10.1371/journal.pone.0003706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002259	Green Submitted, gold, Green Published			2022-12-27	WOS:000265166000006
J	Schmidt, D; Stark, R; Wilson, MD; Brown, GD; Odom, DT				Schmidt, Dominic; Stark, Rory; Wilson, Michael D.; Brown, Gordon D.; Odom, Duncan T.			Genome-Scale Validation of Deep-Sequencing Libraries	PLOS ONE			English	Article								Chromatin immunoprecipitation followed by high-throughput (HTP) sequencing (ChIP-seq) is a powerful tool to establish protein-DNA interactions genome-wide. The primary limitation of its broad application at present is the often-limited access to sequencers. Here we report a protocol, Mab-seq, that generates genome-scale quality evaluations for nucleic acid libraries intended for deep-sequencing. We show how commercially available genomic microarrays can be used to maximize the efficiency of library creation and quickly generate reliable preliminary data on a chromosomal scale in advance of deep sequencing. We also exploit this technique to compare enriched regions identified using microarrays with those identified by sequencing, demonstrating that they agree on a core set of clearly identified enriched regions, while characterizing the additional enriched regions identifiable using HTP sequencing.	[Schmidt, Dominic; Stark, Rory; Wilson, Michael D.; Brown, Gordon D.; Odom, Duncan T.] Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge, England; [Schmidt, Dominic; Odom, Duncan T.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Schmidt, D (corresponding author), Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge, England.	duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014	Wilson, Michael D/0000-0002-4015-3066; Odom, Duncan/0000-0001-6201-5599; Stark, Rory/0000-0002-1790-5469	European Research Council; Hutchinson Whampoa; University of Cambridge; Cancer Research UK	European Research Council(European Research Council (ERC)European Commission); Hutchinson Whampoa; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK)	Supported by the European Research Council (DTO), Hutchinson Whampoa (DTO), University of Cambridge (DTO, DS), and the Cancer Research UK (DTO, DS, RS, MDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; KLEMMER V, 2008, NAT METHODS, V5, P288; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3713	10.1371/journal.pone.0003713	http://dx.doi.org/10.1371/journal.pone.0003713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002256	gold, Green Submitted, Green Published			2022-12-27	WOS:000265166000013
J	Ben-Shachar, D; Karry, R				Ben-Shachar, Dorit; Karry, Rachel			Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SUBUNIT GENE NDUFV2; BASAL GANGLIA; ELECTRON-TRANSPORT; FRONTAL-CORTEX; HUMAN BRAIN; UBIQUINONE OXIDOREDUCTASE; NEUROLEPTIC MEDICATIONS; AXONAL-TRANSPORT; EXPRESSION	Background: Mitochondrial dysfunction was reported in schizophrenia, bipolar disorder and major depression. The present study investigated whether mitochondrial complex I abnormalities show disease-specific characteristics. Methodology/Principal Findings: mRNA and protein levels of complex I subunits NDUFV1, NDUFV2 and NADUFS1, were assessed in striatal and lateral cerebellar hemisphere postmortem specimens and analyzed together with our previous data from prefrontal and parieto-occipital cortices specimens of patients with schizophrenia, bipolar disorder, major depression and healthy subjects. A disease-specific anatomical pattern in complex I subunits alterations was found. Schizophrenia-specific reductions were observed in the prefrontal cortex and in the striatum. The depressed group showed consistent reductions in all three subunits in the cerebellum. The bipolar group, however, showed increased expression in the parieto-occipital cortex, similar to those observed in schizophrenia, and reductions in the cerebellum, yet less consistent than the depressed group. Conclusions/Significance: These results suggest that the neuroanatomical pattern of complex I pathology parallels the diversity and similarities in clinical symptoms of these mental disorders.	[Ben-Shachar, Dorit; Karry, Rachel] Rambam Med Ctr, Psychobiol Lab, Dept Psychiat, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Ben-Shachar, D (corresponding author), Rambam Med Ctr, Psychobiol Lab, Dept Psychiat, Haifa, Israel.	shachar@tx.technion.ac.il	Ben-Shachar, Dorit/D-4703-2015	Ben-Shachar, Dorit/0000-0003-2317-1489	Stanley Medical Research Institute	Stanley Medical Research Institute	Funding for this study was provided by The Stanley Medical Research Institute Grant. The Stanley Medical Research Institute had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Afifi Adel K, 2003, Semin Pediatr Neurol, V10, P3, DOI 10.1016/S1071-9091(02)00003-7; Aleman A, 2002, SCHIZOPHR RES, V57, P315, DOI 10.1016/S0920-9964(01)00291-2; AlMousawi AH, 1996, BRIT J PSYCHIAT, V169, P509, DOI 10.1192/bjp.169.4.509; ALNAES E, 1975, ROLE MITOCHONDRIA TR, P285; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Baethge C, 2005, BIPOLAR DISORD, V7, P136, DOI 10.1111/j.1399-5618.2004.00175.x; Bahn S, 2001, J CHEM NEUROANAT, V22, P79, DOI 10.1016/S0891-0618(01)00099-0; Barnes J, 2000, NEUROPSYCHOLOGIA, V38, P1148, DOI 10.1016/S0028-3932(00)00025-7; Barrientos A, 1998, J NEUROSCI RES, V53, P475, DOI 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0.CO;2-3; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; BENSHACHAR D, 2008, J MOL NEUROSCI; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P966; BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516; Carlson Paul J, 2006, NeuroRx, V3, P22, DOI 10.1016/j.nurx.2005.12.009; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; CHAN P, 1994, J NEUROCHEM, V62, P2484, DOI 10.1046/j.1471-4159.1994.62062484.x; Chouinard G, 1999, SCHIZOPHR RES, V38, P101, DOI 10.1016/S0920-9964(99)00012-2; Corson PW, 2002, BIOL PSYCHIAT, V52, P855, DOI 10.1016/S0006-3223(02)01421-X; Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Daneluzzo E, 2002, SCHIZOPHR RES, V56, P129, DOI 10.1016/S0920-9964(01)00277-8; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Deicken RF, 2000, REV NEUROSCIENCE, V11, P147; Desco M, 2003, PSYCHIAT RES-NEUROIM, V122, P125, DOI 10.1016/S0925-4927(02)00124-5; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116; Dunn RT, 2002, BIOL PSYCHIAT, V51, P387, DOI 10.1016/S0006-3223(01)01244-6; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; FUJIMOTO T, 1992, ACTA PSYCHIAT SCAND, V86, P455, DOI 10.1111/j.1600-0447.1992.tb03297.x; Fukuzako H, 1999, AM J PSYCHIAT, V156, P1205; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GARCIA O, 2005, INCREASED MITOCHONDR, P183; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GREENWOOD SM, 2007, MITOCHONDRIAL DYSFUN, P26235; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HAN AL, 1989, ARCH BIOCHEM BIOPHYS, V275, P166, DOI 10.1016/0003-9861(89)90360-3; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; HEATH RG, 1980, BIOL PSYCHIAT, V15, P243; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jayakumar PN, 2006, ACTA PSYCHIAT SCAND, V114, P346, DOI 10.1111/j.1600-0447.2006.00836.x; Jensen JE, 2006, PSYCHIAT RES-NEUROIM, V146, P127, DOI 10.1016/j.pscychresns.2005.11.004; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012; Kato T, 2005, INT REV NEUROBIOL, V63, P21, DOI 10.1016/S0074-7742(05)63002-4; KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; KIMURA M, 1995, NEUROSCI RES, V22, P353, DOI 10.1016/0168-0102(95)00914-F; Knable MB, 2002, MOL PSYCHIATR, V7, P392, DOI 10.1038/sj.mp.4001034; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Laifenfeld D, 2005, BIOL PSYCHIAT, V57, P716, DOI 10.1016/j.biopsych.2004.12.016; Laugel V, 2007, PEDIATR NEUROL, V36, P54, DOI 10.1016/j.pediatrneurol.2006.08.007; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Manji HK, 2000, BIOL PSYCHIAT, V48, P518, DOI 10.1016/S0006-3223(00)00929-X; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; Maurer I, 1997, MOL CELL BIOCHEM, V174, P255, DOI 10.1023/A:1006872911332; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; MEHLERWEX C, 2006, EUR CHILD ADOLESC PS; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; MIZUNO Y, 1990, J NEUROL SCI, V96, P49, DOI 10.1016/0022-510X(90)90056-S; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; MULCRONE J, 1995, SCHIZOPHR RES, V14, P203, DOI 10.1016/0920-9964(94)00040-F; Nitschke MF, 2005, PROG BRAIN RES, V148, P151, DOI 10.1016/S0079-6123(04)48013-3; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0; Prince JA, 1997, J PHARMACOL EXP THER, V280, P261; PRZEDBORSKI S, 1993, ANN NEUROL, V34, P715, DOI 10.1002/ana.410340515; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; Reddy R, 2003, PROSTAG LEUKOTR ESS, V69, P401, DOI 10.1016/j.plefa.2003.08.011; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Smith KA, 2002, BRIT J PSYCHIAT, V181, P411, DOI 10.1192/bjp.181.5.411; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189; Swerdlow RH, 2006, J NEUROL SCI, V247, P224, DOI 10.1016/j.jns.2006.05.053; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Thach WT, 2007, CEREBELLUM, V6, P163, DOI 10.1080/14734220701373530; Thomas EA, 2003, MOL PSYCHIATR, V8, P167, DOI 10.1038/sj.mp.4001223; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Volz HP, 2000, BIOL PSYCHIAT, V47, P954, DOI 10.1016/S0006-3223(00)00235-3; Washizuka S, 2006, AM J MED GENET B, V141B, P301, DOI 10.1002/ajmg.b.30285; WEINBACH EC, 1986, BIOCHEM PHARMACOL, V35, P1445, DOI 10.1016/0006-2952(86)90108-5; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; White RJ, 1996, J NEUROSCI, V16, P5688; Xu C, 2008, BIPOLAR DISORD, V10, P105, DOI 10.1111/j.1399-5618.2008.00535.x; Yildiz-Yesiloglu A, 2006, PSYCHIAT RES-NEUROIM, V147, P1, DOI 10.1016/j.pscychresns.2005.12.004	117	140	151	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3676	10.1371/journal.pone.0003676	http://dx.doi.org/10.1371/journal.pone.0003676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989376	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134600009
J	Poussin, C; Hall, D; Minehira, K; Galzin, AM; Tarussio, D; Thorens, B				Poussin, Carine; Hall, Diana; Minehira, Kaori; Galzin, Anne-Marie; Tarussio, David; Thorens, Bernard			Different Transcriptional Control of Metabolism and Extracellular Matrix in Visceral and Subcutaneous Fat of Obese and Rimonabant Treated Mice	PLOS ONE			English	Article							CB1 RECEPTOR ANTAGONIST; DIET-INDUCED OBESITY; ADIPOSE-TISSUE DEVELOPMENT; NECROSIS-FACTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; 3T3-L1 ADIPOGENESIS; CARDIOVASCULAR RISK	Background: The visceral (VAT) and subcutaneous (SCAT) adipose tissues play different roles in physiology and obesity. The molecular mechanisms underlying their expansion in obesity and following body weight reduction are poorly defined. Methodology: C57Bl/6 mice fed a high fat diet (HFD) for 6 months developed low, medium, or high body weight as compared to normal chow fed mice. Mice from each groups were then treated with the cannabinoid receptor 1 antagonist rimonabant or vehicle for 24 days to normalize their body weight. Transcriptomic data for visceral and subcutaneous adipose tissues from each group of mice were obtained and analyzed to identify: i) genes regulated by HFD irrespective of body weight, ii) genes whose expression correlated with body weight, iii) the biological processes activated in each tissue using gene set enrichment analysis (GSEA), iv) the transcriptional programs affected by rimonabant. Principal Findings: In VAT, "metabolic'' genes encoding enzymes for lipid and steroid biosynthesis and glucose catabolism were down-regulated irrespective of body weight whereas "structure'' genes controlling cell architecture and tissue remodeling had expression levels correlated with body weight. In SCAT, the identified "metabolic'' and "structure'' genes were mostly different from those identified in VAT and were regulated irrespective of body weight. GSEA indicated active adipogenesis in both tissues but a more prominent involvement of tissue stroma in VAT than in SCAT. Rimonabant treatment normalized most gene expression but further reduced oxidative phosphorylation gene expression in SCAT but not in VAT. Conclusion: VAT and SCAT show strikingly different gene expression programs in response to high fat diet and rimonabant treatment. Our results may lead to identification of therapeutic targets acting on specific fat depots to control obesity.	[Poussin, Carine; Hall, Diana; Minehira, Kaori; Tarussio, David; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanna, Switzerland; [Galzin, Anne-Marie] Sanofi Aventis, Rueil Malmaison, France	University of Lausanne; Sanofi-Aventis	Poussin, C (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanna, Switzerland.	Bernard.Thorens@unil.ch			Sanofi-Aventis; French MINEFI - Ministere de l'Industrie et des Finances; European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP)	Sanofi-Aventis(Sanofi-Aventis); French MINEFI - Ministere de l'Industrie et des Finances; European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP)	This work was supported by grants from Sanofi-Aventis and the the French MINEFI - Ministere de l'Industrie et des Finances - through the project 'Integrated Genomic approaches for the molecular dissection of Cannabinoid receptor 1 signalling and of CB1 antagonist effects in Obesity and in the Metabolic Syndrome'GenObeCB1 and from the European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP). The funder (Sanofi-Aventis) had no role in study data collection and analysis. Study design and decision to publish were taken with the funder. The funder agreed to publish the manuscript that was drafted only by the investigators at the University of Lausanne.	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Aronne LJ, 2007, AM J MED, V120, pS29, DOI 10.1016/j.amjmed.2006.11.015; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; BERTRAND HA, 1984, J NUTR, V114, P127, DOI 10.1093/jn/114.1.127; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; Cohen B, 2001, J BIOL CHEM, V276, P7697, DOI 10.1074/jbc.C000634200; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; DEFOURMESTRAUX V, 2004, J BIOL CHEM; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018; MATIAS I, 2007, NEUROPHARMACOLOGY; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Tan Siok Hwee, 2006, Functional & Integrative Genomics, V6, P235, DOI 10.1007/s10142-005-0016-x; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Voros G, 2006, BBA-GEN SUBJECTS, V1760, P1837, DOI 10.1016/j.bbagen.2006.08.016; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187	63	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3385	10.1371/journal.pone.0003385	http://dx.doi.org/10.1371/journal.pone.0003385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	19030233	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600009
J	van Boven, M; Klinkenberg, D; Pen, I; Weissing, FJ; Heesterbeek, H				van Boven, Michiel; Klinkenberg, Don; Pen, Ido; Weissing, Franz J.; Heesterbeek, Hans			Self-Interest versus Group-Interest in Antiviral Control	PLOS ONE			English	Article							INFLUENZA; VACCINATION; STRATEGIES; DYNAMICS	Antiviral agents have been hailed to hold considerable promise for the treatment and prevention of emerging viral diseases like H5N1 avian influenza and SARS. However, antiviral drugs are not completely harmless, and the conditions under which individuals are willing to participate in a large-scale antiviral drug treatment program are as yet unknown. We provide population dynamical and game theoretical analyses of large-scale prophylactic antiviral treatment programs. Throughout we compare the antiviral control strategy that is optimal from the public health perspective with the control strategy that would evolve if individuals make their own, rational decisions. To this end we investigate the conditions under which a large-scale antiviral control program can prevent an epidemic, and we analyze at what point in an unfolding epidemic the risk of infection starts to outweigh the cost of antiviral treatment. This enables investigation of how the optimal control strategy is moulded by the efficacy of antiviral drugs, the risk of mortality by antiviral prophylaxis, and the transmissibility of the pathogen. Our analyses show that there can be a strong incentive for an individual to take less antiviral drugs than is optimal from the public health perspective. In particular, when public health asks for early and aggressive control to prevent or curb an emerging pathogen, for the individual antiviral drug treatment is attractive only when the risk of infection has become non-negligible. It is even possible that from a public health perspective a situation in which everybody takes antiviral drugs is optimal, while the process of individual choice leads to a situation where nobody is willing to take antiviral drugs.	[van Boven, Michiel; Klinkenberg, Don; Heesterbeek, Hans] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Boven, Michiel] Wageningen Univ, Res Ctr, Animal Sci Grp, Lelystad, Netherlands; [van Boven, Michiel; Pen, Ido; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evol Stud, Haren, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; University of Groningen	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Pen, Ido/F-2478-2010	Weissing, Franz J./0000-0003-3281-663X; Klinkenberg, Don/0000-0002-9449-6873; Heesterbeek, Hans/0000-0001-8537-6418	EU Sixth Framework Programme [SP22-CT-2004-511066]; Netherlands Organisation for Scientific Research [918.56.620]	EU Sixth Framework Programme(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The research of MvB and DK is supported by the EU Sixth Framework Programme for research for policy support (contract SP22-CT-2004-511066). The research of JAPH is supported by the Netherlands Organisation for Scientific Research (NWO grant 918.56.620).	[Anonymous], 2007, NATURE, V446, P358, DOI 10.1038/446358a; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Cinatl J, 2005, ANTIVIR RES, V66, P81, DOI 10.1016/j.antiviral.2005.03.002; Cojocaru MG, 2007, B MATH BIOL, V69, P1453, DOI 10.1007/s11538-006-9173-x; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; *EUR MED AG, 2006, SCI DISC EUR MED EV; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Groneberg DA, 2005, LANCET INFECT DIS, V5, P147, DOI 10.1016/S1473-3099(05)70022-0; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	22	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1558	10.1371/journal.pone.0001558	http://dx.doi.org/10.1371/journal.pone.0001558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	19050769	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900003
J	Osipova, D; Hermes, D; Jensen, O				Osipova, Daria; Hermes, Dora; Jensen, Ole			Gamma Power Is Phase-Locked to Posterior Alpha Activity	PLOS ONE			English	Article							EVOKED-RESPONSES; NEURONAL OSCILLATIONS; HIGH-FREQUENCY; MEMORY TASK; THETA; EEG; HUMANS; CORTEX; ELECTROENCEPHALOGRAM; SYNCHRONIZATION	Neuronal oscillations in various frequency bands have been reported in numerous studies in both humans and animals. While it is obvious that these oscillations play an important role in cognitive processing, it remains unclear how oscillations in various frequency bands interact. In this study we have investigated phase to power locking in MEG activity of healthy human subjects at rest with their eyes closed. To examine cross-frequency coupling, we have computed coherence between the time course of the power in a given frequency band and the signal itself within every channel. The time-course of the power was calculated using a sliding tapered time window followed by a Fourier transform. Our findings show that high-frequency gamma power (30-70 Hz) is phase-locked to alpha oscillations (8-13 Hz) in the ongoing MEG signals. The topography of the coupling was similar to the topography of the alpha power and was strongest over occipital areas. Interestingly, gamma activity per se was not evident in the power spectra and only became detectable when studied in relation to the alpha phase. Intracranial data from an epileptic subject confirmed these findings albeit there was slowing in both the alpha and gamma band. A tentative explanation for this phenomenon is that the visual system is inhibited during most of the alpha cycle whereas a burst of gamma activity at a specific alpha phase ( e. g. at troughs) reflects a window of excitability.	[Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Hermes, Dora] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Sect Brain Funct & Plasticity, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Osipova, D (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	daria.osipova@fcdonders.ru.nl	Jensenq, Ole/D-2120-2010	Jensenq, Ole/0000-0001-8193-8348; Hermes, Dora/0000-0002-8683-8909	Netherlands Organization for Scientific Research Innovative Research Incentive Schemes [864.03.007, Rubicon]; Dutch Technology Foundation STW applied science division of the Netherlands Organization for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht [UGT7685]	Netherlands Organization for Scientific Research Innovative Research Incentive Schemes(Netherlands Organization for Scientific Research (NWO)); Dutch Technology Foundation STW applied science division of the Netherlands Organization for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht	This work was supported by the Netherlands Organization for Scientific Research Innovative Research Incentive Schemes 864.03.007 (to O.J.) and the Rubicon grant from the Netherlands Organization for Scientific Research (to D.O). Intracranial recordings were funded by the Dutch Technology Foundation STW, applied science division of the Netherlands Organization for Scientific Research and the Technology Program of the Ministry of Economic Affairs, and the University of Utrecht grant UGT7685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chorlian DB, 2006, INT J PSYCHOPHYSIOL, V61, P262, DOI 10.1016/j.ijpsycho.2005.11.002; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Diaz GF, 1998, ELECTROEN CLIN NEURO, V106, P501, DOI 10.1016/S0013-4694(98)00026-1; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; GELETY TJ, 1985, CLIN ELECTROENCEPHAL, V16, P94, DOI 10.1177/155005948501600208; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kaiser J, 2004, NEUROIMAGE, V23, P551, DOI 10.1016/j.neuroimage.2004.06.033; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MIYAUCHI T, 1991, EPILEPSIA, V32, P870, DOI 10.1111/j.1528-1157.1991.tb05544.x; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Nikulin VV, 2007, EUR J NEUROSCI, V25, P3146, DOI 10.1111/j.1460-9568.2007.05553.x; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097	35	220	221	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3990	10.1371/journal.pone.0003990	http://dx.doi.org/10.1371/journal.pone.0003990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CA	19098986	Green Submitted, Green Published, gold			2022-12-27	WOS:000265462300003
J	Ben-Simon, E; Podlipsky, I; Arieli, A; Zhdanov, A; Hendler, T				Ben-Simon, Eti; Podlipsky, Ilana; Arieli, Amos; Zhdanov, Andrey; Hendler, Talma			Never Resting Brain: Simultaneous Representation of Two Alpha Related Processes in Humans	PLOS ONE			English	Article							EEG ALPHA; DEFAULT MODE; RHYTHM; OSCILLATIONS; NETWORKS; FMRI; LOCALIZATION; GENERATION; HYPOTHESIS; TRANSFORM	Brain activity is continuously modulated, even at "rest". The alpha rhythm (8-12 Hz) has been known as the hallmark of the brain's idle-state. However, it is still debated if the alpha rhythm reflects synchronization in a distributed network or focal generator and whether it occurs spontaneously or is driven by a stimulus. This EEG/fMRI study aimed to explore the source of alpha modulations and their distribution in the resting brain. By serendipity, while computing the individually defined power modulations of the alpha-band, two simultaneously occurring components of these modulations were found. An 'induced alpha' that was correlated with the paradigm (eyes open/eyes closed), and a 'spontaneous alpha' that was ongoing and unrelated to the paradigm. These alpha components when used as regressors for BOLD activation revealed two segregated activation maps: the 'induced map' included left lateral temporal cortical regions and the hippocampus; the 'spontaneous map' included prefrontal cortical regions and the thalamus. Our combined fMRI/EEG approach allowed to computationally untangle two parallel patterns of alpha modulations and underpin their anatomical basis in the human brain. These findings suggest that the human alpha rhythm represents at least two simultaneously occurring processes which characterize the 'resting brain'; one is related to expected change in sensory information, while the other is endogenous and independent of stimulus change.	[Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Simon, Eti; Podlipsky, Ilana; Zhdanov, Andrey; Hendler, Talma] Tel Aviv Sourasky Med Ctr, Wohl Inst Advanced Imaging, Funct Brain Ctr, Tel Aviv, Israel; [Podlipsky, Ilana] Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel; [Arieli, Amos] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Hendler, Talma] Tel Aviv Univ, Dept Psychol, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Weizmann Institute of Science; Tel Aviv University	Ben-Simon, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	talma@tasmc.health.gov.il	Zhdanov, Andrey/I-7136-2012	Ben Simon, Eti/0000-0002-3862-8288; Zhadnov, Andrey/0000-0002-3379-0251	Israeli Science Foundation; US-Israel Bi-national Science Foundation; National Institute for psychobiology; The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University	Israeli Science Foundation(Israel Science Foundation); US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); National Institute for psychobiology; The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University	This research was supported by the Israeli Science Foundation (Bikura program, TH), the US-Israel Bi-national Science Foundation (TH) and the National Institute for psychobiology (TH), The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University (EBS, IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; [Anonymous], [No title captured]; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Benca RM, 1999, PSYCHOPHYSIOLOGY, V36, P430, DOI 10.1111/1469-8986.3640430; CHAPMAN RM, 1984, ELECTROEN CLIN NEURO, V58, P569, DOI 10.1016/0013-4694(84)90047-6; Christov II, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-28; CREUTZFELDT OD, 1995, PERFORMANCE STRUCTUR, pCH5; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kim KH, 2004, J NEUROSCI METH, V135, P193, DOI 10.1016/j.jneumeth.2003.12.016; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; Miller, 2000, TIME BRAIN; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P151, DOI 10.1016/S0167-8760(00)00138-0; Schurmann M, 2000, NEUROSCI LETT, V292, P175, DOI 10.1016/S0304-3940(00)01456-7; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Travis F, 1999, CONSCIOUS COGN, V8, P302, DOI 10.1006/ccog.1999.0403; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Yazawa S, 2001, INTERNAL MED, V40, P443, DOI 10.2169/internalmedicine.40.443	40	73	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3984	10.1371/journal.pone.0003984	http://dx.doi.org/10.1371/journal.pone.0003984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437AV	19096714	Green Published, Green Submitted, gold			2022-12-27	WOS:000265458800006
J	Jackson, S; Cummins, F; Brady, N				Jackson, Stuart; Cummins, Fred; Brady, Nuala			Rapid Perceptual Switching of a Reversible Biological Figure	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; BINOCULAR-RIVALRY; ALTERNATION; AWARENESS; DYNAMICS; MODEL	Certain visual stimuli can give rise to contradictory perceptions. In this paper we examine the temporal dynamics of perceptual reversals experienced with biological motion, comparing these dynamics to those observed with other ambiguous structure from motion (SFM) stimuli. In our first experiment, naive observers monitored perceptual alternations with an ambiguous rotating walker, a figure that randomly alternates between walking in clockwise (CW) and counter-clockwise (CCW) directions. While the number of reported reversals varied between observers, the observed dynamics (distribution of dominance durations, CW/CCW proportions) were comparable to those experienced with an ambiguous kinetic depth cylinder. In a second experiment, we compared reversal profiles with rotating and standard point-light walkers (i.e. non-rotating). Over multiple test repetitions, three out of four observers experienced consistently shorter mean percept durations with the rotating walker, suggesting that the added rotational component may speed up reversal rates with biomotion. For both stimuli, the drift in alternation rate across trial and across repetition was minimal. In our final experiment, we investigated whether reversals with the rotating walker and a non-biological object with similar global dimensions (rotating cuboid) occur at random phases of the rotation cycle. We found evidence that some observers experience peaks in the distribution of response locations that are relatively stable across sessions. Using control data, we discuss the role of eye movements in the development of these reversal patterns, and the related role of exogenous stimulus characteristics. In summary, we have demonstrated that the temporal dynamics of reversal with biological motion are similar to other forms of ambiguous SFM. We conclude that perceptual switching with biological motion is a robust bistable phenomenon.	[Cummins, Fred] Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 2, Ireland; [Jackson, Stuart; Brady, Nuala] Univ Coll Dublin, Sch Psychol, Percept Lab, Dublin, Ireland	University College Dublin; University College Dublin	Jackson, S (corresponding author), Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 2, Ireland.	stuart.jackson@ucdconnect.ie		Brady, Nuala/0000-0002-9725-1441	Irish Research Council for Science, Engineering and Technology (IRCSET); Science Foundation Ireland (SFI) [04/IN3/I568]	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland (SFI)(Science Foundation Ireland)	SJ is supported by a graduate scholarship from the Irish Research Council for Science, Engineering and Technology (IRCSET). This work is also supported by Science Foundation Ireland (SFI) through Principal Investigator Grant Number 04/IN3/I568 to FC.	Beintema JA, 2006, J VISION, V6, P712, DOI 10.1167/6.7.4; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Bonda E, 1996, J NEUROSCI, V16, P3737; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Brouwer GJ, 2006, VISION RES, V46, P3393, DOI 10.1016/j.visres.2006.03.016; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fang F, 2004, CURR BIOL, V14, P247, DOI 10.1016/j.cub.2004.01.031; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Mamassian P, 1998, VISION RES, V38, P2817, DOI 10.1016/S0042-6989(97)00438-0; NAWROT M, 1991, PERCEPT PSYCHOPHYS, V49, P230, DOI 10.3758/BF03214308; NAWROT M, 1991, VISUAL NEUROSCI, V6, P219, DOI 10.1017/S0952523800006234; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; Suzuki S, 2007, NEURON, V56, P741, DOI 10.1016/j.neuron.2007.09.028; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064	33	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3982	10.1371/journal.pone.0003982	http://dx.doi.org/10.1371/journal.pone.0003982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437AT	19093003	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458600013
J	Watson, BO; MacLean, JN; Yuste, R				Watson, Brendon O.; MacLean, Jason N.; Yuste, Rafael			UP States Protect Ongoing Cortical Activity from Thalamic Inputs	PLOS ONE			English	Article								Cortical neurons in vitro and in vivo fluctuate spontaneously between two stable membrane potentials: a depolarized UP state and a hyperpolarized DOWN state. UP states temporally correspond with multineuronal firing sequences which may be important for information processing. To examine how thalamic inputs interact with ongoing cortical UP state activity, we used calcium imaging and targeted whole-cell recordings of activated neurons in thalamocortical slices of mouse somatosensory cortex. Whereas thalamic stimulation during DOWN states generated multineuronal, synchronized UP states, identical stimulation during UP states had no effect on the subthreshold membrane dynamics of the vast majority of cells or on ongoing multineuronal temporal patterns. Both thalamocortical and corticocortical PSPs were significantly reduced and neuronal input resistance was significantly decreased during cortical UP states - mechanistically consistent with UP state insensitivity. Our results demonstrate that cortical dynamics during UP states are insensitive to thalamic inputs.	[Watson, Brendon O.; MacLean, Jason N.; Yuste, Rafael] Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	Watson, BO (corresponding author), Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA.	bow4@columbia.edu	Watson, Brendon/GON-4927-2022	MacLean, Jason/0000-0002-8021-8063	Kavli Institute for Brain Science; National Eye Institute; National Institute of Neurological Disorders and Stroke; Human Frontiers Science Project	Kavli Institute for Brain Science; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontiers Science Project	Supported by the Kavli Institute for Brain Science, the National Eye Institute, the National Institute of Neurological Disorders and Stroke and the Human Frontiers Science Project.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Beierlein M, 2002, J NEUROSCI, V22, P9885; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Moore D., 2006, INTRO PRACTICE STAT; No R L, 1959, Proc Natl Acad Sci U S A, V45, P592, DOI 10.1073/pnas.45.4.592; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rieke F., 1999, SPIKES EXPLORING NEU; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	30	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3971	10.1371/journal.pone.0003971	http://dx.doi.org/10.1371/journal.pone.0003971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092994	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458600008
J	Harris, LW; Wayland, M; Lan, M; Ryan, M; Giger, T; Lockstone, H; Wuethrich, I; Mimmack, M; Wang, L; Kotter, M; Craddock, R; Bahn, S				Harris, Laura W.; Wayland, Matthew; Lan, Martin; Ryan, Margaret; Giger, Thomas; Lockstone, Helen; Wuethrich, Irene; Mimmack, Michael; Wang, Lan; Kotter, Mark; Craddock, Rachel; Bahn, Sabine			The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; RHEUMATOID-ARTHRITIS; SKIN FLUSH; NEGATIVE ASSOCIATION; PREFRONTAL CORTEX; EXPRESSION; DENSITY; AMPLIFICATION; GENES; CELLS	Background: Previous studies of brain and peripheral tissues in schizophrenia patients have indicated impaired energy supply to the brain. A number of studies have also demonstrated dysfunction of the microvasculature in schizophrenia patients. Together these findings are consistent with a hypothesis of blood-brain barrier dysfunction in schizophrenia. In this study, we have investigated the cerebral vascular endothelium of schizophrenia patients at the level of transcriptomics. Methodology/Principal Findings: We used laser capture microdissection to isolate both microvascular endothelial cells and neurons from post mortem brain tissue from schizophrenia patients and healthy controls. RNA was isolated from these cell populations, amplified, and analysed using two independent microarray platforms, Affymetrix HG133plus2.0 GeneChips and CodeLink Whole Human Genome arrays. In the first instance, we used the dataset to compare the neuronal and endothelial data, in order to demonstrate that the predicted differences between cell types could be detected using this methodology. We then compared neuronal and endothelial data separately between schizophrenic subjects and controls. Analysis of the endothelial samples showed differences in gene expression between schizophrenics and controls which were reproducible in a second microarray platform. Functional profiling revealed that these changes were primarily found in genes relating to inflammatory processes. Conclusions/Significance: This study provides preliminary evidence of molecular alterations of the cerebral microvasculature in schizophrenia patients, suggestive of a hypo-inflammatory state in this tissue type. Further investigation of the blood-brain barrier in schizophrenia is warranted.	[Harris, Laura W.; Wayland, Matthew; Lan, Martin; Ryan, Margaret; Lockstone, Helen; Wuethrich, Irene; Mimmack, Michael; Wang, Lan; Craddock, Rachel; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Giger, Thomas] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Kotter, Mark] Univ Cambridge, Dept Vet Med, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England	University of Cambridge; Max Planck Society; University of Cambridge	Harris, LW (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Wayland, Matthew/V-6751-2019	Wayland, Matthew/0000-0002-8095-858X; Kotter, Mark/0000-0001-5145-7199; Harris, Laura/0000-0003-4312-7223	Molecular Evolution of Human Cognition project [PKB 140404]; NIH [Cambridge health scholarship]; NARSAD [Young Investigator Award, Essel Independent Investigator Fellowship]	Molecular Evolution of Human Cognition project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD)	This study was funded as part of the Molecular Evolution of Human Cognition project (EU Sixth Framework Programme grant PKB 140404). The Stanley Medical Research Institute (SMRI) provided centre support. GE Healthcare UK provided CodeLink Human Whole Genome Bioarrays. ML is the recipient of an NIH-Cambridge health scholarship. MR is the recipient of a NARSAD Young Investigator Award. SB holds a NARSAD Essel Independent Investigator Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boelens MC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-277; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brambilla P, 2007, J PSYCHIATR RES, V41, P502, DOI 10.1016/j.jpsychires.2006.03.002; Burnet PWJ, 2004, BIOL PSYCHIAT, V55, P107, DOI 10.1016/S0006-3223(03)00642-5; CHEADLE C, 2006, MOL CELL PROBES; COHEN BM, 1995, AM J PSYCHIAT, V152, P1801; Craddock RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000692; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; EATON WW, 1992, SCHIZOPHR RES, V6, P181, DOI 10.1016/0920-9964(92)90001-L; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Gorwood P, 2004, SCHIZOPHR RES, V66, P21, DOI 10.1016/S0920-9964(03)00017-3; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; HOLASH JA, 1993, P NATL ACAD SCI USA, V90, P11069, DOI 10.1073/pnas.90.23.11069; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; Hudson CJ, 1997, BIOL PSYCHIAT, V41, P507, DOI 10.1016/S0006-3223(96)00112-6; IRIZARRY R, 2005, AFFY METHODS AFFYMET; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jackson ES, 2005, METHODS, V37, P247, DOI 10.1016/j.ymeth.2005.09.006; Kaposi-Novak P, 2004, BIOTECHNIQUES, V37, P580, DOI 10.2144/04374ST02; Kinnecom K, 2005, BRAIN RES PROTOC, V16, P1, DOI 10.1016/j.brainresprot.2005.08.002; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Kreczmanski P, 2005, ACTA NEUROPATHOL, V109, P510, DOI 10.1007/s00401-005-1003-y; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X; Malaspina D, 2004, BIOL PSYCHIAT, V56, P931, DOI 10.1016/j.biopsych.2004.09.013; McClintick JN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-4; Messamore E, 2003, SCHIZOPHR RES, V62, P251, DOI 10.1016/S0920-9964(02)00311-0; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; O'Connor JA, 2007, SCHIZOPHR RES, V97, P277, DOI 10.1016/j.schres.2007.09.022; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Puri BK, 2001, INT J CLIN PRACT, V55, P368; Regenold WT, 2004, MOL PSYCHIATR, V9, P731, DOI 10.1038/sj.mp.4001517; Riedel M, 2007, J PSYCHIATR RES, V41, P3, DOI 10.1016/j.jpsychires.2005.11.007; RUSSO R, 1994, LANCET, V343, P356, DOI 10.1016/S0140-6736(94)91193-2; Ruzicka WB, 2007, MOL PSYCHIATR, V12, P385, DOI 10.1038/sj.mp.4001954; RYBAKOWSKI J, 1991, BIOL PSYCHIAT, V29, P834, DOI 10.1016/0006-3223(91)90202-W; Schultz SK, 2002, J NEUROPSYCH CLIN N, V14, P19, DOI 10.1176/appi.neuropsych.14.1.19; Shah SH, 2000, SCHIZOPHR RES, V43, P163; Shusta EV, 2002, J CEREBR BLOOD F MET, V22, P245, DOI 10.1097/00004647-200203000-00001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vostrikov V, 2008, WORLD J BIOL PSYCHIA, V9, P34, DOI 10.1080/15622970701210247; Wan C, 2007, AMINO ACIDS, V32, P101, DOI 10.1007/s00726-005-0292-8; Yang YF, 2006, ANAL CHEM, V78, P3571, DOI 10.1021/ac051916x	55	74	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3964	10.1371/journal.pone.0003964	http://dx.doi.org/10.1371/journal.pone.0003964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088852	Green Submitted, Green Published, gold			2022-12-27	WOS:000265458500010
J	Luchman, HA; Benediktsson, H; Villemaire, ML; Peterson, AC; Jirik, FR				Luchman, H. Artee; Benediktsson, Hallgrimur; Villemaire, Michelle L.; Peterson, Alan C.; Jirik, Frank R.			The Pace of Prostatic Intraepithelial Neoplasia Development Is Determined by the Timing of Pten Tumor Suppressor Gene Excision	PLOS ONE			English	Article								Loss of the PTEN tumor suppressor is a common occurrence in human prostate cancer, particularly in advanced disease. In keeping with its role as a pivotal upstream regulator of the phosphatidylinositol 3-kinase signaling pathway, experimentally-induced deletion of Pten in the murine prostate invariably results in neoplasia. However, and unlike humans where prostate tumorigenesis likely evolves over decades, disease progression in the constitutively Pten deficient mouse prostate is relatively rapid, culminating in invasive cancer within several weeks post-puberty. Given that the prostate undergoes rapid androgen-dependent growth at puberty, and that Pten excisions during this time might be especially tumorigenic, we hypothesized that delaying prostate-specific Pten deletions until immediately after puberty might alter the pace of tumorigenesis. To this end we generated mice with a tamoxifen-inducible Cre recombinase transgene enabling temporal control over prostate-specific gene alterations. This line was then interbred with mice carrying floxed Pten alleles. Despite evidence of increased Akt/mTOR/S6K axis activity at early time points in Pten-deficient epithelial cells, excisions induced in the post-pubertal (6 wk-old) prostate yielded gradual acquisition of a range of lesions. These progressed from premalignant changes (nuclear atypia, focal hyperplasia) and low grade prostatic intraepithelial neoplasia (PIN) at 16-20 wks post-tamoxifen exposure, to overtly malignant lesions by similar to 1 yr of age, characterized by high-grade PIN and microinvasive carcinoma. In contrast, when Pten excisions were triggered in the pre-pubertal (2 week-old) prostate, neoplasia evolved over a more abbreviated time-frame, with a spectrum of premalignant lesions, as well as overt PIN and microinvasive carcinoma by 10-12 wks post-tamoxifen exposure. These results indicate that the developmental stage at which Pten deletions are induced dictates the pace of PIN development.	[Villemaire, Michelle L.; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Benediktsson, Hallgrimur] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 1N4, Canada; [Peterson, Alan C.] McGill Univ, Roy Victoria Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada	University of Calgary; University of Calgary; McGill University; Royal Victoria Hospital	Luchman, HA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	jirik@ucalgary.ca		Benediktsson, Hallgrimur/0000-0001-8920-3610	National Cancer Institute of Canada/Prostate Cancer Research Initiative; Alberta Cancer Board [fellowships]; Genome Quebec; Genome Canada; Alberta Heritage Foundation for Medical Research [fellowships]; Canada Research Chair	National Cancer Institute of Canada/Prostate Cancer Research Initiative; Alberta Cancer Board; Genome Quebec; Genome Canada(Genome Canada); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported in its initial stages by a National Cancer Institute of Canada/Prostate Cancer Research Initiative Pilot Grant and subsequently the Alberta Cancer Board (to F.R.J). A.C.P was supported by Genome Quebec and Genome Canada; H.A.L held fellowships from both the Alberta Heritage Foundation for Medical Research and the Alberta Cancer Board. F.R.J. was the recipient of a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kasper S, 1999, J MOL ENDOCRINOL, V22, P313, DOI 10.1677/jme.0.0220313; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; KASPER S, 1994, J BIOL CHEM, V269, P31763; Luchman HA, 2008, GENESIS, V46, P229, DOI 10.1002/dvg.20386; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maddison LA, 2000, GENESIS, V26, P154, DOI 10.1002/(SICI)1526-968X(200002)26:2<154::AID-GENE18>3.0.CO;2-2; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Singh J, 1999, J ANDROL, V20, P251; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yan Y, 1997, PROSTATE, V32, P129; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	30	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3940	10.1371/journal.pone.0003940	http://dx.doi.org/10.1371/journal.pone.0003940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081794	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458200006
J	Moore, TI; Chou, CS; Nie, Q; Jeon, NL; Yi, TM				Moore, Travis I.; Chou, Ching-Shan; Nie, Qing; Jeon, Noo Li; Yi, Tau-Mu			Robust Spatial Sensing of Mating Pheromone Gradients by Yeast Cells	PLOS ONE			English	Article								Projecting or moving up a chemical gradient is a universal behavior of living organisms. We tested the ability of S. cerevisiae a-cells to sense and respond to spatial gradients of the mating pheromone alpha-factor produced in a microfluidics chamber; the focus was on bar1 Delta strains, which do not degrade the pheromone input. The yeast cells exhibited good accuracy with the mating projection typically pointing in the correct direction up the gradient (similar to 80% under certain conditions), excellent sensitivity to shallow gradients, and broad dynamic range so that gradient-sensing was relatively robust over a 1000-fold range of average alpha-factor concentrations. Optimal directional sensing occurred at lower concentrations (5 nM) close to the K-d of the receptor and with steeper gradient slopes. Pheromone supersensitive mutations (sst2 Delta and ste2(300 Delta)) that disrupt the down-regulation of heterotrimeric G-protein signaling caused defects in both sensing and response. Interestingly, yeast cells employed adaptive mechanisms to increase the robustness of the process including filamentous growth (i. e. directional distal budding) up the gradient at low pheromone concentrations, bending of the projection to be more aligned with the gradient, and forming a more accurate second projection when the first projection was in the wrong direction. Finally, the cells were able to amplify a shallow external gradient signal of alpha-factor to produce a dramatic polarization of signaling proteins at the front of the cell. Mathematical modeling revealed insights into the mechanism of this amplification and how the supersensitive mutants can disrupt accurate polarization. Together, these data help to specify and elucidate the abilities of yeast cells to sense and respond to spatial gradients of pheromone.	[Yi, Tau-Mu] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Moore, Travis I.; Chou, Ching-Shan; Nie, Qing; Jeon, Noo Li; Yi, Tau-Mu] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92717 USA; [Chou, Ching-Shan; Nie, Qing] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Moore, TI (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	tmy@uci.edu	Shu, Chi-Wang/A-3216-2013; Moore, Travis/C-7963-2009	Shu, Chi-Wang/0000-0001-7720-9564; Moore, Travis/0000-0002-8503-6023	NIH [R01GM75309, P50GM76516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grants R01GM75309 (through the joint NSF/NIGMS initiative to support research in the area of mathematical biology) to QN and TMY, and P50GM76516 to QN and TMY.	Arkowitz RA, 1997, J CELL BIOL, V138, P17, DOI 10.1083/jcb.138.1.17; Ash J, 2003, GENETICS, V163, P9; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Erdman S, 2001, GENETICS, V159, P919; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Giot L, 1997, MOL BIOL CELL, V8, P987, DOI 10.1091/mbc.8.6.987; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Guthrie C, 1991, GUIDE YEAST GENETICS; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hardman J. G., 1996, GOODMAN GILMANS PHAR; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; KONOPKA JB, 1995, MOL CELL BIOL, V15, P723; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Moukadiri I, 1999, J BACTERIOL, V181, P4741, DOI 10.1128/JB.181.16.4741-4745.1999; Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1; Nern A, 1998, NATURE, V391, P195, DOI 10.1038/34458; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pruyne D, 2000, J CELL SCI, V113, P365; Rasband W., 2006, IMAGEJ; Rodiek R.W., 1998, 1 STEPS SEEING; ROHRER J, 1993, MOL BIOL CELL, V4, P511, DOI 10.1091/mbc.4.5.511; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; SPRAGUE GF, 1992, PHEROMONE RESPONSE S, P657; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Vallier LG, 2002, CELL MOTIL CYTOSKEL, V53, P251, DOI 10.1002/cm.10073; Yi TM, 2007, J STAT PHYS, V128, P193, DOI 10.1007/s10955-007-9285-1; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	41	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3865	10.1371/journal.pone.0003865	http://dx.doi.org/10.1371/journal.pone.0003865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052645	Green Published, gold			2022-12-27	WOS:000265452200011
J	Panagiotou, G; Andersen, MR; Grotkjaer, T; Regueira, TB; Hofmann, G; Nielsen, J; Olsson, L				Panagiotou, Gianni; Andersen, Mikael R.; Grotkjaer, Thomas; Regueira, Torsten B.; Hofmann, Gerald; Nielsen, Jens; Olsson, Lisbeth			Systems Analysis Unfolds the Relationship between the Phosphoketolase Pathway and Growth in Aspergillus nidulans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CDNA MICROARRAYS; METABOLIC FLUXES; WILD-TYPE; GLUCOSE; IDENTIFICATION; NORMALIZATION; ENZYMES; XYLOSE; FLAVUS	Background: Aspergillus nidulans is an important model organism for studies on fundamental eukaryotic cell biology and on industrial processes due to its close relation to A. niger and A. oryzae. Here we identified the gene coding for a novel metabolic pathway in A. nidulans, namely the phosphoketolase pathway, and investigated the role of an increased phosphoketolase activity. Methodology/Principal Findings: Over-expression of the phosphoketolase gene (phk) improved the specific growth rate on xylose, glycerol and ethanol. Transcriptome analysis showed that a total of 1,222 genes were significantly affected by overexpression of the phk, while more than half of the affected genes were carbon source specific. During growth on glucose medium, the transcriptome analysis showed that the response to phk over-expression is targeted to neutralize the effect of the over-expression by regulating the acetate metabolism and initiate a growth dampening response. Conclusions/Significance: Metabolic flux analysis using C-13-labelled glucose, showed that over-expression of phosphoketolase added flexibility to the central metabolism. Our findings further suggests that A. nidulans is not optimized for growth on xylose, glycerol or ethanol as the sole carbon sources.	[Panagiotou, Gianni; Andersen, Mikael R.; Regueira, Torsten B.; Hofmann, Gerald; Nielsen, Jens; Olsson, Lisbeth] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Grotkjaer, Thomas] Fluxome Sci AS, Lyngby, Denmark	Technical University of Denmark	Panagiotou, G (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	lo@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Nielsen, Jens/Q-1347-2017	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; /0000-0002-0827-5442; Nielsen, Jens/0000-0002-9955-6003	Villum Kann Rasmussen and Lundbeck foundations; Danish Research Agency for Technology and Production	Villum Kann Rasmussen and Lundbeck foundations; Danish Research Agency for Technology and Production	This study was partly financed by the Villum Kann Rasmussen and Lundbeck foundations (GP) and the Danish Research Agency for Technology and Production (MRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; *AFF, 2007, PN702232; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Christensen B, 2000, BIOTECHNOL BIOENG, V68, P652, DOI 10.1002/(SICI)1097-0290(20000620)68:6<652::AID-BIT8>3.3.CO;2-A; David H, 2005, MICROBIOL-SGM, V151, P2209, DOI 10.1099/mic.0.27787-0; David H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r108; Guo BZ, 2003, J TOXICOL-TOXIN REV, V22, P287, DOI 10.1081/TXR-120024095; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JOHNSTONE IL, 1985, EMBO J, V4, P1307, DOI 10.1002/j.1460-2075.1985.tb03777.x; Maeda H, 2004, APPL MICROBIOL BIOT, V65, P74, DOI 10.1007/s00253-004-1608-4; Mogensen J, 2006, FUNGAL GENET BIOL, V43, P593, DOI 10.1016/j.fgb.2006.03.003; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; OBrian GR, 2003, FUNGAL GENET BIOL, V39, P118, DOI 10.1016/S1087-1845(03)00014-8; OLIVEIRA AP, 2008, BMC BIOINFO IN PRESS; Panagiotou G, 2007, METABOLOMICS, V3, P503, DOI 10.1007/s11306-007-0061-7; PANAGIOTOU G, 2008, METABOLIC E IN PRESS; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Pedersen H, 1999, APPL ENVIRON MICROB, V65, P11; RATLEDGE C, 1985, APPL MICROBIOL BIOT, V22, P217; ROHR LM, 2005, APPL MICROBIOL BIOT, V68, P567; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Sambrook J., 2001, MOL CLONING; Scheidegger KA, 2003, J TOXICOL-TOXIN REV, V22, P423, DOI 10.1081/TXR-120024100; SENAC T, 1990, APPL ENVIRON MICROB, V56, P120, DOI 10.1128/AEM.56.1.120-126.1990; Sims AH, 2004, FUNGAL GENET BIOL, V41, P199, DOI 10.1016/j.fgb.2003.11.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Thykaer J, 2007, PROCESS BIOCHEM, V42, P1050, DOI 10.1016/j.procbio.2007.04.004; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187	31	33	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3847	10.1371/journal.pone.0003847	http://dx.doi.org/10.1371/journal.pone.0003847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052639	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452200004
J	Shaw, LN; Lindholm, C; Prajsnar, TK; Miller, HK; Brown, MC; Golonka, E; Stewart, GC; Tarkowski, A; Potempa, J				Shaw, Lindsey N.; Lindholm, Catharina; Prajsnar, Tomasz K.; Miller, Halie K.; Brown, Melanie C.; Golonka, Ewa; Stewart, George C.; Tarkowski, Andrej; Potempa, Jan			Identification and Characterization of sigma(S), a Novel Component of the Staphylococcus aureus Stress and Virulence Responses	PLOS ONE			English	Article								S. aureus is a highly successful pathogen that is speculated to be the most common cause of human disease. The progression of disease in S. aureus is subject to multi-factorial regulation, in response to the environments encountered during growth. This adaptive nature is thought to be central to pathogenesis, and is the result of multiple regulatory mechanisms employed in gene regulation. In this work we describe the existence of a novel S. aureus regulator, an as yet uncharacterized ECF-sigma factor (sigma(S)), that appears to be an important component of the stress and pathogenic responses of this organism. Using biochemical approaches we have shown that sigma(S) is able to associates with core-RNAP, and initiate transcription from its own coding region. Using a mutant strain we determined that sigma(S) is important for S. aureus survival during starvation, extended exposure to elevated growth temperatures, and Triton X-100 induced lysis. Coculture studies reveal that a sigma(S) mutant is significantly outcompeted by its parental strain, which is only exacerbated during prolonged growth (7 days), or in the presence of stressor compounds. Interestingly, transcriptional analysis determined that under standard conditions, S. aureus SH1000 does not initiate expression of sigS. Assays performed hourly for 72h revealed expression in typically background ranges. Analysis of a potential anti-sigma factor, encoded downstream of sigS, revealed it to have no obvious role in the upregulation of sigS expression. Using a murine model of septic arthritis, sigS-mutant infected animals lost significantly less weight, developed septic arthritis at significantly lower levels, and had increased survival rates. Studies of mounted immune responses reveal that sigS-mutant infected animals had significantly lower levels of IL-6, indicating only a weak immunological response. Finally, strains of S. aureus lacking sigS were far less able to undergo systemic dissemination, as determined by bacterial loads in the kidneys of infected animals. These results establish that sigma(S) is an important component in S. aureus fitness, and in its adaptation to stress. Additionally it appears to have a significant role in its pathogenic nature, and likely represents a key component in the S. aureus regulatory network.	[Shaw, Lindsey N.; Miller, Halie K.] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Lindholm, Catharina; Golonka, Ewa] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Prajsnar, Tomasz K.; Tarkowski, Andrej; Potempa, Jan] Jagiellonian Univ, Fac Biotechnol, Dept Microbiol, PL-31007 Krakow, Poland; [Brown, Melanie C.; Potempa, Jan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Stewart, George C.] Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA	State University System of Florida; University of South Florida; University of Gothenburg; Jagiellonian University; University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia	Shaw, LN (corresponding author), Univ S Florida, Dept Biol, Tampa, FL 33620 USA.	lshaw@cas.usf.edu	Potempa, Jan/AAA-6850-2021; Shaw, Lindsey/AAI-1741-2020	Shaw, Lindsey/0000-0002-0629-8990; Prajsnar, Tomasz/0000-0001-6562-8630; Miller, Halie/0000-0001-5004-0789; Golonka, Ewa/0000-0002-4013-8616; Potempa, Jan/0000-0002-3600-7461	University of South Florida; Swedish Medical Research Council	University of South Florida; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The financial support for this project was provided by start up funds from the University of South Florida (LNS) and the Swedish Medical Research Council (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2003, FEMS MICROBIOL LETT, V220, P155, DOI 10.1016/S0378-1097(03)00093-4; Bae JB, 2004, J MOL BIOL, V335, P425, DOI 10.1016/j.jmb.2003.10.065; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1825, DOI 10.2741/cheung; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; DEORA R, 1995, BIOCHEM BIOPH RES CO, V208, P610, DOI 10.1006/bbrc.1995.1382; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Fujimoto DF, 1998, J BACTERIOL, V180, P3724, DOI 10.1128/JB.180.14.3724-3726.1998; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; GIRAUDO AT, 1994, CAN J MICROBIOL, V40, P677, DOI 10.1139/m94-107; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Heinrich J, 2006, MOL MICROBIOL, V62, P566, DOI 10.1111/j.1365-2958.2006.05391.x; HELLE M, 1988, EUR J IMMUNOL, V18, P1535, DOI 10.1002/eji.1830181010; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 1999, MOL MICROBIOL, V32, P41, DOI 10.1046/j.1365-2958.1999.01323.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Horsburgh MJ, 2001, MICROBIOL-SGM, V147, P2933, DOI 10.1099/00221287-147-11-2933; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Huang XJ, 1997, J BACTERIOL, V179, P2915, DOI 10.1128/jb.179.9.2915-2921.1997; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jonsson IM, 2004, INFECT IMMUN, V72, P6106, DOI 10.1128/IAI.72.10.6106-6111.2004; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; KEMP EH, 1991, J BACTERIOL, V173, P4646, DOI 10.1128/jb.173.15.4646-4652.1991; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; Matsumoto T, 2005, GENES GENET SYST, V80, P385, DOI 10.1266/ggs.80.385; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Moon JL, 2006, BIOL CHEM, V387, P985, DOI 10.1515/BC.2006.122; Morikawa K, 2003, GENES CELLS, V8, P699, DOI 10.1046/j.1365-2443.2003.00668.x; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000; Resto-Ruiz SI, 2000, INFECT IMMUN, V68, P5970, DOI 10.1128/IAI.68.10.5970-5978.2000; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2007, INFECT IMMUN, V75, P4519, DOI 10.1128/IAI.00491-07; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Turner MS, 2000, J BACTERIOL, V182, P5202, DOI 10.1128/JB.182.18.5202-5210.2000; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001; 2002, MMWR MORB MORTAL WKL, V51, P565; 2002, MMWR MORB MORTAL WKL, V51, P902	84	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3844	10.1371/journal.pone.0003844	http://dx.doi.org/10.1371/journal.pone.0003844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050758	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452100005
J	Larsen, KS; Xu, J; Cermelli, S; Shu, ZY; Gross, SP				Larsen, Kristoffer S.; Xu, Jing; Cermelli, Silvia; Shu, Zhanyong; Gross, Steven P.			BicaudalD Actively Regulates Microtubule Motor Activity in Lipid Droplet Transport	PLOS ONE			English	Article								Background: A great deal of sub-cellular organelle positioning, and essentially all minus-ended organelle transport, depends on cytoplasmic dynein, but how dynein's function is regulated is not well understood. BicD is established to play a critical role in mediating dynein function-loss of BicD results in improperly localized nuclei, mRNA particles, and a dispersed Golgi apparatus-however exactly what BicD's role is remains unknown. Nonetheless, it is widely believed that BicD may act to tether dynein to cargos. Here we use a combination of biophysical and biochemical studies to investigate BicD's role in lipid droplet transport during Drosophila embryogenesis. Methodology/Principal Findings: Functional loss of BicD impairs the embryo's ability to control the net direction of droplet transport; the developmentally controlled reversal in transport is eliminated. We find that minimal BicD expression (near-BicD(null)) decreases the average run length of both plus and minus end directed microtubule (MT) based transport. A point mutation affecting the BicD N-terminus has very similar effects on transport during cellularization (phase II), but in phase III (gastrulation) motion actually appears better than in the wild-type. Conclusions/Significance: In contrast to a simple static tethering model of BicD function, or a role only in initial dynein recruitment to the cargo, our data uncovers a new dynamic role for BicD in actively regulating transport. Lipid droplets move bi-directionally, and our investigations demonstrate that BicD plays a critical-and temporally changing-role in balancing the relative contributions of plus-end and minus-end motors to control the net direction of transport. Our results suggest that while BicD might contribute to recruitment of dynein to the cargo it is not absolutely required for such dynein localization, and it clearly contributes to regulation, helping activation/inactivation of the motors.			Larsen, KS (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	sgross@uci.edu			NIGMS NIH HHS [GM-07311-29, GM64624, R01 GM064624, T32 GM007311] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064624, T32GM007311] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; FOE VE, 1983, J CELL SCI, V61, P31; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MOHLER J, 1985, COLD SPRING HARB SYM, V50, P105, DOI 10.1101/SQB.1985.050.01.015; Oh J, 2000, GENETICS, V154, P713; Petrov DY, 2007, BIOPHYS J, V92, P2953, DOI 10.1529/biophysj.106.097253; SHUBEITA GT, 2008, CELL IN PRESS; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; Vendra G, 2007, RNA, V13, P1860, DOI 10.1261/rna.509007; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9	29	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3763	10.1371/journal.pone.0003763	http://dx.doi.org/10.1371/journal.pone.0003763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018277	Green Published, gold			2022-12-27	WOS:000265448500010
J	Sun, XD; Jin, L; Xiong, MMA				Sun, Xiaodian; Jin, Li; Xiong, Momiao			Extended Kalman Filter for Estimation of Parameters in Nonlinear State-Space Models of Biochemical Networks	PLOS ONE			English	Article							SEQUENTIAL MONTE-CARLO; TIME-COURSE DATA; KINETIC-MODELS; PATHWAY	It is system dynamics that determines the function of cells, tissues and organisms. To develop mathematical models and estimate their parameters are an essential issue for studying dynamic behaviors of biological systems which include metabolic networks, genetic regulatory networks and signal transduction pathways, under perturbation of external stimuli. In general, biological dynamic systems are partially observed. Therefore, a natural way to model dynamic biological systems is to employ nonlinear state-space equations. Although statistical methods for parameter estimation of linear models in biological dynamic systems have been developed intensively in the recent years, the estimation of both states and parameters of nonlinear dynamic systems remains a challenging task. In this report, we apply extended Kalman Filter (EKF) to the estimation of both states and parameters of nonlinear state-space models. To evaluate the performance of the EKF for parameter estimation, we apply the EKF to a simulation dataset and two real datasets: JAK-STAT signal transduction pathway and Ras/Raf/MEK/ERK signaling transduction pathways datasets. The preliminary results show that EKF can accurately estimate the parameters and predict states in nonlinear state-space equations for modeling dynamic biochemical networks.	[Sun, Xiaodian; Jin, Li; Xiong, Momiao] Fudan Univ, Lab Theoret Syst Biol, Shanghai 200433, Peoples R China; [Jin, Li] Chinese Acad Sci, SIBS, MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Xiong, Momiao] Univ Texas, Hlth Sci Ctr, Human Genet Ctr, Houston, TX USA	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston	Sun, XD (corresponding author), Fudan Univ, Lab Theoret Syst Biol, Shanghai 200433, Peoples R China.	Momiao.Xiong@uth.tmc.edu	Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Institutes of Health NIAMS [P01 AR052915-01A1, P50 AR054144-01 CORT, HL74735, ES09912]; Shanghai Commission of Science and Technology Grant [04dz14003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052915, P50AR054144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Shanghai Commission of Science and Technology Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	M. M. Xiong is supported by Grant from National Institutes of Health NIAMS P01 AR052915-01A1, NIAMS P50 AR054144-01 CORT, HL74735, and ES09912 and Shanghai Commission of Science and Technology Grant (04dz14003). X. D. Sun and L. Jin are supported by Grant from Shanghai Commission of Science and Technology (04dz14003).	Arisi I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S6; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Borger S, 2007, GENOME INFORM SER, V18, P215; Cho KH, 2003, LECT NOTES COMPUT SC, V2602, P127; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; COSTA PJ, 1994, IEEE T AERO ELEC SYS, V30, P525, DOI 10.1109/7.272275; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Germani A, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P886; Ghahramani Z, 1999, ADV NEUR IN, V11, P431; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; HarshaRani GV, 2005, J BIOCHEM, V137, P653, DOI 10.1093/jb/mvi083; Henderson D, 2006, STOCHASTIC DIFFERENTIAL EQUATIONS IN SCIENCE AND ENGINEERING, P1, DOI 10.1142/9789812774798; Hu XL, 2008, IEEE T SIGNAL PROCES, V56, P1337, DOI 10.1109/TSP.2007.911295; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kitayama T, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-24; Klipp E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S10; Kunsch HR, 2005, ANN STAT, V33, P1983, DOI 10.1214/009053605000000426; Lang L, 2007, AUTOMATICA, V43, P1615, DOI 10.1016/j.automatica.2007.02.012; Li P, 2004, IEE P-CONTR THEOR AP, V151, P727, DOI 10.1049/ip-cta:20041008; Maiwald T, 2007, ANN NY ACAD SCI, V1115, P212, DOI 10.1196/annals.1407.007; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; NATAL AW, 2006, BRIEF BIOINFORM, V7, P364; NELSON TA, 2000, THESIS OREGON GRADUA; Ogata K., 1998, SYSTEM DYNAMICS, VVol. 3; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Riddihough G, 2008, SCIENCE, V319, P1781, DOI 10.1126/science.319.5871.1781; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; SCHON TB, 2006, THESIS LINKOPING U L; Simon D, 2006, OPTIMAL STATE ESTIMA, DOI DOI 10.1002/0470045345.CH11; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sitz A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016210; Snoep JL, 2005, CURR OPIN BIOTECH, V16, P336, DOI 10.1016/j.copbio.2005.05.003; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Sugimoto M, 2005, BIOSYSTEMS, V80, P155, DOI 10.1016/j.biosystems.2004.11.003; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Tian TH, 2007, BIOINFORMATICS, V23, P84, DOI 10.1093/bioinformatics/btl552; Timmer J, 2004, INT J BIFURCAT CHAOS, V14, P2069, DOI 10.1142/S0218127404010461; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104	46	74	75	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3758	10.1371/journal.pone.0003758	http://dx.doi.org/10.1371/journal.pone.0003758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018286	Green Published, gold			2022-12-27	WOS:000265448500005
J	Huffard, CL; Caldwell, RL; DeLoach, N; Gentry, DW; Humann, P; MacDonald, B; Moore, B; Ross, R; Uno, T; Wong, S				Huffard, Christine L.; Caldwell, Roy L.; DeLoach, Ned; Gentry, David Wayne; Humann, Paul; MacDonald, Bill; Moore, Bruce; Ross, Richard; Uno, Takako; Wong, Stephen			Individually Unique Body Color Patterns in Octopus (Wunderpus photogenicus) Allow for Photoidentification	PLOS ONE			English	Article								Studies on the longevity and migration patterns of wild animals rely heavily on the ability to track individual adults. Non-extractive sampling methods are particularly important when monitoring animals that are commercially important to ecotourism, and/or are rare. The use of unique body patterns to recognize and track individual vertebrates is well-established, but not common in ecological studies of invertebrates. Here we provide a method for identifying individual Wunderpus photogenicus using unique body color patterns. This charismatic tropical octopus is commercially important to the underwater photography, dive tourism, and home aquarium trades, but is yet to be monitored in the wild. Among the adults examined closely, the configurations of fixed white markings on the dorsal mantle were found to be unique. In two animals kept in aquaria, these fixed markings were found not to change over time. We believe another individual was photographed twice in the wild, two months apart. When presented with multiple images of W. photogenicus, volunteer observers reliably matched photographs of the same individuals. Given the popularity of W. photogenicus among underwater photographers, and the ease with which volunteers can correctly identify individuals, photo-identification appears to be a practical means to monitor individuals in the wild.	[Huffard, Christine L.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Caldwell, Roy L.] Univ Calif Berkeley, Dept Integrative Biol, Berkeley, CA 94720 USA; [DeLoach, Ned; Humann, Paul] New World Publications, Jacksonville, FL USA; [MacDonald, Bill] Bill Macdonald Productions, Venice, Italy; [Moore, Bruce] Black Sand Dive Retreat, Kasawari, Indonesia; [Ross, Richard] Steinhart Aquarium, San Francisco, CA USA; [Uno, Takako; Wong, Stephen] Homantin, Kowloon, Peoples R China	Monterey Bay Aquarium Research Institute; University of California System; University of California Berkeley	Huffard, CL (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA USA.	chuffard@berkeley.edu						Anderson TJ, 1999, MAR FRESHWATER RES, V50, P225, DOI 10.1071/MF98152; ARONSON RB, 1989, AM MALACOL BULL, V7, P47; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Boal JG, 2006, VIE MILIEU, V56, P69; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; FRICKE H, 1991, ENVIRON BIOL FISH, V32, P287, DOI 10.1007/BF00007462; HAMMOND PS, 1990, MAMMAL REV, V20, P17, DOI 10.1111/j.1365-2907.1990.tb00099.x; HANLON RT, 1989, AM MALACOL BULL, V7, P21; HANLON RT, 1988, MALACOLOGIA, V29, P247; Hochberg FG, 2006, MOLLUSCAN RES, V26, P128; Hochner B, 2006, BIOL BULL-US, V210, P308, DOI 10.2307/4134567; Huffard CL, 2008, MAR BIOL, V154, P353, DOI 10.1007/s00227-008-0930-2; Huffard CL, 2006, J EXP BIOL, V209, P3697, DOI 10.1242/jeb.02435; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; KUCERA TE, 1978, J MAMMAL, V59, P463, DOI 10.2307/1380224; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Packard A., 1977, Symposia of the Zoological Society of London, P191; Piatkowski U, 2001, FISH RES, V52, P5, DOI 10.1016/S0165-7836(01)00226-0; ROBINSON SMC, 1986, J ZOOL, V209, P559, DOI 10.1111/j.1469-7998.1986.tb03611.x; ROPER CFE, 1988, MALACOLOGIA, V29, P153; Semmens JM, 2007, REV FISH BIOL FISHER, V17, P401, DOI 10.1007/s11160-007-9048-8; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001	26	25	25	15	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3732	10.1371/journal.pone.0003732	http://dx.doi.org/10.1371/journal.pone.0003732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009019	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166400010
J	Molchadsky, A; Shats, I; Goldfinger, N; Pevsner-Fischer, M; Olson, M; Rinon, A; Tzahor, E; Lozano, G; Zipori, D; Sarig, R; Rotter, V				Molchadsky, Alina; Shats, Igor; Goldfinger, Naomi; Pevsner-Fischer, Meirav; Olson, Melissa; Rinon, Ariel; Tzahor, Eldad; Lozano, Guillermina; Zipori, Dov; Sarig, Rachel; Rotter, Varda			p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner	PLOS ONE			English	Article								Background: The tumor suppressor p53 is an important regulator that controls various cellular networks, including cell differentiation. Interestingly, some studies suggest that p53 facilitates cell differentiation, whereas others claim that it suppresses differentiation. Therefore, it is critical to evaluate whether this inconsistency represents an authentic differential p53 activity manifested in the various differentiation programs. Methodology/Principal Findings: To clarify this important issue, we conducted a comparative study of several mesenchymal differentiation programs. The effects of p53 knockdown or enhanced activity were analyzed in mouse and human mesenchymal cells, representing various stages of several differentiation programs. We found that p53 down-regulated the expression of master differentiation-inducing transcription factors, thereby inhibiting osteogenic, adipogenic and smooth muscle differentiation of multiple mesenchymal cell types. In contrast, p53 is essential for skeletal muscle differentiation and osteogenic re-programming of skeletal muscle committed cells. Conclusions: These comparative studies suggest that, depending on the specific cell type and the specific differentiation program, p53 may exert a positive or a negative effect, and thus can be referred as a "guardian of differentiation'' at large.	[Molchadsky, Alina; Shats, Igor; Goldfinger, Naomi; Pevsner-Fischer, Meirav; Zipori, Dov; Sarig, Rachel; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Olson, Melissa; Lozano, Guillermina] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX USA; [Rinon, Ariel; Tzahor, Eldad] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel	Weizmann Institute of Science; University of Texas System; UTMD Anderson Cancer Center; Weizmann Institute of Science	Molchadsky, A (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	lcrachel@mail.weizmann.ac.il	TZAHOR, ELDAD/AAD-9886-2021; Shats, Igor/AAD-8775-2019	Shats, Igor/0000-0001-6449-5979	Flight Attendant Medical Research Institute (FAMRI) [Center of Excellence]; Yad Abraham Center for Cancer Diagnosis and Therapy	Flight Attendant Medical Research Institute (FAMRI); Yad Abraham Center for Cancer Diagnosis and Therapy	This research was supported by a Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI), and Yad Abraham Center for Cancer Diagnosis and Therapy.	Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; ALONIGRINSTEIN R, 1993, ONCOGENE, V8, P3297; ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; BENAYAHU D, 1989, J CELL PHYSIOL, V140, P1, DOI 10.1002/jcp.1041400102; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Berberich SJ, 1999, DIFFERENTIATION, V64, P205, DOI 10.1046/j.1432-0436.1999.6440205.x; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Campbell WA, 2006, J NEUROCHEM, V96, P1423, DOI 10.1111/j.1471-4159.2006.03648.x; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Constance CM, 1996, MOL CELL BIOL, V16, P3878; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Fajas L, 2000, FEBS LETT, V471, P29, DOI 10.1016/S0014-5793(00)01363-6; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Huttinger-Kirchhof N, 2006, CELL DEATH DIFFER, V13, P174, DOI 10.1038/sj.cdd.4401809; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kochupurakkal BS, 2008, BIOCHEM BIOPH RES CO, V365, P846, DOI 10.1016/j.bbrc.2007.11.073; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lefebvre AM, 1999, J ENDOCRINOL, V162, P331, DOI 10.1677/joe.0.1620331; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Linsalata M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-191; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Seargent JM, 2004, BRIT J PHARMACOL, V143, P933, DOI 10.1038/sj.bjp.0705973; Shats I, 2007, CELL CYCLE, V6, P1141, DOI 10.4161/cc.6.10.4251; SHAULSKY G, 1991, P NATL ACAD SCI USA, V88, P8982, DOI 10.1073/pnas.88.20.8982; Slattery ML, 2005, NUTR CANCER, V51, P155, DOI 10.1207/s15327914nc5102_5; Soddu S, 1996, J CELL BIOL, V134, P193, DOI 10.1083/jcb.134.1.193; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tataria M, 2006, J PEDIATR SURG, V41, P624, DOI 10.1016/j.jpedsurg.2005.12.001; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villiard E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-180; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zambetti GP, 2006, J CELL BIOL, V172, P795, DOI 10.1083/jcb.200601114	62	136	140	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3707	10.1371/journal.pone.0003707	http://dx.doi.org/10.1371/journal.pone.0003707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002260	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166000007
J	Merlo, E; Romano, A				Merlo, Emiliano; Romano, Arturo			Memory Extinction Entails the Inhibition of the Transcription Factor NF-kappa B	PLOS ONE			English	Article							LONG-TERM-MEMORY; CRAB CHASMAGNATHUS-GRANULATUS; PROTEIN-SYNTHESIS; FEAR EXTINCTION; CONDITIONED FEAR; RAT HIPPOCAMPUS; DANGER STIMULUS; RECONSOLIDATION; CONSOLIDATION; HABITUATION	In contextual memories, an association between a positive or negative reinforcement and the contextual cues where the reinforcement occurs is formed. The re-exposure to the context without reinforcement can lead to memory extinction or reconsolidation, depending on the number of events or duration of a single event of context re-exposure. Extinction involves the temporary waning of the previously acquired conditioned response. The molecular processes underlying extinction and the mechanisms which determine if memory will reconsolidate or extinguish after retrieval are not well characterized, particularly the role of transcription factors and gene expression. Here we studied the participation of a transcription factor, NF-kappa B, in memory extinction. In the crab context-signal memory, the activation of NF-kappa B plays a critical role in consolidation and reconsolidation, memory processes that are well characterized in this model. The administration of a NF-kappa B inhibitor, sulfasalazine prior to extinction session impeded spontaneous recovery. Moreover, reinstatement experiments showed that the original memory was not affected and that NF-kappa B inhibition by sulfasalazine impaired spontaneous recovery strengthening the ongoing memory extinction process. Interestingly, in animals with fully consolidated memory, a brief re-exposure to the training context induced neuronal NF-kappa B activation and reconsolidation, while prolonged re-exposure induced NF-kappa B inhibition and memory extinction. These data constitutes a novel insight into the molecular mechanisms involved in the switch between memory reconsolidation and extinction. Moreover, we propose the inhibition of NF-kappa B as the engaged mechanism underlying extinction, supporting a novel approach for the pharmacological enhancement of this memory process. The accurate description of the molecular mechanisms that support memory extinction is potentially useful for developing new strategies and drug candidates for therapeutic treatments of the maladaptive memory disorders such as post-traumatic stress, phobias, and drug addiction.	[Merlo, Emiliano; Romano, Arturo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIByNE,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Merlo, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIByNE,CONICET, Ciudad Univ,Pab 2, Buenos Aires, DF, Argentina.	aromano@fbmc.fcen.uba.ar	Merlo, Emiliano/S-5328-2019	Merlo, Emiliano/0000-0001-9162-6858; Romano, Arturo/0000-0002-8457-0494	FONCYT-PICT Argentina [26095]; CONICET PIP [5466]; University of Buenos Aires UBACYT [X251]	FONCYT-PICT Argentina(ANPCyTFONCyT); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires UBACYT(University of Buenos Aires)	This work was supported by FONCYT-PICT 26095 Argentina, CONICET PIP 5466 and University of Buenos Aires UBACYT X251 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOUTON ME, 1991, CURRENT TOPICS IN ANIMAL LEARNING : BRAIN, EMOTION, AND COGNITION, P25; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Davis M, 2006, J TRAUMA STRESS, V19, P571, DOI 10.1002/jts.20149; FALLS WA, 1992, J NEUROSCI, V12, P854; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Freudenthal R, 1998, NEUROSCI LETT, V242, P143, DOI 10.1016/S0304-3940(98)00059-7; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GLEESON RA, 1977, COMP BIOCHEM PHYS A, V56, P411, DOI 10.1016/0300-9629(77)90258-4; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HOEGER U, 1989, COMP BIOCHEM PHYS C, V92, P323, DOI 10.1016/0742-8413(89)90062-5; Howell DC, 1987, STAT METHODS PSYCHOL; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lin CH, 2003, J NEUROSCI, V23, P8310; Lin CH, 2003, J NEUROSCI, V23, P1574; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; LOZADA M, 1990, PHYSIOL BEHAV, V47, P35, DOI 10.1016/0031-9384(90)90039-7; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PEDREIRA ME, 1995, PHARMACOL BIOCHEM BE, V52, P385, DOI 10.1016/0091-3057(95)00124-F; Pedreira ME, 1998, ANIM LEARN BEHAV, V26, P34, DOI 10.3758/BF03199160; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Pereyra P, 2000, NEUROBIOL LEARN MEM, V74, P119, DOI 10.1006/nlme.1999.3945; Perez-Cuesta LM, 2007, LEARN MEMORY, V14, P101, DOI 10.1101/lm.413507; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; ROMANO A, 1990, BEHAV NEURAL BIOL, V53, P113, DOI 10.1016/0163-1047(90)90882-7; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Romano A, 2006, BIOL BULL-US, V210, P280, DOI 10.2307/4134564; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rothbaum BO, 2002, AM J PSYCHOTHER, V56, P59, DOI 10.1176/appi.psychotherapy.2002.56.1.59; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tomsic D, 1998, ANIM LEARN BEHAV, V26, P196, DOI 10.3758/BF03199212; Vianna MR, 2003, NEUROBIOL LEARN MEM, V79, P199, DOI 10.1016/S1074-7427(03)00003-0; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298	53	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3687	10.1371/journal.pone.0003687	http://dx.doi.org/10.1371/journal.pone.0003687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WR	18997870	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165500010
J	Muzzi, A; Moschioni, M; Covacci, A; Rappuoli, R; Donati, C				Muzzi, Alessandro; Moschioni, Monica; Covacci, Antonello; Rappuoli, Rino; Donati, Claudio			Pilus Operon Evolution in Streptococcus pneumoniae Is Driven by Positive Selection and Recombination	PLOS ONE			English	Article							DIVERSIFYING SELECTION; PLASMODIUM-FALCIPARUM; ANTIGENIC DIVERSITY; SEQUENCE; ADAPTATION; SITES; POLYMORPHISM; POPULATIONS; VIRULENCE; PATTERNS	Background: The evolution of bacterial organelles involved in host-pathogen interactions is subject to intense and competing selective pressures due to the need to maintain function while escaping the host immune response. To characterize the interplay of these forces in an important pathogen, we sequenced the rlrA islet, a chromosomal region encoding for a pilus-like structure involved in adherence to lung epithelial cells in vitro and in colonization in a murine model of infection, in 44 clinical isolates of Streptococcus pneumoniae. Results: We found that the rrgA and rrgB genes, encoding the main structural components of the pilus, are under the action of positive selection. In contrast, the rrgC gene, coding for a component present in low quantities in the assembled pilus, and the srtB, srtC and srtD genes, coding for three sortase enzymes essential for pilus assembly but probably not directly exposed to the host immune system, show no evidence of positive selection. We found several events of homologous recombination in the region containing these genes, identifying 4 major recombination hotspots. An analysis of the most recent recombination events shows a high level of mosaicism of the region coding for the rrgC, srtB, srtC and srtD genes. Conclusions: In the rlrA islet, the genes coding for proteins directly exposed to the host immune response are under the action of positive selection, and exist in distinct forms in the population of circulating strains. The genes coding for proteins not directly exposed on the surface of the bacterial cell are more conserved probably due to the homogenizing effect of recombination.	[Muzzi, Alessandro; Moschioni, Monica; Covacci, Antonello; Rappuoli, Rino; Donati, Claudio] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	Muzzi, A (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	claudio.donati@novartis.com	Donati, Claudio/AAF-1246-2020; Donati, Claudio/J-5180-2012	Donati, Claudio/0000-0001-8688-1651				Anisimova M, 2003, GENETICS, V164, P1229; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Baum J, 2003, GENETICS, V163, P1327; Boyd EF, 1998, J MOL EVOL, V47, P258, DOI 10.1007/PL00006383; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fearnhead P, 2001, GENETICS, V159, P1299; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Guttman DS, 2006, MOL BIOL EVOL, V23, P2342, DOI 10.1093/molbev/msl103; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hudson RR, 2001, GENETICS, V159, P1805; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MOSCHIONI M, 2008, J INFECT DIS; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Polley SD, 2001, GENETICS, V158, P1505; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Urwin R, 2002, MOL BIOL EVOL, V19, P1686, DOI 10.1093/oxfordjournals.molbev.a003991; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3660	10.1371/journal.pone.0003660	http://dx.doi.org/10.1371/journal.pone.0003660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987753	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134500006
J	Gavin, EJ; Song, B; Wang, Y; Xi, YG; Ju, JF				Gavin, Elaine J.; Song, Bo; Wang, Yuan; Xi, Yaguang; Ju, Jingfang			Reduction of Orc6 Expression Sensitizes Human Colon Cancer Cells to 5-Fluorouracil and Cisplatin	PLOS ONE			English	Article								Previous studies from our group have shown that the expression levels of Orc6 were highly elevated in colorectal cancer patient specimens and the induction of Orc6 was associated with 5-fluorouracil (5-FU) treatment. The goal of this study was to investigate the molecular and cellular impact of Orc6 in colon cancer. In this study, we use HCT116 (wt-p53) and HCT116 (null-p53) colon cancer cell lines as a model system to investigate the impact of Orc6 on cell proliferation, chemosensitivity and pathways involved with Orc6. We demonstrated that the down regulation of Orc6 sensitizes colon cancer cells to both 5-FU and cisplatin (cis-pt) treatment. Decreased Orc6 expression in HCT-116 (wt-p53) cells by RNA interference triggered cell cycle arrest at G1 phase. Prolonged inhibition of Orc6 expression resulted in multinucleated cells in HCT-116 (wt-p53) cell line. Western immunoblot analysis showed that down regulation of Orc6 induced p21 expression in HCT-116 (wt-p53) cells. The induction of p21 was mediated by increased level of phosphorylated p53 at ser-15. By contrast, there is no elevated expression of p21 in HCT-116 (null-p53) cells. Orc6 down regulation also increased the expression of DNA damaging repair protein GADD45b and reduced the expression level of JNK1. Orc6 may be a potential novel target for future anti cancer therapeutic development in colon cancer.	[Gavin, Elaine J.; Xi, Yaguang; Ju, Jingfang] Univ S Alabama, Canc Genom Lab, Mitchell Canc Inst, Mobile, AL 36688 USA; [Song, Bo; Wang, Yuan; Ju, Jingfang] SUNY Stony Brook, Sch Med, Dept Pathol, Translat Res Lab, Stony Brook, NY USA	University of South Alabama; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gavin, EJ (corresponding author), Univ S Alabama, Canc Genom Lab, Mitchell Canc Inst, Mobile, AL 36688 USA.	jiju@notes.cc.sunysb.edu		Xi, Yaguang/0000-0003-3681-9352; Ju, Jingfang/0000-0002-4821-7458	Mitchell Cancer Institute cancer genomics laboratory; NIH [CA114043]; NATIONAL CANCER INSTITUTE [R21CA114043] Funding Source: NIH RePORTER	Mitchell Cancer Institute cancer genomics laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Mitchell Cancer Institute cancer genomics laboratory start-up fund to (J. Ju) and NIH CA114043 (J. Ju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1990, CANCER RES, V50, P7717; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Chen JM, 2007, SENSORS-BASEL, V7, P2907, DOI 10.3390/S7112907; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Xi Y, 2008, ONCOL REP, V19, P257; Xi YG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-68; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	24	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4054	10.1371/journal.pone.0004054	http://dx.doi.org/10.1371/journal.pone.0004054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112505	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466000015
J	Brisson, B; Jolicoeur, P				Brisson, Benoit; Jolicoeur, Pierre			Express Attentional Re-Engagement but Delayed Entry into Consciousness Following Invalid Spatial Cues in Visual Search	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SHORT-TERM-MEMORY; SELECTIVE ATTENTION; HUMAN ELECTROPHYSIOLOGY; VISUOSPATIAL ATTENTION; LATENCY DIFFERENCES; CONTROL SETTINGS; WORKING-MEMORY	Background: In predictive spatial cueing studies, reaction times (RT) are shorter for targets appearing at cued locations (valid trials) than at other locations (invalid trials). An increase in the amplitude of early P1 and/or N1 event-related potential (ERP) components is also present for items appearing at cued locations, reflecting early attentional sensory gain control mechanisms. However, it is still unknown at which stage in the processing stream these early amplitude effects are translated into latency effects. Methodology/Principal Findings: Here, we measured the latency of two ERP components, the N2pc and the sustained posterior contralateral negativity (SPCN), to evaluate whether visual selection (as indexed by the N2pc) and visual-short term memory processes (as indexed by the SPCN) are delayed in invalid trials compared to valid trials. The P1 was larger contralateral to the cued side, indicating that attention was deployed to the cued location prior to the target onset. Despite these early amplitude effects, the N2pc onset latency was unaffected by cue validity, indicating an express, quasi-instantaneous re-engagement of attention in invalid trials. In contrast, latency effects were observed for the SPCN, and these were correlated to the RT effect. Conclusions/Significance: Results show that latency differences that could explain the RT cueing effects must occur after visual selection processes giving rise to the N2pc, but at or before transfer in visual short-term memory, as reflected by the SPCN, at least in discrimination tasks in which the target is presented concurrently with at least one distractor. Given that the SPCN was previously associated to conscious report, these results further show that entry into consciousness is delayed following invalid cues.	[Brisson, Benoit; Jolicoeur, Pierre] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada	Universite de Montreal	Brisson, B (corresponding author), Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada.	benoit.brisson@umontreal.ca		Brisson, Benoit/0000-0002-3717-3365	Natural Sciences and Engineering Research Council of Canada (NSERC) [postgraduate scholarship]; Canada Research Chairs Program; Universite de Montreal; Fonds de Recherche en Sante du Quebec (FRSQ)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Universite de Montreal; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chairs Program, and the Universite de Montreal awarded to PJ and by an NSERC postgraduate scholarship awarded to BB, as well as by an infrastructure grant from the Fonds de Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAVO MJ, 1992, PERCEPT PSYCHOPHYS, V51, P465, DOI 10.3758/BF03211642; Brisson B, 2007, NEUROPSYCHOLOGIA, V45, P3038, DOI 10.1016/j.neuropsychologia.2007.05.022; Brisson B, 2007, NEUROREPORT, V18, P1627, DOI 10.1097/WNR.0b013e3282f0b559; Brisson B, 2007, PSYCHOPHYSIOLOGY, V44, P323, DOI 10.1111/j.1469-8986.2007.00503.x; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; EIMER M, 2008, J COGNITIVE IN PRESS; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; HAWKINS HL, 1988, PERCEPT PSYCHOPHYS, V44, P484, DOI 10.3758/BF03210434; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Jolicoeur P, 2006, EUR J COGN PSYCHOL, V18, P560, DOI 10.1080/09541440500423210; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; KLEIN RM, 1988, NATURE, V334, P340; KWAK HW, 1991, PERCEPT PSYCHOPHYS, V49, P473, DOI 10.3758/BF03212181; Leblanc E, 2005, CAN J EXP PSYCHOL, V59, P124, DOI 10.1037/h0087467; Leblanc E, 2008, J COGNITIVE NEUROSCI, V20, P657, DOI 10.1162/jocn.2008.20051; Lien MC, 2008, J EXP PSYCHOL HUMAN, V34, P509, DOI 10.1037/0096-1523.34.3.509; Luck S.J., 2005, INTRO EVENT RELATED; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1993, J COGNITIVE NEUROSCI, V5, P188, DOI 10.1162/jocn.1993.5.2.188; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MANGUN GR, 1990, PERCEPT PSYCHOPHYS, V47; Mazza V, 2007, EXP BRAIN RES, V181, P531, DOI 10.1007/s00221-007-1002-4; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; MULLER HJ, 1987, PERCEPT PSYCHOPHYS, V42, P383, DOI 10.3758/BF03203097; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; PERRON R, 2008, PSYCHOL RES IN PRESS; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PTITO A, 2008, PSYCHOPHYSI IN PRESS; REMINGTON R, 1984, PERCEPT PSYCHOPHYS, V35, P393, DOI 10.3758/BF03206344; Robitaille N, 2006, CAN J EXP PSYCHOL, V60, P101, DOI 10.1037/cjep2006011; SAGI D, 1985, SPATIAL VISION, V2, P141; SHAW ML, 1984, ATTENTION PERFORM, V10, P109; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Verleger R, 2006, BIOL PSYCHOL, V73, P298, DOI 10.1016/j.biopsycho.2006.05.005; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Woodman GF, 2003, PSYCHOL SCI, V14, P605, DOI 10.1046/j.0956-7976.2003.psci_1472.x; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121	63	27	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3967	10.1371/journal.pone.0003967	http://dx.doi.org/10.1371/journal.pone.0003967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437AS	19088847	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458500012
J	Prieto, C; Risueno, A; Fontanillo, C; De Las Rivas, J				Prieto, Carlos; Risueno, Alberto; Fontanillo, Celia; De Las Rivas, Javier			Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles	PLOS ONE			English	Article							MICROARRAY DATA; EXPRESSION; AFFYMETRIX; SENSITIVITY; ALGORITHM	Background: Analysis of gene expression data using genome-wide microarrays is a technique often used in genomic studies to find coexpression patterns and locate groups of co-transcribed genes. However, most studies done at global "omic'' scale are not focused on human samples and when they correspond to human very often include heterogeneous datasets, mixing normal with disease-altered samples. Moreover, the technical noise present in genome-wide expression microarrays is another well reported problem that many times is not addressed with robust statistical methods, and the estimation of errors in the data is not provided. Methodology/Principal Findings: Human genome-wide expression data from a controlled set of normal-healthy tissues is used to build a confident human gene coexpression network avoiding both pathological and technical noise. To achieve this we describe a new method that combines several statistical and computational strategies: robust normalization and expression signal calculation; correlation coefficients obtained by parametric and non-parametric methods; random cross-validations; and estimation of the statistical accuracy and coverage of the data. All these methods provide a series of coexpression datasets where the level of error is measured and can be tuned. To define the errors, the rates of true positives are calculated by assignment to biological pathways. The results provide a confident human gene coexpression network that includes 3327 gene-nodes and 15841 coexpression-links and a comparative analysis shows good improvement over previously published datasets. Further functional analysis of a subset core network, validated by two independent methods, shows coherent biological modules that share common transcription factors. The network reveals a map of coexpression clusters organized in well defined functional constellations. Two major regions in this network correspond to genes involved in nuclear and mitochondrial metabolism and investigations on their functional assignment indicate that more than 60% are house-keeping and essential genes. The network displays new non-described gene associations and it allows the placement in a functional context of some unknown non-assigned genes based on their interactions with known gene families. Conclusions/Significance: The identification of stable and reliable human gene to gene coexpression networks is essential to unravel the interactions and functional correlations between human genes at an omic scale. This work contributes to this aim, and we are making available for the scientific community the validated human gene coexpression networks obtained, to allow further analyses on the network or on some specific gene associations. The data are available free online at http://bioinfow.dep.usal.es/coexpression/.	[Prieto, Carlos; Risueno, Alberto; Fontanillo, Celia; De Las Rivas, Javier] USAL, CSIC, CIC IBMCC, Bioinformat & Funct Genom Res Grp,Canc Res Ctr, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Prieto, C (corresponding author), USAL, CSIC, CIC IBMCC, Bioinformat & Funct Genom Res Grp,Canc Res Ctr, Salamanca, Spain.	jrivas@usal.es	Prieto, Carlos/G-2382-2016; De Las Rivas, Javier/G-5936-2014; 2008, Ibsal/A-1268-2012	Prieto, Carlos/0000-0001-8178-9768; De Las Rivas, Javier/0000-0002-0984-9946; Fontanillo, Celia/0000-0002-3631-7881; , Alberto/0000-0002-5544-0762	Ministery of Health, Spanish Government [PI061153]; Ministery of Education, Castilla-Leon Local Government [CSI03A06]	Ministery of Health, Spanish Government; Ministery of Education, Castilla-Leon Local Government	Funding and grant support was provided by the Ministery of Health, Spanish Government (ISCiii-FIS, MSyC; Project reference PI061153) and by the Ministery of Education, Castilla-Leon Local Government (JCyL; Project reference CSI03A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Calza S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm537; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Murtagh F., 1985, MULTIDIMENSIONAL CLU; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Prieto C, 2006, BIOINFORMATICS, V22, P1103, DOI 10.1093/bioinformatics/btl053; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suojanen JN, 1999, NEW ENGL J MED, V341, P131, DOI 10.1056/NEJM199907083410217; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Wang YH, 2007, BIOINFORMATICS, V23, P2088, DOI 10.1093/bioinformatics/btm306	33	194	200	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3911	10.1371/journal.pone.0003911	http://dx.doi.org/10.1371/journal.pone.0003911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081792	Green Published, gold			2022-12-27	WOS:000265458200001
J	Baratt, A; Arkhipov, SN; Maly, IV				Baratt, Arie; Arkhipov, Sergey N.; Maly, Ivan V.			An Experimental and Computational Study of Effects of Microtubule Stabilization on T-Cell Polarity	PLOS ONE			English	Article								T-killer cells eliminate infected and cancerous cells with precision by positioning their centrosome near the interface (Immunological synapse) with the target cell. The mechanism of centrosome positioning has remained controversial, in particular the role of microtubule dynamics in it. We re-examined the issue in the experimental model of Jurkat cells presented with a T cell receptor-binding artificial substrate, which permits controlled stimulation and reproducible measurements. Neither 1-mu m taxol nor 100-nM nocodazole inhibited the centrosome positioning at the "synapse" with the biomimetic substrate. At the same time, in micromolar taxol but not in nanomolar nocodazole the centrosome adopted a distinct peripheral rather than the normally central position within the synapse. This effect was reproduced in a computational energy-minimization model that assumed no microtubule dynamics, but only a taxol-induced increase in the length of the microtubules. Together, the experimental and computational results indicate that microtubule dynamics are not essential for the centrosome positioning, but that the fit of the microtubule array in the deformed body of the conjugated T cell is a major factor. The possibility of modulating the T-cell centrosome position with well-studied drugs and of predicting their effects in silico appears attractive for designing anti-cancer and antiviral therapies.	[Baratt, Arie; Arkhipov, Sergey N.; Maly, Ivan V.] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baratt, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA.	ivanmaly@pitt.edu	Arkhipov, Sergey/M-6858-2019; Arkhipov, Sergey/E-6293-2014	Arkhipov, Sergey/0000-0003-4707-902X	National Institutes of Health [GM078332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM078332 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1979, EXP CELL RES, V120, P111, DOI 10.1016/0014-4827(79)90542-1; Arkhipov SN, 2006, PHYS BIOL, V3, P209, DOI 10.1088/1478-3975/3/3/006; Arkhipov SN, 2006, BIOPHYS J, V91, P4306, DOI 10.1529/biophysj.106.083204; Arkhipov SN, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016006; Arkhipov SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000633; Boal D. H., 2002, MECH CELL; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Boveri T, 2008, CONCERNING ORIGIN MA; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; BUNNELL SC, 2003, SCI STKE, pP18; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; BYKOVSKAJA SN, 1978, CELL IMMUNOL, V40, P164, DOI 10.1016/0008-8749(78)90324-6; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; DYE RB, 1993, J BIOL CHEM, V268, P6847; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; GUDIMA GO, 1988, J CELL SCI, V89, P225; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; JORDAN MA, 1992, J CELL SCI, V102, P401; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; KNOX JD, 1993, CELL MOTIL CYTOSKEL, V24, P129, DOI 10.1002/cm.970240206; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mullins DW, 1998, IMMUNOPHARM IMMUNOT, V20, P473, DOI 10.3109/08923979809031511; Pais-Correia Ana Monica, 2007, Current Immunology Reviews, V3, P170; PARSEY MV, 1993, J IMMUNOL, V151, P1881; PFEFFER TA, 1976, J CELL BIOL, V69, P599, DOI 10.1083/jcb.69.3.599; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ratner S, 1997, J IMMUNOL, V159, P1063; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmidt RF, 1989, HUMAN PHYSL; Smurova K. M., 2007, CELL TISSUE BIOL, V1, P225; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; ZHAI Y, 1994, J CELL SCI, V107, P881	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3861	10.1371/journal.pone.0003861	http://dx.doi.org/10.1371/journal.pone.0003861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060950	Green Accepted, Green Published, gold			2022-12-27	WOS:000265455100001
J	Leroux, A; Rokeach, LA				Leroux, Alexandre; Rokeach, Luis A.			Inter-Species Complementation of the Translocon Beta Subunit Requires Only Its Transmembrane Domain	PLOS ONE			English	Article								In eukaryotes, proteins enter the secretory pathway through the translocon pore of the endoplasmic reticulum. This protein translocation channel is composed of three major subunits, called Sec61 alpha, beta and gamma in mammals. Unlike the other subunits, the beta subunit is dispensable for translocation and cell viability in all organisms studied. Intriguingly, the knockout of the Sec61 beta encoding genes results in different phenotypes in different species. Nevertheless, the beta subunit shows a high level of sequence homology across species, suggesting the conservation of a biological function that remains ill-defined. To address its cellular roles, we characterized the homolog of Sec61 beta in the fission yeast Schizosaccharomyces pombe (Sbh1p). Here, we show that the knockout of sbh1(+) results in severe cold sensitivity, increased sensitivity to cell-wall stress, and reduced protein secretion at 23 degrees C. Sec61 beta homologs from Saccharomyces cerevisiae and human complement the knockout of sbh1(+) in S. pombe. As in S. cerevisiae, the transmembrane domain (TMD) of S. pombe Sec61 beta is sufficient to complement the phenotypes resulting from the knockout of the entire encoding gene. Remarkably, the TMD of Sec61 beta from S. cerevisiae and human also complement the gene knockouts in both yeasts. Together, these observations indicate that the TMD of Sec61 beta exerts a cellular function that is conserved across species.	[Leroux, Alexandre; Rokeach, Luis A.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Leroux, A (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	luis.rokeach@umontreal.ca			NSERC [171325]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a a NSERC grant (#171325) to Luis A. Rokeach and by a NSERC scholarship to Alexandre Leroux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFA C, 1993, EXPT FISSION YEASTS; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Boisrame A, 2002, J CELL SCI, V115, P4947, DOI 10.1242/jcs.00187; BRUNDAGE L, 1992, J BIOL CHEM, V267, P4166; Cao TB, 2003, BBA-BIOMEMBRANES, V1609, P115, DOI 10.1016/S0005-2736(02)00662-4; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Elbe R, 1992, BIOTECHNIQUES, V13, P18; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; Feng D, 2007, J BIOL CHEM, V282, P30618, DOI 10.1074/jbc.M701840200; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Flower AM, 2001, J BACTERIOL, V183, P2006, DOI 10.1128/JB.183.6.2006-2012.2001; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GUERIN R, 2008, MOL BIOL CELL; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Helmers J, 2003, J BIOL CHEM, V278, P23686, DOI 10.1074/jbc.C300180200; Hori O, 2006, MOL CELL BIOL, V26, P4257, DOI 10.1128/MCB.02055-05; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kinch LN, 2002, TRENDS BIOCHEM SCI, V27, P170, DOI 10.1016/S0968-0004(01)02055-2; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Muller S, 1998, YEAST, V14, P1267, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; OSUMI M, 1989, J ELECTRON MICROSC, V38, P457; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; POGLIANO KJ, 1993, GENETICS, V133, P763; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROITSCH T, 1988, EUR J BIOCHEM, V174, P699, DOI 10.1111/j.1432-1033.1988.tb14154.x; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sherman F., 1981, METHODS YEAST GENETI; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Sirisattha S, 2004, WATER RES, V38, P61, DOI 10.1016/j.watres.2003.08.027; Slamovits CH, 2006, J MOL BIOL, V359, P1196, DOI 10.1016/j.jmb.2006.04.028; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Toikkanen JH, 2004, YEAST, V21, P1045, DOI 10.1002/yea.1151; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; Turcotte C, 2007, FEMS YEAST RES, V7, P196, DOI 10.1111/j.1567-1364.2006.00145.x; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Valcarcel R, 1999, J CELL SCI, V112, P4389; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VEGA R, 1986, ARCH MICROBIOL, V144, P124, DOI 10.1007/BF00414721; VERGERES G, 1992, J BIOL CHEM, V267, P12583; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yang Zu-Jun, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P354	70	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3880	10.1371/journal.pone.0003880	http://dx.doi.org/10.1371/journal.pone.0003880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057642	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452300012
J	Jain, R; Dey, B; Dhar, N; Rao, V; Singh, R; Gupta, UD; Katoch, VM; Ramanathan, VD; Tyagi, AK				Jain, Ruchi; Dey, Bappaditya; Dhar, Neeraj; Rao, Vivek; Singh, Ramandeep; Gupta, Umesh D.; Katoch, V. M.; Ramanathan, V. D.; Tyagi, Anil K.			Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; T-CELL EPITOPES; MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIG; CROSSED IMMUNOELECTROPHORESIS; PULMONARY GRANULOMAS; GLOBAL TRENDS; BCG VACCINE; ANTIGEN; EXPRESSION	Background: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Gurein (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosis represents one of the potential approaches for the development of vaccines against TB. Methods/Principal Findings: A recombinant strain of BCG - rBCG85C, over expressing the antigen 85C, a secretory immunodominant protein of M. tuberculosis, was evaluated for its protective efficacy in guinea pigs against M. tuberculosis challenge by aerosol route. Immunization with rBCG85C resulted in a substantial reduction in the lung (1.87 log(10), p<0.01) and spleen (2.36 log(10), p<0.001) bacillary load with a commensurate reduction in pathological damage, when compared to the animals immunized with the parent BCG strain at 10 weeks post-infection. rBCG85C continued to provide superior protection over BCG even when post-challenge period was prolonged to 16 weeks. The cytokine profile of pulmonary granulomas revealed that the superior protection imparted by rBCG85C was associated with the reduced levels of pro-inflammatory cytokines - interleukin (IL)-12, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, moderate levels of anti-inflammatory cytokine - transforming growth factor (TGF)-beta along with up-regulation of inducible nitric oxide synthase (iNOS). In addition, the rBCG85C vaccine induced modulation of the cytokine levels was found to be associated with reduced fibrosis and antigen load accompanied by the restoration of normal lung architecture. Conclusions/Significance: These results clearly indicate the superiority of rBCG85C over BCG as a promising prophylactic vaccine against TB. The enduring protection observed in this study gives enough reason to postulate that if an open-ended study is carried out with low dose of infection, rBCG85C vaccine in all likelihood would show enhanced survival of guinea pigs.	[Jain, Ruchi; Dey, Bappaditya; Dhar, Neeraj; Rao, Vivek; Singh, Ramandeep; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Umesh D.; Katoch, V. M.] Natl JALMA Inst Leprosy & Other Mycobact Dis, Agra, Uttar Pradesh, India; [Ramanathan, V. D.] Tuberculosis Res Ctr, Dept Clin Pathol, Chennai, India; [Dhar, Neeraj] Ecole Polytech Fed Lausanne, Glob Hlth Inst, Lab Bacteriol, Lausanne, Switzerland; [Rao, Vivek] Ridgeweay Mill Hill, Natl Inst Med Res, Div Mycobacter Res, London, England; [Singh, Ramandeep] NIAID, NIH, Lab Clin Infect Dis, Tuberculosis Res Sect, Bethesda, MD USA	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, R (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Dey, Bappaditya/H-1831-2018; Dhar, Neeraj/K-8171-2013	Dey, Bappaditya/0000-0003-2728-4683; Dhar, Neeraj/0000-0002-5887-8137	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, Government of India [research fellowship]	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant to AKT and VDR from the Department of Biotechnology, Ministry of Science and Technology, India. RJ and BD acknowledge Council of Scientific and Industrial Research, Government of India for research fellowship (CSIR JRF/SRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2003, INFECT IMMUN, V71, P4271, DOI 10.1128/IAI.71.8.4271-4277.2003; Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; CLEMENS JD, 1983, JAMA-J AM MED ASSOC, V249, P2362, DOI 10.1001/jama.249.17.2362; CLOSS O, 1980, SCAND J IMMUNOL, V12, P249, DOI 10.1111/j.1365-3083.1980.tb00065.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Dhar N, 2004, MED MICROBIOL IMMUN, V193, P19, DOI 10.1007/s00430-002-0170-x; Dhar N, 2003, IMMUNOL LETT, V88, P175, DOI 10.1016/S0165-2478(03)00043-9; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; Keane MP, 2001, RESP RES, V3; Kumar G, 2008, SCAND J IMMUNOL, V68, P177, DOI 10.1111/j.1365-3083.2008.02133.x; Lee BY, 1999, INFECT IMMUN, V67, P2665, DOI 10.1128/IAI.67.5.2665-2670.1999; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; Ly LH, 2007, CELL MICROBIOL, V9, P1127, DOI 10.1111/j.1462-5822.2006.00854.x; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Shakila H, 1999, INDIAN J MED RES, V110, P4; SILVER RF, 1995, J IMMUNOL, V154, P4665; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; WIKER HG, 1988, SCAND J IMMUNOL, V27, P223, DOI 10.1111/j.1365-3083.1988.tb02342.x; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; World Health Organization, 2008, GLOB TUB CONTR SURV; Yamada H, 2005, EXP ANIM TOKYO, V54, P163, DOI 10.1538/expanim.54.163	46	47	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3869	10.1371/journal.pone.0003869	http://dx.doi.org/10.1371/journal.pone.0003869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052643	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000265452200013
J	Yiannoutsos, CT; An, MW; Frangakis, CE; Musick, BS; Braitstein, P; Wools-Kaloustian, K; Ochieng, D; Martin, JN; Bacon, MC; Ochieng, V; Kimaiyo, S				Yiannoutsos, Constantin T.; An, Ming-Wen; Frangakis, Constantine E.; Musick, Beverly S.; Braitstein, Paula; Wools-Kaloustian, Kara; Ochieng, Daniel; Martin, Jeffrey N.; Bacon, Melanie C.; Ochieng, Vincent; Kimaiyo, Sylvester			Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya	PLOS ONE			English	Article								Background: Monitoring and evaluation (M&E) of HIV care and treatment programs is impacted by losses to follow-up (LTFU) in the patient population. The severity of this effect is undeniable but its extent unknown. Tracing all lost patients addresses this but census methods are not feasible in programs involving rapid scale-up of HIV treatment in the developing world. Sampling-based approaches and statistical adjustment are the only scaleable methods permitting accurate estimation of M&E indices. Methodology/Principal Findings: In a large antiretroviral therapy (ART) program in western Kenya, we assessed the impact of LTFU on estimating patient mortality among 8,977 adult clients of whom, 3,624 were LTFU. Overall, dropouts were more likely male (36.8% versus 33.7%; p = 0.003), and younger than non-dropouts (35.3 versus 35.7 years old; p = 0.020), with lower median CD4 count at enrollment (160 versus 189 cells/ml; p<0.001) and WHO stage 3-4 disease (47.5% versus 41.1%; p<0.001). Urban clinic clients were 75.0% of non-dropouts but 70.3% of dropouts (p<0.001). Of the 3,624 dropouts, 1,143 were sought and 621 had their vital status ascertained. Statistical techniques were used to adjust mortality estimates based on information obtained from located LTFU patients. Observed mortality estimates one year after enrollment were 1.7% (95% Cl 1.3%-2.0%), revised to 2.8% (2.3%-3.1%) when deaths discovered through outreach were added and adjusted to 9.2% (7.8%-10.6%) and 9.9% (8.4%-11.5%) through statistical modeling depending on the method used. The estimates 12 months after ART initiation were 1.7% (1.3%-2.2%), 3.4% (2.9%-4.0%), 10.5% (8.7%-12.3%) and 10.7% (8.9%-12.6%) respectively. Conclusions/Significance Abstract: Assessment of the impact of LTFU is critical in program M&E as estimated mortality based on passive monitoring may underestimate true mortality by up to 80%. This bias can be ameliorated by tracing a sample of dropouts and statistically adjust the mortality estimates to properly evaluate and guide large HIV care and treatment programs.	[Yiannoutsos, Constantin T.; Musick, Beverly S.] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA; [An, Ming-Wen] Vassar Coll, Dept Math, Poughkeepsie, NY 12601 USA; [Frangakis, Constantine E.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21218 USA; [Braitstein, Paula] Indiana Univ, Div Gen Internal Med & Geriat, Indianapolis, IN USA; [Wools-Kaloustian, Kara] Indiana Univ, Div Infect Dis, Indianapolis, IN USA; [Braitstein, Paula; Wools-Kaloustian, Kara; Ochieng, Daniel; Ochieng, Vincent; Kimaiyo, Sylvester] Acad Model Prevent & Treatment HIV AIDS AMPATH, Eldoret, Kenya; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bacon, Melanie C.] Natl Inst Allergies & Infect Dis (NIAID), Bethesda, MD USA; [Braitstein, Paula; Kimaiyo, Sylvester] Moi Univ, Sch Med, Eldoret, Kenya	Indiana University System; Indiana University-Purdue University Indianapolis; Vassar College; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Moi University	Yiannoutsos, CT (corresponding author), Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA.	cyiannou@iupui.edu			National Institutes of Health (NIAID) [U01-AI0669911]; President's Emergency Plan for AIDS Relief (PEPFAR); NIDA [R01-DA023879]; National Eye Institute [EY07127]; Clinical Trials Training Program in Vision Research; NATIONAL EYE INSTITUTE [T32EY007127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023879] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Clinical Trials Training Program in Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by the National Institutes of Health (NIAID) grant number U01-AI0669911 (East Africa IeDEA Regional Consortium), and a Targeted Evaluation supplement to this grant by the President's Emergency Plan for AIDS Relief (PEPFAR). This research was also supported in part by a grant to the USAID-AMPATH Partnership from PEPFAR. Dr. Frangakis' research was supported by NIDA grant R01-DA023879. Dr. An's research was also supported by the National Eye Institute Training Grant EY07127 and Clinical Trials Training Program in Vision Research.	ANGLARET XX, 2005, J ACQ IMMUN DEF SYND, V35, P320; BAKER SG, 1993, BIOMETRICS, V49, P379, DOI 10.2307/2532551; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; EGGER M, 2007, OUTCOMES ART RESOURC; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; *GLOB FUND, 2003, FRAM DOC GLOB FUND F; *I MED, 2007, PEPFAR IMPL PROGR PR; Mamlin Burke W, 2005, AMIA Annu Symp Proc, P490; [Organization WH World Health Organization Joint United Nations Programme on HIV/AIDS], 2003, TREAT 3 MILL 2005 MA; Raboud JM, 1996, J ACQ IMMUN DEF SYND, V12, P46, DOI 10.1097/00042560-199605010-00007; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Touloumi G, 2002, EPIDEMIOLOGY, V13, P347, DOI 10.1097/00001648-200205000-00017; *US 5 YEAR GLOB HI, 2004, PRES EM PLAN AIDS RE; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	24	68	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3843	10.1371/journal.pone.0003843	http://dx.doi.org/10.1371/journal.pone.0003843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048109	gold, Green Published			2022-12-27	WOS:000265452000010
J	Irwin, AJ; Finkel, ZV				Irwin, Andrew J.; Finkel, Zoe V.			Mining a Sea of Data: Deducing the Environmental Controls of Ocean Chlorophyll	PLOS ONE			English	Article							NUMERICAL-SIMULATION; CLIMATE-CHANGE; SARGASSO SEA; UPPER WATERS; TEMPERATURE; CARBON; RATES; GROWTH; MODEL; CYCLE	Chlorophyll biomass in the surface ocean is regulated by a complex interaction of physiological, oceanographic, and ecological factors and in turn regulates the rates of primary production and export of organic carbon to the deep ocean. Mechanistic models of phytoplankton responses to climate change require the parameterization of many processes of which we have limited knowledge. We develop a statistical approach to estimate the response of remote-sensed ocean chlorophyll to a variety of physical and chemical variables. Irradiance over the mixed layer depth, surface nitrate, sea-surface temperature, and latitude and longitude together can predict 83% of the variation in log chlorophyll in the North Atlantic. Light and nitrate regulate biomass through an empirically determined minimum function explaining nearly 50% of the variation in log chlorophyll by themselves and confirming that either light or macronutrients are often limiting and that much of the variation in chlorophyll concentration is determined by bottom-up mechanisms. Assuming the dynamics of the future ocean are governed by the same processes at work today, we should be able to apply these response functions to future climate change scenarios, with changes in temperature, nutrient distributions, irradiance, and ocean physics.	[Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada; [Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB, Canada	Mount Allison University; Mount Allison University	Irwin, AJ (corresponding author), Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada.	airwin@mta.ca	Irwin, Andrew/B-2245-2008; Finkel, Zoe V/B-9626-2008	Finkel, Zoe V/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319	NSERC Canada	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC Canada contributed to the authors' research programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Bissett WP, 1999, DEEP-SEA RES PT I, V46, P271, DOI 10.1016/S0967-0637(98)00063-6; Bissett WP, 1999, DEEP-SEA RES PT I, V46, P205, DOI 10.1016/S0967-0637(98)00062-4; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FELDMAN GC, 2007, MCCLAIN CR OCEAN COL; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Garcia H. E., 2006, WORLD OCEAN ATLAS 20, P396; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; GREGG WW, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GL0116889; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastie T.J., 1990, GEN ADDITIVE MODELS, P352, DOI [10.1214/ss/1177013604, DOI 10.1201/9780203753781]; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; KAMYKOWSKI D, 1986, DEEP-SEA RES, V33, P89, DOI 10.1016/0198-0149(86)90109-3; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Longhurst A, 1998, ECOLOGICAL GEOGRAPHY, P398; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Oliver MJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034238; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramsay J., 2005, FUNCTIONAL DATA ANAL, P430; Raven J, 2005, OCEAN ACIDIFICATION; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; RILEY GA, 1946, J MAR RES, V6, P54; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Uz BM, 2004, DEEP-SEA RES PT II, V51, P1001, DOI [10.1016/j.dsr2.2004.03.003, 10.1016/j.dsr2.2003.03.003]; Watson AJ, 1998, PHILOS T R SOC B, V353, P41, DOI 10.1098/rstb.1998.0189; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood SN, 2017, GEN ADDITIVE MODELS, V2; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942	48	38	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3836	10.1371/journal.pone.0003836	http://dx.doi.org/10.1371/journal.pone.0003836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043583	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451500010
J	Li, ZY; Umeyama, T; Wang, CC				Li, Ziyin; Umeyama, Takashi; Wang, Ching C.			The Chromosomal Passenger Complex and a Mitotic Kinesin Interact with the Tousled-Like Kinase in Trypanosomes to Regulate Mitosis and Cytokinesis	PLOS ONE			English	Article								Aurora B kinase plays essential roles in mitosis and cytokinesis in eukaryotes. In the procyclic form of Trypanosoma brucei, the Aurora B homolog TbAUK1 regulates mitosis and cytokinesis, phosphorylates the Tousled-like kinase TbTLK1, interacts with two mitotic kinesins TbKIN-A and TbKIN-B and forms a novel chromosomal passenger complex (CPC) with two novel proteins TbCPC1 and TbCPC2. Here we show with time-lapse video microscopy the time course of CPC trans-localization from the spindle midzone in late anaphase to the dorsal side of the cell where the anterior end of daughter cell is tethered, and followed by a glide toward the posterior end to divide the cell, representing a novel mode of cytokinesis in eukaryotes. The three subunits of CPC, TbKIN-B and TbTLK1 interact with one another suggesting a close association among the five proteins. An ablation of TbTLK1 inhibited the subsequent trans-localization of CPC and TbKIN-B, whereas a knockdown of CPC or TbKIN-B disrupted the spindle pole localization of TbTLK1 during mitosis. In the bloodstream form of T. brucei, the five proteins also play essential roles in chromosome segregation and cytokinesis and display subcellular localization patterns similar to that in the procyclic form. The CPC in bloodstream form also undergoes a trans-localization during cytokinesis similar to that in the procyclic form. All together, our results indicate that the five-protein complex CPC-TbTLK1-TbKIN-B plays key roles in regulating chromosome segregation in the early phase of mitosis and that the highly unusual mode of cytokinesis mediated by CPC occurs in both forms of trypanosomes.	[Li, Ziyin; Umeyama, Takashi; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu	Umeyama, Takashi/R-6525-2019	Umeyama, Takashi/0000-0002-6635-4288; Li, Ziyin/0000-0002-3960-9716	NIH [AI-21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786, R56AI021786] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH R01 grant AI-21786	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Ehsan H, 2004, PLANT PHYSIOL, V134, P1488, DOI 10.1104/pp.103.038117; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gluenz E, 2008, MOL MICROBIOL, V69, P666, DOI 10.1111/j.1365-2958.2008.06320.x; Han ZB, 2005, CURR BIOL, V15, P894, DOI 10.1016/j.cub.2005.04.019; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Ploubidou A, 1999, J CELL SCI, V112, P4641; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; SASSE R, 1988, J CELL SCI, V90, P577; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	33	42	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3814	10.1371/journal.pone.0003814	http://dx.doi.org/10.1371/journal.pone.0003814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043568	Green Published, gold			2022-12-27	WOS:000265451400006
J	Moulton, EA; Burstein, R; Tully, S; Hargreaves, R; Becerra, L; Borsook, D				Moulton, Eric A.; Burstein, Rami; Tully, Shannon; Hargreaves, Richard; Becerra, Lino; Borsook, David			Interictal Dysfunction of a Brainstem Descending Modulatory Center in Migraine Patients	PLOS ONE			English	Article								Background: The brainstem contains descending circuitry that can modulate nociceptive processing (neural signals associated with pain) in the dorsal horn of the spinal cord and the medullary dorsal horn. In migraineurs, abnormal brainstem function during attacks suggest that dysfunction of descending modulation may facilitate migraine attacks, either by reducing descending inhibition or increasing facilitation. To determine whether a brainstem dysfunction could play a role in facilitating migraine attacks, we measured brainstem function in migraineurs when they were not having an attack (i.e. the interictal phase). Methods and Findings: Using fMRI (functional magnetic resonance imaging), we mapped brainstem activity to heat stimuli in 12 episodic migraine patients during the interictal phase. Separate scans were collected to measure responses to 41 degrees C and noxious heat (pain threshold+1 degrees C). Stimuli were either applied to the forehead on the affected side (as reported during an attack) or the dorsum of the hand. This was repeated in 12 age-gender-matched control subjects, and the side tested corresponded to that in the matched migraine patients. Nucleus cuneiformis (NCF), a component of brainstem pain modulatory circuits, appears to be hypofunctional in migraineurs. 3 out of the 4 thermal stimulus conditions showed significantly greater NCF activation in control subjects than the migraine patients. Conclusions: Altered descending modulation has been postulated to contribute to migraine, leading to loss of inhibition or enhanced facilitation resulting in hyperexcitability of trigeminovascular neurons. NCF function could potentially serve as a diagnostic measure in migraine patients, even when not experiencing an attack. This has important implications for the evaluation of therapies for migraine.	[Moulton, Eric A.; Tully, Shannon; Becerra, Lino; Borsook, David] Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Brain Imaging Ctr, Belmont, MA 02178 USA; [Moulton, Eric A.; Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Burstein, Rami] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Hargreaves, Richard] Merck & Co Inc, West Point, PA USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula Martinos Ctr Bioengn, Dept Radiol, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Merck & Company; Harvard University; Massachusetts General Hospital	Moulton, EA (corresponding author), Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Brain Imaging Ctr, Belmont, MA 02178 USA.	dborsook@partners.org	Moulton, Eric/AAF-8225-2019; Moulton, Eric A/A-7908-2009	Moulton, Eric/0000-0002-7959-8441; 	NIH/NINDS [R01NS056195-02, R01NS051484-04]; Merck and Co; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056195, R01NS051484] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Merck and Co(Merck & Company); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was financially supported by NIH/NINDS grants to David Borsook (R01NS056195-02) and Rami Burstein (R01NS051484-04), and by an unrestricted grant from Merck and Co. These financial sponsors did not have a direct role in this study, and did not participate in the preparation of this manuscript.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; BEHBEHANI MM, 1986, BRAIN RES, V369, P110, DOI 10.1016/0006-8993(86)90518-4; BERNARD JF, 1989, BRAIN RES, V490, P181, DOI 10.1016/0006-8993(89)90449-6; Buchgreitz L, 2006, PAIN, V123, P19, DOI 10.1016/j.pain.2006.01.040; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H.L., 2006, WALL MELZACKS TXB PA; Hadjipavlou G, 2006, PAIN, V123, P169, DOI 10.1016/j.pain.2006.02.027; Haghparast A, 2008, NEUROSCI LETT, V438, P351, DOI 10.1016/j.neulet.2008.04.072; Haghparast A, 2007, NEUROSCI LETT, V427, P44, DOI 10.1016/j.neulet.2007.09.003; HAWS CM, 1989, BRAIN RES, V483, P272, DOI 10.1016/0006-8993(89)90171-6; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Knight YE, 2001, NEUROSCIENCE, V106, P793, DOI 10.1016/S0306-4522(01)00303-7; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Loder E, 2005, HEADACHE, V45, pS33, DOI 10.1111/j.1526-4610.2005.4501002.x; MCMAHON SB, 1985, BRAIN RES, V333, P19, DOI 10.1016/0006-8993(85)90119-2; MENETREY D, 1980, J NEUROPHYSIOL, V44, P862, DOI 10.1152/jn.1980.44.5.862; MOULTON EA, 2008, HUM BRAIN MAPP; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; OLESEN TS, 1987, ARCH NEUROL-CHICAGO, V44, P156; Ossipov MH, 2000, NEUROSCI LETT, V290, P129, DOI 10.1016/S0304-3940(00)01338-0; Pan ZZ, 1996, NEUROSCIENCE, V74, P855, DOI 10.1016/0306-4522(96)00179-0; RICHTER RC, 1991, BRAIN RES, V544, P279, DOI 10.1016/0006-8993(91)90065-4; Rocca MA, 2000, NEUROLOGY, V54, P507, DOI 10.1212/WNL.54.2.507; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Schoenen J, 2006, NEUROL SCI, V27, pS77, DOI 10.1007/s10072-006-0575-1; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tortorella P, 2006, J NEUROL SCI, V244, P137, DOI 10.1016/j.jns.2006.01.015; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2; WIBERG M, 1987, J COMP NEUROL, V264, P92, DOI 10.1002/cne.902640108; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; YEZIERSKI RP, 1984, PAIN S, V2, pS127; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005; ZEMLAN FP, 1988, BRAIN RES, V453, P89, DOI 10.1016/0006-8993(88)90146-1; ZEMLAN FP, 1984, NEUROSCI LETT, V52, P103, DOI 10.1016/0304-3940(84)90358-6	46	161	162	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3799	10.1371/journal.pone.0003799	http://dx.doi.org/10.1371/journal.pone.0003799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030105	gold, Green Submitted, Green Published			2022-12-27	WOS:000265450800009
J	Premi, S; Srivastava, J; Panneer, G; Ali, S				Premi, Sanjay; Srivastava, Jyoti; Panneer, Ganesan; Ali, Sher			Startling Mosaicism of the Y-Chromosome and Tandem Duplication of the SRY and DAZ Genes in Patients with Turner Syndrome	PLOS ONE			English	Article								Presence of the human Y-chromosome in females with Turner Syndrome (TS) enhances the risk of development of gonadoblastoma besides causing several other phenotypic abnormalities. In the present study, we have analyzed the Y chromosome in 15 clinically diagnosed Turner Syndrome (TS) patients and detected high level of mosaicisms ranging from 45, XO:46, XY = 100:0% in 4; 45, XO:46, XY:46XX = 4:94:2 in 8; and 45, XO:46, XY:46XX = 50:30:20 cells in 3 TS patients, unlike previous reports showing 5-8% cells with Y- material. Also, no ring, marker or di-centric Y was observed in any of the cases. of the two TS patients having intact Y chromosome in > 85% cells, one was exceptionally tall. Both the patients were positive for SRY, DAZ, CDY1, DBY, UTY and AZFa, b and c specific STSs. Real Time PCR and FISH demonstrated tandem duplication/multiplication of the SRY and DAZ genes. At sequence level, the SRY was normal in 8 TS patients while the remaining 7 showed either absence of this gene or known and novel mutations within and outside of the HMG box. SNV/SFV analysis showed normal four copies of the DAZ genes in these 8 patients. All the TS patients showed aplastic uterus with no ovaries and no symptom of gonadoblastoma. Present study demonstrates new types of polymorphisms indicating that no two TS patients have identical genotype-phenotype. Thus, a comprehensive analysis of more number of samples is warranted to uncover consensus on the loci affected, to be able to use them as potential diagnostic markers.	[Premi, Sanjay; Srivastava, Jyoti; Panneer, Ganesan; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Premi, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.res.in	SRIVASTAVA, JYOTI/J-6065-2014; Premi, Sanjay/J-4351-2014; Premi, Sanjay/ABB-1423-2020; Srivastava, Jyoti/AAD-7610-2022	SRIVASTAVA, JYOTI/0000-0002-5727-741X; Premi, Sanjay/0000-0002-5492-5469; 	DBT [BT/PR2752/AAQ/01/113/2001, BT/PR8476/AAQ/01/315/2006]; Department of Biotechnology, Govt. of India; Council of Scientific and Industrial Research (CSIR), New Delhi [Senior Research Fellowship]	DBT(Department of Biotechnology (DBT) India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DBT Grants No. BT/PR2752/AAQ/01/113/2001 and BT/PR8476/AAQ/01/315/2006 to SA and a core grant from the Department of Biotechnology, Govt. of India to the National Institute of Immunology, New Delhi. SP is thankful to Council of Scientific and Industrial Research (CSIR), New Delhi for the award of Senior Research Fellowship. This work has been seen and approved by all the authors and they do not have any conflict of personal communication or financial interests.	ALI S, 1986, HUM GENET, V74, P239; Bashamboo A, 2005, MOL HUM REPROD, V11, P117, DOI 10.1093/molehr/gah135; Gravholt CH, 2004, EUR J ENDOCRINOL, V151, P657, DOI 10.1530/eje.0.1510657; Gravholt CH, 2000, J CLIN ENDOCR METAB, V85, P3199, DOI 10.1210/jc.85.9.3199; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HOOK EB, 1977, AM J HUM GENET, V29, P94; HSU LYF, 1994, AM J MED GENET, V53, P108, DOI 10.1002/ajmg.1320530204; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; Kelly TE, 1998, J MED GENET, V35, P862, DOI 10.1136/jmg.35.10.862; Meng HY, 2005, J CLIN ENDOCR METAB, V90, P3419, DOI 10.1210/jc.2005-0544; Premi S, 2006, MOL HUM REPROD, V12, P113, DOI 10.1093/molehr/gal012; Premi S, 2007, HUM GENET, V121, P337, DOI 10.1007/s00439-006-0318-7; PROCTER SE, 1984, CLIN GENET, V25, P273; QUILTER CR, 2002, J MED GENET, V39, P80; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Reddy KS, 1998, CYTOGENET CELL GENET, V82, P52, DOI 10.1159/000015064; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Saenger P, 1997, Curr Ther Endocrinol Metab, V6, P239; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TARAOKA M, 1998, AM J HUM GENET, V78, P424; TUCKMULLER CM, 1995, HUM GENET, V96, P119, DOI 10.1007/BF00214200; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1	23	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3796	10.1371/journal.pone.0003796	http://dx.doi.org/10.1371/journal.pone.0003796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030103	Green Published, Green Submitted, gold			2022-12-27	WOS:000265450800006
J	Wu, EX; Palmer, N; Tian, Z; Moseman, AP; Galdzicki, M; Wang, XT; Berger, B; Zhang, HB; Kohane, IS				Wu, Erxi; Palmer, Nathan; Tian, Ze; Moseman, Annie P.; Galdzicki, Michal; Wang, Xuetao; Berger, Bonnie; Zhang, Hongbing; Kohane, Isaac S.			Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells	PLOS ONE			English	Article								Despite the growing understanding of PDGF signaling, studies of PDGF function have encountered two major obstacles: the functional redundancy of PDGFR alpha and PDGFR beta in vitro and their distinct roles in vivo. Here we used wild-type mouse embryonic fibroblasts (MEF), MEF null for either PDGFR alpha, beta, or both to dissect PDGF-PDGFR signaling pathways. These four PDGFR genetically defined cells provided us a platform to study the relative contributions of the pathways triggered by the two PDGF receptors. They were treated with PDGF-BB and analyzed for differential gene expression, in vitro proliferation and differential response to pharmacological effects. No genes were differentially expressed in the double null cells, suggesting minimal receptor-independent signaling. Protean differentiation and proliferation pathways are commonly regulated by PDGFR alpha, PDGFR beta and PDGFR alpha/beta while each receptor is also responsible for regulating unique signaling pathways. Furthermore, some signaling is solely modulated through heterodimeric PDGFR alpha/beta.	[Wu, Erxi; Tian, Ze; Moseman, Annie P.; Galdzicki, Michal; Wang, Xuetao; Kohane, Isaac S.] Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA; [Wu, Erxi; Kohane, Isaac S.] Harvard Univ, Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA; [Palmer, Nathan; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Zhang, Hongbing] Tsinghua Univ, Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Hongbing] Chinese Acad Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100864, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Sciences	Wu, EX (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	tian, ze/HDM-4308-2022; Kohane, Isaac Kohane/K-3716-2012; Galdzicki, Michal/F-5682-2010	Kohane, Isaac Kohane/0000-0003-2192-5160; Galdzicki, Michal/0000-0002-8392-8183; Wu, Erxi/0000-0002-1680-3639	National Institutes of Health [LM 07092-11]; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health training grant 2 Ta5 LM 07092-11. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript	Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Antipova AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r47; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Levitzki A, 2004, CYTOKINE GROWTH F R, V15, P229, DOI 10.1016/j.cytogfr.2004.03.010; Li L, 2006, J CELL BIOCHEM, V99, P1553, DOI 10.1002/jcb.20993; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; McGary EC, 2002, CLIN CANCER RES, V8, P3584; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	39	88	100	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3794	10.1371/journal.pone.0003794	http://dx.doi.org/10.1371/journal.pone.0003794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030102	Green Published, Green Submitted, gold			2022-12-27	WOS:000265450800004
J	Yaghmur, A; Laggner, P; Almgren, M; Rappolt, M				Yaghmur, Anan; Laggner, Peter; Almgren, Mats; Rappolt, Michael			Self-Assembly in Monoelaidin Aqueous Dispersions: Direct Vesicles to Cubosomes Transition	PLOS ONE			English	Article							LIQUID-CRYSTALLINE PHASES; BICONTINUOUS CUBIC PHASES; LIPID-WATER PHASES; EMULSIFIED MICROEMULSIONS; GLYCERATE SURFACTANTS; ELECTRON-MICROSCOPY; CRYO-TRANSMISSION; SUSTAINED-RELEASE; MEMBRANE-FUSION; OLEIC-ACID	Background: In the present study, synchrotron small-angle X-ray scattering (SAXS) and Cryo-TEM were used to characterize the temperature-induced structural transitions of monoelaidin (ME) aqueous dispersion in the presence of the polymeric stabilizer F127. We prove that the direct transition from vesicles to cubosomes by heating this dispersion is possible. The obtained results were compared with the fully hydrated bulk ME phase. Methodology/Principal Findings: Our results indicate the formation of ME dispersion, which is less stable than that based on the congener monoolein (MO). In addition, the temperature-dependence behavior significantly differs from the fully hydrated bulk phase. SAXS findings indicate a direct L-alpha-V-2 internal transition in the dispersion. While the transition temperature is conserved in the dispersion, the formed cubosomes with internal Im3m symmetry clearly contain more water and this ordered interior is retained over a wider temperature range as compared to its fully hydrated bulk system. At 25 degrees C, Cryo-TEM observations reveal the formation of most likely closely packed onion-like vesicles. Above the lamellar to non-lamellar phase transition at 65 degrees C, flattened cubosomes with an internal nanostructure are observed. However, they have only arbitrary shapes and thus, their morphology is significantly different from that of the well-shaped analogous MO cubosome and hexosome particles. Conclusions/Significance: Our study reveals a direct liposomes-cubosomes transition in ME dispersion. The obtained results suggest that the polymeric stabilizer F127 especially plays a significant role in the membrane fusion processes. F127 incorporates in considerable amount into the internal nanostructure and leads to the formation of a highly swollen Im3m phase.	[Yaghmur, Anan; Laggner, Peter; Rappolt, Michael] Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria; [Almgren, Mats] Uppsala Univ, Dept Phys Chem, S-75105 Uppsala, Sweden	Austrian Academy of Sciences; Uppsala University	Yaghmur, A (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria.	anan.yaghmur@oeaw.ac.at	Almgren, Mats/AAA-9284-2019; Yaghmur, Anan/AGU-9381-2022	Yaghmur, Anan/0000-0003-1608-773X; Rappolt, Michael/0000-0001-9942-3035				Abraham T, 2005, BIOTECHNOL PROGR, V21, P255, DOI 10.1021/bp0498544; Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; Almgren M, 2007, LANGMUIR, V23, P2768, DOI 10.1021/la062482j; Almgren M, 2007, J DISPER SCI TECHNOL, V28, P43, DOI 10.1080/01932690600992613; Almgren M, 2006, J DISPER SCI TECHNOL, V27, P599, DOI 10.1080/01932690600662513; Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; Amenitsch H, 1998, J SYNCHROTRON RADIAT, V5, P506, DOI 10.1107/S090904959800137X; Angelova A, 2005, J PHYS CHEM B, V109, P3089, DOI 10.1021/jp044216p; Barauskas J, 2005, NANO LETT, V5, P1615, DOI 10.1021/nl050678i; Barauskas J, 2003, LANGMUIR, V19, P9562, DOI 10.1021/la0350812; Blijdenstein TBJ, 2004, FOOD HYDROCOLLOID, V18, P857, DOI 10.1016/j.foodhyd.2004.01.003; Boyd BJ, 2007, INT J PHARM, V340, P52, DOI 10.1016/j.ijpharm.2007.03.020; Boyd BJ, 2006, INT J PHARM, V318, P154, DOI 10.1016/j.ijpharm.2006.03.010; Boyd BJ, 2006, INT J PHARM, V309, P218, DOI 10.1016/j.ijpharm.2005.11.033; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Cherezov V, 2002, BIOPHYS J, V83, P3393, DOI 10.1016/S0006-3495(02)75339-3; Chung H, 2002, DIABETOLOGIA, V45, P448, DOI 10.1007/s00125-001-0751-z; Chung H, 1995, BIOPHYS J, V69, P1951, DOI 10.1016/S0006-3495(95)80065-2; Conn CE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108102; CZESLIK C, 1995, BIOPHYS J, V68, P1423, DOI 10.1016/S0006-3495(95)80315-2; de Campo L, 2004, LANGMUIR, V20, P5254, DOI 10.1021/la0499416; Dickinson E, 1997, J CHEM SOC FARADAY T, V93, P2297, DOI 10.1039/a701178d; Dong YD, 2006, LANGMUIR, V22, P9512, DOI 10.1021/la061706v; Esposito E, 2005, PHARM RES-DORDR, V22, P2163, DOI 10.1007/s11095-005-8176-x; Fainerman VB, 1999, LANGMUIR, V15, P1812, DOI 10.1021/la981180h; Fong C, 2005, AUST J CHEM, V58, P683, DOI 10.1071/CH05173; Funari SS, 2003, J LIPID RES, V44, P567, DOI 10.1194/jlr.M200356-JLR200; Gong XJ, 2008, INT J NANOTECHNOL, V5, P370, DOI 10.1504/IJNT.2008.016924; Guillot S, 2006, COLLOID SURFACE A, V291, P78, DOI 10.1016/j.colsurfa.2006.07.059; Gustafsson J, 1996, LANGMUIR, V12, P4611, DOI 10.1021/la960318y; Gustafsson J, 1997, LANGMUIR, V13, P6964, DOI 10.1021/la970566+; Hartley PG, 2007, BIOCONJUGATE CHEM, V18, P152, DOI 10.1021/bc060216b; HUI SW, 1981, SCIENCE, V212, P921, DOI 10.1126/science.7233185; HYDE S, 1997, ELSEVIER BOOK SERIES; Hyde ST, 1996, CURR OPIN SOLID ST M, V1, P653, DOI 10.1016/S1359-0286(96)80047-7; ISREALACHVILI J, 1991, INTERMOLECULAR SURFA; Johnsson M, 2005, J AM CHEM SOC, V127, P1076, DOI 10.1021/ja043331a; Johnsson M, 2006, J NANOSCI NANOTECHNO, V6, P3017, DOI 10.1166/jnn.2006.402; Kaasgaard T, 2006, PHYS CHEM CHEM PHYS, V8, P4957, DOI 10.1039/b609510k; Kraineva J, 2007, LANGMUIR, V23, P7118, DOI 10.1021/la700405y; Lam YM, 1999, PHYS CHEM CHEM PHYS, V1, P3331, DOI 10.1039/a902369k; LANDH T, 1994, J PHYS CHEM-US, V98, P8453, DOI 10.1021/j100085a028; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; LARSSON K, 1989, J PHYS CHEM-US, V93, P7304, DOI 10.1021/j100358a010; Larsson K, 2005, CURR OPIN COLLOID IN, V9, P365, DOI 10.1016/j.cocis.2004.12.002; LARSSON K, 1994, LIPIDS MOL ORG PHYS, V5; Leser ME, 2006, ADV COLLOID INTERFAC, V123, P125, DOI 10.1016/j.cis.2006.07.003; Lopes LB, 2006, PHARM RES-DORDR, V23, P1332, DOI 10.1007/s11095-006-0143-7; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; LUZZATI V, 1993, J MOL BIOL, V229, P540, DOI 10.1006/jmbi.1993.1053; Malmsten M, 2006, SOFT MATTER, V2, P760, DOI 10.1039/b608348j; Mezzenga R, 2005, NAT MATER, V4, P729, DOI 10.1038/nmat1496; Misquitta Y, 2001, BIOPHYS J, V81, P1047, DOI 10.1016/S0006-3495(01)75762-1; Nakano M, 2002, LANGMUIR, V18, P9283, DOI 10.1021/la026297r; PATTON JS, 1979, SCIENCE, V204, P145, DOI 10.1126/science.432636; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rangelov S, 2005, J PHYS CHEM B, V109, P3921, DOI 10.1021/jp0447385; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; RAPPOLT M, 2006, ELSEVIER BOOK SERIES, V5, P253; Rizwan SB, 2007, MICRON, V38, P478, DOI 10.1016/j.micron.2006.08.003; Roach C, 2004, BIOCHEMISTRY-US, V43, P6344, DOI 10.1021/bi049917r; Sagalowicz L, 2006, J MICROSC-OXFORD, V221, P110, DOI 10.1111/j.1365-2818.2006.01544.x; Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9; Sharma PK, 2008, COLLOID SURFACE B, V61, P53, DOI 10.1016/j.colsurfb.2007.07.002; Shearman GC, 2007, LANGMUIR, V23, P7276, DOI 10.1021/la700355a; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; SINGLETON WS, 1953, J AM OIL CHEM SOC, V30, P592, DOI 10.1007/BF02640970; Takahashi H, 2002, PHYS CHEM CHEM PHYS, V4, P2365, DOI 10.1039/b110852b; WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016; Yaghmur A, 2006, LANGMUIR, V22, P517, DOI 10.1021/la052109w; Yaghmur A, 2005, LANGMUIR, V21, P569, DOI 10.1021/la0482711; Yaghmur A, 2006, LANGMUIR, V22, P9919, DOI 10.1021/la061303v; Yaghmur A, 2009, ADV COLLOID INTERFAC, V147-48, P333, DOI 10.1016/j.cis.2008.07.007; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; Yaghmur A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002072; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	77	64	64	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3747	10.1371/journal.pone.0003747	http://dx.doi.org/10.1371/journal.pone.0003747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015726	Green Published, gold			2022-12-27	WOS:000265448400004
J	Schoeman, MC; Jacobs, DS				Schoeman, M. Corrie; Jacobs, David S.			The Relative Influence of Competition and Prey Defenses on the Phenotypic Structure of Insectivorous Bat Ensembles in Southern Africa	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; SPECIES COMPOSITION; ECHOLOCATION CALLS; FISH COMMUNITIES; ECOLOGY; SIZE; ASSEMBLAGES; MORPHOLOGY; DIVERSITY; SUPPORT	Deterministic filters such as competition and prey defences should have a strong influence on the community structure of animals such as insectivorous bats that have life histories characterized by low fecundity, low predation risk, long life expectancy, and stable populations. We investigated the relative influence of these two deterministic filters on the phenotypic structure of insectivorous bat ensembles in southern Africa. We used null models to simulate the random phenotypic patterns expected in the absence of competition or prey defences and analysed the deviations of the observed phenotypic pattern from these expected random patterns. The phenotypic structure at local scales exhibited non-random patterns consistent with both competition and prey defense hypotheses. There was evidence that competition influenced body size distribution across ensembles. Competition also influenced wing and echolocation patterns in ensembles and in functional foraging groups with high species richness or abundance. At the same time, prey defense filters influenced echolocation patterns in two species-poor ensembles. Non-random patterns remained evident even after we removed the influence of body size from wing morphology and echolocation parameters taking phylogeny into account. However, abiotic filters such as geographic distribution ranges of small and large-bodied species, extinction risk, and the physics of flight and sound probably also interacted with biotic filters at local and/or regional scales to influence the community structure of sympatric bats in southern Africa. Future studies should investigate alternative parameters that define bat community structure such as diet and abundance to better determine the influence of competition and prey defences on the structure of insectivorous bat ensembles in southern Africa.	[Schoeman, M. Corrie; Jacobs, David S.] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Schoeman, M. Corrie] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Cape Town; University of Kwazulu Natal	Schoeman, MC (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa.	schoemanc@ukzn.ac.za	Jacobs, David Steve/L-9118-2013; Schoeman, Corrie/G-2616-2010	Jacobs, David Steve/0000-0002-3243-8571; Schoeman, Corrie/0000-0003-3736-0264	National Research Foundation; University of Cape Town Research Fund	National Research Foundation; University of Cape Town Research Fund	Funding for the work was provided by the National Research Foundation, and the University of Cape Town Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier PL, 1998, ECOLOGY, V79, P911, DOI 10.1890/0012-9658(1998)079[0911:LVRIOL]2.0.CO;2; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; Arita HT, 1999, OIKOS, V85, P310, DOI 10.2307/3546497; Arita HT, 1997, J ANIM ECOL, V66, P83, DOI 10.2307/5967; Biscardi S, 2004, ACTA CHIROPTEROL, V6, P347, DOI 10.3161/001.006.0212; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1985, AUK, V102, P251, DOI 10.2307/4086767; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; CASE TJ, 1983, EVOLUTION, V37, P832, DOI 10.1111/j.1558-5646.1983.tb05604.x; Cowling R. M., 1997, P99; DAYAN T, 1990, AM NAT, V136, P39, DOI 10.1086/285081; DAYAN T, 1989, ECOLOGY, V70, P1526, DOI 10.2307/1938210; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Fenton MB, 2001, J MAMMAL, V82, P721, DOI 10.1644/1545-1542(2001)082<0721:TEAZCP>2.0.CO;2; Findley J.S., 1993, BATS COMMUNITY PERSP; FRIEDMAN Y, RED DATA BOOK MAMMAL; Fullard JH, 2003, J EXP BIOL, V206, P281, DOI 10.1242/jeb.00085; Gaston K. J., 2000, PATTERNS PROCESS MAC; Gotelli N.J., 1996, NULL MODELS ECOLOGY, P368; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; HOLMES DJ, 1994, J MAMMAL, V75, P224, DOI 10.2307/1382255; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Jacobs DS, 1999, ACTA CHIROPTEROL, V1, P93; Jacobs DS, 2000, ACTA CHIROPTEROL, V2, P197; Jones G, 2003, BAT ECOLOGY, P301; Jones G, 1996, SYM ZOOL S, P111; JONES G, 1994, FUNCT ECOL, V8, P450, DOI 10.2307/2390068; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Kalko EKV, 1995, SYM ZOOL S, P259; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Lawton J., 2000, COMMUNITY ECOLOGY CH; LOSOS JB, 1990, EVOLUTION, V44, P558, DOI 10.1111/j.1558-5646.1990.tb05938.x; MANLY BFJ, 1991, RANDOMIZED MONTE CAR; Maurer BA, 1999, UNTANGLING ECOLOGICA; MCKENZIE NL, 1986, J ANIM ECOL, V55, P401, DOI 10.2307/4727; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; Midgley J. J., 1997, P278; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Orrock JL, 2005, AM NAT, V166, P107, DOI 10.1086/430641; Palmer A. R., 1997, P167; Patterson BD, 2003, BAT ECOLOGY, P536; POMEROY D, 1990, BIOL J LINN SOC, V40, P53, DOI 10.1111/j.1095-8312.1990.tb00534.x; POOLE RW, 1979, SCIENCE, V203, P470, DOI 10.1126/science.203.4379.470; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROUGHGARDEN J, 1983, AM NAT, V122, P583, DOI 10.1086/284160; Rutherford M. C., 1997, P91; RYDELL J, 1995, OIKOS, V73, P419, DOI 10.2307/3545970; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; SCHLUTER D, 1985, SCIENCE, V227, P1056, DOI 10.1126/science.227.4690.1056; Schnitzler Hans-Ulrich, 1998, P183; Schoeman MC, 2003, OECOLOGIA, V134, P154, DOI 10.1007/s00442-002-1107-1; SCHOEMAN MG, 2006, RELATIVE INFLUENCE C; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Scholes R. J., 1997, P258; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Skinner J. D., 1990, MAMMALS SO AFRICAN S; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stevens RD, 1999, J MAMMAL, V80, P644, DOI 10.2307/1383309; Stevens RD, 2000, OIKOS, V89, P367, DOI 10.1034/j.1600-0706.2000.890218.x; Stoffberg S, 2007, MOL PHYLOGENETICS EV; Strong D.R., 1984, ECOLOGICAL COMMUNITI; TAYLOR PJ, 2000, BATS SO AFRICA; Willig MR, 2003, BAT ECOLOGY, P580; WILLIG MR, 1989, J MAMMAL, V70, P323, DOI 10.2307/1381514	74	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3715	10.1371/journal.pone.0003715	http://dx.doi.org/10.1371/journal.pone.0003715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005563	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166200003
J	Vollmer, SV; Kline, DI				Vollmer, Steven V.; Kline, David I.			Natural Disease Resistance in Threatened Staghorn Corals	PLOS ONE			English	Article							WHITE-BAND DISEASE; SHRIMP PENAEUS-JAPONICUS; CARIBBEAN CORAL; ACROPORA-PALMATA; EASTERN OYSTER; CRASSOSTREA-VIRGINICA; POPULATION-STRUCTURE; COMMUNITY STRUCTURE; CLIMATE-CHANGE; DIVERSITY	Disease epidemics have caused extensive damage to tropical coral reefs and to the reef-building corals themselves, yet nothing is known about the abilities of the coral host to resist disease infection. Understanding the potential for natural disease resistance in corals is critically important, especially in the Caribbean where the two ecologically dominant shallow-water corals, Acropora cervicornis and A. palmata, have suffered an unprecedented mass die-off due to White Band Disease (WBD), and are now listed as threatened under the US Threatened Species Act and as critically endangered under the IUCN Red List criteria. Here we examine the potential for natural resistance to WBD in the staghorn coral Acropora cervicornis by combining microsatellite genotype information with in situ transmission assays and field monitoring of WBD on tagged genotypes. We show that six percent of staghorn coral genotypes (3 out of 49) are resistant to WBD. This natural resistance to WBD in staghorn corals represents the first evidence of host disease resistance in scleractinian corals and demonstrates that staghorn corals have an innate ability to resist WBD infection. These resistant staghorn coral genotypes may explain why pockets of Acropora have been able to survive the WBD epidemic. Understanding disease resistance in these corals may be the critical link to restoring populations of these once dominant corals throughout their range.	[Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Vollmer, Steven V.; Kline, David I.] Smithsonian Trop Res Inst, Balboa, Panama; [Kline, David I.] Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4067, Australia	Northeastern University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Queensland	Vollmer, SV (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	s.vollmer@neu.edu		Kline, David/0000-0001-5128-9439	Smithsonian Marine Science Network [Postdoctoral Fellowships]; Smithsonian Tropical Research Institute [Hoch Fellowship]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	Smithsonian Marine Science Network Postdoctoral Fellowships to SVV and DIK, and a Smithsonian Tropical Research Institute Hoch Fellowship to SVV.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; Aronson RB, 2001, EVOLUTIONARY PALEOECOLOGY, P171; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; BAK RPM, 1982, MAR BIOL LETT, V3, P67; BAK RPM, 1983, ASPECTS COMMUNITY OR, P51; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Brown BL, 2005, AQUAC RES, V36, P1544, DOI 10.1111/j.1365-2109.2005.01377.x; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Calvo LMR, 2003, AQUACULTURE, V220, P69, DOI 10.1016/S0044-8486(02)00399-X; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Culloty SC, 2004, AQUACULTURE, V237, P41, DOI 10.1016/j.aquaculture.2004.04.007; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gaffney PM, 1996, J SHELLFISH RES, V15, P135; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; HOGARTH WT, 2006, FED REGISTER, P26852; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Lively CM, 1996, P ROY SOC B-BIOL SCI, V263, P891, DOI 10.1098/rspb.1996.0132; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller James E., 2007, Human-Wildlife Conflicts, V1, P13; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MOORE JD, 2002, REPORTS CALIFORNIA C, V43, P113; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETERS EC, 1983, J INVERTEBR PATHOL, V41, P394, DOI 10.1016/0022-2011(83)90260-4; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Quinn Norman J, 2006, Rev. biol. trop, V54, P105; Ritchie KB, 1998, REV BIOL TROP, V46, P199; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Yu ZN, 2006, AQUACULTURE, V254, P160, DOI 10.1016/j.aquaculture.2005.10.016; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; 2005, FED REG, V70, P24359	70	93	92	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3718	10.1371/journal.pone.0003718	http://dx.doi.org/10.1371/journal.pone.0003718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005565	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166200006
J	Feng, L; Reeves, PR; Lan, RT; Ren, Y; Gao, CX; Zhou, ZM; Ren, Y; Cheng, JS; Wang, W; Wang, JM; Qian, WB; Li, D; Wang, L				Feng, Lu; Reeves, Peter R.; Lan, Ruiting; Ren, Yi; Gao, Chunxu; Zhou, Zhemin; Ren, Yan; Cheng, Jiansong; Wang, Wei; Wang, Jianmei; Qian, Wubin; Li, Dan; Wang, Lei			A Recalibrated Molecular Clock and Independent Origins for the Cholera Pandemic Clones	PLOS ONE			English	Article								Cholera, caused by Vibrio cholerae, erupted globally from South Asia in 7 pandemics, but there were also local outbreaks between the 6(th) (1899-1923) and 7(th) (1961-present) pandemics. All the above are serotype O1, whereas environmental or invertebrate isolates are antigenically diverse. The pre 7th pandemic isolates mentioned above, and other minor pathogenic clones, are related to the 7(th) pandemic clone, while the 6(th) pandemic clone is in the same lineage but more distantly related, and non-pathogenic isolates show no clonal structure. To understand the origins and relationships of the pandemic clones, we sequenced the genomes of a 1937 prepandemic strain and a 6(th) pandemic isolate, and compared them with the published 7(th) pandemic genome. We distinguished mutational and recombinational events, and allocated these and other events, to specific branches in the evolutionary tree. There were more mutational than recombinational events, but more genes, and 44 times more base pairs, changed by recombination. We used the mutational single-nucleotide polymorphisms and known isolation dates of the prepandemic and 7(th) pandemic isolates to estimate the mutation rate, and found it to be 100 fold higher than usually assumed. We then used this to estimate the divergence date of the 6(th) and 7(th) pandemic clones to be about 1880. While there is a large margin of error, this is far more realistic than the 10,000-50,000 years ago estimated using the usual assumptions. We conclude that the 2 pandemic clones gained pandemic potential independently, and overall there were 29 insertions or deletions of one or more genes. There were also substantial changes in the major integron, attributed to gain of individual cassettes including copying from within, or loss of blocks of cassettes. The approaches used open up new avenues for analysing the origin and history of other important pathogens.	[Feng, Lu; Ren, Yi; Gao, Chunxu; Zhou, Zhemin; Ren, Yan; Cheng, Jiansong; Wang, Wei; Wang, Jianmei; Qian, Wubin; Li, Dan; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Feng, Lu; Wang, Lei] TEDA, Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Reeves, Peter R.] Univ Sydney, Sch Mol & Microb Biosci, Sydney, NSW 2006, Australia; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wang, Wei; Wang, Lei] Nankai Univ, TEDA, Tianjin Key Lab Microb Funct Genom, Tianjin, Peoples R China	Nankai University; University of Sydney; University of New South Wales Sydney; Nankai University	Feng, L (corresponding author), Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	feng, lu/M-5113-2015; Wang, Jianmei/HHZ-0585-2022; Zhou, Zhemin/AAX-5539-2020; Reeves, Peter R/A-6064-2008; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Reeves, Peter R/0000-0003-4479-7974; Wang, Lei/0000-0003-4427-0881; Wang, Wei/0000-0002-6660-8540; Lan, Ruiting/0000-0001-9834-5258	Tianjin Municipal Special Fund for Science and Technology Innovation [05FZZDSH00800]; National Natural Science Foundation of China (NSFC) [30530010, 20536040, 30670038]; National 863 program of China [2006AA020703, 2006AA06Z409]; National Key Science and Technology Project from Ministry of Health of the People's Republic of China [2008ZX10004-009]; National 973 program of China [2007CB9143010, 2009CB522603]	Tianjin Municipal Special Fund for Science and Technology Innovation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 863 program of China(National High Technology Research and Development Program of China); National Key Science and Technology Project from Ministry of Health of the People's Republic of China; National 973 program of China(National Basic Research Program of China)	This work was supported by the Tianjin Municipal Special Fund for Science and Technology Innovation Grant 05FZZDSH00800, the National Natural Science Foundation of China (NSFC) Key Programs Grants 30530010 and 20536040, NSFC General Program Grant 30670038, the National 863 program of China Grants 2006AA020703 and 2006AA06Z409, The National Key Science and Technology Project from Ministry of Health of the People's Republic of China Grant 2008ZX10004-009 and the National 973 program of China Grants 2007CB9143010 and 2009CB522603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; Blake Paul A., 1994, P293; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; GUIDOLIN A, 1987, MICROBIOL REV, V51, P285, DOI 10.1128/MMBR.51.2.285-298.1987; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; KAPUR V, 1994, J INFECT DIS, V170, P1348, DOI 10.1093/infdis/170.5.1348; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Miller MC, 2007, APPL ENVIRON MICROB, V73, P3695, DOI 10.1128/AEM.02735-06; MUKERJEE S, 1963, AM J TROP MED HYG, V12, P388, DOI 10.4269/ajtmh.1963.12.388; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Reeves PR, 1998, BRIT MED BULL, V54, P611, DOI 10.1093/oxfordjournals.bmb.a011714; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Safa A, 2005, J CLIN MICROBIOL, V43, P1401, DOI 10.1128/JCM.43.3.1401-1404.2005; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	32	115	1066	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4053	10.1371/journal.pone.0004053	http://dx.doi.org/10.1371/journal.pone.0004053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115014	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466300003
J	Habig, JW; Aruscavage, PJ; Bass, BL				Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.			In C. elegans, High Levels of dsRNA Allow RNAi in the Absence of RDE-4	PLOS ONE			English	Article								C. elegans Dicer requires an accessory double-stranded RNA binding protein, RDE-4, to enact the first step of RNA interference, the cleavage of dsRNA to produce siRNA. While RDE-4 is typically essential for RNAi, we report that in the presence of high concentrations of trigger dsRNA, rde-4 deficient animals are capable of silencing a transgene. By multiple criteria the silencing occurs by the canonical RNAi pathway. For example, silencing is RDE-1 dependent and exhibits a decrease in the targeted mRNA in response to an increase in siRNA. We also find that high concentrations of dsRNA trigger lead to increased accumulation of primary siRNAs, consistent with the existence of a rate-limiting step during the conversion of primary to secondary siRNAs. Our studies also revealed that transgene silencing occurs at low levels in the soma, even in the presence of ADARs, and that at least some siRNAs accumulate in a temperature-dependent manner. We conclude that an RNAi response varies with different conditions, and this may allow an organism to tailor a response to specific environmental signals.	[Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Habig, Jeffrey W.] Crowley Davis Res, Eagle, ID USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Habig, JW (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	bbass@biochem.utah.edu			National Institutes of Health [GM067106]; Howard Hughes Medical Institute Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds to B.L.B. from the National Institutes of Health (GM067106). B.L.B. is a Howard Hughes Medical Institute Investigator. The study sponsor (BLB) helped in the design, analysis and interpretation of the data, as well as in writing of the paper and the decision to submit the work for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; BRENNER S, 1974, GENETICS, V77, P71; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; HOUGH RF, 1994, J BIOL CHEM, V269, P9933; Jannot G, 2008, RNA, V14, P829, DOI 10.1261/rna.901908; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mello C, 1995, METHOD CELL BIOL, V48, P451; Paddison PJ, 2008, RNA INTERFERENCE; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Parrish S, 2001, RNA, V7, P1397; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473	32	17	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4052	10.1371/journal.pone.0004052	http://dx.doi.org/10.1371/journal.pone.0004052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112503	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466000014
J	Nestor, A; Vettel, JM; Tarr, MJ				Nestor, Adrian; Vettel, Jean M.; Tarr, Michael J.			Task-Specific Codes for Face Recognition: How they Shape the Neural Representation of Features for Detection and Individuation	PLOS ONE			English	Article							OBJECT RECOGNITION; PERCEPTION; FUSIFORM; FMRI; AREA; PROSOPAGNOSIA; INFORMATION; ACTIVATION; IDENTITY; FRAGMENTS	Background: The variety of ways in which faces are categorized makes face recognition challenging for both synthetic and biological vision systems. Here we focus on two face processing tasks, detection and individuation, and explore whether differences in task demands lead to differences both in the features most effective for automatic recognition and in the featural codes recruited by neural processing. Methodology/Principal Findings: Our study appeals to a computational framework characterizing the features representing object categories as sets of overlapping image fragments. Within this framework, we assess the extent to which task-relevant information differs across image fragments. Based on objective differences we find among task-specific representations, we test the sensitivity of the human visual system to these different face descriptions independently of one another. Both behavior and functional magnetic resonance imaging reveal effects elicited by objective task-specific levels of information. Behaviorally, recognition performance with image fragments improves with increasing task-specific information carried by different face fragments. Neurally, this sensitivity to the two tasks manifests as differential localization of neural responses across the ventral visual pathway. Fragments diagnostic for detection evoke larger neural responses than non-diagnostic ones in the right posterior fusiform gyrus and bilaterally in the inferior occipital gyrus. In contrast, fragments diagnostic for individuation evoke larger responses than non-diagnostic ones in the anterior inferior temporal gyrus. Finally, for individuation only, pattern analysis reveals sensitivity to task-specific information within the right "fusiform face area". Conclusions/Significance: Our results demonstrate: 1) information diagnostic for face detection and individuation is roughly separable; 2) the human visual system is independently sensitive to both types of information; 3) neural responses differ according to the type of task-relevant information considered. More generally, these findings provide evidence for the computational utility and the neural validity of fragment-based visual representation and recognition.	[Nestor, Adrian; Vettel, Jean M.; Tarr, Michael J.] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Brown University	Nestor, A (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	michael_tarr@brown.edu		Nestor, Adrian/0000-0002-2250-8759	NSF [0339122, SBE-0542013]; The Ittleson Foundation; DOD SMART Graduate Fellowship	NSF(National Science Foundation (NSF)); The Ittleson Foundation; DOD SMART Graduate Fellowship	This research was supported by NSF Award #0339122, by the Temporal Dynamics of Learning Center (NSF Science of Learning Center SBE-0542013), and through the generosity of The Ittleson Foundation. The MRI system used in the study was purchased in part by an MRI grant from the NSF. JMV was supported by a DOD SMART Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Balas BJ, 2006, ACM T APPL PERCEPT, V3, P354, DOI DOI 10.1145/1190036.1190038; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cover T. M., 1991, ELEMENTS INFORM THEO; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Epshtein B, 2008, P NATL ACAD SCI USA, V105, P14298, DOI 10.1073/pnas.0800968105; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2004, VISION RES, V44, P471, DOI 10.1016/j.visres.2003.10.007; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Harel A, 2007, VISION RES, V47, P2010, DOI 10.1016/j.visres.2007.04.004; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Lerner Y, 2008, J COGNITIVE NEUROSCI, V20, P1189, DOI 10.1162/jocn.2008.20082; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Loffler G, 2005, NAT NEUROSCI, V8, P1386, DOI 10.1038/nn1538; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moghaddam B, 2000, PATTERN RECOGN, V33, P1771, DOI 10.1016/S0031-3203(99)00179-X; Murray RF, 2002, J VISION, V2, P79, DOI 10.1167/2.1.6; Neri P, 2006, VISION RES, V46, P2465, DOI 10.1016/j.visres.2006.02.002; Nestor A, 2008, J VISION, V8, DOI 10.1167/8.7.7; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMAS C, NAT NEUROSC IN PRESS; Thomas C, 2008, J COGNITIVE NEUROSCI, V20, P268, DOI 10.1162/jocn.2008.20025; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Zhang L., 2005, P 27 ANN COGN SCI C, P2428; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	51	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e3978	10.1371/journal.pone.0003978	http://dx.doi.org/10.1371/journal.pone.0003978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112516	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466000001
J	Hagen, NT				Hagen, Nils T.			Harmonic Allocation of Authorship Credit: Source-Level Correction of Bibliometric Bias Assures Accurate Publication and Citation Analysis	PLOS ONE			English	Article							H-INDEX; INDICATORS	Authorship credit for multi-authored scientific publications is routinely allocated either by issuing full publication credit repeatedly to all coauthors, or by dividing one credit equally among all coauthors. The ensuing inflationary and equalizing biases distort derived bibliometric measures of merit by systematically benefiting secondary authors at the expense of primary authors. Here I show how harmonic counting, which allocates credit according to authorship rank and the number of coauthors, provides simultaneous source-level correction for both biases as well as accommodating further decoding of byline information. I also demonstrate large and erratic effects of counting bias on the original h-index, and show how the harmonic version of the h-index provides unbiased bibliometric ranking of scientific merit while retaining the original's essential simplicity, transparency and intended fairness. Harmonic decoding of byline information resolves the conundrum of authorship credit allocation by providing a simple recipe for source-level correction of inflationary and equalizing bias. Harmonic counting could also offer unrivalled accuracy in automated assessments of scientific productivity, impact and achievement.	Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Hagen, NT (corresponding author), Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Norway.	Nils.Hagen@hibo.no						Browman Howard I, 2008, ETHICS SCI ENV POLIT, V8, P1; Buehring GC, 2007, SCIENTOMETRICS, V72, P459, DOI 10.1007/s11192-007-1762-4; Colquhoun D, 2007, PHYSL NEWS, V69, P12; Egghe L, 2000, J AM SOC INFORM SCI, V51, P145, DOI 10.1002/(SICI)1097-4571(2000)51:2<145::AID-ASI6>3.0.CO;2-9; Egghe L, 2008, J AM SOC INF SCI TEC, V59, P1608, DOI 10.1002/asi.20845; Gauffriau M, 2005, SCIENTOMETRICS, V64, P85, DOI 10.1007/s11192-005-0239-6; GAUFFRIAU M, 2008, SCIENTOMETR IN PRESS; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HODGE SE, 1981, SCIENCE, V213, P950; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Kennedy D, 2003, SCIENCE, V301, P733, DOI 10.1126/science.301.5634.733; LARSEN PO, 2008, STATE ART PUBLICATIO; LAWRENCE PA, 2008, ETHICS SCI ENV POLIT, V8, P5; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; PRICE DD, 1981, SCIENCE, V212, P986, DOI 10.1126/science.212.4498.986-a; Rennie D, 2002, SCIENCE, V298, P1554; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Schreiber M, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/30002; SCHREIBER M, 2008, NEW J PHYS, V10, P9, DOI DOI 10.1088/1367-2630/1010/1084/040201; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; Vinkler P, 2007, J INF SCI, V33, P481, DOI 10.1177/0165551506072165; WENDL MC, 2007, H INDEX HOWEVER RANK; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; 2005, NATURE, V436, P889	26	100	104	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4021	10.1371/journal.pone.0004021	http://dx.doi.org/10.1371/journal.pone.0004021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107201	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265463000016
J	Mozziconacci, J; Sandblad, L; Wachsmuth, M; Brunner, D; Karsenti, E				Mozziconacci, Julien; Sandblad, Linda; Wachsmuth, Malte; Brunner, Damian; Karsenti, Eric			Tubulin Dimers Oligomerize before Their Incorporation into Microtubules	PLOS ONE			English	Article								In the presence of GTP, purified dimers of alpha- and beta- tubulin will interact longitudinally and laterally to self-assemble into microtubules (MTs). This property provides a powerful in vitro experimental system to describe MT dynamic behavior at the micrometer scale and to study effects and functioning of a large variety of microtubule associated proteins (MAPs). Despite the plethora of such data produced, the molecular mechanisms of MT assembly remain disputed. Electron microscopy (EM) studies suggested that tubulin dimers interact longitudinally to form short oligomers which form a tube by lateral interaction and which contribute to MT elongation. This idea is however challenged: Based on estimated association constants it was proposed that single dimers represent the major fraction of free tubulin. This view was recently supported by measurements suggesting that MTs elongate by addition of single tubulin dimers. To solve this discrepancy, we performed a direct measurement of the longitudinal interaction energy for tubulin dimers. We quantified the size distribution of tubulin oligomers using EM and fluorescence correlation spectroscopy (FCS). From the distribution we derived the longitudinal interaction energy in the presence of GDP and the non-hydrolysable GTP analog GMPCPP. Our data suggest that MT elongation and nucleation involves interactions of short tubulin oligomers rather than dimers. Our approach provides a solid experimental framework to better understand the role of MAPs in MT nucleation and growth.	[Mozziconacci, Julien] Univ Paris 06, LPTMC, UMR 7600, Paris, France; [Mozziconacci, Julien; Sandblad, Linda; Wachsmuth, Malte; Brunner, Damian; Karsenti, Eric] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL)	Mozziconacci, J (corresponding author), Univ Paris 06, LPTMC, UMR 7600, Paris, France.	brunner@embl.de; karsenti@embl.de	Mozziconacci, Julien/M-4731-2019; Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X	HFSPO [RGP11/2005]	HFSPO(Human Frontier Science Program)	This work was supported in part by the HFSPO grant RGP11/2005.	Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Beuron F, 2001, METH MOL B, V164, P235; Carlier MF, 1997, BIOPHYS J, V73, P418, DOI 10.1016/S0006-3495(97)78081-0; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Flory P. J, 1953, PRINCIPLES POLYM CHE; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Hoenger A, 1996, J MOL BIOL, V263, P114, DOI 10.1006/jmbi.1996.0561; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krouglova T, 2004, BIOPHYS J, V87, P2635, DOI 10.1529/biophysj.104.040717; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oosawa F., 1975, THERMODYNAMICS POLYM; Peloquin J, 2005, NAT METHODS, V2, P299, DOI 10.1038/nmeth0405-299; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	25	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3821	10.1371/journal.pone.0003821	http://dx.doi.org/10.1371/journal.pone.0003821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043587	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451500004
J	Boukovinas, I; Papadaki, C; Mendez, P; Taron, M; Mavroudis, D; Koutsopoulos, A; Sanchez-Ronco, M; Sanchez, JJ; Trypaki, M; Staphopoulos, E; Georgoulias, V; Rosell, R; Souglakos, J				Boukovinas, Ioannis; Papadaki, Chara; Mendez, Pedro; Taron, Miquel; Mavroudis, Dimitris; Koutsopoulos, Anastasios; Sanchez-Ronco, Maria; Javier Sanchez, Jose; Trypaki, Maria; Staphopoulos, Eustathios; Georgoulias, Vassilis; Rosell, Rafael; Souglakos, John			Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; RIBONUCLEOTIDE REDUCTASE; PHASE-III; HUMAN BREAST; CISPLATIN; SURVIVAL; RESISTANCE; CHEMORESISTANCE; OVEREXPRESSION; REGIMENS	Background: Overexpression of RRM1 and RRM2 has been associated with gemcitabine resistance. BRCA1 overexpression increases sensitivity to paclitaxel and docetaxel. We have retrospectively examined the effect of RRM1, RRM2 and BRCA1 expression on outcome to gemcitabine plus docetaxel in advanced non-small-cell lung cancer (NSCLC) patients. Methodology and Principal Findings: Tumor samples were collected from 102 chemotherapy-naive advanced NSCLC patients treated with gemcitabine plus docetaxel as part of a randomized trial. RRM1, RRM2 and BRCA1 mRNA levels were assessed by quantitative PCR and correlated with response, time to progression and survival. As BRCA1 levels increased, the probability of response increased (Odds Ratio [OR], 1.09: p = 0.01) and the risk of progression decreased (hazard ratio [HR], 0.99; p = 0.36). As RRM1 and RRM2 levels increased, the probability of response decreased (RRM1: OR, 0.97; p = 0.82; RRM2: OR, 0.94; p<0.0001) and the risk of progression increased (RRM1: HR, 1.02; p = 0.001; RRM2: HR, 1.005; p = 0.01). An interaction observed between BRCA1 and RRM1 allowed patients to be classified in three risk groups according to combinations of gene expression levels, with times to progression of 10.13, 4.17 and 2.30 months (p = 0.001). Low BRCA1 expression was the only factor significantly associated with longer time to progression in 31 patients receiving cisplatin-based second-line therapy. Conclusions: The mRNA expression of BRCA1, RRM1 and RRM2 is potentially a useful tool for selecting NSCLC patients for individualized chemotherapy and warrants further investigation in prospective studies.	[Boukovinas, Ioannis] Theagenion Krankenhauses, Thessaloniki, Greece; [Papadaki, Chara; Mavroudis, Dimitris; Trypaki, Maria; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Lab Tumor Cell Biol, Iraklion, Greece; [Mendez, Pedro; Taron, Miquel; Rosell, Rafael] Hosp Germans Trias Pujol, Catalan Inst Oncol, Barcelona, Spain; [Taron, Miquel; Rosell, Rafael] USP Dexeus Univ, C Sabino Arana 5, Barcelona, Spain; [Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Koutsopoulos, Anastasios; Staphopoulos, Eustathios] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Greece; [Sanchez-Ronco, Maria] Univ Alcala Henares, Alcala De Henares, Spain; [Javier Sanchez, Jose] Univ Autonoma Madrid, E-28049 Madrid, Spain	University of Crete; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; University Hospital of Heraklion; University Hospital of Heraklion; Universidad de Alcala; Autonomous University of Madrid	Boukovinas, I (corresponding author), Theagenion Krankenhauses, Thessaloniki, Greece.	rrosell@ico.scs.es; georgsec@med.uoc.gr	Koutsopoulos, Anastasios/AAO-9498-2020	Koutsopoulos, Anastasios/0000-0002-8430-7565; PAPADAKI, CHARA/0000-0002-4591-3757	Cretan Association for Biomedical Research (CABR) [fellowship]	Cretan Association for Biomedical Research (CABR)	This work was partly supported by the Cretan Association for Biomedical Research (CABR). Dr. John Souglakos is the recipient of a CABR research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Booton R, 2007, J THORAC ONCOL, V2, P902, DOI 10.1097/JTO.0b013e318155a637; Burdett S, 2007, J THORAC ONCOL, V2, pS337, DOI 10.1097/01.JTO.0000283148.83670.80; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Duxbury MS, 2004, SURGERY, V136, P261, DOI 10.1016/j.surg.2004.04.029; Eelen G, 2008, ONCOGENE, V27, P4233, DOI 10.1038/onc.2008.51; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Georgoulias V, 2005, J CLIN ONCOL, V23, P2937, DOI 10.1200/JCO.2005.04.016; Georgoulias V, 2001, LANCET, V357, P1478, DOI 10.1016/S0140-6736(00)04644-4; Goan YG, 1999, CANCER RES, V59, P4204; Husain A, 1998, CANCER RES, V58, P1120; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873	37	106	115	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3695	10.1371/journal.pone.0003695	http://dx.doi.org/10.1371/journal.pone.0003695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002265	gold, Green Published, Green Submitted			2022-12-27	WOS:000265165600002
J	Urdinguio, RG; Lopez-Serra, L; Lopez-Nieva, P; Alaminos, M; Diaz-Uriarte, R; Fernandez, AF; Esteller, M				Urdinguio, Rocio G.; Lopez-Serra, Lidia; Lopez-Nieva, Pilar; Alaminos, Miguel; Diaz-Uriarte, Ramon; Fernandez, Agustin F.; Esteller, Manel			Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome	PLOS ONE			English	Article								Background: Rett syndrome (RTT) is a complex neurological disorder that is one of the most frequent causes of mental retardation in women. A great landmark in research in this field was the discovery of a relationship between the disease and the presence of mutations in the gene that codes for the methyl-CpG binding protein 2 (MeCP2). Currently, MeCP2 is thought to act as a transcriptional repressor that couples DNA methylation and transcriptional silencing. The present study aimed to identify new target genes regulated by Mecp2 in a mouse model of RTT. Methodology/Principal Findings: We have compared the gene expression profiles of wild type (WT) and Mecp2-null ( KO) mice in three regions of the brain (cortex, midbrain, and cerebellum) by using cDNA microarrays. The results obtained were confirmed by quantitative real-time PCR. Subsequent chromatin immunoprecipitation assays revealed seven direct target genes of Mecp2 bound in vivo (Fkbp5, Mobp, Plagl1, Ddc, Mllt2h, Eya2, and S100a9), and three overexpressed genes due to an indirect effect of a lack of Mecp2 (Irak1, Prodh and Dlk1). The regions bound by Mecp2 were always methylated, suggesting the involvement of the methyl-CpG binding domain of the protein in the mechanism of interaction. Conclusions: We identified new genes that are overexpressed in Mecp2-KO mice and are excellent candidate genes for involvement in various features of the neurological disease. Our results demonstrate new targets of MeCP2 and provide us with a better understanding of the underlying mechanisms of RTT.	[Urdinguio, Rocio G.; Lopez-Serra, Lidia; Lopez-Nieva, Pilar; Alaminos, Miguel; Fernandez, Agustin F.; Esteller, Manel] CNIO, Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid, Spain; [Diaz-Uriarte, Ramon] Spanish Natl Canc Res Ctr CNIO, Stat Comput Team, Madrid, Spain; [Esteller, Manel] Inst Investigac Biomed Bellvitge IDIBELL, Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Esteller, Manel] Inst Catalana Recerca Estudis Avancats ICREA, Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Urdinguio, RG (corresponding author), CNIO, Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid, Spain.	mesteller@idibell.org	Nieva, Pilar López/R-9516-2019; Fernandez, Agustin F./N-7302-2014; Diaz-Uriarte, Ramon/M-5517-2013; Esteller, Manel/L-5956-2014; Urdinguio, Rocio/AAA-9015-2020; ALAMINOS, MIGUEL/N-9960-2016	Nieva, Pilar López/0000-0001-6369-2444; Fernandez, Agustin F./0000-0002-3792-4085; Diaz-Uriarte, Ramon/0000-0002-6637-9039; Esteller, Manel/0000-0003-4490-6093; Urdinguio, Rocio/0000-0003-2736-5758; ALAMINOS, MIGUEL/0000-0003-4876-2672	E-Rare; Comunidad de Madrid FPI Programme; ICREA Funding Source: Custom	E-Rare; Comunidad de Madrid FPI Programme; ICREA(ICREA)	This work was supported by the E-Rare (ERA-Net for research programs on rare diseases) (EuroRETT). R.G.U. is funded by the Comunidad de Madrid FPI Programme. M.E. is an ICREA Research Professor. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFENJAR A, 2007, BRAIN DEV; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2005, HUM GENET, V116, P91, DOI 10.1007/s00439-004-1200-0; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Buckland PR, 1997, MOL BRAIN RES, V49, P266; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C; Delgado IJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-61; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Di Rosa G, 2008, PSYCHIAT GENET, V18, P40, DOI 10.1097/YPG.0b013e3282f08a3d; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; DYCK LE, 1983, J NEUROSCI RES, V10, P211, DOI 10.1002/jnr.490100209; Embry AC, 2004, MOL PHARMACOL, V66, P1325, DOI 10.1124/mol.104.004093; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Fox J, 2002, COX PROPORTIONAL HAZ; Fox Jr J., 2015, APPL REGRESSION ANAL; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hillman MA, 2001, J HUM GENET, V46, P251, DOI 10.1007/s100380170074; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KOH T, 1995, INT J CANCER, V60, P843, DOI 10.1002/ijc.2910600620; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Makedonski K, 2005, HUM MOL GENET, V14, P1049, DOI 10.1093/hmg/ddi097; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MILLER RG, 1997, ANOVA; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; PATERSON IA, 1990, J NEUROCHEM, V55, P1827, DOI 10.1111/j.1471-4159.1990.tb05764.x; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Phang J. M., 2001, METABOLIC MOL BASES; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; R Development Core Team, 2006, LANG ENV STAT COMP; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shimizu T, 2006, PHARMACOL BIOCHEM BE, V85, P643, DOI 10.1016/j.pbb.2006.10.020; Shimizu T, 2004, PAIN, V110, P246, DOI 10.1016/j.pain.2004.03.038; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Sokal RR, 1995, BIOMETRY; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vassiliou AG, 2005, NEUROCHEM RES, V30, P641, DOI 10.1007/s11064-005-2752-7; Yool D, 2002, GLIA, V39, P256, DOI 10.1002/glia.10103	86	88	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3669	10.1371/journal.pone.0003669	http://dx.doi.org/10.1371/journal.pone.0003669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989361	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134600005
J	Katoh, A; Chapman, PJ; Raymond, JL				Katoh, Akira; Chapman, Peter J.; Raymond, Jennifer L.			Disruption of Learned Timing in P/Q Calcium Channel Mutants	PLOS ONE			English	Article								To optimize motor performance, both the amplitude and temporal properties of movements should be modifiable by motor learning. Here we report that the modification of movement timing is highly dependent on signaling through P/Q-type voltage-dependent calcium channels. Two lines of mutant mice heterozygous for P/Q-type voltage-dependent calcium channels exhibited impaired plasticity of eye movement timing, but relatively intact plasticity of movement amplitude during motor learning in the vestibulo-ocular reflex. The results thus demonstrate a distinction between the molecular signaling pathways regulating the timing versus amplitude of movements.	[Katoh, Akira; Chapman, Peter J.; Raymond, Jennifer L.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Katoh, A (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	jenr@stanford.edu	Katoh, Akira/B-2683-2010	Katoh, Akira/0000-0001-7867-2964; Raymond, Jennifer/0000-0002-8145-747X	EJLB Foundation Award; James S. Mcdonnell Foundation 21st Century Research Award; NIH [P01 NS0353862]; Human Frontier Science Program [fellowship]	EJLB Foundation Award; James S. Mcdonnell Foundation 21st Century Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program)	This research was supported by an EJLB Foundation Award, James S. Mcdonnell Foundation 21st Century Research Award and NIH P01 NS0353862 to J.L.R.. A.K. was supported by a long-term fellowship from the Human Frontier Science Program.	Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hirata Y, 2002, J NEUROPHYSIOL, V88, P3194, DOI 10.1152/jn.00698.2001; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Katoh A, 2007, J NEUROPHYSIOL, V97, P1280, DOI 10.1152/jn.00322.2006; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; KRAMER PD, 1995, EXP BRAIN RES, V106, P318; Kramer PD, 1998, EXP BRAIN RES, V120, P184, DOI 10.1007/s002210050392; LI J, 1995, J NEUROPHYSIOL, V74, P489, DOI 10.1152/jn.1995.74.1.489; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; NGUYENVU T, 2007, SOC NEUR ABSTR; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2006, J NEUROPHYSIOL, V95, P1588, DOI 10.1152/jn.00318.2005; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3635	10.1371/journal.pone.0003635	http://dx.doi.org/10.1371/journal.pone.0003635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982062	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134300005
J	Freire, P; Vilela, M; Deus, H; Kim, YW; Koul, D; Colman, H; Aldape, KD; Bogler, O; Yung, WKA; Coombes, K; Mills, GB; Vasconcelos, AT; Almeida, JS				Freire, Pablo; Vilela, Marco; Deus, Helena; Kim, Yong-Wan; Koul, Dimpy; Colman, Howard; Aldape, Kenneth D.; Bogler, Oliver; Yung, W. K. Alfred; Coombes, Kevin; Mills, Gordon B.; Vasconcelos, Ana T.; Almeida, Jonas S.			Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme	PLOS ONE			English	Article								Background: The Cancer Genome Atlas project (TCGA) has initiated the analysis of multiple samples of a variety of tumor types, starting with glioblastoma multiforme. The analytical methods encompass genomic and transcriptomic information, as well as demographic and clinical data about the sample donors. The data create the opportunity for a systematic screening of the components of the molecular machinery for features that may be associated with tumor formation. The wealth of existing mechanistic information about cancer cell biology provides a natural reference for the exploratory exercise. Methodology/Principal Findings: Glioblastoma multiforme DNA copy number data was generated by The Cancer Genome Atlas project for 167 patients using 227 aCGH experiments, and was analyzed to build a catalog of aberrant regions. Genome screening was performed using an information theory approach in order to quantify aberration as a deviation from a centrality without the bias of untested assumptions about its parametric nature. A novel Cancer Genome Browser software application was developed and is made public to provide a user-friendly graphical interface in which the reported results can be reproduced. The application source code and stand alone executable are available at http://code.google.com/p/cancergenome and http://bioinformaticstation.org, respectively. Conclusions/Significance: The most important known copy number alterations for glioblastoma were correctly recovered using entropy as a measure of aberration. Additional alterations were identified in different pathways, such as cell proliferation, cell junctions and neural development. Moreover, novel candidates for oncogenes and tumor suppressors were also detected. A detailed map of aberrant regions is provided.	[Freire, Pablo; Vilela, Marco; Deus, Helena; Coombes, Kevin; Almeida, Jonas S.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Kim, Yong-Wan; Koul, Dimpy; Colman, Howard; Yung, W. K. Alfred] Univ Texas MD Anderson Canc Ctr, Dept Neuro Oncol, Houston, TX USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX USA; [Freire, Pablo; Vasconcelos, Ana T.] Lab Nacl Comput Cient, Lab Bioinformat, Rio De Janeiro, Brazil; [Vilela, Marco; Deus, Helena] Univ Nova Lisboa, Inst Tecnol Quim Biol, Lisbon, Portugal	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade Nova de Lisboa	Freire, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	jalmeida@mdanderson.org	Almeida, Jonas/C-9093-2009; Vasconcelos, Ana Tereza R/I-1011-2012; Colman, Howard/L-5433-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Almeida, Jonas/0000-0002-7883-7922; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Bogler, Oliver/0000-0002-3700-0480; Deus, Helena/0000-0003-2995-568X; Coombes, Kevin/0000-0002-7630-2123	National Institutes of Health (NIH) [1UL1RR024148, RO1CA123304, RO1CA056041]; CAPES; CNPq; FAPERJ; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA123304, R01CA056041, P50CA098258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thankfully acknowledge National Institutes of Health (NIH) support through the Center for Clinical and Translational Sciences under contract no. 1UL1RR024148 through awards RO1CA123304, and RO1CA056041. P Freire and AT Vasconcelos also acknowledge funding from the Brazilian government programs and Institutions CAPES, CNPq and FAPERJ.	Almeida JS, 2006, NAT BIOTECHNOL, V24, P1070, DOI 10.1038/nbt0906-1070; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Beckmann MW, 1997, J MOL MED, V75, P429, DOI 10.1007/s001090050128; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Connett JM, 2005, J INTERF CYTOK RES, V25, P587, DOI 10.1089/jir.2005.25.587; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Farmer J.B., 1905, P ROY SOC LOND B BIO, V77, P336; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; ICHIMURA K, 2007, ONCOGENE; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; KALLIONIEMI A, 2007, CURR OPIN BIOTECHNOL; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Li F, 2006, HUM MOL GENET, V15, P1921, DOI 10.1093/hmg/ddl114; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; McLendon R, 2008, NATURE; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; PARZEN E, 1956, P NATL ACAD SCI USA, V42, P154, DOI 10.1073/pnas.42.3.154; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reifenberger G, 2004, J MOL MED, V82, P656, DOI 10.1007/s00109-004-0564-x; Santos GC, 2007, J CLIN PATHOL, V60, P1, DOI 10.1136/jcp.2005.034389; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; Vandepoele K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002207; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200	41	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4076	10.1371/journal.pone.0004076	http://dx.doi.org/10.1371/journal.pone.0004076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115005	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466300015
J	Oro, D; Margalida, A; Carrete, M; Heredia, R; Donazar, JA				Oro, Daniel; Margalida, Antoni; Carrete, Martina; Heredia, Rafael; Antonio Donazar, Jose			Testing the Goodness of Supplementary Feeding to Enhance Population Viability in an Endangered Vulture	PLOS ONE			English	Article							GYPAETUS-BARBATUS; EXTINCTION RISK; BEARDED VULTURES; CONSERVATION; HABITAT; BIRDS; REPRODUCTION; PERSECUTION; DICLOFENAC; MORTALITY	Background: Human-predator conflicts are directly or indirectly threatening many species with extinction. Thus, biologists are urged to find simple solutions to complex situations while avoiding unforeseen conservation outcomes. The provision of supplementary food at artificial feeding sites (AFS) is frequently used in the conservation of scavenger bird populations currently suffering from indirect poisoning, although no scientific studies on its effectiveness have been conducted. Methodology/Principal Findings: We used a long-term data set of 95 individually marked birds from the largest European core of the endangered bearded vulture (Gypaetus barbatus) to test the long-term effects of specific AFS for bearded vultures on their survival rates (by CMR models) and population dynamics (by Monte Carlo simulations) in an area where fatalities derived from illegal poisoning and the use of other toxics like veterinary drugs have increased over the last several years. Our data support the positive relationship between the use of AFS and survival. However, contrary to theoretical predictions (e. g. high and more stable adult survival among long-lived species), the use of AFS increased only survival of pre-adults. Moreover, AFS buffered the effects of illegal poisoning on this age-class, while adult survival decreased over years. Our simulations predicted a maximum value of extinction probability over a time horizon of 50 years. Population projections run with survival rates expected in scenarios without poisoning predicted the situation of least conservation concern, while including only AFS can maintain a large floater surplus that may delay population decline but fails to reduce poisoning risk among adults. Conclusions/Significance: Although AFS are not effective to save bearded vultures from an expected population decline, they delay population extinction and can be a useful tool for prolonging population viability while combating illegal and indirect poisoning. The eradication of different sources of poisoning is of top priority to ensure the long-term viability of this and many other species.	IMEDEA CSIC UIB, Esporles, Mallorca, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, Lleida, Spain; [Carrete, Martina; Antonio Donazar, Jose] CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Fundacion para la Conservacion del Quebranthuesos (FCQ); Consejo Superior de Investigaciones Cientificas (CSIC)	Oro, D (corresponding author), IMEDEA CSIC UIB, Esporles, Mallorca, Spain.	margalida@inf.entorno.es	Carrete, Martina/D-2618-2017; Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Oro, Daniel/H-4208-2012; Carrete, Martina/A-6376-2009; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Oro, Daniel/0000-0003-4782-3007; Carrete, Martina/0000-0002-0491-2950; Margalida, Antoni/0000-0002-7383-671X; Donazar, Jose Antonio/0000-0002-9433-9755; Margalida, Antoni/0000-0002-3904-6212	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya; Ministry of Environment; Junta de Andalucia	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya(Generalitat de Catalunya); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Junta de Andalucia(Junta de Andalucia)	Financial support for AM was obtained from the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministry of Environment. MC was supported by an Excellence post-doctoral contract (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antor RJ, 2007, ACTA ORNITHOL, V42, P114, DOI 10.3161/068.042.0106; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Blanco G, 2006, ARDEOLA, V53, P341; Bretagnolle V, 2004, BIOL CONSERV, V120, P19, DOI 10.1016/j.biocon.2004.01.023; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; CHOQUET R, 2008, ENV ECOL ST IN PRESS; CLUTHBERT R, 2007, BIOL LETT, V3, P90; CUSHING JM, 2003, CHAOS ECOLOGY EXPT N; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Green RE, 2006, J APPL ECOL, V43, P949, DOI 10.1111/j.1365-2664.2006.01225.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Heredia R., 1990, Acta Biologica Montana, V9, P39; HEREDIA R, 2005, BIOL CONSERVACION QU, P335; Hernandez M, 2008, ECOTOXICOLOGY, V17, P264, DOI 10.1007/s10646-008-0193-1; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; IUCN [International Union for Conservation of Nature], 1990, 1990 IUCN RED LIST T; Lande R., 2003, OXFORD SERIES ECOLOG; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; Margalida A, 2004, IBIS, V146, P386, DOI 10.1111/j.1474-919X.2004.00261.x; Margalida A, 2003, IBIS, V145, P244, DOI 10.1046/j.1474-919X.2003.00148.x; MARGALIDA A, 2009, J APPL ECOL; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Mills LS, 2001, CONSERV BIOL, V15, P281, DOI 10.1046/j.1523-1739.2001.00300.x; Mundy P., 1992, VULTURES AFRICA; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; SCHAUB M, 2008, J APPL ECOL; Sese JA, 2005, BIOL CONSERVACION QU, P279; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tavecchia G, 2007, OIKOS, V116, P1481, DOI 10.1111/j.2007.0030-1299.15791.x; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; WILBUR SR, 1974, J WILDLIFE MANAGE, V38, P343, DOI 10.2307/3800743; WILLIAMS B. K., 2001, ANAL MANAGEMENT ANIM	46	134	137	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4084	10.1371/journal.pone.0004084	http://dx.doi.org/10.1371/journal.pone.0004084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115009	Green Submitted, gold, Green Published			2022-12-27	WOS:000265466300020
J	Sasaki, T; Maier, B; Koclega, KD; Chruszcz, M; Gluba, W; Stukenberg, PT; Minor, W; Scrable, H				Sasaki, Tsutomu; Maier, Bernhard; Koclega, Katarzyna D.; Chruszcz, Maksymilian; Gluba, Wendy; Stukenberg, P. Todd; Minor, Wladek; Scrable, Heidi			Phosphorylation Regulates SIRT1 Function	PLOS ONE			English	Article								Background: SIR2 is an NAD(+)-dependent deacetylase [1-3] implicated in the regulation of lifespan in species as diverse as yeast [4], worms [5], and flies [6]. We previously reported that the level of SIRT1, the mammalian homologue of SIR2 [7,8], is coupled to the level of mitotic activity in cells both in vitro and in vivo [9]. Cells from long-lived mice maintained SIRT1 levels of young mice in tissues that undergo continuous cell replacement by proliferating stem cells. Changes in SIRT1 protein level were not associated with changes in mRNA level, suggesting that SIRT1 could be regulated post-transcriptionally. However, other than a recent report on sumoylation [10] and identification of SIRT1 as a nuclear phospho-protein by mass spectrometry [11], post-translational modifications of this important protein have not been reported. Methodology/Principal Findings: We identified 13 residues in SIRT1 that are phosphorylated in vivo using mass spectrometry. Dephosphorylation by phosphatases in vitro resulted in decreased NAD(+)- dependent deacetylase activity. We identified cyclinB/Cdk1 as a cell cycle-dependent kinase that forms a complex with and phosphorylates SIRT1. Mutation of two residues phosphorylated by Cyclin B/Cdk1 (threonine 530 and serine 540) disturbs normal cell cycle progression and fails to rescue proliferation defects in SIRT1-deficient cells [12,13]. Conclusions/Significance: Pharmacological manipulation of SIRT1 activity is currently being tested as a means of extending lifespan in mammals. Treatment of obese mice with resveratrol, a pharmacological activator of SIRT1, modestly but significantly improved longevity and, perhaps more importantly, offered some protection against the development of type 2 diabetes mellitus and metabolic syndrome [14-16]. Understanding the endogenous mechanisms that regulate the level and activity of SIRT1, therefore, has obvious relevance to human health and disease. Our results identify phosphorylation by cell cycle dependent kinases as a major mechanism controlling the level and function of this sirtuin and complement recent reports of factors that inhibit [17,18] and activate [19] SIRT1 by protein-protein interactions.	[Sasaki, Tsutomu; Scrable, Heidi] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA; [Sasaki, Tsutomu; Maier, Bernhard; Gluba, Wendy; Scrable, Heidi] Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA; [Koclega, Katarzyna D.; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA 22903 USA; [Stukenberg, P. Todd] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Sasaki, T (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Metab Signal, Gunma, Japan.	hs2n@virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090; Stukenberg, Todd/0000-0002-6788-2111; Sasaki, Tsutomu/0000-0001-8041-1915	NIH [AG026094, GM53163, GM74942]; Ellison Foundation for Medical Research [fellow]; Cancer Center [P30 CA45579]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, U54GM074942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026094] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation for Medical Research; Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by PHS grant NIH AG026094 (H.S.) and NIH GM53163 and GM74942 (W.M.). H.S. is a fellow of the Ellison Foundation for Medical Research. The flow cytometry core facility is supported by Cancer Center Support Grant P30 CA45579.	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li MG, 2006, CELL SIGNAL, V18, P1318, DOI 10.1016/j.cellsig.2005.10.020; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; RINE J, 1987, GENETICS, V116, P9; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; SRINIVASAN J, 1995, BIOCHEM J, V309, P927, DOI 10.1042/bj3090927; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; ZHANG JW, 1994, ARCH BIOCHEM BIOPHYS, V315, P415, DOI 10.1006/abbi.1994.1519; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	46	211	218	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4020	10.1371/journal.pone.0004020	http://dx.doi.org/10.1371/journal.pone.0004020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107194	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000015
J	Gopalan, S; Ausubel, FM				Gopalan, Suresh; Ausubel, Frederick M.			A Metasystem of Framework Model Organisms to Study Emergence of New Host-Microbe Adaptations	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SECRETION SYSTEM; BACTERIAL; DEFENSE; PATHOGENICITY; INFECTION; MUTUALISM; RESPONSES; PA14	An unintended consequence of global industrialization and associated societal rearrangements is new interactions of microbes and potential hosts (especially mammals and plants), providing an opportunity for the rapid emergence of host-microbe adaptation and eventual establishment of new microbe-related diseases. We describe a new model system comprising the model plant Arabidopsis thaliana and several microbes, each representing different modes of interaction, to study such "maladaptations". The model microbes include human and agricultural pathogens and microbes that are commonly considered innocuous. The system has a large knowledge base corresponding to each component organism and is amenable to high-throughput automation assisted perturbation screens for identifying components that modulate host-pathogen interactions. This would aid in the study of emergence and progression of host-microbe maladaptations in a controlled environment.	[Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gopalan, Suresh; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gopalan, S (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	gopalan@molbio.mgh.harvard.edu			NIH [R37 GM48707]; NSF [DBI-0114783]; Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center Award [DK57521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by grants R37 GM48707 from NIH and DBI-0114783 from NSF to F.M.A. The Microscopy core is partially supported by an Inflammatory Bowel Disease Grant DK43351 and a Boston Area Diabetes and Endocrinology Research Center Award DK57521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; GRAY KM, 1994, J BACTERIOL, V176, P3076, DOI 10.1128/JB.176.10.3076-3080.1994; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; SONGNUAN W, 2008, P 13 INT C MOL PLANT; Subramanian C, 2006, PLANT J, V48, P138, DOI 10.1111/j.1365-313X.2006.02851.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3891	10.1371/journal.pone.0003891	http://dx.doi.org/10.1371/journal.pone.0003891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066631	Green Published, gold			2022-12-27	WOS:000265455700005
J	Dybas, JM; Madrid-Aliste, CJ; Che, FY; Nieves, E; Rykunov, D; Angeletti, RH; Weiss, LM; Kim, K; Fiser, A				Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Che, Fa-Yun; Nieves, Edward; Rykunov, Dmitry; Angeletti, Ruth Hogue; Weiss, Louis M.; Kim, Kami; Fiser, Andras			Computational Analysis and Experimental Validation of Gene Predictions in Toxoplasma gondii	PLOS ONE			English	Article							PROTEIN IDENTIFICATION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; REVEALS; EXPRESSION	Background: Toxoplasma gondii is an obligate intracellular protozoan that infects 20 to 90% of the population. It can cause both acute and chronic infections, many of which are asymptomatic, and, in immunocompromized hosts, can cause fatal infection due to reactivation from an asymptomatic chronic infection. An essential step towards understanding molecular mechanisms controlling transitions between the various life stages and identifying candidate drug targets is to accurately characterize the T. gondii proteome. Methodology/Principal Findings: We have explored the proteome of T. gondii tachyzoites with high throughput proteomics experiments and by comparison to publicly available cDNA sequence data. Mass spectrometry analysis validated 2,477 gene coding regions with 6,438 possible alternative gene predictions; approximately one third of the T. gondii proteome. The proteomics survey identified 609 proteins that are unique to Toxoplasma as compared to any known species including other Apicomplexan. Computational analysis identified 787 cases of possible gene duplication events and located at least 6,089 gene coding regions. Commonly used gene prediction algorithms produce very disparate sets of protein sequences, with pairwise overlaps ranging from 1.4% to 12%. Through this experimental and computational exercise we benchmarked gene prediction methods and observed false negative rates of 31 to 43%. Conclusions/Significance: This study not only provides the largest proteomics exploration of the T. gondii proteome, but illustrates how high throughput proteomics experiments can elucidate correct gene structures in genomes.	[Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Che, Fa-Yun; Nieves, Edward; Rykunov, Dmitry; Angeletti, Ruth Hogue; Weiss, Louis M.; Kim, Kami; Fiser, Andras] Albert Einstein Coll Med, Biodef Prote Res Ctr, Bronx, NY 10467 USA; [Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Rykunov, Dmitry; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Comput Biol, Bronx, NY USA; [Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Rykunov, Dmitry; Angeletti, Ruth Hogue; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Weiss, Louis M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY USA; [Che, Fa-Yun; Nieves, Edward; Angeletti, Ruth Hogue] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY USA; [Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Che, Fa-Yun; Nieves, Edward; Angeletti, Ruth Hogue] Albert Einstein Coll Med, Lab Macromol Anal & Proteom, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dybas, JM (corresponding author), Albert Einstein Coll Med, Biodef Prote Res Ctr, Bronx, NY 10467 USA.	afiser@aecom.yu.edu		Kim, Kami/0000-0003-3384-152X	NIH-NIAID [HHSN266200400054C]; NATIONAL CANCER INSTITUTE [R33CA101150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039454, R01AI060496] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by NIH-NIAID HHSN266200400054C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Carruthers Vern B., 1999, Parasitology International, V48, P1; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jungblut PR, 2001, INFECT IMMUN, V69, P5905, DOI 10.1128/IAI.69.9.5905-5907.2001; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karlin S, 2001, NATURE, V411, P259, DOI 10.1038/35077152; Khan A, 2006, GENOME RES, V16, P1119, DOI 10.1101/gr.5318106; Khan Asis, 2007, P193; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kissinger Jessica C., 2007, P209; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu FL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-255; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mularoni L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r33; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Roos David S., 1999, Novartis Foundation Symposium, V226, P176; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; SOUSA OE, 1988, AM J TROP MED HYG, V38, P315, DOI 10.4269/ajtmh.1988.38.315; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	34	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3899	10.1371/journal.pone.0003899	http://dx.doi.org/10.1371/journal.pone.0003899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065262	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455200011
J	Ahmer, S; Yousafzai, AW; Bhutto, N; Alam, S; Sarangzai, AK; Iqbal, A				Ahmer, Syed; Yousafzai, Abdul Wahab; Bhutto, Naila; Alam, Sumira; Sarangzai, Amanullah Khan; Iqbal, Arshad			Bullying of Medical Students in Pakistan: A Cross-Sectional Questionnaire Survey	PLOS ONE			English	Article								Background: Several studies from other countries have shown that bullying, harassment, abuse or belittlement are a regular phenomenon faced not only by medical students, but also junior doctors, doctors undertaking research and other healthcare professionals. While research has been carried out on bullying experienced by psychiatrists and psychiatry trainees in Pakistan no such research has been conducted on medical students in this country. Methodology/Principal Findings: We conducted a cross-sectional questionnaire survey on final year medical students in six medical colleges of Pakistan. The response rate was 63%. Fifty-two percent of respondents reported that they had faced bullying or harassment during their medical education, about 28% of them experiencing it once a month or even more frequently. The overwhelming form of bullying had been verbal abuse (57%), while consultants were the most frequent (46%) perpetrators. Students who were slightly older, males, those who reported that their medical college did not have a policy on bullying or harassment, and those who felt that adequate support was not in place at their medical college for bullied individuals, were significantly more likely to have experienced bullying. Conclusion: Bullying or harassment is faced by quite a large proportion of medical students in Pakistan. The most frequent perpetrators of this bullying are consultants. Adoption of a policy against bullying and harassment by medical colleges, and providing avenues of support for students who have been bullied may help reduce this phenomenon, as the presence of these two was associated with decreased likelihood of students reporting having being bullied.	[Yousafzai, Abdul Wahab; Bhutto, Naila] Aga Khan Univ, Dept Psychiat, Karachi, Pakistan; [Alam, Sumira] Serv Inst Hlth Sci, Dept Psychiat, Lahore, Pakistan; [Sarangzai, Amanullah Khan] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Iqbal, Arshad] Aga Khan Univ, Med Coll, Karachi, Pakistan	Aga Khan University; Aga Khan University; Aga Khan University	Ahmer, S (corresponding author), Aga Khan Univ, Dept Psychiat, Karachi, Pakistan.	syed.ahmer@aku.edu						AHMER S, 2009, BULLYING TR IN PRESS; *BMA, 2006, BMA MED STUD WELF SU; Chartered Institute of Personnel and Development, 2004, MAN CONFL WORK SURV; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Frank E, 2006, BMJ-BRIT MED J, V333, P682, DOI 10.1136/bmj.38924.722037.7C; Gadit AAM, 2008, J MED ETHICS, V34, P463, DOI 10.1136/jme.2007.021832; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; Larsson C, 2003, MED EDUC, V37, P39, DOI 10.1046/j.1365-2923.2003.01404.x; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; Maida AM, 2003, MED TEACH, V25, P497, DOI 10.1080/01421590310001606317; Nora LM, 2002, ACAD MED, V77, P1226, DOI 10.1097/00001888-200212000-00018; Paice E, 2004, BRIT MED J, V329, P658, DOI 10.1136/bmj.38133.502569.AE; Paice Elisabeth, 2003, BMJ, V326, pS127, DOI 10.1136/bmj.326.7393.S127; Quine L, 1999, BRIT MED J, V318, P228, DOI 10.1136/bmj.318.7178.228; Quine L, 2002, BRIT MED J, V324, P878, DOI 10.1136/bmj.324.7342.878; Rautio Arja, 2005, BMC Med Educ, V5, P36, DOI 10.1186/1472-6920-5-36; Richardson DA, 1997, ACAD MED, V72, P728, DOI 10.1097/00001888-199708000-00022; RICHMAN JA, 1992, JAMA-J AM MED ASSOC, V267, P692, DOI 10.1001/jama.267.5.692; SHEEHAN KH, 1990, JAMA-J AM MED ASSOC, V263, P533, DOI 10.1001/jama.263.4.533; Stebbing J, 2004, POSTGRAD MED J, V80, P93, DOI 10.1136/pmj.2003.009001; Uhari M, 1994, JAMA, V271, P1049; White GE, 2000, MED EDUC, V34, P980, DOI 10.1046/j.1365-2923.2000.00684.x	23	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3889	10.1371/journal.pone.0003889	http://dx.doi.org/10.1371/journal.pone.0003889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060948	Green Published, gold			2022-12-27	WOS:000265455100008
J	Marchi, M; D'Antoni, A; Formentini, I; Parra, R; Brambilla, R; Ratto, GM; Costa, M				Marchi, Matilde; D'Antoni, Angela; Formentini, Ivan; Parra, Riccardo; Brambilla, Riccardo; Ratto, Gian Michele; Costa, Mario			The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; NUCLEAR TRANSLOCATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; SIGNAL; LOCALIZATION; GROWTH; IDENTIFICATION; CASCADE	The Extracellular Regulated Kinase 1 and 2 transduce a variety of extracellular stimuli regulating processes as diverse as proliferation, differentiation and synaptic plasticity. Once activated in the cytoplasm, ERK1 and ERK2 translocate into the nucleus and interact with nuclear substrates to induce specific programs of gene expression. ERK1/2 share 85% of aminoacid identity and all known functional domains and thence they have been considered functionally equivalent until recent studies found that the ablation of either ERK1 or ERK2 causes dramatically different phenotypes. To search a molecular justification of this dichotomy we investigated whether the different functions of ERK1 and 2 might depend on the properties of their cytoplasmic-nuclear trafficking. Since in the nucleus ERK1/2 is predominantly inactivated, the maintenance of a constant level of nuclear activity requires continuous shuttling of activated protein from the cytoplasm. For this reason, different nuclear-cytoplasmic trafficking of ERK1 and 2 would cause a differential signalling capability. We have characterised the trafficking of fluorescently tagged ERK1 and ERK2 by means of time-lapse imaging in living cells. Surprisingly, we found that ERK1 shuttles between the nucleus and cytoplasm at a much slower rate than ERK2. This difference is caused by a domain of ERK1 located at its N-terminus since the progressive deletion of these residues converted the shuttling features of ERK1 into those of ERK2. Conversely, the fusion of this ERK1 sequence at the N-terminus of ERK2 slowed down its shuttling to a similar value found for ERK1. Finally, computational, biochemical and cellular studies indicated that the reduced nuclear shuttling of ERK1 causes a strong reduction of its nuclear phosphorylation compared to ERK2, leading to a reduced capability of ERK1 to carry proliferative signals to the nucleus. This mechanism significantly contributes to the differential ability of ERK1 and 2 to generate an overall signalling output.	[Ratto, Gian Michele] Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy; [Ratto, Gian Michele; Costa, Mario] CNR, Inst Neurosci, Pisa, Italy; [D'Antoni, Angela; Formentini, Ivan; Brambilla, Riccardo] San Raffele Sci Inst, Milan, Italy; [Parra, Riccardo] Scuola Normale Superiore, Pisa, Italy; [Marchi, Matilde] Italian Inst Technol IIT, Pisa, Italy; [D'Antoni, Angela] Univ Stud Milano, Milan, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Istituto Italiano di Tecnologia - IIT	Marchi, M (corresponding author), Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy.	gimmi@in.cnr.it; costa@in.cnr.it	Costa, Mario/AAC-2362-2022; Ratto, Gian Michele/AAB-8719-2021; Brambilla, Riccardo/A-6082-2010; Ratto, Gian Michele/AAX-8514-2020	Ratto, Gian Michele/0000-0001-9632-7769; Brambilla, Riccardo/0000-0003-3569-5706; Parra, Riccardo/0000-0003-1421-2832; COSTA, Mario/0000-0001-5821-9871	International Foundation for Paraplegia [239]; Italian Ministry of Health	International Foundation for Paraplegia; Italian Ministry of Health(Ministry of Health, Italy)	The study has been supported by a grant of the International Foundation for Paraplegia (grant 239) to GMR, and by a grant from the Italian Ministry of Health to RB.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chambard JC, 2006, BIOCH BIOPHYS ACTA; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Volmat V, 2001, J CELL SCI, V114, P3433; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	51	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3873	10.1371/journal.pone.0003873	http://dx.doi.org/10.1371/journal.pone.0003873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052640	gold, Green Published			2022-12-27	WOS:000265452200014
J	Beck, C; Ognibeni, T; Neumann, H				Beck, Cornelia; Ognibeni, Thilo; Neumann, Heiko			Object Segmentation from Motion Discontinuities and Temporal Occlusions-A Biologically Inspired Model	PLOS ONE			English	Article							NEURAL MECHANISMS; VISION; DEPTH	Background: Optic flow is an important cue for object detection. Humans are able to perceive objects in a scene using only kinetic boundaries, and can perform the task even when other shape cues are not provided. These kinetic boundaries are characterized by the presence of motion discontinuities in a local neighbourhood. In addition, temporal occlusions appear along the boundaries as the object in front covers the background and the objects that are spatially behind it. Methodology/Principal Findings: From a technical point of view, the detection of motion boundaries for segmentation based on optic flow is a difficult task. This is due to the problem that flow detected along such boundaries is generally not reliable. We propose a model derived from mechanisms found in visual areas V1, MT, and MSTl of human and primate cortex that achieves robust detection along motion boundaries. It includes two separate mechanisms for both the detection of motion discontinuities and of occlusion regions based on how neurons respond to spatial and temporal contrast, respectively. The mechanisms are embedded in a biologically inspired architecture that integrates information of different model components of the visual processing due to feedback connections. In particular, mutual interactions between the detection of motion discontinuities and temporal occlusions allow a considerable improvement of the kinetic boundary detection. Conclusions/Significance: A new model is proposed that uses optic flow cues to detect motion discontinuities and object occlusion. We suggest that by combining these results for motion discontinuities and object occlusion, object segmentation within the model can be improved. This idea could also be applied in other models for object segmentation. In addition, we discuss how this model is related to neurophysiological findings. The model was successfully tested both with artificial and real sequences including self and object motion.	[Beck, Cornelia; Ognibeni, Thilo; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany	Ulm University	Beck, C (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.	cornelia.beck@uni-ulm.de			European Union [027198]; ICT [215866-SEARISE]	European Union(European Commission); ICT	This work was supported by grants from the European Union for STREP project no. 027198-Decisions-In-Motion and ICT project no. 215866-SEARISE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Bayerl P, 2007, IEEE T PATTERN ANAL, V29, P246, DOI 10.1109/TPAMI.2007.24; Beck C, 2007, LECT NOTES COMPUT SC, V4673, P53; Black MJ, 2000, INT J COMPUT VISION, V38, P231, DOI 10.1023/A:1008195307933; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chen CC, 2005, NEUROIMAGE, V24, P802, DOI 10.1016/j.neuroimage.2004.09.021; CHOU GT, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P1050, DOI 10.1109/ICCV.1995.466818; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Feldman D, 2008, IEEE T PATTERN ANAL, V30, P1171, DOI 10.1109/TPAMI.2007.70766; Hansen GH, 2008, J ECON GEOGR, V8, P1, DOI 10.1093/jeg/lbm043; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ke QF, 2001, PROC CVPR IEEE, P255; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Movshon A, 1985, PATTERN RECOGN, V54, P117; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; Neumann H, 2007, PHYS LIFE REV, V4, P189, DOI 10.1016/j.plrev.2007.09.001; NIYOGI SA, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P1044, DOI 10.1109/ICCV.1995.466819; Ogale AS, 2005, IEEE T PATTERN ANAL, V27, P988, DOI 10.1109/TPAMI.2005.123; OGALE AS, 2007, IJCV, V71, P9; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; Stein F, 2004, LECT NOTES COMPUT SC, V3175, P79; Thielscher A, 2005, SPATIAL VISION, V18, P227, DOI 10.1163/1568568053320594; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625, DOI 10.1109/83.334981; Weiss Y, 1996, PROC CVPR IEEE, P321, DOI 10.1109/CVPR.1996.517092	31	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3807	10.1371/journal.pone.0003807	http://dx.doi.org/10.1371/journal.pone.0003807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043613	Green Published, gold			2022-12-27	WOS:000265451500001
J	Khorsand, P; Chance, F				Khorsand, Peyman; Chance, Frances			Transient Responses to Rapid Changes in Mean and Variance in Spiking Models	PLOS ONE			English	Article							FIRING RATE; ASYNCHRONOUS STATES; DYNAMICS; POPULATION; NEURONS; NOISE; VARIABILITY; NETWORKS; INFORMATION; DISCHARGE	The mean input and variance of the total synaptic input to a neuron can vary independently, suggesting two distinct information channels. Here we examine the impact of rapidly varying signals, delivered via these two information conduits, on the temporal dynamics of neuronal firing rate responses. We examine the responses of model neurons to step functions in either the mean or the variance of the input current. Our results show that the temporal dynamics governing response onset depends on the choice of model. Specifically, the existence of a hard threshold introduces an instantaneous component into the response onset of a leaky-integrate-and-fire model that is not present in other models studied here. Other response features, for example a decaying oscillatory approach to a new steady-state firing rate, appear to be more universal among neuronal models. The decay time constant of this approach is a power-law function of noise magnitude over a wide range of input parameters. Understanding how specific model properties underlie these response features is important for understanding how neurons will respond to rapidly varying signals, as the temporal dynamics of the response onset and response decay to new steady-state determine what range of signal frequencies a population of neurons can respond to and faithfully encode.	[Khorsand, Peyman; Chance, Frances] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Khorsand, P (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	peyman.khorsand@gmail.com		Chance, Frances/0000-0003-1420-4664	NSF [NSF-IOB-0446129]; Alfred P. Sloan Foundation; University of California Irvine	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of California Irvine(University of California System)	NSF-IOB-0446129, Alfred P. Sloan Foundation, University of California Irvine	ABBOTT LF, 1993, PHYS REV E, V48, P1483, DOI 10.1103/PhysRevE.48.1483; Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Brunel N, 2003, NEURAL COMPUT, V15, P2281, DOI 10.1162/089976603322362365; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fourcaud N, 2002, NEURAL COMPUT, V14, P2057, DOI 10.1162/089976602320264015; Fourcaud-Trocme N, 2005, J COMPUT NEUROSCI, V18, P311, DOI 10.1007/s10827-005-0337-8; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; FOX RF, 1986, PHYS REV A, V33, P467, DOI 10.1103/PhysRevA.33.467; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HOPPENSTEADT FC, 1997, WEAKLY CONNECTED NEU, P428; Knight BW, 2000, NEURAL COMPUT, V12, P1045, DOI 10.1162/089976600300015493; Knight BW, 2000, NEURAL COMPUT, V12, P473, DOI 10.1162/089976600300015673; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Lindner B, 2003, NEURAL COMPUT, V15, P1761, DOI 10.1162/08997660360675035; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; MATSUMURA M, 1988, EXP BRAIN RES, V70, P463; Moreno E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.236801; Naundorf B, 2005, NEUROCOMPUTING, V65, P421, DOI 10.1016/j.neucom.2004.10.040; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; TUCKWELL HC, 1998, INTRO THEORETICAL NE, P265; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	42	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3786	10.1371/journal.pone.0003786	http://dx.doi.org/10.1371/journal.pone.0003786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023442	gold, Green Published			2022-12-27	WOS:000265448800007
J	Wenzel, K; Haase, H; Wallukat, G; Derer, W; Bartel, S; Homuth, V; Herse, F; Hubner, N; Schulz, H; Janczikowski, M; Lindschau, C; Schroeder, C; Verlohren, S; Morano, I; Muller, DN; Luft, FC; Dietz, R; Dechend, R; Karczewski, P				Wenzel, Katrin; Haase, Hannelore; Wallukat, Gerd; Derer, Wolfgang; Bartel, Sabine; Homuth, Volker; Herse, Florian; Hubner, Norbert; Schulz, Herbert; Janczikowski, Marion; Lindschau, Carsten; Schroeder, Christoph; Verlohren, Stefan; Morano, Ingo; Muller, Dominik N.; Luft, Friedrich C.; Dietz, Rainer; Dechend, Ralf; Karczewski, Peter			Potential Relevance of alpha(1)-Adrenergic Receptor Autoantibodies in Refractory Hypertension	PLOS ONE			English	Article								Background: Agonistic autoantibodies directed at the alpha(1)-adrenergic receptor (alpha(1)-AAB) have been described in patients with hypertension. We implied earlier that alpha(1)-AAB might have a mechanistic role and could represent a therapeutic target. Methodology/Principal Findings: To pursue the issue, we performed clinical and basic studies. We observed that 41 of 81 patients with refractory hypertension had alpha(1)-AAB; after immunoadsorption blood pressure was significantly reduced in these patients. Rabbits were immunized to generate alpha(1)-adrenergic receptor antibodies (alpha(1)-AB). Patient alpha(1)-AAB and rabbit alpha(1)-AB were purified using affinity chromatography and characterized both by epitope mapping and surface plasmon resonance measurements. Neonatal rat cardiomyocytes, rat vascular smooth muscle cells (VSMC), and Chinese hamster ovary cells transfected with the human alpha(1A)-adrenergic receptor were incubated with patient alpha(1)-AAB and rabbit alpha(1)-AB and the activation of signal transduction pathways was investigated by Western blot, confocal laser scanning microscopy, and gene expression. We found that phospholipase A2 group IIA (PLA2-IIA) and L-type calcium channel (Cacna1c) genes were upregulated in cardiomyocytes and VSMC after stimulation with both purified antibodies. We showed that patient alpha(1)-AAB and rabbit alpha(1)-AB result in protein kinase C alpha activation and transient extracellular-related kinase (EKR1/2) phosphorylation. Finally, we showed that the antibodies exert acute effects on intracellular Ca2+ in cardiomyocytes and induce mesentery artery segment contraction. Conclusions/Significance: Patient alpha(1)-AAB and rabbit alpha(1)-AB can induce signaling pathways important for hypertension and cardiac remodeling. Our data provide evidence for a potential clinical relevance for alpha(1)-AAB in hypertensive patients, and the notion of immunity as a possible cause of hypertension.	[Wenzel, Katrin; Derer, Wolfgang; Homuth, Volker; Herse, Florian; Janczikowski, Marion; Schroeder, Christoph; Verlohren, Stefan; Luft, Friedrich C.; Dietz, Rainer; Dechend, Ralf] Franz Volhard Clin, Charite, Fac Med, Berlin, Germany; [Haase, Hannelore; Wallukat, Gerd; Bartel, Sabine; Hubner, Norbert; Schulz, Herbert; Morano, Ingo; Muller, Dominik N.; Luft, Friedrich C.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lindschau, Carsten] Leibniz Univ Hannover, Sch Med, Dept Nephrol, D-30167 Hannover, Germany; [Karczewski, Peter] ERDE eV, Berlin, Germany	Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz University Hannover	Wenzel, K (corresponding author), Franz Volhard Clin, Charite, Fac Med, Berlin, Germany.	ralf.dechend@charite.de	Lindschau, Carsten/G-1798-2011; Lindschau, Carsten/AAE-6721-2020	Lindschau, Carsten/0000-0003-1960-099X; Verlohren, Stefan/0000-0003-3507-8636; Muller, Dominik N/0000-0003-3650-5644; Herse, Florian/0000-0002-9305-8134; Luft, Friedrich/0000-0002-8635-1199	Deutsche Forschungsgemeinschaft; ProFIT initiative of the European Community	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ProFIT initiative of the European Community	The Deutsche Forschungsgemeinschaft supported RD, DNM, and FCL with separate grants-in-aid. Part of this work was supported by the ProFIT initiative of the European Community.	Antonelli A, 2001, DIABETES, V50, P985, DOI 10.2337/diabetes.50.5.985; Barzilay Joshua I, 2004, J Clin Hypertens (Greenwich), V6, P116, DOI 10.1111/j.1524-6175.2004.03216.x; BOIVIN V, 2007, EUR HEART J S1, V27; BOIVIN V, 2007, EUR HEART J S1, V24; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Kugiyama K, 2000, CARDIOVASC RES, V47, P159, DOI 10.1016/S0008-6363(00)00060-2; Levick S, 2006, J IMMUNOL, V176, P7000, DOI 10.4049/jimmunol.176.11.7000; Liao YH, 2002, HYPERTENS RES, V25, P641; LUFT FC, 2008, J AM SOC HYPERTENSIO, V1, P571; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Porela P, 2000, BASIC RES CARDIOL, V95, P413, DOI 10.1007/s003950070041; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Shannon R, 2006, AM HEART J, V152, P842, DOI 10.1016/j.ahj.2006.05.017; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	25	82	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3742	10.1371/journal.pone.0003742	http://dx.doi.org/10.1371/journal.pone.0003742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011682	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265448300010
J	Heidary, F; Mahdavi, MRV; Momeni, F; Minaii, B; Rogani, M; Fallah, N; Heidary, R; Gharebaghi, R				Heidary, Fatemeh; Mahdavi, Mohammad Reza Vaeze; Momeni, Farshad; Minaii, Bagher; Rogani, Mehrdad; Fallah, Nader; Heidary, Roghayeh; Gharebaghi, Reza			Food Inequality Negatively Impacts Cardiac Health in Rabbits	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SOCIAL-STATUS; LIPOFUSCIN; ATHEROSCLEROSIS; INCREASE	Background: Individuals with lower socioeconomic status experience higher rates of mortality and are more likely to suffer from numerous diseases. While some studies indicate that humans who suffer from social inequality suffer generally worse health, to our knowledge no controlled experiments of this nature have been done in any species. Lipofuscin is a highly oxidized cross-linked aggregate consisting of oxidized protein and lipid clusters. This eminent terminal oxidation outcome accumulates within cells during aging process. Methodology/Principal Findings: Thirty two rabbits were assigned into four groups randomly of eight each. The first group encountered food deprivation for eight weeks and was kept in an isolated situation. The second group was food deprived for eight weeks but encountered to other groups continuously. The third group suffered two weeks of deprivation and then received free access to food. The fourth group had free access to diet without any deprivation. All hearts were removed for histopathological evaluation. Cross-sections of hearts were examined by light microscopy for the presence of yellow-brown Lpofuscin pigment granules. Here we show that relative food deprivation can cause accumulation of Lipofuscin pigmentation. We find that cardiac Lipofuscin deposition increases the most in the inequitable condition in which food deprived individuals observe well-fed individuals. Conclusions/Significance: Our findings demonstrate that a sense of inequality in food intake can promote aging more than food deprivation alone. These findings should be considered as a basis for further studies on the physiological mechanisms by which inequality negatively impacts health and well-being.	[Heidary, Fatemeh; Mahdavi, Mohammad Reza Vaeze; Rogani, Mehrdad] Shahed Univ, Sch Med, Dept Physiol, Tehran, Iran; [Momeni, Farshad] Allameh Tabatabaei Univ, Econ Dept, Tehran, Iran; [Minaii, Bagher] Univ Tehran Med Sci, Sch Med, Anat Dept, Histol Div, Tehran, Iran; [Fallah, Nader] Shahed Univ, Social Med Dept, Stat Analysis Div, Tehran, Iran; [Heidary, Roghayeh; Gharebaghi, Reza] Middle E Canc Inst, Tehran, Iran	Shahed University; Allameh Tabataba'i University; Tehran University of Medical Sciences; Shahed University	Heidary, F (corresponding author), Shahed Univ, Sch Med, Dept Physiol, Tehran, Iran.	Heidary@sbmu.ac.ir	Vaez-Mahdavi, Mohammad-Reza/I-8185-2016; Fallah, Nader/D-4145-2012	Fallah, Nader/0000-0002-7746-4773; Vaez-Mahdavi, Mohammad-Reza/0000-0002-1490-4364; Heidary, A/Prof. Fatemeh/0000-0002-6558-6132; Roghani, Mehrdad/0000-0002-9209-8484	Shahed University, Tehran, Iran	Shahed University, Tehran, Iran	This study was supported by Shahed University, Tehran, Iran as the thesis in a medical doctorate degree.	ADAMS MR, 1985, ARTERIOSCLEROSIS, V5, P192, DOI 10.1161/01.ATV.5.2.192; BEREGI E, 1991, AGE AGEING, V20, P55, DOI 10.1093/ageing/20.1.55; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Chaudhary A, 1995, GERONTOLOGY, V41, P229; Cooper RS, 2001, INT J EPIDEMIOL, V30, pS48, DOI 10.1093/ije/30.suppl_1.S48; Goldman N, 2001, ANN NY ACAD SCI, V954, P118; Jolly RD, 2002, ARCH GERONTOL GERIAT, V34, P205, DOI 10.1016/S0167-4943(01)00219-9; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; MANUCK SB, 1995, PSYCHOSOM MED, V57, P275, DOI 10.1097/00006842-199505000-00009; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Roffe C, 1998, BRIT J BIOMED SCI, V55, P136; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SCHNEIDERMAN N, 1987, CIRCULATION, V76, P41; Siems W G, 1992, EXS, V62, P124; SIEMS WG, 1995, LIFE SCI, V57, P785, DOI 10.1016/0024-3205(95)02006-5; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P27; Steptoe A, 2007, HEART, V93, P1567, DOI 10.1136/hrt.2006.113993; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3705	10.1371/journal.pone.0003705	http://dx.doi.org/10.1371/journal.pone.0003705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002245	gold, Green Published			2022-12-27	WOS:000265165600010
J	Sun, Z; Chen, Z; Hou, XL; Li, SP; Zhu, HH; Qian, J; Lu, DR; Liu, W				Sun, Zhen; Chen, Zhi; Hou, Xiaoli; Li, Shuping; Zhu, Haihong; Qian, Ji; Lu, Daru; Liu, Wei			Locked Nucleic Acid Pentamers as Universal PCR Primers for Genomic DNA Amplification	PLOS ONE			English	Article								Background: Multiplexing technologies, which allow for simultaneous detection of multiple nucleic acid sequences in a single reaction, can save a lot of time, cost and labor compared to traditional single reaction detection methods. However, the multiplexing method currently used requires precise handiwork and many complicated steps, making a new, simpler technique desirable. Oligonucleotides containing locked nucleic acid residues are an attractive tool because they have strong affinities for their complementary targets, they have been used to avoid dimer formation and mismatch hybridization and to enhance efficient priming. In this study, we aimed to investigate the use of locked nucleic acid pentamers for genomic DNA amplification and multiplex genotyping. Results: We designed locked nucleic acid pentamers as universal PCR primers for genomic DNA amplification. The locked nucleic acid pentamers were able to prime amplification of the selected sequences within the investigated genomes, and the resulting products were similar in length to those obtained by restriction digest. In Real Time PCR of genomic DNA from three bacterial species, locked nucleic acid pentamers showed high priming efficiencies. Data from bias tests demonstrated that locked nucleic acid pentamers have equal affinities for each of the six genes tested from the Klebsiella pneumoniae genome. Combined with suspension array genotyping, locked nucleic acid pentamer-based PCR amplification was able to identify a total of 15 strains, including 3 species of bacteria, by gene- and species-specific probes. Among the 32 species used in the assay, 28 species and 50 different genes were clearly identified using this method. Conclusion: As a novel genomic DNA amplification, the use of locked nucleic acid pentamers as universal primer pairs in conjunction with suspension array genotyping, allows for the identification of multiple distinct genes or species with a single amplification procedure. This demonstrates that locked nucleic acid pentamer-based PCR can be utilized extensively in pathogen identification.	[Sun, Zhen; Hou, Xiaoli; Liu, Wei] Zhejiang Univ, Sch Med, Dept Biochem & Mol Biol, Hangzhou, Peoples R China; [Sun, Zhen; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary & Anthropol, State Key Lab Genet Engn, Shanghai, Peoples R China; [Sun, Zhen; Chen, Zhi; Li, Shuping; Zhu, Haihong] Zhejiang Univ, Sch Med, Inst Med Biotechnol, Hangzhou, Peoples R China; [Sun, Zhen; Chen, Zhi; Li, Shuping; Zhu, Haihong] Zhejiang Univ, Affiliated Hosp 1st, Inst Infect Dis, Natl Key Lab Diagnosis & Treatment Infect Dis, Hangzhou, Peoples R China	Zhejiang University; Fudan University; Zhejiang University; Zhejiang University	Sun, Z (corresponding author), Eppendorf China, Shanghai Off, Unit 1702-1705,You You Int Plaza, Shanghai, Peoples R China.	drlu@fudan.edu.cn; liuwei666@zju.edu.cn		Liu, Wei/0000-0002-8033-4718	National Natural Science Foundation of China [30771090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30771090) to Wei Liu.	Diaz MR, 2004, J CLIN MICROBIOL, V42, P3696, DOI [10.1128/JCM.42.8.3696-3706.2004, 10.1128/jcm.42.8.3696-3706.2004]; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Dunbar SA, 2003, J MICROBIOL METH, V53, P245, DOI 10.1016/S0167-7012(03)00028-9; Gonzalez SF, 2004, J CLIN MICROBIOL, V42, P1414, DOI 10.1128/JCM.42.4.1414-1419.2004; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Hou XL, 2008, J ZHEJIANG UNIV-SC B, V9, P291, DOI 10.1631/jzus.B0710470; Jiang HL, 2006, J MED MICROBIOL, V55, P715, DOI 10.1099/jmm.0.46493-0; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; *LIQUICHIP, 2003, LIQUICHIP APPL HDB P; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Nolan JP, 2001, CELL MOL BIOL, V47, P1241; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Sanchez JJ, 2006, NAT PROTOC, V1, P1370, DOI 10.1038/nprot.2006.247; Smith PL, 1998, CLIN CHEM, V44, P2054; SOBRAL BWS, 1993, THEOR APPL GENET, V86, P105, DOI 10.1007/BF00223814; Spiro A, 2000, APPL ENVIRON MICROB, V66, P4258, DOI 10.1128/AEM.66.10.4258-4265.2000; Spiro A, 2002, APPL ENVIRON MICROB, V68, P1010, DOI 10.1128/AEM.68.2.1010-1013.2002; Sun Z, 2007, GENOMICS, V89, P151, DOI 10.1016/j.ygeno.2006.07.011; TADA M, 1993, CANCER RES, V53, P2472; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28; Zhu Hai-hong, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P524; Zsolnai A, 2003, ELECTROPHORESIS, V24, P634, DOI 10.1002/elps.200390074	25	9	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3701	10.1371/journal.pone.0003701	http://dx.doi.org/10.1371/journal.pone.0003701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002243	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165600007
J	Renesto, P; Rovery, C; Schrenzel, J; Leroy, Q; Huyghe, A; Li, WJ; Lepidi, H; Francois, P; Raoult, D				Renesto, Patricia; Rovery, Clarisse; Schrenzel, Jacques; Leroy, Quentin; Huyghe, Antoine; Li, Wenjun; Lepidi, Hubert; Francois, Patrice; Raoult, Didier			Rickettsia conorii Transcriptional Response within Inoculation Eschar	PLOS ONE			English	Article							MEDITERRANEAN SPOTTED-FEVER; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; STRINGENT RESPONSE; PATHOGEN; HOST; RNA; IDENTIFICATION; RESISTANCE; EVOLUTION	Background: Rickettsia conorii, the causative agent of the Mediterranean spotted fever, is transmitted to humans by the bite of infected ticks Rhipicephalus sanguineus. The skin thus constitutes an important barrier for the entry and propagation of R. conorii. Given this, analysis of the survival strategies used by the bacterium within infected skin is critical for our understanding of rickettsiosis. Methodology/Principal Findings: Here, we report the first genome-wide analysis of R. conorii gene expression from infected human skin biopsies. Our data showed that R. conorii exhibited a striking transcript signature that is remarkably conserved across patients, regardless of genotype. The expression profiles obtained using custom Agilent microarrays were validated by quantitative RT-PCR. Within eschars, the amount of detected R. conorii transcripts was of 55%, this value being of 74% for bacteria grown in Vero cells. In such infected host tissues, approximately 15% (n = 211) of the total predicted R. conorii ORFs appeared differentially expressed compared to bacteria grown in standard laboratory conditions. These genes are mostly down-regulated and encode proteins essential for bacterial replication. Some of the strategies displayed by rickettsiae to overcome the host defense barriers, thus avoiding killing, were also pointed out. The observed up-regulation of rickettsial genes associated with DNA repair is likely to correspond to a DNA-damaging agent enriched environment generated by the host cells to eradicate the pathogens. Survival of R. conorii within eschars also involves adaptation to osmotic stress, changes in cell surface proteins and up-regulation of some virulence factors. Interestingly, in contrast to down-regulated transcripts, we noticed that up-regulated ones rather exhibit a small nucleotide size, most of them being exclusive for the spotted fever group rickettsiae. Conclusion/Significance: Because eschar is a site for rickettsial introduction, the pattern of rickettsial gene expression observed here may define how rickettsiae counteract the host defense.	[Renesto, Patricia; Rovery, Clarisse; Leroy, Quentin; Li, Wenjun; Lepidi, Hubert; Raoult, Didier] Fac Med Marseille, Unite Rickettsies, IRD CNRS, UMR 6236, F-13385 Marseille, France; [Schrenzel, Jacques; Huyghe, Antoine; Francois, Patrice] Univ Geneva, Hosp, Genom Res Lab, Serv Infect Dis, CH-1211 Geneva, Switzerland	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Renesto, P (corresponding author), Fac Med Marseille, Unite Rickettsies, IRD CNRS, UMR 6236, F-13385 Marseille, France.	patricia.renesto@medecine.univ-mrs.fr	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/AAC-5685-2021; Renesto, patricia/M-6105-2014; RAOULT, Didier/A-8434-2008; renesto, patricia/T-6446-2019; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; RAOULT, Didier/0000-0002-0633-5974; renesto, patricia/0000-0002-6749-7862; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X	"Hospital Clinical Research Program" from the French Health Ministry	"Hospital Clinical Research Program" from the French Health Ministry	This project was granted by a research program "Hospital Clinical Research Program" from the French Health Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aravind L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r30; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; de Sousa R, 2007, J INFECT DIS, V196, P770, DOI 10.1086/519739; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; DUJELLA J, 1991, ACTA VIROL, V35, P566; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Heithoff DM, 1997, TRENDS MICROBIOL, V5, P509, DOI 10.1016/S0966-842X(97)01153-0; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Le Gall T, 2005, GENOME RES, V15, P260, DOI 10.1101/gr.2405905; Lepidi H, 2000, AM J CLIN PATHOL, V114, P880, DOI 10.1309/R0KQ-823A-BTC7-MUUJ; MONTENEGRO MR, 1983, VIRCHOWS ARCH A, V400, P309, DOI 10.1007/BF00612192; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; RAOULT D, 1984, J INFECT DIS, V150, P145, DOI 10.1093/infdis/150.1.145; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Scherl A, 2005, J MICROBIOL METH, V60, P247, DOI 10.1016/j.mimet.2004.09.017; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TEYSSEIRE N, 1995, INFECT IMMUN, V63, P366, DOI 10.1128/IAI.63.1.366-374.1995; TEYSSEIRE N, 1992, J CLIN MICROBIOL, V30, P455, DOI 10.1128/JCM.30.2.455-460.1992; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorner AR, 1998, CLIN INFECT DIS, V27, P1353, DOI 10.1086/515037; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7	46	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3681	10.1371/journal.pone.0003681	http://dx.doi.org/10.1371/journal.pone.0003681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997861	Green Submitted, Green Published, gold			2022-12-27	WOS:000265165500004
J	Proekt, A; Wong, J; Zhurov, Y; Kozlova, N; Weiss, KR; Brezina, V				Proekt, Alex; Wong, Jane; Zhurov, Yuriy; Kozlova, Nataliya; Weiss, Klaudiusz R.; Brezina, Vladimir			Predicting Adaptive Behavior in the Environment from Central Nervous System Dynamics	PLOS ONE			English	Article							IDENTIFIED HISTAMINERGIC NEURON; NEUROMUSCULAR MODULATION; DISTINGUISHES INGESTION; FEEDING-BEHAVIOR; APLYSIA; NETWORK; MECHANISMS; PRINCIPLES; TRANSFORM; REJECTION	To generate adaptive behavior, the nervous system is coupled to the environment. The coupling constrains the dynamical properties that the nervous system and the environment must have relative to each other if adaptive behavior is to be produced. In previous computational studies, such constraints have been used to evolve controllers or artificial agents to perform a behavioral task in a given environment. Often, however, we already know the controller, the real nervous system, and its dynamics. Here we propose that the constraints can also be used to solve the inverse problem - to predict from the dynamics of the nervous system the environment to which they are adapted, and so reconstruct the production of the adaptive behavior by the entire coupled system. We illustrate how this can be done in the feeding system of the sea slug Aplysia. At the core of this system is a central pattern generator (CPG) that, with dynamics on both fast and slow time scales, integrates incoming sensory stimuli to produce ingestive and egestive motor programs. We run models embodying these CPG dynamics-in effect, autonomous Aplysia agents-in various feeding environments and analyze the performance of the entire system in a realistic feeding task. We find that the dynamics of the system are tuned for optimal performance in a narrow range of environments that correspond well to those that Aplysia encounter in the wild. In these environments, the slow CPG dynamics implement efficient ingestion of edible seaweed strips with minimal sensory information about them. The fast dynamics then implement a switch to a different behavioral mode in which the system ignores the sensory information completely and follows an internal "goal,'' emergent from the dynamics, to egest again a strip that proves to be inedible. Key predictions of this reconstruction are confirmed in real feeding animals.	[Proekt, Alex; Wong, Jane; Zhurov, Yuriy; Kozlova, Nataliya; Weiss, Klaudiusz R.; Brezina, Vladimir] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Proekt, A (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	Vladimir.Brezina@mssm.edu		Proekt, Alexander/0000-0002-9272-5337	NIH [R01 NS41497]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NIH R01 NS41497. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonov-Barki R, 2001, NEURAL COMPUT, V13, P691, DOI 10.1162/089976601300014529; ANDREWS PLR, 1988, BAILLIERE CLIN GASTR, V2, P141, DOI 10.1016/0950-3528(88)90025-5; Barandiaran X, 2006, ADAPT BEHAV, V14, P171, DOI 10.1177/105971230601400208; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Beer R. D., 1990, INTELLIGENCE ADAPTIV; Beer Randall D., 1992, Adaptive Behavior, V1, P91, DOI 10.1177/105971239200100105; Beer RD, 2003, ADAPT BEHAV, V11, P209, DOI 10.1177/1059712303114001; Beer RD, 1997, ROBOT AUTON SYST, V20, P257, DOI 10.1016/S0921-8890(96)00063-2; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; Belanger JH, 1996, ADAPT BEHAV, V4, P217, DOI 10.1177/105971239600400302; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brezina V, 2005, J NEUROPHYSIOL, V93, P1523, DOI 10.1152/jn.00475.2004; Brezina V, 2003, J NEUROPHYSIOL, V90, P2613, DOI 10.1152/jn.01093.2002; Brezina V, 2003, J NEUROPHYSIOL, V90, P2592, DOI 10.1152/jn.01091.2002; Brezina V, 2000, J NEUROPHYSIOL, V83, P260, DOI 10.1152/jn.2000.83.1.260; Brezina V, 2000, J NEUROPHYSIOL, V83, P232, DOI 10.1152/jn.2000.83.1.232; Brezina V, 2000, J NEUROPHYSIOL, V83, P207, DOI 10.1152/jn.2000.83.1.207; BREZINA V, 2006, SOC NEUROSCI ABSTR; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; Clark, 2001, MINDWARE; Clark A., 1997, BEING THERE; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Deodhar D, 2001, ADAPT BEHAV, V8, P267, DOI 10.1177/105971230000800304; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Elliott CJH, 2002, J EXP BIOL, V205, P877; Horn CC, 2004, J NEUROPHYSIOL, V92, P157, DOI 10.1152/jn.01190.2003; Horn CC, 2008, APPETITE, V50, P430, DOI 10.1016/j.appet.2007.09.015; Hornby PJ, 2001, AM J MED, V111, P106, DOI 10.1016/S0002-9343(01)00849-X; HURWITZ I, 1992, J EXP BIOL, V166, P215; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jonker CM, 2002, J THEOR BIOL, V214, P105, DOI 10.1006/jtbi.2001.2444; KANDEL E.R., 1979, BEHAV BIOL APLYSIA; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KUPFERMA.I, 1974, BEHAV BIOL, V12, P317, DOI 10.1016/S0091-6773(74)91503-X; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; Levi R, 2005, J NEUROSCI, V25, P9807, DOI 10.1523/JNEUROSCI.2249-05.2005; Levi R, 2004, J NEUROPHYSIOL, V91, P336, DOI 10.1152/jn.00753.2003; Lum CS, 2008, J NEUROPHYSIOL, V100, P2453, DOI 10.1152/jn.z9k-9150-corr.2008; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MCCLELLAN AD, 1982, J EXP BIOL, V98, P195; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MORTON DW, 1993, J COMP PHYSIOL A, V173, P519; Nepomnyashchikh VA, 2003, ADAPT BEHAV, V11, P245, DOI 10.1177/1059712303114002; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Proekt A, 2004, P NATL ACAD SCI USA, V101, P9447, DOI 10.1073/pnas.0402002101; Proekt A, 2007, J NEUROPHYSIOL, V97, P3046, DOI 10.1152/jn.01301.2006; ROSEN SC, 1991, J NEUROSCI, V11, P3630; ROSEN SC, 1982, BEHAV NEURAL BIOL, V35, P56, DOI 10.1016/S0163-1047(82)91279-1; Ruppin E, 2002, NAT REV NEUROSCI, V3, P132, DOI 10.1038/nrn729; Sasaki K, 2008, J NEUROSCI, V28, P1916, DOI 10.1523/JNEUROSCI.4755-07.2008; SCHWARZ M, 1986, J NEUROSCI, V6, P1528; Staddon J. E. R., 2001, ADAPTIVE DYNAMICS; Staddon JER, 2005, TRENDS COGN SCI, V9, P312, DOI 10.1016/j.tics.2005.05.013; SUSSWEIN AJ, 1976, J COMP PHYSIOL, V108, P75, DOI 10.1007/BF00625442; SUSSWEIN AJ, 1978, J COMP PHYSIOL, V123, P31, DOI 10.1007/BF00657341; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; van Gelder T, 1998, BEHAV BRAIN SCI, V21, P615, DOI 10.1017/S0140525X98001733; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Weiss K.R., 1982, P25; WEISS KR, 1986, J NEUROSCI, V6, P2403; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu JS, 2007, J NEUROSCI, V27, P10818, DOI 10.1523/JNEUROSCI.1806-07.2007; Ye H, 2006, J NEUROSCI, V26, P1470, DOI 10.1523/JNEUROSCI.3691-05.2006; Ye H, 2006, J NEUROSCI, V26, P10743, DOI 10.1523/JNEUROSCI.3143-06.2006; Zhurov Y, 2005, J NEUROPHYSIOL, V94, P531, DOI 10.1152/jn.01338.2004; Zhurov Y, 2005, J NEUROSCI, V25, P1268, DOI 10.1523/JNEUROSCI.3361-04.2005	75	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3678	10.1371/journal.pone.0003678	http://dx.doi.org/10.1371/journal.pone.0003678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989362	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134600010
J	Prassl, R; Pregetter, M; Amenitsch, H; Kriechbaum, M; Schwarzenbacher, R; Chapman, JM; Laggner, P				Prassl, Ruth; Pregetter, Magdalena; Amenitsch, Heinz; Kriechbaum, Manfred; Schwarzenbacher, Robert; Chapman, John M.; Laggner, Peter			Low Density Lipoproteins as Circulating Fast Temperature Sensors	PLOS ONE			English	Article							HUMAN-PLASMA; THERMAL TRANSITIONS; CORE; LDL; LIPIDS; ORGANIZATION; CHOLESTEROL; RESOLUTION	Background: The potential physiological significance of the nanophase transition of neutral lipids in the core of low density lipoprotein (LDL) particles is dependent on whether the rate is fast enough to integrate small (+2 degrees C) temperature changes in the blood circulation. Methodology/Principal Findings: Using sub-second, time-resolved small-angle X-ray scattering technology with synchrotron radiation, we have monitored the dynamics of structural changes within LDL, which were triggered by temperature-jumps and -drops, respectively. Our findings reveal that the melting transition is complete within less than 10 milliseconds. The freezing transition proceeds slowly with a half-time of approximately two seconds. Thus, the time period over which LDL particles reside in cooler regions of the body readily facilitates structural reorientation of the apolar core lipids. Conclusions/Significance: Low density lipoproteins, the biological nanoparticles responsible for the transport of cholesterol in blood, are shown to act as intrinsic nano-thermometers, which can follow the periodic temperature changes during blood circulation. Our results demonstrate that the lipid core in LDL changes from a liquid crystalline to an oily state within fractions of seconds. This may, through the coupling to the protein structure of LDL, have important repercussions on current theories of the role of LDL in the pathogenesis of atherosclerosis.	[Prassl, Ruth; Pregetter, Magdalena; Amenitsch, Heinz; Kriechbaum, Manfred; Laggner, Peter] Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria; [Schwarzenbacher, Robert] Salzburg Univ, A-5020 Salzburg, Austria; [Chapman, John M.] INSERM, Hop Pitie, Dyslipoproteinem & Atherosclerosis Res Unit, Paris, France	Austrian Academy of Sciences; Salzburg University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Prassl, R (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria.	ruth.prassl@oeaw.ac.at	Prassl, Ruth/AAE-1523-2021	Kriechbaum, Manfred/0000-0002-3852-4198; Prassl, Ruth/0000-0002-1010-9494; Amenitsch, Heinz/0000-0002-0788-1336	Austrian Science Foundation [P-16479-CHE, P-20455-B12]; Seegen Stiftung of the Austrian Acad. Sci.; INSERM; Austrian Science Fund (FWF) [P 20455] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Seegen Stiftung of the Austrian Acad. Sci.; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Foundation (Project No. P-16479-CHE and P-20455-B12 to RP), Seegen Stiftung of the Austrian Acad. Sci. to PL and by INSERM to JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; BAZETT HC, 1948, J APPL PHYSIOL, V1, P3, DOI 10.1152/jappl.1948.1.1.3; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; CHAPMAN MJ, 1988, J LIPID RES, V29, P442; DECKELBAUM RJ, 1977, J BIOL CHEM, V252, P744; DECKELBAUM RJ, 1975, SCIENCE, V190, P392, DOI 10.1126/science.170681; Galeano NF, 1998, J LIPID RES, V39, P1263; GALEANO NF, 1994, J BIOL CHEM, V269, P511; Granberg P O, 1991, Arctic Med Res, V50 Suppl 6, P23; KRIECHBAUM M, 1989, REV SCI INSTRUM, V60, P2541, DOI 10.1063/1.1140670; LAGGNER P, 1978, EUR J BIOCHEM, V84, P227, DOI 10.1111/j.1432-1033.1978.tb12160.x; LAGGNER P, 1977, H-S Z PHYSIOL CHEM, V358, P771, DOI 10.1515/bchm2.1977.358.2.771; LAGGNER P, 1984, P NATL ACAD SCI-BIOL, V81, P4389, DOI 10.1073/pnas.81.14.4389; Lund-Katz S, 1998, BIOCHEMISTRY-US, V37, P12867, DOI 10.1021/bi980828m; Lunin VY, 2001, ACTA CRYSTALLOGR D, V57, P108, DOI 10.1107/S0907444900014608; MATEU L, 1979, ACTA CIENT VENEZ, V30, P478; McCullough L, 2004, AM FAM PHYSICIAN, V70, P2325; Morton RE, 1996, J LIPID RES, V37, P1915; Nathan HJ, 2001, CIRCULATION, V104, pI85; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Pabst G, 2000, LANGMUIR, V16, P8994, DOI 10.1021/1a0003140; Prassl R, 1996, J BIOL CHEM, V271, P28731, DOI 10.1074/jbc.271.46.28731; Prassl R, 1998, BIOCHEMISTRY-US, V37, P938, DOI 10.1021/bi971853f; Pregetter M, 1999, J BIOL CHEM, V274, P1334, DOI 10.1074/jbc.274.3.1334; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P2509, DOI 10.1073/pnas.92.7.2509; Sherman MB, 2003, BIOCHEMISTRY-US, V42, P14988, DOI 10.1021/bi0354738; SMALL DM, 1977, COLL INTERF SCI, V1, P615; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; YANG CY, 1992, STRUCTURE FUNCTION A, P63; ZECHNER R, 1984, CHEM PHYS LIPIDS, V36, P111, DOI 10.1016/0009-3084(84)90064-1	31	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4079	10.1371/journal.pone.0004079	http://dx.doi.org/10.1371/journal.pone.0004079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114995	Green Submitted, Green Published, gold			2022-12-27	WOS:000265466300017
J	Borgatti, M; Rizzo, R; Dal Canto, MB; Fumagalli, D; Renzini, MM; Fadini, R; Stignani, M; Baricordi, OR; Gambari, R				Borgatti, Monica; Rizzo, Roberta; Dal Canto, Maria Beatrice; Fumagalli, Daniela; Renzini, Mario Mignini; Fadini, Rubens; Stignani, Marina; Baricordi, Olavio Roberto; Gambari, Roberto			Release of sICAM-1 in Oocytes and In Vitro Fertilized Human Embryos	PLOS ONE			English	Article								Background: During the last years, several studies have reported the significant relationship between the production of soluble HLA-G molecules (sHLA-G) by 48-72 hours early embryos and an increased implantation rate in IVF protocols. As consequence, the detection of HLA-G modulation was suggested as a marker to identify the best embryos to be transferred. On the opposite, no suitable markers are available for the oocyte selection. Methodology/Principal Findings: The major finding of the present paper is that the release of ICAM-1 might be predictive of oocyte maturation. The results obtained are confirmed using three independent methodologies, such as ELISA, Bio-Plex assay and Western blotting. The sICAM-1 release is very high in immature oocytes, decrease in mature oocytes and become even lower in in vitro fertilized embryos. No significant differences were observed in the levels of sICAM-1 release between immature oocytes with different morphological characteristics. On the contrary, when the mature oocytes were subdivided accordingly to morphological criteria, the mean sICAM-I levels in grade 1 oocytes were significantly decreased when compared to grade 2 and 3 oocytes. Conclusions/Significance: The reduction of the number of fertilized oocytes and transferred embryos represents the main target of assisted reproductive medicine. We propose sICAM-1 as a biochemical marker for oocyte maturation and grading, with a possible interesting rebound in assisted reproduction techniques.	[Gambari, Roberto] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; [Rizzo, Roberta; Stignani, Marina; Baricordi, Olavio Roberto] Univ Ferrara, Dept Expt & Diagnost Med, Lab Immunogenet, I-44100 Ferrara, Italy; [Dal Canto, Maria Beatrice; Fumagalli, Daniela; Renzini, Mario Mignini; Fadini, Rubens] Ist Clin Zucchi, BIOGENESI Reprod Med Ctr, Monza, Italy; [Gambari, Roberto] Univ Ferrara, Biotechnol Ctr, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara	Borgatti, M (corresponding author), Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy.	bri@unife.it; gam@unife.it	Gambari, Roberto/F-9555-2015; Borgatti, Monica/G-2611-2015; Rizzo, Roberta/K-4844-2016	Gambari, Roberto/0000-0001-9205-6033; Borgatti, Monica/0000-0001-8470-2496; Dal Canto, Mariabeatrice/0000-0001-5716-4127; Rizzo, Roberta/0000-0001-9507-9126	Fondazione Cariparo; CIB; UE ITHANET Project; Telethon [GGP07257]; Regione Emilia-Romagna; Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo	Fondazione Cariparo(Fondazione Cariparo); CIB; UE ITHANET Project(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Regione Emilia-Romagna(Regione Emilia Romagna); Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo	R.G. is granted by Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), CIB, by UE ITHANET Project (eInfrastructure for the Thalassaemia Research Network) and by Telethon (contract GGP07257). This research is also supported by Regione Emilia-Romagna (Spinner Project) and by Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan C, 2008, DIGEST DIS SCI, V53, P2000, DOI 10.1007/s10620-007-9914-1; Coticchio G, 2004, ANN NY ACAD SCI, V1034, P132, DOI 10.1196/annals.1335.016; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Deonandan R, 2000, J ASSIST REPROD GEN, V17, P498, DOI 10.1023/A:1009489624045; Desai N, 2006, REPROD BIOMED ONLINE, V13, P272, DOI 10.1016/S1472-6483(10)60626-8; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Ebner T, 2000, HUM REPROD, V15, P427, DOI 10.1093/humrep/15.2.427; Ebner T, 2006, REPROD BIOMED ONLINE, V12, P507, DOI 10.1016/S1472-6483(10)62006-8; Fineschi V, 2005, J MED ETHICS, V31, P536, DOI 10.1136/jme.2004.010231; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; Hallahan DE, 1997, P NATL ACAD SCI USA, V94, P6432, DOI 10.1073/pnas.94.12.6432; Kerr JR, 2004, J MED VIROL, V74, P147, DOI 10.1002/jmv.20158; Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071; Montag M, 2008, REPROD BIOMED ONLINE, V16, P239, DOI 10.1016/S1472-6483(10)60580-9; Mousavi SAR, 2007, EUR J NEUROL, V14, P1397, DOI 10.1111/j.1468-1331.2007.01956.x; Noci I, 2005, HUM REPROD, V20, P138, DOI 10.1093/humrep/deh572; PASCALE MP, 2007, CURRENT TOPICS DEV B, V77, P51; Patrizio P, 2007, REPROD BIOMED ONLINE, V15, P346, DOI 10.1016/S1472-6483(10)60349-5; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Rizzo R, 2007, J REPROD IMMUNOL, V74, P133, DOI 10.1016/j.jri.2007.02.005; Shen Y, 2005, HUM REPROD, V20, P1596, DOI 10.1093/humrep/deh811; Sher G, 2005, HUM REPROD, V20, P1359, DOI 10.1093/humrep/deh758; van den Borne SWM, 2008, J AM COLL CARDIOL, V51, P2184, DOI 10.1016/j.jacc.2008.02.056; Veeck L., 1999, ATLAS HUMAN GAMETES, P47; Wang HW, 2005, FASEB J, V19, P1018, DOI 10.1096/fj.04-3094fje; Yie S, 2005, FERTIL STERIL, V83, P30, DOI 10.1016/j.fertnstert.2004.06.059	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3970	10.1371/journal.pone.0003970	http://dx.doi.org/10.1371/journal.pone.0003970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092999	Green Published, Green Submitted, gold			2022-12-27	WOS:000265458600007
J	Dansithong, W; Wolf, CM; Sarkar, P; Paul, S; Chiang, A; Holt, I; Morris, GE; Branco, D; Sherwood, MC; Comai, L; Berul, CI; Reddy, S				Dansithong, Warunee; Wolf, Cordula M.; Sarkar, Partha; Paul, Sharan; Chiang, Andy; Holt, Ian; Morris, Glenn E.; Branco, Dorothy; Sherwood, Megan C.; Comai, Lucio; Berul, Charles I.; Reddy, Sita			Cytoplasmic CUG RNA Foci Are Insufficient to Elicit Key DM1 Features	PLOS ONE			English	Article							EXPANDED CTG REPEATS; MYOTONIC-DYSTROPHY; CARDIAC INVOLVEMENT; BINDING PROTEIN; TRIPLET REPEAT; MESSENGER-RNA; MOUSE MODEL; CONDUCTION ABNORMALITIES; MUSCLEBLIND PROTEINS; UNTRANSLATED REGION	The genetic basis of myotonic dystrophy type I (DM1) is the expansion of a CTG tract located in the 39 untranslated region of DMPK. Expression of mutant RNAs encoding expanded CUG repeats plays a central role in the development of cardiac disease in DM1. Expanded CUG tracts form both nuclear and cytoplasmic aggregates, yet the relative significance of such aggregates in eliciting DM1 pathology is unclear. To test the pathophysiology of CUG repeat encoding RNAs, we developed and analyzed mice with cardiac-specific expression of a beta-galactosidase cassette in which a (CTG) 400 repeat tract was positioned 39 of the termination codon and 59 of the bovine growth hormone polyadenylation signal. In these animals CUG aggregates form exclusively in the cytoplasm of cardiac cells. A key pathological consequence of expanded CUG repeat RNA expression in DM1 is aberrant RNA splicing. Abnormal splicing results from the functional inactivation of MBNL1, which is hypothesized to occur due to MBNL1 sequestration in CUG foci or from elevated levels of CUG-BP1. We therefore tested the ability of cytoplasmic CUG foci to elicit these changes. Aggregation of CUG RNAs within the cytoplasm results both in Mbnl1 sequestration and in approximately a two fold increase in both nuclear and cytoplasmic Cug-bp1 levels. Significantly, despite these changes RNA splice defects were not observed and functional analysis revealed only subtle cardiac dysfunction, characterized by conduction defects that primarily manifest under anesthesia. Using a human myoblast culture system we show that this transgene, when expressed at similar levels to a second transgene, which encodes expanded CTG tracts and facilitates both nuclear focus formation and aberrant splicing, does not elicit aberrant splicing. Thus the lack of toxicity of cytoplasmic CUG foci does not appear to be a consequence of low expression levels. Our results therefore demonstrate that the cellular location of CUG RNA aggregates is an important variable that influences toxicity and support the hypothesis that small molecules that increase the rate of transport of the mutant DMPK RNA from the nucleus into the cytoplasm may significantly improve DM1 pathology.	[Paul, Sharan; Chiang, Andy; Reddy, Sita] Univ So Calif, Inst Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Wolf, Cordula M.; Branco, Dorothy; Sherwood, Megan C.; Berul, Charles I.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA USA; [Wolf, Cordula M.; Branco, Dorothy; Sherwood, Megan C.; Berul, Charles I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [Sarkar, Partha] Univ Texas, Med Branch, Dept Neurol, Galveston, TX USA; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthoped Hosp, Wolfson Ctr Inherited Neuromusc Dis, Oswestry, Shrops, England; [Comai, Lucio] Univ So Calif, Inst Genet Med, Dept Microbiol & Immunol, Los Angeles, CA USA	University of Southern California; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California	Dansithong, W (corresponding author), Univ So Calif, Inst Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	sitaredd@usc.edu	Comai, Lucio/L-5905-2019; Comai, Lucio/H-9524-2019	Comai, Lucio/0000-0003-3109-1841; 	National Center for Research Resources, National Institutes of Health (NIH) [5R01NS050861, 1R01NS060839]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060839, R01NS050861] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the Dr. Hauschneckt for funds that partially supported this work. This work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 (5R01NS050861, 1R01NS060839) from the National Center for Research Resources, National Institutes of Health (NIH).	Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Caskey CT, 1996, COLD SPRING HARB SYM, V61, P607; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; FALL LH, 1990, OBSTET GYNECOL, V76, P481; FORSBERG H, 1990, BRIT HEART J, V63, P119; FRAGOLA PV, 1994, AM J CARDIOL, V74, P1070, DOI 10.1016/0002-9149(94)90864-8; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; GULICK J, 1991, J BIOL CHEM, V266, P9180; Harper PS, 2001, MYOTONIC DYSTROPHY; HAWLEY RJ, 1991, NEUROLOGY, V41, P259, DOI 10.1212/WNL.41.2_Part_1.259; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Igarashi H, 1998, PEDIATR NEUROL, V18, P366, DOI 10.1016/S0887-8994(97)00216-6; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P3866, DOI 10.1093/nar/gki698; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Le Mee G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001466; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mastroyiannopoulos NP, 2005, EMBO REP, V6, P458, DOI 10.1038/sj.embor.7400390; MELACINI P, 1995, J AM COLL CARDIOL, V25, P239, DOI 10.1016/0735-1097(94)00351-P; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Saba S, 1999, J CARDIOVASC ELECTR, V10, P1214, DOI 10.1111/j.1540-8167.1999.tb00298.x; Sarkar PS, 1998, CELL, V95, P531, DOI 10.1016/S0092-8674(00)81620-7; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; TANAKA N, 1973, JPN HEART J, V14, P202; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; TOKGOZOGLU LS, 1995, JAMA-J AM MED ASSOC, V274, P813, DOI 10.1001/jama.274.10.813; Wakimoto H, 2002, J INTERV CARD ELECTR, V7, P127, DOI 10.1023/A:1020881520353; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	54	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3968	10.1371/journal.pone.0003968	http://dx.doi.org/10.1371/journal.pone.0003968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092997	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265458600005
J	Epstein, JM; Parker, J; Cummings, D; Hammond, RA				Epstein, Joshua M.; Parker, Jon; Cummings, Derek; Hammond, Ross A.			Coupled Contagion Dynamics of Fear and Disease: Mathematical and Computational Explorations	PLOS ONE			English	Article								Background: In classical mathematical epidemiology, individuals do not adapt their contact behavior during epidemics. They do not endogenously engage, for example, in social distancing based on fear. Yet, adaptive behavior is well-documented in true epidemics. We explore the effect of including such behavior in models of epidemic dynamics. Methodology/Principal Findings: Using both nonlinear dynamical systems and agent-based computation, we model two interacting contagion processes: one of disease and one of fear of the disease. Individuals can "contract'' fear through contact with individuals who are infected with the disease (the sick), infected with fear only (the scared), and infected with both fear and disease (the sick and scared). Scared individuals-whether sick or not-may remove themselves from circulation with some probability, which affects the contact dynamic, and thus the disease epidemic proper. If we allow individuals to recover from fear and return to circulation, the coupled dynamics become quite rich, and can include multiple waves of infection. We also study flight as a behavioral response. Conclusions/Significance: In a spatially extended setting, even relatively small levels of fear-inspired flight can have a dramatic impact on spatio-temporal epidemic dynamics. Self-isolation and spatial flight are only two of many possible actions that fear-infected individuals may take. Our main point is that behavioral adaptation of some sort must be considered.	[Parker, Jon; Hammond, Ross A.] Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA; [Epstein, Joshua M.] Santa Fe Inst, Santa Fe, NM USA; [Epstein, Joshua M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Cummings, Derek] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Brookings Institution; The Santa Fe Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Epstein, JM (corresponding author), Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA.	jepstein@brookings.edu			NIH 2008 Director's Pioneer Award [1DP1OD003874-01]; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) [U01-GM070749]; U.S. Department of Homeland Security [N00014-06-1-0991]; Career Award at the Scientific Interface from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, U01GM070749] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	NIH 2008 Director's Pioneer Award; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH 2008 Director's Pioneer Award [1DP1OD003874-01], the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) through grant U01-GM070749, and the U.S. Department of Homeland Security through grant N00014-06-1-0991 awarded to the National Center for Study of Preparedness and Critical Event Response (PACER) at the Johns Hopkins University. Derek Cummings holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. M., 1993, INFECT DIS HUMANS DY; Bartholomew RE, 2002, BRIT J PSYCHIAT, V180, P300, DOI 10.1192/bjp.180.4.300; CAPLINGER C, 2002, TENNESSEE ENCY HIST; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Hatfield E., 1994, REV PERSONALITY SOCI; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kremer M, 1996, Q J ECON, V111, P549, DOI 10.2307/2946687; Kuhnke L., 1990, LIVES RISK PUBLIC HL, V24, P134; Martin A. Lynn, 1973, SIXTEENTH CENT J, V4, P31; MURRAY B, 1989, MATH BIOL BIOMATHEMA, V19; Rosenberg Charles E, 1987, CHOLERA YEARS US 183	12	187	193	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3955	10.1371/journal.pone.0003955	http://dx.doi.org/10.1371/journal.pone.0003955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079607	gold, Green Accepted, Green Published			2022-12-27	WOS:000265458400011
J	Drouyer, E; Dkhissi-Benyahya, O; Chiquet, C; WoldeMussie, E; Ruiz, G; Wheeler, LA; Denis, P; Cooper, HM				Drouyer, Elise; Dkhissi-Benyahya, Ouria; Chiquet, Christophe; WoldeMussie, Elizabeth; Ruiz, Guadalupe; Wheeler, Larry A.; Denis, Philippe; Cooper, Howard M.			Glaucoma Alters the Circadian Timing System	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION TREATMENT; AFFERENT PUPILLARY DEFECTS; SUPRACHIASMATIC NUCLEUS; AXONAL-TRANSPORT; MELANOPSIN; RESPONSES; LIGHT; PROJECTIONS	Glaucoma is a widespread ocular disease and major cause of blindness characterized by progressive, irreversible damage of the optic nerve. Although the degenerative loss of retinal ganglion cells (RGC) and visual deficits associated with glaucoma have been extensively studied, we hypothesize that glaucoma will also lead to alteration of the circadian timing system. Circadian and non-visual responses to light are mediated by a specialized subset of melanopsin expressing RGCs that provide photic input to mammalian endogenous clock in the suprachiasmatic nucleus (SCN). In order to explore the molecular, anatomical and functional consequences of glaucoma we used a rodent model of chronic ocular hypertension, a primary causal factor of the pathology. Quantitative analysis of retinal projections using sensitive anterograde tracing demonstrates a significant reduction (similar to 50-70%) of RGC axon terminals in all visual and non-visual structures and notably in the SCN. The capacity of glaucomatous rats to entrain to light was challenged by exposure to successive shifts of the light dark (LD) cycle associated with step-wise decreases in light intensity. Although glaucomatous rats are able to entrain their locomotor activity to the LD cycle at all light levels, they require more time to re-adjust to a shifted LD cycle and show significantly greater variability in activity onsets in comparison with normal rats. Quantitative PCR reveals the novel finding that melanopsin as well as rod and cone opsin mRNAs are significantly reduced in glaucomatous retinas. Our findings demonstrate that glaucoma impacts on all these aspects of the circadian timing system. In light of these results, the classical view of glaucoma as pathology unique to the visual system should be extended to include anatomical and functional alterations of the circadian timing system.	[Dkhissi-Benyahya, Ouria; Chiquet, Christophe; Denis, Philippe; Cooper, Howard M.] Stem Cell & Brain Res Inst, U846, INSERM, Dept Chronobiol, Bron, France; [Drouyer, Elise; Dkhissi-Benyahya, Ouria; Cooper, Howard M.] Univ Lyon 1, UMR S 846, Lyon, France; [Cooper, Howard M.] Ctr Natl Rech Sci, Lyon, France; [Chiquet, Christophe] Univ Joseph Fourier, Fac Med, CHU Grenoble, Dept Ophthalmol, F-38041 Grenoble, France; [WoldeMussie, Elizabeth] Pfizer Inc, San Diego, CA USA; [Ruiz, Guadalupe; Wheeler, Larry A.] Allergan Pharmaceut Inc, Irvine, CA USA; [Denis, Philippe] CHU Lyon Hop Edouard Herriot, Dept Ophthalmol, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pfizer; AbbVie; Allergan; CHU Lyon	Drouyer, E (corresponding author), Stem Cell & Brain Res Inst, U846, INSERM, Dept Chronobiol, Bron, France.	howard.cooper@inserm.fr	Dkhissi-Benyahya, Ouria/M-5665-2014; Chiquet, Christophe/M-7426-2014; COOPER, HOWARD/M-7304-2014	Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; Chiquet, Christophe/0000-0002-7601-4885; 	Allergan, Inc; Rhone-Alpes-Emergence/Cible; ACT-Vieillissement; ACI Neurosciences; Fondation Recherche Medicale stipend; FP6- EUCLOCK	Allergan, Inc(AbbVieAllergan); Rhone-Alpes-Emergence/Cible; ACT-Vieillissement; ACI Neurosciences; Fondation Recherche Medicale stipend; FP6- EUCLOCK	This work was supported by grants from Allergan, Inc, Rhone-Alpes-Emergence/Cible, ACT-Vieillissement, ACI Neurosciences, Fondation Recherche Medicale stipend to ED, FP6- EUCLOCK.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Chiquet C, 2006, J FR OPHTALMOL, V29, P847, DOI 10.1016/S0181-5512(06)73858-X; Chiquet C, 2004, INVEST OPHTH VIS SCI, V45, pU425; COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DANDONA L, 1991, INVEST OPHTH VIS SCI, V32, P1593; Diaz F, 2005, HISTOL HISTOPATHOL, V20, P1077, DOI 10.14670/HH-20.1077; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; Friedman DS, 2004, AM J OPHTHALMOL, V138, pS19, DOI 10.1016/j.ajo.2004.04.058; Gherghel D, 2004, SURV OPHTHALMOL, V49, P491, DOI 10.1016/j.survophthal.2004.06.003; GLOVINSKY Y, 1993, INVEST OPHTH VIS SCI, V34, P395; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hare WA, 2001, INVEST OPHTH VIS SCI, V42, P127; Harwerth RS, 2004, INVEST OPHTH VIS SCI, V45, P3152, DOI 10.1167/iovs.04-0227; Harwerth RS, 2006, ARCH OPHTHALMOL-CHIC, V124, P853, DOI 10.1001/archopht.124.6.853; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; KABACK MB, 1976, AM J OPHTHALMOL, V81, P768, DOI 10.1016/0002-9394(76)90360-3; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; KOHN AN, 1979, ARCH OPHTHALMOL-CHIC, V97, P294; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; LUND RD, 1974, J COMP NEUROL, V158, P383, DOI 10.1002/cne.901580403; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Onen SH, 2000, ACTA OPHTHALMOL SCAN, V78, P638, DOI 10.1034/j.1600-0420.2000.078006638.x; Palmberg P, 2002, ARCH OPHTHALMOL-CHIC, V120, P829; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pelzel HR, 2006, MOL VIS, V12, P1272; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; PRYWES AS, 1976, ARCH OPHTHALMOL-CHIC, V94, P1286; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Raz D, 2002, INVEST OPHTH VIS SCI, V43, P2027; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sawada A, 1999, EXP EYE RES, V69, P525, DOI 10.1006/exer.1999.0732; SIMINOFF R, 1966, J COMP NEUROL, V127, P435, DOI 10.1002/cne.901270402; Skene DJ, 1999, CLIN ENDOCRINOL, V50, P715; Son YJ, 2007, MOL CELLS, V23, P215; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tabandeh H, 1998, AM J OPHTHALMOL, V126, P707, DOI 10.1016/S0002-9394(98)00133-0; VANBUSKIRK EM, 1992, AM J OPHTHALMOL, V113, P447, DOI 10.1016/S0002-9394(14)76171-9; Ver Hoeve JN, 2001, INVEST OPHTH VIS SCI, V42, pS148; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; WYGNANSKI T, 1995, AM J OPHTHALMOL, V120, P184, DOI 10.1016/S0002-9394(14)72606-6	69	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3931	10.1371/journal.pone.0003931	http://dx.doi.org/10.1371/journal.pone.0003931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079596	Green Published, gold			2022-12-27	WOS:000265456300008
J	Dushek, O; Mueller, S; Soubies, S; Depoil, D; Caramalho, I; Coombs, D; Valitutti, S				Dushek, Omer; Mueller, Sabina; Soubies, Sebastien; Depoil, David; Caramalho, Iris; Coombs, Daniel; Valitutti, Salvatore			Effects of Intracellular Calcium and Actin Cytoskeleton on TCR Mobility Measured by Fluorescence Recovery	PLOS ONE			English	Article								Background: The activation of T lymphocytes by specific antigen is accompanied by the formation of a specialized signaling region termed the immunological synapse, characterized by the clustering and segregation of surface molecules and, in particular, by T cell receptor (TCR) clustering. Methodology/Principal Findings: To better understand TCR motion during cellular activation, we used confocal microscopy and photo-bleaching recovery techniques to investigate the lateral mobility of TCR on the surface of human T lymphocytes under various pharmacological treatments. Using drugs that cause an increase in intracellular calcium, we observed a decrease in TCR mobility that was dependent on a functional actin cytoskeleton. In parallel experiments measurement of filamentous actin by FACS analysis showed that raising intracellular calcium also causes increased polymerization of the actin cytoskeleton. These in vitro results were analyzed using a mathematical model that revealed effective binding parameters between TCR and the actin cytoskeleton. Conclusion/Significance: We propose, based on our results, that increase in intracellular calcium levels leads to actin polymerization and increases TCR/cytoskeleton interactions that reduce the overall mobility of the TCR. In a physiological setting, this may contribute to TCR re-positioning at the immunological synapse.	[Coombs, Daniel] Univ British Columbia, Dept Math, Inst Appl Math, Vancouver, BC, Canada; [Mueller, Sabina; Soubies, Sebastien; Depoil, David; Caramalho, Iris; Valitutti, Salvatore] INSERM, Ctr Physiopathol Toulouse Purpan, U563, Sect Dynam Mol Interact Lymphocytaires, Toulouse, France	University of British Columbia; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Dushek, O (corresponding author), Univ British Columbia, Dept Math, Inst Appl Math, Vancouver, BC, Canada.	salvatore.valitutti@inserm.fr	Caramalho, Iris/L-2491-2014; Valitutti, Salvatore/M-2999-2014	Caramalho, Iris/0000-0003-2479-7846; Valitutti, Salvatore/0000-0002-6432-4421; Soubies, Sebastien Mathieu/0000-0003-3065-3558; Coombs, Daniel/0000-0002-8038-6278	Ligue contre le Cancer "Equipe labellisee 2008", France; National Science and Engineering Research Council; Mathematics in Technology and Complex Systems National Centre of Excellence, Canada; Fundacao para Ciencia e a Tecnologia, Portugal; France-Canada Research Fund	Ligue contre le Cancer "Equipe labellisee 2008", France; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics in Technology and Complex Systems National Centre of Excellence, Canada; Fundacao para Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); France-Canada Research Fund	Ligue contre le Cancer "Equipe labellisee 2008", France. National Science and Engineering Research Council and from the Mathematics in Technology and Complex Systems National Centre of Excellence, Canada. Fundacao para Ciencia e a Tecnologia, Portugal. France-Canada Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; DOWNEY GP, 1990, J CELL BIOL, V110, P1975, DOI 10.1083/jcb.110.6.1975; DUSHEK O, 2008, EUR BIOPHYS J; Dushek O, 2008, J BIOCHEM BIOPH METH, V70, P1224, DOI 10.1016/j.jbbm.2007.07.002; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; LANZAVECCHIA A, 1987, EUR J IMMUNOL, V17, P105, DOI 10.1002/eji.1830170118; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Tooley AJ, 2005, SEMIN IMMUNOL, V17, P65, DOI 10.1016/j.smim.2004.09.006; VALITUTTI S, 1993, EUR J IMMUNOL, V23, P790, DOI 10.1002/eji.1830230403; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287	38	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3913	10.1371/journal.pone.0003913	http://dx.doi.org/10.1371/journal.pone.0003913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079546	gold, Green Submitted, Green Published			2022-12-27	WOS:000265455900005
J	Tam, SP; Kisilevsky, R; Ancsin, JB				Tam, Shui-Pang; Kisilevsky, Robert; Ancsin, John B.			Acute-Phase-HDL Remodeling by Heparan Sulfate Generates a Novel Lipoprotein with Exceptional Cholesterol Efflux Activity from Macrophages	PLOS ONE			English	Article								During episodes of acute-inflammation high-density lipoproteins (HDL), the carrier of so-called good cholesterol, experiences a major change in apolipoprotein composition and becomes acute-phase HDL (AP-HDL). This altered, but physiologically important, HDL has an increased binding affinity for macrophages that is dependent on cell surface heparan sulfate (HS). While exploring the properties of AP-HDL: HS interactions we discovered that HS caused significant remodeling of AP-HDL. The physical nature of this change in structure and its potential importance for cholesterol efflux from cholesterol-loaded macrophages was therefore investigated. In the presence of heparin, or HS, AP-HDL solutions at pH 5.2 became turbid within minutes. Analysis by centrifugation and gel electrophoresis indicated that AP-HDL was remodeled generating novel lipid poor particles composed only of apolipoprotein AI, which we designate beta 2. This remodeling is dependent on pH, glycosaminoglycan type, is promoted by Ca2+ and is independent of protease or lipase activity. Compared to HDL and AP-HDL, remodeled AP-HDL (S-HDL-SAA), containing beta 2 particles, demonstrated a 3-fold greater cholesterol efflux activity from cholesterol-loaded macrophage. Because the identified conditions causing this change in AP-HDL structure and function can exist physiologically at the surface of the macrophage, or in its endosomes, we postulate that AP-HDL contains latent functionalities that become apparent and active when it associates with macrophage cell surface/endosomal HS. In this way initial steps in the reverse cholesterol transport pathway are focused at sites of injury to mobilize cholesterol from macrophages that are actively participating in the phagocytosis of damaged membranes rich in cholesterol. The mechanism may also be of relevance to aspects of atherogenesis.	[Tam, Shui-Pang; Kisilevsky, Robert; Ancsin, John B.] Queens Univ, Kingston Gen Hosp, Syl & Molly Apps Res Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada; [Kisilevsky, Robert] Queens Univ, Dept Biochem, Syl & Molly Apps Res Ctr, Kingston Gen Hosp, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada; Queens University - Canada	Tam, SP (corresponding author), Queens Univ, Kingston Gen Hosp, Syl & Molly Apps Res Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada.	3jba1@queensu.ca	Eckhardt, Erik/G-1567-2010		Canadian Institutes of Health Research [MOP-3153]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-3153 from the Canadian Institutes of Health Research. The granting agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; AXELRAD MA, 1982, LAB INVEST, V47, P139; BANKA CL, 1995, J LIPID RES, V36, P1058; Barter PJ, 2006, CURR OPIN LIPIDOL, V17, P399, DOI 10.1097/01.mol.0000236365.40969.af; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; Benjwal S, 2005, BIOCHEMISTRY-US, V44, P10218, DOI 10.1021/bi050781m; Cabana VG, 1996, J LIPID RES, V37, P2662; CABANA VG, 1989, J LIPID RES, V30, P39; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; CLIFTON PM, 1985, J LIPID RES, V26, P1389; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Ely S, 2001, AMYLOID, V8, P169, DOI 10.3109/13506120109007360; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayat S, 1997, BIOCHEM SOC T, V25, pS348, DOI 10.1042/bst025348s; Hayat S, 2000, SCAND J IMMUNOL, V51, P141; Jayaraman S, 2006, BIOCHEMISTRY-US, V45, P4620, DOI 10.1021/bi0524565; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2008, CURR OPIN INVEST DR, V9, P265; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; LEVIN M, 1972, J CLIN INVEST, V51, P2773, DOI 10.1172/JCI107098; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Manley PN, 2006, MED HYPOTHESES, V66, P784, DOI 10.1016/j.mehy.2005.10.018; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Rocken C, 1997, AMYLOID, V4, P259, DOI 10.3109/13506129709003837; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; TAPE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P295, DOI 10.1016/0005-2760(90)90030-2; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; YOKOYAMA S, 1982, J BIOCHEM, V91, P1267, DOI 10.1093/oxfordjournals.jbchem.a133811	48	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3867	10.1371/journal.pone.0003867	http://dx.doi.org/10.1371/journal.pone.0003867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057652	Green Published, gold, Green Submitted			2022-12-27	WOS:000265452300007
J	Tian, C; Kosoy, R; Lee, A; Ransom, M; Belmont, JW; Gregersen, PK; Seldin, MF				Tian, Chao; Kosoy, Roman; Lee, Annette; Ransom, Michael; Belmont, John W.; Gregersen, Peter K.; Seldin, Michael F.			Analysis of East Asia Genetic Substructure Using Genome-Wide SNP Arrays	PLOS ONE			English	Article								Accounting for population genetic substructure is important in reducing type 1 errors in genetic studies of complex disease. As efforts to understand complex genetic disease are expanded to different continental populations the understanding of genetic substructure within these continents will be useful in design and execution of association tests. In this study, population differentiation (Fst) and Principal Components Analyses (PCA) are examined using >200 K genotypes from multiple populations of East Asian ancestry. The population groups included those from the Human Genome Diversity Panel [Cambodian, Yi, Daur, Mongolian, Lahu, Dai, Hezhen, Miaozu, Naxi, Oroqen, She, Tu, Tujia, Naxi, Xibo, and Yakut], HapMap [ Han Chinese (CHB) and Japanese (JPT)], and East Asian or East Asian American subjects of Vietnamese, Korean, Filipino and Chinese ancestry. Paired Fst (Wei and Cockerham) showed close relationships between CHB and several large East Asian population groups (CHB/Korean, 0.0019; CHB/JPT, 00651; CHB/Vietnamese, 0.0065) with larger separation with Filipino (CHB/Filipino, 0.014). Low levels of differentiation were also observed between Dai and Vietnamese (0.0045) and between Vietnamese and Cambodian (0.0062). Similarly, small Fst's were observed among different presumed Han Chinese populations originating in different regions of mainland of China and Taiwan (Fst's <0.0025 with CHB). For PCA, the first two PC's showed a pattern of relationships that closely followed the geographic distribution of the different East Asian populations. PCA showed substructure both between different East Asian groups and within the Han Chinese population. These studies have also identified a subset of East Asian substructure ancestry informative markers (EASTASAIMS) that may be useful for future complex genetic disease association studies in reducing type 1 errors and in identifying homogeneous groups that may increase the power of such studies.	[Tian, Chao; Kosoy, Roman; Ransom, Michael; Seldin, Michael F.] Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Davis, CA 95616 USA; [Lee, Annette; Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Belmont, John W.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA	University of California System; University of California Davis; Northwell Health; Baylor College of Medicine	Tian, C (corresponding author), Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Davis, CA 95616 USA.	mfseldin@ucdavis.edu	Belmont, John/AAH-6084-2021; Belmont, John W/AAI-2494-2019	Belmont, John W/0000-0001-7409-3578	NIH [DK071185, AR050267, AR44422]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050267, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK071185, AR050267, and AR44422.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2003, NATURE, V426, P789; BALLINGER SW, 1992, GENETICS, V130, P139; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Belkhir K, 2001, 5000 CNRS UMR U MONT; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; CAVALLISFORZA LL, 1996, HIST GEOGRAPHY HUMAN, pR13; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Falush D, 2003, GENETICS, V164, P1567; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Hollander M., 1973, NONPARAMETRIC STAT M, P115; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; KOSOY R, HUMAN MUTAT IN PRESS; Lee HS, 2007, MOL MED, V13, P455, DOI 10.2119/2007-00072.Lee; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin YJ, 2007, GENES IMMUN, V8, P302, DOI 10.1038/sj.gene.6364387; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; NEI M, 1993, MOL BIOL EVOL, V10, P927; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Seldin MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040005; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	39	93	94	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3862	10.1371/journal.pone.0003862	http://dx.doi.org/10.1371/journal.pone.0003862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057645	Green Published, gold, Green Submitted			2022-12-27	WOS:000265452300004
J	Lu, H; Patil, P; Van Sluys, MA; White, FF; Ryan, RP; Dow, JM; Rabinowicz, P; Salzberg, SL; Leach, JE; Sonti, R; Brendel, V; Bogdanove, AJ				Lu, Hong; Patil, Prabhu; Van Sluys, Marie-Anne; White, Frank F.; Ryan, Robert P.; Dow, J. Maxwell; Rabinowicz, Pablo; Salzberg, Steven L.; Leach, Jan E.; Sonti, Ramesh; Brendel, Volker; Bogdanove, Adam J.			Acquisition and Evolution of Plant Pathogenesis-Associated Gene Clusters and Candidate Determinants of Tissue-Specificity in Xanthomonas	PLOS ONE			English	Article							ORYZAE PV.-ORYZAE; EXTRACELLULAR POLYSACCHARIDE PRODUCTION; PATHOGENICITY FACTOR PRODUCTION; CAMPESTRIS PATHOVAR CAMPESTRIS; OUTER-MEMBRANE PROTEIN; GYP DOMAIN PROTEIN; GENOME SEQUENCE; XANTHAN PRODUCTION; ESCHERICHIA-COLI; II SECRETION	Background: Xanthomonas is a large genus of plant-associated and plant-pathogenic bacteria. Collectively, members cause diseases on over 392 plant species. Individually, they exhibit marked host- and tissue-specificity. The determinants of this specificity are unknown. Methodology/Principal Findings: To assess potential contributions to host- and tissue-specificity, pathogenesis-associated gene clusters were compared across genomes of eight Xanthomonas strains representing vascular or non-vascular pathogens of rice, brassicas, pepper and tomato, and citrus. The gum cluster for extracellular polysaccharide is conserved except for gumN and sequences downstream. The xcs and xps clusters for type II secretion are conserved, except in the rice pathogens, in which xcs is missing. In the otherwise conserved hrp cluster, sequences flanking the core genes for type III secretion vary with respect to insertion sequence element and putative effector gene content. Variation at the rpf (regulation of pathogenicity factors) cluster is more pronounced, though genes with established functional relevance are conserved. A cluster for synthesis of lipopolysaccharide varies highly, suggesting multiple horizontal gene transfers and reassortments, but this variation does not correlate with host- or tissue-specificity. Phylogenetic trees based on amino acid alignments of gum, xps, xcs, hrp, and rpf cluster products generally reflect strain phylogeny. However, amino acid residues at four positions correlate with tissue specificity, revealing hpaA and xpsD as candidate determinants. Examination of genome sequences of xanthomonads Xylella fastidiosa and Stenotrophomonas maltophilia revealed that the hrp, gum, and xcs clusters are recent acquisitions in the Xanthomonas lineage. Conclusions/Significance: Our results provide insight into the ancestral Xanthomonas genome and indicate that differentiation with respect to host- and tissue-specificity involved not major modifications or wholesale exchange of clusters, but subtle changes in a small number of genes or in non-coding sequences, and/or differences outside the clusters, potentially among regulatory targets or secretory substrates.	[Lu, Hong; Brendel, Volker] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Patil, Prabhu; Sonti, Ramesh] Council Sci & Indust Res, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Van Sluys, Marie-Anne] IB USP, Dept Bot, Sao Paulo, Brazil; [White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Ryan, Robert P.; Dow, J. Maxwell] Univ Coll Cork, BioSci Inst, BIOMERIT Res Ctr, Cork, Ireland; [Rabinowicz, Pablo] Inst Genom Res, Rockville, MD USA; [Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Van Sluys, Marie-Anne; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Brendel, Volker] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA	Iowa State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Kansas State University; University College Cork; J. Craig Venter Institute; University System of Maryland; University of Maryland College Park; Colorado State University; Iowa State University; Iowa State University	Lu, H (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	ajbog@iastate.edu	Lu, Hong/F-2744-2015; Bogdanove, Adam/ABE-6252-2020; Patil, Prabhu/B-4070-2010; Van Sluys, Marie-Anne/A-8483-2012; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Hong, LU/HDM-0673-2022	Lu, Hong/0000-0002-4026-4292; Van Sluys, Marie-Anne/0000-0002-6506-2734; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Dow, Max/0000-0001-8245-2294; Ryan, Rober/0000-0002-7353-0913	U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program [20043560015022]; Science Foundation of Ireland [Principal Investigator Award]; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program; Science Foundation of Ireland(Science Foundation Ireland); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this study was provided by the U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program (20043560015022 to AB, JL, SS, and FW) and through a Principal Investigator Award from the Science Foundation of Ireland to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P199, DOI 10.1016/0885-5765(87)90033-6; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P207, DOI 10.1016/0885-5765(87)90034-8; Blanch M, 2008, J PLANT PHYSIOL, V165, P366, DOI 10.1016/j.jplph.2007.03.008; Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brosch R, 2001, TRENDS MICROBIOL, V9, P452, DOI 10.1016/S0966-842X(01)02131-X; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2006, MOL MICROBIOL, V59, P513, DOI 10.1111/j.1365-2958.2005.04924.x; Champoiseau P, 2006, PHYTOPATHOLOGY, V96, P1081, DOI 10.1094/PHYTO-96-1081; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; da Silva FR, 2001, FEMS MICROBIOL LETT, V203, P165, DOI 10.1111/j.1574-6968.2001.tb10836.x; DANIELS MJ, 1989, GENETICS BACTERIAL D, P353; DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dharmapuri S, 2001, MOL PLANT MICROBE IN, V14, P1335, DOI 10.1094/MPMI.2001.14.11.1335; Dharmapuri S, 1999, FEMS MICROBIOL LETT, V179, P53, DOI 10.1111/j.1574-6968.1999.tb08707.x; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow JM, 2000, MICROBIOL-SGM, V146, P885, DOI 10.1099/00221287-146-4-885; DOW JM, 1989, J CELL SCI, P59; Dow JM, 2000, YEAST, V17, P263, DOI 10.1002/1097-0061(200012)17:4&lt;263::AID-YEA44&gt;3.0.CO;2-G; DUMS F, 1991, MOL GEN GENET, V229, P357, DOI 10.1007/BF00267456; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fontaniella B, 2002, J CHROMATOGR B, V770, P275, DOI 10.1016/S1570-0232(01)00579-7; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Goncalves ER, 2002, INT J SYST EVOL MICR, V52, P355, DOI 10.1099/00207713-52-2-355; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; Hayward A. C., 1993, Xanthomonas., P1; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; KAMOUN S, 1990, APPL ENVIRON MICROB, V56, P3855, DOI 10.1128/AEM.56.12.3855-3860.1990; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kiraly Z, 1997, J PHYTOPATHOL, V145, P59, DOI 10.1111/j.1439-0434.1997.tb00365.x; KOPLIN R, 1992, J BACTERIOL, V174, P191; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; LEITE RP, 1994, APPL ENVIRON MICROB, V60, P1068, DOI 10.1128/AEM.60.4.1068-1077.1994; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; LIMA WC, 2005, J INTEGRATIVE BIOL, V9, P160; Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x; Lorenz C, 2008, MOL MICROBIOL, V69, P344, DOI 10.1111/j.1365-2958.2008.06280.x; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mooi FR, 1997, TRENDS MICROBIOL, V5, P161, DOI 10.1016/S0966-842X(96)10086-X; Moore ERB, 1997, FEMS MICROBIOL LETT, V151, P145, DOI 10.1016/S0378-1097(97)00152-3; Moreira LM, 2004, ANNU REV PHYTOPATHOL, V42, P163, DOI 10.1146/annurev.phyto.42.040803.140310; Newman MA, 2001, EUR J PLANT PATHOL, V107, P95, DOI 10.1023/A:1008738817551; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Patil PB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-40; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; POSSOT O, 1992, MOL MICROBIOL, V6, P95, DOI 10.1111/j.1365-2958.1992.tb00841.x; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Raymundo A. K., 1993, Philippine Journal of Biotechnology, V4, P29; Reeves PP, 2002, CURR TOP MICROBIOL, V264, P109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9; Siciliano F, 2006, ELECTRON J BIOTECHN, V9, P199, DOI 10.2225/vol9-issue3-fulltext-20; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Steinmann D, 1997, ARCH MICROBIOL, V168, P441, DOI 10.1007/s002030050520; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sugio A, 2005, MOL PLANT MICROBE IN, V18, P546, DOI 10.1094/MPMI-18-0546; Sun QH, 2005, PLANT PATHOL, V54, P15, DOI 10.1111/j.1365-3059.2004.01101.x; Tang JL, 1996, MOL PLANT MICROBE IN, V9, P664, DOI 10.1094/MPMI-9-0664; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; VANDERSLICE RW, 1989, BIOMEDICAL AND BIOTECHNOLOGICAL ADVANCES IN INDUSTRIAL POLYSACCHARIDES, P145; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Yoon KH, 2007, BIOTECHNOL LETT, V29, P95, DOI 10.1007/s10529-006-9217-1	112	72	77	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3828	10.1371/journal.pone.0003828	http://dx.doi.org/10.1371/journal.pone.0003828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043590	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451500008
J	Saenz, A; Azpitarte, M; Armananzas, R; Leturcq, F; Alzualde, A; Inza, I; Garcia-Bragado, F; De la Herran, G; Corcuera, J; Cabello, A; Navarro, C; De la Torre, C; Gallardo, E; Illa, I; de Munain, AL				Saenz, Amets; Azpitarte, Margarita; Armananzas, Ruben; Leturcq, France; Alzualde, Ainhoa; Inza, Inaki; Garcia-Bragado, Federico; De la Herran, Gaspar; Corcuera, Julian; Cabello, Ana; Navarro, Carmen; De la Torre, Carolina; Gallardo, Eduard; Illa, Isabel; Lopez de Munain, Adolfo			Gene Expression Profiling in Limb-Girdle Muscular Dystrophy 2A	PLOS ONE			English	Article								Limb-girdle muscular dystrophy type 2A (LGMD2A) is a recessive genetic disorder caused by mutations in calpain 3 (CAPN3). Calpain 3 plays different roles in muscular cells, but little is known about its functions or in vivo substrates. The aim of this study was to identify the genes showing an altered expression in LGMD2A patients and the possible pathways they are implicated in. Ten muscle samples from LGMD2A patients with in which molecular diagnosis was ascertained were investigated using array technology to analyze gene expression profiling as compared to ten normal muscle samples. Upregulated genes were mostly those related to extracellular matrix (different collagens), cell adhesion (fibronectin), muscle development (myosins and melusin) and signal transduction. It is therefore suggested that different proteins located or participating in the costameric region are implicated in processes regulated by calpain 3 during skeletal muscle development. Genes participating in the ubiquitin proteasome degradation pathway were found to be deregulated in LGMD2A patients, suggesting that regulation of this pathway may be under the control of calpain 3 activity. As frizzled-related protein (FRZB) is upregulated in LGMD2A muscle samples, it could be hypothesized that beta-catenin regulation is also altered at the Wnt signaling pathway, leading to an incorrect myogenesis. Conversely, expression of most transcription factor genes was downregulated (MYC, FOS and EGR1). Finally, the upregulation of IL-32 and immunoglobulin genes may induce the eosinophil chemoattraction explaining the inflammatory findings observed in presymptomatic stages. The obtained results try to shed some light on identification of novel therapeutic targets for limb-girdle muscular dystrophies.	[Saenz, Amets; Azpitarte, Margarita; Alzualde, Ainhoa] Hosp Donostia, Expt Unit, Donostia San Sebastian, Basque Country, Spain; [Armananzas, Ruben; Inza, Inaki] Univ Basque Country, Comp Sci Fac, Department of Comp Sci & Artificial Intelligence, San Sebastian, Spain; [Leturcq, France] Hop Cochin, Groupe Hosp Pitie Salpetriere, Lab Biochim Genet Mol, Paris, France; [Garcia-Bragado, Federico] Hosp Virgen Camino, Dept Pathol, Pamplona, Spain; [De la Herran, Gaspar; Corcuera, Julian] Hosp Donostia, Dept Orthoped Surg, San Sebastian, Spain; [Cabello, Ana] Hosp 12 Octubre, Dept Pathol, Madrid, Spain; [Navarro, Carmen] Hosp Meixoeiro, Dept Pathol, Vigo, Spain; [De la Torre, Carolina; Gallardo, Eduard] Hosp Santa Creu & Sant Pau, Lab Expt Neurol, Barcelona, Spain; [Illa, Isabel] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain; [Lopez de Munain, Adolfo] Hosp Donostia, Dept Neurol, San Sebastian, Spain	University Hospital Donostia; University of Basque Country; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; University Hospital Donostia; Hospital Universitario 12 de Octubre; Complexo Hospitalario Universitario de Vigo; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; University Hospital Donostia	Saenz, A (corresponding author), Hosp Donostia, Expt Unit, Donostia San Sebastian, Basque Country, Spain.	amets.saenzpena@osakidetza.net	ILLA, Isabel/AAD-1816-2019; Sáenz, Amets/E-4761-2019; Armañanzas, Rubén/C-2735-2013; De La Torre Gómez, Carolina/AAP-1738-2020; Armañanzas, Rubén/O-7403-2019; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Navarro, Carmen/A-9210-2012	Sáenz, Amets/0000-0002-0704-1150; Armañanzas, Rubén/0000-0003-4049-0000; De La Torre Gómez, Carolina/0000-0001-9363-291X; Armañanzas, Rubén/0000-0003-4049-0000; INZA CANO, INAKI/0000-0003-4674-1755; Gallardo, Eduard/0000-0002-3942-3436; /0000-0002-9509-4032	Health Research Fund of the Spanish Ministry of Health [FIS CP06/00099]; Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua [76/06]; European Union; Instituto de Salud Carlos III; Basque Foundation for Health Innovation and Research (BIOEF); Basque Government [AE-BFI-05/430]	Health Research Fund of the Spanish Ministry of Health(Instituto de Salud Carlos III); Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua; European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Basque Foundation for Health Innovation and Research (BIOEF); Basque Government(Basque Government)	Health Research Fund of the Spanish Ministry of Health (FIS CP06/00099); Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua, 76/06); European Union (FEDER Funds and CIBERNED); Instituto de Salud Carlos III. AS: Spanish Ministry of Health (FIS) and Basque Foundation for Health Innovation and Research (BIOEF) promoted by the Basque Government Department of Health. RA: Basque Government (AE-BFI-05/430).	ARAHATA K, 1995, MUSCLE NERVE, pS56; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Baldwin KM, 2002, AM J PHYS MED REHAB, V81, pS40, DOI 10.1097/00002060-200211001-00006; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com; Bolstad B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Cai BY, 2000, AM J PATHOL, V156, P1789, DOI 10.1016/S0002-9440(10)65050-X; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Campbell KP, 2003, J BIOL CHEM, V278, P12599, DOI 10.1074/jbc.R300005200; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Duda R.O., 2000, PATTERN CLASSIFICATI; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Figarella-Branger D, 2002, NEUROMUSCULAR DISORD, V12, P4, DOI 10.1016/S0960-8966(01)00245-0; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Hall MA, 1997, P 4 INT C NEUR INF P, P855; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang PB, 2005, MUSCLE NERVE, V32, P483, DOI 10.1002/mus.20356; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; Keira Y, 2007, NEUROSCI RES, V57, P513, DOI 10.1016/j.neures.2006.12.010; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Krahn M, 2006, ANN NEUROL, V59, P905, DOI 10.1002/ana.20833; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Noguchi S, 2003, HUM MOL GENET, V12, P595, DOI 10.1093/hmg/ddg065; Olive M, 1997, NEUROPATH APPL NEURO, V23, P475, DOI 10.1111/j.1365-2990.1997.tb01324.x; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Taniguchi M, 2006, BIOCHEM BIOPH RES CO, V342, P489, DOI 10.1016/j.bbrc.2005.12.224; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Weinstock A, 1997, J CHILD NEUROL, V12, P146, DOI 10.1177/088307389701200214; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wu G, 2004, MOL CELL, V13, P451, DOI 10.1016/S1097-2765(04)00090-5; Zhou XD, 2006, ARTHRITIS RHEUM-US, V54, P2626, DOI 10.1002/art.21973	60	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3750	10.1371/journal.pone.0003750	http://dx.doi.org/10.1371/journal.pone.0003750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015733	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265448400007
J	Broughton, S; Alic, N; Slack, C; Bass, T; Ikeya, T; Vinti, G; Tommasi, AM; Driege, Y; Hafen, E; Partridge, L				Broughton, Susan; Alic, Nazif; Slack, Cathy; Bass, Timothy; Ikeya, Tomoatsu; Vinti, Giovanna; Tommasi, Anna Maria; Driege, Yasmine; Hafen, Ernst; Partridge, Linda			Reduction of DILP2 in Drosophila Triages a Metabolic Phenotype from Lifespan Revealing Redundancy and Compensation among DILPs	PLOS ONE			English	Article								The insulin/IGF-like signalling (IIS) pathway has diverse functions in all multicellular organisms, including determination of lifespan. The seven insulin-like peptides (DILPs) in Drosophila are expressed in a stage- and tissue-specific manner. Partial ablation of the median neurosecretory cells (mNSCs) in the brain, which produce three DILPs, extends lifespan, reduces fecundity, alters lipid and carbohydrate metabolism and increases oxidative stress resistance. To determine if reduced expression of DILPs is causal in these effects, and to investigate possible functional diversification and redundancy between DILPs, we used RNA interference to lower specifically the transcript and protein levels of dilp2, the most highly expressed of the mNSC-derived DILPs. We found that DILP2 was limiting only for the increased whole-body trehalose content associated with mNSC-ablation. We observed a compensatory increase in dilp3 and 5 mRNA upon dilp2 knock down. By manipulation of dfoxo and dInR, we showed that the increase in dilp3 is regulated via autocrine insulin signaling in the mNSCs. Our study demonstrates that, despite the correlation between reduced dilp2 mRNA levels and lifespan-extension often observed, DILP2 reduction is not sufficient to extend lifespan. Nor is the increased trehalose storage associated with reduced IIS sufficient to extend lifespan. To understand the normal regulation of expression of the dilps and any functional diversification between them will require independent control of the expression of different dilps.	[Broughton, Susan; Alic, Nazif; Slack, Cathy; Bass, Timothy; Ikeya, Tomoatsu; Vinti, Giovanna; Tommasi, Anna Maria; Driege, Yasmine; Partridge, Linda] UCL, Inst Healthy Ageing, GEE, London, England; [Hafen, Ernst] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich	Broughton, S (corresponding author), UCL, Inst Healthy Ageing, GEE, London, England.	l.partridge@ucl.ac.uk	Alic, Nazif/B-4665-2009; Partridge, Linda/A-5501-2010; Slack, Cathy/C-2016-2008; Partridge, Linda/E-7342-2015	Alic, Nazif/0000-0003-0356-6600; Partridge, Linda/0000-0001-9615-0094; Broughton, Sue/0000-0001-8168-5387; Slack, Cathy/0000-0002-7949-4079	Wellcome Trust; Biotechnology and Biological Science Research Council; Research into Aging; Marie Curie Fellowship; European Molecular Biology Organisation	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research into Aging; Marie Curie Fellowship(European Commission); European Molecular Biology Organisation	We acknowledge funding by the Wellcome Trust (LP and SB), the Biotechnology and Biological Science Research Council (TB), Research into Aging (CS), a Marie Curie Fellowship (NA) and a European Molecular Biology Organisation Long-term Fellowship (NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DORMAN JB, 1995, GENETICS, V141, P1399; Folk DG, 2004, J EXP BIOL, V207, P2671, DOI 10.1242/jeb.01048; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattaliano MD, 2007, MOL CELL NEUROSCI, V36, P211, DOI 10.1016/j.mcn.2007.06.008; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Nelson DW, 2003, GENE DEV, V17, P813, DOI 10.1101/gad.1090203; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Sokal RR, 1998, BIOMETRY; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P266, DOI 10.1016/0003-2697(65)90014-X; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	36	150	153	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3721	10.1371/journal.pone.0003721	http://dx.doi.org/10.1371/journal.pone.0003721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005568	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000265166200009
J	Nosho, K; Irahara, N; Shima, K; Kure, S; Kirkner, GJ; Schernhammer, ES; Hazra, A; Hunter, DJ; Quackenbush, J; Spiegelman, D; Giovannucci, EL; Fuchs, CS; Ogino, S				Nosho, Katsuhiko; Irahara, Natsumi; Shima, Kaori; Kure, Shoko; Kirkner, Gregory J.; Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Quackenbush, John; Spiegelman, Donna; Giovannucci, Edward L.; Fuchs, Charles S.; Ogino, Shuji			Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample	PLOS ONE			English	Article								Background: The CpG island methylator phenotype (CIMP) is a distinct phenotype associated with microsatellite instability (MSI) and BRAF mutation in colon cancer. Recent investigations have selected 5 promoters (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1) as surrogate markers for CIMP-high. However, no study has comprehensively evaluated an expanded set of methylation markers (including these 5 markers) using a large number of tumors, or deciphered the complex clinical and molecular associations with CIMP-high determined by the validated marker panel. Metholodology/Principal Findings: DNA methylation at 16 CpG islands [the above 5 plus CDKN2A (p16), CHFR, CRABP1, HIC1, IGFBP3, MGMT, MINT1, MINT31, MLH1, p14 (CDKN2A/ARF) and WRN] was quantified in 904 colorectal cancers by real-time PCR (MethyLight). In unsupervised hierarchical clustering analysis, the 5 markers (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1), CDKN2A, CRABP1, MINT31, MLH1, p14 and WRN were generally clustered with each other and with MSI and BRAF mutation. KRAS mutation was not clustered with any methylation marker, suggesting its association with a random methylation pattern in CIMP-low tumors. Utilizing the validated CIMP marker panel ( including the 5 markers), multivariate logistic regression demonstrated that CIMP-high was independently associated with older age, proximal location, poor differentiation, MSI-high, BRAF mutation, and inversely with LINE-1 hypomethylation and beta-catenin (CTNNB1) activation. Mucinous feature, signet ring cells, and p53-negativity were associated with CIMP-high in only univariate analysis. In stratified analyses, the relations of CIMP-high with poor differentiation, KRAS mutation and LINE-1 hypomethylation significantly differed according to MSI status. Conclusions: Our study provides valuable data for standardization of the use of CIMP-high-specific methylation markers. CIMP-high is independently associated with clinical and key molecular features in colorectal cancer. Our data also suggest that KRAS mutation is related with a random CpG island methylation pattern which may lead to CIMP-low tumors.	[Nosho, Katsuhiko; Irahara, Natsumi; Shima, Kaori; Kure, Shoko; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kirkner, Gregory J.; Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Spiegelman, Donna; Giovannucci, Edward L.; Fuchs, Charles S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Schernhammer, Eva S.] Applied Canc Res Inst Translat Res, Ludwig Boltzmann Inst Applied Canc Res, Vienna, Austria; [Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Spiegelman, Donna; Giovannucci, Edward L.; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Quackenbush, John] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat, Boston, MA USA; [Quackenbush, John; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ludwig Boltzmann Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nosho, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	shuji_ogino@dfci.harvard.edu		Schernhammer, Eva/0000-0002-4337-9415; Quackenbush, John/0000-0002-2702-5879; Ogino, Shuji/0000-0002-3909-2323	U.S. National Institute of Health (NIH) [P01 CA87969, P01 CA55075, P50 CA127003, K07 CA122826]; Bennett Family Fund; Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA); Japanese Society for Promotion of Science; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, P50CA127003, K07CA122826] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institute of Health (NIH) grants P01 CA87969, P01 CA55075, P50 CA127003 and K07 CA122826 (to S.O.), and in part by grants from the Bennett Family Fund and from the Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA). K.N. was supported by a fellowship grant from the Japanese Society for Promotion of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000964; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Grady WM, 2007, GUT, V56, P1498, DOI 10.1136/gut.2007.125732; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kawasaki T, 2008, MODERN PATHOL, V21, P245, DOI 10.1038/modpathol.3800982; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Muleris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001632; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2007, MODERN PATHOL, V20, P15, DOI 10.1038/modpathol.3800709; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Suehiro Y, 2008, CLIN CANCER RES, V14, P2560, DOI 10.1158/1078-0432.CCR-07-1802; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2002, CANCER RES, V62, P6011; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	50	247	249	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3698	10.1371/journal.pone.0003698	http://dx.doi.org/10.1371/journal.pone.0003698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002263	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166000004
J	Desgorces, FD; Berthelot, G; El Helou, N; Thibault, V; Guillaume, M; Tafflet, M; Hermine, O; Toussaint, JF				Desgorces, Francois-Denis; Berthelot, Geoffroy; El Helou, Nour; Thibault, Valerie; Guillaume, Marion; Tafflet, Muriel; Hermine, Olivier; Toussaint, Jean-Francois			From Oxford to Hawaii Ecophysiological Barriers Limit Human Progression in Ten Sport Monuments	PLOS ONE			English	Article							PHYSIOLOGY	In order to understand the determinants and trends of human performance evolution, we analyzed ten outdoor events among the oldest and most popular in sports history. Best performances of the Oxford-Cambridge boat race (since 1836), the channel crossing in swimming (1875), the hour cycling record (1893), the Elfstedentocht speed skating race (1909), the cross country ski Vasaloppet (1922), the speed ski record (1930), the Streif down-hill in Kitzbuhel (1947), the eastward and westward sailing transatlantic records (1960) and the triathlon Hawaii ironman (1978) all follow a similar evolutive pattern, best described through a piecewise exponential decaying model (r(2) = 0.95 +/- 0.07). The oldest events present highest progression curvature during their early phase. Performance asymptotic limits predicted from the model may be achieved in fourty years (2049 +/- 32 y). Prolonged progression may be anticipated in disciplines which further rely on technology such as sailing and cycling. Human progression in outdoor sports tends to asymptotic limits depending on physiological and environmental parameters and may temporarily benefit from further technological progresses.	[Desgorces, Francois-Denis; Berthelot, Geoffroy; El Helou, Nour; Thibault, Valerie; Guillaume, Marion; Hermine, Olivier; Toussaint, Jean-Francois] INSEP, Inst Rech Med & Epidemiol Sport, IRMES, Paris, France; [Desgorces, Francois-Denis; Hermine, Olivier; Toussaint, Jean-Francois] Univ Paris 05, Paris, France; [Tafflet, Muriel] Univ Paris Sud, IFR 69, Villejuif, France; [Hermine, Olivier] CNRS, UMR 8147, Serv Hematol Hop Necker, Paris, France; [Toussaint, Jean-Francois] AP HP, Hotel Dieu, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP	Desgorces, FD (corresponding author), INSEP, Inst Rech Med & Epidemiol Sport, IRMES, Paris, France.	Francois.Desgorces@univ-paris5.fr	Hermine, Olivier/Q-7072-2018; Helou, Nour El/AAH-6490-2021	Helou, Nour El/0000-0002-6012-0042; Hermine, Olivier/0000-0003-2574-3874; Berthelot, Geoffroy/0000-0003-4036-6114				Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; de Koning JJ, 2000, J BIOMECH, V33, P1225, DOI 10.1016/S0021-9290(00)00063-4; EISENMAN PA, 1989, SPORTS MED, V8, P67, DOI 10.2165/00007256-198908020-00001; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; FOGEL R, 2003, ESCAPE PREMATURE DEA; Kayser Bengt, 2007, BMC Med Ethics, V8, P2, DOI 10.1186/1472-6939-8-2; LEN S, 2008, BEIJING HUM IN PRESS; Lucia A, 2001, SPORTS MED, V31, P325, DOI 10.2165/00007256-200131050-00004; Mosegaard K, 2002, INVERSE PROBL, V18, pR29, DOI 10.1088/0266-5611/18/3/201; Nevill AM, 2005, MED SCI SPORT EXER, V37, P1785, DOI 10.1249/01.mss.0000181676.62054.79; RUSKO HK, 1992, MED SCI SPORT EXER, V24, P1040; Smith DJ, 2003, SPORTS MED, V33, P1103, DOI 10.2165/00007256-200333150-00003; VANINGEN S, 1994, SPORTS MED, V17, P259	13	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3653	10.1371/journal.pone.0003653	http://dx.doi.org/10.1371/journal.pone.0003653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985149	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134400013
J	Lee, J; Han, K; Meyer, TJ; Kim, HS; Batzer, MA				Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Kim, Heui-Soo; Batzer, Mark A.			Chromosomal Inversions between Human and Chimpanzee Lineages Caused by Retrotransposons	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SEGMENTAL DUPLICATIONS; PERICENTRIC INVERSIONS; STRUCTURAL VARIATION; DNA-SEQUENCES; HUMAN GENOME; RECOMBINATION; EVOLUTION; DELETION; AMPLIFICATION	The long interspersed element-1 (LINE-1 or L1) and Alu elements are the most abundant mobile elements comprising 21% and 11% of the human genome, respectively. Since the divergence of human and chimpanzee lineages, these elements have vigorously created chromosomal rearrangements causing genomic difference between humans and chimpanzees by either increasing or decreasing the size of genome. Here, we report an exotic mechanism, retrotransposon recombination-mediated inversion (RRMI), that usually does not alter the amount of genomic material present. Through the comparison of the human and chimpanzee draft genome sequences, we identified 252 inversions whose respective inversion junctions can clearly be characterized. Our results suggest that L1 and Alu elements cause chromosomal inversions by either forming a secondary structure or providing a fragile site for double-strand breaks. The detailed analysis of the inversion breakpoints showed that L1 and Alu elements are responsible for at least 44% of the 252 inversion loci between human and chimpanzee lineages, including 49 RRMI loci. Among them, three RRMI loci inverted exonic regions in known genes, which implicates this mechanism in generating the genomic and phenotypic differences between human and chimpanzee lineages. This study is the first comprehensive analysis of mobile element bases inversion breakpoints between human and chimpanzee lineages, and highlights their role in primate genome evolution.	[Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Batzer, Mark A.] Louisiana State Univ, Biol Comput & Visual Ctr, Baton Rouge, LA 70803 USA; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Interdisciplin Res Program Bioinformat, PBBRC, Busan, South Korea; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Div Biol Sci, Busan, South Korea	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pusan National University; Pusan National University	Lee, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Han, Kyudong/AAF-1788-2019; Kim, Heui-Soo/ABF-3773-2021	Han, Kyudong/0000-0001-6791-2408; Kim, Heui-Soo/0000-0002-5226-6594	National Science Foundation [BCS-0218338]; National Institutes of Health [RO1 GM59290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant BCS-0218338 (M.A.B.), and National Institutes of Health RO1 GM59290 (M.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BATZER MA, 1991, NUCLEIC ACIDS RES, V19, P5081, DOI 10.1093/nar/19.18.5081; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Casals F, 2007, HEREDITY, V99, P479, DOI 10.1038/sj.hdy.6801046; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cordaux R, 2006, GENE, V373, P138, DOI 10.1016/j.gene.2006.01.020; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dennis A. P., 2004, MOL ENDOCRINOL, V18, P493; FANNING T, 1987, NUCLEIC ACIDS RES, V15, P2251, DOI 10.1093/nar/15.5.2251; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gebow D, 2000, MOL CELL BIOL, V20, P4028, DOI 10.1128/MCB.20.11.4028-4035.2000; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Goidts V, 2005, GENOME RES, V15, P1232, DOI 10.1101/gr.3732505; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Jaarola M, 1998, AM J HUM GENET, V63, P218, DOI 10.1086/301900; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI L, 1993, AM J HUM GENET, V53, P140; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lovsin N, 2001, MOL BIOL EVOL, V18, P2213, DOI 10.1093/oxfordjournals.molbev.a003768; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Nag DK, 1997, GENETICS, V146, P835; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Payseur BA, 2002, MOL BIOL EVOL, V19, P336, DOI 10.1093/oxfordjournals.molbev.a004086; Rieseberg LH, 2003, SCIENCE, V300, P267, DOI 10.1126/science.1084192; Schmidt S, 2005, HUM GENET, V117, P213, DOI 10.1007/s00439-005-1294-z; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; SHEN MR, 1991, J MOL EVOL, V33, P311; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Szamalek JM, 2005, HUM GENET, V117, P168, DOI 10.1007/s00439-005-1287-y; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weiner AM, 2000, NAT GENET, V24, P332, DOI 10.1038/74135; Wessler SR, 2006, IMPLICIT GENOME, P138; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; ZHENG GX, 1988, J BIOL CHEM, V263, P5356	58	58	59	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4047	10.1371/journal.pone.0004047	http://dx.doi.org/10.1371/journal.pone.0004047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112500	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466000011
J	Agrawal, N; Banerjee, R				Agrawal, Nitish; Banerjee, Ruma			Human Polycomb 2 Protein Is a SUMO E3 Ligase and Alleviates Substrate-Induced Inhibition of Cystathionine beta-Synthase Sumoylation	PLOS ONE			English	Article							REDOX REGULATION; PROLIFERATION; GLUTATHIONE; REPRESSION; MECHANISM; MUTATION; TARGET; DOMAIN; HEME; H2S	Human cystathionine beta-synthase (CBS) catalyzes the first irreversible step in the transsulfuration pathway and commits homocysteine to the synthesis of cysteine. Mutations in CBS are the most common cause of severe hereditary hyperhomocysteinemia. A yeast two-hybrid approach to screen for proteins that interact with CBS had previously identified several components of the sumoylation pathway and resulted in the demonstration that CBS is a substrate for sumoylation. In this study, we demonstrate that sumoylation of CBS is enhanced in the presence of human polycomb group protein 2 (hPc2), an interacting partner that was identified in the initial yeast two-hybrid screen. When the substrates for CBS, homocysteine and serine for cystathionine generation and homocysteine and cysteine for H2S generation, are added to the sumoylation mixture, they inhibit the sumoylation reaction, but only in the absence of hPc2. Similarly, the product of the CBS reaction, cystathionine, inhibits sumoylation in the absence of hPc2. Sumoylation in turn decreases CBS activity by similar to 28% in the absence of hPc2 and by 70% in its presence. Based on these results, we conclude that hPc2 serves as a SUMO E3 ligase for CBS, increasing the efficiency of sumoylation. We also demonstrate that gamma-cystathionase, the second enzyme in the transsulfuration pathway is a substrate for sumoylation under in vitro conditions. We speculate that the role of this modification may be for nuclear localization of the cysteine-generating pathway under conditions where nuclear glutathione demand is high.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Agrawal, N (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	AGRAWAL, NITISH/H-6186-2011; AGRAWAL, NITISH/E-3468-2013	AGRAWAL, NITISH/0000-0003-0823-7355; 	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Cmarko D, 2003, J CELL SCI, V116, P335, DOI 10.1242/jcs.00225; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Ho Y.F., 1994, TOXICOLOGIST, V14, P178; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kraus JP, 1999, HUM MUTAT, V13, P362; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	41	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4032	10.1371/journal.pone.0004032	http://dx.doi.org/10.1371/journal.pone.0004032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107218	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000024
J	Miller, MW; Swanson, HM; Wolfe, LL; Quartarone, FG; Huwer, SL; Southwick, CH; Lukacs, PM				Miller, Michael W.; Swanson, Heather M.; Wolfe, Lisa L.; Quartarone, Fred G.; Huwer, Sherri L.; Southwick, Charles H.; Lukacs, Paul M.			Lions and Prions and Deer Demise	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; RANGING MULE DEER; PREDATION; PREVALENCE; COLORADO; EPIDEMIOLOGY; TRANSMISSION; INFECTION; DYNAMICS	Background: Contagious prion diseases - scrapie of sheep and chronic wasting disease of several species in the deer family - give rise to epidemics that seem capable of compromising host population viability. Despite this prospect, the ecological consequences of prion disease epidemics in natural populations have received little consideration. Methodology/Principal Findings: Using a cohort study design, we found that prion infection dramatically lowered survival of free-ranging adult (>2-year-old) mule deer (Odocoileus hemionus): estimated average life expectancy was 5.2 additional years for uninfected deer but only 1.6 additional years for infected deer. Prion infection also increased nearly fourfold the rate of mountain lions (Puma concolor) preying on deer, suggesting that epidemics may alter predator-prey dynamics by facilitating hunting success. Despite selective predation, about one fourth of the adult deer we sampled were infected. High prevalence and low survival of infected deer provided a plausible explanation for the marked decline in this deer population since the 1980s. Conclusion: Remarkably high infection rates sustained in the face of intense predation show that even seemingly complete ecosystems may offer little resistance to the spread and persistence of contagious prion diseases. Moreover, the depression of infected populations may lead to local imbalances in food webs and nutrient cycling in ecosystems in which deer are important herbivores.	[Miller, Michael W.; Wolfe, Lisa L.; Quartarone, Fred G.; Huwer, Sherri L.; Lukacs, Paul M.] Wildlife Res Ctr, Colorado Div Wildlife, Ft Collins, CO USA; [Swanson, Heather M.] City Boulder Open Space & Mt Parks, Boulder, CO USA; [Southwick, Charles H.] Univ Colorado, Dept Ecol & Evolut Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Miller, MW (corresponding author), Wildlife Res Ctr, Colorado Div Wildlife, Ft Collins, CO USA.	mike.miller@state.co.us			Colorado Division of Wildlife; City of Boulder; US Department of Agriculture; Animal&Plant Health Inspection Service, Veterinary Services	Colorado Division of Wildlife; City of Boulder; US Department of Agriculture(United States Department of Agriculture (USDA)); Animal&Plant Health Inspection Service, Veterinary Services	Our funding came from the Colorado Division of Wildlife, the City of Boulder, and the US Department of Agriculture, Animal&Plant Health Inspection Service, Veterinary Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWDEN DC, 1995, J WILDLIFE MANAGE, V59, P840, DOI 10.2307/3801965; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Duffy MA, 2007, OECOLOGIA, V153, P453, DOI 10.1007/s00442-007-0742-y; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hornlimann B, 2007, PRIONS IN HUMANS AND ANIMALS, P1, DOI 10.1515/9783110200171; HOSMER DW, 2000, WILEY PS TX, P1; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson PTJ, 2006, ECOLOGY, V87, P1973, DOI 10.1890/0012-9658(2006)87[1973:DODHIB]2.0.CO;2; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; MCCLINTOCK BT, 2008, BIOMETRICS IN PRESS; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2002, VET REC, V151, P610, DOI 10.1136/vr.151.20.610; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe LL, 2004, WILDLIFE SOC B, V32, P500, DOI 10.2193/0091-7648(2004)32[500:FOTFMC]2.0.CO;2; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124	28	89	91	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4019	10.1371/journal.pone.0004019	http://dx.doi.org/10.1371/journal.pone.0004019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107193	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000014
J	Beaufays, J; Adam, B; Decrem, Y; Prevot, PP; Santini, S; Brasseur, R; Brossard, M; Lins, L; Vanhamme, L; Godfroid, E				Beaufays, Jerome; Adam, Benoit; Decrem, Yves; Prevot, Pierre-Paul; Santini, Sebastien; Brasseur, Robert; Brossard, Michel; Lins, Laurence; Vanhamme, Luc; Godfroid, Edmond			Ixodes ricinus Tick Lipocalins: Identification, Cloning, Phylogenetic Analysis and Biochemical Characterization	PLOS ONE			English	Article							SOFT TICK; BINDING PROTEINS; FAMILY; INHIBITOR; MECHANISM; EVOLUTION; MOUBATIN; CLADE; SHARE	Background: During their blood meal, ticks secrete a wide variety of proteins that interfere with their host's defense mechanisms. Among these proteins, lipocalins play a major role in the modulation of the inflammatory response. Methodology/Principal Findings: Screening a cDNA library in association with RT-PCR and RACE methodologies allowed us to identify 14 new lipocalin genes in the salivary glands of the Ixodes ricinus hard tick. A computational in-depth structural analysis confirmed that LIRs belong to the lipocalin family. These proteins were called LIR for ``Lipocalin from I. ricinus'' and numbered from 1 to 14 (LIR1 to LIR14). According to their percentage identity/similarity, LIR proteins may be assigned to 6 distinct phylogenetic groups. The mature proteins have calculated pM and pI varying from 21.8 kDa to 37.2 kDa and from 4.45 to 9.57 respectively. In a western blot analysis, all recombinant LIRs appeared as a series of thin bands at 50-70 kDa, suggesting extensive glycosylation, which was experimentally confirmed by treatment with N-glycosidase F. In addition, the in vivo expression analysis of LIRs in I. ricinus, examined by RT-PCR, showed homogeneous expression profiles for certain phylogenetic groups and relatively heterogeneous profiles for other groups. Finally, we demonstrated that LIR6 codes for a protein that specifically binds leukotriene B4. Conclusions/Significance: This work confirms that, regarding their biochemical properties, expression profile, and sequence signature, lipocalins in Ixodes hard tick genus, and more specifically in the Ixodes ricinus species, are segregated into distinct phylogenetic groups suggesting potential distinct function. This was particularly demonstrated by the ability of LIR6 to scavenge leukotriene B4. The other LIRs did not bind any of the ligands tested, such as 5-hydroxytryptamine, ADP, norepinephrine, platelet activating factor, prostaglandins D2 and E2, and finally leukotrienes B4 and C4.	[Beaufays, Jerome; Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium; [Adam, Benoit; Santini, Sebastien; Brasseur, Robert; Lins, Laurence] Gembloux Agr Univ, Ctr Biophys Mol Numer, Gembloux, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, CH-2000 Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, IBMM, Lab Mol Parasitol, B-1050 Gosselies, Belgium	Universite Libre de Bruxelles; University of Liege; University of Neuchatel; Universite Libre de Bruxelles	Beaufays, J (corresponding author), Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be	LINS, LAURENCE/Y-1661-2019	LINS, LAURENCE/0000-0001-7772-6748; Santini, Sebastien/0000-0001-7087-1950	Belgian National Fund for Scientific Research [Senior Research Associate]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Adam B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-1; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KELLER PM, 1993, J BIOL CHEM, V268, P5450; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leboulle G, 2002, AM J TROP MED HYG, V66, P225, DOI 10.4269/ajtmh.2002.66.225; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2003, MOL BIOL EVOL, V20, P1158, DOI 10.1093/molbev/msg126; Mans BJ, 2002, TOXICON, V40, P1007, DOI 10.1016/S0041-0101(02)00098-3; Mans BJ, 2001, ELECTROPHORESIS, V22, P1739, DOI 10.1002/1522-2683(200105)22:9&lt;1739::AID-ELPS1739&gt;3.0.CO;2-7; MANS BJ, INSECT BIOCH MOL BIO, V34, P1; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WARLOW RS, 1987, MOL IMMUNOL, V24, P27, DOI 10.1016/0161-5890(87)90108-8	29	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3941	10.1371/journal.pone.0003941	http://dx.doi.org/10.1371/journal.pone.0003941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096708	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458800001
J	Dotson, CD; Zhang, L; Xu, H; Shin, YK; Vigues, S; Ott, SH; Elson, AET; Choi, HJ; Shaw, H; Egan, JM; Mitchell, BD; Li, XD; Steinle, NI; Munger, SD				Dotson, Cedrick D.; Zhang, Lan; Xu, Hong; Shin, Yu-Kyong; Vigues, Stephan; Ott, Sandra H.; Elson, Amanda E. T.; Choi, Hyun Jin; Shaw, Hillary; Egan, Josephine M.; Mitchell, Braxton D.; Li, Xiaodong; Steinle, Nanette I.; Munger, Steven D.			Bitter Taste Receptors Influence Glucose Homeostasis	PLOS ONE			English	Article								TAS1R- and TAS2R-type taste receptors are expressed in the gustatory system, where they detect sweet- and bitter-tasting stimuli, respectively. These receptors are also expressed in subsets of cells within the mammalian gastrointestinal tract, where they mediate nutrient assimilation and endocrine responses. For example, sweeteners stimulate taste receptors on the surface of gut enteroendocrine L cells to elicit an increase in intracellular Ca2+ and secretion of the incretin hormone glucagon-like peptide-1 (GLP-1), an important modulator of insulin biosynthesis and secretion. Because of the importance of taste receptors in the regulation of food intake and the alimentary responses to chemostimuli, we hypothesized that differences in taste receptor efficacy may impact glucose homeostasis. To address this issue, we initiated a candidate gene study within the Amish Family Diabetes Study and assessed the association of taste receptor variants with indicators of glucose dysregulation, including a diagnosis of type 2 diabetes mellitus and high levels of blood glucose and insulin during an oral glucose tolerance test. We report that a TAS2R haplotype is associated with altered glucose and insulin homeostasis. We also found that one SNP within this haplotype disrupts normal responses of a single receptor, TAS2R9, to its cognate ligands ofloxacin, procainamide and pirenzapine. Together, these findings suggest that a functionally compromised TAS2R receptor negatively impacts glucose homeostasis, providing an important link between alimentary chemosensation and metabolic disease.	[Dotson, Cedrick D.; Vigues, Stephan; Elson, Amanda E. T.; Choi, Hyun Jin; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Zhang, Lan; Xu, Hong; Li, Xiaodong] Senomyx Inc, San Diego, CA USA; [Shin, Yu-Kyong; Egan, Josephine M.] NIA, NIH, Baltimore, MD USA; [Ott, Sandra H.; Shaw, Hillary; Mitchell, Braxton D.; Steinle, Nanette I.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore	Dotson, CD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	smung001@umaryland.edu	vigues, stephan/AAG-3390-2020; Mitchell, Braxton/CAF-0876-2022	Elson, Amanda/0000-0002-5744-5954; Dotson, Cedrick/0000-0003-0992-1191; Mitchell, Braxton/0000-0003-4920-4744	NIDCD [DC005786, DC007317]; NHLBI [HL076768]; University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland [DK072488]; Intramural Research Program of the NIH/National Institute on Aging; NIDCR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007317, R01DC005786] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland; Intramural Research Program of the NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the NIDCD (DC005786 to S.D.M.; DC007317 to S.V.), NHLBI (HL076768 to N.I.S.), the University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland (DK072488), and the Intramural Research Program of the NIH/National Institute on Aging (Y.-K.S. and J.M.E.). C.D.D. was supported by NIDCD and NIDCR training grants. L.Z., H.X. and X.L. are employees of Senomyx, Inc. The funders had no role in decision to publish or preparation of the manuscript. With the exception of studies performed at, and funded by, Senomyx, Inc., the funders had no role in the study design, data collection or analysis. For experiments performed at and funded by Senomyx, Inc. (these are restricted to the receptor deorphaning experiments reported in Figure 2), study design, data collection and analysis was performed according to good scientific practices. Analysis and interpretation of these (Figure 2) experiments were also performed by authors CDD and SDM (University of Maryland School of Medicine).	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Assadi-Porter FM, 2008, J AM CHEM SOC, V130, P7212, DOI 10.1021/ja8016939; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Breslin PAS, 2008, CURR BIOL, V18, pR148, DOI 10.1016/j.cub.2007.12.017; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Hansen JL, 2006, CHEM SENSES, V31, P403, DOI 10.1093/chemse/bjj044; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mattes R. D., 2003, Handbook of olfaction and gustation, P881; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Reed DR, 2004, J NEUROSCI, V24, P938, DOI 10.1523/JNEUROSCI.1374-03.2004; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandell MA, 2006, CURR BIOL, V16, pR792, DOI 10.1016/j.cub.2006.08.049; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sclafani A, 2006, PHYSIOL BEHAV, V89, P525, DOI 10.1016/j.physbeh.2006.03.021; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinle NI, 2002, AM J CLIN NUTR, V75, P1098, DOI 10.1093/ajcn/75.6.1098; Sugita M, 2006, CELL MOL LIFE SCI, V63, P2000, DOI 10.1007/s00018-006-6100-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueda T, 2003, J NEUROSCI, V23, P7376; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wooding S, 2006, GENETICS, V172, P2015; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	63	181	187	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3974	10.1371/journal.pone.0003974	http://dx.doi.org/10.1371/journal.pone.0003974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092995	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458600009
J	Horne, AW; Phillips, JA; Kane, N; Lourenco, PC; McDonald, SE; Williams, ARW; Simon, C; Dey, SK; Critchley, HOD				Horne, Andrew W.; Phillips, John A., III; Kane, Nicole; Lourenco, Paula C.; McDonald, Sarah E.; Williams, Alistair R. W.; Simon, Carlos; Dey, Sudhansu K.; Critchley, Hilary O. D.			CB1 Expression Is Attenuated in Fallopian Tube and Decidua of Women with Ectopic Pregnancy	PLOS ONE			English	Article							CANNABINOID RECEPTOR; GENE; CNR1; IMPLANTATION; NICOTINE; OVIDUCT; SYSTEM; SPERM; BRAIN	Background: Embryo retention in the Fallopian tube (FT) is thought to lead to ectopic pregnancy (EP), a considerable cause of morbidity. In mice, genetic/pharmacological silencing of cannabinoid receptor Cnr1, encoding CB1, causes retention of embryos in the oviduct. The role of the endocannabinoids in tubal implantation in humans is not known. Methods and Findings: Timed FT biopsies (n = 18) were collected from women undergoing gynecological procedures for benign conditions. Endometrial biopsies and whole blood were collected from women undergoing surgery for EP (n = 11); management of miscarriage (n = 6), and termination of pregnancy (n = 8). Using RT-PCR and immunohistochemistry, CB1 mRNA and protein expression levels/patterns were examined in FT and endometrial biopsies. The distribution of two polymorphisms of CNR1 was examined by TaqMan analysis of genomic DNA from the whole blood samples. In normal FT, CB1 mRNA was higher in luteal compared to follicular-phase (p<0.05). CB1 protein was located in smooth muscle of the wall and of endothelial vessels, and luminal epithelium of FT. In FT from women with EP, CB1 mRNA expression was low. CB1 mRNA expression was also significantly lower (p<0.05) in endometrium of women with EP compared to intrauterine pregnancies (IUP). Although of 1359G/A (rs1049353) polymorphisms of CNR1 gene suggests differential distribution of genotypes between the small, available cohorts of women with EP and those with IUP, results were not statistically significant. Conclusions: CB1 mRNA shows temporal variation in expression in human FT, likely regulated by progesterone. CB1 mRNA is expressed in low levels in both the FT and endometrium of women with EP. We propose that aberrant endocannabinoid-signaling in human FT leads to EP. Furthermore, our finding of reduced mRNA expression along with a possible association between polymorphism genotypes of the CNR1 gene and EP, suggests a possible genetic predisposition to EP that warrants replication in a larger sample pool.	[Horne, Andrew W.; Kane, Nicole; Lourenco, Paula C.; McDonald, Sarah E.; Critchley, Hilary O. D.] Univ Edinburgh, Ctr Reprod Biol, Dept Reprod & Dev Sci, Queens Med Res Inst, Edinburgh EH3 9EW, Midlothian, Scotland; [Phillips, John A., III] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA; [Williams, Alistair R. W.] Univ Edinburgh, Roy Infirmary Edinburgh, Dept Pathol, Edinburgh EH8 9YL, Midlothian, Scotland; [Simon, Carlos] Univ Valencia, Inst Univ IVI, FIVI, E-46003 Valencia, Spain; [Dey, Sudhansu K.] Cincinnati Childrens Res Fdn, Div Reprod Sci, Cincinnati, OH USA	University of Edinburgh; Vanderbilt University; University of Edinburgh; University of Valencia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Horne, AW (corresponding author), Univ Edinburgh, Ctr Reprod Biol, Dept Reprod & Dev Sci, Queens Med Res Inst, Edinburgh EH3 9EW, Midlothian, Scotland.	hilary.critchley@ed.ac.uk	Simon, Carlos/G-2186-2014	Simon, Carlos/0000-0003-0902-9531; Horne, Andrew/0000-0002-9656-493X; CRITCHLEY, HILARY/0000-0003-1913-4044; McDonald, Sarah/0000-0003-2776-7415	Tenovus Scotland [E06/7]; The Barbour Watson Trust; NHS Lothian Research and Development [SPG2006/7]; NIDA/NIH [DA06668]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006668, R37DA006668] Funding Source: NIH RePORTER	Tenovus Scotland; The Barbour Watson Trust; NHS Lothian Research and Development; NIDA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Tenovus Scotland (E06/7) (AWH), The Barbour Watson Trust (AWH and HODC), and NHS Lothian Research and Development (SPG2006/7) (AWH) and an NIDA/NIH grant (DA06668) (SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BLOCH E, 1978, VITAM HORM, V36, P203; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; CHANG MC, 1993, MOL REPROD DEV, V36, P507, DOI 10.1002/mrd.1080360416; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Hamdani N, 2008, EUR NEUROPSYCHOPHARM, V18, P34, DOI 10.1016/j.euroneuro.2007.05.005; HEILMAN RD, 1976, FERTIL STERIL, V27, P426; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; HOWE GR, 1973, J REPROD FERTIL, V33, P425; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Maccarrone M, 2000, EUR J BIOCHEM, V267, P2991; Mukul LV, 2007, OBSTET GYN CLIN N AM, V34, P403, DOI 10.1016/j.ogc.2007.07.001; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; SAMUELSON UE, 1986, ACTA PHYSIOL SCAND, V126, P355, DOI 10.1111/j.1748-1716.1986.tb07827.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCHUEL H, 1994, P NATL ACAD SCI USA, V91, P7678, DOI 10.1073/pnas.91.16.7678; SMITH CG, 1987, FERTIL STERIL, V48, P355; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; WILHELMSSON L, 1980, FERTIL STERIL, V33, P280; YOSHINAGA K, 1979, BIOL REPROD, V20, P294, DOI 10.1095/biolreprod20.2.294; 2003, SAVING MOTHERS LIVES	30	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3969	10.1371/journal.pone.0003969	http://dx.doi.org/10.1371/journal.pone.0003969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093002	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458600006
J	Throsby, M; van den Brink, E; Jongeneelen, M; Poon, LLM; Alard, P; Cornelissen, L; Bakker, A; Cox, F; van Deventer, E; Guan, Y; Cinatl, J; ter Meulen, J; Lasters, I; Carsetti, R; Peiris, M; de Kruif, J; Goudsmit, J				Throsby, Mark; van den Brink, Edward; Jongeneelen, Mandy; Poon, Leo L. M.; Alard, Philippe; Cornelissen, Lisette; Bakker, Arjen; Cox, Freek; van Deventer, Els; Guan, Yi; Cinatl, Jindrich; ter Meulen, Jan; Lasters, Ignace; Carsetti, Rita; Peiris, Malik; de Kruif, John; Goudsmit, Jaap			Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells	PLOS ONE			English	Article								Background: The hemagglutinin (HA) glycoprotein is the principal target of protective humoral immune responses to influenza virus infections but such antibody responses only provide efficient protection against a narrow spectrum of HA antigenic variants within a given virus subtype. Avian influenza viruses such as H5N1 are currently panzootic and pose a pandemic threat. These viruses are antigenically diverse and protective strategies need to cross protect against diverse viral clades. Furthermore, there are 16 different HA subtypes and no certainty the next pandemic will be caused by an H5 subtype, thus it is important to develop prophylactic and therapeutic interventions that provide heterosubtypic protection. Methods and Findings: Here we describe a panel of 13 monoclonal antibodies (mAbs) recovered from combinatorial display libraries that were constructed from human IgM(+) memory B cells of recent (seasonal) influenza vaccinees. The mAbs have broad heterosubtypic neutralizing activity against antigenically diverse H1, H2, H5, H6, H8 and H9 influenza subtypes. Restriction to variable heavy chain gene IGHV1-69 in the high affinity mAb panel was associated with binding to a conserved hydrophobic pocket in the stem domain of HA. The most potent antibody (CR6261) was protective in mice when given before and after lethal H5N1 or H1N1 challenge. Conclusions: The human monoclonal CR6261 described in this study could be developed for use as a broad spectrum agent for prophylaxis or treatment of human or avian influenza infections without prior strain characterization. Moreover, the CR6261 epitope could be applied in targeted vaccine strategies or in the design of novel antivirals. Finally our approach of screening the IgM+ memory repertoire could be applied to identify conserved and functionally relevant targets on other rapidly evolving pathogens.	[Throsby, Mark; van den Brink, Edward; Jongeneelen, Mandy; Bakker, Arjen; Cox, Freek; van Deventer, Els; ter Meulen, Jan; de Kruif, John; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Poon, Leo L. M.; Guan, Yi; Peiris, Malik] Univ Hong Kong, Queen Mary Hosp, Hong Kong Special Admin Region, Dept Microbiol, Hong Kong, Peoples R China; [Alard, Philippe; Lasters, Ignace] Algonom NV, Ghent, Belgium; [Cornelissen, Lisette] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [Cinatl, Jindrich] Goethe Univ Frankfurt, Inst Med Virol, D-6000 Frankfurt, Germany; [Carsetti, Rita] Bambino Gesu Childrens Res Hosp, Lab Cell Biol, Rome, Italy	Johnson & Johnson; University of Hong Kong; Wageningen University & Research; Goethe University Frankfurt; IRCCS Bambino Gesu	Throsby, M (corresponding author), Merus BV, Utrecht, Netherlands.	j.goudsmit@crucell.com	Carsetti, Rita/K-7616-2016; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Carsetti, Rita/0000-0002-2632-1078; Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Guan, Yi/0000-0001-6057-9243	SenterNovem [IS055026]; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]	SenterNovem; Area of Excellence Scheme of the University Grants Committee, Hong Kong	This work was supported through grant IS055026 from SenterNovem. LLMP, YG and JSMP are supported by an Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Boel E, 2000, J IMMUNOL METHODS, V239, P153, DOI 10.1016/S0022-1759(00)00170-8; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CDC, 1997, MMWR-MORBID MORTAL W, V46, P1204; Chin PS, 2002, J VIROL, V76, P507, DOI 10.1128/JVI.76.2.507-516.2002; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kramer RA, 2005, EUR J IMMUNOL, V35, P2131, DOI 10.1002/eji.200526134; Kramer RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng058; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smirnov YA, 2000, ARCH VIROL, V145, P1733, DOI 10.1007/s007050070088; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; WANG ML, 1986, J VIROL, V57, P124, DOI 10.1128/JVI.57.1.124-128.1986; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; WHO, 2021, CUM NUMB CONF HUM CA; *WHO ECDC, 2008, FREQ ASK QUEST OS RE; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	49	582	690	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3942	10.1371/journal.pone.0003942	http://dx.doi.org/10.1371/journal.pone.0003942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079604	Green Published, gold			2022-12-27	WOS:000265458400003
J	Waldo, J; Scherrer, M				Waldo, Jennifer; Scherrer, Michael			Production and Initial Characterization of Dad1p, a Component of the Dam1-DASH Kinetochore Complex	PLOS ONE			English	Article							DASH COMPLEX; MICROTUBULE INTERFACE; DAM1 COMPLEX; RING; DEPOLYMERIZATION; ARCHITECTURE; ATTACHMENT	In all dividing eukaryotic cells, the mitotic spindle (composed primarily of microtubules) must interact with chromosomes through a complex protein assembly called the kinetochore. In Saccharomyces cerevisiae, the Dam1-DASH complex plays an important role in promoting attachment between the kinetochore and the mitotic spindle. It also actively participates in the physical separation of sister chromatids in anaphase. Understanding the biochemical mechanisms used by Dam1-DASH has been facilitated by bacterial co-expression of the ten Dam1-DASH genes, which results in the production of a heterodecameric protein complex that can be studied in vitro. However, individual protein subunits are not soluble when expressed in E. coli, thus precluding analysis of the nature of the interaction between subunits and an examination of the assembly of the functional complex. In this paper, we describe the expression, solubilization, purification and refolding of Dad1p, one of the Dam1-DASH complex subunits. In addition, we show that Dad1p, when isolated in this manner forms dimers and/or tetramers, dependent upon protein concentration. This work provides an important tool for studying the Dam1-DASH complex that was previously unavailable, and provides an avenue of investigation for understanding how the individual heterodecamers associate with each other to facilitate chromosome segregation.	[Scherrer, Michael] SUNY Coll New Paltz, Dept Biol, New Paltz, NY USA	State University of New York (SUNY) System; SUNY New Paltz	Waldo, J (corresponding author), SUNY Coll New Paltz, Dept Biol, New Paltz, NY USA.	waldoj@newpaltz.edu			SUNY New Paltz [Provost's Research Award]; SUNY New Paltz Summer Undergraduate Research Experience program	SUNY New Paltz; SUNY New Paltz Summer Undergraduate Research Experience program	This work was supported by the Provost's Research Award of SUNY New Paltz, and by the SUNY New Paltz Summer Undergraduate Research Experience program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Li J, 2005, MOL CELL BIOL, V25, P767, DOI 10.1128/MCB.25.2.767-778.2005; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Miranda JJL, 2007, MOL BIOL CELL, V18, P2503, DOI 10.1091/mbc.E07-02-0135; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3888	10.1371/journal.pone.0003888	http://dx.doi.org/10.1371/journal.pone.0003888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065263	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455200006
J	Van't Hof, AE; Marec, F; Saccheri, IJ; Brakefield, PM; Zwaan, BJ				Van't Hof, Arjen E.; Marec, Frantisek; Saccheri, Ilik J.; Brakefield, Paul M.; Zwaan, Bas J.			Cytogenetic Characterization and AFLP-Based Genetic Linkage Mapping for the Butterfly Bicyclus anynana, Covering All 28 Karyotyped Chromosomes	PLOS ONE			English	Article							EPHESTIA-KUEHNIELLA INSECTA; IN-SITU HYBRIDIZATION; BOMBYX-MORI; SEX-CHROMOSOME; W-CHROMOSOME; EVO-DEVO; MOLECULAR DIFFERENTIATION; CODLING MOTH; GENOME SIZE; MAP	Background: The chromosome characteristics of the butterfly Bicyclus anynana, have received little attention, despite the scientific importance of this species. This study presents the characterization of chromosomes in this species by means of cytogenetic analysis and linkage mapping. Methodology/Principal Findings: Physical genomic features in the butterfly B. anynana were examined by karyotype analysis and construction of a linkage map. Lepidoptera possess a female heterogametic W-Z sex chromosome system. The WZ-bivalent in pachytene oocytes of B. anynana consists of an abnormally small, heterochromatic W-chromosome with the Z-chromosome wrapped around it. Accordingly, the W-body in interphase nuclei is much smaller than usual in Lepidoptera. This suggests an intermediate stage in the process of secondary loss of the W-chromosome to a ZZ/Z sex determination system. Two nucleoli are present in the pachytene stage associated with an autosome and the WZ-bivalent respectively. Chromosome counts confirmed a haploid number of n = 28. Linkage mapping had to take account of absence of crossing-over in females, and of our use of a full-sib crossing design. We developed a new method to determine and exclude the non-recombinant uninformative female inherited component in offspring. The linkage map was constructed using a novel approach that uses exclusively JOINMAP-software for Lepidoptera linkage mapping. This approach simplifies the mapping procedure, avoids over-estimation of mapping distance and increases the reliability of relative marker positions. A total of 347 AFLP markers, 9 microsatellites and one single-copy nuclear gene covered all 28 chromosomes, with a mapping distance of 1354 cM. Conserved synteny of Tpi on the Z-chromosome in Lepidoptera was confirmed for B. anynana. The results are discussed in relation to other mapping studies in Lepidoptera. Conclusions/Significance: This study adds to the knowledge of chromosome structure and evolution of an intensively studied organism. On a broader scale it provides an insight in Lepidoptera sex chromosome evolution and it proposes a simpler and more reliable method of linkage mapping than used for Lepidoptera to date.	[Van't Hof, Arjen E.; Brakefield, Paul M.; Zwaan, Bas J.] Leiden Univ, Inst Biol, Dept Evolut Biol, NL-2300 RA Leiden, Netherlands; [Marec, Frantisek] Univ S Bohemia, Fac Biol Sci, Ceske Budejovice, Czech Republic; [Saccheri, Ilik J.] Univ S Bohemia, Inst Entomol, ASCR, Biol Ctr, Ceske Budejovice, Czech Republic; Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	Leiden University; Leiden University - Excl LUMC; Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Liverpool	Van't Hof, AE (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg, Liverpool L69 3BX, Merseyside, England.	b.j.zwaan@biology.leidenuniv.nl	Marec, Frantisek/G-7943-2014; Zwaan, Bas J/D-8721-2015; Van 't Hof, Arjen/AAE-8044-2022	Marec, Frantisek/0000-0002-6745-5603; Zwaan, Bas J/0000-0002-8221-4998; 	Grant Agency of the Czech Republic (Prague) [206/06/1860]; Entomology Institute [Z50070508]	Grant Agency of the Czech Republic (Prague)(Grant Agency of the Czech Republic); Entomology Institute	The financing of the cytogenetic experiments was covered by grant 206/06/1860 of the Grant Agency of the Czech Republic (Prague) and from the Entomology Institute project Z50070508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Beldade P, 2005, EVOL DEV, V7, P101, DOI 10.1111/j.1525-142X.2005.05011.x; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Blake T., 1999, J AGR GENOMICS, V4; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BROWN KS, 1992, HEREDITAS, V117, P109, DOI 10.1111/j.1601-5223.1992.tb00165.x; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; DELESSE H, 1968, ANN SOC ENTOMOL FR, V4, P581; DELESSE H, 1962, B IFAN, V24, P464; DELESSE H, 1965, B IFAN, V27, P1089; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Fukova I, 2007, CHROMOSOMA, V116, P135, DOI 10.1007/s00412-006-0086-0; Gawlowska M., 2005, Pisum Genetics, V37, P19; Gregory TR, 2003, CAN J ZOOL, V81, P1399, DOI 10.1139/Z03-126; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; HIRAI H, 1994, CHROMOSOMA, V103, P171, DOI 10.1007/s004120050021; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Kandul NR, 2007, EVOLUTION, V61, P546, DOI 10.1111/j.1558-5646.2007.00046.x; Kapan DD, 2006, GENETICS, V173, P735, DOI 10.1534/genetics.106.057166; KING M, 1990, GENETICA, V80, P17, DOI 10.1007/BF00120116; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; Marec F, 2001, HEREDITY, V87, P659, DOI 10.1046/j.1365-2540.2001.00958.x; MAREC F, 1994, GENOME, V37, P426, DOI 10.1139/g94-060; Mediouni J, 2004, CARYOLOGIA, V57, P184, DOI 10.1080/00087114.2004.10589391; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Muranty H, 1997, GENET RES, V70, P259, DOI 10.1017/S0016672397003030; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; PROMBOON A, 1995, GENET RES, V66, P1, DOI 10.1017/S0016672300034339; Prowell DP, 1998, ENDLESS FORMS, P309; REGIER JC, 2005, PROTOCOLS CONCEPTS R; Robinson R, 1971, LEPIDOPTERA GENETICS; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sewell MM, 1999, GENETICS, V151, P321; SHI JR, 1995, GENET RES, V66, P109, DOI 10.1017/S0016672300034467; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; SUOMALAINEN E, 1984, CHROMOSOMA, V90, P170, DOI 10.1007/BF00292393; Suomalainen E., 1969, CHROMOSOMES TODAY, V2, P132; Tan YD, 2001, GENETICS, V157, P1277; Tanaka N, 2000, HEREDITAS, V133, P95, DOI 10.1111/j.1601-5223.2000.t01-1-00095.x; Tobler A, 2005, HEREDITY, V94, P408, DOI 10.1038/sj.hdy.6800619; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; Traut W, 1996, Q REV BIOL, V71, P239, DOI 10.1086/419371; TRAUT W, 1986, GENETICA, V70, P69, DOI 10.1007/BF00123216; TRAUT W, 1976, CHROMOSOMA, V58, P275, DOI 10.1007/BF00292094; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Vitkova M, 2007, CHROMOSOME RES, V15, P917, DOI 10.1007/s10577-007-1173-7; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang BQ, 2004, GENETICS, V168, P215, DOI 10.1534/genetics.104.028118; WEITH A, 1986, CHROMOSOMA, V94, P125, DOI 10.1007/BF00286990; WHITE MJD, 1973, CHROMOSOMES; Wijngaarden PJ, 2000, HEREDITY, V85, P471, DOI 10.1046/j.1365-2540.2000.00786.x; Wolf KW, 1996, INT J INSECT MORPHOL, V25, P37, DOI 10.1016/0020-7322(95)00021-6; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Yasukochi Y, 1998, GENETICS, V150, P1513; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; Yoshido A, 2005, CHROMOSOMA, V114, P193, DOI 10.1007/s00412-005-0013-9; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Yoshido Atsuo, 2006, Journal of Insect Biotechnology and Sericology, V75, P147; Zijlstra WG, 2003, EVOLUTION, V57, P1852	69	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3882	10.1371/journal.pone.0003882	http://dx.doi.org/10.1371/journal.pone.0003882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060955	Green Published, gold			2022-12-27	WOS:000265455100005
J	Chua, KB; Voon, K; Crameri, G; Tan, HS; Rosli, J; McEachern, JA; Suluraju, S; Yu, M; Wang, LF				Chua, Kaw Bing; Voon, Kenny; Crameri, Gary; Tan, Hui Siu; Rosli, Juliana; McEachern, Jennifer A.; Suluraju, Sivagami; Yu, Meng; Wang, Lin-Fa			Identification and Characterization of a New Orthoreovirus from Patients with Acute Respiratory Infections	PLOS ONE			English	Article							NIPAH VIRUS; FRUIT BATS; CORONAVIRUSES; SEQUENCE; PREVALENCE; ANTIBODIES; RESERVOIRS; DIVERSITY; HENDRA	First discovered in the early 1950s, reoviruses (respiratory enteric orphan viruses) were not associated with any known disease, and hence named orphan viruses. Recently, our group reported the isolation of the Melaka virus from a patient with acute respiratory disease and provided data suggesting that this new orthoreovirus is capable of human-to-human transmission and is probably of bat origin. Here we report yet another Melaka-like reovirus (named Kampar virus) isolated from the throat swab of a 54 year old male patient in Kampar, Perak, Malaysia who was suffering from high fever, acute respiratory disease and vomiting at the time of virus isolation. Serological studies indicated that Kampar virus was transmitted from the index case to at least one other individual and caused respiratory disease in the contact case. Sequence analysis of the four small class genome segments indicated that Kampar and Melaka viruses are closely related. This was confirmed by virus neutralization assay, showing an effective two-way cross neutralization, i.e., the serum against one virus was able to neutralize the other. Although the exact origin of Kampar virus is unknown, epidemiological tracing revealed that the house of the index case is surrounded by fruit trees frequently visited by fruit bats. There is a high probability that Kampar virus originated from bats and was transmitted to humans via bat droppings or contaminated fruits. The discovery of Kampar virus highlights the increasing trend of emergence of bat zoonotic viruses and the need to expand our understanding of bats as a source of many unknown viruses.	[Chua, Kaw Bing; Rosli, Juliana] Natl Publ Hlth Lab, Sg Buloh, Selangor, Malaysia; [Chua, Kaw Bing; Voon, Kenny] Int Med Univ, Kuala Lumpur, Malaysia; [Crameri, Gary; McEachern, Jennifer A.; Yu, Meng; Wang, Lin-Fa] Australian Biosecurity Cooperative Res Ctr Emerg, Geelong, Vic, Australia; [Crameri, Gary; McEachern, Jennifer A.; Yu, Meng; Wang, Lin-Fa] CSIRO Livestock Industries, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Tan, Hui Siu; Suluraju, Sivagami] Klin Kesihatan Kampar, Perak, Malaysia	International Medical University Malaysia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Chua, KB (corresponding author), Natl Publ Hlth Lab, Sg Buloh, Selangor, Malaysia.	chuakawbing@yahoo.com.sg; linfa.wang@csiro.au	TAN, HUI-SIU/AAE-5686-2020; TAN, HUI-SIU/ABG-2911-2021; Crameri, Gary/H-8441-2013; wang, lin/HHM-2225-2022; Voon, Kenny/AAF-8611-2019; wang, lin/GSE-3040-2022; Barr, Jennifer A/H-9254-2013; Voon, Kenny/I-8827-2017	TAN, HUI-SIU/0000-0003-0714-0009; Voon, Kenny/0000-0002-5418-5309; Wang, Lin-Fa/0000-0003-2752-0535; Barr, Jennifer/0000-0001-5266-9142	National Public Health Laboratory of Malaysia; Australian Animal Health Laboratory	National Public Health Laboratory of Malaysia; Australian Animal Health Laboratory	This work was supported in part by institute funding from the National Public Health Laboratory of Malaysia and the Australian Animal Health Laboratory.	Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chappell J. D., 2005, VIRUS TAXONOMY, P455; Childs JE, 2004, ARCH VIROL, P1; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua Kaw Bing, 2002, Malays J Pathol, V24, P15; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; GARD G, 1970, J VIROL, V6, P100, DOI 10.1128/JVI.6.1.100-106.1970; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Huang Y, 2008, NUCLEIC ACIDS RES, V36, pD504, DOI 10.1093/nar/gkm754; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Olson JG, 2002, EMERG INFECT DIS, V8, P987, DOI 10.3201/eid0809.010515; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	37	99	104	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3803	10.1371/journal.pone.0003803	http://dx.doi.org/10.1371/journal.pone.0003803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030226	Green Submitted, gold, Green Published			2022-12-27	WOS:000265451100003
J	Magalhaes, I; Sizemore, DR; Ahmed, RK; Mueller, S; Wehlin, L; Scanga, C; Weichold, F; Schirru, G; Pau, MG; Goudsmit, J; Kuhlmann-Berenzon, S; Spangberg, M; Andersson, J; Gaines, H; Thorstensson, R; Skeiky, YAW; Sadoff, J; Maeurer, M				Magalhaes, Isabelle; Sizemore, Donata R.; Ahmed, Raija K.; Mueller, Stefanie; Wehlin, Lena; Scanga, Charles; Weichold, Frank; Schirru, Giulia; Pau, Maria Grazia; Goudsmit, Jaap; Kuhlmann-Berenzon, Sharon; Spangberg, Mats; Andersson, Jan; Gaines, Hans; Thorstensson, Rigmor; Skeiky, Yasir A. W.; Sadoff, Jerry; Maeurer, Markus			rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector	PLOS ONE			English	Article								Background: BCG vaccination, combined with adenoviral-delivered boosts, represents a reasonable strategy to augment, broaden and prolong immune protection against tuberculosis (TB). We tested BCG (SSI1331) (in 6 animals, delivered intradermally) and a recombinant (rBCG) AFRO-1 expressing perfringolysin (in 6 animals) followed by two boosts (delivered intramuscullary) with non-replicating adenovirus 35 (rAd35) expressing a fusion protein composed of Ag85A, Ag85B and TB10.4, for the capacity to induce antigen-specific cellular immune responses in rhesus macaques (Macaca mulatta). Control animals received diluent (3 animals). Methods and Findings: Cellular immune responses were analyzed longitudinally (12 blood draws for each animal) using intracellular cytokine staining (TNF-alpha, IL-2 and IFN-gamma), T cell proliferation was measured in CD4(+), CD8alpha/beta(+), and CD8alpha/alpha(+) T cell subsets and IFN-gamma production was tested in 7 day PBMC cultures (whole blood cell assay, WBA) using Ag85A, Ag85B, TB10.4 recombinant proteins, PPD or BCG as stimuli. Animals primed with AFRO-1 showed i) increased Ag85B-specific IFN-gamma production in the WBA assay (median >400 pg/ml for 6 animals) one week after the first boost with adenoviral-delivered TB-antigens as compared to animals primed with BCG (< 200 pg/ml), ii) stronger T cell proliferation in the CD8alpha/alpha(+) T cell subset (proliferative index 17%) as compared to BCG-primed animals (proliferative index 5% in CD8alpha/alpha(+) T cells). Polyfunctional T cells, defined by IFN-gamma, TNF-alpha and IL-2 production were detected in 2/6 animals primed with AFRO-1 directed against Ag85A/b and TB10.4; 4/6 animals primed with BCG showed a Ag85A/b responses, yet only a single animal exhibited Ag85A/b and TB10.4 reactivity. Conclusion: AFRO-1 induces qualitatively and quantitatively different cellular immune responses as compared with BCG in rhesus macaques. Increased IFN-gamma-responses and antigen-specific T cell proliferation in the CD8alpha/alpha(+) T cell subset represents a valuable marker for vaccine-take in BCG-based TB vaccine trials	[Magalhaes, Isabelle; Maeurer, Markus] Karolinska Inst, Microbiol Tumor & Cell Biol Ctr, Solna, Sweden; [Magalhaes, Isabelle; Ahmed, Raija K.; Wehlin, Lena; Kuhlmann-Berenzon, Sharon; Spangberg, Mats; Gaines, Hans; Thorstensson, Rigmor; Maeurer, Markus] Swedish Inst Infect Dis Control, Solna, Sweden; [Sizemore, Donata R.; Mueller, Stefanie; Scanga, Charles; Weichold, Frank; Skeiky, Yasir A. W.; Sadoff, Jerry] Aeras Glob TB Vaccine Fdn, Rockville, MD USA; [Schirru, Giulia; Pau, Maria Grazia; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Andersson, Jan] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Johnson & Johnson; Karolinska Institutet; Karolinska University Hospital	Magalhaes, I (corresponding author), Karolinska Inst, Microbiol Tumor & Cell Biol Ctr, Solna, Sweden.	markus.maeurer@ki.se	Magalhaes, Isabelle/AAC-7898-2020; Kühlmann-Berenzon, Sharon/J-1554-2019; Scanga, Charles/L-2353-2019	Magalhaes, Isabelle/0000-0003-0440-6924; Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Scanga, Charles/0000-0003-3654-5603; Maeurer, Markus/0000-0002-8436-8077	Aeras Foundation; Vetenskapsradet; Soderberg foundation; Karolinska Institutet; Marie Curie Host Fellowship for Early Stage Researchers Training	Aeras Foundation; Vetenskapsradet(Swedish Research Council); Soderberg foundation; Karolinska Institutet(Karolinska Institutet); Marie Curie Host Fellowship for Early Stage Researchers Training(European Commission)	This work was supported by the Aeras Foundation, Vetenskapsradet, the Soderberg foundation and Karolinska Institutet. IM is supported by a Marie Curie Host Fellowship for Early Stage Researchers Training. The authors state that they have a financial interest.	Allers K, 2008, J IMMUNOTHER, V31, P334, DOI 10.1097/CJI.0b013e3181635e7f; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Caruso AM, 1999, J IMMUNOL, V162, P5407; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Gaines H, 2000, METH MOL B, V134, P243; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lacabaratz-Porret C, 2003, J INFECT DIS, V187, P748, DOI 10.1086/368333; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Magalhaes I, 2008, J IMMUNOTHER, V31, P840, DOI 10.1097/CJI.0b013e31818883a1; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	34	75	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3790	10.1371/journal.pone.0003790	http://dx.doi.org/10.1371/journal.pone.0003790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023426	Green Submitted, gold, Green Published			2022-12-27	WOS:000265448800011
J	Lucas, M; Guedon, Y; Jay-Allemand, C; Godin, C; Laplaze, L				Lucas, Mikael; Guedon, Yann; Jay-Allemand, Christian; Godin, Christophe; Laplaze, Laurent			An Auxin Transport-Based Model of Root Branching in Arabidopsis thaliana	PLOS ONE			English	Article							INITIATION; GRAVITROPISM; SHOOT; PHYLLOTAXIS; PERICYCLE; PATHWAYS; APEX	Root architecture is a crucial part of plant adaptation to soil heterogeneity and is mainly controlled by root branching. The process of root system development can be divided into two successive steps: lateral root initiation and lateral root development/emergence which are controlled by different fluxes of the plant hormone auxin. While shoot architecture appears to be highly regular, following rules such as the phyllotactic spiral, root architecture appears more chaotic. We used stochastic modeling to extract hidden rules regulating root branching in Arabidopsis thaliana. These rules were used to build an integrative mechanistic model of root ramification based on auxin. This model was experimentally tested using plants with modified rhythm of lateral root initiation or mutants perturbed in auxin transport. Our analysis revealed that lateral root initiation and lateral root development/emergence are interacting with each other to create a global balance between the respective ratio of initiation and emergence. A mechanistic model based on auxin fluxes successfully predicted this property and the phenotype alteration of auxin transport mutants or plants with modified rythms of lateral root initiation. This suggests that root branching is controlled by mechanisms of lateral inhibition due to a competition between initiation and development/ emergence for auxin.	[Lucas, Mikael; Laplaze, Laurent] Equipe Rhizogenese, INRA IRD Montpellier SupAgro UM2, DIAPC, UMR,IRD, Montpellier, France; [Lucas, Mikael; Guedon, Yann; Godin, Christophe] CIRAD INRIA INRA Montpellier SupAgro UM2, UMR DAP, INRIA, Montpellier, France; [Lucas, Mikael; Jay-Allemand, Christian] Univ Montpellier 2, UMR DIAPC, INRA IRD Montpellier SupAgro UM2, Equipe Rhizogenese, F-34095 Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; INRAE; Inria; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lucas, M (corresponding author), Equipe Rhizogenese, INRA IRD Montpellier SupAgro UM2, DIAPC, UMR,IRD, Montpellier, France.	laurent.laplaze@ird.fr	Han, Liqi/K-6127-2013; Laplaze, Laurent/I-5435-2016; Godin, Christophe/C-1218-2008; LUCAS, Mikaël/A-5925-2015	Laplaze, Laurent/0000-0002-6568-6504; Godin, Christophe/0000-0002-1202-8460; LUCAS, Mikael/0000-0001-6286-7759	IRD; INRIA; CIRAD; French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie	IRD; INRIA; CIRAD; French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie	This work was supported by IRD, INRIA (Virtual Plants project) and CIRAD. M.L. is the recipient of a PhD grant from the French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Csiszar I, 2006, IEEE T INFORM THEORY, V52, P1007, DOI 10.1109/TIT.2005.864431; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; De Smet I, 2006, PLANT MOL BIOL, V60, P871, DOI 10.1007/s11103-005-4547-2; DOUADY S, 1992, PHYS REV LETT, V68, P2098, DOI 10.1103/PhysRevLett.68.2098; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P903, DOI 10.1093/aob/mcj604; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Godin C, 1999, AGRONOMIE, V19, P163, DOI 10.1051/agro:19990301; Guedon Y, 2005, COMPUT STAT DATA AN, V49, P663, DOI 10.1016/j.csda.2004.05.033; Guedon Y, 2003, J COMPUT GRAPH STAT, V12, P604, DOI 10.1198/1061860032030; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; HOFMEIESTER W, 1868, HDB PHYSL BOT, V2; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; PRADAL C, 2008, FUNCT PLANT IN PRESS; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; SNOW M, 1962, PHILOS T ROY SOC B, V244, P483, DOI 10.1098/rstb.1962.0003; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493	33	67	69	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3673	10.1371/journal.pone.0003673	http://dx.doi.org/10.1371/journal.pone.0003673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	18989371	Green Submitted, gold, Green Published			2022-12-27	WOS:000265448500001
J	Zhou, T; Enyeart, PJ; Wilke, CO				Zhou, Tong; Enyeart, Peter J.; Wilke, Claus O.			Detecting Clusters of Mutations	PLOS ONE			English	Article							AMINO-ACID SITES; RELATIVE SOLVENT ACCESSIBILITY; ADAPTIVE PROTEIN EVOLUTION; SYNONYMOUS CODON USAGE; POSITIVE SELECTION; ESCHERICHIA-COLI; SECONDARY STRUCTURE; NATURAL-SELECTION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER	Positive selection for protein function can lead to multiple mutations within a small stretch of DNA, i.e., to a cluster of mutations. Recently, Wagner proposed a method to detect such mutation clusters. His method, however, did not take into account that residues with high solvent accessibility are inherently more variable than residues with low solvent accessibility. Here, we propose a new algorithm to detect clustered evolution. Our algorithm controls for different substitution probabilities at buried and exposed sites in the tertiary protein structure, and uses random permutations to calculate accurate P values for inferred clusters. We apply the algorithm to genomes of bacteria, fly, and mammals, and find several clusters of mutations in functionally important regions of proteins. Surprisingly, clustered evolution is a relatively rare phenomenon. Only between 2% and 10% of the genes we analyze contain a statistically significant mutation cluster. We also find that not controlling for solvent accessibility leads to an excess of clusters in terminal and solvent-exposed regions of proteins. Our algorithm provides a novel method to identify functionally relevant divergence between groups of species. Moreover, it could also be useful to detect artifacts in automatically assembled genomes.	[Zhou, Tong; Wilke, Claus O.] Univ Texas Austin, Sect Integrat Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Enyeart, Peter J.; Wilke, Claus O.] Univ Texas, Inst Cell & Mol Biol, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Zhou, T (corresponding author), Univ Texas Austin, Sect Integrat Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	cwilke@mail.utexas.edu	Wilke, Claus O./B-4643-2008	Enyeart, Peter/0000-0002-1740-2570; Wilke, Claus/0000-0002-7470-9261	NIH [R01 AI065960]; Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI065960 and by a Reeder Centennial Fellowship in Systematic and Evolutionary Biology to C.O.W.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; AKASHI H, 1994, GENETICS, V136, P927; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; CHRISTOPHER JA, 1996, P NATL ACAD SCI USA, V102, P1053; Chung JJ, 2002, TRENDS CELL BIOL, V12, P146, DOI 10.1016/S0962-8924(01)02241-3; Creighton T.E., 1992, PROTEINS STRUCTURES; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Dean AM, 2002, MOL BIOL EVOL, V19, P1846, DOI 10.1093/oxfordjournals.molbev.a004009; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Eames M, 2007, STRUCTURE, V15, P1442, DOI 10.1016/j.str.2007.09.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu YX, 1996, GENETICS, V143, P557; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Giordani R, 2004, EUR J BIOCHEM, V271, P2400, DOI 10.1111/j.1432-1033.2004.04159.x; Goldman N, 1998, GENETICS, V149, P445; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hanada K, 2006, GENE, V385, P83, DOI 10.1016/j.gene.2006.06.029; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Hughes AL, 2008, P NATL ACAD SCI USA, V105, P13193, DOI 10.1073/pnas.0807440105; Hughes AL, 2008, IMMUNOGENETICS, V60, P495, DOI 10.1007/s00251-008-0304-4; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; JORNVALL H, 1993, FEBS LETT, V322, P240, DOI 10.1016/0014-5793(93)81578-N; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Nickel GC, 2008, NUCLEIC ACIDS RES, V36, pD800, DOI 10.1093/nar/gkm764; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Nielsen R, 1998, GENETICS, V148, P929; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Rao-Naik C, 1998, J BIOL CHEM, V273, P34976, DOI 10.1074/jbc.273.52.34976; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; RUIZHERRERA J, 1969, J BACTERIOL, V99, P720, DOI 10.1128/JB.99.3.720-729.1969; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Smith NGC, 2003, J MOL EVOL, V57, P467, DOI 10.1007/s00239-003-2500-z; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; SUKHWINDER SL, 2005, DRUG METAB DISPOS, V33, P254; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; TAJIMA F, 1989, GENETICS, V123, P585; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Thompson MJ, 1996, PROTEINS, V25, P38, DOI 10.1002/(SICI)1097-0134(199605)25:1<38::AID-PROT4>3.3.CO;2-H; Wagner A, 2007, GENETICS, V176, P2451, DOI 10.1534/genetics.107.074732; Wall JD, 2000, GENETICS, V155, P1865; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	80	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3765	10.1371/journal.pone.0003765	http://dx.doi.org/10.1371/journal.pone.0003765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018282	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448500012
J	Tito, RY; Macmil, S; Wiley, G; Najar, F; Cleeland, L; Qu, CM; Wang, P; Romagne, F; Leonard, S; Ruiz, AJ; Reinhard, K; Roe, BA; Lewis, CM				Tito, Raul Y.; Macmil, Simone; Wiley, Graham; Najar, Fares; Cleeland, Lauren; Qu, Chunmei; Wang, Ping; Romagne, Frederic; Leonard, Sylvain; Jimenez Ruiz, Agustin; Reinhard, Karl; Roe, Bruce A.; Lewis, Cecil M., Jr.			Phylotyping and Functional Analysis of Two Ancient Human Microbiomes	PLOS ONE			English	Article								Background: The Human Microbiome Project (HMP) is one of the U. S. National Institutes of Health Roadmap for Medical Research. Primary interests of the HMP include the distinctiveness of different gut microbiomes, the factors influencing microbiome diversity, and the functional redundancies of the members of human microbiotas. In this present work, we contribute to these interests by characterizing two extinct human microbiotas. Methodology/Principal Findings: We examine two paleofecal samples originating from cave deposits in Durango Mexico and dating to approximately 1300 years ago. Contamination control is a serious issue in ancient DNA research; we use a novel approach to control contamination. After we determined that each sample originated from a different human, we generated 45 thousand shotgun DNA sequencing reads. The phylotyping and functional analysis of these reads reveals a signature consistent with the modern gut ecology. Interestingly, inter-individual variability for phenotypes but not functional pathways was observed. The two ancient samples have more similar functional profiles to each other than to a recently published profile for modern humans. This similarity could not be explained by a chance sampling of the databases. Conclusions/Significance: We conduct a phylotyping and functional analysis of ancient human microbiomes, while providing novel methods to control for DNA contamination and novel hypotheses about past microbiome biogeography. We postulate that natural selection has more of an influence on microbiome functional profiles than it does on the species represented in the microbial ecology. We propose that human microbiomes were more geographically structured during pre-Columbian times than today.	[Tito, Raul Y.; Cleeland, Lauren; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Tito, Raul Y.; Cleeland, Lauren; Romagne, Frederic; Leonard, Sylvain; Lewis, Cecil M., Jr.] Univ Oklahoma, Mol Anthropol Lab, Norman, OK 73019 USA; [Macmil, Simone; Wiley, Graham; Najar, Fares; Qu, Chunmei; Wang, Ping; Roe, Bruce A.] Univ Oklahoma, Advanced Ctr Genome Technol, Dept Chem & Biochem, Norman, OK 73019 USA; [Romagne, Frederic; Leonard, Sylvain] Univ Auvergne, Inst Technol, Clermont Ferrand, France; [Jimenez Ruiz, Agustin] Univ Nebraska, State Museum, Lincoln, NE 68583 USA; [Reinhard, Karl] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68583 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Universite Clermont Auvergne (UCA); Universite de Montpellier; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tito, RY (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.	cmlewis@ou.edu	Jimenez, Francisco Agustin/I-6010-2013; Wang, Pingshan/N-3808-2019; Tito, Raul/CAG-3546-2022; Reinhard, Karl/AAT-7881-2020	Jimenez, Francisco Agustin/0000-0002-1047-8185; Wang, Pingshan/0000-0002-1988-7604; Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Cree, Simone/0000-0002-7349-422X	University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry	University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry	We acknowledge that funding for this research was obtained from the University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNPUB; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BROOKS RH, 1962, AM ANTIQUITY, V27, P356, DOI 10.2307/277801; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARSHALL BJ, 1984, LANCET, V1, P1311; Mell LK, 2005, PEDIATRICS, V116, P56, DOI 10.1542/peds.2004-2058; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rizzo R, 2006, J CHILD NEUROL, V21, P747, DOI 10.1177/08830738060210091001; Sidhu H, 2001, J UROLOGY, V166, P1487, DOI 10.1016/S0022-5347(05)65817-X; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TEAM RDC, 2007, R LANGUAGE ENV STAT; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; WILEY G, CURRENT PRO IN PRESS; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	39	64	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3703	10.1371/journal.pone.0003703	http://dx.doi.org/10.1371/journal.pone.0003703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002248	gold, Green Published			2022-12-27	WOS:000265165600008
J	Fukada, T; Civic, N; Furuichi, T; Shimoda, S; Mishima, K; Higashiyama, H; Idaira, Y; Asada, Y; Kitamura, H; Yamasaki, S; Hojyo, S; Nakayama, M; Ohara, O; Koseki, H; dos Santos, HG; Bonafe, L; Ha-Vinh, R; Zankl, A; Unger, S; Kraenzlin, ME; Beckmann, JS; Saito, I; Rivolta, C; Ikegawa, S; Superti-Furga, A; Hirano, T				Fukada, Toshiyuki; Civic, Natacha; Furuichi, Tatsuya; Shimoda, Shinji; Mishima, Kenji; Higashiyama, Hiroyuki; Idaira, Yayoi; Asada, Yoshinobu; Kitamura, Hiroshi; Yamasaki, Satoru; Hojyo, Shintaro; Nakayama, Manabu; Ohara, Osamu; Koseki, Haruhiko; dos Santos, Heloisa G.; Bonafe, Luisa; Ha-Vinh, Russia; Zankl, Andreas; Unger, Sheila; Kraenzlin, Marius E.; Beckmann, Jacques S.; Saito, Ichiro; Rivolta, Carlo; Ikegawa, Shiro; Superti-Furga, Andrea; Hirano, Toshio			The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-beta Signaling Pathways	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; BRITTLE CORNEA SYNDROME; TGF-BETA; CHONDROCYTE DIFFERENTIATION; BONE-FORMATION; GROWTH; DEFICIENCY; MUTATIONS; PROTEINS; FAMILY	Background: Zinc (Zn) is an essential trace element and it is abundant in connective tissues, however biological roles of Zn and its transporters in those tissues and cells remain unknown. Methodology/Principal Findings: Here we report that mice deficient in Zn transporter Slc39a13/Zip13 show changes in bone, teeth and connective tissue reminiscent of the clinical spectrum of human Ehlers-Danlos syndrome (EDS). The Slc39a13 knockout (Slc39a13-KO) mice show defects in the maturation of osteoblasts, chondrocytes, odontoblasts, and fibroblasts. In the corresponding tissues and cells, impairment in bone morphogenic protein (BMP) and TGF-beta signaling were observed. Homozygosity for a SLC39A13 loss of function mutation was detected in sibs affected by a unique variant of EDS that recapitulates the phenotype observed in Slc39a13-KO mice. Conclusions/Significance: Hence, our results reveal a crucial role of SLC39A13/ZIP13 in connective tissue development at least in part due to its involvement in the BMP/TGF-beta signaling pathways. The Slc39a13-KO mouse represents a novel animal model linking zinc metabolism, BMP/TGF-beta signaling and connective tissue dysfunction.	[Fukada, Toshiyuki; Yamasaki, Satoru; Hojyo, Shintaro; Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan; [Fukada, Toshiyuki; Hojyo, Shintaro] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Suita, Osaka 565, Japan; [Civic, Natacha; Beckmann, Jacques S.; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan; [Shimoda, Shinji] Tsurumi Univ, Sch Dent Med, Dept Anat 1, Kanagawa, Japan; [Mishima, Kenji; Higashiyama, Hiroyuki; Saito, Ichiro] Tsurumi Univ, Sch Dent Med, Dept Pathol, Kanagawa, Japan; [Idaira, Yayoi; Asada, Yoshinobu] Tsurumi Univ, Sch Dent Med, Dept Pediat Dent, Kanagawa, Japan; [Kitamura, Hiroshi; Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Lab Immunogenom, Kanagawa, Japan; [Nakayama, Manabu; Ohara, Osamu] Kazusa DNA Res Inst, Lab Genome Technol, Chiba, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Kanagawa, Japan; [dos Santos, Heloisa G.] Hosp S Maria, Serv Genet Med, Lisbon, Portugal; [Bonafe, Luisa; Ha-Vinh, Russia; Zankl, Andreas; Unger, Sheila; Superti-Furga, Andrea] CHU Vaudois, Div Mol Pediat, Lausanne, Switzerland; [Unger, Sheila; Superti-Furga, Andrea] Univ Freiburg, Dept Paediat & Adolescent Med, D-7800 Freiburg, Germany; [Kraenzlin, Marius E.] Univ Hosp, Div Endocrinol, Diabetes & Clin Nutr, Basel, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [Hirano, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Hirano, Toshio] Osaka Univ, Grad Sch Med, Grad Sch Frontier Biosci, CREST Program Japan Sci & Technol Agcy, Suita, Osaka 565, Japan	RIKEN; Osaka University; University of Lausanne; RIKEN; Tsurumi University; Tsurumi University; Tsurumi University; RIKEN; Kazusa DNA Research Institute; RIKEN; Universidade de Lisboa; Hospital Santa Maria; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Osaka University; Osaka University	Fukada, T (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan.	asuperti@uniklinik-freiburg.de; hirano@molonc.med.osaka-u.ac.jp	Zankl, Andreas/F-2044-2010; Ohara, Osamu/A-9119-2012; Beckmann, Jacques S/A-9772-2008; unger, sheila/E-9177-2015; Ha-Vinh Leuchter, Russia/AAA-5924-2022; Koseki, Haruhiko/I-3825-2014; Ikegawa, Shiro/N-6895-2015; superti-furga, andrea/E-9162-2015; Ohara, Osamu/G-5448-2015	Zankl, Andreas/0000-0001-8612-1062; Beckmann, Jacques S/0000-0002-9741-1900; Koseki, Haruhiko/0000-0001-8424-5854; Ikegawa, Shiro/0000-0003-0316-2147; superti-furga, andrea/0000-0002-3543-7531; Ohara, Osamu/0000-0002-3328-9571; Rivolta, Carlo/0000-0002-0733-9950; Ha-Vinh Leuchter, Russia/0000-0001-9068-9670	Ministry of Education, Culture, Sports, Science and Technology in Japan; Swiss National Foundation [3100A0-100485]; German BMBF Rare Diseases network SKELNET [GFGN01141901]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German BMBF Rare Diseases network SKELNET(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan; by the Swiss National Foundation (grant no. 3100A0-100485); and by German BMBF Rare Diseases network SKELNET (Project GFGN01141901).	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/iovs.06-0206; Akhurst RJ, 2004, NAT GENET, V36, P790, DOI 10.1038/ng0804-790; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Al-Hussain H, 2004, AM J MED GENET A, V124A, P28, DOI 10.1002/ajmg.a.20326; Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Amano K, 2007, J BONE MINER RES, V22, pS385; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BERGMAN B, 1968, J NUTR, V94, P6, DOI 10.1093/jn/94.1.6; BIRK DE, 1984, J CELL BIOL, V99, pA76; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; Byers PH, 2004, J CLIN INVEST, V114, P161, DOI 10.1172/JCI200422399; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Hanada K, 1998, J INVEST DERMATOL, V110, P259, DOI 10.1046/j.1523-1747.1998.00125.x; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; JOYNER AL, 1992, GENE TARGETING PRACT, P1; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; MICHAELSSON G, 1980, ACTA DERM-VENEREOL, V60, P295; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; MOLOKHIA MM, 1969, BRIT J DERMATOL, V81, P759, DOI 10.1111/j.1365-2133.1969.tb15937.x; NABARRA B, 1984, CELL TISSUE RES, V238, P209; Nakayama M, 2006, FASEB J, V20, P1718, DOI 10.1096/fj.06-5952fje; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; OHJI M, 1993, CURR EYE RES, V12, P703, DOI 10.3109/02713689308995765; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; PRASAD AS, 1961, AM J MED, V31, P532, DOI 10.1016/0002-9343(61)90137-1; PRASAD AS, 1995, NUTRITION, V11, P93; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; TAYLOR K, 2008, ENDOCRINOLOGY; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thesleff I, 2001, Adv Dent Res, V15, P14; Thesleff I, 2002, INT REV CYTOL, V217, P93; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt;119::AID-JTRA5&gt;3.0.CO;2-3; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	81	213	220	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3642	10.1371/journal.pone.0003642	http://dx.doi.org/10.1371/journal.pone.0003642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985159	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000265134400008
J	Mamiya, A; Beshel, J; Xu, CS; Zhong, Y				Mamiya, Akira; Beshel, Jennifer; Xu, Chunsu; Zhong, Yi			Neural Representations of Airflow in Drosophila Mushroom Body	PLOS ONE			English	Article							MEMORY TRACE; OLFACTORY REPRESENTATIONS; TERM-MEMORY; BODIES; MELANOGASTER; NEURONS; CA2+; LOCALIZATION; ORGANIZATION; INTEGRATION	The Drosophila mushroom body (MB) is a higher olfactory center where olfactory and other sensory information are thought to be associated. However, how MB neurons of Drosophila respond to sensory stimuli other than odor is not known. Here, we characterized the responses of MB neurons to a change in airflow, a stimulus associated with odor perception. In vivo calcium imaging from MB neurons revealed surprisingly strong and dynamic responses to an airflow stimulus. This response was dependent on the movement of the 3(rd) antennal segment, suggesting that Johnston's organ may be detecting the airflow. The calyx, the input region of the MB, responded homogeneously to airflow on. However, in the output lobes of the MB, different types of MB neurons responded with different patterns of activity to airflow on and off. Furthermore, detailed spatial analysis of the responses revealed that even within a lobe that is composed of a single type of MB neuron, there are subdivisions that respond differently to airflow on and off. These subdivisions within a single lobe were organized in a stereotypic manner across flies. For the first time, we show that changes in airflow affect MB neurons significantly and these effects are spatially organized into divisions smaller than previously defined MB neuron types.	[Mamiya, Akira; Beshel, Jennifer; Xu, Chunsu; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xu, Chunsu] SUNY Stony Brook, Stony Brook, NY USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mamiya, A (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.edu		Zhong, Yi/0000-0002-7927-5976; Mamiya, Akira/0000-0002-3199-5341; Zhong, Yi/0000-0001-7810-9899	US National Institutes of Health [5RO1DC005784-05]; DART Neuroscience Inc; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005784] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DART Neuroscience Inc; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by a grant from the US National Institutes of Health (5RO1DC005784-05) and DART Neuroscience Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Budick SA, 2007, J EXP BIOL, V210, P4092, DOI 10.1242/jeb.006502; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Bulkin DA, 2006, CURR OPIN NEUROBIOL, V16, P415, DOI 10.1016/j.conb.2006.06.008; Calvert G., 2004, HDB MULTISENSORY PRO, P915; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Gupta A.P., 1987, ARTHROPOD BRAIN ITS; Han Q, 2005, J COMP PHYSIOL A, V191, P521, DOI 10.1007/s00359-005-0618-8; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Koehl MAR, 2006, CHEM SENSES, V31, P93, DOI 10.1093/chemse/bjj009; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mellon DF, 2005, J EXP BIOL, V208, P3711, DOI 10.1242/jeb.01827; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	47	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4063	10.1371/journal.pone.0004063	http://dx.doi.org/10.1371/journal.pone.0004063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DL	19115002	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265466300006
J	Eckmeier, D; Geurten, BRH; Kress, D; Mertes, M; Kern, R; Egelhaaf, M; Bischof, HJ				Eckmeier, Dennis; Geurten, Bart R. H.; Kress, Daniel; Mertes, Marcel; Kern, Roland; Egelhaaf, Martin; Bischof, Hans-Joachim			Gaze Strategy in the Free Flying Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article								Fast moving animals depend on cues derived from the optic flow on their retina. Optic flow from translational locomotion includes information about the three-dimensional composition of the environment, while optic flow experienced during a rotational self motion does not. Thus, a saccadic gaze strategy that segregates rotations from translational movements during locomotion will facilitate extraction of spatial information from the visual input. We analysed whether birds use such a strategy by highspeed video recording zebra finches from two directions during an obstacle avoidance task. Each frame of the recording was examined to derive position and orientation of the beak in three-dimensional space. The data show that in all flights the head orientation was shifted in a saccadic fashion and was kept straight between saccades. Therefore, birds use a gaze strategy that actively stabilizes their gaze during translation to simplify optic flow based navigation. This is the first evidence of birds actively optimizing optic flow during flight.	[Eckmeier, Dennis; Kress, Daniel; Mertes, Marcel; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany; [Geurten, Bart R. H.; Kress, Daniel; Mertes, Marcel; Kern, Roland; Egelhaaf, Martin] Univ Bielefeld, Lehrstuhl Neurobiol & Ctr Excellence, D-4800 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Eckmeier, D (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany.	dennis.eckmeier@uni-bielefeld.de	Eckmeier, Dennis/AAE-7886-2020; Egelhaaf, Martin/A-9824-2010; Geurten, Bart/I-2037-2019	Eckmeier, Dennis/0000-0002-7818-8993; Egelhaaf, Martin/0000-0002-9336-4270; Geurten, Bart/0000-0002-1816-3241; Kern, Roland/0000-0002-7258-9956	DFG - Deutsche Forschungsgemeinschaft, Germany [Ke 645/2-1]	DFG - Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG))	This study was supported by the DFG - Deutsche Forschungsgemeinschaft, Germany (Ke 645/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGUET JY, 1998, 6 INT C COMP VIS ICC; Bredenkotter M, 1996, BRAIN BEHAV EVOLUT, V47, P23, DOI 10.1159/000113226; DAVIES MNO, 1991, ZOOL JAHRB ALLG ZOOL, V95, P331; DAVIES MNO, 1990, NATURWISSENSCHAFTEN, V77, P142, DOI 10.1007/BF01134481; Eckmeier D, 2008, J COMP PHYSIOL A, V194, P871, DOI 10.1007/s00359-008-0358-7; ENGELAGE J, 1988, EXP BRAIN RES, V70, P79; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311; GIOANNI H, 1988, EXP BRAIN RES, V69, P567, DOI 10.1007/BF00247310; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; LEE DN, 1993, J EXP BIOL, V180, P85; Lindemann J., 2005, VISUAL NAVIGATION VI; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; MARTINOYA C, 1980, 28 INT C PHYS SCI, P477; McFadden Sally A., 1993, P47; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Vaina L. M., 2004, OPTIC FLOW; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Voss J, 2003, J COMP PHYSIOL A, V189, P545, DOI 10.1007/s00359-003-0430-2; Wylie DRW, 1997, J COMP NEUROL, V384, P517, DOI 10.1002/(SICI)1096-9861(19970811)384:4<517::AID-CNE3>3.0.CO;2-5	22	50	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3956	10.1371/journal.pone.0003956	http://dx.doi.org/10.1371/journal.pone.0003956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107185	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000003
J	Vitorino, LR; Margos, G; Feil, EJ; Collares-Pereira, M; Ze-Ze, L; Kurtenbach, K				Vitorino, Liliana R.; Margos, Gabriele; Feil, Edward J.; Collares-Pereira, Margarida; Ze-Ze, Libia; Kurtenbach, Klaus			Fine-Scale Phylogeographic Structure of Borrelia lusitaniae Revealed by Multilocus Sequence Typing	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; LYME-DISEASE; GENETIC DIVERSITY; QUESTING TICKS; GENOMIC GROUPS; RECOMBINATION; POLYMORPHISM; POPULATIONS; PREVALENCE	Borrelia lusitaniae is an Old World species of the Lyme borreliosis (LB) group of tick-borne spirochetes and prevails mainly in countries around the Mediterranean Basin. Lizards of the family Lacertidae have been identified as reservoir hosts of B. lusitaniae. These reptiles are highly structured geographically, indicating limited migration. In order to examine whether host geographic structure shapes the evolution and epidemiology of B. lusitaniae, we analyzed the phylogeographic population structure of this tick-borne bacterium using a recently developed multilocus sequence typing (MLST) scheme based on chromosomal housekeeping genes. A total of 2,099 questing nymphal and adult Ixodes ricinus ticks were collected in two climatically different regions of Portugal, being similar to 130 km apart. All ticks were screened for spirochetes by direct PCR. Attempts to isolate strains yielded 16 cultures of B. lusitaniae in total. Uncontaminated cultures as well as infected ticks were included in this study. The results using MLST show that the regional B. lusitaniae populations constitute genetically distinct populations. In contrast, no clear phylogeographic signals were detected in sequences of the commonly used molecular markers ospA and ospC. The pronounced population structure of B. lusitaniae over a short geographic distance as captured by MLST of the housekeeping genes suggests that the migration rates of B. lusitaniae are rather low, most likely because the distribution of mediterranean lizard populations is highly parapatric. The study underlines the importance of vertebrate hosts in the geographic spread of tick-borne microparasites.	[Ze-Ze, Libia] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Ctr Genet & Biol Mol, P-1200 Lisbon, Portugal; [Vitorino, Liliana R.; Margos, Gabriele; Feil, Edward J.; Kurtenbach, Klaus] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Vitorino, Liliana R.; Collares-Pereira, Margarida] Univ Nova Lisboa, Inst Higiene Med Trop, Unidade Leptospirose Borreliose Lyme, Lisbon, Portugal; [Ze-Ze, Libia] Inst Nacl Saude Dr Ricardo Jorge, Ctr Estud Vectores Doencas Infecciosas, Lisbon, Portugal	Universidade de Lisboa; University of Bath; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto Nacional de Saude Dr. Ricardo Jorge	Vitorino, LR (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Ctr Genet & Biol Mol, Campo Grande, P-1200 Lisbon, Portugal.	kk221@bath.ac.uk	Zé-Zé, Líbia Maria Marques/U-5730-2017	Zé-Zé, Líbia Maria Marques/0000-0001-7258-1439; MARGOS, Gabriele/0000-0001-5304-9615	The Wellcome Trust, London, United Kingdom [074322]; Science Foundation Portugal	The Wellcome Trust, London, United Kingdom(Wellcome Trust); Science Foundation Portugal	The study was funded by grant 074322 of The Wellcome Trust, London, United Kingdom (to K.K.) and the Science Foundation Portugal (to L.R.V.). The sponsors did not have a role in study design and decision to submit it for publication.	Baptista S, 2004, INT J MED MICROBIOL, V293, P109, DOI 10.1016/S1433-1128(04)80016-0; Barral M, 2002, J MED ENTOMOL, V39, P177, DOI 10.1603/0022-2585-39.1.177; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Crowley T. J., 1991, PALAEOCLIMATOLOGY; De Michelis S, 2000, J CLIN MICROBIOL, V38, P2128; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dsouli N, 2006, J MED ENTOMOL, V43, P737, DOI 10.1603/0022-2585(2006)43[737:RROLPA]2.0.CO;2; Escudero R, 2000, J CLIN MICROBIOL, V38, P4026, DOI 10.1128/JCM.38.11.4026-4033.2000; Etti S, 2003, APPL ENVIRON MICROB, V69, P3008, DOI 10.1128/AEM.69.5.3008-3010.2003; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Godinho R, 2006, MOL ECOL, V15, P731, DOI 10.1111/j.1365-294X.2006.02813.x; Godinho R, 2005, AMPHIBIA-REPTILIA, V26, P271, DOI 10.1163/156853805774408667; Grego E, 2007, J MOL EVOL, V65, P512, DOI 10.1007/s00239-007-9029-5; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hubalek Z, 1997, EUR J EPIDEMIOL, V13, P951, DOI 10.1023/A:1007426304900; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jouda F, 2004, J MED ENTOMOL, V41, P162, DOI 10.1603/0022-2585-41.2.162; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 2001, APPL ENVIRON MICROB, V67, P4926, DOI 10.1128/AEM.67.10.4926-4929.2001; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; LeFleche A, 1997, INT J SYST BACTERIOL, V47, P921; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paulo OS, 2008, MOL ECOL, V17, P1535, DOI 10.1111/j.1365-294X.2008.03706.x; Paulo OS, 2002, MOL ECOL, V11, P809, DOI 10.1046/j.1365-294X.2002.01484.x; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Qiu WG, 2002, GENETICS, V160, P833; Qui W, 1997, HEREDITAS, V127, P203; Richter D, 2006, APPL ENVIRON MICROB, V72, P4627, DOI 10.1128/AEM.00285-06; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH JM, 1992, J MOL EVOL, V34, P126; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VOS M, 2008, COMP HOMOLOGOUS RECO, P1; Wang IN, 1999, GENETICS, V151, P15; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; Younsi H, 2005, J CLIN MICROBIOL, V43, P1587, DOI 10.1128/JCM.43.4.1587-1593.2005; Younsi H, 2001, EUR J EPIDEMIOL, V17, P53, DOI 10.1023/A:1010928731281; Zeidner NS, 2001, J MED MICROBIOL, V50, P1055, DOI 10.1099/0022-1317-50-12-1055	52	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4002	10.1371/journal.pone.0004002	http://dx.doi.org/10.1371/journal.pone.0004002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104655	Green Published, Green Submitted, gold			2022-12-27	WOS:000265462400003
J	Castro, FAV; Mariani, D; Panek, AD; Eleutherio, ECA; Pereira, MD				Vieira Castro, Frederico Augusto; Mariani, Diana; Panek, Anita Dolly; Araujo Eleutherio, Elis Cristina; Pereira, Marcos Dias			Cytotoxicity Mechanism of Two Naphthoquinones (Menadione and Plumbagin) in Saccharomyces cerevisiae	PLOS ONE			English	Article								Background: Quinones are compounds extensively used in studies of oxidative stress due to their role in plants as chemicals for defense. These compounds are of great interest for pharmacologists and scientists, in general, because several cancer chemotherapeutic agents contain the quinone nucleus. However, due to differences in structures and diverse pharmacological effects, the exact toxicity mechanisms exerted by quinones are far from elucidatation. Methodology/Principal Findings: Using Saccharomyces cerevisiae, we evaluated the main mechanisms of toxicity of two naphthoquinones, menadione and plumbagin, by determining tolerance and oxidative stress biomarkers such as GSH and GSSG, lipid peroxidation levels, as well as aconitase activity. The importance of glutathione transferases (GST) in quinone detoxification was also addressed. The GSSG/GSH ratio showed that menadione seemed to exert its toxicity mainly through the generation of ROS while plumbagin acted as an electrophile reacting with GSH. However, the results showed that, even by different pathways, both drugs were capable of generating oxidative stress through their toxic effects. Our results showed that the control strain, BY4741, and the glutathione transferase deficient strains (gtt1 Delta and gtt2 Delta) were sensitive to both compounds. With respect to the role of GST isoforms in cellular protection against quinone toxicity, we observed that the Gtt2 deficient strain was unable to overcome lipid peroxidation, even after a plumbagin pre-treatment, indicating that this treatment did not improve tolerance when compared with the wild type strain. Cross-tolerance experiments confirmed distinct cytotoxicity mechanisms for these naphthoquinones since only a pre-treatment with menadione was able to induce acquisition of tolerance against stress with plumbagin. Conclusions/Significance: These results suggest different responses to menadione and plumbagin which could be due to the fact that these compounds use different mechanisms to exert their toxicity. In addition, the Gtt2 isoform seemed to act as a general protective factor involved in quinone detoxification.	[Vieira Castro, Frederico Augusto; Mariani, Diana; Panek, Anita Dolly; Araujo Eleutherio, Elis Cristina; Pereira, Marcos Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, LIFE, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Castro, FAV (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, LIFE, Rio De Janeiro, Brazil.	fredcastro@iq.ufrj.br	Panek, Anita D/J-5821-2013; Pereira, Marcos Dias/D-8982-2014; Eleutherio, Elis C A/J-5468-2013	Pereira, Marcos Dias/0000-0001-5594-2255; Eleutherio, Elis C A/0000-0001-5842-2714	FAPERJ; CNPq; CAPES (PROCAD/MES); FAPESP [04-10067/6]; FINEP	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (PROCAD/MES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	FAPERJ, CNPq, CAPES (PROCAD/MES), FAPESP (04-10067/6) and FINEP. These funders contributed to this manuscript by providing financial support.	Adamis PDB, 2004, TOXICOL LETT, V154, P81, DOI 10.1016/j.toxlet.2004.07.003; Adamis PDB, 2004, J BIOCHEM MOL TOXIC, V18, P12, DOI 10.1002/jbt.20000; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Barreto L, 2006, EUKARYOT CELL, V5, P1748, DOI 10.1128/EC.00216-06; Bernt E., 1974, METHODS ENZYMATIC AN, V4, P1643; Castro FAV, 2007, BBA-GEN SUBJECTS, V1770, P213, DOI 10.1016/j.bbagen.2006.10.013; Chiou TJ, 2000, TOXICOLOGY, V154, P75, DOI 10.1016/S0300-483X(00)00321-8; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; Chung SH, 1999, FEBS LETT, V449, P235, DOI 10.1016/S0014-5793(99)00452-4; Circu ML, 2008, FREE RADICAL BIO MED, V44, P768, DOI 10.1016/j.freeradbiomed.2007.09.011; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; De Paivai SR, 2004, AN ACAD BRAS CIENC, V76, P499, DOI 10.1590/S0001-37652004000300004; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Monks TJ, 1998, ANNU REV PHARMACOL, V38, P229, DOI 10.1146/annurev.pharmtox.38.1.229; POWOLNY AA, 2008, PHARM RES; Rodriguez CE, 2004, TOXICOLOGY, V201, P185, DOI 10.1016/j.tox.2004.04.016; Seung SA, 1998, CHEM-BIOL INTERACT, V113, P133, DOI 10.1016/S0009-2797(98)00024-6; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; STEELS EL, 1994, MICROBIOL-SGM, V140, P569, DOI 10.1099/00221287-140-3-569; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n	28	99	100	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3999	10.1371/journal.pone.0003999	http://dx.doi.org/10.1371/journal.pone.0003999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098979	Green Published, Green Submitted, gold			2022-12-27	WOS:000265462300010
J	Bagwell, CE; Bhat, S; Hawkins, GM; Smith, BW; Biswas, T; Hoover, TR; Saunders, E; Han, CS; Tsodikov, OV; Shimkets, LJ				Bagwell, Christopher E.; Bhat, Swapna; Hawkins, Gary M.; Smith, Bryan W.; Biswas, Tapan; Hoover, Timothy R.; Saunders, Elizabeth; Han, Cliff S.; Tsodikov, Oleg V.; Shimkets, Lawrence J.			Survival in Nuclear Waste, Extreme Resistance, and Potential Applications Gleaned from the Genome Sequence of Kineococcus radiotolerans SRS30216	PLOS ONE			English	Article								Kineococcus radiotolerans SRS30216 was isolated from a high-level radioactive environment at the Savannah River Site (SRS) and exhibits gamma-radiation resistance approaching that of Deinococcus radiodurans. The genome was sequenced by the U. S. Department of Energy's Joint Genome Institute which suggested the existence of three replicons, a 4.76 Mb linear chromosome, a 0.18 Mb linear plasmid, and a 12.92 Kb circular plasmid. Southern hybridization confirmed that the chromosome is linear. The K. radiotolerans genome sequence was examined to learn about the physiology of the organism with regard to ionizing radiation resistance, the potential for bioremediation of nuclear waste, and the dimorphic life cycle. K. radiotolerans may have a unique genetic toolbox for radiation protection as it lacks many of the genes known to confer radiation resistance in D. radiodurans. Additionally, genes involved in the detoxification of reactive oxygen species and the excision repair pathway are overrepresented. K. radiotolerans appears to lack degradation pathways for pervasive soil and groundwater pollutants. However, it can respire on two organic acids found in SRS high-level nuclear waste, formate and oxalate, which promote the survival of cells during prolonged periods of starvation. The dimorphic life cycle involves the production of motile zoospores. The flagellar biosynthesis genes are located on a motility island, though its regulation could not be fully discerned. These results highlight the remarkable ability of K radiotolerans to withstand environmental extremes and suggest that in situ bioremediation of organic complexants from high level radioactive waste may be feasible.	[Bagwell, Christopher E.; Smith, Bryan W.] Savannah River Natl Lab, Aiken, SC USA; [Biswas, Tapan; Tsodikov, Oleg V.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Bhat, Swapna; Hawkins, Gary M.; Hoover, Timothy R.; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Saunders, Elizabeth; Han, Cliff S.] DOE, Joint Genome Inst, Biosci Div, Los Alamos Natl Lab, Los Alamos, NM USA	United States Department of Energy (DOE); Savannah River National Laboratory; University of Michigan System; University of Michigan; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Los Alamos National Laboratory	Bagwell, CE (corresponding author), Savannah River Natl Lab, Aiken, SC USA.	shimkets@uga.edu	/AAD-2121-2020	/0000-0003-1101-8030; Han, Cliff/0000-0003-1972-0692	U.S. Department of Energy, Office of Environmental Management, Laboratory Directed Research and Development Program; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Environmental Remediation Sciences Program [KP1302000]; Office of the Vice President for Research, University of Georgia	U.S. Department of Energy, Office of Environmental Management, Laboratory Directed Research and Development Program(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Environmental Remediation Sciences Program(United States Department of Energy (DOE)); Office of the Vice President for Research, University of Georgia	CEB would like to acknowledge support from the U.S. Department of Energy, Office of Environmental Management as administered through the Laboratory Directed Research and Development Program, and the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Environmental Remediation Sciences Program (Contract #KP1302000). LJS would like to acknowledge support from the Office of the Vice President for Research, University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Bagwell CE, 2008, APPL ENVIRON MICROB, V74, P1376, DOI 10.1128/AEM.02175-07; Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Eschbach M, 2003, FEMS MICROBIOL LETT, V223, P227, DOI 10.1016/S0378-1097(03)00383-5; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; FREDRICKSON JK, 2008, ISME J; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; GUTMAN PD, 1994, MUTAT RES, V314, P87, DOI 10.1016/0921-8777(94)90064-7; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kudo T, 1998, INT J SYST BACTERIOL, V48, P1245, DOI 10.1099/00207713-48-4-1245; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Lee SD, 2006, INT J SYST EVOL MICR, V56, P1279, DOI 10.1099/ijs.0.64128-0; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lloyd JR, 2005, CURR OPIN BIOTECH, V16, P254, DOI 10.1016/j.copbio.2005.04.012; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Phillips RW, 2002, INT J SYST EVOL MICR, V52, P933, DOI 10.1099/00207713-52-3-933; Quardokus EM, 2003, CURR OPIN MICROBIOL, V6, P541, DOI 10.1016/j.mib.2003.10.013; Radajewski S, 2001, MICROB ECOL, V41, P233, DOI 10.1007/s002480000112; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Sale JE, 2007, CURR BIOL, V17, pR12, DOI 10.1016/j.cub.2006.11.037; Seib KL, 2006, MICROBIOL MOL BIOL R, V70, P344, DOI 10.1128/MMBR.00044-05; Servinsky MD, 2007, J BACTERIOL, V189, P5101, DOI 10.1128/JB.00409-07; Sghaier H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-297; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xu ZJ, 2007, MICROBIOL-SGM, V153, P1642, DOI 10.1099/mic.0.2006/002857-0; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; YOKOTA A, 1993, INT J SYST BACTERIOL, V43, P52, DOI 10.1099/00207713-43-1-52; ZACK MB, 1974, CHEST, V66, P240, DOI 10.1378/chest.66.3.240; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; ZHANG L, 2007, ARCH MICROBIOL; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x	61	46	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3878	10.1371/journal.pone.0003878	http://dx.doi.org/10.1371/journal.pone.0003878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057647	Green Submitted, Green Published, gold			2022-12-27	WOS:000265452300011
J	Ropelle, ER; Fernandes, MFA; Flores, MBS; Ueno, M; Rocco, S; Marin, R; Cintra, DE; Velloso, LA; Franchini, KG; Saad, MJA; Carvalheira, JBC				Ropelle, Eduardo R.; Fernandes, Maria Fernanda A.; Flores, Marcelo B. S.; Ueno, Mirian; Rocco, Silvana; Marin, Rodrigo; Cintra, Dennys E.; Velloso, Licio A.; Franchini, Kleber G.; Saad, Mario J. A.; Carvalheira, Jose B. C.			Central Exercise Action Increases the AMPK and mTOR Response to Leptin	PLOS ONE			English	Article								AMP-activated protein kinase (AMPK) and mammalian Target of Rapamycin (mTOR) are key regulators of cellular energy balance and of the effects of leptin on food intake. Acute exercise is associated with increased sensitivity to the effects of leptin on food intake in an IL-6-dependent manner. To determine whether exercise ameliorates the AMPK and mTOR response to leptin in the hypothalamus in an IL-6-dependent manner, rats performed two 3-h exercise bouts, separated by one 45-min rest period. Intracerebroventricular IL-6 infusion reduced food intake and pretreatment with AMPK activators and mTOR inhibitor prevented IL-6-induced anorexia. Activators of AMPK and fasting increased food intake in control rats to a greater extent than that observed in exercised ones, whereas inhibitor of AMPK had the opposite effect. Furthermore, the reduction of AMPK and ACC phosphorylation and increase in phosphorylation of proteins involved in mTOR signal transduction, observed in the hypothalamus after leptin infusion, were more pronounced in both lean and diet-induced obesity rats after acute exercise. Treatment with leptin reduced food intake in exercised rats that were pretreated with vehicle, although no increase in responsiveness to leptin-induced anorexia after pretreatment with anti-IL6 antibody, AICAR or Rapamycin was detected. Thus, the effects of leptin on the AMPK/mTOR pathway, potentiated by acute exercise, may contribute to appetite suppressive actions in the hypothalamus.	[Ropelle, Eduardo R.; Fernandes, Maria Fernanda A.; Flores, Marcelo B. S.; Ueno, Mirian; Rocco, Silvana; Marin, Rodrigo; Cintra, Dennys E.; Velloso, Licio A.; Franchini, Kleber G.; Saad, Mario J. A.; Carvalheira, Jose B. C.] Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Campinas, SP, Brazil	Universidade Estadual de Campinas	Ropelle, ER (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Campinas, SP, Brazil.	carvalheirajbc@uol.com.br	Cintra, Dennys E/N-7758-2017; Saad, Mario/ABD-8262-2020; Carvalheira, Jose B/H-8405-2012; Ropelle, Eduardo R/C-3977-2012	Cintra, Dennys E/0000-0002-7954-5630; Ropelle, Eduardo R/0000-0003-1655-9557	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de desenvolvimento cientifico e tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de desenvolvimento cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	These studies were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento cientifico e tecnologico (CNPq).	Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Andersson U, 2005, BIOCHEM BIOPH RES CO, V329, P719, DOI 10.1016/j.bbrc.2005.02.027; Araujo EP, 2002, FEBS LETT, V531, P437, DOI 10.1016/S0014-5793(02)03580-9; Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bruce CR, 2004, OBES RES, V12, P1158, DOI 10.1038/oby.2004.145; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Carvalheira JBC, 2003, DIABETOLOGIA, V46, P1629, DOI 10.1007/s00125-003-1246-x; Carvalheira JBC, 2001, FEBS LETT, V500, P119, DOI 10.1016/S0014-5793(01)02591-1; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Flores MBS, 2006, DIABETES, V55, P2554, DOI 10.2337/db05-1622; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keller C, 2003, J PHYSIOL-LONDON, V550, P927, DOI 10.1113/jphysiol.2003.044883; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; MAI JK, 1997, ATLAS HUMAN BRAIN, pR8; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995; Martins C, 2007, BRIT J NUTR, V98, P834, DOI 10.1017/S000711450774922X; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Nybo L, 2002, J PHYSIOL-LONDON, V542, P991, DOI 10.1113/jphysiol.2002.022285; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Penkowa M, 2003, FASEB J, V17, DOI 10.1096/fj.03-0311fje; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; RICHARD D, 1989, CAN J PHYSIOL PHARM, V67, P402, DOI 10.1139/y89-064; RICHARD D, 1989, AM J PHYSIOL, V256, pR886, DOI 10.1152/ajpregu.1989.256.4.R886; RIVEST S, 1990, BRAIN RES BULL, V25, P169, DOI 10.1016/0361-9230(90)90270-A; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006; ROTHWELL NJ, 1991, CAN J PHYSIOL PHARM, V69, P1465, DOI 10.1139/y91-219; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SANTTI E, 1994, BRIT J PHARMACOL, V113, P1231, DOI 10.1111/j.1476-5381.1994.tb17129.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shapiro A, 2008, DIABETES, V57, P614, DOI 10.2337/db07-0863; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; STOUTHARD JML, 1995, AM J PHYSIOL-ENDOC M, V268, pE813, DOI 10.1152/ajpendo.1995.268.5.E813; Tsigos C, 1997, NEUROENDOCRINOLOGY, V66, P54, DOI 10.1159/000127219; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Weigert C, 2005, AM J PHYSIOL-ENDOC M, V289, pE251, DOI 10.1152/ajpendo.00448.2004; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	68	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3856	10.1371/journal.pone.0003856	http://dx.doi.org/10.1371/journal.pone.0003856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052642	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452200008
J	Bishop, KL; Pai, AK; Schmitt, D				Bishop, Kristin L.; Pai, Anita K.; Schmitt, Daniel			Whole Body Mechanics of Stealthy Walking in Cats	PLOS ONE			English	Article							SYMMETRICAL GAITS; LOCOMOTION; DYNAMICS; PATTERNS	The metabolic cost associated with locomotion represents a significant part of an animal's metabolic energy budget. Therefore understanding the ways in which animals manage the energy required for locomotion by controlling muscular effort is critical to understanding limb design and the evolution of locomotor behavior. The assumption that energetic economy is the most important target of natural selection underlies many analyses of steady animal locomotion, leading to the prediction that animals will choose gaits and postures that maximize energetic efficiency. Many quadrupedal animals, particularly those that specialize in long distance steady locomotion, do in fact reduce the muscular contribution required for walking by adopting pendulum-like center of mass movements that facilitate exchange between kinetic energy (KE) and potential energy (PE) [1-4]. However, animals that are not specialized for long distance steady locomotion may face a more complex set of requirements, some of which may conflict with the efficient exchange of mechanical energy. For example, the "stealthy'' walking style of cats may demand slow movements performed with the center of mass close to the ground. Force plate and video data show that domestic cats (Felis catus, Linnaeus, 1758) have lower mechanical energy recovery than mammals specialized for distance. A strong negative correlation was found between mechanical energy recovery and diagonality in the footfalls and there was also a negative correlation between limb compression and diagonality of footfalls such that more crouched postures tended to have greater diagonality. These data show a previously unrecognized mechanical relationship in which crouched postures are associated with changes in footfall pattern which are in turn related to reduced mechanical energy recovery. Low energy recovery was not associated with decreased vertical oscillations of the center of mass as theoretically predicted, but rather with posture and footfall pattern on the phase relationship between potential and kinetic energy. An important implication of these results is the possibility of a tradeoff between stealthy walking and economy of locomotion. This potential tradeoff highlights the complex and conflicting pressures that may govern the locomotor choices that animals make.	[Bishop, Kristin L.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; [Pai, Anita K.; Schmitt, Daniel] Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27706 USA	University of California System; University of California Davis; Duke University	Bishop, KL (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	kvwbishop@ucdavis.edu			NSF [DBI-0630670, BCS-0452217]	NSF(National Science Foundation (NSF))	This work was supported by NSF awards DBI-0630670 to KLB and BCS-0452217 to DS.	Ahn AN, 2004, J EXP BIOL, V207, P399, DOI 10.1242/jeb.00761; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Biknevicius AR, 2007, J MORPHOL, V268, P1049; Biknevicius AR, 2006, J EXP ZOOL PART A, V305A, P923, DOI 10.1002/jez.a.332; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; DEMES B, 1994, J HUM EVOL, V26, P353, DOI 10.1006/jhev.1994.1023; Farley CT, 1997, J EXP BIOL, V200, P2177; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Griffin TM, 2004, J EXP BIOL, V207, P3545, DOI 10.1242/jeb.01177; HEDRICK TL, 2005, DLT DATA VIEWER 2; Manter JT, 1938, J EXP BIOL, V15, P522; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Usherwood JR, 2007, J EXP BIOL, V210, P533, DOI 10.1242/jeb.02647; Zani PA, 2005, J EXP BIOL, V208, P1489, DOI 10.1242/jeb.01554	16	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3808	10.1371/journal.pone.0003808	http://dx.doi.org/10.1371/journal.pone.0003808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043580	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451400001
J	Ospina, MB; Seida, JK; Clark, B; Karkhaneh, M; Hartling, L; Tjosvold, L; Vandermeer, B; Smith, V				Ospina, Maria B.; Seida, Jennifer Krebs; Clark, Brenda; Karkhaneh, Mohammad; Hartling, Lisa; Tjosvold, Lisa; Vandermeer, Ben; Smith, Veronica			Behavioural and Developmental Interventions for Autism Spectrum Disorder: A Clinical Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; HIGH-FUNCTIONING AUTISM; YOUNG-CHILDREN; ASPERGER-SYNDROME; COMMUNICATION INTERVENTIONS; METHODOLOGICAL QUALITY; PRESCHOOL-CHILDREN; TRAINING-PROGRAM; SOCIAL BEHAVIORS; TEACCH PROGRAM	Background: Much controversy exists regarding the clinical efficacy of behavioural and developmental interventions for improving the core symptoms of autism spectrum disorders (ASD). We conducted a systematic review to summarize the evidence on the effectiveness of behavioural and developmental interventions for ASD. Methods and Findings: Comprehensive searches were conducted in 22 electronic databases through May 2007. Further information was obtained through hand searching journals, searching reference lists, databases of theses and dissertations, and contacting experts in the field. Experimental and observational analytic studies were included if they were written in English and reported the efficacy of any behavioural or developmental intervention for individuals with ASD. Two independent reviewers made the final study selection, extracted data, and reached consensus on study quality. Results were summarized descriptively and, where possible, meta-analyses of the study results were conducted. One-hundred-and-one studies at predominantly high risk of bias that reported inconsistent results across various interventions were included in the review. Meta-analyses of three controlled clinical trials showed that Lovaas treatment was superior to special education on measures of adaptive behaviour, communication and interaction, comprehensive language, daily living skills, expressive language, overall intellectual functioning and socialization. High-intensity Lovaas was superior to low-intensity Lovaas on measures of intellectual functioning in two retrospective cohort studies. Pooling the results of two randomized controlled trials favoured developmental approaches based on initiative interaction compared to contingency interaction in the amount of time spent in stereotyped behaviours and distal social behaviour, but the effect sizes were not clinically significant. No statistically significant differences were found for: Lovaas versus special education for non-verbal intellectual functioning; Lovaas versus Developmental Individual-difference relationship-based intervention for communication skills; computer assisted instruction versus no treatment for facial expression recognition; and TEACCH versus standard care for imitation skills and eye-hand integration. Conclusions: While this review suggests that Lovaas may improve some core symptoms of ASD compared to special education, these findings are based on pooling of a few, methodologically weak studies with few participants and relatively short-term follow-up. As no definitive behavioural or developmental intervention improves all symptoms for all individuals with ASD, it is recommended that clinical management be guided by individual needs and availability of resources.	[Ospina, Maria B.; Seida, Jennifer Krebs; Karkhaneh, Mohammad; Hartling, Lisa; Tjosvold, Lisa; Vandermeer, Ben] Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Clark, Brenda] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2M7, Canada; [Smith, Veronica] Univ Alberta, Fac Ed, Dept Ed Psychol, Edmonton, AB T6G 2M7, Canada	University of Alberta; University of Alberta; University of Alberta	Ospina, MB (corresponding author), Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	veronica.smith@ualberta.ca		Ospina, Maria/0000-0002-1627-4781; Tjosvold, Lisa/0000-0002-5667-6312; Smith, Veronica/0000-0003-2441-7516; Ospina, Maria/0000-0001-9305-7521	Alberta Centre for Child, Family and Community Research [G299000474]	Alberta Centre for Child, Family and Community Research	This study was funded by the Grant # G299000474 from the Alberta Centre for Child, Family and Community Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Alberta Centre for Child, Family and Community Research.	Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; ALTMAN D, 2001, BMJ-BRIT MED J, V326, P446; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDREWS SM, 2005, DISSERT ABST INT B, V65, P5386; Andrist P, 1998, SCRIPTORIUM, V52, P12; Arnold C.L., 2003, DISS ABSTR INT B, V63, P3897; BADER R, 2006, THESIS ALLIANT INT U; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; BASSETT K, 2001, ANN M INT SOC TECHNO, V17; Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; BECKLOFF DR, 1997, THESIS U N TEXAS DEN; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; BERG HP, 2002, THESIS COLUMBIA U TE; Bernard-Opitz V, 2004, AUTISM, V8, P319, DOI 10.1177/1362361304045212; Bettison S, 1996, J AUTISM DEV DISORD, V26, P361, DOI 10.1007/BF02172480; Bhogal SK, 2005, J CLIN EPIDEMIOL, V58, P668, DOI 10.1016/j.jclinepi.2005.01.002; Birnbrauer J.S., 1993, BEHAV CHANGE, V10, P63, DOI [DOI 10.1017/S0813483900005556, 10.1017/S0813483900005556]; BLOCH J, 1980, J SPEECH HEAR DISORD, V45, P76, DOI 10.1044/jshd.4501.76; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bradburn, 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926.CH15; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; CANTU Y, 2007, INCREASING SOCIAL IN; Carr D, 2007, J AUTISM DEV DISORD, V37, P780, DOI 10.1007/s10803-006-0204-0; Carr D, 2007, J AUTISM DEV DISORD, V37, P724, DOI 10.1007/s10803-006-0203-1; *CDCP, 2000, PREV AUT BRICK TOWNS; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Cohen H, 2006, J DEV BEHAV PEDIATR, V27, pS145, DOI 10.1097/00004703-200604002-00013; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collier D.H., 1987, ADAPTED PHYS ACTIVIT, V4, P226, DOI [https://doi.org/10.1123/apaq.4.3.226, DOI 10.1123/APAQ.4.3.226]; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Deeks J J, 2003, Health Technol Assess, V7, piii; DEMPSEY I, 2001, INT J DISABIL DEV ED, V48, P103; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; DIGGLE T, 2002, COCHRANE DATABASE SY; Drew A, 2002, EUR CHILD ADOLES PSY, V11, P266, DOI 10.1007/s00787-002-0299-6; DUGAN KT, 2006, FACILITATING INDEPEN; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EAGLE R, 2006, THESIS STATE U NEW Y; Edelson SM, 1999, AM J OCCUP THER, V53, P145, DOI 10.5014/ajot.53.2.145; EDELSON SM, 1999, FOCUS AUTISM OTHER D, V14, P73, DOI DOI 10.1177/108835769901400202; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eikeseth S, 2002, BEHAV MODIF, V26, P49, DOI 10.1177/0145445502026001004; Eikeseth S, 2007, BEHAV MODIF, V31, P264, DOI 10.1177/0145445506291396; Eldevik S, 2006, J AUTISM DEV DISORD, V36, P211, DOI 10.1007/s10803-005-0058-x; ELLIOTT RO, 1991, J AUTISM DEV DISORD, V21, P433, DOI 10.1007/BF02206869; Escalona A, 2002, J AUTISM DEV DISORD, V32, P141, DOI 10.1023/A:1014896707002; Escalona A, 2001, J AUTISM DEV DISORD, V31, P513, DOI 10.1023/A:1012273110194; Farrell P., 2005, ED CHILD PSYCHOL, V22, P29; FEINBERG MJ, 2002, DISS ABST INT B, V62, P3797; FENSKE EC, 1985, ANAL INTERVEN DEVEL, V5, P49, DOI 10.1016/S0270-4684(85)80005-7; Field T, 1997, J AUTISM DEV DISORD, V27, P333, DOI 10.1023/A:1025858600220; Field T, 2001, AUTISM, V5, P317, DOI 10.1177/1362361301005003008; FINCH L, 2003, OCCUPATIONAL THERAPY, V5, P20; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Garcia-Villamisar D, 2007, J INTELL DISABIL RES, V51, P142, DOI 10.1111/j.1365-2788.2006.00854.x; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; GONZALEZ JS, 2006, PARENT IMPLEMENTATIO; GREERPAGLIA K, 2006, EXAMINING EFFECTS CR; Harris S. L., 1983, CHILD FAMILY BEHAV T, V4, P151, DOI DOI 10.1300/J019V04N02_16; HARRIS SL, 1990, J AUTISM DEV DISORD, V20, P23, DOI 10.1007/BF02206854; HARRISON JR, 1991, CHILD STUDY J, V21, P153; HARTSHORN K, 2001, EARLY CHILD DEV CARE, V166, P1, DOI DOI 10.1080/0300443011660101; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Heimann M, 2006, INFANT CHILD DEV, V15, P297, DOI 10.1002/icd.463; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILTON JC, 2005, THESIS J MADISON U H; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; HOURMANESH N, 2006, THESIS U UTAH SALT L; *HOUS REPR, 2005, SPEC ED CHILDR AUT; Howard JS, 2005, RES DEV DISABIL, V26, P359, DOI 10.1016/j.ridd.2004.09.005; HOWLIN P, 1981, BRIT J DISORD COMMUN, V16, P73; HUNG DW, 1983, ED TREATMENT CHILDRE, V6, P47; Hutchison-Harris J., 2004, DISS ABSTR INT B, V65, P2609; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JARUSIEWICZ B, 2002, J NEUROTHERAPY, V6, P39, DOI [10.1300/J184v06n04_05, DOI 10.1300/J184V06N04_05]; JELVEH M, 2003, DISS ABST INT A, V64, P397; Jocelyn LJ, 1998, J DEV BEHAV PEDIATR, V19, P326, DOI 10.1097/00004703-199810000-00002; Kalyva E, 2005, J APPL RES INTELLECT, V18, P253, DOI 10.1111/j.1468-3148.2005.00232.x; Kasari C, 2006, J CHILD PSYCHOL PSYC, V47, P611, DOI 10.1111/j.1469-7610.2005.01567.x; Koegel LK, 1997, J AUTISM DEV DISORD, V27, P233, DOI 10.1023/A:1025894213424; Koegel RL, 1996, J AUTISM DEV DISORD, V26, P347, DOI 10.1007/BF02172479; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LANQUETOT R, 1989, J MULTIHANDICAPPED P, V2, P25; LAYTON TL, 1988, J COMMUN DISORD, V21, P333, DOI 10.1016/0021-9924(88)90037-8; Legoff DB, 2006, AUTISM, V10, P317, DOI 10.1177/1362361306064403; LOPATA C, 2006, FOCUS AUTISM OTHER D, V21, P237, DOI DOI 10.1177/10883576060210040501; LORD C, 2001, DIVISION BEHAV SOCIA; Lovaas O.I, 1981, TEACHING DEV DISABLE; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; LUCE JB, 2003, DISS ABST INT B, V64, P1524; LUDWIG S, 2001, INTENSIVE INTERVENTI, P40; MACALPINE ML, 1999, DISS ABST INT B, V59, P5593; MASON MA, 2005, THESIS CAPELLA U MIN; Maurice C.E., 1996, BEHAV INTERVENTION Y; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McConachie H, 2005, J PEDIATR-US, V147, P335, DOI 10.1016/j.jpeds.2005.03.056; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; MCGAHAN L, 2001, BEHAV INTERVENTIONS; MCGAHAN L, 2001, ABSTR SOC NEUROSCI, V27; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; MCMAHON RJ, 2004, M NIH WORK GROUP MET; Millar DC, 2006, J SPEECH LANG HEAR R, V49, P248, DOI 10.1044/1092-4388(2006/021); MILLER LA, 2006, THESIS U UTAH SALT L; Mirenda P., 2001, FOCUS AUTISM DEV DIS, V16, P141, DOI DOI 10.1177/108835760101600302; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moore M, 2000, J AUTISM DEV DISORD, V30, P359, DOI 10.1023/A:1005535602064; Mudford OC, 2000, AM J MENT RETARD, V105, P118, DOI 10.1352/0895-8017(2000)105<0118:AITFCW>2.0.CO;2; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; NELSON DL, 1980, J AUTISM DEV DISORD, V10, P311, DOI 10.1007/BF02408290; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; OPENDEN DA, 2005, THESIS U CALIFORNIA; OXMAN J, 1979, INT J REHABIL RES, V2, P394, DOI 10.1097/00004356-197909000-00018; OZONOFF S, 1995, J AUTISM DEV DISORD, V25, P415, DOI 10.1007/BF02179376; Ozonoff S, 1998, J AUTISM DEV DISORD, V28, P25, DOI 10.1023/A:1026006818310; Panerai S, 2002, J INTELL DISABIL RES, V46, P318, DOI 10.1046/j.1365-2788.2002.00388.x; PAUL VR, 2005, HDB AUTISM PERVASIVE; PECHOUS EA, 2001, DISS ABSTR INT B, V61, P6145; Prizant Barry, 1998, Seminars in Speech and Language, V19, P329; PRIZANT BM, 1998, SEMIN SPEECH LANG, V19, P424; PROVENCAL SL, 2003, DISS ABST INT B, V64, P1504; QUIRMBACH LM, 2006, THESIS ALLIANT INT U; Reynhout G, 2006, J AUTISM DEV DISORD, V36, P445, DOI 10.1007/s10803-006-0086-1; RICCIARDELLI D, 2006, THESIS FAIRLEIGH DIC; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Roberts J, 2006, REV RES IDENTIFY MOS; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; ROMANO J, 2002, DISS ABSTR INT B, V63, P1046; Sallows GO, 2005, AM J MENT RETARD, V110, P417, DOI 10.1352/0895-8017(2005)110[417:IBTFCW]2.0.CO;2; Salt J, 2002, AUTISM, V6, P33, DOI 10.1177/1362361302006001004; Sansosti F. J., 2004, FOCUS AUTISM OTHER D, V19, P194, DOI DOI 10.1177/10883576040190040101; SARAYDARIAN KA, 1994, THESIS COLUMBIA U TE; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Scottish Intercollegiate Guidelines Network, 2004, METH CHECKL 3 COH ST; SEIDA JK, DEV MED CHI IN PRESS; SHADEMONUTEAUX DM, 2003, DISS ABST INT B, V63, P6107; Sheinkopf SJ, 1998, J AUTISM DEV DISORD, V28, P15, DOI 10.1023/A:1026054701472; SHERMAN J, 1988, CHILD PSYCHIAT HUM D, V19, P109, DOI 10.1007/BF00707358; Silver M, 2001, AUTISM, V5, P299, DOI 10.1177/1362361301005003007; SMITH DEP, 1985, J AUTISM DEV DISORD, V15, P285, DOI 10.1007/BF01531499; Smith T, 2000, AM J MENT RETARD, V105, P508; Smith T, 2000, AM J MENT RETARD, V105, P269, DOI 10.1352/0895-8017(2000)105<0269:RTOIEI>2.0.CO;2; Smith T, 1999, CLIN PSYCHOL-SCI PR, V6, P33, DOI 10.1093/clipsy/6.1.33; Smith T, 1997, AM J MENT RETARD, V102, P238, DOI 10.1352/0895-8017(1997)102<0238:IBTFPW>2.0.CO;2; Smith T, 2007, J AUTISM DEV DISORD, V37, P354, DOI 10.1007/s10803-006-0173-3; Sofronoff K, 2005, J CHILD PSYCHOL PSYC, V46, P1152, DOI 10.1111/j.1469-7610.2005.00411.x; Sofronoff K, 2002, AUTISM, V6, P271, DOI 10.1177/1362361302006003005; Sofronoff K, 2004, AUTISM, V8, P301, DOI 10.1177/1362361304045215; Sofronoff K, 2007, J AUTISM DEV DISORD, V37, P1203, DOI 10.1007/s10803-006-0262-3; Solomon M, 2004, J AUTISM DEV DISORD, V34, P649, DOI 10.1007/s10803-004-5286-y; Stahmer A.C., 2001, J POSIT BEHAV INTERV, V3, P75, DOI [DOI 10.1177/109830070100300203, 10.1177/109830070100300203]; SUEDFELD P, 1983, J DEV BEHAV PEDIATR, V4, P196, DOI 10.1097/00004703-198309000-00009; Tonge B, 2006, J AM ACAD CHILD PSY, V45, P561, DOI 10.1097/01.chi.0000205701.48324.26; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Tsang SKM, 2007, J AUTISM DEV DISORD, V37, P390, DOI 10.1007/s10803-006-0199-6; TUNG R, 2005, THESIS SAN JOSE STAT; Van Bourgondien ME, 2003, J AUTISM DEV DISORD, V33, P131, DOI 10.1023/A:1022931224934; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WANG P, 2005, THESIS COLUMBIA U NE; Wells G., 2005, NEWCASTLE OTTAWA SCA; Wetherby AM, 2006, TOP EARLY CHILD SPEC, V26, P67, DOI 10.1177/02711214060260020201; WHITE S, 2000, THESIS U PACIFIC STO; Whitehead WE, 2004, GASTROENTEROLOGY, V126, pS159, DOI 10.1053/j.gastro.2003.10.038; Williams C, 2002, AUTISM, V6, P71, DOI 10.1177/1362361302006001006; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Yoder P, 2006, J SPEECH LANG HEAR R, V49, P698, DOI 10.1044/1092-4388(2006/051); Yoder P, 2006, J CONSULT CLIN PSYCH, V74, P426, DOI 10.1037/0022-006X.74.3.426; YODER PJ, 1988, J AUTISM DEV DISORD, V18, P217, DOI 10.1007/BF02211948; ZIFFERBLATT SM, 1977, J AUTISM CHILD SCHIZ, V7, P337, DOI 10.1007/BF01540392	173	203	208	6	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3755	10.1371/journal.pone.0003755	http://dx.doi.org/10.1371/journal.pone.0003755			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XC	19015734	gold, Green Published			2022-12-27	WOS:000265448400011
J	Yang, HN; Harrington, CA; Vartanian, K; Coldren, CD; Hall, R; Churchill, GA				Yang, Hyuna; Harrington, Christina A.; Vartanian, Kristina; Coldren, Christopher D.; Hall, Rob; Churchill, Gary A.			Randomization in Laboratory Procedure Is Key to Obtaining Reproducible Microarray Results	PLOS ONE			English	Article							GENE-EXPRESSION	The quality of gene expression microarray data has improved dramatically since the first arrays were introduced in the late 1990s. However, the reproducibility of data generated at multiple laboratory sites remains a matter of concern, especially for scientists who are attempting to combine and analyze data from public repositories. We have carried out a study in which a common set of RNA samples was assayed five times in four different laboratories using Affymetrix GeneChip arrays. We observed dramatic differences in the results across laboratories and identified batch effects in array processing as one of the primary causes for these differences. When batch processing of samples is confounded with experimental factors of interest it is not possible to separate their effects, and lists of differentially expressed genes may include many artifacts. This study demonstrates the substantial impact of sample processing on microarray analysis results and underscores the need for randomization in the laboratory as a means to avoid confounding of biological factors with procedural effects.	[Yang, Hyuna; Churchill, Gary A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Harrington, Christina A.; Vartanian, Kristina] Oregon Hlth & Sci Univ, OHSU Canc Inst, Portland, OR USA; [Coldren, Christopher D.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Hall, Rob] Univ Washington, Dept Microbiol, Ctr Array Technol, Seattle, WA 98195 USA	Jackson Laboratory; Oregon Health & Science University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Washington; University of Washington Seattle	Yang, HN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	gary.churchill@jax.org	Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284	NHLBI [R01 HL72321]; NIGMS [GM070683]; CDC [R01 HL7234001]; Cancer Center [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072321, R01HL072340] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI consortium grant (R01 HL72321), NIGMS center of excellence in systems biology (GM070683; GAC), Expression analysis to Study Disease Pathogenesis, Shared Microarray Facilities (R01 HL7234001; CDC), Cancer Center Support Grant CA034196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; *GEN ONT CONS, 2002, NAT GENET, V25, P25; Hartigan J., 1975, CLUSTERING ALGORITHM; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Seo DM, 2007, ANN APPL STAT, V1, P152, DOI 10.1214/07-AOAS110; Shockley KR, 2006, MAMM GENOME, V17, P598, DOI 10.1007/s00335-005-0176-y; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Waring JF, 2004, ENVIRON HEALTH PERSP, V112, P439, DOI 10.1289/ehp.6643	23	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3724	10.1371/journal.pone.0003724	http://dx.doi.org/10.1371/journal.pone.0003724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009020	Green Published, Green Submitted, gold			2022-12-27	WOS:000265166400003
J	Friedrich, B; Weyrich, P; Stancakova, A; Wang, J; Kuusisto, J; Laakso, M; Sesti, G; Succurro, E; Smith, U; Hansen, T; Pedersen, O; Machicao, F; Schafer, S; Lang, F; Risler, T; Ullrich, S; Stefan, N; Fritsche, A; Haring, HU				Friedrich, Bjoern; Weyrich, Peter; Stancakova, Alena; Wang, Jianjung; Kuusisto, Johanna; Laakso, Markku; Sesti, Giorgio; Succurro, Elena; Smith, Ulf; Hansen, Torben; Pedersen, Oluf; Machicao, Fausto; Schaefer, Silke; Lang, Florian; Risler, Teut; Ullrich, Susanne; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich			Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies	PLOS ONE			English	Article								Hypothesis: Serum and Glucocorticoid-inducible Kinase 1 (SGK1) is involved in the regulation of insulin secretion and may represent a candidate gene for the development of type 2 diabetes mellitus in humans. Methods: Three independent European populations were analyzed for the association of SGK1 gene (SGK) variations and insulin secretion traits. The German TUEF project provided the screening population (N = 725), and four tagging SNPs (rs1763527, rs1743966, rs1057293, rs9402571) were investigated. EUGENE2 (N = 827) served as a replication cohort for the detected associations. Finally, the detected associations were validated in the METSIM study, providing 3798 non-diabetic and 659 diabetic (type 2) individuals. Results: Carriers of the minor G allele in rs9402571 had significantly higher C-peptide levels in the 2 h OGTT (+10.8%, p=0.04; dominant model) and higher AUC(C-Peptide)/AUC(Glc) ratios (+7.5%, p=0.04) compared to homozygous wild type TT carriers in the screening population. As interaction analysis for BMIxrs9402571 was significant (p=0.04) for the endpoint insulin secretion, we stratified the TUEF cohort for BMI, using a cut off point of BMI=25. The effect on insulin secretion only remained significant in lean TUEF participants (BMI <= 25). This finding was replicated in lean EUGENE2 rs9402571 minor allele carriers, who had a significantly higher AUC(Ins)/AUC(Glc) (TT: 226 +/- 7, XG: 246 +/- 9; p = 0.019). Accordingly, the METSIM trial revealed a lower prevalence of type 2 diabetes (OR: 0.85; 95%CI: 0.71-1.01; p = 0.065, dominant model) in rs9402571 minor allele carriers. Conclusions: The rs9402571 SGK genotype associates with increased insulin secretion in lean non-diabetic TUEF/EUGENE2 participants and with lower diabetes prevalence in METSIM. Our study in three independent European populations supports the conclusion that SGK variability affects diabetes risk.	[Friedrich, Bjoern; Weyrich, Peter; Machicao, Fausto; Schaefer, Silke; Risler, Teut; Ullrich, Susanne; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany; [Lang, Florian] Univ Tubingen, Dept Physiol, D-72074 Tubingen, Germany; [Stancakova, Alena; Wang, Jianjung; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Sesti, Giorgio; Succurro, Elena] Magna Graecia Univ Catanzaro, Polyclin Mater Domini, Dept Expt & Clin Med, Catanzaro, Italy; [Smith, Ulf] Sahlgrens Univ Hosp, Dept Internal Med, Lundberg Lab Diabetes Res, Gothenburg, Sweden; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Kuopio University Hospital; University of Eastern Finland; Magna Graecia University of Catanzaro; Sahlgrenska University Hospital; Steno Diabetes Center; University of Copenhagen	Friedrich, B (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany.	andreas.fritsche@med.uni-tuebingen.de	Sesti, Giorgio/B-1509-2012; Stancakova, Alena/AAN-6723-2020; Pedersen, Oluf/AAG-8015-2020; Succurro, Elena/K-4138-2016; Pedersen, Oluf/Z-1731-2019	Stancakova, Alena/0000-0002-1375-0252; Succurro, Elena/0000-0003-2578-692X; Pedersen, Oluf/0000-0002-3321-3972; Sesti, Giorgio/0000-0002-1618-7688; Stefan, Norbert/0000-0002-2186-9595; Hansen, Torben/0000-0001-8748-3831	Deutsche Forschungsgemeinschaft [KFO 114, STE 1096/1-1]; European Community's FP6 EUGENE2 [LSHM-CT-2004-512013]; Medical Faculty of the University of Tubingen [1212-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community's FP6 EUGENE2; Medical Faculty of the University of Tubingen	The study was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 114, Heisenberg-Grant to NS: STE 1096/1-1), the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013) and by an intramural grant from the Medical Faculty of the University of Tubingen (Fortune Program Nr. 1212-0-0 to BF).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Grahammer F, 2006, AM J PHYSIOL-GASTR L, V290, pG1114, DOI 10.1152/ajpgi.00231.2005; Grarup N, 2007, CURR OPIN CLIN NUTR, V10, P420, DOI 10.1097/MCO.0b013e3281e2c9ab; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Jeyaraj S, 2007, BIOCHEM BIOPH RES CO, V356, P629, DOI 10.1016/j.bbrc.2007.03.029; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Palmada M, 2006, DIABETES, V55, P421, DOI 10.2337/diabetes.55.02.06.db05-0720; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Thamer C, 2003, DIABETES CARE, V26, P2126, DOI 10.2337/diacare.26.7.2126; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Ullrich S, 2007, BIOCHEM BIOPH RES CO, V352, P662, DOI 10.1016/j.bbrc.2006.11.065; Utzschneider KM, 2007, DIABETOLOGIA, V50, P2516, DOI 10.1007/s00125-007-0819-5; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3506	10.1371/journal.pone.0003506	http://dx.doi.org/10.1371/journal.pone.0003506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985156	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134400001
J	Di Stefano, M; Calabro, ML; Di Gangi, IM; Cantatore, S; Barbierato, M; Bergamo, E; Kfutwah, AJ; Neri, M; Chieco-Bianchi, L; Greco, P; Gesualdo, L; Ayouba, A; Menu, E; Fiore, JR				Di Stefano, Mariantonietta; Calabro, Maria Luisa; Di Gangi, Iole Maria; Cantatore, Santina; Barbierato, Massimo; Bergamo, Elisa; Kfutwah, Anfumbom Jude; Neri, Margherita; Chieco-Bianchi, Luigi; Greco, Pantaleo; Gesualdo, Loreto; Ayouba, Ahidjo; Menu, Elisabeth; Fiore, Jose Ramon			In Vitro and In Vivo Human Herpesvirus 8 Infection of Placenta	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; HERPES-SIMPLEX-VIRUS; HERPESVIRUS/HUMAN HERPESVIRUS-8; TRANSMISSION; PREGNANCY; DNA; CYTOMEGALOVIRUS; REPLICATION; APOPTOSIS; TYPE-1	Herpesvirus infection of placenta may be harmful in pregnancy leading to disorders in fetal growth, premature delivery, miscarriage, or major congenital abnormalities. Although a correlation between human herpesvirus 8 (HHV-8) infection and abortion or low birth weight in children has been suggested, and rare cases of in utero or perinatal HHV-8 transmission have been documented, no direct evidence of HHV-8 infection of placenta has yet been reported. The aim of this study was to evaluate the in vitro and in vivo susceptibility of placental cells to HHV-8 infection. Short-term infection assays were performed on placental chorionic villi isolated from term placentae. Qualitative and quantitative HHV-8 detection were performed by PCR and real-time PCR, and HHV-8 proteins were analyzed by immunohistochemistry. Term placenta samples from HHV-8-seropositive women were analyzed for the presence of HHV-8 DNA and antigens. In vitro infected histocultures showed increasing amounts of HHV-8 DNA in tissues and supernatants; cyto- and syncitiotrophoblasts, as well as endothelial cells, expressed latent and lytic viral antigens. Increased apoptotic phenomena were visualized by the terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end-labeling method in infected histocultures. Ex vivo, HHV-8 DNA and a latent viral antigen were detected in placenta samples from HHV-8-seropositive women. These findings demonstrate that HHV-8, like other human herpesviruses, may infect placental cells in vitro and in vivo, thus providing evidence that this phenomenon might influence vertical transmission and pregnancy outcome in HHV-8-infected women.	[Gesualdo, Loreto] Univ Foggia, Mol Med Lab, Foggia, Italy; [Calabro, Maria Luisa; Di Gangi, Iole Maria; Bergamo, Elisa] IRCCS, Ist Oncol Veneto, Padua, Italy; [Cantatore, Santina] Univ Foggia, Sch Med, Lab Histol, Foggia, Italy; [Barbierato, Massimo; Chieco-Bianchi, Luigi] Univ Padua, Dept Oncol & Surg Sci, Oncol Sect, I-35100 Padua, Italy; [Kfutwah, Anfumbom Jude] Ctr Pasteur, Lab Virol, Yaounde, Cameroon; [Neri, Margherita; Greco, Pantaleo] Univ Foggia, Dept Surg Sci, Foggia, Italy; [Ayouba, Ahidjo] Inst Rech Dev, Unite Mixte Rech 145, Montpellier, France; [Menu, Elisabeth] Inst Pasteur, Unite Regulat Infect Retroviral, Paris, France; [Fiore, Jose Ramon] Univ Foggia, Dept Clin & Occupat Hlth, Foggia, Italy	University of Foggia; IRCCS Istituto Oncologico Veneto (IOV); University of Foggia; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Foggia; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Foggia	Di Stefano, M (corresponding author), Univ Foggia, Mol Med Lab, Foggia, Italy.	j.fiore@unifg.it	Gesualdo, Loreto/K-7751-2016; Neri, Margherita/AAD-4521-2022; MENU, Elisabeth/B-2886-2010; Calabrò, Maria Luisa/H-6015-2016; Greco, Pantaleo/AAC-5173-2022; Ayouba, Ahidjo/G-8775-2017	Gesualdo, Loreto/0000-0002-4861-0911; MENU, Elisabeth/0000-0001-8844-9328; Calabrò, Maria Luisa/0000-0001-9401-6182; Ayouba, Ahidjo/0000-0002-5081-1632; di stefano, mariantonietta/0000-0001-8814-0953; NERI, Margherita/0000-0002-6459-1669; di gangi, iole maria/0000-0001-6192-5451; GRECO, Pantaleo/0000-0003-2461-6777; fiore, jose ramon/0000-0002-3079-5866	Istituto Superiore di Sanita [50G.3, 50G.29]; Associazione Italiana per la Ricerca sul Cancro [fellowship]; Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma; Istituto Oncologico Veneto, IRCCS [fellowship]	Istituto Superiore di Sanita; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma(Fondazione AIRC per la ricerca sul cancro); Istituto Oncologico Veneto, IRCCS	This work was supported by grants from Istituto Superiore di Sanita (grant n. 50G.3, MLC; grant n. 50G.29, JRF) and from Associazione Italiana per la Ricerca sul Cancro (MLC). MB was the recipient of a fellowship from Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma (AIL). IMDG was the recipient of a fellowship from Istituto Oncologico Veneto, IRCCS; EB was the recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7; Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014; Bestetti G, 1998, AIDS, V12, P541; Brayfield BP, 2004, J INFECT DIS, V189, P2260, DOI 10.1086/421119; Brayfield BP, 2003, J INFECT DIS, V187, P559, DOI 10.1086/367985; CALABRESE EJ, 1999, BELLE NEWSLETTER, V8, P1; Carbone A, 2000, LEUKEMIA LYMPHOMA, V36, P447, DOI 10.3109/10428190009148391; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chow SSW, 2006, J MED VIROL, V78, P747, DOI 10.1002/jmv.20618; Csoma E, 2002, J MED VIROL, V67, P67, DOI 10.1002/jmv.2194; Dedicoat M, 2004, J INFECT DIS, V190, P1068, DOI 10.1086/423326; Du MQ, 2007, J CLIN PATHOL, V60, P1350, DOI 10.1136/jcp.2007.047969; Enright AM, 2004, PEDIATR CLIN N AM, V51, P889, DOI 10.1016/j.pcl.2004.03.005; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gasperini P, 2005, J CLIN MICROBIOL, V43, P2866, DOI 10.1128/JCM.43.6.2866-2875.2005; Gaye-Diallo A, 2001, B SOC PATHOL EXOT, V94, P231; Kawana K, 1996, INT J GYNECOL OBSTET, V55, P165, DOI 10.1016/S0020-7292(96)02732-4; Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06; Mantina H, 2001, INT J CANCER, V94, P749, DOI 10.1002/ijc.1529; Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0; Nikkels AF, 2005, J INFECT DIS, V191, P540, DOI 10.1086/426942; Pica F, 2007, CURR OPIN INFECT DIS, V20, P152, DOI 10.1097/QCO.0b013e3280143919; Plancoulaine S, 2004, CANCER RES, V64, P8782, DOI 10.1158/0008-5472.CAN-04-2000; Rezza G, 2000, SEX TRANSM DIS, V27, P159, DOI 10.1097/00007435-200003000-00008; Sarmati L, 2003, J INFECT DIS, V188, P173, DOI 10.1086/375830; Sarmati Loredana, 2004, Herpes, V11, P50; Schleiss Mark R, 2003, Herpes, V10, P4; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1; Toth FD, 1997, VIROLOGY, V229, P400, DOI 10.1006/viro.1997.8449; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Weck RL, 2008, CLIN OBSTET GYNECOL, V51, P349, DOI 10.1097/GRF.0b013e31816f276e; Wojcicki JM, 2004, EPIDEMIOL INFECT, V132, P1191, DOI 10.1017/S0950268804002845	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4073	10.1371/journal.pone.0004073	http://dx.doi.org/10.1371/journal.pone.0004073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115001	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466300013
J	Wei, W; Qing, TT; Ye, X; Liu, HS; Zhang, DH; Yang, WF; Deng, HK				Wei, Wei; Qing, Tingting; Ye, Xin; Liu, Haisong; Zhang, Donghui; Yang, Weifeng; Deng, Hongkui			Primordial Germ Cell Specification from Embryonic Stem Cells	PLOS ONE			English	Article								Background: Primordial germ cell (PGC) specification is the first crucial step in germ line development. However, owing to significant challenges regarding the in vivo system, such as the complex cellular environment and potential problems with embryo manipulation, it is desirable to generate embryonic stem (ES) cells that are capable of overcoming these aforementioned limitations in order to provide a potential in vitro model to recapitulate the developmental processes in vivo. Methodology and Principal Findings: Here, we studied the detailed process of PGC specification from stella-GFP ES cells. We first observed the heterogeneous expression of stella in ES cells. However, neither Stella-positive ES cells nor Stella-negative ES cells shared a similar gene expression pattern with either PGCs or PGC precursors. Second, we derived PGCs from ES cells using two differentiation methods, namely the attachment culture technique and the embryoid body (EB) method. Compared with PGCs derived via the attachment culture technique, PGCs derived via the EB method that had undergone the sequential erasure of Peg3 followed by Igf2r resulted in a cell line in which the expression dynamics of T, Fgf8 and Sox17, in addition to the expression of the epiblast markers, were more similar to the in vivo expression, thus demonstrating that the process of PGC derivation was more faithfully recapitulated using the EB method. Furthermore, we developed an in vitro model of PGC specification in a completely chemically defined medium (CDM) that indicated that BMP4 and Wnt3a promoted PGC derivation, whereas BMP8b and activinA had no observable effect on PGC derivation. Conclusions and Significance: The in vitro model we have established can recapitulate the developmental processes in vivo and provides new insights into the mechanism of PGC specification.	[Wei, Wei; Zhang, Donghui; Yang, Weifeng; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Sch Chem Biol & Biothechnol, Shenzhen, Peoples R China; [Wei, Wei; Qing, Tingting; Ye, Xin; Liu, Haisong; Zhang, Donghui; Yang, Weifeng; Deng, Hongkui] Peking Univ, Coll Life Sci, Lab Stem Cell & Generat Biol, Beijing, Peoples R China; [Qing, Tingting] INSERM, UEVE U861 I Stem, AFM, Evry, France; [Ye, Xin] Univ British Columbia, St Pauls Hosp, Cardiovasc Res Lab, Vancouver, BC V5Z 1M9, Canada	Peking University; University Town of Shenzhen; Peking University; Institut National de la Sante et de la Recherche Medicale (Inserm); St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Wei, W (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Sch Chem Biol & Biothechnol, Shenzhen, Peoples R China.	hongkui_deng@pku.edu.cn	zhang, donghui/I-5130-2013; zhang, donghui/AAY-4690-2021	zhang, donghui/0000-0001-7258-8577; liu, Haisong/0000-0002-7645-0855	National Basic Research Program for China [2007CB947900]; Gongjian project of the Beijing Municipal Education Commission; National Nature Science Foundation of China for Creative Research Groups [30421004]; Bill & Melinda Gates Foundation [37871]; 111 Project	National Basic Research Program for China(National Basic Research Program of China); Gongjian project of the Beijing Municipal Education Commission; National Nature Science Foundation of China for Creative Research Groups(National Natural Science Foundation of China (NSFC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); 111 Project(Ministry of Education, China - 111 Project)	This research was supported by the National Basic Research Program for China (973 Program 2007CB947900), the Gongjian project of the Beijing Municipal Education Commission, the National Nature Science Foundation of China for Creative Research Groups (30421004), a Bill & Melinda Gates Foundation Grant (37871) and a 111 Project to H. Deng. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Dudley BM, 2007, MECH DEVELOP, V124, P68, DOI 10.1016/j.mod.2006.09.005; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kehler J, 2005, SEMIN REPROD MED, V23, P222, DOI 10.1055/s-2005-872450; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee J, 2002, DEVELOPMENT, V129, P1807; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Sadlon TJ, 2004, STEM CELLS, V22, P457, DOI 10.1634/stemcells.22-4-457; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Shen W, 2006, BIOL REPROD, V75, P615, DOI 10.1095/biolreprod.106.051482; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	34	66	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4013	10.1371/journal.pone.0004013	http://dx.doi.org/10.1371/journal.pone.0004013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107197	Green Submitted, gold, Green Published			2022-12-27	WOS:000265463000008
J	Canepari, M; Vogt, KE				Canepari, Marco; Vogt, Kaspar E.			Dendritic Spike Saturation of Endogenous Calcium Buffer and Induction of Postsynaptic Cerebellar LTP	PLOS ONE			English	Article								The architecture of parallel fiber axons contacting cerebellar Purkinje neurons retains spatial information over long distances. Parallel fiber synapses can trigger local dendritic calcium spikes, but whether and how this calcium signal leads to plastic changes that decode the parallel fiber input organization is unknown. By combining voltage and calcium imaging, we show that calcium signals, elicited by parallel fiber stimulation and mediated by voltage-gated calcium channels, increase non-linearly during high-frequency bursts of electrically constant calcium spikes, because they locally and transiently saturate the endogenous buffer. We demonstrate that these non-linear calcium signals, independently of NMDA or metabotropic glutamate receptor activation, can induce parallel fiber long-term potentiation. Two-photon imaging in coronal slices revealed that calcium signals inducing long-term potentiation can be observed by stimulating either the parallel fiber or the ascending fiber pathway. We propose that local dendritic calcium spikes, evoked by synaptic potentials, provide a unique mechanism to spatially decode parallel fiber signals into cerebellar circuitry changes.	[Canepari, Marco; Vogt, Kaspar E.] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland	University of Basel	Canepari, M (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.	marco.canepari@unibas.ch	Canepari, Marco/AAJ-6709-2021; Canepari, Marco/H-6772-2012	Canepari, Marco/0000-0001-9759-2388; Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X	University of Basel	University of Basel	This work was supported by the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coutinho V, 2004, EUR J NEUROSCI, V20, P740, DOI 10.1111/j.1460-9568.2004.03533.x; Dittman JS, 1998, J NEUROSCI, V18, P6147; EBERHARD M, 1994, EUR J BIOCHEM, V222, P21, DOI 10.1111/j.1432-1033.1994.tb18836.x; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kuruma A, 2003, EUR J NEUROSCI, V18, P2677, DOI 10.1111/j.1460-9568.2003.02977.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Tanaka K, 2007, NEURON, V54, P787, DOI 10.1016/j.neuron.2007.05.014; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1	39	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4011	10.1371/journal.pone.0004011	http://dx.doi.org/10.1371/journal.pone.0004011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104665	Green Published, gold			2022-12-27	WOS:000265462400012
J	Ren, YZR; Pan, F; Parvez, S; Fleig, A; Chong, CR; Xu, J; Dang, YJ; Zhang, J; Jiang, HS; Penner, R; Liu, JO				Ren, Yunzhao R.; Pan, Fan; Parvez, Suhel; Fleig, Andrea; Chong, Curtis R.; Xu, Jing; Dang, Yongjun; Zhang, Jin; Jiang, Hongsi; Penner, Reinhold; Liu, Jun O.			Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes	PLOS ONE			English	Article								The Kv1.3 potassium channel plays an essential role in effector memory T cells and has been implicated in several important autoimmune diseases including multiple sclerosis, psoriasis and type 1 diabetes. A number of potent small molecule inhibitors of Kv1.3 channel have been reported, some of which were found to be effective in various animal models of autoimmune diseases. We report herein the identification of clofazimine, a known anti-mycobacterial drug, as a novel inhibitor of human Kv1.3. Clofazimine was initially identified as an inhibitor of intracellular T cell receptor-mediated signaling leading to the transcriptional activation of human interleukin-2 gene in T cells from a screen of the Johns Hopkins Drug Library. A systematic mechanistic deconvolution revealed that clofazimine selectively blocked the Kv1.3 channel activity, perturbing the oscillation frequency of the calcium-release activated calcium channel, which in turn led to the inhibition of the calcineurin-NFAT signaling pathway. These effects of clofazimine provide the first line of experimental evidence in support of a causal relationship between Kv1.3 and calcium oscillation in human T cells. Furthermore, clofazimine was found to be effective in blocking human T cell-mediated skin graft rejection in an animal model in vivo. Together, these results suggest that clofazimine is a promising immunomodulatory drug candidate for treating a variety of autoimmune disorders.	[Pan, Fan; Chong, Curtis R.; Xu, Jing; Dang, Yongjun; Zhang, Jin; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ren, Yunzhao R.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD 21218 USA; [Parvez, Suhel; Fleig, Andrea; Penner, Reinhold; Liu, Jun O.] Queens Med Ctr, Ctr Biomed Res, Honolulu, HI USA; [Parvez, Suhel; Fleig, Andrea] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Jiang, Hongsi] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; The Queen's Medical Center; University of Hawaii System; Northwestern University; Feinberg School of Medicine; Johns Hopkins University	Ren, YZR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	dang, yongjun/A-8095-2011; dang, yongjun/M-6531-2016; Parvez, Suhel/E-6778-2010	dang, yongjun/0000-0001-7237-1132; Parvez, Suhel/0000-0002-6318-6506; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249; Xu, Jing/0000-0002-3307-2719	Department of Pharmacology, Johns Hopkins School of Medicine; Keck Foundation; Flight Attendant Medical Research Institute Fund; Fund for Medical Discovery from Johns Hopkins; Johns Hopkins Malaria Research Institute; National Center for Research Resources (NCRR) [UL1 RR 025005]; National Institutes of Health (NIH) [RO1 GM080555, PO1 GM078195]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080555, P01GM078195] Funding Source: NIH RePORTER	Department of Pharmacology, Johns Hopkins School of Medicine; Keck Foundation(W.M. Keck Foundation); Flight Attendant Medical Research Institute Fund; Fund for Medical Discovery from Johns Hopkins; Johns Hopkins Malaria Research Institute; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Pharmacology, Johns Hopkins School of Medicine, the Keck Foundation, the Flight Attendant Medical Research Institute Fund, the Fund for Medical Discovery from Johns Hopkins and the Johns Hopkins Malaria Research Institute (for initial funding of the library). The project was also supported in part by Grant Number UL1 RR 025005 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. RP was supported by NIH RO1 GM080555 and AF by NIH PO1 GM078195.	AFDHAL NH, 1991, DIGEST DIS SCI, V36, P449, DOI 10.1007/BF01298873; BARRY VC, 1957, NATURE, V179, P1013, DOI 10.1038/1791013a0; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bezerra ELM, 2005, ARTHRITIS RHEUM-US, V52, P3073, DOI 10.1002/art.21358; BROWNE SG, 1977, LEPROSY REV, V48, P283; BURRES NS, 1995, J ANTIBIOT, V48, P380, DOI 10.7164/antibiotics.48.380; Byrne ST, 2007, ANTIMICROB AGENTS CH, V51, P4495, DOI 10.1128/AAC.00753-07; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chong CR, 2006, J MED CHEM, V49, P2677, DOI 10.1021/jm051225t; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; CHUAPRAPAISILP T, 1978, BRIT J DERMATOL, V99, P303, DOI 10.1111/j.1365-2133.1978.tb02001.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Deps PD, 2007, LEPROSY REV, V78, P216; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Felix JP, 1999, BIOCHEMISTRY-US, V38, P4922, DOI 10.1021/bi982954w; GOTO T, 1987, TRANSPLANT P, V19, P4; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Hanson DC, 1999, BRIT J PHARMACOL, V126, P1707, DOI 10.1038/sj.bjp.0702480; HILL RJ, 1995, MOL PHARMACOL, V48, P98; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Koo GC, 1999, CELL IMMUNOL, V197, P99, DOI 10.1006/cimm.1999.1569; KROP LC, 1993, NEW ENGL J MED, V329, P1582; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lee BSJ, 1997, BLOOD, V89, P2298, DOI 10.1182/blood.V89.7.2298; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MACKEY JP, 1974, BRIT J DERMATOL, V91, P93, DOI 10.1111/j.1365-2133.1974.tb06723.x; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MENSING H, 1988, DERMATOLOGICA, V177, P232, DOI 10.1159/000248569; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Nguyen A, 1996, MOL PHARMACOL, V50, P1672; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Peyrin-Biroulet L, 2007, GASTROENTEROLOGY, V132, P2594, DOI 10.1053/j.gastro.2007.04.027; Ramu G, 1976, Lepr India, V48, P722; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SMITH EH, 1984, S AFR MED J, V66, P341; Spencer RH, 1997, J BIOL CHEM, V272, P2389; THOMSON AW, 1993, IMMUNOL REV, V136, P71, DOI 10.1111/j.1600-065X.1993.tb00655.x; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2007, CURR OPIN DRUG DISC, V10, P438; Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049	56	85	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4009	10.1371/journal.pone.0004009	http://dx.doi.org/10.1371/journal.pone.0004009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104661	Green Published, gold, Green Submitted			2022-12-27	WOS:000265462400010
J	Ikegaya, Y; Matsumoto, W; Chiou, HY; Yuste, R; Aaron, G				Ikegaya, Yuji; Matsumoto, Wataru; Chiou, Huei-Yu; Yuste, Rafael; Aaron, Gloster			Statistical Significance of Precisely Repeated Intracellular Synaptic Patterns	PLOS ONE			English	Article								Can neuronal networks produce patterns of activity with millisecond accuracy? It may seem unlikely, considering the probabilistic nature of synaptic transmission. However, some theories of brain function predict that such precision is feasible and can emerge from the non-linearity of the action potential generation in circuits of connected neurons. Several studies have presented evidence for and against this hypothesis. Our earlier work supported the precision hypothesis, based on results demonstrating that precise patterns of synaptic inputs could be found in intracellular recordings from neurons in brain slices and in vivo. To test this hypothesis, we devised a method for finding precise repeats of activity and compared repeats found in the data to those found in surrogate datasets made by shuffling the original data. Because more repeats were found in the original data than in the surrogate data sets, we argued that repeats were not due to chance occurrence. Mokeichev et al. (2007) challenged these conclusions, arguing that the generation of surrogate data was insufficiently rigorous. We have now reanalyzed our previous data with the methods introduced from Mokeichev et al. (2007). Our reanalysis reveals that repeats are statistically significant, thus supporting our earlier conclusions, while also supporting many conclusions that Mokeichev et al. (2007) drew from their recent in vivo recordings. Moreover, we also show that the conditions under which the membrane potential is recorded contributes significantly to the ability to detect repeats and may explain conflicting results. In conclusion, our reevaluation resolves the methodological contradictions between Ikegaya et al. (2004) and Mokeichev et al. (2007), but demonstrates the validity of our previous conclusion that spontaneous network activity is non-randomly organized.	[Matsumoto, Wataru; Chiou, Huei-Yu] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, Tokyo, Japan; [Yuste, Rafael] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Aaron, Gloster] Wesleyan Univ, Hall Atwater & Shanklin Labs, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA	University of Tokyo; Japan Science & Technology Agency (JST); Columbia University; Howard Hughes Medical Institute; Wesleyan University	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	gaaron@wesleyan.edu		Ikegaya, Yuji/0000-0003-2260-8191	KAKENHI [20019014, 19659013]; NSF [CNS-0619508]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSF(National Science Foundation (NSF))	Mouse in vivo experiments were supported in part by a Grant-in-Aid for Science Research on Priority Areas (Elucidation of neural network function in the brain: KAKENHI#20019014) and a Grant-in-Aid for Science Research (KAKENHI# 19659013). Computer time on Wesleyan University's cluster computer was supported by the NSF under grant number CNS-0619508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1991, CAMBRIDGE U PRESS; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Douglas R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/ACPROF:OSO/9780195159561.003.0012, DOI 10.1093/ACPROF:OSO/9780195159561.003]; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; IZHIKEVICH EM, 2004, SPIKE TIMING DYNAMIC; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lestienne R, 1996, BIOL CYBERN, V74, P55, DOI 10.1007/BF00199137; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Molnar G, 2008, PLOS BIOL, V6, P1842, DOI 10.1371/journal.pbio.0060222; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Shmiel T, 2006, J NEUROPHYSIOL, V96, P2645, DOI 10.1152/jn.00798.2005	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3983	10.1371/journal.pone.0003983	http://dx.doi.org/10.1371/journal.pone.0003983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096523	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458800005
J	Linden, SK; Florin, THJ; McGuckin, MA				Linden, Sara K.; Florin, Timothy H. J.; McGuckin, Michael A.			Mucin Dynamics in Intestinal Bacterial Infection	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM STRESS; GROWTH-FACTOR RECEPTOR; CELL-SURFACE MUCIN; HELICOBACTER-PYLORI; EPITHELIAL-CELLS; CITROBACTER-RODENTIUM; STIMULATES MUCIN; GLYCOPROTEIN COMPLEX; GENE-EXPRESSION	Background: Bacterial gastroenteritis causes morbidity and mortality in humans worldwide. Murine Citrobacter rodentium infection is a model for gastroenteritis caused by the human pathogens enteropathogenic Escherichia coli and enterohaemorrhagic E. coli. Mucin glycoproteins are the main component of the first barrier that bacteria encounter in the intestinal tract. Methodology/Principal Findings: Using Immunohistochemistry, we investigated intestinal expression of mucins (Alcian blue/PAS, Muc1, Muc2, Muc4, Muc5AC, Muc13 and Muc3/17) in healthy and C. rodentium infected mice. The majority of the C. rodentium infected mice developed systemic infection and colitis in the mid and distal colon by day 12. C. rodentium bound to the major secreted mucin, Muc2, in vitro, and high numbers of bacteria were found in secreted MUC2 in infected animals in vivo, indicating that mucins may limit bacterial access to the epithelial surface. In the small intestine, caecum and proximal colon, the mucin expression was similar in infected and non-infected animals. In the distal colonic epithelium, all secreted and cell surface mucins decreased with the exception of the Muc1 cell surface mucin which increased after infection (p<0.05). Similarly, during human infection Salmonella St Paul, Campylobacter jejuni and Clostridium difficile induced MUC1 in the colon. Conclusion: Major changes in both the cell- surface and secreted mucins occur in response to intestinal infection.	[Florin, Timothy H. J.; McGuckin, Michael A.] Mater Med Res Inst, Mucosal Dis Program, Mater Hlth Serv, Brisbane, Qld, Australia; [Linden, Sara K.] Univ Gothenburg, Sahlgrenska Acad, Mucosal Immunobiol & Vaccine Ctr, Gothenburg, Sweden; [Florin, Timothy H. J.; McGuckin, Michael A.] Univ Queensland, Dept Med, Brisbane, Qld, Australia	Mater Health Services; Mater Research; University of Gothenburg; University of Queensland	Linden, SK (corresponding author), Mater Med Res Inst, Mucosal Dis Program, Mater Hlth Serv, Brisbane, Qld, Australia.	mmcguckin@mmri.mater.org.au	Florin, Tim HJ/F-1890-2010; McGuckin, Michael/G-2310-2010; Lindén, Sara K/A-3271-2011	McGuckin, Michael/0000-0002-8375-2675; Lindén, Sara K/0000-0002-7751-9586	Swedish Society for Medical Research [post doctoral Fellowship]; Swedish Reasearch Council; Australian NHMRC Project [382309]	Swedish Society for Medical Research; Swedish Reasearch Council; Australian NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by a post doctoral Fellowship from the Swedish Society for Medical Research (to S. Linden), the Swedish Reasearch Council (Vetenskapsradet, to S. Linden) and the Australian NHMRC Project Grant No. 382309.	ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; Dekker J, 1993, J Pediatr Gastroenterol Nutr, V17, P228, DOI 10.1097/00005176-199308000-00019; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; FISCHER BM, 1995, CHEST, V107, pS133, DOI 10.1378/chest.107.3_Supplement.133S; Forgue-Lafitte ME, 2007, INT J CANCER, V121, P1543, DOI 10.1002/ijc.22865; Gottke M, 1996, INFLAMM RES, V45, P209, DOI 10.1007/BF02285163; Grys TE, 2006, J BACTERIOL, V188, P4646, DOI 10.1128/JB.01806-05; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; Hinoda Y, 1998, J CLIN LAB ANAL, V12, P150, DOI 10.1002/(SICI)1098-2825(1998)12:3<150::AID-JCLA4>3.3.CO;2-4; HOLLANDE E, 1995, IN VITRO CELL DEV-AN, V31, P227; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Jarry A, 1996, GUT, V38, P240, DOI 10.1136/gut.38.2.240; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim KC, 2003, INFLAMM RES, V52, P258, DOI 10.1007/s00011-003-1171-y; Kim KC, 1996, EUR RESPIR J, V9, P542, DOI 10.1183/09031936.96.09030542; Kishioka C, 2001, RESP PHYSIOL, V126, P163, DOI 10.1016/S0034-5687(01)00214-6; Klinkspoor JH, 1999, GLYCOBIOLOGY, V9, P13, DOI 10.1093/glycob/9.1.13; Komatsu M, 2002, BIOCHEM J, V368, P41, DOI 10.1042/BJ20020862; LAMBERT ME, 1979, BRIT MED J, V1, P857, DOI 10.1136/bmj.1.6167.857; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; LINDEN S, 2004, BIOCHEM J, V379, P1; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Longman RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1335, DOI 10.1369/jhc.5A6904.2006; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; MASUDA A, 2008, INFECT IMMUN; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Mundy R, 2007, MICROBIOL-SGM, V153, P959, DOI 10.1099/mic.0.2006/003467-0; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Peterson JA, 1998, BIOL NEONATE, V74, P143, DOI 10.1159/000014020; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; REID PE, 1973, J HISTOCHEM CYTOCHEM, V21, P473, DOI 10.1177/21.5.473; Rossi EA, 1996, J BIOL CHEM, V271, P33476, DOI 10.1074/jbc.271.52.33476; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sajjan U, 2004, INFECT IMMUN, V72, P4188, DOI 10.1128/IAI.72.7.4188-4199.2004; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Skinn AC, 2006, CAN J PHYSIOL PHARM, V84, P1301, DOI 10.1139/Y06-086; Slomiany BL, 2004, IUBMB LIFE, V56, P153, DOI 10.1080/15216540410001690456; Slomiany BL, 2006, IUBMB LIFE, V58, P217, DOI 10.1080/15216540600732021; Smirnova MG, 2000, CYTOKINE, V12, P1732, DOI 10.1006/cyto.2000.0763; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tobe T, 2002, CELL MICROBIOL, V4, P29, DOI 10.1046/j.1462-5822.2002.00167.x; TU Q, 2008, J MED MICRO IN PRESS; VOYNOW JA, 1999, AM J PHYSIOL-LUNG C, V20, P835; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078	63	164	170	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3952	10.1371/journal.pone.0003952	http://dx.doi.org/10.1371/journal.pone.0003952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088856	Green Published, gold			2022-12-27	WOS:000265458500003
J	Lahoute, C; Sotiropoulos, A; Favier, M; Guillet-Deniau, I; Charvet, C; Ferry, A; Butler-Browne, G; Metzger, D; Tuil, D; Daegelen, D				Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Charvet, Claude; Ferry, Arnaud; Butler-Browne, Gillian; Metzger, Daniel; Tuil, David; Daegelen, Dominique			Premature Aging in Skeletal Muscle Lacking Serum Response Factor	PLOS ONE			English	Article								Aging is associated with a progressive loss of muscle mass, increased adiposity and fibrosis that leads to sarcopenia. At the molecular level, muscle aging is known to alter the expression of a variety of genes but very little is known about the molecular effectors involved. SRF (Serum Response Factor) is a crucial transcription factor for muscle-specific gene expression and for post-natal skeletal muscle growth. To assess its role in adult skeletal muscle physiology, we developed a post-mitotic myofiber-specific and tamoxifen-inducible SRF knockout model. Five months after SRF loss, no obvious muscle phenotype was observed suggesting that SRF is not crucial for myofiber maintenance. However, mutant mice progressively developed IIB myofiber-specific atrophy accompanied by a metabolic switch towards a more oxidative phenotype, muscular lipid accumulation, sarcomere disorganization and fibrosis. After injury, mutant muscles exhibited an altered regeneration process, showing smaller regenerated fibers and persistent fibrosis. All of these features are strongly reminiscent of abnormalities encountered in aging skeletal muscle. Interestingly, we also observed an important age associated decrease in SRF expression in mice and human muscles. Altogether, these results suggest that a naturally occurring SRF down-regulation precedes and contributes to the muscle aging process. Indeed, triggering SRF loss in the muscles of mutant mice results in an accelerated aging process.	[Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Tuil, David; Daegelen, Dominique] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Tuil, David; Daegelen, Dominique] Inserm, U567, Paris, France; [Charvet, Claude] INRA, UR1282, Infectiol Animal Sante Publ, Nouzilly, France; [Ferry, Arnaud; Butler-Browne, Gillian] UPMC Paris 6, Inserm, UMR S787, Inst Myol, Paris, France; [Ferry, Arnaud] Univ Paris 05, Paris, France; [Metzger, Daniel] Univ Louis Pasteur, Coll France, IGBMC, Dept Funct Genom, Inserm, F-67070 Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lahoute, C (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	david.tuil@inserm.fr; dominique.daegelen@inserm.fr	Sotiropoulos, Athanassia/P-4269-2017; ferry, arnaud/D-2816-2019; Charvet, Claude/X-3751-2019; Mouly, Gillian/G-6595-2017	ferry, arnaud/0000-0002-6050-4556; Charvet, Claude/0000-0002-0596-6598; butler-browne, gillian/0000-0002-3431-242X; Sotiropoulos, Athanassia/0000-0002-7265-1473; Metzger, Daniel/0000-0002-5555-046X	Association Francaise contre les Myopathies (AFM) [fellowship]; European 6th Framework Program Network of Excellence MYORES; Agence Nationale de la Recherche; French Ministry of Research	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); European 6th Framework Program Network of Excellence MYORES; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded by grants from the Association Francaise contre les Myopathies (AFM), by the European 6th Framework Program Network of Excellence MYORES, and by the Agence Nationale de la Recherche (ANR GENOPAT 2008- INAFIB). We also thank Region Ile de France for contributing to the Cochin Institute animal care facility. Lahoute held a grant from the French Ministry of Research and an AFM fellowship. Those funders played no role in the study design, experimentation, decision to publish or writing the paper.	Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Azhar G, 2007, BASIC RES CARDIOL, V102, P233, DOI 10.1007/s00395-006-0634-z; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; Charvet C, 2006, MOL CELL BIOL, V26, P6664, DOI 10.1128/MCB.00138-06; Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Dennis RA, 2008, PHYSIOL GENOMICS, V32, P393, DOI 10.1152/physiolgenomics.00191.2007; Ding W, 2001, J CELL SCI, V114, P1011; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fluck M, 1999, J APPL PHYSIOL, V86, P1793, DOI 10.1152/jappl.1999.86.6.1793; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOPINATH SD, 2008, AGING CELL; Gordon SE, 2001, J APPL PHYSIOL, V90, P1174, DOI 10.1152/jappl.2001.90.3.1174; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; JAISWAL YK, 1990, BIOCHEM BIOPH RES CO, V168, P71, DOI 10.1016/0006-291X(90)91676-J; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lu XG, 1998, J GERONTOL A-BIOL, V53, pB3, DOI 10.1093/gerona/53A.1.B3; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; MUSCAT GE, 1988, MOL CELL BIOL, V8, P4120, DOI 10.1128/MCB.8.10.4120; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3; Pahor M, 1998, J Nutr Health Aging, V2, P97; Parise G, 2000, Curr Opin Clin Nutr Metab Care, V3, P489, DOI 10.1097/00075197-200011000-00012; Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; REGGIANI C, 1992, MUSCLE NERVE, V15, P199, DOI 10.1002/mus.880150212; Sakuma K, 2004, ACTA NEUROPATHOL, V108, P241, DOI 10.1007/s00401-004-0884-5; Sakuma K, 2008, BBA-MOL BASIS DIS, V1782, P453, DOI 10.1016/j.bbadis.2008.03.008; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Schuler M, 2005, GENESIS, V41, P165, DOI 10.1002/gene.20107; Taylor A, 1997, MOL CELL BIOCHEM, V169, P61, DOI 10.1023/A:1006898812618; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200	48	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3910	10.1371/journal.pone.0003910	http://dx.doi.org/10.1371/journal.pone.0003910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079548	Green Published, gold, Green Submitted			2022-12-27	WOS:000265455900004
J	Gaseitsiwe, S; Valentini, D; Mahdavifar, S; Magalhaes, I; Hoft, DF; Zerweck, J; Schutkowski, M; Andersson, J; Reilly, M; Maeurer, MJ				Gaseitsiwe, Simani; Valentini, Davide; Mahdavifar, Shahnaz; Magalhaes, Isabelle; Hoft, Daniel F.; Zerweck, Johannes; Schutkowski, Mike; Andersson, Jan; Reilly, Marie; Maeurer, Markus J.			Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; ANTIGEN; GENE; IDENTIFICATION; EXPRESSION; INFECTION; VACCINE; CD4(+)	Background: Serum antibody-based target identification has been used to identify tumor-associated antigens (TAAs) for development of anti-cancer vaccines. A similar approach can be helpful to identify biologically relevant and clinically meaningful targets in M. tuberculosis (MTB) infection for diagnosis or TB vaccine development in clinically well defined populations. Method: We constructed a high-content peptide microarray with 61 M. tuberculosis proteins as linear 15 aa peptide stretches with 12 aa overlaps resulting in 7446 individual peptide epitopes. Antibody profiling was carried with serum from 34 individuals with active pulmonary TB and 35 healthy individuals in order to obtain an unbiased view of the MTB epitope pattern recognition pattern. Quality data extraction was performed, data sets were analyzed for significant differences and patterns predictive of TB+/-. Findings: Three distinct patterns of IgG reactivity were identified: 89/7446 peptides were differentially recognized (in 34/34 TB+ patients and in 35/35 healthy individuals) and are highly predictive of the division into TB+ and TB-, other targets were exclusively recognized in all patients with TB (e. g. sigmaF) but not in any of the healthy individuals, and a third peptide set was recognized exclusively in healthy individuals (35/35) but no in TB+ patients. The segregation between TB+ and TB- does not cluster into specific recognition of distinct MTB proteins, but into specific peptide epitope 'hotspots' at different locations within the same protein. Antigen recognition pattern profiles in serum from TB+ patients from Armenia vs. patients recruited in Sweden showed that IgG-defined MTB epitopes are very similar in individuals with different genetic background. Conclusions: A uniform target MTB IgG-epitope recognition pattern exists in pulmonary tuberculosis. Unbiased, high-content peptide microarray chip-based testing of clinically well-defined populations allows to visualize biologically relevant targets useful for development of novel TB diagnostics and vaccines.	[Magalhaes, Isabelle; Maeurer, Markus J.] Karolinska Inst Stockholm, Dept Microbiol, Tumor & Cell Biol Ctr MTC, Stockholm, Sweden; [Valentini, Davide; Reilly, Marie] Karolinska Inst, Dept Med Epidemiol & Biostat, S-10401 Stockholm, Sweden; [Gaseitsiwe, Simani; Mahdavifar, Shahnaz; Magalhaes, Isabelle; Maeurer, Markus J.] Swedish Inst Infect Dis Control SMI, Stockholm, Sweden; [Hoft, Daniel F.] St Louis Univ, Med Ctr, Dept Internal Med & Mol Microbiol, Div Immunobiol, St Louis, MO USA; [Zerweck, Johannes; Schutkowski, Mike] JPT, Berlin, Germany; [Andersson, Jan] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Saint Louis University; Karolinska Institutet; Karolinska University Hospital	Gaseitsiwe, S (corresponding author), Karolinska Inst Stockholm, Dept Microbiol, Tumor & Cell Biol Ctr MTC, Stockholm, Sweden.	markus.maeurer@ki.se	Magalhaes, Isabelle/AAC-7898-2020	Magalhaes, Isabelle/0000-0003-0440-6924; Schutkowski, MIke/0000-0003-0919-7076; Maeurer, Markus/0000-0002-8436-8077	EU Curie; Vetenskapradet; SIDA/SAREC; Soderberg-Foundation; Karolinska Institutet	EU Curie; Vetenskapradet; SIDA/SAREC; Soderberg-Foundation; Karolinska Institutet(Karolinska Institutet)	EU Curie Grant to SG; Vetenskapradet, SIDA/SAREC, Soderberg-Foundation and Karolinska Institutet Support to MM.	Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Jager Dirk, 2005, Cancer Immun, V5, P11; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Lee JH, 2008, J BACTERIOL, V190, P1128, DOI 10.1128/JB.00511-07; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Lee SY, 2007, J MICROBIOL BIOTECHN, V17, P879; Lyashchenko K, 1998, INFECT IMMUN, V66, P3606, DOI 10.1128/IAI.66.8.3606-3610.1998; Meena LS, 2002, J CLIN LAB ANAL, V16, P151, DOI 10.1002/jcla.10031; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Michele TM, 1999, ANTIMICROB AGENTS CH, V43, P218, DOI 10.1128/AAC.43.2.218; MUELLER H, 2008, CYTOKINE; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Odunsi Kunle, 2007, Cancer Immun, V7, P3; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Predki Paul F, 2005, Hum Antibodies, V14, P7; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059	31	60	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3840	10.1371/journal.pone.0003840	http://dx.doi.org/10.1371/journal.pone.0003840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065269	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455200001
J	Mietchen, D; Manz, B; Volke, F; Storey, K				Mietchen, Daniel; Manz, Bertram; Volke, Frank; Storey, Kenneth			In Vivo Assessment of Cold Adaptation in Insect Larvae by Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							FAT-BODY CELLS; FREEZE TOLERANCE; GALL FLY; MOTION CORRECTION; ICE NUCLEATION; SELF-DIFFUSION; NMR; WATER; MICROSCOPY; VISUALIZATION	Background: Temperatures below the freezing point of water and the ensuing ice crystal formation pose serious challenges to cell structure and function. Consequently, species living in seasonally cold environments have evolved a multitude of strategies to reorganize their cellular architecture and metabolism, and the underlying mechanisms are crucial to our understanding of life. In multicellular organisms, and poikilotherm animals in particular, our knowledge about these processes is almost exclusively due to invasive studies, thereby limiting the range of conclusions that can be drawn about intact living systems. Methodology: Given that non-destructive techniques like 1 H Magnetic Resonance (MR) imaging and spectroscopy have proven useful for in vivo investigations of a wide range of biological systems, we aimed at evaluating their potential to observe cold adaptations in living insect larvae. Specifically, we chose two cold-hardy insect species that frequently serve as cryobiological model systems-the freeze-avoiding gall moth Epiblema scudderiana and the freeze-tolerant gall fly Eurosta solidaginis. Results: In vivo MR images were acquired from autumn-collected larvae at temperatures between 0 degrees C and about -70 degrees C and at spatial resolutions down to 27 mm. These images revealed three-dimensional (3D) larval anatomy at a level of detail currently not in reach of other in vivo techniques. Furthermore, they allowed visualization of the 3D distribution of the remaining liquid water and of the endogenous cryoprotectants at subzero temperatures, and temperature-weighted images of these distributions could be derived. Finally, individual fat body cells and their nuclei could be identified in intact frozen Eurosta larvae. Conclusions: These findings suggest that high resolution MR techniques provide for interesting methodological options in comparative cryobiological investigations, especially in vivo.	[Mietchen, Daniel; Manz, Bertram; Volke, Frank] Fraunhofer Inst Biomed Engn IBMT, Magnet Resonance Grp, St Ingbert, Germany; [Mietchen, Daniel] Univ Saarland, Fac Phys & Mechatron, Saarbrucken, Germany; [Mietchen, Daniel] Univ Jena, Dept Psychiat, D-6900 Jena, Germany; [Storey, Kenneth] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Fraunhofer Gesellschaft; Saarland University; Friedrich Schiller University of Jena; Carleton University	Mietchen, D (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Magnet Resonance Grp, St Ingbert, Germany.	daniel.mietchen@uni-jena.de	Mietchen, Daniel/A-7748-2009	Mietchen, Daniel/0000-0001-9488-1870; Storey, Kenneth/0000-0002-7363-1853	IBMT	IBMT(International Business Machines (IBM))	The study was supported by an IBMT-internal grant.	Abragam A., 1961, PRINCIPLES NUCL MAGN; AGUAYO JB, 1986, NATURE, V322, P190, DOI 10.1038/322190a0; Bhattacharya P, 2005, MAGN RESON MATER PHY, V18, P245, DOI 10.1007/s10334-005-0007-x; Bliimich B., 1992, MAGNETIC RESONANCE M; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Boesch Chris, 1999, Molecular Aspects of Medicine, V20, P185, DOI 10.1016/S0098-2997(99)00007-2; Bonnet N, 2004, MICRON, V35, P635, DOI 10.1016/j.micron.2004.04.006; Boppart SA, 1996, DEV BIOL, V177, P54, DOI 10.1006/dbio.1996.0144; Borah B, 2001, ANAT RECORD, V265, P101, DOI 10.1002/ar.1060; Borgia GC, 2000, J CULT HERIT, V1, P127, DOI 10.1016/S1296-2074(00)00156-4; BOTTOMLEY PA, 1984, P NATL ACAD SCI-BIOL, V81, P6856, DOI 10.1073/pnas.81.21.6856; BRATEMAN L, 1986, AM J ROENTGENOL, V146, P971, DOI 10.2214/ajr.146.5.971; BUCHANAN GW, 1983, CAN J BIOCHEM CELL B, V61, P1260, DOI 10.1139/o83-162; BURT CT, 1982, LIFE SCI, V31, P2793; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Callaghan PT, 1997, REV SCI INSTRUM, V68, P4263, DOI 10.1063/1.1148340; Catana C, 2008, P NATL ACAD SCI USA, V105, P3705, DOI 10.1073/pnas.0711622105; Ciobanu L, 2003, PROG NUCL MAG RES SP, V42, P69, DOI 10.1016/S0079-6565(03)00004-9; Clarke CJ, 2002, CRYOLETTERS, V23, P89; Collins S.D., 1996, Problemy Kriobiologii, V1, P3; Concha ML, 1998, DEVELOPMENT, V125, P983; Dabos KJ, 2002, NMR BIOMED, V15, P241, DOI 10.1002/nbm.765; Daniel BL, 1999, MAGNET RESON MED, V41, P627, DOI 10.1002/(SICI)1522-2594(199903)41:3<627::AID-MRM28>3.0.CO;2-Q; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016; Davis DJ, 2001, ARCH INSECT BIOCHEM, V48, P199, DOI 10.1002/arch.1072; de Swiet TM, 1998, J MAGN RESON, V133, P385, DOI 10.1006/jmre.1998.1459; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; EDELSTEIN WA, 1991, J GLACIOL, V37, P177; Eicken H, 2000, COLD REG SCI TECHNOL, V31, P207, DOI 10.1016/S0165-232X(00)00016-1; Eisenreich W, 2007, PHYTOCHEMISTRY, V68, P2799, DOI 10.1016/j.phytochem.2007.09.028; FOSTER FS, 1993, IEEE T ULTRASON FERR, V40, P608, DOI 10.1109/58.238115; Ganguly A, 2005, ACAD RADIOL, V12, P1167, DOI 10.1016/j.acra.2005.03.076; GEORGE MF, 1974, PLANT PHYSIOL, V54, P29, DOI 10.1104/pp.54.1.29; Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203; Goldman LW, 2007, J NUCL MED TECHNOL, V35, DOI 10.2967/jnmt.106.037846; GOODMAN BA, 1995, J INSECT PHYSIOL, V41, P419, DOI 10.1016/0022-1910(94)00115-W; Gowland PA, 2005, PROG BIOPHYS MOL BIO, V87, P175, DOI 10.1016/j.pbiomolbio.2004.08.006; Han SI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.144501; Hart A. G., 2003, Journal of Insect Science (Tucson), V3, P1; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hindmarsh JP, 2004, CHEM ENG SCI, V59, P2113, DOI 10.1016/j.ces.2003.12.031; Hsieh CH, 1996, BIOPHYS J, V71, P3278, DOI 10.1016/S0006-3495(96)79520-6; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; KELLER RE, 1978, J MORPHOL, V157, P223, DOI 10.1002/jmor.1051570209; Kerr WL, 1998, FOOD SCI TECHNOL-LEB, V31, P215; Kleinberg RL, 2005, COLD REG SCI TECHNOL, V42, P63, DOI 10.1016/j.coldregions.2004.12.002; Koop T, 2004, Z PHYS CHEM, V218, P1231, DOI 10.1524/zpch.218.11.1231.50812; Koptyug IV, 2007, APPL MAGN RESON, V32, P321, DOI 10.1007/s00723-007-0017-0; Lacey ME, 2001, J CHROMATOGR A, V922, P139, DOI 10.1016/S0021-9673(01)00912-8; Lambert JB, 2000, CHEM SOC REV, V29, P175, DOI 10.1039/a908378b; Larkman DJ, 2007, PHYS MED BIOL, V52, pR15, DOI 10.1088/0031-9155/52/7/R01; Lazovic J, 2005, MAGN RESON MED, V53, P1150, DOI 10.1002/mrm.20459; Ledbetter MP, 2008, P NATL ACAD SCI USA, V105, P2286, DOI 10.1073/pnas.0711505105; LEE AP, 1995, J ARCHAEOL SCI, V22, P257, DOI 10.1006/jasc.1995.0027; Lee CC, 1996, MAGNET RESON MED, V36, P436, DOI 10.1002/mrm.1910360316; Lee R., 1991, INSECTS LOW TEMPERAT; Lee Richard E. Jr., 1995, P257; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Lee SC, 2007, DIFFERENTIATION, V75, P84, DOI 10.1111/j.1432-0436.2006.00114.x; Lemor RM, 2004, ACOUST IMAG, V27, P563; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2; Manz B, 2003, BIOTECHNOL BIOENG, V84, P424, DOI 10.1002/bit.10782; Mariette F, 2005, J AGR FOOD CHEM, V53, P1317, DOI 10.1021/jf049294o; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; Mel'nichenko N. A., 1979, Oceanology, V19, P535; Menzel MI, 2000, J MAGN RESON, V143, P376, DOI 10.1006/jmre.1999.1999; Mietchen D, 2008, BIOGEOSCIENCES, V5, P25, DOI 10.5194/bg-5-25-2008; Mietchen D, 2005, BIOGEOSCIENCES, V2, P133, DOI 10.5194/bg-2-133-2005; Mietchen Daniel, 2005, Biomagn Res Technol, V3, P2, DOI 10.1186/1477-044X-3-2; Moritz C, 2008, CRYOBIOLOGY, V56, P181, DOI 10.1016/j.cryobiol.2008.02.003; Muller WEG, 2006, J STRUCT BIOL, V153, P31, DOI 10.1016/j.jsb.2005.09.008; Nayak KS, 2000, MAGNET RESON MED, V43, P251, DOI 10.1002/(SICI)1522-2594(200002)43:2<251::AID-MRM12>3.0.CO;2-#; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ouwerkerk Ronald, 2007, J Am Coll Radiol, V4, P739, DOI 10.1016/j.jacr.2007.07.001; Peh WCG, 2001, SKELETAL RADIOL, V30, P179, DOI 10.1007/s002560100341; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Price WS, 1997, AUST J PLANT PHYSIOL, V24, P599, DOI 10.1071/PP97049; Purea A, 2004, CONCEPT MAGN RESON B, V22B, P7, DOI 10.1002/cmr.b.20015; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040; Richardson C., 1966, J GLACIOL, V6, P89; RICKARDS J, 1987, J INSECT PHYSIOL, V33, P443, DOI 10.1016/0022-1910(87)90024-2; Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19; Rubinsky B., 1994, American Journal of Physiology, V267, pR1078; Rubinsky B., 1994, American Journal of Physiology, V266, pR1771; Rueden C, 2004, TRAFFIC, V5, P411, DOI 10.1111/j.1600-0854.2004.00189.x; SALT RW, 1959, NATURE, V184, P1426, DOI 10.1038/1841426a0; Samset E, 2005, COMPUT MED IMAG GRAP, V29, P499, DOI 10.1016/j.compmedimag.2005.02.008; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009; Schneider H, 2003, NEW PHYTOL, V159, P487, DOI 10.1046/j.1469-8137.2003.00814.x; Schwarzbauer C, 2006, NEUROIMAGE, V29, P774, DOI 10.1016/j.neuroimage.2005.08.025; Silva AKA, 2006, RADIAT ENVIRON BIOPH, V45, P245, DOI 10.1007/s00411-006-0065-0; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; SLICHTER CP, 1978, PRINCIPLES MAGNETIC; Still BM, 2007, CHEM SOC REV, V36, P665, DOI 10.1039/b606190g; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; STOREY KB, 1984, EUR J BIOCHEM, V142, P591, DOI 10.1111/j.1432-1033.1984.tb08327.x; Storey Kenneth B., 1992, V1, P101; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tsuchihashi Toshio, 2003, Nihon Hoshasen Gijutsu Gakkai Zasshi, V59, P1370; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Van As H, 2007, J EXP BOT, V58, P743, DOI 10.1093/jxb/erl157; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228; Volke F, 1996, CHEM PHYS LETT, V262, P374, DOI 10.1016/0009-2614(96)01062-7; VOLKE F, 1995, BIOPHYS J, V68, P1960, DOI 10.1016/S0006-3495(95)80373-5; Watson P., 2001, CRYOBANKING GENETIC; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wind RA, 2000, J MAGN RESON, V147, P371, DOI 10.1006/jmre.2000.2212; Wu DH, 1997, JMRI-J MAGN RESON IM, V7, P365, DOI 10.1002/jmri.1880070219; Wuthrich K, 1996, FARADAY DISCUSS, V103, P245, DOI 10.1039/fd9960300245; Yi SX, 2003, J INSECT PHYSIOL, V49, P999, DOI 10.1016/S0022-1910(03)00168-9; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zimmermann H, 2004, IEE Proc Nanobiotechnol, V151, P134, DOI 10.1049/ip-nbt:20040908; [No title captured]; [No title captured]; [No title captured]	126	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3826	10.1371/journal.pone.0003826	http://dx.doi.org/10.1371/journal.pone.0003826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057644	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452300002
J	Lopez-Vidal, Y; Ponce-de-Leon, S; Castillo-Rojas, G; Barreto-Zuniga, R; Torre-Delgadillo, A				Lopez-Vidal, Yolanda; Ponce-de-Leon, Sergio; Castillo-Rojas, Gonzalo; Barreto-Zuniga, Rafael; Torre-Delgadillo, Aldo			High Diversity of vacA and cagA Helicobacter pylori Genotypes in Patients with and without Gastric Cancer	PLOS ONE			English	Article								Background: Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer. The aim of this study was to assess the topographical distribution of H. pylori in the stomach as well as the vacA and cagA genotypes in patients with and without gastric cancer. Methodology/Principal Findings: Three gastric biopsies, from predetermined regions, were evaluated in 16 patients with gastric cancer and 14 patients with dyspeptic symptoms. From cancer patients, additional biopsy specimens were obtained from tumor centers and margins; among these samples, the presence of H. pylori vacA and cagA genotypes was evaluated. Positive H. pylori was 38% and 26% in biopsies obtained from the gastric cancer and non-cancer groups, respectively (p = 0.008), and 36% in tumor sites. In cancer patients, we found a preferential distribution of H. pylori in the fundus and corpus, whereas, in the non-cancer group, the distribution was uniform (p = 0.003). A majority of the biopsies were simultaneously cagA gene-positive and-negative. The fundus and corpus demonstrated a higher positivity rate for the cagA gene in the non-cancer group (p = 0.036). A mixture of cagA gene sizes was also significantly more frequent in this group (p = 0.003). Ninety-two percent of all the subjects showed more than one vacA gene genotype; s1b and m1 vacA genotypes were predominantly found in the gastric cancer group. The highest vacA-genotype signal-sequence diversity was found in the corpus and 5 cm from tumor margins. Conclusion/Significance: High H. pylori colonization diversity, along with the cagA gene, was found predominantly in the fundus and corpus of patients with gastric cancer. The genotype diversity observed across systematic whole-organ and tumor sampling was remarkable. We find that there is insufficient evidence to support the association of one isolate with a specific disease, due to the multistrain nature of H. pylori infection shown in this work.	[Lopez-Vidal, Yolanda; Castillo-Rojas, Gonzalo] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico; [Ponce-de-Leon, Sergio] INCMNSZ, Unidad Epidemiol Clin, Mexico City, DF, Mexico; [Barreto-Zuniga, Rafael; Torre-Delgadillo, Aldo] INCMNSZ, Dept Endoscop Gastroenterol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Lopez-Vidal, Y (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico.	lvidal@servidor.unam.mx	Torre, Aldo/AAC-1774-2021; Barreto, Rafael/ABC-1959-2020; López-Vidal, Yolanda/ABE-9501-2021	López-Vidal, Yolanda/0000-0001-7111-8813; Barreto Zuniga, Rafael/0000-0001-9683-4154	Universidad Nacional Autonoma de Mexico (UNAM) [DGAPA PAPIIT-IN207302]; UC-MEXUS; CONACyT-Mexico [47749-M]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); UC-MEXUS; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by grant DGAPA PAPIIT-IN207302 from the Universidad Nacional Autonoma de Mexico (UNAM), UC-MEXUS, and CONACyT-Mexico 47749-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arents NLA, 2001, AM J GASTROENTEROL, V96, P2603, DOI 10.1111/j.1572-0241.2001.04104.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Borrmann R., 1926, HDB SPEZIELLEN PATHO, P864; Camargo MC, 2004, HELICOBACTER, V9, P262, DOI 10.1111/j.1083-4389.2004.00221.x; Castillo-Rojas G, 2002, EUR J GASTROEN HEPAT, V14, P1113, DOI 10.1097/00042737-200210000-00012; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Israel DA, 2001, ALIMENT PHARM THER, V15, P1271, DOI 10.1046/j.1365-2036.2001.01052.x; Japanese Research Society for Gastric Cancer Committee on Histologic Classification of Gastric Cancer, 1981, JPN J SURG, V11, P140; KAJITANI T, 1981, JPN J SURG, V11, P127; Karita M, 2003, MICROBIOL IMMUNOL, V47, P619, DOI 10.1111/j.1348-0421.2003.tb03425.x; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lin HJ, 2004, WORLD J GASTROENTERO, V10, P2493, DOI 10.3748/wjg.v10.i17.2493; Morales-Espinosa R, 1999, J CLIN MICROBIOL, V37, P3001, DOI 10.1128/JCM.37.9.3001-3004.1999; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Rozen P, 2004, EUR J CANCER PREV, V13, P71, DOI 10.1097/00008469-200402000-00011; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Tang YL, 2005, WORLD J GASTROENTERO, V11, P1387, DOI 10.3748/wjg.v11.i9.1387; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Zhang C, 2005, WORLD J GASTROENTERO, V11, P791, DOI 10.3748/wjg.v11.i6.791	24	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3849	10.1371/journal.pone.0003849	http://dx.doi.org/10.1371/journal.pone.0003849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050763	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452100008
J	Li, YL; Wu, GZ; Dawe, GS; Zeng, L; Cui, SS; Loers, G; Tilling, T; Sun, L; Schachner, M; Xiao, ZC				Li, Ya-li; Wu, Guang-zhi; Dawe, Gavin S.; Zeng, Li; Cui, Shu-sen; Loers, Gabriele; Tilling, Thomas; Sun, Li; Schachner, Melitta; Xiao, Zhi-Cheng			Cell Surface Sialylation and Fucosylation Are Regulated by L1 via Phospholipase C gamma and Cooperate to Modulate Neurite Outgrowth, Cell Survival and Migration	PLOS ONE			English	Article							RECOGNITION MOLECULE L1; SIALIC-ACID; ADHESION; GLYCOSYLATION; PROLIFERATION; INHIBITION; GLYCANS; LECTIN; L5	Background: Cell surface glycosylation patterns are markers of cell type and status. However, the mechanisms regulating surface glycosylation patterns remain unknown. Methodology/Principal Findings: Using a panel of carbohydrate surface markers, we have shown that cell surface sialylation and fucosylation were downregulated in L1(-/y) neurons versus L1(+/y) neurons. Consistently, mRNA levels of sialyltransferase ST6Gal1, and fucosyltransferase FUT9 were significantly reduced in L1(-/y) neurons. Moreover, treatment of L1(+/y) neurons with L1 antibodies, triggering signal transduction downstream of L1, led to an increase in cell surface sialylation and fucosylation compared to rat IgG-treated cells. ShRNAs for both ST6Gal1 and FUT9 blocked L1 antibody-mediated enhancement of neurite outgrowth, cell survival and migration. A phospholipase C gamma (PLC gamma) inhibitor and shRNA, as well as an Erk inhibitor, reduced ST6Gal1 and FUT9 mRNA levels and inhibited effects of L1 on neurite outgrowth and cell survival. Conclusions: Neuronal surface sialylation and fucosylation are regulated via PLC gamma by L1, modulating neurite outgrowth, cell survival and migration.	[Li, Ya-li; Wu, Guang-zhi; Xiao, Zhi-Cheng] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Li, Ya-li; Sun, Li; Xiao, Zhi-Cheng] Singapore Gen Hosp, Dept Clin Res, Singapore, Singapore; [Li, Ya-li; Dawe, Gavin S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117548, Singapore; [Wu, Guang-zhi; Cui, Shu-sen] Jilin Univ, China Japan Union Hosp, Surg Dept, Changchun, Peoples R China; [Zeng, Li; Xiao, Zhi-Cheng] Inst Mol & Cell Biol, Dev Biol Div, Singapore, Singapore; [Zeng, Li] Natl Neurosci Inst, Dev Biol Div, Singapore, Singapore; [Loers, Gabriele; Tilling, Thomas; Schachner, Melitta] Univ Hamburg, Zent Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborative Neurosci, Piscataway, NJ USA	University of Hong Kong; Singapore General Hospital; National University of Singapore; Jilin University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Neuroscience Institute (NNI); University of Hamburg; Rutgers State University New Brunswick	Li, YL (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China.	xiaozc@hku.hk	xiao, zhicheng/A-1529-2011	xiao, zhicheng/0000-0001-5172-762X; Dawe, Gavin/0000-0001-6119-701X; Tilling, Thomas/0000-0002-4774-3384	University of Hong Kong; National Medical Research Council of Singapore; Singapore Health Services Pte Ltd; Department of Clinical Research, Singapore General Hospital; Institute of Molecular and Cell Biology, A*STAR, Singapore	University of Hong Kong(University of Hong Kong); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Singapore Health Services Pte Ltd; Department of Clinical Research, Singapore General Hospital; Institute of Molecular and Cell Biology, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants to Z.C. Xiao from the University of Hong Kong, the National Medical Research Council of Singapore, Singapore Health Services Pte Ltd, Department of Clinical Research, Singapore General Hospital and Institute of Molecular and Cell Biology, A*STAR, Singapore, and a grant to G.S. Dawe from the National Medical Research Council of Singapore.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Deryugina EI, 1996, J CELL SCI, V109, P643; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FAHRIG T, 1990, EUR J NEUROSCI, V2, P153, DOI 10.1111/j.1460-9568.1990.tb00407.x; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Goldstein IJ, 2002, J AGR FOOD CHEM, V50, P6583, DOI 10.1021/jf0201879; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; KUCHERER A, 1987, J CELL BIOL, V104, P1597, DOI 10.1083/jcb.104.6.1597; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lowe JB, 2002, BIOCHEM SOC SYMP, V69, P33; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Orczyk-Pawilowicz M, 2006, CLIN CHIM ACTA, V367, P86, DOI 10.1016/j.cca.2005.11.025; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; Streit A, 1996, J NEUROCHEM, V66, P834; Sun HZ, 2004, ENDOCRINOLOGY, V145, P5332, DOI 10.1210/en.2004-0668; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang ZG, 1996, CARBOHYD RES, V295, P25, DOI 10.1016/S0008-6215(96)90116-0; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0	41	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3841	10.1371/journal.pone.0003841	http://dx.doi.org/10.1371/journal.pone.0003841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048108	Green Published, gold, Green Submitted			2022-12-27	WOS:000265452000009
J	Gilestro, GF				Gilestro, Giorgio F.			Redundant Mechanisms for Regulation of Midline Crossing in Drosophila	PLOS ONE			English	Article								During development, all neurons have to decide on whether to cross the longitudinal midline to project on the contralateral side of the body. In vertebrates and invertebrates regulation of crossing is achieved by interfering with Robo signalling either through sorting and degradation of the receptor, in flies, or through silencing of its repulsive activity, in vertebrates. Here I show that in Drosophila a second mechanism of regulation exists that is independent from sorting. Using in vitro and in vivo assays I mapped the region of Robo that is sufficient and required for its interaction with Comm, its sorting receptor. By modifying that region, I generated new forms of Robo that are insensitive to Comm sorting in vitro and in vivo, yet still able to normally translate repulsive activity in vivo. Using gene targeting by homologous recombination I created new conditional alleles of robo that are sorting defective (robo(SD)). Surprisingly, expression of these modified proteins results in phenotypically normal flies, unveiling a sorting independent mechanism of regulation.	[Gilestro, Giorgio F.] Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Gilestro, GF (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	gilestro@wisc.edu	Gilestro, Giorgio/A-8721-2010	Gilestro, Giorgio/0000-0001-7512-8541	Boehringer Ingelheim; Austrian Academy of Sciences	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Academy of Sciences	This work was supported by funding from Boehringer Ingelheim and the Austrian Academy of Sciences. The funding agencies had no role in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Boyan G, 2003, ARTHROPOD STRUCT DEV, V32, P61, DOI 10.1016/S1467-8039(03)00037-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; CHOI Y, 2003, THESIS OHIO STATE U; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Georgiou M, 2003, MECH DEVELOP, V120, P1009, DOI 10.1016/S0925-4773(03)00179-5; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	41	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3798	10.1371/journal.pone.0003798	http://dx.doi.org/10.1371/journal.pone.0003798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030109	Green Published, gold, Green Submitted			2022-12-27	WOS:000265450800008
J	Grutzmann, R; Molnar, B; Pilarsky, C; Habermann, JK; Schlag, PM; Saeger, HD; Miehlke, S; Stolz, T; Model, F; Roblick, UJ; Bruch, HP; Koch, R; Liebenberg, V; deVos, T; Song, XL; Day, RH; Sledziewski, AZ; Lofton-Day, C				Gruetzmann, Robert; Molnar, Bela; Pilarsky, Christian; Habermann, Jens K.; Schlag, Peter M.; Saeger, Hans D.; Miehlke, Stephan; Stolz, Thomas; Model, Fabian; Roblick, Uwe J.; Bruch, Hans-Peter; Koch, Rainer; Liebenberg, Volker; deVos, Theo; Song, Xiaoling; Day, Robert H.; Sledziewski, Andrew Z.; Lofton-Day, Catherine			Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay	PLOS ONE			English	Article								Background: Colorectal cancer (CRC) is the second leading cause of cancer deaths despite the fact that detection of this cancer in early stages results in over 90% survival rate. Currently less than 45% of at-risk individuals in the US are screened regularly, exposing a need for better screening tests. We performed two case-control studies to validate a blood-based test that identifies methylated DNA in plasma from all stages of CRC. Methodology/Principal Findings: Using a PCR assay for analysis of Septin 9 (SEPT9) hypermethylation in DNA extracted from plasma, clinical performance was optimized on 354 samples (252 CRC, 102 controls) and validated in a blinded, independent study of 309 samples (126 CRC, 183 controls). 168 polyps and 411 additional disease controls were also evaluated. Based on the training study SEPT9-based classification detected 120/252 CRCs (48%) and 7/ 102 controls (7%). In the test study 73/126 CRCs (58%) and 18/183 control samples (10%) were positive for SEPT9 validating the training set results. Inclusion of an additional measurement replicate increased the sensitivity of the assay in the testing set to 72% (90/125 CRCs detected) while maintaining 90% specificity (19/183 for controls). Positive rates for plasmas from the other cancers (11/96) and non-cancerous conditions (41/315) were low. The rate of polyp detection (> 1 cm) was similar to 20%. Conclusions/Significance: Analysis of SEPT9 DNA methylation in plasma represents a straightforward, minimally invasive method to detect all stages of CRC with potential to satisfy unmet needs for increased compliance in the screening population. Further clinical testing is warranted.	[Gruetzmann, Robert; Pilarsky, Christian; Saeger, Hans D.] Univ Hosp Carl Gustav Carus Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Molnar, Bela] Semmelweis Univ, H-1085 Budapest, Hungary; [Habermann, Jens K.; Roblick, Uwe J.; Bruch, Hans-Peter] Univ Hosp Schleswig Holstein, Dept Surg, Lubeck, Germany; [Schlag, Peter M.] Robert Rossle Klin, Dept Surg & Surg Oncol, Charite Campus Berlin Buch, Berlin, Germany; [Miehlke, Stephan] Univ Hosp Carl Gustav Carus Dresden, Dept Gastroenterol, Dresden, Germany; [Stolz, Thomas] Volklingen Clin, Volklingen, Germany; [Model, Fabian; Liebenberg, Volker] Epigenom AG, Berlin, Germany; [Koch, Rainer] Tech Univ Dresden, Inst Med Informat & Biomet, Dresden, Germany; [deVos, Theo; Song, Xiaoling; Day, Robert H.; Sledziewski, Andrew Z.; Lofton-Day, Catherine] Epigenom Inc, Seattle, WA USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Semmelweis University; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Grutzmann, R (corresponding author), Univ Hosp Carl Gustav Carus Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.	Robert.Gruetzmann@uniklinikum-dresden.de	Bruch, Hans-Peter/E-7731-2010; Habermann, Jens/AAA-5149-2020; Roblick, Uwe J/F-5906-2011; Liebenberg, Volker/AAY-7687-2021	Pilarsky, Christian/0000-0002-7968-3283; deVos, Theo/0000-0003-2085-2844; Liebenberg, Volker/0000-0003-1936-1247	Epigenomics AG, Berlin	Epigenomics AG, Berlin	The study was sponsored by Epigenomics AG, Berlin. The study sponsor participated in study design and the analysis of the samples. Interpretation of data and writing of the paper as well as the decision to submit it for publication was performed by the all authors including the authors employed by the sponsor.	*AM CANC S, 2005, BEH RISK FACT SURV S; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Davis KC, 1998, PUBLIC HEALTH REP, V113, P346; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Fisher JA, 2006, CANCER EPIDEM BIOMAR, V15, P108, DOI 10.1158/1055-9965.EPI-05-0198; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kurosu T, 2008, INT J HEMATOL, V88, P192, DOI 10.1007/s12185-008-0133-0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Li SR, 2006, INT J CANCER, V118, P3078, DOI 10.1002/ijc.21774; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakayama H, 2002, CANCER LETT, V188, P115, DOI 10.1016/S0304-3835(01)00839-4; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Regueiro CR, 2005, GASTROENTEROLOGY, V129, P1083, DOI 10.1053/j.gastro.2005.06.012; Russell SEH, 2000, CANCER RES, V60, P4729; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Tetzner R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl955; Toyooka S, 2002, CANCER RES, V62, P3382; Toyota M, 2000, CANCER RES, V60, P4044; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967; Zou HZ, 2002, CLIN CANCER RES, V8, P188	35	287	364	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3759	10.1371/journal.pone.0003759	http://dx.doi.org/10.1371/journal.pone.0003759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018278	Green Published, Green Accepted, gold			2022-12-27	WOS:000265448500006
J	Norman, JP; Perry, SW; Reynolds, HM; Kiebala, M; Bentley, KLD; Trejo, M; Volsky, DJ; Maggirwar, SB; Dewhurst, S; Masliah, E; Gelbard, HA				Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Kiebala, Michelle; Bentley, Karen L. De Mesy; Trejo, Margarita; Volsky, David J.; Maggirwar, Sanjay B.; Dewhurst, Stephen; Masliah, Eliezer; Gelbard, Harris A.			HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization	PLOS ONE			English	Article								Neurologic disease caused by human immunodeficiency virus type 1 (HIV-1) is ultimately refractory to highly active antiretroviral therapy (HAART) because of failure of complete virus eradication in the central nervous system (CNS), and disruption of normal neural signaling events by virally induced chronic neuroinflammation. We have previously reported that HIV-1 Tat can induce mitochondrial hyperpolarization in cortical neurons, thus compromising the ability of the neuron to buffer calcium and sustain energy production for normal synaptic communication. In this report, we demonstrate that Tat induces rapid loss of ER calcium mediated by the ryanodine receptor (RyR), followed by the unfolded protein response (UPR) and pathologic dilatation of the ER in cortical neurons in vitro. RyR antagonism attenuated both Tat-mediated mitochondrial hyperpolarization and UPR induction. Delivery of Tat to murine CNS in vivo also leads to long-lasting pathologic ER dilatation and mitochondrial morphologic abnormalities. Finally, we performed ultrastructural studies that demonstrated mitochondria with abnormal morphology and dilated endoplasmic reticulum (ER) in brain tissue of patients with HIV-1 inflammation and neurodegeneration. Collectively, these data suggest that abnormal RyR signaling mediates the neuronal UPR with failure of mitochondrial energy metabolism, and is a critical locus for the neuropathogenesis of HIV-1 in the CNS.	[Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA; [Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Neurol, Child Neurol Div, Rochester, NY 14627 USA; [Bentley, Karen L. De Mesy] Univ Rochester, Sch Med & Dent, Dept Lab Med & Pathol, Rochester, NY 14627 USA; [Kiebala, Michelle; Maggirwar, Sanjay B.; Dewhurst, Stephen; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Volsky, David J.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Mol Virol Div, New York, NY 10027 USA; [Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, Dept Neurosci, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of California System; University of California San Diego	Norman, JP (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA.	harris_gelbard@urmc.rochester.edu	Gelbard, Harris/M-9260-2019	Dewhurst, Stephen/0000-0001-7729-7920; Perry, Seth W/0000-0002-1503-6634; Gelbard, Harris/0000-0001-5095-7976	Geoffrey Waasdorp Pediatric Neurology Fund; NIH [T32ES07026, T32 AI49105, PO1MH64570, R01MH56838, R01MH078989, RO1 NS054578, PO1NS31492, MH62962, MH59745, MH62512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062962, P01MH064570, P30MH062512, R24MH059745, R01MH056838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, P01NS031492] Funding Source: NIH RePORTER	Geoffrey Waasdorp Pediatric Neurology Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Geoffrey Waasdorp Pediatric Neurology Fund, and NIH grants T32ES07026 (to J.P.N.), T32 AI49105 (to M.K. and H.M.R.), PO1MH64570, R01MH56838 and R01MH078989 (to J.N.P, S.W.P., S.B.M., S.D. and H.A.G.); RO1 NS054578 (to S.B.M. and H.A.G.); PO1NS31492 (to D.J.V. and H.A.G.); and MH62962, MH59745, and MH62512 to E.M. No funding sponsor played a role in this research.	ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; An SF, 1997, J NEUROPATH EXP NEUR, V56, P1262, DOI 10.1097/00005072-199711000-00011; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bellizzi MJ, 2005, J CLIN INVEST, V115, P3185, DOI 10.1172/JCI25444; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Buriani A, 1999, J NeuroAIDS, V2, P1, DOI 10.1300/J128v02n02_01; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Del Gaizo V, 2003, MOL GENET METAB, V80, P170, DOI 10.1016/j.ymgme.2003.08.017; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; GENDELMAN HE, 2002, AIDS OTHER MANIFESTA, P86; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; JENSEN KLD, 1983, MASSON MONOGRAPHS DI, V4, P194; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Masliah E, 1996, J NEUROSCI, V16, P5795; Matarrese P, 2003, J IMMUNOL, V170, P6006, DOI 10.4049/jimmunol.170.12.6006; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Petito CK, 1999, J NEUROVIROL, V5, P327, DOI 10.3109/13550289909029474; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Porcheray F, 2006, AM J PHYSIOL-CELL PH, V291, pC618, DOI 10.1152/ajpcell.00021.2006; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Solovyova N, 2002, J NEUROSCI METH, V122, P1, DOI 10.1016/S0165-0270(02)00300-X; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; TARDIEU M, 1992, ANN NEUROL, V32, P11, DOI 10.1002/ana.410320104; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van de Bovenkamp M, 2002, EUR J CLIN INVEST, V32, P619, DOI 10.1046/j.1365-2362.2002.01029.x; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Weis S, 1996, CLIN NEUROPATHOL, V15, P361; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	65	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3731	10.1371/journal.pone.0003731	http://dx.doi.org/10.1371/journal.pone.0003731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009018	gold, Green Published, Green Submitted			2022-12-27	WOS:000265166400009
J	Dashtsoodol, N; Watarai, H; Sakata, S; Taniguchi, M				Dashtsoodol, Nyambayar; Watarai, Hiroshi; Sakata, Sakura; Taniguchi, Masaru			Identification of CD4(-)CD8(-) Double-Negative Natural Killer T Cell Precursors in the Thymus	PLOS ONE			English	Article								Background: It is well known that CD1d-restricted V alpha 14 invariant natural killer T (NKT) cells are derived from cells in the CD4(+)CD8(+) double-positive (DP) population in the thymus. However, the developmental progression of NKT cells in the earlier stages remains unclear, and the possible existence of NKT cell presursors in the earlier stages than DP stage remains to be tested. Principal Findings: Here, we demonstrate that NKT cell precursors that express invariant V alpha 14-J alpha 18 transcripts but devoid of surface expression of the invariant Va14 receptor are present in the late CD4(-)CD8(-) double-negative (DN) 4 stage and have the potential to generate mature NKT cells in both in vivo and in vitro experimental conditions. Moreover, the DN4 population in CD1d knock-out (CD1dKO) mice was similar to those with an NKT cell potential in wild-type (WT) C57BL/6 (B6) mice, but failed to develop into NKT cells in vitro. However, these precursors could develop into NKT cells when co-cultured with normal thymocytes or in an in vivo experimental setting, indicating that functional NKT cell precursors are present in CD1dKO mice. Conclusions: Together, these results demonstrate that thymic DN4 fraction contains NKT cell precursors. Our findings provide new insights into the early development of NKT cells prior to surface expression of the invariant Va14 antigen receptor and suggest the possible alternative developmental pathway of NKT cells.	[Dashtsoodol, Nyambayar; Watarai, Hiroshi; Sakata, Sakura; Taniguchi, Masaru] RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Tsurumi Ku, Kanagawa, Japan	RIKEN	Dashtsoodol, N (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Tsurumi Ku, Kanagawa, Japan.	taniguti@rcai.riken.jp	Watarai, Hiroshi/G-9894-2012	Watarai, Hiroshi/0000-0003-1511-2593; Dashtsoodol, Nyambayar/0000-0003-4890-9267	Ministry of Education, Culture, Sports, Science and Technology, Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bezbradica JS, 2006, IMMUNITY, V25, P487, DOI 10.1016/j.immuni.2006.06.017; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nakagawa K, 1997, P NATL ACAD SCI USA, V94, P2472, DOI 10.1073/pnas.94.6.2472; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515	28	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3688	10.1371/journal.pone.0003688	http://dx.doi.org/10.1371/journal.pone.0003688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997862	Green Published, Green Submitted, gold			2022-12-27	WOS:000265165500011
J	Lucchetta, EM; Vincent, ME; Ismagilov, RF				Lucchetta, Elena M.; Vincent, Meghan E.; Ismagilov, Rustem F.			A Precise Bicoid Gradient Is Nonessential during Cycles 11-13 for Precise Patterning in the Drosophila Blastoderm	PLOS ONE			English	Article								Background: During development, embryos decode maternal morphogen inputs into highly precise zygotic gene expression. The discovery of the morphogen Bicoid and its profound effect on developmental programming in the Drosophila embryo has been a cornerstone in understanding the decoding of maternal inputs. Bicoid has been described as a classical morphogen that forms a concentration gradient along the antero-posterior axis of the embryo by diffusion and initiates expression of target genes in a concentration-dependent manner in the syncytial blastoderm. Recent work has emphasized the stability of the Bicoid gradient as a function of egg length and the role of nuclear dynamics in maintaining the Bicoid gradient. Bicoid and nuclear dynamics were observed but not modulated under the ideal conditions used previously. Therefore, it has not been tested explicitly whether a temporally stable Bicoid gradient prior to cellularization is required for precise patterning. Principal Findings: Here, we modulate both nuclear dynamics and the Bicoid gradient using laminar flows of different temperature in a microfluidic device to determine if stability of the Bicoid gradient prior to cellularization is essential for precise patterning. Dramatic motion of both cytoplasm and nuclei was observed prior to cellularization, and the Bicoid gradient was disrupted by nuclear motion and was highly abnormal as a function of egg length. Despite an abnormal Bicoid gradient during cycles 11-13, Even-skipped patterning in these embryos remained precise. Conclusions: These results indicate that the stability of the Bicoid gradient as a function of egg length is nonessential during syncytial blastoderm stages. Further, presumably no gradient formed by simple diffusion on the scale of egg length could be responsible for the robust antero-posterior patterning observed, as severe cytoplasmic and nuclear motion would disrupt such a gradient. Additional mechanisms for how the embryo could sense its dimensions and interpret the Bicoid gradient are discussed.	[Lucchetta, Elena M.; Vincent, Meghan E.; Ismagilov, Rustem F.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago	Lucchetta, EM (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	r-ismagilov@uchicago.edu			NIH [R01 GM077331]; Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Grant No. R01 GM077331 and the Yen Postdoctoral Fellowship (E.M.L.).	BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bialek W, 2008, CELL, V132, P17, DOI 10.1016/j.cell.2007.12.023; Bird R. B., 2002, INTERPHASE TRANSPORT; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Crest J, 2007, GENETICS, V175, P567, DOI 10.1534/genetics.106.065219; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FOE VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lucchetta EM, 2006, LAB CHIP, V6, P185, DOI 10.1039/b516119c; MIYAMOTO DM, 1982, ROUX ARCH DEV BIOL, V191, P95, DOI 10.1007/BF00848446; OTTINO JM, 1990, ANNU REV FLUID MECH, V22, P207, DOI 10.1146/annurev.fl.22.010190.001231; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Song H, 2003, APPL PHYS LETT, V83, P4664, DOI 10.1063/1.1630378; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318	33	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3651	10.1371/journal.pone.0003651	http://dx.doi.org/10.1371/journal.pone.0003651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989373	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265134600002
J	Dalmasso, C; Carpentier, W; Meyer, L; Rouzioux, C; Goujard, C; Chaix, ML; Lambotte, O; Avettand-Fenoel, V; Le Clerc, S; de Senneville, LD; Deveau, C; Boufassa, F; Debre, P; Delfraissy, JF; Broet, P; Theodorou, I				Dalmasso, Cyril; Carpentier, Wassila; Meyer, Laurence; Rouzioux, Christine; Goujard, Cecile; Chaix, Marie-Laure; Lambotte, Olivier; Avettand-Fenoel, Veronique; Le Clerc, Sigrid; de Senneville, Laure Denis; Deveau, Christiane; Boufassa, Faroudy; Debre, Patrice; Delfraissy, Jean-Francois; Broet, Philippe; Theodorou, Ioannis			Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study	PLOS ONE			English	Article								Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load. We performed a Genome Wide Association study in a cohort of 605 HIV-1-infected seroconverters for detection of novel genetic factors that influence plasma HIV-RNA and cellular HIV-DNA levels. Most of the SNPs strongly associated with HIV-RNA levels were localised in the 6p21 major histocompatibility complex (MHC) region and were in the vicinity of class I and III genes. Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers. Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene). Our data provide evidence that the MHC controls both HIV replication and HIV reservoir. They also indicate that two additional genomic loci may influence the HIV reservoir.	[Broet, Philippe] Univ Paris Sud, JE2492, Fac Med Paris Sud, Villejuif, France; [Carpentier, Wassila; de Senneville, Laure Denis; Debre, Patrice; Theodorou, Ioannis] Univ Paris 06, INSERM, U543, AP HP, F-75252 Paris, France; [Meyer, Laurence; Deveau, Christiane; Boufassa, Faroudy] Univ Paris Sud, Fac Med Paris Sud, AP HP, Hop Bicetre, INSERM, Le Kremlin Bicetre, France; [Rouzioux, Christine; Chaix, Marie-Laure; Avettand-Fenoel, Veronique] Univ Paris 05, CHU Necker, AP HP, EA 3620, Paris, France; [Goujard, Cecile; Lambotte, Olivier; Delfraissy, Jean-Francois] Univ Paris Sud, Fac Med Paris Sud, AP HP, INSERM, U802, Le Kremlin Bicetre, France; [Le Clerc, Sigrid] Conserv Natl Arts Metiers, Paris, France; [Broet, Philippe] Univ Paris Sud, Hop Paul Brousse, AP HP, Serv Sante Publ, Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Dalmasso, C (corresponding author), Univ Paris Sud, JE2492, Fac Med Paris Sud, Villejuif, France.	ioannis.theodorou@psl.ap-hop-paris.fr	Lambotte, Olivier/GRT-0160-2022; Avettand-Fenoel, Véronique/O-6285-2017	Avettand-Fenoel, Véronique/0000-0002-7022-2990; BROET, PHILIPPE/0000-0001-9122-2810	ANRS 101 Rue de Tolbiac, Paris, France [75013]	ANRS 101 Rue de Tolbiac, Paris, France	This study was funded by the ANRS 101 Rue de Tolbiac 75013 Paris FRANCE.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bristow J, 2005, AM J MED GENET C, V139C, P24, DOI 10.1002/ajmg.c.30071; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Desquilbet L, 2004, AIDS, V18, P2361; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fodil N, 1996, IMMUNOGENETICS, V44, P351, DOI 10.1007/s002510050136; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guedj M, 2006, HUM HERED, V61, P210, DOI 10.1159/000094776; Hao K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000109; Hosono K, 2004, GENE, V340, P31, DOI 10.1016/j.gene.2004.06.014; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1991, J INFECT DIS, V163, P78, DOI 10.1093/infdis/163.1.78; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Pellet P, 1997, IMMUNOGENETICS, V46, P434, DOI 10.1007/s002510050299; Prezant TR, 1999, J CLIN ENDOCR METAB, V84, P1149, DOI 10.1210/jc.84.3.1149; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Rupert KL, 2002, J IMMUNOL, V169, P1570, DOI 10.4049/jimmunol.169.3.1570; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schneider A, 2008, J ACCOUNT PUBLIC POL, V27, P1, DOI 10.1016/j.jaccpubpol.2007.11.004; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Turner J, 1999, INT J BIOCHEM CELL B, V31, P1169, DOI 10.1016/S1357-2725(99)00067-9; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; White RA, 2000, CYTOGENET CELL GENET, V89, P272, DOI 10.1159/000015632; Xu J, 2002, J HUM GENET, V47, P681, DOI 10.1007/s100380200104	49	144	147	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3907	10.1371/journal.pone.0003907	http://dx.doi.org/10.1371/journal.pone.0003907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107206	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000001
J	Kweku, M; Liu, DM; Adjuik, M; Binka, F; Seidu, M; Greenwood, B; Chandramohan, D				Kweku, Margaret; Liu, Dongmei; Adjuik, Martin; Binka, Fred; Seidu, Mahmood; Greenwood, Brian; Chandramohan, Daniel			Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; INFANTS; TRANSMISSION; EFFICACY	Background: Malaria and anaemia are the leading causes of morbidity and mortality in children in sub-Saharan Africa. We have investigated the effect of intermittent preventive treatment with sulphadoxine-pyrimethamine or artesunate plus amodiaquine on anaemia and malaria in children in an area of intense, prolonged, seasonal malaria transmission in Ghana. Methods: 2451 children aged 3-59 months from 30 villages were individually randomised to receive placebo or artesunate plus amodiaquine (AS+AQ) monthly or bimonthly, or sulphadoxine-pyrimethamine (SP) bimonthly over a period of six months. The primary outcome measures were episodes of anaemia (Hb<8.0 g/dl) or malaria detected through passive surveillance. Findings: Monthly artesunate plus amodiaquine reduced the incidence of malaria by 69% (95% CI: 63%, 74%) and anaemia by 45% (95% CI: 25%, 60%), bimonthly sulphadoxine-pyrimethamine reduced the incidence of malaria by 24% (95% CI: 14%, 33%) and anaemia by 30% (95% CI: 6%, 49%) and bimonthly artesunate plus amodiaquine reduced the incidence of malaria by 17% (95% CI: 6%, 27%) and anaemia by 32% (95% CI: 7%, 50%) compared to placebo. There were no statistically significant reductions in the episodes of all cause or malaria specific hospital admissions in any of the intervention groups compared to the placebo group. There was no significant increase in the incidence of clinical malaria in the post intervention period in children who were >1 year old when they received IPTc compared to the placebo group. However the incidence of malaria in the post intervention period was higher in children who were >1 year old when they received AS+AQ monthly compared to the placebo group. Interpretation: IPTc is safe and efficacious in reducing the burden of malaria in an area of Ghana with a prolonged, intense malaria transmission season.	[Liu, Dongmei; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, London WC1, England; [Kweku, Margaret; Seidu, Mahmood] Univ Ghana, Ghana Hlth Serv, Accra, Ghana; [Adjuik, Martin] Univ Ghana, Navrongo Hlth Res Ctr, Accra, Ghana; [Binka, Fred] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Seidu, Mahmood] Univ Ghana, Sch Med, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service; University of Ghana; Navrongo Health Research Center; University of Ghana; University of Ghana; University of Ghana	Kweku, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	daniel.chandramohan@lshtm.ac.uk			Gates malaria partnership	Gates malaria partnership	The study received financial support from the Gates malaria partnership. The sponsor had no role in the study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; DICKO A, 2004, AM J TROP MED HYG  S, V71, P6; Dzinjalamala FK, 2005, ANTIMICROB AGENTS CH, V49, P3601, DOI 10.1128/AAC.49.9.3601-3606.2005; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; KWEKU M, 2007, THESIS; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471	12	68	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e4000	10.1371/journal.pone.0004000	http://dx.doi.org/10.1371/journal.pone.0004000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098989	Green Accepted, gold, Green Published			2022-12-27	WOS:000265462300011
J	Brechot, N; Gomez, E; Bignon, M; Khallou-Laschet, J; Dussiot, M; Cazes, A; Alanio-Brechot, C; Durand, M; Philippe, J; Silvestre, JS; Van Rooijen, N; Corvol, P; Nicoletti, A; Chazaud, B; Germain, S				Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Khallou-Laschet, Jamila; Dussiot, Michael; Cazes, Aurelie; Alanio-Brechot, Cecile; Durand, Melanie; Philippe, Josette; Silvestre, Jean-Sebastien; Van Rooijen, Nico; Corvol, Pierre; Nicoletti, Antonino; Chazaud, Benedicte; Germain, Stephane			Modulation of Macrophage Activation State Protects Tissue from Necrosis during Critical Limb Ischemia in Thrombospondin-1-Deficient Mice	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE; ALTERNATIVE ACTIVATION; ALTERED INFLAMMATION; NEGATIVE REGULATOR; NECROTIC CELLS; RECEPTOR-GAMMA; CCR2-/-MICE; PHAGOCYTOSIS	Background: Macrophages, key regulators of healing/regeneration processes, strongly infiltrate ischemic tissues from patients suffering from critical limb ischemia (CLI). However pro-inflammatory markers correlate with disease progression and risk of amputation, suggesting that modulating macrophage activation state might be beneficial. We previously reported that thrombospondin-1 (TSP-1) is highly expressed in ischemic tissues during CLI in humans. TSP-1 is a matricellular protein that displays well-known angiostatic properties in cancer, and regulates inflammation in vivo and macrophages properties in vitro. We therefore sought to investigate its function in a mouse model of CLI. Methods and Findings: Using a genetic model of tsp-1(-/-) mice subjected to femoral artery excision, we report that tsp-1(-/-) mice were clinically and histologically protected from necrosis compared to controls. Tissue protection was associated with increased postischemic angiogenesis and muscle regeneration. We next showed that macrophages present in ischemic tissues exhibited distinct phenotypes in tsp-1(-/-) and wt mice. A strong reduction of necrotic myofibers phagocytosis was observed in tsp-1(-/-) mice. We next demonstrated that phagocytosis of muscle cell debris is a potent pro-inflammatory signal for macrophages in vitro. Consistently with these findings, macrophages that infiltrated ischemic tissues exhibited a reduced postischemic pro-inflammatory activation state in tsp-1(-/-) mice, characterized by a reduced Ly-6C expression and a less pro-inflammatory cytokine expression profile. Finally, we showed that monocyte depletion reversed clinical and histological protection from necrosis observed in tsp-1(-/-) mice, thereby demonstrating that macrophages mediated tissue protection in these mice. Conclusion: This study defines targeting postischemic macrophage activation state as a new potential therapeutic approach to protect tissues from necrosis and promote tissue repair during CLI. Furthermore, our data suggest that phagocytosis plays a crucial role in promoting a deleterious intra-tissular pro-inflammatory macrophage activation state during critical injuries. Finally, our results describe TSP-1 as a new relevant physiological target during critical leg ischemia.	[Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Cazes, Aurelie; Durand, Melanie; Philippe, Josette; Corvol, Pierre; Germain, Stephane] INSERM, U833, Paris, France; [Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Cazes, Aurelie; Durand, Melanie; Philippe, Josette; Corvol, Pierre; Germain, Stephane] Coll France, Lab Angiogenese Embryonnaire Pathol, Paris, France; [Khallou-Laschet, Jamila; Dussiot, Michael; Nicoletti, Antonino] INSERM, U872, Paris, France; [Khallou-Laschet, Jamila; Dussiot, Michael; Nicoletti, Antonino] Univ Paris 06, Ctr Rech Cordeliers, F-75252 Paris, France; [Alanio-Brechot, Cecile] AP HP, Hop Bicetre, LabHematol, Le Kremlin Bicetre, France; [Silvestre, Jean-Sebastien] INSERM, U689, Paris, France; [Silvestre, Jean-Sebastien] Univ Paris 07, Ctr Rech Cardiovasc Lariboisiere, Paris, France; [Van Rooijen, Nico] Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Chazaud, Benedicte] INSERM, U 567, CNRS, UMR 8104, Paris, France; [Chazaud, Benedicte] Univ Paris 05, Inst Cochin, F-75270 Paris, France; [Germain, Stephane] AP HP, Hop Europeen Georges Pompidou, Serv Hematol Biol A, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Brechot, N (corresponding author), INSERM, U833, Paris, France.	stephane.germain@college-de-france.fr	Germain, Stephane/E-2301-2016; Nicoletti, Antonino/A-9460-2015; Perdiguero, Elisa Gomez/U-2120-2018; Van Rooijen, Nico/Z-1578-2019; Bréchot, Nicolas/AAM-7412-2021; Chazaud, Benedicte/N-9291-2017; Silvestre, Jean-Sebastien/K-7695-2017	Germain, Stephane/0000-0001-5992-1275; Nicoletti, Antonino/0000-0002-2623-0897; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Bréchot, Nicolas/0000-0002-7536-287X; Chazaud, Benedicte/0000-0002-1262-502X; Silvestre, Jean-Sebastien/0000-0003-3962-2205; Laschet, Jamila/0000-0002-5090-4417; Alanio, Cecile/0000-0003-2785-7445	European Vascular Genomics Network [LSHMCT-2003-503254]; Agence Nationale de la recherche [ANR-06-JCJC-0160]; Fondation pour la Recherche Medicale	European Vascular Genomics Network; Agence Nationale de la recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work emanates from the European Vascular Genomics Network (http://www.evgn.org) (contract LSHMCT-2003-503254) and is supported by a grant from Agence Nationale de la recherche (ANR-06-JCJC-0160). NB is supported by Fondation pour la Recherche Medicale.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Alleva DG, 2002, J LEUKOCYTE BIOL, V71, P677; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Barani J, 2005, J VASC SURG, V42, P75, DOI 10.1016/j.jvs.2005.03.025; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Chan G, 2008, J IMMUNOL, V181, P698, DOI 10.4049/jimmunol.181.1.698; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Demeure CE, 2000, J IMMUNOL, V164, P2193, DOI 10.4049/jimmunol.164.4.2193; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Engstrom G, 2004, J VASC SURG, V40, P1101, DOI 10.1016/j.jvs.2004.09.017; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Favier J, 2005, J PATHOL, V207, P358, DOI 10.1002/path.1833; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Hayasaki T, 2006, CIRC J, V70, P342, DOI 10.1253/circj.70.342; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Ren Y, 2001, J IMMUNOL, V166, P4743, DOI 10.4049/jimmunol.166.7.4743; REN Y, 1995, J IMMUNOL, V154, P2366; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Stern M, 1996, AM J PATHOL, V149, P911; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tuomisto TT, 2004, ATHEROSCLEROSIS, V174, P111, DOI 10.1016/j.atherosclerosis.2004.01.015; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yamauchi Y, 2002, BIOCHEM BIOPH RES CO, V290, P1551, DOI 10.1006/bbrc.2002.6386	56	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3950	10.1371/journal.pone.0003950	http://dx.doi.org/10.1371/journal.pone.0003950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079608	gold, Green Submitted, Green Published			2022-12-27	WOS:000265458400009
J	Bille, E; Ure, R; Gray, SJ; Kaczmarski, EB; McCarthy, ND; Nassif, X; Maiden, MCJ; Tinsley, CR				Bille, Emmanuelle; Ure, Roisin; Gray, Stephen J.; Kaczmarski, Edward B.; McCarthy, Noel D.; Nassif, Xavier; Maiden, Martin C. J.; Tinsley, Colin R.			Association of a Bacteriophage with Meningococcal Disease in Young Adults	PLOS ONE			English	Article								Despite being the agent of life-threatening meningitis, Neisseria meningitidis is usually carried asymptomatically in the nasopharynx of humans and only occasionally causes disease. The genetic bases for virulence have not been entirely elucidated and the search for new virulence factors in this species is hampered by the lack of an animal model representative of the human disease. As an alternative strategy we employ a molecular epidemiological approach to establish a statistical association of a candidate virulence gene with disease in the human population. We examine the distribution of a previously-identified genetic element, a temperate bacteriophage, in 1288 meningococci isolated from cases of disease and asymptomatic carriage. The phage was over-represented in disease isolates from young adults indicating that it may contribute to invasive disease in this age group. Further statistical analysis indicated that between 20% and 45% of the pathogenic potential of the five most common disease-causing meningococcal groups was linked to the presence of the phage. In the absence of an animal model of human disease, this molecular epidemiological approach permitted the estimation of the influence of the candidate virulence factor. Such an approach is particularly valuable in the investigation of exclusively human diseases.	[Nassif, Xavier; Tinsley, Colin R.] INSERM, Paris, France; [Bille, Emmanuelle; Nassif, Xavier; Tinsley, Colin R.] Univ Paris 05, Fac Med, Unite Pathogen Infect Syst, Paris, France; [Bille, Emmanuelle; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, Lab Microbiol, Paris, France; [Ure, Roisin; McCarthy, Noel D.; Maiden, Martin C. J.] Peter Medawar Building Pathogen Res, Dept Zool, Oxford, England; [Gray, Stephen J.; Kaczmarski, Edward B.] Manchester Roy Infirmary, Hlth Protect Agcy, Meningococcal Reference Unit, Manchester, Lancs, England; [Tinsley, Colin R.] AgroParis Tech, Ctr Grignon, CNRS 2585, INRA 1238, Lab Microbiol Genet Mol, Thiverval Grignon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Health Protection Agency; AgroParisTech; INRAE	Bille, E (corresponding author), INSERM, Paris, France.	tinsley@grignon.inra.fr	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; McCarthy, Noel D/K-3314-2012	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; /0000-0001-9172-0510; McCarthy, Noel/0000-0003-1113-1017; Nassif, Xavier/0000-0003-2855-3240	Institut National de la Sante et de la Recherche Medicale (France); Universite Paris Descartes (France); Wellcome Trust (UK); Health Protection Agency (UK); AgroParisTech (France); Institut National de Recherche Agrnonomique (France); Centre Nationale pour la Recherche Scientifique (France)	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes (France); Wellcome Trust (UK)(Wellcome Trust); Health Protection Agency (UK); AgroParisTech (France); Institut National de Recherche Agrnonomique (France); Centre Nationale pour la Recherche Scientifique (France)	Parts of this study were supported by the Institut National de la Sante et de la Recherche Medicale (France), by the Universite Paris Descartes (France), by the Wellcome Trust (UK), by the Health Protection Agency (UK), by AgroParisTech (France), by the Institut National de Recherche Agrnonomique (France), and by the Centre Nationale pour la Recherche Scientifique (France). The funding agencies did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; DENSEN P, 1989, CLIN MICROBIOL REV, V2, pS11, DOI 10.1128/CMR.2.Suppl.S11-S17.1989; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1990, MICROBIOLOGY, P551; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kawai M, 2006, GENE, V383, P52, DOI 10.1016/j.gene.2006.07.013; KRIZOVA P, 1997, CTR EUR J PUBLIC HLT, V4, P214; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Tinsley CR, 2006, MICROBES INFECT, V8, P1365, DOI 10.1016/j.micinf.2005.12.013; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; WHO, 1998, CONTR EP MEN DIS WHO, V2nd ed.	21	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3885	10.1371/journal.pone.0003885	http://dx.doi.org/10.1371/journal.pone.0003885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065260	Green Submitted, Green Published, gold			2022-12-27	WOS:000265455200005
J	Tsuchiya, N; Kawasaki, H; Oya, H; Howard, MA; Adolphs, R				Tsuchiya, Naotsugu; Kawasaki, Hiroto; Oya, Hiroyuki; Howard, Matthew A., III; Adolphs, Ralph			Decoding Face Information in Time, Frequency and Space from Direct Intracranial Recordings of the Human Brain	PLOS ONE			English	Article							SELECTIVE VISUAL-ATTENTION; FACIAL EXPRESSIONS; OCCIPITOTEMPORAL CORTEX; FUSIFORM GYRUS; FRONTAL-CORTEX; PERCEPTION; RECOGNITION; POTENTIALS; FMRI; IDENTITY	Faces are processed by a neural system with distributed anatomical components, but the roles of these components remain unclear. A dominant theory of face perception postulates independent representations of invariant aspects of faces (e. g., identity) in ventral temporal cortex including the fusiform gyrus, and changeable aspects of faces (e. g., emotion) in lateral temporal cortex including the superior temporal sulcus. Here we recorded neuronal activity directly from the cortical surface in 9 neurosurgical subjects undergoing epilepsy monitoring while they viewed static and dynamic facial expressions. Applying novel decoding analyses to the power spectrogram of electrocorticograms (ECoG) from over 100 contacts in ventral and lateral temporal cortex, we found better representation of both invariant and changeable aspects of faces in ventral than lateral temporal cortex. Critical information for discriminating faces from geometric patterns was carried by power modulations between 50 to 150 Hz. For both static and dynamic face stimuli, we obtained a higher decoding performance in ventral than lateral temporal cortex. For discriminating fearful from happy expressions, critical information was carried by power modulation between 60-150 Hz and below 30 Hz, and again better decoded in ventral than lateral temporal cortex. Task-relevant attention improved decoding accuracy more than 10% across a wide frequency range in ventral but not at all in lateral temporal cortex. Spatial searchlight decoding showed that decoding performance was highest around the middle fusiform gyrus. Finally, we found that the right hemisphere, in general, showed superior decoding to the left hemisphere. Taken together, our results challenge the dominant model for independent face representation of invariant and changeable aspects: information about both face attributes was better decoded from a single region in the middle fusiform gyrus.	[Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Kawasaki, Hiroto; Oya, Hiroyuki; Howard, Matthew A., III; Adolphs, Ralph] Univ Iowa, Dept Neurosurg, Iowa City, IA 52242 USA; [Adolphs, Ralph] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA USA	California Institute of Technology; University of Iowa; University of Iowa; California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	naotsu@gmail.com	; Tsuchiya, Naotsugu/N-8153-2014; Oya, Hiroyuki/Q-2989-2018	Lauwereyns, Jan/0000-0003-0551-2550; Tsuchiya, Naotsugu/0000-0003-4216-8701; Kawasaki, Hiroto/0000-0002-7688-9171; Oya, Hiroyuki/0000-0002-1733-5478; Howard, Matthew/0000-0003-3935-8889	Japan Society for the Promotion of Science [fellowship]; NIH [R03 MH070497-01A2, R01 DC004290-06]; James S. McDonnell Foundation; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH070497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004290] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a fellowship from the Japan Society for the Promotion of Science (N.T.) and grants from NIH (R03 MH070497-01A2 to H.K.; R01 DC004290-06 to M.H.), the James S. McDonnell Foundation (R.A.) and the Gordon and Betty Moore Foundation (R.A.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, NEUROIMAGE, V38, P649, DOI 10.1016/j.neuroimage.2007.02.022; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Macmillan N. A., 1991, DETECTION THEORY USE; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Nir Y., 2008, NAT NEUROSCI; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; Poggio Tomaso, 2003, NOTICES AM MATH SOC, V50, P537; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	59	83	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3892	10.1371/journal.pone.0003892	http://dx.doi.org/10.1371/journal.pone.0003892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZP	19065268	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265455200007
J	Abramson, T; Kedem, H; Relman, DA				Abramson, Tzvia; Kedem, Hassya; Relman, David A.			Modulation of the NF-kappa B Pathway by Bordetella pertussis Filamentous Hemagglutinin	PLOS ONE			English	Article								Background: Filamentous hemagglutinin (FHA) is a cell-associated and secreted adhesin produced by Bordetella pertussis with pro-apoptotic and pro-inflammatory activity in host cells. Given the importance of the NF-kappa B transcription factor family in these host cell responses, we examined the effect of FHA on NF-kappa B activation in macrophages and bronchial epithelial cells, both of which are relevant cell types during natural infection. Methodology/Principal Findings: Exposure to FHA of primary human monocytes and transformed U-937 macrophages, but not BEAS-2B epithelial cells, resulted in early activation of the NF-kappa B pathway, as manifested by the degradation of cytosolic I kappa B alpha, by NF-kappa B DNA binding, and by the subsequent secretion of NF-kappa B-regulated inflammatory cytokines. However, exposure of macrophages and human monocytes to FHA for two hours or more resulted in the accumulation of cytosolic I kappa B alpha, and the failure of TNF-alpha to activate NF-kappa B. Proteasome activity was attenuated following exposure of cells to FHA for 2 hours, as was the nuclear translocation of RelA in BEAS-2B cells. Conclusions: These results reveal a complex temporal dynamic, and suggest that despite short term effects to the contrary, longer exposures of host cells to this secreted adhesin may block NF-kappa B activation, and perhaps lead to a compromised immune response to this bacterial pathogen.	[Abramson, Tzvia; Kedem, Hassya; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Veterans Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Abramson, Tzvia] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	Stanford University; Stanford University; California State University System; San Jose State University	Abramson, T (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	NIH/NIAID [R01 AI39587, R21/33 AI057188]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039587, R33AI057188, R21AI057188] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from NIH/NIAID (R01 AI39587, R21/33 AI057188) to DAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; ISHIBASHI Y, 1994, J EXP MED, V180, P1225, DOI 10.1084/jem.180.4.1225; Ishibashi Y, 2003, MICROB PATHOGENESIS, V35, P169, DOI 10.1016/S0882-4010(03)00113-X; Ishibashi Y, 2001, MICROB PATHOGENESIS, V30, P279, DOI 10.1006/mpat.2001.0432; Jacob-Dubuisson F, 2000, MICROBIOL-SGM, V146, P1211, DOI 10.1099/00221287-146-5-1211; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kettritz R, 2004, J BIOL CHEM, V279, P2657, DOI 10.1074/jbc.M309778200; Legarda D, 2005, CELL MICROBIOL, V7, P489, DOI 10.1111/j.1462-5822.2004.00473.x; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Neish AS, 2004, IMMUNOL RES, V29, P175, DOI 10.1385/IR:29:1-3:175; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; SCHULZELUEHRMAN.J, 2006, B IMMUNITY, V25, P701; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Ward PA, 2002, MOL CELL BIOCHEM, V234, P225, DOI 10.1023/A:1015944709177; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3825	10.1371/journal.pone.0003825	http://dx.doi.org/10.1371/journal.pone.0003825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043589	gold, Green Submitted, Green Published			2022-12-27	WOS:000265451500006
J	Nilsson, C; Skoglund, A; Moran, AP; Annuk, H; Engstrand, L; Normark, S				Nilsson, Christina; Skoglund, Anna; Moran, Anthony P.; Annuk, Heidi; Engstrand, Lars; Normark, Staffan			Lipopolysaccharide Diversity Evolving in Helicobacter pylori Communities through Genetic Modifications in Fucosyltransferases	PLOS ONE			English	Article							LEWIS ANTIGEN-EXPRESSION; BLOOD GROUP ANTIGENS; CARBOXYL-TERMINUS; STRAIN VARIATION; PHASE VARIATION; MOUSE MODEL; SINGLE; INFECTION; ULCER; DIVERSIFICATION	Helicobacter pylori persistently colonizes the gastric mucosa of half the human population. It is one of the most genetically diverse bacterial organisms and subvariants are continuously emerging within an H. pylori population. In this study we characterized a number of single-colony isolates from H. pylori communities in various environmental settings, namely persistent human gastric infection, in vitro bacterial subcultures on agar medium, and experimental in vivo infection in mice. The lipopolysaccharide (LPS) O-antigen chain revealed considerable phenotypic diversity between individual cells in the studied bacterial communities, as demonstrated by size variable O-antigen chains and different levels of Lewis glycosylation. Absence of high-molecular-weight O-antigen chains was notable in a number of experimentally passaged isolates in vitro and in vivo. This phenotype was not evident in bacteria obtained from a human gastric biopsy, where all cells expressed high-molecular-weight O-antigen chains, which thus may be the preferred phenotype for H. pylori colonizing human gastric mucosa. Genotypic variability was monitored in the two genes encoding alpha 1,3-fucosyltransferases, futA and futB, that are involved in Lewis antigen expression. Genetic modifications that could be attributable to recombination events within and between the two genes were commonly detected and created a diversity, which together with phase variation, contributed to divergent LPS expression. Our data suggest that the surrounding environment imposes a selective pressure on H. pylori to express certain LPS phenotypes. Thus, the milieu in a host will select for bacterial variants with particular characteristics that facilitate adaptation and survival in the gastric mucosa of that individual, and will shape the bacterial community structure.	[Nilsson, Christina; Skoglund, Anna; Engstrand, Lars; Normark, Staffan] Karolinska Inst, Dept Microbiol, Tumor & Cell Biol, Stockholm, Sweden; [Nilsson, Christina; Skoglund, Anna; Engstrand, Lars; Normark, Staffan] Swedish Inst Infect Dis Control, Solna, Sweden; [Moran, Anthony P.; Annuk, Heidi] Natl Univ Ireland, Sch Nat Sci, Dept Microbiol, Galway, Ireland; [Moran, Anthony P.] Griffith Univ, Inst Glycom, Nathan, Qld 4111, Australia	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Ollscoil na Gaillimhe-University of Galway; Griffith University	Nilsson, C (corresponding author), Genome Inst Singapore, Singapore, Singapore.	Christina.Nilsson@mtc.ki.se			European Union [LSHC-CT-2005-018704]; Swedish Foundation for Strategic Research; Swedish Cancer Society; Swedish Research Council; Irish Health Research Board; Griffith University	European Union(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Irish Health Research Board; Griffith University(Griffith University)	This work was financially supported by grants from the Sixth Research Framework Programme of the European Union, project INCA (LSHC-CT-2005-018704), the Swedish Foundation for Strategic Research, the Swedish Cancer Society, the Swedish Research Council, the Irish Health Research Board and Griffith University.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P6221, DOI 10.1093/nar/20.23.6221; Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; ASPINALL GO, 1994, CARBOHYDR LETT, V0001; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bjorkholm B, 2001, INFECT IMMUN, V69, P7832, DOI 10.1128/IAI.69.12.7832-7838.2001; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; Cooke CL, 2005, FEMS IMMUNOL MED MIC, V45, P11, DOI 10.1016/j.femsim.2005.04.002; Enroth H, 1999, DIGEST DIS SCI, V44, P102, DOI 10.1023/A:1026658301825; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gibson JR, 1998, LETT APPL MICROBIOL, V26, P399, DOI 10.1046/j.1472-765X.1998.00361.x; Granstrom M, 1997, J CLIN MICROBIOL, V35, P468; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Kuipers EJ, 2000, J INFECT DIS, V181, P273, DOI 10.1086/315173; Levine SM, 2007, FASEB J, V21, P3458, DOI 10.1096/fj.07-8501com; Lin SW, 2006, BIOCHEMISTRY-US, V45, P8108, DOI 10.1021/bi0601297; Lundin A, 2005, INFECT IMMUN, V73, P4818, DOI 10.1128/IAI.73.8.4818-4822.2005; Ma B, 2006, J BIOL CHEM, V281, P6385, DOI 10.1074/jbc.M511320200; Ma B, 2005, J BIOL CHEM, V280, P36848, DOI 10.1074/jbc.M504415200; Ma B, 2003, J BIOL CHEM, V278, P21893, DOI 10.1074/jbc.M301704200; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149; Monteiro MA, 2000, EUR J BIOCHEM, V267, P305, DOI 10.1046/j.1432-1327.2000.01007.x; Monteiro MA, 2001, ADV CARBOHYD CHEM BI, V57, P99, DOI 10.1016/S0065-2318(01)57016-X; Monteiro MA, 2000, GLYCOBIOLOGY, V10, P701, DOI 10.1093/glycob/10.7.701; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 2007, INT J MED MICROBIOL, V297, P307, DOI 10.1016/j.ijmm.2007.03.008; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; MORAN AP, 1995, FEMS IMMUNOL MED MIC, V10, P271; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2003, INFECT IMMUN, V71, P6573, DOI 10.1128/IAI.71.11.6573-6581.2003; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rasko DA, 2000, J BIOL CHEM, V275, P4988, DOI 10.1074/jbc.275.7.4988; Rasko DA, 2000, J INFECT DIS, V181, P1089, DOI 10.1086/315354; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; SALAMA SM, 1995, J CLIN MICROBIOL, V33, P2496, DOI 10.1128/JCM.33.9.2496-2497.1995; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Taylor DE, 1998, GASTROENTEROLOGY, V115, P1113, DOI 10.1016/S0016-5085(98)70082-4; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; Walsh EJ, 1997, J APPL MICROBIOL, V83, P67, DOI 10.1046/j.1365-2672.1997.00164.x; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 2006, FASEB J, V20, P1534, DOI 10.1096/fj.05-5529fje; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996; Wirth HP, 1999, J LAB CLIN MED, V133, P488, DOI 10.1016/S0022-2143(99)90026-4; Wong BCY, 2001, ALIMENT PHARM THERAP, V15, P493, DOI 10.1046/j.1365-2036.2001.00949.x	68	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3811	10.1371/journal.pone.0003811	http://dx.doi.org/10.1371/journal.pone.0003811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043574	gold, Green Published, Green Submitted			2022-12-27	WOS:000265451400003
J	Erlich, RL; Fry, RC; Begley, TJ; Daee, DL; Lahue, RS; Samson, LD				Erlich, Rachel L.; Fry, Rebecca C.; Begley, Thomas J.; Daee, Danielle L.; Lahue, Robert S.; Samson, Leona D.			Anc1, a Protein Associated with Multiple Transcription Complexes, Is Involved in Postreplication Repair Pathway in S-cerevisiae	PLOS ONE			English	Article								Yeast strains lacking Anc1, a member of the YEATS protein family, are sensitive to several DNA damaging agents. The YEATS family includes two human genes that are common fusion partners with MLL in human acute leukemias. Anc1 is a member of seven multi-protein complexes involved in transcription, and the damage sensitivity observed in anc1 Delta cells is mirrored in strains deleted for some other non-essential members of several of these complexes. Here we show that ANC1 is in the same epistasis group as SRS2 and RAD5, members of the postreplication repair (PRR) pathway, but has additive or synergistic interactions with several other members of this pathway. Although PRR is traditionally divided into an "errorprone'' and an "error-free'' branch, ANC1 is not epistatic with all members of either established branch, and instead defines a new error-free branch of the PRR pathway. Like several genes involved in PRR, an intact ANC1 gene significantly suppresses spontaneous mutation rates, including the expansion of (CAG) 25 repeats. Anc1's role in the PRR pathway, as well as its role in suppressing triplet repeats, point to a possible mechanism for a protein of potential medical interest.	[Erlich, Rachel L.; Fry, Rebecca C.; Samson, Leona D.] MIT, Broad Inst, Dept Biol, Cambridge, MA 02139 USA; [Erlich, Rachel L.; Fry, Rebecca C.; Begley, Thomas J.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA USA; [Begley, Thomas J.; Samson, Leona D.] MIT, Dept Biol Engn, Cambridge, MA USA; [Daee, Danielle L.; Lahue, Robert S.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Nebraska System; University of Nebraska Medical Center	Erlich, RL (corresponding author), MIT, Broad Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu		Fry, Rebecca/0000-0003-0899-9018; Lahue, Robert/0000-0002-8870-5616	National Institute of Health [CA055042, ES002109, CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants CA055042, ES002109 and CA14051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brachmann CB, 1998, YEAST, V14, P115; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Cejka P, 2001, GENETICS, V159, P953; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Dixon Michael J., 2004, V277, P29; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Hanna M, 2004, DNA REPAIR, V3, P51, DOI 10.1016/j.dnarep.2003.09.005; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; John S, 2000, GENE DEV, V14, P1196; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Kaplan Y, 2007, CURR GENET, V51, P123, DOI 10.1007/s00294-006-0113-y; KRAMER B, 1989, MOL CELL BIOL, V9, P4432, DOI 10.1128/MCB.9.10.4432; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KUPIEC M, 1986, MUTAT RES, V162, P33, DOI 10.1016/0027-5107(86)90068-0; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Lea D, 1948, J GENET, V49, P264; Minesinger BK, 2005, GENETICS, V169, P1939, DOI 10.1534/genetics.104.033894; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Odagiri N, 2003, DNA REPAIR, V2, P347, DOI 10.1016/S1568-7864(02)00234-3; OSMAN F, 2007, DNA REPAIR AMST; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Paulovich AG, 1997, GENETICS, V145, P45; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1990, GENETICS, V124, P817; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Timchenko LT, 1996, FASEB J, V10, P1589, DOI 10.1096/fasebj.10.14.9002550; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; TREICH I, 1995, MOL CELL BIOL, V15, P4240; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Ulrich Helle D., 2006, P549; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; VINH DBN, 1993, GENETICS, V135, P275; WACH A, 1994, YEAST, V10, P1808; Xiao W, 2000, GENETICS, V155, P1633; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004	70	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3717	10.1371/journal.pone.0003717	http://dx.doi.org/10.1371/journal.pone.0003717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005567	Green Submitted, gold, Green Published			2022-12-27	WOS:000265166200005
J	Roth, LSV; Balkenius, A; Kelber, A				Roth, Lina S. V.; Balkenius, Anna; Kelber, Almut			The Absolute Threshold of Colour Vision in the Horse	PLOS ONE			English	Article								Arrhythmic mammals are active both during day and night if they are allowed. The arrhythmic horses are in possession of one of the largest terrestrial animal eyes and the purpose of this study is to reveal whether their eye is sensitive enough to see colours at night. During the day horses are known to have dichromatic colour vision. To disclose whether they can discriminate colours in dim light a behavioural dual choice experiment was performed. We started the training and testing at daylight intensities and the horses continued to choose correctly at a high frequency down to light intensities corresponding to moonlight. One Shetland pony mare, was able to discriminate colours at 0.08 cd/m(2), while a half blood gelding, still discriminated colours at 0.02 cd/m(2). For comparison, the colour vision limit for several human subjects tested in the very same experiment was also 0.02 cd/m(2). Hence, the threshold of colour vision for the horse that performed best was similar to that of the humans. The behavioural results are in line with calculations of the sensitivity of cone vision where the horse eye and human eye again are similar. The advantage of the large eye of the horse lies not in colour vision at night, but probably instead in achromatic tasks where presumably signal summation enhances sensitivity.	[Roth, Lina S. V.; Kelber, Almut] Lund Univ, Dept Cell & Organism Biol, Vis Grp, Lund, Sweden; [Balkenius, Anna] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden	Lund University; Swedish University of Agricultural Sciences	Roth, LSV (corresponding author), Lund Univ, Dept Cell & Organism Biol, Vis Grp, Lund, Sweden.	lina.roth@cob.lu.se	Roth, Lina S.V./J-6272-2019; Kelber, Almut/H-6216-2014	Kelber, Almut/0000-0003-3937-2808; Roth, Lina S V/0000-0002-3297-1130	Crafoord foundation, Stockholm; Swedish Science council	Crafoord foundation, Stockholm; Swedish Science council	We are grateful for financial support from the Crafoord foundation, Stockholm, for a new spectrometer and from the Swedish Science council (VR) for contribution to half the PhD scholarship of the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Carroll J, 2001, J VISION, V1, P80, DOI 10.1167/1.2.2; Geisbauer G, 2004, CAN J ZOOL, V82, P660, DOI [10.1139/z04-026, 10.1139/Z04-026]; Grzimek B., 1952, Zeitschrift fuer Tierpsychologie, V9, P23; HUGHES A, 1977, HDB SENSORY PHYSL, P614; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Land MF, 2002, ANIMAL EYES; LAND MF, 1981, HDB SENSORY PHYSL, P471; Lythgoe J.N., 1979, ECOLOGY VISION; Macuda T, 1999, BEHAV PROCESS, V44, P301, DOI 10.1016/S0376-6357(98)00039-4; MASON WT, 1973, J ANAT, V115, P289; NICOLAS E, 1930, VET COMP OPHTHALMOLO; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; ROSENGREN A, 1969, Acta Zoologica Fennica, V121, P3; Roth LSV, 2007, J EXP BIOL, V210, P2795, DOI 10.1242/jeb.007377; Roth LSV, 2004, P ROY SOC B-BIOL SCI, V271, pS485, DOI 10.1098/rsbl.2004.0227; SIVAK JG, 1975, VISION RES, V15, P1353, DOI 10.1016/0042-6989(75)90189-3; Smith S, 1999, APPL ANIM BEHAV SCI, V62, P13, DOI 10.1016/S0168-1591(98)00206-8; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Vorobyev M, 1997, SER BIOPHYS BIOCYBER, V1, P280; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	28	27	27	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3711	10.1371/journal.pone.0003711	http://dx.doi.org/10.1371/journal.pone.0003711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002261	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166000011
J	Colinas, J; Schmidler, SC; Bohrer, G; Iordanov, B; Benfey, PN				Colinas, Juliette; Schmidler, Scott C.; Bohrer, Gil; Iordanov, Borislav; Benfey, Philip N.			Intergenic and Genic Sequence Lengths Have Opposite Relationships with Respect to Gene Expression	PLOS ONE			English	Article								Eukaryotic genomes are mostly composed of noncoding DNA whose role is still poorly understood. Studies in several organisms have shown correlations between the length of the intergenic and genic sequences of a gene and the expression of its corresponding mRNA transcript. Some studies have found a positive relationship between intergenic sequence length and expression diversity between tissues, and concluded that genes under greater regulatory control require more regulatory information in their intergenic sequences. Other reports found a negative relationship between expression level and gene length and the interpretation was that there is selection pressure for highly expressed genes to remain small. However, a correlation between gene sequence length and expression diversity, opposite to that observed for intergenic sequences, has also been reported, and to date there is no testable explanation for this observation. To shed light on these varied and sometimes conflicting results, we performed a thorough study of the relationships between sequence length and gene expression using cell-type ( tissue) specific microarray data in Arabidopsis thaliana. We measured median gene expression across tissues ( expression level), expression variability between tissues ( expression pattern uniformity), and expression variability between replicates ( expression noise). We found that intergenic ( upstream and downstream) and genic ( coding and noncoding) sequences have generally opposite relationships with respect to expression, whether it is tissue variability, median, or expression noise. To explain these results we propose a model, in which the lengths of the intergenic and genic sequences have opposite effects on the ability of the transcribed region of the gene to be epigenetically regulated for differential expression. These findings could shed light on the role and influence of noncoding sequences on gene expression.	[Colinas, Juliette; Benfey, Philip N.] Duke Univ, Dept Biol & IGSP, Ctr Syst Biol, Durham, NC 27708 USA; [Schmidler, Scott C.] Duke Univ, Dept Stat Sci, Durham, NC 27706 USA; [Bohrer, Gil] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA	Duke University; Duke University; University System of Ohio; Ohio State University	Colinas, J (corresponding author), Duke Univ, Dept Biol & IGSP, Ctr Syst Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Bohrer, Gil/A-9731-2008	Bohrer, Gil/0000-0002-9209-9540	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the National Science Foundation, Arabidopsis 2010 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; COLINAS J, 2006, NONCODING DNA SEQUEN, P147; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gondor A, 2006, NAT GENET, V38, P1229, DOI 10.1038/ng1106-1229; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Mace DL, 2006, BIOINFORMATICS, V22, pE323, DOI 10.1093/bioinformatics/btl228; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; PINHEIRO JC, 2000, MIXED EFFECTS MODELS, P16; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; SEARLE SR, 2006, VARIANCE COMPONENTS, P23; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2006, NUCLEIC ACIDS RES, V34, P5906, DOI 10.1093/nar/gkl773; WALTHER D, 2007, PLOS GENETICS, V3; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	28	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3670	10.1371/journal.pone.0003670	http://dx.doi.org/10.1371/journal.pone.0003670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989364	Green Published, gold			2022-12-27	WOS:000265134600006
J	Yang, YL; Iyer, LK; Adelstein, SJ; Kassis, AI				Yang, Yongliang; Iyer, Lakshmanan K.; Adelstein, S. James; Kassis, Amin I.			Integrative Genomic Data Mining for Discovery of Potential Blood-Borne Biomarkers for Early Diagnosis of Cancer	PLOS ONE			English	Article								Background: With the arrival of the postgenomic era, there is increasing interest in the discovery of biomarkers for the accurate diagnosis, prognosis, and early detection of cancer. Blood-borne cancer markers are favored by clinicians, because blood samples can be obtained and analyzed with relative ease. We have used a combined mining strategy based on an integrated cancer microarray platform, Oncomine, and the biomarker module of the Ingenuity Pathways Analysis (IPA) program to identify potential blood-based markers for six common human cancer types. Methodology/Principal Findings: In the Oncomine platform, the genes overexpressed in cancer tissues relative to their corresponding normal tissues were filtered by Gene Ontology keywords, with the extracellular environment stipulated and a corrected Q value (false discovery rate) cut-off implemented. The identified genes were imported to the IPA biomarker module to separate out those genes encoding putative secreted or cell-surface proteins as blood-borne (blood/serum/plasma) cancer markers. The filtered potential indicators were ranked and prioritized according to normalized absolute Student t values. The retrieval of numerous marker genes that are already clinically useful or under active investigation confirmed the effectiveness of our mining strategy. To identify the biomarkers that are unique for each cancer type, the upregulated marker genes that are in common between each two tumor types across the six human tumors were also analyzed by the IPA biomarker comparison function. Conclusion/Significance: The upregulated marker genes shared among the six cancer types may serve as a molecular tool to complement histopathologic examination, and the combination of the commonly upregulated and unique biomarkers may serve as differentiating markers for a specific cancer. This approach will be increasingly useful to discover diagnostic signatures as the mass of microarray data continues to grow in the 'omics' era.	[Yang, Yongliang; Adelstein, S. James; Kassis, Amin I.] Harvard Univ, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Ctr Neurosci Res, Boston, MA USA	Harvard University; Harvard Medical School; Tufts University	Yang, YL (corresponding author), Harvard Univ, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA.	amin_kassis@hms.harvard.edu	Kassis, Amin I./O-5175-2014	Iyer, Lakshmanan/0000-0001-9167-6396	US Department of Defense [W81XWH-06-1-0043, W81XWH-04-1-0499, W81XWH-06-1-0204]	US Department of Defense(United States Department of Defense)	This work was supported in part by US Department of Defense grants (to AIK) W81XWH-06-1-0043, Radioimaging and Radiotherapy of Prostate Cancer; W81XWH-04-1-0499, Radiodetection and Radiotherapy of Breast Cancer; and W81XWH-06-1-0204, Radiodiagnosis and Radiotherapy of Ovarian Cancer.	Algul H, 2007, INT J CANCER, V121, P1410, DOI 10.1002/ijc.22779; Baker M, 2005, NAT BIOTECHNOL, V23, P297, DOI 10.1038/nbt0305-297; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomston M, 2002, ANN SURG ONCOL, V9, P668, DOI 10.1245/aso.2002.9.7.668; Campagne F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-481; Chen K, 2006, MOL CANCER THER, V5, P3001, DOI 10.1158/1535-7163.MCT-06-0465; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-25; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; Csernus VJ, 1999, P NATL ACAD SCI USA, V96, P3098, DOI 10.1073/pnas.96.6.3098; Diamandis EP, 2004, CLIN CHEM, V50, P793, DOI 10.1373/clinchem.2004.032177; Ellenrieder V, 2000, INT J CANCER, V85, P14, DOI 10.1002/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.3.CO;2-F; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; He Yudong D., 2006, Cancer Biomarkers, V2, P103; Hoeflich A, 2001, CANCER RES, V61, P8601; Holzman T, 2004, CURR OPIN BIOTECH, V15, P52, DOI 10.1016/j.copbio.2003.12.004; Hough CD, 2001, CANCER RES, V61, P3869; *ING SYST, ING PATHW AN IPA; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kirby J, 2007, ADV CLIN CHEM, V44, P247, DOI 10.1016/S0065-2423(07)44008-2; Koshiba T, 1997, SURG TODAY, V27, P302, DOI 10.1007/BF00941802; Li SH, 2004, ST HEAL T, V107, P778; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Masson D, 1999, BRIT J CANCER, V80, P1995, DOI 10.1038/sj.bjc.6690633; Migita T, 1999, INT J CANCER, V84, P74, DOI 10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pospisil P, 2007, CANCER RES, V67, P2197, DOI 10.1158/0008-5472.CAN-06-3309; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Ransohoff DF, 2003, SCIENCE, V299, P1679, DOI 10.1126/science.1083158; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, ANN NY ACAD SCI, V1020, P32, DOI 10.1196/annals.1310.005; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Sowter HM, 2005, CARCINOGENESIS, V26, P1651, DOI 10.1093/carcin/bgi136; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sumiya J, 1997, J BIOCHEM-TOKYO, V122, P983; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Troyer DA, 2004, DIS MARKERS, V20, P117, DOI 10.1155/2004/509276; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; YU H, 1995, CANCER RES, V55, P2104; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhou W, 1998, CANCER EPIDEM BIOMAR, V7, P109; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P285, DOI 10.1136/mp.54.5.285	56	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3661	10.1371/journal.pone.0003661	http://dx.doi.org/10.1371/journal.pone.0003661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987750	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134500007
J	Reibman, J; Marmor, M; Filner, J; Fernandez-Beros, ME; Rogers, L; Perez-Perez, GI; Blaser, MJ				Reibman, Joan; Marmor, Michael; Filner, Joshua; Fernandez-Beros, Maria-Elena; Rogers, Linda; Perez-Perez, Guillermo I.; Blaser, Martin J.			Asthma Is Inversely Associated with Helicobacter pylori Status in an Urban Population	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; GASTROESOPHAGEAL-REFLUX; INTESTINAL MICROFLORA; T-CELLS; CAGA; INFECTION; PREVALENCE; ANTIBODIES; ADULTS; SEROPREVALENCE	Background: Microbial exposures have been suggested to confer protection from allergic disorders and reduced exposures to gastrointestinal microbiota have been proposed as an explanation for the increase in asthma prevalence. Since the general prevalence of Helicobacter pylori has been decreasing, we hypothesized that H. pylori serostatus would be inversely related to the presence of asthma. Methods: Adults were recruited to participate in the New York University (NYU)/Bellevue Asthma Registry in New York City. Adult asthma cases (N = 318) and controls (N = 208) were identified and serum IgG antibodies to H. pylori whole cell antigens or the immunodominant CagA antigen were measured. Results: As expected, the asthma cases and controls differed with respect to atopy and lung function. Seropositivity to H. pylori or CagA antigen was present in 47.1% of the total case and control study population. Asthma was inversely associated with CagA seropositivity (=OR = 0.57, 95% CI = 0.36-0.89). Median age of onset of asthma (doctor's diagnosis) was older ( 21 years) among individuals with CagA+ strains than among H. pylori-individuals (11 years) (p = 0.006). Conclusion: These data are consistent with the hypothesis that colonization with CagA+ H. pylori strains is inversely associated with asthma and is associated with an older age of asthma onset in an urban population. The data suggest H. pylori as a marker for protection.	[Marmor, Michael; Filner, Joshua; Fernandez-Beros, Maria-Elena; Rogers, Linda; Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Reibman, Joan; Marmor, Michael] NYU, Sch Med, Dept Environm Med, New York, NY USA	New York University; New York University	Reibman, J (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	reibmj01@gcrc.med.nyu.edu	Marmor, Michael/L-9014-2015; Perez, Guillermo Perez/AAJ-3761-2020	Reibman, Joan/0000-0001-7878-1511; Perez Perez, Guillermo/0000-0002-0131-5798; Marmor, Michael/0000-0001-6605-2661	Colton Family Foundation; Diane Belfer Program in Human Microbial Ecology; Senior Scholar Award of the Ellison Medical Foundation;  [MO 1RR00096];  [ES 000260];  [RO1 GM63270]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	Colton Family Foundation; Diane Belfer Program in Human Microbial Ecology; Senior Scholar Award of the Ellison Medical Foundation; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MO 1RR00096, ES 000260 (JR, MM), RO1 GM63270 (MB), Colton Family Foundation, The Diane Belfer Program in Human Microbial Ecology, Senior Scholar Award of the Ellison Medical Foundation (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2005, BRIT MED J, V330, P1037, DOI 10.1136/bmj.330.7499.1037; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Bjorksten B, 2004, SPRINGER SEMIN IMMUN, V25, P257, DOI 10.1007/s00281-003-0142-2; Blaser MJ, 2005, GASTROENTEROLOGY, V128, P1512, DOI 10.1053/j.gastro.2005.03.053; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Cassino C, 2000, AM J RESP CRIT CARE, V162, P1423, DOI 10.1164/ajrccm.162.4.9912140; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Enright PL, 1999, CHEST, V116, P603, DOI 10.1378/chest.116.3.603; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Everhart JE, 2002, CLIN DIAGN LAB IMMUN, V9, P412, DOI 10.1128/CDLI.9.2.412-416.2002; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Guiney DG, 2003, INFECT IMMUN, V71, P4163, DOI 10.1128/IAI.71.7.4163-4166.2003; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harding SM, 2005, IMMUNOL ALLERGY CLIN, V25, P131, DOI 10.1016/j.iac.2004.09.006; Harding SM, 1997, CHEST, V111, P1389, DOI 10.1378/chest.111.5.1389; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Kiljander TO, 2004, CHEST, V126, P1490, DOI 10.1378/chest.126.5.1490; Kosunen TU, 1997, EPIDEMIOL INFECT, V119, P29, DOI 10.1017/S0950268897007565; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Linneberg A, 2003, J ALLERGY CLIN IMMUN, V111, P847, DOI 10.1067/mai.2003.1335; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Malaty HM, 2002, LANCET, V359, P931, DOI 10.1016/S0140-6736(02)08025-X; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; O'Keeffe J, 2008, HELICOBACTER, V13, P1, DOI 10.1111/j.1523-5378.2008.00559.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oderda G, 2007, J PEDIATR GASTR NUTR, V45, P301, DOI 10.1097/MPG.0b013e3180ca8960; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Perez-Perez GI, 2002, GUT, V50, P295, DOI 10.1136/gut.50.3.295; RAITALA A, 2005, MOL IMMUNOL; Ramsey CD, 2005, CURR OPIN PULM MED, V11, P14, DOI 10.1097/01.mcp.0000145791.13714.ae; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Thjodleifsson B, 2007, SCAND J INFECT DIS, V39, P683, DOI 10.1080/00365540701225736; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	54	137	145	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4060	10.1371/journal.pone.0004060	http://dx.doi.org/10.1371/journal.pone.0004060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112508	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000018
J	Shen, YF; Sarin, S; Liu, Y; Hobert, O; Pe'er, I				Shen, Yufeng; Sarin, Sumeet; Liu, Ye; Hobert, Oliver; Pe'er, Itsik			Comparing Platforms for C. elegans Mutant Identification Using High-Throughput Whole-Genome Sequencing	PLOS ONE			English	Article								Background: Whole-genome sequencing represents a promising approach to pinpoint chemically induced mutations in genetic model organisms, thereby short-cutting time-consuming genetic mapping efforts. Principal Findings: We compare here the ability of two leading high-throughput platforms for paired-end deep sequencing, SOLiD (ABI) and Genome Analyzer (Illumina; "Solexa"), to achieve the goal of mutant detection. As a test case we used a mutant C. elegans strain that harbors a mutation in the lsy-12 locus which we compare to the reference wild-type genome sequence. We analyzed the accuracy, sensitivity, and depth-coverage characteristics of the two platforms. Both platforms were able to identify the mutation that causes the phenotype of the mutant C. elegans strain, lsy-12. Based on a 4 MB genomic region in which individual variants were validated by Sanger sequencing, we observe tradeoffs between rates of false positives and false negatives when using both platforms under similar coverage and mapping criteria. Significance: In conclusion, whole-genome sequencing conducted by either platform is a viable approach for the identification of single-nucleotide variations in the C. elegans genome.	[Shen, Yufeng; Liu, Ye; Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Shen, Yufeng; Pe'er, Itsik] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Sarin, Sumeet; Hobert, Oliver] Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Shen, YF (corresponding author), Columbia Univ, Dept Comp Sci, New York, NY 10027 USA.	or38@columbia.edu; ip2169@columbia.edu		Hobert, Oliver/0000-0002-7634-2854	NIH [U54 CA121852, R01NS039996-05, R01NS050266-03]; NSF [CCF-0829882]; HHMI [Investigator];  [NS054540-01]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054540, R01NS039996, R01NS050266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); HHMI(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	YS is supported by NIH grant U54 CA121852, IP is supported by NSF grant CCF-0829882, SS is supported by an F31 predoctoral grant (NS054540-01), OH is supported by NIH grant R01NS039996-05 and R01NS050266-03 and is an Investigator of the HHMI.	Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	6	36	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4012	10.1371/journal.pone.0004012	http://dx.doi.org/10.1371/journal.pone.0004012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107202	Green Published, gold, Green Submitted			2022-12-27	WOS:000265463000007
J	Bordon, A; Bosco, N; Du Roure, C; Bartholdy, B; Kohler, H; Matthias, G; Rolink, AG; Matthias, P				Bordon, Alain; Bosco, Nabil; Du Roure, Camille; Bartholdy, Boris; Kohler, Hubertus; Matthias, Gabriele; Rolink, Antonius G.; Matthias, Patrick			Enforced Expression of the Transcriptional Coactivator OBF1 Impairs B Cell Differentiation at the Earliest Stage of Development	PLOS ONE			English	Article								OBF1, also known as Bob. 1 or OCA-B, is a B lymphocyte-specific transcription factor which coactivates Oct1 and Oct2 on B cell specific promoters. So far, the function of OBF1 has been mainly identified in late stage B cell populations. The central defect of OBF1 deficient mice is a severely reduced immune response to T cell-dependent antigens and a lack of germinal center formation in the spleen. Relatively little is known about a potential function of OBF1 in developing B cells. Here we have generated transgenic mice overexpressing OBF1 in B cells under the control of the immunoglobulin heavy chain promoter and enhancer. Surprisingly, these mice have greatly reduced numbers of follicular B cells in the periphery and have a compromised immune response. Furthermore, B cell differentiation is impaired at an early stage in the bone marrow: a first block is observed during B cell commitment and a second differentiation block is seen at the large preB2 cell stage. The cells that succeed to escape the block and to differentiate into mature B cells have post-translationally downregulated the expression of transgene, indicating that expression of OBF1 beyond the normal level early in B cell development is deleterious. Transcriptome analysis identified genes deregulated in these mice and Id2 and Id3, two known negative regulators of B cell differentiation, were found to be upregulated in the EPLM and preB cells of the transgenic mice. Furthermore, the Id2 and Id3 promoters contain octamer-like sites, to which OBF1 can bind. These results provide evidence that tight regulation of OBF1 expression in early B cells is essential to allow efficient B lymphocyte differentiation.	[Bordon, Alain; Du Roure, Camille; Bartholdy, Boris; Kohler, Hubertus; Matthias, Gabriele; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Bosco, Nabil; Rolink, Antonius G.] Univ Basel, Dept Biomed, Div Dev Mol Immunol, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel	Bordon, A (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	patrick.matthias@fmi.ch	Bosco, Nabil/AAD-1579-2022		Novartis Research Foundation	Novartis Research Foundation	This work was supported by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Brunner C, 2003, J BIOL CHEM, V278, P45231, DOI 10.1074/jbc.M302539200; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Ceredig R, 2006, BLOOD, V108, P1216, DOI 10.1182/blood-2005-10-006643; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Deed RW, 1998, J BIOL CHEM, V273, P8278, DOI 10.1074/jbc.273.14.8278; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; Fuxa M, 2007, CURR OPIN IMMUNOL, V19, P129, DOI 10.1016/j.coi.2007.02.002; Greiner A, 2000, AM J PATHOL, V156, P501, DOI 10.1016/S0002-9440(10)64754-2; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Harfst E, 2005, IMMUNOL LETT, V101, P173, DOI 10.1016/j.imlet.2005.05.013; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Jankovic M, 2003, INT IMMUNOL, V15, P1099, DOI 10.1093/intimm/dxg109; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Karnowski A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003568; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; Massa S, 2003, EUR J IMMUNOL, V33, P2864, DOI 10.1002/eji.200323882; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; Moriuchi M, 2001, J BIOL CHEM, V276, P8639, DOI 10.1074/jbc.M008391200; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; SAMA G, 2002, ATLAS CERAMBYCIDAE E, V1, P1; Sauter P, 1997, IMMUNOBIOLOGY, V198, P207, DOI 10.1016/S0171-2985(97)80041-1; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; Stevens S, 2000, J IMMUNOL, V164, P6372, DOI 10.4049/jimmunol.164.12.6372; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Yu X, 2001, IMMUNITY, V14, P157, DOI 10.1016/S1074-7613(09)00090-9; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Zhang M, 2004, CELL MOL IMMUNOL, V1, P89; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; Zwilling S, 1997, SCIENCE, V277, P221, DOI 10.1126/science.277.5323.221	52	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4007	10.1371/journal.pone.0004007	http://dx.doi.org/10.1371/journal.pone.0004007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104664	Green Published, Green Submitted, gold			2022-12-27	WOS:000265462400008
J	Mullen, LM; Bosse, JT; Nair, SP; Ward, JM; Rycroft, AN; Robertson, G; Langford, PR; Henderson, B				Mullen, Lisa M.; Bosse, Janine T.; Nair, Sean P.; Ward, John M.; Rycroft, Andrew N.; Robertson, Giles; Langford, Paul R.; Henderson, Brian			Pasteurellaceae ComE1 Proteins Combine the Properties of Fibronectin Adhesins and DNA Binding Competence Proteins	PLOS ONE			English	Article								A novel fibronectin-binding protein from Pasteurella multocida (PM1665) that binds to the fibronectin type III(9-10) modules via two helix-hairpin-helix motifs has recently been described [1]. This protein shares homology with competence-related DNA-binding and uptake proteins (ComEA and ComE) from Gram-positive and Gram-negative bacteria. Here, we show that recombinant PM1665 (now designated ComE1) also binds to DNA through the same helix-hairpin-helix motifs required for fibronectin-binding. This binding to DNA is non sequence-specific and is confined to double-stranded DNA. We have cloned and expressed ComE1 proteins from five members of the Pasteurellaceae in order to further investigate the function(s) of these proteins. When expressed as recombinant GST-fusion proteins, all of the homologues bound both to fibronectin and to double-stranded DNA. Inactivation of the gene encoding the ComE1 homologue in Actinobacillus pleuropneumoniae indicates major roles for these proteins in at least two processes: natural transformation, and binding of bacteria to fibronectin.	[Nair, Sean P.; Henderson, Brian] UCL, Eastman Dent Inst, Div Microbial Dis, London, England; [Ward, John M.] UCL, Dept Biochem & Mol Biol, London, England; [Rycroft, Andrew N.] Roy Vet Coll, Dept Pathol & Infect Dis, Hertford, England; [Robertson, Giles] Univ London, Birkbeck Coll, Sch Crystallography, London WC1E 7HU, England; [Bosse, Janine T.; Langford, Paul R.] Imperial Coll London, Dept Paediat, Mol Infect Dis Grp, London, England	University of London; University College London; University of London; University College London; University of London; University of London Royal Veterinary College; University of London; Birkbeck University London; Imperial College London	Mullen, LM (corresponding author), UCL, Eastman Dent Inst, Div Microbial Dis, London, England.	l.mullen@eastman.ucl.ac.uk	Langford, Paul/AAU-4189-2020; Langford, Paul R/B-9092-2008	Langford, Paul/0000-0002-6368-4724; Langford, Paul R/0000-0002-6368-4724; Bosse, Janine/0000-0002-8491-4779; Ward, John/0000-0002-4415-5544; Mullen, Lisa/0000-0001-8278-2226	BBSRC [BBS/B03238, BBS/B/08132]; MRC [G0401038] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/08132, BB/C508193/1] Funding Source: researchfish; Medical Research Council [G0401038] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the financial support of the BBSRC (grant BBS/B03238) to BH, JMW, SPN and ANR for LM and BBSRC (BBS/B/08132) to PL and AR for JB.	Bosse JT, 2004, FEMS MICROBIOL LETT, V233, P277, DOI 10.1111/j.1574-6968.2004.tb09492.x; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; DONACHIE W, 1995, HAEMOPHILUS ACTINOBA, V245; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lee PC, 2002, APPL MICROBIOL BIOT, V58, P663, DOI 10.1007/s00253-002-0935-6; Mullen LM, 2008, INFECT IMMUN, V76, P1093, DOI 10.1128/IAI.01349-07; Mullen LM, 2007, VET MICROBIOL, V122, P123, DOI 10.1016/j.vetmic.2006.12.022; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; REDFIELD RJ, 1988, GENETICS, V119, P213; Redfield RJ, 1997, GENETICS, V146, P27; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Sheehan BJ, 2000, INFECT IMMUN, V68, P4778, DOI 10.1128/IAI.68.8.4778-4781.2000; SMITH HO, 1981, ANNU REV BIOCHEM, V50, P41, DOI 10.1146/annurev.bi.50.070181.000353; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Webb SAR, 2001, METH MOLEC MED, V67, P663, DOI 10.1385/1-59259-149-3:663	26	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3991	10.1371/journal.pone.0003991	http://dx.doi.org/10.1371/journal.pone.0003991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098981	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000265462300004
J	Rodriguez-Vita, J; Sanchez-Galan, E; Santamaria, B; Sanchez-Lopez, E; Rodrigues-Diez, R; Blanco-Colio, LM; Egido, J; Ortiz, A; Ruiz-Ortega, M				Rodriguez-Vita, Juan; Sanchez-Galan, Eva; Santamaria, Beatriz; Sanchez-Lopez, Elsa; Rodrigues-Diez, Raquel; Miguel Blanco-Colio, Luis; Egido, Jesus; Ortiz, Alberto; Ruiz-Ortega, Marta			Essential Role of TGF-beta/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation	PLOS ONE			English	Article								Background: The 3-hydroxy-3-methylglutaryl CoA reductase inhibitors (also called statins) exert proven beneficial effects on cardiovascular diseases. Recent data suggest a protective role for Transforming Growth Factor-beta (TGF-beta) in atherosclerosis by regulating the balance between inflammation and extracellular matrix accumulation. However, there are no studies about the effect of statins on TGF-beta/Smad pathway in atherosclerosis and vascular cells. Methodology: In cultured vascular smooth muscle cells (VSMCs) statins enhanced Smad pathway activation caused by TGF-beta. In addition, statins upregulated TGF-beta receptor type II (TRII), and increased TGF-beta synthesis and TGF-beta/Smad-dependent actions. In this sense, statins, through Smad activation, render VSMCs more susceptible to TGF-beta induced apoptosis and increased TGF-beta-mediated ECM production. It is well documented that high doses of statins induce apoptosis in cultured VSMC in the presence of serum; however the precise mechanism of this effect remains to be elucidated. We have found that statins-induced apoptosis was mediated by TGF-beta/Smad pathway. Finally, we have described that RhoA inhibition is a common intracellular mechanisms involved in statins effects. The in vivo relevance of these findings was assessed in an experimental model of atherosclerosis in apolipoprotein E deficient mice: Treatment with Atorvastatin increased Smad3 phosphorylation and TRII overexpression, associated to elevated ECM deposition in the VSMCs within atheroma plaques, while apoptosis was not detected. Conclusions: Statins enhance TGF-beta/Smad pathway, regulating ligand levels, receptor, main signaling pathway and cellular responses of VSMC, including apoptosis and ECM accumulation. Our findings show that TGF-beta/Smad pathway is essential for statins-dependent actions in VSMCs.	[Rodriguez-Vita, Juan; Sanchez-Lopez, Elsa; Rodrigues-Diez, Raquel; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Fdn Jimenez Diaz, E-28049 Madrid, Spain; [Sanchez-Galan, Eva; Miguel Blanco-Colio, Luis; Egido, Jesus] Univ Autonoma Madrid, Vasc Res Lab, Fdn Jimenez Diaz, Madrid, Spain; [Santamaria, Beatriz; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid	Rodriguez-Vita, J (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Fdn Jimenez Diaz, E-28049 Madrid, Spain.	mruizo@fjd.es	Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; Santamaria, Beatriz/B-3469-2015; Díez, Raquel Rodrigues/ABE-9703-2020; Blanco-Colio, Luis M./Z-2390-2019; ortiz, alberto/Y-7582-2018; Sanchez-Lopez, Elsa/A-7131-2017; Rodriguez-Vita, Juan/U-6337-2019; Rodriguez-Vita, Juan/K-2407-2014; ruiz-ortega, marta/D-3584-2012	Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Díez, Raquel Rodrigues/0000-0002-6348-1505; ortiz, alberto/0000-0002-9805-9523; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Rodriguez-Vita, Juan/0000-0001-9547-5508; Rodriguez-Vita, Juan/0000-0001-9547-5508; ruiz-ortega, marta/0000-0002-1403-2690; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	Ministerio de Educacion y Ciencia [SAF 2005-03378]; Sociedad espanola de Cardiologia; Red tematica de Investigacion Renal, REDINREN [ISCIII-RETIC RD06/0016/0004, 06/0046]; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo [RD06/0014/0035, RD06/0014/0008]; EU project DIALOK [LSHB-CT-2007-036644]; Ministerio de Ciencia y Tecnologia [SAF2007/63648]	Ministerio de Educacion y Ciencia(Spanish Government); Sociedad espanola de Cardiologia(Instituto de Salud Carlos III); Red tematica de Investigacion Renal, REDINREN; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); EU project DIALOK; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by grants from (SAF 2005-03378) the Ministerio de Educacion y Ciencia, Novartis grant form Sociedad espanola de Cardiologia, Red tematica de Investigacion Renal, REDINREN (ISCIII-RETIC RD06/0016/0004 and 06/0046) from the Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo and the EU project DIALOK: LSHB-CT-2007-036644, Ministerio de Ciencia y Tecnologia (SAF2007/63648), Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Redes RECAVA (RD06/0014/0035; RD06/0014/0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; CAJOT JF, 1990, P NATL ACAD SCI USA, V87, P6939, DOI 10.1073/pnas.87.18.6939; CARVAJAL G, 2008, KIDNEY INT; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Cipollone F, 2004, STROKE, V35, P2253, DOI 10.1161/01.STR.0000140739.45472.9c; Clarke M, 2006, CELL CYCLE, V5, P2329, DOI 10.4161/cc.5.20.3383; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Erl Wolfgang, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P135, DOI 10.2174/1568006043586134; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Guijarro C, 1999, KIDNEY INT, V56, pS88, DOI 10.1038/sj.ki.4495409; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leblanc V, 1999, ONCOGENE, V18, P4884, DOI 10.1038/sj.onc.1202855; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; McCaffrey TA, 1995, J CLIN INVEST, V96, P2667, DOI 10.1172/JCI118333; McCaffrey TA, 1999, J MOL CELL CARDIOL, V31, P1627, DOI 10.1006/jmcc.1999.0999; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Park HJ, 1999, P NATL ACAD SCI USA, V96, P11525, DOI 10.1073/pnas.96.20.11525; Porreca E, 2002, J AM COLL CARDIOL, V39, P1752, DOI 10.1016/S0735-1097(02)01857-0; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Smith JD, 1999, CIRC RES, V84, P1212, DOI 10.1161/01.RES.84.10.1212; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c	42	48	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3959	10.1371/journal.pone.0003959	http://dx.doi.org/10.1371/journal.pone.0003959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088845	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458500006
J	Tan, LH; Schedl, P; Song, HJ; Garza, D; Konsolaki, M				Tan, Lihua; Schedl, Paul; Song, Ho-Juhn; Garza, Dan; Konsolaki, Mary			The Toll -> NF kappa B Signaling Pathway Mediates the Neuropathological Effects of the Human Alzheimer's A beta 42 Polypeptide in Drosophila	PLOS ONE			English	Article							NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; DORSAL-VENTRAL POLARITY; A-BETA; ANTIINFLAMMATORY AGENTS; MISSENSE MUTATIONS; IMMUNE-RESPONSE; SENILE-DEMENTIA; IMD PATHWAYS; MOUSE MODEL	Alzheimer's (AD) is a progressive neurodegenerative disease that afflicts a significant fraction of older individuals. Although a proteolytic product of the Amyloid precursor protein, the A beta 42 polypeptide, has been directly implicated in the disease, the genes and biological pathways that are deployed during the process of A beta 42 induced neurodegeneration are not well understood and remain controversial. To identify genes and pathways that mediated A beta 42 induced neurodegeneration we took advantage of a Drosophila model for AD disease in which ectopically expressed human A beta 42 polypeptide induces cell death and tissue degeneration in the compound eye. One of the genes identified in our genetic screen is Toll (Tl). It encodes the receptor for the highly conserved Tl -> NF kappa B innate immunity/inflammatory pathway and is a fly homolog of the mammalian Interleukin-1 (Ilk-1) receptor. We found that Tl loss-of-function mutations dominantly suppress the neuropathological effects of the A beta 42 polypeptide while gain-of-function mutations that increase receptor activity dominantly enhance them. Furthermore, we present evidence demonstrating that Tl and key downstream components of the innate immunity/inflammatory pathway play a central role in mediating the neuropathological activities of A beta 42. We show that the deleterious effects of A beta 42 can be suppressed by genetic manipulations of the Tl -> NF kappa B pathway that downregulate signal transduction. Conversely, manipulations that upregulate signal transduction exacerbate the deleterious effects of A beta 42. Since postmortem studies have shown that the Ilk-1 -> NF kappa B innate immunity pathway is substantially upregulated in the brains of AD patients, the demonstration that the Tl -> NF kappa B signaling actively promotes the process of A beta 42 induced cell death and tissue degeneration in flies points to possible therapeutic targets and strategies.	[Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Song, Ho-Juhn; Garza, Dan] Novartis Inst Biomed Res, Cambridge, MA USA; [Konsolaki, Mary] Rutgers, State Univ New Jersey, Dept Genet, Piscataway, NJ USA	Princeton University; Novartis; Rutgers State University New Brunswick	Tan, LH (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	pschedl@princeton.edu			Novartis	Novartis(Novartis)	Funds were provided by Novartis for a part time post-doctoral stipend for Lihua Tan. There was no other research support. Novartis had no role in the experimental design, in the analysis of the data, or in the preparation of the manuscript.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; BROUWERS N, 2008, ANN MED, V18, P1; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Carter J., 2001, Current Molecular Medicine (Hilversum), V1, P733, DOI 10.2174/1566524013363177; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DREVETS WC, 1989, BIOL PSYCHIAT, V25, P39, DOI 10.1016/0006-3223(89)90145-5; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; FABERLANGENDOEN K, 1988, ANN NEUROL, V23, P365, DOI 10.1002/ana.410230409; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gahtan E, 1999, NEUROSCI BIOBEHAV R, V23, P615, DOI 10.1016/S0149-7634(98)00058-X; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2002, NAT MED, V8, P936, DOI 10.1038/nm0902-936; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Imahori K, 1998, NEUROBIOL AGING, V19, pS93, DOI 10.1016/S0197-4580(98)00025-6; Imler J L, 2000, Rev Immunogenet, V2, P294; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 2006, NEUROBIOL AGING, V27, P1533, DOI 10.1016/j.neurobiolaging.2005.10.001; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shulman JM, 2003, GENETICS, V165, P1233; SORBI S, 1995, LANCET, V346, P439, DOI 10.1016/S0140-6736(95)92809-X; Sorrentino G, 2007, NEUROL SCI, V28, P63, DOI 10.1007/s10072-007-0789-x; St George-Hyslop PH, 2000, ANN NY ACAD SCI, V924, P1; Stein D, 1998, DEVELOPMENT, V125, P2159; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	71	85	89	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3966	10.1371/journal.pone.0003966	http://dx.doi.org/10.1371/journal.pone.0003966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088848	gold, Green Published, Green Submitted			2022-12-27	WOS:000265458500011
J	Cahu, J; Olichon, A; Hentrich, C; Schek, H; Drinjakovic, J; Zhang, CJ; Doherty-Kirby, A; Lajoie, G; Surrey, T				Cahu, Julie; Olichon, Aurelien; Hentrich, Christian; Schek, Henry; Drinjakovic, Jovana; Zhang, Cunjie; Doherty-Kirby, Amanda; Lajoie, Gilles; Surrey, Thomas			Phosphorylation by Cdk1 Increases the Binding of Eg5 to Microtubules In Vitro and in Xenopus Egg Extract Spindles	PLOS ONE			English	Article								Background: Motor proteins from the kinesin-5 subfamily play an essential role in spindle assembly during cell division of most organisms. These motors crosslink and slide microtubules in the spindle. Kinesin-5 motors are phosphorylated at a conserved site by Cyclin-dependent kinase 1 (Cdk1) during mitosis. Xenopus laevis kinesin-5 has also been reported to be phosphorylated by Aurora A in vitro. Methodology/Principal Findings: We investigate here the effect of these phosphorylations on kinesin-5 from Xenopus laevis, called Eg5. We find that phosphorylation at threonine 937 in the C-terminal tail of Eg5 by Cdk1 does not affect the velocity of Eg5, but strongly increases its binding to microtubules assembled in buffer. Likewise, this phosphorylation promotes binding of Eg5 to microtubules in Xenopus egg extract spindles. This enhancement of binding elevates the amount of Eg5 in spindles above a critical level required for bipolar spindle formation. We find furthermore that phosphorylation of Xenopus laevis Eg5 by Aurora A at serine 543 in the stalk is not required for spindle formation. Conclusions/Significance: These results show that phosphorylation of Eg5 by Cdk1 has a direct effect on the interaction of this motor with microtubules. In egg extract, phosphorylation of Eg5 by Cdk1 ensures that the amount of Eg5 in the spindle is above a level that is required for spindle formation. This enhanced targeting to the spindle appears therefore to be, at least in part, a direct consequence of the enhanced binding of Eg5 to microtubules upon phosphorylation by Cdk1. These findings advance our understanding of the regulation of this essential mitotic motor protein.	[Cahu, Julie; Olichon, Aurelien; Hentrich, Christian; Schek, Henry; Drinjakovic, Jovana; Doherty-Kirby, Amanda; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Zhang, Cunjie; Lajoie, Gilles] Univ Western Ontario, Schulich Sch Med, Don Rix Protein Identificat Facil, London, ON N6A 3K7, Canada	European Molecular Biology Laboratory (EMBL); Western University (University of Western Ontario)	Cahu, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	surrey@embl.de	Olichon, Aurelien/M-3115-2014; Olichon, Aurelien/Q-5425-2019; Holt, Janet E/B-2415-2013; Surrey, Thomas/AAC-4608-2021	Olichon, Aurelien/0000-0002-0821-3612; Hentrich, Christian/0000-0001-6697-5001; Surrey, Thomas/0000-0001-9082-1870	DFG; EU STREP Active Biomics; EU MCRTN Spindle Dynamics; EMBO; Ontario Research Development Challenge Fund (ORDCF)	DFG(German Research Foundation (DFG)); EU STREP Active Biomics; EU MCRTN Spindle Dynamics; EMBO(European Molecular Biology Organization (EMBO)); Ontario Research Development Challenge Fund (ORDCF)	T.S. acknowledges financial support from the DFG and the EU STREP Active Biomics, T.S. and A.O. from the DFG, and T.S. and C.H. from the EU MCRTN Spindle Dynamics, H.S. from EMBO, and G.L. from the Ontario Research Development Challenge Fund (ORDCF).	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Drummond DR, 1998, J CELL SCI, V111, P853; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Roghi C, 1998, J CELL SCI, V111, P557; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; UTENG M, 2008, J CELL BIOL; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	46	68	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3936	10.1371/journal.pone.0003936	http://dx.doi.org/10.1371/journal.pone.0003936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079595	Green Submitted, gold, Green Published			2022-12-27	WOS:000265458200003
J	Coll, M; Libralato, S; Tudela, S; Palomera, I; Pranovi, F				Coll, Marta; Libralato, Simone; Tudela, Sergi; Palomera, Isabel; Pranovi, Fabio			Ecosystem Overfishing in the Ocean	PLOS ONE			English	Article							MARINE ECOSYSTEMS; FISHERIES MANAGEMENT; GLOBAL FISHERIES; WORLD FISHERIES; POPULATIONS; ATLANTIC; COLLAPSE; IMPACT; RECOVERY; INDEX	Fisheries catches represent a net export of mass and energy that can no longer be used by trophic levels higher than those fished. Thus, exploitation implies a depletion of secondary production of higher trophic levels (here the production of mass and energy by herbivores and carnivores in the ecosystem) due to the removal of prey. The depletion of secondary production due to the export of biomass and energy through catches was recently formulated as a proxy for evaluating the ecosystem impacts of fishing-i. e., the level of ecosystem overfishing. Here we evaluate the historical and current risk of ecosystem overfishing at a global scale by quantifying the depletion of secondary production using the best available fisheries and ecological data (i.e., catch and primary production). Our results highlight an increasing trend in the number of unsustainable fisheries (i.e., an increase in the risk of ecosystem overfishing) from the 1950s to the 2000s, and illustrate the worldwide geographic expansion of overfishing. These results enable to assess when and where fishing became unsustainable at the ecosystem level. At present, total catch per capita from Large Marine Ecosystems is at least twice the value estimated to ensure fishing at moderate sustainable levels.	[Palomera, Isabel] CSIC, ICM, Barcelona, Spain; [Coll, Marta] Dalhousie Univ, Dept Biol, Halifax, NS B3H 3J5, Canada; [Libralato, Simone] Ist Nazl Oceanograf Geofisica Speriment OGS, Sgonico Zgonik, Italy; [Tudela, Sergi] WWF, Mediterranean Programme Office, Barcelona, Spain; [Pranovi, Fabio] Univ Ca Foscari, Dipartimento Sci Ambientali, Venice, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Dalhousie University; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; World Wildlife Fund; Universita Ca Foscari Venezia	Coll, M (corresponding author), CSIC, ICM, Barcelona, Spain.	martacoll@dal.ca	Libralato, Simone/N-5668-2015; Palomera, Isabel/L-4769-2014; Libralato, Simone/AAR-2198-2020; Coll, Marta/A-9488-2012	Libralato, Simone/0000-0001-8112-1274; Palomera, Isabel/0000-0001-5708-168X; Libralato, Simone/0000-0001-8112-1274; Coll, Marta/0000-0001-6235-5868	Spanish Ministry of Education and Science [Predoctoral fellowship, postdoctoral fellowship]; Dalhousie University (Halifax, Canada)	Spanish Ministry of Education and Science(Spanish Government); Dalhousie University (Halifax, Canada)	MC was supported financially with a Predoctoral and a postdoctoral fellowship from the Spanish Ministry of Education and Science and additional support by Dalhousie University (Halifax, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bouvet M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001126; BRAY K, 2000, IUU20006 FAO; Chan K., 2000, SENSITIVITY ANAL; Christensen V, 2000, MAR FRESHWATER RES, V51, P447, DOI 10.1071/MF99085; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Evans D., 2000, IUU200012 FAO; FAO, 2005, 457 FAO FISH; Fischer M, 2002, TRENDS ECOL EVOL, V17, P61, DOI 10.1016/S0169-5347(01)02419-3; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hoepffner N, 1999, INT J REMOTE SENS, V20, P1435, DOI 10.1080/014311699212812; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; KELLEHER K, 2005, 470 FAO FISH; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MacArthur R.H., 1972, pvii; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; PLATT T, 1988, SCIENCE, V241, P1613, DOI 10.1126/science.241.4873.1613; Sherman K, 1999, MAR ECOL PROG SER, V190, P271, DOI 10.3354/meps190271; Tudela S, 2005, ICES J MAR SCI, V62, P585, DOI 10.1016/j.icesjms.2005.01.008; WALSH JJ, 1981, NATURE, V290, P300, DOI 10.1038/290300a0; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; [No title captured]; [No title captured]	39	156	161	17	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3881	10.1371/journal.pone.0003881	http://dx.doi.org/10.1371/journal.pone.0003881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066624	gold, Green Published			2022-12-27	WOS:000265455700003
J	Vamosi, JC; Vamosi, SM				Vamosi, Jana C.; Vamosi, Steven M.			Extinction Risk Escalates in the Tropics	PLOS ONE			English	Article							SPECIES RICHNESS; NONRANDOM EXTINCTION; SPECIATION; EVOLUTION; RATES; SIZE; GRADIENT	The latitudinal biodiversity gradient remains one of the most widely recognized yet puzzling patterns in nature [ 1]. Presently, the high level of extinction of tropical species, referred to as the "tropical biodiversity crisis", has the potential to erode this pattern. While the connection between species richness, extinction, and speciation has long intrigued biologists [2,3], these interactions have experienced increased poignancy due to their relevancy to where we should concentrate our conservation efforts. Natural extinction is a phenomenon thought to have its own latitudinal gradient, with lower extinction rates in the tropics being reported in beetles, birds, mammals, and bivalves [4-7]. Processes that have buffered ecosystems from high extinction rates in the past may also buffer ecosystems against disturbance of anthropogenic origin. While potential parallels between historical and present-day extinction patterns have been acknowledged, they remain only superficially explored and plant extinction patterns have been particularly neglected. Studies on the disappearances of animal species have reached conflicting conclusions, with the rate of extinction appearing either higher [ 8] or lower [ 9] in species richness hotspots. Our global study of extinction risk in vascular plants finds disproportionately higher extinction risk in tropical countries, even when indicators of human pressure (GDP, population density, forest cover change) are taken into account. Our results are at odds with the notion that the tropics represent a museum of plant biodiversity ( places of historically lowered extinction) and we discuss mechanisms that may reconcile this apparent contradiction.	[Vamosi, Steven M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Vamosi, JC (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jvamosi@ucalgary.ca	Vamosi, Steven/C-8126-2009	Vamosi, Steven/0000-0003-3903-5000; Vamosi, Jana/0000-0002-2376-0729	Natural Sciences and Engineering Research Council (Canada) [Discovery Grants]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by Discovery Grants from the Natural Sciences and Engineering Research Council (Canada) to JCV and SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Crawley MJ, 2005, STAT INTRO USING R; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Dobzhansky T., 1950, American Scientist, V38, P209; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Gaston K.J, 1996, BIODIVERSITY BIOL NU; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Ives AR, 2000, ECOL LETT, V3, P399, DOI 10.1046/j.1461-0248.2000.00144.x; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jamieson IG, 2007, ANIM CONSERV, V10, P139, DOI 10.1111/j.1469-1795.2006.00095.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Martin PR, 2004, EVOLUTION, V58, P938; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Niklas KJ, 2003, ECOL LETT, V6, P631, DOI 10.1046/j.1461-0248.2003.00473.x; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Qian H, 2007, ECOLOGY, V88, P1440, DOI 10.1890/06-0916; R Core Development Team, 2008, R LANG ENV STAT COMP; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rode AL, 2005, J PALEONTOL, V79, P267, DOI 10.1666/0022-3360(2005)079<0267:IEABAC>2.0.CO;2; STEBBINS G L, 1971, Taxon, V20, P3, DOI 10.2307/1218529; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Vamosi SM, 2007, CAN J ZOOL, V85, P443, DOI 10.1139/Z07-021; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; [No title captured]; [No title captured]; [No title captured]	38	40	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3886	10.1371/journal.pone.0003886	http://dx.doi.org/10.1371/journal.pone.0003886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066623	gold, Green Submitted, Green Published			2022-12-27	WOS:000265455700004
J	Polymenidou, M; Moos, R; Scott, M; Sigurdson, C; Shi, YZ; Yajima, B; Hafner-Bratkovic, I; Jerala, R; Hornemann, S; Wuthrich, K; Bellon, A; Vey, M; Garen, G; James, MNG; Kav, N; Aguzzi, A				Polymenidou, Magdalini; Moos, Rita; Scott, Mike; Sigurdson, Christina; Shi, Yong-zhong; Yajima, Bill; Hafner-Bratkovic, Iva; Jerala, Roman; Hornemann, Simone; Wuthrich, Kurt; Bellon, Anne; Vey, Martin; Garen, Graciela; James, Michael N. G.; Kav, Nat; Aguzzi, Adriano			The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes	PLOS ONE			English	Article								PrP(Sc), a misfolded and aggregated form of the cellular prion protein PrP(C), is the only defined constituent of the transmissible agent causing prion diseases. Expression of PrP(C) in the host organism is necessary for prion replication and for prion neurotoxicity. Understanding prion diseases necessitates detailed structural insights into PrP(C) and PrP(Sc). Towards this goal, we have developed a comprehensive collection of monoclonal antibodies denoted POM1 to POM19 and directed against many different epitopes of mouse PrP(C). Three epitopes are located within the N-terminal octarepeat region, one is situated within the central unstructured region, and four epitopes are discontinuous within the globular C-proximal domain of PrP(C). Some of these antibodies recognize epitopes that are resilient to protease digestion in PrP(Sc). Other antibodies immunoprecipitate PrP(C), but not PrP(Sc). A third group was found to immunoprecipitate both PrP isoforms. Some of the latter antibodies could be blocked with epitope-mimicking peptides, and incubation with an excess of these peptides allowed for immunochromatography of PrP(C) and PrP(Sc). Amino-proximal antibodies were found to react with repetitive PrP(C) epitopes, thereby vastly increasing their avidity. We have also created functional single-chain miniantibodies from selected POMs, which retained the binding characteristics despite their low molecular mass. The POM collection, thus, represents a unique set of reagents allowing for studies with a variety of techniques, including western blotting, ELISA, immunoprecipitation, conformation-dependent immunoassays, and plasmon surface plasmon resonance-based assays.	[Polymenidou, Magdalini; Moos, Rita; Sigurdson, Christina; Aguzzi, Adriano] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland; [Scott, Mike] Univ Zurich, ETH, Funct Genom Ctr Zurich, CH-8006 Zurich, Switzerland; [Yajima, Bill; Garen, Graciela; Kav, Nat] Univ Alberta, Dept Agr, Food & Nutr Sci, Edmonton, AB T6G 2M7, Canada; [Garen, Graciela; James, Michael N. G.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2M7, Canada; [Shi, Yong-zhong] Alberta Res Council, Edmonton, AB, Canada; [Hafner-Bratkovic, Iva; Jerala, Roman] Univ Ljubljana, Natl Inst Chem, Dept Biotechnol, Ljubljana 61000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia; [Hornemann, Simone; Wuthrich, Kurt] Swiss Fed Inst Technol, Inst Molekularbiol & Biophys, Zurich, Switzerland; [Wuthrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA USA; [Bellon, Anne; Vey, Martin] ZLB Behring, Marburg, Germany	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Alberta; University of Alberta; Alberta Innovates; National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute	Polymenidou, M (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	adriano.aguzzi@usz.ch	Polymenidou, Magdalini/D-2254-2014; Aguzzi, Adriano/A-3351-2008; Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251; Aguzzi, Adriano/0000-0002-0344-6708	Bundesamt fur Bildung und Wissenschaft; Ernst-Jung-Foundation; Stammbach foundation; European Union; Swiss National Science Foundation; NCCR; ETH Zurich; University of Zurich [career development award]; Alberta Prion Research Institute; Slovenian Research Agency	Bundesamt fur Bildung und Wissenschaft; Ernst-Jung-Foundation; Stammbach foundation; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich); University of Zurich; Alberta Prion Research Institute; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants of the Bundesamt fur Bildung und Wissenschaft (AA), the Ernst-Jung-Foundation (AA), the Stammbach foundation (AA), the European Union (ImmunoPrion and TSEUR to AA and UPMAN to KW), the Swiss National Science Foundation (AA), the NCCR on Neural Plasticity and Repair (AA) and of Structural Biology (KW), the ETH Zurich (KW), and a career development award of the University of Zurich (MP). Financial assistance from the Alberta Prion Research Institute (NK and AA) is gratefully acknowledged. IHB and RJ are supported by grants from the Slovenian Research Agency.	BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burmester J, 2001, J MOL BIOL, V309, P671, DOI 10.1006/jmbi.2001.4663; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Krasemann S, 1999, J BIOTECHNOL, V73, P119, DOI 10.1016/S0168-1656(99)00115-7; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; ROGERS M, 1991, J IMMUNOL, V147, P3568; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; WESTAWAY D, 1986, NUCLEIC ACIDS RES, V14, P2035, DOI 10.1093/nar/14.5.2035; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	27	135	137	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3872	10.1371/journal.pone.0003872	http://dx.doi.org/10.1371/journal.pone.0003872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060956	Green Published, gold, Green Accepted			2022-12-27	WOS:000265455100002
J	Wimberly, MC; Hildreth, MB; Boyte, SP; Lindquist, E; Kightlinger, L				Wimberly, Michael C.; Hildreth, Michael B.; Boyte, Stephen P.; Lindquist, Erik; Kightlinger, Lon			Ecological Niche of the 2003 West Nile Virus Epidemic in the Northern Great Plains of the United States	PLOS ONE			English	Article								Background: The incidence of West Nile virus(WNv) has remained high in the northern Great Plains compared to the rest of the United States. However, the reasons for the sustained high risk of WNv transmission in the regions have not been determined. To assess the environmental drivers of WNv in the northern Great Plains, we analyzed the county-level spatial pattern of human cases during the 2003 epidemic across a seven-state region. Methodology/Principal Findings: County-level data on WNv cases were examined using spatial cluster analysis, and were used to fit statistical models with weather, climate, and land use variables as predictors. In 2003 there was a single large cluster of elevated WNv risk encompassing North Dakota, South Dakota, and Nebraska along with portions of eastern Montana and Wyoming. The relative risk of WNv remained high within the boundaries of this cluster from 2004-2007. WNv incidence during the 2003 epidemic was found to have a stronger relationship with long-term climate patterns than with annual weather in either 2002 or 2003. WNv incidence increased with May-July temperature and had a unimodal relationship with total May-July precipitation. WNv incidence also increased with the percentage of irrigated cropland and with the percentage of the human population living in rural areas. Conclusion/Significance: The spatial pattern of WNv cases during the 2003 epidemic in the northern Great Plains was associated with both climatic gradients and land use patterns. These results were interpreted as evidence that environmental conditions across much of the northern Great Plains created a favorable ecological niche for Culex tarsalis, a particularly efficient vector of WNv. Further research is needed to determine the proximal causes of sustained WNv transmission and to enhance strategies for disease prevention.	[Wimberly, Michael C.; Boyte, Stephen P.; Lindquist, Erik] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [Hildreth, Michael B.] S Dakota State Univ, Dept Biol, Brookings, SD USA; [Kightlinger, Lon] S Dakota Dept Hlth, Pierre, SD USA	South Dakota State University; South Dakota State University	Wimberly, MC (corresponding author), S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA.	michael.wimberly@sdstate.edu		Boyte, Stephen/0000-0002-5462-3225; Wimberly, Michael/0000-0003-1549-3891	South Dakota State University; National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01-AI079411]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079411] Funding Source: NIH RePORTER	South Dakota State University; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this research was provided by South Dakota State University. This study was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant R01-AI079411 to MCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bell JA, 2005, VECTOR-BORNE ZOONOT, V5, P373, DOI 10.1089/vbz.2005.5.373; Bell JA, 2006, EMERG INFECT DIS, V12, P1245, DOI 10.3201/eid1708.060129; Bolling BG, 2005, J VECTOR ECOL, V30, P186; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Cleveland W.S., 1993, STAT METHODS S, P309; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; DALY G, 2004, AMS C APPL CLIM 84 A; DeGroote John P, 2008, Int J Health Geogr, V7, P19, DOI 10.1186/1476-072X-7-19; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; KULLDORF M, 2006, SATSCAN V7 0 3 SOFTW; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kunkel KE, 2006, AM J TROP MED HYG, V74, P168, DOI 10.4269/ajtmh.2006.74.168; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lawson A. B., 2003, DIS MAPPING WINBUGS; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; LUNGSTROM LEON, 1954, TRANS KANSAS ACAD SCI, V57, P86, DOI 10.2307/3625649; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; Nielsen CF, 2008, AM J TROP MED HYG, V78, P53, DOI 10.4269/ajtmh.2008.78.53; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; SPIEGELHALTER D, 2004, WINBUGS USERS MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Takeda T, 2003, J AM MOSQUITO CONTR, V19, P179; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Waller L.A., 2004, APPL SPATIAL STAT PU; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wimberly MC, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-15; Yiannakoulias NW, 2007, ANN NY ACAD SCI, V1102, P135, DOI 10.1196/annals.1408.010; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	41	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3744	10.1371/journal.pone.0003744	http://dx.doi.org/10.1371/journal.pone.0003744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057643	Green Published, gold			2022-12-27	WOS:000265452300001
J	Albrecht-Buehler, G				Albrecht-Buehler, Guenter			Properties and Distribution of Pure GA-Sequences of Mammalian Genomes	PLOS ONE			English	Article							BINDING; ACTIVATION; DNA	The article describes DNA sequences of mammalian genomes that are longer than 50 bases, but consist exclusively of G's and A's ('pure GA-sequences'). Although their frequency of incidence should be 10 216 or smaller, the chromosomes of human, chimpanzee, dog, cat, rat, and mouse contained many tens of thousands of them ubiquitously located along the chromosomes with a species-dependent density, reaching sizes of up to 1300 [b]. With the exception of a small number of poly-A-, poly-G-, poly-GA-, and poly-GAAA-sequences (combined <0.5%), all pure GA-sequences of the mammals tested were unique individuals, contained several repeated short GA-containing motifs, and shared a common hexa-nucleotide spectrum. At most 2% of the human GA-sequences were transcribed into mRNAs; all others were not coding for proteins. Although this could have made them less subject to natural selection, they contained 160 times fewer point mutations than one should expect from the genome at large. As to the presence of other sequences with similarly restricted base contents, there were approximately as many pure TC-sequences as pure GA-sequences, but many fewer pure AC-, TA, and TG-sequences. There were practically no pure GC-sequences. The functions of pure GA-sequences are not known. Supported by a number of observations related to heat shock phenomena, the article speculates that they serve as genomic sign posts which may help guide polymerases and transcription factors to their proper targets, and/or as spatial linkers that help generate the 3-dimensional organization of chromatin.	[Albrecht-Buehler, Guenter] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Albrecht-Buehler, G (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	g-buehler@northwestern.edu			Robert Laughlin Rea endowed Chair	Robert Laughlin Rea endowed Chair	The work was supported by the Robert Laughlin Rea endowed Chair held by the author. Funds from the Chair provided part of the author's salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Buehler G, 2007, GENOMICS, V89, P596, DOI 10.1016/j.ygeno.2006.12.009; Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; ALBRECHTBUEHLER G, 2009, BIOESSAYS IN PRESS; CALLADINE CR, 1982, J MOL BIOL, V161, P343, DOI 10.1016/0022-2836(82)90157-7; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; LU Q, 1993, MOL CELL BIOL, V13, P2802, DOI 10.1128/MCB.13.5.2802; Luchowski R, 2005, CHEM PHYS, V314, P309, DOI 10.1016/j.chemphys.2005.03.012; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Saenger W., 1984, PRINCIPLES NUCLEIC A, P253; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; PARETO DISTRIBUTION	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3818	10.1371/journal.pone.0003818	http://dx.doi.org/10.1371/journal.pone.0003818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043592	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451500003
J	Edwards, AO; Fridley, BL; James, KM; Sharma, AS; Cunningham, JM; Tosakulwong, N				Edwards, Albert O.; Fridley, Brooke L.; James, Katherine M.; Sharma, Anil S.; Cunningham, Julie M.; Tosakulwong, Nirubol			Evaluation of Clustering and Genotype Distribution for Replication in Genome Wide Association Studies: The Age-Related Eye Disease Study	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; SUSCEPTIBILITY GENES; RISK; VARIANT; POLYMORPHISMS; HAPLOTYPES; LOC387715; ALLOTYPES; TESTS	Genome-wide association studies (GWASs) assess correlation between traits and DNA sequence variation using large numbers of genetic variants such as single nucleotide polymorphisms (SNPs) distributed across the genome. A GWAS produces many trait-SNP associations with low p-values, but few are replicated in subsequent studies. We sought to determine if characteristics of the genomic loci associated with a trait could be used to identify initial associations with a higher chance of replication in a second cohort. Data from the age-related eye disease study (AREDS) of 100,000 SNPs on 395 subjects with and 198 without age-related macular degeneration (AMD) were employed. Loci highly associated with AMD were characterized based on the distribution of genotypes, level of significance, and clustering of adjacent SNPs also associated with AMD suggesting linkage disequilibrium or multiple effects. Forty nine loci were highly associated with AMD, including 3 loci (CFH, C2/BF, LOC387715/HTRA1) already known to contain important genetic risks for AMD. One additional locus (C3) reported during the course of this study was identified and replicated in an additional study group. Tag-SNPs and haplotypes for each locus were evaluated for association with AMD in additional cohorts to account for population differences between discovery and replication subjects, but no additional clearly significant associations were identified. Relying on a significant genotype tests using a log-additive model would have excluded 57% of the non-replicated and none of the replicated loci, while use of other SNP features and clustering might have missed true associations.	[Edwards, Albert O.; James, Katherine M.; Sharma, Anil S.; Tosakulwong, Nirubol] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Fridley, Brooke L.] Mayo Clin, Div Biostat, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Edwards, AO (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	edwardslab@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Sharma, Anil/0000-0002-4471-7172	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; Mayo Clinic Foundation;  [EY014467]; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Mayo Clinic Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by EY014467, the Foundation Fighting Blindness, Owing Mills, MD, the American Health Assistance Foundation, Clarksburg, MD, unrestricted departmental grants from Research to Prevent Blindness, New York, NY, and the Mayo Clinic Foundation. The sponsors had no role in the design or conduct of the study.	Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EDWARDS AO, 2007, ANGIOGENESI IN PRESS; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; HAGEMAN GS, 2005, P NATL ACAD SCI US; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Messias-Reason IJ, 2003, TISSUE ANTIGENS, V62, P308, DOI 10.1034/j.1399-0039.2003.00101.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Slager SL, 2007, BRIT J HAEMATOL, V139, P762, DOI 10.1111/j.1365-2141.2007.06872.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teo YY, 2008, CURR OPIN LIPIDOL, V19, P133, DOI 10.1097/MOL.0b013e3282f5dd77; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhang H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-51; ARCH OPHTHALMOL, V119, P1417; NATURE, V447, P661	36	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3813	10.1371/journal.pone.0003813	http://dx.doi.org/10.1371/journal.pone.0003813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043567	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451400005
J	Jiang, SG; Bailey, AS; Goldman, DC; Swain, JR; Wong, MH; Streeter, PR; Fleming, WH				Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Swain, John R.; Wong, Melissa H.; Streeter, Philip R.; Fleming, William H.			Hematopoietic Stem Cells Contribute to Lymphatic Endothelium	PLOS ONE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; MARROW-DERIVED CELLS; TUMOR ANGIOGENESIS; PROGENITOR CELLS; VASCULAR ENDOTHELIUM; VESSEL FORMATION; PERICYTE PROGENITORS; PRECURSOR CELLS; MYELOID CELLS; IN-VIVO	Background: Although the lymphatic system arises as an extension of venous vessels in the embryo, little is known about the role of circulating progenitors in the maintenance or development of lymphatic endothelium. Here, we investigated whether hematopoietic stem cells (HSCs) have the potential to give rise to lymphatic endothelial cells (LEC). Methodology/Principal Findings: Following the transfer of marked HSCs into irradiated recipients, donor-derived LEC that co-express the lymphatic endothelial markers Lyve-1 and VEGFR-3 were identified in several tissues. HSC-derived LEC persisted for more than 12 months and contributed to similar to 3-4% of lymphatic vessels. Donor-derived LECs were not detected in mice transplanted with common myeloid progenitors and granulocyte/ macrophage progenitors, suggesting that myeloid lineage commitment is not a requisite step in HSC contribution to lymphatic endothelium. Analysis of parabiotic mice revealed direct evidence for the existence of functional, circulating lymphatic progenitors in the absence of acute injury. Furthermore, the transplantation of HSCs into Apc(Min/+) mice resulted in the incorporation of donor-derived LEC into the lymphatic vessels of spontaneously arising intestinal tumors. Conclusions/Significance: Our results indicate that HSCs can contribute to normal and tumor associated lymphatic endothelium. These findings suggest that the modification of HSCs may be a novel approach for targeting tumor metastasis and attenuating diseases of the lymphatic system.	[Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Streeter, Philip R.; Fleming, William H.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Swain, John R.; Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA; [Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Swain, John R.; Wong, Melissa H.; Streeter, Philip R.; Fleming, William H.] Oregon Hlth & Sci Univ, Oregon Canc Inst, Oregon Stem Cell Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Jiang, SG (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA.	flemingw@ohsu.edu			NIH [HL077818, HL069133, CA118235]; NATIONAL CANCER INSTITUTE [R01CA118235] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077818, R01HL069133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL077818 and HL069133 (WHF) and CA118235 (MHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dudas J, 2004, ANAT EMBRYOL, V208, P359, DOI 10.1007/s00429-004-0403-4; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Ji RC, 2007, CURR MED CHEM, V14, P2359, DOI 10.2174/092986707781745541; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Montfort MJ, 2002, EXP HEMATOL, V30, P950, DOI 10.1016/S0301-472X(02)00813-5; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Roy HK, 2005, CANCER EPIDEM BIOMAR, V14, P1639, DOI 10.1158/1055-9965.EPI-04-0837; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	46	52	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3812	10.1371/journal.pone.0003812	http://dx.doi.org/10.1371/journal.pone.0003812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043576	Green Submitted, Green Published, gold			2022-12-27	WOS:000265451400004
J	Seitz, AR; Watanabe, T				Seitz, Aaron R.; Watanabe, Takeo			Is Task-Irrelevant Learning Really Task-Irrelevant?	PLOS ONE			English	Article							VISUAL-MOTION; REINFORCEMENT; UNCERTAINTY; REWARD; LEVEL	In the present study we address the question of whether the learning of task-irrelevant stimuli found in the paradigm of task-irrelevant learning (TIPL) [1-9] is truly task irrelevant. To test the hypothesis that associations that are beneficial to task-performance may develop between the task-relevant and task-irrelevant stimuli, or the task-responses and the task-irrelevant stimuli, we designed a new procedure in which correlations between the presentation of task-irrelevant motion stimuli and the identity of task-targets or task-responses were manipulated. We found no evidence for associations developing between the learned (task-irrelevant) motion stimuli and the targets or responses to the letter identification task used during training. Furthermore, the conditions that had the greatest correlations between stimulus and response showed the least amount of TIPL. On the other hand, TIPL was found in conditions of greatest response uncertainty and with the greatest processing requirements for the task-relevant stimuli. This is in line with our previously published model that suggests that task-irrelevant stimuli benefit from the spill-over of learning signals that are released due to processing of task-relevant stimuli.	[Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Seitz, Aaron R.; Watanabe, Takeo] Boston Univ, Dept Psychol, Boston, MA 02215 USA	University of California System; University of California Riverside; Boston University	Seitz, AR (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	aseitz@ucr.edu			NIH [R01 EY015980, R21 EY017737]; NSF [BCS-0345746, BCS-0549036, BCS-PR04-137]; Human Frontier Science Program Organization [RGP18/2004]; NATIONAL EYE INSTITUTE [R21EY017737, R01EY015980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by grants from NIH (R01 EY015980 and R21 EY017737), NSF (BCS-0345746, BCS-0549036, and BCS-PR04-137 Center of Excellence for Learning in Education, Science, and Technology), and the Human Frontier Science Program Organization (RGP18/2004).	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BALL K, 1981, J EXP PSYCHOL HUMAN, V7, P780, DOI 10.1037/0096-1523.7.4.780; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Dayan P, 2003, IETE J RES, V49, P171, DOI 10.1080/03772063.2003.11416335; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; FRANKO E, 2007, EFFECT STIMULUS REIN; FRANKO E, 2006, EFFECT STIMULUS REIN; Herzog MH, 1998, BIOL CYBERN, V78, P107, DOI 10.1007/s004220050418; Kim D, 2007, CURR ALLERGY ASTHM R, V7, P85, DOI 10.1007/s11882-007-0004-4; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Ludwig I, 2002, BIOL PSYCHOL, V59, P187, DOI 10.1016/S0301-0511(02)00009-1; Nishina S, 2007, J VISION, V7, DOI 10.1167/7.13.2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seitz A, 2005, CURR BIOL, V15, pR753, DOI 10.1016/j.cub.2005.09.009; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, J VISION, V6, P966, DOI 10.1167/6.9.9; Seitz AR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000028; Seitz AR, 2005, P NATL ACAD SCI USA, V102, P9080, DOI 10.1073/pnas.0501026102; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; SEITZ AR, 2007, REWARD DRIVEN OCULAR; SEITZ AR, 2007, CURR OPIN NEUROBIOL; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	33	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3792	10.1371/journal.pone.0003792	http://dx.doi.org/10.1371/journal.pone.0003792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YA	19030107	Green Published, Green Submitted, gold			2022-12-27	WOS:000265450800002
J	Leal, WS; Ishida, Y				Leal, Walter S.; Ishida, Yuko			GP-9s Are Ubiquitous Proteins Unlikely Involved in Olfactory Mediation of Social Organization in the Red Imported Fire Ant, Solenopsis invicta	PLOS ONE			English	Article								The red imported fire ant (RIFA), Solenopsis invicta, is an invasive species, accidentally introduced in the United States that can cause painful (sometimes life-threatening) stings to human, pets, and livestock. Their colonies have two social forms: monogyne and polygyne that have a single and multiple functional queens, respectively. A major gene (Gp-9), identified as a putative pheromone-binding protein on the basis of a modest amino acid sequence identity, has been suggested to influence the expression of colony social organization. Monogyne queens are reported to possess only the GP-9B alleles, whereas polygyne queens possess both GP-9B and GP-9b. Thus, both social forms are reported to express GP-9B, with GP-9b being a marker expressed in polygynes but it is absent in monogynes. Here, we report two types of polygyne colonies, one that does not express GP-9b (monogyne-like) and the other expressing both proteins, GP-9B and GP-9b. Given their expression pattern, GP-9s are hemolymph proteins, which are more likely to be involved in the transport of lipids and small ligands within the homocoel. GP-9B existed in two forms, one of them is phosphorylated. The helical-rich content of the protein resembles the secondary structures of a beetle hemolymph protein and moth pheromone-binding proteins. An olfactory role is unlikely given the lack of specific expression in the sensillar lymph. In marked contrast to GP-9s, a chemosensory protein, SinvCSP, is demonstrated to be specifically expressed in the antennae. Within the antennae, expression of SinvCSP is restricted to the last two segments, which are known to house olfactory sensilla.	[Leal, Walter S.; Ishida, Yuko] Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	National Institutes of Health [1U01AI05826-01]; Bedoukian Research Inc; National Research Initiative of the U.S. Department of Agriculture [2003-35302-13648]; National Science Foundation [0234769]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bedoukian Research Inc; National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Institutes of Health (1U01AI05826-01), a research agreement with Bedoukian Research Inc., the National Research Initiative of the U.S. Department of Agriculture (USDA-CSREES 2003-35302-13648) and National Science Foundation (0234769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; Gotzek D, 2008, J INSECT BEHAV, V21, P337, DOI 10.1007/s10905-008-9130-7; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LENNARTZ FE, 1973, THESIS U FLORIDA GAI; Renthal R, 2003, MICRON, V34, P405, DOI 10.1016/S0968-4328(03)00050-7; Ross KG, 1997, GENETICS, V145, P961; Rothemund S, 1999, STRUCT FOLD DES, V7, P1325, DOI 10.1016/S0969-2126(00)80022-2; Rothemund S, 1997, BIOCHEMISTRY-US, V36, P13791, DOI 10.1021/bi971529k; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SHOEMAKER DD, 1992, HEREDITY, V69, P573, DOI 10.1038/hdy.1992.173; Steinbrecht Rudolf Alexander, 1999, P155; Taber SW, 2000, FIRE ANTS; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950	17	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3762	10.1371/journal.pone.0003762	http://dx.doi.org/10.1371/journal.pone.0003762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018280	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448500009
J	Mourier, T; Willerslev, E				Mourier, Tobias; Willerslev, Eske			Does Selection against Transcriptional Interference Shape Retroelement-Free Regions in Mammalian Genomes?	PLOS ONE			English	Article							TRANSPOSON-FREE REGIONS; L1 RETROTRANSPOSITION; EMBRYONIC-DEVELOPMENT; ANTISENSE PROMOTER; HOX GENES; ELEMENTS; EXPRESSION; MECHANISM; BROWSER; REPEATS	Background: Eukaryotic genomes are scattered with retroelements that proliferate through retrotransposition. Although retroelements make up around 40 percent of the human genome, large regions are found to be completely devoid of retroelements. This has been hypothesised to be a result of genomic regions being intolerant to insertions of retroelements. The inadvertent transcriptional activity of retroelements may affect neighbouring genes, which in turn could be detrimental to an organism. We speculate that such retroelement transcription, or transcriptional interference, is a contributing factor in generating and maintaining retroelement-free regions in the human genome. Methodology/Principal Findings: Based on the known transcriptional properties of retroelements, we expect long interspersed elements (LINEs) to be able to display a high degree of transcriptional interference. In contrast, we expect short interspersed elements (SINEs) to display very low levels of transcriptional interference. We find that genomic regions devoid of long interspersed elements (LINEs) are enriched for protein-coding genes, but that this is not the case for regions devoid of short interspersed elements (SINEs). This is expected if genes are subject to selection against transcriptional interference. We do not find microRNAs to be associated with genomic regions devoid of either SINEs or LINEs. We further observe an increased relative activity of genes overlapping LINE-free regions during early embryogenesis, where activity of LINEs has been identified previously. Conclusions/Significance: Our observations are consistent with the notion that selection against transcriptional interference has contributed to the maintenance and/or generation of retroelement-free regions in the human genome.	[Mourier, Tobias; Willerslev, Eske] Univ Copenhagen, Dept Biol, Ancient DNA & Evolut Grp, Copenhagen, Denmark	University of Copenhagen	Mourier, T (corresponding author), Univ Copenhagen, Dept Biol, Ancient DNA & Evolut Grp, Copenhagen, Denmark.	tmourier@bi.ku.dk	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Mourier, Tobias/C-1164-2015	Willerslev, Eske/0000-0002-7081-6748; Mourier, Tobias/0000-0003-2727-1903	Lundbeck Foundation; Villum Kann Rasmussen Foundation; Danish Natural Science Research Council; Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Villum Kann Rasmussen Foundation(Villum Fonden); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	TM is supported by a grant from the Lundbeck Foundation. Work at the Ancient DNA and Evolution group is funded by the Villum Kann Rasmussen Foundation, the Danish Natural Science Research Council and the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Conte C, 2002, EMBO J, V21, P3908, DOI 10.1093/emboj/cdf367; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Eppig Janan T, 2007, Toxicol Pathol, V35, P456, DOI 10.1080/01926230701310536; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Meunier J, 2005, P NATL ACAD SCI USA, V102, P5471, DOI 10.1073/pnas.0408986102; Morgan R, 2006, TRENDS GENET, V22, P67, DOI 10.1016/j.tig.2005.11.004; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pittoggi C, 2003, MOL REPROD DEV, V66, P225, DOI 10.1002/mrd.10349; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tribioli C, 1999, DEVELOPMENT, V126, P5699; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	52	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3760	10.1371/journal.pone.0003760	http://dx.doi.org/10.1371/journal.pone.0003760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018283	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448500007
J	Hong, SK; Dawid, IB				Hong, Sung-Kook; Dawid, Igor B.			Alpha2 Macroglobulin-Like Is Essential for Liver Development in Zebrafish	PLOS ONE			English	Article							BETA-AMYLOID PEPTIDE; ENDODERM FORMATION; GENE-EXPRESSION; ALPHA(2)-MACROGLOBULIN; ALPHA-2-MACROGLOBULIN; PROTEIN; DOMAIN; DIFFERENTIATION	Background: Alpha 2 Macroglobulin family members have been studied extensively with respect to their roles in physiology and human disease including innate immunity and Alzheimer's disease, but little is known about a possible role in liver development loss-of-function in model systems. Principal Findings: We report the isolation of the zebrafish alpha 2 macroglobulin-like (A2ML) gene and its specific expression in the liver during differentiation. Morpholino-based knock-down of A2ML did not block the initial formation of the liver primordium, but inhibited liver growth and differentiation. Significance: This report on A2ML function in zebrafish development provides the first evidence for a specific role of an A2M family gene in liver formation during early embryogenesis in a vertebrate.	[Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver NICHHD, Mol Genet Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hong, SK (corresponding author), Eunice Kennedy Shriver NICHHD, Mol Genet Lab, NIH, Bethesda, MD USA.	idawid@nih.gov			NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008809] Funding Source: NIH RePORTER	NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the NICHD, NIH.	Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Du YS, 1997, J NEUROCHEM, V69, P299; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Galliano MF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002729; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Manfroid I, 2007, DEVELOPMENT, V134, P4011, DOI 10.1242/dev.007823; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Narita M, 1997, J NEUROCHEM, V69, P1904; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pack M, 1996, DEVELOPMENT, V123, P321; Pineda-Salgado L, 2005, GENE EXPR PATTERNS, V6, P3, DOI 10.1016/j.modgep.2005.09.001; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Tayade C, 2005, MOL CELL ENDOCRINOL, V245, P60, DOI 10.1016/j.mce.2005.10.004; Umans L, 1999, AM J PATHOL, V155, P983, DOI 10.1016/S0002-9440(10)65198-X; UMANS L, 1995, J BIOL CHEM, V270, P19778, DOI 10.1074/jbc.270.34.19778; VANLEUVEN F, 1988, J BIOL CHEM, V263, P468; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3736	10.1371/journal.pone.0003736	http://dx.doi.org/10.1371/journal.pone.0003736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011686	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448300004
J	Chen, ZB; Feng, JN; Buzin, CH; Sommer, SS				Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Sommer, Steve S.			Epidemiology of Doublet/Multiplet Mutations in Lung Cancers: Evidence that a Subset Arises by Chronocoordinate Events	PLOS ONE			English	Article								Background: Evidence strongly suggests that spontaneous doublet mutations in normal mouse tissues generally arise from chronocoordinate events. These chronocoordinate mutations sometimes reflect "mutation showers'', which are multiple chronocoordinate mutations spanning many kilobases. However, little is known about mutagenesis of doublet and multiplet mutations (domuplets) in human cancer. Lung cancer accounts for about 25% of all cancer deaths. Herein, we analyze the epidemiology of domuplets in the EGFR and TP53 genes in lung cancer. The EGFR gene is an oncogene in which doublets are generally driver plus driver mutations, while the TP53 gene is a tumor suppressor gene with a more typical situation in which doublets derive from a driver and passenger mutation. Methodology/Principal Findings: EGFR mutations identified by sequencing were collected from 66 published papers and our updated EGFR mutation database (www.egfr.org). TP53 mutations were collected from IARC version 12 (www-p53.iarc.fr). For EGFR and TP53 doublets, no clearly significant differences in race, ethnicity, gender and smoking status were observed. Doublets in the EGFR and TP53 genes in human lung cancer are elevated about eight-and three-fold, respectively, relative to spontaneous doublets in mouse (6% and 2.3% versus 0.7%). Conclusions/Significance: Although no one characteristic is definitive, the aggregate properties of doublet and multiplet mutations in lung cancer are consistent with a subset derived from chronocoordinate events in the EGFR gene: i) the eight frameshift doublets (present in 0.5% of all patients with EGFR mutations) are clustered and produce a net in-frame change; ii) about 32% of doublets are very closely spaced (<= 30 nt); and iii) multiplets contain two or more closely spaced mutations. TP53 mutations in lung cancer are very closely spaced (<= 30 nt) in 33% of doublets, and multiplets generally contain two or more very closely spaced mutations. Work in model systems is necessary to confirm the significance of chronocoordinate events in lung and other cancers.	[Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Sommer, Steve S.] City Hope Natl Med Ctr, Dept Mol Genet, Duarte, CA 91010 USA	City of Hope	Chen, ZB (corresponding author), City Hope Natl Med Ctr, Dept Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	sommerlab@coh.org						Bielas JH, 2005, ENVIRON MOL MUTAGEN, V45, P206, DOI 10.1002/em.20111; Buettner VL, 2000, MUTAT RES-FUND MOL M, V452, P219, DOI 10.1016/S0027-5107(00)00090-7; Buettner VL, 1999, ENVIRON MOL MUTAGEN, V33, P320, DOI 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Cooper D. N., 1993, HUMAN GENE MUTATION; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drake JW, 2005, P NATL ACAD SCI USA, V102, P12849, DOI 10.1073/pnas.0503009102; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Halangoda A, 2001, ENVIRON MOL MUTAGEN, V37, P311, DOI 10.1002/em.1038; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill KA, 2004, MUTAT RES-FUND MOL M, V554, P223, DOI 10.1016/j.mrfmmm.2004.05.005; Hill KA, 2003, MUTAT RES-GEN TOX EN, V534, P173, DOI 10.1016/S1383-5718(02)00277-2; Hill KA, 2002, ENVIRON MOL MUTAGEN, V39, P216, DOI 10.1002/em.10065; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; ROBERTS AR, 1994, CRISIS INTERV TIME-L, V1, P1; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; SOMMER SS, 1990, NATURE, V346, P22, DOI 10.1038/346022b0; SOMMER SS, 1980, J MOL EVOL, V15, P37, DOI 10.1007/BF01732582; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Yokoyama T, 2006, CANCER SCI, V97, P753, DOI 10.1111/j.1349-7006.2006.00233.x	31	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3714	10.1371/journal.pone.0003714	http://dx.doi.org/10.1371/journal.pone.0003714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005564	Green Published, gold, Green Submitted			2022-12-27	WOS:000265166200002
J	Morino, S; Kondo, T; Sasaki, K; Adachi, H; Suico, MA; Sekimoto, E; Matsuda, T; Shuto, T; Araki, E; Kai, H				Morino, Saori; Kondo, Tatsuya; Sasaki, Kazunari; Adachi, Hironori; Suico, Mary Ann; Sekimoto, Erika; Matsuda, Tomoko; Shuto, Tsuyoshi; Araki, Eiichi; Kai, Hirofumi			Mild Electrical Stimulation with Heat Shock Ameliorates Insulin Resistance via Enhanced Insulin Signaling	PLOS ONE			English	Article								Low-intensity electrical current (or mild electrical stimulation; MES) influences signal transduction and activates phosphatidylinositol-3 kinase (PI3K)/Akt pathway. Because insulin resistance is characterized by a marked reduction in insulin-stimulated PI3K-mediated activation of Akt, we asked whether MES could increase Akt phosphorylation and ameliorate insulin resistance. In addition, it was also previously reported that heat shock protein 72 (Hsp72) alleviates hyperglycemia. Thus, we applied MES in combination with heat shock (HS) to in vitro and in vivo models of insulin resistance. Here we show that 10-min treatment with MES at 5 V (0.1 ms pulse duration) together with HS at 42 degrees C increased the phosphorylation of insulin signaling molecules such as insulin receptor substrate (IRS) and Akt in HepG2 cells maintained in high-glucose medium. MES (12 V)+mild HS treatment of high fat-fed mice also increased the phosphorylation of insulin receptor beta subunit (IR beta) and Akt in mice liver. In high fat-fed mice and db/db mice, MES+HS treatment for 10 min applied twice a week for 12-15 weeks significantly decreased fasting blood glucose and insulin levels and improved insulin sensitivity. The treated mice showed significantly lower weight of visceral and subcutaneous fat, a markedly improved fatty liver and decreased size of adipocytes. Our findings indicated that the combination of MES and HS alleviated insulin resistance and improved fat metabolism in diabetes mouse models, in part, by enhancing the insulin signaling pathway.	[Morino, Saori; Suico, Mary Ann; Sekimoto, Erika; Matsuda, Tomoko; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Fac Med & Pharmaceut Sci, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Kondo, Tatsuya; Sasaki, Kazunari; Adachi, Hironori; Araki, Eiichi] Kumamoto Univ, Fac Med & Pharm Sci, Dept Metabol Med, Kumamoto 860, Japan	Kumamoto University; Kumamoto University	Morino, S (corresponding author), Kumamoto Univ, Dept Mol Med, Fac Med & Pharmaceut Sci, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan.	earaki@gpo.kumamoto-u.ac.jp; hirokai@gpo.kumamoto-u.ac.jp	Kazunari, Sasaki/ABF-2853-2020	Kazunari, Sasaki/0000-0003-2514-5778; Suico, Mary Ann/0000-0002-6751-8352; Kondo, Tatsuya/0000-0003-4830-8955	Ministry of Education, Science, Sports and Culture (MEXT) of Japan [19390045, 20390259, 19591058]; JSPS [Fellows]; Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan; Foundation of Medical Innovation of Kumamoto University; Suzuken Memorial Foundation	Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Medical Innovation of Kumamoto University; Suzuken Memorial Foundation	This work is supported by grants from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan to H. Kai (#19390045), E. Araki (#20390259) and T. Kondo (#19591058), by Grant-in-Aid for JSPS Fellows (to S. Morino), and from the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan (to H. Kai), a grant from the Foundation of Medical Innovation of Kumamoto University (to T. Kondo) and a grant from Suzuken Memorial Foundation (to T. Kondo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Cha DR, 2007, DIABETES, V56, P2036, DOI 10.2337/db06-1134; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Ducluzeau PH, 2002, J CELL SCI, V115, P2857; Farese RV, 2005, EXP BIOL MED, V230, P593; Gabai VL, 2000, J BIOL CHEM, V275, P38088, DOI 10.1074/jbc.M006632200; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Hilder TL, 2003, FEBS LETT, V553, P63, DOI 10.1016/S0014-5793(03)00972-4; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V331, P1301, DOI 10.1016/j.bbrc.2005.04.096; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCarty MF, 2006, MED HYPOTHESES, V66, P527, DOI 10.1016/j.mehy.2004.08.033; Mobbs RJ, 2007, J CLIN NEUROSCI, V14, P216, DOI 10.1016/j.jocn.2005.11.007; MORINO S, 2008, J PHARM SCI IN PRESS; Nelson Fred R T, 2003, J Am Acad Orthop Surg, V11, P344; Okamoto H, 2003, J BIOL CHEM, V278, P28359, DOI 10.1074/jbc.R300009200; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Schinner S, 2005, J BIOL CHEM, V280, P7369, DOI 10.1074/jbc.M408560200; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Sekino M, 2003, J APPL PHYS, V94, P5359, DOI 10.1063/1.1607517; Shimizu H, 2006, DIABETIC MED, V23, P253, DOI 10.1111/j.1464-5491.2006.01776.x; Shimohara S, 2005, INT J ONCOL, V27, P1527; STOY RD, 1982, PHYS MED BIOL, V27, P501, DOI 10.1088/0031-9155/27/4/002; Syed NA, 2000, MOL CELL BIOCHEM, V211, P123, DOI 10.1023/A:1007159422667; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Volloch V, 1998, CELL STRESS CHAPERON, V3, P265, DOI 10.1054/csac.1998.0120; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	50	62	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4068	10.1371/journal.pone.0004068	http://dx.doi.org/10.1371/journal.pone.0004068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114996	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466300009
J	Murray, LA; Hackett, TL; Warner, SM; Shaheen, F; Argentieri, RL; Dudas, P; Farrell, FX; Knight, DA				Murray, Lynne A.; Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Argentieri, Rochelle L.; Dudas, Paul; Farrell, Francis X.; Knight, Darryl A.			BMP-7 Does Not Protect against Bleomycin-Induced Lung or Skin Fibrosis	PLOS ONE			English	Article								Bone morphogenic protein (BMP)-7 is a member of the BMP family which are structurally and functionally related, and part of the TGF beta super family of growth factors. BMP-7 has been reported to inhibit renal fibrosis and TGF beta 1-induced epithelial-mesenchymal transition (EMT), in part through negative interactions with TGF beta 1 induced Smad 2/3 activation. We utilized in vivo bleomycin-induced fibrosis models in the skin and lung to determine the potential therapeutic effect of BMP-7. We then determined the effect of BMP-7 on TGF beta 1-induced EMT in lung epithelial cells and collagen production by human lung fibroblasts. We show that BMP-7 did not affect bleomycin-induced fibrosis in either the lung or skin in vivo; had no effect on expression of pro-fibrotic genes by human lung fibroblasts, either at rest or following exposure to TGF beta 1; and did not modulate TGF beta 1-induced EMT in human lung epithelial cells. Taken together our data indicates that BMP-7 has no antifibrotic effect in lung or skin fibrosis either in vivo or in vitro. This suggests that the therapeutic options for BMP-7 may be confined to the renal compartment.	[Murray, Lynne A.; Argentieri, Rochelle L.; Dudas, Paul; Farrell, Francis X.] Centocor Inc, Tissue Remodeling & Metabol Dept, Immunobiol Dept, Radnor, PA USA; [Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Knight, Darryl A.] St Pauls Hosp, James Hogg iCapture Ctr Cardiovasc & Pulmon Res, Vancouver, BC, Canada; [Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol, Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Murray, LA (corresponding author), Promedior Inc, Malvern, PA USA.	lmurray@promedior.com	Murray, Lynne/AAB-1793-2020	Murray, Lynne/0000-0003-4879-966X	Centocor, Inc; Canadian Institutes for Health Research; Wolfe and Gita Churg Foundation	Centocor, Inc(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Wolfe and Gita Churg Foundation	The work in this manuscript was supported by Centocor, Inc and operating funds from the Canadian Institutes for Health Research; the Wolfe and Gita Churg Foundation and an endowment from the Rashpal Dhillon family to DAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Higashiyama H, 2007, J CLIN PATHOL, V60, P283, DOI 10.1136/jcp.2006.037606; Hogaboam GM, 1999, J IMMUNOL, V163, P2193; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karsenty G, 1996, ANN NY ACAD SCI, V785, P98, DOI 10.1111/j.1749-6632.1996.tb56247.x; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Keane MP, 1999, J IMMUNOL, V163, P5686; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lakos G, 2006, PATHOBIOLOGY, V73, P224, DOI 10.1159/000098208; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsushita M, 2004, INT ARCH ALLERGY IMM, V135, P348, DOI 10.1159/000082331; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSL LUNG CELL; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P556, DOI 10.1007/s004030000180; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang HY, 1996, AM J PATHOL, V148, P527	41	49	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4039	10.1371/journal.pone.0004039	http://dx.doi.org/10.1371/journal.pone.0004039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112509	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000008
J	Mercatelli, N; Coppola, V; Bonci, D; Miele, F; Costantini, A; Guadagnoli, M; Bonanno, E; Muto, G; Frajese, GV; De Maria, R; Spagnoli, LG; Farace, MG; Ciafre, SA				Mercatelli, Neri; Coppola, Valeria; Bonci, Desiree; Miele, Francesca; Costantini, Arianna; Guadagnoli, Marco; Bonanno, Elena; Muto, Giovanni; Frajese, Giovanni Vanni; De Maria, Ruggero; Spagnoli, Luigi Giusto; Farace, Maria Giulia; Ciafre, Silvia Anna			The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice	PLOS ONE			English	Article								Background: MiR-221 and miR-222 are two highly homologous microRNAs whose upregulation has been recently described in several types of human tumors, for some of which their oncogenic role was explained by the discovery of their target p27, a key cell cycle regulator. We previously showed this regulatory relationship in prostate carcinoma cell lines in vitro, underlying the role of miR-221/222 as inducers of proliferation and tumorigenicity. Methodology/Principal Findings: Here we describe a number of in vivo approaches confirming our previous data. The ectopic overexpression of miR-221 is able, per se, to confer a high growth advantage to LNCaP-derived tumors in SCID mice. Consistently, the anti-miR-221/222 antagomir treatment of established subcutaneous tumors derived from the highly aggressive PC3 cell line, naturally expressing high levels of miR-221/222, reduces tumor growth by increasing intratumoral p27 amount; this effect is long lasting, as it is detectable as long as 25 days after the treatment. Furthermore, we provide evidence in favour of a clinical relevance of the role of miR-221/222 in prostate carcinoma, by showing their general upregulation in patient-derived primary cell lines, where we find a significant inverse correlation with p27 expression. Conclusions/Significance: These findings suggest that modulating miR-221/222 levels may have a therapeutic potential in prostate carcinoma.	[Mercatelli, Neri; Miele, Francesca; Guadagnoli, Marco; Farace, Maria Giulia; Ciafre, Silvia Anna] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Coppola, Valeria; Bonci, Desiree; De Maria, Ruggero] Ist Superiore Sanita, Dept Hematol, Oncol & Mol Med, Rome, Italy; [Costantini, Arianna; Bonanno, Elena; Spagnoli, Luigi Giusto] Univ Roma Tor Vergata, Dept Biopathol, I-00173 Rome, Italy; [Muto, Giovanni] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy; [Frajese, Giovanni Vanni] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, Catania, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; Mediterranean Institute of Oncology	Mercatelli, N (corresponding author), Inst Andre Lwoff, CNRS, FRE 2944 EPIGENET & CANC, Villejuif, France.	ciafre@uniroma2.it	Coppola, Valeria/K-5120-2016; De Maria, Ruggero/S-6385-2019; Bonci, Desiree/K-6488-2016; ciafrè, silvia anna/G-1783-2012	Coppola, Valeria/0000-0002-5745-2572; De Maria, Ruggero/0000-0003-2255-0583; Bonci, Desiree/0000-0002-2472-5140; ciafrè, silvia anna/0000-0001-6467-8396; bonanno, elena/0000-0002-0222-0141; Spagnoli, Luigi Giusto/0000-0002-0684-5501; Muto, Giovanni/0000-0003-3593-6450	Italian Ministry of Instruction, University and Scientific Research (MIUR); Ministry of Health, FIRB [RBNE01MBEC]; PRIN [20077YZTL8_002]; University of Rome Tor Vergata [PhD fellowship in Endocrinology]	Italian Ministry of Instruction, University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health, FIRB; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Rome Tor Vergata	This study was funded in part by grants from the Italian Ministry of Instruction, University and Scientific Research (MIUR) to SAC and MGF, and from the Ministry of Health, FIRB # RBNE01MBEC and PRIN # 20077YZTL8_002 to MGF. NM was a recipient of a PhD fellowship in Endocrinology, University of Rome "Tor Vergata". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fernandez PL, 2002, PATHOBIOLOGY, V70, P1, DOI 10.1159/000065998; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Said J, 2005, BIOMARKERS, V10, pS83, DOI 10.1080/13547500500215050; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	32	202	211	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4029	10.1371/journal.pone.0004029	http://dx.doi.org/10.1371/journal.pone.0004029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107213	gold, Green Published, Green Submitted			2022-12-27	WOS:000265463000022
J	Krejci, P; Salazar, L; Kashiwada, TA; Chlebova, K; Salasova, A; Thompson, LM; Bryja, V; Kozubik, A; Wilcox, WR				Krejci, Pavel; Salazar, Lisa; Kashiwada, Tamara A.; Chlebova, Katarina; Salasova, Alena; Thompson, Leslie Michels; Bryja, Vitezslav; Kozubik, Alois; Wilcox, William R.			Analysis of STAT1 Activation by Six FGFR3 Mutants Associated with Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage	PLOS ONE			English	Article								Activating mutations in FGFR3 tyrosine kinase cause several forms of human skeletal dysplasia. Although the mechanisms of FGFR3 action in cartilage are not completely understood, it is believed that the STAT1 transcription factor plays a central role in pathogenic FGFR3 signaling. Here, we analyzed STAT1 activation by the N540K, G380R, R248C, Y373C, K650M and K650E-FGFR3 mutants associated with skeletal dysplasias. In a cell-free kinase assay, only K650M and K650E-FGFR3 caused activatory STAT1(Y701) phosphorylation. Similarly, in RCS chondrocytes, HeLa, and 293T cellular environments, only K650M and K650E-FGFR3 caused strong STAT1 activation. Other FGFR3 mutants caused weak (HeLa) or no activation (293T and RCS). This contrasted with ERK MAP kinase activation, which was strongly induced by all six mutants and correlated with the inhibition of proliferation in RCS chondrocytes. Thus the ability to activate STAT1 appears restricted to the K650M and K650E-FGFR3 mutants, which however account for only a small minority of the FGFR3-related skeletal dysplasia cases. Other pathways such as ERK should therefore be considered as central to pathological FGFR3 signaling in cartilage.	[Chlebova, Katarina; Salasova, Alena; Bryja, Vitezslav; Kozubik, Alois] Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav; Kozubik, Alois] ASCR, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Krejci, Pavel; Wilcox, William R.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA USA; [Salazar, Lisa; Kashiwada, Tamara A.; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behavior, Irvine, CA 92717 USA; [Wilcox, William R.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Cedars Sinai Medical Center; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krejci, P (corresponding author), Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic.	pavel.krejci@cshs.org	Bryja, Vít?zslav/H-1925-2014; Kozubík, Alois/H-1954-2014; Bryja, Vítězslav/P-4217-2019; Krejčí, Pavel/I-4285-2014	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Salasova, Alena/0000-0001-9246-6956; Krejci, Pavel/0000-0003-0618-9134	National Institutes of Health [5P01-HD22657]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Academy of Sciences of the Czech Republic [AVOZ50040507, AVOZ50040702]; EMBO Installation grant; Winnick Family Research Scholars award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EMBO Installation grant; Winnick Family Research Scholars award	This work was supported by National Institutes of Health (5P01-HD22657), Ministry of Education, Youth and Sports of the Czech Republic (MSM0021622430), Academy of Sciences of the Czech Republic (AVOZ50040507, AVOZ50040702), EMBO Installation grant (VB), and a Winnick Family Research Scholars award (WRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; Harada D, 2007, BONE, V41, P273, DOI 10.1016/j.bone.2006.11.030; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Lievens PMJ, 2003, J BIOL CHEM, V278, P17344, DOI 10.1074/jbc.M212710200; MATSUSHITA T, 2008, HUM MOL GEN IN PRESS; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nowroozi N, 2005, HUM MOL GENET, V14, P1529, DOI 10.1093/hmg/ddi161; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plowright EE, 2000, BLOOD, V95, P992, DOI 10.1182/blood.V95.3.992.003k29_992_998; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Rozenblatt-Rosen O, 2002, J CELL SCI, V115, P553; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sahni M, 2001, DEVELOPMENT, V128, P2119; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971	33	34	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3961	10.1371/journal.pone.0003961	http://dx.doi.org/10.1371/journal.pone.0003961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088846	Green Published, gold			2022-12-27	WOS:000265458500007
J	Eller, LA; Eller, MA; Ouma, B; Kataaha, P; Kyabaggu, D; Tumusiime, R; Wandege, J; Sanya, R; Sateren, WB; Wabwire-Mangen, F; Kibuuka, H; Robb, ML; Michael, NL; de Souza, MS				Eller, Leigh Anne; Eller, Michael A.; Ouma, Benson; Kataaha, Peter; Kyabaggu, Denis; Tumusiime, Richard; Wandege, Joseph; Sanya, Ronald; Sateren, Warren B.; Wabwire-Mangen, Fred; Kibuuka, Hannah; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark S.			Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials	PLOS ONE			English	Article								Background: Clinical trials are increasingly being conducted internationally. In order to ensure enrollment of healthy participants and proper safety evaluation of vaccine candidates, established reference intervals for clinical tests are required in the target population. Methodology/Principal Findings: We report a reference range study conducted in Ugandan adult blood bank donors establishing reference intervals for hematology and clinical chemistry parameters. Several differences were observed when compared to previously established values from the United States, most notably in neutrophils and eosinophils. Conclusions/Significance: In a recently conducted vaccine trial in Uganda, 31 percent (n = 69) of volunteers screened (n = 223) were excluded due to hematologic abnormalities. If local reference ranges had been employed, 83% of those screened out due to these abnormalities could have been included in the study, drastically reducing workload and cost associated with the screening process. In addition, toxicity tables used in vaccine and drug trial safety evaluations may need adjustment as some clinical reference ranges determined in this study overlap with grade 1 and grade 2 adverse events.	[Eller, Michael A.; Sateren, Warren B.; Robb, Merlin L.; de Souza, Mark S.] US Mil HIV Res Program, Rockville, MD USA; [Eller, Leigh Anne; Eller, Michael A.; Ouma, Benson; Kyabaggu, Denis; Tumusiime, Richard; Wandege, Joseph; Sanya, Ronald; Wabwire-Mangen, Fred; Kibuuka, Hannah] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Kataaha, Peter] Uganda Natl Blood Transfus Serv, Kampala, Uganda; [Michael, Nelson L.] Walter Reed Army Inst Res, Rockville, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok, Thailand	Walter Reed Army Institute of Research (WRAIR); Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Eller, LA (corresponding author), US Mil HIV Res Program, Rockville, MD USA.	leller@muwrp.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877	U.S. Army Medical Research and Materiel Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS [1Y-A1-26-42-07]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Army Medical Research and Materiel Command and its Cooperative Agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine and with an Inter Agency Agreement (1Y-A1-26-42-07) with DAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADENHORST CJ, 1995, E AFR MED J, V72, P19; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BLACK HR, 1986, AM J MED, V81, P479, DOI 10.1016/0002-9343(86)90303-7; *DIAGN R, 2007, INSTR US; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1971, TROP GEOGR MED, V23, P264; EZEILO GC, 1972, LANCET, V2, P1003; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, J VIROL METHODS, V111, P129, DOI 10.1016/S0166-0934(03)00169-1; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; NCCLS, 2000, DEF DET REF INT CLIN, V20; PILIS W, 1988, INT J SPORTS MED, V9, P102, DOI 10.1055/s-2007-1024987; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; SHAPER AG, 1971, LANCET, V2, P1021; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995	18	54	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3919	10.1371/journal.pone.0003919	http://dx.doi.org/10.1371/journal.pone.0003919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079547	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455900006
J	Miele, G; Seeger, H; Marino, D; Eberhard, R; Heikenwalder, M; Stoeck, K; Basagni, M; Knight, R; Green, A; Chianini, F; Wuethrich, RP; Hock, C; Zerr, I; Aguzzi, A				Miele, Gino; Seeger, Harald; Marino, Denis; Eberhard, Ralf; Heikenwalder, Mathias; Stoeck, Katharina; Basagni, Max; Knight, Richard; Green, Alison; Chianini, Francesca; Wuethrich, Rudolf P.; Hock, Christoph; Zerr, Inga; Aguzzi, Adriano			Urinary alpha(1)-Antichymotrypsin: A Biomarker of Prion Infection	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CEREBROSPINAL-FLUID; CYSTATIN-C; ALZHEIMERS-DISEASE; AMYLOID DEPOSITS; SCRAPIE; ALPHA-1-ANTICHYMOTRYPSIN; PROTEIN; PLASMA; SERUM	The occurrence of blood-borne prion transmission incidents calls for identification of potential prion carriers. However, current methods for intravital diagnosis of prion disease rely on invasive tissue biopsies and are unsuitable for large-scale screening. Sensitive biomarkers may help meeting this need. Here we scanned the genome for transcripts elevated upon prion infection and encoding secreted proteins. We found that alpha(1)-antichymotrypsin (alpha(1)-ACT) was highly upregulated in brains of scrapie-infected mice. Furthermore, alpha(1)-ACT levels were dramatically increased in urine of patients suffering from sporadic Creutzfeldt-Jakob disease, and increased progressively throughout the disease. Increased alpha(1)-ACT excretion was also found in cases of natural prion disease of animals. Therefore measurement of urinary alpha(1)-ACT levels may be useful for monitoring the efficacy of therapeutic regimens for prion disease, and possibly also for deferring blood and organ donors that may be at risk of transmitting prion infections.	[Miele, Gino; Seeger, Harald; Marino, Denis; Eberhard, Ralf; Heikenwalder, Mathias; Stoeck, Katharina; Aguzzi, Adriano] Univ Spital Zurich, Inst Neuropathol, Dept Pathol, Zurich, Switzerland; [Basagni, Max] Prion Diagnost Srl, Rho, Italy; [Knight, Richard; Green, Alison] Western Gen Hosp, National Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh, Midlothian, Scotland; [Chianini, Francesca] Moredun Res Inst, Pentlands Sci Park, Edinburgh, Midlothian, Scotland; [Wuethrich, Rudolf P.] Univ Spital Zurich, Clin Nephrol, Zurich, Switzerland; [Hock, Christoph] Univ Zurich, Div Psychiat Res, CH-8006 Zurich, Switzerland; [Zerr, Inga] Univ Gottingen, Med Fac, Dept Neurol, Natl TSE Reference Ctr, D-3400 Gottingen, Germany	University of Zurich; University Zurich Hospital; University of Edinburgh; Moredun Research Institute; University of Zurich; University Zurich Hospital; University of Zurich; University of Gottingen	Miele, G (corresponding author), Univ Dundee, Sir James Black Ctr, Translat Med Res Collaborat, Dundee, Scotland.	g.miele@dundee.ac.uk; adriano.aguzzi@usz.ch	Marino, Denis/AAU-7962-2020; Heikenwalder, Mathias/AAA-2269-2020; Aguzzi, Adriano/A-3351-2008; Chianini, Francesca/K-1451-2013	Marino, Denis/0000-0002-5197-6682; Chianini, Francesca/0000-0001-9962-446X; Aguzzi, Adriano/0000-0002-0344-6708	Swiss National Science Foundation; UK Department of Environment, Food and Rural Affairs; EU Framework Programme 6 STREP; Nationale TSE-Forschungsplattform: Etablierung einer nationalen CJD-Probenbank [01KO0101]; CJK-Netz [01 610 301]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); EU Framework Programme 6 STREP; Nationale TSE-Forschungsplattform: Etablierung einer nationalen CJD-Probenbank; CJK-Netz	This work was supported by a grant from the Swiss National Science Foundation (G.M.), and in part by grants from the UK Department of Environment, Food and Rural Affairs (A.A. & G.M.) an EU Framework Programme 6 STREP grant (A.A.) and Nationale TSE-Forschungsplattform: Etablierung einer nationalen CJD-Probenbank (BMBF, 01KO0101) and CJK-Netz (Forschungsnetz zur Verbesserung der Fruh- und Differentialdiagnose der CJK und rasch progressiver Demenzen, BMBF 01 610 301) to Inga Zerr.	ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; BERNOULLI C, 1977, LANCET, V1, P478; Brown AR, 2004, NEUROPATH APPL NEURO, V30, P555, DOI 10.1111/j.1365-2990.2004.00565.x; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; DUGUID JR, 1990, NUCLEIC ACIDS RES, V18, P2789, DOI 10.1093/nar/18.9.2789; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Halimi M, 2006, J VIROL METHODS, V133, P205, DOI 10.1016/j.jviromet.2005.11.011; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; JIMI T, 1992, CLIN CHIM ACTA, V211, P37, DOI 10.1016/0009-8981(92)90103-W; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Kalman J, 2000, ACTA NEUROL SCAND, V101, P279, DOI 10.1034/j.1600-0404.2000.101004279.x; Kariv-Inbal Z, 2005, J NEUROIMMUNOL, V162, P12, DOI 10.1016/j.jneuroim.2004.12.013; LICASTRO F, 1995, ALZ DIS ASSOC DIS, V9, P112, DOI 10.1097/00002093-199509020-00009; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Miele G, 1998, BIOTECHNIQUES, V25, P138, DOI 10.2144/98251rr02; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; PIRTTILA T, 1994, NEUROBIOL AGING, V15, P313, DOI 10.1016/0197-4580(94)90026-4; Piubelli C, 2006, PROTEOMICS, V6, pS256, DOI 10.1002/pmic.200500294; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAPPAPORT EB, 1987, NEUROLOGY, V37, P1520, DOI 10.1212/WNL.37.9.1520; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sanchez JC, 2004, PROTEOMICS, V4, P2229, DOI 10.1002/pmic.200300799; Sanchez-Juan P, 2006, NEUROLOGY, V67, P637, DOI 10.1212/01.wnl.0000230159.67128.00; Serban A, 2004, J BIOL CHEM, V279, P48817, DOI 10.1074/jbc.M409107200; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sun YX, 2003, DEMENT GERIATR COGN, V16, P136, DOI 10.1159/000071001; Tan GD, 2002, DIABETES CARE, V25, P2004, DOI 10.2337/diacare.25.11.2004; TREVISAN A, 1990, AM J IND MED, V17, P637, DOI 10.1002/ajim.4700170508; Wang XY, 2002, NEUROBIOL AGING, V23, P377, DOI 10.1016/S0197-4580(01)00322-0	38	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3870	10.1371/journal.pone.0003870	http://dx.doi.org/10.1371/journal.pone.0003870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057641	Green Published, Green Submitted, gold			2022-12-27	WOS:000265452300008
J	Hartmann, S; Missimer, JH; Stoeckel, C; Abela, E; Shah, J; Seitz, RJ; Weder, BJ				Hartmann, Susanne; Missimer, John H.; Stoeckel, Cornelia; Abela, Eugenio; Shah, Jon; Seitz, Ruediger J.; Weder, Bruno J.			Functional Connectivity in Tactile Object Discrimination-A Principal Component Analysis of an Event Related fMRI-Study	PLOS ONE			English	Article								Background: Tactile object discrimination is an essential human skill that relies on functional connectivity between the neural substrates of motor, somatosensory and supramodal areas. From a theoretical point of view, such distributed networks elude categorical analysis because subtraction methods are univariate. Thus, the aim of this study was to identify the neural networks involved in somatosensory object discrimination using a voxel-based principal component analysis (PCA) of event-related functional magnetic resonance images. Methodology/Principal Findings: Seven healthy, right-handed subjects aged between 22 and 44 years were required to discriminate with their dominant hand the length differences between otherwise identical parallelepipeds in a two-alternative forced-choice paradigm. Of the 34 principal components retained for analysis according to the 'bootstrapped' Kaiser-Guttman criterion, t-tests applied to the subject-condition expression coefficients showed significant mean differences between the object presentation and inter-stimulus phases in PC 1, 3, 26 and 32. Specifically, PC 1 reflected object exploration or manipulation, PC 3 somatosensory and short-term memory processes. PC 26 evinced the perception that certain parallelepipeds could not be distinguished, while PC 32 emerged in those choices when they could be. Among the cerebral regions evident in the PCs are the left posterior parietal lobe and premotor cortex in PC 1, the left superior parietal lobule (SPL) and the right cuneus in PC 3, the medial frontal and orbitofrontal cortex bilaterally in PC 26, and the right intraparietal sulcus, anterior SPL and dorsolateral prefrontal cortex in PC 32. Conclusions/Significance: The analysis provides evidence for the concerted action of large-scale cortico-subcortical networks mediating tactile object discrimination. Parallel to activity in nodes processing object-related impulses we found activity in key cerebral regions responsible for subjective assessment and validation.	[Hartmann, Susanne; Abela, Eugenio; Weder, Bruno J.] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Missimer, John H.] Paul Scherrer Inst, Villigen, Switzerland; [Stoeckel, Cornelia] Univ Oxford, Dept Clin Neurol, FMRIB Ctr, Oxford OX1 2JD, England; [Shah, Jon; Seitz, Ruediger J.] Univ Hosp Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Seitz, Ruediger J.] Res Ctr Julich, Brain Imaging Ctr W, Julich, Germany; [Weder, Bruno J.] Univ Bern, CH-3012 Bern, Switzerland	Kantonsspital St. Gallen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Research Center Julich; University of Bern	Hartmann, S (corresponding author), Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.	bruno.weder@kssg.ch	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Abela, Eugenio/0000-0002-9356-1450; Weder, Bruno/0000-0002-8106-9899	Deutsche Forschungsgemeinschaft [SFB 194]; Swiss National Foundation [3200B0-118018/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Deutsche Forschungsgemeinschaft (SFB 194) and the Swiss National Foundation (SNF 3200B0-118018/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Gene E., 1994, Human Brain Mapping, V2, P79, DOI 10.1002/hbm.460020108; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bernard FA, 2004, NEUROIMAGE, V22, P1704, DOI 10.1016/j.neuroimage.2004.03.036; Binkofski F, 2001, BRAIN, V124, P132, DOI 10.1093/brain/124.1.132; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bohlhalter S, 2002, BRAIN, V125, P2537, DOI 10.1093/brain/awf245; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Gray JR, 2001, J COMP PHYSIOL A, V187, P115, DOI 10.1007/s003590100182; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Hermsdorfer J, 2001, NEUROIMAGE, V14, P149, DOI 10.1006/nimg.2001.0796; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Horwitz Barry, 1994, Human Brain Mapping, V2, P112, DOI 10.1002/hbm.460020111; Iidaka T, 2000, COGNITIVE BRAIN RES, V9, P73, DOI 10.1016/S0926-6410(99)00047-6; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; KOOB GF, 1988, ANN N Y ACAD SCI, V537, P216; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; MOELLER JR, 1987, J CEREBR BLOOD F MET, V7, P649, DOI 10.1038/jcbfm.1987.118; MOELLER JR, 2006, INT J BIOMED IMAG, P1; Molenberghs P, 2007, CEREB CORTEX, V17, P2703, DOI 10.1093/cercor/bhl179; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Picard N, 1997, J NEUROPHYSIOL, V77, P2197, DOI 10.1152/jn.1997.77.4.2197; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; ROLAND PE, 1987, BRAIN RES REV, V12, P1, DOI 10.1016/0165-0173(87)90017-8; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; ROLAND PE, 1993, BRAIN ACTIVATION, P83; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Seitz RJ, 2001, BRAIN RES BULL, V54, P299, DOI 10.1016/S0361-9230(00)00438-X; SEITZ RJ, 1991, EUR J NEUROSCI, V3, P481, DOI 10.1111/j.1460-9568.1991.tb00835.x; Seitz RJ, 2000, EXP BRAIN RES, V133, P71, DOI 10.1007/s002210000402; Seitz Rudiger J, 2003, Adv Neurol, V93, P281; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Smith JF, 2006, NEUROIMAGE, V32, P325, DOI 10.1016/j.neuroimage.2005.12.010; Stoeckel MC, 2004, EUR J NEUROSCI, V19, P1067, DOI 10.1111/j.0953-816X.2004.03185.x; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Talairach J., 1998, COPLANAR STEREOTAXIC; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weder B, 1998, EXP BRAIN RES, V120, P104, DOI 10.1007/s002210050382; Weder B, 2000, HUM BRAIN MAPP, V11, P131, DOI 10.1002/1097-0193(200011)11:3<131::AID-HBM10>3.3.CO;2-D; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Zysset S, 2006, NEUROIMAGE, V31, P1380, DOI 10.1016/j.neuroimage.2006.01.017	70	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3831	10.1371/journal.pone.0003831	http://dx.doi.org/10.1371/journal.pone.0003831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048104	gold, Green Submitted, Green Published			2022-12-27	WOS:000265452000005
J	Managbanag, JR; Witten, TM; Bonchev, D; Fox, LA; Tsuchiya, M; Kennedy, BK; Kaeberlein, M				Managbanag, J. R.; Witten, Tarynn M.; Bonchev, Danail; Fox, Lindsay A.; Tsuchiya, Mitsuhiro; Kennedy, Brian K.; Kaeberlein, Matt			Shortest-Path Network Analysis Is a Useful Approach toward Identifying Genetic Determinants of Longevity	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; YEAST; CELLS; IDENTIFICATION; PROTEINS; SYSTEMS; RETURN; TIME; TOR	Background: Identification of genes that modulate longevity is a major focus of aging-related research and an area of intense public interest. In addition to facilitating an improved understanding of the basic mechanisms of aging, such genes represent potential targets for therapeutic intervention in multiple age-associated diseases, including cancer, heart disease, diabetes, and neurodegenerative disorders. To date, however, targeted efforts at identifying longevity-associated genes have been limited by a lack of predictive power, and useful algorithms for candidate gene-identification have also been lacking. Methodology/Principal Findings: We have utilized a shortest-path network analysis to identify novel genes that modulate longevity in Saccharomyces cerevisiae. Based on a set of previously reported genes associated with increased life span, we applied a shortest-path network algorithm to a pre-existing protein-protein interaction dataset in order to construct a shortest-path longevity network. To validate this network, the replicative aging potential of 88 single-gene deletion strains corresponding to predicted components of the shortest-path longevity network was determined. Here we report that the single-gene deletion strains identified by our shortest-path longevity analysis are significantly enriched for mutations conferring either increased or decreased replicative life span, relative to a randomly selected set of 564 single-gene deletion strains or to the current data set available for the entire haploid deletion collection. Further, we report the identification of previously unknown longevity genes, several of which function in a conserved longevity pathway believed to mediate life span extension in response to dietary restriction. Conclusions/Significance: This work demonstrates that shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity and represents the first application of network analysis of aging to be extensively validated in a biological system. The novel longevity genes identified in this study are likely to yield further insight into the molecular mechanisms of aging and age-associated disease.	[Managbanag, J. R.; Witten, Tarynn M.; Bonchev, Danail] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Bonchev, Danail] Virginia Commonwealth Univ, Dept Math & Applied Math, Richmond, VA 23284 USA; [Fox, Lindsay A.; Tsuchiya, Mitsuhiro; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Managbanag, JR (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA.	tmwitten@vcu.edu; kaeber@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874; Kaeberlein, Matt/0000-0002-1311-3421	University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging; NIH [5P30 AG013280, RO1 AG025549]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG025549, P50AG005136] Funding Source: NIH RePORTER	University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by a pilot award to M.K. from the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging NIH Grant 5P30 AG013280, an award from the Ellison Medical Foundation to B.K.K. and M.K. and by National Institutes of Health Grant RO1 AG025549 to B.K.K. M.K. is an Ellison Medical Foundation New Scholar in Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonchev D, 2004, CHEM BIODIVERS, V1, P312, DOI 10.1002/cbdv.200490028; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MECH AGEING DEV, V123, P1115, DOI 10.1016/S0047-6374(02)00011-8; Kaeberlein M, 2006, HDB MODELS HUMAN AGI, P109; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; STEFFAN KK, 2008, CELL; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; STEINKRAUS KA, 2008, AGING CELL; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; WARD MP, 1994, MOL CELL BIOL, V14, P5619, DOI 10.1128/MCB.14.9.5619; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITTEN M, 1984, MECH AGEING DEV, V27, P323, DOI 10.1016/0047-6374(84)90056-3; WITTEN M, 1985, MECH AGEING DEV, V32, P141, DOI 10.1016/0047-6374(85)90077-6; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; ZHANG LV, 2005, J BIOL LONDON, V4, pNIL1	32	90	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3802	10.1371/journal.pone.0003802	http://dx.doi.org/10.1371/journal.pone.0003802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030232	Green Published, gold, Green Submitted			2022-12-27	WOS:000265451100002
J	Kantor, L; Pinchasi, D; Mintz, M; Hathout, Y; Vanderver, A; Elroy-Stein, O				Kantor, Liraz; Pinchasi, Dalia; Mintz, Michelle; Hathout, Yetrib; Vanderver, Adeline; Elroy-Stein, Orna			A Point Mutation in Translation Initiation Factor 2B Leads to a Continuous Hyper Stress State in Oligodendroglial-Derived Cells	PLOS ONE			English	Article								Background: Mutations in eukaryotic translation initiation factor 2B (eIF2B) cause Childhood Ataxia with CNS Hypomyelination (CACH), also known as Vanishing White Matter disease (VWM). The disease is manifested by loss of brain myelin upon physiological stress. In a previous study, we showed that fibroblasts isolated from CACH/VWM patients are hypersensitive to pharmacologically-induced endoplasmic reticulum (ER) stress. Since brain cells from affected individuals are not available for research, we wished to assess the effect of eIF2B mutation on oligodendroglial-derived cells. Methodology/Principal Findings: A rat oligodendroglial-derived cell line was used for a stable knock-down of eIF2B5 followed by stable expression of mutated eIF2B5(R195H) cDNA. In response to a pharmacological ER-stress agent, eIF2B5(R195H) expressing cells exhibited heightened ER-stress response demonstrated by hyper induction of ATF4, GADD34, Bip, PDIA1, PDIA3, PDIA4 and PDIA6 proteins. Moreover, even in the absence of a pharmacological stress agent, eIF2B5(R195H)-expressing cells exhibited high basal levels of ATF4, GADD34 and ER-associated Bip, PDIA1 and PDIA3. Significance: The data provide evidence that oligodendroglial-derived cells expressing a mutated eIF2B constantly use their stress response mechanism as an adaptation mean in order to survive. The current study is the first to demonstrate the effects of eIF2B5 mutation on ER homeostasis in oligodendroglial-derived cells.	[Kantor, Liraz; Pinchasi, Dalia; Elroy-Stein, Orna] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Mintz, Michelle; Hathout, Yetrib; Vanderver, Adeline] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC USA	Tel Aviv University; Children's National Health System	Kantor, L (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il	Vanderver, Adeline/CAG-5072-2022	Vanderver, Adeline/0000-0002-6290-6751; Elroy-Stein, Orna/0000-0002-3716-1540	European Leukodystrophy Association; Adams Super Center; USA-Israel Bi-National Science Foundation [2003364]; NIH [IDDRC 1P30HD40677, 5R24 HD050846]; Parson family foundation; Children's Health Research Center at Children's National Medical Center [K12HD001399]; American Academy of Neurology Foundation; Postdoctoral Training in Developmental Disabilities Research [5T32HD046388]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, T32HD046388, K12HD001399, P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	European Leukodystrophy Association; Adams Super Center; USA-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parson family foundation; Children's Health Research Center at Children's National Medical Center; American Academy of Neurology Foundation; Postdoctoral Training in Developmental Disabilities Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the European Leukodystrophy Association, Adams Super Center and the USA-Israel Bi-National Science Foundation grant #2003364 (to OES), NIH grants: IDDRC 1P30HD40677 and 5R24 HD050846, Parson family foundation (to YH), the Children's Health Research Center at Children's National Medical Center (#K12HD001399) and the American Academy of Neurology Foundation (to AV), and Postdoctoral Training in Developmental Disabilities Research #5T32HD046388 (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; EIZENBERG O, 1995, EMBO J, V14, P1136, DOI 10.1002/j.1460-2075.1995.tb07097.x; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Hendershot LM, 2004, MT SINAI J MED, V71, P289; HENSEL G, 1994, EUR J CELL BIOL, V63, P208; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kimball SR, 1996, PROG NUCLEIC ACID RE, V54, P165, DOI 10.1016/S0079-6603(08)60363-3; KIMBALL SR, 1994, BBA-GEN SUBJECTS, V1201, P473, DOI 10.1016/0304-4165(94)90079-5; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Paschen W, 2004, J NEUROCHEM, V90, P694, DOI 10.1111/j.1471-4159.2004.02555.x; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schiffmann R, 2006, MOL GENET METAB, V88, P7, DOI 10.1016/j.ymgme.2005.10.019; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	31	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3783	10.1371/journal.pone.0003783	http://dx.doi.org/10.1371/journal.pone.0003783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023445	Green Submitted, Green Published			2022-12-27	WOS:000265448800004
J	Kalaitzidis, D; Neel, BG				Kalaitzidis, Demetrios; Neel, Benjamin G.			Flow-Cytometric Phosphoprotein Analysis Reveals Agonist and Temporal Differences in Responses of Murine Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; BONE-MARROW; STEM-CELLS; THROMBOPOIETIN; EXPRESSION; PROGENITOR; PROLIFERATION	Hematopoietic stem cells (HSCs) are probably the best-studied adult tissue-restricted stem cells. Although methods for flow cytometric detection of phosphoproteins in hematopoeitic progenitors and mature cells are available, analogous protocols for HSC are lacking. We present a robust method to study intracellular signaling in immunophenotypically-defined murine HSC/progenitor cell (HPC)-enriched populations. Using this method, we uncover differences in the response dynamics of several phosphoproteins representative of the Ras/MAP-Kinase(K), PI3K, mTOR and Jak/STAT pathways in HSC/HPCs stimulated by Scf, Thpo, as well as several other important HSC/HPC agonists.	[Kalaitzidis, Demetrios; Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Canc Biol Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kalaitzidis, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA.	dkalaitzidis@partners.org			NIH [5T32-HL07623-20];  [RO1 CA114945];  [R37 CA49152]; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA114945] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.K. was supported by an NIH postdoctoral institutional training grant in Hematology (5T32-HL07623-20). This work was supported by RO1 CA114945 and R37 CA49152 awarded to B.G.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; CHRISTENSEN JL, 2001, P NATL ACAD SCI USA, V198, P305; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Gilner JB, 2007, STEM CELLS, V25, P279, DOI 10.1634/stemcells.2006-0076; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Ku H, 1996, BLOOD, V87, P4544, DOI 10.1182/blood.V87.11.4544.bloodjournal87114544; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sharma Y, 2007, EXP HEMATOL, V35, P214, DOI 10.1016/j.exphem.2006.10.001; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418	28	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3776	10.1371/journal.pone.0003776	http://dx.doi.org/10.1371/journal.pone.0003776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020663	Green Submitted, Green Published, gold			2022-12-27	WOS:000265448600009
J	Jensen, CB; Martin-Gronert, MS; Storgaard, H; Madsbad, S; Vaag, A; Ozanne, SE				Jensen, Christine B.; Martin-Gronert, Malgorzata S.; Storgaard, Heidi; Madsbad, Sten; Vaag, Allan; Ozanne, Susan E.			Altered PI3-Kinase/Akt Signalling in Skeletal Muscle of Young Men with Low Birth Weight	PLOS ONE			English	Article								Background: Low birth weight ( LBW) is associated with increased future risk of insulin resistance and type 2 diabetes mellitus. The underlying molecular mechanisms remain poorly understood. We have previously shown that young LBW men have reduced skeletal muscle expression of PI3K p85 alpha regulatory subunit and p110 beta catalytic subunit, PKC zeta and GLUT4 in the fasting state. The aim of this study was to determine whether insulin activation of the PI3K/Akt and MAPK signalling pathways is altered in skeletal muscle of young adult men with LBW. Methods: Vastus lateralis muscle biopsies were obtained from 20 healthy 19-yr old men with BW</ = 10(th) percentile for gestational age ( LBW) and 20 normal birth weight controls (NBW), matched for physical fitness and whole-body glucose disposal, prior to ( fasting state) and following a 4-hr hyperinsulinemic euglycemic clamp ( insulin stimulated state). Expression and phosphorylation of selected proteins was determined by Western blotting. Principal Findings: Insulin stimulated expression of aPKC zeta (p < 0.001) and Akt1 (p < 0.001) was decreased in muscle of LBW men when compared to insulin stimulated controls. LBW was associated with increased insulin stimulated levels of IRS1 (p < 0.05), PI3K p85 alpha (p < 0.001) and p110 beta (p < 0.05) subunits, while there was no significant change in these proteins in insulin stimulated control muscle. In addition LBW had reduced insulin stimulated phospho-Akt (Ser 473) (p < 0.01), indicative of reduced Akt signalling. Insulin stimulated expression/phosphorylation of all the MAPK proteins studied [p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), phospho-ERK (Thr 202/Tyr204), JNK1, JNK2 and phospho-JNK (Thr 183/Tyr185)] was not different between groups. Conclusions: We conclude that altered insulin activation of the PI3K/Akt but not the MAPK pathway precedes and may contribute to development of whole-body insulin resistance and type 2 diabetes in men with LBW.	[Jensen, Christine B.; Storgaard, Heidi; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Martin-Gronert, Malgorzata S.; Ozanne, Susan E.] Univ Cambridge, Metabol Res Lab, Inst Metabol Sci, Cambridge CB2 1TN, England; [Madsbad, Sten] Hvidovre Univ Hosp, Dept Endocrinol, Copenhagen, Denmark	Steno Diabetes Center; University of Cambridge; University of Copenhagen	Jensen, CB (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	seo10@cam.ac.uk	Jensen, Christine Bjoern/AAG-7900-2020	Vaag, Allan Arthur/0000-0002-3690-2191; Madsbad, Sten/0000-0002-5017-1815; Storgaard, Heidi/0000-0003-1177-2658; Ozanne, Susan/0000-0001-8753-5144	Danish Diabetes Association; British Heart Foundation; AP Moller Foundation for the Advancement of Science; Laegeforeningens Forskningsfond; IMK Almene Fond; Parthenon Trust; Augustinus Fonden; Danish Strategic Research Council; Arvid Nilssons Fond; Biotechnology and Biological Sciences Research Council [BB/E00797X/1] Funding Source: researchfish; BBSRC [BB/E00797X/1] Funding Source: UKRI	Danish Diabetes Association; British Heart Foundation(British Heart Foundation); AP Moller Foundation for the Advancement of Science; Laegeforeningens Forskningsfond; IMK Almene Fond; Parthenon Trust; Augustinus Fonden; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Arvid Nilssons Fond; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Generous funding was provided by The Danish Diabetes Association, The British Heart Foundation, AP Moller Foundation for the Advancement of Science, Laegeforeningens Forskningsfond, IMK Almene Fond, The Parthenon Trust, Augustinus Fonden, The Danish Strategic Research Council and Arvid Nilssons Fond. This work was carried out in the Steno Diabetes Centre, University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; ANDERSEN PH, 1993, J CLIN ENDOCR METAB, V77, P27, DOI 10.1210/jc.77.1.27; Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Cornier MA, 2006, DIABETOLOGIA, V49, P748, DOI 10.1007/s00125-006-0148-0; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Etgen GJ, 1999, J BIOL CHEM, V274, P22139, DOI 10.1074/jbc.274.32.22139; Farese RV, 2005, EXP BIOL MED, V230, P593; Furtado LM, 2002, BIOCHEM CELL BIOL, V80, P569, DOI 10.1139/O02-156; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; HANDBERG A, 1992, DIABETIC MED, V9, P605, DOI 10.1111/j.1464-5491.1992.tb01854.x; Hermann TS, 2003, J CLIN ENDOCR METAB, V88, P1252, DOI 10.1210/jc.2002-021550; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Kensara OA, 2005, AM J CLIN NUTR, V82, P980; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miller BS, 1996, BIOCHEMISTRY-US, V35, P8769, DOI 10.1021/bi952651r; Oak SA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1321, DOI 10.1152/ajpendo.00437.2005; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	45	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3738	10.1371/journal.pone.0003738	http://dx.doi.org/10.1371/journal.pone.0003738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011679	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448300006
J	Schlee, W; Weisz, N; Bertrand, O; Hartmann, T; Elbert, T				Schlee, Winfried; Weisz, Nathan; Bertrand, Olivier; Hartmann, Thomas; Elbert, Thomas			Using Auditory Steady State Responses to Outline the Functional Connectivity in the Tinnitus Brain	PLOS ONE			English	Article								Background: Tinnitus is an auditory phantom perception that is most likely generated in the central nervous system. Most of the tinnitus research has concentrated on the auditory system. However, it was suggested recently that also non-auditory structures are involved in a global network that encodes subjective tinnitus. We tested this assumption using auditory steady state responses to entrain the tinnitus network and investigated long-range functional connectivity across various non-auditory brain regions. Methods and Findings: Using whole-head magnetoencephalography we investigated cortical connectivity by means of phase synchronization in tinnitus subjects and healthy controls. We found evidence for a deviating pattern of long-range functional connectivity in tinnitus that was strongly correlated with individual ratings of the tinnitus percept. Phase couplings between the anterior cingulum and the right frontal lobe and phase couplings between the anterior cingulum and the right parietal lobe showed significant condition x group interactions and were correlated with the individual tinnitus distress ratings only in the tinnitus condition and not in the control conditions. Conclusions: To the best of our knowledge this is the first study that demonstrates existence of a global tinnitus network of long-range cortical connections outside the central auditory system. This result extends the current knowledge of how tinnitus is generated in the brain. We propose that this global extend of the tinnitus network is crucial for the continuos perception of the tinnitus tone and a therapeutical intervention that is able to change this network should result in relief of tinnitus.	[Schlee, Winfried; Weisz, Nathan; Hartmann, Thomas; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany; [Weisz, Nathan; Bertrand, Olivier] INSERM, U821, Lyon, France	University of Konstanz; Institut National de la Sante et de la Recherche Medicale (Inserm)	Schlee, W (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.	Winfried.Schlee@uni-konstanz.de	Schlee, Winfried/C-8983-2011; Weisz, Nathan/K-3325-2015; Elbert, Thomas/C-8556-2009; Bertrand, Olivier/B-6165-2008; Hartmann, Thomas/ABH-6731-2020	Schlee, Winfried/0000-0001-7942-1788; Weisz, Nathan/0000-0001-7816-0037; Elbert, Thomas/0000-0003-1332-4939; Bertrand, Olivier/0000-0003-0733-7979; Hartmann, Thomas/0000-0002-8298-8125; Lauwereyns, Jan/0000-0003-0551-2550				ALAIN C, 2008, CEREB CORTEX; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Dandy WE, 1941, ANN SURG, V114, P336, DOI 10.1097/00000658-194109000-00003; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Dehaene S., 2004, COGNITIVE NEUROSCIEN, VIII; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Goebel G, 1998, INSTRUMENT ERFASSUNG; GOLDMANRAKIC PS, ANN REV NEUROSCI; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; KALIN NH, 2007, BIOL PSYCHIAT; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Morris JS, 2001, J NEUROSCI, V21, P5304, DOI 10.1523/JNEUROSCI.21-14-05304.2001; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; PANTEV C, 1993, ELECTROENCEPHALOGR C; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; SILVERSTEIN H, 1976, LARYNGOSCOPE, V86, P1777, DOI 10.1002/lary.5540861201; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2004, CLIN NEUROPHYSIOL, V115, P1249, DOI 10.1016/j.clinph.2003.12.034; Weisz N, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-8; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023	41	133	137	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3720	10.1371/journal.pone.0003720	http://dx.doi.org/10.1371/journal.pone.0003720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005566	Green Published, Green Submitted, gold			2022-12-27	WOS:000265166200008
J	Hunter, MP; Ismail, N; Zhang, XL; Aguda, BD; Lee, EJ; Yu, LB; Xiao, T; Schafer, J; Lee, MLT; Schmittgen, TD; Nana-Sinkam, SP; Jarjoura, D; Marsh, CB				Hunter, Melissa Piper; Ismail, Noura; Zhang, Xiaoli; Aguda, Baltazar D.; Lee, Eun Joo; Yu, Lianbo; Xiao, Tao; Schafer, Jeffrey; Lee, Mei-Ling Ting; Schmittgen, Thomas D.; Nana-Sinkam, S. Patrick; Jarjoura, David; Marsh, Clay B.			Detection of microRNA Expression in Human Peripheral Blood Microvesicles	PLOS ONE			English	Article							PLATELET-DERIVED MICROVESICLES; HORIZONTAL TRANSFER; ENDOTHELIAL-CELLS; GENE-EXPRESSION; EXOSOMES; MICROPARTICLES; DIFFERENTIATION; METASTASIS; SIGNATURES; INDUCTION	Background: MicroRNAs (miRNA) are small non-coding RNAs that regulate translation of mRNA and protein. Loss or enhanced expression of miRNAs is associated with several diseases, including cancer. However, the identification of circulating miRNA in healthy donors is not well characterized. Microvesicles, also known as exosomes or microparticles, circulate in the peripheral blood and can stimulate cellular signaling. In this study, we hypothesized that under normal healthy conditions, microvesicles contain miRNAs, contributing to biological homeostasis. Methodology/Principal Findings: Microvesicles were isolated from the plasma of normal healthy individuals. RNA was isolated from both the microvesicles and matched mononuclear cells and profiled for 420 known mature miRNAs by real-time PCR. Hierarchical clustering of the data sets indicated significant differences in miRNA expression between peripheral blood mononuclear cells (PBMC) and plasma microvesicles. We observed 71 miRNAs co-expressed between microvesicles and PBMC. Notably, we found 33 and 4 significantly differentially expressed miRNAs in the plasma microvesicles and mononuclear cells, respectively. Prediction of the gene targets and associated biological pathways regulated by the detected miRNAs was performed. The majority of the miRNAs expressed in the microvesicles from the blood were predicted to regulate cellular differentiation of blood cells and metabolic pathways. Interestingly, a select few miRNAs were also predicted to be important modulators of immune function. Conclusions: This study is the first to identify and define miRNA expression in circulating plasma microvesicles of normal subjects. The data generated from this study provides a basis for future studies to determine the predictive role of peripheral blood miRNA signatures in human disease and will enable the definition of the biological processes regulated by these miRNA.	[Hunter, Melissa Piper; Ismail, Noura; Schafer, Jeffrey; Nana-Sinkam, S. Patrick; Marsh, Clay B.] Ohio State Univ, Coll Med, Div Pulm, Columbus, OH 43210 USA; [Ismail, Noura; Marsh, Clay B.] Ohio State Univ, Coll Biol Sci, Mol, Cellular, Dev Biol Program, Columbus, OH 43210 USA; [Zhang, Xiaoli; Yu, Lianbo; Jarjoura, David] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Aguda, Baltazar D.] Ohio State Univ, Coll Med, Math Biosc Inst, Columbus, OH 43210 USA; [Lee, Eun Joo; Schmittgen, Thomas D.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Xiao, Tao] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Lee, Mei-Ling Ting] Univ Maryland, Dept Epidemiol & Biostat, College Pk, MD 20742 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Maryland; University of Maryland College Park	Hunter, MP (corresponding author), Ohio State Univ, Coll Med, Div Pulm, Columbus, OH 43210 USA.	Clay.Marsh@osumc.edu	Piper, Melissa/E-3872-2011; yu, lianbo/B-3472-2010	Xiao, Tao/0000-0002-5477-156X	Battelle Memorial Institute; NHLBI [R01 HL067176]; Parker B. Francis Fellow in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067176] Funding Source: NIH RePORTER	Battelle Memorial Institute; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Fellow in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported through funding from Battelle Memorial Institute and NHLBI grant (R01 HL067176). Dr. M. Piper Hunter is a Parker B. Francis Fellow in Pulmonary Research.	Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; GAL H, 2008, BIOCH BIOPHYS RES CO; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Losche W, 2004, PLATELETS, V15, P109, DOI 10.1080/09537100310001649885; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Majka M, 2007, FOLIA HISTOCHEM CYTO, V45, P27; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Meziani F, 2008, PHARMACOL REP, V60, P75; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Setzer F, 2006, PLATELETS, V17, P571, DOI 10.1080/09537100600760244; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; Zou XH, 2008, CELL RES, V18, DOI 10.1038/cr.2008.171	64	1106	1225	5	205	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3694	10.1371/journal.pone.0003694	http://dx.doi.org/10.1371/journal.pone.0003694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002258	Green Published, Green Submitted, gold			2022-12-27	WOS:000265165600001
J	Riehle, MM; Xu, JN; Lazzaro, BP; Rottschaefer, SM; Coulibaly, B; Sacko, M; Niare, O; Morlais, I; Traore, SF; Vernick, KD				Riehle, Michelle M.; Xu, Jiannong; Lazzaro, Brian P.; Rottschaefer, Susan M.; Coulibaly, Boubacar; Sacko, Madjou; Niare, Oumou; Morlais, Isabelle; Traore, Sekou F.; Vernick, Kenneth D.			Anopheles gambiae APL1 Is a Family of Variable LRR Proteins Required for Rel1-Mediated Protection from the Malaria Parasite, Plasmodium berghei	PLOS ONE			English	Article								Background: We previously identified by genetic mapping an Anopheles gambiae chromosome region with strong influence over the outcome of malaria parasite infection in nature. Candidate gene studies in the genetic interval, including functional tests using the rodent malaria parasite Plasmodium berghei, identified a novel leucine-rich repeat gene, APL1, with functional activity against P. berghei. Principal Findings: Manual reannotation now reveals APL1 to be a family of at least 3 independently transcribed genes, APL1A, APL1B, and APL1C. Functional dissection indicates that among the three known APL1 family members, APL1C alone is responsible for host defense against P. berghei. APL1C functions within the Rel1-Cactus immune signaling pathway, which regulates APL1C transcript and protein abundance. Gene silencing of APL1C completely abolishes Rel1-mediated host protection against P. berghei, and thus the presence of APL1C is required for this protection. Further highlighting the influence of this chromosome region, allelic haplotypes at the APL1 locus are genetically associated with and have high explanatory power for the success or failure of P. berghei parasite infection. Conclusions: APL1C functions as a required transducer of Rel1-dependent immune signal(s) to efficiently protect mosquitoes from P. berghei infection, and allelic genetic haplotypes of the APL1 locus display distinct levels of susceptibility and resistance to P. berghei.	[Riehle, Michelle M.; Xu, Jiannong; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Lazzaro, Brian P.; Rottschaefer, Susan M.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Coulibaly, Boubacar; Sacko, Madjou; Niare, Oumou; Traore, Sekou F.] Univ Bamako, Malaria Res & Train Ctr, Bamako, Mali; [Morlais, Isabelle] Inst Rech pour Devel IRD OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Vernick, Kenneth D.] Inst Pasteur, CNRS, Dept Parasitol & Mycol, Unit Insect Vector Genet & Genom, Paris, France	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University of Bamako; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Riehle, MM (corresponding author), Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA.	kvernick@pasteur.fr	Xu, Jiannong/N-1583-2019; Morlais, Isabelle/F-5078-2014; Morlais, Isabelle/Q-2171-2019	Xu, Jiannong/0000-0001-7332-4370; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670	NIH [AI042361, AI073685]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361, R01AI062995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The reported work was supported by NIH AI042361 and AI073685 to KDV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; NENE V, 2007, SCIENCE; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Vernick KD, 2004, NEW ENGL J MED, V351, P1901, DOI 10.1056/NEJMcibr042899; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x	26	59	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3672	10.1371/journal.pone.0003672	http://dx.doi.org/10.1371/journal.pone.0003672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989366	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134600008
J	Letenneur, L; Peres, K; Fleury, H; Garrigue, I; Barberger-Gateau, P; Helmer, C; Orgogozo, JM; Gauthier, S; Dartigues, JF				Letenneur, Luc; Peres, Karine; Fleury, Herve; Garrigue, Isabelle; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Gauthier, Serge; Dartigues, Jean-Francois			Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study	PLOS ONE			English	Article								Background: Herpes Simplex Virus (HSV) infection has been proposed as a possible risk factor of Alzheimer's Disease (AD) notably because it is neurotropic, ubiquitous in the general population and able to establish lifelong latency in the host. The fact that HSV was present in elderly subjects with AD suggests that the virus could be a co-factor of the disease. We investigated the risk of developing AD in anti-HSV immunoglobulin G (IgG) positive subjects (indicator of a lifelong infection to HSV) and IgM-positive subjects (indicator of primary infection or reactivation of the virus) in a longitudinal population-based cohort of elderly subjects living in the community. Methods: Cox proportional hazard models were used to study the risk of developing AD according to the presence or not of anti-HSV IgG and IgM antibodies, assessed in the sera of 512 elderly initially free of dementia followed for 14 years. Results: During the follow-up, 77 incident AD cases were diagnosed. Controlled for age, gender, educational level and Apolipoprotein E4 (APOE4) status, IgM-positive subjects showed a significant higher risk of developing AD (HR = 2.55; 95% CI [1.38-4.72]), although no significant increased risk was observed in IgG-positive subjects (HR = 1.67; 95% CI [0.75-3.73]). No modification effect with APOE4 status was found. Conclusion: Reactivation of HSV seropositivity is highly correlated with incident AD. HSV chronic infection may therefore be contributive to the progressive brain damage characteristic of AD.	[Letenneur, Luc; Peres, Karine; Fleury, Herve; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] INSERM, U897, Bordeaux, France; [Letenneur, Luc; Peres, Karine; Fleury, Herve; Garrigue, Isabelle; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] Univ Victor Segalen Bordeaux 2, Bordeaux, France; [Garrigue, Isabelle] Univ Victor Segalen Bordeaux 2, Lab Virol, Bordeaux, France; [Gauthier, Serge] McGill Univ, Ctr Studies Aging, Montreal, PQ H3A 2T5, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; McGill University	Letenneur, L (corresponding author), INSERM, U897, Bordeaux, France.	luc.letenneur@inserm.fr	LETENNEUR, Luc/T-4424-2019; PERES, Karine/T-4128-2019; HELMER, Catherine/AAG-5126-2021; Garrigue, isabelle/AGZ-8837-2022; HELMER, Catherine/I-6581-2015; DARTIGUES, Jean François/T-4513-2019	LETENNEUR, Luc/0000-0002-3274-937X; PERES, Karine/0000-0002-0720-0684; HELMER, Catherine/0000-0002-5169-7421; 	Fondation de France; Novartis Laboratories; IPSEN laboratories; Conseil General de la Gironde; Conseil Regional d'Aquitaine; SCOR Insurance (France)	Fondation de France(Fondation de France); Novartis Laboratories; IPSEN laboratories(Ipsen); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); SCOR Insurance (France)	The PAQUID study was supported by grants from Fondation de France, Novartis Laboratories, IPSEN laboratories, Conseil General de la Gironde, Conseil Regional d'Aquitaine, SCOR Insurance (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; APA, 1987, DIAGN STAT MAN MENT, V3rd; Beffert U, 1998, LANCET, V351, P1330, DOI 10.1016/S0140-6736(05)79057-7; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10; Chaudhuri A, 2002, POSTGRAD MED J, V78, P575, DOI 10.1136/pmj.78.924.575; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; FORSGREN M, 1989, SERODIAG IMMUN INF D, V3, P259, DOI 10.1016/0888-0786(89)90006-1; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki Ruth, 2004, Herpes, V11 Suppl 2, p77A; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Kammerman EM, 2006, MED HYPOTHESES, V66, P294, DOI 10.1016/j.mehy.2005.07.033; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Knipe D.M., 2001, FIELDS VIROLOGY; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x; OUNANIAN A, 1990, J CLIN LAB ANAL, V4, P367, DOI 10.1002/jcla.1860040510; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pyles R B, 2001, Herpes, V8, P64; RENVOIZE EB, 1987, AGE AGEING, V16, P311, DOI 10.1093/ageing/16.5.311; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; Thackray AM, 2004, J VIROL, V78, P13697, DOI 10.1128/JVI.78.24.13697-13707.2004; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	28	154	163	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3637	10.1371/journal.pone.0003637	http://dx.doi.org/10.1371/journal.pone.0003637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982063	Green Published, gold			2022-12-27	WOS:000265134300007
J	Mouw, T; Koster, A; Wright, ME; Blank, MM; Moore, SC; Hollenbeck, A; Schatzkin, A				Mouw, Traci; Koster, Annemarie; Wright, Margaret E.; Blank, Madeleine M.; Moore, Steven C.; Hollenbeck, Albert; Schatzkin, Arthur			Education and Risk of Cancer in a Large Cohort of Men and Women in the United States	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ASSOCIATION; ALCOHOL; HEALTH; LEVEL; DIET	Background: Education inequalities in cancer incidence have long been noted. It is not clear, however, whether such inequalities persist in the United States, especially for less common malignancies and after adjustment for individual risk factors. Methodology/Principal Findings: Within the NIH-AARP Diet and Health Study, we examined the association between education and the risk of developing cancers in a prospective cohort of 498 455 participants who were 50-71 year old and without cancer at enrollment in 1995/96. During a maximum 8.2 years of follow-up we identified 40 443 cancers in men and 18 367 in women. In age-adjusted models, the least educated men (, high school), compared to those with the most education (post-graduate), had increased risks of developing cancers of the esophagus (RR: 2.64, 95% CI: 1.86-3.75), head and neck ( 1.98, 1.54-2.54), stomach (2.32, 1.68-3.18), colon (1.31, 1.12-1.53), rectum (1.68, 1.32-2.13), liver (1.90, 1.22-2.95), lung (3.67, 3.25-4.15), pleura (4.01, 1.91-8.42), bladder (1.56, 1.33-1.83) and combined smoking-related cancers (2.41, 2.22-2.62). In contrast, lower education level was associated with a decreased risk of melanoma of the skin (0.43, 0.35-0.54) and local prostate cancers (0.79, 0.74-0.85). Women with the least education had increased risks of colon (1.60, 1.24-2.05), lung (2.14, 1.79-2.56), kidney (1.68, 1.12-2.54) and combined smoking-related cancers (1.66, 1.43-1.92) but a lower risk of melanoma of the skin (0.33, 0.22-0.51), endometrial (0.67, 0.51-0.89) and invasive breast cancers (0.72, 0.61-0.84). Adjustment for smoking and other risk factors did not eliminate these associations, except those for cancers of the head and neck, colon, and liver in men and kidney in women. Conclusions/Significance: We found a higher risk of malignant disease, particularly smoking-related cancers, among those in the lowest educational attainment category. Only some of the educational gradient is attributable to smoking. The persistence of substantial education inequalities in cancer incidence poses a challenge for etiologic research and public health policy.	[Mouw, Traci] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, Fac Med, London, England; [Koster, Annemarie] NIA, Lab Epidemiol, Demography, & Biomet, NIH, Bethesda, MD USA; [Koster, Annemarie] Univ Maastricht, Fac Hlth, Med & Life Sci, Maastricht, Netherlands; [Wright, Margaret E.] Univ Illinois, Dept Pathol, Chicago, IL 60680 USA; [Blank, Madeleine M.; Moore, Steven C.; Schatzkin, Arthur] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD USA; [Hollenbeck, Albert] AARP, Washington, DC USA	Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Mouw, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, Fac Med, London, England.	schatzka@mail.nih.gov	Moore, Steven/D-8760-2016; Koster, Annemarie/E-7438-2010; Hollenbeck, Albert/AAG-9461-2020	Moore, Steven/0000-0002-8169-1661; Koster, Annemarie/0000-0003-1583-7391; Wright, Margaret/0000-0002-4410-4157	Intramural Research Programs at the National Cancer Institute; National Institute on Aging, NIH; NATIONAL CANCER INSTITUTE [Z01CP010196] Funding Source: NIH RePORTER	Intramural Research Programs at the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported (in part) by the Intramural Research Programs at the National Cancer Institute and the National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; BERKMAN LF, 1997, IARC SCI PUBL, V5164; Braaten T, 2005, CANCER EPIDEM BIOMAR, V14, P2591, DOI 10.1158/1055-9965.EPI-05-0345; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dano H, 2003, INT J EPIDEMIOL, V32, P218, DOI 10.1093/ije/dyg049; FAGGIANO F, 1994, J EPIDEMIOL COMMUN H, V48, P447, DOI 10.1136/jech.48.5.447; FAGGIANO F, 1997, IARC SCI PUBL; Freedman ND, 2007, BRIT J CANCER, V96, P1469, DOI 10.1038/sj.bjc.6603713; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Harrison RA, 1998, ANN EPIDEMIOL, V8, P327, DOI 10.1016/S1047-2797(97)00231-7; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P796; Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284; Louwman WJ, 2004, EUR J CANCER PREV, V13, P119, DOI 10.1097/00008469-200404000-00005; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; NAGEL G, 2007, INT J EPIDEMIOL; Pamuk E., 1998, SOCIOECONOMIC STATUS; Price B, 1997, AM J EPIDEMIOL, V145, P211, DOI 10.1093/oxfordjournals.aje.a009093; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; SCHOTTENFELD D, 2006, CANC EPIDEMIOLOGY PR, P174; Stolzenberg-Solomon RZ, 2006, AM J EPIDEMIOL, V163, pS109, DOI 10.1093/aje/163.suppl_11.S109-b; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; 2007, SURVEILLANCE EPIDEMI	23	71	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3639	10.1371/journal.pone.0003639	http://dx.doi.org/10.1371/journal.pone.0003639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LJ	18982064	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134300009
J	Druce, DJ; Shannon, G; Page, BR; Grant, R; Slotow, R				Druce, Dave J.; Shannon, Graeme; Page, Bruce R.; Grant, Rina; Slotow, Rob			Ecological Thresholds in the Savanna Landscape: Developing a Protocol for Monitoring the Change in Composition and Utilisation of Large Trees	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; WOODY VEGETATION; REGIME SHIFTS; LOW RAINFALL; ELEPHANTS; WOODLANDS; IMPACT; FIRE; PERTURBATIONS; BIODIVERSITY	Background: Acquiring greater understanding of the factors causing changes in vegetation structure-particularly with the potential to cause regime shifts - is important in adaptively managed conservation areas. Large trees (>= 5 m in height) play an important ecosystem function, and are associated with a stable ecological state in the African savanna. There is concern that large tree densities are declining in a number of protected areas, including the Kruger National Park, South Africa. In this paper the results of a field study designed to monitor change in a savanna system are presented and discussed. Methodology/Principal Findings: Developing the first phase of a monitoring protocol to measure the change in tree species composition, density and size distribution, whilst also identifying factors driving change. A central issue is the discrete spatial distribution of large trees in the landscape, making point sampling approaches relatively ineffective. Accordingly, fourteen 10 m wide transects were aligned perpendicular to large rivers (3.0-6.6 km in length) and eight transects were located at fixed-point photographic locations (1.0-1.6 km in length). Using accumulation curves, we established that the majority of tree species were sampled within 3 km. Furthermore, the key ecological drivers (e. g. fire, herbivory, drought and disease) which influence large tree use and impact were also recorded within 3 km. Conclusions/Significance: The technique presented provides an effective method for monitoring changes in large tree abundance, size distribution and use by the main ecological drivers across the savanna landscape. However, the monitoring of rare tree species would require individual marking approaches due to their low densities and specific habitat requirements. Repeat sampling intervals would vary depending on the factor of concern and proposed management mitigation. Once a monitoring protocol has been identified and evaluated, the next stage is to integrate that protocol into a decision-making system, which highlights potential leading indicators of change. Frequent monitoring would be required to establish the rate and direction of change. This approach may be useful in generating monitoring protocols for other dynamic systems.	[Druce, Dave J.; Shannon, Graeme; Page, Bruce R.; Slotow, Rob] Univ KwaZulu Natal, Amarula Elephant Res Programme, Durban, South Africa; [Grant, Rina] Kruger Natl Pk, Sci Serv, Skukuza, South Africa	University of Kwazulu Natal	Druce, DJ (corresponding author), Univ KwaZulu Natal, Amarula Elephant Res Programme, Westville Campus, Durban, South Africa.	shannongraeme@gmail.com	Shannon, Graeme/A-5790-2011; Slotow, Rob/AAM-9053-2020; Page, Bruce R/G-1245-2010	Shannon, Graeme/0000-0002-5039-4904; Page, Bruce R/0000-0001-7979-5229; Druce, Dave/0000-0003-2976-6029; Slotow, Rob/0000-0001-9469-1508	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation [FA2006032300024]	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation	Distell (Pty) Ltd funded the study through a donation to the Amarula Elephant Research Programme, University of KwaZulu-Natal. This donation paid for the fieldwork component of the study. UKZN and the National Research Foundation (grant FA2006032300024) provided post-doctoral funding for DD and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderies JM, 2002, ECOSYSTEMS, V5, P23, DOI 10.1007/s10021-001-0053-9; Baxter PWJ, 2005, ECOL APPL, V15, P1331, DOI 10.1890/02-5382; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BenShahar R, 1996, J TROP ECOL, V12, P505, DOI 10.1017/S0266467400009731; Biggs H. C., 2003, KRUGER EXPERIENCE EC, P59; BIGGS HC, 2008, ASSESSMENT S AFRICAN, P278; Birkett A, 2005, AFR J ECOL, V43, P123, DOI 10.1111/j.1365-2028.2005.00555.x; Bowland JM, 1997, S AFR J WILDL RES, V27, P31; BUECHNER HK, 1961, ECOLOGY, V42, P752, DOI 10.2307/1933504; Calenge C, 2002, J TROP ECOL, V18, P599, DOI 10.1017/S0266467402002390; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Coetzee B.J., 1979, Koedoe, V22, P39; Cumming DHM, 1997, S AFR J SCI, V93, P231; Cumming GS, 2006, ECOL SOC, V11; de Beer Y, 2006, J ARID ENVIRON, V64, P412, DOI 10.1016/j.jaridenv.2005.06.015; Dean WRJ, 1999, J ARID ENVIRON, V41, P61, DOI 10.1006/jare.1998.0455; Drury KLS, 2007, THEOR POPUL BIOL, V72, P153, DOI 10.1016/j.tpb.2007.03.010; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Duffy KJ, 2002, S AFR J WILDL RES, V32, P23; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gillson Lindsey, 2004, Ecological Complexity, V1, P281, DOI 10.1016/j.ecocom.2004.06.001; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Holdo RM, 2006, J VEG SCI, V17, P369, DOI 10.1111/j.1654-1103.2006.tb02457.x; JACHMANN H, 1985, AFR J ECOL, V23, P245, DOI 10.1111/j.1365-2028.1985.tb00955.x; Jacobs OS, 2002, S AFR J WILDL RES, V32, P13; KERLEY GIH, 2008, ASSESSMENT S AFRICAN, P101; *KRUG NAT PARK, 2008, PARK MAN PLAN; Landman M, 2008, J ZOOL, V274, P51, DOI 10.1111/j.1469-7998.2007.00356.x; LAWS RM, 1970, OIKOS, V21, P1, DOI 10.2307/3543832; Low AB, 1996, VEGETATION S AFRICAN; Ludwig F, 2008, OECOLOGIA, V155, P487, DOI 10.1007/s00442-007-0878-9; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Mapaure IN, 2002, AFR J ECOL, V40, P212, DOI 10.1046/j.1365-2028.2002.00355.x; Mosugelo DK, 2002, AFR J ECOL, V40, P232, DOI 10.1046/j.1365-2028.2002.00361.x; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Penzhorn B.L., 1974, Koedoe, V17, P137; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Reyers B, 2007, S AFR J SCI, V103, P295; SHANNON G, SPATIAL SCALE UNPUB; Shannon G, 2008, J TROP ECOL, V24, P281, DOI 10.1017/S0266467408004951; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; SWANEPOEL CM, 1993, AFR J ECOL, V31, P220, DOI 10.1111/j.1365-2028.1993.tb00535.x; Van de Vijver CADM, 1999, J TROP ECOL, V15, P545, DOI 10.1017/S0266467499001017; van Essen LD, 2002, AFR J ECOL, V40, P76, DOI 10.1046/j.0141-6707.2001.00339.x; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Wyk P., 1969, Koedoe, VNo. 12, P57; Venter F. J., 1986, Koedoe, V29, P125; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Walker B, 1998, WILDLIFE RES, V25, P1, DOI 10.1071/WR97030; Whyte I. J., 1999, Koedoe, V42, P111; Whyte I.J., 2007, RESULTS 2006 2007 CE; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Wiseman R, 2004, S AFR J WILDL RES, V34, P25	57	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3979	10.1371/journal.pone.0003979	http://dx.doi.org/10.1371/journal.pone.0003979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092993	Green Submitted, gold, Green Published			2022-12-27	WOS:000265458600012
J	Lee, S; Kasif, S; Weng, ZP; Cantor, CR				Lee, Soohyun; Kasif, Simon; Weng, Zhiping; Cantor, Charles R.			Quantitative Analysis of Single Nucleotide Polymorphisms within Copy Number Variation	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; SEGMENTAL DUPLICATIONS; SEQUENCE VARIATION; GENOTYPING ERRORS; GENE CONVERSION; DEVIATIONS; ADMIXTURE; DETECT; MAP	Background: Single nucleotide polymorphisms (SNPs) have been used extensively in genetics and epidemiology studies. Traditionally, SNPs that did not pass the Hardy-Weinberg equilibrium (HWE) test were excluded from these analyses. Many investigators have addressed possible causes for departure from HWE, including genotyping errors, population admixture and segmental duplication. Recent large-scale surveys have revealed abundant structural variations in the human genome, including copy number variations (CNVs). This suggests that a significant number of SNPs must be within these regions, which may cause deviation from HWE. Results: We performed a Bayesian analysis on the potential effect of copy number variation, segmental duplication and genotyping errors on the behavior of SNPs. Our results suggest that copy number variation is a major factor of HWE violation for SNPs with a small minor allele frequency, when the sample size is large and the genotyping error rate is 0 similar to 1%. Conclusions: Our study provides the posterior probability that a SNP falls in a CNV or a segmental duplication, given the observed allele frequency of the SNP, sample size and the significance level of HWE testing.	[Lee, Soohyun; Kasif, Simon; Weng, Zhiping; Cantor, Charles R.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kasif, Simon; Weng, Zhiping; Cantor, Charles R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kasif, Simon] Harvard Univ, MIT Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Cantor, Charles R.] Sequenom Inc, San Diego, CA USA; [Weng, Zhiping] Univ Massachusetts, Worcester, MA USA	Boston University; Boston University; Harvard University; Boston Children's Hospital; Sequenom; University of Massachusetts System; University of Massachusetts Worcester	Lee, S (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	zhiping@umassmed.edu; ccantor@sequenom.com		Lee, Soohyun/0000-0002-3594-6213	Sequenom [R01 GM080625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080625] Funding Source: NIH RePORTER	Sequenom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM080625 & Sequenom Support	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Council N. R., 1996, EV FOR DNA EV; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Deng HW, 2001, GENETICS, V157, P885; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Olson JM, 1996, BIOMETRICS, V52, P971, DOI 10.2307/2533058; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shoemaker J, 1998, GENETICS, V149, P2079; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; Weir BS., 1996, GENETIC DATA ANAL; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; ZOGOPOULOS G, 2007, HUM GENET	33	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3906	10.1371/journal.pone.0003906	http://dx.doi.org/10.1371/journal.pone.0003906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093001	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458600001
J	Beyrouthy, MJ; Alexander, KE; Baldwin, A; Whitfield, ML; Bass, HW; McGee, D; Hurt, MM				Beyrouthy, Maroun J.; Alexander, Karen E.; Baldwin, Amy; Whitfield, Michael L.; Bass, Hank W.; McGee, Dan; Hurt, Myra M.			Identification of G1-Regulated Genes in Normally Cycling Human Cells	PLOS ONE			English	Article								Background: Obtaining synchronous cell populations is essential for cell-cycle studies. Methods such as serum withdrawal or use of drugs which block cells at specific points in the cell cycle alter cellular events upon re-entry into the cell cycle. Regulatory events occurring in early G1 phase of a new cell cycle could have been overlooked. Methodology and Findings: We used a robotic mitotic shake-off apparatus to select cells in late mitosis for genome-wide gene expression studies. Two separate microarray experiments were conducted, one which involved isolation of RNA hourly for several hours from synchronous cell populations, and one experiment which examined gene activity every 15 minutes from late telophase of mitosis into G1 phase. To verify synchrony of the cell populations under study, we utilized methods including BrdU uptake, FACS, and microarray analyses of histone gene activity. We also examined stress response gene activity. Our analysis enabled identification of 200 early G1-regulated genes, many of which currently have unknown functions. We also confirmed the expression of a set of genes candidates (fos, atf3 and tceb) by qPCR to further validate the newly identified genes. Conclusion and Significance: Genome-scale expression analyses of the first two hours of G1 in naturally cycling cells enabled the discovery of a unique set of G1-regulated genes, many of which currently have unknown functions, in cells progressing normally through the cell division cycle. This group of genes may contain future targets for drug development and treatment of human disease.	[Alexander, Karen E.; Hurt, Myra M.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Baldwin, Amy] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Baldwin, Amy] Brigham and Womens Hosp, Channing Lab, Boston, MA USA; [Whitfield, Michael L.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Hanover, NH USA; [Beyrouthy, Maroun J.; Bass, Hank W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Beyrouthy, Maroun J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH USA; [McGee, Dan] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; Harvard University; Harvard Medical School; Dartmouth College; Norris Cotton Cancer Center; State University System of Florida; Florida State University; Dartmouth College; State University System of Florida; Florida State University	Beyrouthy, MJ (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	myra.hurt@med.fsu.edu	Bass, Hank W./I-4962-2012; Whitfield, Michael/AAC-5010-2020	Bass, Hank W./0000-0003-0522-0881; 	HHMI; V Foundation for Cancer Research; Scleroderma Research Foundation; Florida Division of the American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA130795] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); V Foundation for Cancer Research; Scleroderma Research Foundation; Florida Division of the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MLW has been supported by HHMI, and by grants from the V Foundation for Cancer Research and the Scleroderma Research Foundation. This work was supported in part by a grant to MMH from the Florida Division of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Ashihara T, 1979, Methods Enzymol, V58, P248; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BECKER JF, 1979, CHEM-BIOL INTERACT, V26, P257, DOI 10.1016/0009-2797(79)90029-2; Blanchard JM, 2000, BIOCHEM PHARMACOL, V60, P1179, DOI 10.1016/S0006-2952(00)00384-1; BOWMAN TL, 1995, NUCLEIC ACIDS RES, V23, P3083, DOI 10.1093/nar/23.16.3083; Bravo R, 1990, Semin Cancer Biol, V1, P37; BRUSH D, 1985, MOL CELL BIOL, V5, P1307, DOI 10.1128/MCB.5.6.1307; CAMPISI J, 1984, EXP CELL RES, V152, P459, DOI 10.1016/0014-4827(84)90647-5; Cui WC, 2001, MOL BIOL REP, V28, P123, DOI 10.1023/A:1015288412047; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EICHENLAUBRITTER U, 1989, CYTOGENET CELL GENET, V52, P170, DOI 10.1159/000132871; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GRAVES RA, 1985, P NATL ACAD SCI USA, V82, P5685, DOI 10.1073/pnas.82.17.5685; HATCH CL, 1990, J BIOL CHEM, V265, P15211; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; HURT MM, 1991, MOL CELL BIOL, V11, P2929, DOI 10.1128/MCB.11.6.2929; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Ji C, 1997, ONCOGENE, V15, P2749, DOI 10.1038/sj.onc.1201441; Kaarniranta K, 2003, BIORHEOLOGY, V40, P87; Kaludov NK, 1996, P NATL ACAD SCI USA, V93, P4465, DOI 10.1073/pnas.93.9.4465; Kaysen JH, 1999, J MEMBRANE BIOL, V168, P77; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kothapalli D, 2000, J CELL PHYSIOL, V182, P119, DOI 10.1002/(SICI)1097-4652(200001)182:1<119::AID-JCP13>3.0.CO;2-4; Liu BC, 2006, NEPHRON EXP NEPHROL, V103, P16, DOI 10.1159/000090504; LONGIARU M, 1979, NUCLEIC ACIDS RES, V6, P3369, DOI 10.1093/nar/6.10.3369; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; MIRONESCU S, 1977, J CELL PHYSIOL, V90, P281, DOI 10.1002/jcp.1040900214; Myokai F, 2003, J PERIODONTAL RES, V38, P255, DOI 10.1034/j.1600-0765.2003.00602.x; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; PEHRSON JR, 1982, BIOCHEMISTRY-US, V21, P456, DOI 10.1021/bi00532a006; Peng D, 1996, CANCER RES, V56, P3666; PICKERING SJ, 1987, HUM REPROD, V2, P207, DOI 10.1093/oxfordjournals.humrep.a136516; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHNEIDERMAN MH, 1972, EXP CELL RES, V74, P430, DOI 10.1016/0014-4827(72)90398-9; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SEYFERT VL, 1990, J IMMUNOL, V145, P3647; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shin HY, 2002, PHYSIOL GENOMICS, V11, P245, DOI 10.1152/physiolgenomics.00068.2002; STEIN G, HISTONE GENES STRUCT, P281; Takita M, 2003, CYTOM PART A, V55A, P24, DOI 10.1002/cyto.a.10066; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; Tessema M, 2004, VIRCHOWS ARCH, V444, P313, DOI 10.1007/s00428-003-0971-3; Wahab NA, 2002, J AM SOC NEPHROL, V13, P2437, DOI 10.1097/01.ASN.0000031828.58276.02; WELLS D, 1985, P NATL ACAD SCI USA, V82, P2834, DOI 10.1073/pnas.82.9.2834; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; ZIMMERMAN RJ, 1981, CARCINOGENESIS, V2, P1303, DOI 10.1093/carcin/2.12.1303	57	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3943	10.1371/journal.pone.0003943	http://dx.doi.org/10.1371/journal.pone.0003943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079774	Green Published, gold			2022-12-27	WOS:000265458200007
J	Ullrich, RT; Zander, T; Neumaier, B; Koker, M; Shimamura, T; Waerzeggers, Y; Borgman, CL; Tawadros, S; Li, HF; Sos, ML; Backes, H; Shapiro, GI; Wolf, J; Jacobs, AH; Thomas, RK; Winkeler, A				Ullrich, Roland T.; Zander, Thomas; Neumaier, Bernd; Koker, Mirjam; Shimamura, Takeshi; Waerzeggers, Yannic; Borgman, Christa L.; Tawadros, Samir; Li, Hongfeng; Sos, Martin L.; Backes, Heiko; Shapiro, Geoffrey I.; Wolf, Juergen; Jacobs, Andreas H.; Thomas, Roman K.; Winkeler, Alexandra			Early Detection of Erlotinib Treatment Response in NSCLC by 3 '-Deoxy-3 '-[F-18]-Fluoro-L-Thymidine ([F-18]FLT) Positron Emission Tomography (PET)	PLOS ONE			English	Article								Background: Inhibition of the epidermal growth factor receptor ( EGFR) has shown clinical success in patients with advanced non-small cell lung cancer (NSCLC). Somatic mutations of EGFR were found in lung adenocarcinoma that lead to exquisite dependency on EGFR signaling; thus patients with EGFR-mutant tumors are at high chance of response to EGFR inhibitors. However, imaging approaches affording early identification of tumor response in EGFR-dependent carcinomas have so far been lacking. Methodology/Principal Findings: We performed a systematic comparison of 39-Deoxy-39-[18F]-fluoro-L-thymidine ([F-18]FLT) and 2-[F-18]-fluoro-2-deoxy-D-glucose ([F-18]FDG) positron emission tomography (PET) for their potential to identify response to EGFR inhibitors in a model of EGFR-dependent lung cancer early after treatment initiation. While erlotinib-sensitive tumors exhibited a striking and reproducible decrease in [F-18]FLT uptake after only two days of treatment, [F-18]FDG PET based imaging revealed no consistent reduction in tumor glucose uptake. In sensitive tumors, a decrease in [F-18]FLT PET but not [F-18]FDG PET uptake correlated with cell cycle arrest and induction of apoptosis. The reduction in [F-18]FLT PET signal at day 2 translated into dramatic tumor shrinkage four days later. Furthermore, the specificity of our results is confirmed by the complete lack of [F-18]FLT PET response of tumors expressing the T790M erlotinib resistance mutation of EGFR. Conclusions: [F-18]FLT PET enables robust identification of erlotinib response in EGFR-dependent tumors at a very early stage. [F-18]FLT PET imaging may represent an appropriate method for early prediction of response to EGFR TKI treatment in patients with NSCLC.	[Neumaier, Bernd; Koker, Mirjam; Waerzeggers, Yannic; Li, Hongfeng; Sos, Martin L.; Backes, Heiko; Jacobs, Andreas H.; Thomas, Roman K.; Winkeler, Alexandra] Univ Cologne, Max Planck Inst Neurol Res, Max Planck Soc, Fac Med,Klaus Joachim Zulch Labs, Cologne, Germany; [Ullrich, Roland T.; Jacobs, Andreas H.; Winkeler, Alexandra] Ctr Mol Med Cologne CMMC, Cologne, Germany; [Jacobs, Andreas H.] Klin Fulda, Fulda, Germany; [Shimamura, Takeshi; Borgman, Christa L.; Shapiro, Geoffrey I.] Harvard Univ, Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Med Oncol, Boston, MA USA; [Shimamura, Takeshi; Borgman, Christa L.; Shapiro, Geoffrey I.] Harvard Univ, Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Zander, Thomas; Tawadros, Samir; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Dept Internal Med I, D-5000 Cologne, Germany; [Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany	Max Planck Society; University of Cologne; University of Cologne; Klinikum Fulda; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cologne; Max Planck Society	Ullrich, RT (corresponding author), Univ Cologne, Max Planck Inst Neurol Res, Max Planck Soc, Fac Med,Klaus Joachim Zulch Labs, Cologne, Germany.	nini@nf.mpg.de	Sos, Martin L/I-1852-2014; Winkeler, Alexandra/B-7436-2014; Jacobs, Andreas H./AAA-6794-2020; Neumaier, Bernd/G-7058-2019	Winkeler, Alexandra/0000-0003-3397-2570; Neumaier, Bernd/0000-0001-5425-3116	Koeln Fortune Program, University of Cologne; International Association for the Study of Lung Cancer (IASLC) [fellow]; Deutsche Krebshilfe [107954]; German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program; 6th FW EU grant EMIL [LSHC-CT-2004-503569]; EC-FP6-Project DiMI [LSHB-CT-2005-512146]; EC-FP6-Clinigene [LSBH-CT-06-018933]	Koeln Fortune Program, University of Cologne; International Association for the Study of Lung Cancer (IASLC); Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program; 6th FW EU grant EMIL; EC-FP6-Project DiMI(European Commission); EC-FP6-Clinigene	RTU is supported by the Koeln Fortune Program, University of Cologne. RTK is a fellow of the International Association for the Study of Lung Cancer (IASLC). This work was supported by the Deutsche Krebshilfe through grant 107954 to RTK and by the German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program. YW, AHJ and AW are supported by the 6th FW EU grant EMIL (LSHC-CT-2004-503569), EC-FP6-Project DiMI (LSHB-CT-2005-512146) and EC-FP6-Clinigene (LSBH-CT-06-018933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck AK, 2002, CANCER RES, V62, P3331; Fueger BJ, 2006, J NUCL MED, V47, P999; HAMACHER K, 1986, J NUCL MED, V27, P235; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machulla HJ, 2000, J RADIOANAL NUCL CH, V243, P843, DOI 10.1023/A:1010684101509; Moyer JD, 1997, CANCER RES, V57, P4838; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Schiffer WK, 2007, J NUCL MED, V48, P277; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Solit DB, 2007, CANCER RES, V67, P11463, DOI 10.1158/0008-5472.CAN-07-2976; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THOMAS RK, 2007, NAT GENET; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Toyohara J, 2002, NUCL MED BIOL, V29, P281, DOI 10.1016/S0969-8051(02)00286-X; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Weber WA, 2003, NUKLEARMED-NUCL MED, V42, P135	20	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3908	10.1371/journal.pone.0003908	http://dx.doi.org/10.1371/journal.pone.0003908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079597	gold, Green Published, Green Submitted			2022-12-27	WOS:000265456300001
J	Mcintyre, GJ; Groneman, JL; Tran, A; Applegate, TL				Mcintyre, Glen John; Groneman, Jennifer Lynne; Tran, Anna; Applegate, Tanya Lynn			An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA	PLOS ONE			English	Article								Vector construction with restriction enzymes (REs) typically involves the ligation of a digested donor fragment (insert) to a reciprocally digested recipient fragment (vector backbone). Creating a suitable cloning plan becomes increasingly difficult for complex strategies requiring repeated insertions such as constructing multiple short hairpin RNA (shRNA) expression vectors for RNA interference (RNAi) studies. The problem lies in the reduced availability of suitable RE recognition sites with an increasing number of cloning events and or vector size. This report details a technically simple, directional cloning solution using REs with compatible cohesive ends that are repeatedly destroyed and simultaneously re-introduced with each round of cloning. Donor fragments can be made by PCR or sub-cloned from pre-existing vectors and inserted ad infinitum in any combination. The design incorporates several cloning cores in order to be compatible with as many donor sequences as possible. We show that joining sub-combinations made in parallel is more time-efficient than sequential construction (of one cassette at a time) for any combination of 4 or more insertions. Screening for the successful construction of combinations using Taq polymerase based PCR became increasingly difficult with increasing number of repeated sequence elements. A Pfu polymerase based PCR was developed and successfully used to amplify combinations of up to eleven consecutive hairpin expression cassettes. The identified PCR conditions can be beneficial to others working with multiple shRNA or other repeated sequences, and the infinitely expandable cloning strategy serves as a general solution applicable to many cloning scenarios.	[Mcintyre, Glen John; Groneman, Jennifer Lynne; Tran, Anna; Applegate, Tanya Lynn] Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia	Johnson & Johnson	Mcintyre, GJ (corresponding author), Johnson & Johnson Res Pty Ltd, Australian Technol Pk, Eveleigh, NSW, Australia.	glen@madebyglen.com		Applegate, Tanya/0000-0002-8657-4261	Johnson and Johnson Research	Johnson and Johnson Research	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Johnson and Johnson Research was the company for which the three authors were working for at the time of the research. JJR also funded the open access payment fee. There is no advantage to be gained by the company in publishing this work.	Anderson JC, 2005, AM J GASTROENTEROL, V100, P2049, DOI 10.1111/j.1572-0241.2005.41832.x; DARDEL F, 1988, NUCLEIC ACIDS RES, V16, P1767, DOI 10.1093/nar/16.5.1767; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; GOU, 2007, J GENE MED, P751; HENRY, 2006, MOL THER, P485; HINTON TM, 2008, ANTIVIR RES, DOI DOI 10.1016/J.ANTIVIRAL.2008.1005.1009; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jazag A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni130; McIntyre GJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-1; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SONG J, 2008, BMB REPORTS, P358; Tao QZ, 1998, NUCLEIC ACIDS RES, V26, P4901, DOI 10.1093/nar/26.21.4901; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	17	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3827	10.1371/journal.pone.0003827	http://dx.doi.org/10.1371/journal.pone.0003827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043584	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451500007
J	Esposito, A; Tiffert, T; Mauritz, JMA; Schlachter, S; Bannister, LH; Kaminski, CF; Lew, VL				Esposito, Alessandro; Tiffert, Teresa; Mauritz, Jakob M. A.; Schlachter, Simon; Bannister, Lawrence H.; Kaminski, Clemens F.; Lew, Virgilio L.			FRET Imaging of Hemoglobin Concentration in Plasmodium falciparum-Infected Red Cells	PLOS ONE			English	Article							CALCIUM-CHELATOR ESTERS; MALARIA PARASITES; ENERGY-TRANSFER; MAURERS CLEFTS; GENERATION; DIGESTION; ERYTHROCYTES; FORMALDEHYDE; TRANSPORT; VOLUME	Background: During its intraerythrocytic asexual reproduction cycle Plasmodium falciparum consumes up to 80% of the host cell hemoglobin, in large excess over its metabolic needs. A model of the homeostasis of falciparum-infected red blood cells suggested an explanation based on the need to reduce the colloid-osmotic pressure within the host cell to prevent its premature lysis. Critical for this hypothesis was that the hemoglobin concentration within the host cell be progressively reduced from the trophozoite stage onwards. Methodology/Principal Findings: The experiments reported here were designed to test this hypothesis by direct measurements of the hemoglobin concentration in live, infected red cells. We developed a novel, non-invasive method to quantify the hemoglobin concentration in single cells, based on Forster resonance energy transfer between hemoglobin molecules and the fluorophore calcein. Fluorescence lifetime imaging allowed the quantitative mapping of the hemoglobin concentration within the cells. The average fluorescence lifetimes of uninfected cohorts was 270 +/- 30 ps (mean +/- SD; N = 45). In the cytoplasm of infected cells the fluorescence lifetime of calcein ranged from 290 +/- 20 ps for cells with ring stage parasites to 590 +/- 13 ps and 1050 +/- 60 ps for cells with young trophozoites and late stage trophozoite/early schizonts, respectively. This was equivalent to reductions in hemoglobin concentration spanning the range from 7.3 to 2.3 mM, in line with the model predictions. An unexpected ancillary finding was the existence of a microdomain under the host cell membrane with reduced calcein quenching by hemoglobin in cells with mature trophozoite stage parasites. Conclusions/Significance: The results support the predictions of the colloid-osmotic hypothesis and provide a better understanding of the homeostasis of malaria-infected red cells. In addition, they revealed the existence of a distinct peripheral microdomain in the host cell with limited access to hemoglobin molecules indicating the concentration of substantial amounts of parasite-exported material.	[Esposito, Alessandro; Mauritz, Jakob M. A.; Schlachter, Simon; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Esposito, Alessandro; Tiffert, Teresa; Mauritz, Jakob M. A.; Lew, Virgilio L.] Univ Cambridge, Dept Physiol, Dev & Neurosci, Cambridge CB2 1TN, England; [Bannister, Lawrence H.] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Kaminski, Clemens F.] Univ Erlangen Nurnberg, Div 3, Max Planck Res Grp, Sch Advanced Optical Technol, D-8520 Erlangen, Germany	University of Cambridge; University of Cambridge; University of London; King's College London; Max Planck Society; University of Erlangen Nuremberg	Esposito, A (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	aesposito@quantitative-microscopy.org	Esposito, Alessandro/A-8536-2008; Kaminski, Clemens/G-7488-2016	Esposito, Alessandro/0000-0002-5051-091X; Kaminski, Clemens/0000-0002-5194-0962	EPSRC [EP/E059384]; BBSRC [BB/E008542/1]; Biotechnology and Biological Sciences Research Council [BB/E008542/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funds from the EPSRC (EP/E059384) and BBSRC (BB/E008542/1).	AWAYA T, 1979, NUCL INSTRUM METHODS, V165, P317, DOI 10.1016/0029-554X(79)90287-8; BARBER PR, 2005, SPIE, P171; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Beghetto C, 2000, EUR J BIOCHEM, V267, P5585, DOI 10.1046/j.1432-1327.2000.01625.x; BENNETT RG, 1964, J CHEM PHYS, V41, P3037, DOI 10.1063/1.1725670; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Esposito A., 2007, STANDARDIZATION FLUO; ESPOSITO A, 2004, FLUORESCENCE LIFETIM; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; FRANK JH, 2007, J MICROSCOPY; Frischknecht F, 2008, MOL MICROBIOL, V67, P687, DOI 10.1111/j.1365-2958.2007.06095.x; GARCIASANCHO J, 1985, BIOCHIM BIOPHYS ACTA, V813, P148, DOI 10.1016/0005-2736(85)90357-8; GINSBURG H, 1983, MOL BIOCHEM PARASIT, V8, P177, DOI 10.1016/0166-6851(83)90008-7; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; HARRISON DG, 1968, J PHYSIOL-LONDON, V199, P367, DOI 10.1113/jphysiol.1968.sp008658; Horecker BL, 1943, J BIOL CHEM, V148, P173; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; LEW VL, 1993, BIOCHIM BIOPHYS ACTA, V1148, P152, DOI 10.1016/0005-2736(93)90172-V; LEW VL, 1995, BLOOD, V86, P334, DOI 10.1182/blood.V86.1.334.bloodjournal861334; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Przyborski JM, 2008, TRENDS PARASITOL, V24, P285, DOI 10.1016/j.pt.2008.04.002; Roberts KE, 2003, J FLUORESC, V13, P513, DOI 10.1023/B:JOFL.0000008062.85865.c6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; Taraschi TF, 2003, BLOOD, V102, P3420, DOI 10.1182/blood-2003-05-1448; TIFFERT T, 1984, BIOCHIM BIOPHYS ACTA, V773, P143, DOI 10.1016/0005-2736(84)90559-5; Tiffert T, 2000, J PHYSIOL-LONDON, V525, P125, DOI 10.1111/j.1469-7793.2000.00125.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wouters FS, 2008, HFSP J, V2, P7, DOI 10.2976/1.2833600; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	41	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3780	10.1371/journal.pone.0003780	http://dx.doi.org/10.1371/journal.pone.0003780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023444	gold, Green Published, Green Submitted			2022-12-27	WOS:000265448800001
J	Zhang, CL; Qiu, CF; Hu, FB; David, RM; van Dam, RM; Bralley, A; Williams, MA				Zhang, Cuilin; Qiu, Chunfang; Hu, Frank B.; David, Robert M.; van Dam, Rob M.; Bralley, Alexander; Williams, Michelle A.			Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus	PLOS ONE			English	Article								Background: Evidence is accumulating for a role of vitamin D in maintaining normal glucose homeostasis. However, studies that prospectively examined circulating concentrations of 25-hydroxyvitamin D ( 25-[OH] D) in relation to diabetes risk are limited. Our objective is to determine the association between maternal plasma 25-[OH] D concentrations in early pregnancy and the risk for gestational diabetes mellitus (GDM). Methods: A nested case-control study was conducted among a prospective cohort of 953 pregnant women. Among them, 57 incident GDM cases were ascertained and 114 women who were not diagnosed with GDM were selected as controls. Controls were frequency matched to cases for the estimated season of conception of the index pregnancy. Results: Among women who developed GDM, maternal plasma 25-[OH] D concentrations at an average of 16 weeks of gestation were significantly lower than controls (24.2 vs. 30.1 ng/ml, P < 0.001). This difference remained significant (3.62 ng/ml lower on average in GDM cases than controls (P value = 0.018)) after the adjustment for maternal age, race, family history of diabetes, and pre-pregnancy BMI. Approximately 33% of GDM cases, compared with 14% of controls (P < 0.001), had maternal plasma 25-[OH] D concentrations consistent with a pre-specified diagnosis of vitamin D deficiency (<20 ng/ml). After adjustment for the aforementioned covariates including BMI, vitamin D deficiency was associated with a 2.66-fold (OR (95% CI): 2.66 (1.01-7.02)) increased GDM risk. Moreover, each 5 ng/ml decrease in 25-[OH] D concentrations was related to a 1.29-fold increase in GDM risk (OR (95% CI): 1.29 (1.05-1.60)). Additional adjustment for season and physical activity did not change findings substantially. Conclusions: Findings from the present study suggest that maternal vitamin D deficiency in early pregnancy is significantly associated with an elevated risk for GDM.	[Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA; [Qiu, Chunfang; Williams, Michelle A.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [David, Robert M.; Bralley, Alexander] Metametrix Clin Lab, Norcross, GA USA; [Williams, Michelle A.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Swedish Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Zhang, CL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA.	zhangcu@mail.nih.gov	van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734; Zhang, Cuilin/0000-0002-8014-2708	National Institutes of Health [HD/HL 32562]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008889, ZIAHD008888] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by award (HD/HL 32562) from the National Institutes of Health. Dr. Cuilin Zhang was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health.	[Anonymous], DIABETES; Baynes KCR, 1997, DIABETOLOGIA, V40, P344, DOI 10.1007/s001250050685; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; BOUCHER BJ, 1995, DIABETOLOGIA, V38, P1239, DOI 10.1007/BF00422375; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CHERTOW BS, 1983, ENDOCRINOLOGY, V113, P1511, DOI 10.1210/endo-113-4-1511; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; DENT CE, 1975, LANCET, V2, P1057; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; DRAZNIN B, 1988, J CLIN INVEST, V82, P1848, DOI 10.1172/JCI113801; FARRANT HJ, 2008, EUR J CLIN NUTR 0220; GEDIK O, 1986, DIABETOLOGIA, V29, P142, DOI 10.1007/BF02427083; GIOVANNUCCI E, 2008, ANN EPIDEMIOL; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2006, CAN MED ASSOC J, V174, P1287, DOI 10.1503/cmaj.060149; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; KristalBoneh E, 1997, HYPERTENSION, V30, P1289, DOI 10.1161/01.HYP.30.5.1289; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; LIND L, 1989, DIABETES RES CLIN EX, V11, P141; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; MAK RHK, 1992, KIDNEY INT, V41, P1049, DOI 10.1038/ki.1992.159; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; ORWOLL E, 1994, AM J CLIN NUTR, V59, P1083, DOI 10.1093/ajcn/59.5.1083; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Sooy K, 1999, J BIOL CHEM, V274, P34343, DOI 10.1074/jbc.274.48.34343; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhang CL, 2004, EPIDEMIOLOGY, V15, P597, DOI 10.1097/01.ede.0000134864.90563.fa; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4; 2004, DIABETES CARE S1, V27, P88	40	249	281	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3753	10.1371/journal.pone.0003753	http://dx.doi.org/10.1371/journal.pone.0003753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015731	Green Published, Green Submitted, gold			2022-12-27	WOS:000265448400010
J	Mooers, AO; Faith, DP; Maddison, WP				Mooers, Arne O.; Faith, Daniel P.; Maddison, Wayne P.			Converting Endangered Species Categories to Probabilities of Extinction for Phylogenetic Conservation Prioritization	PLOS ONE			English	Article								Background: Categories of imperilment like the global IUCN Red List have been transformed to probabilities of extinction and used to rank species by the amount of imperiled evolutionary history they represent ( e. g. by the Edge of Existence programme). We investigate the stability of such lists when ranks are converted to probabilities of extinction under different scenarios. Methodology and Principal Findings: Using a simple example and computer simulation, we show that preserving the categories when converting such list designations to probabilities of extinction does not guarantee the stability of the resulting lists. Significance: Care must be taken when choosing a suitable transformation, especially if conservation dollars are allocated to species in a ranked fashion. We advocate routine sensitivity analyses.	[Mooers, Arne O.; Faith, Daniel P.; Maddison, Wayne P.] Inst Adv Study, Berlin, Germany; [Mooers, Arne O.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Faith, Daniel P.] Australian Museum, Sydney, NSW, Australia; [Maddison, Wayne P.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; Australian Museum; University of British Columbia	Mooers, AO (corresponding author), Inst Adv Study, Berlin, Germany.	amooers@sfu.ca			Institute for Advanced Study in Berlin [fellowship]; NSERC Canada; Australian Research Foundation [RN0457921]	Institute for Advanced Study in Berlin; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Foundation(Australian Research Council)	This contribution was supported by fellowships (AOM and WPM ) and a visiting stipend (DPF) from the Institute for Advanced Study in Berlin. AOM and WPM each acknowledge NSERC Canada, and DPF acknowledges the Australian Research Foundation (RN0457921) for further research support.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Faith Daniel P., 2008, P99; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gardenfors Ulf, 1999, Species, V31-32, P58; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hartmann K, 2006, SYST BIOL, V55, P644, DOI 10.1080/10635150600873876; Hartmann Klaas, 2007, P171; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2001, IUCN RED LIST CAT CR; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Maddison W. P., 2007, TUATARA CONSERVATION; Munton P., 1987, P71; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Regan HM, 2000, BIOL CONSERV, V92, P101, DOI 10.1016/S0006-3207(99)00060-9; Steel M, 2007, EVOL BIOINFORM, V3, P237; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Williams Paul H., 1994, Biodiversity Letters, V2, P67, DOI 10.2307/2999760; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	27	88	88	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3700	10.1371/journal.pone.0003700	http://dx.doi.org/10.1371/journal.pone.0003700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002251	Green Published, gold, Green Submitted			2022-12-27	WOS:000265165600006
J	Kuparinen, A; O'Hara, RB; Merila, J				Kuparinen, Anna; O'Hara, Robert B.; Merila, Juha			Probabilistic Models for Continuous Ontogenetic Transition Processes	PLOS ONE			English	Article							MATURATION REACTION NORMS; REGRESSION-MODELS; AGE; SIZE; EVOLUTION; RISK	Background: Probabilistic reaction norms (PRNs) are an extension of the concept of reaction norms, developed to account for stochasticity in ontogenetic transitions. However, logistic regression based PRNs are restricted to discrete time intervals, whereas previously proposed models for continuous transitions are demanding in terms of modelling effort and data needed. Methodology/Principal Findings: Here we introduce two alternative approaches for the probabilistic modelling of continuous ontogenetic transitions. The models are simplified in their description of forces underlying transitions, thus being empirical rather than mechanistic by their nature, but therefore applicable to situations where data and prior knowledge of transitions are limited. The models provide continuous time description of the transition pattern, insights into how it is affected by covariates, at the same time allowing for fine scale transition probability predictions. Performance of the models is demonstrated using empirical data on metamorphosis in common frogs (Rana temporaria) reared in a common garden experiment. Conclusions/Significance: As being user-friendly and methodologically easily accessible, the models introduced in this study aid the concept of probabilistic reaction norms becoming as general and applicable tool in the studies of life-history variation as the deterministic reaction norms are today.	[Kuparinen, Anna; Merila, Juha] Univ Helsinki, Ecol Genet Res Unit, Dept Biol & Environm Sci, Helsinki, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Kuparinen, A (corresponding author), Univ Helsinki, Ecol Genet Res Unit, Dept Biol & Environm Sci, Helsinki, Finland.	anna.kuparinen@helsinki.fi	O'Hara, Bob/A-7499-2008; Merila, Juha/A-4061-2008	O'Hara, Bob/0000-0001-9737-3724; Merila, Juha/0000-0001-9614-0072	University of Helsinki; Academy of Finland	University of Helsinki; Academy of Finland(Academy of Finland)	This study was funded by the University of Helsinki and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; ALLISON PD, 2004, SURVIVAL ANAL USING; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Barot S, 2004, ECOL APPL, V14, P1257, DOI 10.1890/03-5066; COX DR, 1972, J R STAT SOC B, V34, P187; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; Do KA, 2000, STAT MED, V19, P1217; Engelhard GH, 2004, MAR ECOL PROG SER, V272, P245, DOI 10.3354/meps272245; Grift RE, 2007, MAR ECOL PROG SER, V334, P213, DOI 10.3354/meps334213; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Klein JP, 2003, SURVIVAL ANAL; Kraak SBM, 2007, MAR ECOL PROG SER, V335, P295, DOI 10.3354/meps335295; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lynch M., 1998, GENETICS ANAL QUANTI; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Pereira E, 2006, J ANIM BREED GENET, V123, P64, DOI 10.1111/j.1439-0388.2006.00567.x; Pigliucci M., 2001, SYN ECO EVO; R Core Team, 2018, R LANG ENV STAT COMP; Roff Derek A., 1992; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Stearns S.C., 1992, pi; Tarres J, 2005, J ANIM SCI, V83, P543; Van Dooren TJM, 2005, EVOLUTION, V59, P500, DOI 10.1554/04-356; Venables W., 2013, MODERN APPL STAT S, V53, P86; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3677	10.1371/journal.pone.0003677	http://dx.doi.org/10.1371/journal.pone.0003677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997864	gold, Green Published, Green Submitted			2022-12-27	WOS:000265165500002
J	Go, T; Konishi, Y				Go, Tohshin; Konishi, Yukuo			Neonatal Oral Imitation in Patients with Severe Brain Damage	PLOS ONE			English	Article								Background: Neonates reproduce facial movements in response to an adult model just after birth. This neonatal oral imitation usually disappears at about 2- to 3-months of age following the development of cortical control. There is controversy relating to the nature and neural basis of such neonatal imitation. To address this issue, we studied the relationship between oral imitation, primitive reflexes, and residual voluntary movement in patients with severe brain damage. Methods: Six male and six female patients with cerebral palsy, from 4 to 39 years, were included in this study. Oral imitation was examined when they were awake and looked at the experimenter. Patients were evaluated as performing oral imitation when they opened their mouth repeatedly without visual feedback regarding their own behavior in response to the experimenter's oral movement. Tongue or lip protrusion was not examined because none of patients were able to do those behaviors due to their physical disability. Rooting and sucking reflexes were also investigated as representatives of primitive reflexes. Results: Six patients (50%) performed oral imitation. Mouth opening was not observed repeatedly in response to other facial expression without opening the mouth such as surprise or smile, excluding the possibility of nonspecific oral reaction. They exhibited little voluntary movement of their extremities. Half of them also manifested at least one primitive reflex. No patients exhibiting residual voluntary movements of their extremities performed oral imitation or primitive reflexes. Conclusions: Oral imitation reappears in a similar way to primitive reflexes in patients showing severely impaired cortical function and little voluntary movement of their extremities due to severe brain damage, suggesting that neonatal oral imitation is mainly controlled by the subcortical brain region.	[Go, Tohshin; Konishi, Yukuo] Tokyo Womens Med Univ, Dept Infants Brain & Cognit Dev, Shinjuku Ku, Tokyo, Japan; [Go, Tohshin; Konishi, Yukuo] Japan Sci & Technol Agcy, Core Res Evolutional Sci & Technol CREST, Saitama, Japan	Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Go, T (corresponding author), Tokyo Womens Med Univ, Dept Infants Brain & Cognit Dev, Shinjuku Ku, Tokyo, Japan.	go-go@umin.ac.jp			Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	The present study was supported in part by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST).	ABRAVANEL E, 1984, CHILD DEV, V55, P381, DOI 10.2307/1129950; Amiel-Tison C, 2006, J PERINAT MED, V34, P437, DOI 10.1515/JPM.2006.088; Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; FIELD TM, 1982, SCIENCE, V218, P179, DOI 10.1126/science.7123230; FONTAINE R, 1984, INFANT BEHAV DEV, V7, P323, DOI 10.1016/S0163-6383(84)80047-8; Heimann M, 2001, EMERGING COGNITIVE ABILITIES IN EARLY INFANCY, P231; Kawakami K, 2007, INFANT BEHAV DEV, V30, P146, DOI 10.1016/j.infbeh.2006.08.004; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Myowa-Yamakoshi M, 2004, DEVELOPMENTAL SCI, V7, P437, DOI 10.1111/j.1467-7687.2004.00364.x; Takeshita H, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P37, DOI 10.1007/4-431-30248-4_2; TRIMBLE MR, 2000, NEUROLOGY CLIN PRACT, V1, P89	15	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3668	10.1371/journal.pone.0003668	http://dx.doi.org/10.1371/journal.pone.0003668			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989360	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134600004
J	Okech, BA; Mwobobia, IK; Kamau, A; Muiruri, S; Mutiso, N; Nyambura, J; Mwatele, C; Amano, T; Mwandawiro, CS				Okech, Bernard A.; Mwobobia, Isaac K.; Kamau, Anthony; Muiruri, Samuel; Mutiso, Noah; Nyambura, Joyce; Mwatele, Cassian; Amano, Teruaki; Mwandawiro, Charles S.			Use of Integrated Malaria Management Reduces Malaria in Kenya	PLOS ONE			English	Article								Background: During an entomological survey in preparation for malaria control interventions in Mwea division, the number of malaria cases at the Kimbimbi sub-district hospital was in a steady decline. The underlying factors for this reduction were unknown and needed to be identified before any malaria intervention tools were deployed in the area. We therefore set out to investigate the potential factors that could have contributed to the decline of malaria cases in the hospital by analyzing the malaria control knowledge, attitudes and practices (KAP) that the residents in Mwea applied in an integrated fashion, also known as integrated malaria management (IMM). Methods: Integrated Malaria Management was assessed among community members of Mwea division, central Kenya using KAP survey. The KAP study evaluated community members' malaria disease management practices at the home and hospitals, personal protection measures used at the household level and malaria transmission prevention methods relating to vector control. Concurrently, we also passively examined the prevalence of malaria parasite infection via outpatient admission records at the major referral hospital in the area. In addition we studied the mosquito vector population dynamics, the malaria sporozoite infection status and entomological inoculation rates (EIR) over an 8 month period in 6 villages to determine the risk of malaria transmission in the entire division. Results: A total of 389 households in Mwea division were interviewed in the KAP study while 90 houses were surveyed in the entomological study. Ninety eight percent of the households knew about malaria disease while approximately 70% of households knew its symptoms and methods to manage it. Ninety seven percent of the interviewed households went to a health center for malaria diagnosis and treatment. Similarly a higher proportion (81%) used anti-malarial medicines bought from local pharmacies. Almost 90% of households reported owning and using an insecticide treated bed net and 81% reported buying the nets within the last 5 years. The community also used mosquito reduction measures including, in order of preference, environmental management (35%), mosquito repellent and smoke (31%) insecticide canister sprays (11%), and window and door screens (6%). These methods used by the community comprise an integrated malaria management (IMM) package. Over the last 4 years prior to this study, the malaria cases in the community hospital reduced from about 40% in 2000 to less than 10% by 2004 and by the year 2007 malaria cases decreased to zero. In addition, a one time cross-sectional malaria parasite survey detected no Plasmodium infection in 300 primary school children in the area. Mosquito vector populations were variable in the six villages but were generally lower in villages that did not engage in irrigation activities. The malaria risk as estimated by EIR remained low and varied by village and proximity to irrigation areas. The average EIR in the area was estimated at 0.011 infectious bites per person per day. Conclusions: The usage of a combination of malaria control tools in an integrated fashion by residents of Mwea division might have influenced the decreased malaria cases in the district hospital and in the school children. A vigorous campaign emphasizing IMM should be adopted and expanded in Mwea division and in other areas with different eco-epidemiological patterns of malaria transmission. With sustained implementation and support from community members integrated malaria management can reduce malaria significantly in affected communities in Africa.	[Mwobobia, Isaac K.; Nyambura, Joyce; Mwatele, Cassian; Amano, Teruaki; Mwandawiro, Charles S.] KEMRI, ESACIPAC, Nairobi, Kenya; [Okech, Bernard A.] KEMRI, CBRD, Nairobi, Kenya; [Kamau, Anthony] Minist Hlth, AMREF, Nairobi, Kenya; [Muiruri, Samuel; Mutiso, Noah] Minist Hlth, DVBD, Nairobi, Kenya; [Okech, Bernard A.] Univ Florida, Environm Hlth Program, Dept Epidemiol & Biostat, St Augustine, FL USA; [Okech, Bernard A.] Univ Florida, Emerging Pathogens Inst, St Augustine, FL USA; [Okech, Bernard A.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA	African Medical & Research Foundation (AMREF); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okech, BA (corresponding author), KEMRI, ESACIPAC, Nairobi, Kenya.	Okech@whitney.ufl.edu			Japanese International Cooperation Agency; Government of Kenya	Japanese International Cooperation Agency; Government of Kenya	This study was supported by the Japanese International Cooperation Agency and the Government of Kenya. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BEIER JC, 1991, J MED ENTOMOL, V28, P533, DOI 10.1093/jmedent/28.4.533; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Kamau L, 2003, J AM MOSQUITO CONTR, V19, P130; Kibe Lydiah W, 2006, Afr Health Sci, V6, P240; Kitua AY, 2008, SCIENCE, V319, P900, DOI 10.1126/science.319.5865.900c; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; MUKIAMA TK, 1989, ACTA TROP, V46, P181, DOI 10.1016/0001-706X(89)90035-1; Mutero CM, 2000, ACTA TROP, V76, P253, DOI 10.1016/S0001-706X(00)00109-1; Mutero CM, 2004, ACTA TROP, V89, P171, DOI 10.1016/j.actatropica.2003.07.003; Muturi EJ, 2008, AM J TROP MED HYG, V78, P270, DOI 10.4269/ajtmh.2008.78.270; Nahlen BL, 2003, AM J TROP MED HYG, V68, P1; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Utzinger J, 2002, NATURE, V419, P431, DOI 10.1038/419431a; Winstanley P, 2006, ADV PARASIT, V61, P47, DOI 10.1016/S0065-308X(05)61002-0; 2003, TROP MED INT HLTH, V8, P860	21	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4050	10.1371/journal.pone.0004050	http://dx.doi.org/10.1371/journal.pone.0004050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115000	Green Submitted, gold, Green Published			2022-12-27	WOS:000265466300002
J	Reiner, R; Krasnov-Yoeli, N; Dehtiar, Y; Jarrous, N				Reiner, Robert; Krasnov-Yoeli, Natalie; Dehtiar, Yana; Jarrous, Nayef			Function and Assembly of a Chromatin-Associated RNase P that Is Required for Efficient Transcription by RNA Polymerase I	PLOS ONE			English	Article								Background: Human RNase P has been initially described as a tRNA processing enzyme, consisting of H1 RNA and at least ten distinct protein subunits. Recent findings, however, indicate that this catalytic ribonucleoprotein is also required for transcription of small noncoding RNA genes by RNA polymerase III (Pol III). Notably, subunits of human RNase P are localized in the nucleolus, thus raising the possibility that this ribonucleoprotein complex is implicated in transcription of rRNA genes by Pol I. Methodology/Principal Findings: By using biochemical and reverse genetic means we show here that human RNase P is required for efficient transcription of rDNA by Pol I. Thus, inactivation of RNase P by targeting its protein subunits for destruction by RNA interference or its H1 RNA moiety for specific cleavage causes marked reduction in transcription of rDNA by Pol I. However, RNase P restores Pol I transcription in a defined reconstitution system. Nuclear run on assays reveal that inactivation of RNase P reduces the level of nascent transcription by Pol I, and more considerably that of Pol III. Moreover, RNase P copurifies and associates with components of Pol I and its transcription factors and binds to chromatin of the promoter and coding region of rDNA. Strikingly, RNase P detaches from transcriptionally inactive rDNA in mitosis and reassociates with it at G1 phase through a dynamic and stepwise assembly process that is correlated with renewal of transcription. Conclusions/Significance: Our findings reveal that RNase P activates transcription of rDNA by Pol I through a novel assembly process and that this catalytic ribonucleoprotein determines the transcription output of Pol I and Pol III, two functionally coordinated transcription machineries.	[Reiner, Robert; Krasnov-Yoeli, Natalie; Dehtiar, Yana; Jarrous, Nayef] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Reiner, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel.	jarrous@md.huji.ac.il	Jarrous, Nayef/S-6825-2019		United States-Israel Binational Science Foundation [2005/009]; Israel Science Foundation [673/06]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This research is supported by the United States-Israel Binational Science Foundation (grant no. 2005/009) and the Israel Science Foundation (grant no. 673/06) to N. J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Ferrari R, 2008, CELL MOL BIOL LETT, V13, P112, DOI 10.2478/s11658-007-0041-y; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Jarrous N, 2002, RNA, V8, P1, DOI 10.1017/S1355838202011184; Jarrous N, 2001, METHOD ENZYMOL, V342, P93, DOI 10.1016/S0076-6879(01)42538-9; Jarrous N, 2007, NUCLEIC ACIDS RES, V35, P3519, DOI 10.1093/nar/gkm071; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Kovrigina E, 2003, P NATL ACAD SCI USA, V100, P1598, DOI 10.1073/pnas.0337661100; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Li Y, 2001, P NATL ACAD SCI USA, V98, P441, DOI 10.1073/pnas.021555498; Lunyak VV, 2008, CURR OPIN CELL BIOL, V20, P281, DOI 10.1016/j.ceb.2008.03.018; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; Schnapp A, 1996, METHOD ENZYMOL, V273, P233; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seither P, 1998, J MOL BIOL, V275, P43, DOI 10.1006/jmbi.1997.1434; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Wassarman KM, 2004, NAT STRUCT MOL BIOL, V11, P803, DOI 10.1038/nsmb0904-803; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; Zhang HF, 2004, J MOL BIOL, V342, P1077, DOI 10.1016/j.jmb.2004.06.006	51	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4072	10.1371/journal.pone.0004072	http://dx.doi.org/10.1371/journal.pone.0004072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115013	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466300012
J	Choi, YH; Cowan, DB; Nathan, M; Poutias, D; Stamm, C; del Nido, PJ; McGowan, FX				Choi, Yeong-Hoon; Cowan, Douglas B.; Nathan, Meena; Poutias, Dimitrios; Stamm, Christof; del Nido, Pedro J.; McGowan, Francis X., Jr.			Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia	PLOS ONE			English	Article							GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; TARGET GENES; HIF-2-ALPHA; ACTIVATION; HIF-1-ALPHA; EXPRESSION; ISCHEMIA; RECEPTOR	Background: Cyanosis and myocardial hypertrophy frequently occur in combination. Hypoxia or cyanosis can be potent inducers of angiogenesis, regulating the expression of hypoxia-inducible factors (HIF), vascular endothelial growth factors (VEGF), and VEGF receptors (VEGFR-1 and 2); in contrast, pressure overload hypertrophy is often associated with impaired pro-angiogenic signaling and decreased myocardial capillary density. We hypothesized that the physiological pro-angiogenic response to cyanosis in the hypertrophied myocardium is blunted through differential HIF and VEGF-associated signaling. Methods and Results: Newborn rabbits underwent aortic banding and, together with sham-operated littermates, were transferred into a hypoxic chamber (FiO(2) = 0.12) at 3 weeks of age. Control banded or sham-operated rabbits were housed in normoxia. Systemic cyanosis was confirmed (hematocrit, arterial oxygen saturation, and serum erythropoietin). Myocardial tissue was assayed for low oxygen concentrations using a pimonidazole adduct. At 4 weeks of age, HIF-1 alpha and HIF-2 alpha protein levels, HIF-1 alpha DNA-binding activity, and expression of VEGFR-1, VEGFR-2, and VEGF were determined in hypoxic and normoxic rabbits. At 6 weeks of age, left-ventricular capillary density was assessed by immunohistochemistry. Under normoxia, capillary density was decreased in the banded rabbits compared to non-banded littermates. As expected, non-hypertrophied hearts responded to hypoxia with increased capillary density; however, banded hypoxic rabbits demonstrated no increase in angiogenesis. This blunted pro-angiogenic response to hypoxia in the hypertrophied myocardium was associated with lower HIF-2 alpha and VEGFR-2 levels and increased HIF-1 alpha activity and VEGFR-1 expression. In contrast, non-hypertrophied hearts responded to hypoxia with increased HIF-2 alpha and VEGFR-2 expression with lower VEGFR-1 expression. Conclusion: The participation of HIF-2 alpha and VEGFR-2 appear to be required for hypoxia-stimulated myocardial angiogenesis. In infant rabbit hearts with pressure overload hypertrophy, this pro-angiogenic response to hypoxia is effectively uncoupled, apparently in part due to altered HIF-mediated signaling and VEGFR subtype expression.	[Choi, Yeong-Hoon; Nathan, Meena; Stamm, Christof; del Nido, Pedro J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, Boston, MA USA; [Cowan, Douglas B.; Poutias, Dimitrios; McGowan, Francis X., Jr.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol, Perioperat & Pain Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Choi, YH (corresponding author), Heartctr Univ Cologne, Dept Cardiothorac Surg, Ctr Mol Med Cologne, Cologne, Germany.	yh.choi@uk-koeln.de	Stamm, Christof/J-5719-2014	Cowan, Douglas/0000-0002-6309-2737	National Institutes of Health [HL074734, HL066186, HL63095, HL068915]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063095, R01HL066186, P50HL074734, R01HL068915, R01HL088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (grants HL074734, HL066186, HL63095, and HL068915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; ALLARD MF, 1994, J MOL CELL CARDIOL, V26, P1551, DOI 10.1006/jmcc.1994.1175; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; BAKER EJ, 1995, AM J PHYSIOL-HEART C, V268, pH1165, DOI 10.1152/ajpheart.1995.268.3.H1165; Baker JE, 1997, CIRCULATION, V95, P1278; Baker JE, 1997, J MOL CELL CARDIOL, V29, P845, DOI 10.1006/jmcc.1996.0361; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Cowan DB, 2000, AM J PHYSIOL-HEART C, V279, pH619, DOI 10.1152/ajpheart.2000.279.2.H619; COWAN DB, 1993, J BIOL CHEM, V268, P26904; del Nido PJ, 1998, AM J PHYSIOL-HEART C, V274, pH728, DOI 10.1152/ajpheart.1998.274.2.H728; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Friehs I, 1999, CIRCULATION, V100, P187; Friehs I, 2004, ANN THORAC SURG, V77, P2004, DOI 10.1016/j.athoracsur.2003.11.003; Friehs I, 2003, ANN THORAC SURG, V75, pS678, DOI 10.1016/S0003-4975(02)04692-1; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; PARK JE, 1994, J BIOL CHEM, V269, P25646; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SEETHARAM L, 1995, ONCOGENE, V10, P135; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; SINK JD, 1981, J THORAC CARDIOV SUR, V81, P865; Stamm C, 2002, CIRCULATION, V106, pI290, DOI 10.1161/01.cir.0000032896.55215.a0; Takeuchi K, 1998, CIRCULATION, V98, pII234; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	41	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4042	10.1371/journal.pone.0004042	http://dx.doi.org/10.1371/journal.pone.0004042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112498	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466000009
J	Sharma, TS; Hughes, J; Murillo, A; Riley, J; Soares, A; Little, F; Mitchell, CD; Hanekom, WA				Sharma, Tanvi S.; Hughes, Jane; Murillo, Amarylis; Riley, Joanne; Soares, Andreia; Little, Francesca; Mitchell, Charles D.; Hanekom, Willem A.			CD8+T-Cell Interleukin-7 Receptor Alpha Expression as a Potential Indicator of Disease Status in HIV-Infected Children	PLOS ONE			English	Article								Background: Initiation and modification of antiretroviral therapy in HIV-infected children depend on viral load and CD4+ T-cell count. However, these surrogates have limitations, and complementary immunological markers to assess therapeutic response are needed. Our aim was to evaluate CD8+ T-cell expression of CD127 as a marker of disease status in HIV-infected children, based on adult data suggesting its usefulness. We hypothesized that CD127 expression on CD8+ T-cells is lower in children with more advanced disease. Methods: In a cross-sectional evaluation, we used flow cytometry to measure CD127+ expression on CD8+ T-cells in whole blood from HIV-infected children with varying disease status. This was compared with expression of CD38 on this subset, currently used in clinical practice as a marker of disease status. Results: 51 HIV-infected children were enrolled. There was a strong positive correlation between CD127 expression on CD8+ T-cells and CD4+ T-cell count, and height and weight z-scores, and a strong negative correlation between CD127 expression and viral load. In contrast, we found no association between CD38 expression and these disease status markers. Conclusions: CD8+ T-cell CD127 expression is significantly higher in children with better HIV disease control, and may have a role as an immunologic indicator of disease status. Longitudinal studies are needed to determine the utility of this marker as a potential indicator of HIV disease progression.	Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Infect Dis, Boston, MA 02115 USA; [Hughes, Jane; Riley, Joanne; Soares, Andreia; Hanekom, Willem A.] Sch Child & Adolescent Hlth, S African Tuberculosis Vaccine Initiative, Cape Town, South Africa; [Murillo, Amarylis; Mitchell, Charles D.] Univ Miami, Miller Sch Med, Div Pediat Infect Dis, Miami, FL USA; [Little, Francesca] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Miami; University of Cape Town	Sharma, TS (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Infect Dis, Boston, MA 02115 USA.	Willem.hanekom@uct.ac.za		Hanekom, Willem/0000-0003-3070-6154; Little, Francesca/0000-0002-5917-9928	University of Miami Comprehensive AIDS Program; Green Family Foundation; NIH [D43-TW01280, UO1-AI27560, RO1-AI065653, NO1-A195383]; FOGARTY INTERNATIONAL CENTER [D43TW001280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065653, U01AI027560] Funding Source: NIH RePORTER	University of Miami Comprehensive AIDS Program; Green Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	University of Miami Comprehensive AIDS Program (WH); Green Family Foundation (TS, WH); NIH (D43-TW01280 and UO1-AI27560 to CM, RO1-AI065653 and NO1-A195383 to WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, CURR HIV RES, V3, P261, DOI 10.2174/1570162054368093; Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Arpadi SM, 2000, J ACQ IMMUN DEF SYND, V25, pS37, DOI 10.1097/00126334-200010001-00006; Beq S, 2005, EUR CYTOKINE NETW, V16, P293; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Bohler T, 1999, AIDS, V13, P779, DOI 10.1097/00002030-199905070-00006; Borkowsky W, 2000, J INFECT DIS, V182, P96, DOI 10.1086/315672; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Chiappini E, 2003, JAIDS-J ACQ IMM DEF, V33, P601, DOI 10.1097/00126334-200308150-00008; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Essajee SM, 1999, AIDS, V13, P2523, DOI 10.1097/00002030-199912240-00005; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Mocroft A, 1997, J ACQ IMMUN DEF SYND, V14, P158, DOI 10.1097/00042560-199702010-00009; Mussini C, 2002, AIDS, V16, P1609, DOI 10.1097/00002030-200208160-00006; Nunnari G, 2005, EXPERT OPIN BIOL TH, V5, P1421, DOI 10.1517/14712598.5.11.1421; Pahwa R, 2006, J INFECT DIS, V193, P879, DOI 10.1086/500471; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Pett Sarah L, 2003, Expert Rev Anti Infect Ther, V1, P83, DOI 10.1586/14787210.1.1.83; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Resino S, 2005, ACTA PAEDIATR, V94, P170, DOI 10.1080/08035250410020208; Resino S, 2004, CLIN EXP IMMUNOL, V137, P570, DOI 10.1111/j.1365-2249.2004.02583.x; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; SCHLESINGER M, 1995, PEDIATR RES, V38, P390, DOI 10.1203/00006450-199509000-00020; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Vigano A, 2000, CHEM IMMUNOL, V75, P207; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017	39	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3986	10.1371/journal.pone.0003986	http://dx.doi.org/10.1371/journal.pone.0003986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096522	Green Published, Green Submitted, gold			2022-12-27	WOS:000265458800008
J	Silva, M; Pereira, HS; Bento, M; Santos, AP; Shaw, P; Delgado, M; Neves, N; Viegas, W				Silva, Manuela; Pereira, H. Sofia; Bento, Miguel; Santos, Ana Paula; Shaw, Peter; Delgado, Margarida; Neves, Nuno; Viegas, Wanda			Interplay of Ribosomal DNA Loci in Nucleolar Dominance: Dominant NORs Are Up-Regulated by Chromatin Dynamics in the Wheat-Rye System	PLOS ONE			English	Article							RNA GENES; NUCLEAR ARCHITECTURE; ORGANIZATION; HETEROCHROMATIN; CHROMOSOMES; METHYLATION; GENOME; TRANSCRIPTION; INTERPHASE	Background: Chromatin organizational and topological plasticity, and its functions in gene expression regulation, have been strongly revealed by the analysis of nucleolar dominance in hybrids and polyploids where one parental set of ribosomal RNA ( rDNA) genes that are clustered in nucleolar organizing regions (NORs), is rendered silent by epigenetic pathways and heterochromatization. However, information on the behaviour of dominant NORs is very sparse and needed for an integrative knowledge of differential gene transcription levels and chromatin specific domain interactions. Methodology/Principal Findings: Using molecular and cytological approaches in a wheat-rye addition line (wheat genome plus the rye nucleolar chromosome pair 1R), we investigated transcriptional activity and chromatin topology of the wheat dominant NORs in a nucleolar dominance situation. Herein we report dominant NORs up-regulation in the addition line through quantitative real-time PCR and silver-staining technique. Accompanying this modification in wheat rDNA trascription level, we also disclose that perinucleolar knobs of ribosomal chromatin are almost transcriptionally silent due to the residual detection of BrUTP incorporation in these domains, contrary to the marked labelling of intranucleolar condensed rDNA. Further, by comparative confocal analysis of nuclei probed to wheat and rye NORs, we found that in the wheat-rye addition line there is a significant decrease in the number of wheat-origin perinucleolar rDNA knobs, corresponding to a diminution of the rDNA heterochromatic fraction of the dominant (wheat) NORs. Conclusions/Significance: We demonstrate that inter-specific interactions leading to wheat-origin NOR dominance results not only on the silencing of rye origin NOR loci, but dominant NORs are also modified in their transcriptional activity and interphase organization. The results show a cross-talk between wheat and rye NORs, mediated by ribosomal chromatin dynamics, revealing a conceptual shift from differential amphiplasty to 'mutual amphiplasty' in the nucleolar dominance process.	[Silva, Manuela; Pereira, H. Sofia; Bento, Miguel; Santos, Ana Paula; Delgado, Margarida; Neves, Nuno; Viegas, Wanda] Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada Agricultura, Lisbon, Portugal; [Santos, Ana Paula; Shaw, Peter] John Innes Ctr, Norwich, Norfolk, England; [Delgado, Margarida] Univ Lusofona Humanidades Tecnol, Lisbon, Portugal; [Neves, Nuno] Univ Nova Lisboa, Fac Ciencias Tecnol, Dept Ciencias Vida, Monte De Caparica, Portugal	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Lusofona University; Universidade Nova de Lisboa	Silva, M (corresponding author), Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada Agricultura, Lisbon, Portugal.	manuelasilva@isa.utl.pt	Santos, Ana Paula/D-3154-2012; Delgado, Margarida/E-2764-2014; Silva, Manuela/ABF-7085-2020; shaw, peter j/E-5511-2011; Silva, Manuela/GSN-4031-2022	Santos, Ana Paula/0000-0002-8108-1863; Silva, Manuela/0000-0003-4677-870X; shaw, peter j/0000-0003-1076-2669; Pereira, H. Sofia/0000-0002-7933-6097; Bento, Miguel/0000-0002-7545-8943; Delgado, Margarida/0000-0003-3132-3278; Viegas, Wanda/0000-0003-4660-1226	Fundacao para a Ciencia e Tecnologia [POCI/BIA-BDE/57575/2004, POCI/BIA-BCM/59389/2004]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Fundacao para a Ciencia e Tecnologia (projects POCI/BIA-BDE/57575/2004 to M.S. and POCI/BIA-BCM/59389/2004 to N.N.).	Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Akhmanova A, 2000, J CELL SCI, V113, P4463; Caperta AD, 2002, J CELL SCI, V115, P2839; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Carvalho C, 2001, MOL BIOL CELL, V12, P3563, DOI 10.1091/mbc.12.11.3563; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Cheutin T, 2002, J CELL SCI, V115, P3297; DURICA DS, 1977, DEV BIOL, V59, P62, DOI 10.1016/0012-1606(77)90240-8; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLAVELL RB, 1976, HEREDITY, V37, P377, DOI 10.1038/hdy.1976.102; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hasterok R, 2000, GENOME, V43, P574, DOI 10.1139/gen-43-3-574; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houchins K, 1997, MOL GEN GENET, V255, P294, DOI 10.1007/s004380050500; LACADENA JR, 1984, THEOR APPL GENET, V67, P207, DOI 10.1007/BF00317037; LEITCH AR, 1992, J CELL SCI, V101, P751; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Morais-Cecilio L, 2000, CHROMOSOME RES, V8, P341, DOI 10.1023/A:1009291714371; MUKAI Y, 1991, CHROMOSOMA, V100, P71, DOI 10.1007/BF00418239; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; Neves N, 1997, CHROMOSOME RES, V5, P125, DOI 10.1023/A:1018470208730; Neves N, 2005, CYTOGENET GENOME RES, V109, P104, DOI 10.1159/000082388; Pecinka A, 2004, CHROMOSOMA, V113, P258, DOI 10.1007/s00412-004-0316-2; Pikaard CS, 2007, CHROMOSOME RES, V15, P18; Pikaard CS, 2001, TRENDS GENET, V17, P675, DOI 10.1016/S0168-9525(01)02545-8; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Santos AP, 2002, J CELL SCI, V115, P4597, DOI 10.1242/jcs.00160; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237	39	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3824	10.1371/journal.pone.0003824	http://dx.doi.org/10.1371/journal.pone.0003824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048103	gold, Green Published			2022-12-27	WOS:000265452000004
J	Bain, MB; Singkran, N; Mills, KE				Bain, Mark B.; Singkran, Nuanchan; Mills, Katherine E.			Integrated Ecosystem Assessment: Lake Ontario Water Management	PLOS ONE			English	Article							GREAT-LAKES; COASTAL WETLANDS; BLACK TERN; NEARSHORE; EROSION; MACROPHYTES; ECOLOGY; IMPACT; DEPTH; INDEX	Background: Ecosystem management requires organizing, synthesizing, and projecting information at a large scale while simultaneously addressing public interests, dynamic ecological properties, and a continuum of physicochemical conditions. We compared the impacts of seven water level management plans for Lake Ontario on a set of environmental attributes of public relevance. Methodology and Findings: Our assessment method was developed with a set of established impact assessment tools (checklists, classifications, matrices, simulations, representative taxa, and performance relations) and the concept of archetypal geomorphic shoreline classes. We considered each environmental attribute and shoreline class in its typical and essential form and predicted how water level change would interact with defining properties. The analysis indicated that about half the shoreline of Lake Ontario is potentially sensitive to water level change with a small portion being highly sensitive. The current water management plan may be best for maintaining the environmental resources. In contrast, a natural water regime plan designed for greatest environmental benefits most often had adverse impacts, impacted most shoreline classes, and the largest portion of the lake coast. Plans that balanced multiple objectives and avoided hydrologic extremes were found to be similar relative to the environment, low on adverse impacts, and had many minor impacts across many shoreline classes. Significance: The Lake Ontario ecosystem assessment provided information that can inform decisions about water management and the environment. No approach and set of methods will perfectly and unarguably accomplish integrated ecosystem assessment. For managing water levels in Lake Ontario, we found that there are no uniformly good and bad options for environmental conservation. The scientific challenge was selecting a set of tools and practices to present broad, relevant, unbiased, and accessible information to guide decision-making on a set of management options.	[Bain, Mark B.; Singkran, Nuanchan; Mills, Katherine E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University	Bain, MB (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	Mark.Bain@Cornell.edu			US Army Corps of Engineers; International Joint Commission; National Science Foundation [OCE-0083625]; Great Lakes Commission; US Environmental Protection Agency	US Army Corps of Engineers(United States Department of DefenseUnited States Army); International Joint Commission; National Science Foundation(National Science Foundation (NSF)); Great Lakes Commission; US Environmental Protection Agency(United States Environmental Protection Agency)	Our approach was developed under a grant to MBB from the US Army Corps of Engineers and the International Joint Commission. These sponsors did not specify or influence the study design, findings, and interpretations. They were not aware of the conclusions prior to publication, and our findings are independent of agency policies. Field studies of the Lake Ontario coastal zone were supported by grants from the National Science Foundation (OCE-0083625), the Great Lakes Commission, and the US Environmental Protection Agency.	Allen A.W., 1983, HABITAT SUITABILITY; ALSOP FJ, 2001, BIRDS N AM; Amin SMN, 1997, J COASTAL RES, V13, P1093; BARTON D R, 1978, Journal of Great Lakes Research, V4, P27; BARTON DR, 1984, J GREAT LAKES RES, V10, P407, DOI 10.1016/S0380-1330(84)71857-0; BEDFORD KW, 1992, J GREAT LAKES RES, V18, P571, DOI 10.1016/S0380-1330(92)71323-9; Brewer R, 1991, ATLAS BREEDING BIRDS; *CAN WILDL SERV, 2008, BIRD FACT SHEETS KIL; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; CHAMBERS PA, 1985, CAN J FISH AQUAT SCI, V42, P701, DOI 10.1139/f85-090; *CHES BAY PROGR, 2007, 903R07001 EPA; *CJ STEW CONS, 2001, REV POT DAT SOURC US; CLARK CF, 1950, COPEIA, P285; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Curnutt JL, 2000, ECOL APPL, V10, P1849, DOI 10.1890/1051-0761(2000)010[1849:LBSESI]2.0.CO;2; CURRIER CL, 2000, SPEC AN ABSTR CHLID; DAVIDSONARNOTT RGD, 1995, MAR GEOL, V122, P349, DOI 10.1016/0025-3227(94)00115-2; Davies SP, 2006, ECOL APPL, V16, P1251, DOI 10.1890/1051-0761(2006)016[1251:TBCGAD]2.0.CO;2; *ENV CAN, 2008, PIP PLOV E CAN; *ENV CAN, 2007, SPEC RISK PUBL REG; FABRICIUS E, 1950, I FRESHWATER RES DRO, V29, P57; Fitz C, 2003, MODEL DYN SYST, P143; *FUNCT GROUP 2, 1989, LIV LAK CHALL OPP AN; Great Lakes Commission, 2003, WAT RES MAN DEC SUPP; Hall SR, 2003, J GREAT LAKES RES, V29, P54, DOI 10.1016/S0380-1330(03)70415-8; HARRIS SW, 1963, ECOLOGY, V44, P331, DOI 10.2307/1932180; Harrison H.H, 1979, FIELD GUIDE W BIRDS; HAUG PT, 1984, J ENVIRON MANAGE, V18, P15; HERDENDORF CE, 1992, J GREAT LAKES RES, V18, P533, DOI 10.1016/S0380-1330(92)71321-5; Hickey JM, 1997, COLON WATERBIRD, V20, P582, DOI 10.2307/1521614; *HIGH PERF SYST IN, 2003, STELLA RES VERS 8 0; Hudon C, 2000, CAN J FISH AQUAT SCI, V57, P31, DOI 10.1139/f99-232; JOHNSGARD PA, 1956, ECOLOGY, V37, P689, DOI 10.2307/1933059; JUDE DJ, 1992, J GREAT LAKES RES, V18, P651, DOI 10.1016/S0380-1330(92)71328-8; KEAST A, 1977, Environmental Biology of Fishes, V2, P235, DOI 10.1007/BF00005992; KEDDY PA, 1982, AM J BOT, V69, P13, DOI 10.2307/2442827; KEDDY PA, 1985, VEGETATION DYNAMICS, P38; KRIEGER KA, 1992, J GREAT LAKES RES, V18, P525, DOI 10.1016/S0380-1330(92)71319-7; *LAK ONT BIOC PROJ, 2007, LAK ONT BIOC STUD PH; *LAK ONT STL RIV S, 2006, OPT MAN LAK ONT ST L; LAWRENCE PL, 1994, GEOMORPHOLOGY, V10, P65, DOI 10.1016/0169-555X(94)90008-6; LISTER R, 2008, BIRD FACT SHEETS MAL; Lund J., 2007, ENVISIONING FUTURES; *MAN MUS MAN NAT, 2008, MARSH WREN CIST PAL; Mazzocchi IM, 1997, COLON WATERBIRD, V20, P596, DOI 10.2307/1521615; MEANLEY B, 1969, NATURAL HIST KING RA, P67; Mortsch LD, 1998, CLIMATIC CHANGE, V40, P391, DOI 10.1023/A:1005445709728; MUMFORD RE, 2000, BIRDS INDIANA; *NAT BIOL INF INFR, 2006, US FISH WILDL SERV F; National Research Council, 2001, INL NAV SYST PLANN U; National Research Council, 2002, MISS RIV EC EXPL PRO, P176, DOI [10.17226/10277, DOI 10.17226/10277]; *NY DEP ENV CONS, 2008, PIP PLOV FACT SHEET; *NY DEP ENV CONS, 2007, LIST END THREAT SPEC; Palmer R.S., 1962, HDB N AM BIRDS, V1; PARKER B, 2003, ENV TECHNICAL WORK G, P6; Randall RG, 1996, CAN J FISH AQUAT SCI, V53, P35, DOI 10.1139/cjfas-53-S1-35; ROBEL ROBERT J., 1962, JOUR WILDLIFE MANAGEMENT, V26, P221, DOI 10.2307/3798611; Scott WB., 1973, FRESHWATER FISHES CA; SHOPLEY JB, 1984, J ENVIRON MANAGE, V18, P25; Smith C.L., 1985, INLAND FISHES NEW YO; STEWART CJ, 1993, EROSION PROCESSES TA; *STILLW SCI, 2006, SACR RIV EC FLOWS ST; *STLAWR RIV LAK ON, 1999, PLAN STUD CRIT REV O; Taft OW, 2002, J APPL ECOL, V39, P987, DOI 10.1046/j.1365-2664.2002.00763.x; Tufts R.W., 1986, BIRDS NOVA SCOTIA; *US ARM CORPS ENG, 2004, 2004 REP C; *US EPA, 1987, GREAT LAK ENV ATL RE; *US FISH WILDL SER, 2008, PIP PLOV; WESTMAN WE, 1985, ECOLOGY IMPACT ASSES; Wilcox D.A., 2007, LAKE LEVEL VARIABILI, P1311; WILCOX DA, 1992, WETLANDS, V12, P192; WILCOX DA, 1995, NAT AREA J, V15, P240; WILLIAMS DC, 1995, THESIS U MICHIGAN MI; WILLIAMSON LO, 1942, WISCONSIN CONSERVATI, V7, P10	75	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3806	10.1371/journal.pone.0003806	http://dx.doi.org/10.1371/journal.pone.0003806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030230	Green Published, Green Submitted, gold			2022-12-27	WOS:000265451100006
J	Sussan, TE; Jun, J; Thimmulappa, R; Bedja, D; Antero, M; Gabrielson, KL; Polotsky, VY; Biswal, S				Sussan, Thomas E.; Jun, Jonathan; Thimmulappa, Rajesh; Bedja, Djahida; Antero, Maria; Gabrielson, Kathleen L.; Polotsky, Vsevolod Y.; Biswal, Shyam			Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENHANCES SUSCEPTIBILITY; OXIDATIVE STRESS; LDL; GLUTATHIONE; PROGRESSION; DEFICIENT; INDUCTION; RESPONSES; CD36	Background: Oxidative stress and inflammation are two critical factors that drive the formation of plaques in atherosclerosis. Nrf2 is a redox-sensitive transcription factor that upregulates a battery of antioxidative genes and cytoprotective enzymes that constitute the cellular response to oxidative stress. Our previous studies have shown that disruption of Nrf2 in mice (Nrf2(-/-)) causes increased susceptibility to pulmonary emphysema, asthma and sepsis due to increased oxidative stress and inflammation. Here we have tested the hypothesis that disruption of Nrf2 in mice causes increased atherosclerosis. Principal Findings: To investigate the role of Nrf2 in the development of atherosclerosis, we crossed Nrf2(-/-) mice with apoliporotein E-deficient (ApoE(-/-)) mice. ApoE(-/-) and ApoE(-/-) Nrf2(-/-) mice were fed an atherogenic diet for 20 weeks, and plaque area was assessed in the aortas. Surprisingly, ApoE(-/-) Nrf2(-/-) mice exhibited significantly smaller plaque area than ApoE(-/-) controls (11.5% vs 29.5%). This decrease in plaque area observed in ApoE(-/-) Nrf2(-/-) mice was associated with a significant decrease in uptake of modified low density lipoproteins (AcLDL) by isolated macrophages from ApoE(-/-) Nrf2(-/-) mice. Furthermore, atherosclerotic plaques and isolated macrophages from ApoE(-/-) Nrf2(-/-) mice exhibited decreased expression of the scavenger receptor CD36. Conclusions: Nrf2 is pro-atherogenic in mice, despite its antioxidative function. The net pro-atherogenic effect of Nrf2 may be mediated via positive regulation of CD36. Our data demonstrates that the potential effects of Nrf2-targeted therapies on cardiovascular disease need to be investigated.	[Sussan, Thomas E.; Thimmulappa, Rajesh; Antero, Maria; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Jun, Jonathan; Polotsky, Vsevolod Y.; Biswal, Shyam] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulmonary & Critical Care Med, Baltimore, MD 21218 USA; [Bedja, Djahida; Gabrielson, Kathleen L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Sussan, TE (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	sbiswal@jhsph.edu	Thimmulappa, Rajesh/AAW-5013-2021	Thimmulappa, Rajesh/0000-0001-6050-1323; Sussan, Thomas/0000-0002-5240-4299	NIH [HL081205, HL080105]; NHLBI SCCOR [P50HL084945, HL07534]; NIEHS [P50ES015903, ES07141]; Maryland Cigarette Restitution Fund; FAMRI Clinical Innovator award; AHA [0765293U]; National Sleep Foundation [SF-78568-N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081205, R01HL080105, P50HL084945, T32HL007534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141, P50ES015903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Maryland Cigarette Restitution Fund; FAMRI Clinical Innovator award; AHA(American Heart Association); National Sleep Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant HL081205, NHLBI SCCOR grant P50HL084945 (SB and VYP), NIEHS grant P50ES015903, Maryland Cigarette Restitution Fund research grant, and FAMRI Clinical Innovator award to SB, and NIH grant HL080105 and AHA grant 0765293U to VYP. TES is supported by the NIEHS training grant ES07141. JJ is supported by the NHLBI T32 training grant HL07534 and National Sleep Foundation grant SF-78568-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BJORKHEM I, 1991, ARTERIOSCLER THROMB, V11, P15, DOI 10.1161/01.ATV.11.1.15; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Hsich E, 2000, CIRCULATION, V101, P1234, DOI 10.1161/01.CIR.101.11.1234; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; MARUYAMA A, 2008, ARCH BIOCH BIOPHYS; Minuz Pietro, 2006, Pharmacol Rep, V58 Suppl, P57; Morrison JA, 1999, CIRCULATION, V100, P2244, DOI 10.1161/01.CIR.100.22.2244; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SPARROW CP, 1992, J CLIN INVEST, V89, P1885, DOI 10.1172/JCI115793; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tomasian D, 2000, CARDIOVASC RES, V47, P426, DOI 10.1016/S0008-6363(00)00103-6; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Zhao L, 2005, PROSTAG OTH LIPID M, V78, P185, DOI 10.1016/j.prostaglandins.2005.07.003; Zureik M, 2004, ARTERIOSCL THROM VAS, V24, P1485, DOI 10.1161/01.ATV.0000136648.62973.c8	36	128	143	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3791	10.1371/journal.pone.0003791	http://dx.doi.org/10.1371/journal.pone.0003791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023427	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448800012
J	Wang, JL; Wang, H; Li, ZZ; Wu, QL; Lathia, JD; McLendon, RE; Hjelmeland, AB; Rich, JN				Wang, Jialiang; Wang, Hui; Li, Zhizhong; Wu, Qiulian; Lathia, Justin D.; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.			c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells	PLOS ONE			English	Article								Background: Malignant gliomas rank among the most lethal cancers. Gliomas display a striking cellular heterogeneity with a hierarchy of differentiation states. Recent studies support the existence of cancer stem cells in gliomas that are functionally defined by their capacity for extensive self-renewal and formation of secondary tumors that phenocopy the original tumors. As the c-Myc oncoprotein has recognized roles in normal stem cell biology, we hypothesized that c-Myc may contribute to cancer stem cell biology as these cells share characteristics with normal stem cells. Methodology/Principal Findings: Based on previous methods that we and others have employed, tumor cell populations were enriched or depleted for cancer stem cells using the stem cell marker CD133 (Prominin-1). We characterized c-Myc expression in matched tumor cell populations using real time PCR, immunoblotting, immunofluorescence and flow cytometry. Here we report that c-Myc is highly expressed in glioma cancer stem cells relative to non-stem glioma cells. To interrogate the significance of c-Myc expression in glioma cancer stem cells, we targeted its expression using lentivirally transduced short hairpin RNA (shRNA). Knockdown of c-Myc in glioma cancer stem cells reduced proliferation with concomitant cell cycle arrest in the G(0)/G(1) phase and increased apoptosis. Non-stem glioma cells displayed limited dependence on c-Myc expression for survival and proliferation. Further, glioma cancer stem cells with decreased c-Myc levels failed to form neurospheres in vitro or tumors when xenotransplanted into the brains of immunocompromised mice. Conclusions/Significance: These findings support a central role of c-Myc in regulating proliferation and survival of glioma cancer stem cells. Targeting core stem cell pathways may offer improved therapeutic approaches for advanced cancers.	[Wang, Jialiang; Wu, Qiulian; Lathia, Justin D.; Hjelmeland, Anita B.; Rich, Jeremy N.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Wang, Hui; Li, Zhizhong; Rich, Jeremy N.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Rich, Jeremy N.] Duke Univ, Dept Med, Durham, NC 27706 USA; [Wang, Jialiang; Wang, Hui; Li, Zhizhong; Wu, Qiulian; Lathia, Justin D.; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27706 USA; [Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regen Biol, Cleveland, OH USA	Duke University; Duke University; Duke University; Duke University; Duke University; Cleveland Clinic Foundation	Wang, JL (corresponding author), Duke Univ, Dept Surg, Durham, NC 27710 USA.	richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022		American Brain Tumor Association Basic Research Fellowship; Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH [NS047409, NS054276, CA116659]; Damon Runyon Cancer Research Foundation [Damon Runyon-Lilly Clinical Investigator]; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA116659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054276, K02NS047409] Funding Source: NIH RePORTER	American Brain Tumor Association Basic Research Fellowship; Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Jialiang Wang is a recipient of the American Brain Tumor Association Basic Research Fellowship. Other financial support was provided by the Childhood Brain Tumor Foundation, the Pediatric Brain Tumor Foundation of the United States, Accelerate Brain Cancer Cure, Alexander and Margaret Stewart Trust, Brain Tumor Society, Goldhirsh Foundation, Duke Comprehensive Cancer Center Stem Cell Initiative Grant (J.R.), NIH grants NS047409, NS054276, and CA116659 (J.R.). J.R. is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation and a Sidney Kimmel Foundation for Cancer Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; BAO S, 2008, CANC RES IN PRESS; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kaptein JS, 1996, J BIOL CHEM, V271, P18875, DOI 10.1074/jbc.271.31.18875; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Knezevic D, 2004, CELL CYCLE, V3, P729; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	63	313	322	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3769	10.1371/journal.pone.0003769	http://dx.doi.org/10.1371/journal.pone.0003769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020659	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448600002
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Losing the Big Picture: How Religion May Control Visual Attention	PLOS ONE			English	Article							PERCEPTION; CULTURE	Despite the abundance of evidence that human perception is penetrated by beliefs and expectations, scientific research so far has entirely neglected the possible impact of religious background on attention. Here we show that Dutch Calvinists and atheists, brought up in the same country and culture and controlled for race, intelligence, sex, and age, differ with respect to the way they attend to and process the global and local features of complex visual stimuli: Calvinists attend less to global aspects of perceived events, which fits with the idea that people's attentional processing style reflects possible biases rewarded by their religious belief system.	[Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Amsterdam Ctr Study Adaptive Control Brain & Behav, Psychol Dept, NL-1012 WX Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	Dutch Organization for Scientific Research (NWO) [VENI]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of LSC and WVDW is supported by VENI grants awarded by the Dutch Organization for Scientific Research (NWO). NWO had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Bratt J. D., 1998, ABRAHAM KUYPER CENTE; ERDELYI MH, 1974, PSYCHOL REV, V81, P1, DOI 10.1037/h0035852; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; KERSTEN GH, 1980, HOORT ROEDE DEEL, V1; Kuhnen U, 2002, J EXP SOC PSYCHOL, V38, P492, DOI 10.1016/S0022-1031(02)00011-2; Lin ZC, 2008, BIOL PSYCHOL, V77, P93, DOI 10.1016/j.biopsycho.2007.08.002; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nisbett R. E., 2003, GEOGRAPHY THOUGHT; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Raven JC, 1988, MANUAL RAVENS PROGR	13	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3679	10.1371/journal.pone.0003679	http://dx.doi.org/10.1371/journal.pone.0003679			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WW	19002253	gold, Green Published			2022-12-27	WOS:000265166000002
J	Etzel, JA; Gazzola, V; Keysers, C				Etzel, Joset A.; Gazzola, Valeria; Keysers, Christian			Testing Simulation Theory with Cross-Modal Multivariate Classification of fMRI Data	PLOS ONE			English	Article								The discovery of mirror neurons has suggested a potential neural basis for simulation and common coding theories of action perception, theories which propose that we understand other people's actions because perceiving their actions activates some of our neurons in much the same way as when we perform the actions. We propose testing this model directly in humans with functional magnetic resonance imaging (fMRI) by means of cross-modal classification. Cross-modal classification evaluates whether a classifier that has learned to separate stimuli in the sensory domain can also separate the stimuli in the motor domain. Successful classification provides support for simulation theories because it means that the fMRI signal, and presumably brain activity, is similar when perceiving and performing actions. In this paper we demonstrate the feasibility of the technique by showing that classifiers which have learned to discriminate whether a participant heard a hand or a mouth action, based on the activity patterns in the premotor cortex, can also determine, without additional training, whether the participant executed a hand or mouth action. This provides direct evidence that, while perceiving others' actions, (1) the pattern of activity in premotor voxels with sensory properties is a significant source of information regarding the nature of these actions, and (2) that this information shares a common code with motor execution.	[Etzel, Joset A.; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands	University of Groningen	Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	j.a.etzel@med.umcg.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619	Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI; European Commission [Marie Curie Excellence]	Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI; European Commission(European CommissionEuropean Commission Joint Research Centre)	The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI and a Marie Curie Excellence grant of the European Commission to C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bennett K., 2000, SIGKDD EXPLORATIONS, V2, P1, DOI DOI 10.1145/380995.380999; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; DAMASIO AR, 1994, DESCARTES ERROR EMOT, pR19; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; EDGINGTON ES, 1995, RANDOMIZATION TESTS, pR22; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; MUKHERJEE S, 2003, 2003019 MIT COMP SCI; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oouchida Y, 2004, NEUROREPORT, V15, P2019, DOI 10.1097/00001756-200409150-00005; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; R Development Core Team, 2006, R LANG ENV STAT COMP; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	46	83	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3690	10.1371/journal.pone.0003690	http://dx.doi.org/10.1371/journal.pone.0003690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997869	gold, Green Published, Green Submitted			2022-12-27	WOS:000265165500013
J	Ghisovan, N; Nemri, A; Shumikhina, S; Molotchnikoff, S				Ghisovan, Narcis; Nemri, Abdellatif; Shumikhina, Svetlana; Molotchnikoff, Stephane			Visual Cells Remember Earlier Applied Target: Plasticity of Orientation Selectivity	PLOS ONE			English	Article								Background: A canonical proposition states that, in mature brain, neurons responsive to sensory stimuli are tuned to specific properties installed shortly after birth. It is amply demonstrated that that neurons in adult visual cortex of cats are orientation-selective that is they respond with the highest firing rates to preferred oriented stimuli. Methodology/Principal Findings: In anesthetized cats, prepared in a conventional fashion for single cell recordings, the present investigation shows that presenting a stimulus uninterruptedly at a non-preferred orientation for twelve minutes induces changes in orientation preference. Across all conditions orientation tuning curves were investigated using a trial by trial method. Contrary to what has been previously reported with shorter adaptation duration, twelve minutes of adaptation induces mostly attractive shifts, i. e. toward the adapter. After a recovery period allowing neurons to restore their original orientation tuning curves, we carried out a second adaptation which produced three major results: (1) more frequent attractive shifts, (2) an increase of their magnitude, and (3) an additional enhancement of responses at the new or acquired preferred orientation. Additionally, we also show that the direction of shifts depends on the duration of the adaptation: shorter adaptation in most cases produces repulsive shifts, whereas adaptation exceeding nine minutes results in attractive shifts, in the same unit. Consequently, shifts in preferred orientation depend on the duration of adaptation. Conclusion/Significance: The supplementary response improvements indicate that neurons in area 17 keep a memory trace of the previous stimulus properties, thereby upgrading cellular performance. It also highlights the dynamic nature of basic neuronal properties in adult cortex since repeated adaptations modified both the orientation tuning selectivity and the response strength to the preferred orientation. These enhanced neuronal responses suggest that the range of neuronal plasticity available to the visual system is broader than anticipated.	[Ghisovan, Narcis; Nemri, Abdellatif; Shumikhina, Svetlana; Molotchnikoff, Stephane] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada	Universite de Montreal	Ghisovan, N (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	stephane.molotchnikoff@umontreal.ca	Shumikhina, Svetlana/AAC-3533-2022	/0000-0003-3044-8730; Nemri, Abdellatif/0000-0003-1459-5634	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bex PJ, 1999, PERCEPT PSYCHOPHYS, V61, P1066, DOI 10.3758/BF03207614; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BOUCHARD M, 2008, EXP BRAIN R IN PRESS; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Ghisovan N, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-60; HENRY GH, 1974, VISION RES, V14, P767, DOI 10.1016/0042-6989(74)90141-2; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; HENRY GH, 1978, EXP BRAIN RES, V32, P245; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Ibbotson M. R., 2005, FITTING MIND WORLD A, P17; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Krekelberg B, 2006, J NEUROPHYSIOL, V95, P255, DOI 10.1152/jn.00750.2005; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mather G., 1998, MOTION AFTEREFFECT M; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; NELSON SB, 1991, J NEUROSCI, V11, P357; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; ORBAN GA, 1981, J NEUROPHYSIOL, V45, P1043, DOI 10.1152/jn.1981.45.6.1043; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Sabatini BL, 2007, NATURE, V450, P1173, DOI 10.1038/4501173a; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; VIDYASAGAR TR, 1990, NEUROSCIENCE, V36, P175, DOI 10.1016/0306-4522(90)90360-G	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3689	10.1371/journal.pone.0003689	http://dx.doi.org/10.1371/journal.pone.0003689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997867	gold, Green Submitted, Green Published			2022-12-27	WOS:000265165500012
J	Chotpitayasunondh, T; Thisyakorn, U; Pancharoen, C; Pepin, S; Nougarede, N				Chotpitayasunondh, Tawee; Thisyakorn, Usa; Pancharoen, Chitsanu; Pepin, Stephanie; Nougarede, Nolwenn			Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children	PLOS ONE			English	Article							A H5N1 INFECTION; AVIAN INFLUENZA; PANDEMIC INFLUENZA; IMMUNIZATION	Background: Highly pathogenic influenza A/H5N1 has caused outbreaks in wild birds and poultry in Asia, Africa and Europe. It has also infected people, especially children, causing severe illness and death. Although the virus shows limited ability to transmit between humans, A/H5N1 represents a potential source of the next influenza pandemic. This study assesses the safety and immunogenicity of aluminium hydroxide adjuvanted (Al) and non adjuvanted influenza A/Vietnam/1194/2004 NIBRG-14 (H5N1) vaccine in children. Methods and Findings: In a Phase II, open, randomised, multicentre trial 180 children aged 6 months to 17 years received two injections, 21 days apart, of vaccine containing either: 30 mu g haemagglutinin (HA) with adjuvant (30 mu g+Al) or 7.5 mu g HA without adjuvant. An additional 60 children aged 6-35 months received two "half dose" injections (ie 15 mu g+Al or 3.8 mu g). Safety was followed for 21 days after vaccination. Antibody responses were assessed 21 days after each injection and cellular immune responses were explored. Vaccination appeared well tolerated in all age groups. The 30 mu g+Al formulation was more immunogenic than 7.5 mu g in all age groups: in these two groups 79% and 46% had haemagglutinination inhibition antibody titres >= 32 (1/dil). Among 6-35 month-olds, the full doses were more immunogenic than their half dose equivalents. Vaccination induced a predominantly Th2 response against H5 HA. Conclusions: This influenza A(H5N1) vaccine was well tolerated and immunogenic in children and infants, with Al adjuvant providing a clear immunogenic advantage. These results demonstrate that an H5N1 Al-adjuvanted vaccine, previously shown to be immunogenic and safe in adults, can also be used in children, the group most at risk for pandemic influenza.	Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Thisyakorn, Usa; Pancharoen, Chitsanu] Chulalongkorn Hosp, Bangkok, Thailand; [Pepin, Stephanie; Nougarede, Nolwenn] Sanofi Pasteur, Marcy Letoile, France	Chulalongkorn University	Chotpitayasunondh, T (corresponding author), Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand.	stephanie.pepin@sanofipasteur.com			Sanofi Pasteur	Sanofi Pasteur	This study was funded by Sanofi Pasteur. Through its clinical team, the sponsor contributed to protocol design, data analysis, as well as manuscript preparation and submission. The sponsor had no role in the recruitment, vaccination and follow-up of subjects, nor in the collection of data other than immunogenicity results which were generated and collected by staff at sanofi pasteur.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bocchini JA, 2007, PEDIATRICS, V119, P846, DOI 10.1542/peds.2007-0164; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Congressional Budget Office, 2005, POT INFL PAND POSS M; Delespesse G, 1998, VACCINE, V16, P1415, DOI 10.1016/S0264-410X(98)00101-7; Delore V, 2006, VACCINE, V24, P1586, DOI 10.1016/j.vaccine.2005.10.008; *EUR COMM PROPR ME, 1996, CPMPBWP21496 EUR COM; European Committee for Proprietary Medicinal Products, 2004, CPMPVEG471703 EUR CO; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; He XS, 2008, J INFECT DIS, V197, P803, DOI 10.1086/528804; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Schwartz B, 2005, J INFECT DIS, V191, P1207, DOI 10.1086/428952; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; *WHO, 2003, AR REP CONF OCC H5N1; *WHO, TABL CLIN TRIALS PAN; Wood JM, 2002, VACCINE, V20, pB40, DOI 10.1016/S0264-410X(02)00509-1; World Health Organization, CUM NUMB CONF HUM CA; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	28	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4028	10.1371/journal.pone.0004028	http://dx.doi.org/10.1371/journal.pone.0004028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112513	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000003
J	Piao, S; Lee, SH; Kim, H; Yum, S; Stamos, JL; Xu, YB; Lee, SJ; Lee, J; Oh, S; Han, JK; Park, BJ; Weis, WI; Ha, NC				Piao, Shunfu; Lee, Sun-Hye; Kim, Hyunjoon; Yum, Soohwan; Stamos, Jennifer L.; Xu, Yongbin; Lee, Su-Jin; Lee, Jaewon; Oh, Sangtaek; Han, Jin-Kwan; Park, Bum-Joon; Weis, William I.; Ha, Nam-Chul			Direct Inhibition of GSK3 beta by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/beta-Catenin Signaling	PLOS ONE			English	Article								Wnt/beta-catenin signaling plays a central role in development and is also involved in a diverse array of diseases. Binding of Wnts to the coreceptors Frizzled and LRP6/5 leads to phosphorylation of PPPSPxS motifs in the LRP6/5 intracellular region and the inhibition of GSK3 beta bound to the scaffold protein Axin. However, it remains unknown how GSK3 beta is specifically inhibited upon Wnt stimulation. Here, we show that overexpression of the intracellular region of LRP6 containing a Ser/Thr rich cluster and a PPPSPxS motif impairs the activity of GSK3 beta in cells. Synthetic peptides containing the PPPSPxS motif strongly inhibit GSK3b in vitro only when they are phosphorylated. Microinjection of these peptides into Xenopus embryos confirms that the phosphorylated PPPSPxS motif potentiates Wnt-induced second body axis formation. In addition, we show that the Ser/Thr rich cluster of LRP6 plays an important role in LRP6 binding to GSK3 beta. These observations demonstrate that phosphorylated LRP6/5 both recruits and directly inhibits GSK3 beta using two distinct portions of its cytoplasmic sequence, and suggest a novel mechanism of activation in this signaling pathway.	[Yum, Soohwan; Xu, Yongbin; Lee, Jaewon; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Pusan, South Korea; [Piao, Shunfu; Yum, Soohwan; Xu, Yongbin; Lee, Jaewon; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan, South Korea; [Lee, Sun-Hye; Lee, Su-Jin; Park, Bum-Joon] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea; [Kim, Hyunjoon; Han, Jin-Kwan] POSTECH, Div Mol & Life Sci, Pohang, South Korea; [Stamos, Jennifer L.; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oh, Sangtaek] Inje Univ, PharmcoGenom Res Ctr, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pohang University of Science & Technology (POSTECH); Stanford University; Inje University	Piao, S (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan, South Korea.	hnc@pusan.ac.kr	Weis, William I/G-1437-2011; Lee, Jaewon/N-9064-2013	Weis, William I/0000-0002-5583-6150; Lee, Jaewon/0000-0003-3203-2130; Kim, Hyunjoon/0000-0002-0207-1190	Korea Research Foundation [KRF-2007-C00620]; U.S. National Institutes of Health [GM56169]; Basic Research Program of the Korea Science & Engineering Foundation [R01-2006-000-10521-0]; Advanced Basic Research Laboratory Program [R14-2002-012-01001-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Research Program of the Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); Advanced Basic Research Laboratory Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by a Korea Research Foundation Grant (KRF-2007-C00620) to N-C.H. and by U.S. National Institutes of Health grant GM56169 to W.I.W. The Basic Research Program of the Korea Science & Engineering Foundation (R01-2006-000-10521-0), and The Advanced Basic Research Laboratory Program (R14-2002-012-01001-0) of KRF partly supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dominguez I, 2000, DEVELOPMENT, V127, P861; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pearl LH, 2002, CURR OPIN STRUC BIOL, V12, P761, DOI 10.1016/S0959-440X(02)00386-X; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yanagawa SI, 1997, J BIOL CHEM, V272, P25243, DOI 10.1074/jbc.272.40.25243; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	35	150	156	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4046	10.1371/journal.pone.0004046	http://dx.doi.org/10.1371/journal.pone.0004046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107203	Green Submitted, Green Published, gold			2022-12-27	WOS:000265463000032
J	Kuznetsov, S; Khokhlatchev, AV				Kuznetsov, Sergey; Khokhlatchev, Andrei V.			The Growth and Tumor Suppressors NORE1A and RASSF1A Are Targets for Calpain-Mediated Proteolysis	PLOS ONE			English	Article								Background: NORE1A and RASSF1A are growth and tumour suppressors inactivated in a variety of cancers. Methylation of NORE1A and RASSF1A promoters is the predominant mechanism for downregulation of these proteins; however, other mechanisms are likely to exist. Methodology/Principal Findings: Here we describe a proteolysis of NORE1A and RASSF1A by calpains as alternative mechanism of their downregulation. Extracts of H358 cell line, a human bronchoalveolar carcinoma, and H460, a large cell carcinoma, were capable of proteolysis of NORE1A protein in the calpain-dependent manner. Likewise, RASSF1A tumor suppressor was proteolyzed by the H358 cell extract. Addition of calpain inhibitor to H358 and H460 cells growing in tissue culture resulted in re-expression of endogenous NORE1A. A survey of 10 human lung tumours revealed that three of them contain an activity capable of inducing NORE1A degradation. Conclusions/Significance: Thus, degradation by calpains is a novel mechanism for downregulation of NORE1A and RASSF1A proteins and might be the mechanism allowing cancer cells to escape growth suppression.	Univ Rhode Isl, Dept Phys, Kingston, RI 02881 USA; [Khokhlatchev, Andrei V.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Rhode Island; University of Virginia	Kuznetsov, S (corresponding author), Univ Rhode Isl, Dept Phys, East Hall, Kingston, RI 02881 USA.	ak9k@virginia.edu	Kuznetsov, Sergey B./GRX-6475-2022	Kuznetsov, Sergey B./0000-0003-4013-2991	University of Virginia Department of Pathology	University of Virginia Department of Pathology	University of Virginia Department of Pathology Startup funds, provided to AVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Atencio IA, 2000, CELL GROWTH DIFFER, V11, P247; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665; Darnell GA, 2007, J BIOL CHEM, V282, P37492, DOI 10.1074/jbc.M706860200; Delmas C, 2003, J BIOL CHEM, V278, P12443, DOI 10.1074/jbc.M209523200; Demarchi F, 2007, CELL CYCLE, V6, P136; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; FOUKAKIS T, 2005, FUSION J CLIN ENDOCR; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191; Hiwasa T, 2002, BIOCHEM BIOPH RES CO, V290, P510, DOI 10.1006/bbrc.2001.6197; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kimura Y, 2000, NEUROPATHOLOGY, V20, P153, DOI 10.1046/j.1440-1789.2000.00326.x; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Pan ZG, 2005, CANCER BIOL THER, V4, P1116, DOI 10.4161/cbt.4.10.2023; Shiba, 1996, Breast Cancer, V3, P13, DOI 10.1007/BF02966957; Shiba E, 1996, ANTICANCER RES, V16, P773; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3997	10.1371/journal.pone.0003997	http://dx.doi.org/10.1371/journal.pone.0003997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098985	Green Published, gold, Green Submitted			2022-12-27	WOS:000265462300008
J	Jeong, JH; Wang, ZX; Guimaraes, AS; Ouyang, X; Figueiredo, JL; Ding, ZH; Jiang, S; Guney, I; Kang, GH; Shin, E; Hahn, WC; Loda, MF; Abate-Shen, C; Weissleder, R; Chin, L				Jeong, Joseph H.; Wang, Zhenxiong; Guimaraes, Alexander S.; Ouyang, Xuesong; Figueiredo, Jose L.; Ding, Zhihu; Jiang, Shan; Guney, Isil; Kang, Gyeong Hoon; Shin, Eyoung; Hahn, William C.; Loda, Massimo F.; Abate-Shen, Cory; Weissleder, Ralph; Chin, Lynda			BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma	PLOS ONE			English	Article								Prostate cancer is the second leading cause of cancer-related deaths in men. Activation of MAP kinase signaling pathway has been implicated in advanced and androgen-independent prostate cancers, although formal genetic proof has been lacking. In the course of modeling malignant melanoma in a tyrosinase promoter transgenic system, we developed a genetically-engineered mouse (GEM) model of invasive prostate cancers, whereby an activating mutation of BRAF(V600E)-a mutation found in similar to 10% of human prostate tumors-was targeted to the epithelial compartment of the prostate gland on the background of Ink4a/Arf deficiency. These GEM mice developed prostate gland hyperplasia with progression to rapidly growing invasive adenocarcinoma without evidence of AKT activation, providing genetic proof that activation of MAP kinase signaling is sufficient to drive prostate tumorigenesis. Importantly, genetic extinction of BRAF(V600E) in established prostate tumors did not lead to tumor regression, indicating that while sufficient to initiate development of invasive prostate adenocarcinoma, BRAF(V600E) is not required for its maintenance.	[Jeong, Joseph H.; Wang, Zhenxiong; Ding, Zhihu; Jiang, Shan; Guney, Isil; Hahn, William C.; Loda, Massimo F.; Chin, Lynda] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Guimaraes, Alexander S.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Syst Biol, Boston, MA 02115 USA; [Ouyang, Xuesong; Abate-Shen, Cory] Columbia Univ, Coll Physicians & Surgeons, Herbert Irving Comprehensive Canc Ctr, Dept Urol & Pathol, New York, NY 10027 USA; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Shin, Eyoung; Loda, Massimo F.] Harvard Univ, Sch Med, Brigham and Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Guney, Isil; Hahn, William C.; Loda, Massimo F.] MIT, Broad Inst Harvard, Cambridge, MA USA; [Guimaraes, Alexander S.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Columbia University; Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School	Jeong, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu	Abate-Shen, Cory/O-2520-2014; Kang, Gyeong Hoon/F-1051-2010	Abate-Shen, Cory/0000-0002-5021-0570; Kang, Gyeong Hoon/0000-0003-2380-6675; /0000-0003-0828-4143	Department of Defense (DOD) [Prostate Cancer Training Awards]; NIH [PO1 CA089021, RO1 CA109038, RO1 CA076501, UO1 CA084294, R24 CA92782, P50 CA86355, U54 CA119349, UO1 CA84313, RO1 CA93947]; Prostate Cancer Foundation (PCF) Award; DFCI-Novartis Investigator award; NATIONAL CANCER INSTITUTE [R01CA093947, P01CA089021, U01CA084294, R01CA076501, R24CA092782, R01CA109038, U01CA084313, P50CA086355, U54CA119349] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation (PCF) Award; DFCI-Novartis Investigator award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.H. Jeong and I. Guney are supported by Department of Defense (DOD) Prostate Cancer Training Awards. M.F. Loda is supported by NIH PO1 CA089021, Prostate Cancer Foundation (PCF) Award and DFCI-Novartis Investigator award. W.C. Hahn is supported by NIH RO1 CA109038 and the Prostate Cancer Foundation (PCF) Award. C. Abate-Shen is supported by NIH RO1 CA076501 and UO1 CA084294. R. Weissleder and all imaging studies are supported by NIH R24 CA92782, P50 CA86355, and U54 CA119349. This work is supported by grants from the NIH (UO1 CA84313; RO1 CA93947) to L. Chin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bentel JM, 1996, J ENDOCRINOL, V151, P1, DOI 10.1677/joe.0.1510001; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Brewster SF, 1999, J UROLOGY, V161, P1238, DOI 10.1016/S0022-5347(01)61646-X; Byers RJ, 2007, J MOL DIAGN, V9, P20, DOI 10.2353/jmoldx.2007.060119; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gioeli D, 1999, CANCER RES, V59, P279; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; Hudson DL, 2004, PROSTATE CANCER P D, V7, P188, DOI 10.1038/sj.pcan.4500745; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Kasper Susan, 2003, Methods Mol Med, V81, P113; Kim MJ, 2002, CANCER RES, V62, P2999; Konishi N, 1997, PROSTATE, V30, P53; Lin S, 2002, J BIOL CHEM, V277, P41725, DOI 10.1074/jbc.M203957200; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Navone NM, 1999, J UROLOGY, V161, P304, DOI 10.1016/S0022-5347(01)62136-0; Regales L, 2003, PIGM CELL RES, V16, P685, DOI 10.1046/j.1600-0749.2003.00100.x; Sasaki Y, 2004, J INVEST DERMATOL, V123, P177, DOI 10.1111/j.0022-202X.2004.22722.x; Segawa N, 2001, PATHOL INT, V51, P452, DOI 10.1046/j.1440-1827.2001.01226.x; Shiraishi T, 1998, ANTICANCER RES, V18, P2789; Stackhouse GB, 1999, J UROLOGY, V162, P2040, DOI 10.1016/S0022-5347(05)68095-0; SUZUKI H, 1994, JPN J CANCER RES, V85, P847, DOI 10.1111/j.1349-7006.1994.tb02957.x; Theodorescu D, 1997, J UROLOGY, V158, P131, DOI 10.1097/00005392-199707000-00040; Tholouli E, 2006, BIOCHEM BIOPH RES CO, V348, P628, DOI 10.1016/j.bbrc.2006.07.122; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tief K, 1997, PIGM CELL RES, V10, P153; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Uzgare AR, 2004, CANCER RES, V64, P6190, DOI 10.1158/0008-5472.CAN-04-0968; VERHAGEN APM, 1992, CANCER RES, V52, P6182; VOELLER HJ, 1991, MOL ENDOCRINOL, V5, P209, DOI 10.1210/mend-5-2-209; Wang L, 2003, CANCER RES, V63, P5209; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200	47	38	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3949	10.1371/journal.pone.0003949	http://dx.doi.org/10.1371/journal.pone.0003949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079609	Green Published, gold, Green Submitted			2022-12-27	WOS:000265458400008
J	Yu, DH; Macdonald, J; Liu, GH; Lee, AS; Ly, MM; Davis, T; Ke, N; Zhou, D; Wong-Staal, F; Li, QX				Yu, De-Hua; Macdonald, James; Liu, Guohong; Lee, Amy S.; Ly, Mimi; Davis, Timothy; Ke, Ning; Zhou, Demin; Wong-Staal, Flossie; Li, Qi-Xiang			Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE; GRP78 PROMOTER; TUMOR-CELLS; CANCER; STRESS; INDUCTION; KINASE; ACTIVATION; IDENTIFICATION; EXPRESSION	We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (, 10 fold). It was also reported by others to have anti-tumor activity in vivo and selective toxicity against cancer cells under glucose starvation in vitro, but with unknown mechanism. Here, we provide evidence that pyrvinium suppresses the transcriptional activation of GRP78 and GRP94 induced by glucose deprivation or 2-deoxyglucose (2DG, a glycolysis inhibitor), but not by tunicamycin or A23187. Other UPR pathways induced by glucose starvation, e. g. XBP-1, ATF4, were also found suppressed by pyrvinium. Constitutive expression of GRP78 via transgene partially protected cells from pyrvinium induced cell death under glucose starvation, suggesting that suppression of the UPR is involved in pyrvinium mediated cytotoxicity under glucose starvation. Xenograft experiments showed rather marginal overall anti-tumor activity for pyrvinium as a monotherapy. However, the combination of pyrvinium and Doxorubicin demonstrated significantly enhanced efficacy in vivo, supporting a mechanistic treatment concept based on tumor hypoglycemia and UPR.	[Yu, De-Hua; Macdonald, James; Liu, Guohong; Lee, Amy S.; Ly, Mimi; Davis, Timothy; Ke, Ning; Zhou, Demin; Wong-Staal, Flossie; Li, Qi-Xiang] iTherX Pharmaceut Inc, San Diego, CA USA; [Lee, Amy S.] Univ So Calif, Keck Sch Med, Norris Comprehensive Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California	Yu, DH (corresponding author), iTherX Pharmaceut Inc, San Diego, CA USA.	yu@itherx.com; hqxl@yahoo.com		Lee, Amy/0000-0002-0378-5443	NIH [1R43CA130386-01A1, CA27607]; NATIONAL CANCER INSTITUTE [R01CA027607, R37CA027607, R43CA130386] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	iTherX Pharmaceuticals, Inc. was the major study sponsor and responsible for decision for publication. Yu DH was partially supported by NIH grant 1R43CA130386-01A1. ASL was supported by NIH grant CA27607. NIH had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brown JM, 1998, CANCER RES, V58, P1408; CLAASSEN G, 2004, PRECLINICA, V2, P435; El-Zawahry A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-2; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; Izuishi K, 2000, CANCER RES, V60, P6201; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; Ke N, 2006, EXP CELL RES, V312, P2726, DOI 10.1016/j.yexcr.2006.05.001; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; LI WWF, 1993, J BIOL CHEM, V268, P12003; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song MS, 2001, CANCER RES, V61, P8322; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Yu DH, 2006, EXP CELL RES, V312, P865, DOI 10.1016/j.yexcr.2005.12.006; Yu DH, 2005, ASSAY DRUG DEV TECHN, V3, P401, DOI 10.1089/adt.2005.3.401	35	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3951	10.1371/journal.pone.0003951	http://dx.doi.org/10.1371/journal.pone.0003951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079611	Green Published, Green Submitted, gold			2022-12-27	WOS:000265458400010
J	Gomez-Nunez, M; Haro, KJ; Dao, T; Chau, DM; Won, A; Escobar-Alvarez, S; Zakhaleva, V; Korontsvit, T; Gin, DY; Scheinberg, DA				Gomez-Nunez, Marta; Haro, Kurtis J.; Dao, Tao; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy; Zakhaleva, Victoriya; Korontsvit, Tatyana; Gin, David Y.; Scheinberg, David A.			Non-Natural and Photo-Reactive Amino Acids as Biochemical Probes of Immune Function	PLOS ONE			English	Article							WILMS-TUMOR GENE; CYTOTOXIC T-LYMPHOCYTES; SITE-SPECIFIC INCORPORATION; WT1 PEPTIDE; ANALOGS; EXPRESSION; VACCINE; BINDING; CELLS; EPITOPE	Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by incorporating non-natural and photo-reactive amino acids into the sequence of WT1 peptides. Thirteen WT1 peptides sequences were synthesized with chemically modified amino acids (via fluorination and photo-reactive group additions) at MHC and T cell receptor binding positions. Certain new non-natural peptide analogs could stabilize MHC class I molecules better than the native sequences and were also able to elicit specific T-cell responses and sometimes cytotoxicity to leukemia cells. Two photo-reactive peptides, also modified with a biotin handle for pull-down studies, formed covalent interactions with MHC molecules on live cells and provided kinetic data showing the rapid clearance of the peptide-MHC complex. Despite "infinite affinity'' provided by the covalent peptide bonding to the MHC, immunogenicity was not enhanced by these peptides because the peptide presentation on the surface was dominated by catabolism of the complex and only a small percentage of peptide molecules covalently bound to the MHC molecules. This study shows that non-natural amino acids can be successfully incorporated into T cell epitopes to provide novel immunological, biochemical and kinetic information.	[Gomez-Nunez, Marta; Haro, Kurtis J.; Dao, Tao; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy; Zakhaleva, Victoriya; Korontsvit, Tatyana; Gin, David Y.; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Haro, Kurtis J.; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy] Weill Cornell, Grad Sch Med Sci, New York, NY USA	Memorial Sloan Kettering Cancer Center	Gomez-Nunez, M (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org		Escobar Alvarez, Sindy/0000-0002-8294-5918	NIH [PO1 23766, RO1 55349, RO1 58833]; Ellen and Sandy Levin fund; Lymphoma Foundation; The Glades fund; Experimental Therapeutics Center; Geoffrey Beene Center;  [GM73546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellen and Sandy Levin fund; Lymphoma Foundation; The Glades fund; Experimental Therapeutics Center; Geoffrey Beene Center; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH PO1 23766, RO1 55349, RO1 58833, the Ellen and Sandy Levin fund, the Lymphoma Foundation, The Glades fund, the Experimental Therapeutics Center, and the Geoffrey Beene Center. This work was further supported by training grant #GM73546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Bellantuono I, 2002, BLOOD, V100, P3835, DOI 10.1182/blood.V100.10.3835; Brieger J, 1995, ANN ONCOL, V6, P811, DOI 10.1093/oxfordjournals.annonc.a059321; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cilloni D, 2003, J CLIN ONCOL, V21, P1988, DOI 10.1200/JCO.2003.10.503; Douat-Casassus C, 2007, J MED CHEM, V50, P1598, DOI 10.1021/jm0613368; Doubrovina ES, 2004, CLIN CANCER RES, V10, P7207, DOI 10.1158/1078-0432.CCR-04-1040; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Guichard G, 1996, J MED CHEM, V39, P2030, DOI 10.1021/jm9509511; Guichard G, 2000, J MED CHEM, V43, P3803, DOI 10.1021/jm000909s; Herr W, 1997, J IMMUNOL METHODS, V203, P141, DOI 10.1016/S0022-1759(97)00019-7; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; Jones MA, 2006, ORG BIOMOL CHEM, V4, P3769, DOI 10.1039/b611170j; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Krebs S, 1998, J PEPT SCI, V4, P378, DOI 10.1002/(SICI)1099-1387(199809)4:6<378::AID-PSC157>3.0.CO;2-B; Mailander V, 2004, LEUKEMIA, V18, P165, DOI 10.1038/sj.leu.2403186; Marastoni M, 2002, BIOORGAN MED CHEM, V10, P3061, DOI 10.1016/S0968-0896(02)00033-0; Marastoni M, 2001, J MED CHEM, V44, P2370, DOI 10.1021/jm001136a; Maurer U, 1997, EXP HEMATOL, V25, P945; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ohminami H, 2000, BLOOD, V95, P286; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oka Y, 2000, IMMUNOGENETICS, V51, P99, DOI 10.1007/s002510050018; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; PARK S, 1993, NAT GENET, V4, P415, DOI 10.1038/ng0893-415; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Pinilla-Ibarz J, 2006, LEUKEMIA, V20, P2025, DOI 10.1038/sj.leu.2404380; Poenaru S, 1999, J MED CHEM, V42, P2318, DOI 10.1021/jm981123l; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Quesnel A, 2001, J PEPT SCI, V7, P157, DOI 10.1002/psc.311; Tsuboi A, 2002, CANCER IMMUNOL IMMUN, V51, P614, DOI 10.1007/s00262-002-0328-9; Tsuboi A, 2004, MICROBIOL IMMUNOL, V48, P175, DOI 10.1111/j.1348-0421.2004.tb03503.x; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Webb AI, 2005, J IMMUNOL, V175, P3810, DOI 10.4049/jimmunol.175.6.3810; Weber PJA, 1997, J PEPT RES, V49, P375	38	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3938	10.1371/journal.pone.0003938	http://dx.doi.org/10.1371/journal.pone.0003938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079589	Green Submitted, Green Published, gold			2022-12-27	WOS:000265458200005
J	Nguyen, HTT; Dalmasso, G; Yan, YT; Obertone, TS; Sitaraman, SV; Merlin, D				Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier			Ecto-Phosphorylation of CD98 Regulates Cell-Cell Interactions	PLOS ONE			English	Article								Ecto-phosphorylation plays an important role in many cellular functions. The transmembrane glycoprotein CD98 contains potential phosphorylation sites in its extracellular C-terminal tail. We hypothesized that extracellular signaling through ectoprotein kinases (ePKs) might lead to ecto-phosphorylation of CD98 and influence its multiple functions, including its role in cell-cell interactions. Our results show that recombinant CD98 was phosphorylated in vitro by ePKs from Jurkat cells and by the commercial casein kinase 2 (CK2). Alanine substitutions at serines-305/307/309 or serines-426/430 attenuated CK2-mediated CD98 phosphorylation, suggesting that these residues are the dominant phosphorylation sites for CK2. Furthermore, CD98 expressed in the basolateral membranes of intestinal epithelial Caco2-BBE cells was ecto-phosphorylated by Jurkat cell-derived ePKs and ecto-CK2 was involved in this process. Importantly, cell attachment studies showed that the ecto-phosphorylation of CD98 enhanced heterotypic cell-cell interactions and that the extracellular domain of CD98, which possesses the serine phosphorylation sites, was crucial for this effect. In addition, phosphorylation of recombinant CD98 increased its interactions with Jurkat and Caco2-BBE cells, and promoted cell attachment and spreading. In conclusion, here we demonstrated the ecto-phosphorylation of CD98 by ePKs and its functional importance in cell-cell interactions. Our findings reveal a novel mechanism involved in regulating the multiple functions of CD98 and raise CD98 as a promising target for therapeutic modulations of cell-cell interactions.	[Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Nguyen, HTT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	hnguye9@emory.edu	Nguyen, Hang/N-2441-2018; Dalmasso, Guillaume/N-2443-2018	Nguyen, Hang/0000-0001-7431-5126; Dalmasso, Guillaume/0000-0002-3433-870X	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [RO1-DK-071594]; Crohn's and Colitis Foundation of America [research fellowship]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071594] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases by the grant RO1-DK-071594. G. Dalmasso and Y. Yan are recipients of a research fellowship award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; APASOV S, 1995, IMMUNOL REV, V146, P5, DOI 10.1111/j.1600-065X.1995.tb00680.x; Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; FAIS S, 1989, GASTROENTEROLOGY, V97, P1435, DOI 10.1016/0016-5085(89)90387-9; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAYNES BF, 1981, J IMMUNOL, V126, P1409; IMADA S, 1988, EXP CELL RES, V179, P554, DOI 10.1016/0014-4827(88)90293-5; KANG ES, 1984, CELL IMMUNOL, V87, P319, DOI 10.1016/0008-8749(84)90001-7; KUBLER D, 1983, P NATL ACAD SCI-BIOL, V80, P4021, DOI 10.1073/pnas.80.13.4021; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; LITCHFIELD DW, 1990, FEBS LETT, V261, P117, DOI 10.1016/0014-5793(90)80650-8; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1991, FEBS LETT, V279, P307, DOI 10.1016/0014-5793(91)80174-2; MEGGIO F, 1992, BIOCHEM BIOPH RES CO, V182, P1460, DOI 10.1016/0006-291X(92)91898-Z; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Merlin D, 2001, J BIOL CHEM, V276, P39282, DOI 10.1074/jbc.M105077200; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; REDEGELD F, 1991, J IMMUNOL, V147, P3638; Redegeld FA, 1999, TRENDS PHARMACOL SCI, V20, P453, DOI 10.1016/S0165-6147(99)01399-1; Redegeld FA, 1997, BBA-BIOMEMBRANES, V1328, P151, DOI 10.1016/S0005-2736(97)00082-5; Sarno S, 2000, BIOCHEMISTRY-US, V39, P12324, DOI 10.1021/bi0011431; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SCHREIBER S, 1991, GASTROENTEROLOGY, V101, P1020, DOI 10.1016/0016-5085(91)90729-5; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; SKUBITZ KM, 1991, J IMMUNOL, V147, P638; Stepanova V, 2002, J BIOL CHEM, V277, P10265, DOI 10.1074/jbc.M109057200; Teshima R, 1997, J IMMUNOL, V159, P964; Teshima R, 1999, IMMUNOL LETT, V68, P369, DOI 10.1016/S0165-2478(99)00086-3; Thu Nguyen HT, 2007, AM J PHYSIOL-GASTR L, V293, pG1155, DOI 10.1152/ajpgi.00334.2007; Trachana V, 2005, INT J BIOCHEM CELL B, V37, P478, DOI 10.1016/j.biocel.2004.08.001; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; YAN Y, 2008, BIOCH BIOPHYS ACTA; Yan Y, 2007, J MEMBRANE BIOL, V215, P15, DOI 10.1007/s00232-007-9001-8; Zien P, 2003, BIOCHEM BIOPH RES CO, V306, P129, DOI 10.1016/S0006-291X(03)00928-8; Zimina EP, 2007, J BIOL CHEM, V282, P22737, DOI 10.1074/jbc.M701937200	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3895	10.1371/journal.pone.0003895	http://dx.doi.org/10.1371/journal.pone.0003895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065266	Green Published, Green Submitted, gold			2022-12-27	WOS:000265455200009
J	Thomas, B; Holland, JD; Minot, EO				Thomas, Bindi; Holland, John D.; Minot, Edward O.			Elephant (Loxodonta africana) Home Ranges in Sabi Sand Reserve and Kruger National Park: A Five-Year Satellite Tracking Study	PLOS ONE			English	Article								During a five-year GPS satellite tracking study in Sabi Sand Reserve (SSR) and Kruger National Park (KNP) we monitored the daily movements of an elephant cow (Loxodonta africana) from September 2003 to August 2008. The study animal was confirmed to be part of a group of seven elephants therefore her position is representative of the matriarchal group. We found that the study animal did not use habitat randomly and confirmed strong seasonal fidelity to its summer and winter five-year home ranges. The cow's summer home range was in KNP in an area more than four times that of her SSR winter home range. She exhibited clear park habitation with up to three visits per year travelling via a well-defined northern or southern corridor. There was a positive correlation between the daily distance the elephant walked and minimum daily temperature and the elephant was significantly closer to rivers and artificial waterholes than would be expected if it were moving randomly in KNP and SSR. Transect lines established through the home ranges were surveyed to further understand the fine scale of the landscape and vegetation representative of the home ranges.	[Thomas, Bindi; Holland, John D.; Minot, Edward O.] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand	Massey University	Thomas, B (corresponding author), Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand.	j.d.holland@massey.ac.nz			Institute of Natural Resources, Massey University	Institute of Natural Resources, Massey University	We gratefully acknowledge the financial support of the Institute of Natural Resources, Massey University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; de Beer Y, 2006, J ARID ENVIRON, V64, P412, DOI 10.1016/j.jaridenv.2005.06.015; DIXON KR, 1980, ECOLOGY, V61, P1040, DOI 10.2307/1936821; Dolmia NM, 2007, AFR J ECOL, V45, P594, DOI 10.1111/j.1365-2028.2007.00777.x; FAIRALL N, 1979, HDB BIOTELEMETRY RAD, P673; FYVIE C, 2008, TREES KRUGER NATL PA; HOOGE K, 1997, ANIMAL MOVEMENT EXTE; JduP Bothma, 2002, GAME RANCH MANAGEMEN; Kenward RE., 2000, MANUAL WILDLIFE RADI; LINDEQUE M, 1991, AFR J ECOL, V27, P198; NTUMI CP, 2005, GREAT ELEPHANT INDAB; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Smit IPJ, 2007, DIVERS DISTRIB, V13, P666, DOI 10.1111/j.1472-4642.2007.00403.x; Whyte I.J., 2007, RESULTS 2006 2007 CE; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; WHYTE IJ, 2001, THESIS U PRETORIA PR; 2008, AFRICA WILDLIFE TRAC	19	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3902	10.1371/journal.pone.0003902	http://dx.doi.org/10.1371/journal.pone.0003902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065264	gold, Green Published, Green Submitted			2022-12-27	WOS:000265455200014
J	Dettman, EJ; Justice, MJ				Dettman, E. J.; Justice, Monica J.			The Zinc Finger SET Domain Gene Prdm14 Is Overexpressed in Lymphoblastic Lymphomas with Retroviral Insertions at Evi32	PLOS ONE			English	Article								Background: AKXD recombinant inbred strains of mice have proven to be very useful in the identification of potential oncogenes and tumor suppressors involved in the development of lymphoid and myeloid malignancies. In these tumors, the hematopoietic insertion of an active AKV murine leukemia virus (MuLV) is associated with the onset of disease. Common sites of retroviral insertion (CIS) identify genes causally associated with the development or initiation of lymphoma. Methodology: In the present study, we analyzed a previously uncharacterized CIS, Ecotropic Viral Integration Site 32 (Evi32), which is located on mouse chromosome 1. We analyzed candidate genes in the region to identify those involved in Evi32 mediated oncogenesis. Results: Here we show that proviral insertion at Evi32 correlates with significant overexpression of a putative transcription factor, PR-domain containing 14 (Prdm14). Tumors with insertions at Evi32 are consistently lymphoid in nature. Prdm14 is normally expressed early in embryonic development with the highest expression in undifferentiated embryonic stem (ES) cells. This study implicates Prdm14 as a proto-oncogene involved in lymphoblastic lymphoma formation.	[Dettman, E. J.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Justice, Monica J.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Dettman, EJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu		Dettman, E.J./0000-0002-0059-836X	NIH [R01 CA63229]; NATIONAL CANCER INSTITUTE [R01CA063229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the work in this manuscript was provided from NIH grant R01 CA63229 to MJJ. The funding agency had no role in study design, data collection and analysis, decision to publish or prepare the manuscript.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; CHATTOPADHYAY SK, 1980, P NATL ACAD SCI-BIOL, V77, P5774, DOI 10.1073/pnas.77.10.5774; Chen SL, 2000, GENE DEV, V14, P1209; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; JUSTICE MJ, 1994, J VIROL, V68, P1293, DOI 10.1128/JVI.68.3.1293-1300.1994; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Liang J, 1998, BLOOD, V92, P2118, DOI 10.1182/blood.V92.6.2118.418k09_2118_2122; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Sakai I, 2005, GENE CHROMOSOME CANC, V44, P265, DOI 10.1002/gcc.20241; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Sorensen KD, 2007, VIROLOGY, V362, P179, DOI 10.1016/j.virol.2006.12.016; Stevens-Kroef MJPL, 2006, LEUKEMIA, V20, P1187, DOI 10.1038/sj.leu.2404210; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Weiser KC, 2007, MAMM GENOME, V18, P709, DOI 10.1007/s00335-007-9060-2; Xiao ZJ, 2006, LEUKEMIA RES, V30, P332, DOI 10.1016/j.leukres.2005.07.002; Xinh PT, 2003, GENE CHROMOSOME CANC, V36, P313, DOI 10.1002/gcc.10176; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x	38	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3823	10.1371/journal.pone.0003823	http://dx.doi.org/10.1371/journal.pone.0003823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043588	Green Submitted, gold, Green Published			2022-12-27	WOS:000265451500005
J	Halpern, V; Ogunsola, F; Obunge, O; Wang, CH; Onyejepu, N; Oduyebo, O; Taylor, D; McNeil, L; Mehta, N; Umo-Otong, J; Otusanya, S; Crucitti, T; Abdellati, S				Halpern, Vera; Ogunsola, Folasade; Obunge, Orikomaba; Wang, Chin-Hua; Onyejepu, Nneka; Oduyebo, Oyinola; Taylor, Doug; McNeil, Linda; Mehta, Neha; Umo-Otong, John; Otusanya, Sakiru; Crucitti, Tania; Abdellati, Said			Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria	PLOS ONE			English	Article							I SAFETY; SEX; ACCEPTABILITY; TRANSMISSION; ACQUISITION; TOLERANCE; WOMEN	Background: This trial evaluated the safety and effectiveness of 6% cellulose sulfate vaginal gel in preventing male-to-female vaginal transmission of HIV, gonorrhea and chlamydial infection. Methods: This Phase III, double-blind, randomized, placebo-controlled trial was conducted between November 2004 and March 2007 in Lagos and Port Harcourt, Nigeria. We enrolled 1644 HIV-antibody negative women at high risk of HIV acquisition. Study participants were randomized 1: 1 to cellulose sulfate or placebo and asked to use gel plus a condom for each act of vaginal intercourse over one year of follow-up. The participants were evaluated monthly for HIV, gonorrhea and chlamydial infection, and for adverse events. Results: The trial was stopped prematurely after the data safety monitoring board of a parallel trial concluded that cellulose sulfate might be increasing the risk of HIV. In contrast, we observed fewer infections in the active arm (10) than on placebo (13), a difference that was nonetheless not statistically significant (HR = 0.8, 95% CI 0.3-1.8; p = 0.56). Rates of gonorrhea and chlamydial infection were lower in the CS group but the difference was likewise not statistically significant (HR = 0.8, 95% CI 0.5-1.1; p = 0.19 for the combined STI outcome). Rates of adverse events were similar across study arms. No serious adverse events related to cellulose sulfate use were reported. Conclusions: Cellulose sulfate gel appeared to be safe in the evaluated study population but we found insufficient evidence that it prevented male-to-female vaginal transmission of HIV, gonorrhea or chlamydial infection. The early closure of the trial compromised the ability to draw definitive conclusions about the effectiveness of cellulose sulfate against HIV.	[Halpern, Vera; Wang, Chin-Hua; Taylor, Doug; McNeil, Linda; Mehta, Neha] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Ogunsola, Folasade; Oduyebo, Oyinola; Otusanya, Sakiru] Univ Lagos, Coll Med, Lagos, Nigeria; [Obunge, Orikomaba; Onyejepu, Nneka; Umo-Otong, John] Univ Port Harcourt, Teaching Hosp, Port Harcourt, Nigeria; [Crucitti, Tania; Abdellati, Said] Inst Trop Med, HIV STI Epidemiol & Control Unit, Antwerp, Belgium	University of Lagos; University of Port Harcourt; Institute of Tropical Medicine (ITM)	Halpern, V (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	vhalpern@fhi.org	obunge, orikomaba/AID-3766-2022; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Oduyebo, Oyinlola/0000-0002-2894-4367; ONYEJEPU, NNEKA/0000-0002-0522-4383	United States Agency for International Development; CONRAD	United States Agency for International Development(United States Agency for International Development (USAID)); CONRAD(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development and sponsored by CONRAD. The funder and sponsor monitored the progress of the trial through regular reports, meetings and technical consultations. CONRAD provided the study product (CS and placebo-gel applicators), held the IND, reviewed and approved the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; *CONRAD, 2007, INV BROCH SOD CELL S; Doh AS, 2007, CONTRACEPTION, V76, P245, DOI 10.1016/j.contraception.2007.05.083; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; *FED MIN HLTH DEP, 2001, TECHN REP 2001 NAT H; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Feldblum PJ, 2005, SEX TRANSM INFECT, V81, P166, DOI 10.1136/sti.2004.010074; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Malonza IM, 2005, AIDS, V19, P2157, DOI 10.1097/01.aids.0000194797.59046.8f; Mauck C, 2001, CONTRACEPTION, V64, P377, DOI 10.1016/S0010-7824(01)00270-0; Mauck C, 2001, CONTRACEPTION, V64, P383, DOI 10.1016/S0010-7824(01)00271-2; Mauck CK, 2008, OBSTET GYNECOL, V111, P739, DOI 10.1097/AOG.0b013e3181644598; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; *NAT POP COMM ORC, 2003, NIG DEM HLTH SURV; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Raymond EG, 2007, SEX TRANSM DIS, V34, P1035, DOI 10.1097/OLQ.0b013e3180e90586; Richardson BA, 2001, SEX TRANSM DIS, V28, P394, DOI 10.1097/00007435-200107000-00006; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNAIDS, 2007, AIDS EP UPD; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; VANDAMME L, 2007, 14 C RETR OPP INF LO	25	129	130	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3784	10.1371/journal.pone.0003784	http://dx.doi.org/10.1371/journal.pone.0003784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023429	Green Published, gold, Green Submitted			2022-12-27	WOS:000265448800005
J	Ferrante, A; Anderson, MW; Klug, CS; Gorski, J				Ferrante, Andrea; Anderson, Matthew W.; Klug, Candice S.; Gorski, Jack			HLA-DM Mediates Epitope Selection by a "Compare-Exchange'' Mechanism when a Potential Peptide Pool Is Available	PLOS ONE			English	Article								Background: HLA-DM (DM) mediates exchange of peptides bound to MHC class II (MHCII) during the epitope selection process. Although DM has been shown to have two activities, peptide release and MHC class II refolding, a clear characterization of the mechanism by which DM facilitates peptide exchange has remained elusive. Methodology/Principal Findings: We have previously demonstrated that peptide binding to and dissociation from MHCII in the absence of DM are cooperative processes, likely related to conformational changes in the peptide-MHCII complex. Here we show that DM promotes peptide release by a non-cooperative process, whereas it enhances cooperative folding of the exchange peptide. Through electron paramagnetic resonance (EPR) and fluorescence polarization (FP) we show that DM releases prebound peptide very poorly in the absence of a candidate peptide for the exchange process. The affinity and concentration of the candidate peptide are also important for the release of the prebound peptide. Increased fluorescence energy transfer between the prebound and exchange peptides in the presence of DM is evidence for a tetramolecular complex which resolves in favor of the peptide that has superior folding properties. Conclusion/Significance: This study shows that both the peptide releasing activity on loaded MHCII and the facilitating of MHCII binding by a candidate exchange peptide are integral to DM mediated epitope selection. The exchange process is initiated only in the presence of candidate peptides, avoiding possible release of a prebound peptide and loss of a potential epitope. In a tetramolecular transitional complex, the candidate peptides are checked for their ability to replace the prebound peptide with a geometry that allows the rebinding of the original peptide. Thus, DM promotes a "compare-exchange'' sorting algorithm on an available peptide pool. Such a "third party''-mediated mechanism may be generally applicable for diverse ligand recognition in other biological systems.	[Ferrante, Andrea; Anderson, Matthew W.; Gorski, Jack] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Ferrante, A (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA.	andrea.ferrante@bcw.edu			NIH [RO1AI63016]; National Biomedical EPR Center [EB001980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Biomedical EPR Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grants RO1AI63016 (J.G.) and EB001980 (National Biomedical EPR Center). The authors have no conflicting financial interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MW, 2005, BIOCHEMISTRY-US, V44, P5617, DOI 10.1021/bi048675s; Anderson MW, 2003, J IMMUNOL, V171, P5683, DOI 10.4049/jimmunol.171.11.5683; Anderson TG, 1999, BIOPHYS J, V77, P2451, DOI 10.1016/S0006-3495(99)77081-5; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; DEKROON AIPM, 1994, J IMMUNOL, V152, P609; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; DONALD E, 1998, ART COMPUTER PROGRAM, V3; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GREEN JM, 1995, J IMMUNOL, V155, P3759; GROTENBERG GM, 2007, J BIOL CHEM; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3; Klug Candice S., 2004, V24, P269; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; KROPSHOFER H, 1993, P NATL ACAD SCI USA, V90, P403, DOI 10.1073/pnas.90.2.403; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nelson C A, 1999, Rev Immunogenet, V1, P47; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Schmitt L, 1998, BIOCHEMISTRY-US, V37, P17371, DOI 10.1021/bi9815593; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schmitt L, 1999, P NATL ACAD SCI USA, V96, P6581, DOI 10.1073/pnas.96.12.6581; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; TAMPE R, 1991, SCIENCE, V254, P87, DOI 10.1126/science.1656526; Watts C, 1999, Rev Immunogenet, V1, P60; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zavala-Ruiz Z, 2003, J BIOL CHEM, V278, P44904, DOI 10.1074/jbc.M307652200	45	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3722	10.1371/journal.pone.0003722	http://dx.doi.org/10.1371/journal.pone.0003722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005572	Green Published, Green Submitted, gold			2022-12-27	WOS:000265166200010
J	Inzelberg, R; Schechtman, E; Hocherman, S				Inzelberg, Rivka; Schechtman, Edna; Hocherman, Shraga			Visuo-Motor Coordination Deficits and Motor Impairments in Parkinson's Disease	PLOS ONE			English	Article							TRACKING; ABNORMALITIES; MECHANISMS; FEEDBACK; BEHAVIOR	Background: Visuo-motor coordination (VMC) requires normal cognitive executive functionality, an ability to transform visual inputs into movement plans and motor-execution skills, all of which are known to be impaired in Parkinson's disease (PD). Not surprisingly, a VMC deficit in PD is well documented. Still, it is not known how this deficit relates to motor symptoms that are assessed routinely in the neurological clinic. Such relationship should reveal how particular motor dysfunctions combine with cognitive and sensory-motor impairments to produce a complex behavioral disability. Methods and Findings: Thirty nine early/moderate PD patients were routinely evaluated, including motor Unified Parkinson's Disease Rating Scale (UPDRS) based assessment, A VMC testing battery in which the subjects had to track a target moving on screen along 3 different paths, and to freely trace these paths followed. Detailed kinematic analysis of tracking/tracing performance was done. Statistical analysis of the correlations between measures depicting various aspects of VMC control and UPDRS items was performed. The VMC measures which correlated most strongly with clinical symptoms represent the ability to organize tracking movements and program their direction, rather than measures representing motor-execution skills of the hand. The strong correlations of these VMC measures with total UPDRS score were weakened when the UPDRS hand-motor part was considered specifically, and were insignificant in relation to tremor of the hand. In contrast, all correlations of VMC measures with the gait/posture part of the UPDRS were found to be strongest. Conclusions: Our apparently counterintuitive findings suggest that the VMC deficit pertains more strongly to a PD related change in cognitive-executive control, than to a reduction in motor capabilities. The recently demonstrated relationship between gait/posture impairment and a cognitive decline, as found in PD, concords with this suggestion and may explain the strong correlation between VMC dysfunction and gait/posture impairment. Accordingly, we propose that what appears to reflect a motor deficit in fact represents a multisystem failure, dominated by a cognitive decline.	[Inzelberg, Rivka] Sheba Med Ctr, Sagol Neurosci Ctr, Tel Hashomer, Israel; [Schechtman, Edna] Ben Gurion Univ Negev, Dept Industrial Engn & Managem, IL-84105 Beer Sheva, Israel; [Hocherman, Shraga] Technion, Fac Med, Dept Physiol, Haifa, Israel	Chaim Sheba Medical Center; Ben Gurion University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Inzelberg, R (corresponding author), Sheba Med Ctr, Sagol Neurosci Ctr, Tel Hashomer, Israel.	Shraga@tx.technion.ac.il	SCHECHTMAN, EDNA/F-1160-2012; Inzelberg, Rivka/E-5861-2010	SCHECHTMAN, EDNA/0000-0001-7350-9068; Inzelberg, Rivka/0000-0002-0720-0502				Bloem BR, 2000, ANN NEUROL, V48, P268, DOI 10.1002/1531-8249(200008)48:2<268::AID-ANA21>3.0.CO;2-4; Bond JM, 2000, ARCH PHYS MED REHAB, V81, P110, DOI 10.1016/S0003-9993(00)90230-2; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; DAY BL, 1984, J NEUROL NEUROSUR PS, V47, P1299, DOI 10.1136/jnnp.47.12.1299; Fahn S., 1987, RECENT DEV PARKINSON, P153; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; FLOWERS K, 1978, BRAIN, V101, P35, DOI 10.1093/brain/101.1.35; FLOWERS K, 1978, BRAIN, V101, P19, DOI 10.1093/brain/101.1.19; Fucetola R, 1997, ACTA PSYCHOL, V95, P255, DOI 10.1016/S0001-6918(96)00043-1; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Hocherman S, 1998, NEUROLOGY, V50, P1648, DOI 10.1212/WNL.50.6.1648; HOCHERMAN S, 1994, NEUROLOGY, V44, P111, DOI 10.1212/WNL.44.1.111; Hocherman S, 2000, PERCEPT MOTOR SKILL, V90, P1235, DOI 10.2466/PMS.90.3.1235-1248; Hocherman S, 2004, COGNITIVE BRAIN RES, V21, P77, DOI 10.1016/j.cogbrainres.2004.05.008; Hocherman S, 1998, J NEURAL TRANSM-SUPP, P63; Hocherman S, 1998, Parkinsonism Relat Disord, V4, P129, DOI 10.1016/S1353-8020(98)00034-0; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; Johnson MTV, 1996, BRAIN, V119, P801, DOI 10.1093/brain/119.3.801; Kurata K, 2002, J NEUROPHYSIOL, V88, P3118, DOI 10.1152/jn.00070.2002; LEVIN BE, 1991, NEUROLOGY, V41, P365, DOI 10.1212/WNL.41.3.365; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Schwartz M, 1999, MOVEMENT DISORD, V14, P988, DOI 10.1002/1531-8257(199911)14:6<988::AID-MDS1012>3.0.CO;2-M; Schwartz M, 2004, PARKINSONISM RELAT D, V10, P385, DOI 10.1016/j.parkreldis.2004.03.004; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; van der Kooij H, 2007, J NEURAL TRANSM, V114, P1333, DOI 10.1007/s00702-007-0801-x; WEISSBLUETH E, 2008, PARKINSONIS IN PRESS; Williams ZM, 2005, EXP BRAIN RES, V162, P407, DOI 10.1007/s00221-004-2035-6	32	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3663	10.1371/journal.pone.0003663	http://dx.doi.org/10.1371/journal.pone.0003663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987752	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134500009
J	Engler, C; Kandzia, R; Marillonnet, S				Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre			A One Pot, One Step, Precision Cloning Method with High Throughput Capability	PLOS ONE			English	Article							RESTRICTION; PCR	Current cloning technologies based on site-specific recombination are efficient, simple to use, and flexible, but have the drawback of leaving recombination site sequences in the final construct, adding an extra 8 to 13 amino acids to the expressed protein. We have devised a simple and rapid subcloning strategy to transfer any DNA fragment of interest from an entry clone into an expression vector, without this shortcoming. The strategy is based on the use of type IIs restriction enzymes, which cut outside of their recognition sequence. With proper design of the cleavage sites, two fragments cut by type IIs restriction enzymes can be ligated into a product lacking the original restriction site. Based on this property, a cloning strategy called 'Golden Gate' cloning was devised that allows to obtain in one tube and one step close to one hundred percent correct recombinant plasmids after just a 5 minute restriction-ligation. This method is therefore as efficient as currently used recombination-based cloning technologies but yields recombinant plasmids that do not contain unwanted sequences in the final construct, thus providing precision for this fundamental process of genetic manipulation.	[Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre] Icon Genet GmbH, Biozentrum Halle, Halle, Germany	ICON plc	Engler, C (corresponding author), Icon Genet GmbH, Biozentrum Halle, Halle, Germany.	marillonnet@icongenetics.de			Icon Genetics GmbH	Icon Genetics GmbH	Work funded by Icon Genetics GmbH.	BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; BERGER SL, 1993, ANAL BIOCHEM, V214, P571, DOI 10.1006/abio.1993.1540; Berlin Y A, 1999, Curr Issues Mol Biol, V1, P21; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Fromme Tobias, 2007, J Biol Eng, V1, P7, DOI 10.1186/1754-1611-1-7; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C	14	1191	1397	22	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3647	10.1371/journal.pone.0003647	http://dx.doi.org/10.1371/journal.pone.0003647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985154	Green Submitted, gold, Green Published			2022-12-27	WOS:000265134400010
J	Wang, X; Sun, Q; McGrath, SD; Mardis, ER; Soloway, PD; Clark, AG				Wang, Xu; Sun, Qi; McGrath, Sean D.; Mardis, Elaine R.; Soloway, Paul D.; Clark, Andrew G.			Transcriptome-Wide Identification of Novel Imprinted Genes in Neonatal Mouse Brain	PLOS ONE			English	Article								Imprinted genes display differential allelic expression in a manner that depends on the sex of the transmitting parent. The degree of imprinting is often tissue-specific and/or developmental stage-specific, and may be altered in some diseases including cancer. Here we applied Illumina/Solexa sequencing of the transcriptomes of reciprocal F1 mouse neonatal brains and identified 26 genes with parent-of-origin dependent differential allelic expression. Allele-specific Pyrosequencing verified 17 of them, including three novel imprinted genes. The known and novel imprinted genes all are found in proximity to previously reported differentially methylated regions (DMRs). Ten genes known to be imprinted in placenta had sufficient expression levels to attain a read depth that provided statistical power to detect imprinting, and yet all were consistent with non-imprinting in our transcript count data for neonatal brain. Three closely linked and reciprocally imprinted gene pairs were also discovered, and their pattern of expression suggests transcriptional interference. Despite the coverage of more than 5000 genes, this scan only identified three novel imprinted refseq genes in neonatal brain, suggesting that this tissue is nearly exhaustively characterized. This approach has the potential to yield an complete catalog of imprinted genes after application to multiple tissues and developmental stages, shedding light on the mechanism, bioinformatic prediction, and evolution of imprinted genes and diseases associated with genomic imprinting.	[Wang, Xu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Life Sci Core Lab Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63130 USA; [Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Washington University (WUSTL); Cornell University	Wang, X (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu	Wang, Xu/B-4587-2008; Soloway, Paul/T-8243-2019; McGrath, Sean David/AAT-3540-2020; Mardis, Elaine/W-2202-2019; Tang, Shuang/F-9115-2014	Wang, Xu/0000-0002-7594-5004; McGrath, Sean David/0000-0001-9064-8449; Soloway, Paul/0000-0003-1967-0437; Tang, Shuang/0000-0002-3084-0903; Zheng, Zhi-Ming/0000-0001-5547-7912; Clark, Andrew/0000-0001-7159-8511	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 79006, R01 CA095713, CA 95713, CA 94141, R01 CA094141] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BJORNSSON HT, 2008, GENOME RES; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davies W, 2004, GENE EXPR PATTERNS, V4, P741, DOI 10.1016/j.modgep.2004.03.008; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Evans HK, 2005, MOL BIOL EVOL, V22, P1740, DOI 10.1093/molbev/msi165; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lehmann EL, 2005, TESTING STAT HYPOTHE, pxiv; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Matoba R, 2000, GENE, V241, P125, DOI 10.1016/S0378-1119(99)00457-6; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mergenthaler S, 2001, AM J HUM GENET, V68, P543, DOI 10.1086/318192; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Weinstein LS, 2000, AM J PHYSIOL-RENAL, V278, pF507, DOI 10.1152/ajprenal.2000.278.4.F507; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yamazawa K, 2008, AM J MED GENET A, V146A, P514, DOI 10.1002/ajmg.a.32125; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	74	250	262	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3839	10.1371/journal.pone.0003839	http://dx.doi.org/10.1371/journal.pone.0003839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	18596939	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452200001
